group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00001,2.070777641836081,FUN_000185-T1,Peve_00037402,Pocillopora_meandrina_HIv1___RNAseq.g28886.t1,three_way,71.059,FUN_000185-T1,Q32LQ0,AMPE_BOVIN,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Bos taurus (Bovine),41.5,881.0,1.4e-197,691.4,sp|Q32LQ0|AMPE_BOVIN Glutamyl aminopeptidase OS=Bos taurus OX=9913 GN=ENPEP PE=2 SV=1,GO:0003081; GO:0004177; GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048870; GO:0050886; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; cell motility; endocrine process; catalytic activity, acting on a protein"
OG_00005,1.196145008483812,FUN_000192-T1,Peve_00038466,Pocillopora_meandrina_HIv1___RNAseq.g28893.t1,three_way,81.15866666666666,FUN_000192-T1,Q1LWX3,,,,,54.3,188.0,3.5e-53,209.5,sp|Q1LWX3|NTAQ1_DANRE Protein N-terminal glutamine amidohydrolase OS=Danio rerio OX=7955 GN=ntaq1 PE=2 SV=1,,,,,,
OG_00006,1.3476095049926264,FUN_000193-T1,Peve_00038467,Pocillopora_meandrina_HIv1___RNAseq.g28894.t1,three_way,70.21933333333334,FUN_000193-T1,Q5I0K7,,,,,53.2,158.0,3.4e-41,169.5,sp|Q5I0K7|ALG13_RAT UDP-N-acetylglucosamine transferase subunit ALG13 OS=Rattus norvegicus OX=10116 GN=Alg13 PE=1 SV=1,,,,,,
OG_00007,2.531660987724909,FUN_000194-T1,Peve_00038470,Pocillopora_meandrina_HIv1___RNAseq.g28898.t1,three_way,77.11833333333334,FUN_000194-T1,P70182,,,,,60.2,447.0,3.4e-147,523.5,sp|P70182|PI51A_MOUSE Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2,,,,,,
OG_00008,1.5981604795358817,FUN_000195-T1,Peve_00038471,Pocillopora_meandrina_HIv1___RNAseq.g28899.t1,three_way,68.38,FUN_000195-T1,B8D9S0,,,,,38.5,148.0,9e-19,95.1,sp|B8D9S0|FMT_BUCA5 Methionyl-tRNA formyltransferase OS=Buchnera aphidicola subsp. Acyrthosiphon pisum (strain 5A) OX=563178 GN=fmt PE=3 SV=1,,,,,,
OG_00012,1.062638724548732,FUN_000202-T1,Peve_00024058,Pocillopora_meandrina_HIv1___RNAseq.g28907.t1,three_way,80.12266666666666,FUN_000202-T1,Q9TU32,,,,,40.9,479.0,8.4e-93,342.4,sp|Q9TU32|LMAN1_CHLAE Protein ERGIC-53 OS=Chlorocebus aethiops OX=9534 GN=LMAN1 PE=1 SV=1,,,,,,
OG_00014,1.2252954178593876,FUN_000206-T1,Peve_00027728,Pocillopora_meandrina_HIv1___RNAseq.g28910.t1,three_way,70.863,,,,,,,,,,,,,,,,,
OG_00018,2.7392666164502475,FUN_000213-T2,Peve_00002451,Pocillopora_meandrina_HIv1___RNAseq.g28916.t1,three_way,60.77916666666667,FUN_000213-T2,Q8LHH9,,,,,38.3,830.0,2.1000000000000001e-134,482.6,sp|Q8LHH9|SHL2_ORYSJ Probable RNA-dependent RNA polymerase SHL2 OS=Oryza sativa subsp. japonica OX=39947 GN=SHL2 PE=2 SV=1,,,,,,
OG_00019,2.587608117919946,FUN_000215-T1,Peve_00002445,Pocillopora_meandrina_HIv1___RNAseq.g28918.t1,three_way,61.82416666666666,FUN_000215-T1,P15541,,,,,34.2,918.0,1.8e-142,508.4,sp|P15541|AMPN_RABIT Aminopeptidase N OS=Oryctolagus cuniculus OX=9986 GN=ANPEP PE=1 SV=4,,,,,,
OG_00022,1.1723705792398764,FUN_000219-T1,Peve_00019412,Pocillopora_meandrina_HIv1___RNAseq.g28928.t1,three_way,64.90866666666666,,,,,,,,,,,,,,,,,
OG_00024,2.696114712740485,FUN_000223-T1,Peve_00012031,Pocillopora_meandrina_HIv1___RNAseq.g28933.t1,three_way,77.22633333333333,FUN_000223-T1,Q80UY1,,,,,52.0,358.0,2.1e-107,390.6,sp|Q80UY1|CARME_MOUSE Carnosine N-methyltransferase OS=Mus musculus OX=10090 GN=Carnmt1 PE=1 SV=1,,,,,,
OG_00025,1.6975840180075688,FUN_000226-T1,Peve_00012014,Pocillopora_meandrina_HIv1___RNAseq.g28941.t1,three_way,60.776,FUN_000226-T1,Q6P4K1,,,,,55.3,94.0,2.3e-23,112.1,sp|Q6P4K1|HDGR2_XENTR Hepatoma-derived growth factor-related protein 2 OS=Xenopus tropicalis OX=8364 GN=hdgfl2 PE=2 SV=1,,,,,,
OG_00025,1.6975840180075688,FUN_000226-T1,Peve_00012014,Pocillopora_meandrina_HIv1___RNAseq.g28941.t1,three_way,60.776,FUN_000226-T1,Q6P4K1,,,,,36.7,79.0,2.4e-09,65.5,sp|Q6P4K1|HDGR2_XENTR Hepatoma-derived growth factor-related protein 2 OS=Xenopus tropicalis OX=8364 GN=hdgfl2 PE=2 SV=1,,,,,,
OG_00027,2.669793307990724,FUN_000230-T1,Peve_00012012,Pocillopora_meandrina_HIv1___RNAseq.g28945.t1,three_way,54.19533333333334,FUN_000230-T1,Q5VTE6,ANGE2_HUMAN,,Protein angel homolog 2,Homo sapiens (Human),44.9,254.0,8.199999999999999e-53,209.9,sp|Q5VTE6|ANGE2_HUMAN Protein angel homolog 2 OS=Homo sapiens OX=9606 GN=ANGEL2 PE=1 SV=1,GO:0003730; GO:0003824; GO:0005737; GO:0005739; GO:0005759; GO:0015030; GO:0045930; GO:0070935; GO:0090616,3'-UTR-mediated mRNA stabilization [GO:0070935]; mitochondrial mRNA 3'-end processing [GO:0090616]; negative regulation of mitotic cell cycle [GO:0045930],Cajal body [GO:0015030]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],catalytic activity [GO:0003824]; mRNA 3'-UTR binding [GO:0003730],GO:0003723; GO:0003824; GO:0005739; GO:0016071; GO:0043226; GO:0140053,RNA binding; catalytic activity; mitochondrion; mRNA metabolic process; organelle; mitochondrial gene expression
OG_00031,3.160027521059656,FUN_000237-T1,Peve_00033367,Pocillopora_meandrina_HIv1___RNAseq.g28953.t1,three_way,74.7705,FUN_000237-T1,Q2KHR2,RFX7_HUMAN,,DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2),Homo sapiens (Human),45.1,255.0,3.3999999999999997e-47,191.8,sp|Q2KHR2|RFX7_HUMAN DNA-binding protein RFX7 OS=Homo sapiens OX=9606 GN=RFX7 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000979; GO:0000981; GO:0005634; GO:0006357; GO:0045944; GO:1990837,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_00037,2.0276247316851257,FUN_000247-T2,Peve_00033364,Pocillopora_meandrina_HIv1___RNAseq.g28974.t1,three_way,71.2625,FUN_000247-T2,P22045,,,,,36.9,271.0,1.1e-36,157.1,"sp|P22045|PGFS_LEIMA 9,11-endoperoxide prostaglandin H2 reductase OS=Leishmania major OX=5664 GN=P100/11E PE=1 SV=3",,,,,,
OG_00039,1.6704741901145277,FUN_000261-T1,Peve_00027784,Pocillopora_meandrina_HIv1___RNAseq.g28976.t1,three_way,77.24933333333334,,,,,,,,,,,,,,,,,
OG_00040,2.600517027019501,FUN_000263-T1,Peve_00027785,Pocillopora_meandrina_HIv1___RNAseq.g28977.t2,three_way,82.65166666666667,FUN_000263-T1,Q5ZLW3,,,,,49.3,690.0,7.099999999999997e-175,615.5,sp|Q5ZLW3|DYM_CHICK Dymeclin OS=Gallus gallus OX=9031 GN=DYM PE=2 SV=1,,,,,,
OG_00047,2.3436532263399936,FUN_000283-T1,Peve_00033555,Pocillopora_meandrina_HIv1___RNAseq.g29073.t1,three_way,79.09333333333333,FUN_000283-T1,Q9I8C7,,,,,46.3,322.0,4.6e-86,320.1,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_00048,1.2098299764398217,FUN_000285-T1,Peve_00033562,Pocillopora_meandrina_HIv1___RNAseq.g29071.t1,three_way,75.66833333333334,FUN_000285-T1,Q8BYH7,,,,,30.3,307.0,1.2e-37,159.1,sp|Q8BYH7|TBC17_MOUSE TBC1 domain family member 17 OS=Mus musculus OX=10090 GN=Tbc1d17 PE=1 SV=2,,,,,,
OG_00054,1.2831899712119152,FUN_000329-T1,Peve_00033549,Pocillopora_meandrina_HIv1___RNAseq.g29081.t1,three_way,98.41266666666668,FUN_000329-T1,O15182,CETN3_HUMAN,,Centrin-3,Homo sapiens (Human),80.2,167.0,1.1999999999999999e-70,267.3,sp|O15182|CETN3_HUMAN Centrin-3 OS=Homo sapiens OX=9606 GN=CETN3 PE=1 SV=2,GO:0000226; GO:0005509; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0007098; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390,cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mRNA transport [GO:0051028]; protein transport [GO:0015031],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390],calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; microtubule binding [GO:0008017],GO:0005730; GO:0005815; GO:0007010; GO:0008092; GO:0043226,nucleolus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_00056,2.21775144777073,FUN_000334-T1,Peve_00033540,Pocillopora_meandrina_HIv1___RNAseq.g29089.t1,three_way,52.14833333333333,FUN_000334-T1,Q6XHB2,ROCO4_DICDI,,Probable serine/threonine-protein kinase roco4 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 4),Dictyostelium discoideum (Social amoeba),25.8,419.0,1.4e-16,90.9,sp|Q6XHB2|ROCO4_DICDI Probable serine/threonine-protein kinase roco4 OS=Dictyostelium discoideum OX=44689 GN=roco4 PE=1 SV=1,GO:0000302; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006120; GO:0007165; GO:0031150; GO:0042331; GO:0106310,"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; phototaxis [GO:0042331]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]; sorocarp stalk development [GO:0031150]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005739; GO:0005829; GO:0006091; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; generation of precursor metabolites and energy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00059,1.289603227371207,FUN_000351-T1,Peve_00033536,Pocillopora_meandrina_HIv1___RNAseq.g29115.t1,three_way,75.824,FUN_000351-T1,Q8BLA8,TRPA1_MOUSE,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Mus musculus (Mouse),25.2,1062.0,6.900000000000001e-80,300.8,sp|Q8BLA8|TRPA1_MOUSE Transient receptor potential cation channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Trpa1 PE=1 SV=1,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_00060,1.2603799305461774,FUN_000352-T1,Peve_00033531,Pocillopora_meandrina_HIv1___RNAseq.g29116.t1,three_way,77.85483333333333,FUN_000352-T1,P18395,,,,,46.0,817.0,5.600000000000001e-180,632.9,sp|P18395|CSDE1_RAT Cold shock domain-containing protein E1 OS=Rattus norvegicus OX=10116 GN=Csde1 PE=2 SV=1,,,,,,
OG_00063,4.367552086294158,FUN_000374-T1,Peve_00033526,Pocillopora_meandrina_HIv1___TS.g6338.t1,three_way,32.86933333333334,FUN_000374-T1,Q96EQ9,,,,,33.5,254.0,3.2e-30,136.7,sp|Q96EQ9|PRDM9_MOUSE Histone-lysine N-methyltransferase PRDM9 OS=Mus musculus OX=10090 GN=Prdm9 PE=1 SV=2,,,,,,
OG_00064,1.2687913218224738,FUN_000375-T1,Peve_00028988,Pocillopora_meandrina_HIv1___RNAseq.g12644.t1,three_way,70.61166666666666,,,,,,,,,,,,,,,,,
OG_00066,2.143515420081103,FUN_000384-T1,Peve_00033599,Pocillopora_meandrina_HIv1___RNAseq.g29126.t1,three_way,70.015,FUN_000384-T1,O43586,PPIP1_HUMAN,,Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1) (CD2-binding protein 1) (H-PIP),Homo sapiens (Human),35.0,428.0,1.0000000000000001e-65,252.3,sp|O43586|PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens OX=9606 GN=PSTPIP1 PE=1 SV=1,GO:0001931; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0016020; GO:0030027; GO:0032154; GO:0042802; GO:0045087; GO:0048471,cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931],identical protein binding [GO:0042802],GO:0002376; GO:0005829; GO:0005856; GO:0005886; GO:0006954; GO:0007155; GO:0016192; GO:0043226; GO:0098542,immune system process; cytosol; cytoskeleton; plasma membrane; inflammatory response; cell adhesion; vesicle-mediated transport; organelle; defense response to other organism
OG_00067,1.3190595642028629,FUN_000387-T1,Peve_00033598,Pocillopora_meandrina_HIv1___TS.g6342.t3c,three_way,83.94266666666667,FUN_000387-T1,Q64512,PTN13_MOUSE,,Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (PTP36) (Protein tyrosine phosphatase DPZPTP) (Protein tyrosine phosphatase PTP-BL) (Protein-tyrosine phosphatase RIP),Mus musculus (Mouse),28.3,1042.0,5.499999999999999e-90,334.0,sp|Q64512|PTN13_MOUSE Tyrosine-protein phosphatase non-receptor type 13 OS=Mus musculus OX=10090 GN=Ptpn13 PE=1 SV=2,GO:0004725; GO:0005634; GO:0005737; GO:0005856; GO:0030027; GO:0030496; GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634],protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005634; GO:0005856; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytoskeleton; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00068,2.03316983343248,FUN_000390-T1,Peve_00033596,Pocillopora_meandrina_HIv1___RNAseq.g2524.t1,three_way,49.54833333333334,,,,,,,,,,,,,,,,,
OG_00076,1.3377278399601706,FUN_000401-T1,Peve_00033535,Pocillopora_meandrina_HIv1___RNAseq.13430_t,three_way,67.23816666666667,FUN_000401-T1,Q8TDX6,,,,,40.5,375.0,2.6e-77,291.2,sp|Q8TDX6|CGAT1_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=CSGALNACT1 PE=1 SV=2,,,,,,
OG_00077,3.8524737806637006,FUN_000402-T1,Peve_00033527,Pocillopora_meandrina_HIv1___RNAseq.g2543.t1,three_way,81.73866666666666,FUN_000402-T1,Q9NYL9,,,,,46.9,130.0,2.2e-23,110.2,sp|Q9NYL9|TMOD3_HUMAN Tropomodulin-3 OS=Homo sapiens OX=9606 GN=TMOD3 PE=1 SV=1,,,,,,
OG_00080,3.0424319407442946,FUN_000408-T1,Peve_00033593,Pocillopora_meandrina_HIv1___RNAseq.g2518.t1,three_way,59.73233333333334,FUN_000408-T1,Q8BP40,,,,,33.6,390.0,5.7e-51,203.4,sp|Q8BP40|PPA6_MOUSE Lysophosphatidic acid phosphatase type 6 OS=Mus musculus OX=10090 GN=Acp6 PE=1 SV=1,,,,,,
OG_00081,3.624791561861799,FUN_000409-T1,Peve_00033505,Pocillopora_meandrina_HIv1___RNAseq.g2517.t1,three_way,55.74733333333334,FUN_000409-T1,Q6A044,,,,,26.9,312.0,9.8e-18,93.2,sp|Q6A044|EREP2_MOUSE Protein ENTREP2 OS=Mus musculus OX=10090 GN=Entrep2 PE=2 SV=3,,,,,,
OG_00085,2.214048071975412,FUN_000433-T1,Peve_00011195,Pocillopora_meandrina_HIv1___RNAseq.g2325.t1,three_way,73.84433333333334,FUN_000433-T1,P26714,,,,,33.7,291.0,2.3e-51,204.9,sp|P26714|GBRB_LYMST Gamma-aminobutyric acid receptor subunit beta OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_00086,1.1419735995949405,FUN_000437-T1,Peve_00011193,Pocillopora_meandrina_HIv1___RNAseq.g2323.t1,three_way,77.881,FUN_000437-T1,F1MNN4,FBXW7_BOVIN,,F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7),Bos taurus (Bovine),36.4,195.0,1.9999999999999998e-26,122.5,sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3,GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992],chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0030163; GO:0043226; GO:0060090; GO:0098772,nucleus; nucleoplasm; chromosome; DNA repair; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_00087,3.164124340778637,FUN_000440-T1,Peve_00003439,Pocillopora_meandrina_HIv1___RNAseq.g2328.t2,three_way,87.82716666666667,FUN_000440-T1,P11029,,,,,63.2,2251.0,0.0,2921.0,sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1,,,,,,
OG_00089,1.168436907548838,FUN_000445-T1,Peve_00019114,Pocillopora_meandrina_HIv1___RNAseq.g2334.t1,three_way,76.51133333333333,,,,,,,,,,,,,,,,,
OG_00090,1.8695066812819352,FUN_000448-T1,Peve_00019115,Pocillopora_meandrina_HIv1___RNAseq.g2336.t1,three_way,72.33566666666667,FUN_000448-T1,Q8N945,,,,,42.6,176.0,6e-33,142.1,sp|Q8N945|PRLD2_HUMAN PRELI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PRELID2 PE=1 SV=1,,,,,,
OG_00091,2.69614541676624,FUN_000449-T1,Peve_00019109,Pocillopora_meandrina_HIv1___RNAseq.g2337.t1,three_way,66.32566666666666,FUN_000449-T1,Q64378,FKBP5_MOUSE,,Peptidyl-prolyl cis-trans isomerase FKBP5 (PPIase FKBP5) (EC 5.2.1.8) (51 kDa FK506-binding protein) (51 kDa FKBP) (FKBP-51) (FK506-binding protein 5) (FKBP-5) (Rotamase),Mus musculus (Mouse),33.8,272.0,1.4000000000000001e-28,128.3,sp|Q64378|FKBP5_MOUSE Peptidyl-prolyl cis-trans isomerase FKBP5 OS=Mus musculus OX=10090 GN=Fkbp5 PE=1 SV=1,GO:0003755; GO:0005654; GO:0005829; GO:0009617; GO:0030674; GO:0031072; GO:0042220; GO:0061077; GO:0097305,chaperone-mediated protein folding [GO:0061077]; response to alcohol [GO:0097305]; response to bacterium [GO:0009617]; response to cocaine [GO:0042220],cytosol [GO:0005829]; nucleoplasm [GO:0005654],heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005654; GO:0005829; GO:0016853; GO:0060090; GO:0140096,"catalytic activity; nucleoplasm; cytosol; isomerase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_00098,1.7862184451172134,FUN_000478-T1,Peve_00038239,Pocillopora_meandrina_HIv1___TS.g4854.t1,three_way,80.23833333333333,FUN_000478-T1,Q9BLY8,,,,,37.9,306.0,2.7e-57,224.6,sp|Q9BLY8|GBRB_DROSI Gamma-aminobutyric acid receptor subunit beta OS=Drosophila simulans OX=7240 GN=Rdl PE=2 SV=1,,,,,,
OG_00099,1.2137286014115651,FUN_000482-T1,Peve_00038234,Pocillopora_meandrina_HIv1___RNAseq.g2344.t1,three_way,63.321333333333335,FUN_000482-T1,O88854,,,,,38.6,308.0,1.6999999999999998e-43,178.3,sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2,,,,,,
OG_00104,2.5858652290636,FUN_000490-T1,Peve_00043823,Pocillopora_meandrina_HIv1___RNAseq.g2411.t1,three_way,66.018,,,,,,,,,,,,,,,,,
OG_00106,1.6443816294347542,FUN_000498-T1,Peve_00024154,Pocillopora_meandrina_HIv1___RNAseq.g2413.t1,three_way,61.16866666666667,FUN_000498-T1,Q8VHI4,,,,,47.4,340.0,1.9000000000000002e-80,302.4,sp|Q8VHI4|CARTF_MOUSE Calcium-responsive transcription factor OS=Mus musculus OX=10090 GN=Carf PE=2 SV=1,,,,,,
OG_00111,2.5599107836308144,FUN_000503-T1,Peve_00043531,Pocillopora_meandrina_HIv1___RNAseq.g18598.t1,three_way,56.31033333333333,,,,,,,,,,,,,,,,,
OG_00113,1.6724392066233411,FUN_000511-T1,Peve_00029231,Pocillopora_meandrina_HIv1___RNAseq.g2404.t1,three_way,60.635333333333335,,,,,,,,,,,,,,,,,
OG_00118,2.103643036067178,FUN_000536-T1,Peve_00039803,Pocillopora_meandrina_HIv1___TS.g4882.t1,three_way,81.95033333333333,FUN_000536-T1,Q921G8,,,,,55.2,944.0,5.600000000000001e-277,955.3,sp|Q921G8|GCP2_MOUSE Gamma-tubulin complex component 2 OS=Mus musculus OX=10090 GN=Tubgcp2 PE=1 SV=2,,,,,,
OG_00119,4.248230319751198,FUN_000537-T1,Peve_00039797,Pocillopora_meandrina_HIv1___RNAseq.g2375.t1,three_way,66.51866666666668,FUN_000537-T1,Q56A06,,,,,51.3,710.0,5.7e-140,500.0,sp|Q56A06|TMTC2_MOUSE Protein O-mannosyl-transferase TMTC2 OS=Mus musculus OX=10090 GN=Tmtc2 PE=2 SV=1,,,,,,
OG_00122,1.7798673932128048,FUN_000542-T1,Peve_00039829,Pocillopora_meandrina_HIv1___RNAseq.g2370.t1,three_way,61.55866666666667,FUN_000542-T1,P40657,,,,,45.3,148.0,5.2e-26,120.2,sp|P40657|SOX15_DROME Putative transcription factor SOX-15 OS=Drosophila melanogaster OX=7227 GN=Sox15 PE=2 SV=2,,,,,,
OG_00123,1.199804550270252,FUN_000544-T1,Peve_00039828,Pocillopora_meandrina_HIv1___RNAseq.g2369.t1,three_way,76.021,FUN_000544-T1,Q8IY45,,,,,52.4,252.0,2.1e-39,164.1,sp|Q8IY45|AMN1_HUMAN Protein AMN1 homolog OS=Homo sapiens OX=9606 GN=AMN1 PE=1 SV=4,,,,,,
OG_00124,1.5346561231075109,FUN_000545-T1,Peve_00039827,Pocillopora_meandrina_HIv1___RNAseq.g2368.t1,three_way,90.48633333333332,FUN_000545-T1,Q9Y315,DEOC_HUMAN,,Deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase),Homo sapiens (Human),67.6,321.0,1.5999999999999999e-127,457.2,sp|Q9Y315|DEOC_HUMAN Deoxyribose-phosphate aldolase OS=Homo sapiens OX=9606 GN=DERA PE=1 SV=2,GO:0004139; GO:0005576; GO:0005654; GO:0005829; GO:0006098; GO:0009264; GO:0016052; GO:0034774; GO:0046121; GO:0046386; GO:1904813,carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]; pentose-phosphate shunt [GO:0006098],cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774],deoxyribose-phosphate aldolase activity [GO:0004139],GO:0003824; GO:0005576; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0016829; GO:0055086; GO:1901135,catalytic activity; extracellular region; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; lyase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00127,3.0933561516146857,FUN_000554-T1,Peve_00039816,Pocillopora_meandrina_HIv1___RNAseq.g2466.t1,three_way,58.334,,,,,,,,,,,,,,,,,
OG_00132,1.153421914648214,FUN_000563-T1,Peve_00041882,Pocillopora_meandrina_HIv1___RNAseq.g2457.t1,three_way,50.783,,,,,,,,,,,,,,,,,
OG_00133,3.010558876543249,FUN_000564-T1,Peve_00041880,Pocillopora_meandrina_HIv1___TS.g4968.t1,three_way,70.89666666666666,,,,,,,,,,,,,,,,,
OG_00134,1.900045604421676,FUN_000568-T1,Peve_00034143,Pocillopora_meandrina_HIv1___RNAseq.g2453.t1,three_way,59.7515,FUN_000568-T1,Q99816,TS101_HUMAN,,Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101),Homo sapiens (Human),36.5,307.0,1e-30,135.6,sp|Q99816|TS101_HUMAN Tumor susceptibility gene 101 protein OS=Homo sapiens OX=9606 GN=TSG101 PE=1 SV=2,GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005813; GO:0005829; GO:0005886; GO:0006858; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0016236; GO:0019076; GO:0030216; GO:0031625; GO:0031901; GO:0031902; GO:0036211; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043328; GO:0043405; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0051726; GO:0070062; GO:0090148; GO:0090543; GO:0097352; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397,autophagosome maturation [GO:0097352]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein modification process [GO:0036211]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790],GO:0003677; GO:0005730; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0006914; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0140110,DNA binding; nucleolus; endosome; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; autophagy; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; transcription regulator activity
OG_00136,1.8080148947203216,FUN_000570-T1,Peve_00034728,Pocillopora_meandrina_HIv1___RNAseq.g2451.t1,three_way,62.78066666666667,,,,,,,,,,,,,,,,,
OG_00138,1.5034137156290164,FUN_000576-T1,Peve_00034748,Pocillopora_meandrina_HIv1___RNAseq.g2437.t1,three_way,77.08166666666666,FUN_000576-T1,Q9Z2D5,,,,,34.0,247.0,6.199999999999997e-29,129.4,sp|Q9Z2D5|NPY2R_CAVPO Neuropeptide Y receptor type 2 OS=Cavia porcellus OX=10141 GN=NPY2R PE=3 SV=1,,,,,,
OG_00139,1.6152475699394693,FUN_000577-T1,Peve_00034749,Pocillopora_meandrina_HIv1___RNAseq.g2436.t1,three_way,60.07216666666667,,,,,,,,,,,,,,,,,
OG_00140,1.3311102223750595,FUN_000578-T1,Peve_00034754,Pocillopora_meandrina_HIv1___TS.g4935.t1,three_way,56.79733333333333,FUN_000578-T1,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),45.6,329.0,2.2e-68,262.3,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_00143,2.728432955052547,FUN_000585-T1,Peve_00034705,Pocillopora_meandrina_HIv1___RNAseq.g29297.t1,three_way,50.52733333333334,FUN_000585-T1,Q6TLH3,,,,,33.4,326.0,2.6999999999999997e-31,137.5,sp|Q6TLH3|CUED2_DANRE CUE domain-containing protein 2 OS=Danio rerio OX=7955 GN=cuedc2 PE=2 SV=1,,,,,,
OG_00150,1.2513856501461935,FUN_000596-T1,Peve_00041271,Pocillopora_meandrina_HIv1___RNAseq.g29285.t1,three_way,84.07066666666667,FUN_000596-T1,P36543,VATE1_HUMAN,,V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (p31) (Vacuolar proton pump subunit E 1),Homo sapiens (Human),61.9,226.0,6.7e-69,261.9,sp|P36543|VATE1_HUMAN V-type proton ATPase subunit E 1 OS=Homo sapiens OX=9606 GN=ATP6V1E1 PE=1 SV=1,GO:0000221; GO:0005765; GO:0005768; GO:0005829; GO:0005902; GO:0016241; GO:0016324; GO:0016469; GO:0030665; GO:0030672; GO:0046961; GO:0051117; GO:0070062; GO:0097401; GO:1902600,proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401],"apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; proton-transporting two-sector ATPase complex [GO:0016469]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]","ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0005768; GO:0005829; GO:0031410; GO:0043226; GO:0055085; GO:0140657,transporter activity; endosome; cytosol; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_00153,1.245641921836859,FUN_000607-T1,Peve_00041268,Pocillopora_meandrina_HIv1___RNAseq.g2497.t1,three_way,77.315,FUN_000607-T1,Q16543,,,,,63.4,372.0,2.3e-90,334.0,sp|Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo sapiens OX=9606 GN=CDC37 PE=1 SV=1,,,,,,
OG_00157,2.058265086017013,FUN_000612-T1,Peve_00023943,Pocillopora_meandrina_HIv1___RNAseq.g1719.t1,three_way,81.25433333333334,FUN_000612-T1,Q8N7B6,PACRL_HUMAN,,PACRG-like protein,Homo sapiens (Human),61.2,206.0,1.6e-61,237.3,sp|Q8N7B6|PACRL_HUMAN PACRG-like protein OS=Homo sapiens OX=9606 GN=PACRGL PE=1 SV=2,,,,,,
OG_00158,2.778116524134305,FUN_000614-T1,Peve_00036774,Pocillopora_meandrina_HIv1___RNAseq.g1715.t1,three_way,67.67916666666667,FUN_000614-T1,Q5ZLL7,,,,,44.8,397.0,5.2999999999999996e-92,340.1,sp|Q5ZLL7|WDR91_CHICK WD repeat-containing protein 91 OS=Gallus gallus OX=9031 GN=WDR91 PE=2 SV=1,,,,,,
OG_00159,2.8421874463038708,FUN_000616-T1,Peve_00036773,Pocillopora_meandrina_HIv1___RNAseq.g1713.t1,three_way,72.57533333333333,FUN_000616-T1,P31729,,,,,58.0,162.0,2.7e-51,203.0,sp|P31729|OV16_ONCVO OV-16 antigen OS=Onchocerca volvulus OX=6282 GN=OV16 PE=2 SV=2,,,,,,
OG_00160,2.2448595979883343,FUN_000617-T3,Peve_00036770,Pocillopora_meandrina_HIv1___RNAseq.g1710.t1,three_way,72.46133333333333,FUN_000617-T3,Q9Y3Q0,NALD2_HUMAN,,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),Homo sapiens (Human),41.7,762.0,2.4e-155,550.8,sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129,carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508],membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_00161,1.3019358693791885,FUN_000618-T1,Peve_00043948,Pocillopora_meandrina_HIv1___TS.g4276.t2,three_way,66.084,FUN_000618-T1,Q6DRN3,NOC3L_DANRE,,Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein),Danio rerio (Zebrafish) (Brachydanio rerio),39.2,694.0,9.7e-120,432.6,sp|Q6DRN3|NOC3L_DANRE Nucleolar complex protein 3 homolog OS=Danio rerio OX=7955 GN=noc3l PE=2 SV=1,GO:0003682; GO:0005634; GO:0005730; GO:0006270; GO:0007517; GO:0019216,DNA replication initiation [GO:0006270]; muscle organ development [GO:0007517]; regulation of lipid metabolic process [GO:0019216],nucleolus [GO:0005730]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005730; GO:0043226; GO:0048856,nucleus; nucleolus; organelle; anatomical structure development
OG_00165,1.1930328113171706,FUN_000640-T1,Peve_00030248,Pocillopora_meandrina_HIv1___RNAseq.g1812.t1,three_way,61.307,,,,,,,,,,,,,,,,,
OG_00166,1.8356095947109188,FUN_000641-T1,Peve_00012249,Pocillopora_meandrina_HIv1___TS.g17921.t4,three_way,55.0825,FUN_000641-T1,A6QLA0,,,,,45.6,780.0,1.1e-188,662.1,sp|A6QLA0|NFX1_BOVIN Transcriptional repressor NF-X1 OS=Bos taurus OX=9913 GN=NFX1 PE=2 SV=1,,,,,,
OG_00167,1.1373665068543624,FUN_000643-T2,Peve_00029422,Pocillopora_meandrina_HIv1___RNAseq.g1780.t1,three_way,52.015,FUN_000643-T2,Q8TF61,,,,,39.0,326.0,3.4e-57,225.3,sp|Q8TF61|FBX41_HUMAN F-box only protein 41 OS=Homo sapiens OX=9606 GN=FBXO41 PE=1 SV=5,,,,,,
OG_00172,1.4362271727875602,FUN_000859-T2,Peve_00004524,Pocillopora_meandrina_HIv1___RNAseq.g1862.t1,three_way,78.86366666666667,FUN_000859-T2,Q13724,,,,,44.4,752.0,2.1000000000000001e-184,647.5,sp|Q13724|MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens OX=9606 GN=MOGS PE=1 SV=5,,,,,,
OG_00175,1.4798677133861635,FUN_000863-T1,Peve_00004533,Pocillopora_meandrina_HIv1___RNAseq.g1859.t1,three_way,58.988,,,,,,,,,,,,,,,,,
OG_00177,1.0231771922884845,FUN_000870-T1,Peve_00002066,Pocillopora_meandrina_HIv1___RNAseq.g1813.t1,three_way,92.69433333333332,FUN_000870-T1,P55039,DRG2_HUMAN,,Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-),Homo sapiens (Human),78.6,364.0,2.1000000000000002e-165,583.2,sp|P55039|DRG2_HUMAN Developmentally-regulated GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=DRG2 PE=1 SV=1,GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0043231; GO:0046872,cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],GO:0002181; GO:0003723; GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226,cytoplasmic translation; RNA binding; catalytic activity; GTPase activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle
OG_00178,2.568348427203237,FUN_000871-T1,Peve_00002056,Pocillopora_meandrina_HIv1___RNAseq.g1814.t1,three_way,62.229,FUN_000871-T1,A6QPC8,,,,,34.4,323.0,5.6e-35,149.8,sp|A6QPC8|EID3_BOVIN EP300-interacting inhibitor of differentiation 3 OS=Bos taurus OX=9913 GN=EID3 PE=2 SV=1,,,,,,
OG_00179,1.6036397257171302,FUN_000872-T1,Peve_00002057,Pocillopora_meandrina_HIv1___RNAseq.g1815.t1,three_way,56.59033333333333,FUN_000872-T1,Q08288,LYAR_MOUSE,,Cell growth-regulating nucleolar protein (Ly1 antibody-reactive protein) (Protein expressed in male leptotene and zygotene spermatocytes 264) (MLZ-264),Mus musculus (Mouse),40.4,406.0,2.3e-39,164.5,sp|Q08288|LYAR_MOUSE Cell growth-regulating nucleolar protein OS=Mus musculus OX=10090 GN=Lyar PE=1 SV=2,GO:0000122; GO:0001750; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008270; GO:0042802; GO:0045087; GO:0045824; GO:0045943; GO:0048821; GO:0050766; GO:0140297; GO:0140416,erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750],DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription regulator inhibitor activity [GO:0140416]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0048856; GO:0098542; GO:0098772,immune system process; DNA binding; nucleus; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; anatomical structure development; defense response to other organism; molecular function regulator activity
OG_00181,1.9578205257128567,FUN_000876-T1,Peve_00039671,Pocillopora_meandrina_HIv1___RNAseq.g29425.t1,three_way,67.38333333333334,FUN_000876-T1,Q6PFL8,,,,,72.5,171.0,1.4e-71,270.8,sp|Q6PFL8|THYN1_DANRE Thymocyte nuclear protein 1 OS=Danio rerio OX=7955 GN=thyn1 PE=2 SV=1,,,,,,
OG_00185,1.1359385274481015,FUN_000880-T1,Peve_00039672,Pocillopora_meandrina_HIv1___RNAseq.g29432.t1,three_way,73.261,FUN_000880-T1,P79795,NRP1_CHICK,,Neuropilin-1 (A5 protein),Gallus gallus (Chicken),35.6,180.0,9.8e-19,97.8,sp|P79795|NRP1_CHICK Neuropilin-1 OS=Gallus gallus OX=9031 GN=NRP1 PE=2 SV=1,GO:0001570; GO:0001755; GO:0002040; GO:0005021; GO:0005886; GO:0005925; GO:0007155; GO:0007411; GO:0008201; GO:0009611; GO:0010595; GO:0017154; GO:0022035; GO:0030424; GO:0030947; GO:0031966; GO:0032584; GO:0038085; GO:0043679; GO:0044295; GO:0046872; GO:0048010; GO:0048729; GO:0051491; GO:0070852; GO:0098743,axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell aggregation [GO:0098743]; neural crest cell migration [GO:0001755]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to wounding [GO:0009611]; rhombomere cell migration [GO:0022035]; sprouting angiogenesis [GO:0002040]; tissue morphogenesis [GO:0048729]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570],axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell body fiber [GO:0070852]; focal adhesion [GO:0005925]; growth cone membrane [GO:0032584]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886],heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0030154; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; cell differentiation; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_00186,1.376517242719416,FUN_000885-T1,Peve_00029323,Pocillopora_meandrina_HIv1___RNAseq.g29436.t1,three_way,58.51866666666667,,,,,,,,,,,,,,,,,
OG_00188,1.5675228020894276,FUN_000892-T1,Peve_00026758,Pocillopora_meandrina_HIv1___RNAseq.g29444.t1,three_way,81.38833333333334,,,,,,,,,,,,,,,,,
OG_00195,3.244165615939694,FUN_000905-T1,Peve_00009733,Pocillopora_meandrina_HIv1___RNAseq.g29456.t1,three_way,66.77466666666666,FUN_000905-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),37.3,753.0,5.9e-130,466.5,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00199,2.4074582696375004,FUN_000912-T1,Peve_00010054,Pocillopora_meandrina_HIv1___RNAseq.g29489.t1,three_way,68.19866666666667,FUN_000912-T1,Q8BSF5,,,,,22.8,479.0,1.7e-26,122.9,sp|Q8BSF5|KLH38_MOUSE Kelch-like protein 38 OS=Mus musculus OX=10090 GN=Klhl38 PE=2 SV=1,,,,,,
OG_00207,3.129326247388409,FUN_000926-T1,Peve_00009718,Pocillopora_meandrina_HIv1___RNAseq.g29467.t1,three_way,63.42333333333334,FUN_000926-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),29.5,319.0,9.100000000000001e-33,142.9,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_00212,2.103255889957496,FUN_000931-T1,Peve_00009723,Pocillopora_meandrina_HIv1___RNAseq.g29462.t1,three_way,72.855,FUN_000931-T1,Q5E9J5,DHCR7_BOVIN,,"7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Cholesterol-5,6-epoxide hydrolase subunit DHCR7) (EC 3.3.2.11) (Sterol Delta(7)-reductase)",Bos taurus (Bovine),50.6,437.0,1.1000000000000002e-124,448.4,sp|Q5E9J5|DHCR7_BOVIN 7-dehydrocholesterol reductase OS=Bos taurus OX=9913 GN=DHCR7 PE=2 SV=1,GO:0005640; GO:0005789; GO:0006695; GO:0033490; GO:0033963; GO:0047598; GO:0050661; GO:0160020,cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via lathosterol [GO:0033490]; positive regulation of ferroptosis [GO:0160020],endoplasmic reticulum membrane [GO:0005789]; nuclear outer membrane [GO:0005640],"7-dehydrocholesterol reductase activity [GO:0047598]; cholesterol-5,6-oxide hydrolase activity [GO:0033963]; NADP binding [GO:0050661]",GO:0003824; GO:0006629; GO:0016491; GO:0016787,catalytic activity; lipid metabolic process; oxidoreductase activity; hydrolase activity
OG_00214,1.3779075393921356,FUN_000933-T1,Peve_00009727,Pocillopora_meandrina_HIv1___RNAseq.g29459.t1,three_way,43.35483333333333,,,,,,,,,,,,,,,,,
OG_00215,2.6743403519640205,FUN_000934-T1,Peve_00009728,Pocillopora_meandrina_HIv1___RNAseq.g29458.t1,three_way,74.37933333333334,FUN_000934-T1,Q9BW85,YJU2_HUMAN,,Splicing factor YJU2 (Coiled-coil domain-containing protein 94),Homo sapiens (Human),68.8,173.0,7.7e-64,245.7,sp|Q9BW85|YJU2_HUMAN Splicing factor YJU2 OS=Homo sapiens OX=9606 GN=YJU2 PE=1 SV=1,GO:0000349; GO:0005654; GO:0008380; GO:0043518; GO:0046872; GO:0071006,"generation of catalytic spliceosome for first transesterification step [GO:0000349]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]",nucleoplasm [GO:0005654]; U2-type catalytic step 1 spliceosome [GO:0071006],metal ion binding [GO:0046872],GO:0005654; GO:0065003,nucleoplasm; protein-containing complex assembly
OG_00217,1.4435455928102554,FUN_000943-T1,Peve_00010048,Pocillopora_meandrina_HIv1___RNAseq.g29499.t1,three_way,73.82233333333333,FUN_000943-T1,Q791V5,MTCH2_MOUSE,,Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein),Mus musculus (Mouse),41.5,284.0,2.7e-60,233.8,sp|Q791V5|MTCH2_MOUSE Mitochondrial carrier homolog 2 OS=Mus musculus OX=10090 GN=Mtch2 PE=1 SV=1,GO:0005739; GO:0005741; GO:0005743; GO:0006089; GO:0010635; GO:0010917; GO:0032977; GO:0035701; GO:0042775; GO:0043065; GO:0045040; GO:0045820; GO:0055088; GO:0061484; GO:0070585; GO:0071478; GO:0090152; GO:0097284; GO:1902108; GO:1902231; GO:2000738,cellular response to radiation [GO:0071478]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration [GO:0035701]; hepatocyte apoptotic process [GO:0097284]; lactate metabolic process [GO:0006089]; lipid homeostasis [GO:0055088]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of stem cell differentiation [GO:2000738]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108],mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],membrane insertase activity [GO:0032977],GO:0005739; GO:0006091; GO:0007005; GO:0012501; GO:0043226; GO:0048870; GO:0061024; GO:0140104,mitochondrion; generation of precursor metabolites and energy; mitochondrion organization; programmed cell death; organelle; cell motility; membrane organization; molecular carrier activity
OG_00221,1.9005810466667472,FUN_000948-T1,Peve_00031011,Pocillopora_meandrina_HIv1___TS.g6689.t1b,three_way,66.4105,FUN_000948-T1,B1H1P9,,,,,42.3,345.0,2.5000000000000003e-72,274.2,sp|B1H1P9|PPAL_XENLA Lysosomal acid phosphatase OS=Xenopus laevis OX=8355 GN=acp2 PE=2 SV=1,,,,,,
OG_00222,1.059567083167465,FUN_000953-T1,Peve_00010057,Pocillopora_meandrina_HIv1___RNAseq.g29503.t1,three_way,81.21966666666667,,,,,,,,,,,,,,,,,
OG_00224,1.3064657852135848,FUN_000959-T1,Peve_00021381,Pocillopora_meandrina_HIv1___RNAseq.g2549.t1,three_way,47.7295,FUN_000959-T1,O18806,,,,,37.9,153.0,9.9e-26,120.9,sp|O18806|FA8_CANLF Coagulation factor VIII OS=Canis lupus familiaris OX=9615 GN=F8 PE=2 SV=1,,,,,,
OG_00226,1.3801813110082335,FUN_000961-T1,Peve_00008026,Pocillopora_meandrina_HIv1___TS.g5059.t2,three_way,69.25816666666667,FUN_000961-T1,Q26613,,,,,43.4,632.0,3.5e-159,563.9,sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1,,,,,,
OG_00227,1.035448934786234,FUN_000962-T1,Peve_00008025,Pocillopora_meandrina_HIv1___TS.g5027.t1,three_way,64.00016666666667,FUN_000962-T1,O73606,,,,,40.3,77.0,1.3e-06,56.2,sp|O73606|KCNG2_CHICK Voltage-gated potassium channel regulatory subunit KCNG2 OS=Gallus gallus OX=9031 GN=KCNG2 PE=2 SV=1,,,,,,
OG_00233,1.45732911574419,FUN_000987-T1,Peve_00022148,Pocillopora_meandrina_HIv1___RNAseq.g29210.t1,three_way,63.864666666666665,,,,,,,,,,,,,,,,,
OG_00234,5.234474229485253,FUN_000988-T1,Peve_00022149,Pocillopora_meandrina_HIv1___RNAseq.g29209.t1,three_way,82.41166666666666,FUN_000988-T1,Q92828,,,,,47.6,401.0,3.4e-101,370.5,sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2,,,,,,
OG_00237,1.9937923152224075,FUN_000992-T1,Peve_00004455,Pocillopora_meandrina_HIv1___RNAseq.g29194.t1,three_way,92.068,FUN_000992-T1,P82471,GNAQ_RAT,,Guanine nucleotide-binding protein G(q) subunit alpha (EC 3.6.5.-) (Guanine nucleotide-binding protein alpha-q),Rattus norvegicus (Rat),82.2,353.0,8.9e-169,594.3,sp|P82471|GNAQ_RAT Guanine nucleotide-binding protein G(q) subunit alpha OS=Rattus norvegicus OX=10116 GN=Gnaq PE=2 SV=2,GO:0001501; GO:0001508; GO:0001664; GO:0003924; GO:0003925; GO:0005096; GO:0005525; GO:0005737; GO:0005794; GO:0005834; GO:0005886; GO:0005901; GO:0007186; GO:0007189; GO:0007200; GO:0007206; GO:0007207; GO:0007208; GO:0007215; GO:0007218; GO:0007507; GO:0008217; GO:0009791; GO:0010543; GO:0016020; GO:0016322; GO:0021884; GO:0030234; GO:0030425; GO:0031683; GO:0031965; GO:0032024; GO:0034695; GO:0042711; GO:0042733; GO:0043066; GO:0043267; GO:0044297; GO:0044877; GO:0045634; GO:0046872; GO:0047391; GO:0048066; GO:0050821; GO:0060158; GO:0060828; GO:0086100; GO:0098793; GO:0099524; GO:1904888; GO:1990806,action potential [GO:0001508]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; endothelin receptor signaling pathway [GO:0086100]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; ligand-gated ion channel signaling pathway [GO:1990806]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; neuron remodeling [GO:0016322]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of insulin secretion [GO:0032024]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of blood pressure [GO:0008217]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; regulation of platelet activation [GO:0010543]; response to prostaglandin E [GO:0034695]; skeletal system development [GO:0001501],caveola [GO:0005901]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynapse [GO:0098793],alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; enzyme regulator activity [GO:0030234]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0003924; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; GTPase activity; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_00239,1.6622855302505568,FUN_000995-T1,Peve_00004445,Pocillopora_meandrina_HIv1___RNAseq.g29191.t1,three_way,42.72733333333333,,,,,,,,,,,,,,,,,
OG_00241,1.747414090703781,FUN_001004-T1,Peve_00015283,Pocillopora_meandrina_HIv1___RNAseq.g29176.t1,three_way,47.563,,,,,,,,,,,,,,,,,
OG_00243,4.0122021785346655,FUN_001006-T1,Peve_00015278,Pocillopora_meandrina_HIv1___RNAseq.g29174.t1,three_way,60.991,FUN_001006-T1,Q498G2,,,,,27.4,727.0,1.3e-40,171.0,sp|Q498G2|CE152_XENLA Centrosomal protein of 152 kDa OS=Xenopus laevis OX=8355 GN=cep152 PE=2 SV=1,,,,,,
OG_00244,1.7298714863732094,FUN_001007-T1,Peve_00015280,Pocillopora_meandrina_HIv1___RNAseq.g29172.t1,three_way,50.94766666666667,,,,,,,,,,,,,,,,,
OG_00246,3.4205531791854824,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_00247,1.8332111492261065,FUN_001010-T1,Peve_00041051,Pocillopora_meandrina_HIv1___RNAseq.g29165.t1,three_way,58.97366666666667,FUN_001010-T1,Q5E9Y6,,,,,36.6,402.0,8.4e-51,202.6,sp|Q5E9Y6|PRUN1_BOVIN Exopolyphosphatase PRUNE1 OS=Bos taurus OX=9913 GN=PRUNE1 PE=2 SV=1,,,,,,
OG_00249,2.152489776251989,FUN_001012-T1,Peve_00041036,Pocillopora_meandrina_HIv1___TS.g6378.t1,three_way,76.26333333333334,FUN_001012-T1,P49641,MA2A2_HUMAN,,"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",Homo sapiens (Human),44.9,1158.0,9.3e-292,1004.6,sp|P49641|MA2A2_HUMAN Alpha-mannosidase 2x OS=Homo sapiens OX=9606 GN=MAN2A2 PE=1 SV=3,GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0016799; GO:0030246; GO:0046872,mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486],Golgi membrane [GO:0000139],"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]",GO:0003824; GO:0005975; GO:0006486; GO:0009101; GO:0016787; GO:1901135,catalytic activity; carbohydrate metabolic process; protein glycosylation; glycoprotein biosynthetic process; hydrolase activity; carbohydrate derivative metabolic process
OG_00250,2.107811323449552,FUN_001013-T1,Peve_00041041,Pocillopora_meandrina_HIv1___RNAseq.g29162.t1,three_way,71.989,FUN_001013-T1,Q5R6Z8,CYBP_PONAB,,Calcyclin-binding protein (CacyBP),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),42.5,221.0,1.6000000000000001e-38,161.0,sp|Q5R6Z8|CYBP_PONAB Calcyclin-binding protein OS=Pongo abelii OX=9601 GN=CACYBP PE=2 SV=1,GO:0005634; GO:0005737; GO:0007507; GO:0015631; GO:0031625; GO:0044548,heart development [GO:0007507],cytoplasm [GO:0005737]; nucleus [GO:0005634],S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0008092; GO:0043226; GO:0048856,nucleus; cytoskeletal protein binding; organelle; anatomical structure development
OG_00252,5.291695219401374,FUN_001016-T1,Peve_00041043,Pocillopora_meandrina_HIv1___RNAseq.g29160.t1,three_way,48.55133333333333,FUN_001016-T1,Q0IHU9,,,,,42.9,203.0,7.6e-44,180.6,sp|Q0IHU9|PRUN2_XENTR Protein prune homolog 2 OS=Xenopus tropicalis OX=8364 GN=Prune2 PE=2 SV=1,,,,,,
OG_00253,4.76162403823353,FUN_001017-T2,Peve_00041044,Pocillopora_meandrina_HIv1___RNAseq.g29159.t1,three_way,66.55,,,,,,,,,,,,,,,,,
OG_00255,2.2911252827900364,FUN_001019-T1,Peve_00041047,Pocillopora_meandrina_HIv1___RNAseq.g29550.t1,three_way,74.728,FUN_001019-T1,E1C1R4,,,,,44.2,1361.0,1.6999999999999999e-301,1036.9,sp|E1C1R4|UBP47_CHICK Ubiquitin carboxyl-terminal hydrolase 47 OS=Gallus gallus OX=9031 GN=USP47 PE=3 SV=1,,,,,,
OG_00256,1.4989031355048317,FUN_001020-T1,Peve_00041048,Pocillopora_meandrina_HIv1___RNAseq.g29551.t1,three_way,71.137,FUN_001020-T1,Q6NVU6,UFSP1_HUMAN,,Ufm1-specific protease 1 (UfSP1) (EC 3.4.22.-),Homo sapiens (Human),45.8,216.0,1.3000000000000001e-48,194.5,sp|Q6NVU6|UFSP1_HUMAN Ufm1-specific protease 1 OS=Homo sapiens OX=9606 GN=UFSP1 PE=1 SV=3,GO:0005829; GO:0006508; GO:0008234; GO:0051604; GO:0071567; GO:0071569,protein maturation [GO:0051604]; protein ufmylation [GO:0071569]; proteolysis [GO:0006508],cytosol [GO:0005829],cysteine-type peptidase activity [GO:0008234]; deUFMylase activity [GO:0071567],GO:0003824; GO:0005829; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; cytosol; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_00259,2.036864865366209,FUN_001028-T1,Peve_00041059,Pocillopora_meandrina_HIv1___RNAseq.g29614.t1,three_way,51.323,,,,,,,,,,,,,,,,,
OG_00260,1.077245675118546,FUN_001031-T1,Peve_00041063,Pocillopora_meandrina_HIv1___RNAseq.g29618.t2,three_way,62.334,,,,,,,,,,,,,,,,,
OG_00261,1.640752933550958,FUN_001032-T1,Peve_00041064,Pocillopora_meandrina_HIv1___RNAseq.g29619.t1,three_way,55.168,FUN_001032-T1,C3ZQF9,,,,,23.7,304.0,2e-14,81.6,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_00262,1.2520600048083652,FUN_001033-T1,Peve_00041066,Pocillopora_meandrina_HIv1___RNAseq.g29620.t2,three_way,42.79083333333333,,,,,,,,,,,,,,,,,
OG_00266,1.1782493121772395,FUN_001044-T1,Peve_00041039,Pocillopora_meandrina_HIv1___TS.g6802.t1a,three_way,45.7765,,,,,,,,,,,,,,,,,
OG_00267,1.2081744986060985,FUN_001046-T1,Peve_00041040,Pocillopora_meandrina_HIv1___TS.g6802.t1b,three_way,57.10733333333334,,,,,,,,,,,,,,,,,
OG_00268,1.1254726261851462,FUN_001047-T1,Peve_00017182,Pocillopora_meandrina_HIv1___RNAseq.g4933.t1,three_way,56.60166666666667,FUN_001047-T1,Q7ZTV5,FSHR_CAIMO,,Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor),Cairina moschata (Muscovy duck),25.5,322.0,7.3e-08,60.5,sp|Q7ZTV5|FSHR_CAIMO Follicle-stimulating hormone receptor OS=Cairina moschata OX=8855 GN=FSHR PE=2 SV=1,GO:0004963; GO:0005886; GO:0007186; GO:0007189; GO:0008528; GO:0008584; GO:0009755; GO:0010738; GO:0016020; GO:0042699; GO:0043235; GO:0051897; GO:0070374; GO:0071372,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of protein kinase A signaling [GO:0010738],membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_00275,1.1731075660145818,FUN_001059-T1,Peve_00030107,Pocillopora_meandrina_HIv1___RNAseq.g29647.t1,three_way,70.47333333333333,FUN_001059-T1,P57093,PAHX_RAT,,"Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)",Rattus norvegicus (Rat),61.6,284.0,3.6e-103,376.3,"sp|P57093|PAHX_RAT Phytanoyl-CoA dioxygenase, peroxisomal OS=Rattus norvegicus OX=10116 GN=Phyh PE=1 SV=2",GO:0001561; GO:0003824; GO:0005777; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731,2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089],9+0 non-motile cilium [GO:0097731]; peroxisome [GO:0005777],carboxylic acid binding [GO:0031406]; catalytic activity [GO:0003824]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244],GO:0003824; GO:0005777; GO:0005929; GO:0006629; GO:0016491; GO:0043226,catalytic activity; peroxisome; cilium; lipid metabolic process; oxidoreductase activity; organelle
OG_00276,1.044571143206298,FUN_001061-T2,Peve_00005407,Pocillopora_meandrina_HIv1___RNAseq.g29648.t1,three_way,69.14066666666666,FUN_001061-T2,P22758,,,,,40.8,686.0,2.1999999999999998e-142,508.1,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_00277,1.8127692964909825,FUN_001062-T1,Peve_00005412,Pocillopora_meandrina_HIv1___RNAseq.g29651.t1,three_way,79.03666666666666,,,,,,,,,,,,,,,,,
OG_00280,1.7350715274573916,FUN_001066-T1,Peve_00018849,Pocillopora_meandrina_HIv1___RNAseq.g29655.t1,three_way,63.10516666666666,FUN_001066-T1,P22758,,,,,39.4,695.0,3.2e-132,474.2,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_00281,3.987933293900332,FUN_001067-T1,Peve_00029706,Pocillopora_meandrina_HIv1___RNAseq.g29656.t1,three_way,64.9165,FUN_001067-T1,A0AVK6,E2F8_HUMAN,,Transcription factor E2F8 (E2F-8),Homo sapiens (Human),40.1,304.0,1.1e-41,173.3,sp|A0AVK6|E2F8_HUMAN Transcription factor E2F8 OS=Homo sapiens OX=9606 GN=E2F8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0048144; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837,cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; fibroblast proliferation [GO:0048144]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0000278; GO:0003677; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,mitotic cell cycle; DNA binding; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00282,1.944771155135963,FUN_001068-T1,Peve_00019956,Pocillopora_meandrina_HIv1___RNAseq.g29658.t1,three_way,75.84883333333333,FUN_001068-T1,Q92621,NU205_HUMAN,,Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205),Homo sapiens (Human),41.1,2082.0,0.0,1488.8,sp|Q92621|NU205_HUMAN Nuclear pore complex protein Nup205 OS=Homo sapiens OX=9606 GN=NUP205 PE=1 SV=3,GO:0005635; GO:0005643; GO:0005829; GO:0006913; GO:0006999; GO:0015031; GO:0016020; GO:0017056; GO:0031965; GO:0034399; GO:0044611; GO:0051028; GO:0051292,mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005829; GO:0006913; GO:0065003,structural molecule activity; nuclear envelope; cytosol; nucleocytoplasmic transport; protein-containing complex assembly
OG_00283,1.5316892532596478,FUN_001071-T1,Peve_00019958,Pocillopora_meandrina_HIv1___RNAseq.g29659.t2,three_way,62.99216666666667,FUN_001071-T1,Q8BUG5,,,,,37.3,434.0,2.1e-78,295.0,sp|Q8BUG5|CAYP2_MOUSE Calcyphosin-2 OS=Mus musculus OX=10090 GN=Caps2 PE=2 SV=2,,,,,,
OG_00284,1.7195264993793338,FUN_001072-T1,Peve_00019957,Pocillopora_meandrina_HIv1___TS.g6834.t1,three_way,76.98933333333333,,,,,,,,,,,,,,,,,
OG_00285,1.325656675126074,FUN_001075-T1,Peve_00011328,Pocillopora_meandrina_HIv1___RNAseq.g29662.t2,three_way,73.35966666666667,FUN_001075-T1,O22719,,,,,23.3,430.0,5.6e-17,90.5,sp|O22719|LHTL3_ARATH Lysine histidine transporter-like 3 OS=Arabidopsis thaliana OX=3702 GN=At1g61270 PE=3 SV=2,,,,,,
OG_00286,3.1070401784706654,FUN_001076-T1,Peve_00037405,Pocillopora_meandrina_HIv1___RNAseq.g2716.t1,three_way,76.12899999999999,FUN_001076-T1,Q75V66,ANO5_HUMAN,,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),Homo sapiens (Human),42.4,850.0,1.3999999999999999e-187,658.3,sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; plasma membrane; organelle; transmembrane transport; membrane organization
OG_00287,2.0759534933453736,FUN_001077-T1,Peve_00037392,Pocillopora_meandrina_HIv1___TS.g5224.t1,three_way,47.706,FUN_001077-T1,P13233,CN37_RAT,,"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)",Rattus norvegicus (Rat),28.8,416.0,1e-38,162.9,"sp|P13233|CN37_RAT 2',3'-cyclic-nucleotide 3'-phosphodiesterase OS=Rattus norvegicus OX=10116 GN=Cnp PE=1 SV=2",GO:0003723; GO:0004113; GO:0005615; GO:0005737; GO:0005741; GO:0005743; GO:0005902; GO:0007409; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0030551; GO:0030900; GO:0031143; GO:0032496; GO:0035748; GO:0035749; GO:0042470; GO:0042995; GO:0043209; GO:0046902; GO:0048471; GO:0048709,adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636],cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143],"2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]",GO:0003723; GO:0003824; GO:0005615; GO:0007005; GO:0016787; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0055086; GO:0061024,RNA binding; catalytic activity; extracellular space; mitochondrion organization; hydrolase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; membrane organization
OG_00290,2.567114238670657,FUN_001081-T1,Peve_00037397,Pocillopora_meandrina_HIv1___RNAseq.g2712.t1,three_way,88.91366666666667,FUN_001081-T1,Q13557,,,,,72.0,468.0,8.2e-197,688.0,sp|Q13557|KCC2D_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Homo sapiens OX=9606 GN=CAMK2D PE=1 SV=3,,,,,,
OG_00300,1.1904018014217563,FUN_001098-T1,Peve_00003181,Pocillopora_meandrina_HIv1___RNAseq.g29379.t1a,three_way,85.81566666666667,FUN_001098-T1,Q5E964,,,,,55.2,375.0,4.9000000000000005e-117,422.5,sp|Q5E964|PSD13_BOVIN 26S proteasome non-ATPase regulatory subunit 13 OS=Bos taurus OX=9913 GN=PSMD13 PE=2 SV=1,,,,,,
OG_00304,3.013384117653802,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_00305,2.8790583265744343,FUN_001107-T1,Peve_00029366,Pocillopora_meandrina_HIv1___RNAseq.g29366.t1,three_way,86.59933333333333,FUN_001107-T1,Q9GZN1,ARP6_HUMAN,,Actin-related protein 6 (hArp6) (hARPX),Homo sapiens (Human),60.3,398.0,3.2e-143,509.6,sp|Q9GZN1|ARP6_HUMAN Actin-related protein 6 OS=Homo sapiens OX=9606 GN=ACTR6 PE=1 SV=1,GO:0000786; GO:0000812; GO:0005634; GO:0005730; GO:0005737; GO:0005856; GO:0006338; GO:0006355; GO:0007000; GO:0016479; GO:0031491; GO:0045943,chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleolus organization [GO:0007000]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of DNA-templated transcription [GO:0006355],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812],nucleosome binding [GO:0031491],GO:0005634; GO:0005730; GO:0005856; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleolus; cytoskeleton; chromatin organization; regulation of DNA-templated transcription; organelle
OG_00306,1.9592608139708776,FUN_001108-T1,Peve_00029386,Pocillopora_meandrina_HIv1___TS.g6556.t1,three_way,75.97966666666667,FUN_001108-T1,Q6PBP3,,,,,49.3,205.0,5.6e-43,175.6,sp|Q6PBP3|PXL2A_DANRE Peroxiredoxin-like 2A OS=Danio rerio OX=7955 GN=prxl2a PE=2 SV=2,,,,,,
OG_00307,2.1499991076657383,FUN_001109-T1,Peve_00029332,Pocillopora_meandrina_HIv1___RNAseq.g29364.t1,three_way,74.86366666666667,FUN_001109-T1,Q571G4,LIN54_MOUSE,,Protein lin-54 homolog,Mus musculus (Mouse),44.9,499.0,9.2e-94,345.9,sp|Q571G4|LIN54_MOUSE Protein lin-54 homolog OS=Mus musculus OX=10090 GN=Lin54 PE=2 SV=2,GO:0001067; GO:0003680; GO:0034728; GO:0046872; GO:0090571,nucleosome organization [GO:0034728],RNA polymerase II transcription repressor complex [GO:0090571],metal ion binding [GO:0046872]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; transcription regulatory region nucleic acid binding [GO:0001067],GO:0003677; GO:0006325,DNA binding; chromatin organization
OG_00308,4.045988086669726,FUN_001110-T1,Peve_00029335,Pocillopora_meandrina_HIv1___RNAseq.g29363.t1,three_way,71.534,FUN_001110-T1,P15384,,,,,49.9,407.0,2.3e-84,314.7,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_00309,1.19547680694712,FUN_001111-T1,Peve_00029358,Pocillopora_meandrina_HIv1___RNAseq.g29362.t1,three_way,69.821,,,,,,,,,,,,,,,,,
OG_00310,1.0840415701770565,FUN_001113-T1,Peve_00029360,Pocillopora_meandrina_HIv1___RNAseq.g29360.t1,three_way,39.53033333333333,,,,,,,,,,,,,,,,,
OG_00312,1.1544235260980136,FUN_001115-T1,Peve_00029363,Pocillopora_meandrina_HIv1___RNAseq.g29357.t1,three_way,97.802,FUN_001115-T1,Q7ZUG0,RUXE_DANRE,,Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE),Danio rerio (Zebrafish) (Brachydanio rerio),86.5,89.0,6.1e-37,154.5,sp|Q7ZUG0|RUXE_DANRE Small nuclear ribonucleoprotein E OS=Danio rerio OX=7955 GN=snrpe PE=3 SV=1,GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]",cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_00313,2.5342779371113977,FUN_001116-T2,Peve_00029365,Pocillopora_meandrina_HIv1___RNAseq.g29354.t1,three_way,60.4465,FUN_001116-T2,Q12912,IRAG2_HUMAN,,"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2]",Homo sapiens (Human),29.0,217.0,9e-15,84.7,"sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3",GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577,immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0002376; GO:0005635; GO:0005694; GO:0005815; GO:0005886; GO:0008092; GO:0022414; GO:0043226; GO:0061024,immune system process; nuclear envelope; chromosome; microtubule organizing center; plasma membrane; cytoskeletal protein binding; reproductive process; organelle; membrane organization
OG_00314,2.3475204808014127,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_00315,2.4384269076077323,FUN_001122-T1,Peve_00029372,Pocillopora_meandrina_HIv1___TS.g6543.t1,three_way,62.12316666666666,FUN_001122-T1,O75691,UTP20_HUMAN,,Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6),Homo sapiens (Human),32.2,1710.0,8.1e-220,766.1,sp|O75691|UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens OX=9606 GN=UTP20 PE=1 SV=3,GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040; GO:0042274,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]",RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0005730; GO:0005886; GO:0043226,RNA binding; nucleoplasm; nucleolus; plasma membrane; organelle
OG_00320,2.505053252416896,FUN_001139-T1,Peve_00029334,Pocillopora_meandrina_HIv1___RNAseq.g29336.t1,three_way,78.20866666666667,FUN_001139-T1,Q761V0,SC6A5_MOUSE,,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Mus musculus (Mouse),46.3,609.0,5.5e-158,559.3,sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1,GO:0001504; GO:0005886; GO:0015375; GO:0046872; GO:0098690; GO:0098793; GO:0098810,neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504],glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynapse [GO:0098793],glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_00321,1.0046581846570488,FUN_001140-T2,Peve_00029337,Pocillopora_meandrina_HIv1___RNAseq.g29334.t1,three_way,83.7735,FUN_001140-T2,Q6DIR8,,,,,39.4,866.0,2.9999999999999998e-173,610.5,sp|Q6DIR8|PALD_XENTR Paladin OS=Xenopus tropicalis OX=8364 GN=pald1 PE=2 SV=1,,,,,,
OG_00322,1.9554700597780537,FUN_001141-T1,Peve_00029338,Pocillopora_meandrina_HIv1___RNAseq.g29333.t1,three_way,78.69883333333334,FUN_001141-T1,Q8WML3,,,,,47.3,752.0,2.700000000000001e-186,654.1,sp|Q8WML3|KAT6B_MACFA Histone acetyltransferase KAT6B OS=Macaca fascicularis OX=9541 GN=KAT6B PE=2 SV=1,,,,,,
OG_00324,1.5017199887173154,FUN_001144-T1,Peve_00029341,Pocillopora_meandrina_HIv1___RNAseq.g29331.t1,three_way,57.1545,,,,,,,,,,,,,,,,,
OG_00327,2.111369661660011,FUN_001147-T1,Peve_00029344,Pocillopora_meandrina_HIv1___TS.g6522.t1,three_way,73.868,FUN_001147-T1,Q17QK3,CBPQ_BOVIN,,Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase),Bos taurus (Bovine),57.9,470.0,3.5e-152,539.7,sp|Q17QK3|CBPQ_BOVIN Carboxypeptidase Q OS=Bos taurus OX=9913 GN=CPQ PE=2 SV=1,GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0006590; GO:0042246; GO:0042803; GO:0043171; GO:0046872; GO:0070573,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764],carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005794; GO:0006575; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; endoplasmic reticulum; Golgi apparatus; modified amino acid metabolic process; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00329,1.933123498433894,FUN_001150-T1,Peve_00002868,Pocillopora_meandrina_HIv1___RNAseq.g29325.t1,three_way,67.18033333333334,FUN_001150-T1,Q5PPY2,,,,,37.7,199.0,5.5e-25,115.9,sp|Q5PPY2|BORC5_XENLA BLOC-1-related complex subunit 5 OS=Xenopus laevis OX=8355 GN=borcs5 PE=2 SV=1,,,,,,
OG_00335,1.0005264854028029,FUN_001156-T1,Peve_00002858,Pocillopora_meandrina_HIv1___RNAseq.g29318.t1,three_way,61.01533333333333,,,,,,,,,,,,,,,,,
OG_00337,2.46861182675657,FUN_001158-T1,Peve_00043471,Pocillopora_meandrina_HIv1___RNAseq.g29220.t1,three_way,76.751,FUN_001158-T1,Q7ZXG7,,,,,68.5,232.0,3.9e-96,352.4,sp|Q7ZXG7|GAMTA_XENLA Guanidinoacetate N-methyltransferase A OS=Xenopus laevis OX=8355 GN=gamt-a PE=2 SV=1,,,,,,
OG_00342,3.27304583040884,FUN_001167-T1,Peve_00015996,Pocillopora_meandrina_HIv1___RNAseq.g29154.t1,three_way,76.15266666666666,FUN_001167-T1,Q01617,,,,,51.7,172.0,6.1e-35,149.4,sp|Q01617|CPO_DROME Protein couch potato OS=Drosophila melanogaster OX=7227 GN=cpo PE=2 SV=4,,,,,,
OG_00345,1.0173062484147788,FUN_001172-T1,Peve_00034801,Pocillopora_meandrina_HIv1___RNAseq.g29144.t1,three_way,58.16183333333333,FUN_001172-T1,O60678,ANM3_HUMAN,,Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3),Homo sapiens (Human),47.6,538.0,1.7e-131,471.1,sp|O60678|ANM3_HUMAN Protein arginine N-methyltransferase 3 OS=Homo sapiens OX=9606 GN=PRMT3 PE=1 SV=4,GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0008168; GO:0008270; GO:0016274; GO:0031397; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0044020; GO:0045669; GO:0045815; GO:1900053,chromatin remodeling [GO:0006338]; methylation [GO:0032259]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of DNA-templated transcription [GO:0006355]; transcription initiation-coupled chromatin remodeling [GO:0045815],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00347,1.7714062089405551,FUN_001174-T1,Peve_00002993,Pocillopora_meandrina_HIv1___RNAseq.g29214.t1,three_way,71.508,FUN_001174-T1,P00377,,,,,41.3,184.0,6.499999999999997e-41,168.7,sp|P00377|DYR_PIG Dihydrofolate reductase OS=Sus scrofa OX=9823 GN=DHFR PE=1 SV=1,,,,,,
OG_00348,2.988169655108524,FUN_001175-T1,Peve_00015994,Pocillopora_meandrina_HIv1___RNAseq.g29156.t1,three_way,64.6045,FUN_001175-T1,Q1LUQ4,,,,,24.8,568.0,1.6e-35,152.5,sp|Q1LUQ4|MFD6A_DANRE Major facilitator superfamily domain-containing protein 6-A OS=Danio rerio OX=7955 GN=mfsd6a PE=3 SV=1,,,,,,
OG_00349,2.530015054959915,FUN_001176-T1,Peve_00015993,Pocillopora_meandrina_HIv1___TS.g6373.t1,three_way,71.25133333333333,FUN_001176-T1,O43451,MGA_HUMAN,,"Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20)",Homo sapiens (Human),48.8,853.0,2.6e-247,856.7,sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6,GO:0000025; GO:0003824; GO:0004339; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027,dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821],"alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; oligo-1,6-glucosidase activity [GO:0004574]",GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0043226,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; organelle
OG_00350,1.6545293631745872,FUN_001177-T2,Peve_00027161,Pocillopora_meandrina_HIv1___TS.g6731.t1,three_way,57.35983333333333,,,,,,,,,,,,,,,,,
OG_00351,1.2104972022040894,FUN_001178-T1,Peve_00027159,Pocillopora_meandrina_HIv1___RNAseq.g29546.t1,three_way,73.34033333333333,FUN_001178-T1,Q9NUJ3,T11L1_HUMAN,,T-complex protein 11-like protein 1,Homo sapiens (Human),39.4,447.0,1.8e-84,314.7,sp|Q9NUJ3|T11L1_HUMAN T-complex protein 11-like protein 1 OS=Homo sapiens OX=9606 GN=TCP11L1 PE=1 SV=1,GO:0005874; GO:0007165,signal transduction [GO:0007165],microtubule [GO:0005874],,,
OG_00353,1.052632888212701,FUN_001181-T1,Peve_00018945,Pocillopora_meandrina_HIv1___RNAseq.g29543.t1,three_way,82.81166666666667,FUN_001181-T1,A8WH18,,,,,63.5,482.0,5e-176,619.0,sp|A8WH18|NARFL_XENTR Cytosolic Fe-S cluster assembly factor narfl OS=Xenopus tropicalis OX=8364 GN=narfl PE=2 SV=1,,,,,,
OG_00359,1.3136058780982611,FUN_001192-T1,Peve_00006923,Pocillopora_meandrina_HIv1___RNAseq.g29528.t2,three_way,68.40133333333334,FUN_001192-T1,Q5RGE6,,,,,42.7,511.0,3.2000000000000002e-111,403.7,sp|Q5RGE6|HSP7E_DANRE Heat shock 70 kDa protein 14 OS=Danio rerio OX=7955 GN=hspa14 PE=2 SV=1,,,,,,
OG_00360,1.650223386238157,FUN_001193-T1,Peve_00006937,Pocillopora_meandrina_HIv1___RNAseq.g29527.t1,three_way,63.272,FUN_001193-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),34.4,326.0,6.6e-40,166.4,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_00361,4.983840590991444,FUN_001195-T1,Peve_00006935,Pocillopora_meandrina_HIv1___RNAseq.g29525.t1,three_way,41.97683333333333,,,,,,,,,,,,,,,,,
OG_00362,2.07044814454866,FUN_001197-T1,Peve_00022306,Pocillopora_meandrina_HIv1___RNAseq.g29523.t1,three_way,67.18616666666667,FUN_001197-T1,Q2YDF6,RT35_BOVIN,,"Small ribosomal subunit protein mS35 (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt) (28S ribosomal protein S35, mitochondrial) (MRP-S35) (S35mt)",Bos taurus (Bovine),52.7,182.0,1.4e-49,198.0,sp|Q2YDF6|RT35_BOVIN Small ribosomal subunit protein mS35 OS=Bos taurus OX=9913 GN=MRPS35 PE=1 SV=1,GO:0003735; GO:0005743; GO:0005763; GO:0005829; GO:0032543,mitochondrial translation [GO:0032543],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763],structural constituent of ribosome [GO:0003735],GO:0005198; GO:0005829,structural molecule activity; cytosol
OG_00368,1.1325835132006858,FUN_001209-T1,Peve_00033820,Pocillopora_meandrina_HIv1___RNAseq.g29516.t1,three_way,79.10166666666666,FUN_001209-T1,Q1JQD2,GRWD1_BOVIN,,Glutamate-rich WD repeat-containing protein 1,Bos taurus (Bovine),50.0,416.0,2.6000000000000002e-110,400.6,sp|Q1JQD2|GRWD1_BOVIN Glutamate-rich WD repeat-containing protein 1 OS=Bos taurus OX=9913 GN=GRWD1 PE=2 SV=1,GO:0003682; GO:0003688; GO:0005634; GO:0005694; GO:0005730; GO:0006260; GO:0006334; GO:0006337; GO:0042254; GO:0042393,DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; ribosome biogenesis [GO:0042254],chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393],GO:0003677; GO:0005634; GO:0005694; GO:0005730; GO:0006260; GO:0006325; GO:0042254; GO:0042393; GO:0043226; GO:0065003,DNA binding; nucleus; chromosome; nucleolus; DNA replication; chromatin organization; ribosome biogenesis; histone binding; organelle; protein-containing complex assembly
OG_00370,2.196494937561824,FUN_001211-T1,Peve_00033815,Pocillopora_meandrina_HIv1___RNAseq.g29514.t2c,three_way,72.93533333333333,FUN_001211-T1,Q9VZS6,,,,,40.4,275.0,2.8e-55,217.6,sp|Q9VZS6|NSMA_DROME Putative neutral sphingomyelinase OS=Drosophila melanogaster OX=7227 GN=nSMase PE=2 SV=2,,,,,,
OG_00374,1.5397831933735755,FUN_001217-T1,Peve_00035371,Pocillopora_meandrina_HIv1___RNAseq.g2551.t1,three_way,78.48366666666666,FUN_001217-T1,Q8BGF9,,,,,38.9,306.0,9.1e-58,225.3,sp|Q8BGF9|S2544_MOUSE Solute carrier family 25 member 44 OS=Mus musculus OX=10090 GN=Slc25a44 PE=1 SV=1,,,,,,
OG_00380,1.6011948131646845,FUN_001228-T1,Peve_00027708,Pocillopora_meandrina_HIv1___RNAseq.g29245.t1,three_way,84.69233333333334,FUN_001228-T1,Q569D5,,,,,71.9,469.0,1.8e-212,740.0,sp|Q569D5|SBP1_XENTR Methanethiol oxidase OS=Xenopus tropicalis OX=8364 GN=selenbp1 PE=2 SV=1,,,,,,
OG_00383,1.8572847739577016,FUN_001235-T1,Peve_00002839,Pocillopora_meandrina_HIv1___TS.g5021.t3,three_way,88.22116666666666,FUN_001235-T1,Q60520,SIN3A_MOUSE,,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),Mus musculus (Mouse),56.3,1191.0,0.0,1134.4,sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3,GO:0000122; GO:0000776; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351,activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337],kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416],GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006325; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; RNA binding; nucleus; nucleoplasm; nucleolus; DNA replication; chromatin organization; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_00384,1.1114060544361648,FUN_001236-T2,Peve_00002840,Pocillopora_meandrina_HIv1___RNAseq.g2513.t1,three_way,67.85933333333332,FUN_001236-T2,Q61907,PEMT_MOUSE,,Phosphatidylethanolamine N-methyltransferase (PEAMT) (PEMT) (EC 2.1.1.17) (EC 2.1.1.71) (Phospholipid methyltransferase) (PLMT),Mus musculus (Mouse),46.0,187.0,9.2e-45,181.8,sp|Q61907|PEMT_MOUSE Phosphatidylethanolamine N-methyltransferase OS=Mus musculus OX=10090 GN=Pemt PE=1 SV=4,GO:0000773; GO:0001835; GO:0004608; GO:0005739; GO:0005740; GO:0005789; GO:0005829; GO:0006656; GO:0006686; GO:0008757; GO:0031966; GO:0032259; GO:0120162,blastocyst hatching [GO:0001835]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cold-induced thermogenesis [GO:0120162]; sphingomyelin biosynthetic process [GO:0006686],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial envelope [GO:0005740]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],phosphatidyl-N-methylethanolamine N-methyltransferase activity [GO:0000773]; phosphatidylethanolamine N-methyltransferase activity [GO:0004608]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0005739; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; cytosol; lipid metabolic process; transferase activity; organelle
OG_00385,2.222259918435935,FUN_001237-T1,Peve_00002841,Pocillopora_meandrina_HIv1___RNAseq.g2514.t1,three_way,72.78383333333333,,,,,,,,,,,,,,,,,
OG_00388,2.2306862878647253,FUN_001241-T1,Peve_00022814,Pocillopora_meandrina_HIv1___TS.g4819.t1,three_way,90.189,FUN_001241-T1,Q5BJ41,CNOT6_XENLA,,CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase),Xenopus laevis (African clawed frog),59.0,558.0,8e-140,498.8,sp|Q5BJ41|CNOT6_XENLA CCR4-NOT transcription complex subunit 6 OS=Xenopus laevis OX=8355 GN=cnot6 PE=1 SV=1,GO:0000175; GO:0000289; GO:0003713; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0035279; GO:0046872; GO:0070966,"miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]",CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0031047; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_00389,2.4715569780584405,FUN_001244-T1,Peve_00037040,Pocillopora_meandrina_HIv1___RNAseq.g2296.t1,three_way,77.55366666666667,FUN_001244-T1,Q5MNH6,,,,,28.5,253.0,1e-20,102.1,sp|Q5MNH6|LOLO2_EPIUN 2-oxoglutarate-dependent dioxygenase lolO2 OS=Epichloe uncinata OX=5050 GN=lolO2 PE=1 SV=1,,,,,,
OG_00391,1.5585169810283237,FUN_001249-T1,Peve_00004684,Pocillopora_meandrina_HIv1___RNAseq.g2306.t1,three_way,61.718,FUN_001249-T1,P34888,WNT1_CAEEL,,Protein Wnt-1,Caenorhabditis elegans,28.9,384.0,5.9e-32,139.8,sp|P34888|WNT1_CAEEL Protein Wnt-1 OS=Caenorhabditis elegans OX=6239 GN=cwn-1 PE=2 SV=1,GO:0001708; GO:0001764; GO:0005109; GO:0005125; GO:0005615; GO:0005737; GO:0005886; GO:0010468; GO:0016055; GO:0030182; GO:0030971; GO:0040028; GO:0045165; GO:0048018; GO:0060070; GO:0097402; GO:0097475; GO:1904936; GO:1905485; GO:1905488; GO:1905491,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; interneuron migration [GO:1904936]; motor neuron migration [GO:0097475]; neuroblast migration [GO:0097402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; positive regulation of anterior/posterior axon guidance [GO:1905488]; positive regulation of motor neuron migration [GO:1905485]; positive regulation of sensory neuron axon guidance [GO:1905491]; regulation of gene expression [GO:0010468]; regulation of vulval development [GO:0040028]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971],GO:0005615; GO:0005886; GO:0030154; GO:0048018; GO:0048870; GO:0098772,extracellular space; plasma membrane; cell differentiation; receptor ligand activity; cell motility; molecular function regulator activity
OG_00392,1.732889212392578,FUN_001251-T1,Peve_00004681,Pocillopora_meandrina_HIv1___RNAseq.g2309.t1,three_way,55.928666666666665,,,,,,,,,,,,,,,,,
OG_00397,1.4423254688314977,FUN_001264-T1,Peve_00008779,Pocillopora_meandrina_HIv1___RNAseq.g2179.t1,three_way,87.813,FUN_001264-T1,Q62862,MP2K5_RAT,,Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5),Rattus norvegicus (Rat),60.5,430.0,2.4e-147,523.5,sp|Q62862|MP2K5_RAT Dual specificity mitogen-activated protein kinase kinase 5 OS=Rattus norvegicus OX=10116 GN=Map2k5 PE=1 SV=1,GO:0000122; GO:0000165; GO:0004672; GO:0004707; GO:0004708; GO:0004713; GO:0005524; GO:0005819; GO:0005829; GO:0007507; GO:0016020; GO:0030307; GO:0032717; GO:0034115; GO:0034392; GO:0043124; GO:0045944; GO:0046872; GO:0048009; GO:0050679; GO:0051247; GO:0060761; GO:0070375; GO:0071363; GO:0090051; GO:0106310; GO:2000342; GO:2001240,cellular response to growth factor stimulus [GO:0071363]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; MAPK cascade [GO:0000165]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytosol [GO:0005829]; membrane [GO:0016020]; spindle [GO:0005819],ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00398,1.3290950798490568,FUN_001267-T1,Peve_00008777,Pocillopora_meandrina_HIv1___RNAseq.13067_t,three_way,88.795,FUN_001267-T1,P50637,,,,,43.7,158.0,1.2e-38,161.0,sp|P50637|TSPO_MOUSE Translocator protein OS=Mus musculus OX=10090 GN=Tspo PE=1 SV=1,,,,,,
OG_00399,1.9982795437008256,FUN_001270-T1,Peve_00008764,Pocillopora_meandrina_HIv1___RNAseq.g2183.t1,three_way,76.675,FUN_001270-T1,Q9NWT6,HIF1N_HUMAN,,Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase),Homo sapiens (Human),59.9,319.0,1.2e-120,434.5,sp|Q9NWT6|HIF1N_HUMAN Hypoxia-inducible factor 1-alpha inhibitor OS=Homo sapiens OX=9606 GN=HIF1AN PE=1 SV=2,GO:0000122; GO:0003714; GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0019826; GO:0030947; GO:0031406; GO:0036139; GO:0036140; GO:0042803; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0061629; GO:0062101; GO:0071532; GO:2001214,negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],[protein]-asparagine 3-dioxygenase activity [GO:0036140]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0016491; GO:0060090; GO:0098772; GO:0140096; GO:0140110; GO:0140299,"catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; oxidoreductase activity; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein; transcription regulator activity; molecular sensor activity"
OG_00400,2.796691360543093,FUN_001271-T1,Peve_00008757,Pocillopora_meandrina_HIv1___RNAseq.g2184.t1,three_way,83.30966666666667,FUN_001271-T1,P0C605,KGP1_MOUSE,,cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI),Mus musculus (Mouse),58.6,630.0,9.7e-210,731.5,sp|P0C605|KGP1_MOUSE cGMP-dependent protein kinase 1 OS=Mus musculus OX=10090 GN=Prkg1 PE=1 SV=1,GO:0001669; GO:0001764; GO:0004672; GO:0004674; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0006468; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043087; GO:0045986; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0106310; GO:1904706; GO:1904753; GO:2000224,cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; regulation of testosterone biosynthetic process [GO:2000224]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003012; GO:0003824; GO:0005654; GO:0005794; GO:0005886; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0098772; GO:0140096,"muscle system process; catalytic activity; nucleoplasm; Golgi apparatus; plasma membrane; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00409,1.861935134308084,FUN_001299-T1,Peve_00036999,Pocillopora_meandrina_HIv1___RNAseq.g2232.t1,three_way,50.557,,,,,,,,,,,,,,,,,
OG_00413,1.318259913485661,FUN_001312-T1,Peve_00036981,Pocillopora_meandrina_HIv1___RNAseq.g2250.t1,three_way,72.822,FUN_001312-T1,Q04609,FOLH1_HUMAN,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen) (PSM) (PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase),Homo sapiens (Human),37.4,754.0,1.8e-137,491.5,sp|Q04609|FOLH1_HUMAN Glutamate carboxypeptidase 2 OS=Homo sapiens OX=9606 GN=FOLH1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005737; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0035609; GO:0046872; GO:0070062; GO:1904492; GO:1904493,C-terminal protein deglutamylation [GO:0035609]; folic acid-containing compound metabolic process [GO:0006760]; proteolysis [GO:0006508],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00415,1.9532566374928109,FUN_001317-T1,Peve_00036963,Pocillopora_meandrina_HIv1___TS.g4770.t2,three_way,81.075,FUN_001317-T1,Q8WU76,,,,,35.4,675.0,5.7e-108,393.3,sp|Q8WU76|SCFD2_HUMAN Sec1 family domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCFD2 PE=1 SV=2,,,,,,
OG_00416,1.6509662708213917,FUN_001318-T1,Peve_00036962,Pocillopora_meandrina_HIv1___TS.g4771.t1b,three_way,45.996,,,,,,,,,,,,,,,,,
OG_00418,2.280802717324323,FUN_001323-T1,Peve_00036961,Pocillopora_meandrina_HIv1___RNAseq.g2265.t1,three_way,51.98283333333333,,,,,,,,,,,,,,,,,
OG_00421,1.929597662797171,FUN_001328-T1,Peve_00036956,Pocillopora_meandrina_HIv1___RNAseq.g2270.t1b,three_way,79.90283333333333,FUN_001328-T1,Q5F471,,,,,41.4,903.0,8.500000000000001e-174,612.5,sp|Q5F471|PP6R3_CHICK Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Gallus gallus OX=9031 GN=PPP6R3 PE=2 SV=1,,,,,,
OG_00422,1.384351934652498,FUN_001330-T1,Peve_00036948,Pocillopora_meandrina_HIv1___TS.g21139.t2a,three_way,69.44166666666666,FUN_001330-T1,Q9Z0K8,,,,,47.4,489.0,2.3e-117,424.1,sp|Q9Z0K8|VNN1_MOUSE Pantetheinase OS=Mus musculus OX=10090 GN=Vnn1 PE=1 SV=3,,,,,,
OG_00423,1.056971965146573,FUN_001331-T1,Peve_00036947,Pocillopora_meandrina_HIv1___RNAseq.g2277.t1,three_way,71.115,,,,,,,,,,,,,,,,,
OG_00427,1.6824041861034635,FUN_001335-T1,Peve_00036944,Pocillopora_meandrina_HIv1___RNAseq.g2285.t1,three_way,72.06533333333333,FUN_001335-T1,Q8IYJ1,CPNE9_HUMAN,,Copine-9 (Copine IX),Homo sapiens (Human),33.5,462.0,1.0000000000000001e-72,275.8,sp|Q8IYJ1|CPNE9_HUMAN Copine-9 OS=Homo sapiens OX=9606 GN=CPNE9 PE=1 SV=3,GO:0005544; GO:0005615; GO:0005886; GO:0030154; GO:0046872; GO:0070062; GO:0071277; GO:1903861,cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872],GO:0005615; GO:0005886; GO:0008289; GO:0030154; GO:0043226,extracellular space; plasma membrane; lipid binding; cell differentiation; organelle
OG_00428,1.506536859661825,FUN_001336-T1,Peve_00036943,Pocillopora_meandrina_HIv1___RNAseq.g2286.t1,three_way,80.96633333333334,FUN_001336-T1,Q86UD5,SL9B2_HUMAN,,Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Homo sapiens (Human),47.8,485.0,6.2e-115,416.0,sp|Q86UD5|SL9B2_HUMAN Sodium/hydrogen exchanger 9B2 OS=Homo sapiens OX=9606 GN=SLC9B2 PE=1 SV=2,GO:0005739; GO:0005743; GO:0005886; GO:0006814; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:0098662; GO:2001206,clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; inorganic cation transmembrane transport [GO:0098662]; lithium ion transport [GO:0010351]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672],identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005739; GO:0005768; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870; GO:0055085,transporter activity; mitochondrion; endosome; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility; transmembrane transport
OG_00434,3.67001241094913,FUN_001344-T1,Peve_00037041,Pocillopora_meandrina_HIv1___TS.g4804.t1,three_way,84.807,FUN_001344-T1,Q9DGA5,CDK1_ORYCU,,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),Oryzias curvinotus (Hynann ricefish) (Aplocheilus curvinotus),68.6,299.0,4.0999999999999997e-120,432.6,sp|Q9DGA5|CDK1_ORYCU Cyclin-dependent kinase 1 OS=Oryzias curvinotus OX=104658 GN=cdk1 PE=2 SV=1,GO:0000086; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007095; GO:0008353; GO:0051301; GO:0106310,cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic G2 DNA damage checkpoint signaling [GO:0007095],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00437,1.3190037864292228,FUN_001348-T1,Peve_00023407,Pocillopora_meandrina_HIv1___RNAseq.g1877.t1,three_way,60.797,,,,,,,,,,,,,,,,,
OG_00438,1.2404732174628068,FUN_001349-T1,Peve_00023406,Pocillopora_meandrina_HIv1___RNAseq.g1876.t1,three_way,83.4015,FUN_001349-T1,Q8IYW2,,,,,31.7,2766.0,0.0,1193.3,sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3,,,,,,
OG_00442,2.360332741436468,FUN_001355-T1,Peve_00028946,Pocillopora_meandrina_HIv1___TS.g4661.t1a,three_way,69.34483333333333,FUN_001355-T1,Q3UDE2,,,,,45.6,654.0,3.9e-159,563.1,sp|Q3UDE2|TTL12_MOUSE Tubulin--tyrosine ligase-like protein 12 OS=Mus musculus OX=10090 GN=Ttll12 PE=1 SV=1,,,,,,
OG_00443,3.535678847365065,FUN_001356-T1,Peve_00005527,Pocillopora_meandrina_HIv1___RNAseq.g2154.t1,three_way,89.02,FUN_001356-T1,Q571I9,,,,,42.8,828.0,1.5e-185,651.4,sp|Q571I9|A16A1_MOUSE Aldehyde dehydrogenase family 16 member A1 OS=Mus musculus OX=10090 GN=Aldh16a1 PE=1 SV=2,,,,,,
OG_00447,1.2348809474967468,FUN_001367-T1,Peve_00036761,Pocillopora_meandrina_HIv1___RNAseq.g2144.t1,three_way,66.2335,FUN_001367-T1,Q13610,,,,,52.7,495.0,6.1999999999999995e-105,382.9,sp|Q13610|PWP1_HUMAN Periodic tryptophan protein 1 homolog OS=Homo sapiens OX=9606 GN=PWP1 PE=1 SV=1,,,,,,
OG_00454,1.0594550379648306,FUN_001381-T2,Peve_00035160,Pocillopora_meandrina_HIv1___RNAseq.g2133.t1,three_way,56.10666666666667,FUN_001381-T2,O97512,,,,,31.4,299.0,2.0000000000000002e-23,111.7,sp|O97512|NK3R_RABIT Neuromedin-K receptor OS=Oryctolagus cuniculus OX=9986 GN=TACR3 PE=2 SV=2,,,,,,
OG_00456,1.7468243205186762,FUN_001385-T1,Peve_00019351,Pocillopora_meandrina_HIv1___RNAseq.g2129.t1,three_way,85.12266666666667,FUN_001385-T1,O75398,DEAF1_HUMAN,,Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5),Homo sapiens (Human),43.0,291.0,1.5e-50,202.2,sp|O75398|DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens OX=9606 GN=DEAF1 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001650; GO:0001662; GO:0001843; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0007281; GO:0008270; GO:0008542; GO:0009653; GO:0033599; GO:0045892; GO:0045893; GO:0048706; GO:0090575,anatomical structure morphogenesis [GO:0009653]; behavioral fear response [GO:0001662]; embryonic skeletal system development [GO:0048706]; germ cell development [GO:0007281]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542],chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005576; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0050877; GO:0140110,DNA binding; extracellular region; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_00457,1.7238733287377002,FUN_001388-T1,Peve_00019354,Pocillopora_meandrina_HIv1___RNAseq.g2127.t1,three_way,77.53466666666667,FUN_001388-T1,Q62739,RAB3I_RAT,,Rab-3A-interacting protein (Rab3A-interacting protein) (Rabin-3) (SSX2-interacting protein),Rattus norvegicus (Rat),39.6,217.0,1.2e-33,145.6,sp|Q62739|RAB3I_RAT Rab-3A-interacting protein OS=Rattus norvegicus OX=10116 GN=Rab3ip PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006612; GO:0015031; GO:0030027; GO:0031267; GO:0042802; GO:0045724; GO:0048471; GO:0051020; GO:0051490; GO:0120229; GO:1990635,negative regulation of filopodium assembly [GO:0051490]; positive regulation of cilium assembly [GO:0045724]; protein localization to motile cilium [GO:0120229]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031],centrosome [GO:0005813]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proximal dendrite [GO:1990635],GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0043226; GO:0098772,nucleus; nucleoplasm; microtubule organizing center; cytosol; organelle; molecular function regulator activity
OG_00462,2.091348576009266,FUN_001394-T1,Peve_00019360,Pocillopora_meandrina_HIv1___RNAseq.g2121.t1,three_way,76.95333333333333,FUN_001394-T1,A9JRD8,BTB6A_DANRE,,BTB/POZ domain-containing protein 6-A,Danio rerio (Zebrafish) (Brachydanio rerio),32.9,389.0,1.7e-56,222.2,sp|A9JRD8|BTB6A_DANRE BTB/POZ domain-containing protein 6-A OS=Danio rerio OX=7955 GN=btbd6a PE=1 SV=2,GO:0005634; GO:0005829; GO:0022008; GO:0050767,neurogenesis [GO:0022008]; regulation of neurogenesis [GO:0050767],cytosol [GO:0005829]; nucleus [GO:0005634],,GO:0005634; GO:0005829; GO:0030154; GO:0043226,nucleus; cytosol; cell differentiation; organelle
OG_00465,2.888005012821434,FUN_001401-T1,Peve_00008770,Pocillopora_meandrina_HIv1___RNAseq.g2113.t1,three_way,79.55216666666666,FUN_001401-T1,Q8C8M1,SHCAF_MOUSE,,SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein),Mus musculus (Mouse),43.0,235.0,2.4e-40,167.2,sp|Q8C8M1|SHCAF_MOUSE SIN3-HDAC complex-associated factor OS=Mus musculus OX=10090 GN=Sinhcaf PE=1 SV=1,GO:0000122; GO:0005634; GO:0008284; GO:0030336; GO:0030512; GO:0045596; GO:0070822; GO:1902455; GO:1902459,negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459],nucleus [GO:0005634]; Sin3-type complex [GO:0070822],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_00466,1.6642597805397523,FUN_001402-T1,Peve_00008766,Pocillopora_meandrina_HIv1___TS.g4618.t1,three_way,89.81483333333334,FUN_001402-T1,P38976,,,,,74.9,195.0,1.2000000000000001e-74,280.8,sp|P38976|RAS2_HYDVU Ras-like protein RAS2 OS=Hydra vulgaris OX=6087 GN=RAS2 PE=2 SV=1,,,,,,
OG_00467,1.945848874001845,FUN_001403-T1,Peve_00008765,Pocillopora_meandrina_HIv1___RNAseq.g2111.t1,three_way,78.99133333333334,FUN_001403-T1,Q8AYK6,,,,,49.5,509.0,2.5e-117,424.1,sp|Q8AYK6|WEE1A_XENLA Wee1-like protein kinase 1-A OS=Xenopus laevis OX=8355 GN=wee1-a PE=2 SV=1,,,,,,
OG_00469,1.4810080631415607,FUN_001405-T1,Peve_00008761,Pocillopora_meandrina_HIv1___RNAseq.g2108.t1,three_way,74.93433333333333,FUN_001405-T1,Q920G9,,,,,45.3,433.0,4.3999999999999996e-107,389.8,sp|Q920G9|GMCL1_MOUSE Germ cell-less protein-like 1 OS=Mus musculus OX=10090 GN=Gmcl1 PE=1 SV=2,,,,,,
OG_00471,1.801866464058732,FUN_001407-T1,Peve_00008758,Pocillopora_meandrina_HIv1___RNAseq.g2106.t1,three_way,80.07066666666667,FUN_001407-T1,Q8NFH4,NUP37_HUMAN,,Nucleoporin Nup37 (p37) (Nup107-160 subcomplex subunit Nup37),Homo sapiens (Human),46.6,322.0,3.4e-82,306.6,sp|Q8NFH4|NUP37_HUMAN Nucleoporin Nup37 OS=Homo sapiens OX=9606 GN=NUP37 PE=1 SV=1,GO:0000776; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006913; GO:0007059; GO:0015031; GO:0031080; GO:0051028; GO:0051301,cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006913; GO:0007059; GO:0043226,nucleus; nuclear envelope; nucleoplasm; cytosol; nucleocytoplasmic transport; chromosome segregation; organelle
OG_00472,1.5421065546574302,FUN_001411-T1,Peve_00008755,Pocillopora_meandrina_HIv1___RNAseq.g2103.t1,three_way,87.10533333333333,FUN_001411-T1,Q06234,,,,,45.9,122.0,3.3e-14,79.7,sp|Q06234|ASCL1_XENLA Achaete-scute homolog 1 OS=Xenopus laevis OX=8355 GN=ascl1 PE=2 SV=1,,,,,,
OG_00475,2.6112983621059684,FUN_001414-T1,Peve_00008747,Pocillopora_meandrina_HIv1___RNAseq.g2100.t1,three_way,79.928,FUN_001414-T1,P50553,ASCL1_HUMAN,,Achaete-scute homolog 1 (ASH-1) (hASH1) (Class A basic helix-loop-helix protein 46) (bHLHa46),Homo sapiens (Human),60.3,63.0,3.9e-13,76.6,sp|P50553|ASCL1_HUMAN Achaete-scute homolog 1 OS=Homo sapiens OX=9606 GN=ASCL1 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003358; GO:0003359; GO:0003676; GO:0003682; GO:0003700; GO:0005634; GO:0007219; GO:0007346; GO:0007400; GO:0007405; GO:0007423; GO:0007507; GO:0010468; GO:0014003; GO:0021527; GO:0021530; GO:0021750; GO:0021892; GO:0021902; GO:0021954; GO:0021987; GO:0022008; GO:0030182; GO:0030856; GO:0032526; GO:0042802; GO:0043025; GO:0043066; GO:0043425; GO:0043525; GO:0045665; GO:0045666; GO:0045747; GO:0045787; GO:0045892; GO:0045944; GO:0046983; GO:0048469; GO:0048485; GO:0048663; GO:0048665; GO:0048666; GO:0048935; GO:0050767; GO:0050769; GO:0050883; GO:0051593; GO:0060163; GO:0060165; GO:0060166; GO:0060487; GO:0060579; GO:0061100; GO:0061102; GO:0061103; GO:0061104; GO:0061549; GO:0070849; GO:0070888; GO:0071259; GO:0090575; GO:0097475; GO:1990837; GO:2000179,"adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; motor neuron migration [GO:0097475]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]",chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_00477,2.503677495773309,FUN_001416-T1,Peve_00008744,Pocillopora_meandrina_HIv1___RNAseq.g2098.t1,three_way,82.74133333333333,FUN_001416-T1,Q924X7,STK33_MOUSE,,Serine/threonine-protein kinase 33 (EC 2.7.11.1),Mus musculus (Mouse),54.2,345.0,2e-101,370.9,sp|Q924X7|STK33_MOUSE Serine/threonine-protein kinase 33 OS=Mus musculus OX=10090 GN=Stk33 PE=1 SV=2,GO:0002177; GO:0004674; GO:0005524; GO:0007283; GO:0046777; GO:0048471; GO:0106310; GO:1905198,manchette assembly [GO:1905198]; protein autophosphorylation [GO:0046777]; spermatogenesis [GO:0007283],manchette [GO:0002177]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0140096,"catalytic activity; transferase activity; reproductive process; catalytic activity, acting on a protein"
OG_00478,1.7364759377843249,FUN_001417-T1,Peve_00008743,Pocillopora_meandrina_HIv1___RNAseq.g2096.t1,three_way,84.827,FUN_001417-T1,Q8C5L3,CNOT2_MOUSE,,CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2),Mus musculus (Mouse),43.2,562.0,2.8e-94,347.8,sp|Q8C5L3|CNOT2_MOUSE CCR4-NOT transcription complex subunit 2 OS=Mus musculus OX=10090 GN=Cnot2 PE=1 SV=2,GO:0000122; GO:0001222; GO:0001829; GO:0004535; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006417; GO:0010606; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:2000036,negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829],CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],poly(A)-specific ribonuclease activity [GO:0004535]; transcription corepressor binding [GO:0001222],GO:0003824; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0031047; GO:0140098,"catalytic activity; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; regulatory ncRNA-mediated gene silencing; catalytic activity, acting on RNA"
OG_00480,1.1275918261166618,FUN_001422-T3,Peve_00008797,Pocillopora_meandrina_HIv1___RNAseq.g2170.t1,three_way,83.918,FUN_001422-T3,Q6A078,CE290_MOUSE,,Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein homolog) (Nephrocystin-6),Mus musculus (Mouse),38.2,2233.0,0.0,1093.6,sp|Q6A078|CE290_MOUSE Centrosomal protein of 290 kDa OS=Mus musculus OX=10090 GN=Cep290 PE=1 SV=2,GO:0000226; GO:0001750; GO:0001822; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0007163; GO:0007368; GO:0007507; GO:0008104; GO:0015031; GO:0030902; GO:0030916; GO:0031410; GO:0032391; GO:0032991; GO:0034451; GO:0034976; GO:0035869; GO:0036038; GO:0042462; GO:0045494; GO:0045893; GO:0048793; GO:0060041; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:0120200; GO:0120205; GO:0120206; GO:1905349; GO:1905515,ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; establishment or maintenance of cell polarity [GO:0007163]; eye photoreceptor cell development [GO:0042462]; heart development [GO:0007507]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; microtubule cytoskeleton organization [GO:0000226]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; pronephros development [GO:0048793]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; response to endoplasmic reticulum stress [GO:0034976]; retina development in camera-type eye [GO:0060041],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]; photoreceptor proximal connecting cilium [GO:0120205]; protein-containing complex [GO:0032991]; rod photoreceptor outer segment [GO:0120200],,GO:0005634; GO:0005815; GO:0005829; GO:0006355; GO:0007010; GO:0007163; GO:0031410; GO:0043226; GO:0044782; GO:0048856,nucleus; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; establishment or maintenance of cell polarity; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development
OG_00488,1.1974445912838654,FUN_001454-T1,Peve_00018435,Pocillopora_meandrina_HIv1___RNAseq.g27059.t1,three_way,67.482,,,,,,,,,,,,,,,,,
OG_00492,2.1117177588498306,FUN_001462-T1,Peve_00027129,Pocillopora_meandrina_HIv1___RNAseq.g1962.t1,three_way,78.42083333333333,FUN_001462-T1,Q7ZYZ7,PCGF1_DANRE,,Polycomb group RING finger protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),49.2,244.0,2.4e-59,230.3,sp|Q7ZYZ7|PCGF1_DANRE Polycomb group RING finger protein 1 OS=Danio rerio OX=7955 GN=pcgf1 PE=3 SV=1,GO:0000122; GO:0006338; GO:0008270; GO:0021915; GO:0031519; GO:0035102; GO:0048589; GO:1990841,chromatin remodeling [GO:0006338]; developmental growth [GO:0048589]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915],PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102],promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270],GO:0006325; GO:0006355; GO:0048856,chromatin organization; regulation of DNA-templated transcription; anatomical structure development
OG_00496,2.1913490101994184,FUN_001466-T1,Peve_00027123,Pocillopora_meandrina_HIv1___RNAseq.g1967.t1,three_way,67.97266666666667,FUN_001466-T1,A0JNK3,HTRA2_BOVIN,,"Serine protease HTRA2, mitochondrial (EC 3.4.21.108)",Bos taurus (Bovine),47.0,334.0,1.0999999999999999e-75,285.4,"sp|A0JNK3|HTRA2_BOVIN Serine protease HTRA2, mitochondrial OS=Bos taurus OX=9913 GN=HTRA2 PE=2 SV=1",GO:0004252; GO:0005739; GO:0005758; GO:0006508; GO:0006915; GO:0012501; GO:0031966; GO:0043065,apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508],mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005739; GO:0012501; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; programmed cell death; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00497,2.053361149402086,FUN_001467-T3,Peve_00027122,Pocillopora_meandrina_HIv1___RNAseq.g1968.t1,three_way,81.8265,FUN_001467-T3,Q8CDM8,,,,,50.3,760.0,4.1e-197,689.5,sp|Q8CDM8|FHI2A_MOUSE FHF complex subunit HOOK interacting protein 2A OS=Mus musculus OX=10090 GN=Fhip2a PE=1 SV=2,,,,,,
OG_00500,3.4392419285655667,FUN_001473-T1,Peve_00029354,Pocillopora_meandrina_HIv1___TS.g4480.t1,three_way,91.325,FUN_001473-T1,Q5ZLT0,,,,,70.9,1080.0,0.0,1511.1,sp|Q5ZLT0|XPO7_CHICK Exportin-7 OS=Gallus gallus OX=9031 GN=XPO7 PE=2 SV=1,,,,,,
OG_00502,1.5735808614027622,FUN_001477-T1,Peve_00011493,Pocillopora_meandrina_HIv1___RNAseq.g1914.t1,three_way,81.65333333333334,FUN_001477-T1,P33731,,,,,47.5,503.0,3.9e-133,476.5,sp|P33731|SRP72_CANLF Signal recognition particle subunit SRP72 OS=Canis lupus familiaris OX=9615 GN=SRP72 PE=1 SV=3,,,,,,
OG_00504,1.1887807081194777,FUN_001480-T1,Peve_00029351,Pocillopora_meandrina_HIv1___RNAseq.g1916.t1,three_way,74.41033333333333,FUN_001480-T1,Q91770,,,,,43.8,169.0,1e-21,105.1,sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1,,,,,,
OG_00505,1.928434107239265,FUN_001481-T1,Peve_00029350,Pocillopora_meandrina_HIv1___TS.g4427.t1,three_way,71.991,,,,,,,,,,,,,,,,,
OG_00507,1.304311107204975,FUN_001483-T1,Peve_00029348,Pocillopora_meandrina_HIv1___RNAseq.g1919.t1,three_way,97.90966666666668,FUN_001483-T1,P31410,,,,,89.2,493.0,5.4999999999999995e-257,887.9,sp|P31410|VATB_HELVI V-type proton ATPase subunit B OS=Heliothis virescens OX=7102 GN=VHA55 PE=2 SV=1,,,,,,
OG_00509,1.7738359033512503,FUN_001493-T1,Peve_00002848,Pocillopora_meandrina_HIv1___RNAseq.g1906.t1,three_way,65.069,FUN_001493-T1,Q9NQA5,TRPV5_HUMAN,,Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3),Homo sapiens (Human),28.2,170.0,3.5e-07,58.9,sp|Q9NQA5|TRPV5_HUMAN Transient receptor potential cation channel subfamily V member 5 OS=Homo sapiens OX=9606 GN=TRPV5 PE=1 SV=3,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016324; GO:0034704; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809],apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003014; GO:0005215; GO:0005886; GO:0055085; GO:0065003,renal system process; transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_00512,1.1445278203333036,FUN_001504-T1,Peve_00012115,Pocillopora_meandrina_HIv1___RNAseq.g1890.t1,three_way,97.17433333333334,FUN_001504-T1,A5PJW8,RPB2_BOVIN,,DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (RNA-directed RNA polymerase II subunit RPB2) (EC 2.7.7.48),Bos taurus (Bovine),87.3,1174.0,0.0,2134.4,sp|A5PJW8|RPB2_BOVIN DNA-directed RNA polymerase II subunit RPB2 OS=Bos taurus OX=9913 GN=POLR2B PE=1 SV=1,GO:0000781; GO:0003677; GO:0003682; GO:0003899; GO:0003968; GO:0005665; GO:0005739; GO:0006366; GO:0008270; GO:0016787; GO:0032549; GO:0071667,transcription by RNA polymerase II [GO:0006366],"chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; RNA polymerase II, core complex [GO:0005665]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; hydrolase activity [GO:0016787]; ribonucleoside binding [GO:0032549]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005739; GO:0006351; GO:0016740; GO:0016787; GO:0043226; GO:0140098,"DNA binding; catalytic activity; mitochondrion; DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_00514,4.011832149684935,FUN_001507-T1,Peve_00012118,Pocillopora_meandrina_HIv1___TS.g4396.t1a,three_way,54.123666666666665,FUN_001507-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),42.2,398.0,5.3e-88,328.2,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_00516,1.4633028794652605,FUN_001509-T1,Peve_00012120,Pocillopora_meandrina_HIv1___RNAseq.g1886.t1,three_way,70.55866666666667,,,,,,,,,,,,,,,,,
OG_00518,1.1435310468343574,FUN_001515-T1,Peve_00012126,Pocillopora_meandrina_HIv1___RNAseq.g1884.t1,three_way,81.4485,FUN_001515-T1,A2A259,PK2L1_MOUSE,,Polycystin-2-like protein 1 (Polycystin-2L1) (Polycystic kidney disease 2-like 1 protein) (Polycystin-2 homolog),Mus musculus (Mouse),21.7,300.0,3.4e-09,65.5,sp|A2A259|PK2L1_MOUSE Polycystin-2-like protein 1 OS=Mus musculus OX=10090 GN=Pkd2l1 PE=1 SV=1,GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0009415; GO:0015269; GO:0015629; GO:0031410; GO:0034703; GO:0034704; GO:0042802; GO:0043235; GO:0044325; GO:0050912; GO:0051262; GO:0051289; GO:0051371; GO:0060170; GO:0071467; GO:0071468; GO:0097730; GO:0098662; GO:0160128; GO:1990760,cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transport [GO:0006812]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; smoothened signaling pathway [GO:0007224],actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; pH-gated monoatomic ion channel activity [GO:0160128]; sodium channel activity [GO:0005272]; transmembrane transporter binding [GO:0044325],GO:0005215; GO:0005783; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0008092; GO:0031410; GO:0043226; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,transporter activity; endoplasmic reticulum; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeletal protein binding; cytoplasmic vesicle; organelle; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_00519,2.0608937396253166,FUN_001517-T1,Peve_00012127,Pocillopora_meandrina_HIv1___TS.g4391.t1,three_way,84.86149999999999,FUN_001517-T1,Q3SZ40,,,,,56.4,535.0,3.6000000000000003e-158,559.7,sp|Q3SZ40|DDX56_BOVIN Probable ATP-dependent RNA helicase DDX56 OS=Bos taurus OX=9913 GN=DDX56 PE=2 SV=1,,,,,,
OG_00529,1.5415256732698652,FUN_001534-T1,Peve_00014191,Pocillopora_meandrina_HIv1___RNAseq.12922_t,three_way,52.932500000000005,FUN_001534-T1,O13024,,,,,52.7,110.0,1.1e-20,104.0,sp|O13024|INCEA_XENLA Inner centromere protein A OS=Xenopus laevis OX=8355 GN=incenp-a PE=1 SV=1,,,,,,
OG_00533,1.332459382716516,FUN_001547-T1,Peve_00020470,Pocillopora_meandrina_HIv1___RNAseq.g2064.t1,three_way,91.406,FUN_001547-T1,E9Q8T7,DYH1_MOUSE,,Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7),Mus musculus (Mouse),64.2,4208.0,0.0,5480.6,sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1,GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0007288; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288],extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; cytoskeleton organization; microtubule-based movement; isomerase activity; reproductive process; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_00535,2.542946719446848,FUN_001550-T1,Peve_00003916,Pocillopora_meandrina_HIv1___RNAseq.g2091.t1,three_way,65.51033333333334,FUN_001550-T1,Q54I58,,,,,32.0,219.0,6.2e-26,119.4,sp|Q54I58|NIPSN_DICDI Protein NipSnap homolog OS=Dictyostelium discoideum OX=44689 GN=nipsnap PE=3 SV=1,,,,,,
OG_00537,2.608454836887314,FUN_001553-T1,Peve_00003908,Pocillopora_meandrina_HIv1___RNAseq.g1998.t1,three_way,60.30766666666667,FUN_001553-T1,Q9UQF2,JIP1_HUMAN,,C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1),Homo sapiens (Human),40.5,242.0,1.5e-50,201.8,sp|Q9UQF2|JIP1_HUMAN C-Jun-amino-terminal kinase-interacting protein 1 OS=Homo sapiens OX=9606 GN=MAPK8IP1 PE=1 SV=1,GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0007254; GO:0008432; GO:0016192; GO:0019894; GO:0031434; GO:0031435; GO:0031966; GO:0043025; GO:0043508; GO:0044294; GO:0044295; GO:0044302; GO:0045202; GO:0046328; GO:0046330; GO:0048471; GO:2000564; GO:2001243,"JNK cascade [GO:0007254]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of DNA-templated transcription [GO:0006355]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]",axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202],JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase inhibitor activity [GO:0004860],GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0008092; GO:0016192; GO:0043226; GO:0060090; GO:0098772,nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeletal protein binding; vesicle-mediated transport; organelle; molecular adaptor activity; molecular function regulator activity
OG_00543,2.2794490534080065,FUN_001577-T1,Peve_00010785,Pocillopora_meandrina_HIv1___RNAseq.g2029.t1,three_way,69.47,FUN_001577-T1,Q6A039,,,,,55.0,453.0,3.1e-134,480.7,sp|Q6A039|TBC12_MOUSE TBC1 domain family member 12 OS=Mus musculus OX=10090 GN=Tbc1d12 PE=1 SV=2,,,,,,
OG_00544,1.4836876941732169,FUN_001579-T1,Peve_00005420,Pocillopora_meandrina_HIv1___RNAseq.g2031.t1,three_way,69.11233333333334,,,,,,,,,,,,,,,,,
OG_00549,3.1690342641554303,FUN_001590-T1,Peve_00023229,Pocillopora_meandrina_HIv1___RNAseq.g1994.t1,three_way,58.80866666666667,FUN_001590-T1,Q9VAN6,SLBP_DROME,,Histone RNA hairpin-binding protein (Histone stem-loop-binding protein),Drosophila melanogaster (Fruit fly),46.8,79.0,1.9e-16,88.2,sp|Q9VAN6|SLBP_DROME Histone RNA hairpin-binding protein OS=Drosophila melanogaster OX=7227 GN=Slbp PE=1 SV=1,GO:0003729; GO:0005634; GO:0005737; GO:0006398; GO:0007076; GO:0035613; GO:0051028; GO:0071204; GO:0071207; GO:1990825,mitotic chromosome condensation [GO:0007076]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028],cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleus [GO:0005634],histone pre-mRNA stem-loop binding [GO:0071207]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_00551,2.251644057077636,FUN_001592-T1,Peve_00023231,Pocillopora_meandrina_HIv1___RNAseq.g1991.t1,three_way,51.281666666666666,FUN_001592-T1,O35144,TERF2_MOUSE,,Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein),Mus musculus (Mouse),20.8,457.0,4.8e-06,54.3,sp|O35144|TERF2_MOUSE Telomeric repeat-binding factor 2 OS=Mus musculus OX=10090 GN=Terf2 PE=1 SV=3,GO:0000723; GO:0000781; GO:0000782; GO:0001673; GO:0001701; GO:0003691; GO:0003720; GO:0005654; GO:0016233; GO:0016604; GO:0019899; GO:0030424; GO:0031627; GO:0031848; GO:0032206; GO:0032208; GO:0032211; GO:0042162; GO:0042803; GO:0044877; GO:0061820; GO:0070187; GO:0070198; GO:0098505; GO:0099088; GO:1904354; GO:1904430; GO:1905839; GO:2000773,"axonal transport of messenger ribonucleoprotein complex [GO:0099088]; in utero embryonic development [GO:0001701]; negative regulation of cellular senescence [GO:2000773]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere capping [GO:1904354]; negative regulation of telomere maintenance via recombination [GO:0032208]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]; telomeric loop formation [GO:0031627]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; telomere cap complex [GO:0000782]",double-stranded telomeric DNA binding [GO:0003691]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomerase activity [GO:0003720]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0007018; GO:0016740; GO:0032200; GO:0043226; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule-based movement; transferase activity; telomere organization; organelle; anatomical structure development; catalytic activity, acting on DNA"
OG_00552,2.4456454772495357,FUN_001595-T1,Peve_00004149,Pocillopora_meandrina_HIv1___TS.g4491.t1,three_way,73.311,FUN_001595-T1,Q9LMG7,PPA2_ARATH,,Probable inactive purple acid phosphatase 2,Arabidopsis thaliana (Mouse-ear cress),34.2,573.0,7.2e-83,309.7,sp|Q9LMG7|PPA2_ARATH Probable inactive purple acid phosphatase 2 OS=Arabidopsis thaliana OX=3702 GN=PAP2 PE=2 SV=1,GO:0003993; GO:0005576; GO:0005739; GO:0005740; GO:0005768; GO:0005794; GO:0005802; GO:0006109; GO:0006626; GO:0009507; GO:0009941; GO:0030943; GO:0045040; GO:0046872,protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; regulation of carbohydrate metabolic process [GO:0006109],chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; trans-Golgi network [GO:0005802],acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]; mitochondrion targeting sequence binding [GO:0030943],GO:0003824; GO:0005576; GO:0005739; GO:0005768; GO:0005794; GO:0007005; GO:0009536; GO:0016787; GO:0031410; GO:0043226; GO:0061024,catalytic activity; extracellular region; mitochondrion; endosome; Golgi apparatus; mitochondrion organization; plastid; hydrolase activity; cytoplasmic vesicle; organelle; membrane organization
OG_00554,2.9808939031630413,FUN_001599-T1,Peve_00004146,Pocillopora_meandrina_HIv1___RNAseq.g1982.t1,three_way,81.72066666666667,FUN_001599-T1,Q9Y2D4,EXC6B_HUMAN,,Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2),Homo sapiens (Human),50.0,800.0,4.7e-223,775.8,sp|Q9Y2D4|EXC6B_HUMAN Exocyst complex component 6B OS=Homo sapiens OX=9606 GN=EXOC6B PE=1 SV=3,GO:0000145; GO:0000281; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522],exocyst [GO:0000145],,GO:0000910; GO:0006886; GO:0016192; GO:0061024,cytokinesis; intracellular protein transport; vesicle-mediated transport; membrane organization
OG_00555,1.1232568049642786,FUN_001603-T1,Peve_00043865,Pocillopora_meandrina_HIv1___RNAseq.g1979.t2,three_way,62.14733333333333,FUN_001603-T1,Q8BFW6,ENTP3_MOUSE,,Ectonucleoside triphosphate diphosphohydrolase 3 (NTPDase 3) (EC 3.6.1.5) (Ecto-ATP diphosphohydrolase 3) (Ecto-ATPDase 3) (Ecto-ATPase 3),Mus musculus (Mouse),37.9,443.0,4.9e-78,293.5,sp|Q8BFW6|ENTP3_MOUSE Ectonucleoside triphosphate diphosphohydrolase 3 OS=Mus musculus OX=10090 GN=Entpd3 PE=1 SV=1,GO:0004050; GO:0005524; GO:0005886; GO:0009134; GO:0009143; GO:0017110; GO:0017111,nucleoside diphosphate catabolic process [GO:0009134]; nucleoside triphosphate catabolic process [GO:0009143],plasma membrane [GO:0005886],apyrase activity [GO:0004050]; ATP binding [GO:0005524]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111],GO:0003824; GO:0005886; GO:0016787; GO:0055086,catalytic activity; plasma membrane; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_00556,1.43240885757099,FUN_001608-T2,Peve_00045305,Pocillopora_meandrina_HIv1___RNAseq.g1923.t1,three_way,86.59616666666666,FUN_001608-T2,Q5W8I8,VGL2A_DANRE,,Vesicular glutamate transporter 2.1 (Protein blumenkohl) (Solute carrier family 17 member 6-B) (Vesicular glutamate transporter 2-A),Danio rerio (Zebrafish) (Brachydanio rerio),43.0,470.0,2e-108,394.4,sp|Q5W8I8|VGL2A_DANRE Vesicular glutamate transporter 2.1 OS=Danio rerio OX=7955 GN=slc17a6b PE=2 SV=2,GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0006817; GO:0007268; GO:0007601; GO:0008021; GO:0015386; GO:0015813; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0051938; GO:0055062; GO:0060076; GO:0098700; GO:0140788,"chemical synaptic transmission [GO:0007268]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]; visual perception [GO:0007601]",chloride channel complex [GO:0034707]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamate uniporter activity [GO:0140788]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0050877; GO:0055085,transporter activity; plasma membrane; signaling; cytoplasmic vesicle; organelle; nervous system process; transmembrane transport
OG_00558,1.4118332700817926,FUN_001612-T1,Peve_00045309,Pocillopora_meandrina_HIv1___RNAseq.g1976.t1,three_way,61.33033333333333,FUN_001612-T1,Q8CAQ8,,,,,35.7,771.0,1.3000000000000001e-37,159.8,sp|Q8CAQ8|MIC60_MOUSE MICOS complex subunit Mic60 OS=Mus musculus OX=10090 GN=Immt PE=1 SV=1,,,,,,
OG_00559,1.7333332792114502,FUN_001613-T1,Peve_00045310,Pocillopora_meandrina_HIv1___TS.g4484.t1,three_way,71.21433333333333,FUN_001613-T1,P97931,UNG_MOUSE,,Uracil-DNA glycosylase (UDG) (EC 3.2.2.27),Mus musculus (Mouse),55.3,311.0,6.6e-91,335.5,sp|P97931|UNG_MOUSE Uracil-DNA glycosylase OS=Mus musculus OX=10090 GN=Ung PE=1 SV=3,GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0016446; GO:0016447; GO:0043024; GO:0045190; GO:0097510,"base-excision repair, AP site formation via deaminated base removal [GO:0097510]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]",mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0140097,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_00565,1.4544806325608852,FUN_001621-T1,Peve_00012529,Pocillopora_meandrina_HIv1___RNAseq.g1948.t1,three_way,82.54650000000001,FUN_001621-T1,Q8VCD6,,,,,61.8,152.0,1.3000000000000001e-48,194.5,sp|Q8VCD6|REEP2_MOUSE Receptor expression-enhancing protein 2 OS=Mus musculus OX=10090 GN=Reep2 PE=1 SV=2,,,,,,
OG_00572,1.9063349554175169,FUN_001631-T1,Peve_00029327,Pocillopora_meandrina_HIv1___RNAseq.g2162.t1,three_way,60.284333333333336,FUN_001631-T1,Q5FWK3,RHG01_MOUSE,,Rho GTPase-activating protein 1 (Rho-type GTPase-activating protein 1),Mus musculus (Mouse),47.0,372.0,3.2e-91,337.4,sp|Q5FWK3|RHG01_MOUSE Rho GTPase-activating protein 1 OS=Mus musculus OX=10090 GN=Arhgap1 PE=1 SV=1,GO:0001726; GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0007264; GO:0010008; GO:0016197; GO:0017124; GO:0031252; GO:0031267; GO:0033572; GO:0048471; GO:0097443; GO:2001136,endosomal transport [GO:0016197]; negative regulation of endocytic recycling [GO:2001136]; small GTPase-mediated signal transduction [GO:0007264]; transferrin transport [GO:0033572],cell leading edge [GO:0031252]; cilium [GO:0005929]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; sorting endosome [GO:0097443],GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267],GO:0005768; GO:0005829; GO:0005886; GO:0005929; GO:0016192; GO:0031410; GO:0043226; GO:0098772,endosome; cytosol; plasma membrane; cilium; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_00573,1.21615352573016,FUN_001632-T1,Peve_00029329,Pocillopora_meandrina_HIv1___RNAseq.g2161.t1,three_way,72.24716666666667,FUN_001632-T1,B0BLT0,,,,,57.5,106.0,1.4e-27,124.0,sp|B0BLT0|ZN593_XENTR Zinc finger protein 593 OS=Xenopus tropicalis OX=8364 GN=znf593 PE=2 SV=1,,,,,,
OG_00574,1.0423221901362454,FUN_001633-T1,Peve_00029328,Pocillopora_meandrina_HIv1___RNAseq.g2159.t1,three_way,47.73266666666667,,,,,,,,,,,,,,,,,
OG_00575,1.3400511957620729,FUN_001636-T1,Peve_00030249,Pocillopora_meandrina_HIv1___RNAseq.g2156.t1,three_way,45.20433333333334,,,,,,,,,,,,,,,,,
OG_00576,1.5487960871024176,FUN_001638-T1,Peve_00009933,Pocillopora_meandrina_HIv1___TS.g14306.t1,three_way,61.513666666666666,FUN_001638-T1,Q9UGK8,SRGEF_HUMAN,,Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor) (DelGEF) (Guanine nucleotide exchange factor-related protein),Homo sapiens (Human),41.6,401.0,2.7000000000000003e-73,277.3,sp|Q9UGK8|SRGEF_HUMAN Secretion-regulating guanine nucleotide exchange factor OS=Homo sapiens OX=9606 GN=SERGEF PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0050709,negative regulation of protein secretion [GO:0050709]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005634; GO:0005654; GO:0005829; GO:0043226; GO:0098772,nucleus; nucleoplasm; cytosol; organelle; molecular function regulator activity
OG_00577,1.4042023969353283,FUN_001639-T1,Peve_00020138,Pocillopora_meandrina_HIv1___RNAseq.g29422.t1,three_way,78.42066666666666,FUN_001639-T1,Q5ZIH2,,,,,53.5,445.0,6.7e-134,479.2,sp|Q5ZIH2|MON1A_CHICK Vacuolar fusion protein MON1 homolog A OS=Gallus gallus OX=9031 GN=MON1A PE=2 SV=1,,,,,,
OG_00586,1.2419515239096826,FUN_001664-T1,Peve_00038398,Pocillopora_meandrina_HIv1___RNAseq.g29392.t1,three_way,64.99366666666667,FUN_001664-T1,Q5ZML9,,,,,43.8,500.0,6.500000000000002e-110,399.4,sp|Q5ZML9|SETD3_CHICK Actin-histidine N-methyltransferase OS=Gallus gallus OX=9031 GN=SETD3 PE=2 SV=1,,,,,,
OG_00596,3.823506849342124,FUN_001733-T1,Peve_00007896,Pocillopora_meandrina_HIv1___RNAseq.g2642.t1,three_way,61.95166666666667,FUN_001733-T1,P27544,CERS1_HUMAN,,Ceramide synthase 1 (CerS1) (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299),Homo sapiens (Human),43.5,269.0,6.9e-55,216.1,sp|P27544|CERS1_HUMAN Ceramide synthase 1 OS=Homo sapiens OX=9606 GN=CERS1 PE=1 SV=1,GO:0005783; GO:0005789; GO:0007420; GO:0010614; GO:0016020; GO:0030148; GO:0036146; GO:0043231; GO:0046325; GO:0046513; GO:0050291; GO:0071466; GO:0071492; GO:0072721; GO:1901526,brain development [GO:0007420]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of D-glucose import [GO:0046325]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],sphingosine N-acyltransferase activity [GO:0050291],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226; GO:0048856,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle; anatomical structure development
OG_00598,1.060569738259716,FUN_001739-T1,Peve_00025011,Pocillopora_meandrina_HIv1___RNAseq.g2646.t1,three_way,73.694,FUN_001739-T1,A7S4N4,,,,,41.6,267.0,9.2e-50,199.5,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_00599,3.1318228474592877,FUN_001747-T1,Peve_00023224,Pocillopora_meandrina_HIv1___RNAseq.13551_t,three_way,50.601,,,,,,,,,,,,,,,,,
OG_00602,2.246384091698974,FUN_001750-T1,Peve_00019399,Pocillopora_meandrina_HIv1___RNAseq.g2655.t1,three_way,82.17433333333334,,,,,,,,,,,,,,,,,
OG_00604,2.240333760490253,FUN_001765-T1,Peve_00023733,Pocillopora_meandrina_HIv1___RNAseq.13574_t,three_way,60.79216666666667,,,,,,,,,,,,,,,,,
OG_00612,2.1208426953315622,FUN_001778-T1,Peve_00035593,Pocillopora_meandrina_HIv1___RNAseq.g2685.t1,three_way,54.77516666666666,FUN_001778-T1,Q80VL1,TDRKH_MOUSE,,Tudor and KH domain-containing protein (Tudor domain-containing protein 2),Mus musculus (Mouse),31.1,549.0,2.7e-66,255.4,sp|Q80VL1|TDRKH_MOUSE Tudor and KH domain-containing protein OS=Mus musculus OX=10090 GN=Tdrkh PE=1 SV=1,GO:0003723; GO:0005737; GO:0005739; GO:0005829; GO:0007140; GO:0007283; GO:0009566; GO:0030154; GO:0034587; GO:0071546; GO:0071547,cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; pi-body [GO:0071546]; piP-body [GO:0071547],RNA binding [GO:0003723],GO:0003723; GO:0005739; GO:0005829; GO:0022414; GO:0030154; GO:0043226; GO:0140013,RNA binding; mitochondrion; cytosol; reproductive process; cell differentiation; organelle; meiotic nuclear division
OG_00616,2.171729334973788,FUN_001782-T1,Peve_00011614,Pocillopora_meandrina_HIv1___RNAseq.g2693.t1,three_way,67.33749999999999,FUN_001782-T1,Q08DU8,BL1S6_BOVIN,,Biogenesis of lysosome-related organelles complex 1 subunit 6 (BLOC-1 subunit 6) (Pallid protein homolog) (Pallidin),Bos taurus (Bovine),35.2,88.0,1.2e-13,77.8,sp|Q08DU8|BL1S6_BOVIN Biogenesis of lysosome-related organelles complex 1 subunit 6 OS=Bos taurus OX=9913 GN=BLOC1S6 PE=1 SV=1,GO:0001725; GO:0001726; GO:0001822; GO:0002936; GO:0003016; GO:0003158; GO:0005737; GO:0005768; GO:0005925; GO:0006536; GO:0006541; GO:0006605; GO:0006644; GO:0007596; GO:0007613; GO:0008089; GO:0009410; GO:0010467; GO:0014823; GO:0021542; GO:0021854; GO:0030133; GO:0030318; GO:0031083; GO:0031175; GO:0031201; GO:0031941; GO:0032402; GO:0032816; GO:0033299; GO:0033484; GO:0035264; GO:0035646; GO:0042311; GO:0042745; GO:0042803; GO:0043227; GO:0044291; GO:0046034; GO:0046085; GO:0046907; GO:0048286; GO:0048490; GO:0048872; GO:0050942; GO:0051015; GO:0051017; GO:0055088; GO:0060090; GO:0060271; GO:0061025; GO:0070938; GO:0071364; GO:0071806; GO:1904115; GO:1905144; GO:1990742,actin filament bundle assembly [GO:0051017]; adenosine metabolic process [GO:0046085]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; ATP metabolic process [GO:0046034]; blood coagulation [GO:0007596]; bradykinin biosynthetic process [GO:0002936]; cellular response to epidermal growth factor stimulus [GO:0071364]; cilium assembly [GO:0060271]; circadian sleep/wake cycle [GO:0042745]; dentate gyrus development [GO:0021542]; endosome to melanosome transport [GO:0035646]; endothelium development [GO:0003158]; gene expression [GO:0010467]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; homeostasis of number of cells [GO:0048872]; hypothalamus development [GO:0021854]; intracellular nitric oxide homeostasis [GO:0033484]; intracellular transport [GO:0046907]; kidney development [GO:0001822]; lipid homeostasis [GO:0055088]; lung alveolus development [GO:0048286]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; membrane fusion [GO:0061025]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; neuron projection development [GO:0031175]; phospholipid metabolic process [GO:0006644]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of pigment cell differentiation [GO:0050942]; protein targeting [GO:0006605]; protein transmembrane transport [GO:0071806]; respiratory system process [GO:0003016]; response to acetylcholine [GO:1905144]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; secretion of lysosomal enzymes [GO:0033299]; vasodilation [GO:0042311],axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell-cell contact zone [GO:0044291]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; endosome [GO:0005768]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; membrane-bounded organelle [GO:0043227]; microvesicle [GO:1990742]; ruffle [GO:0001726]; SNARE complex [GO:0031201]; stress fiber [GO:0001725]; transport vesicle [GO:0030133],actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803],GO:0003013; GO:0003016; GO:0005768; GO:0006520; GO:0006629; GO:0007018; GO:0008092; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0055085; GO:0055086; GO:0060090; GO:0061024; GO:1901135,circulatory system process; respiratory system process; endosome; amino acid metabolic process; lipid metabolic process; microtubule-based movement; cytoskeletal protein binding; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; nervous system process; transmembrane transport; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; carbohydrate derivative metabolic process
OG_00619,2.9529878914241072,FUN_001787-T1,Peve_00008715,Pocillopora_meandrina_HIv1___RNAseq.g2639.t1,three_way,71.26766666666667,FUN_001787-T1,Q9HCE0,EPG5_HUMAN,,Ectopic P granules protein 5 homolog,Homo sapiens (Human),30.6,2484.0,0.0,1120.1,sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2,GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786,autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],,GO:0002376; GO:0005764; GO:0005773; GO:0006954; GO:0012501; GO:0016192; GO:0030154; GO:0043226,immune system process; lysosome; vacuole; inflammatory response; programmed cell death; vesicle-mediated transport; cell differentiation; organelle
OG_00620,1.1152109312302376,FUN_001788-T1,Peve_00008725,Pocillopora_meandrina_HIv1___RNAseq.g2638.t2,three_way,72.532,FUN_001788-T1,A1L243,,,,,44.0,184.0,4.1e-34,146.4,sp|A1L243|MESD_DANRE LRP chaperone MESD OS=Danio rerio OX=7955 GN=mesd PE=2 SV=2,,,,,,
OG_00623,2.646483015774198,FUN_001794-T1,Peve_00037091,Pocillopora_meandrina_HIv1___RNAseq.g15131.t1,three_way,57.70583333333334,FUN_001794-T1,P05183,CP3A2_RAT,,Cytochrome P450 3A2 (EC 1.14.14.1) (CYPIIIA2) (Cytochrome P450-PCN2) (Cytochrome P450/6-beta-A) (Testosterone 6-beta-hydroxylase),Rattus norvegicus (Rat),39.3,504.0,7.0000000000000015e-90,332.8,sp|P05183|CP3A2_RAT Cytochrome P450 3A2 OS=Rattus norvegicus OX=10116 GN=Cyp3a2 PE=1 SV=2,GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006706; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016098; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0032451; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021,alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789],"1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity
OG_00626,3.094101265119664,FUN_001842-T1,Peve_00006790,Pocillopora_meandrina_HIv1___RNAseq.g2620.t1,three_way,88.205,FUN_001842-T1,Q9GKQ9,,,,,60.2,558.0,1.9e-172,607.1,sp|Q9GKQ9|SMAD4_PIG Mothers against decapentaplegic homolog 4 OS=Sus scrofa OX=9823 GN=SMAD4 PE=2 SV=1,,,,,,
OG_00627,2.644958089629331,FUN_001845-T1,Peve_00006788,Pocillopora_meandrina_HIv1___RNAseq.g2618.t1,three_way,61.23066666666666,FUN_001845-T1,Q13395,TARB1_HUMAN,,tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 (EC 2.1.1.34) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185),Homo sapiens (Human),29.4,1429.0,3.8e-169,597.8,sp|Q13395|TARB1_HUMAN tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 OS=Homo sapiens OX=9606 GN=TARBP1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488; GO:0141100,regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488],nucleus [GO:0005634],RNA binding [GO:0003723]; tRNA (guanine(18)-2'-O)-methyltransferase activity [GO:0141100]; tRNA (guanine) methyltransferase activity [GO:0016423],GO:0003723; GO:0003824; GO:0005634; GO:0006355; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_00629,3.8728945692661103,FUN_001847-T1,Peve_00025829,Pocillopora_meandrina_HIv1___RNAseq.g2613.t1,three_way,82.766,FUN_001847-T1,O88576,S6A18_MOUSE,,Sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3),Mus musculus (Mouse),51.0,486.0,7.500000000000001e-145,515.4,sp|O88576|S6A18_MOUSE Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Mus musculus OX=10090 GN=Slc6a18 PE=1 SV=1,GO:0003333; GO:0005886; GO:0006836; GO:0015175; GO:0015804; GO:0016324; GO:0031526; GO:0140931; GO:1990297,amino acid transmembrane transport [GO:0003333]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; renal amino acid absorption [GO:1990297],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],neutral L-amino acid transmembrane transporter activity [GO:0015175]; neutral L-amino acid:sodium:chloride symporter activity [GO:0140931],GO:0003014; GO:0005215; GO:0005886; GO:0055085,renal system process; transporter activity; plasma membrane; transmembrane transport
OG_00630,2.641358972206712,FUN_001848-T1,Peve_00018077,Pocillopora_meandrina_HIv1___RNAseq.g2612.t1a,three_way,57.900333333333336,FUN_001848-T1,Q9NH13,,,,,25.7,346.0,5.4e-20,100.9,sp|Q9NH13|RP43_RIFPA Exoskeleton protein RP43 OS=Riftia pachyptila OX=6426 PE=1 SV=1,,,,,,
OG_00633,2.3910220263969544,FUN_001856-T1,Peve_00043869,Pocillopora_meandrina_HIv1___RNAseq.g2601.t1,three_way,76.085,FUN_001856-T1,P70699,LYAG_MOUSE,,Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase),Mus musculus (Mouse),49.0,880.0,5.3999999999999995e-247,855.5,sp|P70699|LYAG_MOUSE Lysosomal alpha-glucosidase OS=Mus musculus OX=10090 GN=Gaa PE=1 SV=2,GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0035904; GO:0043181; GO:0043896; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0120282,aorta development [GO:0035904]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181],autolysosome lumen [GO:0120282]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; glucan 1,6-alpha-glucosidase activity [GO:0043896]",GO:0003012; GO:0003016; GO:0003824; GO:0005764; GO:0005773; GO:0005975; GO:0006091; GO:0006914; GO:0007040; GO:0016787; GO:0043226; GO:0048856; GO:0050877,muscle system process; respiratory system process; catalytic activity; lysosome; vacuole; carbohydrate metabolic process; generation of precursor metabolites and energy; autophagy; lysosome organization; hydrolase activity; organelle; anatomical structure development; nervous system process
OG_00634,1.4002427328288902,FUN_001857-T1,Peve_00009168,Pocillopora_meandrina_HIv1___TS.g9153.t1,three_way,64.31066666666666,,,,,,,,,,,,,,,,,
OG_00638,2.201999678049222,FUN_001867-T1,Peve_00030491,Pocillopora_meandrina_HIv1___RNAseq.g2595.t1,three_way,85.47733333333333,FUN_001867-T1,Q02241,KIF23_HUMAN,,Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1),Homo sapiens (Human),44.4,967.0,2.9e-197,690.3,sp|Q02241|KIF23_HUMAN Kinesin-like protein KIF23 OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=3,GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149,microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467],centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0000910; GO:0003774; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytokinesis; cytoskeletal motor activity; catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_00640,2.0259844176152897,FUN_001879-T1,Peve_00030499,Pocillopora_meandrina_HIv1___RNAseq.g2593.t1,three_way,62.20333333333333,FUN_001879-T1,Q6NTR1,,,,,38.1,691.0,1.8e-112,408.3,sp|Q6NTR1|EFNMT_XENLA eEF1A lysine and N-terminal methyltransferase OS=Xenopus laevis OX=8355 GN=mettl13 PE=2 SV=1,,,,,,
OG_00643,1.1187204386478529,FUN_001887-T1,Peve_00030489,Pocillopora_meandrina_HIv1___RNAseq.g29129.t1,three_way,64.38266666666667,FUN_001887-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),40.6,286.0,1.8000000000000002e-44,181.8,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_00644,1.8605566164590832,FUN_001889-T1,Peve_00030492,Pocillopora_meandrina_HIv1___RNAseq.g2578.t2,three_way,70.65033333333334,,,,,,,,,,,,,,,,,
OG_00648,2.125743193215764,FUN_001901-T1,Peve_00018643,Pocillopora_meandrina_HIv1___TS.g5085.t1,three_way,66.03566666666667,,,,,,,,,,,,,,,,,
OG_00653,1.1205048780866318,FUN_001917-T1,Peve_00024476,Pocillopora_meandrina_HIv1___TS.g5073.t1,three_way,50.27666666666666,,,,,,,,,,,,,,,,,
OG_00655,1.6770658560014395,FUN_001941-T1,Peve_00024483,Pocillopora_meandrina_HIv1___TS.g6439.t1,three_way,68.33433333333333,FUN_001941-T1,Q6IPM2,IQCE_HUMAN,,IQ domain-containing protein E,Homo sapiens (Human),30.0,433.0,1.4e-21,107.1,sp|Q6IPM2|IQCE_HUMAN IQ domain-containing protein E OS=Homo sapiens OX=9606 GN=IQCE PE=1 SV=2,GO:0005929; GO:0035108; GO:0060170,limb morphogenesis [GO:0035108],ciliary membrane [GO:0060170]; cilium [GO:0005929],,GO:0005929; GO:0043226,cilium; organelle
OG_00662,1.993225019433894,FUN_001955-T1,Peve_00041246,Pocillopora_meandrina_HIv1___RNAseq.g2487.t1,three_way,54.437666666666665,,,,,,,,,,,,,,,,,
OG_00664,2.6061632520458216,FUN_001957-T1,Peve_00041244,Pocillopora_meandrina_HIv1___RNAseq.g2489.t1,three_way,78.50733333333334,FUN_001957-T1,Q8CHW4,EI2BE_MOUSE,,Translation initiation factor eIF2B subunit epsilon (eIF2B GDP-GTP exchange factor subunit epsilon),Mus musculus (Mouse),41.6,671.0,1e-123,445.7,sp|Q8CHW4|EI2BE_MOUSE Translation initiation factor eIF2B subunit epsilon OS=Mus musculus OX=10090 GN=Eif2b5 PE=1 SV=1,GO:0001541; GO:0002183; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045948; GO:0048708; GO:0050852,astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634],guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0005634; GO:0005829; GO:0030154; GO:0043226; GO:0048856; GO:0098772,immune system process; nucleus; cytosol; cell differentiation; organelle; anatomical structure development; molecular function regulator activity
OG_00671,2.7838973455021003,FUN_002079-T1,Peve_00036467,Pocillopora_meandrina_HIv1___RNAseq.g1723.t1,three_way,66.33500000000001,FUN_002079-T1,Q99614,,,,,45.6,160.0,7.2e-36,152.5,sp|Q99614|TTC1_HUMAN Tetratricopeptide repeat protein 1 OS=Homo sapiens OX=9606 GN=TTC1 PE=1 SV=1,,,,,,
OG_00674,2.001837209010757,FUN_002085-T1,Peve_00006425,Pocillopora_meandrina_HIv1___RNAseq.g1726.t1,three_way,71.64233333333334,FUN_002085-T1,O60258,FGF17_HUMAN,,Fibroblast growth factor 17 (FGF-17),Homo sapiens (Human),35.8,173.0,5e-23,109.8,sp|O60258|FGF17_HUMAN Fibroblast growth factor 17 OS=Homo sapiens OX=9606 GN=FGF17 PE=1 SV=1,GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0007399; GO:0008083; GO:0008284; GO:0008543; GO:0022008; GO:0030334; GO:0043410,cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0005576; GO:0005615; GO:0023052; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; signaling; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_00677,3.053166080123774,FUN_002092-T1,Peve_00004296,Pocillopora_meandrina_HIv1___RNAseq.g1730.t2,three_way,68.856,FUN_002092-T1,H3BCW1,ADPRS_LATCH,,ADP-ribosylhydrolase ARH3 (ADP-ribose glycohydrolase ARH3) (LchARH3) (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-),Latimeria chalumnae (Coelacanth),40.8,355.0,2.2e-61,237.7,sp|H3BCW1|ADPRS_LATCH ADP-ribosylhydrolase ARH3 OS=Latimeria chalumnae OX=7897 GN=adprs PE=1 SV=1,GO:0000287; GO:0004649; GO:0005634; GO:0005694; GO:0005759; GO:0006281; GO:0060546; GO:0140290; GO:0140292,DNA repair [GO:0006281]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine ADP-deribosylation [GO:0140290],chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634],ADP-ribosylserine hydrolase activity [GO:0140292]; magnesium ion binding [GO:0000287]; poly(ADP-ribose) glycohydrolase activity [GO:0004649],GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; DNA repair; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00678,3.190601388888671,FUN_002093-T1,Peve_00004291,Pocillopora_meandrina_HIv1___RNAseq.g1731.t2,three_way,44.53733333333333,,,,,,,,,,,,,,,,,
OG_00680,1.3981750626825833,FUN_002105-T1,Peve_00028438,Pocillopora_meandrina_HIv1___RNAseq.g1739.t1,three_way,80.535,FUN_002105-T1,Q5EBF1,5NTC_XENTR,,Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (EC 3.1.3.99) (Cytosolic nucleoside phosphotransferase 5'N) (EC 2.7.1.77),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),62.7,472.0,1e-172,608.2,sp|Q5EBF1|5NTC_XENTR Cytosolic purine 5'-nucleotidase OS=Xenopus tropicalis OX=8364 GN=nt5c2 PE=2 SV=1,GO:0005524; GO:0005829; GO:0008253; GO:0042802; GO:0046037; GO:0046040; GO:0046054; GO:0046872; GO:0050146; GO:0050483; GO:0050484; GO:0106411,dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP metabolic process [GO:0046040],cytosol [GO:0005829],5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146]; XMP 5'-nucleosidase activity [GO:0106411],GO:0003824; GO:0005829; GO:0016740; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; transferase activity; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00681,1.7603186954528889,FUN_002115-T1,Peve_00035152,Pocillopora_meandrina_HIv1___RNAseq.g1741.t1,three_way,74.249,FUN_002115-T1,Q8BP78,,,,,63.8,163.0,1.6e-60,234.2,sp|Q8BP78|F10C1_MOUSE Protein FRA10AC1 homolog OS=Mus musculus OX=10090 GN=Fra10ac1 PE=1 SV=3,,,,,,
OG_00682,2.6277011457892243,FUN_002200-T1,Peve_00043658,Pocillopora_meandrina_HIv1___RNAseq.g30301.t1,three_way,78.49766666666667,FUN_002200-T1,Q14746,,,,,39.1,750.0,7.1e-144,512.7,sp|Q14746|COG2_HUMAN Conserved oligomeric Golgi complex subunit 2 OS=Homo sapiens OX=9606 GN=COG2 PE=1 SV=1,,,,,,
OG_00685,1.782464930871886,FUN_002352-T1,Peve_00022332,Pocillopora_meandrina_HIv1___RNAseq.g33.t1,three_way,56.47666666666667,FUN_002352-T1,Q69ZL1,,,,,41.2,658.0,7.2e-121,437.6,"sp|Q69ZL1|FGD6_MOUSE FYVE, RhoGEF and PH domain-containing protein 6 OS=Mus musculus OX=10090 GN=Fgd6 PE=1 SV=2",,,,,,
OG_00686,1.2725692358242773,FUN_002355-T1,Peve_00023010,Pocillopora_meandrina_HIv1___RNAseq.g38.t1,three_way,67.03033333333333,FUN_002355-T1,Q0VCH3,,,,,43.4,113.0,1.3e-23,110.5,sp|Q0VCH3|CDPF1_BOVIN Cysteine-rich DPF motif domain-containing protein 1 OS=Bos taurus OX=9913 GN=CDPF1 PE=2 SV=1,,,,,,
OG_00692,2.6368693946136688,FUN_002379-T1,Peve_00034020,Pocillopora_meandrina_HIv1___RNAseq.g20.t2,three_way,83.75166666666667,FUN_002379-T1,Q00537,CDK17_HUMAN,,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),Homo sapiens (Human),57.9,525.0,3.6e-160,566.2,sp|Q00537|CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens OX=9606 GN=CDK17 PE=1 SV=2,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310; GO:1901987,protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00693,1.6726969851789386,FUN_002382-T1,Peve_00034022,Pocillopora_meandrina_HIv1___RNAseq.g14908.t1,three_way,68.7255,FUN_002382-T1,Q4R2Y9,ABHD2_MACFA,,Monoacylglycerol lipase ABHD2 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Acetylesterase) (EC 3.1.1.6) (Triacylglycerol lipase) (EC 3.1.1.79),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),40.2,408.0,1.7e-86,321.2,sp|Q4R2Y9|ABHD2_MACFA Monoacylglycerol lipase ABHD2 OS=Macaca fascicularis OX=9541 GN=ABHD2 PE=2 SV=1,GO:0001669; GO:0003707; GO:0004806; GO:0007340; GO:0008126; GO:0009611; GO:0014909; GO:0014912; GO:0032570; GO:0036126; GO:0042562; GO:0043401; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524; GO:0120516,acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of smooth muscle cell migration [GO:0014912]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; smooth muscle cell migration [GO:0014909]; sperm capacitation [GO:0048240]; steroid hormone receptor signaling pathway [GO:0043401],acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524],acetylesterase activity [GO:0008126]; diacylglycerol lipase activity [GO:0120516]; hormone binding [GO:0042562]; monoacylglycerol lipase activity [GO:0047372]; nuclear steroid receptor activity [GO:0003707]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005886; GO:0005929; GO:0006629; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0048870; GO:0060089; GO:0140110,catalytic activity; plasma membrane; cilium; lipid metabolic process; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; cell motility; molecular transducer activity; transcription regulator activity
OG_00694,1.931691513174596,FUN_002404-T1,Peve_00034027,Pocillopora_meandrina_HIv1___RNAseq.g14812.t1,three_way,68.69066666666666,FUN_002404-T1,G5E8P0,,,,,33.2,1574.0,2.5e-156,555.1,sp|G5E8P0|GCP6_MOUSE Gamma-tubulin complex component 6 OS=Mus musculus OX=10090 GN=Tubgcp6 PE=1 SV=1,,,,,,
OG_00698,1.2315447573335718,FUN_002428-T1,Peve_00034033,Pocillopora_meandrina_HIv1___RNAseq.g14846.t1,three_way,88.449,,,,,,,,,,,,,,,,,
OG_00701,1.9020237294989,FUN_002451-T1,Peve_00043794,Pocillopora_meandrina_HIv1___RNAseq.g14889.t1,three_way,85.959,FUN_002451-T1,P47897,SYQ_HUMAN,,Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS),Homo sapiens (Human),62.5,778.0,1.2e-290,1000.3,sp|P47897|SYQ_HUMAN Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1,GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0006418; GO:0006425; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234,brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stress-activated MAPK cascade [GO:0032873]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860],GO:0003824; GO:0005829; GO:0006355; GO:0006399; GO:0006520; GO:0016874; GO:0048856; GO:0098772; GO:0140098,"catalytic activity; cytosol; regulation of DNA-templated transcription; tRNA metabolic process; amino acid metabolic process; ligase activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on RNA"
OG_00702,1.5069687331080417,FUN_002452-T1,Peve_00043792,Pocillopora_meandrina_HIv1___RNAseq.g14890.t1,three_way,76.96466666666667,FUN_002452-T1,B9EJX3,,,,,37.0,154.0,4.3e-13,76.3,sp|B9EJX3|SMIP1_MOUSE Protein SPMIP1 OS=Mus musculus OX=10090 GN=Spmip1 PE=2 SV=1,,,,,,
OG_00704,1.6054842544018622,FUN_002454-T2,Peve_00023669,Pocillopora_meandrina_HIv1___RNAseq.g14892.t1,three_way,71.75366666666666,FUN_002454-T2,Q9N0P9,,,,,51.2,254.0,6.2e-71,269.6,sp|Q9N0P9|PIM1_BOVIN Serine/threonine-protein kinase pim-1 OS=Bos taurus OX=9913 GN=PIM1 PE=2 SV=1,,,,,,
OG_00706,4.058041941436882,FUN_002463-T1,Peve_00034010,Pocillopora_meandrina_HIv1___RNAseq.g14902.t1,three_way,92.76133333333334,FUN_002463-T1,P55861,,,,,73.9,789.0,7.3e-312,1070.8,sp|P55861|MCM2_XENLA DNA replication licensing factor mcm2 OS=Xenopus laevis OX=8355 GN=mcm2 PE=1 SV=2,,,,,,
OG_00709,1.218723949066136,FUN_002473-T1,Peve_00033998,Pocillopora_meandrina_HIv1___RNAseq.g14856.t1,three_way,72.90066666666667,FUN_002473-T1,Q3SZH7,LKHA4_BOVIN,,Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4),Bos taurus (Bovine),52.6,578.0,8.8e-180,631.7,sp|Q3SZH7|LKHA4_BOVIN Leukotriene A-4 hydrolase OS=Bos taurus OX=9913 GN=LTA4H PE=2 SV=3,GO:0004177; GO:0004301; GO:0004463; GO:0005634; GO:0005829; GO:0006508; GO:0008237; GO:0008270; GO:0019370; GO:0043171; GO:0045148,leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],cytosol [GO:0005829]; nucleus [GO:0005634],aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metallopeptidase activity [GO:0008237]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00711,1.1367295085927465,FUN_002578-T1,Peve_00011540,Pocillopora_meandrina_HIv1___RNAseq.g25721.t1,three_way,67.49366666666667,FUN_002578-T1,Q9JMA7,,,,,37.9,496.0,6.6e-88,326.2,sp|Q9JMA7|CP341_MOUSE Cytochrome P450 3A41 OS=Mus musculus OX=10090 GN=Cyp3a41a PE=1 SV=2,,,,,,
OG_00713,1.2768728841810888,FUN_002581-T1,Peve_00002776,Pocillopora_meandrina_HIv1___RNAseq.g25723.t1,three_way,84.074,FUN_002581-T1,Q6C7A6,NBP35_YARLI,,Cytosolic Fe-S cluster assembly factor NBP35 (Nucleotide-binding protein 35),Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica),51.3,298.0,1.8e-85,317.4,sp|Q6C7A6|NBP35_YARLI Cytosolic Fe-S cluster assembly factor NBP35 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) OX=284591 GN=NBP35 PE=3 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539; GO:0140663,iron-sulfur cluster assembly [GO:0016226],cytosol [GO:0005829]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]",GO:0005634; GO:0005829; GO:0043226; GO:0140104; GO:0140657,nucleus; cytosol; organelle; molecular carrier activity; ATP-dependent activity
OG_00714,2.4081430386663,FUN_002582-T1,Peve_00002778,Pocillopora_meandrina_HIv1___RNAseq.g25727.t1,three_way,60.239666666666665,,,,,,,,,,,,,,,,,
OG_00717,2.2416332423232896,FUN_002649-T1,Peve_00040095,Pocillopora_meandrina_HIv1___RNAseq.g25705.t1,three_way,67.51933333333334,,,,,,,,,,,,,,,,,
OG_00718,2.030298270928497,FUN_002650-T1,Peve_00040096,Pocillopora_meandrina_HIv1___RNAseq.g25706.t1,three_way,65.42783333333333,FUN_002650-T1,Q8K2I9,FBH1_MOUSE,,F-box DNA helicase 1 (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18),Mus musculus (Mouse),38.3,757.0,1.4000000000000002e-124,449.5,sp|Q8K2I9|FBH1_MOUSE F-box DNA helicase 1 OS=Mus musculus OX=10090 GN=Fbh1 PE=1 SV=1,GO:0000724; GO:0000785; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042,DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429],chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_00722,1.4820717106184946,FUN_002666-T1,Peve_00025542,Pocillopora_meandrina_HIv1___RNAseq.g20659.t1,three_way,55.13616666666667,FUN_002666-T1,A8MY62,,,,,30.6,494.0,1.8e-54,215.3,sp|A8MY62|BLML_HUMAN Putative beta-lactamase-like 1 OS=Homo sapiens OX=9606 GN=LACTBL1 PE=1 SV=2,,,,,,
OG_00723,1.534410578954806,FUN_002667-T1,Peve_00005211,Pocillopora_meandrina_HIv1___TS.g27716.t1,three_way,60.518,FUN_002667-T1,Q60854,,,,,42.2,379.0,7.6e-73,275.8,sp|Q60854|SPB6_MOUSE Serpin B6 OS=Mus musculus OX=10090 GN=Serpinb6 PE=1 SV=1,,,,,,
OG_00724,2.0776038133304144,FUN_002669-T1,Peve_00019954,Pocillopora_meandrina_HIv1___RNAseq.g20691.t1,three_way,60.89933333333333,FUN_002669-T1,Q5XGL1,,,,,29.7,263.0,5.6e-26,119.8,sp|Q5XGL1|CENPK_XENLA Centromere protein K OS=Xenopus laevis OX=8355 GN=cenpk PE=2 SV=2,,,,,,
OG_00725,1.7998350381644956,FUN_002670-T1,Peve_00005202,Pocillopora_meandrina_HIv1___TS.g27719.t1,three_way,57.01833333333333,FUN_002670-T1,Q2KJ34,,,,,30.4,184.0,6.3e-13,76.6,sp|Q2KJ34|HBP1_BOVIN HMG box-containing protein 1 OS=Bos taurus OX=9913 GN=HBP1 PE=2 SV=1,,,,,,
OG_00727,2.4985731881931303,FUN_002690-T1,Peve_00009951,Pocillopora_meandrina_HIv1___RNAseq.g20729.t1,three_way,49.989,FUN_002690-T1,Q3ZBG4,HES1_BOVIN,,Transcription factor HES-1 (Hairy and enhancer of split 1),Bos taurus (Bovine),59.4,64.0,4.6e-11,69.7,sp|Q3ZBG4|HES1_BOVIN Transcription factor HES-1 OS=Bos taurus OX=9913 GN=HES1 PE=2 SV=1,GO:0000122; GO:0001227; GO:0005634; GO:0007219; GO:0021861; GO:0042531; GO:0042803; GO:0043388; GO:0043565; GO:0045665; GO:0045892; GO:0046425; GO:0046427; GO:0048711; GO:0048715; GO:0050767; GO:0060253; GO:0065003; GO:0070888; GO:0071820; GO:2000974; GO:2000978,forebrain radial glial cell differentiation [GO:0021861]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of DNA binding [GO:0043388]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of neurogenesis [GO:0050767]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425],nucleus [GO:0005634],"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0065003; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; protein-containing complex assembly; transcription regulator activity
OG_00729,3.786074307212985,FUN_002695-T1,Peve_00009946,Pocillopora_meandrina_HIv1___RNAseq.g20725.t1,three_way,61.78816666666667,FUN_002695-T1,Q90VV1,HES4B_XENLA,,Transcription factor HES-4-B (Hairy and enhancer of split 4-B) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2b),Xenopus laevis (African clawed frog),37.6,194.0,7.2e-20,99.0,sp|Q90VV1|HES4B_XENLA Transcription factor HES-4-B OS=Xenopus laevis OX=8355 GN=hes4-b PE=1 SV=1,GO:0000122; GO:0000978; GO:0002088; GO:0005634; GO:0007219; GO:0007517; GO:0014029; GO:0021501; GO:0033504; GO:0043066; GO:0043565; GO:0045892; GO:0046982; GO:0048642; GO:0050767,floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; prechordal plate formation [GO:0021501]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development
OG_00731,1.0171099509399726,FUN_002697-T1,Peve_00034498,Pocillopora_meandrina_HIv1___RNAseq.g20722.t1,three_way,78.81233333333333,FUN_002697-T1,C1C4R8,DHRS6_AQUCT,,Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.-) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (EC 1.1.1.30) (4-oxo-L-proline reductase) (EC 1.1.1.104) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1),Aquarana catesbeiana (American bullfrog) (Rana catesbeiana),63.9,244.0,5.9e-83,308.9,sp|C1C4R8|DHRS6_AQUCT Dehydrogenase/reductase SDR family member 6 OS=Aquarana catesbeiana OX=8400 GN=bdh2 PE=2 SV=1,GO:0003858; GO:0005737; GO:0006629; GO:0016617; GO:0016628; GO:0019290; GO:0042168,heme metabolic process [GO:0042168]; lipid metabolic process [GO:0006629]; siderophore biosynthetic process [GO:0019290],cytoplasm [GO:0005737],"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; 4-oxoproline reductase activity [GO:0016617]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_00732,2.560081815399374,FUN_002698-T1,Peve_00034497,Pocillopora_meandrina_HIv1___RNAseq.g20728.t1,three_way,72.25633333333333,FUN_002698-T1,Q6IRB2,HES1A_XENLA,,Transcription factor HES-1-A (Hairy and enhancer of split 1-A) (Protein hairy-1) (Xhairy-1) (Xhairy1) (Xlh1),Xenopus laevis (African clawed frog),39.2,245.0,2.4e-26,120.6,sp|Q6IRB2|HES1A_XENLA Transcription factor HES-1-A OS=Xenopus laevis OX=8355 GN=hes1-a PE=1 SV=1,GO:0000122; GO:0000978; GO:0005634; GO:0007219; GO:0043425; GO:0043565; GO:0045665; GO:0045892; GO:0046982; GO:0048635; GO:0050767,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],bHLH transcription factor binding [GO:0043425]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_00733,1.77575416695384,FUN_002700-T1,Peve_00043786,Pocillopora_meandrina_HIv1___RNAseq.g14882.t1c,three_way,78.37583333333333,FUN_002700-T1,Q96SK2,,,,,32.7,510.0,9.1e-70,266.2,sp|Q96SK2|TM209_HUMAN Transmembrane protein 209 OS=Homo sapiens OX=9606 GN=TMEM209 PE=1 SV=2,,,,,,
OG_00735,1.5208016075068038,FUN_002716-T1,Peve_00027493,Pocillopora_meandrina_HIv1___RNAseq.g20658.t1,three_way,59.64266666666666,,,,,,,,,,,,,,,,,
OG_00736,3.241466074250362,FUN_002718-T1,Peve_00025049,Pocillopora_meandrina_HIv1___RNAseq.g20657.t1,three_way,73.45766666666667,FUN_002718-T1,Q66H43,,,,,48.1,104.0,2.7999999999999998e-24,113.6,sp|Q66H43|BORC6_RAT BLOC-1-related complex subunit 6 OS=Rattus norvegicus OX=10116 GN=Borcs6 PE=2 SV=2,,,,,,
OG_00739,1.7553579705056732,FUN_002721-T1,Peve_00025046,Pocillopora_meandrina_HIv1___RNAseq.g14941.t1,three_way,84.38783333333333,,,,,,,,,,,,,,,,,
OG_00742,1.604858699157663,FUN_002724-T1,Peve_00025037,Pocillopora_meandrina_HIv1___RNAseq.g14944.t1a,three_way,71.285,,,,,,,,,,,,,,,,,
OG_00746,2.5923534320114143,FUN_002736-T1,Peve_00041437,Pocillopora_meandrina_HIv1___RNAseq.g14951.t1,three_way,65.202,FUN_002736-T1,Q9BXT6,M10L1_HUMAN,,RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1),Homo sapiens (Human),39.3,1153.0,1.3999999999999999e-221,771.5,sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196,germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; cytosol; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_00748,1.5378007976086014,FUN_002805-T1,Peve_00018547,Pocillopora_meandrina_HIv1___RNAseq.g14957.t1,three_way,49.68866666666666,FUN_002805-T1,Q5SY16,NOL9_HUMAN,,Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.78) (Nucleolar protein 9),Homo sapiens (Human),31.2,592.0,2.6e-70,268.5,sp|Q5SY16|NOL9_HUMAN Polynucleotide 5'-hydroxyl-kinase NOL9 OS=Homo sapiens OX=9606 GN=NOL9 PE=1 SV=1,GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0016020; GO:0045111; GO:0046404; GO:0051731; GO:0051736,"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]",intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005856; GO:0016740; GO:0043226,RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytoskeleton; transferase activity; organelle
OG_00751,2.2480691313899435,FUN_002808-T1,Peve_00044269,Pocillopora_meandrina_HIv1___RNAseq.g14968.t1,three_way,67.566,FUN_002808-T1,Q9UNF1,MAGD2_HUMAN,,Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen),Homo sapiens (Human),35.8,201.0,2.1000000000000002e-32,141.0,sp|Q9UNF1|MAGD2_HUMAN Melanoma-associated antigen D2 OS=Homo sapiens OX=9606 GN=MAGED2 PE=1 SV=2,GO:0000122; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007565; GO:0016020; GO:0031093; GO:0070294,female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294],cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093],,GO:0003014; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0022414; GO:0043226,renal system process; extracellular region; nucleus; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle
OG_00754,2.9369688739948647,FUN_002813-T1,Peve_00044244,Pocillopora_meandrina_HIv1___RNAseq.g14958.t1,three_way,72.313,FUN_002813-T1,C4A0D9,BAP1_BRAFL,,Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1),Branchiostoma floridae (Florida lancelet) (Amphioxus),39.8,694.0,2.9999999999999997e-97,357.5,sp|C4A0D9|BAP1_BRAFL Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Branchiostoma floridae OX=7739 GN=BAP1 PE=3 SV=1,GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0016579; GO:0031507; GO:0035517; GO:0045892; GO:0051726; GO:0071108,heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517],chromatin binding [GO:0003682]; cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0006325; GO:0006355; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00756,1.3676485559034697,FUN_002871-T1,Peve_00013073,Pocillopora_meandrina_HIv1___TS.g15581.t1,three_way,81.83266666666667,FUN_002871-T1,Q21086,GNL3_CAEEL,,Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1),Caenorhabditis elegans,46.8,457.0,2.7e-109,397.5,sp|Q21086|GNL3_CAEEL Guanine nucleotide-binding protein-like 3 homolog OS=Caenorhabditis elegans OX=6239 GN=nst-1 PE=3 SV=1,GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127,germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0022414; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; reproductive process; organelle; anatomical structure development
OG_00760,1.848735840619164,FUN_003166-T1,Peve_00013723,Pocillopora_meandrina_HIv1___RNAseq.g6223.t1,three_way,65.014,FUN_003166-T1,C0HAC0,FBXL5_SALSA,,F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5),Salmo salar (Atlantic salmon),34.3,759.0,7.2e-78,293.1,sp|C0HAC0|FBXL5_SALSA F-box/LRR-repeat protein 5 OS=Salmo salar OX=8030 GN=fbxl5 PE=2 SV=1,GO:0005506; GO:0005634; GO:0006879; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0051536,intracellular iron ion homeostasis [GO:0006879]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536],GO:0005634; GO:0030163; GO:0043226,nucleus; protein catabolic process; organelle
OG_00761,1.5407504303029165,FUN_003384-T2,Peve_00000967,Pocillopora_meandrina_HIv1___TS.g15574.t2,three_way,69.08866666666667,,,,,,,,,,,,,,,,,
OG_00763,1.4793901278705186,FUN_003432-T1,Peve_00013657,Pocillopora_meandrina_HIv1___RNAseq.g22188.t1,three_way,69.05233333333334,FUN_003432-T1,Q9HC36,MRM3_HUMAN,,"rRNA methyltransferase 3, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1)",Homo sapiens (Human),33.2,313.0,7.499999999999997e-41,169.1,"sp|Q9HC36|MRM3_HUMAN rRNA methyltransferase 3, mitochondrial OS=Homo sapiens OX=9606 GN=MRM3 PE=1 SV=2",GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0006364; GO:0042802; GO:0070039,rRNA 2'-O-methylation [GO:0000451]; rRNA processing [GO:0006364],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039],GO:0003723; GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on RNA"
OG_00765,2.2193980584212523,FUN_003434-T1,Peve_00010306,Pocillopora_meandrina_HIv1___RNAseq.g9162.t1,three_way,49.788,,,,,,,,,,,,,,,,,
OG_00766,1.1413272691549317,FUN_003489-T1,Peve_00020062,Pocillopora_meandrina_HIv1___RNAseq.g24644.t1,three_way,58.79866666666666,,,,,,,,,,,,,,,,,
OG_00768,1.7654319900848638,FUN_003711-T1,Peve_00001358,Pocillopora_meandrina_HIv1___RNAseq.g17371.t1,three_way,72.969,FUN_003711-T1,A7SJ66,,,,,65.6,160.0,3.1e-60,232.6,sp|A7SJ66|U587_NEMVE UPF0587 protein v1g245604 OS=Nematostella vectensis OX=45351 GN=v1g245604 PE=3 SV=1,,,,,,
OG_00769,2.8919608706403017,FUN_003713-T1,Peve_00001357,Pocillopora_meandrina_HIv1___RNAseq.g17373.t2,three_way,74.59033333333333,FUN_003713-T1,A7RX69,TIKI1_NEMVE,,Metalloprotease TIKI homolog (EC 3.4.-.-),Nematostella vectensis (Starlet sea anemone),59.5,373.0,5.4999999999999996e-129,462.6,sp|A7RX69|TIKI1_NEMVE Metalloprotease TIKI homolog OS=Nematostella vectensis OX=45351 GN=v1g27680 PE=2 SV=2,GO:0004222; GO:0006508; GO:0016020; GO:0030178; GO:0046872,negative regulation of Wnt signaling pathway [GO:0030178]; proteolysis [GO:0006508],membrane [GO:0016020],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_00771,2.605048789623453,FUN_003839-T1,Peve_00042654,Pocillopora_meandrina_HIv1___RNAseq.g11160.t1,three_way,68.94483333333334,FUN_003839-T1,Q9Z254,GIPC1_RAT,,PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin),Rattus norvegicus (Rat),59.0,290.0,3.8e-93,343.2,sp|Q9Z254|GIPC1_RAT PDZ domain-containing protein GIPC1 OS=Rattus norvegicus OX=10116 GN=Gipc1 PE=1 SV=2,GO:0003779; GO:0005102; GO:0005737; GO:0005829; GO:0005903; GO:0005938; GO:0006605; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030139; GO:0030165; GO:0030511; GO:0031410; GO:0031647; GO:0032435; GO:0032467; GO:0042802; GO:0043197; GO:0043198; GO:0043542; GO:0048023; GO:0048167; GO:0098685; GO:0098761; GO:0098793; GO:0098794; GO:0098978; GO:0099171,cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167],brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506],actin binding [GO:0003779]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102],GO:0005829; GO:0008092; GO:0023052; GO:0031410; GO:0043226; GO:0048870,cytosol; cytoskeletal protein binding; signaling; cytoplasmic vesicle; organelle; cell motility
OG_00772,3.4299270668612256,FUN_003840-T1,Peve_00003890,Pocillopora_meandrina_HIv1___RNAseq.g11708.t1,three_way,63.461333333333336,FUN_003840-T1,A7MBJ4,PTPRF_BOVIN,,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),Bos taurus (Bovine),31.0,1540.0,1.8000000000000001e-162,575.5,sp|A7MBJ4|PTPRF_BOVIN Receptor-type tyrosine-protein phosphatase F OS=Bos taurus OX=9913 GN=PTPRF PE=2 SV=1,GO:0004725; GO:0007165; GO:0008201; GO:0016020; GO:0016477; GO:0035335; GO:0099560; GO:1900121,cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560],membrane [GO:0016020],heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0007155; GO:0016787; GO:0048870; GO:0140096,"catalytic activity; cell adhesion; hydrolase activity; cell motility; catalytic activity, acting on a protein"
OG_00773,1.1015424982412252,FUN_003843-T1,Peve_00042650,Pocillopora_meandrina_HIv1___TS.g7797.t1,three_way,79.19866666666667,FUN_003843-T1,P51687,SUOX_HUMAN,,"Sulfite oxidase, mitochondrial (EC 1.8.3.1)",Homo sapiens (Human),58.0,500.0,1.2999999999999999e-169,597.8,"sp|P51687|SUOX_HUMAN Sulfite oxidase, mitochondrial OS=Homo sapiens OX=9606 GN=SUOX PE=1 SV=2",GO:0005739; GO:0005758; GO:0005759; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546,sulfur compound metabolic process [GO:0006790],mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482],GO:0003824; GO:0005739; GO:0006790; GO:0016491; GO:0043226,catalytic activity; mitochondrion; sulfur compound metabolic process; oxidoreductase activity; organelle
OG_00775,2.529443644475588,FUN_003847-T1,Peve_00009243,Pocillopora_meandrina_HIv1___RNAseq.g11165.t1,three_way,62.71566666666666,FUN_003847-T1,Q80TL4,PHF24_MOUSE,,PHD finger protein 24,Mus musculus (Mouse),30.2,268.0,2.8e-31,137.9,sp|Q80TL4|PHF24_MOUSE PHD finger protein 24 OS=Mus musculus OX=10090 GN=Phf24 PE=1 SV=2,GO:0007214; GO:0008270; GO:0008277; GO:0030672; GO:0032228; GO:0050966; GO:0098978,"detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic transmission, GABAergic [GO:0032228]",glutamatergic synapse [GO:0098978]; synaptic vesicle membrane [GO:0030672],zinc ion binding [GO:0008270],GO:0023052,signaling
OG_00778,2.738922340873977,FUN_003852-T2,Peve_00012768,Pocillopora_meandrina_HIv1___RNAseq.g11582.t1,three_way,50.0285,FUN_003852-T2,Q9QYT7,,,,,39.9,318.0,3.4e-54,214.5,sp|Q9QYT7|PIGQ_MOUSE Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q OS=Mus musculus OX=10090 GN=Pigq PE=1 SV=3,,,,,,
OG_00780,1.6776025604008704,FUN_003878-T1,Peve_00009218,Pocillopora_meandrina_HIv1___RNAseq.g11578.t2,three_way,60.194833333333335,FUN_003878-T1,Q7TT28,,,,,47.5,438.0,1.0999999999999998e-105,385.2,sp|Q7TT28|REXO1_MOUSE RNA exonuclease 1 homolog OS=Mus musculus OX=10090 GN=Rexo1 PE=1 SV=1,,,,,,
OG_00781,2.478527622476108,FUN_003881-T1,Peve_00023686,Pocillopora_meandrina_HIv1___RNAseq.g11577.t1,three_way,74.771,FUN_003881-T1,Q66KE8,,,,,30.9,459.0,4.3e-50,201.4,sp|Q66KE8|CCD78_XENLA Coiled-coil domain-containing protein 78 OS=Xenopus laevis OX=8355 GN=ccdc78 PE=2 SV=1,,,,,,
OG_00783,1.343211979564532,FUN_003893-T1,Peve_00015146,Pocillopora_meandrina_HIv1___RNAseq.g11573.t1,three_way,87.305,FUN_003893-T1,Q9H2P9,,,,,65.8,272.0,9.3e-105,381.3,sp|Q9H2P9|DPH5_HUMAN Diphthine methyl ester synthase OS=Homo sapiens OX=9606 GN=DPH5 PE=1 SV=2,,,,,,
OG_00784,1.3525938441030452,FUN_003894-T1,Peve_00015142,Pocillopora_meandrina_HIv1___RNAseq.g11707.t1,three_way,79.82766666666667,FUN_003894-T1,P35574,,,,,51.0,1345.0,0.0,1379.0,sp|P35574|GDE_RABIT Glycogen debranching enzyme OS=Oryctolagus cuniculus OX=9986 GN=AGL PE=1 SV=1,,,,,,
OG_00786,1.8730025421648369,FUN_003899-T1,Peve_00015155,Pocillopora_meandrina_HIv1___RNAseq.g11681.t1,three_way,79.42999999999999,FUN_003899-T1,Q9V0D5,,,,,38.2,353.0,3.400000000000001e-65,250.4,sp|Q9V0D5|MDH_PYRAB Malate dehydrogenase OS=Pyrococcus abyssi (strain GE5 / Orsay) OX=272844 GN=mdh PE=3 SV=1,,,,,,
OG_00787,3.6500557618617617,FUN_003900-T1,Peve_00025157,Pocillopora_meandrina_HIv1___RNAseq.g17184.t1,three_way,80.535,FUN_003900-T1,Q69ZJ7,RIC1_MOUSE,,Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1),Mus musculus (Mouse),40.0,1396.0,3.9000000000000003e-284,979.5,sp|Q69ZJ7|RIC1_MOUSE Guanine nucleotide exchange factor subunit RIC1 OS=Mus musculus OX=10090 GN=Ric1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547,"intracellular protein transport [GO:0006886]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005829; GO:0006886; GO:0016192; GO:0098772,cytosol; intracellular protein transport; vesicle-mediated transport; molecular function regulator activity
OG_00788,1.3768416617034764,FUN_003901-T1,Peve_00012083,Pocillopora_meandrina_HIv1___RNAseq.g17185.t1,three_way,78.26033333333334,FUN_003901-T1,Q4KM73,KCY_RAT,,UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK),Rattus norvegicus (Rat),58.6,191.0,3.2e-57,223.0,sp|Q4KM73|KCY_RAT UMP-CMP kinase OS=Rattus norvegicus OX=10116 GN=Cmpk1 PE=1 SV=2,GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006225; GO:0006227; GO:0006240; GO:0009041; GO:0018963; GO:0022602; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0050145,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; dCDP biosynthetic process [GO:0006240]; dUDP biosynthetic process [GO:0006227]; ovulation cycle process [GO:0022602]; phthalate metabolic process [GO:0018963]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; nucleus [GO:0005634],(d)CMP kinase activity [GO:0004127]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862]; UMP/dUMP kinase activity [GO:0009041],GO:0003824; GO:0005634; GO:0016740; GO:0022414; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; transferase activity; reproductive process; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00789,1.1781833144632918,FUN_003934-T1,Peve_00006586,Pocillopora_meandrina_HIv1___RNAseq.g11751.t1,three_way,62.47316666666666,FUN_003934-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),34.2,184.0,3e-23,113.2,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_00790,2.738614126639473,FUN_003935-T1,Peve_00041379,Pocillopora_meandrina_HIv1___RNAseq.g11752.t1,three_way,90.497,FUN_003935-T1,Q2M2T6,,,,,72.6,84.0,2.0000000000000002e-29,129.4,sp|Q2M2T6|ASTER_BOVIN PAT complex subunit Asterix OS=Bos taurus OX=9913 GN=WDR83OS PE=3 SV=1,,,,,,
OG_00791,1.7103181524087236,FUN_003937-T1,Peve_00041383,Pocillopora_meandrina_HIv1___RNAseq.g11755.t1,three_way,80.51333333333334,FUN_003937-T1,Q9N4X8,,,,,26.7,217.0,9.7e-14,79.0,sp|Q9N4X8|GSTPA_CAEEL Glutathione S-transferase P 10 OS=Caenorhabditis elegans OX=6239 GN=gst-10 PE=1 SV=3,,,,,,
OG_00793,3.095723136230109,FUN_003940-T1,Peve_00038457,Pocillopora_meandrina_HIv1___RNAseq.g11757.t1,three_way,58.294,FUN_003940-T1,Q6DG99,,,,,53.7,95.0,7.6e-19,96.3,sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1,,,,,,
OG_00796,2.657634702019124,FUN_003982-T1,Peve_00038451,Pocillopora_meandrina_HIv1___TS.g7876.t1,three_way,62.93233333333333,,,,,,,,,,,,,,,,,
OG_00798,1.8310832208076784,FUN_003990-T1,Peve_00038455,Pocillopora_meandrina_HIv1___RNAseq.g17198.t1,three_way,89.71566666666666,FUN_003990-T1,Q6DHU4,,,,,74.7,190.0,1.4e-81,304.7,sp|Q6DHU4|PR38A_DANRE Pre-mRNA-splicing factor 38A OS=Danio rerio OX=7955 GN=prpf38a PE=2 SV=1,,,,,,
OG_00800,1.0356080315100669,FUN_003996-T1,Peve_00038453,Pocillopora_meandrina_HIv1___RNAseq.g17200.t1,three_way,59.2325,FUN_003996-T1,P24524,GLRA3_RAT,,Glycine receptor subunit alpha-3,Rattus norvegicus (Rat),27.8,399.0,5.9e-36,153.3,sp|P24524|GLRA3_RAT Glycine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Glra3 PE=1 SV=1,GO:0004888; GO:0005886; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0042734; GO:0043204; GO:0046872; GO:0051260; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099171; GO:0099634; GO:1902476,cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734],extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888],GO:0005215; GO:0005886; GO:0055085; GO:0060089; GO:0065003,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity; protein-containing complex assembly
OG_00801,1.9305306679259429,FUN_003999-T1,Peve_00034334,Pocillopora_meandrina_HIv1___RNAseq.g11693.t1,three_way,63.882666666666665,FUN_003999-T1,P21956,MFGM_MOUSE,,Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (MP47),Mus musculus (Mouse),32.1,346.0,3.3e-32,141.0,sp|P21956|MFGM_MOUSE Lactadherin OS=Mus musculus OX=10090 GN=Mfge8 PE=1 SV=3,GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0043277; GO:0050766; GO:0062023,"angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]",acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615],integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786],GO:0005615; GO:0007155; GO:0008289; GO:0016192; GO:0022414; GO:0061024,extracellular space; cell adhesion; lipid binding; vesicle-mediated transport; reproductive process; membrane organization
OG_00803,1.2236995998389488,FUN_004001-T1,Peve_00034328,Pocillopora_meandrina_HIv1___RNAseq.g11699.t1,three_way,70.47566666666667,FUN_004001-T1,Q90240,CBPD_ANAPL,,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) (p170),Anas platyrhynchos (Mallard) (Anas boschas),54.0,376.0,4.3e-119,430.3,sp|Q90240|CBPD_ANAPL Carboxypeptidase D OS=Anas platyrhynchos OX=8839 GN=CPD PE=1 SV=1,GO:0004181; GO:0005615; GO:0005886; GO:0006508; GO:0006518; GO:0008270; GO:0016020; GO:0016485,peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_00808,3.063489783675602,FUN_004007-T1,Peve_00044893,Pocillopora_meandrina_HIv1___RNAseq.g11703.t1b,three_way,74.065,FUN_004007-T1,O95405,,,,,43.3,743.0,2.8000000000000003e-161,571.2,sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2,,,,,,
OG_00812,1.5467051085552292,FUN_004015-T2,Peve_00034335,Pocillopora_meandrina_HIv1___RNAseq.g11692.t1,three_way,62.5775,,,,,,,,,,,,,,,,,
OG_00816,3.037957556581788,FUN_004029-T1,Peve_00003922,Pocillopora_meandrina_HIv1___TS.g18515.t2,three_way,93.10066666666664,FUN_004029-T1,Q9R050,,,,,40.6,414.0,1.6999999999999998e-53,211.5,sp|Q9R050|SSBP3_RAT Single-stranded DNA-binding protein 3 OS=Rattus norvegicus OX=10116 GN=Ssbp3 PE=1 SV=1,,,,,,
OG_00817,1.6213020711883244,FUN_004035-T1,Peve_00008958,Pocillopora_meandrina_HIv1___RNAseq.g11552.t1,three_way,38.5565,,,,,,,,,,,,,,,,,
OG_00820,2.491455062942054,FUN_004038-T1,Peve_00008961,Pocillopora_meandrina_HIv1___RNAseq.g11549.t1,three_way,96.45366666666666,FUN_004038-T1,Q2KJ81,AP1M1_BOVIN,,AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin),Bos taurus (Bovine),81.5,422.0,8.299999999999998e-206,717.6,sp|Q2KJ81|AP1M1_BOVIN AP-1 complex subunit mu-1 OS=Bos taurus OX=9913 GN=AP1M1 PE=1 SV=3,GO:0005794; GO:0006886; GO:0016192; GO:0030131; GO:0030136; GO:0030665; GO:0035615,intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794],clathrin adaptor activity [GO:0035615],GO:0005794; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090,Golgi apparatus; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_00821,2.969328868250773,FUN_004039-T1,Peve_00008962,Pocillopora_meandrina_HIv1___RNAseq.g11550.t1,three_way,79.03166666666667,FUN_004039-T1,D3YXK1,SAMD1_MOUSE,,Sterile alpha motif domain-containing protein 1 (SAM domain-containing protein 1) (Atherin),Mus musculus (Mouse),54.7,75.0,7.5e-17,90.1,sp|D3YXK1|SAMD1_MOUSE Sterile alpha motif domain-containing protein 1 OS=Mus musculus OX=10090 GN=Samd1 PE=1 SV=1,GO:0000122; GO:0003677; GO:0003682; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0030169; GO:0034439; GO:0051260; GO:0090077; GO:0160217,chromatin organization [GO:0006325]; foam cell differentiation [GO:0090077]; lipoprotein lipid oxidation [GO:0034439]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription initiation-coupled chromatin remodeling [GO:0160217]; protein homooligomerization [GO:0051260],chromosome [GO:0005694]; extracellular space [GO:0005615]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; low-density lipoprotein particle binding [GO:0030169],GO:0003677; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0006355; GO:0006629; GO:0030154; GO:0043226; GO:0065003,DNA binding; extracellular space; nucleus; chromosome; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_00823,1.4254227861394655,FUN_004050-T1,Peve_00003959,Pocillopora_meandrina_HIv1___RNAseq.g12634.t1,three_way,73.86366666666666,FUN_004050-T1,A2VDD2,,,,,41.5,130.0,1.7e-19,97.4,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_00824,1.9408069235961505,FUN_004053-T1,Peve_00003958,Pocillopora_meandrina_HIv1___RNAseq.g12635.t1,three_way,54.064,,,,,,,,,,,,,,,,,
OG_00825,2.2993815389873253,FUN_004054-T1,Peve_00003957,Pocillopora_meandrina_HIv1___RNAseq.g12636.t1,three_way,93.765,FUN_004054-T1,Q28DV3,HDAC3_XENTR,,Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),70.9,423.0,2.2e-182,639.8,sp|Q28DV3|HDAC3_XENTR Histone deacetylase 3 OS=Xenopus tropicalis OX=8364 GN=hdac3 PE=2 SV=1,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005694; GO:0005737; GO:0005829; GO:0017053; GO:0032922; GO:0033558; GO:0042752; GO:0046872; GO:0141221; GO:0160008; GO:0160009; GO:0160010; GO:0160216,circadian regulation of gene expression [GO:0032922]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone decrotonylase activity [GO:0160009]; metal ion binding [GO:0046872]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein decrotonylase activity [GO:0160008]; protein lysine deacetylase activity [GO:0033558]; protein lysine delactylase activity [GO:0160216]; transcription corepressor activity [GO:0003714]",GO:0003824; GO:0005634; GO:0005694; GO:0005829; GO:0006355; GO:0016787; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; cytosol; regulation of DNA-templated transcription; hydrolase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_00826,1.094485220377864,FUN_004055-T1,Peve_00004708,Pocillopora_meandrina_HIv1___TS.g18498.t1,three_way,83.49266666666666,FUN_004055-T1,Q29RZ2,,,,,66.3,596.0,1e-236,820.8,sp|Q29RZ2|PPWD1_BOVIN Peptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Bos taurus OX=9913 GN=PPWD1 PE=2 SV=1,,,,,,
OG_00827,2.6838801153441274,FUN_004056-T1,Peve_00007130,Pocillopora_meandrina_HIv1___TS.g18499.t1,three_way,72.9045,FUN_004056-T1,Q6P0Q8,MAST2_HUMAN,,Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1),Homo sapiens (Human),43.5,1429.0,1.8999999999999997e-236,821.2,sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2,GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310,cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_00830,2.015282839644409,FUN_004061-T1,Peve_00024041,Pocillopora_meandrina_HIv1___RNAseq.g12603.t1,three_way,78.07933333333334,FUN_004061-T1,Q95LM1,,,,,47.3,146.0,1.4e-32,142.1,sp|Q95LM1|UBE2U_MACFA Ubiquitin-conjugating enzyme E2 U OS=Macaca fascicularis OX=9541 GN=UBE2U PE=2 SV=1,,,,,,
OG_00833,3.7568890343761496,FUN_004078-T1,Peve_00006662,Pocillopora_meandrina_HIv1___RNAseq.g17237.t1,three_way,69.94466666666666,FUN_004078-T1,B1AS42,NB5R5_MOUSE,,NADH-cytochrome b5 reductase-like (EC 1.6.2.2),Mus musculus (Mouse),39.5,311.0,9.999999999999999e-64,245.4,sp|B1AS42|NB5R5_MOUSE NADH-cytochrome b5 reductase-like OS=Mus musculus OX=10090 GN=Cyb5rl PE=2 SV=1,GO:0004128; GO:0005654; GO:0005789,,endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]",GO:0003824; GO:0005654; GO:0016491,catalytic activity; nucleoplasm; oxidoreductase activity
OG_00834,1.6740178621511768,FUN_004079-T1,Peve_00007133,Pocillopora_meandrina_HIv1___RNAseq.g17243.t1,three_way,61.05466666666667,FUN_004079-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),36.1,651.0,7.7e-94,347.4,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_00835,1.7878269010450665,FUN_004084-T1,Peve_00006656,Pocillopora_meandrina_HIv1___RNAseq.g17235.t1,three_way,83.86,FUN_004084-T1,Q8IWG1,DNAI3_HUMAN,,Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63),Homo sapiens (Human),48.8,801.0,4.1e-223,776.2,sp|Q8IWG1|DNAI3_HUMAN Dynein axonemal intermediate chain 3 OS=Homo sapiens OX=9606 GN=DNAI3 PE=1 SV=1,GO:0005737; GO:0005858; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933,cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669],axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156],Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503],GO:0007018; GO:0065003,microtubule-based movement; protein-containing complex assembly
OG_00837,1.9590192376494668,FUN_004087-T1,Peve_00024026,Pocillopora_meandrina_HIv1___RNAseq.g12612.t1,three_way,69.48666666666666,FUN_004087-T1,Q8NE22,,,,,43.2,294.0,6.8e-60,232.3,sp|Q8NE22|SETD9_HUMAN SET domain-containing protein 9 OS=Homo sapiens OX=9606 GN=SETD9 PE=1 SV=2,,,,,,
OG_00838,1.8392702603108644,FUN_004088-T1,Peve_00024024,Pocillopora_meandrina_HIv1___RNAseq.29948_t,three_way,59.1695,FUN_004088-T1,Q0KIA2,,,,,44.8,232.0,3.5e-49,197.6,sp|Q0KIA2|Y9801_DROME PP2C-like domain-containing protein CG9801 OS=Drosophila melanogaster OX=7227 GN=CG9801 PE=2 SV=1,,,,,,
OG_00842,1.2486545559463291,FUN_004093-T1,Peve_00003956,Pocillopora_meandrina_HIv1___RNAseq.g12637.t1,three_way,72.56333333333333,FUN_004093-T1,O60235,TM11D_HUMAN,,Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain],Homo sapiens (Human),44.9,245.0,7.2e-58,225.7,sp|O60235|TM11D_HUMAN Transmembrane protease serine 11D OS=Homo sapiens OX=9606 GN=TMPRSS11D PE=1 SV=1,GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0007585; GO:0008233; GO:0070062,proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00843,3.15831814866902,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_00844,3.405346789594119,FUN_004095-T1,Peve_00028986,Pocillopora_meandrina_HIv1___RNAseq.g11568.t1,three_way,55.16966666666666,FUN_004095-T1,Q96S53,TESK2_HUMAN,,Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2),Homo sapiens (Human),50.5,287.0,5.2e-76,287.0,sp|Q96S53|TESK2_HUMAN Dual specificity testis-specific protein kinase 2 OS=Homo sapiens OX=9606 GN=TESK2 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007283; GO:0016604; GO:0030036; GO:0046872; GO:0048041; GO:0106310,actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0007010; GO:0016740; GO:0022414; GO:0034330; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytoskeleton organization; transferase activity; reproductive process; cell junction organization; organelle; catalytic activity, acting on a protein"
OG_00846,1.4044701622759217,FUN_004097-T1,Peve_00028981,Pocillopora_meandrina_HIv1___RNAseq.g11566.t1,three_way,55.645,FUN_004097-T1,Q0V8E4,,,,,39.4,787.0,1.6000000000000006e-130,468.4,sp|Q0V8E4|ASND1_BOVIN Asparagine synthetase domain-containing protein 1 OS=Bos taurus OX=9913 GN=ASNSD1 PE=2 SV=1,,,,,,
OG_00851,2.551960871261275,FUN_004110-T1,Peve_00015644,Pocillopora_meandrina_HIv1___RNAseq.g11664.t1,three_way,73.29766666666667,FUN_004110-T1,Q5ZL21,MMAC_CHICK,,Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase) (EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating)) (EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein) (MMACHC),Gallus gallus (Chicken),51.5,233.0,3.2e-64,246.5,sp|Q5ZL21|MMAC_CHICK Cyanocobalamin reductase / alkylcobalamin dealkylase OS=Gallus gallus OX=9031 GN=MMACHC PE=2 SV=1,GO:0005737; GO:0005829; GO:0006749; GO:0009235; GO:0016491; GO:0016740; GO:0031419; GO:0032451; GO:0033787; GO:0043295; GO:0070988; GO:0071949,cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749],cytoplasm [GO:0005737]; cytosol [GO:0005829],cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) (NADP+) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740],GO:0003824; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740,catalytic activity; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity
OG_00854,2.2196385797208524,FUN_004117-T1,Peve_00038521,Pocillopora_meandrina_HIv1___RNAseq.g11674.t1,three_way,85.43533333333333,FUN_004117-T1,F1Q8K0,RAD54_DANRE,,DNA repair and recombination protein RAD54-like (EC 3.6.4.12),Danio rerio (Zebrafish) (Brachydanio rerio),66.8,744.0,3.7000000000000004e-292,1005.4,sp|F1Q8K0|RAD54_DANRE DNA repair and recombination protein RAD54-like OS=Danio rerio OX=7955 GN=rad54l PE=1 SV=1,GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0008094; GO:0015616; GO:0016787; GO:0045003,double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131],nucleus [GO:0005634],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]",GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_00855,1.2109031024485966,FUN_004118-T1,Peve_00038523,Pocillopora_meandrina_HIv1___RNAseq.g11675.t1,three_way,73.94633333333333,FUN_004118-T1,Q9D6Z0,ALKB7_MOUSE,,"Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7)",Mus musculus (Mouse),55.4,168.0,3.8e-49,196.4,"sp|Q9D6Z0|ALKB7_MOUSE Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial OS=Mus musculus OX=10090 GN=Alkbh7 PE=1 SV=1",GO:0005739; GO:0005759; GO:0006631; GO:0006974; GO:0010883; GO:0046872; GO:0051213; GO:1902445,DNA damage response [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0006629; GO:0007005; GO:0016491; GO:0043226; GO:0061024,catalytic activity; mitochondrion; lipid metabolic process; mitochondrion organization; oxidoreductase activity; organelle; membrane organization
OG_00857,2.284247737482314,FUN_004120-T1,Peve_00038526,Pocillopora_meandrina_HIv1___RNAseq.g11677.t1,three_way,73.13033333333333,FUN_004120-T1,Q8IZS6,,,,,35.3,119.0,1.4e-13,77.8,sp|Q8IZS6|DYLT2_HUMAN Dynein light chain Tctex-type protein 2 OS=Homo sapiens OX=9606 GN=DYNLT2 PE=1 SV=1,,,,,,
OG_00858,1.4104382894782577,FUN_004121-T2,Peve_00029608,Pocillopora_meandrina_HIv1___RNAseq.g11680.t2,three_way,75.833,FUN_004121-T2,Q6DCG4,RHBGB_XENLA,,Ammonium transporter Rh type B-B (Rhesus blood group family type B glycoprotein B) (Rh family type B glycoprotein B) (Rh type B glycoprotein B),Xenopus laevis (African clawed frog),48.8,445.0,2e-110,401.0,sp|Q6DCG4|RHBGB_XENLA Ammonium transporter Rh type B-B OS=Xenopus laevis OX=8355 GN=rhbg-b PE=2 SV=1,GO:0005886; GO:0008519; GO:0016323; GO:0030659; GO:0072488; GO:0097272,ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488],basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886],ammonium channel activity [GO:0008519],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_00859,1.9538581804084256,FUN_004123-T1,Peve_00009572,Pocillopora_meandrina_HIv1___RNAseq.g11558.t1,three_way,79.28416666666666,,,,,,,,,,,,,,,,,
OG_00862,2.43686755432044,FUN_004127-T1,Peve_00004367,Pocillopora_meandrina_HIv1___RNAseq.g11562.t1,three_way,66.90633333333334,FUN_004127-T1,Q2I327,,,,,32.2,357.0,2.5e-27,124.8,sp|Q2I327|DMTA2_XIPMA Doublesex- and mab-3-related transcription factor A2 OS=Xiphophorus maculatus OX=8083 GN=dmrta2 PE=2 SV=1,,,,,,
OG_00863,1.579219155013084,FUN_004128-T1,Peve_00021772,Pocillopora_meandrina_HIv1___RNAseq.g16786.t1,three_way,47.478,,,,,,,,,,,,,,,,,
OG_00866,4.120261212412012,FUN_004140-T2,Peve_00009429,Pocillopora_meandrina_HIv1___RNAseq.g11564.t1,three_way,92.6315,FUN_004140-T2,Q07343,PDE4B_HUMAN,,"3',5'-cyclic-AMP phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32) (cAMP-specific phosphodiesterase 4B)",Homo sapiens (Human),56.3,551.0,1.1000000000000001e-168,595.1,"sp|Q07343|PDE4B_HUMAN 3',5'-cyclic-AMP phosphodiesterase 4B OS=Homo sapiens OX=9606 GN=PDE4B PE=1 SV=1",GO:0000930; GO:0001780; GO:0004115; GO:0005246; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0008021; GO:0014069; GO:0019933; GO:0030018; GO:0030552; GO:0030593; GO:0032729; GO:0032743; GO:0043015; GO:0043197; GO:0044325; GO:0046872; GO:0047555; GO:0050852; GO:0050900; GO:0060076; GO:0071222; GO:0071466; GO:0071872; GO:0071878; GO:0086004; GO:1901898; GO:1902514,cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; leukocyte migration [GO:0050900]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of type II interferon production [GO:0032729]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell contraction [GO:0086004]; T cell receptor signaling pathway [GO:0050852],centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium channel regulator activity [GO:0005246]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]",GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0048870; GO:0055086; GO:0098772; GO:1901135,immune system process; catalytic activity; microtubule organizing center; cytosol; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; cell motility; nucleobase-containing small molecule metabolic process; molecular function regulator activity; carbohydrate derivative metabolic process
OG_00867,2.622735124029945,FUN_004142-T1,Peve_00004368,Pocillopora_meandrina_HIv1___RNAseq.g144.t1,three_way,51.94683333333333,FUN_004142-T1,Q5T890,ER6L2_HUMAN,,DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) (DNA repair and recombination protein RAD26-like) (Excision repair cross-complementation group 6-like 2),Homo sapiens (Human),31.5,1000.0,5.9999999999999986e-93,344.0,sp|Q5T890|ER6L2_HUMAN DNA excision repair protein ERCC-6-like 2 OS=Homo sapiens OX=9606 GN=ERCC6L2 PE=1 SV=3,GO:0000775; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0006974; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0097680,cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; interstrand cross-link repair [GO:0036297],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0006281; GO:0016787; GO:0016853; GO:0043226; GO:0140657,DNA binding; catalytic activity; nucleus; mitochondrion; microtubule organizing center; DNA repair; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_00870,1.4355189935774555,FUN_004158-T1,Peve_00031569,Pocillopora_meandrina_HIv1___RNAseq.g16773.t1,three_way,68.55266666666667,FUN_004158-T1,Q96SL4,GPX7_HUMAN,,Glutathione peroxidase 7 (GPx-7) (GSHPx-7) (EC 1.11.1.9) (CL683),Homo sapiens (Human),50.3,151.0,2.7e-39,163.3,sp|Q96SL4|GPX7_HUMAN Glutathione peroxidase 7 OS=Homo sapiens OX=9606 GN=GPX7 PE=1 SV=1,GO:0004096; GO:0004601; GO:0004602; GO:0005576; GO:0005783; GO:0005788; GO:0034599,cellular response to oxidative stress [GO:0034599],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576],catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601],GO:0003824; GO:0005576; GO:0005783; GO:0016209; GO:0016491; GO:0043226,catalytic activity; extracellular region; endoplasmic reticulum; antioxidant activity; oxidoreductase activity; organelle
OG_00872,2.075145518764125,FUN_004160-T1,Peve_00031557,Pocillopora_meandrina_HIv1___RNAseq.g16770.t1,three_way,82.089,FUN_004160-T1,Q6QI06,RICTR_MOUSE,,Rapamycin-insensitive companion of mTOR (AVO3 homolog) (mAVO3) (Protein pianissimo),Mus musculus (Mouse),48.6,1035.0,4.7e-280,966.5,sp|Q6QI06|RICTR_MOUSE Rapamycin-insensitive companion of mTOR OS=Mus musculus OX=10090 GN=Rictor PE=1 SV=2,GO:0001932; GO:0001938; GO:0005524; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005886; GO:0007010; GO:0008270; GO:0008610; GO:0009792; GO:0010468; GO:0019901; GO:0030036; GO:0030307; GO:0030335; GO:0030838; GO:0031669; GO:0031932; GO:0032008; GO:0038203; GO:0043022; GO:0043066; GO:0043539; GO:0050727; GO:0051896; GO:0051897; GO:0140767; GO:1902554; GO:2000114,actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein phosphorylation [GO:0001932]; TORC2 signaling [GO:0038203],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; serine/threonine protein kinase complex [GO:1902554]; TORC2 complex [GO:0031932],ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270],GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0006629; GO:0007010; GO:0043226; GO:0048856; GO:0060090; GO:0098772,lysosome; vacuole; endoplasmic reticulum; plasma membrane; lipid metabolic process; cytoskeleton organization; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_00875,1.2357835620386657,FUN_004164-T1,Peve_00031562,Pocillopora_meandrina_HIv1___RNAseq.g16741.t2,three_way,58.028333333333336,FUN_004164-T1,Q6GQ33,CMKMT_XENLA,,Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60),Xenopus laevis (African clawed frog),41.3,276.0,1.4999999999999998e-49,198.0,sp|Q6GQ33|CMKMT_XENLA Calmodulin-lysine N-methyltransferase OS=Xenopus laevis OX=8355 GN=camkmt PE=1 SV=1,GO:0005634; GO:0005737; GO:0018025; GO:0032259,methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],calmodulin-lysine N-methyltransferase activity [GO:0018025],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00878,1.1742659094496173,FUN_004171-T1,Peve_00031567,Pocillopora_meandrina_HIv1___TS.g17567.t1,three_way,78.7845,FUN_004171-T1,Q865S1,,,,,55.2,1283.0,0.0,1110.1,sp|Q865S1|AP3D1_BOVIN AP-3 complex subunit delta-1 OS=Bos taurus OX=9913 GN=AP3D1 PE=1 SV=2,,,,,,
OG_00882,1.342814851272405,FUN_004197-T1,Peve_00030901,Pocillopora_meandrina_HIv1___RNAseq.g17019.t1,three_way,60.303666666666665,FUN_004197-T1,Q9H6X5,,,,,37.4,147.0,5.9e-19,97.1,sp|Q9H6X5|CS044_HUMAN Uncharacterized protein C19orf44 OS=Homo sapiens OX=9606 GN=C19orf44 PE=1 SV=1,,,,,,
OG_00883,1.2319366396540885,FUN_004198-T1,Peve_00030902,Pocillopora_meandrina_HIv1___RNAseq.g17020.t1,three_way,77.056,FUN_004198-T1,A2VDD2,,,,,46.6,178.0,5.9e-36,152.5,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_00884,1.3455162634237807,FUN_004199-T1,Peve_00030912,Pocillopora_meandrina_HIv1___RNAseq.g17021.t1,three_way,61.85633333333333,FUN_004199-T1,D3YTS9,PPAT_MOUSE,,Testicular acid phosphatase (EC 3.1.3.2) (Acid phosphatase 4),Mus musculus (Mouse),26.8,332.0,8.2e-14,79.7,sp|D3YTS9|PPAT_MOUSE Testicular acid phosphatase OS=Mus musculus OX=10090 GN=Acp4 PE=1 SV=2,GO:0003993; GO:0004725; GO:0010955; GO:0010977; GO:0016020; GO:0030971; GO:0042476; GO:0048168; GO:0120154; GO:1990264,negative regulation of ERBB4 signaling pathway [GO:0120154]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein processing [GO:0010955]; odontogenesis [GO:0042476]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of neuronal synaptic plasticity [GO:0048168],membrane [GO:0016020],acid phosphatase activity [GO:0003993]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_00885,1.8396032825023192,FUN_004200-T1,Peve_00030913,Pocillopora_meandrina_HIv1___RNAseq.g17022.t1,three_way,70.74116666666667,FUN_004200-T1,Q5ZJ32,,,,,41.7,103.0,4.3e-11,68.9,sp|Q5ZJ32|SOSSC_CHICK SOSS complex subunit C OS=Gallus gallus OX=9031 GN=INIP PE=3 SV=1,,,,,,
OG_00886,1.5841485723587725,FUN_004201-T1,Peve_00030920,Pocillopora_meandrina_HIv1___RNAseq.g17023.t1,three_way,67.14383333333333,,,,,,,,,,,,,,,,,
OG_00887,3.715031221145033,FUN_004202-T1,Peve_00008456,Pocillopora_meandrina_HIv1___RNAseq.g16814.t1,three_way,83.68566666666666,FUN_004202-T1,Q91W43,GCSP_MOUSE,,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))",Mus musculus (Mouse),66.0,968.0,0.0,1327.0,"sp|Q91W43|GCSP_MOUSE Glycine dehydrogenase (decarboxylating), mitochondrial OS=Mus musculus OX=10090 GN=Gldc PE=1 SV=1",GO:0004375; GO:0005654; GO:0005739; GO:0005886; GO:0005960; GO:0006546; GO:0016594; GO:0016829; GO:0019464; GO:0019899; GO:0030170; GO:0036255; GO:0042803; GO:0065003; GO:0070280; GO:1903442; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein-containing complex assembly [GO:0065003]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005886; GO:0006520; GO:0016491; GO:0016829; GO:0043226; GO:0065003,catalytic activity; nucleoplasm; mitochondrion; plasma membrane; amino acid metabolic process; oxidoreductase activity; lyase activity; organelle; protein-containing complex assembly
OG_00889,2.201500675440077,FUN_004204-T1,Peve_00018652,Pocillopora_meandrina_HIv1___RNAseq.g16708.t1,three_way,74.196,FUN_004204-T1,Q96LT7,CI072_HUMAN,,Guanine nucleotide exchange factor C9orf72,Homo sapiens (Human),32.5,459.0,9.2e-60,232.6,sp|Q96LT7|CI072_HUMAN Guanine nucleotide exchange factor C9orf72 OS=Homo sapiens OX=9606 GN=C9orf72 PE=1 SV=2,GO:0000932; GO:0001933; GO:0005085; GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005776; GO:0005829; GO:0006897; GO:0006914; GO:0010494; GO:0010506; GO:0016239; GO:0030425; GO:0031267; GO:0031965; GO:0032045; GO:0032880; GO:0034063; GO:0043204; GO:0043231; GO:0044295; GO:0044304; GO:0045920; GO:0048675; GO:0050777; GO:0061909; GO:0090543; GO:0098686; GO:0098693; GO:0098794; GO:0098978; GO:0099523; GO:0110053; GO:1902774; GO:1903432; GO:2000785,autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of protein localization [GO:0032880]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063],autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005615; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0098772,extracellular space; nucleus; lysosome; endosome; vacuole; cytosol; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; molecular function regulator activity
OG_00891,1.7740583346730758,FUN_004206-T1,Peve_00011052,Pocillopora_meandrina_HIv1___RNAseq.g11215.t1,three_way,57.277,FUN_004206-T1,F4INN2,,,,,33.9,165.0,2e-17,90.9,sp|F4INN2|GGP4_ARATH Gamma-glutamyl peptidase 4 OS=Arabidopsis thaliana OX=3702 GN=GGP4 PE=3 SV=1,,,,,,
OG_00893,3.985545743516239,FUN_004208-T2,Peve_00011048,Pocillopora_meandrina_HIv1___RNAseq.g11218.t1,three_way,83.40266666666666,FUN_004208-T2,P51688,SPHM_HUMAN,,N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase),Homo sapiens (Human),63.4,432.0,4.3e-168,592.4,sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1,GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062,determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_00898,1.5315302839460705,FUN_004213-T1,Peve_00008868,Pocillopora_meandrina_HIv1___RNAseq.g11223.t1,three_way,82.36266666666667,FUN_004213-T1,Q16739,CEGT_HUMAN,,Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (Glycosylceramide synthase) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase),Homo sapiens (Human),43.0,386.0,1e-91,338.6,sp|Q16739|CEGT_HUMAN Ceramide glucosyltransferase OS=Homo sapiens OX=9606 GN=UGCG PE=1 SV=1,GO:0000139; GO:0006497; GO:0006679; GO:0006688; GO:0008120; GO:0008544; GO:0009966; GO:0016020; GO:0030154; GO:0030216; GO:0033210; GO:0048666; GO:0061436; GO:0098856; GO:1903575,cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid biosynthetic process [GO:0006688]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966],Golgi membrane [GO:0000139]; membrane [GO:0016020],ceramide glucosyltransferase activity [GO:0008120],GO:0003824; GO:0006629; GO:0016740; GO:0022600; GO:0030154; GO:0048856; GO:0061024; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; digestive system process; cell differentiation; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_00899,1.349014976330951,FUN_004222-T1,Peve_00008875,Pocillopora_meandrina_HIv1___RNAseq.g11224.t1,three_way,60.746833333333335,,,,,,,,,,,,,,,,,
OG_00902,1.9035266726828344,FUN_004225-T1,Peve_00008866,Pocillopora_meandrina_HIv1___RNAseq.g11227.t1,three_way,81.6255,FUN_004225-T1,Q8BHI9,,,,,63.7,366.0,7.2e-134,478.8,sp|Q8BHI9|NIM1_MOUSE Serine/threonine-protein kinase NIM1 OS=Mus musculus OX=10090 GN=Nim1k PE=2 SV=1,,,,,,
OG_00903,1.993331766365345,FUN_004226-T1,Peve_00012172,Pocillopora_meandrina_HIv1___RNAseq.g11228.t1,three_way,71.90066666666667,FUN_004226-T1,Q5EA53,T2FA_BOVIN,,General transcription factor IIF subunit 1 (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha),Bos taurus (Bovine),51.5,546.0,1.4e-43,179.1,sp|Q5EA53|T2FA_BOVIN General transcription factor IIF subunit 1 OS=Bos taurus OX=9913 GN=GTF2F1 PE=2 SV=1,GO:0001096; GO:0003677; GO:0005669; GO:0005674; GO:0006367; GO:0006368; GO:0009615; GO:0016251; GO:0019211; GO:0019903; GO:0019904; GO:0030054; GO:0032091; GO:0032968; GO:0045944; GO:1990841,negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; response to virus [GO:0009615]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367],cell junction [GO:0030054]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674],DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096],GO:0003677; GO:0006355; GO:0098772; GO:0140223,DNA binding; regulation of DNA-templated transcription; molecular function regulator activity; general transcription initiation factor activity
OG_00905,1.0239176868025903,FUN_004231-T1,Peve_00004622,Pocillopora_meandrina_HIv1___RNAseq.g12557.t1,three_way,62.44083333333334,FUN_004231-T1,Q9Z1N2,ORC1_MOUSE,,Origin recognition complex subunit 1,Mus musculus (Mouse),61.6,398.0,3.2e-132,474.2,sp|Q9Z1N2|ORC1_MOUSE Origin recognition complex subunit 1 OS=Mus musculus OX=10090 GN=Orc1 PE=1 SV=2,GO:0000781; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0006260; GO:0006270; GO:0016887; GO:0046872,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270],"chromosome, telomeric region [GO:0000781]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006260; GO:0016787; GO:0043226,DNA binding; catalytic activity; nucleus; nucleoplasm; DNA replication; hydrolase activity; organelle
OG_00907,1.2164653539945496,FUN_004235-T1,Peve_00037954,Pocillopora_meandrina_HIv1___RNAseq.g11536.t1,three_way,58.8465,FUN_004235-T1,Q6UXP7,,,,,44.5,227.0,5.3e-42,172.6,sp|Q6UXP7|F151B_HUMAN Protein FAM151B OS=Homo sapiens OX=9606 GN=FAM151B PE=1 SV=2,,,,,,
OG_00909,1.4249501054898144,FUN_004237-T1,Peve_00017641,Pocillopora_meandrina_HIv1___RNAseq.g11534.t1,three_way,79.0,,,,,,,,,,,,,,,,,
OG_00910,2.345092600779786,FUN_004238-T1,Peve_00006799,Pocillopora_meandrina_HIv1___RNAseq.g11533.t1,three_way,59.7285,,,,,,,,,,,,,,,,,
OG_00911,1.3890595574023898,FUN_004239-T1,Peve_00017639,Pocillopora_meandrina_HIv1___RNAseq.g11532.t1,three_way,83.35266666666666,,,,,,,,,,,,,,,,,
OG_00912,1.1116310446442788,FUN_004246-T1,Peve_00019439,Pocillopora_meandrina_HIv1___RNAseq.g11530.t1,three_way,76.00466666666667,FUN_004246-T1,Q2T9T9,,,,,28.8,393.0,4.6e-38,160.6,sp|Q2T9T9|FBXW9_BOVIN F-box/WD repeat-containing protein 9 OS=Bos taurus OX=9913 GN=FBXW9 PE=2 SV=1,,,,,,
OG_00914,1.4016078607805018,FUN_004251-T1,Peve_00006779,Pocillopora_meandrina_HIv1___RNAseq.g11526.t1,three_way,72.405,FUN_004251-T1,Q3ULD5,,,,,49.4,557.0,2.3999999999999998e-139,497.3,"sp|Q3ULD5|MCCB_MOUSE Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Mus musculus OX=10090 GN=Mccc2 PE=1 SV=1",,,,,,
OG_00916,2.2573208005800773,FUN_004253-T1,Peve_00001928,Pocillopora_meandrina_HIv1___RNAseq.g11418.t1,three_way,75.71549999999999,FUN_004253-T1,Q9MA55,,,,,30.2,364.0,6e-33,143.7,sp|Q9MA55|ACBP4_ARATH Acyl-CoA-binding domain-containing protein 4 OS=Arabidopsis thaliana OX=3702 GN=ACBP4 PE=1 SV=1,,,,,,
OG_00917,1.3803427136902766,FUN_004254-T1,Peve_00008964,Pocillopora_meandrina_HIv1___RNAseq.g11417.t1,three_way,77.678,FUN_004254-T1,Q8C0T1,,,,,27.2,489.0,1.4e-37,160.2,sp|Q8C0T1|FM1AB_MOUSE Protein fem-1 homolog A-like OS=Mus musculus OX=10090 GN=Fem1al PE=2 SV=1,,,,,,
OG_00921,2.085671611251724,FUN_004263-T1,Peve_00008934,Pocillopora_meandrina_HIv1___RNAseq.g11364.t1,three_way,72.5965,,,,,,,,,,,,,,,,,
OG_00927,1.0771649006457098,FUN_004270-T1,Peve_00021042,Pocillopora_meandrina_HIv1___RNAseq.g11363.t1,three_way,74.17066666666666,FUN_004270-T1,O35459,,,,,53.2,297.0,1.8e-91,337.4,"sp|O35459|ECH1_MOUSE Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial OS=Mus musculus OX=10090 GN=Ech1 PE=1 SV=1",,,,,,
OG_00928,1.0214784068430018,FUN_004272-T1,Peve_00008943,Pocillopora_meandrina_HIv1___RNAseq.g11367.t1,three_way,57.94233333333333,,,,,,,,,,,,,,,,,
OG_00930,2.128450305492859,FUN_004275-T1,Peve_00008946,Pocillopora_meandrina_HIv1___RNAseq.g12553.t1,three_way,69.154,FUN_004275-T1,Q7ZVP8,TM38B_DANRE,,Trimeric intracellular cation channel type B (TRIC-B) (TRICB) (Transmembrane protein 38B),Danio rerio (Zebrafish) (Brachydanio rerio),35.1,251.0,9.999999999999999e-32,138.7,sp|Q7ZVP8|TM38B_DANRE Trimeric intracellular cation channel type B OS=Danio rerio OX=7955 GN=tmem38b PE=2 SV=1,GO:0005267; GO:0005783; GO:0005789; GO:0030500; GO:0031101; GO:0042802; GO:0051279; GO:1903010,fin regeneration [GO:0031101]; regulation of bone development [GO:1903010]; regulation of bone mineralization [GO:0030500]; regulation of release of sequestered calcium ion into cytosol [GO:0051279],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],identical protein binding [GO:0042802]; potassium channel activity [GO:0005267],GO:0005215; GO:0005783; GO:0043226; GO:0048856,transporter activity; endoplasmic reticulum; organelle; anatomical structure development
OG_00932,1.2803378590004066,FUN_004277-T1,Peve_00008949,Pocillopora_meandrina_HIv1___RNAseq.g12518.t1,three_way,65.70383333333334,FUN_004277-T1,F7C1E2,,,,,36.2,345.0,4.2000000000000004e-48,193.4,sp|F7C1E2|SARAF_XENTR Store-operated calcium entry-associated regulatory factor OS=Xenopus tropicalis OX=8364 GN=saraf PE=3 SV=2,,,,,,
OG_00935,1.101412670729187,FUN_004284-T1,Peve_00030010,Pocillopora_meandrina_HIv1___RNAseq.g12512.t1,three_way,59.60416666666666,FUN_004284-T1,Q9V576,WUN_DROME,,Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen),Drosophila melanogaster (Fruit fly),35.2,261.0,1.2999999999999998e-43,178.3,sp|Q9V576|WUN_DROME Putative phosphatidate phosphatase OS=Drosophila melanogaster OX=7227 GN=wun PE=1 SV=2,GO:0005886; GO:0005918; GO:0006644; GO:0007165; GO:0007424; GO:0008195; GO:0008354; GO:0016328; GO:0016791; GO:0019991; GO:0030703; GO:0035233; GO:0035234; GO:0045177; GO:0045824; GO:0046839; GO:0050829,defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; eggshell formation [GO:0030703]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165],apical part of cell [GO:0045177]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; septate junction [GO:0005918],phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195],GO:0003824; GO:0005886; GO:0006629; GO:0012501; GO:0016787; GO:0022414; GO:0034330; GO:0048856; GO:0048870,catalytic activity; plasma membrane; lipid metabolic process; programmed cell death; hydrolase activity; reproductive process; cell junction organization; anatomical structure development; cell motility
OG_00936,1.4511874456606864,FUN_004285-T1,Peve_00018587,Pocillopora_meandrina_HIv1___TS.g7877.t1,three_way,51.23383333333334,FUN_004285-T1,Q15811,,,,,38.4,86.0,2.3e-07,60.1,sp|Q15811|ITSN1_HUMAN Intersectin-1 OS=Homo sapiens OX=9606 GN=ITSN1 PE=1 SV=3,,,,,,
OG_00937,1.2628122462693894,FUN_004286-T1,Peve_00018586,Pocillopora_meandrina_HIv1___RNAseq.g11765.t1,three_way,67.23033333333333,FUN_004286-T1,Q6NU91,,,,,42.3,515.0,5.9e-106,386.3,sp|Q6NU91|NOC4B_XENLA Nucleolar complex protein 4 homolog B OS=Xenopus laevis OX=8355 GN=noc4l-b PE=2 SV=1,,,,,,
OG_00942,2.480031495857952,FUN_004293-T1,Peve_00008382,Pocillopora_meandrina_HIv1___RNAseq.g11771.t1,three_way,62.1905,FUN_004293-T1,A2A9C3,SZT2_MOUSE,,KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR),Mus musculus (Mouse),30.2,3639.0,0.0,1353.6,sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1,GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130,cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667],GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777],,GO:0005777; GO:0043226; GO:0048856,peroxisome; organelle; anatomical structure development
OG_00945,3.312860868236225,FUN_004302-T1,Peve_00033935,Pocillopora_meandrina_HIv1___RNAseq.g11774.t1,three_way,84.65366666666667,FUN_004302-T1,Q90988,SMC2_CHICK,,Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome scaffold protein ScII),Gallus gallus (Chicken),61.0,1173.0,6.6999999999999996e-264,912.1,sp|Q90988|SMC2_CHICK Structural maintenance of chromosomes protein 2 OS=Gallus gallus OX=9031 GN=SMC2 PE=2 SV=1,GO:0000785; GO:0000793; GO:0000796; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0007076; GO:0016887; GO:0051301,cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682],GO:0003824; GO:0005634; GO:0005694; GO:0016787; GO:0043226,catalytic activity; nucleus; chromosome; hydrolase activity; organelle
OG_00946,3.285265775721181,FUN_004303-T1,Peve_00033932,Pocillopora_meandrina_HIv1___RNAseq.g11775.t1,three_way,66.79366666666667,FUN_004303-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),39.8,698.0,4.9e-140,500.0,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00947,1.0348341379520816,FUN_004306-T1,Peve_00033931,Pocillopora_meandrina_HIv1___RNAseq.g11777.t1,three_way,85.68866666666666,FUN_004306-T1,Q86VS8,HOOK3_HUMAN,,Protein Hook homolog 3 (h-hook3) (hHK3),Homo sapiens (Human),49.9,711.0,5.7e-82,307.0,sp|Q86VS8|HOOK3_HUMAN Protein Hook homolog 3 OS=Homo sapiens OX=9606 GN=HOOK3 PE=1 SV=2,GO:0000242; GO:0005737; GO:0005801; GO:0005813; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150; GO:1905719,cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242],dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0007040; GO:0008092; GO:0016192; GO:0043226,microtubule organizing center; cytoskeleton organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; organelle
OG_00950,1.885660063906338,FUN_004310-T1,Peve_00033937,Pocillopora_meandrina_HIv1___RNAseq.g16984.t1,three_way,77.72666666666666,FUN_004310-T1,Q9JJT0,,,,,62.3,374.0,1.7e-141,503.8,sp|Q9JJT0|RCL1_MOUSE RNA 3'-terminal phosphate cyclase-like protein OS=Mus musculus OX=10090 GN=Rcl1 PE=2 SV=1,,,,,,
OG_00953,4.217323409891613,FUN_004313-T1,Peve_00033929,Pocillopora_meandrina_HIv1___RNAseq.g16987.t1,three_way,67.48483333333334,FUN_004313-T1,Q90693,,,,,37.8,1339.0,2e-235,817.8,sp|Q90693|PTC1_CHICK Protein patched homolog 1 OS=Gallus gallus OX=9031 GN=PTCH1 PE=1 SV=1,,,,,,
OG_00957,3.583567533884029,FUN_004321-T1,Peve_00016506,Pocillopora_meandrina_HIv1___RNAseq.g11786.t1,three_way,75.91266666666667,FUN_004321-T1,P54357,,,,,42.0,143.0,3.7e-23,109.4,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_00961,3.5850946549621385,FUN_004330-T1,Peve_00016550,Pocillopora_meandrina_HIv1___RNAseq.g12529.t1,three_way,89.566,FUN_004330-T1,A6QPA3,,,,,37.2,277.0,1.1999999999999999e-41,171.8,sp|A6QPA3|BTBDJ_BOVIN BTB/POZ domain-containing protein 19 OS=Bos taurus OX=9913 GN=BTBD19 PE=2 SV=1,,,,,,
OG_00962,1.936324006114852,FUN_004331-T1,Peve_00016476,Pocillopora_meandrina_HIv1___TS.g18404.t1,three_way,55.634,FUN_004331-T1,Q9V9S7,,,,,33.4,347.0,5.9e-43,177.9,sp|Q9V9S7|SYDE_DROME Rho GTPase-activating protein 100F OS=Drosophila melanogaster OX=7227 GN=RhoGAP100F PE=1 SV=2,,,,,,
OG_00963,2.841427333611501,FUN_004332-T1,Peve_00016477,Pocillopora_meandrina_HIv1___RNAseq.g12532.t1,three_way,86.59233333333333,FUN_004332-T1,Q9UNH5,CC14A_HUMAN,,Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A),Homo sapiens (Human),60.3,459.0,1.4000000000000002e-161,570.9,sp|Q9UNH5|CC14A_HUMAN Dual specificity protein phosphatase CDC14A OS=Homo sapiens OX=9606 GN=CDC14A PE=1 SV=1,GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005813; GO:0005829; GO:0007096; GO:0007605; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686; GO:1902636,cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426],protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005730; GO:0005783; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0016787; GO:0043226; GO:0044782; GO:0050877; GO:0140096,"catalytic activity; nucleoplasm; nucleolus; endoplasmic reticulum; microtubule organizing center; cytosol; cilium; cytoskeleton organization; hydrolase activity; organelle; cilium organization; nervous system process; catalytic activity, acting on a protein"
OG_00969,2.797318454498726,FUN_004342-T1,Peve_00016486,Pocillopora_meandrina_HIv1___RNAseq.g12543.t1,three_way,62.193333333333335,FUN_004342-T1,Q9Y5Q9,,,,,36.5,824.0,3.8999999999999996e-142,507.3,sp|Q9Y5Q9|TF3C3_HUMAN General transcription factor 3C polypeptide 3 OS=Homo sapiens OX=9606 GN=GTF3C3 PE=1 SV=1,,,,,,
OG_00974,2.079600088775289,FUN_004350-T1,Peve_00016543,Pocillopora_meandrina_HIv1___RNAseq.g12505.t1,three_way,81.94066666666667,FUN_004350-T1,P28288,ABCD3_HUMAN,,ATP-binding cassette sub-family D member 3 (EC 3.1.2.-) (EC 7.6.2.-) (70 kDa peroxisomal membrane protein) (PMP70),Homo sapiens (Human),66.0,617.0,2.2999999999999998e-245,849.7,sp|P28288|ABCD3_HUMAN ATP-binding cassette sub-family D member 3 OS=Homo sapiens OX=9606 GN=ABCD3 PE=1 SV=1,GO:0000038; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0006699; GO:0007031; GO:0009410; GO:0015721; GO:0015910; GO:0016020; GO:0016887; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0047617; GO:0140359; GO:1903512,bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_00977,2.0684807496653104,FUN_004356-T1,Peve_00016494,Pocillopora_meandrina_HIv1___RNAseq.g12547.t1,three_way,92.93433333333331,FUN_004356-T1,Q9R1K5,FZR1_MOUSE,,Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog),Mus musculus (Mouse),72.8,500.0,3.4e-203,709.1,sp|Q9R1K5|FZR1_MOUSE Fizzy-related protein homolog OS=Mus musculus OX=10090 GN=Fzr1 PE=1 SV=1,GO:0005654; GO:0006281; GO:0007095; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0051301; GO:0051603; GO:0070306; GO:0097027; GO:1904668; GO:1990756; GO:2000773,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of meiotic nuclear division [GO:0040020],nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654],anaphase-promoting complex binding [GO:0010997]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005654; GO:0006281; GO:0030154; GO:0030163; GO:0060090; GO:0098772,nucleoplasm; DNA repair; cell differentiation; protein catabolic process; molecular adaptor activity; molecular function regulator activity
OG_00981,1.4978673124627686,FUN_004361-T1,Peve_00016675,Pocillopora_meandrina_HIv1___RNAseq.g11448.t1,three_way,87.992,FUN_004361-T1,Q6DC04,CARM1_DANRE,,Histone-arginine methyltransferase CARM1 (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4),Danio rerio (Zebrafish) (Brachydanio rerio),59.8,435.0,4.5e-141,502.7,sp|Q6DC04|CARM1_DANRE Histone-arginine methyltransferase CARM1 OS=Danio rerio OX=7955 GN=carm1 PE=2 SV=1,GO:0000976; GO:0003713; GO:0005634; GO:0005829; GO:0006338; GO:0006355; GO:0008757; GO:0016274; GO:0032259; GO:0033146; GO:0035242; GO:0035642; GO:0043596; GO:0045600; GO:0048742; GO:0070611; GO:0071932; GO:0140903,chromatin remodeling [GO:0006338]; methylation [GO:0032259]; positive regulation of fat cell differentiation [GO:0045600]; regulation of DNA-templated transcription [GO:0006355]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of skeletal muscle fiber development [GO:0048742]; replication fork reversal [GO:0071932],cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634],histone H3R17 methyltransferase activity [GO:0035642]; histone H3R2 methyltransferase activity [GO:0070611]; histone H3R26 methyltransferase activity [GO:0140903]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_00988,1.1171740038986795,FUN_004375-T1,Peve_00008062,Pocillopora_meandrina_HIv1___RNAseq.g16792.t1,three_way,78.937,FUN_004375-T1,Q7KWX9,,,,,46.4,224.0,2.9e-54,213.4,sp|Q7KWX9|EXOS3_DICDI Putative exosome complex component rrp40 OS=Dictyostelium discoideum OX=44689 GN=exosc3 PE=3 SV=1,,,,,,
OG_00990,1.846564778165545,FUN_004377-T1,Peve_00024392,Pocillopora_meandrina_HIv1___RNAseq.g16802.t1,three_way,68.536,FUN_004377-T1,Q96DX4,,,,,36.3,182.0,3.4e-23,112.8,sp|Q96DX4|RSPRY_HUMAN RING finger and SPRY domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RSPRY1 PE=1 SV=1,,,,,,
OG_00991,1.507446393767979,FUN_004378-T1,Peve_00008066,Pocillopora_meandrina_HIv1___RNAseq.g16801.t1,three_way,63.01283333333333,FUN_004378-T1,P13994,YJU2B_HUMAN,,Probable splicing factor YJU2B (Coiled-coil domain-containing protein 130),Homo sapiens (Human),54.2,310.0,8.3e-87,322.4,sp|P13994|YJU2B_HUMAN Probable splicing factor YJU2B OS=Homo sapiens OX=9606 GN=YJU2B PE=1 SV=2,GO:0000398; GO:0005684; GO:0008380; GO:0009615; GO:0071014,"mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA splicing [GO:0008380]",post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684],,GO:0016071,mRNA metabolic process
OG_00992,2.329755475932054,FUN_004379-T1,Peve_00008069,Pocillopora_meandrina_HIv1___TS.g17623.t1,three_way,59.47683333333333,FUN_004379-T1,A2AJ76,HMCN2_MOUSE,,Hemicentin-2,Mus musculus (Mouse),31.6,190.0,1.7e-16,89.7,sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0030054; GO:0032154; GO:0062023,,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],calcium ion binding [GO:0005509],GO:0005576; GO:0030312; GO:0031012,extracellular region; external encapsulating structure; extracellular matrix
OG_00994,1.3427684201023098,FUN_004402-T1,Peve_00009341,Pocillopora_meandrina_HIv1___TS.g8719.t1,three_way,63.466166666666666,FUN_004402-T1,F4JG10,,,,,38.8,366.0,3.3e-66,254.2,"sp|F4JG10|XYN3_ARATH Endo-1,4-beta-xylanase 3 OS=Arabidopsis thaliana OX=3702 GN=XYN3 PE=2 SV=1",,,,,,
OG_00997,2.952961422103958,FUN_004406-T1,Peve_00017185,Pocillopora_meandrina_HIv1___RNAseq.g4937.t1,three_way,59.73633333333333,FUN_004406-T1,Q9BUJ2,,,,,50.9,389.0,1.8e-111,404.8,sp|Q9BUJ2|HNRL1_HUMAN Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Homo sapiens OX=9606 GN=HNRNPUL1 PE=1 SV=2,,,,,,
OG_00998,2.479414156009778,FUN_004407-T1,Peve_00017184,Pocillopora_meandrina_HIv1___RNAseq.g4936.t1,three_way,80.429,FUN_004407-T1,Q96KB5,,,,,50.2,303.0,6.2e-71,269.2,sp|Q96KB5|TOPK_HUMAN Lymphokine-activated killer T-cell-originated protein kinase OS=Homo sapiens OX=9606 GN=PBK PE=1 SV=3,,,,,,
OG_01001,1.5622663298352617,FUN_004415-T1,Peve_00028020,Pocillopora_meandrina_HIv1___RNAseq.g11586.t2,three_way,58.41816666666666,FUN_004415-T1,Q9D2E2,,,,,39.2,487.0,1.3e-82,308.5,sp|Q9D2E2|TOE1_MOUSE Target of EGR1 protein 1 OS=Mus musculus OX=10090 GN=Toe1 PE=1 SV=1,,,,,,
OG_01005,1.51830045731885,FUN_004427-T1,Peve_00033227,Pocillopora_meandrina_HIv1___RNAseq.g11386.t1,three_way,54.113166666666665,FUN_004427-T1,Q9I829,,,,,32.1,427.0,1.5e-45,185.3,sp|Q9I829|KCNA1_ONCMY Shaker-related potassium channel tsha2 OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1,,,,,,
OG_01007,2.607714533324217,FUN_004431-T1,Peve_00033220,Pocillopora_meandrina_HIv1___RNAseq.g11379.t1,three_way,81.504,FUN_004431-T1,Q7ZW46,,,,,57.3,321.0,2.5e-101,370.2,sp|Q7ZW46|S35B4_DANRE UDP-xylose and UDP-N-acetylglucosamine transporter OS=Danio rerio OX=7955 GN=slc35b4 PE=2 SV=1,,,,,,
OG_01009,2.395244215695973,FUN_004436-T1,Peve_00033216,Pocillopora_meandrina_HIv1___RNAseq.g11488.t1,three_way,71.79266666666666,FUN_004436-T1,Q9H3R0,,,,,38.8,1037.0,4.0999999999999996e-191,669.8,sp|Q9H3R0|KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens OX=9606 GN=KDM4C PE=1 SV=2,,,,,,
OG_01010,1.3951708894367365,FUN_004437-T1,Peve_00033214,Pocillopora_meandrina_HIv1___RNAseq.g11487.t2,three_way,77.86816666666667,FUN_004437-T1,Q8NI36,WDR36_HUMAN,,WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP),Homo sapiens (Human),45.4,904.0,1.5e-236,820.8,sp|Q8NI36|WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens OX=9606 GN=WDR36 PE=1 SV=2,GO:0003723; GO:0005654; GO:0006364; GO:0007601; GO:0032040; GO:0034388; GO:0042274,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; visual perception [GO:0007601],nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0050877,RNA binding; nucleoplasm; nervous system process
OG_01012,1.750147457349441,FUN_004440-T1,Peve_00033212,Pocillopora_meandrina_HIv1___RNAseq.g11481.t1,three_way,80.817,FUN_004440-T1,Q9UNH6,SNX7_HUMAN,,Sorting nexin-7,Homo sapiens (Human),48.7,191.0,7.4e-49,195.7,sp|Q9UNH6|SNX7_HUMAN Sorting nexin-7 OS=Homo sapiens OX=9606 GN=SNX7 PE=1 SV=1,GO:0000407; GO:0000423; GO:0005769; GO:0015031; GO:0031901; GO:0032456; GO:0034727; GO:0035091; GO:0061709; GO:2000786,endocytic recycling [GO:0032456]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031]; reticulophagy [GO:0061709],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phagophore assembly site [GO:0000407],phosphatidylinositol binding [GO:0035091],GO:0005768; GO:0006914; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; autophagy; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_01013,2.0652276269352785,FUN_004441-T1,Peve_00033211,Pocillopora_meandrina_HIv1___RNAseq.g11480.t1,three_way,74.31,FUN_004441-T1,Q0P5N6,ARL16_HUMAN,,ADP-ribosylation factor-like protein 16,Homo sapiens (Human),43.7,174.0,6.4000000000000005e-28,125.6,sp|Q0P5N6|ARL16_HUMAN ADP-ribosylation factor-like protein 16 OS=Homo sapiens OX=9606 GN=ARL16 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005737,,cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016787,catalytic activity; GTPase activity; hydrolase activity
OG_01017,3.815268330982648,FUN_004446-T1,Peve_00024328,Pocillopora_meandrina_HIv1___RNAseq.g12519.t3,three_way,72.83733333333333,FUN_004446-T1,Q6DCD1,,,,,55.2,554.0,3.5000000000000005e-180,632.9,sp|Q6DCD1|FGGY_XENLA FGGY carbohydrate kinase domain-containing protein OS=Xenopus laevis OX=8355 GN=fggy PE=2 SV=2,,,,,,
OG_01019,2.20373318373397,FUN_004448-T1,Peve_00024324,Pocillopora_meandrina_HIv1___RNAseq.g11247.t1,three_way,61.9365,FUN_004448-T1,Q3UVK0,ERMP1_MOUSE,,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),Mus musculus (Mouse),39.5,837.0,2.0000000000000003e-164,581.3,sp|Q3UVK0|ERMP1_MOUSE Endoplasmic reticulum metallopeptidase 1 OS=Mus musculus OX=10090 GN=Ermp1 PE=1 SV=2,GO:0005789; GO:0006508; GO:0008235; GO:0030968; GO:0034599; GO:0046872,cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508],endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_01024,2.796430244751521,FUN_004456-T1,Peve_00028023,Pocillopora_meandrina_HIv1___RNAseq.g4969.t1,three_way,72.8845,FUN_004456-T1,A2VDD2,,,,,28.7,178.0,1.5e-13,77.8,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_01025,1.083909039142957,FUN_004459-T1,Peve_00028021,Pocillopora_meandrina_HIv1___RNAseq.g4967.t1,three_way,62.04566666666667,,,,,,,,,,,,,,,,,
OG_01027,3.1912949918437863,FUN_004461-T1,Peve_00023630,Pocillopora_meandrina_HIv1___RNAseq.g4962.t1,three_way,86.20783333333334,FUN_004461-T1,E7FDB3,,,,,57.7,71.0,3.2e-18,93.6,sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1,,,,,,
OG_01030,1.4643080643341897,FUN_004465-T1,Peve_00007162,Pocillopora_meandrina_HIv1___RNAseq.g4956.t1,three_way,76.52466666666666,FUN_004465-T1,P70032,,,,,39.7,633.0,2.2e-128,461.1,sp|P70032|PLK1_XENLA Serine/threonine-protein kinase PLK1 OS=Xenopus laevis OX=8355 GN=plk1 PE=1 SV=1,,,,,,
OG_01032,1.332020251599258,FUN_004467-T1,Peve_00007165,Pocillopora_meandrina_HIv1___RNAseq.g4954.t1,three_way,70.01933333333334,,,,,,,,,,,,,,,,,
OG_01033,2.182558893800507,FUN_004468-T1,Peve_00007166,Pocillopora_meandrina_HIv1___RNAseq.g4953.t1,three_way,63.32233333333333,FUN_004468-T1,P23727,P85A_BOVIN,,Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha),Bos taurus (Bovine),32.1,636.0,1.2e-79,299.7,sp|P23727|P85A_BOVIN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Bos taurus OX=9913 GN=PIK3R1 PE=1 SV=1,GO:0001678; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005942; GO:0005943; GO:0008286; GO:0015031; GO:0032869; GO:0033120; GO:0034446; GO:0034976; GO:0035014; GO:0042307; GO:0042802; GO:0043066; GO:0043125; GO:0043491; GO:0043548; GO:0043560; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0140767; GO:0141038; GO:1900103; GO:1903078,cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular glucose homeostasis [GO:0001678]; negative regulation of apoptotic process [GO:0043066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446],"nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]",1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; enzyme-substrate adaptor activity [GO:0140767]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0005634; GO:0006355; GO:0006629; GO:0007155; GO:0043226; GO:0060090; GO:0098772,nucleus; regulation of DNA-templated transcription; lipid metabolic process; cell adhesion; organelle; molecular adaptor activity; molecular function regulator activity
OG_01036,1.575785925243789,FUN_004471-T1,Peve_00007169,Pocillopora_meandrina_HIv1___RNAseq.g4950.t1,three_way,83.27766666666666,FUN_004471-T1,Q5R610,,,,,54.5,200.0,3.7e-55,216.1,sp|Q5R610|COMD2_PONAB COMM domain-containing protein 2 OS=Pongo abelii OX=9601 GN=COMMD2 PE=2 SV=1,,,,,,
OG_01037,2.071327807196672,FUN_004472-T1,Peve_00007171,Pocillopora_meandrina_HIv1___RNAseq.g4949.t1,three_way,82.363,FUN_004472-T1,Q13042,,,,,53.3,533.0,1.6e-165,584.3,sp|Q13042|CDC16_HUMAN Cell division cycle protein 16 homolog OS=Homo sapiens OX=9606 GN=CDC16 PE=1 SV=2,,,,,,
OG_01038,2.093876809545444,FUN_004473-T1,Peve_00007172,Pocillopora_meandrina_HIv1___RNAseq.g4948.t1,three_way,45.68216666666667,FUN_004473-T1,P98081,DAB_DROME,,Protein disabled,Drosophila melanogaster (Fruit fly),41.4,157.0,2.5e-28,129.4,sp|P98081|DAB_DROME Protein disabled OS=Drosophila melanogaster OX=7227 GN=Dab PE=1 SV=2,GO:0005118; GO:0005829; GO:0006898; GO:0007349; GO:0007391; GO:0008045; GO:0016319; GO:0017124; GO:0030424; GO:0035591; GO:0042051; GO:0045874; GO:0048488; GO:0072583; GO:0098793,cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; positive regulation of sevenless signaling pathway [GO:0045874]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488],axon [GO:0030424]; cytosol [GO:0005829]; presynapse [GO:0098793],sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591],GO:0005829; GO:0016192; GO:0048856; GO:0060090,cytosol; vesicle-mediated transport; anatomical structure development; molecular adaptor activity
OG_01041,1.336202404282878,FUN_004481-T1,Peve_00008403,Pocillopora_meandrina_HIv1___RNAseq.g11617.t2,three_way,80.77366666666667,FUN_004481-T1,Q96LB3,,,,,39.8,553.0,9.4e-89,329.3,sp|Q96LB3|IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens OX=9606 GN=IFT74 PE=1 SV=1,,,,,,
OG_01043,1.416607578332245,FUN_004485-T1,Peve_00008396,Pocillopora_meandrina_HIv1___RNAseq.g11621.t1,three_way,67.02483333333333,FUN_004485-T1,O95801,TTC4_HUMAN,,Tetratricopeptide repeat protein 4 (TPR repeat protein 4),Homo sapiens (Human),42.7,377.0,1.4e-71,271.6,sp|O95801|TTC4_HUMAN Tetratricopeptide repeat protein 4 OS=Homo sapiens OX=9606 GN=TTC4 PE=1 SV=3,GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879],GO:0002376; GO:0005634; GO:0005654; GO:0006457; GO:0043226; GO:0098542,immune system process; nucleus; nucleoplasm; protein folding; organelle; defense response to other organism
OG_01045,1.622610736598783,FUN_004491-T1,Peve_00003206,Pocillopora_meandrina_HIv1___RNAseq.g11626.t1,three_way,79.37166666666667,FUN_004491-T1,Q9NXG6,,,,,38.8,361.0,2.6e-64,247.7,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_01047,1.0311240264807082,FUN_004494-T1,Peve_00003208,Pocillopora_meandrina_HIv1___RNAseq.g11630.t1,three_way,64.765,FUN_004494-T1,Q9LN20,,,,,33.0,176.0,9.2e-14,79.7,sp|Q9LN20|P4H3_ARATH Probable prolyl 4-hydroxylase 3 OS=Arabidopsis thaliana OX=3702 GN=P4H3 PE=2 SV=1,,,,,,
OG_01048,1.098535467564584,FUN_004495-T1,Peve_00003209,Pocillopora_meandrina_HIv1___RNAseq.g11631.t1,three_way,70.42516666666667,FUN_004495-T1,Q8N543,OGFD1_HUMAN,,Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (Termination and polyadenylation 1 homolog) (uS12 prolyl 3-hydroxylase),Homo sapiens (Human),45.4,515.0,7.400000000000001e-124,445.7,sp|Q8N543|OGFD1_HUMAN Prolyl 3-hydroxylase OGFOD1 OS=Homo sapiens OX=9606 GN=OGFOD1 PE=1 SV=1,GO:0005506; GO:0005654; GO:0005737; GO:0005829; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0019511; GO:0031418; GO:0031543; GO:0031544; GO:0034063,cell population proliferation [GO:0008283]; peptidyl-proline hydroxylation [GO:0019511]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543],GO:0003824; GO:0005654; GO:0005829; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_01054,3.707115735967879,FUN_004506-T1,Peve_00044059,Pocillopora_meandrina_HIv1___RNAseq.g11391.t1,three_way,79.72433333333333,FUN_004506-T1,Q96NR8,RDH12_HUMAN,,Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2),Homo sapiens (Human),54.7,298.0,9.599999999999999e-82,305.1,sp|Q96NR8|RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens OX=9606 GN=RDH12 PE=1 SV=3,GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0102354; GO:0110095,cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342],11-cis-retinol dehydrogenase activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0006629; GO:0016491; GO:0050877; GO:0098754,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process; detoxification
OG_01055,1.1303717845202816,FUN_004508-T1,Peve_00012959,Pocillopora_meandrina_HIv1___RNAseq.g11640.t1,three_way,76.12733333333334,FUN_004508-T1,H9JW43,,,,,39.8,364.0,4.4e-76,286.6,sp|H9JW43|CDA8_BOMMO Chitin deacetylase 8 OS=Bombyx mori OX=7091 GN=CDA8 PE=1 SV=2,,,,,,
OG_01062,2.762838651855556,FUN_004517-T1,Peve_00044062,Pocillopora_meandrina_HIv1___RNAseq.g11317.t1,three_way,69.30250000000001,FUN_004517-T1,Q5R5M5,ENPP3_PONAB,,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (Alkaline phosphodiesterase I) (EC 3.1.4.1) (Dinucleoside polyphosphatase) (EC 3.6.1.-) (Nucleotide diphosphatase) (Nucleotide pyrophosphatase) (NPPase) (EC 3.6.1.9) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),35.5,766.0,1.2e-133,478.8,sp|Q5R5M5|ENPP3_PONAB Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 OS=Pongo abelii OX=9601 GN=ENPP3 PE=2 SV=1,GO:0002276; GO:0003676; GO:0004081; GO:0004528; GO:0005509; GO:0005524; GO:0005576; GO:0005886; GO:0006220; GO:0008270; GO:0009143; GO:0009897; GO:0016324; GO:0033007; GO:0034432; GO:0036219; GO:0036221; GO:0046034; GO:0047429; GO:0047693; GO:0047710; GO:0050728; GO:0070667,ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; pyrimidine nucleotide metabolic process [GO:0006220],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; calcium ion binding [GO:0005509]; GTP diphosphatase activity [GO:0036219]; nucleic acid binding [GO:0003676]; nucleoside triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; UTP diphosphatase activity [GO:0036221]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0055086; GO:1901135,immune system process; catalytic activity; extracellular region; plasma membrane; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01063,1.384779011059206,FUN_004519-T1,Peve_00044060,Pocillopora_meandrina_HIv1___RNAseq.g11313.t1,three_way,81.71333333333332,FUN_004519-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),48.6,395.0,8.699999999999999e-94,345.5,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_01064,1.655043509586953,FUN_004521-T1,Peve_00044057,Pocillopora_meandrina_HIv1___RNAseq.g11304.t1,three_way,66.62666666666667,FUN_004521-T1,Q8CGF5,,,,,39.5,243.0,6.4e-47,189.1,sp|Q8CGF5|TLCD4_MOUSE TLC domain-containing protein 4 OS=Mus musculus OX=10090 GN=Tlcd4 PE=2 SV=1,,,,,,
OG_01065,1.8706454806566108,FUN_004525-T1,Peve_00003214,Pocillopora_meandrina_HIv1___RNAseq.g11634.t1,three_way,83.67433333333334,FUN_004525-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),49.4,857.0,3.6999999999999996e-242,839.3,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_01066,1.4641523446354672,FUN_004546-T1,Peve_00042939,Pocillopora_meandrina_HIv1___RNAseq.g7628.t1,three_way,71.06,FUN_004546-T1,Q80W37,,,,,47.8,347.0,1.9e-84,314.3,sp|Q80W37|SPN1_MOUSE Snurportin-1 OS=Mus musculus OX=10090 GN=Snupn PE=2 SV=1,,,,,,
OG_01068,1.8667791672460472,FUN_004549-T1,Peve_00042944,Pocillopora_meandrina_HIv1___RNAseq.15379_t,three_way,64.58533333333334,FUN_004549-T1,P9WIT2,,,,,20.5,493.0,1.5e-10,69.3,"sp|P9WIT2|GULDH_MYCTO L-gulono-1,4-lactone dehydrogenase OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=MT1821 PE=3 SV=1",,,,,,
OG_01071,1.631389703981181,FUN_004553-T1,Peve_00016048,Pocillopora_meandrina_HIv1___RNAseq.g8235.t1,three_way,65.80633333333333,FUN_004553-T1,P47802,,,,,41.3,305.0,3.9e-65,250.0,sp|P47802|MTX1_MOUSE Metaxin-1 OS=Mus musculus OX=10090 GN=Mtx1 PE=1 SV=1,,,,,,
OG_01072,2.204504896204185,FUN_004554-T1,Peve_00016046,Pocillopora_meandrina_HIv1___RNAseq.g8234.t1,three_way,72.76433333333334,FUN_004554-T1,P20700,LMNB1_HUMAN,,Lamin-B1,Homo sapiens (Human),33.0,542.0,1.7e-60,235.3,sp|P20700|LMNB1_HUMAN Lamin-B1 OS=Homo sapiens OX=9606 GN=LMNB1 PE=1 SV=2,GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0007097; GO:0016020; GO:0016363; GO:0031507; GO:0031965; GO:0043274; GO:0051664; GO:0090435; GO:0160123; GO:1990837,heterochromatin formation [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435],lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of nuclear lamina [GO:0160123],GO:0003677; GO:0005198; GO:0005634; GO:0005635; GO:0005654; GO:0006325; GO:0043226; GO:0061024,DNA binding; structural molecule activity; nucleus; nuclear envelope; nucleoplasm; chromatin organization; organelle; membrane organization
OG_01073,1.095128519078054,FUN_004557-T1,Peve_00016044,Pocillopora_meandrina_HIv1___RNAseq.g8230.t1,three_way,62.48366666666666,FUN_004557-T1,Q8R368,DAAF4_MOUSE,,Dynein axonemal assembly factor 4 (Dyslexia susceptibility 1 candidate gene 1 protein homolog),Mus musculus (Mouse),30.4,316.0,9.3e-29,129.0,sp|Q8R368|DAAF4_MOUSE Dynein axonemal assembly factor 4 OS=Mus musculus OX=10090 GN=Dnaaf4 PE=1 SV=2,GO:0001764; GO:0003341; GO:0003351; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0007611; GO:0030331; GO:0033146; GO:0036158; GO:0036159; GO:0043005; GO:0051649; GO:0061136; GO:0097730; GO:0120293,cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; heart development [GO:0007507]; inner dynein arm assembly [GO:0036159]; learning or memory [GO:0007611]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886],nuclear estrogen receptor binding [GO:0030331],GO:0005576; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007018; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0065003,extracellular region; nucleus; microtubule organizing center; cytosol; plasma membrane; cilium; microtubule-based movement; organelle; anatomical structure development; cell motility; nervous system process; protein-containing complex assembly
OG_01074,1.6945571721191417,FUN_004560-T1,Peve_00016042,Pocillopora_meandrina_HIv1___RNAseq.g8228.t1,three_way,65.01533333333333,FUN_004560-T1,Q16595,,,,,60.7,117.0,2.1000000000000002e-36,153.7,"sp|Q16595|FRDA_HUMAN Frataxin, mitochondrial OS=Homo sapiens OX=9606 GN=FXN PE=1 SV=2",,,,,,
OG_01079,1.6009415296786056,FUN_004567-T1,Peve_00016037,Pocillopora_meandrina_HIv1___RNAseq.g8223.t1,three_way,80.84933333333333,FUN_004567-T1,Q9UGJ1,GCP4_HUMAN,,Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76),Homo sapiens (Human),49.0,670.0,2.7999999999999998e-171,603.6,sp|Q9UGJ1|GCP4_HUMAN Gamma-tubulin complex component 4 OS=Homo sapiens OX=9606 GN=TUBGCP4 PE=1 SV=1,GO:0000278; GO:0000922; GO:0000930; GO:0000931; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0055037; GO:0065003,cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922],gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0005198; GO:0005768; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0008092; GO:0022414; GO:0031410; GO:0043226; GO:0065003,mitotic cell cycle; structural molecule activity; endosome; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_01081,1.6269660213013313,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),27.6,757.0,3.2999999999999997e-41,172.6,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01081,1.6269660213013313,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),34.8,224.0,3.6e-27,125.9,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01082,2.3032171964539465,FUN_004570-T1,Peve_00041478,Pocillopora_meandrina_HIv1___RNAseq.g6646.t1a,three_way,78.209,FUN_004570-T1,Q6NRZ4,,,,,43.9,640.0,5.6e-150,532.7,sp|Q6NRZ4|CERT_XENLA Ceramide transfer protein OS=Xenopus laevis OX=8355 GN=cert1 PE=2 SV=1,,,,,,
OG_01083,1.8587550722203672,FUN_004573-T1,Peve_00041481,Pocillopora_meandrina_HIv1___RNAseq.g6645.t1,three_way,57.525666666666666,FUN_004573-T1,P12394,,,,,34.0,509.0,1.3e-72,275.4,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_01086,1.432089599321836,FUN_004577-T1,Peve_00016268,Pocillopora_meandrina_HIv1___RNAseq.g6607.t1,three_way,87.703,FUN_004577-T1,P07902,GALT_HUMAN,,Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase),Homo sapiens (Human),63.7,344.0,8.699999999999999e-135,481.5,sp|P07902|GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens OX=9606 GN=GALT PE=1 SV=3,GO:0005737; GO:0005794; GO:0005829; GO:0006011; GO:0006012; GO:0008108; GO:0008270; GO:0033499,"galactose catabolic process via UDP-galactose, Leloir pathway [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-alpha-D-glucose metabolic process [GO:0006011]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794],UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005829; GO:0005975; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; Golgi apparatus; cytosol; carbohydrate metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01088,1.5469810485134532,FUN_004581-T1,Peve_00012389,Pocillopora_meandrina_HIv1___RNAseq.g6605.t2,three_way,90.10633333333334,FUN_004581-T1,Q9D0R2,SYTC_MOUSE,,"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)",Mus musculus (Mouse),72.3,678.0,3.7e-307,1055.0,"sp|Q9D0R2|SYTC_MOUSE Threonine--tRNA ligase 1, cytoplasmic OS=Mus musculus OX=10090 GN=Tars1 PE=1 SV=2",GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0008270; GO:0042802,threonyl-tRNA aminoacylation [GO:0006435],cytoplasm [GO:0005737],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270],GO:0003824; GO:0006399; GO:0006520; GO:0016874; GO:0140098,"catalytic activity; tRNA metabolic process; amino acid metabolic process; ligase activity; catalytic activity, acting on RNA"
OG_01098,1.889243777296539,FUN_004598-T1,Peve_00012407,Pocillopora_meandrina_HIv1___RNAseq.g6588.t1,three_way,65.93233333333333,,,,,,,,,,,,,,,,,
OG_01100,2.213716181937972,FUN_004601-T1,Peve_00020781,Pocillopora_meandrina_HIv1___RNAseq.g6777.t1,three_way,49.251333333333335,,,,,,,,,,,,,,,,,
OG_01102,1.4783532597581892,FUN_004616-T1,Peve_00012390,Pocillopora_meandrina_HIv1___RNAseq.g8689.t1,three_way,73.84366666666666,FUN_004616-T1,F1PZV2,,,,,45.6,456.0,1.4e-106,388.3,sp|F1PZV2|MFS12_CANLF Major facilitator superfamily domain-containing protein 12 OS=Canis lupus familiaris OX=9615 GN=MFSD12 PE=1 SV=3,,,,,,
OG_01104,1.2403606941976435,FUN_004622-T1,Peve_00039255,Pocillopora_meandrina_HIv1___RNAseq.g8687.t2,three_way,71.77533333333334,FUN_004622-T1,Q9WYJ1,,,,,38.8,322.0,1.8e-51,204.5,sp|Q9WYJ1|TSAL_THEMA L-threonine ammonia-lyase OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0356 PE=1 SV=1,,,,,,
OG_01106,1.4285257849056627,FUN_004625-T1,Peve_00039248,Pocillopora_meandrina_HIv1___RNAseq.g8089.t1,three_way,76.86866666666667,FUN_004625-T1,Q8CG46,SMC5_MOUSE,,Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (mSMC5) (Protein expressed in male leptotene and zygotene spermatocytes 453) (MLZ-453),Mus musculus (Mouse),38.8,1073.0,5.9e-184,646.4,sp|Q8CG46|SMC5_MOUSE Structural maintenance of chromosomes protein 5 OS=Mus musculus OX=10090 GN=Smc5 PE=1 SV=1,GO:0000217; GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0005737; GO:0006974; GO:0007059; GO:0016605; GO:0016607; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0044828; GO:0051301; GO:0051984; GO:0071459; GO:0090398,"cell division [GO:0051301]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle phase transition [GO:0044772]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]","cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]",ATP binding [GO:0005524]; DNA secondary structure binding [GO:0000217],GO:0003677; GO:0005634; GO:0005694; GO:0006281; GO:0006310; GO:0007059; GO:0032200; GO:0043226,DNA binding; nucleus; chromosome; DNA repair; DNA recombination; chromosome segregation; telomere organization; organelle
OG_01111,1.915821729004904,FUN_004642-T1,Peve_00039264,Pocillopora_meandrina_HIv1___TS.g1351.t1,three_way,45.49066666666667,,,,,,,,,,,,,,,,,
OG_01112,1.452030039903199,FUN_004651-T1,Peve_00035138,Pocillopora_meandrina_HIv1___RNAseq.g8738.t1,three_way,59.5195,,,,,,,,,,,,,,,,,
OG_01113,1.5042848080933362,FUN_004652-T1,Peve_00035139,Pocillopora_meandrina_HIv1___RNAseq.g8739.t1,three_way,72.61366666666666,,,,,,,,,,,,,,,,,
OG_01118,1.5513248012440055,FUN_004663-T1,Peve_00035116,Pocillopora_meandrina_HIv1___RNAseq.g8745.t1,three_way,40.65533333333333,,,,,,,,,,,,,,,,,
OG_01119,1.6084723330308748,FUN_004681-T1,Peve_00035120,Pocillopora_meandrina_HIv1___RNAseq.g8769.t1,three_way,60.601333333333336,,,,,,,,,,,,,,,,,
OG_01121,3.215433481315312,FUN_004684-T1,Peve_00035122,Pocillopora_meandrina_HIv1___RNAseq.g8765.t1,three_way,65.35983333333333,FUN_004684-T1,Q07008,NOTC1_RAT,,Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Rattus norvegicus (Rat),42.2,628.0,7.7e-77,291.2,sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3,GO:0000122; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006915; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008283; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685],"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003677; GO:0005634; GO:0005783; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006954; GO:0012501; GO:0016192; GO:0022414; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; nucleus; endoplasmic reticulum; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; inflammatory response; programmed cell death; vesicle-mediated transport; reproductive process; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular transducer activity; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_01122,1.2435819289184045,FUN_004690-T1,Peve_00035123,Pocillopora_meandrina_HIv1___RNAseq.g8764.t2,three_way,68.1555,FUN_004690-T1,Q8BX70,VP13C_MOUSE,,Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C),Mus musculus (Mouse),30.1,3835.0,0.0,1442.9,sp|Q8BX70|VP13C_MOUSE Intermembrane lipid transfer protein VPS13C OS=Mus musculus OX=10090 GN=Vps13c PE=1 SV=2,GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006869; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:1905090,lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of type 2 mitophagy [GO:1905090]; response to insulin [GO:0032868],cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741],,GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0007005; GO:0031410; GO:0043226,lysosome; endosome; vacuole; lipid droplet; cytosol; mitochondrion organization; cytoplasmic vesicle; organelle
OG_01124,2.4788262372778616,FUN_004693-T1,Peve_00003276,Pocillopora_meandrina_HIv1___RNAseq.g8747.t1,three_way,73.396,,,,,,,,,,,,,,,,,
OG_01126,1.953677460442157,FUN_004695-T1,Peve_00044672,Pocillopora_meandrina_HIv1___RNAseq.g8771.t1,three_way,71.41250000000001,,,,,,,,,,,,,,,,,
OG_01127,2.365830388294285,FUN_004696-T1,Peve_00044673,Pocillopora_meandrina_HIv1___RNAseq.g8775.t1,three_way,45.049,,,,,,,,,,,,,,,,,
OG_01128,1.3351881394778478,FUN_004698-T1,Peve_00044677,Pocillopora_meandrina_HIv1___RNAseq.g8778.t1,three_way,56.21066666666667,,,,,,,,,,,,,,,,,
OG_01129,1.8353776331484144,FUN_004699-T1,Peve_00044676,Pocillopora_meandrina_HIv1___RNAseq.g8779.t2,three_way,49.28933333333333,,,,,,,,,,,,,,,,,
OG_01132,1.1598656506183502,FUN_004702-T1,Peve_00044681,Pocillopora_meandrina_HIv1___RNAseq.g8782.t1b,three_way,68.05683333333333,,,,,,,,,,,,,,,,,
OG_01134,1.3135099158764851,FUN_004711-T1,Peve_00005084,Pocillopora_meandrina_HIv1___RNAseq.g8798.t1,three_way,84.41083333333333,FUN_004711-T1,Q8CFW7,C2D2A_MOUSE,,Coiled-coil and C2 domain-containing protein 2A,Mus musculus (Mouse),42.9,1526.0,8.4e-310,1065.1,sp|Q8CFW7|C2D2A_MOUSE Coiled-coil and C2 domain-containing protein 2A OS=Mus musculus OX=10090 GN=Cc2d2a PE=1 SV=1,GO:0001822; GO:0001843; GO:0005737; GO:0005856; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:1904491; GO:1905515; GO:1990403,axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224],ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; MKS complex [GO:0036038],,GO:0005856; GO:0007010; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeleton organization; organelle; cilium organization; anatomical structure development
OG_01136,1.659973132867295,FUN_004714-T1,Peve_00005079,Pocillopora_meandrina_HIv1___RNAseq.g8807.t1,three_way,78.63366666666667,FUN_004714-T1,Q5R5N8,,,,,54.3,1021.0,0.0,1082.0,sp|Q5R5N8|DI3L1_PONAB DIS3-like exonuclease 1 OS=Pongo abelii OX=9601 GN=DIS3L PE=2 SV=1,,,,,,
OG_01138,2.612081116061437,FUN_004718-T1,Peve_00011539,Pocillopora_meandrina_HIv1___RNAseq.g8832.t1,three_way,75.06166666666667,FUN_004718-T1,Q92546,RGP1_HUMAN,,RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog),Homo sapiens (Human),41.7,405.0,1.1e-80,302.0,sp|Q92546|RGP1_HUMAN RAB6A-GEF complex partner protein 2 OS=Homo sapiens OX=9606 GN=RGP1 PE=1 SV=1,GO:0000139; GO:0005085; GO:0005829; GO:0005886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547,"negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005829; GO:0005886; GO:0016192; GO:0098772,cytosol; plasma membrane; vesicle-mediated transport; molecular function regulator activity
OG_01140,1.0586175524768349,FUN_004720-T1,Peve_00005067,Pocillopora_meandrina_HIv1___RNAseq.g8836.t1,three_way,72.571,FUN_004720-T1,Q2F5J3,,,,,40.6,180.0,1.5e-18,94.4,sp|Q2F5J3|PYM_BOMMO Partner of Y14 and mago OS=Bombyx mori OX=7091 GN=Pym PE=2 SV=1,,,,,,
OG_01141,4.018925025489625,FUN_004721-T1,Peve_00005068,Pocillopora_meandrina_HIv1___RNAseq.g8837.t2,three_way,47.232,,,,,,,,,,,,,,,,,
OG_01143,1.2927669906054111,FUN_004723-T1,Peve_00005075,Pocillopora_meandrina_HIv1___RNAseq.g8839.t1,three_way,56.89366666666667,FUN_004723-T1,Q8WZ42,TITIN_HUMAN,,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),Homo sapiens (Human),25.3,194.0,5.5e-09,64.7,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,GO:0000794; GO:0002020; GO:0003009; GO:0003300; GO:0004672; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0045214; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733,cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433],GO:0000228; GO:0003012; GO:0003824; GO:0005198; GO:0005576; GO:0005694; GO:0005829; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"nuclear chromosome; muscle system process; catalytic activity; structural molecule activity; extracellular region; chromosome; cytosol; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01148,2.003294598151356,FUN_004747-T1,Peve_00007770,Pocillopora_meandrina_HIv1___RNAseq.g8813.t1,three_way,66.33366666666667,,,,,,,,,,,,,,,,,
OG_01149,1.113698879907392,FUN_004748-T1,Peve_00007768,Pocillopora_meandrina_HIv1___RNAseq.g8814.t1,three_way,81.6025,FUN_004748-T1,Q8C7R4,UBA6_MOUSE,,Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2),Mus musculus (Mouse),56.9,1018.0,0.0,1156.0,sp|Q8C7R4|UBA6_MOUSE Ubiquitin-like modifier-activating enzyme 6 OS=Mus musculus OX=10090 GN=Uba6 PE=1 SV=1,GO:0004839; GO:0005524; GO:0006511; GO:0007612; GO:0007626; GO:0016567; GO:0019780; GO:0021764; GO:0021766; GO:0060996,amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],,ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839],GO:0003824; GO:0016874; GO:0048856; GO:0050877; GO:0140096; GO:0140657,"catalytic activity; ligase activity; anatomical structure development; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_01151,1.398867016875838,FUN_004752-T1,Peve_00007764,Pocillopora_meandrina_HIv1___RNAseq.g8818.t1,three_way,85.092,FUN_004752-T1,P27463,,,,,69.5,485.0,1.3e-195,684.9,sp|P27463|AL1A1_CHICK Aldehyde dehydrogenase 1A1 OS=Gallus gallus OX=9031 GN=ALDH1A1 PE=2 SV=1,,,,,,
OG_01160,3.880590880130314,FUN_004779-T1,Peve_00037747,Pocillopora_meandrina_HIv1___RNAseq.g6693.t1,three_way,80.62566666666666,FUN_004779-T1,A2A2Y4,FRMD3_HUMAN,,FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O),Homo sapiens (Human),49.3,341.0,6.399999999999999e-96,352.8,sp|A2A2Y4|FRMD3_HUMAN FERM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FRMD3 PE=1 SV=1,GO:0005856; GO:0008092; GO:0016020; GO:0031032,actomyosin structure organization [GO:0031032],cytoskeleton [GO:0005856]; membrane [GO:0016020],cytoskeletal protein binding [GO:0008092],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_01162,1.2700979007756918,FUN_004781-T1,Peve_00037742,Pocillopora_meandrina_HIv1___RNAseq.g6688.t1,three_way,84.00166666666667,FUN_004781-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),31.8,534.0,1.1e-64,249.6,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01165,2.784103306565767,FUN_004785-T1,Peve_00037753,Pocillopora_meandrina_HIv1___RNAseq.g27039.t1,three_way,60.36183333333333,FUN_004785-T1,Q9CQX4,PAF15_MOUSE,,PCNA-associated factor (HCV NS5A-transactivated protein 9 homolog) (PCNA-associated factor of 15 kDa) (PAF15) (p15PAF) (PCNA-clamp-associated factor),Mus musculus (Mouse),37.6,109.0,9e-08,57.8,sp|Q9CQX4|PAF15_MOUSE PCNA-associated factor OS=Mus musculus OX=10090 GN=Pclaf PE=1 SV=1,GO:0003682; GO:0005634; GO:0005813; GO:0006260; GO:0006974; GO:0007098; GO:0009411; GO:0019985; GO:0048471; GO:0051726; GO:0060090,centrosome cycle [GO:0007098]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985],centrosome [GO:0005813]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090],GO:0005634; GO:0005815; GO:0006260; GO:0006281; GO:0043226; GO:0060090,nucleus; microtubule organizing center; DNA replication; DNA repair; organelle; molecular adaptor activity
OG_01167,1.8141052427638151,FUN_004787-T1,Peve_00010251,Pocillopora_meandrina_HIv1___RNAseq.g8521.t1,three_way,75.73400000000001,FUN_004787-T1,Q6TFL3,,,,,37.2,807.0,6.2e-84,313.9,sp|Q6TFL3|CC171_HUMAN Coiled-coil domain-containing protein 171 OS=Homo sapiens OX=9606 GN=CCDC171 PE=1 SV=1,,,,,,
OG_01168,2.283747027440012,FUN_004791-T1,Peve_00010255,Pocillopora_meandrina_HIv1___RNAseq.g8522.t1,three_way,63.762,FUN_004791-T1,P56705,WNT4_HUMAN,,Protein Wnt-4,Homo sapiens (Human),39.4,322.0,1.8999999999999998e-62,241.1,sp|P56705|WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens OX=9606 GN=WNT4 PE=1 SV=4,GO:0001658; GO:0001822; GO:0001837; GO:0001838; GO:0001889; GO:0003714; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0008543; GO:0008584; GO:0008585; GO:0009267; GO:0009986; GO:0010629; GO:0010894; GO:0022407; GO:0030182; GO:0030237; GO:0030325; GO:0030336; GO:0030501; GO:0030666; GO:0031012; GO:0032349; GO:0032967; GO:0033080; GO:0035567; GO:0040037; GO:0042445; GO:0043410; GO:0045165; GO:0045596; GO:0045669; GO:0045836; GO:0045892; GO:0045893; GO:0048018; GO:0048599; GO:0051145; GO:0051496; GO:0051894; GO:0060008; GO:0060070; GO:0060126; GO:0060129; GO:0060231; GO:0060748; GO:0061045; GO:0061180; GO:0061184; GO:0061205; GO:0061369; GO:0070062; GO:0071560; GO:0072033; GO:0072034; GO:0072162; GO:0072174; GO:0072273; GO:0097190; GO:0140013; GO:1904238; GO:2000019; GO:2000066; GO:2000180; GO:2000225; GO:2001234,adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005576; GO:0005615; GO:0005886; GO:0006355; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048018; GO:0048856; GO:0060090; GO:0098772; GO:0140013; GO:0140110,immune system process; extracellular region; extracellular space; plasma membrane; regulation of DNA-templated transcription; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; receptor ligand activity; anatomical structure development; molecular adaptor activity; molecular function regulator activity; meiotic nuclear division; transcription regulator activity
OG_01169,1.5863833106256802,FUN_004792-T1,Peve_00010256,Pocillopora_meandrina_HIv1___RNAseq.g8523.t1,three_way,63.660500000000006,,,,,,,,,,,,,,,,,
OG_01174,1.4024662941489396,FUN_004803-T2,Peve_00023849,Pocillopora_meandrina_HIv1___RNAseq.g8569.t1,three_way,51.61816666666667,FUN_004803-T2,A7E2V4,ZSWM8_HUMAN,,Zinc finger SWIM domain-containing protein 8,Homo sapiens (Human),29.1,453.0,2.6e-39,166.4,sp|A7E2V4|ZSWM8_HUMAN Zinc finger SWIM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=ZSWIM8 PE=1 SV=1,GO:0005829; GO:0006515; GO:0008270; GO:0016567; GO:0031462; GO:0031463; GO:0043161; GO:0140958; GO:1990756; GO:2000627,positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829],ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270],GO:0005829; GO:0030163; GO:0060090,cytosol; protein catabolic process; molecular adaptor activity
OG_01177,3.690906161861091,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_01184,2.44475029606581,FUN_004834-T1,Peve_00019417,Pocillopora_meandrina_HIv1___RNAseq.g8609.t1,three_way,70.38799999999999,FUN_004834-T1,Q9UKP4,ATS7_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-),Homo sapiens (Human),45.7,924.0,7.5e-249,862.1,sp|Q9UKP4|ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens OX=9606 GN=ADAMTS7 PE=1 SV=2,GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773,cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0140096; GO:1901135,"catalytic activity; extracellular region; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01186,1.2360408658268984,FUN_004836-T1,Peve_00019420,Pocillopora_meandrina_HIv1___RNAseq.g8611.t1,three_way,80.11233333333334,FUN_004836-T1,Q8WUQ7,CATIN_HUMAN,,Splicing factor Cactin (Renal carcinoma antigen NY-REN-24),Homo sapiens (Human),60.5,580.0,1.1e-156,555.1,sp|Q8WUQ7|CATIN_HUMAN Splicing factor Cactin OS=Homo sapiens OX=9606 GN=CACTIN PE=1 SV=3,GO:0000398; GO:0001933; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0016607; GO:0031665; GO:0032088; GO:0032688; GO:0032717; GO:0032720; GO:0034122; GO:0043124; GO:0045087; GO:0045292; GO:0045824; GO:0060339; GO:0071013; GO:0071222; GO:0071347; GO:0071356,"cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0016071; GO:0043226; GO:0098542,immune system process; RNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle; defense response to other organism
OG_01187,3.127462852230018,FUN_004838-T1,Peve_00019421,Pocillopora_meandrina_HIv1___RNAseq.g8612.t1b,three_way,74.21666666666667,FUN_004838-T1,P43681,ACHA4_HUMAN,,Neuronal acetylcholine receptor subunit alpha-4,Homo sapiens (Human),41.8,325.0,5.9e-75,283.1,sp|P43681|ACHA4_HUMAN Neuronal acetylcholine receptor subunit alpha-4 OS=Homo sapiens OX=9606 GN=CHRNA4 PE=1 SV=2,GO:0001508; GO:0001666; GO:0005886; GO:0005892; GO:0006281; GO:0006811; GO:0006816; GO:0006979; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0009897; GO:0014059; GO:0015276; GO:0015464; GO:0016020; GO:0019233; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042113; GO:0042166; GO:0042391; GO:0042734; GO:0043005; GO:0043025; GO:0045202; GO:0045211; GO:0050877; GO:0050890; GO:0051899; GO:0060080; GO:0095500; GO:0098878,"acetylcholine receptor signaling pathway [GO:0095500]; action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; inhibitory postsynaptic potential [GO:0060080]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0002376; GO:0005215; GO:0005886; GO:0006281; GO:0023052; GO:0050877; GO:0055085; GO:0060089,immune system process; transporter activity; plasma membrane; DNA repair; signaling; nervous system process; transmembrane transport; molecular transducer activity
OG_01192,1.1118289699471813,FUN_004850-T1,Peve_00013710,Pocillopora_meandrina_HIv1___RNAseq.g8605.t1,three_way,55.08,FUN_004850-T1,Q9EP86,,,,,22.8,320.0,2.5e-12,74.7,sp|Q9EP86|NPFF1_RAT Neuropeptide FF receptor 1 OS=Rattus norvegicus OX=10116 GN=Npffr1 PE=1 SV=1,,,,,,
OG_01194,2.297341943069491,FUN_004852-T1,Peve_00043740,Pocillopora_meandrina_HIv1___RNAseq.g8639.t1,three_way,66.92133333333334,FUN_004852-T1,P70473,AMACR_RAT,,Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-arylpropionyl-CoA epimerase) (2-methylacyl-CoA racemase),Rattus norvegicus (Rat),53.2,280.0,6.7e-82,305.4,sp|P70473|AMACR_RAT Alpha-methylacyl-CoA racemase OS=Rattus norvegicus OX=10116 GN=Amacr PE=1 SV=3,GO:0005737; GO:0005739; GO:0005777; GO:0006631; GO:0006699; GO:0008111; GO:0008206,bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777],alpha-methylacyl-CoA racemase activity [GO:0008111],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016853; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; isomerase activity; organelle
OG_01195,1.2817610144009493,FUN_004853-T1,Peve_00043741,Pocillopora_meandrina_HIv1___RNAseq.g8638.t1,three_way,86.89533333333333,FUN_004853-T1,Q86X52,CHSS1_HUMAN,,Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1),Homo sapiens (Human),39.8,533.0,1.5e-102,374.8,sp|Q86X52|CHSS1_HUMAN Chondroitin sulfate synthase 1 OS=Homo sapiens OX=9606 GN=CHSY1 PE=1 SV=3,GO:0000139; GO:0002063; GO:0005576; GO:0009954; GO:0016020; GO:0030279; GO:0031667; GO:0032580; GO:0045880; GO:0046872; GO:0047238; GO:0050510; GO:0050650; GO:0051923; GO:0060349,bone morphogenesis [GO:0060349]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020],glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510],GO:0003824; GO:0005576; GO:0006790; GO:0009101; GO:0016740; GO:0048856; GO:1901135,catalytic activity; extracellular region; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_01197,2.090006795462489,FUN_004855-T1,Peve_00043745,Pocillopora_meandrina_HIv1___RNAseq.15663_t,three_way,76.852,FUN_004855-T1,Q6NXE6,ARMC6_HUMAN,,Armadillo repeat-containing protein 6,Homo sapiens (Human),38.6,298.0,8.2e-45,183.0,sp|Q6NXE6|ARMC6_HUMAN Armadillo repeat-containing protein 6 OS=Homo sapiens OX=9606 GN=ARMC6 PE=1 SV=2,GO:0002244; GO:0005829,hematopoietic progenitor cell differentiation [GO:0002244],cytosol [GO:0005829],,GO:0005829; GO:0030154,cytosol; cell differentiation
OG_01199,2.319058133365145,FUN_004862-T1,Peve_00043709,Pocillopora_meandrina_HIv1___RNAseq.g8631.t2,three_way,66.93066666666667,FUN_004862-T1,Q9JJQ0,,,,,43.5,540.0,3.3e-122,440.3,"sp|Q9JJQ0|PIGB_MOUSE GPI alpha-1,2-mannosyltransferase 3 OS=Mus musculus OX=10090 GN=Pigb PE=2 SV=2",,,,,,
OG_01201,4.385526654313569,FUN_004865-T1,Peve_00043712,Pocillopora_meandrina_HIv1___RNAseq.g8628.t1,three_way,55.48716666666667,FUN_004865-T1,Q5F416,,,,,38.2,228.0,8.000000000000001e-29,129.8,sp|Q5F416|TIPIN_CHICK TIMELESS-interacting protein OS=Gallus gallus OX=9031 GN=TIPIN PE=2 SV=1,,,,,,
OG_01203,1.5216897326745036,FUN_004867-T1,Peve_00043717,Pocillopora_meandrina_HIv1___RNAseq.g8625.t1,three_way,77.072,FUN_004867-T1,O00471,EXOC5_HUMAN,,Exocyst complex component 5 (Exocyst complex component Sec10) (hSec10),Homo sapiens (Human),47.9,710.0,3e-176,620.2,sp|O00471|EXOC5_HUMAN Exocyst complex component 5 OS=Homo sapiens OX=9606 GN=EXOC5 PE=1 SV=1,GO:0000145; GO:0000281; GO:0001736; GO:0005737; GO:0005829; GO:0006887; GO:0006892; GO:0006893; GO:0006904; GO:0015031; GO:0030496; GO:0031267; GO:0072659; GO:0090148; GO:0090522; GO:1904019; GO:1905515,epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; non-motile cilium assembly [GO:1905515]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522],cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496],small GTPase binding [GO:0031267],GO:0000910; GO:0005829; GO:0012501; GO:0016192; GO:0044782; GO:0061024; GO:0072659,cytokinesis; cytosol; programmed cell death; vesicle-mediated transport; cilium organization; membrane organization; protein localization to plasma membrane
OG_01206,1.9958517714265032,FUN_004873-T1,Peve_00043731,Pocillopora_meandrina_HIv1___TS.g20376.t1,three_way,42.24266666666667,,,,,,,,,,,,,,,,,
OG_01207,1.150842328653339,FUN_004880-T1,Peve_00043729,Pocillopora_meandrina_HIv1___RNAseq.g8656.t1,three_way,70.81866666666667,FUN_004880-T1,Q6DFB8,,,,,33.7,1627.0,1.2000000000000001e-223,778.9,sp|Q6DFB8|TTC37_XENLA Tetratricopeptide repeat protein 37 OS=Xenopus laevis OX=8355 GN=ttc37 PE=2 SV=1,,,,,,
OG_01216,1.5046669983656764,FUN_004897-T1,Peve_00015867,Pocillopora_meandrina_HIv1___RNAseq.g8671.t1,three_way,80.57000000000001,FUN_004897-T1,Q9Y3U8,,,,,63.4,93.0,7.6e-25,114.4,sp|Q9Y3U8|RL36_HUMAN Large ribosomal subunit protein eL36 OS=Homo sapiens OX=9606 GN=RPL36 PE=1 SV=3,,,,,,
OG_01217,2.484287694207564,FUN_004898-T1,Peve_00015868,Pocillopora_meandrina_HIv1___RNAseq.g8672.t1,three_way,81.91366666666667,FUN_004898-T1,F1RQM2,AGM1_PIG,,Phosphoacetylglucosamine mutase (PAGM) (PGlcNAc mutase) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3),Sus scrofa (Pig),58.6,534.0,2e-172,607.1,sp|F1RQM2|AGM1_PIG Phosphoacetylglucosamine mutase OS=Sus scrofa OX=9823 GN=PGM3 PE=1 SV=2,GO:0000287; GO:0004610; GO:0005975; GO:0006048; GO:0030097,carbohydrate metabolic process [GO:0005975]; hemopoiesis [GO:0030097]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],,magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610],GO:0003824; GO:0005975; GO:0016853; GO:0048856; GO:0055086; GO:1901135,catalytic activity; carbohydrate metabolic process; isomerase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01220,1.4202462136003768,FUN_004902-T1,Peve_00028647,Pocillopora_meandrina_HIv1___RNAseq.g8330.t1,three_way,50.007,,,,,,,,,,,,,,,,,
OG_01222,1.747615230668424,FUN_004904-T1,Peve_00028659,Pocillopora_meandrina_HIv1___RNAseq.g8332.t1,three_way,63.89233333333333,FUN_004904-T1,Q8BGZ3,DCA12_MOUSE,,DDB1- and CUL4-associated factor 12 (WD repeat-containing protein 40A),Mus musculus (Mouse),41.8,411.0,4.5e-81,303.1,sp|Q8BGZ3|DCA12_MOUSE DDB1- and CUL4-associated factor 12 OS=Mus musculus OX=10090 GN=Dcaf12 PE=2 SV=1,GO:0005634; GO:0005813; GO:0005829; GO:0010506; GO:0016567; GO:0042110; GO:0080008; GO:0140627; GO:1990756,protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleus [GO:0005634],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0005634; GO:0005815; GO:0005829; GO:0030163; GO:0043226; GO:0060090,immune system process; nucleus; microtubule organizing center; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_01223,2.93455498545906,FUN_004905-T1,Peve_00028658,Pocillopora_meandrina_HIv1___RNAseq.g8333.t1,three_way,69.76066666666667,FUN_004905-T1,Q61555,FBN2_MOUSE,,Fibrillin-2 [Cleaved into: Placensin],Mus musculus (Mouse),53.2,2537.0,9.1e-126,454.5,sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2,GO:0001527; GO:0005179; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023,bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527],calcium ion binding [GO:0005509]; hormone activity [GO:0005179],GO:0005576; GO:0048018; GO:0048856; GO:0098772,extracellular region; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01225,1.905427500235614,FUN_004907-T1,Peve_00026331,Pocillopora_meandrina_HIv1___RNAseq.g8340.t1,three_way,55.694,FUN_004907-T1,Q9WTY1,,,,,38.0,213.0,7.8e-26,120.2,sp|Q9WTY1|PDCD7_MOUSE Programmed cell death protein 7 OS=Mus musculus OX=10090 GN=Pdcd7 PE=1 SV=1,,,,,,
OG_01227,2.1179521084609867,FUN_004909-T1,Peve_00026333,Pocillopora_meandrina_HIv1___RNAseq.g8343.t1,three_way,58.292,FUN_004909-T1,Q5T7B8,KIF24_HUMAN,,Kinesin-like protein KIF24,Homo sapiens (Human),42.5,631.0,7.1e-116,419.9,sp|Q5T7B8|KIF24_HUMAN Kinesin-like protein KIF24 OS=Homo sapiens OX=9606 GN=KIF24 PE=1 SV=2,GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0032991; GO:0042802; GO:0060271; GO:1902018,cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_01229,2.4425402437794337,FUN_004913-T1,Peve_00034774,Pocillopora_meandrina_HIv1___RNAseq.g8346.t1,three_way,79.94333333333333,FUN_004913-T1,Q99M01,,,,,55.9,401.0,7.4e-133,475.3,"sp|Q99M01|SYFM_MOUSE Phenylalanine--tRNA ligase, mitochondrial OS=Mus musculus OX=10090 GN=Fars2 PE=1 SV=1",,,,,,
OG_01233,1.3605053879359044,FUN_004918-T1,Peve_00044507,Pocillopora_meandrina_HIv1___RNAseq.g8351.t1,three_way,63.02783333333333,FUN_004918-T1,B2RUR8,OTU7B_MOUSE,,OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne),Mus musculus (Mouse),41.4,529.0,4.6e-93,344.0,sp|B2RUR8|OTU7B_MOUSE OTU domain-containing protein 7B OS=Mus musculus OX=10090 GN=Otud7b PE=1 SV=1,GO:0000122; GO:0001701; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0008234; GO:0008270; GO:0016579; GO:0032717; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:1900181; GO:1904262; GO:1904515; GO:1990380,adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"immune system process; DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01234,1.1527607855113209,FUN_004919-T1,Peve_00044506,Pocillopora_meandrina_HIv1___RNAseq.g8352.t1,three_way,72.428,FUN_004919-T1,Q16566,KCC4_HUMAN,,Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR),Homo sapiens (Human),63.4,290.0,1e-102,374.8,sp|Q16566|KCC4_HUMAN Calcium/calmodulin-dependent protein kinase type IV OS=Homo sapiens OX=9606 GN=CAMK4 PE=1 SV=1,GO:0001650; GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006468; GO:0006954; GO:0007165; GO:0007616; GO:0009931; GO:0033081; GO:0035556; GO:0043011; GO:0045670; GO:0045893; GO:0070062; GO:0106310,adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of DNA-templated transcription [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005783; GO:0006355; GO:0006954; GO:0016740; GO:0030154; GO:0043226; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; endoplasmic reticulum; regulation of DNA-templated transcription; inflammatory response; transferase activity; cell differentiation; organelle; nervous system process; catalytic activity, acting on a protein"
OG_01236,1.3936039092235168,FUN_004921-T1,Peve_00044503,Pocillopora_meandrina_HIv1___TS.g20096.t1,three_way,79.03483333333334,,,,,,,,,,,,,,,,,
OG_01238,1.1746162611817754,FUN_004924-T1,Peve_00034321,Pocillopora_meandrina_HIv1___RNAseq.g8362.t1,three_way,53.07116666666667,FUN_004924-T1,Q92733,PRCC_HUMAN,,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),Homo sapiens (Human),42.9,156.0,6.3e-20,100.5,sp|Q92733|PRCC_HUMAN Proline-rich protein PRCC OS=Homo sapiens OX=9606 GN=PRCC PE=1 SV=1,GO:0005634; GO:0005654; GO:0016607; GO:0051726,regulation of cell cycle [GO:0051726],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0043226,nucleus; nucleoplasm; organelle
OG_01241,2.5407231071137955,FUN_004929-T1,Peve_00034771,Pocillopora_meandrina_HIv1___RNAseq.g8368.t1,three_way,72.67233333333333,,,,,,,,,,,,,,,,,
OG_01242,2.669095794273268,FUN_004932-T1,Peve_00034773,Pocillopora_meandrina_HIv1___RNAseq.g8372.t1,three_way,69.01916666666666,,,,,,,,,,,,,,,,,
OG_01243,2.6138004760389344,FUN_004933-T1,Peve_00014403,Pocillopora_meandrina_HIv1___RNAseq.g8373.t1,three_way,72.1075,,,,,,,,,,,,,,,,,
OG_01244,1.429319713800137,FUN_004939-T1,Peve_00014400,Pocillopora_meandrina_HIv1___RNAseq.g8389.t1,three_way,65.75466666666667,,,,,,,,,,,,,,,,,
OG_01246,1.5108901556307577,FUN_004941-T1,Peve_00024450,Pocillopora_meandrina_HIv1___TS.g20127.t1,three_way,74.99733333333333,FUN_004941-T1,A2RUC4,TYW5_HUMAN,,tRNA wybutosine-synthesizing protein 5 (hTYW5) (tRNA yW-synthesizing protein 5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase),Homo sapiens (Human),28.9,249.0,2.1e-16,88.6,sp|A2RUC4|TYW5_HUMAN tRNA wybutosine-synthesizing protein 5 OS=Homo sapiens OX=9606 GN=TYW5 PE=1 SV=1,GO:0000049; GO:0005506; GO:0005737; GO:0031591; GO:0042803; GO:0102524,wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524],GO:0003723; GO:0003824; GO:0006399; GO:0016491; GO:0140098; GO:1901135,"RNA binding; catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_01248,1.168848893251567,FUN_004947-T1,Peve_00043267,Pocillopora_meandrina_HIv1___RNAseq.g8394.t1,three_way,76.3205,FUN_004947-T1,Q9BY12,SCAPE_HUMAN,,S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291),Homo sapiens (Human),41.5,1440.0,9.2e-140,500.0,sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2,GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917,antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827],nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0005654; GO:0005783; GO:0005829; GO:0022414; GO:0043226; GO:0048856,nucleoplasm; endoplasmic reticulum; cytosol; reproductive process; organelle; anatomical structure development
OG_01249,3.704966765783246,FUN_004949-T1,Peve_00043273,Pocillopora_meandrina_HIv1___RNAseq.g8396.t1,three_way,89.491,FUN_004949-T1,P50211,,,,,57.0,335.0,2.3e-100,367.1,sp|P50211|ISL1_CHICK Insulin gene enhancer protein ISL-1 OS=Gallus gallus OX=9031 GN=ISL1 PE=1 SV=1,,,,,,
OG_01251,1.0994369949307177,FUN_004979-T1,Peve_00031942,Pocillopora_meandrina_HIv1___TS.g20137.t4,three_way,53.51116666666667,FUN_004979-T1,Q13332,,,,,34.1,249.0,7.1e-29,131.3,sp|Q13332|PTPRS_HUMAN Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens OX=9606 GN=PTPRS PE=1 SV=3,,,,,,
OG_01254,2.1530142463236817,FUN_004985-T1,Peve_00015857,Pocillopora_meandrina_HIv1___RNAseq.g7568.t1,three_way,84.217,FUN_004985-T1,Q6TGY8,,,,,57.4,282.0,9.5e-87,321.6,sp|Q6TGY8|EMC2_DANRE ER membrane protein complex subunit 2 OS=Danio rerio OX=7955 GN=emc2 PE=2 SV=1,,,,,,
OG_01255,2.2314302310119256,FUN_004986-T1,Peve_00015856,Pocillopora_meandrina_HIv1___RNAseq.g7569.t1,three_way,84.39133333333334,FUN_004986-T1,P97390,,,,,66.1,564.0,1.8000000000000003e-214,746.9,sp|P97390|VPS45_MOUSE Vacuolar protein sorting-associated protein 45 OS=Mus musculus OX=10090 GN=Vps45 PE=1 SV=1,,,,,,
OG_01256,1.4543022160788133,FUN_004988-T1,Peve_00015878,Pocillopora_meandrina_HIv1___RNAseq.g8683.t1,three_way,55.67733333333334,FUN_004988-T1,Q5EAR6,VMA22_DANRE,,Vacuolar ATPase assembly protein VMA22 (Coiled-coil domain-containing protein 115),Danio rerio (Zebrafish) (Brachydanio rerio),34.2,219.0,2.6e-18,94.0,sp|Q5EAR6|VMA22_DANRE Vacuolar ATPase assembly protein VMA22 OS=Danio rerio OX=7955 GN=vma22 PE=2 SV=1,GO:0005764; GO:0005768; GO:0005783; GO:0005793; GO:0006879; GO:0016471; GO:0030137; GO:0051082; GO:0070072,intracellular iron ion homeostasis [GO:0006879]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; lysosome [GO:0005764]; vacuolar proton-transporting V-type ATPase complex [GO:0016471],unfolded protein binding [GO:0051082],GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0031410; GO:0043226; GO:0065003,lysosome; endosome; vacuole; endoplasmic reticulum; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_01258,1.988735786463365,FUN_004990-T1,Peve_00015881,Pocillopora_meandrina_HIv1___RNAseq.g8685.t1,three_way,78.06383333333333,FUN_004990-T1,Q7Z2Z2,EFL1_HUMAN,,Elongation factor-like GTPase 1 (EC 3.6.5.-) (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A),Homo sapiens (Human),53.6,1185.0,0.0,1171.8,sp|Q7Z2Z2|EFL1_HUMAN Elongation factor-like GTPase 1 OS=Homo sapiens OX=9606 GN=EFL1 PE=1 SV=2,GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0042256; GO:0043022; GO:0046039; GO:1990904,cytosolic ribosome assembly [GO:0042256]; GTP metabolic process [GO:0046039],cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; GTPase activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01260,1.620759355586394,FUN_005021-T1,Peve_00032188,Pocillopora_meandrina_HIv1___RNAseq.g27443.t1,three_way,52.18333333333334,,,,,,,,,,,,,,,,,
OG_01261,7.124672481254457,FUN_005023-T1,Peve_00028649,Pocillopora_meandrina_HIv1___RNAseq.g8329.t1,three_way,83.2865,FUN_005023-T1,A2BEA6,,,,,62.1,195.0,1.3e-58,228.8,sp|A2BEA6|ARI3A_DANRE AT-rich interactive domain-containing protein 3A OS=Danio rerio OX=7955 GN=arid3a PE=1 SV=1,,,,,,
OG_01262,1.7848347784233336,FUN_005024-T1,Peve_00028650,Pocillopora_meandrina_HIv1___RNAseq.g8327.t1,three_way,62.04933333333333,,,,,,,,,,,,,,,,,
OG_01268,1.935842198705032,FUN_005036-T1,Peve_00016743,Pocillopora_meandrina_HIv1___RNAseq.g8315.t1,three_way,67.82966666666667,FUN_005036-T1,Q99853,FOXB1_HUMAN,,Forkhead box protein B1 (Transcription factor FKH-5),Homo sapiens (Human),61.9,181.0,2.2999999999999998e-55,217.2,sp|Q99853|FOXB1_HUMAN Forkhead box protein B1 OS=Homo sapiens OX=9606 GN=FOXB1 PE=1 SV=3,GO:0000785; GO:0000978; GO:0000981; GO:0001655; GO:0001756; GO:0005634; GO:0006357; GO:0007412; GO:0007595; GO:0008542; GO:0009653; GO:0021510; GO:0021767; GO:0021794; GO:0021855; GO:0022029; GO:0030154; GO:0030901; GO:0033504; GO:0043524; GO:0043565; GO:0061030; GO:0061374; GO:0061377; GO:0061379; GO:0061381; GO:1990837,anatomical structure morphogenesis [GO:0009653]; axon target recognition [GO:0007412]; cell differentiation [GO:0030154]; cell migration in diencephalon [GO:0061381]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; floor plate development [GO:0033504]; hypothalamus cell migration [GO:0021855]; inferior colliculus development [GO:0061379]; lactation [GO:0007595]; mammary gland lobule development [GO:0061377]; mammillary body development [GO:0021767]; mammillothalamic axonal tract development [GO:0061374]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]; visual learning [GO:0008542],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_01273,1.1609284228425167,FUN_005050-T1,Peve_00016732,Pocillopora_meandrina_HIv1___RNAseq.g8308.t1,three_way,70.75333333333333,FUN_005050-T1,Q96KP1,,,,,40.4,89.0,1.7e-08,62.0,sp|Q96KP1|EXOC2_HUMAN Exocyst complex component 2 OS=Homo sapiens OX=9606 GN=EXOC2 PE=1 SV=1,,,,,,
OG_01274,1.6287980638544772,FUN_005052-T2,Peve_00016731,Pocillopora_meandrina_HIv1___RNAseq.g8307.t1,three_way,71.36033333333333,FUN_005052-T2,Q98D10,,,,,24.9,305.0,3.6e-13,77.4,sp|Q98D10|XYLD_RHILO Putative D-xylulose reductase OS=Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) OX=266835 GN=mlr4915 PE=3 SV=1,,,,,,
OG_01280,1.255216317707696,FUN_005061-T1,Peve_00030179,Pocillopora_meandrina_HIv1___RNAseq.g1034.t1,three_way,97.5,FUN_005061-T1,P62312,LSM6_HUMAN,,U6 snRNA-associated Sm-like protein LSm6,Homo sapiens (Human),94.6,74.0,3.7999999999999996e-35,148.3,sp|P62312|LSM6_HUMAN U6 snRNA-associated Sm-like protein LSm6 OS=Homo sapiens OX=9606 GN=LSM6 PE=1 SV=1,GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005730; GO:0005732; GO:0005737; GO:0005829; GO:0006402; GO:0008033; GO:0008380; GO:0030490; GO:0030532; GO:0046540; GO:0046982; GO:0071005; GO:0120115,"maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; tRNA processing [GO:0008033]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; small nuclear ribonucleoprotein complex [GO:0030532]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688],protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006399; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; nucleolus; cytosol; tRNA metabolic process; mRNA metabolic process; organelle
OG_01281,1.168665381489083,FUN_005062-T1,Peve_00030182,Pocillopora_meandrina_HIv1___TS.g20038.t1,three_way,69.87166666666667,FUN_005062-T1,Q5M7P5,,,,,46.0,1111.0,8.000000000000001e-272,938.3,sp|Q5M7P5|NOL6_XENTR Nucleolar protein 6 OS=Xenopus tropicalis OX=8364 GN=nol6 PE=2 SV=1,,,,,,
OG_01282,2.171999693101889,FUN_005063-T1,Peve_00030190,Pocillopora_meandrina_HIv1___RNAseq.g8293.t1,three_way,74.4175,FUN_005063-T1,B2RR83,YTDC2_MOUSE,,3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2),Mus musculus (Mouse),47.1,1526.0,0.0,1282.7,sp|B2RR83|YTDC2_MOUSE 3'-5' RNA helicase YTHDC2 OS=Mus musculus OX=10090 GN=Ythdc2 PE=1 SV=1,GO:0003723; GO:0005524; GO:0005737; GO:0005783; GO:0007286; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247,"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063],GO:0003723; GO:0003824; GO:0005783; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0140098; GO:0140657,"RNA binding; catalytic activity; endoplasmic reticulum; hydrolase activity; isomerase activity; reproductive process; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01283,2.831170568560573,FUN_005101-T1,Peve_00007482,Pocillopora_meandrina_HIv1___RNAseq.g8276.t1,three_way,63.833666666666666,FUN_005101-T1,P20585,MSH3_HUMAN,,DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1),Homo sapiens (Human),44.8,859.0,3.4e-194,680.2,sp|P20585|MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens OX=9606 GN=MSH3 PE=1 SV=4,GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0016020; GO:0016447; GO:0019899; GO:0030983; GO:0032302; GO:0043570; GO:0045910; GO:0140664,DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; somatic recombination of immunoglobulin gene segments [GO:0016447],membrane [GO:0016020]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01285,1.2768086954739388,FUN_005106-T1,Peve_00007470,Pocillopora_meandrina_HIv1___RNAseq.g8273.t1,three_way,77.06266666666667,FUN_005106-T1,Q90744,NAGAB_CHICK,,Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B),Gallus gallus (Chicken),56.7,386.0,2.7e-129,463.4,sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1,GO:0004557; GO:0005737; GO:0005764; GO:0006629; GO:0008456; GO:0009311; GO:0016139,glycoside catabolic process [GO:0016139]; lipid metabolic process [GO:0006629]; oligosaccharide metabolic process [GO:0009311],cytoplasm [GO:0005737]; lysosome [GO:0005764],alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456],GO:0003824; GO:0005764; GO:0005773; GO:0005975; GO:0006629; GO:0016787; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_01287,2.0593225581283474,FUN_005108-T1,Peve_00007468,Pocillopora_meandrina_HIv1___RNAseq.g8270.t1,three_way,63.20066666666666,FUN_005108-T1,Q96B86,,,,,35.5,361.0,3.8e-52,207.2,sp|Q96B86|RGMA_HUMAN Repulsive guidance molecule A OS=Homo sapiens OX=9606 GN=RGMA PE=1 SV=4,,,,,,
OG_01288,1.1447936280962143,FUN_005111-T1,Peve_00007466,Pocillopora_meandrina_HIv1___RNAseq.g8272.t1,three_way,81.19166666666666,FUN_005111-T1,Q90744,NAGAB_CHICK,,Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B),Gallus gallus (Chicken),53.2,389.0,1.1000000000000001e-125,451.4,sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1,GO:0004557; GO:0005737; GO:0005764; GO:0006629; GO:0008456; GO:0009311; GO:0016139,glycoside catabolic process [GO:0016139]; lipid metabolic process [GO:0006629]; oligosaccharide metabolic process [GO:0009311],cytoplasm [GO:0005737]; lysosome [GO:0005764],alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456],GO:0003824; GO:0005764; GO:0005773; GO:0005975; GO:0006629; GO:0016787; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_01291,2.653013056065004,FUN_005114-T1,Peve_00007462,Pocillopora_meandrina_HIv1___RNAseq.g8267.t1,three_way,89.027,FUN_005114-T1,Q9Y6I4,UBP3_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3),Homo sapiens (Human),49.9,531.0,1.3e-149,531.2,sp|Q9Y6I4|UBP3_HUMAN Ubiquitin carboxyl-terminal hydrolase 3 OS=Homo sapiens OX=9606 GN=USP3 PE=1 SV=2,GO:0000785; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006508; GO:0008270; GO:0016579; GO:0036464; GO:0042393; GO:0090543; GO:0140861; GO:0140936; GO:0140950,DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0016787; GO:0042393; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; DNA repair; chromatin organization; hydrolase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_01292,2.814748391726116,FUN_005115-T1,Peve_00007461,Pocillopora_meandrina_HIv1___RNAseq.g8266.t1,three_way,64.81533333333333,FUN_005115-T1,Q8BUN9,NCKX2_MOUSE,,Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2),Mus musculus (Mouse),44.7,622.0,6.2e-134,479.6,sp|Q8BUN9|NCKX2_MOUSE Sodium/potassium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc24a2 PE=1 SV=1,GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007602; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0016020; GO:0034220; GO:0036368; GO:0051649; GO:0060291; GO:0060292; GO:0070050; GO:0071486; GO:0098703; GO:0098793; GO:0098794,calcium ion import across plasma membrane [GO:0098703]; calcium ion transport [GO:0006816]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; establishment of localization in cell [GO:0051649]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; neuron cellular homeostasis [GO:0070050]; phototransduction [GO:0007602],membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]",GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_01293,1.9410914336451863,FUN_005117-T1,Peve_00007460,Pocillopora_meandrina_HIv1___RNAseq.g8265.t1,three_way,71.62033333333333,FUN_005117-T1,O88801,HOME2_RAT,,Homer protein homolog 2 (Homer-2) (Cupidin) (VASP/Ena-related gene up-regulated during seizure and LTP 2) (Vesl-2),Rattus norvegicus (Rat),49.3,221.0,4.7e-47,190.3,sp|O88801|HOME2_RAT Homer protein homolog 2 OS=Rattus norvegicus OX=10116 GN=Homer2 PE=1 SV=1,GO:0003779; GO:0005737; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0019722; GO:0019904; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035254; GO:0035256; GO:0042802; GO:0043025; GO:0043229; GO:0044877; GO:0045177; GO:0048148; GO:0070885; GO:0098978; GO:2001256,behavioral response to cocaine [GO:0048148]; calcium-mediated signaling [GO:0019722]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; synaptic receptor adaptor activity [GO:0030160],GO:0005886; GO:0008092; GO:0043226; GO:0050877; GO:0060090,plasma membrane; cytoskeletal protein binding; organelle; nervous system process; molecular adaptor activity
OG_01298,2.184684939371893,FUN_005132-T1,Peve_00026674,Pocillopora_meandrina_HIv1___TS.g20000.t1,three_way,85.70366666666666,FUN_005132-T1,Q91348,,,,,60.1,439.0,3.7e-156,552.7,"sp|Q91348|F26L_CHICK 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase OS=Gallus gallus OX=9031 PE=2 SV=2",,,,,,
OG_01299,3.804099788999271,FUN_005133-T1,Peve_00026671,Pocillopora_meandrina_HIv1___RNAseq.g8258.t1,three_way,85.96366666666667,FUN_005133-T1,Q05116,,,,,70.0,377.0,4.3e-148,525.8,sp|Q05116|MP2K1_XENLA Dual specificity mitogen-activated protein kinase kinase 1 OS=Xenopus laevis OX=8355 GN=map2k1 PE=1 SV=2,,,,,,
OG_01301,1.9786908286095832,FUN_005155-T1,Peve_00014626,Pocillopora_meandrina_HIv1___RNAseq.g8081.t2,three_way,50.48,,,,,,,,,,,,,,,,,
OG_01302,1.6061535333033403,FUN_005157-T1,Peve_00035209,Pocillopora_meandrina_HIv1___RNAseq.g8082.t1,three_way,71.84466666666667,,,,,,,,,,,,,,,,,
OG_01306,1.66525682395029,FUN_005161-T1,Peve_00015385,Pocillopora_meandrina_HIv1___RNAseq.g8087.t1,three_way,63.32866666666666,,,,,,,,,,,,,,,,,
OG_01308,1.2125416067524113,FUN_005166-T1,Peve_00015380,Pocillopora_meandrina_HIv1___RNAseq.g8086.t1,three_way,81.01533333333333,FUN_005166-T1,Q9Y3D8,,,,,66.3,163.0,2.3e-61,236.5,sp|Q9Y3D8|KAD6_HUMAN Adenylate kinase isoenzyme 6 OS=Homo sapiens OX=9606 GN=AK6 PE=1 SV=1,,,,,,
OG_01309,2.247993805815568,FUN_005171-T1,Peve_00004281,Pocillopora_meandrina_HIv1___RNAseq.g7588.t1,three_way,75.09433333333332,,,,,,,,,,,,,,,,,
OG_01310,1.6832753222519743,FUN_005172-T1,Peve_00004280,Pocillopora_meandrina_HIv1___RNAseq.g7586.t1,three_way,47.22166666666666,,,,,,,,,,,,,,,,,
OG_01312,1.2100096705556724,FUN_005175-T1,Peve_00011874,Pocillopora_meandrina_HIv1___RNAseq.g7581.t1,three_way,61.32216666666667,FUN_005175-T1,Q9VW71,,,,,22.0,2889.0,4.9e-74,283.1,sp|Q9VW71|FAT2_DROME Fat-like cadherin-related tumor suppressor homolog OS=Drosophila melanogaster OX=7227 GN=kug PE=2 SV=3,,,,,,
OG_01313,1.402966529354612,FUN_005176-T1,Peve_00030152,Pocillopora_meandrina_HIv1___RNAseq.g7583.t1,three_way,39.89633333333333,FUN_005176-T1,O95393,BMP10_HUMAN,,Bone morphogenetic protein 10 (BMP-10),Homo sapiens (Human),25.7,358.0,4.6e-21,103.6,sp|O95393|BMP10_HUMAN Bone morphogenetic protein 10 OS=Homo sapiens OX=9606 GN=BMP10 PE=1 SV=1,GO:0001822; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0007512; GO:0008083; GO:0009986; GO:0010596; GO:0010613; GO:0010614; GO:0010628; GO:0030018; GO:0030308; GO:0030336; GO:0030509; GO:0031433; GO:0032924; GO:0033612; GO:0045214; GO:0045893; GO:0055009; GO:0055010; GO:0055015; GO:0055117; GO:0060038; GO:0060045; GO:0060298; GO:0060347; GO:0060391; GO:0061036; GO:1903242; GO:2000138,activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018],cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433],GO:0005576; GO:0005615; GO:0006355; GO:0007010; GO:0007155; GO:0008092; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01315,2.662442486454611,FUN_005178-T1,Peve_00022721,Pocillopora_meandrina_HIv1___RNAseq.g7585.t1,three_way,63.69316666666666,FUN_005178-T1,Q5ZM55,,,,,28.4,627.0,5.7e-31,137.5,sp|Q5ZM55|FEM1B_CHICK Protein fem-1 homolog B OS=Gallus gallus OX=9031 GN=FEM1B PE=2 SV=1,,,,,,
OG_01316,1.2644074977723028,FUN_005181-T1,Peve_00039094,Pocillopora_meandrina_HIv1___RNAseq.g8093.t1,three_way,72.30133333333333,FUN_005181-T1,O81916,,,,,31.0,261.0,3.9000000000000004e-27,123.6,sp|O81916|YC22_ARATH Uncharacterized calcium-binding protein At1g02270 OS=Arabidopsis thaliana OX=3702 GN=At1g02270 PE=2 SV=2,,,,,,
OG_01318,2.0452997453517163,FUN_005183-T2,Peve_00017162,Pocillopora_meandrina_HIv1___RNAseq.g8095.t1,three_way,55.7445,FUN_005183-T2,A0JMF1,,,,,26.8,358.0,7.6e-14,81.6,sp|A0JMF1|CTC1_DANRE CST complex subunit CTC1 OS=Danio rerio OX=7955 GN=ctc1 PE=2 SV=1,,,,,,
OG_01325,2.3936853566970515,FUN_005197-T1,Peve_00017150,Pocillopora_meandrina_HIv1___RNAseq.g8105.t1,three_way,77.661,FUN_005197-T1,Q9DBT9,,,,,62.3,823.0,0.0,1102.8,"sp|Q9DBT9|M2GD_MOUSE Dimethylglycine dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Dmgdh PE=1 SV=1",,,,,,
OG_01328,1.129185839912641,FUN_005216-T1,Peve_00035486,Pocillopora_meandrina_HIv1___RNAseq.g8126.t1,three_way,74.56533333333333,FUN_005216-T1,Q32ZE2,,,,,31.3,323.0,1.4999999999999998e-24,115.2,sp|Q32ZE2|AA2BR_RABIT Adenosine receptor A2b OS=Oryctolagus cuniculus OX=9986 GN=ADORA2B PE=2 SV=1,,,,,,
OG_01330,6.363767395802496,FUN_005220-T1,Peve_00035492,Pocillopora_meandrina_HIv1___TS.g19865.t1,three_way,97.09066666666666,FUN_005220-T1,Q9TTR8,,,,,73.7,266.0,5e-111,402.1,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_01332,1.7995337113751135,FUN_005226-T1,Peve_00035495,Pocillopora_meandrina_HIv1___RNAseq.g8118.t1,three_way,70.23566666666666,FUN_005226-T1,Q91W67,,,,,35.7,336.0,9.3e-22,105.9,sp|Q91W67|UBL7_MOUSE Ubiquitin-like protein 7 OS=Mus musculus OX=10090 GN=Ubl7 PE=1 SV=2,,,,,,
OG_01333,2.324267494159366,FUN_005230-T1,Peve_00042881,Pocillopora_meandrina_HIv1___RNAseq.g8115.t1,three_way,67.631,FUN_005230-T1,Q8C9M2,,,,,67.3,49.0,1.1e-13,79.7,sp|Q8C9M2|CCD15_MOUSE Coiled-coil domain-containing protein 15 OS=Mus musculus OX=10090 GN=Ccdc15 PE=2 SV=2,,,,,,
OG_01337,2.621200937961488,FUN_005234-T1,Peve_00042867,Pocillopora_meandrina_HIv1___RNAseq.g8111.t1,three_way,51.85633333333333,,,,,,,,,,,,,,,,,
OG_01338,1.5631782202039357,FUN_005235-T1,Peve_00042868,Pocillopora_meandrina_HIv1___RNAseq.g8110.t1,three_way,58.79666666666667,,,,,,,,,,,,,,,,,
OG_01339,1.4832342454534757,FUN_005238-T1,Peve_00014029,Pocillopora_meandrina_HIv1___RNAseq.g8109.t1,three_way,79.287,,,,,,,,,,,,,,,,,
OG_01340,2.0580028951953517,FUN_005239-T1,Peve_00014036,Pocillopora_meandrina_HIv1___RNAseq.g8108.t1,three_way,64.7975,FUN_005239-T1,Q6GPB8,,,,,46.3,549.0,2.3e-128,460.7,sp|Q6GPB8|DBR1A_XENLA Lariat debranching enzyme A OS=Xenopus laevis OX=8355 GN=dbr1-a PE=2 SV=1,,,,,,
OG_01341,1.5343718883989297,FUN_005242-T1,Peve_00014454,Pocillopora_meandrina_HIv1___RNAseq.g8138.t1,three_way,65.22766666666666,FUN_005242-T1,Q6P2C0,,,,,24.4,698.0,2.4e-40,168.7,sp|Q6P2C0|WDR93_HUMAN WD repeat-containing protein 93 OS=Homo sapiens OX=9606 GN=WDR93 PE=1 SV=1,,,,,,
OG_01343,2.383551735743255,FUN_005244-T1,Peve_00003366,Pocillopora_meandrina_HIv1___RNAseq.g8140.t2,three_way,77.56250000000001,FUN_005244-T1,Q8TDJ6,,,,,34.9,3319.0,0.0,1533.5,sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2,,,,,,
OG_01347,1.969059284159452,FUN_005248-T1,Peve_00003362,Pocillopora_meandrina_HIv1___RNAseq.g8144.t1,three_way,61.9315,,,,,,,,,,,,,,,,,
OG_01350,1.639570660933082,FUN_005253-T1,Peve_00003358,Pocillopora_meandrina_HIv1___RNAseq.g8149.t1,three_way,40.75233333333333,,,,,,,,,,,,,,,,,
OG_01352,2.3042439832958244,FUN_005260-T1,Peve_00003354,Pocillopora_meandrina_HIv1___RNAseq.g8151.t1,three_way,68.60516666666666,FUN_005260-T1,Q6PCN7,HLTF_MOUSE,,Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (P113) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3) (TNF-response element-binding protein),Mus musculus (Mouse),43.8,843.0,2.9e-177,624.4,sp|Q6PCN7|HLTF_MOUSE Helicase-like transcription factor OS=Mus musculus OX=10090 GN=Hltf PE=1 SV=1,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0006325; GO:0008094; GO:0008270; GO:0016363; GO:0016567; GO:0016740; GO:0016818; GO:0031625; GO:0042789; GO:0045944; GO:0050767; GO:0090575,chromatin organization [GO:0006325]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005654; GO:0005730; GO:0006325; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; nucleolus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_01356,1.8589078497045493,FUN_005270-T1,Peve_00003341,Pocillopora_meandrina_HIv1___RNAseq.g8160.t1,three_way,74.97566666666667,FUN_005270-T1,O95163,ELP1_HUMAN,,Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) (p150),Homo sapiens (Human),45.8,1348.0,0.0,1135.9,sp|O95163|ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens OX=9606 GN=ELP1 PE=1 SV=3,GO:0000049; GO:0002098; GO:0002926; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0033588,regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634],tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005829; GO:0006399; GO:0043226,RNA binding; nucleus; cytosol; tRNA metabolic process; organelle
OG_01357,2.0425109202272003,FUN_005271-T1,Peve_00003340,Pocillopora_meandrina_HIv1___RNAseq.g8161.t2,three_way,41.66616666666667,,,,,,,,,,,,,,,,,
OG_01360,1.1161515712943142,FUN_005303-T1,Peve_00003331,Pocillopora_meandrina_HIv1___RNAseq.g8168.t1,three_way,74.298,FUN_005303-T1,Q64267,XPA_MOUSE,,DNA repair protein complementing XP-A cells homolog (Xeroderma pigmentosum group A-complementing protein homolog),Mus musculus (Mouse),49.4,269.0,4.6e-56,219.5,sp|Q64267|XPA_MOUSE DNA repair protein complementing XP-A cells homolog OS=Mus musculus OX=10090 GN=Xpa PE=1 SV=2,GO:0003684; GO:0005634; GO:0005662; GO:0005829; GO:0006281; GO:0006289; GO:0006979; GO:0008270; GO:0008630; GO:0009411; GO:0009636; GO:0009650; GO:0010506; GO:0016604; GO:0019904; GO:0034504; GO:0035264; GO:0042803; GO:0060261; GO:1990837,DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein localization to nucleus [GO:0034504]; regulation of autophagy [GO:0010506]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; UV protection [GO:0009650],cytosol [GO:0005829]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nucleus [GO:0005634],damaged DNA binding [GO:0003684]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005829; GO:0006281; GO:0006355; GO:0043226,DNA binding; nucleus; cytosol; DNA repair; regulation of DNA-templated transcription; organelle
OG_01361,1.9309073541265267,FUN_005304-T1,Peve_00003330,Pocillopora_meandrina_HIv1___RNAseq.g8169.t1,three_way,81.89466666666667,FUN_005304-T1,Q8R092,,,,,28.2,188.0,9.1e-14,79.0,sp|Q8R092|CA043_MOUSE Protein C1orf43 homolog OS=Mus musculus OX=10090 PE=2 SV=1,,,,,,
OG_01364,2.398210713140862,FUN_005307-T1,Peve_00003314,Pocillopora_meandrina_HIv1___RNAseq.g8172.t1,three_way,66.42383333333333,FUN_005307-T1,A7YSY2,AFG2B_BOVIN,,ATPase family gene 2 protein homolog B (EC 3.6.4.10) (AFG2 AAA ATPase homolog B) (Ribosome biogenesis protein SPATA5L1) (Spermatogenesis-associated protein 5-like protein 1),Bos taurus (Bovine),41.4,789.0,4.1000000000000005e-161,570.1,sp|A7YSY2|AFG2B_BOVIN ATPase family gene 2 protein homolog B OS=Bos taurus OX=9913 GN=AFG2B PE=2 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0016887; GO:0030970; GO:0031593; GO:0034098; GO:0042273; GO:0042802; GO:0043161; GO:0051228; GO:0097352; GO:1990275,"autophagosome maturation [GO:0097352]; mitotic spindle disassembly [GO:0051228]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ribosomal large subunit biogenesis [GO:0042273]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; preribosome binding [GO:1990275],GO:0003824; GO:0005634; GO:0005829; GO:0006886; GO:0007010; GO:0016787; GO:0030163; GO:0043226,catalytic activity; nucleus; cytosol; intracellular protein transport; cytoskeleton organization; hydrolase activity; protein catabolic process; organelle
OG_01365,1.183594966084213,FUN_005308-T1,Peve_00003313,Pocillopora_meandrina_HIv1___RNAseq.g8173.t1,three_way,54.452,,,,,,,,,,,,,,,,,
OG_01368,1.4507737079122407,FUN_005316-T1,Peve_00003310,Pocillopora_meandrina_HIv1___RNAseq.g8176.t1,three_way,89.855,FUN_005316-T1,Q9UNP9,,,,,70.9,296.0,2.3e-124,446.8,sp|Q9UNP9|PPIE_HUMAN Peptidyl-prolyl cis-trans isomerase E OS=Homo sapiens OX=9606 GN=PPIE PE=1 SV=1,,,,,,
OG_01375,1.4928300602144209,FUN_005331-T1,Peve_00003302,Pocillopora_meandrina_HIv1___TS.g19933.t1,three_way,77.45716666666667,FUN_005331-T1,A0JN62,CE120_BOVIN,,Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100),Bos taurus (Bovine),42.1,525.0,8.4e-83,309.3,sp|A0JN62|CE120_BOVIN Centrosomal protein of 120 kDa OS=Bos taurus OX=9913 GN=CEP120 PE=2 SV=2,GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0045724; GO:1903724; GO:1904951,astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737],,GO:0005815; GO:0007010; GO:0030154; GO:0043226; GO:0048856,microtubule organizing center; cytoskeleton organization; cell differentiation; organelle; anatomical structure development
OG_01376,1.3827315453790985,FUN_005333-T1,Peve_00003300,Pocillopora_meandrina_HIv1___RNAseq.g8193.t1,three_way,71.21333333333332,,,,,,,,,,,,,,,,,
OG_01381,1.214326722238531,FUN_005338-T1,Peve_00035212,Pocillopora_meandrina_HIv1___RNAseq.g8199.t1,three_way,54.7785,FUN_005338-T1,Q9QWF0,,,,,37.2,479.0,2.4e-36,155.6,sp|Q9QWF0|CAF1A_MOUSE Chromatin assembly factor 1 subunit A OS=Mus musculus OX=10090 GN=Chaf1a PE=1 SV=1,,,,,,
OG_01382,1.6761755400917129,FUN_005339-T1,Peve_00035213,Pocillopora_meandrina_HIv1___RNAseq.g8200.t1,three_way,93.732,FUN_005339-T1,Q32P79,,,,,78.6,117.0,6.1e-50,198.0,sp|Q32P79|RPB11_BOVIN DNA-directed RNA polymerase II subunit RPB11 OS=Bos taurus OX=9913 GN=POLR2J PE=1 SV=1,,,,,,
OG_01386,2.00501631934192,FUN_005355-T1,Peve_00016031,Pocillopora_meandrina_HIv1___RNAseq.g8213.t1,three_way,76.06266666666666,FUN_005355-T1,Q2TBL4,,,,,45.5,534.0,9.5e-119,428.7,sp|Q2TBL4|RPC3_BOVIN DNA-directed RNA polymerase III subunit RPC3 OS=Bos taurus OX=9913 GN=POLR3C PE=2 SV=1,,,,,,
OG_01389,3.117882446486013,FUN_005363-T1,Peve_00016035,Pocillopora_meandrina_HIv1___RNAseq.g8221.t1,three_way,93.72233333333334,FUN_005363-T1,Q7L5Y6,DET1_HUMAN,,DET1 homolog (De-etiolated-1 homolog),Homo sapiens (Human),66.1,481.0,1.1e-185,651.0,sp|Q7L5Y6|DET1_HUMAN DET1 homolog OS=Homo sapiens OX=9606 GN=DET1 PE=1 SV=2,GO:0005634; GO:0016567; GO:0031461; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleus [GO:0005634],protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0043226; GO:0060090; GO:0065003,nucleus; organelle; molecular adaptor activity; protein-containing complex assembly
OG_01390,1.1405606262256551,FUN_005365-T1,Peve_00016036,Pocillopora_meandrina_HIv1___RNAseq.g8222.t1,three_way,83.86883333333333,FUN_005365-T1,O01727,,,,,80.4,189.0,2.900000000000001e-86,319.7,sp|O01727|RS6_BRAFL Small ribosomal subunit protein eS6 OS=Branchiostoma floridae OX=7739 GN=RPS6 PE=3 SV=1,,,,,,
OG_01391,1.3322677329746433,FUN_005366-T1,Peve_00041492,Pocillopora_meandrina_HIv1___RNAseq.g6638.t1,three_way,90.41666666666669,FUN_005366-T1,Q9CR47,,,,,71.3,174.0,1.5999999999999999e-62,240.7,sp|Q9CR47|NSA2_MOUSE Ribosome biogenesis protein NSA2 homolog OS=Mus musculus OX=10090 GN=Nsa2 PE=2 SV=1,,,,,,
OG_01392,2.8209520914163084,FUN_005367-T1,Peve_00041491,Pocillopora_meandrina_HIv1___RNAseq.g6637.t3,three_way,81.581,,,,,,,,,,,,,,,,,
OG_01393,1.5964540423577938,FUN_005369-T1,Peve_00041469,Pocillopora_meandrina_HIv1___RNAseq.g6632.t2,three_way,79.86133333333333,FUN_005369-T1,Q9UPW5,CBPC1_HUMAN,,Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1 homolog) (Protein deglutamylase CCP1),Homo sapiens (Human),42.5,1201.0,9.6e-233,808.5,sp|Q9UPW5|CBPC1_HUMAN Cytosolic carboxypeptidase 1 OS=Homo sapiens OX=9606 GN=AGTPBP1 PE=1 SV=3,GO:0001754; GO:0004181; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006508; GO:0007005; GO:0007628; GO:0008270; GO:0008285; GO:0015630; GO:0015631; GO:0021702; GO:0021772; GO:0021954; GO:0034451; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0050905; GO:0060041; GO:0098957; GO:0098958; GO:1904115; GO:2000060,adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958],axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007005; GO:0007018; GO:0008092; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; mitochondrion organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_01397,2.2974147740834527,FUN_005373-T1,Peve_00041490,Pocillopora_meandrina_HIv1___RNAseq.g6636.t1,three_way,82.66833333333334,FUN_005373-T1,Q9H857,,,,,47.5,457.0,6.1e-121,436.0,sp|Q9H857|NT5D2_HUMAN 5'-nucleotidase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NT5DC2 PE=1 SV=1,,,,,,
OG_01407,4.846008899070543,FUN_005476-T1,Peve_00041489,Pocillopora_meandrina_HIv1___RNAseq.g6630.t1,three_way,45.82566666666667,,,,,,,,,,,,,,,,,
OG_01411,2.024683716675587,FUN_005697-T1,Peve_00008482,Pocillopora_meandrina_HIv1___RNAseq.g19565.t1,three_way,83.81866666666667,FUN_005697-T1,O93308,,,,,50.9,1241.0,1.7e-278,960.7,sp|O93308|SMC1A_XENLA Structural maintenance of chromosomes protein 1A OS=Xenopus laevis OX=8355 GN=smc1a PE=1 SV=1,,,,,,
OG_01413,4.071612627329706,FUN_005700-T1,Peve_00008485,Pocillopora_meandrina_HIv1___RNAseq.g19563.t1,three_way,75.503,FUN_005700-T1,Q9Z2V9,,,,,40.4,213.0,5.4e-36,152.9,sp|Q9Z2V9|CCNI_MOUSE Cyclin-I OS=Mus musculus OX=10090 GN=Ccni PE=2 SV=4,,,,,,
OG_01416,1.200274229367798,FUN_005722-T1,Peve_00039598,Pocillopora_meandrina_HIv1___RNAseq.g8780.t1,three_way,70.38866666666667,,,,,,,,,,,,,,,,,
OG_01418,2.3528976781910624,FUN_005725-T1,Peve_00039545,Pocillopora_meandrina_HIv1___RNAseq.g19424.t1,three_way,40.257666666666665,,,,,,,,,,,,,,,,,
OG_01422,1.2327567180448349,FUN_005751-T1,Peve_00020859,Pocillopora_meandrina_HIv1___RNAseq.g19446.t2,three_way,80.624,FUN_005751-T1,Q8CBC7,,,,,65.6,294.0,4.9e-107,389.0,sp|Q8CBC7|TRM7_MOUSE tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase OS=Mus musculus OX=10090 GN=Ftsj1 PE=1 SV=1,,,,,,
OG_01423,1.3939486059687716,FUN_005753-T1,Peve_00038388,Pocillopora_meandrina_HIv1___RNAseq.g19557.t1,three_way,71.96666666666667,FUN_005753-T1,Q15269,PWP2_HUMAN,,Periodic tryptophan protein 2 homolog,Homo sapiens (Human),49.4,877.0,1.7e-250,867.1,sp|Q15269|PWP2_HUMAN Periodic tryptophan protein 2 homolog OS=Homo sapiens OX=9606 GN=PWP2 PE=1 SV=2,GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0032040; GO:0034388; GO:0042274,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]",nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0065003,RNA binding; nucleoplasm; protein-containing complex assembly
OG_01428,2.9098954605039427,FUN_005821-T1,Peve_00034064,Pocillopora_meandrina_HIv1___TS.g29038.t2,three_way,69.24366666666667,FUN_005821-T1,Q9JLG8,,,,,50.0,640.0,1.2000000000000001e-182,641.7,sp|Q9JLG8|CAN15_MOUSE Calpain-15 OS=Mus musculus OX=10090 GN=Capn15 PE=1 SV=1,,,,,,
OG_01429,1.2931975234927258,FUN_005822-T3,Peve_00034062,Pocillopora_meandrina_HIv1___RNAseq.g19653.t1,three_way,66.30766666666668,FUN_005822-T3,Q2ABP2,,,,,41.0,234.0,2e-40,167.5,sp|Q2ABP2|PGAP2_CRIGR Acyltransferase PGAP2 OS=Cricetulus griseus OX=10029 GN=Pgap2 PE=1 SV=1,,,,,,
OG_01431,1.521459505971623,FUN_005824-T1,Peve_00034060,Pocillopora_meandrina_HIv1___RNAseq.g19655.t1,three_way,78.75233333333333,FUN_005824-T1,Q5R9T6,,,,,43.8,297.0,1.8e-72,274.2,sp|Q5R9T6|WDR55_PONAB WD repeat-containing protein 55 OS=Pongo abelii OX=9601 GN=WDR55 PE=2 SV=1,,,,,,
OG_01433,1.5805850309382237,FUN_005832-T2,Peve_00034054,Pocillopora_meandrina_HIv1___RNAseq.g19672.t1,three_way,60.95,FUN_005832-T2,Q3L254,WNT7B_CHICK,,Protein Wnt-7b,Gallus gallus (Chicken),47.4,333.0,2.7e-88,327.0,sp|Q3L254|WNT7B_CHICK Protein Wnt-7b OS=Gallus gallus OX=9031 GN=WNT7B PE=2 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0021871; GO:0030182; GO:0045165; GO:0046330; GO:0048144; GO:0060070; GO:0070307; GO:0071300; GO:0072089,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089],extracellular space [GO:0005615],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01435,2.731508667513987,FUN_005856-T1,Peve_00034053,Pocillopora_meandrina_HIv1___TS.g29054.t1,three_way,52.05916666666666,FUN_005856-T1,P41221,WNT5A_HUMAN,,Protein Wnt-5a,Homo sapiens (Human),41.0,376.0,1.5e-79,298.1,sp|P41221|WNT5A_HUMAN Protein Wnt-5a OS=Homo sapiens OX=9606 GN=WNT5A PE=1 SV=2,GO:0001736; GO:0001756; GO:0001822; GO:0001837; GO:0001843; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002720; GO:0003138; GO:0003139; GO:0003281; GO:0003283; GO:0003323; GO:0003344; GO:0003408; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006954; GO:0007200; GO:0007223; GO:0007254; GO:0007411; GO:0007442; GO:0007494; GO:0008104; GO:0008543; GO:0008584; GO:0008595; GO:0009986; GO:0010463; GO:0010595; GO:0010628; GO:0010631; GO:0010742; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030509; GO:0030514; GO:0030666; GO:0030669; GO:0031012; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0043410; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048846; GO:0048850; GO:0050680; GO:0050727; GO:0050729; GO:0050807; GO:0051216; GO:0051885; GO:0051897; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060809; GO:0060907; GO:0061036; GO:0062009; GO:0070062; GO:0070242; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090090; GO:0090103; GO:0097325; GO:0098685; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099170; GO:0099175; GO:0099566; GO:0140013; GO:0150012; GO:1900020; GO:1902035; GO:1902379; GO:1902474; GO:1904861; GO:1904862; GO:1904934; GO:1904948; GO:2000049; GO:2000052; GO:2001235,"anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to calcium ion [GO:0071277]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to type II interferon [GO:0071346]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell migration [GO:0010631]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inflammatory response [GO:0006954]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; meiotic nuclear division [GO:0140013]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation [GO:0010463]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midbrain dopaminergic neuron differentiation [GO:1904948]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; pericardium morphogenesis [GO:0003344]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type II interferon production [GO:0032729]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein localization [GO:0008104]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; thymocyte apoptotic process [GO:0070242]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventricular septum development [GO:0003281]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]",cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685],chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115],GO:0005576; GO:0005615; GO:0005886; GO:0006355; GO:0006954; GO:0007163; GO:0008289; GO:0012501; GO:0022414; GO:0023052; GO:0030154; GO:0030312; GO:0031012; GO:0034330; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772; GO:0140013,extracellular region; extracellular space; plasma membrane; regulation of DNA-templated transcription; inflammatory response; establishment or maintenance of cell polarity; lipid binding; programmed cell death; reproductive process; signaling; cell differentiation; external encapsulating structure; extracellular matrix; cell junction organization; wound healing; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity; meiotic nuclear division
OG_01436,2.5769893854499784,FUN_005858-T1,Peve_00015774,Pocillopora_meandrina_HIv1___RNAseq.g19665.t1,three_way,77.938,FUN_005858-T1,Q8IV35,,,,,25.4,906.0,2.2e-77,292.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_01437,6.203170944675357,FUN_005873-T1,Peve_00015756,Pocillopora_meandrina_HIv1___RNAseq.g19664.t1,three_way,58.21833333333333,,,,,,,,,,,,,,,,,
OG_01445,2.5409159699303747,FUN_005893-T1,Peve_00015773,Pocillopora_meandrina_HIv1___RNAseq.g19681.t1,three_way,81.42,FUN_005893-T1,G5EBX9,PPE_CAEEL,,Serine/threonine-protein phosphatase with EF-hands pef-1 (CePPEF) (EC 3.1.3.16) (Phosphatase with EF hands 1),Caenorhabditis elegans,49.7,580.0,1.8000000000000001e-162,574.3,sp|G5EBX9|PPE_CAEEL Serine/threonine-protein phosphatase with EF-hands pef-1 OS=Caenorhabditis elegans OX=6239 GN=pef-1 PE=1 SV=1,GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0030145; GO:0030424; GO:0030425; GO:0043025; GO:0043204; GO:0050906,detection of stimulus involved in sensory perception [GO:0050906],axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; cilium; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01446,1.923739748349394,FUN_005894-T1,Peve_00035818,Pocillopora_meandrina_HIv1___RNAseq.g19682.t1,three_way,75.725,FUN_005894-T1,Q9BVK2,ALG8_HUMAN,,"Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)",Homo sapiens (Human),55.1,296.0,6.5e-84,312.4,"sp|Q9BVK2|ALG8_HUMAN Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG8 PE=1 SV=2",GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0018279; GO:0042283; GO:0098553,dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553],"dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_01448,1.6542926436848204,FUN_005899-T1,Peve_00035816,Pocillopora_meandrina_HIv1___RNAseq.3178_t,three_way,96.55533333333334,FUN_005899-T1,Q15319,PO4F3_HUMAN,,"POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C)",Homo sapiens (Human),59.5,259.0,1.4e-66,254.6,"sp|Q15319|PO4F3_HUMAN POU domain, class 4, transcription factor 3 OS=Homo sapiens OX=9606 GN=POU4F3 PE=1 SV=1",GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007601; GO:0007605; GO:0021562; GO:0031290; GO:0042472; GO:0042491; GO:0045944; GO:0048675; GO:0050885; GO:0051402; GO:1990837,axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_01451,1.6135384915784716,FUN_005905-T1,Peve_00033233,Pocillopora_meandrina_HIv1___RNAseq.g19576.t1,three_way,48.1295,FUN_005905-T1,Q8JI28,,,,,24.0,271.0,2.7e-13,77.8,sp|Q8JI28|TLL1_XENLA Tolloid-like protein 1 OS=Xenopus laevis OX=8355 GN=tll1 PE=1 SV=1,,,,,,
OG_01453,1.2338595740468958,FUN_005909-T1,Peve_00038382,Pocillopora_meandrina_HIv1___RNAseq.g19572.t1,three_way,90.43466666666669,FUN_005909-T1,A7S3I2,,,,,87.0,69.0,2.9e-24,112.8,sp|A7S3I2|BBIP1_NEMVE BBSome-interacting protein 1 OS=Nematostella vectensis OX=45351 GN=bbip1 PE=3 SV=1,,,,,,
OG_01457,1.7176328022279592,FUN_005931-T1,Peve_00011544,Pocillopora_meandrina_HIv1___TS.g26522.t1,three_way,59.55316666666667,,,,,,,,,,,,,,,,,
OG_01458,2.485611883482203,FUN_005970-T1,Peve_00015060,Pocillopora_meandrina_HIv1___RNAseq.g19790.t1,three_way,78.61566666666667,FUN_005970-T1,A7RPT4,NNRE_NEMVE,,NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase),Nematostella vectensis (Starlet sea anemone),71.1,228.0,3.5e-98,359.4,sp|A7RPT4|NNRE_NEMVE NAD(P)H-hydrate epimerase OS=Nematostella vectensis OX=45351 GN=v1g228490 PE=3 SV=1,GO:0000166; GO:0005739; GO:0046872; GO:0052856,,mitochondrion [GO:0005739],metal ion binding [GO:0046872]; NAD(P)HX epimerase activity [GO:0052856]; nucleotide binding [GO:0000166],GO:0003824; GO:0005739; GO:0016853; GO:0043226,catalytic activity; mitochondrion; isomerase activity; organelle
OG_01463,2.846043481839504,FUN_005998-T1,Peve_00036045,Pocillopora_meandrina_HIv1___RNAseq.g19934.t1,three_way,70.90683333333334,FUN_005998-T1,P23780,BGAL_MOUSE,,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),Mus musculus (Mouse),50.4,625.0,1.3e-181,637.9,sp|P23780|BGAL_MOUSE Beta-galactosidase OS=Mus musculus OX=10090 GN=Glb1 PE=1 SV=1,GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0006516; GO:0006689; GO:0016020; GO:0016787; GO:0016936; GO:0019388; GO:0042340; GO:0042803; GO:0051413; GO:1904016,galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; keratan sulfate proteoglycan catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020],beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0005975; GO:0006629; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; Golgi apparatus; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_01466,1.7644149321354097,FUN_006002-T1,Peve_00036060,Pocillopora_meandrina_HIv1___RNAseq.g19927.t1,three_way,76.86133333333333,FUN_006002-T1,A0A1U8QWA2,ATR12_EMENI,,Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)],Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans),38.2,1317.0,3.3e-237,823.5,sp|A0A1U8QWA2|ATR12_EMENI Glycine betaine reductase ATRR OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=ATRR PE=1 SV=1,GO:0009058; GO:0016491; GO:0031177,biosynthetic process [GO:0009058],,oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_01468,1.8445730680300687,FUN_006004-T1,Peve_00036048,Pocillopora_meandrina_HIv1___RNAseq.g19925.t1,three_way,79.33333333333333,FUN_006004-T1,Q7T0P7,,,,,50.5,196.0,3.7e-47,189.5,sp|Q7T0P7|ATP23_XENLA Mitochondrial inner membrane protease ATP23 homolog OS=Xenopus laevis OX=8355 GN=atp23 PE=2 SV=1,,,,,,
OG_01473,1.1273281770750467,FUN_006011-T1,Peve_00032349,Pocillopora_meandrina_HIv1___TS.g29304.t1,three_way,62.3305,,,,,,,,,,,,,,,,,
OG_01474,1.8190629703166528,FUN_006026-T1,Peve_00043468,Pocillopora_meandrina_HIv1___RNAseq.g11262.t1,three_way,44.10966666666667,FUN_006026-T1,Q07409,,,,,29.4,282.0,1.1e-22,110.5,sp|Q07409|CNTN3_MOUSE Contactin-3 OS=Mus musculus OX=10090 GN=Cntn3 PE=1 SV=2,,,,,,
OG_01478,2.119989240672586,FUN_006041-T1,Peve_00040856,Pocillopora_meandrina_HIv1___TS.g29901.t1a,three_way,85.28133333333334,FUN_006041-T1,Q5M823,NUDC2_RAT,,NudC domain-containing protein 2,Rattus norvegicus (Rat),58.0,150.0,6.2e-50,198.4,sp|Q5M823|NUDC2_RAT NudC domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Nudcd2 PE=2 SV=1,GO:0000776; GO:0000922; GO:0005737; GO:0005813; GO:0006457; GO:0051082,protein folding [GO:0006457],centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; spindle pole [GO:0000922],unfolded protein binding [GO:0051082],GO:0005815; GO:0006457; GO:0043226,microtubule organizing center; protein folding; organelle
OG_01479,3.834231806870104,FUN_006042-T1,Peve_00017140,Pocillopora_meandrina_HIv1___RNAseq.g20180.t1,three_way,75.429,FUN_006042-T1,Q99JW2,,,,,59.5,393.0,1.2e-140,501.1,sp|Q99JW2|ACY1_MOUSE Aminoacylase-1 OS=Mus musculus OX=10090 GN=Acy1 PE=1 SV=1,,,,,,
OG_01481,1.2736789393704588,FUN_006108-T1,Peve_00011648,Pocillopora_meandrina_HIv1___RNAseq.g20395.t1,three_way,81.35466666666666,FUN_006108-T1,Q8BYW9,,,,,55.0,484.0,1.7000000000000001e-161,570.9,sp|Q8BYW9|EOGT_MOUSE EGF domain-specific O-linked N-acetylglucosamine transferase OS=Mus musculus OX=10090 GN=Eogt PE=1 SV=1,,,,,,
OG_01483,1.5039788129947105,FUN_006117-T1,Peve_00011322,Pocillopora_meandrina_HIv1___RNAseq.g20401.t1,three_way,36.36283333333333,,,,,,,,,,,,,,,,,
OG_01488,2.060883355710739,FUN_006164-T1,Peve_00023606,Pocillopora_meandrina_HIv1___RNAseq.g20425.t1,three_way,70.08466666666666,FUN_006164-T1,Q9X1H7,,,,,41.6,173.0,2.1e-27,124.4,sp|Q9X1H7|ENGB_THEMA Probable GTP-binding protein EngB OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=engB PE=1 SV=1,,,,,,
OG_01489,4.948107123249896,FUN_006165-T1,Peve_00023607,Pocillopora_meandrina_HIv1___RNAseq.g20426.t1,three_way,60.60533333333333,FUN_006165-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),33.7,5014.0,0.0,2299.2,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_01491,4.624169709938388,FUN_006167-T2,Peve_00021030,Pocillopora_meandrina_HIv1___RNAseq.g20429.t1,three_way,75.59433333333334,FUN_006167-T2,Q06S87,,,,,54.3,116.0,2.3e-27,125.6,sp|Q06S87|HIUH_DANRE 5-hydroxyisourate hydrolase OS=Danio rerio OX=7955 GN=urah PE=1 SV=1,,,,,,
OG_01492,2.204644603380715,FUN_006168-T1,Peve_00021029,Pocillopora_meandrina_HIv1___RNAseq.g20428.t1,three_way,70.18666666666667,FUN_006168-T1,Q07G10,,,,,42.8,661.0,8.4e-152,538.9,sp|Q07G10|ALKB8_XENTR tRNA (carboxymethyluridine(34)-5-O)-methyltransferase alkbh8 OS=Xenopus tropicalis OX=8364 GN=alkbh8 PE=2 SV=2,,,,,,
OG_01493,1.9078190346249475,FUN_006169-T1,Peve_00021028,Pocillopora_meandrina_HIv1___RNAseq.g20427.t1,three_way,83.96716666666667,FUN_006169-T1,Q80UV9,TAF1_MOUSE,,Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250),Mus musculus (Mouse),45.8,1844.0,0.0,1349.7,sp|Q80UV9|TAF1_MOUSE Transcription initiation factor TFIID subunit 1 OS=Mus musculus OX=10090 GN=Taf1 PE=1 SV=2,GO:0003677; GO:0004402; GO:0004674; GO:0005524; GO:0005634; GO:0005669; GO:0016251; GO:0017025; GO:0042789; GO:0045120; GO:0051123; GO:0060261; GO:0071339; GO:0106310; GO:1990841,mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123],MLL1 complex [GO:0071339]; nucleus [GO:0005634]; pronucleus [GO:0045120]; transcription factor TFIID complex [GO:0005669],ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025],GO:0003677; GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0043226; GO:0065003; GO:0140096; GO:0140223,"DNA binding; catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; general transcription initiation factor activity"
OG_01494,2.7220402533542205,FUN_006172-T1,Peve_00028675,Pocillopora_meandrina_HIv1___RNAseq.g20432.t1,three_way,61.756,FUN_006172-T1,Q9QXG2,,,,,42.3,684.0,1.2000000000000002e-124,448.7,sp|Q9QXG2|RAE1_MOUSE Rab proteins geranylgeranyltransferase component A 1 OS=Mus musculus OX=10090 GN=Chm PE=1 SV=1,,,,,,
OG_01498,4.485164918878098,FUN_006222-T1,Peve_00020211,Pocillopora_meandrina_HIv1___RNAseq.g20439.t1,three_way,85.01766666666667,FUN_006222-T1,P56560,,,,,53.5,505.0,2.2e-152,540.4,sp|P56560|AOFB_BOVIN Amine oxidase [flavin-containing] B OS=Bos taurus OX=9913 GN=MAOB PE=1 SV=4,,,,,,
OG_01499,1.1355444676049449,FUN_006223-T1,Peve_00011448,Pocillopora_meandrina_HIv1___RNAseq.g20440.t1,three_way,75.15666666666667,FUN_006223-T1,A5A6P2,ASAH1_PANTR,,Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta],Pan troglodytes (Chimpanzee),52.0,367.0,7.8e-118,425.2,sp|A5A6P2|ASAH1_PANTR Acid ceramidase OS=Pan troglodytes OX=9598 GN=ASAH1 PE=2 SV=1,GO:0005615; GO:0005764; GO:0006631; GO:0016020; GO:0017040; GO:0017064; GO:0030216; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356,cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512],extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020],fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0006629; GO:0016787; GO:0030154; GO:0043226,catalytic activity; extracellular space; lysosome; vacuole; lipid metabolic process; hydrolase activity; cell differentiation; organelle
OG_01501,1.3748574948152583,FUN_006227-T1,Peve_00002943,Pocillopora_meandrina_HIv1___TS.g29772.t1,three_way,66.25183333333334,FUN_006227-T1,P49793,,,,,37.4,1753.0,1.3e-226,788.9,sp|P49793|NUP98_RAT Nuclear pore complex protein Nup98-Nup96 OS=Rattus norvegicus OX=10116 GN=Nup98 PE=1 SV=2,,,,,,
OG_01503,3.780862386881788,FUN_006230-T1,Peve_00002942,Pocillopora_meandrina_HIv1___RNAseq.g20449.t1,three_way,69.12416666666667,FUN_006230-T1,Q5SZK8,FREM2_HUMAN,,FRAS1-related extracellular matrix protein 2 (ECM3 homolog),Homo sapiens (Human),41.5,1242.0,4.8e-265,916.0,sp|Q5SZK8|FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens OX=9606 GN=FREM2 PE=1 SV=3,GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0009653; GO:0042733; GO:0046872; GO:0048839; GO:0062023; GO:0070062,anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],metal ion binding [GO:0046872],GO:0005886; GO:0007155; GO:0030312; GO:0031012; GO:0043226; GO:0048856,plasma membrane; cell adhesion; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_01510,3.2144563209718413,FUN_006245-T1,Peve_00002946,Pocillopora_meandrina_HIv1___RNAseq.g20390.t1b,three_way,45.26566666666667,,,,,,,,,,,,,,,,,
OG_01514,1.0638310571370635,FUN_006253-T1,Peve_00012679,Pocillopora_meandrina_HIv1___RNAseq.g20382.t1,three_way,89.648,FUN_006253-T1,P37235,HPCL1_HUMAN,,Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3),Homo sapiens (Human),51.6,188.0,6.6e-52,205.3,sp|P37235|HPCL1_HUMAN Hippocalcin-like protein 1 OS=Homo sapiens OX=9606 GN=HPCAL1 PE=1 SV=3,GO:0005509; GO:0009966; GO:0016020,regulation of signal transduction [GO:0009966],membrane [GO:0016020],calcium ion binding [GO:0005509],,
OG_01515,1.3354267652706788,FUN_006255-T1,Peve_00012684,Pocillopora_meandrina_HIv1___TS.g29759.t1b,three_way,59.60883333333333,,,,,,,,,,,,,,,,,
OG_01516,1.5203832890245044,FUN_006259-T1,Peve_00031978,Pocillopora_meandrina_HIv1___TS.g29759.t1a,three_way,91.737,FUN_006259-T1,Q8R323,,,,,75.8,351.0,2.9e-159,562.8,sp|Q8R323|RFC3_MOUSE Replication factor C subunit 3 OS=Mus musculus OX=10090 GN=Rfc3 PE=1 SV=1,,,,,,
OG_01520,2.109886167445381,FUN_006266-T1,Peve_00019724,Pocillopora_meandrina_HIv1___RNAseq.g20372.t1,three_way,75.93266666666666,,,,,,,,,,,,,,,,,
OG_01523,1.0159147195818852,FUN_006278-T1,Peve_00018295,Pocillopora_meandrina_HIv1___RNAseq.g20361.t1,three_way,65.20033333333333,FUN_006278-T1,A1Z7G7,LPHN_DROME,,Latrophilin Cirl,Drosophila melanogaster (Fruit fly),22.5,329.0,7e-12,74.7,sp|A1Z7G7|LPHN_DROME Latrophilin Cirl OS=Drosophila melanogaster OX=7227 GN=Cirl PE=1 SV=2,GO:0004888; GO:0004930; GO:0005886; GO:0007166; GO:0008344; GO:0019230; GO:0030246; GO:0140897,adult locomotory behavior [GO:0008344]; cell surface receptor signaling pathway [GO:0007166]; proprioception [GO:0019230],plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; mechanoreceptor activity [GO:0140897]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_01524,2.1926320851024106,FUN_006320-T1,Peve_00021264,Pocillopora_meandrina_HIv1___RNAseq.g20359.t1,three_way,67.9575,FUN_006320-T1,Q8BV79,,,,,30.9,2660.0,1.4999999999999998e-286,988.8,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_01525,1.5896959611504715,FUN_006321-T1,Peve_00021265,Pocillopora_meandrina_HIv1___RNAseq.g20358.t1,three_way,74.99366666666667,FUN_006321-T1,Q3KNI6,DAAF6_MOUSE,,Dynein axonemal assembly factor 6 (PIH1 domain-containing protein 3),Mus musculus (Mouse),34.6,185.0,4.4e-21,102.8,sp|Q3KNI6|DAAF6_MOUSE Dynein axonemal assembly factor 6 OS=Mus musculus OX=10090 GN=Dnaaf6 PE=1 SV=1,GO:0003341; GO:0005737; GO:0005802; GO:0030317; GO:0036158; GO:0036159; GO:0045505; GO:0051087; GO:0070286,axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158],cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802],dynein intermediate chain binding [GO:0045505]; protein-folding chaperone binding [GO:0051087],GO:0007018; GO:0022414; GO:0048870; GO:0065003,microtubule-based movement; reproductive process; cell motility; protein-containing complex assembly
OG_01527,1.6702461587576076,FUN_006323-T1,Peve_00012583,Pocillopora_meandrina_HIv1___RNAseq.g20356.t1,three_way,61.63033333333333,,,,,,,,,,,,,,,,,
OG_01529,1.757160929207843,FUN_006328-T1,Peve_00012587,Pocillopora_meandrina_HIv1___RNAseq.g20352.t1,three_way,90.09566666666666,FUN_006328-T1,O43772,MCAT_HUMAN,,Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (Solute carrier family 25 member 20),Homo sapiens (Human),61.7,298.0,5.4e-109,395.6,sp|O43772|MCAT_HUMAN Mitochondrial carnitine/acylcarnitine carrier protein OS=Homo sapiens OX=9606 GN=SLC25A20 PE=1 SV=1,GO:0001701; GO:0005476; GO:0005739; GO:0005740; GO:0005743; GO:0005829; GO:0006839; GO:0006853; GO:0015227; GO:1902603,carnitine shuttle [GO:0006853]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839],cytosol [GO:0005829]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],carnitine:O-acyl-L-carnitine antiporter activity [GO:0005476]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227],GO:0005215; GO:0005739; GO:0005829; GO:0043226; GO:0048856; GO:0055085,transporter activity; mitochondrion; cytosol; organelle; anatomical structure development; transmembrane transport
OG_01530,1.5694166362061264,FUN_006329-T1,Peve_00012586,Pocillopora_meandrina_HIv1___RNAseq.g20351.t1,three_way,88.88233333333334,FUN_006329-T1,P09623,DLDH_PIG,,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)",Sus scrofa (Pig),75.5,470.0,1.1e-207,724.2,"sp|P09623|DLDH_PIG Dihydrolipoyl dehydrogenase, mitochondrial OS=Sus scrofa OX=9823 GN=DLD PE=1 SV=1",GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0006090; GO:0006103; GO:0031514; GO:0045252; GO:0050660,2-oxoglutarate metabolic process [GO:0006103]; pyruvate metabolic process [GO:0006090],acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252],dihydrolipoyl dehydrogenase (NADH) activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660],GO:0003824; GO:0005634; GO:0005739; GO:0005929; GO:0016491; GO:0031410; GO:0043226,catalytic activity; nucleus; mitochondrion; cilium; oxidoreductase activity; cytoplasmic vesicle; organelle
OG_01537,1.181485105456857,FUN_006368-T3,Peve_00007383,Pocillopora_meandrina_HIv1___RNAseq.g20337.t1,three_way,62.754666666666665,,,,,,,,,,,,,,,,,
OG_01538,2.150945492587597,FUN_006369-T1,Peve_00007373,Pocillopora_meandrina_HIv1___TS.g29715.t2,three_way,76.103,FUN_006369-T1,Q9P055,,,,,42.9,294.0,3.7999999999999996e-62,240.0,sp|Q9P055|JKAMP_HUMAN JNK1/MAPK8-associated membrane protein OS=Homo sapiens OX=9606 GN=JKAMP PE=1 SV=4,,,,,,
OG_01541,2.3124860397063425,FUN_006411-T1,Peve_00018195,Pocillopora_meandrina_HIv1___RNAseq.g20262.t1,three_way,76.773,FUN_006411-T1,Q9NTJ4,,,,,49.9,1007.0,1.9e-293,1010.0,sp|Q9NTJ4|MA2C1_HUMAN Alpha-mannosidase 2C1 OS=Homo sapiens OX=9606 GN=MAN2C1 PE=1 SV=1,,,,,,
OG_01542,1.4478233190191483,FUN_006414-T1,Peve_00043556,Pocillopora_meandrina_HIv1___RNAseq.g20274.t1,three_way,74.46766666666667,FUN_006414-T1,Q0ZDF7,,,,,46.1,154.0,4.3e-28,126.3,sp|Q0ZDF7|URAD_AMICA 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Amia calva OX=7924 GN=urad PE=3 SV=1,,,,,,
OG_01544,1.91280714298537,FUN_006418-T1,Peve_00043553,Pocillopora_meandrina_HIv1___RNAseq.g20277.t1,three_way,85.8545,FUN_006418-T1,Q1KL12,,,,,61.2,80.0,1.7e-18,94.4,sp|Q1KL12|HXA3A_TAKRU Homeobox protein Hox-A3a OS=Takifugu rubripes OX=31033 GN=hoxa3a PE=3 SV=1,,,,,,
OG_01546,2.65927260303329,FUN_006421-T1,Peve_00043551,Pocillopora_meandrina_HIv1___RNAseq.g20280.t2,three_way,73.73433333333334,FUN_006421-T1,A7RS11,,,,,57.5,207.0,3.2e-66,253.1,sp|A7RS11|HPF1_NEMVE Histone PARylation factor 1 OS=Nematostella vectensis OX=45351 GN=HPF1 PE=1 SV=1,,,,,,
OG_01550,2.929410548473492,FUN_006425-T1,Peve_00043546,Pocillopora_meandrina_HIv1___TS.g29666.t1,three_way,69.39816666666667,FUN_006425-T1,Q96P50,,,,,30.0,253.0,1.1e-26,124.4,"sp|Q96P50|ACAP3_HUMAN Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ACAP3 PE=1 SV=2",,,,,,
OG_01565,3.7021540221489886,FUN_006447-T1,Peve_00038421,Pocillopora_meandrina_HIv1___RNAseq.3855_t,three_way,43.964333333333336,,,,,,,,,,,,,,,,,
OG_01566,2.2828427189518883,FUN_006448-T1,Peve_00038420,Pocillopora_meandrina_HIv1___RNAseq.g20307.t1a,three_way,70.55933333333333,,,,,,,,,,,,,,,,,
OG_01567,2.4179878124165683,FUN_006449-T1,Peve_00038439,Pocillopora_meandrina_HIv1___RNAseq.g20307.t1b,three_way,72.05333333333333,FUN_006449-T1,Q6ZWJ1,STXB4_HUMAN,,Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip),Homo sapiens (Human),28.6,768.0,1.2e-64,250.0,sp|Q6ZWJ1|STXB4_HUMAN Syntaxin-binding protein 4 OS=Homo sapiens OX=9606 GN=STXBP4 PE=1 SV=2,GO:0006605; GO:0006974; GO:0008286; GO:0010827; GO:0010838; GO:0019905; GO:0031410; GO:0045335; GO:0050821; GO:0061178; GO:0070062; GO:0071346; GO:1902808,cellular response to type II interferon [GO:0071346]; DNA damage response [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178],cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335],syntaxin binding [GO:0019905],GO:0031410; GO:0043226,cytoplasmic vesicle; organelle
OG_01570,1.1902327772299162,FUN_006568-T1,Peve_00038422,Pocillopora_meandrina_HIv1___RNAseq.g20309.t1,three_way,78.6515,FUN_006568-T1,Q08DP6,,,,,49.5,588.0,1.7e-150,534.6,sp|Q08DP6|RHG10_BOVIN Rho GTPase-activating protein 10 OS=Bos taurus OX=9913 GN=ARHGAP10 PE=2 SV=1,,,,,,
OG_01571,1.7426985239293031,FUN_006571-T1,Peve_00011459,Pocillopora_meandrina_HIv1___RNAseq.g20311.t2,three_way,68.144,FUN_006571-T1,Q61191,HCFC1_MOUSE,,Host cell factor 1 (HCF) (HCF-1) (C1 factor) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6],Mus musculus (Mouse),74.4,387.0,1.5e-185,651.7,sp|Q61191|HCFC1_MOUSE Host cell factor 1 OS=Mus musculus OX=10090 GN=Hcfc1 PE=1 SV=2,GO:0000122; GO:0000123; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005737; GO:0006325; GO:0010628; GO:0019046; GO:0031490; GO:0042802; GO:0043025; GO:0043254; GO:0044545; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0062023; GO:0071339; GO:0140297,blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; release from viral latency [GO:0019046],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188],chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_01573,3.451541092733011,FUN_006573-T1,Peve_00011457,Pocillopora_meandrina_HIv1___RNAseq.g20313.t1,three_way,82.19833333333334,FUN_006573-T1,P46850,RTCB_ECOLI,,RNA-splicing ligase RtcB (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase),Escherichia coli (strain K12),60.3,401.0,8.1e-135,481.9,sp|P46850|RTCB_ECOLI RNA-splicing ligase RtcB OS=Escherichia coli (strain K12) OX=83333 GN=rtcB PE=1 SV=3,GO:0003909; GO:0005525; GO:0006281; GO:0006396; GO:0006974; GO:0030145; GO:0042245; GO:0170057,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; RNA processing [GO:0006396]; RNA repair [GO:0042245],,DNA ligase activity [GO:0003909]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; RNA ligase (GTP) activity [GO:0170057],GO:0003824; GO:0006281; GO:0016874; GO:0140097; GO:0140098,"catalytic activity; DNA repair; ligase activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_01579,2.076465027545891,FUN_006613-T2,Peve_00023430,Pocillopora_meandrina_HIv1___RNAseq.g20254.t1,three_way,74.73116666666667,FUN_006613-T2,Q7T2C4,S26A5_DANRE,,Prestin (Solute carrier family 26 member 5),Danio rerio (Zebrafish) (Brachydanio rerio),34.5,730.0,3.7e-114,414.1,sp|Q7T2C4|S26A5_DANRE Prestin OS=Danio rerio OX=7955 GN=slc26a5 PE=2 SV=1,GO:0005737; GO:0005886; GO:0006821; GO:0008271; GO:0015075; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0016020; GO:0019531; GO:0019532; GO:0042391; GO:0160044; GO:0160046; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; oxalate transport [GO:0019532]; regulation of membrane potential [GO:0042391]; sulfate transmembrane transport [GO:1902358],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; formate transmembrane transporter activity [GO:0015499]; monoatomic ion transmembrane transporter activity [GO:0015075]; oxalate transmembrane transporter activity [GO:0019531]; oxalate:chloride antiporter activity [GO:0160046]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01580,1.1016293880856047,FUN_006614-T1,Peve_00040860,Pocillopora_meandrina_HIv1___RNAseq.g20509.t1,three_way,66.381,FUN_006614-T1,Q5SSI6,,,,,41.4,493.0,2.2e-97,357.8,sp|Q5SSI6|UTP18_MOUSE U3 small nucleolar RNA-associated protein 18 homolog OS=Mus musculus OX=10090 GN=Utp18 PE=1 SV=1,,,,,,
OG_01581,2.5053258813003647,FUN_006617-T1,Peve_00040861,Pocillopora_meandrina_HIv1___RNAseq.g20508.t1,three_way,60.46966666666667,,,,,,,,,,,,,,,,,
OG_01586,1.1695752538000854,FUN_006624-T1,Peve_00040869,Pocillopora_meandrina_HIv1___RNAseq.g20171.t1,three_way,48.2,,,,,,,,,,,,,,,,,
OG_01591,2.454859751022484,FUN_006631-T1,Peve_00040841,Pocillopora_meandrina_HIv1___TS.g29548.t1a,three_way,67.0835,,,,,,,,,,,,,,,,,
OG_01595,1.9754041968716625,FUN_006637-T1,Peve_00024050,Pocillopora_meandrina_HIv1___RNAseq.g20237.t1,three_way,73.5665,FUN_006637-T1,Q9P2Q2,FRM4A_HUMAN,,FERM domain-containing protein 4A,Homo sapiens (Human),44.8,504.0,7.7000000000000005e-118,426.4,sp|Q9P2Q2|FRM4A_HUMAN FERM domain-containing protein 4A OS=Homo sapiens OX=9606 GN=FRMD4A PE=1 SV=3,GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162,establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],protein-macromolecule adaptor activity [GO:0030674],GO:0005856; GO:0007163; GO:0043226; GO:0060090,cytoskeleton; establishment or maintenance of cell polarity; organelle; molecular adaptor activity
OG_01602,2.8531423979993,FUN_006645-T1,Peve_00029047,Pocillopora_meandrina_HIv1___RNAseq.g19947.t1,three_way,43.628166666666665,,,,,,,,,,,,,,,,,
OG_01603,1.877750114783272,FUN_006646-T1,Peve_00029030,Pocillopora_meandrina_HIv1___RNAseq.g19948.t1,three_way,55.7015,FUN_006646-T1,Q9BY77,PDIP3_HUMAN,,Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein) (p46) (S6K1 Aly/REF-like target) (SKAR),Homo sapiens (Human),50.7,69.0,2.3e-13,78.2,sp|Q9BY77|PDIP3_HUMAN Polymerase delta-interacting protein 3 OS=Homo sapiens OX=9606 GN=POLDIP3 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016607; GO:0016973; GO:0036464; GO:0044877; GO:0045727,poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006913; GO:0043226,RNA binding; nucleus; nucleoplasm; cytosol; nucleocytoplasmic transport; organelle
OG_01606,3.3643445703089414,FUN_006650-T1,Peve_00029034,Pocillopora_meandrina_HIv1___RNAseq.g19953.t1,three_way,78.253,FUN_006650-T1,Q9UI36,DACH1_HUMAN,,Dachshund homolog 1 (Dach1),Homo sapiens (Human),27.6,479.0,9.2e-19,96.7,sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279,development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0022414; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle; transcription regulator activity
OG_01607,1.656972439872986,FUN_006651-T1,Peve_00029038,Pocillopora_meandrina_HIv1___RNAseq.g19954.t1,three_way,73.84383333333334,FUN_006651-T1,Q96M89,,,,,35.0,448.0,2.3e-63,245.0,sp|Q96M89|CC138_HUMAN Coiled-coil domain-containing protein 138 OS=Homo sapiens OX=9606 GN=CCDC138 PE=1 SV=1,,,,,,
OG_01608,3.749273904813988,FUN_006652-T1,Peve_00029039,Pocillopora_meandrina_HIv1___RNAseq.g19955.t1,three_way,64.58433333333333,FUN_006652-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),32.4,1666.0,2.3000000000000004e-224,781.6,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_01609,2.7992426807909268,FUN_006654-T1,Peve_00029040,Pocillopora_meandrina_HIv1___TS.g29343.t1,three_way,81.31466666666667,FUN_006654-T1,Q8IZU2,,,,,51.7,1313.0,0.0,1184.1,sp|Q8IZU2|WDR17_HUMAN WD repeat-containing protein 17 OS=Homo sapiens OX=9606 GN=WDR17 PE=1 SV=2,,,,,,
OG_01615,3.140443457511652,FUN_006706-T1,Peve_00022745,Pocillopora_meandrina_HIv1___RNAseq.g19996.t1,three_way,57.7245,FUN_006706-T1,Q8VE88,,,,,36.3,411.0,8e-51,203.4,sp|Q8VE88|F1142_MOUSE Protein FAM114A2 OS=Mus musculus OX=10090 GN=Fam114a2 PE=1 SV=2,,,,,,
OG_01618,2.232435055912277,FUN_006727-T1,Peve_00039555,Pocillopora_meandrina_HIv1___RNAseq.g20013.t1,three_way,71.43566666666666,FUN_006727-T1,Q3UTQ8,CDKL5_MOUSE,,Cyclin-dependent kinase-like 5 (EC 2.7.11.22),Mus musculus (Mouse),44.0,616.0,8.800000000000001e-125,449.5,sp|Q3UTQ8|CDKL5_MOUSE Cyclin-dependent kinase-like 5 OS=Mus musculus OX=10090 GN=Cdkl5 PE=1 SV=1,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0016301; GO:0034504; GO:0036064; GO:0097542; GO:0106310; GO:1902017,protein localization to nucleus [GO:0034504]; regulation of cilium assembly [GO:1902017],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01619,1.950559407740989,FUN_006728-T1,Peve_00039557,Pocillopora_meandrina_HIv1___RNAseq.g20014.t1,three_way,68.159,,,,,,,,,,,,,,,,,
OG_01621,2.4150205079133853,FUN_006730-T1,Peve_00039561,Pocillopora_meandrina_HIv1___TS.g29404.t2,three_way,70.635,FUN_006730-T1,Q9CQF6,,,,,50.4,254.0,2.0000000000000002e-72,273.9,sp|Q9CQF6|ADPPT_MOUSE L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase OS=Mus musculus OX=10090 GN=Aasdhppt PE=1 SV=1,,,,,,
OG_01622,1.5488072004878646,FUN_006731-T1,Peve_00039563,Pocillopora_meandrina_HIv1___RNAseq.g20017.t1,three_way,82.17733333333334,FUN_006731-T1,Q7ZVK4,,,,,55.0,387.0,1.3e-112,407.9,sp|Q7ZVK4|VPS36_DANRE Vacuolar protein-sorting-associated protein 36 OS=Danio rerio OX=7955 GN=vps36 PE=2 SV=1,,,,,,
OG_01623,1.2155250944912523,FUN_006732-T1,Peve_00039564,Pocillopora_meandrina_HIv1___RNAseq.g20521.t1,three_way,90.959,FUN_006732-T1,Q2KIE4,,,,,66.3,178.0,6.2e-65,248.4,sp|Q2KIE4|MCTS1_BOVIN Malignant T-cell-amplified sequence 1 OS=Bos taurus OX=9913 GN=MCTS1 PE=2 SV=1,,,,,,
OG_01624,1.378175469124622,FUN_006733-T1,Peve_00039566,Pocillopora_meandrina_HIv1___RNAseq.g20522.t1,three_way,76.06866666666667,FUN_006733-T1,Q8N5Y2,,,,,30.1,509.0,1.4e-43,178.7,sp|Q8N5Y2|MS3L1_HUMAN MSL complex subunit 3 OS=Homo sapiens OX=9606 GN=MSL3 PE=1 SV=1,,,,,,
OG_01636,2.4431638008275525,FUN_006769-T1,Peve_00027411,Pocillopora_meandrina_HIv1___RNAseq.g20028.t1,three_way,57.7305,FUN_006769-T1,Q9Y2U8,MAN1_HUMAN,,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),Homo sapiens (Human),42.9,317.0,7.4e-55,216.9,sp|Q9Y2U8|MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2,GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446,negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446],GO:0003677,DNA binding
OG_01637,3.1921195442479173,FUN_006771-T1,Peve_00027409,Pocillopora_meandrina_HIv1___RNAseq.g20026.t1,three_way,45.833333333333336,,,,,,,,,,,,,,,,,
OG_01639,1.7192271963307124,FUN_006776-T1,Peve_00012349,Pocillopora_meandrina_HIv1___RNAseq.g20024.t1,three_way,61.361666666666665,FUN_006776-T1,Q5F489,,,,,35.5,262.0,1.3000000000000001e-30,136.3,sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1,,,,,,
OG_01639,1.7192271963307124,FUN_006776-T1,Peve_00012349,Pocillopora_meandrina_HIv1___RNAseq.g20024.t1,three_way,61.361666666666665,FUN_006776-T1,Q5F489,,,,,54.2,72.0,2.9e-14,82.0,sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1,,,,,,
OG_01640,1.5287194619221205,FUN_006777-T1,Peve_00012351,Pocillopora_meandrina_HIv1___TS.g29411.t1,three_way,62.50533333333333,FUN_006777-T1,Q8CFG5,CA2D3_RAT,,Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3],Rattus norvegicus (Rat),29.8,1024.0,4.8e-117,424.1,sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1,GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314,calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174],GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891],calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0098772,transporter activity; molecular function regulator activity
OG_01650,2.4157271991948472,FUN_006805-T1,Peve_00023740,Pocillopora_meandrina_HIv1___RNAseq.g20488.t1a,three_way,80.63166666666666,FUN_006805-T1,Q52T38,ZDH22_ARATH,,Protein S-acyltransferase 24 (EC 2.3.1.225) (Ankyrin repeat-containing S-palmitoyltransferase) (Palmitoyltransferase TIP1) (Protein TIP GROWTH DEFECTIVE 1) (AtTIP1) (Zinc finger DHHC domain-containing protein TIP1),Arabidopsis thaliana (Mouse-ear cress),32.0,222.0,5.1e-27,124.0,sp|Q52T38|ZDH22_ARATH Protein S-acyltransferase 24 OS=Arabidopsis thaliana OX=3702 GN=PAT24 PE=1 SV=1,GO:0000035; GO:0000139; GO:0005768; GO:0005794; GO:0005802; GO:0009932; GO:0016417; GO:0019706; GO:0030659; GO:2000652; GO:2001006,cell tip growth [GO:0009932]; regulation of cellulose biosynthetic process [GO:2001006]; regulation of secondary cell wall biogenesis [GO:2000652],cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],acyl binding [GO:0000035]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; S-acyltransferase activity [GO:0016417],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_01656,6.3111408267999805,FUN_006826-T1,Peve_00023770,Pocillopora_meandrina_HIv1___RNAseq.g20475.t1,three_way,76.18166666666667,,,,,,,,,,,,,,,,,
OG_01657,2.4080846823037008,FUN_006827-T2,Peve_00023772,Pocillopora_meandrina_HIv1___RNAseq.g20474.t1,three_way,59.91866666666667,FUN_006827-T2,Q566X8,DMX1B_DANRE,,Diencephalon/mesencephalon homeobox protein 1-B,Danio rerio (Zebrafish) (Brachydanio rerio),60.8,97.0,1.8e-21,104.4,sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074,midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_01659,3.7281758198796737,FUN_006830-T1,Peve_00023775,Pocillopora_meandrina_HIv1___RNAseq.g20471.t1,three_way,73.49133333333333,FUN_006830-T1,Q9U637,,,,,37.9,198.0,7.3e-17,89.0,sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1,,,,,,
OG_01662,2.392469702356661,FUN_006845-T1,Peve_00023780,Pocillopora_meandrina_HIv1___RNAseq.g20467.t2,three_way,74.246,FUN_006845-T1,Q8AWB5,,,,,49.5,386.0,1.9e-105,384.4,sp|Q8AWB5|OFUT3_CHICK GDP-fucose protein O-fucosyltransferase 3 OS=Gallus gallus OX=9031 GN=FUT10 PE=2 SV=2,,,,,,
OG_01665,2.026966056118116,FUN_006848-T1,Peve_00023783,Pocillopora_meandrina_HIv1___RNAseq.g20485.t1,three_way,69.09166666666667,,,,,,,,,,,,,,,,,
OG_01667,1.2903488009900597,FUN_006852-T1,Peve_00042993,Pocillopora_meandrina_HIv1___RNAseq.g20241.t1,three_way,74.726,,,,,,,,,,,,,,,,,
OG_01669,3.0565337292238675,FUN_006856-T1,Peve_00016201,Pocillopora_meandrina_HIv1___RNAseq.g19911.t1,three_way,74.561,FUN_006856-T1,P24861,,,,,48.5,454.0,1.7e-95,351.3,sp|P24861|CCNA_PATVU G2/mitotic-specific cyclin-A OS=Patella vulgata OX=6465 PE=2 SV=1,,,,,,
OG_01670,2.285160587053437,FUN_006857-T1,Peve_00016203,Pocillopora_meandrina_HIv1___RNAseq.g19910.t1b,three_way,63.460166666666666,FUN_006857-T1,B9EJ80,PDZD8_MOUSE,,PDZ domain-containing protein 8,Mus musculus (Mouse),28.5,1009.0,2.5000000000000004e-80,302.0,sp|B9EJ80|PDZD8_MOUSE PDZ domain-containing protein 8 OS=Mus musculus OX=10090 GN=Pdzd8 PE=1 SV=1,GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008270; GO:0008289; GO:0022604; GO:0044233; GO:0051560; GO:1990456,cytoskeleton organization [GO:0007010]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604],endoplasmic reticulum membrane [GO:0005789]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; zinc ion binding [GO:0008270],GO:0005739; GO:0007010; GO:0008289; GO:0043226,mitochondrion; cytoskeleton organization; lipid binding; organelle
OG_01671,1.2583799054226277,FUN_006858-T1,Peve_00006602,Pocillopora_meandrina_HIv1___RNAseq.g19910.t1a,three_way,92.78333333333332,FUN_006858-T1,Q27802,,,,,65.6,4362.0,0.0,5570.0,sp|Q27802|DYHC2_TRIGR Cytoplasmic dynein 2 heavy chain 1 OS=Tripneustes gratilla OX=7673 GN=DYH1B PE=2 SV=2,,,,,,
OG_01672,1.82553717037575,FUN_006861-T1,Peve_00006606,Pocillopora_meandrina_HIv1___RNAseq.g19909.t1,three_way,69.55666666666666,FUN_006861-T1,O97860,,,,,48.4,304.0,4.8e-84,312.8,sp|O97860|PPA5_RABIT Tartrate-resistant acid phosphatase type 5 OS=Oryctolagus cuniculus OX=9986 GN=ACP5 PE=2 SV=1,,,,,,
OG_01673,1.6312225055332124,FUN_006864-T2,Peve_00003792,Pocillopora_meandrina_HIv1___RNAseq.g19906.t1,three_way,83.79033333333334,FUN_006864-T2,P20000,ALDH2_BOVIN,,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)",Bos taurus (Bovine),68.6,510.0,5.1000000000000004e-213,741.9,"sp|P20000|ALDH2_BOVIN Aldehyde dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ALDH2 PE=1 SV=2",GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0008957; GO:0018937; GO:0046185; GO:0051287; GO:0106435; GO:1903179; GO:1905627,aldehyde catabolic process [GO:0046185]; ethanol catabolic process [GO:0006068]; nitroglycerin metabolic process [GO:0018937]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; carboxylesterase activity [GO:0106435]; NAD binding [GO:0051287]; phenylacetaldehyde dehydrogenase (NAD+) activity [GO:0008957],GO:0003824; GO:0005739; GO:0016491; GO:0016787; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; hydrolase activity; organelle
OG_01674,1.5985434471488886,FUN_006869-T2,Peve_00039239,Pocillopora_meandrina_HIv1___RNAseq.g19796.t1,three_way,64.51466666666667,FUN_006869-T2,P00530,,,,,25.6,437.0,2e-18,96.7,sp|P00530|FPS_FUJSV Tyrosine-protein kinase transforming protein Fps OS=Fujinami sarcoma virus OX=11885 GN=V-FPS PE=3 SV=1,,,,,,
OG_01675,1.150778467606523,FUN_006872-T1,Peve_00039240,Pocillopora_meandrina_HIv1___RNAseq.g19797.t2,three_way,68.479,FUN_006872-T1,Q13286,,,,,49.5,404.0,1.9e-96,354.4,sp|Q13286|CLN3_HUMAN Battenin OS=Homo sapiens OX=9606 GN=CLN3 PE=1 SV=1,,,,,,
OG_01679,2.751941650404654,FUN_006889-T1,Peve_00009369,Pocillopora_meandrina_HIv1___RNAseq.g19815.t1,three_way,70.95,FUN_006889-T1,P61328,FGF12_HUMAN,,Fibroblast growth factor 12 (FGF-12) (Fibroblast growth factor homologous factor 1) (FHF-1) (Myocyte-activating factor),Homo sapiens (Human),29.0,131.0,3.1e-16,87.0,sp|P61328|FGF12_HUMAN Fibroblast growth factor 12 OS=Homo sapiens OX=9606 GN=FGF12 PE=1 SV=1,GO:0005615; GO:0005634; GO:0005737; GO:0007165; GO:0007254; GO:0007267; GO:0007268; GO:0007399; GO:0007507; GO:0008083; GO:0008201; GO:0008344; GO:0010765; GO:0017080; GO:0022008; GO:0044325; GO:0045202; GO:0050905; GO:0086002; GO:0098908; GO:1902305; GO:1905150,adult locomotory behavior [GO:0008344]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; heart development [GO:0007507]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuromuscular process [GO:0050905]; positive regulation of sodium ion transport [GO:0010765]; regulation of neuronal action potential [GO:0098908]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; synapse [GO:0045202],growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325],GO:0005615; GO:0005634; GO:0023052; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0050877; GO:0098772,extracellular space; nucleus; signaling; cell differentiation; organelle; receptor ligand activity; anatomical structure development; nervous system process; molecular function regulator activity
OG_01680,3.1612126565601293,FUN_006890-T1,Peve_00009370,Pocillopora_meandrina_HIv1___RNAseq.g19814.t1,three_way,60.797666666666665,FUN_006890-T1,Q19791,GON1_CAEEL,,A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1),Caenorhabditis elegans,25.1,338.0,3.3e-18,94.4,sp|Q19791|GON1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs gon-1 OS=Caenorhabditis elegans OX=6239 GN=gon-1 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005604; GO:0005783; GO:0005794; GO:0006508; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0030198; GO:0031012; GO:0048644; GO:1905607,cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]; proteolysis [GO:0006508],basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0016192; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; vesicle-mediated transport; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_01683,2.4791170766369164,FUN_006901-T1,Peve_00044416,Pocillopora_meandrina_HIv1___RNAseq.g19809.t1,three_way,59.586,,,,,,,,,,,,,,,,,
OG_01687,1.72228950249022,FUN_006920-T1,Peve_00044401,Pocillopora_meandrina_HIv1___RNAseq.g19804.t1,three_way,87.06683333333334,FUN_006920-T1,Q28CH8,,,,,65.9,208.0,5.100000000000001e-74,278.9,sp|Q28CH8|YIPF6_XENTR Protein YIPF6 OS=Xenopus tropicalis OX=8364 GN=yipf6 PE=2 SV=1,,,,,,
OG_01688,1.2471529237646533,FUN_006922-T1,Peve_00044403,Pocillopora_meandrina_HIv1___RNAseq.g19841.t1,three_way,67.363,FUN_006922-T1,Q9NX08,COMD8_HUMAN,,COMM domain-containing protein 8,Homo sapiens (Human),35.6,177.0,3.5e-26,119.8,sp|Q9NX08|COMD8_HUMAN COMM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=COMMD8 PE=1 SV=1,GO:0005654; GO:0005829; GO:0007165; GO:0051059,signal transduction [GO:0007165],cytosol [GO:0005829]; nucleoplasm [GO:0005654],NF-kappaB binding [GO:0051059],GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_01694,1.412327385328524,FUN_006935-T1,Peve_00036200,Pocillopora_meandrina_HIv1___RNAseq.g20119.t1,three_way,82.61133333333333,,,,,,,,,,,,,,,,,
OG_01695,1.5057413329031326,FUN_006936-T2,Peve_00001498,Pocillopora_meandrina_HIv1___RNAseq.g20120.t2,three_way,80.58433333333333,FUN_006936-T2,A7SBF0,,,,,67.5,664.0,4e-279,961.8,sp|A7SBF0|INT9_NEMVE Integrator complex subunit 9 homolog OS=Nematostella vectensis OX=45351 GN=ints9 PE=3 SV=1,,,,,,
OG_01699,2.3682979467211425,FUN_006942-T1,Peve_00014295,Pocillopora_meandrina_HIv1___RNAseq.g20148.t2,three_way,70.609,FUN_006942-T1,P23770,,,,,42.9,385.0,1.3e-66,255.4,sp|P23770|GATA2_XENLA GATA-binding factor 2 OS=Xenopus laevis OX=8355 GN=gata2 PE=2 SV=1,,,,,,
OG_01701,3.0975936814371536,FUN_006944-T1,Peve_00020225,Pocillopora_meandrina_HIv1___TS.g29510.t1,three_way,85.65633333333334,FUN_006944-T1,Q96P70,IPO9_HUMAN,,Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9),Homo sapiens (Human),60.4,916.0,2.2e-310,1066.2,sp|Q96P70|IPO9_HUMAN Importin-9 OS=Homo sapiens OX=9606 GN=IPO9 PE=1 SV=3,GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0016020; GO:0031144; GO:0031267; GO:0042393; GO:0061608; GO:0140713,proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654],histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267],GO:0005635; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0042393; GO:0140104,nuclear envelope; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; histone binding; molecular carrier activity
OG_01704,3.1890191963652748,FUN_006949-T1,Peve_00001501,Pocillopora_meandrina_HIv1___RNAseq.g20122.t1,three_way,65.41066666666667,FUN_006949-T1,Q9D4H7,,,,,35.5,617.0,9e-100,365.9,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_01708,1.171004054582421,FUN_006981-T1,Peve_00045261,Pocillopora_meandrina_HIv1___TS.g29608.t2a,three_way,80.34333333333333,FUN_006981-T1,Q86XE3,MICU3_HUMAN,,"Calcium uptake protein 3, mitochondrial (hMICU3) (EF-hand domain-containing family member A2)",Homo sapiens (Human),35.0,203.0,1e-24,115.2,"sp|Q86XE3|MICU3_HUMAN Calcium uptake protein 3, mitochondrial OS=Homo sapiens OX=9606 GN=MICU3 PE=1 SV=1",GO:0001956; GO:0005246; GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0036444; GO:0046982; GO:0051560; GO:0061891; GO:0071277; GO:1990246,calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of neurotransmitter secretion [GO:0001956],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246],calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982],GO:0005739; GO:0043226; GO:0055085; GO:0098772; GO:0140299,mitochondrion; organelle; transmembrane transport; molecular function regulator activity; molecular sensor activity
OG_01709,3.787045458541075,FUN_006982-T1,Peve_00045260,Pocillopora_meandrina_HIv1___TS.g29608.t2b,three_way,78.57366666666667,FUN_006982-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),44.9,187.0,1.9e-40,167.5,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_01710,3.380631617042706,FUN_006983-T1,Peve_00045259,Pocillopora_meandrina_HIv1___RNAseq.3765_t,three_way,61.745333333333335,FUN_006983-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),38.7,248.0,5.7e-40,166.0,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_01711,1.807333604471261,FUN_006985-T1,Peve_00045265,Pocillopora_meandrina_HIv1___RNAseq.g20222.t1,three_way,77.84,FUN_006985-T1,Q05086,UBE3A_HUMAN,,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54),Homo sapiens (Human),53.1,755.0,9.8e-221,768.1,sp|Q05086|UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens OX=9606 GN=UBE3A PE=1 SV=4,GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0008021; GO:0008270; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042752; GO:0043161; GO:0045944; GO:0048167; GO:0048511; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061630; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:2000058,androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; proteasome complex [GO:0000502]; synaptic vesicle [GO:0008021],transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016192; GO:0016740; GO:0022414; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; vesicle-mediated transport; transferase activity; reproductive process; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_01713,2.826026601593396,FUN_006988-T1,Peve_00009621,Pocillopora_meandrina_HIv1___RNAseq.g20160.t1,three_way,80.87866666666667,FUN_006988-T1,P57760,STK16_RAT,,Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2),Rattus norvegicus (Rat),40.4,297.0,1.4999999999999999e-55,218.0,sp|P57760|STK16_RAT Serine/threonine-protein kinase 16 OS=Rattus norvegicus OX=10116 GN=Stk16 PE=2 SV=2,GO:0000978; GO:0004672; GO:0004674; GO:0004715; GO:0005524; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0016604; GO:0045944; GO:0048471; GO:0071560; GO:0106310,cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0003824; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"DNA binding; catalytic activity; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_01715,3.004938376194908,FUN_006995-T1,Peve_00035637,Pocillopora_meandrina_HIv1___RNAseq.g20064.t1,three_way,61.722166666666666,,,,,,,,,,,,,,,,,
OG_01716,1.7778328500772107,FUN_007001-T2,Peve_00035633,Pocillopora_meandrina_HIv1___RNAseq.g20061.t1,three_way,70.36216666666665,FUN_007001-T2,Q2VIQ3,KIF4B_HUMAN,,Chromosome-associated kinesin KIF4B (Chromokinesin-B),Homo sapiens (Human),40.7,1167.0,3.4e-162,574.3,sp|Q2VIQ3|KIF4B_HUMAN Chromosome-associated kinesin KIF4B OS=Homo sapiens OX=9606 GN=KIF4B PE=1 SV=2,GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005829; GO:0005874; GO:0005875; GO:0007018; GO:0007052; GO:0008017; GO:0016363; GO:0046872; GO:0051231; GO:0051256; GO:0051536,microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; spindle elongation [GO:0051231],cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nuclear matrix [GO:0016363],ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0000910; GO:0003677; GO:0003774; GO:0003824; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0140657,cytokinesis; DNA binding; cytoskeletal motor activity; catalytic activity; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_01719,1.497925044216042,FUN_007005-T2,Peve_00016928,Pocillopora_meandrina_HIv1___TS.g29423.t1a,three_way,82.74166666666666,FUN_007005-T2,Q9P2G9,KLHL8_HUMAN,,Kelch-like protein 8,Homo sapiens (Human),42.3,338.0,7.9e-79,296.2,sp|Q9P2G9|KLHL8_HUMAN Kelch-like protein 8 OS=Homo sapiens OX=9606 GN=KLHL8 PE=1 SV=4,GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0031463; GO:0043161; GO:1990756,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0030163; GO:0060090,nucleoplasm; protein catabolic process; molecular adaptor activity
OG_01723,1.675324034809731,FUN_007011-T1,Peve_00021642,Pocillopora_meandrina_HIv1___RNAseq.g20537.t1,three_way,77.91333333333333,FUN_007011-T1,Q9Y2L1,RRP44_HUMAN,,Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44),Homo sapiens (Human),56.1,547.0,7.1e-173,608.6,sp|Q9Y2L1|RRP44_HUMAN Exosome complex exonuclease RRP44 OS=Homo sapiens OX=9606 GN=DIS3 PE=1 SV=2,GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000288; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0016075; GO:0071031; GO:0071034,"CUT catabolic process [GO:0071034]; nuclear mRNA surveillance of mRNA 3'-end processing [GO:0071031]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]",cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0098772; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; mRNA metabolic process; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on RNA"
OG_01727,3.883242443057403,FUN_007019-T1,Peve_00037183,Pocillopora_meandrina_HIv1___TS.g29924.t1,three_way,69.06633333333333,FUN_007019-T1,P0DPD6,ECE2_HUMAN,,Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71),Homo sapiens (Human),35.5,761.0,4e-129,463.8,sp|P0DPD6|ECE2_HUMAN Endothelin-converting enzyme 2 OS=Homo sapiens OX=9606 GN=ECE2 PE=1 SV=1,GO:0000139; GO:0004222; GO:0005886; GO:0007186; GO:0007267; GO:0008168; GO:0016485; GO:0016486; GO:0030658; GO:0030659; GO:0032259; GO:0046872,cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; methylation [GO:0032259]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485],cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168],GO:0003824; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; transferase activity; hydrolase activity; signaling; protein maturation; catalytic activity, acting on a protein"
OG_01734,1.3533405249710515,FUN_007053-T1,Peve_00003800,Pocillopora_meandrina_HIv1___RNAseq.g20070.t1,three_way,78.94083333333333,FUN_007053-T1,Q8VDL9,GLIS2_MOUSE,,Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein) (Zinc finger protein GLI5),Mus musculus (Mouse),53.3,90.0,4.900000000000003e-22,107.1,sp|Q8VDL9|GLIS2_MOUSE Zinc finger protein GLIS2 OS=Mus musculus OX=10090 GN=Glis2 PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0001227; GO:0001228; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007399; GO:0008270; GO:0016607; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0061005; GO:0061484; GO:0097730; GO:1900182,cell differentiation involved in kidney development [GO:0061005]; hematopoietic stem cell homeostasis [GO:0061484]; kidney development [GO:0001822]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005929; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cilium; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_01735,4.076546346564667,FUN_007054-T1,Peve_00003799,Pocillopora_meandrina_HIv1___RNAseq.g20071.t1,three_way,78.438,FUN_007054-T1,Q01664,TFAP4_HUMAN,,Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41),Homo sapiens (Human),53.6,140.0,7.5e-27,122.5,sp|Q01664|TFAP4_HUMAN Transcription factor AP-4 OS=Homo sapiens OX=9606 GN=TFAP4 PE=1 SV=2,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0008285; GO:0010629; GO:0017053; GO:0030330; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071549; GO:1901990; GO:1990837,"cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0043226; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; transcription regulator activity
OG_01736,1.877223526150268,FUN_007055-T1,Peve_00003798,Pocillopora_meandrina_HIv1___RNAseq.g20072.t1,three_way,88.616,FUN_007055-T1,Q5SQX6,CYFP2_MOUSE,,Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121),Mus musculus (Mouse),61.2,1252.0,0.0,1540.4,sp|Q5SQX6|CYFP2_MOUSE Cytoplasmic FMR1-interacting protein 2 OS=Mus musculus OX=10090 GN=Cyfip2 PE=1 SV=2,GO:0005634; GO:0005737; GO:0006915; GO:0030833; GO:0031175; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0097484; GO:0098609; GO:0150052,apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; regulation of postsynapse assembly [GO:0150052],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202],small GTPase binding [GO:0031267],GO:0005634; GO:0007155; GO:0012501; GO:0043226,nucleus; cell adhesion; programmed cell death; organelle
OG_01737,1.93376483740448,FUN_007056-T1,Peve_00003796,Pocillopora_meandrina_HIv1___RNAseq.g20073.t1,three_way,72.12466666666667,FUN_007056-T1,Q9VXB5,,,,,46.6,148.0,3.5e-27,122.9,sp|Q9VXB5|RM22_DROME Large ribosomal subunit protein uL22m OS=Drosophila melanogaster OX=7227 GN=mRpL22 PE=2 SV=2,,,,,,
OG_01738,1.3652101044122575,FUN_007057-T1,Peve_00003777,Pocillopora_meandrina_HIv1___TS.g29459.t2,three_way,64.8275,FUN_007057-T1,Q8BX17,GEMI5_MOUSE,,Gem-associated protein 5 (Gemin5),Mus musculus (Mouse),39.4,1203.0,2.2e-212,741.5,sp|Q8BX17|GEMI5_MOUSE Gem-associated protein 5 OS=Mus musculus OX=10090 GN=Gemin5 PE=1 SV=2,GO:0000340; GO:0000387; GO:0003730; GO:0005829; GO:0006412; GO:0006417; GO:0017069; GO:0030619; GO:0030621; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0097504,regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412],cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719],mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621],GO:0003723; GO:0005829; GO:0043226; GO:0065003,RNA binding; cytosol; organelle; protein-containing complex assembly
OG_01739,1.8684873402463968,FUN_007060-T1,Peve_00022328,Pocillopora_meandrina_HIv1___TS.g29460.t1,three_way,77.21333333333334,FUN_007060-T1,Q90X46,GP161_DANRE,,G-protein coupled receptor 161,Danio rerio (Zebrafish) (Brachydanio rerio),28.9,308.0,3.5999999999999997e-35,150.6,sp|Q90X46|GP161_DANRE G-protein coupled receptor 161 OS=Danio rerio OX=7955 GN=gpr161 PE=2 SV=2,GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0007368; GO:0051924; GO:0055037; GO:0060170; GO:1901621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; determination of left/right symmetry [GO:0007368]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; regulation of calcium ion transport [GO:0051924],ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037],G protein-coupled receptor activity [GO:0004930],GO:0005768; GO:0005929; GO:0031410; GO:0043226; GO:0060089,endosome; cilium; cytoplasmic vesicle; organelle; molecular transducer activity
OG_01744,1.1186228668664502,FUN_007067-T1,Peve_00016332,Pocillopora_meandrina_HIv1___RNAseq.g20098.t1,three_way,67.65816666666666,FUN_007067-T1,Q95NN1,,,,,63.9,355.0,8.400000000000003e-119,428.7,"sp|Q95NN1|T23O_TRICA Tryptophan 2,3-dioxygenase OS=Tribolium castaneum OX=7070 PE=2 SV=1",,,,,,
OG_01745,1.4363770341542677,FUN_007069-T1,Peve_00019900,Pocillopora_meandrina_HIv1___RNAseq.g20089.t1,three_way,62.687666666666665,,,,,,,,,,,,,,,,,
OG_01746,1.270035675184828,FUN_007072-T2,Peve_00019898,Pocillopora_meandrina_HIv1___RNAseq.g20086.t1,three_way,53.24433333333334,FUN_007072-T2,B1AT66,MOT7_MOUSE,,Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6),Mus musculus (Mouse),24.3,202.0,2.2e-15,85.1,sp|B1AT66|MOT7_MOUSE Monocarboxylate transporter 7 OS=Mus musculus OX=10090 GN=Slc16a6 PE=1 SV=1,GO:0005368; GO:0016323,,basolateral plasma membrane [GO:0016323],taurine transmembrane transporter activity [GO:0005368],GO:0005215,transporter activity
OG_01752,2.439539528477804,FUN_007092-T1,Peve_00019879,Pocillopora_meandrina_HIv1___RNAseq.g19058.t1,three_way,57.32516666666667,FUN_007092-T1,Q8CDI6,,,,,27.6,174.0,1.1e-07,61.2,sp|Q8CDI6|CD158_MOUSE Coiled-coil domain-containing protein 158 OS=Mus musculus OX=10090 GN=Ccdc158 PE=2 SV=1,,,,,,
OG_01757,1.42176049418368,FUN_007100-T1,Peve_00033790,Pocillopora_meandrina_HIv1___RNAseq.g19049.t1b,three_way,84.0445,FUN_007100-T1,O95714,HERC2_HUMAN,,E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2),Homo sapiens (Human),53.6,4960.0,0.0,4944.0,sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; plasma membrane; DNA repair; intracellular protein transport; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01761,1.907444255500136,FUN_007116-T1,Peve_00043797,Pocillopora_meandrina_HIv1___RNAseq.g18996.t1,three_way,88.80166666666666,FUN_007116-T1,Q32LE3,,,,,67.9,159.0,9e-33,141.7,sp|Q32LE3|CETN1_BOVIN Centrin-1 OS=Bos taurus OX=9913 GN=CETN1 PE=2 SV=1,,,,,,
OG_01763,1.2227566042171223,FUN_007118-T1,Peve_00043802,Pocillopora_meandrina_HIv1___RNAseq.g18999.t1,three_way,83.32566666666666,FUN_007118-T1,Q9XVI9,,,,,34.0,97.0,2.8e-12,73.6,sp|Q9XVI9|MLC5_CAEEL Myosin-2 essential light chain OS=Caenorhabditis elegans OX=6239 GN=mlc-5 PE=1 SV=1,,,,,,
OG_01764,2.000858300186428,FUN_007119-T1,Peve_00043804,Pocillopora_meandrina_HIv1___RNAseq.g19000.t1,three_way,66.69666666666666,FUN_007119-T1,Q498J9,,,,,50.0,192.0,1.3000000000000002e-44,181.0,sp|Q498J9|MBLC1_XENLA Metallo-beta-lactamase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=mblac1 PE=2 SV=2,,,,,,
OG_01768,1.7220162846791054,FUN_007125-T1,Peve_00012337,Pocillopora_meandrina_HIv1___RNAseq.g19008.t1a,three_way,45.29433333333333,,,,,,,,,,,,,,,,,
OG_01770,1.0200775561097482,FUN_007137-T1,Peve_00019729,Pocillopora_meandrina_HIv1___RNAseq.g19685.t1,three_way,58.20933333333333,FUN_007137-T1,Q4V8V2,NUD17_DANRE,,m7GpppN-mRNA hydrolase NUDT17 (EC 3.6.1.62) (Nucleoside diphosphate-linked moiety X motif 17) (Nudix motif 17),Danio rerio (Zebrafish) (Brachydanio rerio),41.2,262.0,2.3e-46,187.6,sp|Q4V8V2|NUD17_DANRE m7GpppN-mRNA hydrolase NUDT17 OS=Danio rerio OX=7955 GN=nudt17 PE=2 SV=1,GO:0005777; GO:0006734; GO:0006742; GO:0019677; GO:0035529; GO:0046872,NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742],peroxisome [GO:0005777],metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529],GO:0003824; GO:0005777; GO:0016787; GO:0043226; GO:0055086,catalytic activity; peroxisome; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_01778,2.3571434268217986,FUN_007150-T1,Peve_00028250,Pocillopora_meandrina_HIv1___RNAseq.g19714.t1,three_way,81.34100000000001,FUN_007150-T1,Q96DB2,HDA11_HUMAN,,Histone deacetylase 11 (HD11) (EC 3.5.1.98),Homo sapiens (Human),63.6,319.0,6.7e-119,428.7,sp|Q96DB2|HDA11_HUMAN Histone deacetylase 11 OS=Homo sapiens OX=9606 GN=HDAC11 PE=1 SV=1,GO:0000118; GO:0004407; GO:0005634; GO:0005886; GO:0006325; GO:0040029; GO:0140297; GO:0141221,chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029],histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; chromatin organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01788,1.6069844176961676,FUN_007166-T1,Peve_00042484,Pocillopora_meandrina_HIv1___RNAseq.g19745.t1,three_way,75.658,FUN_007166-T1,P57695,,,,,37.9,457.0,8.7e-76,285.8,sp|P57695|GLRA1_BOVIN Glycine receptor subunit alpha-1 OS=Bos taurus OX=9913 GN=GLRA1 PE=1 SV=1,,,,,,
OG_01789,1.5821245625900644,FUN_007169-T1,Peve_00026948,Pocillopora_meandrina_HIv1___RNAseq.g19749.t1,three_way,52.4205,FUN_007169-T1,P51587,BRCA2_HUMAN,,Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein),Homo sapiens (Human),31.1,1439.0,3.1e-152,542.3,sp|P51587|BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens OX=9606 GN=BRCA2 PE=1 SV=4,GO:0000152; GO:0000722; GO:0000724; GO:0000781; GO:0000800; GO:0001556; GO:0001833; GO:0002020; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0007141; GO:0007283; GO:0007420; GO:0008585; GO:0010165; GO:0010225; GO:0010332; GO:0010484; GO:0010485; GO:0030141; GO:0030330; GO:0032465; GO:0032991; GO:0033593; GO:0033600; GO:0042771; GO:0042802; GO:0043015; GO:0045893; GO:0045931; GO:0051298; GO:0070200; GO:0071425; GO:0071479; GO:0090398; GO:1990391; GO:1990426; GO:2000001,"brain development [GO:0007420]; cellular response to ionizing radiation [GO:0071479]; cellular senescence [GO:0090398]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hematopoietic stem cell proliferation [GO:0071425]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of cytokinesis [GO:0032465]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA-templated transcription [GO:0006355]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]","BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; lateral element [GO:0000800]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]",gamma-tubulin binding [GO:0043015]; histone H3 acetyltransferase activity [GO:0010484]; histone H4 acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006310; GO:0006355; GO:0008092; GO:0016740; GO:0022414; GO:0031410; GO:0032200; GO:0043226; GO:0048856; GO:0140013; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; DNA recombination; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; reproductive process; cytoplasmic vesicle; telomere organization; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on a protein"
OG_01791,2.3223870825909607,FUN_007171-T1,Peve_00019731,Pocillopora_meandrina_HIv1___RNAseq.g19751.t1,three_way,75.6985,FUN_007171-T1,Q7ZW24,,,,,56.6,498.0,2e-160,567.4,"sp|Q7ZW24|ALG11_DANRE GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase OS=Danio rerio OX=7955 GN=alg11 PE=2 SV=2",,,,,,
OG_01795,1.7889641012758888,FUN_007180-T1,Peve_00042731,Pocillopora_meandrina_HIv1___RNAseq.g19780.t1,three_way,75.47366666666666,FUN_007180-T1,P95329,,,,,40.0,475.0,2.5e-97,357.5,sp|P95329|MASY_MYXXD Malate synthase OS=Myxococcus xanthus (strain DK1622) OX=246197 GN=mls PE=3 SV=2,,,,,,
OG_01801,1.2690894485219597,FUN_007229-T1,Peve_00043687,Pocillopora_meandrina_HIv1___TS.g22606.t1,three_way,68.12899999999999,,,,,,,,,,,,,,,,,
OG_01803,1.3858643206444563,FUN_007337-T1,Peve_00043689,Pocillopora_meandrina_HIv1___RNAseq.g30307.t1,three_way,76.888,FUN_007337-T1,Q6P7Q4,LGUL_RAT,,Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase),Rattus norvegicus (Rat),66.3,169.0,3.1e-65,249.6,sp|Q6P7Q4|LGUL_RAT Lactoylglutathione lyase OS=Rattus norvegicus OX=10116 GN=Glo1 PE=1 SV=3,GO:0004462; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066,glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0006575; GO:0006790; GO:0016829; GO:0030154,catalytic activity; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; modified amino acid metabolic process; sulfur compound metabolic process; lyase activity; cell differentiation
OG_01804,1.5174538634998378,FUN_007338-T1,Peve_00043690,Pocillopora_meandrina_HIv1___RNAseq.27619_t,three_way,62.425666666666665,,,,,,,,,,,,,,,,,
OG_01807,1.7281833173959094,FUN_007606-T1,Peve_00034276,Pocillopora_meandrina_HIv1___TS.g24525.t2,three_way,41.922,,,,,,,,,,,,,,,,,
OG_01811,1.7009583044269767,FUN_007646-T1,Peve_00034271,Pocillopora_meandrina_HIv1___RNAseq.g5811.t1,three_way,71.30533333333334,FUN_007646-T1,Q92994,,,,,44.1,551.0,3.1e-91,337.4,sp|Q92994|TF3B_HUMAN Transcription factor IIIB 90 kDa subunit OS=Homo sapiens OX=9606 GN=BRF1 PE=1 SV=1,,,,,,
OG_01814,1.3012467428822525,FUN_007677-T1,Peve_00034811,Pocillopora_meandrina_HIv1___RNAseq.g5865.t1,three_way,70.54666666666667,FUN_007677-T1,Q9TRY0,,,,,30.6,186.0,2.9e-17,90.1,sp|Q9TRY0|FKBP4_BOVIN Peptidyl-prolyl cis-trans isomerase FKBP4 OS=Bos taurus OX=9913 GN=FKBP4 PE=1 SV=4,,,,,,
OG_01820,3.0565884088767765,FUN_007693-T1,Peve_00026595,Pocillopora_meandrina_HIv1___RNAseq.g18006.t2,three_way,58.693666666666665,FUN_007693-T1,B0BM95,ACTMP_XENTR,,Actin maturation protease (EC 3.4.11.-) (Actin aminopeptidase ACTMAP),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),38.7,261.0,1.1e-41,171.8,sp|B0BM95|ACTMP_XENTR Actin maturation protease OS=Xenopus tropicalis OX=8364 GN=actmap PE=2 SV=2,GO:0004239; GO:0005737; GO:0016485,protein processing [GO:0016485],cytoplasm [GO:0005737],initiator methionyl aminopeptidase activity [GO:0004239],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_01822,2.776994026665176,FUN_007695-T1,Peve_00026597,Pocillopora_meandrina_HIv1___RNAseq.g18003.t1,three_way,72.62466666666667,,,,,,,,,,,,,,,,,
OG_01823,1.7580761530059663,FUN_007696-T1,Peve_00026598,Pocillopora_meandrina_HIv1___RNAseq.g17999.t1,three_way,72.92433333333334,FUN_007696-T1,O14772,FPGT_HUMAN,,Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30) (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase),Homo sapiens (Human),42.2,588.0,1.1e-115,418.7,sp|O14772|FPGT_HUMAN Fucose-1-phosphate guanylyltransferase OS=Homo sapiens OX=9606 GN=FPGT PE=1 SV=3,GO:0005525; GO:0005737; GO:0005829; GO:0006004; GO:0042350; GO:0047341,fucose metabolic process [GO:0006004]; GDP-L-fucose biosynthetic process [GO:0042350],cytoplasm [GO:0005737]; cytosol [GO:0005829],fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525],GO:0003824; GO:0005829; GO:0005975; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01825,1.864062743171165,FUN_007699-T1,Peve_00030615,Pocillopora_meandrina_HIv1___RNAseq.g17995.t1,three_way,69.25383333333333,FUN_007699-T1,G3M4F8,,,,,26.0,315.0,2.5e-17,91.3,sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1,,,,,,
OG_01827,1.376098015202008,FUN_007701-T1,Peve_00031491,Pocillopora_meandrina_HIv1___RNAseq.g18026.t1,three_way,51.928666666666665,FUN_007701-T1,P49852,HMP_BACSU,,Flavohemoprotein (Flavohemoglobin) (Hemoglobin-like protein) (Nitric oxide dioxygenase) (NO oxygenase) (NOD) (EC 1.14.12.17),Bacillus subtilis (strain 168),30.3,132.0,1e-11,72.0,sp|P49852|HMP_BACSU Flavohemoprotein OS=Bacillus subtilis (strain 168) OX=224308 GN=hmp PE=2 SV=1,GO:0005344; GO:0005737; GO:0008941; GO:0009636; GO:0019825; GO:0020037; GO:0046210; GO:0046872; GO:0071500; GO:0071949,cellular response to nitrosative stress [GO:0071500]; nitric oxide catabolic process [GO:0046210]; response to toxic substance [GO:0009636],cytoplasm [GO:0005737],FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase NAD(P)H activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],GO:0003824; GO:0016491; GO:0140104,catalytic activity; oxidoreductase activity; molecular carrier activity
OG_01828,1.5348733278940692,FUN_007708-T1,Peve_00013719,Pocillopora_meandrina_HIv1___RNAseq.g5861.t1,three_way,82.725,FUN_007708-T1,Q70CQ2,UBP34_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34),Homo sapiens (Human),42.6,3491.0,0.0,2497.2,sp|Q70CQ2|UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2,GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0031647; GO:0071108; GO:0090263,positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01837,2.8387996430008444,FUN_007773-T1,Peve_00036438,Pocillopora_meandrina_HIv1___RNAseq.g5836.t1,three_way,57.734,FUN_007773-T1,Q8JFW4,,,,,39.7,378.0,5.499999999999999e-63,243.0,sp|Q8JFW4|ADAT3_DANRE Probable inactive tRNA-specific adenosine deaminase-like protein 3 OS=Danio rerio OX=7955 GN=adat3 PE=2 SV=2,,,,,,
OG_01839,3.449776900913076,FUN_007785-T1,Peve_00032269,Pocillopora_meandrina_HIv1___RNAseq.g5904.t3,three_way,77.73566666666667,FUN_007785-T1,Q7ZZC8,NEK9_XENLA,,Serine/threonine-protein kinase Nek9 (xNek9) (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9),Xenopus laevis (African clawed frog),45.7,637.0,6e-157,556.2,sp|Q7ZZC8|NEK9_XENLA Serine/threonine-protein kinase Nek9 OS=Xenopus laevis OX=8355 GN=nek9 PE=2 SV=1,GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0019901; GO:0030295; GO:0046872; GO:0051301; GO:0106310,cell division [GO:0051301]; mitotic cell cycle [GO:0000278],centrosome [GO:0005813]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000278; GO:0003824; GO:0005815; GO:0016740; GO:0098772; GO:0140096,"mitotic cell cycle; catalytic activity; microtubule organizing center; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01844,2.768197414774995,FUN_007790-T1,Peve_00022038,Pocillopora_meandrina_HIv1___RNAseq.g5899.t1,three_way,82.86166666666666,FUN_007790-T1,Q8R1Q9,,,,,56.1,305.0,1.3000000000000001e-89,331.3,sp|Q8R1Q9|RBSK_MOUSE Ribokinase OS=Mus musculus OX=10090 GN=Rbks PE=1 SV=1,,,,,,
OG_01845,3.4816763928175987,FUN_007791-T1,Peve_00022040,Pocillopora_meandrina_HIv1___TS.g24621.t1,three_way,47.446,FUN_007791-T1,Q9UHC1,MLH3_HUMAN,,DNA mismatch repair protein Mlh3 (MutL protein homolog 3),Homo sapiens (Human),27.8,1446.0,1.3e-121,439.5,sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3,GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664,female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130],chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0043226; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; hydrolase activity; reproductive process; organelle; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01848,2.339145375535936,FUN_007798-T1,Peve_00022052,Pocillopora_meandrina_HIv1___RNAseq.g18342.t1,three_way,82.26133333333333,FUN_007798-T1,Q9UGV2,,,,,42.5,325.0,1.2e-66,255.0,sp|Q9UGV2|NDRG3_HUMAN Protein NDRG3 OS=Homo sapiens OX=9606 GN=NDRG3 PE=1 SV=2,,,,,,
OG_01849,2.0697981189050303,FUN_007799-T1,Peve_00022053,Pocillopora_meandrina_HIv1___RNAseq.g18341.t1,three_way,65.1245,FUN_007799-T1,Q9UHY8,FEZ2_HUMAN,,Fasciculation and elongation protein zeta-2 (Zygin II) (Zygin-2),Homo sapiens (Human),30.6,268.0,2e-21,104.8,sp|Q9UHY8|FEZ2_HUMAN Fasciculation and elongation protein zeta-2 OS=Homo sapiens OX=9606 GN=FEZ2 PE=1 SV=2,GO:0005737; GO:0007165; GO:0007399; GO:0007411; GO:0030424; GO:1902902,axon guidance [GO:0007411]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; signal transduction [GO:0007165],axon [GO:0030424]; cytoplasm [GO:0005737],,GO:0048856,anatomical structure development
OG_01850,1.2752913637710876,FUN_007800-T1,Peve_00022054,Pocillopora_meandrina_HIv1___RNAseq.g18340.t1,three_way,66.119,FUN_007800-T1,Q8CES0,NAA30_MOUSE,,N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit),Mus musculus (Mouse),76.1,163.0,2.700000000000001e-65,250.4,sp|Q8CES0|NAA30_MOUSE N-alpha-acetyltransferase 30 OS=Mus musculus OX=10090 GN=Naa30 PE=1 SV=2,GO:0004596; GO:0005634; GO:0005737; GO:0031417; GO:0050821; GO:0120518,protein stabilization [GO:0050821],cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634],protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01851,1.6975366451455205,FUN_007801-T1,Peve_00022055,Pocillopora_meandrina_HIv1___RNAseq.g18338.t1,three_way,56.8715,,,,,,,,,,,,,,,,,
OG_01852,2.996339773624876,FUN_007803-T2,Peve_00022056,Pocillopora_meandrina_HIv1___RNAseq.g18339.t1,three_way,75.05483333333333,FUN_007803-T2,Q96JM7,,,,,34.7,862.0,6.800000000000001e-134,479.9,sp|Q96JM7|LMBL3_HUMAN Lethal(3)malignant brain tumor-like protein 3 OS=Homo sapiens OX=9606 GN=L3MBTL3 PE=1 SV=2,,,,,,
OG_01853,4.330998327649895,FUN_007804-T1,Peve_00022057,Pocillopora_meandrina_HIv1___RNAseq.g18346.t1,three_way,62.281666666666666,,,,,,,,,,,,,,,,,
OG_01855,1.6889032104229302,FUN_007807-T1,Peve_00022060,Pocillopora_meandrina_HIv1___RNAseq.g18349.t1,three_way,61.16866666666667,FUN_007807-T1,Q9UNW1,,,,,32.3,446.0,2.1e-56,221.5,sp|Q9UNW1|MINP1_HUMAN Multiple inositol polyphosphate phosphatase 1 OS=Homo sapiens OX=9606 GN=MINPP1 PE=1 SV=1,,,,,,
OG_01856,1.9430536732981805,FUN_007808-T1,Peve_00022061,Pocillopora_meandrina_HIv1___RNAseq.g18350.t1,three_way,71.29266666666666,FUN_007808-T1,Q58D06,,,,,38.4,378.0,2.9e-69,263.8,sp|Q58D06|WDR74_BOVIN WD repeat-containing protein 74 OS=Bos taurus OX=9913 GN=WDR74 PE=2 SV=1,,,,,,
OG_01859,1.465982131637689,FUN_007818-T1,Peve_00038749,Pocillopora_meandrina_HIv1___RNAseq.g18385.t1,three_way,58.894666666666666,FUN_007818-T1,Q9YGL3,,,,,27.4,518.0,1.1e-42,176.0,sp|Q9YGL3|NR2E1_ORYLA Nuclear receptor subfamily 2 group E member 1 OS=Oryzias latipes OX=8090 GN=nr2e1 PE=2 SV=1,,,,,,
OG_01860,2.177815759197434,FUN_007819-T1,Peve_00038748,Pocillopora_meandrina_HIv1___RNAseq.g18386.t1,three_way,62.80433333333333,FUN_007819-T1,Q803U7,,,,,52.0,344.0,8e-93,343.2,sp|Q803U7|EXO1_DANRE Exonuclease 1 OS=Danio rerio OX=7955 GN=exo1 PE=2 SV=1,,,,,,
OG_01862,2.3186336124636195,FUN_007821-T1,Peve_00038746,Pocillopora_meandrina_HIv1___RNAseq.g18388.t1,three_way,57.14966666666667,,,,,,,,,,,,,,,,,
OG_01863,2.2929276385974124,FUN_007823-T1,Peve_00038744,Pocillopora_meandrina_HIv1___RNAseq.21899_t,three_way,75.6335,FUN_007823-T1,Q3U1V8,M3K9_MOUSE,,Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25),Mus musculus (Mouse),51.9,617.0,1.8999999999999998e-138,495.0,sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus OX=10090 GN=Map3k9 PE=2 SV=2,GO:0004709; GO:0005524; GO:0006915; GO:0106310,apoptotic process [GO:0006915],,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_01864,1.7355874313702484,FUN_007824-T1,Peve_00032624,Pocillopora_meandrina_HIv1___RNAseq.g18390.t1,three_way,76.27866666666667,FUN_007824-T1,Q8CE96,,,,,41.7,458.0,4.7e-88,326.6,sp|Q8CE96|TRM6_MOUSE tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Mus musculus OX=10090 GN=Trmt6 PE=1 SV=1,,,,,,
OG_01867,1.6264176101869452,FUN_007833-T1,Peve_00003987,Pocillopora_meandrina_HIv1___RNAseq.g18399.t1,three_way,68.14616666666667,,,,,,,,,,,,,,,,,
OG_01871,1.2921217930597797,FUN_007838-T1,Peve_00019309,Pocillopora_meandrina_HIv1___RNAseq.g18420.t1,three_way,79.68333333333334,,,,,,,,,,,,,,,,,
OG_01872,1.7027248945468023,FUN_007839-T1,Peve_00019308,Pocillopora_meandrina_HIv1___TS.g21414.t1,three_way,62.15633333333333,FUN_007839-T1,Q61830,,,,,29.1,299.0,1.1e-23,112.8,sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2,,,,,,
OG_01876,3.8561775875935007,FUN_007849-T1,Peve_00039898,Pocillopora_meandrina_HIv1___RNAseq.g18286.t1,three_way,90.37933333333334,FUN_007849-T1,O00470,MEIS1_HUMAN,,Homeobox protein Meis1,Homo sapiens (Human),58.7,349.0,4.1e-94,347.1,sp|O00470|MEIS1_HUMAN Homeobox protein Meis1 OS=Homo sapiens OX=9606 GN=MEIS1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001654; GO:0002089; GO:0003677; GO:0003682; GO:0005634; GO:0005667; GO:0007420; GO:0007626; GO:0008284; GO:0009880; GO:0009887; GO:0030097; GO:0035855; GO:0045638; GO:0045665; GO:0045944; GO:0060216; GO:0061049,angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell growth involved in cardiac muscle cell development [GO:0061049]; definitive hemopoiesis [GO:0060216]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; lens morphogenesis in camera-type eye [GO:0002089]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944],chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_01877,2.843821002742301,FUN_007850-T1,Peve_00021800,Pocillopora_meandrina_HIv1___RNAseq.g18287.t1,three_way,66.41766666666666,,,,,,,,,,,,,,,,,
OG_01879,1.4478196180692704,FUN_007852-T1,Peve_00021798,Pocillopora_meandrina_HIv1___TS.g21280.t1a,three_way,73.76766666666667,FUN_007852-T1,A5PJS2,,,,,56.2,242.0,1.5e-72,274.2,sp|A5PJS2|S5A1_BOVIN 3-oxo-5-alpha-steroid 4-dehydrogenase 1 OS=Bos taurus OX=9913 GN=SRD5A1 PE=2 SV=1,,,,,,
OG_01881,2.997032668545546,FUN_007857-T1,Peve_00024166,Pocillopora_meandrina_HIv1___RNAseq.g18294.t1,three_way,59.664,FUN_007857-T1,Q5T6L9,,,,,33.1,602.0,5.7e-82,307.0,sp|Q5T6L9|EMARD_HUMAN Endoplasmic reticulum membrane-associated RNA degradation protein OS=Homo sapiens OX=9606 GN=ERMARD PE=1 SV=1,,,,,,
OG_01885,2.075509009781314,FUN_007864-T1,Peve_00044449,Pocillopora_meandrina_HIv1___RNAseq.g18299.t1,three_way,76.96966666666667,FUN_007864-T1,Q96P50,,,,,44.0,209.0,1.4999999999999999e-40,169.5,"sp|Q96P50|ACAP3_HUMAN Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ACAP3 PE=1 SV=2",,,,,,
OG_01889,2.2382851300316875,FUN_007871-T1,Peve_00009886,Pocillopora_meandrina_HIv1___RNAseq.g18307.t1,three_way,66.36216666666667,FUN_007871-T1,Q13613,,,,,32.8,466.0,6.600000000000003e-60,234.2,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_01891,2.00606590358453,FUN_007877-T1,Peve_00009879,Pocillopora_meandrina_HIv1___TS.g21243.t1,three_way,32.146166666666666,,,,,,,,,,,,,,,,,
OG_01893,2.2139092722428466,FUN_007891-T1,Peve_00009872,Pocillopora_meandrina_HIv1___RNAseq.g18248.t1,three_way,58.57216666666667,,,,,,,,,,,,,,,,,
OG_01894,1.8991495036731127,FUN_007892-T1,Peve_00009871,Pocillopora_meandrina_HIv1___RNAseq.g18244.t2,three_way,59.311,FUN_007892-T1,Q80UF4,SDCG8_MOUSE,,Serologically defined colon cancer antigen 8 homolog (Centrosomal colon cancer autoantigen protein) (mCCCAP),Mus musculus (Mouse),34.7,496.0,1.8e-15,86.3,sp|Q80UF4|SDCG8_MOUSE Serologically defined colon cancer antigen 8 homolog OS=Mus musculus OX=10090 GN=Sdccag8 PE=1 SV=1,GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0007098; GO:0030010; GO:0030030; GO:0031023; GO:0034451; GO:0035148; GO:0036064; GO:0097733; GO:1902017,cell projection organization [GO:0030030]; centrosome cycle [GO:0007098]; establishment of cell polarity [GO:0030010]; microtubule organizing center organization [GO:0031023]; neuron migration [GO:0001764]; regulation of cilium assembly [GO:1902017]; tube formation [GO:0035148],cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor cell cilium [GO:0097733],,GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0007163; GO:0043226; GO:0048870,nucleoplasm; microtubule organizing center; cytosol; cilium; establishment or maintenance of cell polarity; organelle; cell motility
OG_01898,3.305350363145557,FUN_007909-T1,Peve_00040664,Pocillopora_meandrina_HIv1___RNAseq.g30061.t1,three_way,70.45833333333333,FUN_007909-T1,A8J4S9,TREA_APIME,,"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)",Apis mellifera (Honeybee),45.2,571.0,2e-152,540.8,sp|A8J4S9|TREA_APIME Trehalase OS=Apis mellifera OX=7460 PE=1 SV=1,GO:0004555; GO:0005993; GO:0016020,trehalose catabolic process [GO:0005993],membrane [GO:0016020],"alpha,alpha-trehalase activity [GO:0004555]",GO:0003824; GO:0005975; GO:0016787,catalytic activity; carbohydrate metabolic process; hydrolase activity
OG_01901,1.5070944502161376,FUN_007914-T1,Peve_00040670,Pocillopora_meandrina_HIv1___RNAseq.g30117.t1,three_way,58.692,,,,,,,,,,,,,,,,,
OG_01902,3.0699649771524884,FUN_007915-T1,Peve_00040671,Pocillopora_meandrina_HIv1___RNAseq.g30118.t1,three_way,55.7275,,,,,,,,,,,,,,,,,
OG_01904,2.1560379480201486,FUN_007918-T1,Peve_00040674,Pocillopora_meandrina_HIv1___RNAseq.g30119.t1,three_way,52.329166666666666,FUN_007918-T1,Q9D6X6,,,,,34.3,289.0,4.4e-36,153.7,sp|Q9D6X6|PRS23_MOUSE Serine protease 23 OS=Mus musculus OX=10090 GN=Prss23 PE=2 SV=2,,,,,,
OG_01906,1.8190496904681632,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),61.6,620.0,3.3e-199,697.6,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01906,1.8190496904681632,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),40.4,146.0,3.1999999999999997e-29,132.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01907,1.5050879942575337,FUN_007921-T1,Peve_00040678,Pocillopora_meandrina_HIv1___RNAseq.g30088.t1,three_way,83.092,FUN_007921-T1,P02513,,,,,42.2,90.0,6.3e-14,79.3,sp|P02513|HSP17_CAEEL Heat shock protein Hsp-16.48/Hsp-16.49 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.48 PE=2 SV=1,,,,,,
OG_01909,1.1586258994818015,FUN_007923-T1,Peve_00040680,Pocillopora_meandrina_HIv1___RNAseq.g30085.t1,three_way,80.15333333333334,FUN_007923-T1,Q9HAT8,PELI2_HUMAN,,E3 ubiquitin-protein ligase pellino homolog 2 (Pellino-2) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 2),Homo sapiens (Human),54.2,402.0,2.4e-123,443.7,sp|Q9HAT8|PELI2_HUMAN E3 ubiquitin-protein ligase pellino homolog 2 OS=Homo sapiens OX=9606 GN=PELI2 PE=1 SV=1,GO:0000209; GO:0001934; GO:0005829; GO:0008592; GO:0034450; GO:0043123; GO:0043410; GO:0061630,positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592],cytosol [GO:0005829],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_01910,1.6720965387409197,FUN_007925-T1,Peve_00040685,Pocillopora_meandrina_HIv1___RNAseq.g30084.t1,three_way,71.54366666666667,,,,,,,,,,,,,,,,,
OG_01911,3.259095645877531,FUN_007927-T1,Peve_00040689,Pocillopora_meandrina_HIv1___RNAseq.g18108.t1,three_way,68.03966666666666,FUN_007927-T1,Q10AZ7,GPA3_ORYSJ,,Protein GLUTELIN PRECURSOR ACCUMULATION 3,Oryza sativa subsp. japonica (Rice),24.2,194.0,2.9e-12,75.1,sp|Q10AZ7|GPA3_ORYSJ Protein GLUTELIN PRECURSOR ACCUMULATION 3 OS=Oryza sativa subsp. japonica OX=39947 GN=GPA3 PE=1 SV=1,GO:0000325; GO:0000326; GO:0005802; GO:0006886,intracellular protein transport [GO:0006886],plant-type vacuole [GO:0000325]; protein storage vacuole [GO:0000326]; trans-Golgi network [GO:0005802],,GO:0005773; GO:0006886; GO:0043226,vacuole; intracellular protein transport; organelle
OG_01913,1.1962450255357873,FUN_007929-T1,Peve_00040692,Pocillopora_meandrina_HIv1___RNAseq.g18115.t1,three_way,57.39533333333333,,,,,,,,,,,,,,,,,
OG_01915,1.0693663049113145,FUN_007941-T1,Peve_00040695,Pocillopora_meandrina_HIv1___RNAseq.g18119.t1,three_way,41.262,,,,,,,,,,,,,,,,,
OG_01916,2.0329159288257803,FUN_007943-T1,Peve_00040696,Pocillopora_meandrina_HIv1___RNAseq.g18120.t1,three_way,83.53,FUN_007943-T1,Q9NW15,,,,,28.6,623.0,1.9e-60,235.3,sp|Q9NW15|ANO10_HUMAN Anoctamin-10 OS=Homo sapiens OX=9606 GN=ANO10 PE=1 SV=2,,,,,,
OG_01919,2.8461026259267763,FUN_007948-T1,Peve_00044442,Pocillopora_meandrina_HIv1___RNAseq.g18135.t1,three_way,64.81733333333334,FUN_007948-T1,Q3TTY0,PLB1_MOUSE,,"Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3)",Mus musculus (Mouse),39.7,345.0,6.200000000000003e-66,253.4,"sp|Q3TTY0|PLB1_MOUSE Phospholipase B1, membrane-associated OS=Mus musculus OX=10090 GN=Plb1 PE=1 SV=2",GO:0004622; GO:0004806; GO:0016324; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344,diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; positive regulation of acrosome reaction [GO:2000344]; triglyceride catabolic process [GO:0019433],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526],calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_01923,1.7752730169211042,FUN_007957-T1,Peve_00039189,Pocillopora_meandrina_HIv1___RNAseq.g30070.t1,three_way,65.248,FUN_007957-T1,P25703,,,,,42.9,403.0,6.099999999999999e-75,282.7,sp|P25703|BMP2A_XENLA Bone morphogenetic protein 2-A OS=Xenopus laevis OX=8355 GN=bmp2-a PE=2 SV=1,,,,,,
OG_01925,1.3318779543409018,FUN_007961-T1,Peve_00039186,Pocillopora_meandrina_HIv1___RNAseq.g30072.t1,three_way,79.55666666666667,FUN_007961-T1,Q9UQM7,KCC2A_HUMAN,,Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17),Homo sapiens (Human),36.8,302.0,1.4e-52,208.4,sp|Q9UQM7|KCC2A_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit alpha OS=Homo sapiens OX=9606 GN=CAMK2A PE=1 SV=2,GO:0000082; GO:0002931; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005954; GO:0006468; GO:0006816; GO:0010666; GO:0014069; GO:0016301; GO:0030666; GO:0035254; GO:0035458; GO:0038166; GO:0042802; GO:0042803; GO:0043005; GO:0043197; GO:0046427; GO:0046872; GO:0046928; GO:0048168; GO:0051092; GO:0051346; GO:0051928; GO:0060291; GO:0060996; GO:0071346; GO:0106310; GO:1902108; GO:1903076; GO:1990443; GO:2000124; GO:2001222,angiotensin-activated signaling pathway [GO:0038166]; calcium ion transport [GO:0006816]; cellular response to interferon-beta [GO:0035458]; cellular response to type II interferon [GO:0071346]; dendritic spine development [GO:0060996]; G1/S transition of mitotic cell cycle [GO:0000082]; long-term synaptic potentiation [GO:0060291]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; protein phosphorylation [GO:0006468]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein localization to plasma membrane [GO:1903076]; response to ischemia [GO:0002931],calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006355; GO:0007005; GO:0016740; GO:0043226; GO:0048856; GO:0061024; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; regulation of DNA-templated transcription; mitochondrion organization; transferase activity; organelle; anatomical structure development; membrane organization; catalytic activity, acting on a protein"
OG_01926,2.5459719593310317,FUN_007963-T1,Peve_00030095,Pocillopora_meandrina_HIv1___RNAseq.g30028.t1,three_way,80.453,FUN_007963-T1,Q6PBN2,AIDA_DANRE,,"Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist)",Danio rerio (Zebrafish) (Brachydanio rerio),45.6,307.0,7.1e-71,268.9,"sp|Q6PBN2|AIDA_DANRE Axin interactor, dorsalization-associated protein OS=Danio rerio OX=7955 GN=aida PE=1 SV=1",GO:0009953; GO:0016020; GO:0031333; GO:0035091; GO:0043508; GO:0046329; GO:0048264; GO:2000016,determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333],membrane [GO:0016020],phosphatidylinositol binding [GO:0035091],GO:0008289,lipid binding
OG_01927,2.322506895505801,FUN_007964-T1,Peve_00030094,Pocillopora_meandrina_HIv1___RNAseq.g30026.t1,three_way,69.93233333333333,FUN_007964-T1,Q66HG4,,,,,48.8,281.0,1.6e-70,267.7,sp|Q66HG4|GALM_RAT Galactose mutarotase OS=Rattus norvegicus OX=10116 GN=Galm PE=1 SV=1,,,,,,
OG_01936,1.372529666995738,FUN_007977-T1,Peve_00040182,Pocillopora_meandrina_HIv1___RNAseq.g18172.t1,three_way,58.66166666666667,FUN_007977-T1,O60566,BUB1B_HUMAN,,Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (hBUBR1) (Mitotic checkpoint kinase MAD3L) (Protein SSK1),Homo sapiens (Human),35.7,420.0,2.9e-63,245.7,sp|O60566|BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens OX=9606 GN=BUB1B PE=1 SV=3,GO:0000776; GO:0000940; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0006915; GO:0007091; GO:0007094; GO:0033597; GO:0036064; GO:0048471; GO:0051301; GO:0051754; GO:0071459; GO:0106310,"apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]",anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01940,1.4878383818694445,FUN_007990-T1,Peve_00040190,Pocillopora_meandrina_HIv1___RNAseq.g18166.t1,three_way,74.74333333333333,FUN_007990-T1,Q61103,REQU_MOUSE,,"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)",Mus musculus (Mouse),41.2,391.0,2.7e-74,280.8,sp|Q61103|REQU_MOUSE Zinc finger protein ubi-d4 OS=Mus musculus OX=10090 GN=Dpf2 PE=1 SV=1,GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006338; GO:0006357; GO:0006915; GO:0008270; GO:0016514; GO:0030071; GO:0070316; GO:0140015; GO:0140046; GO:1902459; GO:1905454; GO:2000045; GO:2000781; GO:2000819,apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],histone H3K14ac reader activity [GO:0140015]; histone H4K16ac reader activity [GO:0140046]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006325; GO:0006355; GO:0012501; GO:0043226; GO:0060090,nucleus; nucleoplasm; microtubule organizing center; cytosol; chromatin organization; regulation of DNA-templated transcription; programmed cell death; organelle; molecular adaptor activity
OG_01941,5.3806576622349365,FUN_007993-T1,Peve_00018053,Pocillopora_meandrina_HIv1___RNAseq.g5090.t1,three_way,42.72566666666666,FUN_007993-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),25.9,587.0,7.1e-39,163.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_01943,1.0894662334891996,FUN_007997-T1,Peve_00005544,Pocillopora_meandrina_HIv1___TS.g21145.t1,three_way,55.695,FUN_007997-T1,Q56X76,RH39_ARATH,,DEAD-box ATP-dependent RNA helicase 39 (EC 3.6.4.13),Arabidopsis thaliana (Mouse-ear cress),36.5,438.0,9.999999999999999e-69,262.7,sp|Q56X76|RH39_ARATH DEAD-box ATP-dependent RNA helicase 39 OS=Arabidopsis thaliana OX=3702 GN=RH39 PE=2 SV=2,GO:0003724; GO:0003729; GO:0005524; GO:0009507; GO:0016887; GO:0070180; GO:0110102; GO:1901259,chloroplast rRNA processing [GO:1901259]; ribulose bisphosphate carboxylase complex assembly [GO:0110102],chloroplast [GO:0009507],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; large ribosomal subunit rRNA binding [GO:0070180]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0009536; GO:0016787; GO:0016853; GO:0043226; GO:0065003; GO:0140098; GO:0140657,"RNA binding; catalytic activity; plastid; hydrolase activity; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01945,1.8206494035139589,FUN_008000-T1,Peve_00022011,Pocillopora_meandrina_HIv1___RNAseq.g18155.t1,three_way,76.23933333333333,FUN_008000-T1,P51948,MAT1_HUMAN,,CDK-activating kinase assembly factor MAT1 (CDK7/cyclin-H assembly factor) (Cyclin-G1-interacting protein) (Menage a trois) (RING finger protein 66) (RING finger protein MAT1) (p35) (p36),Homo sapiens (Human),46.0,313.0,6.999999999999997e-69,262.3,sp|P51948|MAT1_HUMAN CDK-activating kinase assembly factor MAT1 OS=Homo sapiens OX=9606 GN=MNAT1 PE=1 SV=1,GO:0000082; GO:0000307; GO:0000439; GO:0005654; GO:0005675; GO:0006281; GO:0006289; GO:0006357; GO:0006367; GO:0007512; GO:0008270; GO:0021591; GO:0043066; GO:0048661; GO:0051592; GO:0061575; GO:0070516; GO:0070985; GO:2000045,adult heart development [GO:0007512]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; response to calcium ion [GO:0051592]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ventricular system development [GO:0021591],CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985],cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; zinc ion binding [GO:0008270],GO:0005654; GO:0006281; GO:0006355; GO:0048856; GO:0098772,nucleoplasm; DNA repair; regulation of DNA-templated transcription; anatomical structure development; molecular function regulator activity
OG_01946,2.21674998406518,FUN_008001-T1,Peve_00006650,Pocillopora_meandrina_HIv1___TS.g21139.t2b,three_way,61.92966666666666,FUN_008001-T1,Q8IWY9,CDAN1_HUMAN,,Codanin-1,Homo sapiens (Human),30.4,1310.0,1.6e-117,426.0,sp|Q8IWY9|CDAN1_HUMAN Codanin-1 OS=Homo sapiens OX=9606 GN=CDAN1 PE=1 SV=4,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0008104; GO:0012505; GO:0051170,chromatin organization [GO:0006325]; import into nucleus [GO:0051170]; protein localization [GO:0008104],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005829; GO:0005886; GO:0006325; GO:0006913; GO:0043226,nucleus; cytosol; plasma membrane; chromatin organization; nucleocytoplasmic transport; organelle
OG_01947,2.039250899227292,FUN_008003-T1,Peve_00006648,Pocillopora_meandrina_HIv1___RNAseq.g18148.t1,three_way,64.2115,FUN_008003-T1,Q9HAW4,CLSPN_HUMAN,,Claspin (hClaspin),Homo sapiens (Human),32.9,304.0,3.5e-24,114.4,sp|Q9HAW4|CLSPN_HUMAN Claspin OS=Homo sapiens OX=9606 GN=CLSPN PE=1 SV=3,GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0007095; GO:0010997; GO:0018105; GO:0032147; GO:0033314,activation of protein kinase activity [GO:0032147]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105],Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217],GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0043226,DNA binding; nucleus; nucleoplasm; Golgi apparatus; DNA repair; organelle
OG_01951,2.554573596397787,FUN_008016-T1,Peve_00031315,Pocillopora_meandrina_HIv1___RNAseq.g30338.t1,three_way,69.895,FUN_008016-T1,Q6GYQ0,RGPA1_HUMAN,,Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240),Homo sapiens (Human),36.5,2122.0,0.0,1175.6,sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1,GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630,activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; nucleus [GO:0005634],GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982],GO:0005634; GO:0043226; GO:0098772,nucleus; organelle; molecular function regulator activity
OG_01952,2.6610374892109467,FUN_008018-T1,Peve_00031314,Pocillopora_meandrina_HIv1___RNAseq.g30339.t1,three_way,80.18366666666667,FUN_008018-T1,P18754,RCC1_HUMAN,,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),Homo sapiens (Human),49.0,433.0,2.4e-107,390.6,sp|P18754|RCC1_HUMAN Regulator of chromosome condensation OS=Homo sapiens OX=9606 GN=RCC1 PE=1 SV=1,GO:0000082; GO:0000785; GO:0000794; GO:0003682; GO:0005085; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007052; GO:0007059; GO:0007084; GO:0007088; GO:0007346; GO:0016032; GO:0031267; GO:0031491; GO:0031492; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301; GO:1901673,cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]; viral process [GO:0016032],chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199],GO:0000228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0007010; GO:0007059; GO:0042393; GO:0043226; GO:0061024; GO:0098772,nuclear chromosome; DNA binding; nucleus; nucleoplasm; chromosome; cytoskeleton organization; chromosome segregation; histone binding; organelle; membrane organization; molecular function regulator activity
OG_01953,1.1572608886575149,FUN_008019-T1,Peve_00031304,Pocillopora_meandrina_HIv1___RNAseq.g30340.t1,three_way,72.098,FUN_008019-T1,Q9CXE6,XRCC3_MOUSE,,DNA repair protein XRCC3 (X-ray repair cross-complementing protein 3),Mus musculus (Mouse),45.8,347.0,1.1999999999999998e-69,265.0,sp|Q9CXE6|XRCC3_MOUSE DNA repair protein XRCC3 OS=Mus musculus OX=10090 GN=Xrcc3 PE=2 SV=1,GO:0000400; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005759; GO:0005829; GO:0008821; GO:0010824; GO:0033065; GO:0036297; GO:0048471; GO:0071140; GO:0090267; GO:0090656; GO:0140664,double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; resolution of mitotic recombination intermediates [GO:0071140]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0032200; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; telomere organization; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01955,1.7022267721312174,FUN_008021-T1,Peve_00031303,Pocillopora_meandrina_HIv1___RNAseq.g30342.t1,three_way,69.569,,,,,,,,,,,,,,,,,
OG_01959,1.1962474214152825,FUN_008029-T1,Peve_00011343,Pocillopora_meandrina_HIv1___RNAseq.g30354.t1,three_way,75.087,,,,,,,,,,,,,,,,,
OG_01961,1.6201031123480167,FUN_008036-T1,Peve_00045157,Pocillopora_meandrina_HIv1___TS.g22662.t1,three_way,59.35066666666667,FUN_008036-T1,A1A5Z0,G6PC3_DANRE,,Glucose-6-phosphatase 3 (G-6-Pase 3) (G6Pase 3) (EC 3.1.3.9),Danio rerio (Zebrafish) (Brachydanio rerio),36.1,355.0,4.799999999999999e-53,209.9,sp|A1A5Z0|G6PC3_DANRE Glucose-6-phosphatase 3 OS=Danio rerio OX=7955 GN=g6pc3 PE=2 SV=1,GO:0002244; GO:0004346; GO:0005789; GO:0006094; GO:0016020; GO:0051156,gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; hematopoietic progenitor cell differentiation [GO:0002244],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],glucose-6-phosphatase activity [GO:0004346],GO:0003824; GO:0005975; GO:0016787; GO:0030154; GO:1901135,catalytic activity; carbohydrate metabolic process; hydrolase activity; cell differentiation; carbohydrate derivative metabolic process
OG_01962,1.910565441315233,FUN_008045-T1,Peve_00045144,Pocillopora_meandrina_HIv1___RNAseq.g30364.t1,three_way,63.13066666666666,FUN_008045-T1,Q0P4W3,,,,,41.6,125.0,3e-26,119.4,sp|Q0P4W3|RMD2_XENTR Regulator of microtubule dynamics protein 2 OS=Xenopus tropicalis OX=8364 GN=rmdn2 PE=2 SV=1,,,,,,
OG_01963,1.8832293725419464,FUN_008046-T1,Peve_00045145,Pocillopora_meandrina_HIv1___RNAseq.g30363.t1,three_way,54.59633333333333,,,,,,,,,,,,,,,,,
OG_01964,1.768260416457938,FUN_008047-T1,Peve_00045146,Pocillopora_meandrina_HIv1___RNAseq.g30362.t2,three_way,56.651333333333326,,,,,,,,,,,,,,,,,
OG_01966,2.336483549107237,FUN_008049-T1,Peve_00045150,Pocillopora_meandrina_HIv1___RNAseq.g30360.t1,three_way,52.505,,,,,,,,,,,,,,,,,
OG_01968,2.1661324532600665,FUN_008058-T1,Peve_00017188,Pocillopora_meandrina_HIv1___RNAseq.g17900.t1,three_way,70.506,FUN_008058-T1,Q8AWD2,MOCS3_DANRE,,Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)],Danio rerio (Zebrafish) (Brachydanio rerio),53.7,492.0,1e-135,485.0,sp|Q8AWD2|MOCS3_DANRE Adenylyltransferase and sulfurtransferase MOCS3 OS=Danio rerio OX=7955 GN=mocs3 PE=2 SV=1,GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605,Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292],GO:0003824; GO:0005829; GO:0006399; GO:0016740; GO:0016874; GO:0140096; GO:0140657,"catalytic activity; cytosol; tRNA metabolic process; transferase activity; ligase activity; catalytic activity, acting on a protein; ATP-dependent activity"
OG_01972,1.6372295157304446,FUN_008075-T2,Peve_00013209,Pocillopora_meandrina_HIv1___TS.g22375.t1a,three_way,80.586,FUN_008075-T2,P47990,XDH_CHICK,,Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)],Gallus gallus (Chicken),61.2,1361.0,0.0,1679.1,sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1,GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949,urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777],"2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]",GO:0003824; GO:0005615; GO:0005777; GO:0005829; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; peroxisome; cytosol; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_01974,1.7517327191312235,FUN_008079-T1,Peve_00041217,Pocillopora_meandrina_HIv1___RNAseq.g30082.t1,three_way,88.34400000000001,FUN_008079-T1,Q9Z2Q4,,,,,69.2,1253.0,0.0,1754.2,sp|Q9Z2Q4|METH_RAT Methionine synthase OS=Rattus norvegicus OX=10116 GN=Mtr PE=1 SV=1,,,,,,
OG_01978,2.2236944879048464,FUN_008085-T1,Peve_00041225,Pocillopora_meandrina_HIv1___RNAseq.g18088.t1,three_way,66.205,FUN_008085-T1,Q80ZM8,,,,,51.3,197.0,2.7e-49,197.2,sp|Q80ZM8|CRLS1_MOUSE Cardiolipin synthase (CMP-forming) OS=Mus musculus OX=10090 GN=Crls1 PE=1 SV=1,,,,,,
OG_01980,1.775468991085296,FUN_008087-T1,Peve_00018940,Pocillopora_meandrina_HIv1___RNAseq.g18085.t1,three_way,47.927,,,,,,,,,,,,,,,,,
OG_01982,1.7488386620555765,FUN_008090-T1,Peve_00033656,Pocillopora_meandrina_HIv1___RNAseq.g30101.t1,three_way,80.22983333333333,FUN_008090-T1,P58405,STRN3_RAT,,Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen),Rattus norvegicus (Rat),44.9,824.0,2.0999999999999996e-171,604.4,sp|P58405|STRN3_RAT Striatin-3 OS=Rattus norvegicus OX=10116 GN=Strn3 PE=1 SV=2,GO:0005516; GO:0005654; GO:0005794; GO:0005886; GO:0019901; GO:0030425; GO:0030674; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0035331; GO:0043025; GO:0044877; GO:0045892; GO:0051721; GO:0070016; GO:0090443; GO:0098794,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; response to estradiol [GO:0032355],dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0043226; GO:0060090,nucleoplasm; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_01985,2.470198065946388,FUN_008093-T1,Peve_00038989,Pocillopora_meandrina_HIv1___RNAseq.g30098.t1,three_way,63.867666666666665,FUN_008093-T1,Q8BGQ1,SPE39_MOUSE,,Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction),Mus musculus (Mouse),38.4,385.0,1.5e-67,258.8,sp|Q8BGQ1|SPE39_MOUSE Spermatogenesis-defective protein 39 homolog OS=Mus musculus OX=10090 GN=Vipas39 PE=1 SV=1,GO:0005737; GO:0005769; GO:0005770; GO:0005794; GO:0006886; GO:0007283; GO:0008333; GO:0030154; GO:0030199; GO:0032963; GO:0043687; GO:0044877; GO:0055037; GO:0099023,cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023],protein-containing complex binding [GO:0044877],GO:0005768; GO:0005794; GO:0006886; GO:0016192; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226,endosome; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle
OG_01987,1.8325213608847304,FUN_008095-T1,Peve_00038997,Pocillopora_meandrina_HIv1___RNAseq.g30134.t1,three_way,81.409,FUN_008095-T1,Q5E951,TBCB_BOVIN,,Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B),Bos taurus (Bovine),48.1,243.0,2.3000000000000002e-59,230.3,sp|Q5E951|TBCB_BOVIN Tubulin-folding cofactor B OS=Bos taurus OX=9913 GN=TBCB PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0007021; GO:0007023; GO:0007399; GO:0030154; GO:0031122; GO:0035371; GO:0043014; GO:0051010,cell differentiation [GO:0030154]; cytoplasmic microtubule organization [GO:0031122]; nervous system development [GO:0007399]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634],alpha-tubulin binding [GO:0043014]; microtubule plus-end binding [GO:0051010],GO:0005634; GO:0005829; GO:0006457; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0065003,nucleus; cytosol; protein folding; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly
OG_01988,1.7637370391226213,FUN_008096-T1,Peve_00038988,Pocillopora_meandrina_HIv1___RNAseq.g30135.t1,three_way,71.50766666666667,FUN_008096-T1,Q96L50,,,,,39.4,411.0,9.9e-42,172.6,sp|Q96L50|LLR1_HUMAN Leucine-rich repeat protein 1 OS=Homo sapiens OX=9606 GN=LRR1 PE=1 SV=2,,,,,,
OG_01990,1.3040792301415751,FUN_008098-T1,Peve_00038884,Pocillopora_meandrina_HIv1___RNAseq.g30141.t1,three_way,74.036,FUN_008098-T1,Q9NQC3,RTN4_HUMAN,,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),Homo sapiens (Human),38.9,190.0,1.3e-26,121.7,sp|Q9NQC3|RTN4_HUMAN Reticulon-4 OS=Homo sapiens OX=9606 GN=RTN4 PE=1 SV=2,GO:0001825; GO:0002523; GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0007029; GO:0007413; GO:0007420; GO:0010634; GO:0014069; GO:0021801; GO:0022009; GO:0030054; GO:0030182; GO:0030308; GO:0030334; GO:0030517; GO:0031625; GO:0033601; GO:0034165; GO:0035022; GO:0035441; GO:0042803; GO:0042981; GO:0043005; GO:0043025; GO:0045202; GO:0045296; GO:0045766; GO:0046872; GO:0050804; GO:0050821; GO:0051292; GO:0051897; GO:0060317; GO:0060907; GO:0061462; GO:0070161; GO:0071456; GO:0071782; GO:0071786; GO:0071787; GO:0090156; GO:0098826; GO:0098978; GO:0120078; GO:0150052; GO:1902430; GO:1902624; GO:1905523; GO:1905552; GO:1905580; GO:1905653; GO:1990809; GO:2000172; GO:2000347; GO:2001213,apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; brain development [GO:0007420]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; intracellular sphingolipid homeostasis [GO:0090156]; leukocyte migration involved in inflammatory response [GO:0002523]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; neuron differentiation [GO:0030182]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]; regulation of postsynapse assembly [GO:0150052],anchoring junction [GO:0070161]; cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625],GO:0002376; GO:0003723; GO:0005635; GO:0005783; GO:0005886; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0061024; GO:0065003,immune system process; RNA binding; nuclear envelope; endoplasmic reticulum; plasma membrane; cell adhesion; programmed cell death; cell differentiation; organelle; anatomical structure development; cell motility; membrane organization; protein-containing complex assembly
OG_01992,3.1889827356974747,FUN_008100-T1,Peve_00038880,Pocillopora_meandrina_HIv1___RNAseq.g30139.t1,three_way,44.18833333333333,,,,,,,,,,,,,,,,,
OG_01994,2.235458044370343,FUN_008103-T1,Peve_00017193,Pocillopora_meandrina_HIv1___RNAseq.g17899.t1,three_way,61.52516666666666,FUN_008103-T1,Q3T1I9,,,,,33.8,1354.0,5.6000000000000005e-182,640.2,sp|Q3T1I9|RPAP1_RAT RNA polymerase II-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Rpap1 PE=1 SV=1,,,,,,
OG_01996,2.937929979679412,FUN_008107-T1,Peve_00019589,Pocillopora_meandrina_HIv1___RNAseq.21377_t,three_way,82.86116666666668,FUN_008107-T1,Q2PFW9,,,,,36.0,458.0,2.5000000000000002e-58,227.6,sp|Q2PFW9|NOVA1_MACFA RNA-binding protein Nova-1 OS=Macaca fascicularis OX=9541 GN=NOVA1 PE=2 SV=1,,,,,,
OG_01997,2.7190954764120394,FUN_008108-T1,Peve_00019590,Pocillopora_meandrina_HIv1___RNAseq.g17896.t1,three_way,76.08733333333333,FUN_008108-T1,P31669,,,,,54.0,985.0,1.6999999999999996e-286,986.9,sp|P31669|PARP1_XENLA Poly [ADP-ribose] polymerase 1 (Fragment) OS=Xenopus laevis OX=8355 GN=parp1 PE=2 SV=1,,,,,,
OG_02003,2.573285761775735,FUN_008117-T1,Peve_00022344,Pocillopora_meandrina_HIv1___RNAseq.21365_t,three_way,73.45166666666667,FUN_008117-T1,Q08DJ7,,,,,45.6,215.0,1.3000000000000002e-44,181.0,sp|Q08DJ7|AAR2_BOVIN Protein AAR2 homolog OS=Bos taurus OX=9913 GN=AAR2 PE=2 SV=1,,,,,,
OG_02005,1.354747456816454,FUN_008120-T1,Peve_00022346,Pocillopora_meandrina_HIv1___RNAseq.g17885.t1,three_way,95.69133333333332,FUN_008120-T1,Q8VD72,TTC8_MOUSE,,Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein homolog),Mus musculus (Mouse),61.7,379.0,2.3999999999999997e-83,310.8,sp|Q8VD72|TTC8_MOUSE Tetratricopeptide repeat protein 8 OS=Mus musculus OX=10090 GN=Ttc8 PE=1 SV=1,GO:0001650; GO:0001736; GO:0005737; GO:0005814; GO:0005929; GO:0007411; GO:0007608; GO:0015031; GO:0016020; GO:0021772; GO:0032391; GO:0032880; GO:0034451; GO:0034464; GO:0035264; GO:0036064; GO:0045198; GO:0045444; GO:0048560; GO:0051492; GO:0060122; GO:0060170; GO:0060219; GO:0060271; GO:0061326; GO:0061629; GO:0072659; GO:1903251; GO:1905515,axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; fat cell differentiation [GO:0045444]; inner ear receptor cell stereocilium organization [GO:0060122]; multi-ciliated epithelial cell differentiation [GO:1903251]; multicellular organism growth [GO:0035264]; non-motile cilium assembly [GO:1905515]; olfactory bulb development [GO:0021772]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]; regulation of stress fiber assembly [GO:0051492]; renal tubule development [GO:0061326]; sensory perception of smell [GO:0007608],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0005815; GO:0005929; GO:0007163; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0072659,microtubule organizing center; cilium; establishment or maintenance of cell polarity; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein localization to plasma membrane
OG_02007,2.9107389763476226,FUN_008122-T1,Peve_00022348,Pocillopora_meandrina_HIv1___RNAseq.g17883.t1,three_way,77.1465,FUN_008122-T1,Q8R4P9,MRP7_MOUSE,,ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7),Mus musculus (Mouse),49.7,1236.0,0.0,1107.0,sp|Q8R4P9|MRP7_MOUSE ATP-binding cassette sub-family C member 10 OS=Mus musculus OX=10090 GN=Abcc10 PE=1 SV=1,GO:0005524; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0016323; GO:0016887; GO:0071716; GO:0140359,leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869],basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323],ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005215; GO:0016787; GO:0140657,catalytic activity; transporter activity; hydrolase activity; ATP-dependent activity
OG_02008,1.513755369665562,FUN_008124-T1,Peve_00037845,Pocillopora_meandrina_HIv1___TS.g20865.t1c,three_way,71.69683333333333,FUN_008124-T1,Q86X10,,,,,37.7,1615.0,9.4e-255,882.1,sp|Q86X10|RLGPB_HUMAN Ral GTPase-activating protein subunit beta OS=Homo sapiens OX=9606 GN=RALGAPB PE=1 SV=1,,,,,,
OG_02010,1.541283040314595,FUN_008129-T1,Peve_00037859,Pocillopora_meandrina_HIv1___RNAseq.g29986.t1,three_way,67.05333333333333,FUN_008129-T1,Q9QZE7,,,,,42.8,257.0,1.9e-53,211.5,sp|Q9QZE7|TSNAX_MOUSE Translin-associated protein X OS=Mus musculus OX=10090 GN=Tsnax PE=1 SV=1,,,,,,
OG_02013,1.4038643601699698,FUN_008186-T1,Peve_00018750,Pocillopora_meandrina_HIv1___TS.g22292.t1,three_way,69.749,FUN_008186-T1,Q91YJ5,,,,,47.6,553.0,7.4e-132,472.6,"sp|Q91YJ5|IF2M_MOUSE Translation initiation factor IF-2, mitochondrial OS=Mus musculus OX=10090 GN=Mtif2 PE=1 SV=2",,,,,,
OG_02015,3.2797466266716784,FUN_008188-T1,Peve_00010859,Pocillopora_meandrina_HIv1___RNAseq.g29996.t1,three_way,81.78566666666667,FUN_008188-T1,Q99NB1,ACS2L_MOUSE,,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)",Mus musculus (Mouse),62.1,612.0,1.7e-229,797.0,"sp|Q99NB1|ACS2L_MOUSE Acetyl-coenzyme A synthetase 2-like, mitochondrial OS=Mus musculus OX=10090 GN=Acss1 PE=1 SV=1",GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218,acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218],GO:0003824; GO:0005739; GO:0006629; GO:0006790; GO:0016874; GO:0043226; GO:0055086; GO:0140657,catalytic activity; mitochondrion; lipid metabolic process; sulfur compound metabolic process; ligase activity; organelle; nucleobase-containing small molecule metabolic process; ATP-dependent activity
OG_02021,1.1286846518510698,FUN_008210-T1,Peve_00027982,Pocillopora_meandrina_HIv1___RNAseq.g30179.t1,three_way,58.69616666666667,,,,,,,,,,,,,,,,,
OG_02022,1.07618307795908,FUN_008211-T1,Peve_00027427,Pocillopora_meandrina_HIv1___TS.g22475.t1,three_way,37.799166666666665,,,,,,,,,,,,,,,,,
OG_02025,1.5443305611913622,FUN_008215-T1,Peve_00005269,Pocillopora_meandrina_HIv1___RNAseq.g30184.t1,three_way,71.14333333333333,FUN_008215-T1,Q8VCX6,,,,,42.6,394.0,6.2e-84,312.8,sp|Q8VCX6|KPTN_MOUSE KICSTOR complex protein kaptin OS=Mus musculus OX=10090 GN=Kptn PE=2 SV=1,,,,,,
OG_02027,1.2891781601539285,FUN_008228-T1,Peve_00039965,Pocillopora_meandrina_HIv1___RNAseq.g30194.t1,three_way,60.135,FUN_008228-T1,O13076,,,,,27.2,316.0,2e-16,88.2,sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1,,,,,,
OG_02028,1.376703220467978,FUN_008229-T1,Peve_00039966,Pocillopora_meandrina_HIv1___RNAseq.g30195.t1,three_way,59.528666666666666,FUN_008229-T1,P13466,,,,,41.4,70.0,5.5e-08,60.8,sp|P13466|GELA_DICDI Gelation factor OS=Dictyostelium discoideum OX=44689 GN=abpC PE=1 SV=1,,,,,,
OG_02031,3.14875943361406,FUN_008232-T1,Peve_00039956,Pocillopora_meandrina_HIv1___RNAseq.g30199.t1,three_way,66.05233333333334,FUN_008232-T1,Q6DC37,,,,,28.3,304.0,4e-22,107.1,sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1,,,,,,
OG_02032,1.2733044708532022,FUN_008233-T1,Peve_00039958,Pocillopora_meandrina_HIv1___RNAseq.21398_t,three_way,65.03,FUN_008233-T1,Q90964,FOXG1_CHICK,,Forkhead box protein G1 (FoxG1) (Brain factor 1) (BF-1) (BF1) (cBF-1) (CEQ 3-1) (Forkhead-related protein FKHL1) (N-62-5) (Proto-oncogene C-QIN),Gallus gallus (Chicken),61.5,187.0,2.1999999999999997e-53,211.1,sp|Q90964|FOXG1_CHICK Forkhead box protein G1 OS=Gallus gallus OX=9031 GN=FOXG1 PE=2 SV=1,GO:0000122; GO:0002052; GO:0003700; GO:0005634; GO:0006357; GO:0007346; GO:0007405; GO:0009953; GO:0016199; GO:0021852; GO:0042472; GO:0045665; GO:0045666; GO:0045787; GO:0048664; GO:1990837,axon midline choice point recognition [GO:0016199]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; sequence-specific double-stranded DNA binding [GO:1990837],GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cell motility; transcription regulator activity
OG_02034,1.2808125691095888,FUN_008235-T1,Peve_00039963,Pocillopora_meandrina_HIv1___RNAseq.g17926.t1,three_way,70.18299999999999,FUN_008235-T1,P46718,,,,,44.8,375.0,1.1e-82,308.5,sp|P46718|PDCD2_MOUSE Programmed cell death protein 2 OS=Mus musculus OX=10090 GN=Pdcd2 PE=2 SV=2,,,,,,
OG_02036,2.3957768423157986,FUN_008238-T1,Peve_00003880,Pocillopora_meandrina_HIv1___RNAseq.g17929.t1,three_way,69.81566666666667,FUN_008238-T1,Q8R2K4,TAF6L_MOUSE,,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha),Mus musculus (Mouse),43.2,472.0,5.600000000000001e-89,330.1,sp|Q8R2K4|TAF6L_MOUSE TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L OS=Mus musculus OX=10090 GN=Taf6l PE=1 SV=1,GO:0000124; GO:0005634; GO:0005669; GO:0006282; GO:0006355; GO:0006367; GO:0016251; GO:0043484; GO:0045893; GO:0046695; GO:0046982; GO:1904672,positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; transcription initiation at RNA polymerase II promoter [GO:0006367],nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669],protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0005634; GO:0006355; GO:0043226; GO:0140223,nucleus; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_02037,1.7720978363440418,FUN_008239-T1,Peve_00031796,Pocillopora_meandrina_HIv1___TS.g20917.t2b,three_way,81.074,FUN_008239-T1,Q6T938,FIBP_DANRE,,Acidic fibroblast growth factor intracellular-binding protein B (aFGF intracellular-binding protein B) (FGF-1 intracellular-binding protein B),Danio rerio (Zebrafish) (Brachydanio rerio),42.8,367.0,1.7e-82,307.8,sp|Q6T938|FIBP_DANRE Acidic fibroblast growth factor intracellular-binding protein B OS=Danio rerio OX=7955 GN=fibpb PE=1 SV=1,GO:0005634; GO:0007368; GO:0012505; GO:0016020; GO:0017134; GO:0060026; GO:0060271; GO:0070121,cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; Kupffer's vesicle development [GO:0070121],endomembrane system [GO:0012505]; membrane [GO:0016020]; nucleus [GO:0005634],fibroblast growth factor binding [GO:0017134],GO:0005634; GO:0043226; GO:0044782; GO:0048856,nucleus; organelle; cilium organization; anatomical structure development
OG_02038,1.154854631098805,FUN_008242-T1,Peve_00031783,Pocillopora_meandrina_HIv1___RNAseq.g17937.t1,three_way,69.76933333333334,,,,,,,,,,,,,,,,,
OG_02041,1.0783250675417209,FUN_008246-T1,Peve_00031790,Pocillopora_meandrina_HIv1___RNAseq.g17950.t1,three_way,76.36933333333333,FUN_008246-T1,Q3LXA3,TKFC_HUMAN,,Triokinase/FMN cyclase (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) [Includes: ATP-dependent dihydroxyacetone kinase (DHA kinase) (EC 2.7.1.28) (EC 2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase); FAD-AMP lyase (cyclizing) (EC 4.6.1.15) (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase)],Homo sapiens (Human),48.7,591.0,8.3e-143,508.8,sp|Q3LXA3|TKFC_HUMAN Triokinase/FMN cyclase OS=Homo sapiens OX=9606 GN=TKFC PE=1 SV=2,GO:0004371; GO:0005524; GO:0005634; GO:0005829; GO:0005975; GO:0019563; GO:0034012; GO:0039534; GO:0045088; GO:0046835; GO:0046872; GO:0050354; GO:0061624; GO:0070062,carbohydrate metabolic process [GO:0005975]; carbohydrate phosphorylation [GO:0046835]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354],GO:0003824; GO:0005634; GO:0005829; GO:0005975; GO:0009975; GO:0016740; GO:0016829; GO:0043226; GO:1901135,catalytic activity; nucleus; cytosol; carbohydrate metabolic process; cyclase activity; transferase activity; lyase activity; organelle; carbohydrate derivative metabolic process
OG_02043,4.568192972654217,FUN_008248-T1,Peve_00031792,Pocillopora_meandrina_HIv1___RNAseq.g17952.t2,three_way,55.662,FUN_008248-T1,P83618,,,,,25.9,185.0,9.7e-14,78.6,sp|P83618|RN28_PANGI Ribonuclease-like storage protein OS=Panax ginseng OX=4054 PE=1 SV=2,,,,,,
OG_02044,1.6655971137798893,FUN_008249-T1,Peve_00031793,Pocillopora_meandrina_HIv1___RNAseq.g17953.t1,three_way,65.32433333333334,FUN_008249-T1,A0A1L8ER70,,,,,28.1,317.0,4.8e-20,100.1,sp|A0A1L8ER70|HYLS1_XENLA Centriolar and ciliogenesis-associated protein HYLS1 OS=Xenopus laevis OX=8355 GN=hyls-1 PE=1 SV=1,,,,,,
OG_02045,2.623039190477844,FUN_008250-T1,Peve_00025019,Pocillopora_meandrina_HIv1___RNAseq.21440_t,three_way,71.38866666666667,FUN_008250-T1,Q9DCU6,,,,,44.4,216.0,2.7999999999999997e-41,170.6,sp|Q9DCU6|RM04_MOUSE Large ribosomal subunit protein uL4m OS=Mus musculus OX=10090 GN=Mrpl4 PE=1 SV=1,,,,,,
OG_02049,4.1097335843346805,FUN_008259-T1,Peve_00042075,Pocillopora_meandrina_HIv1___RNAseq.g17963.t1,three_way,74.48566666666667,FUN_008259-T1,O88559,MEN1_MOUSE,,Menin,Mus musculus (Mouse),42.6,599.0,3.6e-116,420.2,sp|O88559|MEN1_MOUSE Menin OS=Mus musculus OX=10090 GN=Men1 PE=1 SV=2,GO:0000122; GO:0000781; GO:0000976; GO:0001216; GO:0001503; GO:0001776; GO:0002051; GO:0002076; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006338; GO:0008283; GO:0008285; GO:0010468; GO:0010628; GO:0017053; GO:0030097; GO:0035097; GO:0035265; GO:0043565; GO:0044342; GO:0044346; GO:0045668; GO:0045669; GO:0045815; GO:0045893; GO:0045944; GO:0046621; GO:0048144; GO:0048147; GO:0048704; GO:0048863; GO:0051301; GO:0051781; GO:0060021; GO:0060135; GO:0072089; GO:1904691; GO:2000045; GO:2000271; GO:2000647; GO:2000738,cell division [GO:0051301]; cell population proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; embryonic skeletal system morphogenesis [GO:0048704]; fibroblast apoptotic process [GO:0044346]; fibroblast proliferation [GO:0048144]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; organ growth [GO:0035265]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of cell division [GO:0051781]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription initiation-coupled chromatin remodeling [GO:0045815]; type B pancreatic cell proliferation [GO:0044342],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976],GO:0002376; GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02053,1.5100254083111972,FUN_008264-T1,Peve_00000655,Pocillopora_meandrina_HIv1___RNAseq.g17972.t1,three_way,81.23766666666667,FUN_008264-T1,Q7T3H2,INS1B_DANRE,,Insulinoma-associated protein 1b (Insulinoma-associated 1-like protein b) (Zinc finger protein IA-1b),Danio rerio (Zebrafish) (Brachydanio rerio),46.3,244.0,2.8000000000000002e-33,144.4,sp|Q7T3H2|INS1B_DANRE Insulinoma-associated protein 1b OS=Danio rerio OX=7955 GN=insm1b PE=2 SV=1,GO:0000122; GO:0000978; GO:0001227; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0008270; GO:0010564; GO:0017053; GO:0030182; GO:0031490; GO:0060290,negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; regulation of cell cycle process [GO:0010564]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309],nucleus [GO:0005634]; transcription repressor complex [GO:0017053],"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_02056,1.944888320888717,FUN_008267-T1,Peve_00001964,Pocillopora_meandrina_HIv1___RNAseq.g17977.t1,three_way,65.56033333333333,FUN_008267-T1,Q6Z690,,,,,29.3,208.0,7.3e-12,72.8,sp|Q6Z690|LDL1_ORYSJ Lysine-specific histone demethylase 1 homolog 1 OS=Oryza sativa subsp. japonica OX=39947 GN=Os02g0755200 PE=2 SV=1,,,,,,
OG_02058,1.438886802387601,FUN_008272-T1,Peve_00001961,Pocillopora_meandrina_HIv1___RNAseq.g17980.t1,three_way,78.47733333333333,FUN_008272-T1,P55807,,,,,29.5,237.0,2.9e-15,84.7,sp|P55807|NRT2_CHICK NAD(P)(+)--arginine ADP-ribosyltransferase 2 OS=Gallus gallus OX=9031 PE=2 SV=1,,,,,,
OG_02063,1.0002111129578164,FUN_008277-T1,Peve_00001956,Pocillopora_meandrina_HIv1___RNAseq.g17985.t1,three_way,62.73766666666667,,,,,,,,,,,,,,,,,
OG_02068,1.1219001490460083,FUN_008282-T1,Peve_00022943,Pocillopora_meandrina_HIv1___RNAseq.g17990.t1,three_way,61.2045,FUN_008282-T1,A0A974H8H3,DICRL_XENLA,,Endoribonuclease Dicer-L (EC 3.1.26.3),Xenopus laevis (African clawed frog),31.1,1891.0,3.0000000000000003e-224,780.8,sp|A0A974H8H3|DICRL_XENLA Endoribonuclease Dicer-L OS=Xenopus laevis OX=8355 GN=dicer1.L PE=2 SV=1,GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0030422; GO:0031054; GO:0070578,apoptotic DNA fragmentation [GO:0006309]; pre-miRNA processing [GO:0031054]; siRNA processing [GO:0030422],cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578],ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02079,1.0449184827910127,FUN_008296-T1,Peve_00012966,Pocillopora_meandrina_HIv1___RNAseq.g18012.t1,three_way,75.1305,FUN_008296-T1,Q86TM6,SYVN1_HUMAN,,E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1),Homo sapiens (Human),80.5,333.0,1.8999999999999998e-153,544.3,sp|Q86TM6|SYVN1_HUMAN E3 ubiquitin-protein ligase synoviolin OS=Homo sapiens OX=9606 GN=SYVN1 PE=1 SV=2,GO:0000836; GO:0000839; GO:0002327; GO:0005654; GO:0005783; GO:0005789; GO:0005790; GO:0006511; GO:0008270; GO:0012505; GO:0016020; GO:0016567; GO:0030970; GO:0036503; GO:0036513; GO:0043161; GO:0044322; GO:0050821; GO:0051082; GO:0051087; GO:0051117; GO:0061630; GO:0070936; GO:0140297; GO:1902236; GO:1904380; GO:1990381,"endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790],ATPase binding [GO:0051117]; DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005654; GO:0005783; GO:0006886; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0140096; GO:1901135,"immune system process; catalytic activity; nucleoplasm; endoplasmic reticulum; intracellular protein transport; transferase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02082,1.3551041044146668,FUN_008305-T1,Peve_00015427,Pocillopora_meandrina_HIv1___RNAseq.g5791.t1,three_way,61.97,FUN_008305-T1,Q9BQP7,MGME1_HUMAN,,Mitochondrial genome maintenance exonuclease 1 (EC 3.1.-.-),Homo sapiens (Human),40.1,202.0,5.200000000000001e-32,140.2,sp|Q9BQP7|MGME1_HUMAN Mitochondrial genome maintenance exonuclease 1 OS=Homo sapiens OX=9606 GN=MGME1 PE=1 SV=1,GO:0000002; GO:0005739; GO:0005759; GO:0006264; GO:0008297; GO:0017108; GO:0043504; GO:0045145,mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],5'-flap endonuclease activity [GO:0017108]; single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145]; single-stranded DNA exodeoxyribonuclease activity [GO:0008297],GO:0003824; GO:0005739; GO:0006260; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"catalytic activity; mitochondrion; DNA replication; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_02088,2.431963876049837,FUN_008314-T1,Peve_00026747,Pocillopora_meandrina_HIv1___RNAseq.g5785.t1,three_way,57.846,,,,,,,,,,,,,,,,,
OG_02090,5.439462946607874,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02091,1.4657157315208444,FUN_008329-T1,Peve_00007606,Pocillopora_meandrina_HIv1___RNAseq.g5444.t1,three_way,68.1515,FUN_008329-T1,Q80TN7,NAV3_MOUSE,,Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1),Mus musculus (Mouse),34.7,101.0,5e-13,78.2,sp|Q80TN7|NAV3_MOUSE Neuron navigator 3 OS=Mus musculus OX=10090 GN=Nav3 PE=1 SV=2,GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0016887; GO:0022008,neurogenesis [GO:0022008],nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005634; GO:0005635; GO:0016787; GO:0030154; GO:0043226,catalytic activity; nucleus; nuclear envelope; hydrolase activity; cell differentiation; organelle
OG_02092,2.901259805532653,FUN_008331-T3,Peve_00007611,Pocillopora_meandrina_HIv1___RNAseq.g5441.t1,three_way,61.8445,FUN_008331-T3,O15040,TCPR2_HUMAN,,Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297),Homo sapiens (Human),24.6,1344.0,7.3e-81,304.3,sp|O15040|TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=TECPR2 PE=1 SV=4,GO:0005737; GO:0006914; GO:0032527,autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527],cytoplasm [GO:0005737],,GO:0006886; GO:0006914,intracellular protein transport; autophagy
OG_02094,1.3528707349902789,FUN_008365-T1,Peve_00005520,Pocillopora_meandrina_HIv1___RNAseq.g5716.t1,three_way,73.69866666666667,FUN_008365-T1,H9J9M0,,,,,27.5,258.0,2.9e-20,100.5,sp|H9J9M0|CDA1_BOMMO Chitin deacetylase 1 OS=Bombyx mori OX=7091 GN=CDA1 PE=1 SV=1,,,,,,
OG_02095,3.53056234310212,FUN_008367-T1,Peve_00014479,Pocillopora_meandrina_HIv1___RNAseq.g5715.t1,three_way,60.782,FUN_008367-T1,Q5S007,LRRK2_HUMAN,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin),Homo sapiens (Human),21.4,1717.0,2.7e-72,276.6,sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2,GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005615; GO:0005654; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0007040; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0061024; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; extracellular space; nucleoplasm; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02102,2.655268632175377,FUN_008381-T1,Peve_00002115,Pocillopora_meandrina_HIv1___RNAseq.g18435.t2,three_way,41.09916666666667,FUN_008381-T1,Q8IW19,APLF_HUMAN,,Aprataxin and PNK-like factor (EC 3.1.-.-) (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1),Homo sapiens (Human),30.1,522.0,2.7e-22,109.0,sp|Q8IW19|APLF_HUMAN Aprataxin and PNK-like factor OS=Homo sapiens OX=9606 GN=APLF PE=1 SV=1,GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006974; GO:0007566; GO:0008270; GO:0008408; GO:0010717; GO:0035861; GO:0042393; GO:0044183; GO:0045191; GO:0071168; GO:0072572; GO:0090734; GO:0140713; GO:0140861; GO:0160002,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryo implantation [GO:0007566]; protein localization to chromatin [GO:0071168]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861],3'-5' exonuclease activity [GO:0008408]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; DNA endonuclease activity [GO:0004520]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose binding [GO:0072572]; protein folding chaperone [GO:0044183]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006325; GO:0016787; GO:0022414; GO:0042393; GO:0043226; GO:0044183; GO:0140097; GO:0140104,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; chromatin organization; hydrolase activity; reproductive process; histone binding; organelle; protein folding chaperone; catalytic activity, acting on DNA; molecular carrier activity"
OG_02103,1.785125644373194,FUN_008382-T1,Peve_00002119,Pocillopora_meandrina_HIv1___TS.g21432.t1,three_way,43.963,FUN_008382-T1,Q9Y3Q0,NALD2_HUMAN,,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),Homo sapiens (Human),31.3,747.0,3.3999999999999998e-68,261.2,sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129,carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508],membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_02107,2.2006729435011443,FUN_008390-T1,Peve_00028171,Pocillopora_meandrina_HIv1___RNAseq.12433_t,three_way,87.16266666666667,FUN_008390-T1,Q54BM3,,,,,41.3,300.0,1.1e-64,248.4,sp|Q54BM3|MCFG_DICDI Mitochondrial substrate carrier family protein G OS=Dictyostelium discoideum OX=44689 GN=mcfG PE=2 SV=1,,,,,,
OG_02116,2.0199676969922007,FUN_008401-T1,Peve_00043702,Pocillopora_meandrina_HIv1___RNAseq.g6183.t1,three_way,61.59283333333333,FUN_008401-T1,Q9QUG2,POLK_MOUSE,,DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP),Mus musculus (Mouse),47.0,624.0,1.0999999999999999e-141,505.4,sp|Q9QUG2|POLK_MOUSE DNA polymerase kappa OS=Mus musculus OX=10090 GN=Polk PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0008270; GO:0016604; GO:0034644; GO:0042276; GO:0060090; GO:0090734,"cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]",nuclear body [GO:0016604]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0043226; GO:0060090; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on DNA"
OG_02117,1.7756115812641096,FUN_008402-T1,Peve_00001054,Pocillopora_meandrina_HIv1___RNAseq.g18036.t1,three_way,81.348,FUN_008402-T1,Q9U518,,,,,45.7,552.0,1.3e-134,481.5,sp|Q9U518|ASPG_DIRIM L-asparaginase OS=Dirofilaria immitis OX=6287 PE=1 SV=1,,,,,,
OG_02118,2.183542201733024,FUN_008403-T1,Peve_00001052,Pocillopora_meandrina_HIv1___RNAseq.g18035.t1,three_way,75.79083333333332,FUN_008403-T1,Q9U518,,,,,39.1,594.0,1.1e-117,425.6,sp|Q9U518|ASPG_DIRIM L-asparaginase OS=Dirofilaria immitis OX=6287 PE=1 SV=1,,,,,,
OG_02122,2.044745321469565,FUN_008415-T1,Peve_00015094,Pocillopora_meandrina_HIv1___RNAseq.g18042.t1,three_way,72.59683333333334,FUN_008415-T1,Q9H2M9,RBGPR_HUMAN,,Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit),Homo sapiens (Human),37.2,1459.0,3.6999999999999996e-242,840.1,sp|Q9H2M9|RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP2 PE=1 SV=1,GO:0005096; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006886; GO:0008047; GO:0016236; GO:0030234; GO:0031267; GO:0032991; GO:0042734; GO:0043087; GO:0097051; GO:0099536; GO:1903061; GO:1903373; GO:2000786,establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]; synaptic signaling [GO:0099536],autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991],enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0023052; GO:0043226; GO:0098772,vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; signaling; organelle; molecular function regulator activity
OG_02133,2.4579112056399164,FUN_008438-T1,Peve_00024973,Pocillopora_meandrina_HIv1___RNAseq.g18056.t1,three_way,83.8915,FUN_008438-T1,A7SMW7,,,,,69.4,448.0,5.4e-187,655.2,"sp|A7SMW7|L2HDH_NEMVE L-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g172254 PE=3 SV=1",,,,,,
OG_02134,2.6907329802561195,FUN_008440-T1,Peve_00024976,Pocillopora_meandrina_HIv1___RNAseq.g18057.t1,three_way,74.42933333333333,FUN_008440-T1,Q8CDU6,,,,,34.3,685.0,9.799999999999999e-96,353.2,sp|Q8CDU6|HECD2_MOUSE Probable E3 ubiquitin-protein ligase HECTD2 OS=Mus musculus OX=10090 GN=Hectd2 PE=1 SV=2,,,,,,
OG_02136,2.219881688689905,FUN_008442-T1,Peve_00024978,Pocillopora_meandrina_HIv1___RNAseq.g18060.t1,three_way,83.17033333333333,FUN_008442-T1,Q9C026,TRIM9_HUMAN,,E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING finger protein 91) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9),Homo sapiens (Human),44.3,704.0,9.099999999999999e-175,615.1,sp|Q9C026|TRIM9_HUMAN E3 ubiquitin-protein ligase TRIM9 OS=Homo sapiens OX=9606 GN=TRIM9 PE=1 SV=1,GO:0005737; GO:0005856; GO:0008021; GO:0008270; GO:0016567; GO:0019904; GO:0030425; GO:0042803; GO:0043161; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; synaptic vesicle [GO:0008021],protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005856; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_02140,1.0755602491808445,FUN_008446-T1,Peve_00025572,Pocillopora_meandrina_HIv1___RNAseq.g18064.t1,three_way,96.747,FUN_008446-T1,Q2NL22,IF4A3_BOVIN,,"Eukaryotic initiation factor 4A-III (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic translation initiation factor 4A isoform 3) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed]",Bos taurus (Bovine),88.3,402.0,8.8e-205,714.1,sp|Q2NL22|IF4A3_BOVIN Eukaryotic initiation factor 4A-III OS=Bos taurus OX=9913 GN=EIF4A3 PE=2 SV=3,GO:0000184; GO:0000381; GO:0000398; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0008143; GO:0016607; GO:0016887; GO:0017148; GO:0035145; GO:0045727; GO:0048701; GO:0051028; GO:0071006; GO:0071013; GO:2000622,"embryonic cranial skeleton morphogenesis [GO:0048701]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; rRNA processing [GO:0006364]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleolus; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02143,1.36821701773339,FUN_008449-T1,Peve_00027473,Pocillopora_meandrina_HIv1___RNAseq.g18067.t1,three_way,83.48466666666667,,,,,,,,,,,,,,,,,
OG_02145,3.8551107457268494,FUN_008451-T1,Peve_00015483,Pocillopora_meandrina_HIv1___RNAseq.g18071.t1,three_way,76.60533333333333,,,,,,,,,,,,,,,,,
OG_02146,1.5724705578605689,FUN_008453-T1,Peve_00031938,Pocillopora_meandrina_HIv1___RNAseq.g18072.t1,three_way,62.222166666666666,FUN_008453-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),43.1,218.0,9.7e-57,221.9,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_02149,2.1155431730012197,FUN_008469-T2,Peve_00028805,Pocillopora_meandrina_HIv1___TS.g21072.t1,three_way,57.63733333333333,FUN_008469-T2,B8UU59,PK1L_ACRMI,,Polycystin-1-related protein (Polycystic kidney disease 1-related protein),Acropora millepora (Staghorn coral) (Heteropora millepora),33.5,373.0,5e-53,212.2,sp|B8UU59|PK1L_ACRMI Polycystin-1-related protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005261; GO:0005886; GO:0005929; GO:0006816,calcium ion transport [GO:0006816],cilium [GO:0005929]; plasma membrane [GO:0005886],monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_02150,1.052415411258445,FUN_008473-T1,Peve_00023658,Pocillopora_meandrina_HIv1___RNAseq.g16416.t1,three_way,77.08333333333333,FUN_008473-T1,P90893,,,,,36.6,454.0,6.1e-78,293.1,sp|P90893|YM9I_CAEEL Putative serine protease F56F10.1 OS=Caenorhabditis elegans OX=6239 GN=F56F10.1 PE=1 SV=2,,,,,,
OG_02154,1.5878139503557838,FUN_008484-T2,Peve_00028794,Pocillopora_meandrina_HIv1___RNAseq.g30394.t1,three_way,58.80383333333334,FUN_008484-T2,Q8BK35,NOP53_MOUSE,,Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (PreS1-binding protein),Mus musculus (Mouse),34.6,448.0,5.4e-35,150.2,sp|Q8BK35|NOP53_MOUSE Ribosome biogenesis protein NOP53 OS=Mus musculus OX=10090 GN=Nop53 PE=1 SV=1,GO:0000027; GO:0000122; GO:0001650; GO:0001932; GO:0002039; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0007095; GO:0008097; GO:0031333; GO:0032435; GO:0032436; GO:0033553; GO:0039535; GO:0042802; GO:0042981; GO:0050821; GO:0051726; GO:0051898; GO:0071456; GO:1901797; GO:1901837; GO:1902570; GO:1903006; GO:1903715; GO:1990173,cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; ribosomal large subunit assembly [GO:0000027],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553],5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006355; GO:0043226; GO:0065003,RNA binding; nucleoplasm; nucleolus; cytosol; DNA repair; regulation of DNA-templated transcription; organelle; protein-containing complex assembly
OG_02155,1.428206533788262,FUN_008486-T1,Peve_00028792,Pocillopora_meandrina_HIv1___RNAseq.g30385.t1,three_way,68.478,FUN_008486-T1,Q6R5J2,DISP1_DANRE,,Protein dispatched homolog 1 (Protein chameleon),Danio rerio (Zebrafish) (Brachydanio rerio),35.0,925.0,2.2e-151,538.1,sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1,GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839,adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224],membrane [GO:0016020],,GO:0003013; GO:0048856,circulatory system process; anatomical structure development
OG_02158,1.5777784630172955,FUN_008490-T1,Peve_00028832,Pocillopora_meandrina_HIv1___RNAseq.g30381.t1,three_way,71.13933333333334,FUN_008490-T1,Q6A070,TGRM1_MOUSE,,TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B),Mus musculus (Mouse),27.4,2074.0,5.2e-149,531.2,sp|Q6A070|TGRM1_MOUSE TOG array regulator of axonemal microtubules protein 1 OS=Mus musculus OX=10090 GN=Togaram1 PE=1 SV=3,GO:0005737; GO:0005929; GO:0031116; GO:0035082; GO:0036064; GO:1905515,axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005815; GO:0005929; GO:0007010; GO:0043226; GO:0044782,microtubule organizing center; cilium; cytoskeleton organization; organelle; cilium organization
OG_02168,1.525312543492629,FUN_008517-T1,Peve_00042434,Pocillopora_meandrina_HIv1___TS.g3919.t1b,three_way,62.54983333333333,FUN_008517-T1,Q9ESJ4,,,,,38.8,402.0,5.6e-78,293.5,sp|Q9ESJ4|SPN90_MOUSE NCK-interacting protein with SH3 domain OS=Mus musculus OX=10090 GN=Nckipsd PE=1 SV=2,,,,,,
OG_02173,3.977916003319244,FUN_008522-T1,Peve_00012217,Pocillopora_meandrina_HIv1___RNAseq.g14762.t2,three_way,80.53666666666668,FUN_008522-T1,Q9UPE1,,,,,59.4,547.0,7.599999999999999e-136,485.7,sp|Q9UPE1|SRPK3_HUMAN SRSF protein kinase 3 OS=Homo sapiens OX=9606 GN=SRPK3 PE=1 SV=2,,,,,,
OG_02174,1.719482058058666,FUN_008523-T1,Peve_00012210,Pocillopora_meandrina_HIv1___RNAseq.g14753.t1,three_way,78.93833333333333,FUN_008523-T1,Q8NBL1,PGLT1_HUMAN,,Protein O-glucosyltransferase 1 (EC 2.4.1.376) (CAP10-like 46 kDa protein) (hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein) (O-glucosyltransferase Rumi homolog) (hRumi) (Protein O-xylosyltransferase POGLUT1) (EC 2.4.2.63),Homo sapiens (Human),61.8,356.0,2.9e-139,496.5,sp|Q8NBL1|PGLT1_HUMAN Protein O-glucosyltransferase 1 OS=Homo sapiens OX=9606 GN=POGLUT1 PE=1 SV=1,GO:0001756; GO:0005783; GO:0005788; GO:0006493; GO:0007369; GO:0010470; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0045747; GO:0046527; GO:0048318; GO:0048339; GO:0060537; GO:0072359; GO:0140561; GO:0140562,axial mesoderm development [GO:0048318]; circulatory system development [GO:0072359]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470]; somitogenesis [GO:0001756],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252],GO:0003824; GO:0005783; GO:0009101; GO:0016740; GO:0043226; GO:0048856; GO:1901135,catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; transferase activity; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_02179,2.362758186708863,FUN_008530-T1,Peve_00011877,Pocillopora_meandrina_HIv1___RNAseq.g14745.t1,three_way,87.72200000000001,,,,,,,,,,,,,,,,,
OG_02180,1.481535886932273,FUN_008531-T1,Peve_00011876,Pocillopora_meandrina_HIv1___RNAseq.g14744.t1,three_way,54.064,,,,,,,,,,,,,,,,,
OG_02181,2.4963488274842205,FUN_008534-T1,Peve_00014007,Pocillopora_meandrina_HIv1___RNAseq.g14740.t1,three_way,62.36966666666667,FUN_008534-T1,Q28E45,MCM10_XENTR,,Protein MCM10 homolog,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),36.7,645.0,4.0999999999999996e-92,340.9,sp|Q28E45|MCM10_XENTR Protein MCM10 homolog OS=Xenopus tropicalis OX=8364 GN=mcm10 PE=2 SV=1,GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0008270,DNA damage response [GO:0006974]; DNA replication initiation [GO:0006270],nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0043226,DNA binding; nucleus; organelle
OG_02184,1.5514723103495165,FUN_008537-T1,Peve_00044625,Pocillopora_meandrina_HIv1___RNAseq.g14737.t1,three_way,73.81949999999999,FUN_008537-T1,Q7Z6B7,SRGP1_HUMAN,,SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13),Homo sapiens (Human),33.9,834.0,3.3e-120,434.5,sp|Q7Z6B7|SRGP1_HUMAN SLIT-ROBO Rho GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=SRGAP1 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0007266; GO:0016477; GO:0030336; GO:0031267,cell migration [GO:0016477]; negative regulation of cell migration [GO:0030336]; Rho protein signal transduction [GO:0007266],cytoplasm [GO:0005737]; cytosol [GO:0005829],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0048870; GO:0098772,cytosol; cell motility; molecular function regulator activity
OG_02188,2.171364011279946,FUN_008542-T1,Peve_00013759,Pocillopora_meandrina_HIv1___RNAseq.g6360.t1,three_way,88.51266666666666,FUN_008542-T1,Q299F9,,,,,61.9,357.0,9e-99,361.7,sp|Q299F9|FAM50_DROPS Protein FAM50 homolog OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=GA11514 PE=3 SV=1,,,,,,
OG_02189,1.1192852300158505,FUN_008543-T1,Peve_00013760,Pocillopora_meandrina_HIv1___RNAseq.g6359.t1,three_way,63.07300000000001,FUN_008543-T1,Q8IXR9,,,,,34.4,375.0,2.6e-50,201.8,sp|Q8IXR9|CL056_HUMAN Uncharacterized protein C12orf56 OS=Homo sapiens OX=9606 GN=C12orf56 PE=2 SV=3,,,,,,
OG_02191,1.1093182416082668,FUN_008545-T1,Peve_00013778,Pocillopora_meandrina_HIv1___RNAseq.g6330.t1,three_way,84.39466666666667,FUN_008545-T1,Q26619,,,,,56.8,380.0,3.3999999999999997e-113,409.8,sp|Q26619|KAPR_STRPU cAMP-dependent protein kinase type II regulatory subunit OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_02192,1.8900550032092216,FUN_008547-T1,Peve_00034512,Pocillopora_meandrina_HIv1___RNAseq.g6327.t1,three_way,36.30383333333333,,,,,,,,,,,,,,,,,
OG_02193,1.56487143144614,FUN_008548-T1,Peve_00013780,Pocillopora_meandrina_HIv1___RNAseq.g6326.t1,three_way,74.56866666666666,FUN_008548-T1,Q6INP8,,,,,33.3,474.0,7.7e-62,240.4,sp|Q6INP8|MED1_XENLA Mediator of RNA polymerase II transcription subunit 1 OS=Xenopus laevis OX=8355 GN=med1 PE=2 SV=1,,,,,,
OG_02196,1.864294589177256,FUN_008558-T1,Peve_00044735,Pocillopora_meandrina_HIv1___RNAseq.g69.t1,three_way,76.34233333333333,FUN_008558-T1,F1MUG2,,,,,47.2,212.0,1.6e-43,177.9,sp|F1MUG2|CEP41_BOVIN Centrosomal protein of 41 kDa OS=Bos taurus OX=9913 GN=CEP41 PE=3 SV=2,,,,,,
OG_02200,3.267383174557656,FUN_008569-T1,Peve_00044727,Pocillopora_meandrina_HIv1___RNAseq.g12789.t1,three_way,62.34433333333333,,,,,,,,,,,,,,,,,
OG_02202,1.4541639434441276,FUN_008577-T1,Peve_00028423,Pocillopora_meandrina_HIv1___RNAseq.g12779.t1,three_way,77.05433333333333,FUN_008577-T1,Q80Y56,,,,,37.4,505.0,3.3e-76,287.3,sp|Q80Y56|RBNS5_MOUSE Rabenosyn-5 OS=Mus musculus OX=10090 GN=Rbsn PE=1 SV=1,,,,,,
OG_02203,1.84307313117388,FUN_008578-T1,Peve_00028420,Pocillopora_meandrina_HIv1___RNAseq.g12780.t1,three_way,73.47233333333334,FUN_008578-T1,Q9VY28,,,,,42.7,157.0,1.5000000000000002e-28,127.5,sp|Q9VY28|RT25_DROME Small ribosomal subunit protein mS25 OS=Drosophila melanogaster OX=7227 GN=mRpS25 PE=1 SV=1,,,,,,
OG_02204,1.0986511369974787,FUN_008579-T1,Peve_00028419,Pocillopora_meandrina_HIv1___RNAseq.g12781.t1,three_way,51.49733333333333,,,,,,,,,,,,,,,,,
OG_02206,1.4195143559994108,FUN_008581-T1,Peve_00028410,Pocillopora_meandrina_HIv1___RNAseq.g12783.t1,three_way,70.744,FUN_008581-T1,O42260,,,,,41.7,259.0,1.3e-50,201.4,sp|O42260|GEMI2_XENLA Gem-associated protein 2 OS=Xenopus laevis OX=8355 GN=gemin2 PE=2 SV=1,,,,,,
OG_02207,2.9424749960916423,FUN_008583-T1,Peve_00028408,Pocillopora_meandrina_HIv1___RNAseq.g12778.t1,three_way,81.406,FUN_008583-T1,Q5RB35,MKLN1_PONAB,,Muskelin,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),61.2,738.0,2.1e-273,943.0,sp|Q5RB35|MKLN1_PONAB Muskelin OS=Pongo abelii OX=9601 GN=MKLN1 PE=2 SV=1,GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030036; GO:0042803; GO:0098895; GO:0098968; GO:0098982; GO:0099003; GO:0099164,actin cytoskeleton organization [GO:0030036]; cell-matrix adhesion [GO:0007160]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport in synapse [GO:0099003],cell cortex [GO:0005938]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; nucleoplasm [GO:0005654]; postsynaptic endosome membrane [GO:0098895]; postsynaptic specialization membrane of symmetric synapse [GO:0099164]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151],protein homodimerization activity [GO:0042803],GO:0005654; GO:0005829; GO:0007010; GO:0007155; GO:0016192,nucleoplasm; cytosol; cytoskeleton organization; cell adhesion; vesicle-mediated transport
OG_02209,1.375404742955105,FUN_008585-T1,Peve_00026589,Pocillopora_meandrina_HIv1___TS.g118.t1,three_way,43.182,FUN_008585-T1,Q5VU97,CAHD1_HUMAN,,VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1),Homo sapiens (Human),25.5,1077.0,8.3e-84,313.9,sp|Q5VU97|CAHD1_HUMAN VWFA and cache domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CACHD1 PE=1 SV=2,GO:0005245; GO:0005891,,voltage-gated calcium channel complex [GO:0005891],voltage-gated calcium channel activity [GO:0005245],GO:0005215,transporter activity
OG_02211,1.399214828712409,FUN_008587-T1,Peve_00028398,Pocillopora_meandrina_HIv1___RNAseq.g12773.t1,three_way,39.733,,,,,,,,,,,,,,,,,
OG_02214,1.4272138173445064,FUN_008599-T1,Peve_00002260,Pocillopora_meandrina_HIv1___RNAseq.g12757.t1,three_way,66.727,FUN_008599-T1,Q9BV10,,,,,46.6,451.0,8.3e-102,373.2,"sp|Q9BV10|ALG12_HUMAN Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase OS=Homo sapiens OX=9606 GN=ALG12 PE=1 SV=1",,,,,,
OG_02215,1.3099081786526598,FUN_008604-T2,Peve_00020824,Pocillopora_meandrina_HIv1___RNAseq.g12756.t2,three_way,78.7245,FUN_008604-T2,O75131,CPNE3_HUMAN,,Copine-3 (Copine III),Homo sapiens (Human),56.5,531.0,1.1e-170,601.3,sp|O75131|CPNE3_HUMAN Copine-3 OS=Homo sapiens OX=9606 GN=CPNE3 PE=1 SV=1,GO:0003723; GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0035577; GO:0038128; GO:0046872; GO:0048306; GO:0070062; GO:0071277; GO:0071363,cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335],azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0008289; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; plasma membrane; lipid binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02216,2.937058827125377,FUN_008605-T1,Peve_00020826,Pocillopora_meandrina_HIv1___RNAseq.g12755.t1,three_way,59.71116666666666,FUN_008605-T1,Q4V8X0,,,,,39.7,267.0,3e-41,170.6,sp|Q4V8X0|TPRA1_DANRE Transmembrane protein adipocyte-associated 1 homolog OS=Danio rerio OX=7955 GN=tpra1 PE=2 SV=1,,,,,,
OG_02219,1.6747422320331158,FUN_008614-T1,Peve_00040315,Pocillopora_meandrina_HIv1___RNAseq.g6261.t1,three_way,64.44066666666667,FUN_008614-T1,O18499,,,,,34.0,374.0,6.1e-56,220.7,sp|O18499|ACT1_SACKO Actin-1 OS=Saccoglossus kowalevskii OX=10224 PE=2 SV=1,,,,,,
OG_02220,3.75179449876074,FUN_008615-T1,Peve_00015389,Pocillopora_meandrina_HIv1___RNAseq.g12744.t1,three_way,73.05916666666667,FUN_008615-T1,O35161,CELR1_MOUSE,,Cadherin EGF LAG seven-pass G-type receptor 1,Mus musculus (Mouse),33.5,2618.0,0.0,1375.5,sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3,GO:0001736; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007166; GO:0007266; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475,anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell surface receptor signaling pathway [GO:0007166]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060],membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005886; GO:0007155; GO:0042060; GO:0048856; GO:0048870; GO:0060089,nucleoplasm; plasma membrane; cell adhesion; wound healing; anatomical structure development; cell motility; molecular transducer activity
OG_02222,2.3291760927812266,FUN_008617-T1,Peve_00015391,Pocillopora_meandrina_HIv1___TS.g89.t1,three_way,78.33666666666666,FUN_008617-T1,Q5XTS1,PLPL8_RABIT,,Calcium-independent phospholipase A2-gamma (EC 3.1.1.-) (EC 3.1.1.5) (Group VIB calcium-independent phospholipase A2) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (Patatin-like phospholipase domain-containing protein 8),Oryctolagus cuniculus (Rabbit),47.3,427.0,2.200000000000001e-111,404.1,sp|Q5XTS1|PLPL8_RABIT Calcium-independent phospholipase A2-gamma OS=Oryctolagus cuniculus OX=9986 GN=PNPLA8 PE=1 SV=1,GO:0004622; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0008970; GO:0016020; GO:0016042; GO:0019369; GO:0031966; GO:0032048; GO:0047499; GO:0055088; GO:0070328,arachidonate metabolic process [GO:0019369]; cardiolipin metabolic process [GO:0032048]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; triglyceride homeostasis [GO:0070328],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phospholipase A1 activity [GO:0008970],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016787; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; hydrolase activity; organelle
OG_02228,3.6126230904163914,FUN_008634-T1,Peve_00021941,Pocillopora_meandrina_HIv1___RNAseq.g14919.t2,three_way,51.94316666666667,FUN_008634-T1,P42166,LAP2A_HUMAN,,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]",Homo sapiens (Human),35.0,197.0,9.1e-16,85.9,"sp|P42166|LAP2A_HUMAN Lamina-associated polypeptide 2, isoform alpha OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2",GO:0000785; GO:0003677; GO:0005521; GO:0005634; GO:0005635; GO:0045296,,chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nucleus [GO:0005634],cadherin binding [GO:0045296]; DNA binding [GO:0003677]; lamin binding [GO:0005521],GO:0003677; GO:0005634; GO:0005635; GO:0043226,DNA binding; nucleus; nuclear envelope; organelle
OG_02229,2.612979340837469,FUN_008635-T1,Peve_00024235,Pocillopora_meandrina_HIv1___RNAseq.g14918.t1,three_way,76.26733333333334,FUN_008635-T1,Q6NWJ4,DNJC2_DANRE,,DnaJ homolog subfamily C member 2,Danio rerio (Zebrafish) (Brachydanio rerio),55.8,618.0,1.4000000000000002e-124,448.4,sp|Q6NWJ4|DNJC2_DANRE DnaJ homolog subfamily C member 2 OS=Danio rerio OX=7955 GN=dnajc2 PE=2 SV=1,GO:0003682; GO:0005634; GO:0005829; GO:0006450; GO:0030544; GO:0042393; GO:0043022; GO:0045893; GO:0051083; GO:0061649,'de novo' cotranslational protein folding [GO:0051083]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of translational fidelity [GO:0006450],cytosol [GO:0005829]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; ubiquitin-modified histone reader activity [GO:0061649],GO:0005634; GO:0005829; GO:0006355; GO:0006457; GO:0042393; GO:0043226; GO:0060090,nucleus; cytosol; regulation of DNA-templated transcription; protein folding; histone binding; organelle; molecular adaptor activity
OG_02231,2.553479520272105,FUN_008641-T1,Peve_00021174,Pocillopora_meandrina_HIv1___RNAseq.30196_t,three_way,85.19133333333333,FUN_008641-T1,A6QP15,,,,,63.5,469.0,9.1e-177,621.3,"sp|A6QP15|HOT_BOVIN Hydroxyacid-oxoacid transhydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ADHFE1 PE=2 SV=1",,,,,,
OG_02233,1.882940551150855,FUN_008644-T1,Peve_00031674,Pocillopora_meandrina_HIv1___RNAseq.g10.t1,three_way,70.55633333333333,FUN_008644-T1,Q5E965,C56D2_BOVIN,,Transmembrane reductase CYB561D2 (EC 7.2.1.3) (Cytochrome b561 domain-containing protein 2),Bos taurus (Bovine),39.0,205.0,8.500000000000001e-33,142.1,sp|Q5E965|C56D2_BOVIN Transmembrane reductase CYB561D2 OS=Bos taurus OX=9913 GN=CYB561D2 PE=2 SV=1,GO:0005783; GO:0005789; GO:0020037; GO:0030659; GO:0031982; GO:0046872; GO:0140571; GO:0140575; GO:0140576,ascorbate homeostasis [GO:0140576],cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; vesicle [GO:0031982],heme binding [GO:0020037]; metal ion binding [GO:0046872]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575],GO:0003824; GO:0005215; GO:0005783; GO:0016491; GO:0043226,catalytic activity; transporter activity; endoplasmic reticulum; oxidoreductase activity; organelle
OG_02238,1.9675170719436927,FUN_008650-T1,Peve_00032564,Pocillopora_meandrina_HIv1___RNAseq.g16.t1,three_way,59.9695,FUN_008650-T1,Q99LJ2,,,,,46.0,502.0,4.8999999999999996e-120,433.0,sp|Q99LJ2|ABTB1_MOUSE Ankyrin repeat and BTB/POZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Abtb1 PE=2 SV=1,,,,,,
OG_02242,2.0675828781144245,FUN_008659-T1,Peve_00016766,Pocillopora_meandrina_HIv1___RNAseq.g14869.t1,three_way,64.205,FUN_008659-T1,Q8NA03,,,,,27.0,359.0,3e-08,61.6,sp|Q8NA03|FSIP1_HUMAN Fibrous sheath-interacting protein 1 OS=Homo sapiens OX=9606 GN=FSIP1 PE=1 SV=1,,,,,,
OG_02244,1.7404835696341778,FUN_008661-T1,Peve_00002969,Pocillopora_meandrina_HIv1___RNAseq.g14876.t1,three_way,82.85233333333333,FUN_008661-T1,P51650,SSDH_RAT,,"Succinate-semialdehyde dehydrogenase, mitochondrial (SSADH) (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)",Rattus norvegicus (Rat),62.6,478.0,4.1e-180,632.5,"sp|P51650|SSDH_RAT Succinate-semialdehyde dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Aldh5a1 PE=1 SV=2",GO:0004777; GO:0005739; GO:0006105; GO:0006536; GO:0007417; GO:0009448; GO:0009450; GO:0009791; GO:0031406; GO:0042802; GO:0045202; GO:0051287; GO:0051932,"central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glutamate metabolic process [GO:0006536]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]; synaptic transmission, GABAergic [GO:0051932]",mitochondrion [GO:0005739]; synapse [GO:0045202],carboxylic acid binding [GO:0031406]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777],GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0023052; GO:0043226; GO:0048856,catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; signaling; organelle; anatomical structure development
OG_02245,1.1085033773301558,FUN_008662-T1,Peve_00044718,Pocillopora_meandrina_HIv1___RNAseq.g14877.t1,three_way,86.88,FUN_008662-T1,Q8CDU4,,,,,32.1,669.0,8.7e-92,339.7,sp|Q8CDU4|FXL13_MOUSE F-box and leucine-rich repeat protein 13 OS=Mus musculus OX=10090 GN=Fbxl13 PE=1 SV=2,,,,,,
OG_02246,2.242091587912059,FUN_008663-T1,Peve_00044714,Pocillopora_meandrina_HIv1___RNAseq.g14878.t1,three_way,73.19,FUN_008663-T1,P13439,UMPS_MOUSE,,Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMPdecase)],Mus musculus (Mouse),52.2,467.0,2.1e-133,477.2,sp|P13439|UMPS_MOUSE Uridine 5'-monophosphate synthase OS=Mus musculus OX=10090 GN=Umps PE=1 SV=3,GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0006207; GO:0006225; GO:0044205,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; nucleus [GO:0005634],orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590],GO:0003824; GO:0005634; GO:0016740; GO:0016829; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; transferase activity; lyase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02247,1.3732627063588336,FUN_008664-T1,Peve_00044713,Pocillopora_meandrina_HIv1___RNAseq.g14879.t1,three_way,78.34966666666666,FUN_008664-T1,A1YFA7,PQBP1_GORGO,,Polyglutamine-binding protein 1 (PQBP-1) (Polyglutamine tract-binding protein 1),Gorilla gorilla gorilla (Western lowland gorilla),33.6,295.0,1.1000000000000001e-27,125.2,sp|A1YFA7|PQBP1_GORGO Polyglutamine-binding protein 1 OS=Gorilla gorilla gorilla OX=9595 GN=PQBP1 PE=3 SV=1,GO:0000380; GO:0002218; GO:0002230; GO:0003690; GO:0005737; GO:0005829; GO:0010494; GO:0016604; GO:0016607; GO:0031175; GO:0032481; GO:0036064; GO:0043021; GO:0043484; GO:0045087; GO:0048814; GO:0051607; GO:0071360; GO:0071598,"activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]",ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607],double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021],GO:0002376; GO:0003677; GO:0005815; GO:0005829; GO:0016071; GO:0043226; GO:0098542,immune system process; DNA binding; microtubule organizing center; cytosol; mRNA metabolic process; organelle; defense response to other organism
OG_02248,2.356416315605411,FUN_008665-T1,Peve_00044711,Pocillopora_meandrina_HIv1___RNAseq.g64.t1,three_way,73.61466666666666,FUN_008665-T1,Q6RHR9,,,,,33.7,1372.0,3.9e-185,650.6,"sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1",,,,,,
OG_02253,1.5749743710324713,FUN_008699-T1,Peve_00035972,Pocillopora_meandrina_HIv1___RNAseq.g6277.t1,three_way,57.66416666666667,FUN_008699-T1,Q9ESV0,,,,,40.4,639.0,1.6e-122,441.8,sp|Q9ESV0|DDX24_MOUSE ATP-dependent RNA helicase DDX24 OS=Mus musculus OX=10090 GN=Ddx24 PE=1 SV=2,,,,,,
OG_02254,1.3361780727365655,FUN_008700-T1,Peve_00025639,Pocillopora_meandrina_HIv1___RNAseq.g12731.t1,three_way,66.20166666666667,,,,,,,,,,,,,,,,,
OG_02255,2.233188132076317,FUN_008701-T1,Peve_00034980,Pocillopora_meandrina_HIv1___RNAseq.g25726.t1,three_way,81.37066666666666,FUN_008701-T1,Q925U4,,,,,59.6,530.0,3.8e-185,649.4,sp|Q925U4|EDEM1_MOUSE ER degradation-enhancing alpha-mannosidase-like protein 1 OS=Mus musculus OX=10090 GN=Edem1 PE=1 SV=1,,,,,,
OG_02256,1.7115904726422095,FUN_008702-T1,Peve_00034981,Pocillopora_meandrina_HIv1___RNAseq.g25725.t1,three_way,77.15733333333334,FUN_008702-T1,Q99685,MGLL_HUMAN,,Monoglyceride lipase (MGL) (EC 3.1.1.23) (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase) (MAGL),Homo sapiens (Human),45.5,279.0,6.900000000000003e-66,252.3,sp|Q99685|MGLL_HUMAN Monoglyceride lipase OS=Homo sapiens OX=9606 GN=MGLL PE=1 SV=2,GO:0004622; GO:0005789; GO:0005829; GO:0005886; GO:0006629; GO:0006633; GO:0006954; GO:0009966; GO:0016020; GO:0019369; GO:0019433; GO:0042803; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:2000124,acylglycerol catabolic process [GO:0046464]; arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],lysophospholipase activity [GO:0004622]; monoacylglycerol lipase activity [GO:0047372]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0006954; GO:0016787,catalytic activity; cytosol; plasma membrane; lipid metabolic process; inflammatory response; hydrolase activity
OG_02257,2.162313158684903,FUN_008703-T1,Peve_00034982,Pocillopora_meandrina_HIv1___RNAseq.g25724.t1,three_way,65.04466666666667,FUN_008703-T1,Q4R684,,,,,36.8,288.0,1.1e-45,185.3,sp|Q4R684|AMZ2_MACFA Archaemetzincin-2 OS=Macaca fascicularis OX=9541 GN=AMZ2 PE=2 SV=2,,,,,,
OG_02260,2.642430971568446,FUN_008707-T1,Peve_00034989,Pocillopora_meandrina_HIv1___TS.g9102.t1,three_way,77.2585,FUN_008707-T1,Q99246,,,,,52.7,1458.0,0.0,1323.9,sp|Q99246|CAC1D_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1D OS=Mus musculus OX=10090 GN=Cacna1d PE=1 SV=3,,,,,,
OG_02261,1.424593602189928,FUN_008709-T1,Peve_00033504,Pocillopora_meandrina_HIv1___RNAseq.g25665.t2,three_way,54.63916666666667,FUN_008709-T1,Q3U564,,,,,46.0,113.0,6.6e-18,93.2,sp|Q3U564|DCP1B_MOUSE mRNA-decapping enzyme 1B OS=Mus musculus OX=10090 GN=Dcp1b PE=1 SV=1,,,,,,
OG_02262,1.1016144193258692,FUN_008710-T1,Peve_00025636,Pocillopora_meandrina_HIv1___RNAseq.g25661.t1,three_way,60.197,FUN_008710-T1,O43463,SUV91_HUMAN,,Histone-lysine N-methyltransferase SUV39H1 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 1) (H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1) (Su(var)3-9 homolog 1),Homo sapiens (Human),50.0,310.0,1.7000000000000002e-74,281.6,sp|O43463|SUV91_HUMAN Histone-lysine N-methyltransferase SUV39H1 OS=Homo sapiens OX=9606 GN=SUV39H1 PE=1 SV=1,GO:0000122; GO:0000183; GO:0000775; GO:0000792; GO:0000794; GO:0000976; GO:0000977; GO:0001835; GO:0003682; GO:0005634; GO:0005652; GO:0005654; GO:0005677; GO:0005730; GO:0005886; GO:0006282; GO:0006325; GO:0006364; GO:0006974; GO:0007623; GO:0008270; GO:0008340; GO:0008757; GO:0030154; GO:0030500; GO:0031410; GO:0032259; GO:0033553; GO:0040014; GO:0042054; GO:0042149; GO:0044725; GO:0045786; GO:0045892; GO:0046015; GO:0046974; GO:0061773; GO:0071456; GO:0097009; GO:0140938; GO:0140947; GO:0140949; GO:2000772,blastocyst hatching [GO:0001835]; cell differentiation [GO:0030154]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; circadian rhythm [GO:0007623]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; energy homeostasis [GO:0097009]; epigenetic programming in the zygotic pronuclei [GO:0044725]; methylation [GO:0032259]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; rDNA heterochromatin formation [GO:0000183]; regulation of bone mineralization [GO:0030500]; regulation of cellular senescence [GO:2000772]; regulation of DNA repair [GO:0006282]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364],"chromatin silencing complex [GO:0005677]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; cytoplasmic vesicle [GO:0031410]; eNoSc complex [GO:0061773]; heterochromatin [GO:0000792]; nuclear lamina [GO:0005652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]",chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H3K9me2 methyltransferase activity [GO:0140947]; histone methyltransferase activity [GO:0042054]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270],GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005886; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0140096,"nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; plasma membrane; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_02263,1.186083948451656,FUN_008711-T1,Peve_00025640,Pocillopora_meandrina_HIv1___RNAseq.g25660.t1,three_way,79.735,FUN_008711-T1,Q2KI14,NAA10_BOVIN,,N-alpha-acetyltransferase 10 (EC 2.3.1.255) (N-terminal acetyltransferase complex ARD1 subunit homolog A) (NatA catalytic subunit Naa10),Bos taurus (Bovine),88.2,152.0,1.5e-74,280.8,sp|Q2KI14|NAA10_BOVIN N-alpha-acetyltransferase 10 OS=Bos taurus OX=9913 GN=NAA10 PE=2 SV=1,GO:0004596; GO:0005634; GO:0005737; GO:0006474; GO:0008999; GO:0031415; GO:1990189; GO:1990190; GO:2000719,"N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000719]",cytoplasm [GO:0005737]; NatA complex [GO:0031415]; nucleus [GO:0005634],protein N-terminal-serine acetyltransferase activity [GO:1990189]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596]; protein-N-terminal-alanine acetyltransferase activity [GO:0008999]; protein-N-terminal-glutamate acetyltransferase activity [GO:1990190],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_02268,1.132877775104448,FUN_008718-T1,Peve_00035347,Pocillopora_meandrina_HIv1___RNAseq.g76.t1,three_way,81.45666666666666,FUN_008718-T1,Q80ZJ7,,,,,25.9,382.0,7.5e-25,116.3,sp|Q80ZJ7|SNX32_MOUSE Sorting nexin-32 OS=Mus musculus OX=10090 GN=Snx32 PE=2 SV=1,,,,,,
OG_02270,2.177504925263744,FUN_008729-T1,Peve_00013706,Pocillopora_meandrina_HIv1___TS.g68.t1,three_way,80.84783333333333,FUN_008729-T1,Q80TR8,DCAF1_MOUSE,,DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1),Mus musculus (Mouse),47.6,1400.0,0.0,1181.8,sp|Q80TR8|DCAF1_MOUSE DDB1- and CUL4-associated factor 1 OS=Mus musculus OX=10090 GN=Dcaf1 PE=1 SV=4,GO:0000122; GO:0001650; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0008180; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043161; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756,B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151],centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; histone H2AT120 kinase activity [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0003824; GO:0005654; GO:0005815; GO:0006310; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0060090; GO:0140096,"immune system process; catalytic activity; nucleoplasm; microtubule organizing center; DNA recombination; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_02272,1.393848206566361,FUN_008748-T1,Peve_00015782,Pocillopora_meandrina_HIv1___RNAseq.g12748.t1,three_way,61.57383333333333,,,,,,,,,,,,,,,,,
OG_02274,1.062370140423756,FUN_008752-T1,Peve_00015784,Pocillopora_meandrina_HIv1___RNAseq.g12714.t1,three_way,88.82533333333333,FUN_008752-T1,Q6DBU5,GMPPB_DANRE,,Mannose-1-phosphate guanylyltransferase catalytic subunit beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta),Danio rerio (Zebrafish) (Brachydanio rerio),74.5,361.0,1.7e-143,510.4,sp|Q6DBU5|GMPPB_DANRE Mannose-1-phosphate guanylyltransferase catalytic subunit beta OS=Danio rerio OX=7955 GN=gmppb PE=1 SV=1,GO:0004475; GO:0005525; GO:0005737; GO:0006486; GO:0007519; GO:0009298; GO:0046872; GO:0048666; GO:0055001,GDP-mannose biosynthetic process [GO:0009298]; muscle cell development [GO:0055001]; neuron development [GO:0048666]; protein glycosylation [GO:0006486]; skeletal muscle tissue development [GO:0007519],cytoplasm [GO:0005737],GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase (GTP) activity [GO:0004475]; metal ion binding [GO:0046872],GO:0003824; GO:0006486; GO:0016740; GO:0048856; GO:0055086; GO:1901135,catalytic activity; protein glycosylation; transferase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02278,2.567660369395972,FUN_008769-T1,Peve_00036718,Pocillopora_meandrina_HIv1___RNAseq.g12704.t1,three_way,66.35966666666667,FUN_008769-T1,Q9JHZ4,GRAP1_RAT,,GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)],Rattus norvegicus (Rat),33.5,179.0,7.9e-18,94.4,sp|Q9JHZ4|GRAP1_RAT GRIP1-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Gripap1 PE=1 SV=1,GO:0005085; GO:0005654; GO:0005829; GO:0015031; GO:0030424; GO:0030425; GO:0035255; GO:0042734; GO:0042802; GO:0043025; GO:0055038; GO:0098685; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1903828; GO:1903910,"negative regulation of protein localization [GO:1903828]; negative regulation of receptor clustering [GO:1903910]; protein transport [GO:0015031]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]",axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685],guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255],GO:0005654; GO:0005829; GO:0098772,nucleoplasm; cytosol; molecular function regulator activity
OG_02280,1.004491726159145,FUN_008772-T1,Peve_00036716,Pocillopora_meandrina_HIv1___RNAseq.g12702.t1,three_way,55.00416666666666,FUN_008772-T1,P30974,,,,,26.0,412.0,1.6e-18,95.9,sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2,,,,,,
OG_02281,1.1794141023207092,FUN_008776-T1,Peve_00036712,Pocillopora_meandrina_HIv1___RNAseq.g12696.t1,three_way,60.681666666666665,FUN_008776-T1,P52703,,,,,21.1,380.0,1.2e-10,69.3,sp|P52703|DRD3_CHLAE D(3) dopamine receptor OS=Chlorocebus aethiops OX=9534 GN=DRD3 PE=2 SV=1,,,,,,
OG_02287,1.2458970410894092,FUN_008794-T1,Peve_00042601,Pocillopora_meandrina_HIv1___RNAseq.g12688.t1,three_way,83.54666666666667,FUN_008794-T1,Q9EQX9,UBE2N_RAT,,Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (Bendless-like ubiquitin-conjugating enzyme) (E2 ubiquitin-conjugating enzyme N) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N),Rattus norvegicus (Rat),85.7,147.0,3.8999999999999995e-68,258.8,sp|Q9EQX9|UBE2N_RAT Ubiquitin-conjugating enzyme E2 N OS=Rattus norvegicus OX=10116 GN=Ube2n PE=1 SV=1,GO:0000151; GO:0000209; GO:0000724; GO:0000729; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006301; GO:0006511; GO:0006513; GO:0016567; GO:0031371; GO:0031372; GO:0031625; GO:0032991; GO:0043123; GO:0043130; GO:0043161; GO:0045739; GO:0050852; GO:0061631; GO:0070534; GO:0097027; GO:0098794; GO:0098978; GO:0140252; GO:0140374; GO:1902523; GO:1902533; GO:1904262; GO:2000781,antiviral innate immune response [GO:0140374]; DNA double-strand break processing [GO:0000729]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0006310; GO:0016740; GO:0030163; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; DNA repair; DNA recombination; transferase activity; protein catabolic process; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02288,2.8759378229368613,FUN_008795-T1,Peve_00042598,Pocillopora_meandrina_HIv1___RNAseq.g12685.t1a,three_way,70.187,FUN_008795-T1,Q8IYQ7,,,,,47.4,685.0,3.8e-168,593.2,sp|Q8IYQ7|THNS1_HUMAN Threonine synthase-like 1 OS=Homo sapiens OX=9606 GN=THNSL1 PE=1 SV=2,,,,,,
OG_02290,1.3646408081681751,FUN_008802-T1,Peve_00034042,Pocillopora_meandrina_HIv1___RNAseq.g25.t1,three_way,61.15833333333333,FUN_008802-T1,Q58588,,,,,20.7,367.0,1.6e-13,79.0,sp|Q58588|Y1187_METJA Uncharacterized protein MJ1187 OS=Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) OX=243232 GN=MJ1187 PE=1 SV=1,,,,,,
OG_02293,2.6320953393502915,FUN_008871-T1,Peve_00000781,Pocillopora_meandrina_HIv1___RNAseq.g4009.t1,three_way,72.09516666666667,FUN_008871-T1,Q5RID7,,,,,45.6,401.0,2.6000000000000002e-110,400.6,sp|Q5RID7|SNX17_DANRE Sorting nexin-17 OS=Danio rerio OX=7955 GN=snx17 PE=2 SV=1,,,,,,
OG_02296,3.8040535586031705,FUN_008874-T1,Peve_00000786,Pocillopora_meandrina_HIv1___RNAseq.g4012.t1,three_way,67.04350000000001,,,,,,,,,,,,,,,,,
OG_02298,2.107183745976269,FUN_008877-T1,Peve_00043352,Pocillopora_meandrina_HIv1___TS.g30031.t1,three_way,72.87216666666667,FUN_008877-T1,Q8IZQ1,WDFY3_HUMAN,,WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy),Homo sapiens (Human),36.1,2785.0,0.0,1567.7,sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2,GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204,aggrephagy [GO:0035973],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605],1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270],GO:0005635; GO:0005654; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006914; GO:0008289; GO:0043226,nuclear envelope; nucleoplasm; nucleolus; vacuole; cytosol; plasma membrane; autophagy; lipid binding; organelle
OG_02300,3.751878630530851,FUN_008879-T1,Peve_00043354,Pocillopora_meandrina_HIv1___RNAseq.g14471.t1,three_way,77.52583333333332,FUN_008879-T1,O93310,,,,,39.9,642.0,2.8e-79,297.7,sp|O93310|RAD21_XENLA Double-strand-break repair protein rad21 homolog OS=Xenopus laevis OX=8355 GN=rad21 PE=1 SV=1,,,,,,
OG_02302,1.4054793327667312,FUN_008881-T1,Peve_00032861,Pocillopora_meandrina_HIv1___RNAseq.g14469.t1,three_way,94.62233333333332,FUN_008881-T1,Q96DI7,SNR40_HUMAN,,U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57),Homo sapiens (Human),68.7,345.0,7.6e-96,352.1,sp|Q96DI7|SNR40_HUMAN U5 small nuclear ribonucleoprotein 40 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP40 PE=1 SV=1,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0005732; GO:0005829; GO:0006396; GO:0008380; GO:0016607; GO:0046540; GO:0071007; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; cytosol; mRNA metabolic process; organelle
OG_02303,1.3573324032450855,FUN_008882-T1,Peve_00032041,Pocillopora_meandrina_HIv1___RNAseq.g14468.t1,three_way,62.712,FUN_008882-T1,Q32KN7,,,,,41.7,192.0,3.3e-26,120.9,sp|Q32KN7|ZC21B_BOVIN Zinc finger C2HC domain-containing protein 1B OS=Bos taurus OX=9913 GN=ZC2HC1B PE=2 SV=1,,,,,,
OG_02305,2.768545185990058,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,42.3,137.0,2.1e-31,140.2,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_02305,2.768545185990058,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,46.9,128.0,2.5e-29,133.3,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_02315,1.5268693327467318,FUN_008906-T1,Peve_00027550,Pocillopora_meandrina_HIv1___RNAseq.g3970.t1,three_way,79.61966666666666,FUN_008906-T1,Q96MD2,KICS2_HUMAN,,KICSTOR subunit 2 (KICSTOR complex protein C12orf66),Homo sapiens (Human),45.2,418.0,2.3e-100,367.5,sp|Q96MD2|KICS2_HUMAN KICSTOR subunit 2 OS=Homo sapiens OX=9606 GN=KICS2 PE=1 SV=5,GO:0005764; GO:0005765; GO:0034198; GO:0042149; GO:0045171; GO:0061462; GO:0140007; GO:1904262,cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462],intercellular bridge [GO:0045171]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],,GO:0005764; GO:0005773; GO:0043226,lysosome; vacuole; organelle
OG_02316,1.3106895992829195,FUN_008907-T1,Peve_00027548,Pocillopora_meandrina_HIv1___RNAseq.g3972.t1,three_way,56.05233333333333,FUN_008907-T1,Q8CH34,ZP4_RAT,,Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4) (Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4],Rattus norvegicus (Rat),27.7,332.0,4.3e-14,80.5,sp|Q8CH34|ZP4_RAT Zona pellucida sperm-binding protein 4 OS=Rattus norvegicus OX=10116 GN=Zp4 PE=2 SV=1,GO:0002922; GO:0005576; GO:0005886; GO:0007339; GO:0032190; GO:0035804; GO:0035805; GO:0042102; GO:0042802; GO:0060468; GO:0060478; GO:0062023; GO:2000344; GO:2000360,acrosomal vesicle exocytosis [GO:0060478]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of humoral immune response [GO:0002922]; positive regulation of T cell proliferation [GO:0042102]; prevention of polyspermy [GO:0060468],collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],acrosin binding [GO:0032190]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804],GO:0005198; GO:0005576; GO:0005886; GO:0016192; GO:0030312; GO:0031012,structural molecule activity; extracellular region; plasma membrane; vesicle-mediated transport; external encapsulating structure; extracellular matrix
OG_02317,4.069689264812805,FUN_008908-T1,Peve_00017912,Pocillopora_meandrina_HIv1___TS.g30016.t1,three_way,61.309333333333335,FUN_008908-T1,G8HTB6,,,,,95.7,349.0,1.3e-187,657.1,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02318,1.7316463692687212,FUN_008909-T1,Peve_00017911,Pocillopora_meandrina_HIv1___RNAseq.g3974.t1,three_way,62.283166666666666,FUN_008909-T1,Q9EQZ7,,,,,32.2,1005.0,1.6e-93,346.7,sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1,,,,,,
OG_02319,1.9717811502908624,FUN_008911-T1,Peve_00019472,Pocillopora_meandrina_HIv1___RNAseq.g3976.t1,three_way,68.34216666666667,FUN_008911-T1,O60266,ADCY3_HUMAN,,"Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3)",Homo sapiens (Human),39.5,1100.0,4.3e-204,713.4,sp|O60266|ADCY3_HUMAN Adenylate cyclase type 3 OS=Homo sapiens OX=9606 GN=ADCY3 PE=1 SV=3,GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:1904322,acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338],ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886],adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0005886; GO:0005929; GO:0007018; GO:0009975; GO:0016829; GO:0022414; GO:0043226; GO:0048870; GO:0050877; GO:0055086; GO:1901135,catalytic activity; Golgi apparatus; plasma membrane; cilium; microtubule-based movement; cyclase activity; lyase activity; reproductive process; organelle; cell motility; nervous system process; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02321,1.547989912928713,FUN_008913-T1,Peve_00033015,Pocillopora_meandrina_HIv1___RNAseq.g3978.t1,three_way,86.956,FUN_008913-T1,Q56K14,RLA1_BOVIN,,Large ribosomal subunit protein P1 (60S acidic ribosomal protein P1),Bos taurus (Bovine),67.7,65.0,1.8e-17,90.1,sp|Q56K14|RLA1_BOVIN Large ribosomal subunit protein P1 OS=Bos taurus OX=9913 GN=RPLP1 PE=3 SV=1,GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0030295; GO:0043021,cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414],cytosolic large ribosomal subunit [GO:0022625],protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0098772,cytoplasmic translation; structural molecule activity; molecular function regulator activity
OG_02329,1.6379118936227426,FUN_008922-T1,Peve_00006942,Pocillopora_meandrina_HIv1___RNAseq.g4040.t1,three_way,58.734,,,,,,,,,,,,,,,,,
OG_02335,1.7648843848995164,FUN_008930-T1,Peve_00036392,Pocillopora_meandrina_HIv1___RNAseq.g14260.t1,three_way,86.96233333333333,FUN_008930-T1,Q9H5Z1,DHX35_HUMAN,,Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35),Homo sapiens (Human),65.6,677.0,2.9e-259,896.0,sp|Q9H5Z1|DHX35_HUMAN Probable ATP-dependent RNA helicase DHX35 OS=Homo sapiens OX=9606 GN=DHX35 PE=1 SV=2,GO:0000398; GO:0001701; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005654; GO:0016887; GO:0071013,"in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005654; GO:0016071; GO:0016787; GO:0016853; GO:0048856; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleoplasm; mRNA metabolic process; hydrolase activity; isomerase activity; anatomical structure development; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02337,1.6581145230261007,FUN_008933-T1,Peve_00036390,Pocillopora_meandrina_HIv1___RNAseq.g14258.t1,three_way,90.02433333333333,FUN_008933-T1,A6QQY2,,,,,39.1,92.0,1.2e-09,65.5,sp|A6QQY2|KLH13_BOVIN Kelch-like protein 13 OS=Bos taurus OX=9913 GN=KLHL13 PE=2 SV=1,,,,,,
OG_02339,1.8169890650073288,FUN_008935-T1,Peve_00036395,Pocillopora_meandrina_HIv1___TS.g5740.t1,three_way,79.28566666666667,FUN_008935-T1,A0JM56,,,,,51.8,1431.0,1.4000000000000001e-186,655.6,sp|A0JM56|LRRC9_XENTR Leucine-rich repeat-containing protein 9 OS=Xenopus tropicalis OX=8364 GN=lrrc9 PE=2 SV=2,,,,,,
OG_02340,2.5662048717940853,FUN_008938-T1,Peve_00007199,Pocillopora_meandrina_HIv1___RNAseq.g4080.t1,three_way,43.816833333333335,FUN_008938-T1,Q5F4A1,,,,,43.0,300.0,1.6000000000000001e-71,272.3,sp|Q5F4A1|G2E3_CHICK G2/M phase-specific E3 ubiquitin-protein ligase OS=Gallus gallus OX=9031 GN=G2E3 PE=2 SV=1,,,,,,
OG_02344,1.1411312354393943,FUN_008945-T3,Peve_00011190,Pocillopora_meandrina_HIv1___RNAseq.g4059.t1,three_way,61.92066666666667,FUN_008945-T3,Q3T1J2,MBOA2_RAT,,Membrane-bound glycerophospholipid O-acyltransferase 2 (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase) (LPAAT) (Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4) (Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophospholipid acyltransferase 2) (LPLAT 2) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2),Rattus norvegicus (Rat),40.0,407.0,2.3e-76,287.7,sp|Q3T1J2|MBOA2_RAT Membrane-bound glycerophospholipid O-acyltransferase 2 OS=Rattus norvegicus OX=10116 GN=Mboat2 PE=2 SV=2,GO:0003841; GO:0005789; GO:0008654; GO:0016020; GO:0016746; GO:0030258; GO:0032330; GO:0036150; GO:0036151; GO:0036152; GO:0047184; GO:0106262; GO:0106263,lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; acyltransferase activity [GO:0016746],GO:0003824; GO:0006575; GO:0006629; GO:0016740,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity
OG_02345,2.038648350028435,FUN_008946-T1,Peve_00011182,Pocillopora_meandrina_HIv1___TS.g30097.t1,three_way,63.37166666666667,FUN_008946-T1,Q6ZWT7,MBOA2_HUMAN,,Membrane-bound glycerophospholipid O-acyltransferase 2 (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase MBOAT2) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase MBOAT2) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine MBOAT2 O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase) (LPAAT) (Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4) (Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophospholipid acyltransferase 2) (LPLAT 2) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2),Homo sapiens (Human),39.6,475.0,4.3e-92,340.1,sp|Q6ZWT7|MBOA2_HUMAN Membrane-bound glycerophospholipid O-acyltransferase 2 OS=Homo sapiens OX=9606 GN=MBOAT2 PE=1 SV=2,GO:0003841; GO:0005789; GO:0008654; GO:0016020; GO:0016746; GO:0030258; GO:0032330; GO:0036150; GO:0036151; GO:0036152; GO:0047144; GO:0047184; GO:0106262; GO:0106263,lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746],GO:0003824; GO:0006575; GO:0006629; GO:0016740,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity
OG_02352,1.4796119245023622,FUN_008953-T2,Peve_00037684,Pocillopora_meandrina_HIv1___TS.g30089.t1,three_way,80.953,FUN_008953-T2,G5E8K5,ANK3_MOUSE,,Ankyrin-3 (ANK-3) (Ankyrin-G),Mus musculus (Mouse),36.2,624.0,2.2000000000000001e-100,369.4,sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1,GO:0005764; GO:0005886; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043194; GO:0043266; GO:0044325; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0090314; GO:0098794; GO:0099103; GO:0099612; GO:1900827; GO:1902260,axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018],cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; transmembrane transporter binding [GO:0044325],GO:0005764; GO:0005773; GO:0005783; GO:0005856; GO:0005886; GO:0008092; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659; GO:0098772,lysosome; vacuole; endoplasmic reticulum; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane; molecular function regulator activity
OG_02352,1.4796119245023622,FUN_008953-T2,Peve_00037684,Pocillopora_meandrina_HIv1___TS.g30089.t1,three_way,80.953,FUN_008953-T2,G5E8K5,ANK3_MOUSE,,Ankyrin-3 (ANK-3) (Ankyrin-G),Mus musculus (Mouse),57.1,42.0,3.5e-05,53.1,sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1,GO:0005764; GO:0005886; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043194; GO:0043266; GO:0044325; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0090314; GO:0098794; GO:0099103; GO:0099612; GO:1900827; GO:1902260,axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018],cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; transmembrane transporter binding [GO:0044325],GO:0005764; GO:0005773; GO:0005783; GO:0005856; GO:0005886; GO:0008092; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659; GO:0098772,lysosome; vacuole; endoplasmic reticulum; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane; molecular function regulator activity
OG_02353,3.7552187059537534,FUN_008955-T1,Peve_00037682,Pocillopora_meandrina_HIv1___RNAseq.g4048.t1,three_way,75.81333333333333,FUN_008955-T1,Q149N8,,,,,35.5,1772.0,5.0000000000000005e-278,959.5,sp|Q149N8|SHPRH_HUMAN E3 ubiquitin-protein ligase SHPRH OS=Homo sapiens OX=9606 GN=SHPRH PE=1 SV=2,,,,,,
OG_02357,1.46187789201668,FUN_008960-T1,Peve_00021628,Pocillopora_meandrina_HIv1___RNAseq.g4043.t1,three_way,50.3,,,,,,,,,,,,,,,,,
OG_02358,2.0579984173804453,FUN_008961-T1,Peve_00006948,Pocillopora_meandrina_HIv1___RNAseq.g4042.t1,three_way,60.446,,,,,,,,,,,,,,,,,
OG_02359,2.9968535886291363,FUN_008962-T1,Peve_00007353,Pocillopora_meandrina_HIv1___RNAseq.g3914.t1,three_way,53.4015,FUN_008962-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),31.7,489.0,3.1e-54,214.9,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02360,1.735389983228088,FUN_008964-T1,Peve_00007334,Pocillopora_meandrina_HIv1___RNAseq.13698_t,three_way,63.264,FUN_008964-T1,Q8BKN5,,,,,34.9,1036.0,4.9e-148,526.9,sp|Q8BKN5|GCP5_MOUSE Gamma-tubulin complex component 5 OS=Mus musculus OX=10090 GN=Tubgcp5 PE=2 SV=2,,,,,,
OG_02362,2.366657191108548,FUN_008967-T1,Peve_00007330,Pocillopora_meandrina_HIv1___RNAseq.g14273.t1,three_way,70.74066666666667,FUN_008967-T1,Q9UBI4,,,,,35.1,350.0,6.9e-45,183.0,sp|Q9UBI4|STML1_HUMAN Stomatin-like protein 1 OS=Homo sapiens OX=9606 GN=STOML1 PE=1 SV=1,,,,,,
OG_02363,2.338315272559972,FUN_008968-T1,Peve_00007329,Pocillopora_meandrina_HIv1___TS.g5755.t2,three_way,62.23483333333333,FUN_008968-T1,A8F4F7,,,,,34.1,211.0,5.5e-25,116.3,sp|A8F4F7|RL1_PSELT Large ribosomal subunit protein uL1 OS=Pseudothermotoga lettingae (strain ATCC BAA-301 / DSM 14385 / NBRC 107922 / TMO) OX=416591 GN=rplA PE=3 SV=1,,,,,,
OG_02365,2.60645946617716,FUN_008972-T1,Peve_00025074,Pocillopora_meandrina_HIv1___RNAseq.g14268.t1,three_way,56.09883333333333,FUN_008972-T1,Q9BXT4,TDRD1_HUMAN,,Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1),Homo sapiens (Human),22.4,961.0,1.8999999999999998e-35,153.3,sp|Q9BXT4|TDRD1_HUMAN Tudor domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TDRD1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_02367,1.2994458668516344,FUN_008974-T1,Peve_00007753,Pocillopora_meandrina_HIv1___RNAseq.g3944.t1,three_way,88.335,FUN_008974-T1,Q803I2,,,,,65.2,356.0,1.8e-140,500.4,sp|Q803I2|ERGI3_DANRE Endoplasmic reticulum-Golgi intermediate compartment protein 3 OS=Danio rerio OX=7955 GN=ergic3 PE=2 SV=1,,,,,,
OG_02372,2.978428253161816,FUN_008981-T1,Peve_00017856,Pocillopora_meandrina_HIv1___RNAseq.g3907.t1,three_way,83.092,FUN_008981-T1,Q9UK96,,,,,33.1,505.0,5.8e-66,254.2,sp|Q9UK96|FBX10_HUMAN F-box only protein 10 OS=Homo sapiens OX=9606 GN=FBXO10 PE=1 SV=3,,,,,,
OG_02384,3.089757867485063,FUN_009006-T1,Peve_00029130,Pocillopora_meandrina_HIv1___RNAseq.g14283.t1,three_way,69.471,FUN_009006-T1,Q96RG2,,,,,34.2,1207.0,2.8e-153,544.7,sp|Q96RG2|PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=PASK PE=1 SV=3,,,,,,
OG_02385,2.533692781768764,FUN_009007-T1,Peve_00029131,Pocillopora_meandrina_HIv1___RNAseq.g14284.t1,three_way,70.31566666666667,,,,,,,,,,,,,,,,,
OG_02386,1.4642451845993762,FUN_009008-T1,Peve_00031170,Pocillopora_meandrina_HIv1___RNAseq.13704_t,three_way,75.398,FUN_009008-T1,Q6SKR2,HEMK2_MOUSE,,Methyltransferase HEMK2 (HemK methyltransferase family member 2) (M.HsaHemK2P) (Lysine N-methyltransferase 9) (EC 2.1.1.-) (Methylarsonite methyltransferase N6AMT1) (EC 2.1.1.-) (Methyltransferase N6AMT1) (Protein N(5)-glutamine methyltransferase) (EC 2.1.1.-),Mus musculus (Mouse),56.0,209.0,1.6000000000000006e-59,230.7,sp|Q6SKR2|HEMK2_MOUSE Methyltransferase HEMK2 OS=Mus musculus OX=10090 GN=Hemk2 PE=1 SV=1,GO:0003676; GO:0005634; GO:0008276; GO:0009404; GO:0018364; GO:0018872; GO:0030307; GO:0030791; GO:0032259; GO:0032991; GO:0036009; GO:0045814; GO:0045815; GO:0140984; GO:1904047,"arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404]; transcription initiation-coupled chromatin remodeling [GO:0045815]",nucleus [GO:0005634]; protein-containing complex [GO:0032991],arsenite methyltransferase activity [GO:0030791]; histone H4K12 methyltransferase activity [GO:0140984]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-glutamine N-methyltransferase activity [GO:0036009]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0005634; GO:0006325; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromatin organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02387,2.1839700355765963,FUN_009009-T1,Peve_00031168,Pocillopora_meandrina_HIv1___RNAseq.g14286.t1,three_way,79.08683333333333,FUN_009009-T1,E1BYJ2,,,,,50.9,1325.0,0.0,1195.6,sp|E1BYJ2|MSH6_CHICK DNA mismatch repair protein Msh6 OS=Gallus gallus OX=9031 GN=MSH6 PE=3 SV=2,,,,,,
OG_02390,2.6164144773363773,FUN_009014-T1,Peve_00021062,Pocillopora_meandrina_HIv1___RNAseq.g14291.t1,three_way,68.24033333333333,FUN_009014-T1,Q3U0M1,TPPC9_MOUSE,,Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein),Mus musculus (Mouse),31.7,1140.0,3e-141,504.6,sp|Q3U0M1|TPPC9_MOUSE Trafficking protein particle complex subunit 9 OS=Mus musculus OX=10090 GN=Trappc9 PE=1 SV=2,GO:0005737; GO:0005783; GO:0006888; GO:0006901; GO:0021987; GO:0030182; GO:0099022; GO:1990071,cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; TRAPPII protein complex [GO:1990071],,GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048856,endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development
OG_02401,1.8008036055509724,FUN_009042-T1,Peve_00033723,Pocillopora_meandrina_HIv1___RNAseq.g14377.t1,three_way,63.53966666666667,FUN_009042-T1,O95551,TYDP2_HUMAN,,Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (hTDP2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (ETS1-associated protein 2) (ETS1-associated protein II) (EAPII) (TRAF and TNF receptor-associated protein) (Tyrosyl-RNA phosphodiesterase) (VPg unlinkase),Homo sapiens (Human),39.8,334.0,1.1999999999999999e-61,238.4,sp|O95551|TYDP2_HUMAN Tyrosyl-DNA phosphodiesterase 2 OS=Homo sapiens OX=9606 GN=TDP2 PE=1 SV=1,GO:0000287; GO:0003697; GO:0003714; GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0007166; GO:0016235; GO:0016604; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260,cell surface receptor signaling pathway [GO:0007166]; double-strand break repair [GO:0006302]; neuron development [GO:0048666],aggresome [GO:0016235]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714]; tyrosyl-RNA phosphodiesterase activity [GO:0036317],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0016787; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140098; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; hydrolase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; transcription regulator activity"
OG_02405,2.6420894408839573,FUN_009054-T1,Peve_00032030,Pocillopora_meandrina_HIv1___RNAseq.g14498.t1,three_way,59.42516666666667,FUN_009054-T1,Q9WVK8,CP46A_MOUSE,,Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1),Mus musculus (Mouse),32.7,493.0,1.3000000000000001e-67,258.8,sp|Q9WVK8|CP46A_MOUSE Cholesterol 24-hydroxylase OS=Mus musculus OX=10090 GN=Cyp46a1 PE=1 SV=1,GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044,cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805],dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793],cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_02409,2.0571555321268384,FUN_009268-T1,Peve_00032035,Pocillopora_meandrina_HIv1___RNAseq.g3994.t1,three_way,78.74633333333333,FUN_009268-T1,Q4R516,ELOV5_MACFA,,Very long chain fatty acid elongase 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Elongation of very long chain fatty acids protein 5) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),35.5,231.0,4.8e-25,116.3,sp|Q4R516|ELOV5_MACFA Very long chain fatty acid elongase 5 OS=Macaca fascicularis OX=9541 GN=ELOVL5 PE=2 SV=1,GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0043025; GO:0097447,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",dendrite [GO:0030425]; dendritic tree [GO:0097447]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0006629; GO:0006790; GO:0016740; GO:0055086,catalytic activity; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process
OG_02410,1.7580282769200497,FUN_009269-T1,Peve_00032037,Pocillopora_meandrina_HIv1___RNAseq.g3995.t1,three_way,77.785,FUN_009269-T1,A0A0C5PHQ7,ELOV5_TACFU,,Very long chain fatty acid elongase 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Elongation of very long chain fatty acids protein 5) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5),Tachysurus fulvidraco (Yellow catfish) (Pimelodus fulvidraco),33.8,228.0,1.0999999999999998e-24,115.2,sp|A0A0C5PHQ7|ELOV5_TACFU Very long chain fatty acid elongase 5 OS=Tachysurus fulvidraco OX=1234273 GN=ELOVL5 PE=2 SV=1,GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0006629; GO:0006790; GO:0016740; GO:0055086,catalytic activity; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process
OG_02411,3.0004107102713524,FUN_009270-T1,Peve_00032038,Pocillopora_meandrina_HIv1___RNAseq.g3996.t1,three_way,56.53483333333333,,,,,,,,,,,,,,,,,
OG_02412,2.148952496915223,FUN_009271-T1,Peve_00032040,Pocillopora_meandrina_HIv1___RNAseq.g14262.t1,three_way,73.62033333333333,FUN_009271-T1,Q56585,,,,,50.5,99.0,4.8e-22,105.5,sp|Q56585|BOLA_VIBAL DNA-binding transcriptional regulator BolA OS=Vibrio alginolyticus OX=663 GN=bolA PE=3 SV=1,,,,,,
OG_02413,2.1510217613771707,FUN_009273-T1,Peve_00038894,Pocillopora_meandrina_HIv1___RNAseq.g24167.t1,three_way,69.17233333333334,,,,,,,,,,,,,,,,,
OG_02414,1.4696296843316647,FUN_009283-T1,Peve_00000866,Pocillopora_meandrina_HIv1___RNAseq.g15507.t1,three_way,65.01933333333334,,,,,,,,,,,,,,,,,
OG_02415,2.5180421976046774,FUN_009296-T1,Peve_00041170,Pocillopora_meandrina_HIv1___RNAseq.g14453.t3,three_way,46.81766666666667,,,,,,,,,,,,,,,,,
OG_02417,3.8645327338127897,FUN_009301-T1,Peve_00025384,Pocillopora_meandrina_HIv1___RNAseq.g14448.t1,three_way,83.23466666666667,FUN_009301-T1,Q867C9,,,,,59.6,757.0,8.799999999999999e-268,924.5,"sp|Q867C9|PFKAM_HORSE ATP-dependent 6-phosphofructokinase, muscle type OS=Equus caballus OX=9796 GN=PFKM PE=2 SV=3",,,,,,
OG_02421,2.259339893158968,FUN_009312-T2,Peve_00021837,Pocillopora_meandrina_HIv1___RNAseq.g14441.t1,three_way,44.22516666666667,,,,,,,,,,,,,,,,,
OG_02424,4.081784472966374,FUN_009349-T1,Peve_00038081,Pocillopora_meandrina_HIv1___RNAseq.g14427.t2,three_way,67.24183333333333,,,,,,,,,,,,,,,,,
OG_02430,3.374486968431309,FUN_009383-T1,Peve_00026822,Pocillopora_meandrina_HIv1___RNAseq.g14536.t2,three_way,52.69433333333333,FUN_009383-T1,O57382,,,,,33.2,238.0,1.9e-27,125.9,sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1,,,,,,
OG_02431,1.062023771931298,FUN_009401-T1,Peve_00004579,Pocillopora_meandrina_HIv1___RNAseq.g4531.t1,three_way,45.29166666666666,,,,,,,,,,,,,,,,,
OG_02433,1.1109799980196526,FUN_009439-T1,Peve_00031030,Pocillopora_meandrina_HIv1___RNAseq.g25069.t1c,three_way,55.01983333333333,FUN_009439-T1,P59723,HIF1N_DANRE,,Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Hypoxia-inducible factor asparagine hydroxylase),Danio rerio (Zebrafish) (Brachydanio rerio),44.6,267.0,1.4999999999999998e-62,241.9,sp|P59723|HIF1N_DANRE Hypoxia-inducible factor 1-alpha inhibitor OS=Danio rerio OX=7955 GN=hif1an PE=2 SV=2,GO:0005634; GO:0005737; GO:0008198; GO:0008270; GO:0030947; GO:0031406; GO:0036139; GO:0036140; GO:0042803; GO:0045746; GO:0048471; GO:0062101; GO:1901343,negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of vasculature development [GO:1901343]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],[protein]-asparagine 3-dioxygenase activity [GO:0036140]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_02435,1.5010625273100608,FUN_009441-T1,Peve_00031034,Pocillopora_meandrina_HIv1___RNAseq.g25070.t1,three_way,55.70133333333333,,,,,,,,,,,,,,,,,
OG_02436,1.7327377041975394,FUN_009442-T1,Peve_00031035,Pocillopora_meandrina_HIv1___RNAseq.g25071.t1,three_way,65.98966666666666,FUN_009442-T1,Q9UMS0,,,,,65.8,193.0,2.4e-71,270.4,"sp|Q9UMS0|NFU1_HUMAN NFU1 iron-sulfur cluster scaffold homolog, mitochondrial OS=Homo sapiens OX=9606 GN=NFU1 PE=1 SV=2",,,,,,
OG_02437,1.9719768891559009,FUN_009450-T1,Peve_00009284,Pocillopora_meandrina_HIv1___RNAseq.g25115.t1,three_way,64.19466666666666,FUN_009450-T1,Q9DBW0,CP4V2_MOUSE,,Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),Mus musculus (Mouse),47.4,508.0,6.2e-131,469.2,sp|Q9DBW0|CP4V2_MOUSE Cytochrome P450 4V2 OS=Mus musculus OX=10090 GN=Cyp4v2 PE=1 SV=1,GO:0005506; GO:0005789; GO:0010430; GO:0020037; GO:0102033,fatty acid omega-oxidation [GO:0010430],endoplasmic reticulum membrane [GO:0005789],heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_02439,2.706801808773276,FUN_009459-T2,Peve_00010355,Pocillopora_meandrina_HIv1___RNAseq.g25133.t1,three_way,61.281333333333336,FUN_009459-T2,Q24JV9,,,,,58.1,105.0,3.1999999999999997e-31,139.0,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02441,2.308518410482254,FUN_009464-T1,Peve_00031025,Pocillopora_meandrina_HIv1___RNAseq.g25059.t1,three_way,87.40733333333333,FUN_009464-T1,Q6IML7,,,,,66.2,260.0,1.6e-101,370.5,sp|Q6IML7|DJC27_RAT DnaJ homolog subfamily C member 27 OS=Rattus norvegicus OX=10116 GN=Dnajc27 PE=2 SV=1,,,,,,
OG_02443,3.2359678091932085,FUN_009512-T1,Peve_00040630,Pocillopora_meandrina_HIv1___TS.g24209.t1,three_way,57.00666666666667,FUN_009512-T1,A6LX31,,,,,46.4,252.0,2.1e-56,221.5,sp|A6LX31|Y2760_CLOB8 Putative hydro-lyase Cbei_2760 OS=Clostridium beijerinckii (strain ATCC 51743 / NCIMB 8052) OX=290402 GN=Cbei_2760 PE=3 SV=1,,,,,,
OG_02444,1.794665192987462,FUN_009515-T1,Peve_00013293,Pocillopora_meandrina_HIv1___RNAseq.g24489.t1,three_way,58.22533333333333,,,,,,,,,,,,,,,,,
OG_02446,1.365564143337752,FUN_009517-T1,Peve_00009091,Pocillopora_meandrina_HIv1___RNAseq.g24504.t1,three_way,60.57866666666666,,,,,,,,,,,,,,,,,
OG_02447,1.0574924727848471,FUN_009518-T1,Peve_00014185,Pocillopora_meandrina_HIv1___RNAseq.g24502.t1,three_way,48.7565,,,,,,,,,,,,,,,,,
OG_02448,1.8402721630055807,FUN_009519-T1,Peve_00014186,Pocillopora_meandrina_HIv1___RNAseq.g24501.t1,three_way,81.64666666666666,FUN_009519-T1,Q02874,H2AY_RAT,,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y),Rattus norvegicus (Rat),55.9,381.0,1.7e-101,370.9,sp|Q02874|H2AY_RAT Core histone macro-H2A.1 OS=Rattus norvegicus OX=10116 GN=Macroh2a1 PE=1 SV=5,GO:0000122; GO:0000182; GO:0000228; GO:0000785; GO:0000786; GO:0000793; GO:0000976; GO:0000977; GO:0001740; GO:0002082; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006281; GO:0006334; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0030527; GO:0031490; GO:0031492; GO:0031507; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0071169; GO:0072570; GO:0090734; GO:0160002; GO:1901837; GO:1902688; GO:1902750; GO:1902882; GO:1903226; GO:1904815; GO:1990841,"DNA repair [GO:0006281]; epigenetic regulation of gene expression [GO:0040029]; establishment of protein localization to chromatin [GO:0071169]; heterochromatin formation [GO:0031507]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of NAD metabolic process [GO:1902688]; regulation of oxidative phosphorylation [GO:0002082]; regulation of response to oxidative stress [GO:1902882]; sex-chromosome dosage compensation [GO:0007549]; transcription initiation-coupled chromatin remodeling [GO:0045815]",Barr body [GO:0001740]; chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734],ADP-D-ribose binding [GO:0072570]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976],GO:0000228; GO:0003677; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006325; GO:0006355; GO:0043226; GO:0065003; GO:0098772,nuclear chromosome; DNA binding; structural molecule activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; chromatin organization; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; molecular function regulator activity
OG_02452,2.906202803749339,FUN_009530-T1,Peve_00009552,Pocillopora_meandrina_HIv1___RNAseq.g24495.t1,three_way,46.4995,FUN_009530-T1,Q460N3,PAR15_HUMAN,,Protein mono-ADP-ribosyltransferase PARP15 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15) (PARP-15),Homo sapiens (Human),27.4,201.0,6.3e-14,80.9,sp|Q460N3|PAR15_HUMAN Protein mono-ADP-ribosyltransferase PARP15 OS=Homo sapiens OX=9606 GN=PARP15 PE=1 SV=2,GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0010629; GO:0016779; GO:0070212; GO:0070403; GO:0140806; GO:0140807; GO:1990404,negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein poly-ADP-ribosylation [GO:0070212],cytoplasm [GO:0005737]; nucleus [GO:0005634],NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02456,1.7964932988439677,FUN_009640-T1,Peve_00032789,Pocillopora_meandrina_HIv1___RNAseq.g24615.t1,three_way,48.79566666666667,,,,,,,,,,,,,,,,,
OG_02458,1.2077824034411788,FUN_009648-T1,Peve_00003561,Pocillopora_meandrina_HIv1___RNAseq.g24588.t1,three_way,67.06866666666667,FUN_009648-T1,O62714,,,,,32.4,893.0,4.8e-129,463.8,sp|O62714|CASR_PIG Extracellular calcium-sensing receptor OS=Sus scrofa OX=9823 GN=CASR PE=2 SV=3,,,,,,
OG_02459,1.7995697574372818,FUN_009649-T1,Peve_00003562,Pocillopora_meandrina_HIv1___RNAseq.g24589.t1,three_way,62.382666666666665,FUN_009649-T1,P48442,CASR_RAT,,Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR),Rattus norvegicus (Rat),26.8,892.0,1e-78,296.6,sp|P48442|CASR_RAT Extracellular calcium-sensing receptor OS=Rattus norvegicus OX=10116 GN=Casr PE=1 SV=1,GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; vasodilation [GO:0042311],apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0005886; GO:0048856; GO:0055085; GO:0060089,circulatory system process; plasma membrane; anatomical structure development; transmembrane transport; molecular transducer activity
OG_02464,1.6001646112918595,FUN_009655-T1,Peve_00003554,Pocillopora_meandrina_HIv1___RNAseq.g24582.t1,three_way,64.32866666666666,,,,,,,,,,,,,,,,,
OG_02471,1.0163727887182952,FUN_009673-T1,Peve_00009666,Pocillopora_meandrina_HIv1___RNAseq.g24571.t1,three_way,77.39833333333334,FUN_009673-T1,Q8WU67,ABHD3_HUMAN,,Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3),Homo sapiens (Human),45.5,378.0,2.5e-98,360.5,sp|Q8WU67|ABHD3_HUMAN Phospholipase ABHD3 OS=Homo sapiens OX=9606 GN=ABHD3 PE=1 SV=2,GO:0004623; GO:0005886; GO:0006656; GO:0008126; GO:0008970; GO:0046470; GO:0047372; GO:0051792; GO:0051793,medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470],plasma membrane [GO:0005886],acetylesterase activity [GO:0008126]; monoacylglycerol lipase activity [GO:0047372]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623],GO:0003824; GO:0005886; GO:0006629; GO:0016787,catalytic activity; plasma membrane; lipid metabolic process; hydrolase activity
OG_02478,1.3527918484662056,FUN_009766-T1,Peve_00002099,Pocillopora_meandrina_HIv1___RNAseq.g24563.t1,three_way,57.70433333333334,,,,,,,,,,,,,,,,,
OG_02482,1.9401414014746017,FUN_009776-T1,Peve_00002105,Pocillopora_meandrina_HIv1___TS.g12502.t1,three_way,70.31866666666666,FUN_009776-T1,Q9JID6,,,,,50.2,665.0,5.3e-189,662.5,sp|Q9JID6|ACSL1_CAVPO Long-chain-fatty-acid--CoA ligase 1 OS=Cavia porcellus OX=10141 GN=ACSL1 PE=2 SV=1,,,,,,
OG_02483,3.1964286903153334,FUN_009777-T1,Peve_00002096,Pocillopora_meandrina_HIv1___RNAseq.g24558.t1,three_way,79.21533333333333,FUN_009777-T1,Q9JID6,,,,,48.5,699.0,9.999999999999999e-193,674.9,sp|Q9JID6|ACSL1_CAVPO Long-chain-fatty-acid--CoA ligase 1 OS=Cavia porcellus OX=10141 GN=ACSL1 PE=2 SV=1,,,,,,
OG_02484,3.802149487038132,FUN_009778-T1,Peve_00026798,Pocillopora_meandrina_HIv1___RNAseq.g24554.t1,three_way,71.61233333333334,FUN_009778-T1,P41216,,,,,47.2,642.0,8e-176,618.6,sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2,,,,,,
OG_02485,1.3266133754675784,FUN_009817-T1,Peve_00020547,Pocillopora_meandrina_HIv1___RNAseq.g24553.t1,three_way,74.48683333333334,FUN_009817-T1,Q3UQI9,,,,,37.9,771.0,2.3e-118,427.9,sp|Q3UQI9|MINY4_MOUSE Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 OS=Mus musculus OX=10090 GN=Mindy4 PE=1 SV=1,,,,,,
OG_02489,1.6823379885888077,FUN_009821-T1,Peve_00042913,Pocillopora_meandrina_HIv1___RNAseq.g24546.t1,three_way,47.9915,,,,,,,,,,,,,,,,,
OG_02493,1.2146364389233066,FUN_009827-T1,Peve_00042907,Pocillopora_meandrina_HIv1___RNAseq.g24538.t1,three_way,56.699,FUN_009827-T1,Q0IHA2,,,,,41.0,278.0,2.7e-48,193.7,sp|Q0IHA2|ELP6_XENLA Elongator complex protein 6 OS=Xenopus laevis OX=8355 GN=elp6 PE=2 SV=1,,,,,,
OG_02494,1.8840416909782605,FUN_009828-T1,Peve_00042906,Pocillopora_meandrina_HIv1___TS.g12483.t2,three_way,70.49633333333334,FUN_009828-T1,Q58D00,,,,,50.3,344.0,1e-50,202.2,sp|Q58D00|FBXW2_BOVIN F-box/WD repeat-containing protein 2 OS=Bos taurus OX=9913 GN=FBXW2 PE=2 SV=1,,,,,,
OG_02500,1.0630906549297077,FUN_009849-T1,Peve_00030326,Pocillopora_meandrina_HIv1___RNAseq.27460_t,three_way,66.62333333333333,FUN_009849-T1,P55024,,,,,37.1,474.0,1.3e-99,365.2,sp|P55024|TYRO_CHICK Tyrosinase OS=Gallus gallus OX=9031 GN=TYR PE=2 SV=1,,,,,,
OG_02504,1.4826065369753207,FUN_009960-T1,Peve_00007862,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1b,three_way,73.25516666666667,,,,,,,,,,,,,,,,,
OG_02507,3.381952924780225,FUN_010019-T1,Peve_00036456,Pocillopora_meandrina_HIv1___TS.g12195.t1a,three_way,70.6275,FUN_010019-T1,Q7Z5K2,WAPL_HUMAN,,Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor),Homo sapiens (Human),38.7,545.0,3.8e-92,340.9,sp|Q7Z5K2|WAPL_HUMAN Wings apart-like protein homolog OS=Homo sapiens OX=9606 GN=WAPL PE=1 SV=1,GO:0000070; GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0035562; GO:0043231; GO:0045171; GO:0045875; GO:0051301; GO:0071168; GO:0072686; GO:0140083,cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; protein localization to chromatin [GO:0071168],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP-dependent protein-DNA unloader activity [GO:0140083],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007059; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; chromosome segregation; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02512,2.3685707503651785,FUN_010555-T1,Peve_00032733,Pocillopora_meandrina_HIv1___RNAseq.g21411.t1,three_way,87.566,FUN_010555-T1,Q9R244,TRPC2_MOUSE,,Short transient receptor potential channel 2 (TrpC2) (Transient receptor protein 2) (TRP-2) (mTrp2),Mus musculus (Mouse),25.4,508.0,1.8e-30,137.1,sp|Q9R244|TRPC2_MOUSE Short transient receptor potential channel 2 OS=Mus musculus OX=10090 GN=Trpc2 PE=2 SV=2,GO:0000012; GO:0000139; GO:0002118; GO:0002121; GO:0002124; GO:0003684; GO:0005516; GO:0005634; GO:0005635; GO:0005789; GO:0005886; GO:0006816; GO:0007204; GO:0007340; GO:0008050; GO:0010468; GO:0012505; GO:0015279; GO:0019236; GO:0019992; GO:0032590; GO:0048047; GO:0070679; GO:1902436,"acrosome reaction [GO:0007340]; aggressive behavior [GO:0002118]; calcium ion transport [GO:0006816]; female courtship behavior [GO:0008050]; inter-male aggressive behavior [GO:0002121]; mating behavior, sex discrimination [GO:0048047]; negative regulation of male mating behavior [GO:1902436]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of gene expression [GO:0010468]; response to pheromone [GO:0019236]; single strand break repair [GO:0000012]; territorial aggressive behavior [GO:0002124]",dendrite membrane [GO:0032590]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calmodulin binding [GO:0005516]; damaged DNA binding [GO:0003684]; diacylglycerol binding [GO:0019992]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0003677; GO:0005215; GO:0005634; GO:0005635; GO:0005886; GO:0006281; GO:0008289; GO:0022414; GO:0043226,DNA binding; transporter activity; nucleus; nuclear envelope; plasma membrane; DNA repair; lipid binding; reproductive process; organelle
OG_02516,1.866838319004943,FUN_010575-T1,Peve_00032734,Pocillopora_meandrina_HIv1___RNAseq.g21523.t1,three_way,73.19066666666667,FUN_010575-T1,Q9C091,GRB1L_HUMAN,,GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein),Homo sapiens (Human),33.4,1940.0,6.8e-250,866.3,sp|Q9C091|GRB1L_HUMAN GREB1-like protein OS=Homo sapiens OX=9606 GN=GREB1L PE=1 SV=2,GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0061205; GO:0072177,branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065],membrane [GO:0016020],,GO:0022414; GO:0030154; GO:0042254; GO:0048856,reproductive process; cell differentiation; ribosome biogenesis; anatomical structure development
OG_02519,1.232285874778703,FUN_010579-T1,Peve_00032738,Pocillopora_meandrina_HIv1___RNAseq.g21519.t1,three_way,42.1245,FUN_010579-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),23.7,329.0,4.3e-11,71.2,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_02520,1.0396051386761875,FUN_010583-T1,Peve_00032748,Pocillopora_meandrina_HIv1___RNAseq.g21517.t1,three_way,94.21833333333332,FUN_010583-T1,Q28FC1,UBE2W_XENTR,,Ubiquitin-conjugating enzyme E2 W (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme W) (N-terminal E2 ubiquitin-conjugating enzyme) (EC 2.3.2.25) (Ubiquitin carrier protein W) (Ubiquitin-protein ligase W),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),73.3,150.0,1.2e-66,253.8,sp|Q28FC1|UBE2W_XENTR Ubiquitin-conjugating enzyme E2 W OS=Xenopus tropicalis OX=8364 GN=ube2w PE=2 SV=1,GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006515; GO:0043161; GO:0061631; GO:0071218,cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0006281; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA repair; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02521,3.035729677929974,FUN_010586-T1,Peve_00032749,Pocillopora_meandrina_HIv1___RNAseq.g21514.t1,three_way,59.089333333333336,FUN_010586-T1,Q28EM3,PARI_XENTR,,PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),24.7,636.0,5.9000000000000005e-30,134.0,sp|Q28EM3|PARI_XENTR PCNA-interacting partner OS=Xenopus tropicalis OX=8364 GN=parpbp PE=2 SV=2,GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:2000042,DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0006281; GO:0043226,DNA binding; nucleus; DNA repair; organelle
OG_02522,2.115408943786417,FUN_010588-T1,Peve_00032700,Pocillopora_meandrina_HIv1___RNAseq.g21512.t1,three_way,83.79533333333333,FUN_010588-T1,Q6INX4,,,,,58.8,434.0,3.0000000000000003e-161,569.7,sp|Q6INX4|ENOF1_XENLA Mitochondrial enolase superfamily member 1 OS=Xenopus laevis OX=8355 GN=enosf1 PE=2 SV=1,,,,,,
OG_02525,1.0088289327710869,FUN_010597-T1,Peve_00032712,Pocillopora_meandrina_HIv1___RNAseq.g21497.t1,three_way,66.67666666666666,FUN_010597-T1,Q9LQV2,,,,,31.0,432.0,1.0999999999999999e-47,193.0,sp|Q9LQV2|RDR1_ARATH RNA-dependent RNA polymerase 1 OS=Arabidopsis thaliana OX=3702 GN=RDR1 PE=2 SV=1,,,,,,
OG_02526,3.193086086001238,FUN_010598-T1,Peve_00032709,Pocillopora_meandrina_HIv1___RNAseq.g21501.t1,three_way,41.12233333333334,FUN_010598-T1,O82504,,,,,24.5,420.0,8.599999999999999e-24,113.6,sp|O82504|RDR2_ARATH RNA-dependent RNA polymerase 2 OS=Arabidopsis thaliana OX=3702 GN=RDR2 PE=1 SV=1,,,,,,
OG_02527,4.081912916817831,FUN_010601-T1,Peve_00032713,Pocillopora_meandrina_HIv1___RNAseq.g21495.t1,three_way,71.13166666666666,,,,,,,,,,,,,,,,,
OG_02528,1.641697583191078,FUN_010603-T1,Peve_00032714,Pocillopora_meandrina_HIv1___RNAseq.g21494.t1,three_way,81.04033333333334,FUN_010603-T1,O54992,,,,,46.6,468.0,1.4e-121,438.0,sp|O54992|MAPK5_MOUSE MAP kinase-activated protein kinase 5 OS=Mus musculus OX=10090 GN=Mapkapk5 PE=1 SV=1,,,,,,
OG_02529,1.6441170557126437,FUN_010604-T1,Peve_00032717,Pocillopora_meandrina_HIv1___RNAseq.g21493.t1,three_way,50.83316666666667,,,,,,,,,,,,,,,,,
OG_02530,1.5468272260008151,FUN_010605-T1,Peve_00032718,Pocillopora_meandrina_HIv1___RNAseq.g21492.t1,three_way,67.90016666666666,FUN_010605-T1,Q9ULK6,,,,,40.0,95.0,5.7e-13,77.0,sp|Q9ULK6|RN150_HUMAN RING finger protein 150 OS=Homo sapiens OX=9606 GN=RNF150 PE=1 SV=2,,,,,,
OG_02532,1.1075226369926778,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_02534,2.037647281510983,FUN_010613-T1,Peve_00013441,Pocillopora_meandrina_HIv1___RNAseq.g21489.t1,three_way,59.64266666666666,FUN_010613-T1,Q569U0,,,,,43.5,835.0,1.6000000000000002e-170,601.7,sp|Q569U0|MYO19_XENLA Unconventional myosin-XIX OS=Xenopus laevis OX=8355 GN=myo19 PE=2 SV=1,,,,,,
OG_02536,3.266234883557573,FUN_010615-T1,Peve_00013370,Pocillopora_meandrina_HIv1___RNAseq.g21487.t1,three_way,60.214333333333336,FUN_010615-T1,Q8HZ58,,,,,23.2,293.0,1.3e-09,67.0,sp|Q8HZ58|CCHCR_PONPY Coiled-coil alpha-helical rod protein 1 OS=Pongo pygmaeus OX=9600 GN=CCHCR1 PE=3 SV=1,,,,,,
OG_02537,2.9773409043982206,FUN_010620-T1,Peve_00031460,Pocillopora_meandrina_HIv1___TS.g26115.t1,three_way,50.77283333333333,FUN_010620-T1,O14514,AGRB1_HUMAN,,Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)],Homo sapiens (Human),29.6,659.0,1.9999999999999999e-63,246.9,sp|O14514|AGRB1_HUMAN Adhesion G protein-coupled receptor B1 OS=Homo sapiens OX=9606 GN=ADGRB1 PE=1 SV=2,GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016020; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]",cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786],GO:0002376; GO:0005615; GO:0005886; GO:0007155; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0060089; GO:0061024; GO:0098542,immune system process; extracellular space; plasma membrane; cell adhesion; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; molecular transducer activity; membrane organization; defense response to other organism
OG_02538,1.3742166190524818,FUN_010621-T1,Peve_00010093,Pocillopora_meandrina_HIv1___RNAseq.g20926.t1,three_way,86.82916666666667,FUN_010621-T1,Q32PW3,,,,,56.5,901.0,4.6000000000000006e-303,1042.0,sp|Q32PW3|TAF2_DANRE Transcription initiation factor TFIID subunit 2 OS=Danio rerio OX=7955 GN=taf2 PE=2 SV=2,,,,,,
OG_02543,2.435393992172889,FUN_010626-T1,Peve_00004474,Pocillopora_meandrina_HIv1___RNAseq.g21298.t1,three_way,89.19266666666667,FUN_010626-T1,Q91YL3,,,,,66.8,400.0,5.5e-149,528.9,sp|Q91YL3|UCKL1_MOUSE Uridine-cytidine kinase-like 1 OS=Mus musculus OX=10090 GN=Uckl1 PE=1 SV=1,,,,,,
OG_02544,1.6521839348866945,FUN_010629-T1,Peve_00004477,Pocillopora_meandrina_HIv1___RNAseq.g21301.t1,three_way,72.79866666666668,,,,,,,,,,,,,,,,,
OG_02546,2.6514650833579,FUN_010633-T1,Peve_00004481,Pocillopora_meandrina_HIv1___RNAseq.g21305.t1,three_way,37.91866666666667,FUN_010633-T1,Q6P0J3,SP8_DANRE,,Transcription factor Sp8,Danio rerio (Zebrafish) (Brachydanio rerio),48.8,84.0,4.1e-15,84.7,sp|Q6P0J3|SP8_DANRE Transcription factor Sp8 OS=Danio rerio OX=7955 GN=sp8b PE=2 SV=1,GO:0000978; GO:0000981; GO:0003690; GO:0005634; GO:0006357; GO:0008270; GO:0030326; GO:0035118; GO:0045743,embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_02547,2.2764802082261717,FUN_010634-T1,Peve_00009631,Pocillopora_meandrina_HIv1___RNAseq.g21306.t1,three_way,52.05883333333333,,,,,,,,,,,,,,,,,
OG_02548,2.558561115349529,FUN_010635-T1,Peve_00009633,Pocillopora_meandrina_HIv1___RNAseq.g21307.t2,three_way,60.11416666666666,FUN_010635-T1,P07996,TSP1_HUMAN,,Thrombospondin-1 (Glycoprotein G),Homo sapiens (Human),59.6,525.0,5.4e-56,221.5,sp|P07996|TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens OX=9606 GN=THBS1 PE=1 SV=2,GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002020; GO:0002040; GO:0002544; GO:0002581; GO:0002605; GO:0004866; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006915; GO:0006954; GO:0006955; GO:0006986; GO:0007155; GO:0008201; GO:0008284; GO:0008285; GO:0009410; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032693; GO:0032695; GO:0032720; GO:0032760; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0038060; GO:0040037; GO:0042327; GO:0042803; GO:0043032; GO:0043066; GO:0043236; GO:0043394; GO:0043410; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237,apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide-cGMP-mediated signaling [GO:0038060]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phosphorylation [GO:0042327]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141],calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; endopeptidase inhibitor activity [GO:0004866]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431],GO:0002376; GO:0005198; GO:0005576; GO:0005615; GO:0005783; GO:0006954; GO:0007155; GO:0008289; GO:0012501; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048870; GO:0061024; GO:0098772,immune system process; structural molecule activity; extracellular region; extracellular space; endoplasmic reticulum; inflammatory response; cell adhesion; lipid binding; programmed cell death; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; cell motility; membrane organization; molecular function regulator activity
OG_02550,4.39746667765171,FUN_010638-T1,Peve_00009636,Pocillopora_meandrina_HIv1___RNAseq.g21309.t1,three_way,85.60366666666667,FUN_010638-T1,P79733,RIR2_DANRE,,Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit),Danio rerio (Zebrafish) (Brachydanio rerio),79.4,335.0,5.3e-151,535.4,sp|P79733|RIR2_DANRE Ribonucleoside-diphosphate reductase subunit M2 OS=Danio rerio OX=7955 GN=rrm2 PE=1 SV=1,GO:0004748; GO:0005829; GO:0009263; GO:0046872,deoxyribonucleotide biosynthetic process [GO:0009263],cytosol [GO:0005829],"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",GO:0003824; GO:0005829; GO:0016491; GO:0055086; GO:1901135,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02552,1.2815545782990976,FUN_010640-T1,Peve_00031464,Pocillopora_meandrina_HIv1___RNAseq.g21361.t1,three_way,91.932,FUN_010640-T1,Q6GL89,IF2A_XENTR,,Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),71.2,312.0,6.1e-121,435.3,sp|Q6GL89|IF2A_XENTR Eukaryotic translation initiation factor 2 subunit 1 OS=Xenopus tropicalis OX=8364 GN=eif2s1 PE=2 SV=1,GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0010494; GO:0032057; GO:0034198; GO:0034644; GO:0034976; GO:0036499,cellular response to amino acid starvation [GO:0034198]; cellular response to UV [GO:0034644]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; response to endoplasmic reticulum stress [GO:0034976],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850],RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0005829; GO:0043226,RNA binding; cytosol; organelle
OG_02554,1.15369900942889,FUN_010643-T1,Peve_00031455,Pocillopora_meandrina_HIv1___RNAseq.g21331.t1,three_way,67.60733333333333,FUN_010643-T1,Q6GM78,ASGL1_XENLA,,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],Xenopus laevis (African clawed frog),47.9,311.0,6.4e-70,265.8,sp|Q6GM78|ASGL1_XENLA Isoaspartyl peptidase/L-asparaginase OS=Xenopus laevis OX=8355 GN=asrgl1 PE=2 SV=1,GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917],asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798],GO:0003824; GO:0006520; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; hydrolase activity; catalytic activity, acting on a protein"
OG_02555,1.256916377755812,FUN_010644-T1,Peve_00031456,Pocillopora_meandrina_HIv1___RNAseq.g21330.t1,three_way,73.147,FUN_010644-T1,Q6GM78,ASGL1_XENLA,,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],Xenopus laevis (African clawed frog),47.9,317.0,2.7999999999999997e-68,260.4,sp|Q6GM78|ASGL1_XENLA Isoaspartyl peptidase/L-asparaginase OS=Xenopus laevis OX=8355 GN=asrgl1 PE=2 SV=1,GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917],asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798],GO:0003824; GO:0006520; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; hydrolase activity; catalytic activity, acting on a protein"
OG_02557,2.4482942597787805,FUN_010654-T1,Peve_00031468,Pocillopora_meandrina_HIv1___RNAseq.g21322.t1,three_way,49.04883333333333,FUN_010654-T1,Q5FWF5,ESCO1_HUMAN,,N-acetyltransferase ESCO1 (EC 2.3.1.-) (CTF7 homolog 1) (Establishment factor-like protein 1) (EFO1) (EFO1p) (hEFO1) (Establishment of cohesion 1 homolog 1) (ECO1 homolog 1) (ESO1 homolog 1),Homo sapiens (Human),47.1,240.0,5.2e-58,227.3,sp|Q5FWF5|ESCO1_HUMAN N-acetyltransferase ESCO1 OS=Homo sapiens OX=9606 GN=ESCO1 PE=1 SV=3,GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0006275; GO:0007062; GO:0007064; GO:0008080; GO:0008270; GO:0016407; GO:0018394; GO:0034421; GO:0042802; GO:0061733,mitotic sister chromatid cohesion [GO:0007064]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062],chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; protein-lysine-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02559,1.2427216763033693,FUN_010656-T2,Peve_00031470,Pocillopora_meandrina_HIv1___RNAseq.g21320.t1,three_way,60.860166666666665,FUN_010656-T2,Q5ZKG3,DNA2_CHICK,,DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)],Gallus gallus (Chicken),36.6,831.0,2.4999999999999998e-139,498.4,sp|Q5ZKG3|DNA2_CHICK DNA replication ATP-dependent helicase/nuclease DNA2 OS=Gallus gallus OX=9031 GN=DNA2 PE=2 SV=2,GO:0000076; GO:0000729; GO:0003677; GO:0003723; GO:0004518; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006260; GO:0006264; GO:0006284; GO:0016887; GO:0016890; GO:0017108; GO:0017116; GO:0033567; GO:0043137; GO:0043139; GO:0045740; GO:0046872; GO:0051539; GO:0071932,"base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; mitochondrial DNA replication [GO:0006264]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]",cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0006260; GO:0006281; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; DNA replication; DNA repair; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02561,1.497711694201869,FUN_010660-T1,Peve_00031473,Pocillopora_meandrina_HIv1___RNAseq.g21312.t1,three_way,68.91783333333333,,,,,,,,,,,,,,,,,
OG_02563,2.5949191805927376,FUN_010662-T1,Peve_00031441,Pocillopora_meandrina_HIv1___RNAseq.g21360.t1,three_way,72.268,FUN_010662-T1,Q8BZT9,LACC1_MOUSE,,Purine nucleoside phosphorylase LACC1 (EC 2.4.2.1) (Adenosine deaminase LACC1) (EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1) (EC 2.4.2.28),Mus musculus (Mouse),42.9,266.0,7.3e-54,213.0,sp|Q8BZT9|LACC1_MOUSE Purine nucleoside phosphorylase LACC1 OS=Mus musculus OX=10090 GN=Lacc1 PE=1 SV=1,GO:0002221; GO:0002720; GO:0004000; GO:0004731; GO:0005634; GO:0005737; GO:0005777; GO:0005783; GO:0006954; GO:0017061; GO:0030641; GO:0045087; GO:0046872; GO:0047975; GO:0050727; GO:0070431; GO:1900542,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of cellular pH [GO:0030641]; regulation of inflammatory response [GO:0050727]; regulation of purine nucleotide metabolic process [GO:1900542],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; peroxisome [GO:0005777],adenosine deaminase activity [GO:0004000]; guanosine phosphorylase activity [GO:0047975]; metal ion binding [GO:0046872]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061],GO:0002376; GO:0003824; GO:0005634; GO:0005777; GO:0005783; GO:0006954; GO:0016740; GO:0016787; GO:0043226; GO:0098542,immune system process; catalytic activity; nucleus; peroxisome; endoplasmic reticulum; inflammatory response; transferase activity; hydrolase activity; organelle; defense response to other organism
OG_02564,3.38942325321492,FUN_010663-T1,Peve_00031442,Pocillopora_meandrina_HIv1___RNAseq.g21359.t1,three_way,44.581500000000005,FUN_010663-T1,Q99MV1,TDRD1_MOUSE,,Tudor domain-containing protein 1,Mus musculus (Mouse),28.6,814.0,2.1e-72,277.7,sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005829; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,cytosol; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_02568,3.859896742278543,FUN_010668-T1,Peve_00031448,Pocillopora_meandrina_HIv1___RNAseq.g21354.t1,three_way,71.776,FUN_010668-T1,Q6GLL2,ABH6A_XENLA,,Monoacylglycerol lipase abhd6-A (EC 3.1.1.23) (Abhydrolase domain-containing protein 6-A),Xenopus laevis (African clawed frog),39.1,289.0,3.3e-56,220.3,sp|Q6GLL2|ABH6A_XENLA Monoacylglycerol lipase abhd6-A OS=Xenopus laevis OX=8355 GN=abhd6-a PE=2 SV=1,GO:0005765; GO:0016020; GO:0031902; GO:0031966; GO:0032281; GO:0046464; GO:0047372; GO:0052651; GO:2001311,acylglycerol catabolic process [GO:0046464]; lysobisphosphatidic acid metabolic process [GO:2001311]; monoacylglycerol catabolic process [GO:0052651],AMPA glutamate receptor complex [GO:0032281]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966],monoacylglycerol lipase activity [GO:0047372],GO:0003824; GO:0006629; GO:0016787; GO:1901135,catalytic activity; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_02570,2.243532782780618,FUN_010672-T1,Peve_00031451,Pocillopora_meandrina_HIv1___RNAseq.g21351.t1,three_way,71.39183333333334,FUN_010672-T1,Q9UL68,,,,,56.0,175.0,1.5e-17,93.2,sp|Q9UL68|MYT1L_HUMAN Myelin transcription factor 1-like protein OS=Homo sapiens OX=9606 GN=MYT1L PE=1 SV=3,,,,,,
OG_02570,2.243532782780618,FUN_010672-T1,Peve_00031451,Pocillopora_meandrina_HIv1___RNAseq.g21351.t1,three_way,71.39183333333334,FUN_010672-T1,Q9UL68,,,,,73.0,37.0,1.8e-10,69.7,sp|Q9UL68|MYT1L_HUMAN Myelin transcription factor 1-like protein OS=Homo sapiens OX=9606 GN=MYT1L PE=1 SV=3,,,,,,
OG_02570,2.243532782780618,FUN_010672-T1,Peve_00031451,Pocillopora_meandrina_HIv1___RNAseq.g21351.t1,three_way,71.39183333333334,FUN_010672-T1,Q9UL68,,,,,51.2,41.0,3e-05,52.4,sp|Q9UL68|MYT1L_HUMAN Myelin transcription factor 1-like protein OS=Homo sapiens OX=9606 GN=MYT1L PE=1 SV=3,,,,,,
OG_02571,1.7688357941992996,FUN_010674-T1,Peve_00044786,Pocillopora_meandrina_HIv1___RNAseq.g21350.t1,three_way,81.68766666666667,FUN_010674-T1,O75116,ROCK2_HUMAN,,"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)",Homo sapiens (Human),50.3,445.0,8.199999999999999e-109,396.7,sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=4,GO:0000281; GO:0001837; GO:0001934; GO:0002020; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007266; GO:0008270; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0036464; GO:0042752; GO:0043410; GO:0044788; GO:0045019; GO:0045616; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061133; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; mitotic cytokinesis [GO:0000281]; modulation by host of viral process [GO:0044788]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; zinc ion binding [GO:0008270],GO:0000910; GO:0003012; GO:0003013; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0030154; GO:0043226; GO:0072659; GO:0098772; GO:0140096,"cytokinesis; muscle system process; circulatory system process; RNA binding; catalytic activity; structural molecule activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; cell differentiation; organelle; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02572,1.7565904691974077,FUN_010675-T1,Peve_00044784,Pocillopora_meandrina_HIv1___RNAseq.g21349.t1,three_way,66.34933333333333,FUN_010675-T1,Q8K2L8,,,,,46.4,435.0,4.8e-112,407.1,sp|Q8K2L8|TPC12_MOUSE Trafficking protein particle complex subunit 12 OS=Mus musculus OX=10090 GN=Trappc12 PE=1 SV=2,,,,,,
OG_02575,1.451418617972518,FUN_010681-T1,Peve_00044788,Pocillopora_meandrina_HIv1___TS.g26095.t1,three_way,79.83833333333334,,,,,,,,,,,,,,,,,
OG_02576,1.087176387745081,FUN_010682-T1,Peve_00044787,Pocillopora_meandrina_HIv1___TS.g26094.t1,three_way,77.71233333333333,FUN_010682-T1,Q9CQN6,,,,,50.5,109.0,3.1999999999999998e-24,112.5,sp|Q9CQN6|TM14C_MOUSE Transmembrane protein 14C OS=Mus musculus OX=10090 GN=Tmem14c PE=1 SV=1,,,,,,
OG_02580,1.7805348058628463,FUN_010696-T1,Peve_00040382,Pocillopora_meandrina_HIv1___RNAseq.g6938.t1,three_way,55.94833333333333,FUN_010696-T1,F4JTS8,NOV_ARATH,,Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597),Arabidopsis thaliana (Mouse-ear cress),26.4,2000.0,7.3e-152,541.2,sp|F4JTS8|NOV_ARATH Protein NO VEIN OS=Arabidopsis thaliana OX=3702 GN=NOV PE=1 SV=1,GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364,auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827],nucleus [GO:0005634],,GO:0005634; GO:0022414; GO:0043226; GO:0048856,nucleus; reproductive process; organelle; anatomical structure development
OG_02587,1.312006640222003,FUN_010707-T1,Peve_00005096,Pocillopora_meandrina_HIv1___RNAseq.g8834.t1,three_way,53.306333333333335,FUN_010707-T1,A0A2B4RP11,,,,,26.2,378.0,3.4e-14,81.6,sp|A0A2B4RP11|CGLR1_STYPI Cyclic GMP-AMP synthase-like receptor 1 OS=Stylophora pistillata OX=50429 GN=cGLR1 PE=1 SV=1,,,,,,
OG_02589,1.2575579694899466,FUN_010709-T1,Peve_00022594,Pocillopora_meandrina_HIv1___RNAseq.g20962.t1,three_way,45.36966666666667,FUN_010709-T1,Q21313,EPI1_CAEEL,,Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1),Caenorhabditis elegans,29.1,110.0,3.4e-06,55.1,sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1,GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0022414; GO:0040017; GO:0042127; GO:0051788; GO:0071711,animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; reproductive process [GO:0022414]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888],basement membrane [GO:0005604]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0007155; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0048870,structural molecule activity; extracellular region; cell adhesion; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; cell motility
OG_02591,1.465627367813891,FUN_010711-T1,Peve_00022576,Pocillopora_meandrina_HIv1___RNAseq.g20960.t1,three_way,81.52633333333333,FUN_010711-T1,Q9UHY1,NRBP_HUMAN,,Nuclear receptor-binding protein,Homo sapiens (Human),54.0,470.0,1.6e-136,487.6,sp|Q9UHY1|NRBP_HUMAN Nuclear receptor-binding protein OS=Homo sapiens OX=9606 GN=NRBP1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005938; GO:0006888; GO:0006974; GO:0012505; GO:0016020; GO:0030027; GO:0042803,DNA damage response [GO:0006974]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005654; GO:0016192; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_02592,1.8204804198465545,FUN_010712-T1,Peve_00022571,Pocillopora_meandrina_HIv1___RNAseq.g20959.t1,three_way,69.79433333333333,FUN_010712-T1,Q96NA8,,,,,31.0,200.0,1.8e-14,81.6,sp|Q96NA8|TSNA1_HUMAN t-SNARE domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TSNARE1 PE=1 SV=2,,,,,,
OG_02593,1.097279874682236,FUN_010713-T1,Peve_00022566,Pocillopora_meandrina_HIv1___RNAseq.g20958.t1,three_way,82.25733333333334,FUN_010713-T1,Q8R3G1,PP1R8_MOUSE,,Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8),Mus musculus (Mouse),53.2,365.0,6.9e-92,339.0,sp|Q8R3G1|PP1R8_MOUSE Nuclear inhibitor of protein phosphatase 1 OS=Mus musculus OX=10090 GN=Ppp1r8 PE=1 SV=1,GO:0003677; GO:0003723; GO:0004864; GO:0005681; GO:0006397; GO:0008283; GO:0008380; GO:0016607; GO:0019888,cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0016071; GO:0043226; GO:0098772,DNA binding; RNA binding; mRNA metabolic process; organelle; molecular function regulator activity
OG_02594,2.395873129572444,FUN_010714-T1,Peve_00022559,Pocillopora_meandrina_HIv1___RNAseq.g20957.t1,three_way,53.61783333333334,FUN_010714-T1,Q8WV22,NSE1_HUMAN,,Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 2.3.2.27),Homo sapiens (Human),34.5,258.0,3.2e-35,150.2,sp|Q8WV22|NSE1_HUMAN Non-structural maintenance of chromosomes element 1 homolog OS=Homo sapiens OX=9606 GN=NSMCE1 PE=1 SV=5,GO:0000724; GO:0000775; GO:0000781; GO:0004842; GO:0005634; GO:0005654; GO:0006974; GO:0008270; GO:0016925; GO:0030915; GO:0032204; GO:0043231; GO:0046983; GO:0061630; GO:0097431; GO:0140588,chromatin looping [GO:0140588]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204],"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]",protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02597,1.2514167412239317,FUN_010718-T1,Peve_00029907,Pocillopora_meandrina_HIv1___RNAseq.g20953.t1,three_way,54.03416666666666,,,,,,,,,,,,,,,,,
OG_02599,5.264711935678795,FUN_010720-T1,Peve_00029905,Pocillopora_meandrina_HIv1___RNAseq.g20949.t2,three_way,83.7885,FUN_010720-T1,P58197,AP2A_RAT,,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),Rattus norvegicus (Rat),63.4,227.0,3.3e-68,260.8,sp|P58197|AP2A_RAT Transcription factor AP-2-alpha OS=Rattus norvegicus OX=10116 GN=Tfap2a PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001501; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:1990837; GO:2000378,anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559],clathrin-coated pit [GO:0005905]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0012501; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; extracellular matrix organization; organelle; anatomical structure development; cell motility; nervous system process; molecular adaptor activity; transcription regulator activity
OG_02600,2.801422162578735,FUN_010726-T1,Peve_00038971,Pocillopora_meandrina_HIv1___RNAseq.g20947.t1,three_way,72.91166666666666,FUN_010726-T1,Q17QM4,EPT1_BOVIN,,Ethanolaminephosphotransferase 1 (EC 2.7.8.1) (Selenoprotein I) (SelI),Bos taurus (Bovine),44.5,380.0,3.2999999999999996e-90,333.6,sp|Q17QM4|EPT1_BOVIN Ethanolaminephosphotransferase 1 OS=Bos taurus OX=9913 GN=SELENOI PE=2 SV=3,GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0008611; GO:0042552; GO:0046872,ether lipid biosynthetic process [GO:0008611]; myelination [GO:0042552]; phosphatidylethanolamine biosynthetic process [GO:0006646],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0006629; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; lipid metabolic process; transferase activity; organelle
OG_02601,2.3043390961222765,FUN_010727-T1,Peve_00038972,Pocillopora_meandrina_HIv1___RNAseq.g20946.t1,three_way,71.91666666666667,FUN_010727-T1,Q6GL75,,,,,42.6,383.0,3.6000000000000003e-81,303.5,sp|Q6GL75|DCC1_XENTR Sister chromatid cohesion protein DCC1 OS=Xenopus tropicalis OX=8364 GN=dscc1 PE=2 SV=1,,,,,,
OG_02614,2.635996325781679,FUN_010753-T1,Peve_00004503,Pocillopora_meandrina_HIv1___RNAseq.g21292.t1,three_way,87.76683333333334,FUN_010753-T1,Q9NV56,,,,,61.1,90.0,1.4e-26,120.9,sp|Q9NV56|MRGBP_HUMAN MRG/MORF4L-binding protein OS=Homo sapiens OX=9606 GN=MRGBP PE=1 SV=1,,,,,,
OG_02617,2.570143582906609,FUN_010756-T1,Peve_00008040,Pocillopora_meandrina_HIv1___RNAseq.g20928.t1,three_way,75.21683333333334,FUN_010756-T1,P33610,,,,,53.5,460.0,2e-140,500.7,sp|P33610|PRI2_MOUSE DNA primase large subunit OS=Mus musculus OX=10090 GN=Prim2 PE=1 SV=1,,,,,,
OG_02624,2.115635223952033,FUN_010774-T1,Peve_00004493,Pocillopora_meandrina_HIv1___RNAseq.g21201.t1,three_way,81.71166666666666,FUN_010774-T1,Q9PWA0,,,,,45.9,133.0,1.7000000000000002e-27,124.0,sp|Q9PWA0|RGS17_CHICK Regulator of G-protein signaling 17 OS=Gallus gallus OX=9031 GN=RGS17 PE=2 SV=1,,,,,,
OG_02626,3.4198815813443493,FUN_010776-T1,Peve_00004491,Pocillopora_meandrina_HIv1___RNAseq.g21203.t1,three_way,66.07983333333334,,,,,,,,,,,,,,,,,
OG_02627,2.109996308324286,FUN_010779-T1,Peve_00004487,Pocillopora_meandrina_HIv1___TS.g25955.t1,three_way,91.82266666666666,FUN_010779-T1,Q9D1P2,KAT8_MOUSE,,"Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (Males-absent on the first protein homolog) (mMof) (Protein acetyltransferase KAT8) (EC 2.3.1.-) (Protein propionyltransferase KAT8) (EC 2.3.1.-)",Mus musculus (Mouse),76.1,397.0,6.4e-180,631.7,sp|Q9D1P2|KAT8_MOUSE Histone acetyltransferase KAT8 OS=Mus musculus OX=10090 GN=Kat8 PE=1 SV=1,GO:0000123; GO:0000776; GO:0003713; GO:0005634; GO:0005694; GO:0005739; GO:0008270; GO:0009048; GO:0010506; GO:0010719; GO:0016363; GO:0016407; GO:0019899; GO:0022008; GO:0030099; GO:0032480; GO:0035166; GO:0043995; GO:0043996; GO:0044545; GO:0045815; GO:0045892; GO:0045893; GO:0046972; GO:0048477; GO:0050684; GO:0060261; GO:0061629; GO:0061733; GO:0061920; GO:0071339; GO:0072487; GO:1902726; GO:1903108; GO:1990841,dosage compensation by inactivation of X chromosome [GO:0009048]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; promoter-specific chromatin binding [GO:1990841]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005694; GO:0005739; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; mitochondrion; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02630,2.5584451473146244,FUN_010783-T1,Peve_00004471,Pocillopora_meandrina_HIv1___RNAseq.g21210.t1,three_way,72.516,FUN_010783-T1,Q8IXJ9,,,,,32.9,429.0,7.2e-42,173.7,sp|Q8IXJ9|ASXL1_HUMAN Polycomb group protein ASXL1 OS=Homo sapiens OX=9606 GN=ASXL1 PE=1 SV=4,,,,,,
OG_02634,1.1535401687435878,FUN_010796-T1,Peve_00007588,Pocillopora_meandrina_HIv1___RNAseq.g21226.t1,three_way,85.93299999999999,FUN_010796-T1,Q7ZTL7,,,,,64.3,414.0,4.5e-159,562.4,sp|Q7ZTL7|BCS1_XENLA Mitochondrial chaperone BCS1 OS=Xenopus laevis OX=8355 GN=bcs1l PE=2 SV=1,,,,,,
OG_02635,1.9882470087466952,FUN_010802-T1,Peve_00007033,Pocillopora_meandrina_HIv1___TS.g25986.t1,three_way,47.278,FUN_010802-T1,Q8NDA2,,,,,20.6,880.0,4.9e-29,131.7,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_02636,1.7725958885326338,FUN_010803-T1,Peve_00021409,Pocillopora_meandrina_HIv1___RNAseq.g21236.t1,three_way,82.66833333333334,FUN_010803-T1,Q9BSC4,,,,,62.3,687.0,1.6999999999999999e-205,717.2,sp|Q9BSC4|NOL10_HUMAN Nucleolar protein 10 OS=Homo sapiens OX=9606 GN=NOL10 PE=1 SV=1,,,,,,
OG_02638,2.748873375796813,FUN_010805-T1,Peve_00006505,Pocillopora_meandrina_HIv1___RNAseq.g26670.t1,three_way,61.43866666666667,FUN_010805-T1,P31228,OXDD_BOVIN,,D-aspartate oxidase (DASOX) (DASPO) (DDO) (EC 1.4.3.1),Bos taurus (Bovine),26.8,406.0,3.7999999999999995e-24,114.0,sp|P31228|OXDD_BOVIN D-aspartate oxidase OS=Bos taurus OX=9913 GN=DDO PE=1 SV=3,GO:0005737; GO:0005782; GO:0005829; GO:0008445; GO:0019478; GO:0047821; GO:0050877; GO:0071949,D-amino acid catabolic process [GO:0019478]; nervous system process [GO:0050877],cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782],D-aspartate oxidase activity [GO:0008445]; D-glutamate oxidase activity [GO:0047821]; FAD binding [GO:0071949],GO:0003824; GO:0005829; GO:0006520; GO:0016491; GO:0050877,catalytic activity; cytosol; amino acid metabolic process; oxidoreductase activity; nervous system process
OG_02639,2.492264302204724,FUN_010807-T1,Peve_00006506,Pocillopora_meandrina_HIv1___RNAseq.g20902.t1,three_way,83.408,FUN_010807-T1,Q9QXG4,ACSA_MOUSE,,"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)",Mus musculus (Mouse),65.8,679.0,2.1999999999999999e-280,966.1,"sp|Q9QXG4|ACSA_MOUSE Acetyl-coenzyme A synthetase, cytoplasmic OS=Mus musculus OX=10090 GN=Acss2 PE=1 SV=2",GO:0003682; GO:0003713; GO:0003987; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006085; GO:0006629; GO:0007616; GO:0050218,acetyl-CoA biosynthetic process [GO:0006085]; lipid metabolic process [GO:0006629]; long-term memory [GO:0007616],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; propionate-CoA ligase activity [GO:0050218]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005829; GO:0006629; GO:0006790; GO:0016874; GO:0043226; GO:0050877; GO:0055086; GO:0060090; GO:0140110; GO:0140657,catalytic activity; nucleus; cytosol; lipid metabolic process; sulfur compound metabolic process; ligase activity; organelle; nervous system process; nucleobase-containing small molecule metabolic process; molecular adaptor activity; transcription regulator activity; ATP-dependent activity
OG_02640,3.021284822367148,FUN_010808-T1,Peve_00006509,Pocillopora_meandrina_HIv1___RNAseq.g20903.t1,three_way,79.348,FUN_010808-T1,Q3TYL0,,,,,49.1,489.0,1.2e-64,249.2,sp|Q3TYL0|IQAK1_MOUSE IQ motif and ankyrin repeat domain-containing protein 1 OS=Mus musculus OX=10090 GN=Iqank1 PE=1 SV=3,,,,,,
OG_02642,3.4891107601347096,FUN_010810-T1,Peve_00006510,Pocillopora_meandrina_HIv1___RNAseq.g20905.t1,three_way,54.041,FUN_010810-T1,Q49LS8,,,,,31.2,420.0,1e-51,207.2,sp|Q49LS8|XKR6_TETNG XK-related protein 6 OS=Tetraodon nigroviridis OX=99883 GN=xkr6 PE=2 SV=1,,,,,,
OG_02643,2.593365917267908,FUN_010811-T1,Peve_00006518,Pocillopora_meandrina_HIv1___RNAseq.g20907.t1,three_way,57.91116666666667,FUN_010811-T1,Q0P4V4,,,,,29.0,715.0,7.6e-73,276.9,sp|Q0P4V4|KTU_XENTR Protein kintoun OS=Xenopus tropicalis OX=8364 GN=dnaaf2 PE=2 SV=1,,,,,,
OG_02644,2.0682288471888213,FUN_010814-T1,Peve_00006521,Pocillopora_meandrina_HIv1___RNAseq.g20908.t1,three_way,94.45533333333331,FUN_010814-T1,Q96BR1,SGK3_HUMAN,,Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like),Homo sapiens (Human),64.1,485.0,1e-175,617.8,sp|Q96BR1|SGK3_HUMAN Serine/threonine-protein kinase Sgk3 OS=Homo sapiens OX=9606 GN=SGK3 PE=1 SV=1,GO:0001558; GO:0004672; GO:0004674; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0006468; GO:0015459; GO:0017080; GO:0017081; GO:0030334; GO:0035091; GO:0035556; GO:0042127; GO:0051090; GO:0055037; GO:0106310; GO:2001240,intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090],cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037],ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080],GO:0003824; GO:0005768; GO:0005829; GO:0006355; GO:0008289; GO:0016740; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endosome; cytosol; regulation of DNA-templated transcription; lipid binding; transferase activity; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02646,1.5763001012376454,FUN_010827-T1,Peve_00006524,Pocillopora_meandrina_HIv1___RNAseq.g20910.t1,three_way,77.81533333333333,FUN_010827-T1,Q80UK8,,,,,45.5,1277.0,4.8e-286,985.7,sp|Q80UK8|INT2_MOUSE Integrator complex subunit 2 OS=Mus musculus OX=10090 GN=Ints2 PE=1 SV=2,,,,,,
OG_02647,1.599396162548282,FUN_010829-T1,Peve_00017534,Pocillopora_meandrina_HIv1___RNAseq.g20912.t1,three_way,43.3975,,,,,,,,,,,,,,,,,
OG_02655,2.45754131219282,FUN_010838-T1,Peve_00014585,Pocillopora_meandrina_HIv1___RNAseq.g21010.t1,three_way,86.72466666666666,FUN_010838-T1,Q4V7Z0,,,,,63.6,280.0,6.3e-101,368.6,sp|Q4V7Z0|GPN3_XENLA GPN-loop GTPase 3 OS=Xenopus laevis OX=8355 GN=gpn3 PE=2 SV=1,,,,,,
OG_02656,1.9264516126689208,FUN_010839-T1,Peve_00014584,Pocillopora_meandrina_HIv1___RNAseq.g21009.t1,three_way,68.30383333333333,FUN_010839-T1,Q8TAC1,,,,,46.9,128.0,1.1000000000000001e-30,134.4,sp|Q8TAC1|RFESD_HUMAN Rieske domain-containing protein OS=Homo sapiens OX=9606 GN=RFESD PE=1 SV=1,,,,,,
OG_02657,2.292236379594734,FUN_010840-T3,Peve_00014596,Pocillopora_meandrina_HIv1___RNAseq.g21008.t1,three_way,71.34866666666667,FUN_010840-T3,Q05B79,DHX36_BOVIN,,ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein),Bos taurus (Bovine),49.9,1010.0,5.3e-265,915.6,sp|Q05B79|DHX36_BOVIN ATP-dependent DNA/RNA helicase DHX36 OS=Bos taurus OX=9913 GN=DHX36 PE=1 SV=1,GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:0140640; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]",GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006355; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0098542; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; defense response to other organism; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02658,1.6462694557314663,FUN_010841-T1,Peve_00024826,Pocillopora_meandrina_HIv1___RNAseq.g21007.t1,three_way,64.80283333333334,FUN_010841-T1,Q8NDL9,CBPC5_HUMAN,,Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5),Homo sapiens (Human),47.5,703.0,2.5e-179,630.9,sp|Q8NDL9|CBPC5_HUMAN Cytosolic carboxypeptidase-like protein 5 OS=Homo sapiens OX=9606 GN=AGBL5 PE=1 SV=1,GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0051607; GO:0072686,C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02660,1.5113239509639371,FUN_010874-T1,Peve_00030154,Pocillopora_meandrina_HIv1___RNAseq.g21026.t1,three_way,89.481,FUN_010874-T1,Q6DUZ9,,,,,47.3,391.0,1.4999999999999999e-92,341.3,sp|Q6DUZ9|EIPR1_GEKJA EARP-interacting protein homolog OS=Gekko japonicus OX=146911 GN=eipr1 PE=2 SV=1,,,,,,
OG_02661,1.1842502000539534,FUN_010875-T1,Peve_00009757,Pocillopora_meandrina_HIv1___RNAseq.g7085.t1,three_way,62.856,FUN_010875-T1,Q99LH1,,,,,67.8,466.0,6.2e-182,639.4,sp|Q99LH1|NOG2_MOUSE Nucleolar GTP-binding protein 2 OS=Mus musculus OX=10090 GN=Gnl2 PE=1 SV=2,,,,,,
OG_02662,2.658864091242383,FUN_010878-T1,Peve_00009759,Pocillopora_meandrina_HIv1___TS.128_t,three_way,78.95733333333334,FUN_010878-T1,Q86WA6,BPHL_HUMAN,,Serine hydrolase BPHL (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA) (L-homocysteine-thiolactonase BPHL) (Valacyclovir hydrolase) (VACVase) (Valacyclovirase),Homo sapiens (Human),57.3,253.0,1.5e-85,317.4,sp|Q86WA6|BPHL_HUMAN Serine hydrolase BPHL OS=Homo sapiens OX=9606 GN=BPHL PE=1 SV=1,GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0017171; GO:0047658; GO:0050667,amino acid metabolic process [GO:0006520]; homocysteine metabolic process [GO:0050667]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],alpha-amino-acid esterase activity [GO:0047658]; serine hydrolase activity [GO:0017171],GO:0003824; GO:0005739; GO:0006520; GO:0006790; GO:0016787; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; sulfur compound metabolic process; hydrolase activity; organelle
OG_02663,2.180687460753312,FUN_010879-T1,Peve_00035832,Pocillopora_meandrina_HIv1___RNAseq.g21030.t1,three_way,86.78866666666667,FUN_010879-T1,Q2KJI3,CYRIB_BOVIN,,CYFIP-related Rac1 interactor B (Protein FAM49B),Bos taurus (Bovine),65.7,327.0,8.4e-116,418.3,sp|Q2KJI3|CYRIB_BOVIN CYFIP-related Rac1 interactor B OS=Bos taurus OX=9913 GN=CYRIB PE=2 SV=1,GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031267; GO:0032729; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568,cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of type II interferon production [GO:0032729]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140],cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739],"MHC class Ib protein binding, via antigen binding groove [GO:0023030]; small GTPase binding [GO:0031267]",GO:0005739; GO:0005929; GO:0043226,mitochondrion; cilium; organelle
OG_02669,2.331074684281049,FUN_010888-T1,Peve_00035840,Pocillopora_meandrina_HIv1___RNAseq.g21001.t1,three_way,71.89333333333333,FUN_010888-T1,Q8VCM5,MUL1_MOUSE,,Mitochondrial ubiquitin ligase activator of NFKB 1 (EC 2.3.2.27) (E3 ubiquitin-protein ligase MUL1) (Growth inhibition and death E3 ligase) (Protein Hades) (RING-type E3 ubiquitin transferase NFKB 1),Mus musculus (Mouse),34.8,339.0,9.3e-59,228.8,sp|Q8VCM5|MUL1_MOUSE Mitochondrial ubiquitin ligase activator of NFKB 1 OS=Mus musculus OX=10090 GN=Mul1 PE=1 SV=2,GO:0000209; GO:0000266; GO:0002039; GO:0005739; GO:0005741; GO:0005777; GO:0006915; GO:0008270; GO:0010637; GO:0016567; GO:0016925; GO:0019789; GO:0030424; GO:0031625; GO:0031647; GO:0031648; GO:0033235; GO:0042802; GO:0043025; GO:0043123; GO:0045824; GO:0050689; GO:0050821; GO:0051646; GO:0051881; GO:0051898; GO:0060339; GO:0061630; GO:0071360; GO:0071650; GO:0090141; GO:1901028; GO:1903861; GO:1905091,apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of innate immune response [GO:0045824]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite extension [GO:1903861]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of type 2 mitophagy [GO:1905091]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein sumoylation [GO:0016925]; protein ubiquitination [GO:0016567]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of protein stability [GO:0031647],axon [GO:0030424]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777],identical protein binding [GO:0042802]; p53 binding [GO:0002039]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0005777; GO:0007005; GO:0012501; GO:0016740; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; mitochondrion; peroxisome; mitochondrion organization; programmed cell death; transferase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_02672,1.5366043375519685,FUN_010897-T1,Peve_00044944,Pocillopora_meandrina_HIv1___RNAseq.91_t,three_way,74.07666666666667,FUN_010897-T1,D3ZAT9,,,,,38.3,227.0,9.3e-45,181.8,sp|D3ZAT9|FAXC_RAT Failed axon connections homolog OS=Rattus norvegicus OX=10116 GN=Faxc PE=3 SV=1,,,,,,
OG_02676,2.11307736313873,FUN_010925-T1,Peve_00005955,Pocillopora_meandrina_HIv1___RNAseq.g21797.t1,three_way,57.31033333333333,,,,,,,,,,,,,,,,,
OG_02679,2.827644186259298,FUN_010929-T1,Peve_00005959,Pocillopora_meandrina_HIv1___RNAseq.g20983.t1,three_way,77.19966666666666,FUN_010929-T1,Q29RS4,IN80E_BOVIN,,INO80 complex subunit E (Coiled-coil domain-containing protein 95),Bos taurus (Bovine),70.3,64.0,1.3e-16,88.6,sp|Q29RS4|IN80E_BOVIN INO80 complex subunit E OS=Bos taurus OX=9913 GN=INO80E PE=2 SV=1,GO:0006281; GO:0006310; GO:0006338; GO:0031011,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],Ino80 complex [GO:0031011],,GO:0006281; GO:0006310; GO:0006325,DNA repair; DNA recombination; chromatin organization
OG_02680,2.0629733017976584,FUN_010930-T1,Peve_00005960,Pocillopora_meandrina_HIv1___RNAseq.g20982.t1a,three_way,40.99766666666667,,,,,,,,,,,,,,,,,
OG_02687,2.1835172683919475,FUN_010947-T1,Peve_00040399,Pocillopora_meandrina_HIv1___RNAseq.g21805.t1,three_way,64.768,,,,,,,,,,,,,,,,,
OG_02689,1.8822080067957632,FUN_010949-T1,Peve_00040395,Pocillopora_meandrina_HIv1___RNAseq.g21802.t1,three_way,77.62,FUN_010949-T1,Q7ZU90,CHD1L_DANRE,,Chromodomain-helicase-DNA-binding protein 1-like (EC 3.6.4.-),Danio rerio (Zebrafish) (Brachydanio rerio),52.9,877.0,3.7999999999999996e-235,816.2,sp|Q7ZU90|CHD1L_DANRE Chromodomain-helicase-DNA-binding protein 1-like OS=Danio rerio OX=7955 GN=chd1l PE=2 SV=1,GO:0000166; GO:0003678; GO:0005524; GO:0005634; GO:0006281; GO:0006338; GO:0006974; GO:0007420; GO:0016887; GO:0031491; GO:0035861; GO:0140566; GO:0140658; GO:0160004,brain development [GO:0007420]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA repair [GO:0006281],nucleus [GO:0005634]; site of double-strand break [GO:0035861],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; histone reader activity [GO:0140566]; nucleosome binding [GO:0031491]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004],GO:0003824; GO:0005634; GO:0006281; GO:0006325; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140657,"catalytic activity; nucleus; DNA repair; chromatin organization; hydrolase activity; isomerase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02691,1.4388030720376317,FUN_010951-T1,Peve_00015013,Pocillopora_meandrina_HIv1___TS.g26577.t1,three_way,51.42233333333333,,,,,,,,,,,,,,,,,
OG_02696,1.814238472769672,FUN_010960-T1,Peve_00007918,Pocillopora_meandrina_HIv1___RNAseq.g21827.t1,three_way,80.13816666666666,FUN_010960-T1,Q5F259,AN13B_MOUSE,,Ankyrin repeat domain-containing protein 13B,Mus musculus (Mouse),45.7,532.0,1.2e-126,455.3,sp|Q5F259|AN13B_MOUSE Ankyrin repeat domain-containing protein 13B OS=Mus musculus OX=10090 GN=Ankrd13b PE=2 SV=1,GO:0002091; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0048471; GO:0140036,negative regulation of receptor internalization [GO:0002091],cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ubiquitin-modified protein reader activity [GO:0140036],GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0060090,endosome; plasma membrane; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_02698,1.0370824604582138,FUN_010966-T1,Peve_00007917,Pocillopora_meandrina_HIv1___RNAseq.g21968.t1,three_way,49.817166666666665,,,,,,,,,,,,,,,,,
OG_02703,1.5512387308353426,FUN_010978-T1,Peve_00013381,Pocillopora_meandrina_HIv1___RNAseq.g22015.t1,three_way,71.64766666666667,FUN_010978-T1,Q9JMB7,PIWL1_MOUSE,,Piwi-like protein 1 (EC 3.1.26.-),Mus musculus (Mouse),50.6,765.0,4.8999999999999995e-237,822.4,sp|Q9JMB7|PIWL1_MOUSE Piwi-like protein 1 OS=Mus musculus OX=10090 GN=Piwil1 PE=1 SV=1,GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0007286; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0035092; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:0140990; GO:0140991; GO:0141006; GO:2000765,meiotic cell cycle [GO:0051321]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; primary piRNA processing [GO:0140990]; regulation of cytoplasmic translation [GO:2000765]; regulatory ncRNA-mediated gene silencing [GO:0031047]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186],metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; protein kinase binding [GO:0019901]; RNA endonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140098,"RNA binding; catalytic activity; nucleus; cytosol; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_02704,2.4291474489277047,FUN_010979-T2,Peve_00013382,Pocillopora_meandrina_HIv1___RNAseq.g22013.t1,three_way,50.22,,,,,,,,,,,,,,,,,
OG_02707,2.570155825797621,FUN_010984-T1,Peve_00013386,Pocillopora_meandrina_HIv1___RNAseq.g22009.t1,three_way,79.6975,FUN_010984-T1,Q7Z3V4,UBE3B_HUMAN,,Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B),Homo sapiens (Human),50.4,1075.0,3.1e-310,1065.8,sp|Q7Z3V4|UBE3B_HUMAN Ubiquitin-protein ligase E3B OS=Homo sapiens OX=9606 GN=UBE3B PE=1 SV=3,GO:0000209; GO:0005739; GO:0006511; GO:0014069; GO:0061630; GO:0098978; GO:0150052,protein polyubiquitination [GO:0000209]; regulation of postsynapse assembly [GO:0150052]; ubiquitin-dependent protein catabolic process [GO:0006511],glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; postsynaptic density [GO:0014069],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02708,1.1495615723107149,FUN_010985-T1,Peve_00013387,Pocillopora_meandrina_HIv1___RNAseq.g22008.t1,three_way,72.90966666666667,FUN_010985-T1,Q96JM7,,,,,33.9,840.0,2.0999999999999998e-129,464.9,sp|Q96JM7|LMBL3_HUMAN Lethal(3)malignant brain tumor-like protein 3 OS=Homo sapiens OX=9606 GN=L3MBTL3 PE=1 SV=2,,,,,,
OG_02709,3.0147795912962816,FUN_010986-T1,Peve_00013392,Pocillopora_meandrina_HIv1___RNAseq.g22007.t2,three_way,74.76766666666667,FUN_010986-T1,Q96LW2,,,,,38.4,315.0,3.4e-61,237.3,sp|Q96LW2|KS6R_HUMAN Ribosomal protein S6 kinase-related protein OS=Homo sapiens OX=9606 GN=RSKR PE=1 SV=3,,,,,,
OG_02710,1.0858219775985771,FUN_010988-T1,Peve_00013393,Pocillopora_meandrina_HIv1___TS.g26769.t2,three_way,57.87616666666666,FUN_010988-T1,Q6NWI1,,,,,32.3,189.0,1.5e-11,72.0,sp|Q6NWI1|RSRC2_DANRE Arginine/serine-rich coiled-coil protein 2 OS=Danio rerio OX=7955 GN=rsrc2 PE=2 SV=1,,,,,,
OG_02711,1.344664667455758,FUN_010989-T1,Peve_00013395,Pocillopora_meandrina_HIv1___RNAseq.g22004.t1c,three_way,72.40866666666666,,,,,,,,,,,,,,,,,
OG_02712,2.723725854990665,FUN_010990-T1,Peve_00013396,Pocillopora_meandrina_HIv1___TS.g29847.t1,three_way,54.55116666666667,FUN_010990-T1,Q6J4K2,NCLX_HUMAN,,"Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)",Homo sapiens (Human),39.1,539.0,1.6e-99,365.2,sp|Q6J4K2|NCLX_HUMAN Mitochondrial sodium/calcium exchanger protein OS=Homo sapiens OX=9606 GN=SLC8B1 PE=1 SV=2,GO:0005432; GO:0005739; GO:0005743; GO:0005886; GO:0006811; GO:0006851; GO:0006874; GO:0015368; GO:0016020; GO:0030061; GO:0031966; GO:0042383; GO:0042593; GO:0042803; GO:0050796; GO:0051480; GO:0051560; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256,calcium export from the mitochondrion [GO:0099093]; glucose homeostasis [GO:0042593]; intracellular calcium ion homeostasis [GO:0006874]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; monoatomic ion transport [GO:0006811]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256],membrane [GO:0016020]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],calcium:monoatomic cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_02716,2.283532387373007,FUN_010999-T1,Peve_00013407,Pocillopora_meandrina_HIv1___RNAseq.g22023.t1,three_way,83.44866666666667,FUN_010999-T1,A4IF93,,,,,42.4,582.0,1.5999999999999999e-127,458.0,sp|A4IF93|TBCC1_BOVIN TBCC domain-containing protein 1 OS=Bos taurus OX=9913 GN=TBCCD1 PE=2 SV=1,,,,,,
OG_02717,1.0867135929686176,FUN_011000-T1,Peve_00013408,Pocillopora_meandrina_HIv1___RNAseq.g22022.t1,three_way,93.14033333333332,FUN_011000-T1,A7S8T5,,,,,85.2,304.0,7.2e-122,438.3,sp|A7S8T5|CCD42_NEMVE Coiled-coil domain-containing protein 42 homolog OS=Nematostella vectensis OX=45351 GN=v1g187067 PE=3 SV=1,,,,,,
OG_02718,3.995341941698172,FUN_011001-T1,Peve_00013415,Pocillopora_meandrina_HIv1___RNAseq.g22019.t1,three_way,62.246,FUN_011001-T1,A8WFU8,KIF22_DANRE,,Kinesin-like protein KIF22,Danio rerio (Zebrafish) (Brachydanio rerio),41.6,632.0,3.4e-120,433.7,sp|A8WFU8|KIF22_DANRE Kinesin-like protein KIF22 OS=Danio rerio OX=7955 GN=kif22 PE=2 SV=1,GO:0001756; GO:0001966; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007409; GO:0007420; GO:0008017; GO:0016887; GO:0021952; GO:0048592,axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; eye morphogenesis [GO:0048592]; microtubule-based movement [GO:0007018]; somitogenesis [GO:0001756]; thigmotaxis [GO:0001966],cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003677; GO:0003774; GO:0003824; GO:0005634; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0140657,DNA binding; cytoskeletal motor activity; catalytic activity; nucleus; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; anatomical structure development; ATP-dependent activity
OG_02719,1.9959561844085107,FUN_011046-T1,Peve_00013440,Pocillopora_meandrina_HIv1___RNAseq.g21485.t2,three_way,75.79966666666667,FUN_011046-T1,Q567Y6,,,,,48.7,187.0,3.3999999999999995e-53,209.9,sp|Q567Y6|IFT22_DANRE Intraflagellar transport protein 22 homolog OS=Danio rerio OX=7955 GN=ift22 PE=2 SV=1,,,,,,
OG_02722,1.4172431608771008,FUN_011051-T1,Peve_00022611,Pocillopora_meandrina_HIv1___RNAseq.g20976.t1,three_way,89.26266666666666,FUN_011051-T1,Q7T312,,,,,73.6,208.0,1.3e-58,227.6,sp|Q7T312|CCD25_DANRE Coiled-coil domain-containing protein 25 OS=Danio rerio OX=7955 GN=ccdc25 PE=1 SV=1,,,,,,
OG_02723,2.0951730025985693,FUN_011058-T1,Peve_00009503,Pocillopora_meandrina_HIv1___RNAseq.g22353.t1,three_way,79.46733333333333,FUN_011058-T1,P57772,SELB_HUMAN,,"Selenocysteine-specific elongation factor (EC 3.6.5.-) (Elongation factor sec) (Eukaryotic elongation factor, selenocysteine-tRNA-specific)",Homo sapiens (Human),58.6,594.0,1.7999999999999998e-190,667.2,sp|P57772|SELB_HUMAN Selenocysteine-specific elongation factor OS=Homo sapiens OX=9606 GN=EEFSEC PE=1 SV=4,GO:0000049; GO:0001514; GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0035368; GO:0043021; GO:1990904,selenocysteine incorporation [GO:0001514],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0003924; GO:0005634; GO:0016787; GO:0043226,RNA binding; catalytic activity; GTPase activity; nucleus; hydrolase activity; organelle
OG_02725,1.073885115180592,FUN_011065-T1,Peve_00009498,Pocillopora_meandrina_HIv1___TS.g27087.t1,three_way,52.62766666666667,,,,,,,,,,,,,,,,,
OG_02727,1.9644683343899456,FUN_011179-T1,Peve_00006850,Pocillopora_meandrina_HIv1___RNAseq.g22322.t1,three_way,55.33916666666666,FUN_011179-T1,Q0V9E9,KMT5A_XENTR,,N-lysine methyltransferase KMT5A (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine-specific methylase 5A) (SET domain-containing protein 8),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),50.6,174.0,1.2999999999999998e-47,191.8,sp|Q0V9E9|KMT5A_XENTR N-lysine methyltransferase KMT5A OS=Xenopus tropicalis OX=8364 GN=kmt5a PE=2 SV=1,GO:0005634; GO:0005694; GO:0032259; GO:0042054; GO:0051301; GO:0140944,cell division [GO:0051301]; methylation [GO:0032259],chromosome [GO:0005694]; nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054],GO:0003824; GO:0005634; GO:0005694; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02728,2.778612580134159,FUN_011252-T1,Peve_00024318,Pocillopora_meandrina_HIv1___RNAseq.g11307.t1,three_way,52.192,,,,,,,,,,,,,,,,,
OG_02730,1.558781883510995,FUN_011258-T1,Peve_00030534,Pocillopora_meandrina_HIv1___RNAseq.g22312.t1,three_way,68.89616666666667,FUN_011258-T1,A7MBS7,THS7A_DANRE,,Thrombospondin type-1 domain-containing protein 7A,Danio rerio (Zebrafish) (Brachydanio rerio),37.6,85.0,3.7e-08,60.5,sp|A7MBS7|THS7A_DANRE Thrombospondin type-1 domain-containing protein 7A OS=Danio rerio OX=7955 GN=thsd7aa PE=1 SV=2,GO:0001525; GO:0002040; GO:0003094; GO:0005886; GO:0008593; GO:0030036; GO:0032835; GO:0042995; GO:0043534; GO:0048675; GO:0072015,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; blood vessel endothelial cell migration [GO:0043534]; glomerular filtration [GO:0003094]; glomerulus development [GO:0032835]; podocyte development [GO:0072015]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040],cell projection [GO:0042995]; plasma membrane [GO:0005886],,GO:0003014; GO:0005886; GO:0007010; GO:0048856; GO:0048870,renal system process; plasma membrane; cytoskeleton organization; anatomical structure development; cell motility
OG_02731,2.8600690958045147,FUN_011259-T1,Peve_00032917,Pocillopora_meandrina_HIv1___RNAseq.g20815.t1,three_way,43.78766666666667,,,,,,,,,,,,,,,,,
OG_02733,1.6548136651703649,FUN_011263-T1,Peve_00030535,Pocillopora_meandrina_HIv1___RNAseq.g22311.t1,three_way,85.00733333333334,FUN_011263-T1,Q7ZTI5,,,,,56.7,134.0,1.0000000000000001e-29,131.0,sp|Q7ZTI5|MED21_DANRE Mediator of RNA polymerase II transcription subunit 21 OS=Danio rerio OX=7955 GN=med21 PE=2 SV=1,,,,,,
OG_02734,1.2267374819220276,FUN_011264-T1,Peve_00030536,Pocillopora_meandrina_HIv1___RNAseq.g22310.t1,three_way,79.29683333333332,FUN_011264-T1,P02401,,,,,70.6,68.0,7.3e-19,94.7,sp|P02401|RLA2_RAT Large ribosomal subunit protein P2 OS=Rattus norvegicus OX=10116 GN=Rplp2 PE=1 SV=2,,,,,,
OG_02735,1.6431044350683812,FUN_011273-T1,Peve_00042902,Pocillopora_meandrina_HIv1___RNAseq.g22332.t1,three_way,93.65966666666668,FUN_011273-T1,P80317,TCPZ_MOUSE,,T-complex protein 1 subunit zeta (TCP-1-zeta) (EC 3.6.1.-) (CCT-zeta-1),Mus musculus (Mouse),79.5,531.0,1e-240,833.9,sp|P80317|TCPZ_MOUSE T-complex protein 1 subunit zeta OS=Mus musculus OX=10090 GN=Cct6a PE=1 SV=3,GO:0001669; GO:0002199; GO:0005524; GO:0005832; GO:0007339; GO:0016887; GO:0044297; GO:0051082; GO:0140662,binding of sperm to zona pellucida [GO:0007339],acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; zona pellucida receptor complex [GO:0002199],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082],GO:0003824; GO:0016787; GO:0031410; GO:0043226; GO:0044183; GO:0140657,catalytic activity; hydrolase activity; cytoplasmic vesicle; organelle; protein folding chaperone; ATP-dependent activity
OG_02738,1.0707959561852125,FUN_011279-T1,Peve_00030533,Pocillopora_meandrina_HIv1___RNAseq.g16628.t1,three_way,79.54599999999999,FUN_011279-T1,Q96FV9,THOC1_HUMAN,,THO complex subunit 1 (Nuclear matrix protein p84) (p84N5) (hTREX84),Homo sapiens (Human),57.0,530.0,2.1999999999999998e-166,587.0,sp|Q96FV9|THOC1_HUMAN THO complex subunit 1 OS=Homo sapiens OX=9606 GN=THOC1 PE=1 SV=1,GO:0000346; GO:0000347; GO:0000445; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607,apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346],DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006913; GO:0012501; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; nucleocytoplasmic transport; programmed cell death; mRNA metabolic process; organelle
OG_02739,1.9963105128049343,FUN_011280-T1,Peve_00037297,Pocillopora_meandrina_HIv1___RNAseq.g22318.t1,three_way,82.50566666666667,FUN_011280-T1,Q5FW48,,,,,49.3,282.0,2.3000000000000002e-74,280.4,sp|Q5FW48|ASPDH_XENTR Aspartate dehydrogenase domain-containing protein OS=Xenopus tropicalis OX=8364 GN=aspdh PE=2 SV=1,,,,,,
OG_02743,1.8155855544907005,FUN_011307-T1,Peve_00042903,Pocillopora_meandrina_HIv1___RNAseq.g22315.t1,three_way,85.486,FUN_011307-T1,Q07994,,,,,59.8,478.0,1.3e-170,600.9,sp|Q07994|NCPR_MUSDO NADPH--cytochrome P450 reductase OS=Musca domestica OX=7370 PE=2 SV=1,,,,,,
OG_02745,2.202259903807156,FUN_011322-T1,Peve_00039481,Pocillopora_meandrina_HIv1___TS.g19552.t1,three_way,71.28733333333334,,,,,,,,,,,,,,,,,
OG_02750,2.9008476877420764,FUN_011418-T1,Peve_00033617,Pocillopora_meandrina_HIv1___TS.g27039.t1,three_way,80.7965,FUN_011418-T1,Q96ES7,,,,,62.4,290.0,1.7999999999999998e-96,354.0,sp|Q96ES7|SGF29_HUMAN SAGA-associated factor 29 OS=Homo sapiens OX=9606 GN=SGF29 PE=1 SV=1,,,,,,
OG_02751,2.0133392685468388,FUN_011680-T1,Peve_00027006,Pocillopora_meandrina_HIv1___TS.g16787.t2,three_way,51.315666666666665,FUN_011680-T1,Q58DQ5,RT09_BOVIN,,"Small ribosomal subunit protein uS9m (28S ribosomal protein S9, mitochondrial) (MRP-S9) (S9mt)",Bos taurus (Bovine),38.9,211.0,8.200000000000001e-32,139.8,sp|Q58DQ5|RT09_BOVIN Small ribosomal subunit protein uS9m OS=Bos taurus OX=9913 GN=MRPS9 PE=1 SV=3,GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0006412,translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198,RNA binding; structural molecule activity
OG_02752,2.2027268765404906,FUN_011681-T1,Peve_00027007,Pocillopora_meandrina_HIv1___RNAseq.g23914.t1,three_way,78.4315,FUN_011681-T1,Q13492,,,,,59.6,349.0,2e-112,407.5,sp|Q13492|PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens OX=9606 GN=PICALM PE=1 SV=2,,,,,,
OG_02753,1.1883557455126152,FUN_011682-T1,Peve_00027009,Pocillopora_meandrina_HIv1___RNAseq.g23916.t1,three_way,59.67133333333334,FUN_011682-T1,Q8K4Z4,,,,,26.8,317.0,1.8e-17,91.7,sp|Q8K4Z4|ADRB2_CAVPO Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1,,,,,,
OG_02754,2.5727038195835976,FUN_011684-T1,Peve_00027010,Pocillopora_meandrina_HIv1___RNAseq.g23917.t1b,three_way,67.25733333333334,FUN_011684-T1,Q9KX40,,,,,31.0,187.0,4.1e-13,78.2,sp|Q9KX40|ESTB_BURGA Esterase EstB OS=Burkholderia gladioli OX=28095 GN=estB PE=1 SV=1,,,,,,
OG_02755,2.144505741127,FUN_011686-T1,Peve_00027012,Pocillopora_meandrina_HIv1___TS.g16793.t1,three_way,69.86533333333334,FUN_011686-T1,Q5U2R1,,,,,41.5,347.0,1.8e-64,248.1,sp|Q5U2R1|DLP1_RAT All trans-polyprenyl-diphosphate synthase PDSS2 OS=Rattus norvegicus OX=10116 GN=Pdss2 PE=2 SV=1,,,,,,
OG_02759,2.1603026125604003,FUN_011696-T1,Peve_00010715,Pocillopora_meandrina_HIv1___RNAseq.g23904.t1,three_way,73.33366666666667,FUN_011696-T1,A8XJZ8,,,,,45.2,93.0,1.1e-14,83.2,sp|A8XJZ8|LST2_CAEBR Lateral signaling target protein 2 OS=Caenorhabditis briggsae OX=6238 GN=lst-2 PE=3 SV=1,,,,,,
OG_02761,2.166789505402271,FUN_011698-T1,Peve_00018061,Pocillopora_meandrina_HIv1___RNAseq.g23828.t1,three_way,91.74833333333332,FUN_011698-T1,P31365,,,,,51.6,320.0,9.500000000000001e-71,268.9,"sp|P31365|P3F2A_XENLA POU domain, class 3, transcription factor 2-A OS=Xenopus laevis OX=8355 GN=pou3f2-a PE=2 SV=2",,,,,,
OG_02763,1.059677688778684,FUN_011701-T1,Peve_00018057,Pocillopora_meandrina_HIv1___RNAseq.g23825.t1,three_way,69.27133333333333,FUN_011701-T1,Q9CZJ1,,,,,49.8,205.0,8.9e-46,185.3,sp|Q9CZJ1|UTP11_MOUSE Probable U3 small nucleolar RNA-associated protein 11 OS=Mus musculus OX=10090 GN=Utp11 PE=2 SV=1,,,,,,
OG_02766,2.004271912611346,FUN_011704-T1,Peve_00025152,Pocillopora_meandrina_HIv1___RNAseq.g23821.t1,three_way,60.856,,,,,,,,,,,,,,,,,
OG_02770,1.9120160163392943,FUN_011709-T1,Peve_00025138,Pocillopora_meandrina_HIv1___RNAseq.g23817.t1,three_way,57.62166666666666,,,,,,,,,,,,,,,,,
OG_02773,1.451792637387067,FUN_011716-T1,Peve_00039703,Pocillopora_meandrina_HIv1___TS.g16734.t1,three_way,63.82533333333333,FUN_011716-T1,Q9UBS5,,,,,31.7,715.0,1.3e-98,362.5,sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1,,,,,,
OG_02775,1.5978886423278291,FUN_011723-T1,Peve_00039705,Pocillopora_meandrina_HIv1___RNAseq.g23852.t1,three_way,65.70083333333334,FUN_011723-T1,Q8C142,ARH_MOUSE,,Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein homolog),Mus musculus (Mouse),31.4,287.0,7.900000000000001e-28,126.3,sp|Q8C142|ARH_MOUSE Low density lipoprotein receptor adapter protein 1 OS=Mus musculus OX=10090 GN=Ldlrap1 PE=1 SV=3,GO:0001540; GO:0001784; GO:0005102; GO:0005546; GO:0005737; GO:0005769; GO:0005829; GO:0005883; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0031623; GO:0034383; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0048260; GO:0050750; GO:0055037; GO:0071345; GO:0090118; GO:1903076; GO:1904707; GO:1905581; GO:1905602,amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein localization to plasma membrane [GO:1903076],basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; recycling endosome [GO:0055037],"amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159]",GO:0005768; GO:0005829; GO:0006629; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0060090,endosome; cytosol; lipid metabolic process; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_02776,2.7449794629299387,FUN_011724-T1,Peve_00039706,Pocillopora_meandrina_HIv1___RNAseq.g23851.t1,three_way,75.24866666666667,FUN_011724-T1,Q6ZV70,,,,,39.1,238.0,1.7999999999999998e-35,151.0,sp|Q6ZV70|LANC3_HUMAN LanC-like protein 3 OS=Homo sapiens OX=9606 GN=LANCL3 PE=1 SV=2,,,,,,
OG_02777,2.1356750931967525,FUN_011725-T1,Peve_00039709,Pocillopora_meandrina_HIv1___RNAseq.g23849.t1,three_way,80.71566666666666,FUN_011725-T1,Q4R918,KIF25_MACFA,,Kinesin-like protein KIF25,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),41.1,604.0,4.1000000000000004e-111,403.7,sp|Q4R918|KIF25_MACFA Kinesin-like protein KIF25 OS=Macaca fascicularis OX=9541 GN=KIF25 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647,establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; protein-containing complex assembly; ATP-dependent activity
OG_02778,1.8853175195447944,FUN_011727-T1,Peve_00001116,Pocillopora_meandrina_HIv1___RNAseq.g23847.t1,three_way,87.899,FUN_011727-T1,Q6PUR6,,,,,66.2,278.0,8.1e-108,391.7,sp|Q6PUR6|GPN2_DANRE GPN-loop GTPase 2 OS=Danio rerio OX=7955 GN=gpn2 PE=2 SV=1,,,,,,
OG_02779,1.7967194699424056,FUN_011729-T1,Peve_00001119,Pocillopora_meandrina_HIv1___RNAseq.g23842.t1,three_way,77.98466666666667,FUN_011729-T1,Q9Y233,PDE10_HUMAN,,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17)",Homo sapiens (Human),39.8,757.0,1.0000000000000001e-159,565.5,"sp|Q9Y233|PDE10_HUMAN cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A OS=Homo sapiens OX=9606 GN=PDE10A PE=1 SV=2",GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0010754; GO:0019933; GO:0030552; GO:0030553; GO:0046069; GO:0046872; GO:0047555; GO:0098978; GO:0106070; GO:0141161,cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of cAMP/PKA signal transduction [GO:0141161],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02782,2.219070451929318,FUN_011733-T1,Peve_00001121,Pocillopora_meandrina_HIv1___RNAseq.g23840.t2,three_way,53.03233333333333,FUN_011733-T1,Q6ZPR6,,,,,30.4,1491.0,1.3e-160,569.3,sp|Q6ZPR6|IBTK_MOUSE Inhibitor of Bruton tyrosine kinase OS=Mus musculus OX=10090 GN=Ibtk PE=1 SV=3,,,,,,
OG_02784,2.2655485493156724,FUN_011739-T1,Peve_00034110,Pocillopora_meandrina_HIv1___RNAseq.g23880.t1,three_way,77.65533333333333,,,,,,,,,,,,,,,,,
OG_02785,1.6386900372987552,FUN_011740-T1,Peve_00034096,Pocillopora_meandrina_HIv1___RNAseq.g23881.t1,three_way,76.12266666666666,,,,,,,,,,,,,,,,,
OG_02790,1.3147807654581372,FUN_011746-T1,Peve_00034104,Pocillopora_meandrina_HIv1___RNAseq.g23886.t1,three_way,89.25333333333334,FUN_011746-T1,A7SD85,CDC5L_NEMVE,,Cell division cycle 5-related protein (Cdc5-like protein),Nematostella vectensis (Starlet sea anemone),75.6,807.0,0.0,1146.3,sp|A7SD85|CDC5L_NEMVE Cell division cycle 5-related protein OS=Nematostella vectensis OX=45351 GN=cdc5l PE=3 SV=1,GO:0000398; GO:0000974; GO:0000977; GO:0000981; GO:0003723; GO:0005681; GO:0005737; GO:0006281; GO:0006357,"DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; regulation of transcription by RNA polymerase II [GO:0006357]",cytoplasm [GO:0005737]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0003723; GO:0006281; GO:0006355; GO:0016071; GO:0140110,DNA binding; RNA binding; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; transcription regulator activity
OG_02796,1.375165776925198,FUN_011761-T1,Peve_00005550,Pocillopora_meandrina_HIv1___TS.g16681.t2,three_way,83.095,FUN_011761-T1,Q8TBF4,,,,,75.6,131.0,1.9e-54,213.4,sp|Q8TBF4|ZCRB1_HUMAN Zinc finger CCHC-type and RNA-binding motif-containing protein 1 OS=Homo sapiens OX=9606 GN=ZCRB1 PE=1 SV=2,,,,,,
OG_02797,1.2688544712345835,FUN_011764-T1,Peve_00035077,Pocillopora_meandrina_HIv1___RNAseq.g23801.t1,three_way,73.43533333333333,FUN_011764-T1,O95684,CEP43_HUMAN,,Centrosomal protein 43 (FGFR1 oncogene partner),Homo sapiens (Human),41.7,422.0,3.699999999999999e-43,177.2,sp|O95684|CEP43_HUMAN Centrosomal protein 43 OS=Homo sapiens OX=9606 GN=CEP43 PE=1 SV=1,GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0006469; GO:0008284; GO:0019901; GO:0030030; GO:0030292; GO:0030307; GO:0030335; GO:0034453; GO:0042803; GO:0042995; GO:0048471,cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284],cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292],GO:0005634; GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; cytoskeleton organization; organelle; molecular function regulator activity
OG_02798,1.9428903004744325,FUN_011765-T1,Peve_00035074,Pocillopora_meandrina_HIv1___RNAseq.g23800.t1,three_way,86.81066666666666,FUN_011765-T1,P43246,MSH2_HUMAN,,DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2),Homo sapiens (Human),59.3,934.0,0.0,1095.9,sp|P43246|MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens OX=9606 GN=MSH2 PE=1 SV=1,GO:0000781; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0007281; GO:0008047; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0030183; GO:0031573; GO:0032137; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0140664,B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204],"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; guanine/thymine mispair binding [GO:0032137]; protein homodimerization activity [GO:0042803]",GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006091; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; generation of precursor metabolites and energy; DNA repair; DNA recombination; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_02799,1.29375238177773,FUN_011766-T1,Peve_00029899,Pocillopora_meandrina_HIv1___RNAseq.g23799.t1,three_way,72.32466666666667,,,,,,,,,,,,,,,,,
OG_02801,1.858562633507248,FUN_011772-T2,Peve_00034382,Pocillopora_meandrina_HIv1___RNAseq.g23369.t1,three_way,80.90816666666667,FUN_011772-T2,Q3T9Z9,,,,,45.5,363.0,7.700000000000001e-73,276.2,sp|Q3T9Z9|ZUP1_MOUSE Zinc finger-containing ubiquitin peptidase 1 OS=Mus musculus OX=10090 GN=Zup1 PE=2 SV=2,,,,,,
OG_02809,1.598851351335095,FUN_011782-T1,Peve_00041236,Pocillopora_meandrina_HIv1___RNAseq.g23305.t1,three_way,58.14066666666667,FUN_011782-T1,Q8R149,,,,,48.5,204.0,3.2e-45,184.5,sp|Q8R149|BUD13_MOUSE BUD13 homolog OS=Mus musculus OX=10090 GN=Bud13 PE=1 SV=1,,,,,,
OG_02810,1.0919792164843285,FUN_011785-T1,Peve_00041233,Pocillopora_meandrina_HIv1___RNAseq.g23258.t1c,three_way,64.76466666666667,,,,,,,,,,,,,,,,,
OG_02815,1.7894507223460767,FUN_011802-T1,Peve_00028440,Pocillopora_meandrina_HIv1___RNAseq.g23252.t1,three_way,63.55466666666666,FUN_011802-T1,B9FAF3,KN14E_ORYSJ,,Kinesin-like protein KIN-14E,Oryza sativa subsp. japonica (Rice),45.6,377.0,1.2e-84,316.2,sp|B9FAF3|KN14E_ORYSJ Kinesin-like protein KIN-14E OS=Oryza sativa subsp. japonica OX=39947 GN=KIN14E PE=2 SV=1,GO:0003777; GO:0005524; GO:0005874; GO:0007017; GO:0007018; GO:0008017; GO:0015630,microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017],microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005856; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; ATP-dependent activity
OG_02820,1.862852025498642,FUN_011808-T1,Peve_00020938,Pocillopora_meandrina_HIv1___RNAseq.g23246.t1,three_way,76.82233333333333,,,,,,,,,,,,,,,,,
OG_02821,2.2010743378181705,FUN_011809-T1,Peve_00020918,Pocillopora_meandrina_HIv1___RNAseq.g23245.t1b,three_way,79.96799999999999,FUN_011809-T1,Q5TH69,,,,,30.1,2503.0,1.9e-256,888.3,sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3,,,,,,
OG_02824,1.4706366703511105,FUN_011814-T1,Peve_00020927,Pocillopora_meandrina_HIv1___RNAseq.g23235.t1,three_way,75.693,FUN_011814-T1,Q71B07,,,,,48.0,710.0,7.700000000000002e-180,632.1,sp|Q71B07|D19L3_MOUSE Protein C-mannosyl-transferase DPY19L3 OS=Mus musculus OX=10090 GN=Dpy19l3 PE=1 SV=2,,,,,,
OG_02826,1.0415259422461065,FUN_011841-T1,Peve_00020934,Pocillopora_meandrina_HIv1___RNAseq.g23233.t1,three_way,49.15833333333333,,,,,,,,,,,,,,,,,
OG_02827,1.1158992278474489,FUN_011842-T1,Peve_00034375,Pocillopora_meandrina_HIv1___RNAseq.g23372.t1,three_way,85.59066666666666,FUN_011842-T1,O46560,,,,,58.2,304.0,8.999999999999999e-94,345.1,sp|O46560|PDXK_PIG Pyridoxal kinase OS=Sus scrofa OX=9823 GN=PDXK PE=1 SV=1,,,,,,
OG_02830,1.024244046709148,FUN_011845-T1,Peve_00034371,Pocillopora_meandrina_HIv1___RNAseq.g23375.t1,three_way,84.46166666666666,FUN_011845-T1,Q16798,,,,,61.5,551.0,2.1e-202,706.8,"sp|Q16798|MAON_HUMAN NADP-dependent malic enzyme, mitochondrial OS=Homo sapiens OX=9606 GN=ME3 PE=1 SV=2",,,,,,
OG_02833,1.587256885878836,FUN_011848-T1,Peve_00034362,Pocillopora_meandrina_HIv1___TS.g16261.t2,three_way,56.089333333333336,,,,,,,,,,,,,,,,,
OG_02835,2.550653462316117,FUN_011853-T1,Peve_00034403,Pocillopora_meandrina_HIv1___RNAseq.g23381.t1,three_way,67.724,FUN_011853-T1,Q3ZBE6,,,,,37.9,443.0,1.8e-72,274.6,sp|Q3ZBE6|TM135_BOVIN Transmembrane protein 135 OS=Bos taurus OX=9913 GN=TMEM135 PE=2 SV=1,,,,,,
OG_02836,1.526657044394126,FUN_011855-T1,Peve_00034401,Pocillopora_meandrina_HIv1___RNAseq.g23382.t1,three_way,65.68350000000001,FUN_011855-T1,Q5R673,RIOX2_PONAB,,Ribosomal oxygenase 2 (Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA) (EC 1.14.11.79) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),33.7,409.0,5.4e-54,213.8,sp|Q5R673|RIOX2_PONAB Ribosomal oxygenase 2 OS=Pongo abelii OX=9601 GN=RIOX2 PE=2 SV=1,GO:0005654; GO:0005730; GO:0032453; GO:0036139; GO:0042254; GO:0042802; GO:0046872; GO:0051864,ribosome biogenesis [GO:0042254],nucleolus [GO:0005730]; nucleoplasm [GO:0005654],histone H3K36 demethylase activity [GO:0051864]; histone H3K4 demethylase activity [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-histidine dioxygenase activity [GO:0036139],GO:0003824; GO:0005654; GO:0005730; GO:0016491; GO:0042254; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; nucleolus; oxidoreductase activity; ribosome biogenesis; organelle; catalytic activity, acting on a protein"
OG_02840,1.7630537526846664,FUN_011864-T1,Peve_00006755,Pocillopora_meandrina_HIv1___RNAseq.g23388.t1,three_way,63.86766666666667,,,,,,,,,,,,,,,,,
OG_02841,1.892656977128756,FUN_011865-T1,Peve_00006754,Pocillopora_meandrina_HIv1___RNAseq.g23392.t1,three_way,81.326,FUN_011865-T1,Q921W4,,,,,48.3,321.0,2.4e-73,277.3,sp|Q921W4|QORL1_MOUSE Quinone oxidoreductase-like protein 1 OS=Mus musculus OX=10090 GN=Cryzl1 PE=1 SV=1,,,,,,
OG_02843,2.746876860488112,FUN_011867-T1,Peve_00005279,Pocillopora_meandrina_HIv1___RNAseq.g26657.t1,three_way,72.6535,,,,,,,,,,,,,,,,,
OG_02844,1.865238068828962,FUN_011870-T1,Peve_00018846,Pocillopora_meandrina_HIv1___RNAseq.g23394.t1,three_way,71.88266666666667,FUN_011870-T1,Q9QXE2,,,,,43.5,566.0,1.6e-122,442.2,sp|Q9QXE2|DPOLL_MOUSE DNA polymerase lambda OS=Mus musculus OX=10090 GN=Poll PE=2 SV=1,,,,,,
OG_02846,2.0518598490276307,FUN_011873-T1,Peve_00018843,Pocillopora_meandrina_HIv1___TS.g16282.t1,three_way,69.31633333333333,FUN_011873-T1,Q9C0E2,XPO4_HUMAN,,Exportin-4 (Exp4),Homo sapiens (Human),41.9,1157.0,2.2000000000000003e-253,877.1,sp|Q9C0E2|XPO4_HUMAN Exportin-4 OS=Homo sapiens OX=9606 GN=XPO4 PE=1 SV=2,GO:0005049; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0031267; GO:0046827,positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267],GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0140104,nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular carrier activity
OG_02852,1.1933503772739285,FUN_011884-T1,Peve_00018834,Pocillopora_meandrina_HIv1___RNAseq.g23404.t1,three_way,69.9975,FUN_011884-T1,P48553,TPC10_HUMAN,,Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein) (EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1),Homo sapiens (Human),32.6,1271.0,3.4000000000000005e-167,590.9,sp|P48553|TPC10_HUMAN Trafficking protein particle complex subunit 10 OS=Homo sapiens OX=9606 GN=TRAPPC10 PE=1 SV=2,GO:0005737; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0034498; GO:0099022; GO:1990071,early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022],cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071],,GO:0005829; GO:0016192,cytosol; vesicle-mediated transport
OG_02853,4.908959253765965,FUN_011890-T1,Peve_00042786,Pocillopora_meandrina_HIv1___RNAseq.g13675.t1,three_way,73.18133333333333,FUN_011890-T1,Q9ULI1,,,,,28.0,898.0,2.4e-78,296.2,sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3,,,,,,
OG_02854,1.7114770903743337,FUN_011892-T1,Peve_00008036,Pocillopora_meandrina_HIv1___RNAseq.g23808.t1,three_way,61.0615,FUN_011892-T1,E1C231,,,,,33.0,1901.0,8.200000000000001e-258,892.5,sp|E1C231|LTN1_CHICK E3 ubiquitin-protein ligase listerin OS=Gallus gallus OX=9031 GN=LTN1 PE=3 SV=1,,,,,,
OG_02857,1.8861288536865488,FUN_011899-T1,Peve_00010113,Pocillopora_meandrina_HIv1___RNAseq.g23787.t1,three_way,67.8275,FUN_011899-T1,Q5R9B8,DCAF6_PONAB,,DDB1- and CUL4-associated factor 6 (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),39.1,843.0,7.8e-144,512.7,sp|Q5R9B8|DCAF6_PONAB DDB1- and CUL4-associated factor 6 OS=Pongo abelii OX=9601 GN=DCAF6 PE=2 SV=2,GO:0005634; GO:0005737; GO:0016567; GO:0045944; GO:0080008,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_02858,1.9947460215402664,FUN_011900-T1,Peve_00010115,Pocillopora_meandrina_HIv1___RNAseq.g23788.t1,three_way,86.81633333333333,FUN_011900-T1,Q9GRC0,,,,,48.8,256.0,1.1e-61,238.4,sp|Q9GRC0|MOS_PATPE Serine/threonine-protein kinase mos OS=Patiria pectinifera OX=7594 GN=mos PE=1 SV=1,,,,,,
OG_02859,3.189130861672173,FUN_011901-T1,Peve_00032854,Pocillopora_meandrina_HIv1___TS.g16663.t2,three_way,70.4165,FUN_011901-T1,A7MBI0,PACN1_BOVIN,,Protein kinase C and casein kinase substrate in neurons protein 1,Bos taurus (Bovine),33.7,306.0,7.9e-41,169.5,sp|A7MBI0|PACN1_BOVIN Protein kinase C and casein kinase substrate in neurons protein 1 OS=Bos taurus OX=9913 GN=PACSIN1 PE=2 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043679; GO:0048488; GO:0048812; GO:0072657; GO:0097320; GO:1900006,actin filament organization [GO:0007015]; cytoskeleton organization [GO:0007010]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488],axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; ruffle membrane [GO:0032587],phospholipid binding [GO:0005543],GO:0005768; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_02862,1.5638668087151035,FUN_011907-T1,Peve_00014640,Pocillopora_meandrina_HIv1___RNAseq.g23364.t1,three_way,57.48433333333333,,,,,,,,,,,,,,,,,
OG_02863,1.018700384292604,FUN_011910-T1,Peve_00039385,Pocillopora_meandrina_HIv1___RNAseq.g23362.t1,three_way,65.31233333333333,FUN_011910-T1,A5D9D4,,,,,33.9,584.0,4.6e-82,307.0,sp|A5D9D4|MSTO1_BOVIN Protein misato homolog 1 OS=Bos taurus OX=9913 GN=MSTO1 PE=2 SV=2,,,,,,
OG_02865,2.784958616361753,FUN_011912-T1,Peve_00020699,Pocillopora_meandrina_HIv1___RNAseq.g23360.t1,three_way,69.96266666666666,FUN_011912-T1,Q92562,FIG4_HUMAN,,"Polyphosphoinositide phosphatase (EC 3.1.3.-) (EC 3.1.3.36) (EC 3.1.3.86) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4) (EC 3.1.3.16)",Homo sapiens (Human),45.8,1014.0,7.2e-216,752.3,sp|Q92562|FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens OX=9606 GN=FIG4 PE=1 SV=1,GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037,locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033],early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037],"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722]",GO:0003824; GO:0005768; GO:0005811; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endosome; lipid droplet; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02866,1.0506609643810318,FUN_011913-T1,Peve_00010940,Pocillopora_meandrina_HIv1___RNAseq.g23315.t1,three_way,81.39533333333333,FUN_011913-T1,Q5F2N3,OFUT3_DANRE,,GDP-fucose protein O-fucosyltransferase 3 (EC 2.4.1.221) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10),Danio rerio (Zebrafish) (Brachydanio rerio),29.8,295.0,1.5e-26,122.1,sp|Q5F2N3|OFUT3_DANRE GDP-fucose protein O-fucosyltransferase 3 OS=Danio rerio OX=7955 GN=fut10 PE=2 SV=3,GO:0000139; GO:0005783; GO:0005789; GO:0036065; GO:0046920; GO:0046922; GO:0050714,fucosylation [GO:0036065]; positive regulation of protein secretion [GO:0050714],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],alpha-(1->3)-fucosyltransferase activity [GO:0046920]; peptide-O-fucosyltransferase activity [GO:0046922],GO:0003824; GO:0005783; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02875,1.710732840587523,FUN_011925-T1,Peve_00008894,Pocillopora_meandrina_HIv1___RNAseq.g23324.t1,three_way,81.14933333333333,FUN_011925-T1,Q9NYS0,KBRS1_HUMAN,,NF-kappa-B inhibitor-interacting Ras-like protein 1 (I-kappa-B-interacting Ras-like protein 1) (Kappa B-Ras protein 1) (KappaB-Ras1),Homo sapiens (Human),44.4,169.0,1.8e-36,154.1,sp|Q9NYS0|KBRS1_HUMAN NF-kappa-B inhibitor-interacting Ras-like protein 1 OS=Homo sapiens OX=9606 GN=NKIRAS1 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005783; GO:0005829; GO:0010803; GO:0032484; GO:0032794; GO:0043124; GO:0043129; GO:0048286,lung alveolus development [GO:0048286]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; Ral protein signal transduction [GO:0032484]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783],GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005783; GO:0005829; GO:0016787; GO:0043226; GO:0048856,catalytic activity; GTPase activity; endoplasmic reticulum; cytosol; hydrolase activity; organelle; anatomical structure development
OG_02878,2.3815597690378896,FUN_011928-T1,Peve_00039387,Pocillopora_meandrina_HIv1___RNAseq.g23329.t1,three_way,69.43666666666667,FUN_011928-T1,Q5E9H9,ABHDA_BOVIN,,"Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)",Bos taurus (Bovine),44.6,251.0,9.7e-64,245.0,"sp|Q5E9H9|ABHDA_BOVIN Palmitoyl-protein thioesterase ABHD10, mitochondrial OS=Bos taurus OX=9913 GN=ABHD10 PE=2 SV=1",GO:0002084; GO:0004553; GO:0005739; GO:0008474; GO:0102390,protein depalmitoylation [GO:0002084],mitochondrion [GO:0005739],"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; palmitoyl-(protein) hydrolase activity [GO:0008474]",GO:0003824; GO:0005739; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02879,1.8400308598657584,FUN_011929-T1,Peve_00039637,Pocillopora_meandrina_HIv1___RNAseq.g23330.t1,three_way,69.50066666666667,FUN_011929-T1,Q54MF3,CANB2_DICDI,,Calcineurin subunit B type 2 (Calcineurin regulatory subunit 2) (Protein phosphatase 2B regulatory subunit 2),Dictyostelium discoideum (Social amoeba),24.2,161.0,1e-11,71.6,sp|Q54MF3|CANB2_DICDI Calcineurin subunit B type 2 OS=Dictyostelium discoideum OX=44689 GN=cnbB PE=3 SV=1,GO:0005509; GO:0005955; GO:0008597; GO:0019902; GO:0097720,calcineurin-mediated signaling [GO:0097720],calcineurin complex [GO:0005955],calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; phosphatase binding [GO:0019902],GO:0098772,molecular function regulator activity
OG_02881,2.0521719142206027,FUN_011931-T1,Peve_00039635,Pocillopora_meandrina_HIv1___RNAseq.g23332.t1,three_way,79.66666666666667,FUN_011931-T1,Q8CAY6,,,,,62.2,389.0,6.4e-139,495.4,"sp|Q8CAY6|THIC_MOUSE Acetyl-CoA acetyltransferase, cytosolic OS=Mus musculus OX=10090 GN=Acat2 PE=1 SV=2",,,,,,
OG_02883,1.8815387631161835,FUN_011933-T1,Peve_00039642,Pocillopora_meandrina_HIv1___RNAseq.g23334.t1,three_way,74.492,FUN_011933-T1,Q9TZM3,,,,,26.5,2417.0,9.3e-178,627.1,sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6,,,,,,
OG_02887,1.1639646254266551,FUN_011941-T1,Peve_00013077,Pocillopora_meandrina_HIv1___RNAseq.g23341.t1,three_way,69.871,FUN_011941-T1,A7SPW6,,,,,55.2,290.0,6.5e-81,302.4,"sp|A7SPW6|EFTS_NEMVE Elongation factor Ts, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g215604 PE=3 SV=1",,,,,,
OG_02890,2.5345072413929537,FUN_011945-T1,Peve_00016921,Pocillopora_meandrina_HIv1___RNAseq.g9189.t2,three_way,87.27733333333333,FUN_011945-T1,Q9YH18,,,,,42.9,324.0,4.7e-59,229.6,sp|Q9YH18|QKI_CHICK KH domain-containing RNA-binding protein QKI OS=Gallus gallus OX=9031 GN=QKI PE=2 SV=2,,,,,,
OG_02891,1.4454376309838664,FUN_011946-T1,Peve_00016920,Pocillopora_meandrina_HIv1___RNAseq.g9190.t1,three_way,81.93116666666667,FUN_011946-T1,O75937,DNJC8_HUMAN,,DnaJ homolog subfamily C member 8 (Splicing protein spf31),Homo sapiens (Human),46.0,163.0,6.8e-34,145.6,sp|O75937|DNJC8_HUMAN DnaJ homolog subfamily C member 8 OS=Homo sapiens OX=9606 GN=DNAJC8 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005829; GO:0030544; GO:0045171,,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],Hsp70 protein binding [GO:0030544],GO:0005634; GO:0005654; GO:0005829; GO:0043226,nucleus; nucleoplasm; cytosol; organelle
OG_02892,1.0345200667827226,FUN_011947-T1,Peve_00016919,Pocillopora_meandrina_HIv1___RNAseq.g9191.t1,three_way,79.90299999999999,FUN_011947-T1,Q8N5D0,WDTC1_HUMAN,,WD and tetratricopeptide repeats protein 1,Homo sapiens (Human),50.3,723.0,1.3e-187,657.9,sp|Q8N5D0|WDTC1_HUMAN WD and tetratricopeptide repeats protein 1 OS=Homo sapiens OX=9606 GN=WDTC1 PE=1 SV=2,GO:0000122; GO:0001701; GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0008361; GO:0016567; GO:0032869; GO:0035264; GO:0042393; GO:0042826; GO:0045717; GO:0055082; GO:0080008,cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; intracellular chemical homeostasis [GO:0055082]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826],GO:0005654; GO:0005829; GO:0005975; GO:0006355; GO:0042393; GO:0048856; GO:0098772,nucleoplasm; cytosol; carbohydrate metabolic process; regulation of DNA-templated transcription; histone binding; anatomical structure development; molecular function regulator activity
OG_02894,1.069105657925882,FUN_011951-T1,Peve_00016914,Pocillopora_meandrina_HIv1___RNAseq.g24085.t1,three_way,83.9735,FUN_011951-T1,A7T167,,,,,68.2,509.0,2.3e-202,706.4,sp|A7T167|GDAP2_NEMVE Protein GDAP2 homolog OS=Nematostella vectensis OX=45351 GN=gdap2 PE=3 SV=1,,,,,,
OG_02896,1.3193769315875177,FUN_011953-T1,Peve_00018991,Pocillopora_meandrina_HIv1___RNAseq.g24083.t1,three_way,75.15899999999999,,,,,,,,,,,,,,,,,
OG_02897,1.5505217936054632,FUN_011955-T2,Peve_00027881,Pocillopora_meandrina_HIv1___RNAseq.g24080.t2,three_way,41.57966666666667,,,,,,,,,,,,,,,,,
OG_02898,1.0311276064516164,FUN_011956-T3,Peve_00027888,Pocillopora_meandrina_HIv1___RNAseq.g23736.t1,three_way,67.98933333333333,FUN_011956-T3,Q66KI9,,,,,34.9,387.0,2.4e-50,201.1,sp|Q66KI9|NSUN4_XENTR 5-cytosine rRNA methyltransferase NSUN4 OS=Xenopus tropicalis OX=8364 GN=nsun4 PE=2 SV=1,,,,,,
OG_02901,1.0085329977027724,FUN_011960-T1,Peve_00027955,Pocillopora_meandrina_HIv1___RNAseq.g23739.t1,three_way,72.62466666666667,FUN_011960-T1,P82931,,,,,46.2,65.0,2.7e-11,69.3,sp|P82931|RT06_BOVIN Small ribosomal subunit protein bS6m OS=Bos taurus OX=9913 GN=MRPS6 PE=1 SV=4,,,,,,
OG_02902,1.861343097709336,FUN_011961-T1,Peve_00032575,Pocillopora_meandrina_HIv1___RNAseq.g12963.t1,three_way,70.89166666666667,FUN_011961-T1,Q5ZID0,,,,,42.0,300.0,3.1e-64,246.9,sp|Q5ZID0|NMRL1_CHICK NmrA-like family domain-containing protein 1 OS=Gallus gallus OX=9031 GN=NMRAL1 PE=2 SV=1,,,,,,
OG_02903,2.9179231875705343,FUN_011973-T1,Peve_00001000,Pocillopora_meandrina_HIv1___RNAseq.g23724.t1,three_way,61.82216666666667,FUN_011973-T1,Q54G43,SHKE_DICDI,,Dual specificity protein kinase shkE (EC 2.7.11.1) (SH2 domain-containing protein 5) (SH2 domain-containing protein E),Dictyostelium discoideum (Social amoeba),31.5,251.0,1.8e-23,113.2,sp|Q54G43|SHKE_DICDI Dual specificity protein kinase shkE OS=Dictyostelium discoideum OX=44689 GN=shkE PE=3 SV=1,GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0106310,signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_02904,1.5727142656248732,FUN_011974-T1,Peve_00000999,Pocillopora_meandrina_HIv1___RNAseq.g23723.t1,three_way,49.84633333333333,FUN_011974-T1,Q9BQF6,SENP7_HUMAN,,Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7),Homo sapiens (Human),48.3,321.0,1.3e-68,263.1,sp|Q9BQF6|SENP7_HUMAN Sentrin-specific protease 7 OS=Homo sapiens OX=9606 GN=SENP7 PE=1 SV=4,GO:0005634; GO:0005737; GO:0006508; GO:0016926; GO:0070139; GO:0099523; GO:0099524; GO:0140374,antiviral innate immune response [GO:0140374]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523],SUMO-specific endopeptidase activity [GO:0070139],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; hydrolase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_02907,1.245585834012156,FUN_011984-T1,Peve_00000523,Pocillopora_meandrina_HIv1___TS.g16589.t1,three_way,64.19166666666666,FUN_011984-T1,Q8JHI3,AR13B_DANRE,,ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein scorpion),Danio rerio (Zebrafish) (Brachydanio rerio),53.8,208.0,2.4999999999999997e-62,241.1,sp|Q8JHI3|AR13B_DANRE ADP-ribosylation factor-like protein 13B OS=Danio rerio OX=7955 GN=arl13b PE=1 SV=1,GO:0003924; GO:0005525; GO:0005929; GO:0007224; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0035845; GO:0060170; GO:0060271; GO:0097500; GO:0097730; GO:1905515,cilium assembly [GO:0060271]; formation of radial glial scaffolds [GO:0021943]; interneuron migration from the subpallium to the cortex [GO:0021830]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224],ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005929; GO:0016787; GO:0043226; GO:0044782; GO:0048870,catalytic activity; GTPase activity; cilium; hydrolase activity; organelle; cilium organization; cell motility
OG_02908,3.9513843110080646,FUN_011985-T1,Peve_00000524,Pocillopora_meandrina_HIv1___RNAseq.g23714.t1,three_way,77.837,FUN_011985-T1,P21872,,,,,57.5,1039.0,0.0,1168.3,sp|P21872|PUR2_CHICK Trifunctional purine biosynthetic protein adenosine-3 OS=Gallus gallus OX=9031 GN=GART PE=1 SV=1,,,,,,
OG_02909,1.1742064855451249,FUN_011986-T1,Peve_00000525,Pocillopora_meandrina_HIv1___RNAseq.g23713.t1,three_way,73.51033333333334,FUN_011986-T1,Q8WWV3,RT4I1_HUMAN,,"NAD(P)H oxidoreductase RTN4IP1, mitochondrial (EC 1.6.5.-) (NOGO-interacting mitochondrial protein) (Reticulon-4-interacting protein 1)",Homo sapiens (Human),47.3,368.0,1.7e-86,321.2,"sp|Q8WWV3|RT4I1_HUMAN NAD(P)H oxidoreductase RTN4IP1, mitochondrial OS=Homo sapiens OX=9606 GN=RTN4IP1 PE=1 SV=2",GO:0005739; GO:0005741; GO:0005759; GO:0006744; GO:0007399; GO:0008270; GO:0008753; GO:0050773,nervous system development [GO:0007399]; regulation of dendrite development [GO:0050773]; ubiquinone biosynthetic process [GO:0006744],mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],NADPH dehydrogenase (quinone) activity [GO:0008753]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0016491; GO:0043226; GO:0048856,catalytic activity; mitochondrion; oxidoreductase activity; organelle; anatomical structure development
OG_02912,3.4257437015808163,FUN_011991-T1,Peve_00000528,Pocillopora_meandrina_HIv1___RNAseq.g23706.t1,three_way,78.50233333333333,FUN_011991-T1,P11620,,,,,48.9,174.0,5.2e-39,162.5,sp|P11620|YPT1_SCHPO GTP-binding protein ypt1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ypt1 PE=1 SV=2,,,,,,
OG_02920,1.922359786885968,FUN_012003-T1,Peve_00016378,Pocillopora_meandrina_HIv1___RNAseq.g24026.t1,three_way,71.5695,FUN_012003-T1,Q5VVH5,IKBP1_HUMAN,,Interleukin-1 receptor-associated kinase 1-binding protein 1 (IRAK1-binding protein 1),Homo sapiens (Human),45.4,119.0,6.2e-23,109.0,sp|Q5VVH5|IKBP1_HUMAN Interleukin-1 receptor-associated kinase 1-binding protein 1 OS=Homo sapiens OX=9606 GN=IRAK1BP1 PE=1 SV=1,GO:0005634; GO:0005737; GO:0006955; GO:0035591; GO:0043123,immune response [GO:0006955]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],cytoplasm [GO:0005737]; nucleus [GO:0005634],signaling adaptor activity [GO:0035591],GO:0002376; GO:0005634; GO:0043226; GO:0060090,immune system process; nucleus; organelle; molecular adaptor activity
OG_02921,1.5660329571038016,FUN_012004-T1,Peve_00016377,Pocillopora_meandrina_HIv1___RNAseq.g24027.t1,three_way,69.86833333333334,FUN_012004-T1,Q1L864,JGN1B_DANRE,,Protein jagunal homolog 1-B,Danio rerio (Zebrafish) (Brachydanio rerio),34.8,187.0,7.4e-23,108.6,sp|Q1L864|JGN1B_DANRE Protein jagunal homolog 1-B OS=Danio rerio OX=7955 GN=jagn1b PE=3 SV=1,GO:0002446; GO:0005783; GO:0005789; GO:0007029; GO:0015031; GO:0016192; GO:0030223; GO:0038158; GO:0050832; GO:1990266,defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0002376; GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048870,immune system process; endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; cell motility
OG_02925,1.8187245511919,FUN_012012-T1,Peve_00030428,Pocillopora_meandrina_HIv1___RNAseq.g24037.t1,three_way,73.38199999999999,FUN_012012-T1,O95935,TBX18_HUMAN,,T-box transcription factor TBX18 (T-box protein 18),Homo sapiens (Human),53.3,336.0,4e-86,320.1,sp|O95935|TBX18_HUMAN T-box transcription factor TBX18 OS=Homo sapiens OX=9606 GN=TBX18 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001708; GO:0001756; GO:0003163; GO:0005634; GO:0005654; GO:0006357; GO:0016331; GO:0021999; GO:0042803; GO:0045893; GO:0051145; GO:0060930; GO:0060931; GO:0072189; GO:0090090; GO:0090103; GO:0090571; GO:0098907; GO:1990837,cell fate specification [GO:0001708]; cochlea morphogenesis [GO:0090103]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate anterior/posterior regionalization [GO:0021999]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of SA node cell action potential [GO:0098907]; regulation of transcription by RNA polymerase II [GO:0006357]; sinoatrial node cell development [GO:0060931]; sinoatrial node cell fate commitment [GO:0060930]; sinoatrial node development [GO:0003163]; smooth muscle cell differentiation [GO:0051145]; somitogenesis [GO:0001756]; ureter development [GO:0072189],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02926,1.1235791812869147,FUN_012013-T1,Peve_00030433,Pocillopora_meandrina_HIv1___RNAseq.g24039.t1,three_way,69.86566666666667,FUN_012013-T1,P32297,ACHA3_HUMAN,,Neuronal acetylcholine receptor subunit alpha-3,Homo sapiens (Human),33.8,547.0,1.2000000000000001e-74,282.3,sp|P32297|ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 OS=Homo sapiens OX=9606 GN=CHRNA3 PE=1 SV=4,GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006811; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0014056; GO:0015276; GO:0015464; GO:0016020; GO:0016607; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0043231; GO:0044853; GO:0045202; GO:0045211; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098878; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005730; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; nucleolus; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; signaling; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_02930,1.8471058499197284,FUN_012029-T1,Peve_00044958,Pocillopora_meandrina_HIv1___RNAseq.g24045.t1,three_way,82.663,FUN_012029-T1,P11533,,,,,29.7,3968.0,0.0,1575.5,sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1,,,,,,
OG_02932,1.5248269849123233,FUN_012033-T1,Peve_00037665,Pocillopora_meandrina_HIv1___RNAseq.g24057.t1,three_way,77.83616666666667,FUN_012033-T1,Q5ZIN1,NUDC_CHICK,,Nuclear migration protein nudC (Nuclear distribution protein C homolog),Gallus gallus (Chicken),62.9,329.0,2.6e-77,290.4,sp|Q5ZIN1|NUDC_CHICK Nuclear migration protein nudC OS=Gallus gallus OX=9031 GN=NUDC PE=2 SV=1,GO:0005737; GO:0005874; GO:0006457; GO:0007052; GO:0007080; GO:0030496; GO:0051082; GO:0051301; GO:0072686,cell division [GO:0051301]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; protein folding [GO:0006457],cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686],unfolded protein binding [GO:0051082],GO:0006457; GO:0007010; GO:0043226,protein folding; cytoskeleton organization; organelle
OG_02934,2.3682970045360263,FUN_012035-T1,Peve_00037664,Pocillopora_meandrina_HIv1___RNAseq.g24058.t1,three_way,60.38016666666667,FUN_012035-T1,Q29RT6,KI20A_BOVIN,,Kinesin-like protein KIF20A,Bos taurus (Bovine),35.5,843.0,4.8e-114,414.8,sp|Q29RT6|KI20A_BOVIN Kinesin-like protein KIF20A OS=Bos taurus OX=9913 GN=KIF20A PE=2 SV=1,GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0030496; GO:0032465; GO:0061952,microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465],cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0000910; GO:0003774; GO:0003824; GO:0005634; GO:0005794; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0061024; GO:0140657,cytokinesis; cytoskeletal motor activity; catalytic activity; nucleus; Golgi apparatus; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; membrane organization; ATP-dependent activity
OG_02937,1.2658351599376274,FUN_012044-T1,Peve_00013735,Pocillopora_meandrina_HIv1___RNAseq.g24064.t1,three_way,82.75833333333333,FUN_012044-T1,Q3T022,SAP18_BOVIN,,Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p18),Bos taurus (Bovine),64.5,141.0,1.1e-44,181.0,sp|Q3T022|SAP18_BOVIN Histone deacetylase complex subunit SAP18 OS=Bos taurus OX=9913 GN=SAP18 PE=2 SV=1,GO:0000381; GO:0003714; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0043065; GO:0045892; GO:0048025; GO:0061574,"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0140110,nucleus; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_02938,1.1971048375458897,FUN_012045-T1,Peve_00013736,Pocillopora_meandrina_HIv1___RNAseq.g23652.t1,three_way,86.85833333333333,FUN_012045-T1,O73770,,,,,41.0,183.0,2.4999999999999998e-31,137.1,sp|O73770|DGCR6_CHICK Protein DGCR6 OS=Gallus gallus OX=9031 GN=DGCR6 PE=2 SV=1,,,,,,
OG_02939,1.6427605809325023,FUN_012046-T1,Peve_00013730,Pocillopora_meandrina_HIv1___TS.g16525.t1,three_way,75.98333333333333,FUN_012046-T1,Q9Y5B6,PAXB1_HUMAN,,PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1),Homo sapiens (Human),38.1,839.0,2.6e-119,431.4,sp|Q9Y5B6|PAXB1_HUMAN PAX3- and PAX7-binding protein 1 OS=Homo sapiens OX=9606 GN=PAXBP1 PE=1 SV=2,GO:0000398; GO:0003677; GO:0005634; GO:0005829; GO:0006366; GO:0007517; GO:0014842; GO:0045944; GO:1990226; GO:2000288,"mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; transcription by RNA polymerase II [GO:0006366]",cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226],GO:0003677; GO:0005634; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0043226; GO:0048856,DNA binding; nucleus; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; organelle; anatomical structure development
OG_02941,4.052039365306006,FUN_012050-T2,Peve_00004087,Pocillopora_meandrina_HIv1___RNAseq.g23649.t1,three_way,70.43433333333333,,,,,,,,,,,,,,,,,
OG_02949,4.562512230335494,FUN_012067-T1,Peve_00004104,Pocillopora_meandrina_HIv1___RNAseq.g23636.t1,three_way,67.023,FUN_012067-T1,Q7Z020,,,,,28.6,553.0,9.3e-45,184.1,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02951,1.4009342263337836,FUN_012070-T1,Peve_00025863,Pocillopora_meandrina_HIv1___TS.g16508.t1,three_way,72.754,,,,,,,,,,,,,,,,,
OG_02956,1.5471480027164006,FUN_012101-T1,Peve_00007425,Pocillopora_meandrina_HIv1___TS.g16821.t1,three_way,77.79899999999999,FUN_012101-T1,Q6PF24,,,,,51.5,1000.0,2.2e-308,1059.7,"sp|Q6PF24|PREP_XENLA Presequence protease, mitochondrial OS=Xenopus laevis OX=8355 GN=pitrm1 PE=2 SV=1",,,,,,
OG_02957,1.5596650401054857,FUN_012102-T1,Peve_00007426,Pocillopora_meandrina_HIv1___RNAseq.g23946.t1,three_way,60.24616666666667,FUN_012102-T1,P18956,GGT_ECOLI,,Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (GGT) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain],Escherichia coli (strain K12),30.7,267.0,7.9000000000000025e-22,107.5,sp|P18956|GGT_ECOLI Glutathione hydrolase proenzyme OS=Escherichia coli (strain K12) OX=83333 GN=ggt PE=1 SV=1,GO:0006750; GO:0006751; GO:0030288; GO:0034722; GO:0036374; GO:0042597; GO:0043102; GO:0097264; GO:0103068,amino acid salvage [GO:0043102]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; self proteolysis [GO:0097264],outer membrane-bounded periplasmic space [GO:0030288]; periplasmic space [GO:0042597],gamma-glutamyl-peptidase activity [GO:0034722]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068],GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0016740; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_02960,1.409840512544094,FUN_012106-T1,Peve_00029236,Pocillopora_meandrina_HIv1___RNAseq.g23936.t1,three_way,58.132666666666665,FUN_012106-T1,P78417,GSTO1_HUMAN,,Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R),Homo sapiens (Human),44.1,222.0,2.4e-45,183.7,sp|P78417|GSTO1_HUMAN Glutathione S-transferase omega-1 OS=Homo sapiens OX=9606 GN=GSTO1 PE=1 SV=2,GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0042178; GO:0045174; GO:0050610; GO:0051280; GO:0051281; GO:0070062; GO:0071243,cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005829; GO:0005975; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0016740; GO:0043226,catalytic activity; cytosol; carbohydrate metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; transferase activity; organelle
OG_02961,1.5243018872719132,FUN_012108-T1,Peve_00045237,Pocillopora_meandrina_HIv1___TS.g16812.t1,three_way,73.217,FUN_012108-T1,E1C2Z0,,,,,28.3,1249.0,3.4e-138,494.6,sp|E1C2Z0|MMS22_CHICK Protein MMS22-like OS=Gallus gallus OX=9031 GN=MMS22L PE=3 SV=1,,,,,,
OG_02962,1.2703432395542635,FUN_012109-T1,Peve_00045236,Pocillopora_meandrina_HIv1___RNAseq.g23941.t1,three_way,81.87883333333333,FUN_012109-T1,O43390,,,,,62.4,388.0,5e-135,483.0,sp|O43390|HNRPR_HUMAN Heterogeneous nuclear ribonucleoprotein R OS=Homo sapiens OX=9606 GN=HNRNPR PE=1 SV=1,,,,,,
OG_02963,1.0485948869509194,FUN_012113-T1,Peve_00045239,Pocillopora_meandrina_HIv1___RNAseq.g23944.t1,three_way,73.61,FUN_012113-T1,Q86U90,YRDC_HUMAN,,Threonylcarbamoyl-AMP synthase (EC 2.7.7.87) (Dopamine receptor-interacting protein 3) (Ischemia/reperfusion-inducible protein homolog) (hIRIP),Homo sapiens (Human),53.8,212.0,6.100000000000001e-57,222.2,sp|Q86U90|YRDC_HUMAN Threonylcarbamoyl-AMP synthase OS=Homo sapiens OX=9606 GN=YRDC PE=1 SV=1,GO:0000049; GO:0002949; GO:0003725; GO:0005737; GO:0005739; GO:0005886; GO:0006450; GO:0016779; GO:0051051; GO:0061710,negative regulation of transport [GO:0051051]; regulation of translational fidelity [GO:0006450]; tRNA threonylcarbamoyladenosine modification [GO:0002949],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],double-stranded RNA binding [GO:0003725]; L-threonylcarbamoyladenylate synthase [GO:0061710]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005739; GO:0005886; GO:0006399; GO:0016740; GO:0043226,RNA binding; catalytic activity; mitochondrion; plasma membrane; tRNA metabolic process; transferase activity; organelle
OG_02964,1.4996735693862735,FUN_012118-T1,Peve_00001673,Pocillopora_meandrina_HIv1___RNAseq.g23934.t1,three_way,73.89166666666667,FUN_012118-T1,Q924W5,SMC6_MOUSE,,Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (mSMC6),Mus musculus (Mouse),40.5,1070.0,1.3999999999999999e-188,661.8,sp|Q924W5|SMC6_MOUSE Structural maintenance of chromosomes protein 6 OS=Mus musculus OX=10090 GN=Smc6 PE=1 SV=1,GO:0000217; GO:0000722; GO:0000775; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0006302; GO:0006974; GO:0016605; GO:0016607; GO:0016887; GO:0030915; GO:0031625; GO:0035061; GO:0035861; GO:0044828; GO:0051984; GO:0090398; GO:0097431,cellular senescence [GO:0090398]; DNA damage response [GO:0006974]; double-strand break repair [GO:0006302]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of chromosome segregation [GO:0051984]; telomere maintenance via recombination [GO:0000722],"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA secondary structure binding [GO:0000217]; ubiquitin protein ligase binding [GO:0031625],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0006310; GO:0016787; GO:0032200; GO:0043226,DNA binding; catalytic activity; nucleus; chromosome; DNA repair; DNA recombination; hydrolase activity; telomere organization; organelle
OG_02965,1.6727272076194593,FUN_012119-T2,Peve_00035451,Pocillopora_meandrina_HIv1___RNAseq.g23933.t1,three_way,52.12533333333333,,,,,,,,,,,,,,,,,
OG_02966,3.1663819421568804,FUN_012120-T1,Peve_00035447,Pocillopora_meandrina_HIv1___TS.g16803.t2,three_way,75.527,FUN_012120-T1,Q8VIH3,S28A3_RAT,,Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (rCNT3),Rattus norvegicus (Rat),47.3,499.0,1.3e-119,431.8,sp|Q8VIH3|S28A3_RAT Solute carrier family 28 member 3 OS=Rattus norvegicus OX=10116 GN=Slc28a3 PE=2 SV=1,GO:0001895; GO:0005886; GO:0015213; GO:0015389; GO:0015390; GO:0015860; GO:0015862; GO:0015864; GO:0031526; GO:0072531; GO:1901642,nucleoside transmembrane transport [GO:1901642]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; pyrimidine-containing compound transmembrane transport [GO:0072531]; retina homeostasis [GO:0001895]; uridine transmembrane transport [GO:0015862],brush border membrane [GO:0031526]; plasma membrane [GO:0005886],purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenosine-specific:sodium symporter activity [GO:0015389]; uridine transmembrane transporter activity [GO:0015213],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_02968,2.320898480483228,FUN_012130-T1,Peve_00035469,Pocillopora_meandrina_HIv1___RNAseq.g23786.t1,three_way,43.8205,FUN_012130-T1,Q5R7K9,,,,,32.1,156.0,7.5e-10,66.6,sp|Q5R7K9|EDIL3_PONAB EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Pongo abelii OX=9601 GN=EDIL3 PE=2 SV=1,,,,,,
OG_02971,1.6664546338631978,FUN_012134-T1,Peve_00035463,Pocillopora_meandrina_HIv1___RNAseq.g23780.t2,three_way,75.01566666666668,FUN_012134-T1,Q32L92,CNN3_BOVIN,,"Calponin-3 (Calponin, acidic isoform)",Bos taurus (Bovine),36.9,130.0,1.5e-15,84.0,sp|Q32L92|CNN3_BOVIN Calponin-3 OS=Bos taurus OX=9913 GN=CNN3 PE=2 SV=1,GO:0005516; GO:0007015; GO:0008017; GO:0015629; GO:0031032; GO:0051015,actin filament organization [GO:0007015]; actomyosin structure organization [GO:0031032],actin cytoskeleton [GO:0015629],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_02973,1.1224664048447233,FUN_012138-T1,Peve_00035457,Pocillopora_meandrina_HIv1___RNAseq.g23776.t1,three_way,70.50333333333333,FUN_012138-T1,Q8NCR3,,,,,42.0,255.0,1.2e-51,205.7,sp|Q8NCR3|MFI_HUMAN Protein MFI OS=Homo sapiens OX=9606 GN=MFI PE=1 SV=1,,,,,,
OG_02974,1.683855944605943,FUN_012139-T1,Peve_00001103,Pocillopora_meandrina_HIv1___RNAseq.g23864.t3,three_way,77.9845,FUN_012139-T1,Q8N7X0,ADGB_HUMAN,,Androglobin,Homo sapiens (Human),29.8,1939.0,1.4e-185,652.5,sp|Q8N7X0|ADGB_HUMAN Androglobin OS=Homo sapiens OX=9606 GN=ADGB PE=1 SV=3,GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227,proteolysis [GO:0006508]; spermatid development [GO:0007286],sperm annulus [GO:0097227]; sperm midpiece [GO:0097225],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825],GO:0003824; GO:0016787; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; hydrolase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_02975,2.4570640863903632,FUN_012141-T1,Peve_00001102,Pocillopora_meandrina_HIv1___RNAseq.9491_t,three_way,51.589,,,,,,,,,,,,,,,,,
OG_02976,1.378846697036025,FUN_012142-T1,Peve_00001101,Pocillopora_meandrina_HIv1___RNAseq.g23866.t1,three_way,57.71,,,,,,,,,,,,,,,,,
OG_02977,1.5360968446194323,FUN_012144-T1,Peve_00035455,Pocillopora_meandrina_HIv1___RNAseq.g23870.t1,three_way,72.23966666666666,FUN_012144-T1,Q9GRC0,,,,,46.6,268.0,2.6e-56,220.7,sp|Q9GRC0|MOS_PATPE Serine/threonine-protein kinase mos OS=Patiria pectinifera OX=7594 GN=mos PE=1 SV=1,,,,,,
OG_02978,2.1112237487100507,FUN_012145-T1,Peve_00033299,Pocillopora_meandrina_HIv1___RNAseq.g23871.t1,three_way,72.78233333333333,FUN_012145-T1,Q9Y6R4,M3K4_HUMAN,,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),Homo sapiens (Human),35.0,1732.0,4.6e-247,856.7,sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2,GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745,chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_02980,2.881025326358135,FUN_012150-T1,Peve_00035454,Pocillopora_meandrina_HIv1___RNAseq.9397_t,three_way,84.231,FUN_012150-T1,Q00796,DHSO_HUMAN,,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)",Homo sapiens (Human),58.6,263.0,1.2e-85,317.8,sp|Q00796|DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens OX=9606 GN=SORD PE=1 SV=4,GO:0000721; GO:0003939; GO:0005615; GO:0005829; GO:0006006; GO:0006062; GO:0008270; GO:0016020; GO:0019640; GO:0030246; GO:0030317; GO:0031514; GO:0031966; GO:0042802; GO:0046370; GO:0046526; GO:0047833; GO:0050255; GO:0051160; GO:0051164; GO:0051287; GO:0070062,D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; sorbitol catabolic process [GO:0006062]; xylitol catabolic process [GO:0051160]; xylitol metabolic process [GO:0051164],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514],"(R,R)-butanediol dehydrogenase activity [GO:0000721]; carbohydrate binding [GO:0030246]; D-sorbitol dehydrogenase (acceptor) activity [GO:0047833]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase (NAD+) activity [GO:0003939]; NAD binding [GO:0051287]; ribitol 2-dehydrogenase (NAD+) activity [GO:0050255]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005615; GO:0005829; GO:0005929; GO:0005975; GO:0007018; GO:0016491; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; extracellular space; cytosol; cilium; carbohydrate metabolic process; microtubule-based movement; oxidoreductase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_02981,2.5294385901367407,FUN_012151-T1,Peve_00035456,Pocillopora_meandrina_HIv1___RNAseq.g23773.t1,three_way,68.10066666666667,FUN_012151-T1,Q91W96,,,,,33.8,769.0,1.4999999999999999e-92,342.4,sp|Q91W96|APC4_MOUSE Anaphase-promoting complex subunit 4 OS=Mus musculus OX=10090 GN=Anapc4 PE=1 SV=1,,,,,,
OG_02982,3.712033807057751,FUN_012152-T1,Peve_00035458,Pocillopora_meandrina_HIv1___TS.g16648.t1,three_way,75.35416666666667,FUN_012152-T1,Q8NEN0,,,,,32.3,885.0,5.2000000000000004e-117,423.7,sp|Q8NEN0|ARMC2_HUMAN Armadillo repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=ARMC2 PE=1 SV=4,,,,,,
OG_02984,1.3837168905575183,FUN_012154-T1,Peve_00040790,Pocillopora_meandrina_HIv1___RNAseq.g23436.t1,three_way,76.696,,,,,,,,,,,,,,,,,
OG_02985,3.5670659496370245,FUN_012155-T1,Peve_00040791,Pocillopora_meandrina_HIv1___RNAseq.g23435.t1,three_way,55.4285,FUN_012155-T1,E7FA21,,,,,24.2,854.0,6.6e-38,161.0,sp|E7FA21|SMR8A_DANRE Guanine nucleotide exchange protein smcr8a OS=Danio rerio OX=7955 GN=smcr8a PE=3 SV=1,,,,,,
OG_02986,2.079349386338789,FUN_012156-T1,Peve_00040786,Pocillopora_meandrina_HIv1___RNAseq.g23443.t3,three_way,55.64566666666666,FUN_012156-T1,Q2PFX0,,,,,47.5,524.0,3.500000000000001e-118,426.8,sp|Q2PFX0|ATE1_MACFA Arginyl-tRNA--protein transferase 1 OS=Macaca fascicularis OX=9541 GN=ATE1 PE=2 SV=1,,,,,,
OG_02987,2.499804206271433,FUN_012159-T1,Peve_00040785,Pocillopora_meandrina_HIv1___RNAseq.g23444.t1,three_way,81.69933333333333,FUN_012159-T1,Q6DGJ3,,,,,64.5,93.0,6e-25,114.8,sp|Q6DGJ3|TIM13_DANRE Mitochondrial import inner membrane translocase subunit Tim13 OS=Danio rerio OX=7955 GN=timm13 PE=3 SV=1,,,,,,
OG_02989,1.0490153955709742,FUN_012161-T1,Peve_00008621,Pocillopora_meandrina_HIv1___TS.g16331.t1,three_way,59.656,,,,,,,,,,,,,,,,,
OG_02994,1.3949713984010474,FUN_012170-T1,Peve_00008637,Pocillopora_meandrina_HIv1___RNAseq.g23453.t1,three_way,85.069,FUN_012170-T1,P08559,ODPA_HUMAN,,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)",Homo sapiens (Human),58.4,389.0,1.4000000000000001e-133,477.6,"sp|P08559|ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial OS=Homo sapiens OX=9606 GN=PDHA1 PE=1 SV=3",GO:0004739; GO:0005634; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0006086; GO:0006099; GO:0034604; GO:0045254; GO:0046872,glucose metabolic process [GO:0006006]; pyruvate decarboxylation to acetyl-CoA [GO:0006086]; tricarboxylic acid cycle [GO:0006099],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254],metal ion binding [GO:0046872]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604],GO:0003824; GO:0005634; GO:0005730; GO:0005739; GO:0005975; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; nucleus; nucleolus; mitochondrion; carbohydrate metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_02997,2.082907952862583,FUN_012176-T1,Peve_00040994,Pocillopora_meandrina_HIv1___RNAseq.g23858.t1,three_way,63.23466666666666,FUN_012176-T1,Q709C8,VP13C_HUMAN,,Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C),Homo sapiens (Human),24.7,4222.0,0.0,1083.2,sp|Q709C8|VP13C_HUMAN Intermembrane lipid transfer protein VPS13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090,Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of type 2 mitophagy [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741],,GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0006886; GO:0007005; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; lipid droplet; cytosol; intracellular protein transport; mitochondrion organization; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_02999,1.029395576724707,FUN_012178-T1,Peve_00040999,Pocillopora_meandrina_HIv1___RNAseq.g23862.t1,three_way,94.48333333333332,FUN_012178-T1,Q7ZTY4,,,,,88.7,424.0,2.8999999999999996e-198,692.6,sp|Q7ZTY4|RBBP7_DANRE Histone-binding protein RBBP7 OS=Danio rerio OX=7955 GN=rbbp7 PE=2 SV=1,,,,,,
OG_03001,1.944304515991548,FUN_012180-T1,Peve_00020513,Pocillopora_meandrina_HIv1___RNAseq.g23512.t1,three_way,61.40383333333333,FUN_012180-T1,J9HGJ1,,,,,34.1,88.0,9.7e-08,59.3,sp|J9HGJ1|LTRIN_AEDAE Lymphotoxin beta receptor inhibitor OS=Aedes aegypti OX=7159 GN=AaeL_AAEL017253 PE=1 SV=1,,,,,,
OG_03003,3.0947176437264137,FUN_012187-T2,Peve_00027771,Pocillopora_meandrina_HIv1___RNAseq.g23457.t1,three_way,57.22,,,,,,,,,,,,,,,,,
OG_03005,2.294350121391909,FUN_012193-T1,Peve_00013740,Pocillopora_meandrina_HIv1___RNAseq.g23420.t1,three_way,60.66016666666667,FUN_012193-T1,Q91VW3,,,,,44.8,87.0,1.9e-17,89.7,sp|Q91VW3|SH3L3_MOUSE SH3 domain-binding glutamic acid-rich-like protein 3 OS=Mus musculus OX=10090 GN=Sh3bgrl3 PE=1 SV=1,,,,,,
OG_03009,2.345551382071992,FUN_012218-T1,Peve_00005373,Pocillopora_meandrina_HIv1___TS.g16318.t1,three_way,65.238,FUN_012218-T1,Q008S8,,,,,35.3,405.0,6.800000000000001e-58,226.5,sp|Q008S8|ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens OX=9606 GN=ECT2L PE=1 SV=2,,,,,,
OG_03011,1.7100575559238815,FUN_012229-T2,Peve_00020576,Pocillopora_meandrina_HIv1___TS.g16417.t1,three_way,92.94133333333332,FUN_012229-T2,Q9TTF0,,,,,47.9,378.0,1.1e-92,341.7,sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2,,,,,,
OG_03016,2.263232127905531,FUN_012236-T1,Peve_00020567,Pocillopora_meandrina_HIv1___RNAseq.g23529.t1,three_way,64.901,FUN_012236-T1,Q75AE1,,,,,28.7,394.0,3.8999999999999995e-28,127.9,sp|Q75AE1|ROK1_EREGS ATP-dependent RNA helicase ROK1 OS=Eremothecium gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=ROK1 PE=3 SV=1,,,,,,
OG_03020,1.0802567978424968,FUN_012240-T1,Peve_00020563,Pocillopora_meandrina_HIv1___TS.g16404.t1,three_way,71.79433333333333,FUN_012240-T1,Q7XJJ7,,,,,38.9,525.0,8.899999999999999e-92,339.3,sp|Q7XJJ7|FAAH_ARATH Fatty acid amide hydrolase OS=Arabidopsis thaliana OX=3702 GN=FAAH PE=1 SV=1,,,,,,
OG_03024,2.3983055691751045,FUN_012250-T1,Peve_00020519,Pocillopora_meandrina_HIv1___RNAseq.g23517.t1,three_way,75.335,FUN_012250-T1,Q5T5C0,STXB5_HUMAN,,Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1),Homo sapiens (Human),38.5,1156.0,1.5999999999999999e-208,728.0,sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807],acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075],GO:0005829; GO:0005886; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_03025,1.4352712043575044,FUN_012251-T3,Peve_00020516,Pocillopora_meandrina_HIv1___RNAseq.g23515.t3,three_way,59.599,,,,,,,,,,,,,,,,,
OG_03028,2.889926558879818,FUN_012254-T1,Peve_00036363,Pocillopora_meandrina_HIv1___RNAseq.g23560.t1a,three_way,48.51266666666667,FUN_012254-T1,Q6NV72,,,,,22.0,641.0,1.3e-16,89.7,sp|Q6NV72|WDCP_MOUSE WD repeat and coiled-coil-containing protein OS=Mus musculus OX=10090 GN=Wdcp PE=2 SV=2,,,,,,
OG_03029,1.7069805209762616,FUN_012257-T2,Peve_00036357,Pocillopora_meandrina_HIv1___TS.g16433.t1,three_way,75.69800000000001,FUN_012257-T2,Q795M8,,,,,37.6,93.0,5.2e-06,54.3,sp|Q795M8|YUGO_BACSU Putative potassium channel protein YugO OS=Bacillus subtilis (strain 168) OX=224308 GN=yugO PE=4 SV=2,,,,,,
OG_03030,1.2580226081938568,FUN_012261-T1,Peve_00036354,Pocillopora_meandrina_HIv1___RNAseq.g23549.t1,three_way,84.05866666666667,FUN_012261-T1,E1BNG3,ASCC3_BOVIN,,Activating signal cointegrator 1 complex subunit 3 (EC 5.6.2.4),Bos taurus (Bovine),60.5,2206.0,0.0,2650.5,sp|E1BNG3|ASCC3_BOVIN Activating signal cointegrator 1 complex subunit 3 OS=Bos taurus OX=9913 GN=ascc3 PE=3 SV=1,GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0016607; GO:0016887; GO:0032790; GO:0043138; GO:0072344; GO:1990116,DNA alkylation repair [GO:0006307]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676],GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0016787; GO:0016853; GO:0030163; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; cytosol; DNA repair; hydrolase activity; isomerase activity; protein catabolic process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03032,1.9552145894679416,FUN_012266-T1,Peve_00036382,Pocillopora_meandrina_HIv1___RNAseq.g23541.t2,three_way,83.19966666666666,FUN_012266-T1,Q921C3,BRWD1_MOUSE,,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),Mus musculus (Mouse),45.5,1509.0,1.3e-305,1051.2,sp|Q921C3|BRWD1_MOUSE Bromodomain and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Brwd1 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005930; GO:0006357; GO:0007010; GO:0008360; GO:0031514,cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357],axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005929; GO:0006355; GO:0007010; GO:0043226,nucleus; nucleoplasm; nucleolus; cytosol; cilium; regulation of DNA-templated transcription; cytoskeleton organization; organelle
OG_03035,1.2391741207536964,FUN_012273-T1,Peve_00023570,Pocillopora_meandrina_HIv1___RNAseq.g23877.t1,three_way,69.00583333333333,FUN_012273-T1,Q8WUA2,,,,,69.7,373.0,1.7e-149,530.8,sp|Q8WUA2|PPIL4_HUMAN Peptidyl-prolyl cis-trans isomerase-like 4 OS=Homo sapiens OX=9606 GN=PPIL4 PE=1 SV=1,,,,,,
OG_03036,1.905395366570101,FUN_012274-T1,Peve_00026376,Pocillopora_meandrina_HIv1___RNAseq.g23878.t1,three_way,73.09366666666666,FUN_012274-T1,Q76I89,NDC80_CHICK,,Kinetochore protein NDC80 homolog (Kinetochore protein Hec1) (Kinetochore-associated protein 2),Gallus gallus (Chicken),35.0,491.0,2.9e-69,264.6,sp|Q76I89|NDC80_CHICK Kinetochore protein NDC80 homolog OS=Gallus gallus OX=9031 GN=NDC80 PE=1 SV=1,GO:0000132; GO:0000776; GO:0005813; GO:0005829; GO:0007052; GO:0007057; GO:0007059; GO:0008017; GO:0008315; GO:0014841; GO:0016607; GO:0030332; GO:0031262; GO:0031647; GO:0042802; GO:0051298; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:0140483,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase chromosome alignment [GO:0051310]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of protein stability [GO:0031647]; skeletal muscle satellite cell proliferation [GO:0014841]; spindle assembly involved in female meiosis I [GO:0007057],centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; nuclear speck [GO:0016607],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]; microtubule binding [GO:0008017],GO:0005815; GO:0005829; GO:0007010; GO:0007059; GO:0008092; GO:0022414; GO:0043226; GO:0060090,microtubule organizing center; cytosol; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; reproductive process; organelle; molecular adaptor activity
OG_03040,2.176537305803436,FUN_012279-T1,Peve_00014710,Pocillopora_meandrina_HIv1___RNAseq.g23569.t1,three_way,80.28833333333333,FUN_012279-T1,Q8BHB4,,,,,63.4,938.0,2.5e-138,494.6,sp|Q8BHB4|WDR3_MOUSE WD repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Wdr3 PE=1 SV=1,,,,,,
OG_03042,3.0426605444819588,FUN_012281-T1,Peve_00024232,Pocillopora_meandrina_HIv1___RNAseq.g23579.t1,three_way,65.3465,FUN_012281-T1,Q5TB80,CE162_HUMAN,,Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog),Homo sapiens (Human),31.5,791.0,2.9e-91,339.0,sp|Q5TB80|CE162_HUMAN Centrosomal protein of 162 kDa OS=Homo sapiens OX=9606 GN=CEP162 PE=1 SV=2,GO:0005654; GO:0005794; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005879; GO:0034451; GO:0036064; GO:0043231; GO:0060271,cilium assembly [GO:0060271],axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; spindle [GO:0005819],,GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0043226; GO:0044782,nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; organelle; cilium organization
OG_03045,2.06411953849408,FUN_012285-T1,Peve_00010523,Pocillopora_meandrina_HIv1___RNAseq.g23575.t1,three_way,61.77216666666666,FUN_012285-T1,A1L2Q8,,,,,41.9,265.0,1.7e-55,217.6,sp|A1L2Q8|P5CR3_XENLA Pyrroline-5-carboxylate reductase 3 OS=Xenopus laevis OX=8355 GN=pycr3 PE=2 SV=2,,,,,,
OG_03048,2.774789531661879,FUN_012295-T1,Peve_00036365,Pocillopora_meandrina_HIv1___RNAseq.g23560.t1b,three_way,72.36266666666667,FUN_012295-T1,D3ZGS3,OCRL_RAT,,"Inositol polyphosphate 5-phosphatase OCRL (EC 3.1.3.36) (EC 3.1.3.56) (Inositol polyphosphate 5-phosphatase OCRL-1) (OCRL-1) (Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase) (EC 3.1.3.86)",Rattus norvegicus (Rat),48.5,616.0,3.2e-174,613.6,sp|D3ZGS3|OCRL_RAT Inositol polyphosphate 5-phosphatase OCRL OS=Rattus norvegicus OX=10116 GN=Ocrl PE=1 SV=1,GO:0001701; GO:0001750; GO:0004439; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005802; GO:0005886; GO:0005905; GO:0007165; GO:0016020; GO:0030136; GO:0030670; GO:0031267; GO:0031901; GO:0034485; GO:0043005; GO:0046856; GO:0052658; GO:0052659; GO:0052745; GO:0060271,cilium assembly [GO:0060271]; in utero embryonic development [GO:0001701]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],"GTPase activator activity [GO:0005096]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; small GTPase binding [GO:0031267]",GO:0003824; GO:0005634; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0098772,catalytic activity; nucleus; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_03050,2.098099029629282,FUN_012297-T1,Peve_00002352,Pocillopora_meandrina_HIv1___RNAseq.g23872.t1,three_way,57.568,FUN_012297-T1,Q13112,CAF1B_HUMAN,,Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60) (M-phase phosphoprotein 7),Homo sapiens (Human),42.2,566.0,2.3000000000000002e-104,381.3,sp|Q13112|CAF1B_HUMAN Chromatin assembly factor 1 subunit B OS=Homo sapiens OX=9606 GN=CHAF1B PE=1 SV=1,GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0032991; GO:0033186; GO:0042393; GO:0051082,DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334],CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082],GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006325; GO:0042393; GO:0043226; GO:0065003,nucleus; nucleoplasm; DNA replication; DNA repair; chromatin organization; histone binding; organelle; protein-containing complex assembly
OG_03051,1.420702013586024,FUN_012298-T1,Peve_00038614,Pocillopora_meandrina_HIv1___RNAseq.g23768.t1,three_way,61.748,,,,,,,,,,,,,,,,,
OG_03052,3.7190137690067258,FUN_012299-T1,Peve_00038613,Pocillopora_meandrina_HIv1___RNAseq.g23767.t1,three_way,72.542,,,,,,,,,,,,,,,,,
OG_03055,1.147440062166652,FUN_012302-T1,Peve_00038607,Pocillopora_meandrina_HIv1___RNAseq.g23764.t1,three_way,58.20183333333334,FUN_012302-T1,Q640M1,,,,,32.3,764.0,3.5e-72,274.6,sp|Q640M1|UT14A_MOUSE U3 small nucleolar RNA-associated protein 14 homolog A OS=Mus musculus OX=10090 GN=Utp14a PE=1 SV=1,,,,,,
OG_03056,1.5793000202525014,FUN_012303-T1,Peve_00038606,Pocillopora_meandrina_HIv1___RNAseq.g23763.t1,three_way,76.919,FUN_012303-T1,Q9NRZ5,PLCD_HUMAN,,1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta),Homo sapiens (Human),37.2,379.0,4.7e-67,256.5,sp|Q9NRZ5|PLCD_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase delta OS=Homo sapiens OX=9606 GN=AGPAT4 PE=1 SV=1,GO:0003841; GO:0005741; GO:0005783; GO:0005789; GO:0006654; GO:0008654; GO:0012505; GO:0016024,CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_03059,1.5440393438286366,FUN_012317-T1,Peve_00038600,Pocillopora_meandrina_HIv1___RNAseq.g23744.t1,three_way,77.02933333333333,FUN_012317-T1,O75027,ABCB7_HUMAN,,"Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) (ATP-binding cassette transporter 7) (ABC transporter 7 protein)",Homo sapiens (Human),62.2,640.0,2.1e-225,783.5,"sp|O75027|ABCB7_HUMAN Iron-sulfur clusters transporter ABCB7, mitochondrial OS=Homo sapiens OX=9606 GN=ABCB7 PE=1 SV=2",GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0015232; GO:0016226; GO:0016887; GO:0034755; GO:0042626; GO:0042802; GO:0042803; GO:0055085; GO:0070455; GO:0140466; GO:0140481; GO:1903331; GO:1903427,intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of iron-sulfur cluster assembly [GO:1903331]; transmembrane transport [GO:0055085],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_03061,5.024363059994029,FUN_012325-T1,Peve_00022885,Pocillopora_meandrina_HIv1___RNAseq.g23751.t1,three_way,82.00566666666667,FUN_012325-T1,Q8R3S2,TSN33_MOUSE,,Tetraspanin-33 (Tspan-33) (Penumbra) (mPen) (Proerythroblast new membrane),Mus musculus (Mouse),45.7,258.0,7.699999999999999e-56,218.8,sp|Q8R3S2|TSN33_MOUSE Tetraspanin-33 OS=Mus musculus OX=10090 GN=Tspan33 PE=1 SV=1,GO:0005737; GO:0005912; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197,pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197],enzyme binding [GO:0019899],GO:0051604; GO:0065003; GO:0072659,protein maturation; protein-containing complex assembly; protein localization to plasma membrane
OG_03062,1.057995753738364,FUN_012326-T1,Peve_00023484,Pocillopora_meandrina_HIv1___RNAseq.g23752.t1,three_way,88.28433333333334,FUN_012326-T1,Q64331,MYO6_MOUSE,,Unconventional myosin-VI (Protein twist) (Unconventional myosin-6),Mus musculus (Mouse),58.0,1266.0,0.0,1217.2,sp|Q64331|MYO6_MOUSE Unconventional myosin-VI OS=Mus musculus OX=10090 GN=Myo6 PE=1 SV=2,GO:0003774; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0005905; GO:0006605; GO:0006897; GO:0007268; GO:0007416; GO:0007605; GO:0007626; GO:0008104; GO:0012506; GO:0014047; GO:0014069; GO:0015031; GO:0016358; GO:0016459; GO:0030136; GO:0030175; GO:0030424; GO:0032587; GO:0042472; GO:0042491; GO:0043025; GO:0045202; GO:0048167; GO:0048471; GO:0048839; GO:0051015; GO:0071257; GO:0098683; GO:0098685; GO:0098833; GO:0098871; GO:0098884; GO:0098978; GO:0099171,cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; glutamate secretion [GO:0014047]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein localization [GO:0008104]; protein targeting [GO:0006605]; protein transport [GO:0015031]; regulation of synaptic plasticity [GO:0048167]; sensory perception of sound [GO:0007605]; synapse assembly [GO:0007416],axon [GO:0030424]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cochlear hair cell ribbon synapse [GO:0098683]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; presynaptic endocytic zone [GO:0098833]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; vesicle membrane [GO:0012506],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774],GO:0003774; GO:0005634; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0023052; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,cytoskeletal motor activity; nucleus; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; signaling; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_03075,1.842299909503012,FUN_012347-T1,Peve_00012044,Pocillopora_meandrina_HIv1___RNAseq.g24068.t1,three_way,72.92833333333333,FUN_012347-T1,Q9UGM6,SYWM_HUMAN,,"Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS)",Homo sapiens (Human),48.6,329.0,9.8e-91,335.1,"sp|Q9UGM6|SYWM_HUMAN Tryptophan--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=WARS2 PE=1 SV=1",GO:0001570; GO:0004830; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0006418; GO:0045766; GO:0070183,mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; positive regulation of angiogenesis [GO:0045766]; tRNA aminoacylation for protein translation [GO:0006418]; vasculogenesis [GO:0001570],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830],GO:0003824; GO:0005654; GO:0005739; GO:0005886; GO:0006399; GO:0006520; GO:0016874; GO:0030154; GO:0043226; GO:0140098,"catalytic activity; nucleoplasm; mitochondrion; plasma membrane; tRNA metabolic process; amino acid metabolic process; ligase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_03076,3.05333817755279,FUN_012348-T1,Peve_00029070,Pocillopora_meandrina_HIv1___RNAseq.g24069.t1,three_way,66.19800000000001,FUN_012348-T1,P0C8E4,M3K7_RAT,,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25),Rattus norvegicus (Rat),36.2,796.0,1.6e-112,408.7,sp|P0C8E4|M3K7_RAT Mitogen-activated protein kinase kinase kinase 7 OS=Rattus norvegicus OX=10116 GN=Map3k7 PE=1 SV=1,GO:0000165; GO:0000287; GO:0001223; GO:0001525; GO:0001649; GO:0001666; GO:0001841; GO:0002726; GO:0004674; GO:0004707; GO:0004708; GO:0004709; GO:0005114; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0006955; GO:0007179; GO:0007249; GO:0007252; GO:0007254; GO:0008349; GO:0010508; GO:0010629; GO:0014069; GO:0016239; GO:0030971; GO:0031625; GO:0032743; GO:0034142; GO:0035173; GO:0038066; GO:0038172; GO:0038173; GO:0042742; GO:0042802; GO:0043123; GO:0043276; GO:0043410; GO:0043507; GO:0045787; GO:0045793; GO:0046330; GO:0051403; GO:0060348; GO:0060546; GO:0070498; GO:0071356; GO:0071456; GO:0071560; GO:0097110; GO:0097190; GO:0106310; GO:0120283; GO:0140297; GO:0140672; GO:1901224; GO:1902443; GO:1904385; GO:1904707; GO:1904754; GO:1990450; GO:1990776; GO:2000377; GO:2000378; GO:2001234,angiogenesis [GO:0001525]; anoikis [GO:0043276]; apoptotic signaling pathway [GO:0097190]; bone development [GO:0060348]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; defense response to bacterium [GO:0042742]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression [GO:0010629]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; osteoblast differentiation [GO:0001649]; p38MAPK cascade [GO:0038066]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell size [GO:0045793]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to angiotensin [GO:1990776]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; toll-like receptor 4 signaling pathway [GO:0034142]; transforming growth factor beta receptor signaling pathway [GO:0007179],ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; histone kinase activity [GO:0035173]; identical protein binding [GO:0042802]; linear polyubiquitin binding [GO:1990450]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625],GO:0002376; GO:0003824; GO:0005829; GO:0005886; GO:0006954; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; cytosol; plasma membrane; inflammatory response; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03081,1.6776010389279763,FUN_012353-T1,Peve_00042562,Pocillopora_meandrina_HIv1___RNAseq.g23278.t2,three_way,88.492,FUN_012353-T1,Q6ZQ88,KDM1A_MOUSE,,Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2),Mus musculus (Mouse),68.2,692.0,4.4000000000000004e-274,945.3,sp|Q6ZQ88|KDM1A_MOUSE Lysine-specific histone demethylase 1A OS=Mus musculus OX=10090 GN=Kdm1a PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0006366; GO:0010569; GO:0010718; GO:0010725; GO:0016491; GO:0019899; GO:0021983; GO:0030154; GO:0030851; GO:0031398; GO:0032452; GO:0032453; GO:0032454; GO:0032880; GO:0032991; GO:0034644; GO:0043426; GO:0045648; GO:0045654; GO:0045944; GO:0050660; GO:0050681; GO:0050767; GO:0050768; GO:0055001; GO:0061629; GO:0071480; GO:0106222; GO:0120162; GO:0140297; GO:0140682; GO:0140684; GO:0140861; GO:0160217; GO:1990138; GO:1990391; GO:1990841; GO:2000179; GO:2000648,cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA repair-dependent chromatin remodeling [GO:0140861]; granulocyte differentiation [GO:0030851]; muscle cell development [GO:0055001]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription initiation-coupled chromatin remodeling [GO:0160217]; neuron projection extension [GO:1990138]; pituitary gland development [GO:0021983]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neurogenesis [GO:0050767]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; DNA repair complex [GO:1990391]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; FAD-dependent H3K4me/H3K4me3 demethylase activity [GO:0140682]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone H3K4 demethylase activity [GO:0032453]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me2/H3K9me3 demethylase activity [GO:0140684]; lncRNA binding [GO:0106222]; MRF binding [GO:0043426]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity [GO:0016491]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0006325; GO:0006351; GO:0006355; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"DNA binding; RNA binding; catalytic activity; nucleus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_03084,2.054674183701358,FUN_012357-T1,Peve_00042558,Pocillopora_meandrina_HIv1___TS.g16156.t2,three_way,49.562333333333335,,,,,,,,,,,,,,,,,
OG_03085,2.039489779488292,FUN_012358-T1,Peve_00042557,Pocillopora_meandrina_HIv1___RNAseq.g23273.t1,three_way,74.58133333333333,FUN_012358-T1,Q24133,DNAJ1_DROME,,DnaJ protein homolog 1 (DROJ1),Drosophila melanogaster (Fruit fly),53.0,332.0,1.4e-84,314.7,sp|Q24133|DNAJ1_DROME DnaJ protein homolog 1 OS=Drosophila melanogaster OX=7227 GN=DnaJ-1 PE=1 SV=3,GO:0005829; GO:0006457; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0140297,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408],cytosol [GO:0005829],DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005829; GO:0006457,cytosol; protein folding
OG_03090,1.748321611111311,FUN_012363-T1,Peve_00042552,Pocillopora_meandrina_HIv1___RNAseq.g23268.t1,three_way,71.113,FUN_012363-T1,Q32L99,,,,,56.1,344.0,5.8e-107,389.0,sp|Q32L99|PTGR2_BOVIN Prostaglandin reductase 2 OS=Bos taurus OX=9913 GN=PTGR2 PE=2 SV=1,,,,,,
OG_03094,2.123896265644868,FUN_012379-T1,Peve_00042533,Pocillopora_meandrina_HIv1___TS.g16234.t1b,three_way,77.48716666666667,FUN_012379-T1,P91620,SIF2_DROME,,"Protein still life, isoforms C/SIF type 2",Drosophila melanogaster (Fruit fly),32.8,1044.0,4.7e-133,477.6,"sp|P91620|SIF2_DROME Protein still life, isoforms C/SIF type 2 OS=Drosophila melanogaster OX=7227 GN=sif PE=2 SV=2",GO:0005085; GO:0007264; GO:0016020; GO:0030036; GO:0045202; GO:0050770; GO:0050772; GO:0050803; GO:0051491,actin cytoskeleton organization [GO:0030036]; positive regulation of axonogenesis [GO:0050772]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; small GTPase-mediated signal transduction [GO:0007264],membrane [GO:0016020]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0007010; GO:0098772,cytoskeleton organization; molecular function regulator activity
OG_03095,1.6429210159020646,FUN_012380-T1,Peve_00042535,Pocillopora_meandrina_HIv1___RNAseq.g23350.t1,three_way,70.097,FUN_012380-T1,Q9BRP4,PAAF1_HUMAN,,Proteasomal ATPase-associated factor 1 (Protein G-16) (WD repeat-containing protein 71),Homo sapiens (Human),51.5,396.0,4.1e-56,220.3,sp|Q9BRP4|PAAF1_HUMAN Proteasomal ATPase-associated factor 1 OS=Homo sapiens OX=9606 GN=PAAF1 PE=1 SV=2,GO:0000124; GO:0000502; GO:0005669; GO:0005829; GO:0006367,transcription initiation at RNA polymerase II promoter [GO:0006367],cytosol [GO:0005829]; proteasome complex [GO:0000502]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669],,GO:0005829,cytosol
OG_03097,1.5656739122350447,FUN_012384-T1,Peve_00030646,Pocillopora_meandrina_HIv1___TS.g16227.t2,three_way,74.24833333333333,FUN_012384-T1,Q6P4K5,,,,,68.0,197.0,2.6e-64,247.7,sp|Q6P4K5|FL2D_XENTR Pre-mRNA-splicing regulator WTAP OS=Xenopus tropicalis OX=8364 GN=wtap PE=2 SV=1,,,,,,
OG_03098,2.160104724507717,FUN_012385-T1,Peve_00030647,Pocillopora_meandrina_HIv1___RNAseq.g23346.t1,three_way,76.08833333333334,FUN_012385-T1,Q99ND9,,,,,51.5,231.0,8.2e-43,175.3,sp|Q99ND9|RWDD1_RAT RWD domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Rwdd1 PE=2 SV=1,,,,,,
OG_03101,2.73073575804143,FUN_012388-T1,Peve_00029782,Pocillopora_meandrina_HIv1___RNAseq.g23654.t1,three_way,67.31333333333333,,,,,,,,,,,,,,,,,
OG_03106,1.2386293146451537,FUN_012402-T1,Peve_00023469,Pocillopora_meandrina_HIv1___RNAseq.g23670.t1,three_way,45.885,FUN_012402-T1,Q6UXI7,VITRN_HUMAN,,Vitrin,Homo sapiens (Human),28.8,184.0,5.1e-15,84.7,sp|Q6UXI7|VITRN_HUMAN Vitrin OS=Homo sapiens OX=9606 GN=VIT PE=1 SV=1,GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198,extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510],extracellular region [GO:0005576]; interstitial matrix [GO:0005614],glycosaminoglycan binding [GO:0005539],GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_03107,1.4242140768200493,FUN_012403-T1,Peve_00023468,Pocillopora_meandrina_HIv1___RNAseq.g23671.t1,three_way,40.333,,,,,,,,,,,,,,,,,
OG_03110,1.875838962238984,FUN_012413-T1,Peve_00037989,Pocillopora_meandrina_HIv1___RNAseq.g23678.t1,three_way,80.74566666666666,FUN_012413-T1,Q28HM1,TFB1M_XENTR,,"Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)",Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),40.6,335.0,5.3000000000000003e-73,276.2,"sp|Q28HM1|TFB1M_XENTR Dimethyladenosine transferase 1, mitochondrial OS=Xenopus tropicalis OX=8364 GN=tfb1m PE=2 SV=1",GO:0000179; GO:0003677; GO:0003723; GO:0005739; GO:0031167; GO:1904047,rRNA methylation [GO:0031167],mitochondrion [GO:0005739],"DNA binding [GO:0003677]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; S-adenosyl-L-methionine binding [GO:1904047]",GO:0003677; GO:0003723; GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on RNA"
OG_03115,1.0776406499161002,FUN_012420-T1,Peve_00026918,Pocillopora_meandrina_HIv1___RNAseq.g23691.t1,three_way,83.90433333333334,FUN_012420-T1,Q9EQS3,,,,,59.2,76.0,1.2e-19,97.4,sp|Q9EQS3|MYCBP_MOUSE c-Myc-binding protein OS=Mus musculus OX=10090 GN=Mycbp PE=1 SV=5,,,,,,
OG_03119,2.1542818104068155,FUN_012467-T1,Peve_00007948,Pocillopora_meandrina_HIv1___RNAseq.g23979.t1,three_way,72.50066666666666,FUN_012467-T1,Q9HF54,,,,,41.9,186.0,3.7e-35,150.2,sp|Q9HF54|RHO1_EREGS GTP-binding protein RHO1 OS=Eremothecium gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=RHO1 PE=3 SV=1,,,,,,
OG_03120,1.6152577919062616,FUN_012469-T1,Peve_00007945,Pocillopora_meandrina_HIv1___RNAseq.g27161.t1,three_way,62.98266666666667,FUN_012469-T1,Q9XTR8,,,,,29.8,302.0,2.6e-34,147.9,sp|Q9XTR8|LIP1_CAEEL Lipase ZK262.3 OS=Caenorhabditis elegans OX=6239 GN=txt-8 PE=1 SV=1,,,,,,
OG_03123,1.751527759082313,FUN_012477-T1,Peve_00004006,Pocillopora_meandrina_HIv1___RNAseq.g23991.t1,three_way,62.38933333333333,,,,,,,,,,,,,,,,,
OG_03126,3.129357711480237,FUN_012482-T1,Peve_00004001,Pocillopora_meandrina_HIv1___RNAseq.g23996.t2,three_way,49.154,FUN_012482-T1,O15287,FANCG_HUMAN,,Fanconi anemia group G protein (Protein FACG) (DNA repair protein XRCC9),Homo sapiens (Human),26.7,243.0,4.6e-08,61.6,sp|O15287|FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens OX=9606 GN=FANCG PE=1 SV=1,GO:0000785; GO:0001541; GO:0003684; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006974; GO:0007005; GO:0007286; GO:0009314; GO:0016607; GO:0036297; GO:0043240,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; mitochondrion organization [GO:0007005]; ovarian follicle development [GO:0001541]; response to radiation [GO:0009314]; spermatid development [GO:0007286],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],damaged DNA binding [GO:0003684],GO:0003677; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0007005; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleoplasm; mitochondrion; cytosol; DNA repair; mitochondrion organization; reproductive process; organelle; anatomical structure development
OG_03127,2.483870585377757,FUN_012485-T1,Peve_00010916,Pocillopora_meandrina_HIv1___RNAseq.g24000.t1,three_way,82.52933333333333,FUN_012485-T1,Q28DT7,,,,,66.6,356.0,4.8e-145,515.8,sp|Q28DT7|EED_XENTR Polycomb protein eed OS=Xenopus tropicalis OX=8364 GN=eed PE=2 SV=1,,,,,,
OG_03130,1.968915807107079,FUN_012490-T1,Peve_00007944,Pocillopora_meandrina_HIv1___RNAseq.g23964.t1,three_way,84.40183333333333,FUN_012490-T1,E9PZZ1,PRD13_MOUSE,,PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13),Mus musculus (Mouse),55.2,87.0,6.6e-20,100.1,sp|E9PZZ1|PRD13_MOUSE PR domain zinc finger protein 13 OS=Mus musculus OX=10090 GN=Prdm13 PE=2 SV=1,GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0021979; GO:0022008; GO:0032259; GO:0042054; GO:0061629; GO:0097154,GABAergic neuron differentiation [GO:0097154]; hypothalamus cell differentiation [GO:0021979]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_03132,1.0939420216197868,FUN_012494-T1,Peve_00007950,Pocillopora_meandrina_HIv1___RNAseq.g23966.t1,three_way,73.58933333333333,FUN_012494-T1,A1ZAY1,DLISH_DROME,,SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains),Drosophila melanogaster (Fruit fly),30.5,419.0,7.6e-41,169.5,sp|A1ZAY1|DLISH_DROME SH3 domain-containing protein Dlish OS=Drosophila melanogaster OX=7227 GN=Dlish PE=1 SV=1,GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219,establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251],apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219],cadherin binding [GO:0045296],GO:0005929; GO:0007163; GO:0043226,cilium; establishment or maintenance of cell polarity; organelle
OG_03133,1.6534164514576375,FUN_012495-T1,Peve_00007942,Pocillopora_meandrina_HIv1___RNAseq.g23967.t1,three_way,78.17366666666666,FUN_012495-T1,P02607,,,,,45.3,148.0,2.4000000000000002e-30,133.3,sp|P02607|MYL6_CHICK Myosin light polypeptide 6 OS=Gallus gallus OX=9031 GN=MYL6 PE=1 SV=3,,,,,,
OG_03137,2.648731620870074,FUN_012518-T1,Peve_00022370,Pocillopora_meandrina_HIv1___RNAseq.g23957.t1,three_way,84.53366666666666,FUN_012518-T1,Q8CHX6,MBTP2_MOUSE,,Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P),Mus musculus (Mouse),40.6,508.0,4.7e-104,379.8,sp|Q8CHX6|MBTP2_MOUSE Membrane-bound transcription factor site-2 protease OS=Mus musculus OX=10090 GN=Mbtps2 PE=2 SV=1,GO:0000139; GO:0004222; GO:0005737; GO:0005789; GO:0007095; GO:0008203; GO:0031293; GO:0034976; GO:0045542; GO:0045944; GO:0046872; GO:0051604; GO:0070977; GO:0140537,bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein maturation [GO:0051604]; response to endoplasmic reticulum stress [GO:0034976],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; transcription regulator activator activity [GO:0140537],GO:0003824; GO:0006355; GO:0006629; GO:0016787; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; regulation of DNA-templated transcription; lipid metabolic process; hydrolase activity; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03140,1.273263725661138,FUN_012524-T1,Peve_00029781,Pocillopora_meandrina_HIv1___RNAseq.g23963.t1,three_way,62.26433333333333,,,,,,,,,,,,,,,,,
OG_03141,1.8632768310662529,FUN_012525-T1,Peve_00019857,Pocillopora_meandrina_HIv1___RNAseq.g23978.t1,three_way,41.14233333333333,FUN_012525-T1,Q9H4Q3,PRD13_HUMAN,,PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13),Homo sapiens (Human),58.3,84.0,7.9999999999999985e-25,117.1,sp|Q9H4Q3|PRD13_HUMAN PR domain zinc finger protein 13 OS=Homo sapiens OX=9606 GN=PRDM13 PE=1 SV=2,GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0010468; GO:0021979; GO:0032259; GO:0042054; GO:0061629; GO:0097154,GABAergic neuron differentiation [GO:0097154]; hypothalamus cell differentiation [GO:0021979]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468],nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_03143,1.8238432370710191,FUN_012528-T1,Peve_00013908,Pocillopora_meandrina_HIv1___RNAseq.g23974.t1,three_way,64.574,FUN_012528-T1,Q14149,MORC3_HUMAN,,MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3),Homo sapiens (Human),59.4,483.0,9.3e-152,539.3,sp|Q14149|MORC3_HUMAN MORC family CW-type zinc finger protein 3 OS=Homo sapiens OX=9606 GN=MORC3 PE=1 SV=3,GO:0000122; GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006468; GO:0008270; GO:0009791; GO:0016363; GO:0016605; GO:0016887; GO:0018105; GO:0030674; GO:0032688; GO:0035064; GO:0048147; GO:0050821; GO:0051457; GO:0140002; GO:0140374; GO:2000774,antiviral innate immune response [GO:0140374]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular senescence [GO:2000774]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821],chromatin [GO:0000785]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; histone H3K4me3 reader activity [GO:0140002]; methylated histone binding [GO:0035064]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016787; GO:0043226; GO:0060090; GO:0098542,immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; hydrolase activity; organelle; molecular adaptor activity; defense response to other organism
OG_03146,2.2967520826404475,FUN_012532-T1,Peve_00013905,Pocillopora_meandrina_HIv1___RNAseq.g23955.t1,three_way,55.178666666666665,,,,,,,,,,,,,,,,,
OG_03147,2.492155201367189,FUN_012533-T1,Peve_00034230,Pocillopora_meandrina_HIv1___RNAseq.g23954.t1,three_way,57.28066666666667,,,,,,,,,,,,,,,,,
OG_03153,1.7508438873965446,FUN_012542-T1,Peve_00034213,Pocillopora_meandrina_HIv1___RNAseq.g23623.t1,three_way,74.7105,FUN_012542-T1,O15442,,,,,51.8,251.0,1.3e-72,274.6,sp|O15442|MPPD1_HUMAN Metallophosphoesterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MPPED1 PE=1 SV=3,,,,,,
OG_03154,1.1941867486444269,FUN_012545-T1,Peve_00030392,Pocillopora_meandrina_HIv1___RNAseq.g23621.t1,three_way,90.88266666666668,FUN_012545-T1,Q9DC48,,,,,66.9,550.0,4.299999999999999e-229,795.4,sp|Q9DC48|PRP17_MOUSE Pre-mRNA-processing factor 17 OS=Mus musculus OX=10090 GN=Cdc40 PE=1 SV=1,,,,,,
OG_03155,1.3115370178123609,FUN_012546-T1,Peve_00030399,Pocillopora_meandrina_HIv1___RNAseq.g23612.t1,three_way,72.47733333333333,FUN_012546-T1,O43719,HTSF1_HUMAN,,17S U2 SnRNP complex component HTATSF1 (HIV Tat-specific factor 1) (Tat-SF1),Homo sapiens (Human),44.5,384.0,5.600000000000001e-89,329.3,sp|O43719|HTSF1_HUMAN 17S U2 SnRNP complex component HTATSF1 OS=Homo sapiens OX=9606 GN=HTATSF1 PE=1 SV=1,GO:0000398; GO:0000724; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0035861; GO:0140463; GO:0160004; GO:1903241; GO:1990166,"double-strand break repair via homologous recombination [GO:0000724]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to site of double-strand break [GO:1990166]; U2-type prespliceosome assembly [GO:1903241]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684],chromatin-protein adaptor activity [GO:0140463]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016071; GO:0043226; GO:0060090; GO:0065003,RNA binding; nucleus; nucleoplasm; DNA repair; DNA recombination; mRNA metabolic process; organelle; molecular adaptor activity; protein-containing complex assembly
OG_03158,3.631899207897726,FUN_012554-T1,Peve_00030421,Pocillopora_meandrina_HIv1___RNAseq.g23587.t2,three_way,58.8805,,,,,,,,,,,,,,,,,
OG_03160,2.1508028834827733,FUN_012556-T1,Peve_00030424,Pocillopora_meandrina_HIv1___RNAseq.g23585.t1,three_way,70.635,FUN_012556-T1,Q4V8S3,,,,,44.0,91.0,9e-11,68.2,sp|Q4V8S3|TM242_DANRE Transmembrane protein 242 OS=Danio rerio OX=7955 GN=tmem242 PE=2 SV=2,,,,,,
OG_03162,1.1125988900641617,FUN_012560-T1,Peve_00016376,Pocillopora_meandrina_HIv1___RNAseq.g23583.t2,three_way,80.59633333333333,FUN_012560-T1,O19072,,,,,62.7,316.0,7.9e-115,415.2,"sp|O19072|OTC_PIG Ornithine transcarbamylase, mitochondrial (Fragment) OS=Sus scrofa OX=9823 GN=OTC PE=2 SV=1",,,,,,
OG_03163,2.297643512368177,FUN_012561-T1,Peve_00016373,Pocillopora_meandrina_HIv1___RNAseq.g23582.t1,three_way,69.20983333333334,FUN_012561-T1,Q92834,RPGR_HUMAN,,X-linked retinitis pigmentosa GTPase regulator,Homo sapiens (Human),44.0,448.0,1.1e-68,263.1,sp|Q92834|RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens OX=9606 GN=RPGR PE=1 SV=2,GO:0001750; GO:0003723; GO:0005085; GO:0005737; GO:0005794; GO:0005813; GO:0006511; GO:0006886; GO:0007601; GO:0010508; GO:0016567; GO:0032391; GO:0036064; GO:0036126; GO:0042073; GO:0042462; GO:0060271; GO:0061630; GO:0097499,cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; positive regulation of autophagy [GO:0010508]; protein localization to non-motile cilium [GO:0097499]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126],guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630],GO:0003723; GO:0003824; GO:0005794; GO:0005815; GO:0005929; GO:0006886; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0098772; GO:0140096,"RNA binding; catalytic activity; Golgi apparatus; microtubule organizing center; cilium; intracellular protein transport; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; nervous system process; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03165,2.609325700080223,FUN_012571-T1,Peve_00015689,Pocillopora_meandrina_HIv1___RNAseq.g12855.t1,three_way,43.12116666666667,FUN_012571-T1,P0C6Y7,PRDM9_RAT,,Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361),Rattus norvegicus (Rat),40.5,173.0,1.4e-32,143.3,sp|P0C6Y7|PRDM9_RAT Histone-lysine N-methyltransferase PRDM9 OS=Rattus norvegicus OX=10116 GN=Prdm9 PE=3 SV=1,GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0007127; GO:0007129; GO:0007283; GO:0007292; GO:0008270; GO:0010468; GO:0010844; GO:0010845; GO:0032259; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0045944; GO:0046975; GO:0048232; GO:0060903; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:0140999; GO:1905516; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiosis I [GO:0007127]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; nucleus [GO:0005634],histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0140013; GO:0140096,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_03166,2.606876576090203,FUN_012588-T1,Peve_00038785,Pocillopora_meandrina_HIv1___TS.g2635.t1,three_way,81.07383333333334,FUN_012588-T1,Q18297,TRPA1_CAEEL,,Transient receptor potential cation channel subfamily A member 1 homolog,Caenorhabditis elegans,30.8,568.0,2.3e-54,216.1,sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5,GO:0005216; GO:0005886; GO:0043025; GO:0097730,,neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],monoatomic ion channel activity [GO:0005216],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_03167,1.5765751142603592,FUN_012589-T1,Peve_00038783,Pocillopora_meandrina_HIv1___RNAseq.g13638.t1,three_way,75.37183333333333,FUN_012589-T1,Q9D572,,,,,36.1,485.0,1.2e-72,275.4,sp|Q9D572|UBX11_MOUSE UBX domain-containing protein 11 OS=Mus musculus OX=10090 GN=Ubxn11 PE=1 SV=1,,,,,,
OG_03168,3.424301059348472,FUN_012590-T1,Peve_00038782,Pocillopora_meandrina_HIv1___RNAseq.g13637.t1,three_way,72.70233333333334,FUN_012590-T1,Q53FA7,QORX_HUMAN,,Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein),Homo sapiens (Human),53.7,322.0,9.4e-97,355.1,sp|Q53FA7|QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens OX=9606 GN=TP53I3 PE=1 SV=2,GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0048038; GO:0070402,NADP metabolic process [GO:0006739],cytosol [GO:0005829],NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038],GO:0003824; GO:0005829; GO:0016491; GO:0055086,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_03169,1.5976439868104704,FUN_012591-T1,Peve_00038779,Pocillopora_meandrina_HIv1___RNAseq.g13635.t2,three_way,63.194,FUN_012591-T1,Q96PZ0,PUS7_HUMAN,,Pseudouridylate synthase 7 homolog (EC 5.4.99.-),Homo sapiens (Human),44.0,577.0,1.9e-143,511.1,sp|Q96PZ0|PUS7_HUMAN Pseudouridylate synthase 7 homolog OS=Homo sapiens OX=9606 GN=PUS7 PE=1 SV=2,GO:0001522; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:0160150; GO:1902036; GO:1990481; GO:2000380,mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119],nucleus [GO:0005634],enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine(13) synthase activity [GO:0160150],GO:0003723; GO:0003824; GO:0005634; GO:0006399; GO:0016071; GO:0016853; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; tRNA metabolic process; mRNA metabolic process; isomerase activity; organelle; catalytic activity, acting on RNA"
OG_03171,1.1489082316443102,FUN_012594-T1,Peve_00042400,Pocillopora_meandrina_HIv1___RNAseq.g13631.t1,three_way,63.02033333333333,FUN_012594-T1,Q91YI6,GLD2_MOUSE,,Poly(A) RNA polymerase GLD2 (mGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4) (Terminal nucleotidyltransferase 2),Mus musculus (Mouse),35.1,328.0,2.3e-38,161.0,sp|Q91YI6|GLD2_MOUSE Poly(A) RNA polymerase GLD2 OS=Mus musculus OX=10090 GN=Tent2 PE=1 SV=1,GO:0002244; GO:0005524; GO:0005634; GO:0005737; GO:0031124; GO:0046872; GO:0071044; GO:0140958; GO:1990817; GO:2000626,hematopoietic progenitor cell differentiation [GO:0002244]; histone mRNA catabolic process [GO:0071044]; mRNA 3'-end processing [GO:0031124]; negative regulation of miRNA catabolic process [GO:2000626]; target-directed miRNA degradation [GO:0140958],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nucleus; mRNA metabolic process; transferase activity; cell differentiation; organelle
OG_03172,1.9180321949358248,FUN_012595-T1,Peve_00042401,Pocillopora_meandrina_HIv1___TS.g2626.t1,three_way,93.69466666666666,FUN_012595-T1,Q8BWD8,,,,,81.7,367.0,3.4e-181,636.0,sp|Q8BWD8|CDK19_MOUSE Cyclin-dependent kinase 19 OS=Mus musculus OX=10090 GN=Cdk19 PE=2 SV=1,,,,,,
OG_03179,1.1251265778397206,FUN_012625-T1,Peve_00040110,Pocillopora_meandrina_HIv1___RNAseq.g13729.t1,three_way,75.87533333333333,FUN_012625-T1,Q55FK2,RAB6_DICDI,,Ras-related protein Rab-6,Dictyostelium discoideum (Social amoeba),48.7,189.0,7.6e-44,178.7,sp|Q55FK2|RAB6_DICDI Ras-related protein Rab-6 OS=Dictyostelium discoideum OX=44689 GN=rab6 PE=3 SV=1,GO:0003924; GO:0005525; GO:0005794; GO:0005811; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0042147; GO:0140220,"intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; pathogen-containing vacuole [GO:0140220],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005794; GO:0005811; GO:0005829; GO:0006886; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; Golgi apparatus; lipid droplet; cytosol; intracellular protein transport; vesicle-mediated transport; hydrolase activity; organelle
OG_03180,2.3944880181459283,FUN_012628-T1,Peve_00040111,Pocillopora_meandrina_HIv1___RNAseq.g13728.t1,three_way,73.136,FUN_012628-T1,Q5BKR2,SL9B2_MOUSE,,Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Mus musculus (Mouse),50.6,451.0,9.2e-114,412.1,sp|Q5BKR2|SL9B2_MOUSE Sodium/hydrogen exchanger 9B2 OS=Mus musculus OX=10090 GN=Slc9b2 PE=1 SV=2,GO:0005765; GO:0005886; GO:0010008; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0046872; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:2001206,clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; lithium ion transport [GO:0010351]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672],identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; metal ion binding [GO:0046872]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005768; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870,transporter activity; endosome; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_03183,1.4355894432107408,FUN_012638-T1,Peve_00036816,Pocillopora_meandrina_HIv1___RNAseq.g22910.t1,three_way,71.77066666666667,FUN_012638-T1,Q6P1A2,MBOA5_HUMAN,,Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5),Homo sapiens (Human),39.7,448.0,2e-91,337.8,sp|Q6P1A2|MBOA5_HUMAN Lysophospholipid acyltransferase 5 OS=Homo sapiens OX=9606 GN=LPCAT3 PE=1 SV=1,GO:0003841; GO:0005789; GO:0006656; GO:0016020; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047144; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0106262; GO:0106263; GO:1903573; GO:1905885,chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; very-low-density lipoprotein particle assembly [GO:0034379],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617],GO:0003824; GO:0006575; GO:0006629; GO:0016740; GO:0061024; GO:0065003,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity; membrane organization; protein-containing complex assembly
OG_03184,1.7240015989372253,FUN_012639-T1,Peve_00036806,Pocillopora_meandrina_HIv1___RNAseq.g22909.t1,three_way,74.95033333333333,FUN_012639-T1,Q5THJ4,VP13D_HUMAN,,Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D),Homo sapiens (Human),35.7,4659.0,0.0,2452.2,sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2,GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526,lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623],extracellular exosome [GO:0070062]; mitochondrion [GO:0005739],,GO:0005739; GO:0006886; GO:0007005; GO:0043226,mitochondrion; intracellular protein transport; mitochondrion organization; organelle
OG_03185,1.167678256221826,FUN_012640-T1,Peve_00041557,Pocillopora_meandrina_HIv1___RNAseq.g22908.t1,three_way,69.78033333333333,FUN_012640-T1,Q7T2D1,,,,,37.7,326.0,1.1999999999999999e-61,238.4,sp|Q7T2D1|RD10B_DANRE Retinol dehydrogenase 10-B OS=Danio rerio OX=7955 GN=rdh10b PE=2 SV=2,,,,,,
OG_03190,1.7649789936332458,FUN_012662-T1,Peve_00020495,Pocillopora_meandrina_HIv1___RNAseq.g22891.t1,three_way,60.961666666666666,FUN_012662-T1,Q8BZ20,,,,,32.8,649.0,2e-78,295.0,sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3,,,,,,
OG_03198,1.9024932243000496,FUN_012677-T1,Peve_00042301,Pocillopora_meandrina_HIv1___RNAseq.g22878.t1,three_way,73.87016666666666,FUN_012677-T1,Q9C0J8,WDR33_HUMAN,,pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa),Homo sapiens (Human),74.4,406.0,2.2e-161,571.2,sp|Q9C0J8|WDR33_HUMAN pre-mRNA 3' end processing protein WDR33 OS=Homo sapiens OX=9606 GN=WDR33 PE=1 SV=2,GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0007283; GO:0031124,mRNA 3'-end processing [GO:0031124]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283],collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0016071; GO:0022414; GO:0043226,RNA binding; nucleus; nucleoplasm; DNA repair; mRNA metabolic process; reproductive process; organelle
OG_03199,1.6779987643027057,FUN_012684-T1,Peve_00042302,Pocillopora_meandrina_HIv1___RNAseq.g22874.t1,three_way,80.24466666666666,FUN_012684-T1,P52209,6PGD_HUMAN,,"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)",Homo sapiens (Human),76.5,481.0,1.5999999999999998e-221,770.0,"sp|P52209|6PGD_HUMAN 6-phosphogluconate dehydrogenase, decarboxylating OS=Homo sapiens OX=9606 GN=PGD PE=1 SV=3",GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0019521; GO:0030246; GO:0031406; GO:0050661; GO:0070062,"D-gluconate metabolic process [GO:0019521]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]",cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616],GO:0003824; GO:0005634; GO:0005829; GO:0005975; GO:0006091; GO:0016491; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03202,1.0671019354149451,FUN_012688-T1,Peve_00016837,Pocillopora_meandrina_HIv1___RNAseq.g22865.t1,three_way,53.63766666666667,,,,,,,,,,,,,,,,,
OG_03203,2.579725580066462,FUN_012689-T1,Peve_00016816,Pocillopora_meandrina_HIv1___RNAseq.g22864.t1,three_way,78.05083333333333,FUN_012689-T1,Q9YHY6,,,,,42.0,1454.0,3.1999999999999995e-300,1033.1,sp|Q9YHY6|CND1_XENLA Condensin complex subunit 1 OS=Xenopus laevis OX=8355 GN=ncapd2 PE=1 SV=1,,,,,,
OG_03204,1.179690913481461,FUN_012693-T1,Peve_00016824,Pocillopora_meandrina_HIv1___TS.g15743.t1,three_way,82.26066666666667,FUN_012693-T1,Q7L8C5,SYT13_HUMAN,,Synaptotagmin-13 (Synaptotagmin XIII) (SytXIII),Homo sapiens (Human),29.4,194.0,6.1e-11,70.5,sp|Q7L8C5|SYT13_HUMAN Synaptotagmin-13 OS=Homo sapiens OX=9606 GN=SYT13 PE=1 SV=1,GO:0000149; GO:0005544; GO:0005886; GO:0016192; GO:0017158; GO:0030133; GO:0030424; GO:0030672; GO:0031045; GO:0043231; GO:0061891; GO:0070382; GO:0099502; GO:2000300,calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of synaptic vesicle exocytosis [GO:2000300]; vesicle-mediated transport [GO:0016192],axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; transport vesicle [GO:0030133],calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149],GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_03205,1.274813879445381,FUN_012696-T1,Peve_00016827,Pocillopora_meandrina_HIv1___RNAseq.g22856.t1,three_way,62.6505,FUN_012696-T1,Q5F3A1,,,,,56.6,290.0,9.4e-52,205.7,sp|Q5F3A1|SEC62_CHICK Translocation protein SEC62 OS=Gallus gallus OX=9031 GN=SEC62 PE=2 SV=1,,,,,,
OG_03206,1.0007411617863342,FUN_012698-T1,Peve_00016828,Pocillopora_meandrina_HIv1___RNAseq.g22855.t1,three_way,79.2805,FUN_012698-T1,Q62901,RERE_RAT,,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-related protein),Rattus norvegicus (Rat),46.5,514.0,8.900000000000001e-124,446.4,sp|Q62901|RERE_RAT Arginine-glutamic acid dipeptide repeats protein OS=Rattus norvegicus OX=10116 GN=Rere PE=1 SV=2,GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0008270; GO:0016605; GO:0021549; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813,branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942],histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605],chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; chromatin organization; organelle; anatomical structure development; cell motility; molecular adaptor activity; transcription regulator activity
OG_03207,2.6260577625632138,FUN_012699-T1,Peve_00016830,Pocillopora_meandrina_HIv1___RNAseq.g22854.t1,three_way,70.60966666666667,FUN_012699-T1,O94923,GLCE_HUMAN,,D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase),Homo sapiens (Human),44.1,612.0,9.099999999999999e-137,488.8,sp|O94923|GLCE_HUMAN D-glucuronyl C5-epimerase OS=Homo sapiens OX=9606 GN=GLCE PE=1 SV=3,GO:0000139; GO:0005509; GO:0005794; GO:0008284; GO:0015012; GO:0016857; GO:0030210; GO:0031345; GO:0042803; GO:0047464; GO:0060391,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; negative regulation of cell projection organization [GO:0031345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of SMAD protein signal transduction [GO:0060391],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]",GO:0003824; GO:0005794; GO:0009101; GO:0016853; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; isomerase activity; organelle; carbohydrate derivative metabolic process
OG_03208,3.4429212242767284,FUN_012700-T1,Peve_00016832,Pocillopora_meandrina_HIv1___RNAseq.g12826.t1,three_way,67.51966666666667,FUN_012700-T1,Q12794,,,,,39.9,353.0,2.5000000000000002e-73,278.1,sp|Q12794|HYAL1_HUMAN Hyaluronidase-1 OS=Homo sapiens OX=9606 GN=HYAL1 PE=1 SV=2,,,,,,
OG_03211,2.092743166435266,FUN_012707-T1,Peve_00004150,Pocillopora_meandrina_HIv1___RNAseq.g12831.t1,three_way,67.89066666666668,FUN_012707-T1,A7YY53,ADPRM_BOVIN,,Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase (EC 3.6.1.13) (EC 3.6.1.16) (EC 3.6.1.53) (ADPRibase-Mn) (CDP-choline phosphohydrolase),Bos taurus (Bovine),41.1,333.0,1.1e-70,268.5,sp|A7YY53|ADPRM_BOVIN Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase OS=Bos taurus OX=9913 GN=ADPRM PE=2 SV=2,GO:0008663; GO:0030145; GO:0047631; GO:0047734,,,"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; manganese ion binding [GO:0030145]",GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_03212,1.3569566325092135,FUN_012708-T1,Peve_00004160,Pocillopora_meandrina_HIv1___RNAseq.g12832.t1,three_way,54.59816666666666,,,,,,,,,,,,,,,,,
OG_03214,1.0392906372337412,FUN_012711-T1,Peve_00000958,Pocillopora_meandrina_HIv1___RNAseq.g12836.t1c,three_way,66.162,FUN_012711-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),32.7,284.0,9.999999999999999e-33,142.9,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_03218,1.811375675185912,FUN_012742-T1,Peve_00045169,Pocillopora_meandrina_HIv1___RNAseq.g23181.t1,three_way,60.48133333333333,,,,,,,,,,,,,,,,,
OG_03220,2.1700605885591746,FUN_012757-T1,Peve_00044225,Pocillopora_meandrina_HIv1___TS.g16058.t1,three_way,41.0565,,,,,,,,,,,,,,,,,
OG_03224,2.431251991562989,FUN_012764-T2,Peve_00006134,Pocillopora_meandrina_HIv1___TS.g16045.t1,three_way,49.54133333333333,FUN_012764-T2,Q5RFG8,UBE3D_PONAB,,E3 ubiquitin-protein ligase E3D (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase E3D) (UbcH10-binding protein with a HECT-like domain) (Ubiquitin-conjugating enzyme E2C-binding protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,359.0,8.100000000000001e-28,126.3,sp|Q5RFG8|UBE3D_PONAB E3 ubiquitin-protein ligase E3D OS=Pongo abelii OX=9601 GN=UBE3D PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005829; GO:0006513; GO:0030332; GO:0031624; GO:0043161; GO:0051865; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],cyclin binding [GO:0030332]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03225,1.1742464903796408,FUN_012766-T1,Peve_00026363,Pocillopora_meandrina_HIv1___RNAseq.g23151.t1c,three_way,53.47366666666667,,,,,,,,,,,,,,,,,
OG_03227,2.18176295973209,FUN_012769-T1,Peve_00016323,Pocillopora_meandrina_HIv1___RNAseq.g13659.t1,three_way,77.668,FUN_012769-T1,Q68EJ0,NB5R4_RAT,,Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R),Rattus norvegicus (Rat),42.8,544.0,7.9e-116,419.1,sp|Q68EJ0|NB5R4_RAT Cytochrome b5 reductase 4 OS=Rattus norvegicus OX=10116 GN=Cyb5r4 PE=1 SV=2,GO:0003958; GO:0004128; GO:0005737; GO:0005783; GO:0006739; GO:0006801; GO:0016174; GO:0016653; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0050660; GO:0072593,cell development [GO:0048468]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; NADP metabolic process [GO:0006739]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]",GO:0003824; GO:0005783; GO:0016491; GO:0043226; GO:0048856; GO:0055086,catalytic activity; endoplasmic reticulum; oxidoreductase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_03230,1.2949257549561706,FUN_012772-T1,Peve_00007600,Pocillopora_meandrina_HIv1___RNAseq.g13653.t1,three_way,86.02266666666667,FUN_012772-T1,Q9DFQ7,,,,,76.6,111.0,5.199999999999999e-43,175.6,sp|Q9DFQ7|RL24_GILMI Large ribosomal subunit protein eL24 OS=Gillichthys mirabilis OX=8222 GN=rpl24 PE=2 SV=2,,,,,,
OG_03231,2.127622095238758,FUN_012774-T1,Peve_00007593,Pocillopora_meandrina_HIv1___RNAseq.g13651.t1,three_way,88.069,FUN_012774-T1,O43741,,,,,45.0,280.0,3.1e-60,233.4,sp|O43741|AAKB2_HUMAN 5'-AMP-activated protein kinase subunit beta-2 OS=Homo sapiens OX=9606 GN=PRKAB2 PE=1 SV=1,,,,,,
OG_03233,2.064436130653563,FUN_012778-T1,Peve_00017055,Pocillopora_meandrina_HIv1___RNAseq.g12882.t1,three_way,73.01033333333334,FUN_012778-T1,A7RL75,,,,,52.5,179.0,4e-40,166.4,sp|A7RL75|TTC36_NEMVE Tetratricopeptide repeat protein 36 homolog OS=Nematostella vectensis OX=45351 GN=ttc36 PE=3 SV=1,,,,,,
OG_03236,2.109686802787039,FUN_012786-T1,Peve_00018304,Pocillopora_meandrina_HIv1___RNAseq.g12888.t1,three_way,86.545,FUN_012786-T1,Q6IWH7,ANO7_HUMAN,,Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G),Homo sapiens (Human),45.7,879.0,2.2e-213,743.8,sp|Q6IWH7|ANO7_HUMAN Anoctamin-7 OS=Homo sapiens OX=9606 GN=ANO7 PE=1 SV=2,GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0034220; GO:0046983; GO:0061588; GO:0070161; GO:1902476,calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220],anchoring junction [GO:0070161]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; organelle; transmembrane transport; membrane organization
OG_03237,1.9171342229403,FUN_012787-T1,Peve_00023538,Pocillopora_meandrina_HIv1___TS.g1877.t1,three_way,62.16516666666666,FUN_012787-T1,Q920Q2,REV1_MOUSE,,DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase),Mus musculus (Mouse),33.0,1286.0,1.2e-152,542.3,sp|Q920Q2|REV1_MOUSE DNA repair protein REV1 OS=Mus musculus OX=10090 GN=Rev1 PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0009411; GO:0017125; GO:0042276; GO:0046872,error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411],nucleus [GO:0005634],damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_03238,1.7039864941039498,FUN_012788-T1,Peve_00010079,Pocillopora_meandrina_HIv1___RNAseq.g12891.t1,three_way,80.43083333333334,FUN_012788-T1,Q5RCR5,,,,,56.2,274.0,4.7e-94,345.9,sp|Q5RCR5|SUMF2_PONAB Inactive C-alpha-formylglycine-generating enzyme 2 OS=Pongo abelii OX=9601 GN=SUMF2 PE=2 SV=1,,,,,,
OG_03241,1.0687713406956043,FUN_012795-T1,Peve_00022361,Pocillopora_meandrina_HIv1___TS.g1884.t1,three_way,59.97133333333333,FUN_012795-T1,Q05793,PGBM_MOUSE,,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) [Cleaved into: Endorepellin; LG3 peptide],Mus musculus (Mouse),32.0,1366.0,6.4e-204,713.0,sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1,GO:0001525; GO:0001958; GO:0002020; GO:0002062; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007420; GO:0008104; GO:0030198; GO:0031012; GO:0048704; GO:0048738; GO:0060351; GO:0062023,angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796],calcium ion binding [GO:0005509]; protease binding [GO:0002020],GO:0005576; GO:0016192; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; vesicle-mediated transport; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_03243,1.0311913526086434,FUN_012870-T1,Peve_00003570,Pocillopora_meandrina_HIv1___TS.g1932.t2,three_way,76.04733333333334,FUN_012870-T1,D2GXS7,,,,,41.0,78.0,4e-12,74.7,sp|D2GXS7|TRIM2_AILME Tripartite motif-containing protein 2 OS=Ailuropoda melanoleuca OX=9646 GN=TRIM2 PE=3 SV=1,,,,,,
OG_03246,1.7449802708899838,FUN_012889-T1,Peve_00033084,Pocillopora_meandrina_HIv1___RNAseq.g13862.t1,three_way,72.43866666666666,FUN_012889-T1,P53111,,,,,34.3,361.0,2.6e-35,151.0,sp|P53111|ARI1_YEAST NADPH-dependent aldehyde reductase ARI1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=ARI1 PE=1 SV=1,,,,,,
OG_03247,1.631702232714804,FUN_012926-T1,Peve_00000427,Pocillopora_meandrina_HIv1___TS.g1951.t2a,three_way,82.53266666666667,FUN_012926-T1,D3ZG27,UBIA1_RAT,,UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-) (EC 2.5.1.39),Rattus norvegicus (Rat),58.4,293.0,3.7e-86,319.7,sp|D3ZG27|UBIA1_RAT UbiA prenyltransferase domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Ubiad1 PE=3 SV=1,GO:0000139; GO:0001885; GO:0004659; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006744; GO:0009233; GO:0009234; GO:0016020; GO:0016209; GO:0031966; GO:0042371; GO:0042374; GO:0072359,circulatory system development [GO:0072359]; endothelial cell development [GO:0001885]; menaquinone biosynthetic process [GO:0009234]; menaquinone metabolic process [GO:0009233]; phylloquinone metabolic process [GO:0042374]; ubiquinone biosynthetic process [GO:0006744]; vitamin K biosynthetic process [GO:0042371],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634],antioxidant activity [GO:0016209]; prenyltransferase activity [GO:0004659],GO:0003824; GO:0005634; GO:0005783; GO:0006766; GO:0016209; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; endoplasmic reticulum; vitamin metabolic process; antioxidant activity; transferase activity; organelle; anatomical structure development
OG_03256,2.4565292749870467,FUN_013024-T1,Peve_00032573,Pocillopora_meandrina_HIv1___RNAseq.g12957.t1,three_way,92.86466666666666,FUN_013024-T1,Q9UNL4,,,,,66.7,93.0,4.8e-28,125.2,sp|Q9UNL4|ING4_HUMAN Inhibitor of growth protein 4 OS=Homo sapiens OX=9606 GN=ING4 PE=1 SV=1,,,,,,
OG_03259,1.9846198721655903,FUN_013077-T2,Peve_00027399,Pocillopora_meandrina_HIv1___RNAseq.g13103.t1,three_way,65.751,,,,,,,,,,,,,,,,,
OG_03263,1.4285521552836815,FUN_013089-T1,Peve_00034077,Pocillopora_meandrina_HIv1___RNAseq.g216.t1,three_way,78.51933333333334,FUN_013089-T1,Q8WXG1,RSAD2_HUMAN,,"S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (EC 4.2.-.-) (Cytomegalovirus-induced gene 5 protein) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin)",Homo sapiens (Human),74.7,292.0,4.3000000000000004e-134,479.2,sp|Q8WXG1|RSAD2_HUMAN S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 OS=Homo sapiens OX=9606 GN=RSAD2 PE=1 SV=1,GO:0001650; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0009615; GO:0016829; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0050778; GO:0051539; GO:0051607; GO:2000553,"CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],"4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]",GO:0002376; GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005811; GO:0016829; GO:0030154; GO:0043226; GO:0098542,immune system process; catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; lipid droplet; lyase activity; cell differentiation; organelle; defense response to other organism
OG_03264,1.51249755879266,FUN_013106-T1,Peve_00027393,Pocillopora_meandrina_HIv1___RNAseq.g13093.t1,three_way,69.684,FUN_013106-T1,Q6P1B1,,,,,47.2,494.0,6.899999999999999e-127,455.7,sp|Q6P1B1|XPP1_MOUSE Xaa-Pro aminopeptidase 1 OS=Mus musculus OX=10090 GN=Xpnpep1 PE=1 SV=1,,,,,,
OG_03268,1.4367411748187917,FUN_013137-T1,Peve_00042384,Pocillopora_meandrina_HIv1___RNAseq.g23023.t1,three_way,71.50933333333333,FUN_013137-T1,Q7M3E1,,,,,42.1,254.0,7.8e-44,179.5,sp|Q7M3E1|CTRC_BOVIN Chymotrypsin-C OS=Bos taurus OX=9913 GN=CTRC PE=1 SV=2,,,,,,
OG_03272,2.141088860136386,FUN_013145-T1,Peve_00027383,Pocillopora_meandrina_HIv1___RNAseq.g13822.t1,three_way,65.41383333333333,FUN_013145-T1,Q01780,EXOSX_HUMAN,,Exosome complex component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2),Homo sapiens (Human),45.4,707.0,2.4e-159,564.3,sp|Q01780|EXOSX_HUMAN Exosome complex component 10 OS=Homo sapiens OX=9606 GN=EXOSC10 PE=1 SV=2,GO:0000166; GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000791; GO:0000956; GO:0003723; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0032040; GO:0032211; GO:0042274; GO:0046872; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071051; GO:0101019; GO:1904872; GO:1905746,"CUT catabolic process [GO:0071034]; DNA repair [GO:0006281]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; ribosomal small subunit biogenesis [GO:0042274]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]",cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006399; GO:0016071; GO:0016073; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; tRNA metabolic process; mRNA metabolic process; snRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03273,3.219729527552341,FUN_013146-T1,Peve_00024360,Pocillopora_meandrina_HIv1___RNAseq.g13823.t1,three_way,75.41933333333333,FUN_013146-T1,Q5U247,,,,,34.6,673.0,1e-96,355.9,sp|Q5U247|EXOC8_XENLA Exocyst complex component 8 OS=Xenopus laevis OX=8355 GN=exoc8 PE=2 SV=1,,,,,,
OG_03277,1.441144297074483,FUN_013156-T1,Peve_00022446,Pocillopora_meandrina_HIv1___RNAseq.g12981.t1,three_way,74.53133333333334,FUN_013156-T1,Q6P3S6,FBX42_HUMAN,,F-box only protein 42 (Just one F-box and Kelch domain-containing protein),Homo sapiens (Human),45.5,321.0,8.000000000000001e-76,285.8,sp|Q6P3S6|FBX42_HUMAN F-box only protein 42 OS=Homo sapiens OX=9606 GN=FBXO42 PE=1 SV=1,GO:0019005; GO:1990756,,SCF ubiquitin ligase complex [GO:0019005],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0060090,molecular adaptor activity
OG_03281,1.1809949613532191,FUN_013162-T1,Peve_00022440,Pocillopora_meandrina_HIv1___RNAseq.g13110.t3,three_way,66.35566666666666,FUN_013162-T1,Q924H0,,,,,27.5,360.0,9.1e-18,92.8,sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2,,,,,,
OG_03283,1.033732189329081,FUN_013319-T1,Peve_00024429,Pocillopora_meandrina_HIv1___TS.g12277.t1a,three_way,72.86233333333334,,,,,,,,,,,,,,,,,
OG_03285,1.973871236299777,FUN_013323-T1,Peve_00027397,Pocillopora_meandrina_HIv1___RNAseq.g941.t1,three_way,74.55333333333333,FUN_013323-T1,Q9D2I5,ARMC9_MOUSE,,LisH domain-containing protein ARMC9,Mus musculus (Mouse),50.8,675.0,6.9e-166,585.9,sp|Q9D2I5|ARMC9_MOUSE LisH domain-containing protein ARMC9 OS=Mus musculus OX=10090 GN=Armc9 PE=1 SV=1,GO:0005737; GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542,cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005815; GO:0005929; GO:0043226; GO:0044782,microtubule organizing center; cilium; organelle; cilium organization
OG_03287,1.0982377988300345,FUN_013327-T1,Peve_00022435,Pocillopora_meandrina_HIv1___TS.g2081.t2,three_way,73.69733333333333,FUN_013327-T1,Q3B7Z2,OSBP1_MOUSE,,Oxysterol-binding protein 1,Mus musculus (Mouse),43.5,310.0,1.6e-66,254.6,sp|Q3B7Z2|OSBP1_MOUSE Oxysterol-binding protein 1 OS=Mus musculus OX=10090 GN=Osbp PE=1 SV=3,GO:0000139; GO:0005654; GO:0005730; GO:0005789; GO:0005802; GO:0005829; GO:0006686; GO:0015914; GO:0015918; GO:0019904; GO:0030054; GO:0032367; GO:0035627; GO:0035774; GO:0048471; GO:0070273; GO:0120015; GO:1904411,ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918],cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802],phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol transfer activity [GO:0120015],GO:0005215; GO:0005654; GO:0005730; GO:0005829; GO:0006629; GO:0008289; GO:0043226,transporter activity; nucleoplasm; nucleolus; cytosol; lipid metabolic process; lipid binding; organelle
OG_03289,1.8699592785201005,FUN_013330-T1,Peve_00022425,Pocillopora_meandrina_HIv1___RNAseq.g12990.t1a,three_way,66.249,FUN_013330-T1,P42893,,,,,37.2,686.0,2.6000000000000003e-133,477.6,sp|P42893|ECE1_RAT Endothelin-converting enzyme 1 OS=Rattus norvegicus OX=10116 GN=Ece1 PE=1 SV=2,,,,,,
OG_03292,1.2309412641060722,FUN_013354-T2,Peve_00041984,Pocillopora_meandrina_HIv1___RNAseq.g13178.t1,three_way,92.6225,FUN_013354-T2,P42345,MTOR_HUMAN,,Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1) (Tyrosine-protein kinase mTOR) (EC 2.7.10.2),Homo sapiens (Human),64.6,2550.0,0.0,3192.9,sp|P42345|MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens OX=9606 GN=MTOR PE=1 SV=1,GO:0000139; GO:0000822; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006112; GO:0006207; GO:0006954; GO:0006974; GO:0007010; GO:0007281; GO:0008361; GO:0009267; GO:0009408; GO:0009615; GO:0009791; GO:0010507; GO:0010592; GO:0010718; GO:0010831; GO:0012505; GO:0016020; GO:0016236; GO:0016241; GO:0016242; GO:0016605; GO:0019228; GO:0030307; GO:0030425; GO:0030838; GO:0031295; GO:0031529; GO:0031641; GO:0031648; GO:0031667; GO:0031669; GO:0031670; GO:0031929; GO:0031931; GO:0031932; GO:0032869; GO:0032956; GO:0033173; GO:0034198; GO:0035264; GO:0038202; GO:0038203; GO:0042752; GO:0042802; GO:0043022; GO:0043066; GO:0043200; GO:0043276; GO:0044325; GO:0045335; GO:0045670; GO:0045727; GO:0045792; GO:0045821; GO:0045945; GO:0045948; GO:0046627; GO:0046889; GO:0048266; GO:0048709; GO:0048714; GO:0050821; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051897; GO:0055013; GO:0060048; GO:0061431; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0090559; GO:0097700; GO:0106310; GO:1900034; GO:1900181; GO:1901796; GO:1901838; GO:1902554; GO:1903691; GO:1904059; GO:1904690; GO:1905671; GO:1905672; GO:1905857; GO:1990253; GO:2000060; GO:2000785,"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to methionine [GO:0061431]; cellular response to nutrient [GO:0031670]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lysosome organization [GO:1905672]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein localization to nucleus [GO:1900181]; neuronal action potential [GO:0019228]; oligodendrocyte differentiation [GO:0048709]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagosome assembly [GO:2000785]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of locomotor rhythm [GO:1904059]; regulation of lysosome organization [GO:1905671]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; TORC2 signaling [GO:0038203]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]; voluntary musculoskeletal movement [GO:0050882]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; PML body [GO:0016605]; serine/threonine protein kinase complex [GO:1902554]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0003012; GO:0003677; GO:0003824; GO:0005634; GO:0005635; GO:0005654; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0005886; GO:0006091; GO:0006355; GO:0006914; GO:0006954; GO:0007010; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:0140096,"immune system process; muscle system process; DNA binding; catalytic activity; nucleus; nuclear envelope; nucleoplasm; lysosome; vacuole; endoplasmic reticulum; cytosol; plasma membrane; generation of precursor metabolites and energy; regulation of DNA-templated transcription; autophagy; inflammatory response; cytoskeleton organization; programmed cell death; transferase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein"
OG_03293,1.0276987726085571,FUN_013357-T1,Peve_00001204,Pocillopora_meandrina_HIv1___TS.g2335.t2,three_way,57.15766666666666,FUN_013357-T1,P58340,MLF1_HUMAN,,Myeloid leukemia factor 1 (Myelodysplasia-myeloid leukemia factor 1),Homo sapiens (Human),40.2,234.0,1.6999999999999999e-35,151.4,sp|P58340|MLF1_HUMAN Myeloid leukemia factor 1 OS=Homo sapiens OX=9606 GN=MLF1 PE=1 SV=1,GO:0002318; GO:0003677; GO:0005634; GO:0005737; GO:0005929; GO:0006351; GO:0006355; GO:0019904; GO:0036064; GO:0048471; GO:1901796; GO:1902806,DNA-templated transcription [GO:0006351]; myeloid progenitor cell differentiation [GO:0002318]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of DNA-templated transcription [GO:0006355]; regulation of signal transduction by p53 class mediator [GO:1901796],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],DNA binding [GO:0003677]; protein domain specific binding [GO:0019904],GO:0003677; GO:0005634; GO:0005815; GO:0005929; GO:0006351; GO:0006355; GO:0030154; GO:0043226,DNA binding; nucleus; microtubule organizing center; cilium; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle
OG_03294,1.4466122531521723,FUN_013359-T1,Peve_00001202,Pocillopora_meandrina_HIv1___TS.g2338.t1,three_way,77.81466666666667,,,,,,,,,,,,,,,,,
OG_03296,2.158011416572938,FUN_013363-T1,Peve_00001194,Pocillopora_meandrina_HIv1___RNAseq.g13339.t1,three_way,64.70333333333333,FUN_013363-T1,P61007,,,,,60.4,169.0,2.2e-55,216.9,sp|P61007|RAB8A_CANLF Ras-related protein Rab-8A OS=Canis lupus familiaris OX=9615 GN=RAB8A PE=1 SV=1,,,,,,
OG_03305,1.800511650271317,FUN_013377-T1,Peve_00020454,Pocillopora_meandrina_HIv1___RNAseq.g22986.t1,three_way,67.67733333333334,FUN_013377-T1,Q7TS68,,,,,46.7,469.0,2e-112,407.5,sp|Q7TS68|NSUN6_MOUSE tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 OS=Mus musculus OX=10090 GN=Nsun6 PE=2 SV=2,,,,,,
OG_03310,2.067623260917998,FUN_013387-T1,Peve_00034571,Pocillopora_meandrina_HIv1___RNAseq.g22979.t1,three_way,82.8835,FUN_013387-T1,Q3UY96,,,,,33.7,1633.0,7.6e-245,849.4,sp|Q3UY96|CFA74_MOUSE Cilia- and flagella-associated protein 74 OS=Mus musculus OX=10090 GN=Cfap74 PE=2 SV=3,,,,,,
OG_03311,4.131418513824258,FUN_013389-T1,Peve_00031288,Pocillopora_meandrina_HIv1___TS.g15861.t1,three_way,67.08366666666667,,,,,,,,,,,,,,,,,
OG_03320,2.5166693949806542,FUN_013399-T1,Peve_00028082,Pocillopora_meandrina_HIv1___RNAseq.g22938.t1,three_way,78.69366666666667,FUN_013399-T1,Q7T3H7,,,,,49.5,194.0,3.4e-48,193.0,sp|Q7T3H7|MED18_DANRE Mediator of RNA polymerase II transcription subunit 18 OS=Danio rerio OX=7955 GN=med18 PE=2 SV=1,,,,,,
OG_03329,1.408207850170339,FUN_013420-T1,Peve_00038576,Pocillopora_meandrina_HIv1___RNAseq.g22951.t1,three_way,63.70666666666667,,,,,,,,,,,,,,,,,
OG_03332,3.348791657464342,FUN_013545-T1,Peve_00038572,Pocillopora_meandrina_HIv1___RNAseq.g22955.t1a,three_way,83.74533333333333,FUN_013545-T1,Q99570,PI3R4_HUMAN,,Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein),Homo sapiens (Human),51.6,1405.0,0.0,1382.1,sp|Q99570|PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PIK3R4 PE=1 SV=3,GO:0000425; GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005929; GO:0005930; GO:0006468; GO:0006622; GO:0006623; GO:0010506; GO:0015630; GO:0016020; GO:0016241; GO:0030670; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0036064; GO:0036092; GO:0042149; GO:0043231; GO:0043491; GO:0045022; GO:0045171; GO:0045324; GO:0071561; GO:0097352; GO:0106310,autophagosome maturation [GO:0097352]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; pexophagy [GO:0000425]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241],"autophagosome [GO:0005776]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]",ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005768; GO:0005773; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; vacuole; microtubule organizing center; cytosol; cytoskeleton; cilium; lipid metabolic process; intracellular protein transport; autophagy; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_03342,2.310715469765833,FUN_013572-T1,Peve_00022291,Pocillopora_meandrina_HIv1___RNAseq.g13520.t1,three_way,69.9175,FUN_013572-T1,Q9TRC7,AOC1_PIG,,Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein) (Amine oxidase copper domain-containing protein 1) (Histaminase),Sus scrofa (Pig),39.3,746.0,1.2e-157,558.5,sp|Q9TRC7|AOC1_PIG Diamine oxidase [copper-containing] OS=Sus scrofa OX=9823 GN=AOC1 PE=1 SV=3,GO:0005507; GO:0005509; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0009445; GO:0042803; GO:0048038; GO:0050232; GO:0052597; GO:0052598; GO:0070062,putrescine metabolic process [GO:0009445],bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; primary methylamine oxidase activity [GO:0008131]; protein homodimerization activity [GO:0042803]; putrescine oxidase activity [GO:0050232]; quinone binding [GO:0048038],GO:0003824; GO:0005615; GO:0005886; GO:0016491; GO:0043226,catalytic activity; extracellular space; plasma membrane; oxidoreductase activity; organelle
OG_03346,3.298742029061505,FUN_013582-T1,Peve_00018189,Pocillopora_meandrina_HIv1___RNAseq.g13504.t1,three_way,62.93,,,,,,,,,,,,,,,,,
OG_03351,2.28325376174303,FUN_013587-T1,Peve_00018181,Pocillopora_meandrina_HIv1___RNAseq.g13494.t1,three_way,61.905,FUN_013587-T1,A1A5V9,,,,,27.1,303.0,1.1000000000000001e-27,125.6,sp|A1A5V9|ELP5_DANRE Elongator complex protein 5 OS=Danio rerio OX=7955 GN=elp5 PE=2 SV=1,,,,,,
OG_03352,1.1107473021712218,FUN_013588-T1,Peve_00018182,Pocillopora_meandrina_HIv1___TS.g2490.t1,three_way,50.96683333333333,FUN_013588-T1,Q5XJP0,B3G5B_DANRE,,"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase B (EC 2.4.1.206) (Lactotriaosylceramide synthase B) (Lc(3)Cer synthase B) (Lc3 synthase B) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5B) (BGnT-5B) (Beta-1,3-Gn-T5B) (Beta-1,3-N-acetylglucosaminyltransferase 5B) (Beta3Gn-T5B)",Danio rerio (Zebrafish) (Brachydanio rerio),33.0,215.0,1.4000000000000002e-23,112.1,"sp|Q5XJP0|B3G5B_DANRE Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase B OS=Danio rerio OX=7955 GN=b3gnt5b PE=2 SV=1",GO:0000139; GO:0006493; GO:0016757; GO:0047256,protein O-linked glycosylation [GO:0006493],Golgi membrane [GO:0000139],"glycosyltransferase activity [GO:0016757]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_03354,1.7502825848063812,FUN_013590-T1,Peve_00018179,Pocillopora_meandrina_HIv1___RNAseq.g13492.t1,three_way,62.60416666666666,FUN_013590-T1,Q9CR24,NUDT8_MOUSE,,Mitochondrial coenzyme A diphosphatase NUDT8 (EC 3.6.1.-) (EC 3.6.1.77) (Nucleoside diphosphate-linked moiety X motif 8) (Nudix motif 8),Mus musculus (Mouse),43.2,206.0,4.7999999999999997e-35,149.8,sp|Q9CR24|NUDT8_MOUSE Mitochondrial coenzyme A diphosphatase NUDT8 OS=Mus musculus OX=10090 GN=Nudt8 PE=1 SV=1,GO:0000287; GO:0005739; GO:0005759; GO:0010945; GO:0015938; GO:0030145; GO:0036114; GO:0044580; GO:0046356; GO:1901289; GO:1902859; GO:2001294,acetyl-CoA catabolic process [GO:0046356]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA catabolic process [GO:1902859]; succinyl-CoA catabolic process [GO:1901289],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],coenzyme A diphosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145],GO:0003824; GO:0005739; GO:0006629; GO:0006790; GO:0016787; GO:0043226; GO:0055086,catalytic activity; mitochondrion; lipid metabolic process; sulfur compound metabolic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03356,1.895622206532696,FUN_013593-T1,Peve_00018176,Pocillopora_meandrina_HIv1___RNAseq.g13486.t1,three_way,88.194,FUN_013593-T1,O95619,YETS4_HUMAN,,YEATS domain-containing protein 4 (Glioma-amplified sequence 41) (Gas41) (NuMA-binding protein 1) (NuBI-1) (NuBI1),Homo sapiens (Human),62.1,224.0,2.1999999999999998e-75,283.5,sp|O95619|YETS4_HUMAN YEATS domain-containing protein 4 OS=Homo sapiens OX=9606 GN=YEATS4 PE=1 SV=1,GO:0000278; GO:0000786; GO:0005200; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0016363; GO:0031965; GO:0035267; GO:0042393; GO:0042981; GO:0045893; GO:0051726; GO:0140044; GO:0140119; GO:1905168; GO:2000779,chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357],NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634],histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0005198; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0060090,mitotic cell cycle; structural molecule activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; molecular adaptor activity
OG_03357,2.242016663836824,FUN_013594-T1,Peve_00029572,Pocillopora_meandrina_HIv1___RNAseq.g6546.t1,three_way,67.05166666666666,,,,,,,,,,,,,,,,,
OG_03359,1.0508576480502914,FUN_013596-T1,Peve_00018172,Pocillopora_meandrina_HIv1___RNAseq.g13484.t1,three_way,75.14,FUN_013596-T1,Q4DJ07,,,,,34.4,279.0,1.7e-37,159.8,"sp|Q4DJ07|PGFS_TRYCC 9,11-endoperoxide prostaglandin H2 reductase OS=Trypanosoma cruzi (strain CL Brener) OX=353153 GN=Tc00.1047053511287.49 PE=1 SV=2",,,,,,
OG_03360,1.2700812548385738,FUN_013597-T1,Peve_00018171,Pocillopora_meandrina_HIv1___TS.g2479.t1,three_way,67.01816666666667,,,,,,,,,,,,,,,,,
OG_03361,1.395514390416992,FUN_013599-T1,Peve_00018167,Pocillopora_meandrina_HIv1___RNAseq.14767_t,three_way,48.52133333333333,,,,,,,,,,,,,,,,,
OG_03362,2.391549016084978,FUN_013601-T1,Peve_00018166,Pocillopora_meandrina_HIv1___RNAseq.g13480.t1,three_way,70.76016666666666,,,,,,,,,,,,,,,,,
OG_03363,1.603663734744303,FUN_013603-T1,Peve_00018165,Pocillopora_meandrina_HIv1___RNAseq.g13479.t1,three_way,65.08200000000001,FUN_013603-T1,H3BPM6,,,,,34.7,199.0,1.4000000000000001e-33,144.4,sp|H3BPM6|MKROS_HUMAN MKRN2 opposite strand protein OS=Homo sapiens OX=9606 GN=MKRN2OS PE=1 SV=1,,,,,,
OG_03364,2.4679165658007194,FUN_013606-T1,Peve_00002653,Pocillopora_meandrina_HIv1___RNAseq.g13526.t1,three_way,79.673,FUN_013606-T1,Q60HE5,,,,,52.4,614.0,6.400000000000001e-186,652.1,sp|Q60HE5|MTHR_MACFA Methylenetetrahydrofolate reductase (NADPH) OS=Macaca fascicularis OX=9541 GN=MTHFR PE=2 SV=1,,,,,,
OG_03366,1.1126741940281892,FUN_013610-T1,Peve_00002650,Pocillopora_meandrina_HIv1___RNAseq.g13529.t1,three_way,95.495,FUN_013610-T1,O15514,RPB4_HUMAN,,DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit) (RPB16),Homo sapiens (Human),77.5,142.0,4.9e-54,211.8,sp|O15514|RPB4_HUMAN DNA-directed RNA polymerase II subunit RPB4 OS=Homo sapiens OX=9606 GN=POLR2D PE=1 SV=1,GO:0000166; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006366; GO:0006367; GO:0016607; GO:0031369,transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]",nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369],GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0043226,nucleus; nucleoplasm; cytosol; DNA-templated transcription; organelle
OG_03370,1.878024565380728,FUN_013616-T1,Peve_00002647,Pocillopora_meandrina_HIv1___RNAseq.g13535.t1,three_way,68.612,FUN_013616-T1,Q9Y2G8,DJC16_HUMAN,,DnaJ homolog subfamily C member 16 (Endoplasmic reticulum DNA J domain-containing protein 8) (ER-resident protein ERdj8) (ERdj8),Homo sapiens (Human),31.9,781.0,3.7e-95,350.9,sp|Q9Y2G8|DJC16_HUMAN DnaJ homolog subfamily C member 16 OS=Homo sapiens OX=9606 GN=DNAJC16 PE=1 SV=3,GO:0005789; GO:0016243,regulation of autophagosome size [GO:0016243],endoplasmic reticulum membrane [GO:0005789],,,
OG_03373,1.034659498890653,FUN_013619-T1,Peve_00014990,Pocillopora_meandrina_HIv1___RNAseq.g13538.t1,three_way,54.383,FUN_013619-T1,F4JAU3,P4H2_ARATH,,Prolyl 4-hydroxylase 2 (AtP4H-2) (AtP4H2) (EC 1.14.11.2),Arabidopsis thaliana (Mouse-ear cress),31.1,180.0,2.5e-16,88.2,sp|F4JAU3|P4H2_ARATH Prolyl 4-hydroxylase 2 OS=Arabidopsis thaliana OX=3702 GN=P4H2 PE=1 SV=1,GO:0000137; GO:0000139; GO:0004656; GO:0005506; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0018401; GO:0031418; GO:0080147,peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; root hair cell development [GO:0080147],endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656],GO:0003824; GO:0005768; GO:0005794; GO:0006520; GO:0006575; GO:0016491; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endosome; Golgi apparatus; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03374,2.2347458815783594,FUN_013620-T1,Peve_00014987,Pocillopora_meandrina_HIv1___RNAseq.g13541.t1,three_way,88.12266666666667,FUN_013620-T1,B9GCH9,UREA_ORYSJ,,Urease (EC 3.5.1.5) (Urea amidohydrolase),Oryza sativa subsp. japonica (Rice),62.3,862.0,3.4e-307,1055.4,sp|B9GCH9|UREA_ORYSJ Urease OS=Oryza sativa subsp. japonica OX=39947 GN=Os12g0234800 PE=3 SV=2,GO:0009039; GO:0016151; GO:0035550; GO:0043419,urea catabolic process [GO:0043419],urease complex [GO:0035550],nickel cation binding [GO:0016151]; urease activity [GO:0009039],GO:0003824; GO:0016787; GO:0071941,catalytic activity; hydrolase activity; nitrogen cycle metabolic process
OG_03376,1.2355035823357554,FUN_013622-T1,Peve_00014995,Pocillopora_meandrina_HIv1___RNAseq.g13543.t1,three_way,92.35383333333333,FUN_013622-T1,A7HHN3,,,,,71.4,217.0,1.1e-84,314.3,sp|A7HHN3|UREG_ANADF Urease accessory protein UreG OS=Anaeromyxobacter sp. (strain Fw109-5) OX=404589 GN=ureG PE=3 SV=1,,,,,,
OG_03377,2.720424582456103,FUN_013623-T1,Peve_00014994,Pocillopora_meandrina_HIv1___RNAseq.g13544.t1,three_way,69.24266666666666,FUN_013623-T1,A9GP79,,,,,32.0,256.0,1.0999999999999998e-24,115.5,sp|A9GP79|URED_SORC5 Urease accessory protein UreD OS=Sorangium cellulosum (strain So ce56) OX=448385 GN=ureD PE=3 SV=2,,,,,,
OG_03378,2.2724122641945765,FUN_013626-T1,Peve_00013600,Pocillopora_meandrina_HIv1___RNAseq.g13546.t1,three_way,86.476,FUN_013626-T1,P49915,GUAA_HUMAN,,GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase),Homo sapiens (Human),65.0,666.0,4.9e-264,911.8,sp|P49915|GUAA_HUMAN GMP synthase [glutamine-hydrolyzing] OS=Homo sapiens OX=9606 GN=GMPS PE=1 SV=1,GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0009113; GO:0009168,GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168],cytosol [GO:0005829],ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921],GO:0003824; GO:0005829; GO:0016874; GO:0055086; GO:1901135,catalytic activity; cytosol; ligase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03379,2.858488124096687,FUN_013627-T1,Peve_00018598,Pocillopora_meandrina_HIv1___RNAseq.g13548.t1,three_way,66.10166666666667,,,,,,,,,,,,,,,,,
OG_03380,1.637711642715378,FUN_013628-T1,Peve_00018590,Pocillopora_meandrina_HIv1___RNAseq.g13551.t1,three_way,57.17233333333333,,,,,,,,,,,,,,,,,
OG_03381,2.3095630264144518,FUN_013631-T1,Peve_00039074,Pocillopora_meandrina_HIv1___RNAseq.g13554.t1,three_way,65.295,FUN_013631-T1,Q6PBI8,,,,,24.7,296.0,4.9e-17,90.1,sp|Q6PBI8|TM177_DANRE Transmembrane protein 177 OS=Danio rerio OX=7955 GN=tmem177 PE=2 SV=1,,,,,,
OG_03382,1.8588036871443776,FUN_013634-T1,Peve_00039087,Pocillopora_meandrina_HIv1___RNAseq.g13560.t1,three_way,39.31766666666667,,,,,,,,,,,,,,,,,
OG_03386,1.3072332919353626,FUN_013641-T1,Peve_00019982,Pocillopora_meandrina_HIv1___RNAseq.g13568.t1,three_way,45.04066666666667,,,,,,,,,,,,,,,,,
OG_03388,1.022612184696152,FUN_013649-T1,Peve_00012813,Pocillopora_meandrina_HIv1___RNAseq.g2586.t1,three_way,66.73133333333334,FUN_013649-T1,Q8K4H1,KFA_MOUSE,,Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF),Mus musculus (Mouse),39.9,288.0,2.6000000000000004e-57,223.8,sp|Q8K4H1|KFA_MOUSE Kynurenine formamidase OS=Mus musculus OX=10090 GN=Afmid PE=1 SV=1,GO:0004061; GO:0005634; GO:0005737; GO:0005829; GO:0019441; GO:0034354,'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; L-tryptophan catabolic process to kynurenine [GO:0019441],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],arylformamidase activity [GO:0004061],GO:0003824; GO:0005634; GO:0005829; GO:0006520; GO:0016787; GO:0043226; GO:0055086,catalytic activity; nucleus; cytosol; amino acid metabolic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03393,1.5409442618302085,FUN_014123-T2,Peve_00030269,Pocillopora_meandrina_HIv1___RNAseq.g15590.t1,three_way,84.48033333333333,FUN_014123-T2,O73787,,,,,51.1,915.0,1.6999999999999999e-251,870.5,sp|O73787|GCP3_XENLA Gamma-tubulin complex component 3 homolog OS=Xenopus laevis OX=8355 GN=tubgcp3 PE=1 SV=1,,,,,,
OG_03394,2.6902375821801985,FUN_014166-T1,Peve_00026508,Pocillopora_meandrina_HIv1___RNAseq.g7362.t1,three_way,57.504,FUN_014166-T1,Q9H2K2,,,,,28.4,211.0,3.9e-08,62.0,sp|Q9H2K2|TNKS2_HUMAN Poly [ADP-ribose] polymerase tankyrase-2 OS=Homo sapiens OX=9606 GN=TNKS2 PE=1 SV=1,,,,,,
OG_03399,1.5340975767123124,FUN_014438-T1,Peve_00020049,Pocillopora_meandrina_HIv1___RNAseq.g24661.t1,three_way,86.73333333333333,FUN_014438-T1,Q0VG85,,,,,31.7,944.0,1.5000000000000001e-123,446.8,sp|Q0VG85|CC162_MOUSE Coiled-coil domain-containing protein 162 OS=Mus musculus OX=10090 GN=Ccdc162 PE=1 SV=4,,,,,,
OG_03400,2.259305169092353,FUN_014439-T1,Peve_00000664,Pocillopora_meandrina_HIv1___TS.g12605.t1,three_way,76.63716666666666,FUN_014439-T1,O43913,,,,,52.0,431.0,1.4999999999999999e-120,434.5,sp|O43913|ORC5_HUMAN Origin recognition complex subunit 5 OS=Homo sapiens OX=9606 GN=ORC5 PE=1 SV=1,,,,,,
OG_03401,2.790839283398248,FUN_014440-T1,Peve_00002505,Pocillopora_meandrina_HIv1___TS.g8856.t1b,three_way,69.38566666666667,FUN_014440-T1,Q692V3,,,,,30.4,918.0,3e-104,381.7,sp|Q692V3|TTC41_MOUSE Tetratricopeptide repeat protein 41 OS=Mus musculus OX=10090 GN=Ttc41 PE=1 SV=1,,,,,,
OG_03403,1.2707507028074323,FUN_014442-T1,Peve_00009611,Pocillopora_meandrina_HIv1___RNAseq.g22833.t1,three_way,60.98433333333333,FUN_014442-T1,Q55C17,,,,,27.9,247.0,2.8e-16,87.4,sp|Q55C17|TECR_DICDI Very-long-chain enoyl-CoA reductase OS=Dictyostelium discoideum OX=44689 GN=gpsn2 PE=3 SV=1,,,,,,
OG_03413,1.8223347757010904,FUN_014461-T1,Peve_00014815,Pocillopora_meandrina_HIv1___RNAseq.g22645.t1,three_way,61.391666666666666,FUN_014461-T1,Q3T0X9,,,,,38.1,113.0,6e-13,75.1,sp|Q3T0X9|DPOD4_BOVIN DNA polymerase delta subunit 4 OS=Bos taurus OX=9913 GN=POLD4 PE=1 SV=1,,,,,,
OG_03423,1.572270435198076,FUN_014477-T1,Peve_00037306,Pocillopora_meandrina_HIv1___RNAseq.g22817.t1,three_way,73.20533333333333,FUN_014477-T1,Q9NZ71,,,,,43.0,1046.0,9.9e-235,815.1,sp|Q9NZ71|RTEL1_HUMAN Regulator of telomere elongation helicase 1 OS=Homo sapiens OX=9606 GN=RTEL1 PE=1 SV=2,,,,,,
OG_03426,1.5324293898607029,FUN_014481-T1,Peve_00037299,Pocillopora_meandrina_HIv1___RNAseq.g22814.t1,three_way,43.44533333333333,,,,,,,,,,,,,,,,,
OG_03427,1.4914958527472113,FUN_014483-T1,Peve_00037300,Pocillopora_meandrina_HIv1___RNAseq.g22813.t2,three_way,92.40566666666666,FUN_014483-T1,Q6NVL5,ELP3_XENTR,,Elongator complex protein 3 (EC 2.3.1.311) (tRNA uridine(34) acetyltransferase),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),81.4,532.0,7.4e-262,904.0,sp|Q6NVL5|ELP3_XENTR Elongator complex protein 3 OS=Xenopus tropicalis OX=8364 GN=elp3 PE=2 SV=1,GO:0000049; GO:0001755; GO:0002098; GO:0005634; GO:0005737; GO:0006357; GO:0008607; GO:0031397; GO:0046872; GO:0050821; GO:0051539; GO:0106261,negative regulation of protein ubiquitination [GO:0031397]; neural crest cell migration [GO:0001755]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]",GO:0003723; GO:0003824; GO:0005634; GO:0006355; GO:0006399; GO:0016740; GO:0043226; GO:0048870; GO:0098772; GO:0140098,"RNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; tRNA metabolic process; transferase activity; organelle; cell motility; molecular function regulator activity; catalytic activity, acting on RNA"
OG_03428,1.1362260087279017,FUN_014484-T1,Peve_00037302,Pocillopora_meandrina_HIv1___RNAseq.g22812.t1,three_way,51.21066666666667,FUN_014484-T1,Q84JS1,,,,,35.1,365.0,1.5e-57,226.1,sp|Q84JS1|PAE6_ARATH Pectin acetylesterase 6 OS=Arabidopsis thaliana OX=3702 GN=PAE6 PE=2 SV=1,,,,,,
OG_03429,1.3418328924031575,FUN_014485-T1,Peve_00037303,Pocillopora_meandrina_HIv1___RNAseq.g22811.t1,three_way,75.97416666666666,FUN_014485-T1,O35887,,,,,29.0,155.0,5.5e-09,63.5,sp|O35887|CALU_MOUSE Calumenin OS=Mus musculus OX=10090 GN=Calu PE=1 SV=1,,,,,,
OG_03434,1.6860445106618571,FUN_014491-T1,Peve_00013879,Pocillopora_meandrina_HIv1___RNAseq.g22517.t1,three_way,91.102,FUN_014491-T1,Q5ZIY4,SBDS_CHICK,,Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog),Gallus gallus (Chicken),73.7,251.0,1.1000000000000001e-101,370.9,sp|Q5ZIY4|SBDS_CHICK Ribosome maturation protein SBDS OS=Gallus gallus OX=9031 GN=SBDS PE=2 SV=1,GO:0000922; GO:0002244; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0007052; GO:0008017; GO:0019843; GO:0030282; GO:0030595; GO:0042256; GO:0043022; GO:0048539,bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cytosolic ribosome assembly [GO:0042256]; hematopoietic progenitor cell differentiation [GO:0002244]; leukocyte chemotaxis [GO:0030595]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843],GO:0002376; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0048870,immune system process; RNA binding; nucleoplasm; nucleolus; cytosol; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; cell motility
OG_03435,2.028329584555552,FUN_014492-T1,Peve_00024063,Pocillopora_meandrina_HIv1___RNAseq.g22516.t1,three_way,57.00866666666666,FUN_014492-T1,Q9DB28,,,,,38.6,145.0,4.2e-26,119.4,sp|Q9DB28|POP5_MOUSE Ribonuclease P/MRP protein subunit POP5 OS=Mus musculus OX=10090 GN=Pop5 PE=1 SV=1,,,,,,
OG_03438,2.2105933674578515,FUN_014497-T1,Peve_00037310,Pocillopora_meandrina_HIv1___RNAseq.1964_t,three_way,81.125,FUN_014497-T1,Q5R8D0,,,,,65.0,343.0,1.3e-132,474.2,sp|Q5R8D0|GALE_PONAB UDP-glucose 4-epimerase OS=Pongo abelii OX=9601 GN=GALE PE=2 SV=1,,,,,,
OG_03439,3.509889399781939,FUN_014498-T1,Peve_00013882,Pocillopora_meandrina_HIv1___RNAseq.g22640.t1,three_way,72.19283333333334,,,,,,,,,,,,,,,,,
OG_03441,1.1023353188194631,FUN_014501-T1,Peve_00013880,Pocillopora_meandrina_HIv1___RNAseq.g22638.t1,three_way,67.336,FUN_014501-T1,P06734,FCER2_HUMAN,,Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form],Homo sapiens (Human),32.5,126.0,1.1e-07,60.1,sp|P06734|FCER2_HUMAN Low affinity immunoglobulin epsilon Fc receptor OS=Homo sapiens OX=9606 GN=FCER2 PE=1 SV=1,GO:0002020; GO:0002450; GO:0002925; GO:0005178; GO:0005886; GO:0006955; GO:0009897; GO:0010628; GO:0019769; GO:0019863; GO:0030246; GO:0038096; GO:0038187; GO:0042116; GO:0042742; GO:0046872; GO:0070062; GO:0160006,B cell antigen processing and presentation [GO:0002450]; defense response to bacterium [GO:0042742]; Fc receptor-mediated immune complex endocytosis [GO:0160006]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; macrophage activation [GO:0042116]; positive regulation of gene expression [GO:0010628]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925],external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; low-affinity IgE receptor activity [GO:0019769]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; protease binding [GO:0002020],GO:0002376; GO:0005886; GO:0016192; GO:0043226; GO:0060089,immune system process; plasma membrane; vesicle-mediated transport; organelle; molecular transducer activity
OG_03442,1.1243642501814333,FUN_014502-T1,Peve_00025868,Pocillopora_meandrina_HIv1___RNAseq.g22637.t1,three_way,80.94816666666667,FUN_014502-T1,Q9DG67,,,,,56.6,657.0,2.3e-210,733.4,sp|Q9DG67|RA54B_CHICK DNA repair and recombination protein RAD54B OS=Gallus gallus OX=9031 GN=RAD54B PE=2 SV=1,,,,,,
OG_03444,1.6784740351515446,FUN_014506-T1,Peve_00015332,Pocillopora_meandrina_HIv1___RNAseq.g22634.t1,three_way,64.51866666666666,FUN_014506-T1,Q5XHG1,NSMA3_XENLA,,Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III),Xenopus laevis (African clawed frog),32.9,828.0,6.3e-106,386.7,sp|Q5XHG1|NSMA3_XENLA Sphingomyelin phosphodiesterase 4 OS=Xenopus laevis OX=8355 GN=smpd4 PE=2 SV=2,GO:0000139; GO:0004767; GO:0005635; GO:0005783; GO:0005789; GO:0006685; GO:0042383; GO:0046475; GO:0046513; GO:0046872; GO:0050290; GO:0071356,cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; sarcolemma [GO:0042383],metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290],GO:0003824; GO:0005635; GO:0005783; GO:0005886; GO:0006629; GO:0016787; GO:0043226,catalytic activity; nuclear envelope; endoplasmic reticulum; plasma membrane; lipid metabolic process; hydrolase activity; organelle
OG_03446,1.964595643635768,FUN_014510-T1,Peve_00024077,Pocillopora_meandrina_HIv1___RNAseq.g22630.t1,three_way,76.287,FUN_014510-T1,Q8CG45,ARK72_RAT,,Aflatoxin B1 aldehyde reductase member 2 (rAFAR2) (EC 1.1.1.n11) (Succinic semialdehyde reductase) (SSA reductase),Rattus norvegicus (Rat),52.2,322.0,1.1e-94,348.2,sp|Q8CG45|ARK72_RAT Aflatoxin B1 aldehyde reductase member 2 OS=Rattus norvegicus OX=10116 GN=Akr7a2 PE=1 SV=2,GO:0004032; GO:0004033; GO:0005635; GO:0005737; GO:0005739; GO:0005795; GO:0006629; GO:0019119; GO:0044597; GO:0044598,daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629],cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635],"aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]",GO:0003824; GO:0005635; GO:0005739; GO:0006629; GO:0016491; GO:0016787; GO:0043226; GO:1901135,catalytic activity; nuclear envelope; mitochondrion; lipid metabolic process; oxidoreductase activity; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_03447,4.81377243171433,FUN_014512-T1,Peve_00032000,Pocillopora_meandrina_HIv1___TS.g27391.t1,three_way,41.315000000000005,,,,,,,,,,,,,,,,,
OG_03449,1.3247788605691346,FUN_014522-T1,Peve_00044386,Pocillopora_meandrina_HIv1___TS.g27385.t1,three_way,62.00833333333333,,,,,,,,,,,,,,,,,
OG_03450,2.1747643173574165,FUN_014523-T1,Peve_00044381,Pocillopora_meandrina_HIv1___RNAseq.g22620.t2,three_way,65.71566666666666,,,,,,,,,,,,,,,,,
OG_03452,4.146033277362367,FUN_014527-T1,Peve_00044379,Pocillopora_meandrina_HIv1___RNAseq.g22617.t1,three_way,81.44616666666667,FUN_014527-T1,O15297,PPM1D_HUMAN,,Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1),Homo sapiens (Human),51.3,277.0,1.2e-79,298.5,sp|O15297|PPM1D_HUMAN Protein phosphatase 1D OS=Homo sapiens OX=9606 GN=PPM1D PE=1 SV=1,GO:0000086; GO:0004674; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006346; GO:0006470; GO:0008285; GO:0009267; GO:0009314; GO:0009617; GO:0030330; GO:0035970; GO:0045814; GO:0046872; GO:0051019; GO:0060260; GO:1902531,"cellular response to starvation [GO:0009267]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; regulation of intracellular signal transduction [GO:1902531]; regulation of transcription initiation by RNA polymerase II [GO:0060260]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]",cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03453,2.000294172614108,FUN_014528-T1,Peve_00044378,Pocillopora_meandrina_HIv1___RNAseq.g22616.t1,three_way,85.47933333333333,FUN_014528-T1,P56839,,,,,81.2,292.0,4.7e-137,488.8,sp|P56839|PEPM_MYTED Phosphoenolpyruvate phosphomutase OS=Mytilus edulis OX=6550 PE=1 SV=3,,,,,,
OG_03454,2.0875156597145583,FUN_014529-T1,Peve_00044375,Pocillopora_meandrina_HIv1___RNAseq.g22615.t1,three_way,84.25116666666666,FUN_014529-T1,P61267,,,,,57.3,267.0,9.1e-74,278.5,sp|P61267|STX1B_BOVIN Syntaxin-1B OS=Bos taurus OX=9913 GN=STX1B PE=1 SV=1,,,,,,
OG_03457,2.6199412652030225,FUN_014533-T1,Peve_00040829,Pocillopora_meandrina_HIv1___RNAseq.g22609.t1,three_way,87.76966666666667,FUN_014533-T1,Q9UBR1,BUP1_HUMAN,,Beta-ureidopropionase (EC 3.5.1.6) (BUP-1) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase),Homo sapiens (Human),71.8,379.0,2.1e-163,576.6,sp|Q9UBR1|BUP1_HUMAN Beta-ureidopropionase OS=Homo sapiens OX=9606 GN=UPB1 PE=1 SV=1,GO:0001701; GO:0001889; GO:0003837; GO:0005829; GO:0006248; GO:0006249; GO:0033396; GO:0042803; GO:0046050; GO:0046079; GO:0046135; GO:0051260; GO:0051289; GO:0070062,beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside catabolic process [GO:0046135]; UMP catabolic process [GO:0046050],cytosol [GO:0005829]; extracellular exosome [GO:0070062],beta-ureidopropionase activity [GO:0003837]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016787; GO:0043226; GO:0048856; GO:0055086; GO:0065003; GO:1901135,catalytic activity; cytosol; amino acid metabolic process; hydrolase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_03458,1.657876923424521,FUN_014534-T1,Peve_00040836,Pocillopora_meandrina_HIv1___RNAseq.g22608.t1,three_way,82.51333333333334,FUN_014534-T1,Q5ZLG0,,,,,64.0,655.0,3.2999999999999996e-257,889.0,sp|Q5ZLG0|AACS_CHICK Acetoacetyl-CoA synthetase OS=Gallus gallus OX=9031 GN=AACS PE=2 SV=1,,,,,,
OG_03463,1.1212665560068475,FUN_014544-T1,Peve_00035997,Pocillopora_meandrina_HIv1___RNAseq.g22594.t1,three_way,59.593,FUN_014544-T1,A2VDX7,,,,,34.7,369.0,6.9e-50,199.5,sp|A2VDX7|EXO5_BOVIN Exonuclease V OS=Bos taurus OX=9913 GN=EXO5 PE=2 SV=2,,,,,,
OG_03466,1.3736353673228343,FUN_014551-T1,Peve_00009116,Pocillopora_meandrina_HIv1___RNAseq.g22699.t1,three_way,69.395,FUN_014551-T1,Q84JE8,,,,,45.0,191.0,4.4e-42,172.9,sp|Q84JE8|ZDP_ARATH Polynucleotide 3'-phosphatase ZDP OS=Arabidopsis thaliana OX=3702 GN=ZDP PE=1 SV=1,,,,,,
OG_03467,1.2255056096005283,FUN_014552-T1,Peve_00009117,Pocillopora_meandrina_HIv1___RNAseq.g22698.t1,three_way,65.17083333333333,FUN_014552-T1,Q9Y4C8,,,,,44.6,998.0,6.599999999999999e-198,692.6,sp|Q9Y4C8|RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3,,,,,,
OG_03468,2.1722455762527,FUN_014553-T1,Peve_00035991,Pocillopora_meandrina_HIv1___RNAseq.g22697.t1,three_way,82.49233333333333,FUN_014553-T1,P29674,,,,,52.4,315.0,1.2000000000000001e-80,301.6,sp|P29674|LHX1_XENLA LIM/homeobox protein Lhx1 OS=Xenopus laevis OX=8355 GN=lhx1 PE=1 SV=1,,,,,,
OG_03471,1.266526967676627,FUN_014558-T1,Peve_00035994,Pocillopora_meandrina_HIv1___RNAseq.g22694.t1,three_way,76.857,FUN_014558-T1,A0JN61,,,,,60.5,76.0,8e-18,91.3,sp|A0JN61|RPC9_BOVIN DNA-directed RNA polymerase III subunit RPC9 OS=Bos taurus OX=9913 GN=CRCP PE=2 SV=1,,,,,,
OG_03473,4.21266546931914,FUN_014561-T1,Peve_00023543,Pocillopora_meandrina_HIv1___RNAseq.g22703.t1,three_way,65.42583333333333,FUN_014561-T1,Q96S52,PIGS_HUMAN,,GPI-anchor transamidase component PIGS (Phosphatidylinositol-glycan biosynthesis class S protein),Homo sapiens (Human),36.6,508.0,2.9e-81,304.3,sp|Q96S52|PIGS_HUMAN GPI-anchor transamidase component PIGS OS=Homo sapiens OX=9606 GN=PIGS PE=1 SV=3,GO:0005789; GO:0006506; GO:0016020; GO:0016255; GO:0042765; GO:0180046,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046],endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020],,GO:0006629; GO:0051604; GO:1901135,lipid metabolic process; protein maturation; carbohydrate derivative metabolic process
OG_03478,2.62192092674063,FUN_014572-T1,Peve_00027631,Pocillopora_meandrina_HIv1___RNAseq.1861_t,three_way,78.95566666666666,FUN_014572-T1,Q6DDL7,,,,,50.4,282.0,2.600000000000001e-71,270.4,sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1,,,,,,
OG_03479,1.01338849508771,FUN_014573-T3,Peve_00027630,Pocillopora_meandrina_HIv1___RNAseq.g22711.t1,three_way,76.72633333333333,FUN_014573-T3,Q6DFR1,,,,,31.8,494.0,5.1e-54,213.8,sp|Q6DFR1|S22AF_XENTR Solute carrier family 22 member 15 OS=Xenopus tropicalis OX=8364 GN=slc22a15 PE=2 SV=2,,,,,,
OG_03480,1.5983968166035816,FUN_014574-T1,Peve_00027629,Pocillopora_meandrina_HIv1___TS.g27474.t1,three_way,69.878,FUN_014574-T1,Q9VCA2,,,,,36.1,527.0,8.1e-84,312.8,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_03481,2.045078886340264,FUN_014575-T1,Peve_00037170,Pocillopora_meandrina_HIv1___RNAseq.g22712.t1,three_way,86.77133333333333,FUN_014575-T1,Q0IIF2,,,,,60.7,300.0,5.3e-94,345.9,sp|Q0IIF2|EI2BA_BOVIN Translation initiation factor eIF2B subunit alpha OS=Bos taurus OX=9913 GN=EIF2B1 PE=2 SV=1,,,,,,
OG_03483,1.0333969710471298,FUN_014585-T1,Peve_00001488,Pocillopora_meandrina_HIv1___RNAseq.g22722.t1,three_way,62.20133333333333,,,,,,,,,,,,,,,,,
OG_03486,2.156609910864744,FUN_014589-T1,Peve_00011858,Pocillopora_meandrina_HIv1___TS.g27493.t1,three_way,81.65599999999999,FUN_014589-T1,O43147,,,,,45.5,1038.0,4.3e-227,789.6,sp|O43147|SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens OX=9606 GN=SGSM2 PE=1 SV=4,,,,,,
OG_03492,4.046097330401596,FUN_014601-T1,Peve_00034546,Pocillopora_meandrina_HIv1___RNAseq.g22743.t1,three_way,50.54366666666667,,,,,,,,,,,,,,,,,
OG_03495,2.126040212502101,FUN_014604-T1,Peve_00028205,Pocillopora_meandrina_HIv1___RNAseq.g22749.t1,three_way,70.68266666666666,FUN_014604-T1,A2BGR3,,,,,54.5,635.0,3.2000000000000004e-185,650.2,sp|A2BGR3|ERC6L_DANRE DNA excision repair protein ERCC-6-like OS=Danio rerio OX=7955 GN=ercc6l PE=1 SV=1,,,,,,
OG_03496,2.2651708995011104,FUN_014605-T1,Peve_00001902,Pocillopora_meandrina_HIv1___RNAseq.g22752.t1,three_way,91.59133333333334,FUN_014605-T1,Q14254,FLOT2_HUMAN,,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1),Homo sapiens (Human),58.5,417.0,1.6999999999999998e-105,384.4,sp|Q14254|FLOT2_HUMAN Flotillin-2 OS=Homo sapiens OX=9606 GN=FLOT2 PE=1 SV=2,GO:0001931; GO:0002020; GO:0002080; GO:0005768; GO:0005886; GO:0005901; GO:0005912; GO:0005925; GO:0007155; GO:0008544; GO:0010629; GO:0016020; GO:0016323; GO:0016600; GO:0030027; GO:0030139; GO:0031410; GO:0031982; GO:0032839; GO:0043123; GO:0043231; GO:0044291; GO:0044860; GO:0045661; GO:0048471; GO:0050821; GO:0070062; GO:0072659; GO:0098937; GO:0098978; GO:0099072; GO:1902992; GO:1903905,anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of establishment of T cell polarity [GO:1903905]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982],protease binding [GO:0002020],GO:0005768; GO:0005886; GO:0007018; GO:0007155; GO:0031410; GO:0043226; GO:0048856; GO:0072659,endosome; plasma membrane; microtubule-based movement; cell adhesion; cytoplasmic vesicle; organelle; anatomical structure development; protein localization to plasma membrane
OG_03497,1.3108303591548105,FUN_014606-T1,Peve_00002397,Pocillopora_meandrina_HIv1___RNAseq.g22772.t1,three_way,87.05833333333334,FUN_014606-T1,O14735,,,,,66.0,162.0,4.5e-54,212.2,sp|O14735|CDIPT_HUMAN CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Homo sapiens OX=9606 GN=CDIPT PE=1 SV=1,,,,,,
OG_03498,2.2760264545315327,FUN_014607-T1,Peve_00002391,Pocillopora_meandrina_HIv1___RNAseq.g22765.t1,three_way,71.34233333333333,FUN_014607-T1,Q4QMZ7,,,,,31.5,127.0,8.9e-10,65.9,"sp|Q4QMZ7|APAH_HAEI8 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical OS=Haemophilus influenzae (strain 86-028NP) OX=281310 GN=apaH PE=3 SV=1",,,,,,
OG_03501,1.83833811572312,FUN_014611-T1,Peve_00027568,Pocillopora_meandrina_HIv1___TS.g27528.t1,three_way,54.368,,,,,,,,,,,,,,,,,
OG_03502,1.3558218292683315,FUN_014612-T1,Peve_00027569,Pocillopora_meandrina_HIv1___RNAseq.g22760.t1,three_way,63.5955,FUN_014612-T1,A2CEI4,,,,,30.4,756.0,3.1e-94,347.8,sp|A2CEI4|NUP88_DANRE Nucleoporin 88 OS=Danio rerio OX=7955 GN=nup88 PE=1 SV=1,,,,,,
OG_03506,2.469186882581448,FUN_014616-T1,Peve_00001903,Pocillopora_meandrina_HIv1___RNAseq.g22756.t1,three_way,96.60133333333332,FUN_014616-T1,Q6IP91,,,,,90.6,309.0,1.3e-168,593.6,sp|Q6IP91|PP4C_XENLA Serine/threonine-protein phosphatase 4 catalytic subunit OS=Xenopus laevis OX=8355 GN=ppp4c PE=2 SV=1,,,,,,
OG_03509,2.301260800447433,FUN_014619-T1,Peve_00002405,Pocillopora_meandrina_HIv1___RNAseq.g22775.t1,three_way,73.92766666666667,,,,,,,,,,,,,,,,,
OG_03510,2.351636399557453,FUN_014621-T1,Peve_00002408,Pocillopora_meandrina_HIv1___RNAseq.g22778.t1,three_way,70.79983333333334,FUN_014621-T1,A4QNN3,UBP30_XENTR,,Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),39.8,450.0,2.7e-74,280.8,sp|A4QNN3|UBP30_XENTR Ubiquitin carboxyl-terminal hydrolase 30 OS=Xenopus tropicalis OX=8364 GN=usp30 PE=2 SV=1,GO:0000422; GO:0004197; GO:0004843; GO:0005739; GO:0005741; GO:0006508; GO:0008053; GO:0016579; GO:0035871; GO:0044313,autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; proteolysis [GO:0006508],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005739; GO:0006914; GO:0007005; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; autophagy; mitochondrion organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03511,1.057326191772075,FUN_014622-T1,Peve_00002409,Pocillopora_meandrina_HIv1___RNAseq.g22779.t1,three_way,69.165,FUN_014622-T1,Q6GNG8,,,,,57.8,109.0,3e-27,123.2,sp|Q6GNG8|PKRI1_XENLA PRKR-interacting protein 1 homolog OS=Xenopus laevis OX=8355 GN=prkrip1 PE=2 SV=1,,,,,,
OG_03514,3.870518145637189,FUN_014625-T1,Peve_00002412,Pocillopora_meandrina_HIv1___TS.g27550.t1,three_way,56.03566666666666,,,,,,,,,,,,,,,,,
OG_03517,3.88972844260725,FUN_014630-T1,Peve_00002417,Pocillopora_meandrina_HIv1___RNAseq.g22787.t1,three_way,63.39333333333334,FUN_014630-T1,Q5R5S1,,,,,31.7,612.0,1.1999999999999999e-75,285.8,sp|Q5R5S1|FBX21_PONAB F-box only protein 21 OS=Pongo abelii OX=9601 GN=FBXO21 PE=2 SV=1,,,,,,
OG_03518,1.5239745182034174,FUN_014631-T1,Peve_00002419,Pocillopora_meandrina_HIv1___RNAseq.g22788.t1,three_way,71.69266666666667,FUN_014631-T1,Q99J99,THTM_MOUSE,,3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2),Mus musculus (Mouse),49.3,284.0,5.9e-78,292.4,sp|Q99J99|THTM_MOUSE 3-mercaptopyruvate sulfurtransferase OS=Mus musculus OX=10090 GN=Mpst PE=1 SV=4,GO:0001822; GO:0001889; GO:0004792; GO:0005737; GO:0005739; GO:0005743; GO:0016784; GO:0019346; GO:0021510; GO:0042802; GO:0043005; GO:0045202; GO:0070814,hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; spinal cord development [GO:0021510]; transsulfuration [GO:0019346],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202],3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792],GO:0003824; GO:0005739; GO:0006520; GO:0006790; GO:0016740; GO:0043226; GO:0048856,catalytic activity; mitochondrion; amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle; anatomical structure development
OG_03526,1.8872129998933205,FUN_014641-T1,Peve_00002430,Pocillopora_meandrina_HIv1___RNAseq.g22798.t1,three_way,72.066,FUN_014641-T1,Q96CM3,,,,,36.0,250.0,5.5e-33,142.9,"sp|Q96CM3|RUSD4_HUMAN Pseudouridylate synthase RPUSD4, mitochondrial OS=Homo sapiens OX=9606 GN=RPUSD4 PE=1 SV=1",,,,,,
OG_03528,1.933420530004921,FUN_014643-T1,Peve_00002386,Pocillopora_meandrina_HIv1___RNAseq.g22800.t1,three_way,82.04466666666667,FUN_014643-T1,Q9DAX9,,,,,52.4,435.0,1.7e-119,431.0,sp|Q9DAX9|APBP2_MOUSE Amyloid protein-binding protein 2 OS=Mus musculus OX=10090 GN=Appbp2 PE=2 SV=1,,,,,,
OG_03529,1.5037646167660423,FUN_014644-T1,Peve_00002387,Pocillopora_meandrina_HIv1___TS.g27455.t1,three_way,73.52783333333333,FUN_014644-T1,Q5SPX1,,,,,38.6,345.0,6.2e-48,194.1,sp|Q5SPX1|CC157_MOUSE Coiled-coil domain-containing protein 157 OS=Mus musculus OX=10090 GN=Ccdc157 PE=1 SV=1,,,,,,
OG_03538,2.892328339329709,FUN_014657-T1,Peve_00014510,Pocillopora_meandrina_HIv1___RNAseq.g22581.t2,three_way,74.71600000000001,FUN_014657-T1,Q9NUQ2,PLCE_HUMAN,,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon),Homo sapiens (Human),45.6,261.0,1.9e-63,244.2,sp|Q9NUQ2|PLCE_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon OS=Homo sapiens OX=9606 GN=AGPAT5 PE=1 SV=3,GO:0002244; GO:0003841; GO:0005635; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0006639; GO:0006654; GO:0008654; GO:0012505; GO:0016024; GO:0016746; GO:0036149,acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746],GO:0003824; GO:0005635; GO:0005730; GO:0005739; GO:0005783; GO:0006629; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nuclear envelope; nucleolus; mitochondrion; endoplasmic reticulum; lipid metabolic process; transferase activity; cell differentiation; organelle
OG_03544,2.4045260229708143,FUN_014670-T1,Peve_00030803,Pocillopora_meandrina_HIv1___RNAseq.g22675.t1,three_way,86.73983333333334,FUN_014670-T1,Q13356,PPIL2_HUMAN,,RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2),Homo sapiens (Human),58.3,527.0,1.1e-178,627.9,sp|Q13356|PPIL2_HUMAN RING-type E3 ubiquitin-protein ligase PPIL2 OS=Homo sapiens OX=9606 GN=PPIL2 PE=1 SV=1,GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006397; GO:0006457; GO:0008380; GO:0034450; GO:0061630; GO:0071013; GO:0072659,mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; RNA splicing [GO:0008380],catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0005654; GO:0005886; GO:0006457; GO:0016071; GO:0016740; GO:0043226; GO:0072659; GO:0140096,"catalytic activity; nucleus; nucleoplasm; plasma membrane; protein folding; mRNA metabolic process; transferase activity; organelle; protein localization to plasma membrane; catalytic activity, acting on a protein"
OG_03546,4.01639036395857,FUN_014673-T1,Peve_00013033,Pocillopora_meandrina_HIv1___RNAseq.g22680.t1,three_way,77.56683333333334,FUN_014673-T1,Q96AY4,TTC28_HUMAN,,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),Homo sapiens (Human),44.3,828.0,5.7e-171,604.4,sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4,GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301,cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922],kinase binding [GO:0019900],GO:0005815,microtubule organizing center
OG_03549,1.2553407179870253,FUN_014679-T1,Peve_00004252,Pocillopora_meandrina_HIv1___RNAseq.g22587.t1,three_way,65.30366666666667,FUN_014679-T1,Q5U508,,,,,40.3,528.0,3.7999999999999996e-107,390.2,sp|Q5U508|TBCE_XENLA Tubulin-specific chaperone E OS=Xenopus laevis OX=8355 GN=tbce PE=2 SV=1,,,,,,
OG_03550,1.5171054885446045,FUN_014682-T1,Peve_00004258,Pocillopora_meandrina_HIv1___RNAseq.g22590.t1,three_way,83.26683333333334,FUN_014682-T1,Q9UJX3,APC7_HUMAN,,Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7),Homo sapiens (Human),39.4,523.0,2.5000000000000002e-104,380.9,sp|Q9UJX3|APC7_HUMAN Anaphase-promoting complex subunit 7 OS=Homo sapiens OX=9606 GN=ANAPC7 PE=1 SV=5,GO:0000792; GO:0005634; GO:0005654; GO:0005680; GO:0005819; GO:0005829; GO:0007346; GO:0007420; GO:0015630; GO:0016567; GO:0019903; GO:0031145; GO:0043231; GO:0045171; GO:0045842; GO:0051301; GO:0051445; GO:0070936; GO:0070979; GO:0072686; GO:0140767; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; brain development [GO:0007420]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase binding [GO:0019903],GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0030163; GO:0043226; GO:0048856; GO:0060090,nucleus; nucleoplasm; cytosol; cytoskeleton; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity
OG_03555,1.1088246894831997,FUN_014693-T1,Peve_00006835,Pocillopora_meandrina_HIv1___RNAseq.g22555.t1,three_way,67.01950000000001,FUN_014693-T1,Q8R3V6,,,,,37.2,309.0,2.4e-31,137.5,sp|Q8R3V6|CUED1_MOUSE CUE domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cuedc1 PE=2 SV=2,,,,,,
OG_03556,1.059694219599282,FUN_014694-T1,Peve_00006830,Pocillopora_meandrina_HIv1___RNAseq.g22552.t1,three_way,85.36166666666666,FUN_014694-T1,Q9VX98,,,,,52.0,171.0,4.5e-42,172.6,sp|Q9VX98|DENR_DROME Density-regulated protein homolog OS=Drosophila melanogaster OX=7227 GN=DENR PE=1 SV=3,,,,,,
OG_03563,3.407279125327165,FUN_014712-T1,Peve_00028586,Pocillopora_meandrina_HIv1___RNAseq.g22528.t1,three_way,51.81133333333333,,,,,,,,,,,,,,,,,
OG_03564,3.0310130487792395,FUN_014713-T1,Peve_00028587,Pocillopora_meandrina_HIv1___RNAseq.g22527.t1,three_way,84.00266666666667,FUN_014713-T1,Q96DM3,,,,,53.3,647.0,7.699999999999999e-198,691.8,sp|Q96DM3|RMC1_HUMAN Regulator of MON1-CCZ1 complex OS=Homo sapiens OX=9606 GN=RMC1 PE=1 SV=2,,,,,,
OG_03569,2.5555804162205704,FUN_014720-T1,Peve_00006843,Pocillopora_meandrina_HIv1___RNAseq.g22498.t1,three_way,63.56933333333333,FUN_014720-T1,Q9VCR7,,,,,26.0,204.0,1.7e-07,58.5,sp|Q9VCR7|CTNS_DROME Cystinosin OS=Drosophila melanogaster OX=7227 GN=Ctns PE=1 SV=2,,,,,,
OG_03572,1.1022432439381051,FUN_014726-T1,Peve_00009492,Pocillopora_meandrina_HIv1___RNAseq.g22493.t1,three_way,44.585,,,,,,,,,,,,,,,,,
OG_03573,2.283488516334228,FUN_014727-T1,Peve_00009517,Pocillopora_meandrina_HIv1___RNAseq.g22492.t1,three_way,75.87566666666666,FUN_014727-T1,A9KJR7,,,,,25.7,222.0,8.7e-11,68.9,sp|A9KJR7|UREF_LACP7 Urease accessory protein UreF OS=Lachnoclostridium phytofermentans (strain ATCC 700394 / DSM 18823 / ISDg) OX=357809 GN=ureF PE=3 SV=1,,,,,,
OG_03576,1.193079344171314,FUN_014730-T1,Peve_00009496,Pocillopora_meandrina_HIv1___RNAseq.g22489.t1,three_way,68.61999999999999,FUN_014730-T1,Q5R831,,,,,64.4,267.0,5e-92,339.3,sp|Q5R831|S35B3_PONAB Adenosine 3'-phospho 5'-phosphosulfate transporter 2 OS=Pongo abelii OX=9601 GN=SLC35B3 PE=2 SV=1,,,,,,
OG_03577,1.7549672558615808,FUN_014731-T1,Peve_00010437,Pocillopora_meandrina_HIv1___TS.g27252.t1,three_way,82.48166666666667,FUN_014731-T1,Q7SXP2,,,,,58.6,526.0,3.0999999999999996e-189,662.9,sp|Q7SXP2|ULA1_DANRE NEDD8-activating enzyme E1 regulatory subunit OS=Danio rerio OX=7955 GN=nae1 PE=2 SV=2,,,,,,
OG_03585,1.4837949669670063,FUN_014741-T1,Peve_00027513,Pocillopora_meandrina_HIv1___RNAseq.g22473.t1,three_way,84.87833333333333,FUN_014741-T1,Q28GJ2,,,,,51.9,314.0,7.7e-95,348.6,sp|Q28GJ2|CK054_XENTR Ester hydrolase C11orf54 homolog OS=Xenopus tropicalis OX=8364 GN=TEgg069a24.1 PE=2 SV=1,,,,,,
OG_03587,1.3568939955609292,FUN_014743-T1,Peve_00007238,Pocillopora_meandrina_HIv1___RNAseq.g22471.t2,three_way,64.66933333333333,FUN_014743-T1,Q5YCC5,,,,,31.2,557.0,2.8e-64,248.1,sp|Q5YCC5|TMC7_CHICK Transmembrane channel-like protein 7 OS=Gallus gallus OX=9031 GN=Tmc7 PE=2 SV=1,,,,,,
OG_03597,2.327372118106756,FUN_014756-T1,Peve_00039153,Pocillopora_meandrina_HIv1___RNAseq.g22442.t1,three_way,67.01416666666667,FUN_014756-T1,Q07066,,,,,38.9,180.0,1.1e-35,151.4,sp|Q07066|PXMP2_RAT Peroxisomal membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Pxmp2 PE=1 SV=2,,,,,,
OG_03599,1.9414880891487736,FUN_014758-T1,Peve_00039156,Pocillopora_meandrina_HIv1___RNAseq.g22440.t1,three_way,60.02083333333333,,,,,,,,,,,,,,,,,
OG_03600,1.6312671150898774,FUN_014764-T1,Peve_00000342,Pocillopora_meandrina_HIv1___RNAseq.g22434.t1,three_way,79.31733333333334,FUN_014764-T1,P70645,,,,,53.3,465.0,1.3e-151,537.7,sp|P70645|BLMH_RAT Bleomycin hydrolase OS=Rattus norvegicus OX=10116 GN=Blmh PE=1 SV=1,,,,,,
OG_03602,1.9673387459352008,FUN_014769-T1,Peve_00000348,Pocillopora_meandrina_HIv1___RNAseq.g22568.t1,three_way,57.41133333333333,,,,,,,,,,,,,,,,,
OG_03604,1.980558507887205,FUN_014771-T1,Peve_00014607,Pocillopora_meandrina_HIv1___RNAseq.g22566.t1,three_way,79.51866666666668,FUN_014771-T1,Q8K370,,,,,57.8,1018.0,0.0,1177.2,sp|Q8K370|ACD10_MOUSE Acyl-CoA dehydrogenase family member 10 OS=Mus musculus OX=10090 GN=Acad10 PE=1 SV=1,,,,,,
OG_03607,1.2495414048422715,FUN_014783-T1,Peve_00014593,Pocillopora_meandrina_HIv1___RNAseq.g22511.t1,three_way,54.09,FUN_014783-T1,B3EWZ8,,,,,39.9,158.0,6.1e-23,110.9,sp|B3EWZ8|ECT_ACRMI Ectin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_03608,1.6442823471711772,FUN_014785-T2,Peve_00001849,Pocillopora_meandrina_HIv1___RNAseq.g22512.t1a,three_way,42.24616666666667,,,,,,,,,,,,,,,,,
OG_03612,2.3287220612992785,FUN_014793-T1,Peve_00015736,Pocillopora_meandrina_HIv1___RNAseq.g22428.t1,three_way,75.05016666666667,FUN_014793-T1,A1L2H9,RFA2B_XENLA,,Replication protein A 32 kDa subunit-B (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34),Xenopus laevis (African clawed frog),44.4,295.0,3.9999999999999997e-56,219.9,sp|A1L2H9|RFA2B_XENLA Replication protein A 32 kDa subunit-B OS=Xenopus laevis OX=8355 GN=rpa2-b PE=2 SV=1,GO:0000076; GO:0000723; GO:0000724; GO:0000781; GO:0000785; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006284; GO:0006289; GO:0006298; GO:0016605; GO:0034502; GO:0035861; GO:0042162; GO:2000001,base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; telomere maintenance [GO:0000723],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]",damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0032200; GO:0043226,DNA binding; nucleus; DNA replication; DNA repair; DNA recombination; telomere organization; organelle
OG_03623,2.940373240329468,FUN_014810-T1,Peve_00022206,Pocillopora_meandrina_HIv1___RNAseq.g22405.t1,three_way,74.15333333333334,FUN_014810-T1,Q9NXZ2,,,,,46.8,577.0,2.1e-146,521.2,sp|Q9NXZ2|DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens OX=9606 GN=DDX43 PE=1 SV=2,,,,,,
OG_03625,1.3866921606977487,FUN_014814-T1,Peve_00038796,Pocillopora_meandrina_HIv1___RNAseq.g22400.t1,three_way,65.43366666666667,FUN_014814-T1,Q08CA1,,,,,37.2,341.0,1e-50,202.2,sp|Q08CA1|GDPP1_DANRE GDP-D-glucose phosphorylase 1 OS=Danio rerio OX=7955 GN=gdpgp1 PE=2 SV=1,,,,,,
OG_03627,1.0598328259797425,FUN_014818-T1,Peve_00038833,Pocillopora_meandrina_HIv1___RNAseq.g22396.t1,three_way,36.711666666666666,,,,,,,,,,,,,,,,,
OG_03630,1.2643778800644012,FUN_014847-T1,Peve_00038811,Pocillopora_meandrina_HIv1___RNAseq.g22384.t1,three_way,66.74766666666666,,,,,,,,,,,,,,,,,
OG_03633,2.7643553351889527,FUN_014852-T1,Peve_00038812,Pocillopora_meandrina_HIv1___RNAseq.g22380.t1b,three_way,70.72466666666666,FUN_014852-T1,Q9BW91,NUDT9_HUMAN,,"ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)",Homo sapiens (Human),52.1,317.0,2.1e-89,330.5,"sp|Q9BW91|NUDT9_HUMAN ADP-ribose pyrophosphatase, mitochondrial OS=Homo sapiens OX=9606 GN=NUDT9 PE=1 SV=1",GO:0005739; GO:0005759; GO:0005829; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0046032; GO:0047631; GO:0055086; GO:0070062,ADP catabolic process [GO:0046032]; nucleobase-containing small molecule metabolic process [GO:0055086],cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965],ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144],GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03634,1.527186322566898,FUN_014854-T1,Peve_00038807,Pocillopora_meandrina_HIv1___TS.g27144.t2,three_way,77.016,FUN_014854-T1,Q99MP8,BRAP_MOUSE,,BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING-type E3 ubiquitin transferase BRAP2),Mus musculus (Mouse),45.8,594.0,5.2e-139,496.1,sp|Q99MP8|BRAP_MOUSE BRCA1-associated protein OS=Mus musculus OX=10090 GN=Brap PE=1 SV=1,GO:0000151; GO:0000165; GO:0003676; GO:0005654; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630,MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151],identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_03635,1.598405860451818,FUN_014855-T1,Peve_00038800,Pocillopora_meandrina_HIv1___RNAseq.g22371.t1,three_way,96.05733333333332,FUN_014855-T1,Q6P2Q9,PRP8_HUMAN,,Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220),Homo sapiens (Human),92.1,2321.0,0.0,4492.2,sp|Q6P2Q9|PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens OX=9606 GN=PRPF8 PE=1 SV=2,GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157,"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_03639,3.577585591311801,FUN_014861-T1,Peve_00016000,Pocillopora_meandrina_HIv1___RNAseq.g22368.t1,three_way,62.06,FUN_014861-T1,Q69ZM6,STK36_MOUSE,,Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog),Mus musculus (Mouse),25.5,1026.0,5.9e-57,224.6,sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus OX=10090 GN=Stk36 PE=1 SV=3,GO:0001222; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007224; GO:0007420; GO:0009791; GO:0035082; GO:0042995; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310,axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222],GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005856; GO:0006355; GO:0007010; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0140096,"catalytic activity; extracellular region; nucleus; cytosol; cytoskeleton; regulation of DNA-templated transcription; cytoskeleton organization; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; catalytic activity, acting on a protein"
OG_03645,2.172851754962576,FUN_014876-T1,Peve_00013646,Pocillopora_meandrina_HIv1___RNAseq.g21045.t1,three_way,76.93633333333334,FUN_014876-T1,P22061,PIMT_HUMAN,,Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase),Homo sapiens (Human),60.5,223.0,5.6e-76,285.4,sp|P22061|PIMT_HUMAN Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Homo sapiens OX=9606 GN=PCMT1 PE=1 SV=4,GO:0004719; GO:0005737; GO:0005829; GO:0006479; GO:0030091; GO:0045296; GO:0070062; GO:1903561,protein methylation [GO:0006479]; protein repair [GO:0030091],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561],cadherin binding [GO:0045296]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719],GO:0003824; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03646,1.994360109575612,FUN_014877-T1,Peve_00013644,Pocillopora_meandrina_HIv1___RNAseq.g21046.t1,three_way,63.173,,,,,,,,,,,,,,,,,
OG_03650,2.473068986991532,FUN_014882-T1,Peve_00013645,Pocillopora_meandrina_HIv1___RNAseq.g21054.t1,three_way,56.43533333333333,FUN_014882-T1,Q5SSG4,GA2L2_MOUSE,,GAS2-like protein 2 (Growth arrest-specific protein 2-like 2),Mus musculus (Mouse),35.9,473.0,1.6999999999999998e-53,213.0,sp|Q5SSG4|GA2L2_MOUSE GAS2-like protein 2 OS=Mus musculus OX=10090 GN=Gas2l2 PE=1 SV=1,GO:0001578; GO:0001725; GO:0001965; GO:0005737; GO:0005884; GO:0005886; GO:0007026; GO:0008017; GO:0008093; GO:0035371; GO:0036064; GO:0045745; GO:0051015; GO:0060296; GO:1904825,microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein localization to microtubule plus-end [GO:1904825]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; plasma membrane [GO:0005886]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; G-protein alpha-subunit binding [GO:0001965]; microtubule binding [GO:0008017],GO:0005815; GO:0005886; GO:0007010; GO:0008092; GO:0060090,microtubule organizing center; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; molecular adaptor activity
OG_03655,1.796805377217647,FUN_014891-T1,Peve_00003550,Pocillopora_meandrina_HIv1___RNAseq.g21064.t1,three_way,52.26566666666667,,,,,,,,,,,,,,,,,
OG_03656,1.0776892549822357,FUN_014892-T1,Peve_00003549,Pocillopora_meandrina_HIv1___RNAseq.g21108.t1,three_way,89.12416666666667,FUN_014892-T1,Q96AX1,VP33A_HUMAN,,Vacuolar protein sorting-associated protein 33A (hVPS33A),Homo sapiens (Human),56.3,606.0,8.2e-186,651.7,sp|Q96AX1|VP33A_HUMAN Vacuolar protein sorting-associated protein 33A OS=Homo sapiens OX=9606 GN=VPS33A PE=1 SV=1,GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0010008; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0034058; GO:0035542; GO:0035751; GO:0048070; GO:0048471; GO:0097352,autophagosome maturation [GO:0097352]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192],autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],,GO:0005764; GO:0005768; GO:0005773; GO:0006886; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0061024,lysosome; endosome; vacuole; intracellular protein transport; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; membrane organization
OG_03657,2.3820847226685147,FUN_014893-T1,Peve_00003548,Pocillopora_meandrina_HIv1___RNAseq.g21106.t1,three_way,54.15466666666666,,,,,,,,,,,,,,,,,
OG_03658,4.479254920750809,FUN_014895-T1,Peve_00003547,Pocillopora_meandrina_HIv1___RNAseq.g21105.t1,three_way,67.7525,FUN_014895-T1,Q0VH32,,,,,50.8,122.0,6.3999999999999975e-25,116.3,sp|Q0VH32|MNT_XENLA Max-binding protein MNT OS=Xenopus laevis OX=8355 GN=mnt PE=2 SV=1,,,,,,
OG_03660,1.3995144465679894,FUN_014897-T1,Peve_00003545,Pocillopora_meandrina_HIv1___RNAseq.g21065.t1,three_way,70.15983333333334,FUN_014897-T1,Q9Y4D8,,,,,34.5,4127.0,0.0,2025.4,sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5,,,,,,
OG_03661,1.4089634155745403,FUN_014899-T1,Peve_00003543,Pocillopora_meandrina_HIv1___RNAseq.g21066.t1,three_way,81.57033333333334,FUN_014899-T1,Q13889,TF2H3_HUMAN,,General transcription factor IIH subunit 3 (Basic transcription factor 2 34 kDa subunit) (BTF2 p34) (General transcription factor IIH polypeptide 3) (TFIIH basal transcription factor complex p34 subunit),Homo sapiens (Human),51.8,311.0,1.6e-84,314.3,sp|Q13889|TF2H3_HUMAN General transcription factor IIH subunit 3 OS=Homo sapiens OX=9606 GN=GTF2H3 PE=1 SV=2,GO:0000438; GO:0000439; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006289; GO:0006355; GO:0006366; GO:0008270; GO:0016251; GO:0097550,DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; regulation of DNA-templated transcription [GO:0006355]; transcription by RNA polymerase II [GO:0006366],core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550],RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0043226; GO:0140223,nucleus; nucleoplasm; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_03662,2.4062542946652483,FUN_014900-T1,Peve_00003542,Pocillopora_meandrina_HIv1___RNAseq.g21067.t1,three_way,61.59133333333333,FUN_014900-T1,Q9WVS8,,,,,64.2,355.0,5.6999999999999994e-129,463.8,sp|Q9WVS8|MK07_MOUSE Mitogen-activated protein kinase 7 OS=Mus musculus OX=10090 GN=Mapk7 PE=1 SV=1,,,,,,
OG_03664,1.9670094565833032,FUN_014903-T1,Peve_00003540,Pocillopora_meandrina_HIv1___RNAseq.g21069.t1,three_way,57.27183333333333,,,,,,,,,,,,,,,,,
OG_03666,2.2798106082312786,FUN_014905-T1,Peve_00003537,Pocillopora_meandrina_HIv1___RNAseq.g21071.t1,three_way,89.49799999999999,FUN_014905-T1,P14866,HNRPL_HUMAN,,Heterogeneous nuclear ribonucleoprotein L (hnRNP L),Homo sapiens (Human),46.7,210.0,4.3e-39,163.7,sp|P14866|HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2,GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0016020; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045892; GO:0070062; GO:0097157; GO:1990904,"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; synapse [GO:0045202],mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_03667,1.1269621214420538,FUN_014907-T1,Peve_00003536,Pocillopora_meandrina_HIv1___RNAseq.g21072.t1,three_way,37.61533333333333,,,,,,,,,,,,,,,,,
OG_03669,1.8241253384881608,FUN_014909-T1,Peve_00003534,Pocillopora_meandrina_HIv1___RNAseq.g21074.t1,three_way,64.27283333333332,,,,,,,,,,,,,,,,,
OG_03671,5.764538268428322,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_03672,1.1342099137453971,FUN_014922-T1,Peve_00022028,Pocillopora_meandrina_HIv1___RNAseq.g21080.t1,three_way,79.228,,,,,,,,,,,,,,,,,
OG_03676,1.8462805781030944,FUN_014928-T1,Peve_00033454,Pocillopora_meandrina_HIv1___RNAseq.g21087.t1a,three_way,85.25866666666667,FUN_014928-T1,Q15735,PI5PA_HUMAN,,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (EC 3.1.3.36) (Inositol polyphosphate 5-phosphatase J) (Phosphatidylinositol 1,3,4,5-tetrakisphosphate 5-phosphatase) (EC 3.1.3.56) (Phosphatidylinositol 1,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.56)",Homo sapiens (Human),35.4,429.0,4.3999999999999995e-69,263.5,"sp|Q15735|PI5PA_HUMAN Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A OS=Homo sapiens OX=9606 GN=INPP5J PE=1 SV=3",GO:0001726; GO:0004439; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0010977; GO:0017124; GO:0030426; GO:0031115; GO:0034485; GO:0043005; GO:0043198; GO:0043647; GO:0046030; GO:0046856; GO:0052658; GO:0052659,inositol phosphate metabolic process [GO:0043647]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]",GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016787,catalytic activity; cytosol; plasma membrane; lipid metabolic process; hydrolase activity
OG_03678,2.824259730814042,FUN_014932-T1,Peve_00037144,Pocillopora_meandrina_HIv1___RNAseq.g21090.t2,three_way,93.364,FUN_014932-T1,P26818,,,,,66.9,680.0,9.099999999999999e-271,934.1,sp|P26818|ARBK2_BOVIN G protein-coupled receptor kinase 3 OS=Bos taurus OX=9913 GN=GRK3 PE=2 SV=1,,,,,,
OG_03681,1.0015338698586675,FUN_014940-T1,Peve_00037136,Pocillopora_meandrina_HIv1___RNAseq.g21097.t1,three_way,75.71733333333333,FUN_014940-T1,Q8WV93,AFG1L_HUMAN,,AFG1-like ATPase (Lactation elevated protein 1) (EC 3.6.-.-) (Protein AFG1 homolog),Homo sapiens (Human),35.5,434.0,6.200000000000003e-66,253.4,sp|Q8WV93|AFG1L_HUMAN AFG1-like ATPase OS=Homo sapiens OX=9606 GN=AFG1L PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0007005; GO:0016887; GO:0031966; GO:0035694; GO:0141164,mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein quality control [GO:0141164]; mitochondrion organization [GO:0007005],cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0043226,catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; organelle
OG_03682,3.6777540689795214,FUN_014941-T2,Peve_00037149,Pocillopora_meandrina_HIv1___RNAseq.g21098.t1,three_way,78.08300000000001,FUN_014941-T2,O43435,TBX1_HUMAN,,T-box transcription factor TBX1 (T-box protein 1) (Testis-specific T-box protein),Homo sapiens (Human),74.4,203.0,2.7e-85,317.4,sp|O43435|TBX1_HUMAN T-box transcription factor TBX1 OS=Homo sapiens OX=9606 GN=TBX1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001568; GO:0001708; GO:0001755; GO:0001934; GO:0001945; GO:0002053; GO:0003007; GO:0003148; GO:0003151; GO:0003677; GO:0005634; GO:0006357; GO:0007368; GO:0007389; GO:0007498; GO:0007507; GO:0007517; GO:0007605; GO:0008283; GO:0008284; GO:0009952; GO:0021644; GO:0030855; GO:0030878; GO:0035019; GO:0035176; GO:0035909; GO:0042471; GO:0042472; GO:0042473; GO:0042474; GO:0042475; GO:0042693; GO:0042803; GO:0043410; GO:0043565; GO:0043587; GO:0044344; GO:0045596; GO:0045893; GO:0045944; GO:0046983; GO:0048384; GO:0048514; GO:0048538; GO:0048644; GO:0048701; GO:0048703; GO:0048752; GO:0048844; GO:0050679; GO:0060017; GO:0060023; GO:0060037; GO:0060325; GO:0060415; GO:0060982; GO:0070166; GO:0071300; GO:0090103; GO:0097152; GO:1990837; GO:2000027; GO:2001037; GO:2001054,angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; coronary artery morphogenesis [GO:0060982]; determination of left/right symmetry [GO:0007368]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; enamel mineralization [GO:0070166]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; lymph vessel development [GO:0001945]; mesenchymal cell apoptotic process [GO:0097152]; mesoderm development [GO:0007498]; middle ear morphogenesis [GO:0042474]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell differentiation [GO:0045596]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tongue muscle cell differentiation [GO:2001037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of animal organ morphogenesis [GO:2000027]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; soft palate development [GO:0060023]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue morphogenesis [GO:0043587]; vagus nerve morphogenesis [GO:0021644],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_03683,3.966216975333164,FUN_014942-T1,Peve_00037148,Pocillopora_meandrina_HIv1___RNAseq.g21099.t1,three_way,86.43466666666666,FUN_014942-T1,Q8AX98,TBX1A_XENLA,,T-box transcription factor TBX1-A (T-box protein 1-A),Xenopus laevis (African clawed frog),74.0,196.0,1.3e-84,315.1,sp|Q8AX98|TBX1A_XENLA T-box transcription factor TBX1-A OS=Xenopus laevis OX=8355 GN=tbx1-a PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0003700; GO:0005634; GO:0006357; GO:0045944; GO:0050793; GO:0060788; GO:0071300,cell fate specification [GO:0001708]; cellular response to retinoic acid [GO:0071300]; ectodermal placode formation [GO:0060788]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_03684,2.571235380101437,FUN_014944-T1,Peve_00037147,Pocillopora_meandrina_HIv1___RNAseq.g21100.t1,three_way,64.583,,,,,,,,,,,,,,,,,
OG_03685,2.30521918137341,FUN_014945-T1,Peve_00037135,Pocillopora_meandrina_HIv1___RNAseq.g21101.t1,three_way,68.88033333333333,FUN_014945-T1,Q6WBX8,RAD9B_HUMAN,,Cell cycle checkpoint control protein RAD9B (DNA repair exonuclease rad9 homolog B) (hRAD9B),Homo sapiens (Human),43.9,287.0,2.2e-65,251.5,sp|Q6WBX8|RAD9B_HUMAN Cell cycle checkpoint control protein RAD9B OS=Homo sapiens OX=9606 GN=RAD9B PE=1 SV=2,GO:0000076; GO:0005634; GO:0005654; GO:0006281; GO:0030896; GO:0031573; GO:0071479,cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573],checkpoint clamp complex [GO:0030896]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0006281; GO:0043226,nucleus; nucleoplasm; DNA repair; organelle
OG_03686,2.1826054829415704,FUN_014948-T1,Peve_00024855,Pocillopora_meandrina_HIv1___RNAseq.g21115.t1,three_way,80.74033333333334,FUN_014948-T1,Q04336,,,,,46.8,939.0,1.3999999999999998e-250,867.5,sp|Q04336|YM54_YEAST Uncharacterized protein YMR196W OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YMR196W PE=1 SV=1,,,,,,
OG_03687,2.228952353091929,FUN_014949-T1,Peve_00006235,Pocillopora_meandrina_HIv1___RNAseq.g21116.t1,three_way,79.29216666666667,FUN_014949-T1,Q9Y6J0,,,,,36.0,1819.0,9e-282,972.2,sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1,,,,,,
OG_03690,3.0213212690943307,FUN_014952-T1,Peve_00006246,Pocillopora_meandrina_HIv1___RNAseq.g21119.t1,three_way,65.61866666666666,,,,,,,,,,,,,,,,,
OG_03699,2.447473351979302,FUN_014970-T1,Peve_00006264,Pocillopora_meandrina_HIv1___RNAseq.g21133.t1,three_way,54.491166666666665,FUN_014970-T1,P18887,XRCC1_HUMAN,,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),Homo sapiens (Human),42.3,123.0,4.6e-20,100.9,sp|P18887|XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens OX=9606 GN=XRCC1 PE=1 SV=3,GO:0000012; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006302; GO:0006303; GO:0010836; GO:0019899; GO:0021766; GO:0032356; GO:0033194; GO:0061819; GO:0070522; GO:0072572; GO:0090734; GO:0160002; GO:1905051; GO:1905765; GO:1990599,base-excision repair [GO:0006284]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; regulation of base-excision repair [GO:1905051]; response to hydroperoxide [GO:0033194]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]",3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; poly-ADP-D-ribose binding [GO:0072572],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016787; GO:0032200; GO:0043226; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; hydrolase activity; telomere organization; organelle; anatomical structure development; catalytic activity, acting on DNA"
OG_03701,1.5062430181854118,FUN_014973-T1,Peve_00006266,Pocillopora_meandrina_HIv1___RNAseq.g21135.t1,three_way,47.29233333333333,,,,,,,,,,,,,,,,,
OG_03702,1.1729126769364824,FUN_014974-T1,Peve_00006267,Pocillopora_meandrina_HIv1___TS.g25888.t1,three_way,80.358,,,,,,,,,,,,,,,,,
OG_03703,2.4268820303349465,FUN_014975-T1,Peve_00024846,Pocillopora_meandrina_HIv1___RNAseq.g21114.t1,three_way,68.426,FUN_014975-T1,Q6DGR4,,,,,47.2,343.0,1.5e-86,321.2,sp|Q6DGR4|HGH1_DANRE Protein HGH1 homolog OS=Danio rerio OX=7955 GN=hgh1 PE=2 SV=1,,,,,,
OG_03705,1.8171669853550667,FUN_014978-T1,Peve_00024839,Pocillopora_meandrina_HIv1___RNAseq.g21140.t1,three_way,50.67916666666667,,,,,,,,,,,,,,,,,
OG_03706,1.4850214052108366,FUN_014979-T1,Peve_00024840,Pocillopora_meandrina_HIv1___RNAseq.g21139.t1,three_way,48.621833333333335,,,,,,,,,,,,,,,,,
OG_03710,1.9706781453583608,FUN_014984-T1,Peve_00039939,Pocillopora_meandrina_HIv1___RNAseq.g21146.t1,three_way,63.29966666666667,FUN_014984-T1,Q29RU9,SOX_BOVIN,,Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase),Bos taurus (Bovine),43.6,397.0,5.7e-87,322.8,sp|Q29RU9|SOX_BOVIN Peroxisomal sarcosine oxidase OS=Bos taurus OX=9913 GN=PIPOX PE=2 SV=2,GO:0005777; GO:0008115; GO:0033514; GO:0050031; GO:0050660,L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514],peroxisome [GO:0005777],flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115],GO:0003824; GO:0005777; GO:0006520; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; peroxisome; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03713,2.13892380875791,FUN_014987-T1,Peve_00039946,Pocillopora_meandrina_HIv1___RNAseq.g21150.t1,three_way,82.91666666666667,FUN_014987-T1,O14874,,,,,55.7,368.0,1.4e-109,397.9,sp|O14874|BCKD_HUMAN Branched-chain alpha-ketoacid dehydrogenase kinase OS=Homo sapiens OX=9606 GN=BCKDK PE=1 SV=2,,,,,,
OG_03717,2.271205925876491,FUN_014992-T1,Peve_00032856,Pocillopora_meandrina_HIv1___RNAseq.g21155.t1,three_way,77.725,FUN_014992-T1,O15254,ACOX3_HUMAN,,Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase),Homo sapiens (Human),52.3,692.0,5.3e-205,715.7,sp|O15254|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens OX=9606 GN=ACOX3 PE=1 SV=2,GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0071949,fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540],cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402],GO:0003824; GO:0005777; GO:0005829; GO:0006629; GO:0008289; GO:0016491; GO:0043226,catalytic activity; peroxisome; cytosol; lipid metabolic process; lipid binding; oxidoreductase activity; organelle
OG_03718,2.9896443170854727,FUN_014993-T1,Peve_00031667,Pocillopora_meandrina_HIv1___RNAseq.g21156.t1,three_way,73.09666666666666,FUN_014993-T1,P51659,DHB4_HUMAN,,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]",Homo sapiens (Human),53.7,751.0,2e-231,803.5,sp|P51659|DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens OX=9606 GN=HSD17B4 PE=1 SV=3,GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0004303; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0006636; GO:0008209; GO:0008210; GO:0016020; GO:0016853; GO:0018812; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042759; GO:0042803; GO:0044594; GO:0060009; GO:0106386; GO:1901570,alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid derivative biosynthetic process [GO:1901570]; long-chain fatty acid biosynthetic process [GO:0042759]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111],cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],"(3R)-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0005777; GO:0005829; GO:0006629; GO:0006790; GO:0016491; GO:0016829; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0055086,catalytic activity; peroxisome; cytosol; lipid metabolic process; sulfur compound metabolic process; oxidoreductase activity; lyase activity; isomerase activity; reproductive process; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_03719,2.9435361091057715,FUN_014995-T1,Peve_00010955,Pocillopora_meandrina_HIv1___RNAseq.g21158.t1,three_way,83.375,FUN_014995-T1,Q23979,MY61F_DROME,,Unconventional myosin IC (MyoIC) (Brush border myosin IB) (BBMIB) (Myosin-IB) (MIB) (Unconventional myosin 1C) (Myo1C),Drosophila melanogaster (Fruit fly),55.3,1014.0,0.0,1112.4,sp|Q23979|MY61F_DROME Unconventional myosin IC OS=Drosophila melanogaster OX=7227 GN=Myo61F PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030048; GO:0032528; GO:0042742; GO:0048803; GO:0051015,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; endocytosis [GO:0006897]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528],actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0003774; GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0016192; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; isomerase activity; reproductive process; organelle; anatomical structure development; ATP-dependent activity
OG_03720,1.271186981888905,FUN_015005-T1,Peve_00034681,Pocillopora_meandrina_HIv1___RNAseq.g21250.t1,three_way,83.25866666666667,FUN_015005-T1,P20132,SDHL_HUMAN,,L-serine dehydratase/L-threonine deaminase (SDH) (EC 4.3.1.17) (Hepatic serine dehydratase) (hSDH) (L-serine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19),Homo sapiens (Human),53.6,321.0,8.999999999999999e-94,345.1,sp|P20132|SDHL_HUMAN L-serine dehydratase/L-threonine deaminase OS=Homo sapiens OX=9606 GN=SDS PE=1 SV=2,GO:0003941; GO:0004794; GO:0005739; GO:0005829; GO:0006094; GO:0006565; GO:0006629; GO:0030170; GO:0042803; GO:0042866,gluconeogenesis [GO:0006094]; L-serine catabolic process [GO:0006565]; lipid metabolic process [GO:0006629]; pyruvate biosynthetic process [GO:0042866],cytosol [GO:0005829]; mitochondrion [GO:0005739],L-serine ammonia-lyase activity [GO:0003941]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; threonine deaminase activity [GO:0004794],GO:0003824; GO:0005739; GO:0005829; GO:0005975; GO:0006520; GO:0006629; GO:0016829; GO:0043226,catalytic activity; mitochondrion; cytosol; carbohydrate metabolic process; amino acid metabolic process; lipid metabolic process; lyase activity; organelle
OG_03723,1.19810299598822,FUN_015008-T1,Peve_00034684,Pocillopora_meandrina_HIv1___RNAseq.g21246.t1,three_way,93.515,FUN_015008-T1,Q08E38,PRP19_BOVIN,,Pre-mRNA-processing factor 19 (EC 2.3.2.27) (PRP19/PSO4 homolog) (RING-type E3 ubiquitin transferase PRP19),Bos taurus (Bovine),72.0,507.0,3.9e-186,652.5,sp|Q08E38|PRP19_BOVIN Pre-mRNA-processing factor 19 OS=Bos taurus OX=9913 GN=PRPF19 PE=2 SV=1,GO:0000077; GO:0000244; GO:0000245; GO:0000398; GO:0000974; GO:0001833; GO:0004842; GO:0005634; GO:0005662; GO:0005737; GO:0005811; GO:0005819; GO:0006303; GO:0008104; GO:0008610; GO:0010498; GO:0016607; GO:0034450; GO:0035861; GO:0042802; GO:0048026; GO:0061630; GO:0070534; GO:0071006; GO:0071007,"DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; protein localization [GO:0008104]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]",cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0005811; GO:0006281; GO:0006629; GO:0016071; GO:0016740; GO:0030163; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; lipid droplet; DNA repair; lipid metabolic process; mRNA metabolic process; transferase activity; protein catabolic process; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_03728,1.2442138243189425,FUN_015021-T2,Peve_00034691,Pocillopora_meandrina_HIv1___RNAseq.g21238.t1,three_way,93.31283333333334,FUN_015021-T2,Q8IVF4,DYH10_HUMAN,,Dynein axonemal heavy chain 10 (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10),Homo sapiens (Human),64.5,4571.0,0.0,5881.6,sp|Q8IVF4|DYH10_HUMAN Dynein axonemal heavy chain 10 OS=Homo sapiens OX=9606 GN=DNAH10 PE=1 SV=4,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_03733,1.8818431133565103,FUN_015026-T1,Peve_00004782,Pocillopora_meandrina_HIv1___RNAseq.g21178.t1,three_way,77.89583333333333,FUN_015026-T1,A4FU69,EFCB5_HUMAN,,EF-hand calcium-binding domain-containing protein 5,Homo sapiens (Human),28.9,1341.0,1.9e-133,478.8,sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3,GO:0005509,,,calcium ion binding [GO:0005509],,
OG_03739,1.2840131290214354,FUN_015043-T1,Peve_00031329,Pocillopora_meandrina_HIv1___RNAseq.g21254.t1,three_way,69.51966666666667,,,,,,,,,,,,,,,,,
OG_03740,2.017503341108429,FUN_015044-T1,Peve_00031330,Pocillopora_meandrina_HIv1___RNAseq.g21255.t1,three_way,47.4195,,,,,,,,,,,,,,,,,
OG_03741,1.387836522306317,FUN_015046-T1,Peve_00001162,Pocillopora_meandrina_HIv1___TS.g26014.t1,three_way,75.864,FUN_015046-T1,Q6GQ82,,,,,68.8,362.0,9.9e-136,484.6,sp|Q6GQ82|SNF5_XENLA SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 OS=Xenopus laevis OX=8355 GN=smarcb1 PE=2 SV=1,,,,,,
OG_03745,1.1964536879114824,FUN_015052-T1,Peve_00001164,Pocillopora_meandrina_HIv1___RNAseq.g21267.t1,three_way,66.9325,FUN_015052-T1,Q6DFQ2,,,,,33.2,340.0,5.7e-31,136.7,sp|Q6DFQ2|NCBP3_XENTR Nuclear cap-binding protein subunit 3 OS=Xenopus tropicalis OX=8364 GN=ncbp3 PE=2 SV=1,,,,,,
OG_03753,2.2886617396017024,FUN_015062-T1,Peve_00015751,Pocillopora_meandrina_HIv1___RNAseq.g21279.t1,three_way,81.46366666666667,FUN_015062-T1,Q9H773,DCTP1_HUMAN,,dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein),Homo sapiens (Human),58.9,141.0,2.9e-39,162.9,sp|Q9H773|DCTP1_HUMAN dCTP pyrophosphatase 1 OS=Homo sapiens OX=9606 GN=DCTPP1 PE=1 SV=1,GO:0000287; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840,dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03757,1.133160651615725,FUN_015066-T1,Peve_00022387,Pocillopora_meandrina_HIv1___RNAseq.g21283.t1,three_way,82.09666666666666,FUN_015066-T1,E1BY51,,,,,54.4,149.0,1.3999999999999999e-39,164.1,sp|E1BY51|TMM17_CHICK Transmembrane protein 17 OS=Gallus gallus OX=9031 GN=TMEM17 PE=3 SV=1,,,,,,
OG_03760,1.4379978131142452,FUN_015069-T1,Peve_00022383,Pocillopora_meandrina_HIv1___RNAseq.g21194.t1,three_way,77.7035,FUN_015069-T1,O96017,CHK2_HUMAN,,Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2),Homo sapiens (Human),52.3,442.0,1.4999999999999998e-127,458.0,sp|O96017|CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens OX=9606 GN=CHEK2 PE=1 SV=1,GO:0000077; GO:0000086; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0008630; GO:0016605; GO:0019901; GO:0030163; GO:0030330; GO:0031573; GO:0031625; GO:0033554; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0070242; GO:0071466; GO:0071480; GO:0090307; GO:0090399; GO:0106310; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210; GO:2000785,"cell division [GO:0051301]; cellular response to bisphenol A [GO:1903926]; cellular response to gamma radiation [GO:0071480]; cellular response to stress [GO:0033554]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of anoikis [GO:2000210]; positive regulation of DNA-templated transcription [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of autophagosome assembly [GO:2000785]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; thymocyte apoptotic process [GO:0070242]",cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0007010; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; Golgi apparatus; DNA repair; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03761,1.5570389285222843,FUN_015071-T1,Peve_00025600,Pocillopora_meandrina_HIv1___RNAseq.g21190.t1,three_way,51.34466666666667,,,,,,,,,,,,,,,,,
OG_03764,2.9418619979132727,FUN_015089-T1,Peve_00010705,Pocillopora_meandrina_HIv1___RNAseq.g21187.t1,three_way,72.56533333333334,FUN_015089-T1,Q71F56,MD13L_HUMAN,,Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like),Homo sapiens (Human),29.0,2382.0,7.899999999999999e-204,713.4,sp|Q71F56|MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens OX=9606 GN=MED13L PE=1 SV=1,GO:0003713; GO:0005654; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592]; nucleoplasm [GO:0005654],transcription coactivator activity [GO:0003713],GO:0005654; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_03765,3.775923098363926,FUN_015090-T1,Peve_00010706,Pocillopora_meandrina_HIv1___RNAseq.g21186.t1,three_way,63.61833333333333,FUN_015090-T1,Q8HZ69,,,,,41.6,505.0,3.8e-115,416.8,sp|Q8HZ69|FMO2_GORGO Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Gorilla gorilla gorilla OX=9595 GN=FMO2 PE=3 SV=3,,,,,,
OG_03767,2.400635104092055,FUN_015095-T1,Peve_00043821,Pocillopora_meandrina_HIv1___RNAseq.g22283.t1,three_way,81.09083333333334,FUN_015095-T1,Q8IZ69,TRM2A_HUMAN,,tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.35) (mRNA (uracil-5-)-methyltransferase TRMT2A) (EC 2.1.1.-),Homo sapiens (Human),40.3,618.0,9.4e-120,432.6,sp|Q8IZ69|TRM2A_HUMAN tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens OX=9606 GN=TRMT2A PE=1 SV=2,GO:0003723; GO:0005829; GO:0006397; GO:0008033; GO:0008169; GO:0030697; GO:0032259,methylation [GO:0032259]; mRNA processing [GO:0006397]; tRNA processing [GO:0008033],cytosol [GO:0005829],"C-methyltransferase activity [GO:0008169]; RNA binding [GO:0003723]; tRNA (uracil(54)-C5)-methyltransferase activity, S-adenosyl methionine-dependent [GO:0030697]",GO:0003723; GO:0003824; GO:0005829; GO:0006399; GO:0016071; GO:0016740; GO:0140098,"RNA binding; catalytic activity; cytosol; tRNA metabolic process; mRNA metabolic process; transferase activity; catalytic activity, acting on RNA"
OG_03768,1.5208051247245562,FUN_015096-T1,Peve_00043816,Pocillopora_meandrina_HIv1___RNAseq.g22282.t2,three_way,74.82266666666666,,,,,,,,,,,,,,,,,
OG_03769,1.760199508422272,FUN_015098-T1,Peve_00009747,Pocillopora_meandrina_HIv1___RNAseq.g22143.t1,three_way,73.82233333333333,FUN_015098-T1,Q8R2J9,RA51C_CRIGR,,DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2),Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),53.1,352.0,1e-99,365.2,sp|Q8R2J9|RA51C_CRIGR DNA repair protein RAD51 homolog 3 OS=Cricetulus griseus OX=10029 GN=RAD51C PE=2 SV=1,GO:0000400; GO:0000707; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0007062; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0048471; GO:0140664,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; sister chromatid cohesion [GO:0007062]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722],cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0065003; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; DNA repair; DNA recombination; hydrolase activity; reproductive process; telomere organization; organelle; protein-containing complex assembly; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_03772,3.218465631770381,FUN_015101-T1,Peve_00027022,Pocillopora_meandrina_HIv1___RNAseq.g22124.t1,three_way,62.69583333333333,FUN_015101-T1,P47708,RP3A_MOUSE,,Rabphilin-3A (Exophilin-1),Mus musculus (Mouse),37.0,683.0,1.8e-109,398.3,sp|P47708|RP3A_MOUSE Rabphilin-3A OS=Mus musculus OX=10090 GN=Rph3a PE=1 SV=2,GO:0005509; GO:0005544; GO:0005546; GO:0006886; GO:0008270; GO:0008430; GO:0016082; GO:0019898; GO:0030141; GO:0030672; GO:0031267; GO:0032991; GO:0042301; GO:0043005; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0061669; GO:0070679,intracellular protein transport [GO:0006886]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle priming [GO:0016082],dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0006886; GO:0008289; GO:0031410; GO:0043226; GO:0065003,intracellular protein transport; lipid binding; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_03773,2.414780299738279,FUN_015102-T1,Peve_00036873,Pocillopora_meandrina_HIv1___RNAseq.g22122.t1,three_way,57.66816666666666,,,,,,,,,,,,,,,,,
OG_03774,2.6527525625626818,FUN_015103-T1,Peve_00036870,Pocillopora_meandrina_HIv1___RNAseq.g22120.t1,three_way,72.14483333333332,FUN_015103-T1,Q9CWK3,,,,,38.8,343.0,6.8e-44,179.5,sp|Q9CWK3|CD2B2_MOUSE CD2 antigen cytoplasmic tail-binding protein 2 OS=Mus musculus OX=10090 GN=Cd2bp2 PE=1 SV=1,,,,,,
OG_03775,1.905192329214339,FUN_015104-T1,Peve_00036871,Pocillopora_meandrina_HIv1___RNAseq.g22119.t3,three_way,78.71466666666666,FUN_015104-T1,Q5ZKJ5,,,,,31.5,496.0,7.6e-55,216.5,sp|Q5ZKJ5|MF13A_CHICK Transmembrane protein 180 OS=Gallus gallus OX=9031 GN=MFSD13A PE=2 SV=1,,,,,,
OG_03781,2.424419047441494,FUN_015136-T1,Peve_00001089,Pocillopora_meandrina_HIv1___RNAseq.g21740.t1,three_way,78.34933333333333,FUN_015136-T1,A1L2R7,,,,,47.0,230.0,7.499999999999999e-53,208.8,sp|A1L2R7|TACAN_XENLA Transmembrane protein 120A OS=Xenopus laevis OX=8355 GN=tmem120a.L PE=2 SV=1,,,,,,
OG_03786,2.33459301132358,FUN_015146-T1,Peve_00001085,Pocillopora_meandrina_HIv1___TS.g26499.t3,three_way,47.95283333333333,,,,,,,,,,,,,,,,,
OG_03792,4.881363458218958,FUN_015158-T1,Peve_00001862,Pocillopora_meandrina_HIv1___RNAseq.g21765.t1,three_way,81.74516666666666,FUN_015158-T1,Q96DH6,,,,,47.2,335.0,2.3e-67,257.7,sp|Q96DH6|MSI2H_HUMAN RNA-binding protein Musashi homolog 2 OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=1,,,,,,
OG_03795,2.5085523087359247,FUN_015167-T1,Peve_00014588,Pocillopora_meandrina_HIv1___RNAseq.g21772.t1,three_way,74.31233333333333,,,,,,,,,,,,,,,,,
OG_03799,1.846467783973268,FUN_015179-T1,Peve_00001854,Pocillopora_meandrina_HIv1___RNAseq.g21786.t1,three_way,59.745333333333335,,,,,,,,,,,,,,,,,
OG_03800,1.737013479648066,FUN_015183-T1,Peve_00023878,Pocillopora_meandrina_HIv1___RNAseq.g22309.t1,three_way,61.66833333333334,FUN_015183-T1,Q86US8,EST1A_HUMAN,,Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a),Homo sapiens (Human),34.5,918.0,1.2999999999999999e-129,466.1,sp|Q86US8|EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens OX=9606 GN=SMG6 PE=1 SV=2,GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006406; GO:0032204; GO:0032210; GO:0035303; GO:0036064; GO:0042162; GO:0043021; GO:0046872; GO:0070034; GO:0070182; GO:1904354,"mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]","chromosome, telomeric region [GO:0000781]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; telomerase holoenzyme complex [GO:0005697]",DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0005815; GO:0005829; GO:0005886; GO:0006913; GO:0016071; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; nucleolus; microtubule organizing center; cytosol; plasma membrane; nucleocytoplasmic transport; mRNA metabolic process; organelle; catalytic activity, acting on RNA"
OG_03803,1.8988650616675424,FUN_015187-T1,Peve_00013021,Pocillopora_meandrina_HIv1___RNAseq.g22307.t1,three_way,65.45766666666667,FUN_015187-T1,O88845,AKA10_MOUSE,,"A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10)",Mus musculus (Mouse),33.2,596.0,9.3e-79,296.2,"sp|O88845|AKA10_MOUSE A-kinase anchor protein 10, mitochondrial OS=Mus musculus OX=10090 GN=Akap10 PE=1 SV=3",GO:0005739; GO:0005829; GO:0005886; GO:0008104; GO:0032991; GO:0051018,protein localization [GO:0008104],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],protein kinase A binding [GO:0051018],GO:0005739; GO:0005829; GO:0005886; GO:0043226,mitochondrion; cytosol; plasma membrane; organelle
OG_03811,1.0117925097342704,FUN_015220-T1,Peve_00013668,Pocillopora_meandrina_HIv1___RNAseq.g22190.t1,three_way,70.237,FUN_015220-T1,Q9CPV4,,,,,64.0,289.0,7.3e-108,391.7,sp|Q9CPV4|GLOD4_MOUSE Glyoxalase domain-containing protein 4 OS=Mus musculus OX=10090 GN=Glod4 PE=1 SV=1,,,,,,
OG_03812,2.9211893266093427,FUN_015222-T1,Peve_00013653,Pocillopora_meandrina_HIv1___RNAseq.g22187.t1,three_way,59.37533333333334,FUN_015222-T1,Q9UHJ6,SHPK_HUMAN,,Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein),Homo sapiens (Human),41.5,472.0,3.3e-94,347.1,sp|Q9UHJ6|SHPK_HUMAN Sedoheptulokinase OS=Homo sapiens OX=9606 GN=SHPK PE=1 SV=4,GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0016310; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353,"carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]",cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; sedoheptulokinase activity [GO:0050277],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03813,2.697464772348876,FUN_015223-T1,Peve_00013652,Pocillopora_meandrina_HIv1___RNAseq.g22186.t1,three_way,75.90233333333333,FUN_015223-T1,Q8K4C0,FMO5_RAT,,Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1),Rattus norvegicus (Rat),49.9,539.0,1.1999999999999998e-153,544.7,sp|Q8K4C0|FMO5_RAT Flavin-containing monooxygenase 5 OS=Rattus norvegicus OX=10116 GN=Fmo5 PE=1 SV=3,GO:0004031; GO:0004497; GO:0004499; GO:0005789; GO:0006629; GO:0006805; GO:0050660; GO:0050661; GO:0090181; GO:0106294,lipid metabolic process [GO:0006629]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"aldehyde oxidase activity [GO:0004031]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_03817,1.7466196753615428,FUN_015228-T1,Peve_00016435,Pocillopora_meandrina_HIv1___RNAseq.g22181.t1,three_way,74.00666666666666,FUN_015228-T1,Q8R216,SIR4_MOUSE,,"NAD-dependent protein lipoamidase sirtuin-4, mitochondrial (EC 2.3.1.-) (NAD-dependent ADP-ribosyltransferase sirtuin-4) (EC 2.4.2.-) (NAD-dependent protein biotinylase sirtuin-4) (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-4) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4)",Mus musculus (Mouse),59.6,280.0,1.5e-93,344.4,"sp|Q8R216|SIR4_MOUSE NAD-dependent protein lipoamidase sirtuin-4, mitochondrial OS=Mus musculus OX=10090 GN=Sirt4 PE=1 SV=3",GO:0000820; GO:0003950; GO:0005739; GO:0005743; GO:0005759; GO:0006541; GO:0006974; GO:0008270; GO:0010667; GO:0016779; GO:0034979; GO:0034983; GO:0046322; GO:0046676; GO:0046889; GO:0061690; GO:0070403; GO:0071456; GO:0072350; GO:0106419; GO:0106420; GO:0140803; GO:1903217; GO:1904182,cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; glutamine metabolic process [GO:0006541]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of pyruvate dehydrogenase activity [GO:1904182]; tricarboxylic acid metabolic process [GO:0072350],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],lipoamidase activity [GO:0061690]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD-dependent protein biotinidase activity [GO:0106420]; NAD-dependent protein lipoamidase activity [GO:0106419]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03818,2.4613621995556576,FUN_015229-T1,Peve_00016434,Pocillopora_meandrina_HIv1___RNAseq.g22180.t1,three_way,49.66866666666667,,,,,,,,,,,,,,,,,
OG_03819,2.180778126995186,FUN_015230-T1,Peve_00025468,Pocillopora_meandrina_HIv1___RNAseq.g22179.t1,three_way,80.00733333333334,FUN_015230-T1,A7RFA1,,,,,61.3,357.0,4.800000000000001e-130,465.7,sp|A7RFA1|PTER_NEMVE Phosphotriesterase-related protein OS=Nematostella vectensis OX=45351 GN=v1g177083 PE=3 SV=1,,,,,,
OG_03820,1.0936937384200105,FUN_015231-T1,Peve_00016438,Pocillopora_meandrina_HIv1___RNAseq.g22178.t1,three_way,73.793,FUN_015231-T1,Q9CWQ2,,,,,39.3,135.0,2.2e-23,110.2,sp|Q9CWQ2|ZSWM7_MOUSE Zinc finger SWIM domain-containing protein 7 OS=Mus musculus OX=10090 GN=Zswim7 PE=2 SV=1,,,,,,
OG_03822,2.191235407441076,FUN_015236-T2,Peve_00003466,Pocillopora_meandrina_HIv1___TS.g26934.t1,three_way,62.57566666666666,FUN_015236-T2,Q91X60,ACHA2_MOUSE,,Neuronal acetylcholine receptor subunit alpha-2,Mus musculus (Mouse),38.2,325.0,4.2999999999999997e-61,237.3,sp|Q91X60|ACHA2_MOUSE Neuronal acetylcholine receptor subunit alpha-2 OS=Mus musculus OX=10090 GN=Chrna2 PE=2 SV=1,GO:0005654; GO:0005892; GO:0015464; GO:0022848; GO:0034703; GO:0045171; GO:0045211; GO:0048167; GO:0050997; GO:0071316; GO:0071944; GO:0098828; GO:0098878; GO:0120111; GO:1901363; GO:1905144,cellular response to nicotine [GO:0071316]; modulation of inhibitory postsynaptic potential [GO:0098828]; regulation of synaptic plasticity [GO:0048167]; response to acetylcholine [GO:1905144],acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cell periphery [GO:0071944]; intercellular bridge [GO:0045171]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; postsynaptic membrane [GO:0045211],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0060089,transporter activity; nucleoplasm; molecular transducer activity
OG_03824,2.393745818098217,FUN_015239-T1,Peve_00003462,Pocillopora_meandrina_HIv1___RNAseq.g22171.t1,three_way,77.89233333333334,FUN_015239-T1,Q8CAM5,,,,,52.4,254.0,7.7e-72,271.9,sp|Q8CAM5|RAB36_MOUSE Ras-related protein Rab-36 OS=Mus musculus OX=10090 GN=Rab36 PE=1 SV=1,,,,,,
OG_03827,1.2535388490563486,FUN_015257-T1,Peve_00014297,Pocillopora_meandrina_HIv1___RNAseq.g22208.t1,three_way,54.744,,,,,,,,,,,,,,,,,
OG_03828,2.121351234955497,FUN_015258-T1,Peve_00014298,Pocillopora_meandrina_HIv1___RNAseq.g22209.t1,three_way,46.362,FUN_015258-T1,Q8BHE0,,,,,37.9,145.0,7e-15,83.2,sp|Q8BHE0|PRR11_MOUSE Proline-rich protein 11 OS=Mus musculus OX=10090 GN=Prr11 PE=2 SV=1,,,,,,
OG_03829,1.8008059526776083,FUN_015262-T1,Peve_00044772,Pocillopora_meandrina_HIv1___RNAseq.g22284.t1,three_way,66.1165,FUN_015262-T1,Q91XW8,FKBP6_MOUSE,,Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (36 kDa FKBP) (FKBP-36) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36),Mus musculus (Mouse),38.3,298.0,7e-52,206.5,sp|Q91XW8|FKBP6_MOUSE Inactive peptidyl-prolyl cis-trans isomerase FKBP6 OS=Mus musculus OX=10090 GN=Fkbp6 PE=1 SV=1,GO:0000795; GO:0001650; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0015630; GO:0030154; GO:0031047; GO:0034587; GO:0042802; GO:0045070; GO:0045171; GO:0051321; GO:0051879; GO:0141196,cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795],Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802],GO:0005654; GO:0005829; GO:0005856; GO:0006325; GO:0006457; GO:0022414; GO:0030154; GO:0031047; GO:0043226,nucleoplasm; cytosol; cytoskeleton; chromatin organization; protein folding; reproductive process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle
OG_03832,1.449048177572122,FUN_015272-T1,Peve_00044766,Pocillopora_meandrina_HIv1___TS.g26974.t1,three_way,61.09433333333334,FUN_015272-T1,Q5ZIA0,MET16_CHICK,,RNA N(6)-adenosine-methyltransferase METTL16 (EC 2.1.1.348) (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346),Gallus gallus (Chicken),47.3,389.0,1.9e-95,351.3,sp|Q5ZIA0|MET16_CHICK RNA N(6)-adenosine-methyltransferase METTL16 OS=Gallus gallus OX=9031 GN=METTL16 PE=2 SV=1,GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0061157; GO:0070475; GO:0120048; GO:0120049,"mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]",cytoplasm [GO:0005737]; nucleus [GO:0005634],mRNA m(6)A methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629],GO:0003723; GO:0003824; GO:0005634; GO:0006790; GO:0016071; GO:0016073; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; sulfur compound metabolic process; mRNA metabolic process; snRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_03834,2.686960799759587,FUN_015291-T1,Peve_00022865,Pocillopora_meandrina_HIv1___RNAseq.g22113.t1,three_way,61.755,FUN_015291-T1,O75771,RA51D_HUMAN,,DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD),Homo sapiens (Human),40.4,319.0,2.5e-56,220.7,sp|O75771|RA51D_HUMAN DNA repair protein RAD51 homolog 4 OS=Homo sapiens OX=9606 GN=RAD51D PE=1 SV=1,GO:0000722; GO:0000723; GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0005815; GO:0006281; GO:0007131; GO:0008094; GO:0016887; GO:0033063; GO:0036297; GO:0042148; GO:0043015; GO:0051726; GO:0140664,DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; reciprocal meiotic recombination [GO:0007131]; regulation of cell cycle [GO:0051726]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0006310; GO:0008092; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; DNA recombination; cytoskeletal protein binding; hydrolase activity; reproductive process; telomere organization; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_03836,2.207106379180753,FUN_015293-T1,Peve_00022868,Pocillopora_meandrina_HIv1___RNAseq.g22111.t2,three_way,70.97083333333333,FUN_015293-T1,Q08D69,,,,,31.1,892.0,3.4999999999999997e-113,411.0,sp|Q08D69|MED16_XENTR Mediator of RNA polymerase II transcription subunit 16 OS=Xenopus tropicalis OX=8364 GN=med16 PE=2 SV=1,,,,,,
OG_03838,1.0864476910556458,FUN_015297-T1,Peve_00004803,Pocillopora_meandrina_HIv1___RNAseq.g22107.t1,three_way,74.56266666666667,FUN_015297-T1,F1NZI4,,,,,39.2,683.0,1.8e-131,471.5,sp|F1NZI4|PGGHG_CHICK Protein-glucosylgalactosylhydroxylysine glucosidase OS=Gallus gallus OX=9031 GN=PGGHG PE=1 SV=3,,,,,,
OG_03839,1.621121367569039,FUN_015298-T1,Peve_00004801,Pocillopora_meandrina_HIv1___RNAseq.g22106.t1,three_way,63.3705,FUN_015298-T1,Q8QFX1,,,,,28.4,1242.0,2.3999999999999997e-83,313.2,sp|Q8QFX1|RIMB2_CHICK RIMS-binding protein 2 OS=Gallus gallus OX=9031 GN=RIMBP2 PE=1 SV=1,,,,,,
OG_03840,1.7741925004523489,FUN_015300-T1,Peve_00004800,Pocillopora_meandrina_HIv1___RNAseq.g22105.t1,three_way,84.87466666666667,FUN_015300-T1,Q9Y2S7,,,,,62.0,308.0,4.2e-107,389.4,sp|Q9Y2S7|PDIP2_HUMAN Polymerase delta-interacting protein 2 OS=Homo sapiens OX=9606 GN=POLDIP2 PE=1 SV=1,,,,,,
OG_03841,1.1703196747688862,FUN_015303-T1,Peve_00004798,Pocillopora_meandrina_HIv1___TS.g26862.t2,three_way,86.89800000000001,FUN_015303-T1,P42207,,,,,64.0,331.0,1.8e-122,440.7,sp|P42207|SEPT1_DROME Septin-1 OS=Drosophila melanogaster OX=7227 GN=Septin1 PE=1 SV=1,,,,,,
OG_03842,1.371780711265093,FUN_015304-T1,Peve_00004797,Pocillopora_meandrina_HIv1___RNAseq.g22098.t1,three_way,76.9795,FUN_015304-T1,Q174D3,,,,,51.8,114.0,2.2e-23,110.9,sp|Q174D3|MED19_AEDAE Mediator of RNA polymerase II transcription subunit 19 OS=Aedes aegypti OX=7159 GN=MED19 PE=3 SV=1,,,,,,
OG_03843,1.6419238918219226,FUN_015308-T1,Peve_00024022,Pocillopora_meandrina_HIv1___RNAseq.g21734.t1,three_way,74.93433333333334,FUN_015308-T1,Q9WU01,KHDR2_MOUSE,,"KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1) (SLM-1) (mSLM-1)",Mus musculus (Mouse),53.1,226.0,9.8e-56,218.8,"sp|Q9WU01|KHDR2_MOUSE KH domain-containing, RNA-binding, signal transduction-associated protein 2 OS=Mus musculus OX=10090 GN=Khdrbs2 PE=1 SV=1",GO:0005634; GO:0006397; GO:0008143; GO:0008266; GO:0017124; GO:0042169; GO:0048024,"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]",nucleus [GO:0005634],poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_03846,1.4882061097295856,FUN_015325-T1,Peve_00023983,Pocillopora_meandrina_HIv1___RNAseq.g21727.t1,three_way,67.91250000000001,FUN_015325-T1,Q9VKJ9,C2D1_DROME,,Coiled-coil and C2 domain-containing protein 1-like (Lethal (2) giant discs 1 protein),Drosophila melanogaster (Fruit fly),40.0,758.0,1e-103,379.8,sp|Q9VKJ9|C2D1_DROME Coiled-coil and C2 domain-containing protein 1-like OS=Drosophila melanogaster OX=7227 GN=l(2)gd1 PE=1 SV=1,GO:0000281; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006357; GO:0006886; GO:0007219; GO:0007423; GO:0007472; GO:0008586; GO:0010008; GO:0016197; GO:0016327; GO:0032509; GO:0045035; GO:0045746; GO:0048132; GO:0048749; GO:0098592; GO:1901981; GO:1905367,compound eye development [GO:0048749]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of intralumenal vesicle formation [GO:1905367]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472],apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidylinositol phosphate binding [GO:1901981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0000910; GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0006886; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0140110,cytokinesis; DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; transcription regulator activity
OG_03847,1.7201895913963343,FUN_015338-T2,Peve_00023985,Pocillopora_meandrina_HIv1___RNAseq.g21723.t1,three_way,71.78633333333333,FUN_015338-T2,Q5BJE1,CC178_HUMAN,,Coiled-coil domain-containing protein 178,Homo sapiens (Human),30.5,131.0,2.5e-09,66.2,sp|Q5BJE1|CC178_HUMAN Coiled-coil domain-containing protein 178 OS=Homo sapiens OX=9606 GN=CCDC178 PE=1 SV=3,GO:0036064,,ciliary basal body [GO:0036064],,GO:0005815,microtubule organizing center
OG_03853,1.0158277642483045,FUN_015345-T1,Peve_00011268,Pocillopora_meandrina_HIv1___RNAseq.g21720.t1,three_way,74.91566666666667,FUN_015345-T1,Q5M7F8,,,,,39.9,138.0,9.200000000000001e-22,105.1,sp|Q5M7F8|CM2CA_XENLA Ciliary microtubule inner protein 2C OS=Xenopus laevis OX=8355 GN=cimip2ca PE=2 SV=1,,,,,,
OG_03855,1.462221452938128,FUN_015347-T1,Peve_00017516,Pocillopora_meandrina_HIv1___RNAseq.g21714.t1,three_way,73.20033333333333,FUN_015347-T1,Q0VCH8,,,,,48.9,178.0,4e-42,172.9,sp|Q0VCH8|TMM65_BOVIN Transmembrane protein 65 OS=Bos taurus OX=9913 GN=TMEM65 PE=2 SV=1,,,,,,
OG_03856,1.5541311123577464,FUN_015349-T1,Peve_00017518,Pocillopora_meandrina_HIv1___RNAseq.g21711.t1,three_way,74.874,FUN_015349-T1,Q54TR1,CFAD_DICDI,,Counting factor associated protein D,Dictyostelium discoideum (Social amoeba),29.7,528.0,3.8000000000000003e-59,231.1,sp|Q54TR1|CFAD_DICDI Counting factor associated protein D OS=Dictyostelium discoideum OX=44689 GN=cfaD PE=1 SV=1,GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0031288; GO:0031410; GO:0072659; GO:0140986; GO:1903665; GO:2001235,G protein-coupled chemorepellent receptor signaling pathway [GO:0140986]; immune response [GO:0006955]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; sorocarp morphogenesis [GO:0031288],cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764],,GO:0002376; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0031410; GO:0043226; GO:0072659,immune system process; extracellular region; extracellular space; lysosome; vacuole; cytoplasmic vesicle; organelle; protein localization to plasma membrane
OG_03858,2.885719082404953,FUN_015352-T1,Peve_00017515,Pocillopora_meandrina_HIv1___RNAseq.g21698.t1,three_way,68.03,FUN_015352-T1,P07098,LIPF_HUMAN,,Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3),Homo sapiens (Human),53.2,370.0,9.900000000000001e-111,401.7,sp|P07098|LIPF_HUMAN Gastric triacylglycerol lipase OS=Homo sapiens OX=9606 GN=LIPF PE=1 SV=1,GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0006641; GO:0008289; GO:0016042; GO:0016615; GO:0043231,lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]; triglyceride metabolic process [GO:0006641],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; malate dehydrogenase activity [GO:0016615]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005576; GO:0005739; GO:0006629; GO:0008289; GO:0016491; GO:0016787; GO:0043226,catalytic activity; extracellular region; mitochondrion; lipid metabolic process; lipid binding; oxidoreductase activity; hydrolase activity; organelle
OG_03862,1.0367004434667748,FUN_015365-T1,Peve_00000208,Pocillopora_meandrina_HIv1___RNAseq.g21709.t1,three_way,84.68366666666667,FUN_015365-T1,P91119,PDE5_CAEEL,,"Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17)",Caenorhabditis elegans,44.3,774.0,3.4e-175,617.1,"sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3",GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0019933; GO:0032528; GO:0042542; GO:0046872; GO:0047555,cAMP-mediated signaling [GO:0019933]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542],,"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]",GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_03864,4.299046950819517,FUN_015372-T1,Peve_00000220,Pocillopora_meandrina_HIv1___RNAseq.g21694.t1,three_way,63.956,FUN_015372-T1,Q9H6I2,SOX17_HUMAN,,Transcription factor SOX-17,Homo sapiens (Human),47.8,178.0,6.5e-29,129.8,sp|Q9H6I2|SOX17_HUMAN Transcription factor SOX-17 OS=Homo sapiens OX=9606 GN=SOX17 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001570; GO:0001656; GO:0001706; GO:0001714; GO:0001828; GO:0001947; GO:0003142; GO:0003143; GO:0003151; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007283; GO:0007493; GO:0007507; GO:0008013; GO:0010467; GO:0010628; GO:0016055; GO:0021903; GO:0023019; GO:0030308; GO:0031648; GO:0035050; GO:0042074; GO:0043279; GO:0045732; GO:0045893; GO:0045944; GO:0045995; GO:0048617; GO:0048866; GO:0050821; GO:0060214; GO:0060913; GO:0060914; GO:0060956; GO:0061009; GO:0061010; GO:0061031; GO:0061629; GO:0072091; GO:0072189; GO:0090090; GO:1903226; GO:1990830; GO:2000035; GO:2000043; GO:2000738,angiogenesis [GO:0001525]; cardiac cell fate determination [GO:0060913]; cardiogenic plate morphogenesis [GO:0003142]; cell migration involved in gastrulation [GO:0042074]; cellular response to leukemia inhibitory factor [GO:1990830]; common bile duct development [GO:0061009]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cell differentiation [GO:0060956]; endocardium formation [GO:0060214]; endoderm formation [GO:0001706]; endodermal cell fate determination [GO:0007493]; endodermal cell fate specification [GO:0001714]; endodermal digestive tract morphogenesis [GO:0061031]; gallbladder development [GO:0061010]; gene expression [GO:0010467]; heart development [GO:0007507]; heart formation [GO:0060914]; heart looping [GO:0001947]; inner cell mass cellular morphogenesis [GO:0001828]; metanephros development [GO:0001656]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; outflow tract morphogenesis [GO:0003151]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of cardiac cell fate specification [GO:2000043]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of stem cell division [GO:2000035]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; rostrocaudal neural tube patterning [GO:0021903]; signal transduction involved in regulation of gene expression [GO:0023019]; spermatogenesis [GO:0007283]; stem cell fate specification [GO:0048866]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_03865,2.3071161505367,FUN_015373-T1,Peve_00000221,Pocillopora_meandrina_HIv1___RNAseq.g10184.t1,three_way,76.64383333333333,FUN_015373-T1,Q01320,TOP2A_MOUSE,,"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)",Mus musculus (Mouse),67.5,1208.0,0.0,1654.4,sp|Q01320|TOP2A_MOUSE DNA topoisomerase 2-alpha OS=Mus musculus OX=10090 GN=Top2a PE=1 SV=2,GO:0000228; GO:0000287; GO:0000775; GO:0000793; GO:0001673; GO:0002244; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006265; GO:0006325; GO:0006974; GO:0007059; GO:0007143; GO:0008301; GO:0009330; GO:0030261; GO:0030263; GO:0040016; GO:0042752; GO:0042803; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:0051309; GO:1990904,apoptotic chromosome condensation [GO:0030263]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511],"centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; male germ cell nucleus [GO:0001673]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]","ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; ubiquitin binding [GO:0043130]",GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006355; GO:0007059; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140097; GO:0140657,"nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; isomerase activity; reproductive process; cell differentiation; organelle; meiotic nuclear division; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03867,1.2023668907729432,FUN_015377-T1,Peve_00000222,Pocillopora_meandrina_HIv1___RNAseq.g21693.t1,three_way,79.768,FUN_015377-T1,Q32LJ2,ARFRP_BOVIN,,ADP-ribosylation factor-related protein 1 (ARF-related protein 1),Bos taurus (Bovine),58.2,201.0,7.3e-67,255.0,sp|Q32LJ2|ARFRP_BOVIN ADP-ribosylation factor-related protein 1 OS=Bos taurus OX=9913 GN=ARFRP1 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0034067; GO:0043001,Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067],Golgi apparatus [GO:0005794],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005794; GO:0006886; GO:0016192; GO:0016787; GO:0043226; GO:0072659,catalytic activity; GTPase activity; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; hydrolase activity; organelle; protein localization to plasma membrane
OG_03870,1.5969365987806337,FUN_015388-T1,Peve_00006063,Pocillopora_meandrina_HIv1___RNAseq.g21662.t1,three_way,81.37566666666667,FUN_015388-T1,Q5ZKT8,,,,,48.2,228.0,1.1e-50,201.4,sp|Q5ZKT8|RM15_CHICK Large ribosomal subunit protein uL15m OS=Gallus gallus OX=9031 GN=MRPL15 PE=2 SV=1,,,,,,
OG_03871,1.0981938074145243,FUN_015401-T1,Peve_00006062,Pocillopora_meandrina_HIv1___TS.g26410.t1,three_way,59.00933333333333,FUN_015401-T1,Q02363,ID2_HUMAN,,DNA-binding protein inhibitor ID-2 (Class B basic helix-loop-helix protein 26) (bHLHb26) (Inhibitor of DNA binding 2) (Inhibitor of differentiation 2),Homo sapiens (Human),50.0,72.0,3.5e-14,79.3,sp|Q02363|ID2_HUMAN DNA-binding protein inhibitor ID-2 OS=Homo sapiens OX=9606 GN=ID2 PE=1 SV=1,GO:0000122; GO:0000791; GO:0001656; GO:0001779; GO:0001966; GO:0003149; GO:0003166; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007507; GO:0007623; GO:0008344; GO:0010628; GO:0010629; GO:0014003; GO:0019216; GO:0021772; GO:0030182; GO:0030183; GO:0032922; GO:0032991; GO:0033598; GO:0042752; GO:0043153; GO:0043353; GO:0043433; GO:0044325; GO:0045475; GO:0045578; GO:0045600; GO:0045648; GO:0045651; GO:0045664; GO:0045668; GO:0045777; GO:0045892; GO:0045893; GO:0046983; GO:0048469; GO:0048541; GO:0048557; GO:0048661; GO:0048663; GO:0048667; GO:0048708; GO:0048711; GO:0048715; GO:0050872; GO:0051148; GO:0060612; GO:0060749; GO:0061030; GO:0061031; GO:0061629; GO:0071285; GO:0071542; GO:0090398; GO:0140416; GO:1904339; GO:2000045; GO:2000177,adipose tissue development [GO:0060612]; adult locomotory behavior [GO:0008344]; astrocyte differentiation [GO:0048708]; B cell differentiation [GO:0030183]; bundle of His development [GO:0003166]; cell maturation [GO:0048469]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to lithium ion [GO:0071285]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dopaminergic neuron differentiation [GO:0071542]; embryonic digestive tract morphogenesis [GO:0048557]; endodermal digestive tract morphogenesis [GO:0061031]; entrainment of circadian clock by photoperiod [GO:0043153]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; heart development [GO:0007507]; locomotor rhythm [GO:0045475]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; membranous septum morphogenesis [GO:0003149]; metanephros development [GO:0001656]; natural killer cell differentiation [GO:0001779]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; olfactory bulb development [GO:0021772]; oligodendrocyte development [GO:0014003]; Peyer's patch development [GO:0048541]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of blood pressure [GO:0045777]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of circadian rhythm [GO:0042752]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lipid metabolic process [GO:0019216]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; thigmotaxis [GO:0001966]; white fat cell differentiation [GO:0050872],cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],protein dimerization activity [GO:0046983]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140110,immune system process; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_03872,1.0148160772269974,FUN_015402-T1,Peve_00006057,Pocillopora_meandrina_HIv1___TS.g26409.t1,three_way,53.396,FUN_015402-T1,P61593,,,,,27.6,821.0,6.4e-45,184.1,sp|P61593|MCPH1_PANTR Microcephalin OS=Pan troglodytes OX=9598 GN=MCPH1 PE=3 SV=1,,,,,,
OG_03874,2.730353381720384,FUN_015405-T1,Peve_00000200,Pocillopora_meandrina_HIv1___RNAseq.g21681.t1,three_way,86.47533333333334,FUN_015405-T1,Q26619,,,,,47.3,383.0,1.5e-89,331.3,sp|Q26619|KAPR_STRPU cAMP-dependent protein kinase type II regulatory subunit OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_03877,2.1282691417057267,FUN_015410-T1,Peve_00026944,Pocillopora_meandrina_HIv1___TS.g26425.t1,three_way,75.58566666666667,,,,,,,,,,,,,,,,,
OG_03878,2.6858280512082997,FUN_015411-T1,Peve_00026943,Pocillopora_meandrina_HIv1___RNAseq.g21674.t1,three_way,92.28733333333334,FUN_015411-T1,Q7ZVM1,WASC5_DANRE,,WASH complex subunit 5 (WASH complex subunit strumpellin),Danio rerio (Zebrafish) (Brachydanio rerio),67.2,1161.0,0.0,1580.8,sp|Q7ZVM1|WASC5_DANRE WASH complex subunit 5 OS=Danio rerio OX=7955 GN=washc5 PE=2 SV=1,GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0048738; GO:0051125; GO:0060047; GO:0071203; GO:0140285; GO:1905304,actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; cardiac muscle tissue development [GO:0048738]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of cardiac myofibril assembly [GO:1905304],early endosome [GO:0005769]; endosome [GO:0005768]; WASH complex [GO:0071203],,GO:0003013; GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0065003,circulatory system process; endosome; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly
OG_03881,1.7421226297840822,FUN_015423-T1,Peve_00011818,Pocillopora_meandrina_HIv1___RNAseq.g21657.t1,three_way,82.22166666666666,FUN_015423-T1,Q5E9X1,,,,,78.6,140.0,3.3000000000000004e-57,223.8,sp|Q5E9X1|NFYC_BOVIN Nuclear transcription factor Y subunit gamma OS=Bos taurus OX=9913 GN=NFYC PE=2 SV=1,,,,,,
OG_03884,1.8903592724877265,FUN_015429-T1,Peve_00033649,Pocillopora_meandrina_HIv1___RNAseq.g22262.t1,three_way,84.209,FUN_015429-T1,Q5ZI89,,,,,48.9,1121.0,0.0,1077.0,sp|Q5ZI89|TPC11_CHICK Trafficking protein particle complex subunit 11 OS=Gallus gallus OX=9031 GN=TRAPPC11 PE=2 SV=1,,,,,,
OG_03889,1.3190199501842728,FUN_015442-T1,Peve_00024428,Pocillopora_meandrina_HIv1___RNAseq.g22272.t2,three_way,80.65666666666667,FUN_015442-T1,Q7KZ85,SPT6H_HUMAN,,Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),Homo sapiens (Human),55.5,1411.0,0.0,1521.5,sp|Q7KZ85|SPT6H_HUMAN Transcription elongation factor SPT6 OS=Homo sapiens OX=9606 GN=SUPT6H PE=1 SV=2,GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0031491; GO:0034728; GO:0042393; GO:0045191; GO:0051028; GO:0051147; GO:0140673,blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; regulation of isotype switching [GO:0045191]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673],nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023],DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005654; GO:0006325; GO:0016071; GO:0042393,DNA binding; RNA binding; nucleoplasm; chromatin organization; mRNA metabolic process; histone binding
OG_03891,2.055197821224993,FUN_015445-T1,Peve_00013658,Pocillopora_meandrina_HIv1___TS.g26948.t2,three_way,62.11333333333334,FUN_015445-T1,O75140,DEPD5_HUMAN,,GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5),Homo sapiens (Human),33.7,1699.0,4.9e-238,826.6,sp|O75140|DEPD5_HUMAN GATOR1 complex protein DEPDC5 OS=Homo sapiens OX=9606 GN=DEPDC5 PE=1 SV=2,GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0031267; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130,cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508],cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267],GO:0005764; GO:0005773; GO:0005829; GO:0043226; GO:0098772,lysosome; vacuole; cytosol; organelle; molecular function regulator activity
OG_03893,1.7616219106112203,FUN_015448-T1,Peve_00013022,Pocillopora_meandrina_HIv1___RNAseq.g22266.t1,three_way,60.5595,FUN_015448-T1,Q08E13,RNF10_BOVIN,,E3 ubiquitin-protein ligase RNF10 (EC 2.3.2.27) (RING finger protein 10),Bos taurus (Bovine),39.1,791.0,5.5e-107,390.2,sp|Q08E13|RNF10_BOVIN E3 ubiquitin-protein ligase RNF10 OS=Bos taurus OX=9913 GN=RNF10 PE=2 SV=1,GO:0000976; GO:0005634; GO:0005737; GO:0006513; GO:0008270; GO:0031643; GO:0045944; GO:0061630; GO:1990116,positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein monoubiquitination [GO:0006513]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytoplasm [GO:0005737]; nucleus [GO:0005634],transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03896,2.3301818163029826,FUN_015474-T1,Peve_00009512,Pocillopora_meandrina_HIv1___TS.g26531.t2,three_way,73.673,FUN_015474-T1,Q14CX7,NAA25_HUMAN,,"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)",Homo sapiens (Human),36.3,980.0,6.4000000000000005e-161,569.7,"sp|Q14CX7|NAA25_HUMAN N-alpha-acetyltransferase 25, NatB auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA25 PE=1 SV=1",GO:0005737; GO:0005794; GO:0005829; GO:0007010; GO:0010698; GO:0031416,cytoskeleton organization [GO:0007010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416],acetyltransferase activator activity [GO:0010698],GO:0005794; GO:0005829; GO:0007010; GO:0043226; GO:0098772,Golgi apparatus; cytosol; cytoskeleton organization; organelle; molecular function regulator activity
OG_03897,1.6767270230470088,FUN_015475-T1,Peve_00009511,Pocillopora_meandrina_HIv1___RNAseq.g16116.t1,three_way,69.93583333333333,FUN_015475-T1,Q9CPR1,,,,,47.8,186.0,5.4e-37,155.6,sp|Q9CPR1|RWDD4_MOUSE RWD domain-containing protein 4 OS=Mus musculus OX=10090 GN=Rwdd4 PE=2 SV=1,,,,,,
OG_03898,1.3814981858307058,FUN_015476-T1,Peve_00040441,Pocillopora_meandrina_HIv1___RNAseq.g18726.t1,three_way,63.078333333333326,,,,,,,,,,,,,,,,,
OG_03899,1.968090655389913,FUN_015485-T1,Peve_00009508,Pocillopora_meandrina_HIv1___TS.g25731.t1,three_way,66.67466666666667,FUN_015485-T1,Q9EP89,LACTB_MOUSE,,"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)",Mus musculus (Mouse),44.9,432.0,2.1e-105,384.0,"sp|Q9EP89|LACTB_MOUSE Serine beta-lactamase-like protein LACTB, mitochondrial OS=Mus musculus OX=10090 GN=Lactb PE=1 SV=1",GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802,lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216],cytosol [GO:0005829]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; peptidase activity [GO:0008233],GO:0003824; GO:0005739; GO:0005829; GO:0006629; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; cytosol; lipid metabolic process; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03903,2.9518832539214603,FUN_015977-T1,Peve_00032728,Pocillopora_meandrina_HIv1___RNAseq.g21409.t1,three_way,72.505,,,,,,,,,,,,,,,,,
OG_03907,2.242412029214708,FUN_015983-T2,Peve_00024011,Pocillopora_meandrina_HIv1___RNAseq.g21403.t1,three_way,53.04383333333333,FUN_015983-T2,Q99575,POP1_HUMAN,,Ribonucleases P/MRP protein subunit POP1 (hPOP1),Homo sapiens (Human),29.6,1024.0,4.0000000000000003e-104,380.9,sp|Q99575|POP1_HUMAN Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens OX=9606 GN=POP1 PE=1 SV=2,GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005615; GO:0005654; GO:0005655; GO:0005730; GO:0008033; GO:0016078; GO:0030681; GO:0033204,tRNA 5'-leader removal [GO:0001682]; tRNA decay [GO:0016078]; tRNA processing [GO:0008033],extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172],ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005615; GO:0005654; GO:0005730; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; extracellular space; nucleoplasm; nucleolus; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03908,1.634213696266663,FUN_015984-T1,Peve_00024010,Pocillopora_meandrina_HIv1___RNAseq.g21402.t1,three_way,68.71833333333333,FUN_015984-T1,Q9WTL7,LYPA2_MOUSE,,Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase 2) (Lysophospholipase II) (LPL-II) (LysoPLA II) (mLyso II) (Palmitoyl-protein hydrolase) (EC 3.1.2.22),Mus musculus (Mouse),52.0,229.0,5.7e-64,245.7,sp|Q9WTL7|LYPA2_MOUSE Acyl-protein thioesterase 2 OS=Mus musculus OX=10090 GN=Lypla2 PE=1 SV=1,GO:0002084; GO:0004622; GO:0005654; GO:0005737; GO:0005795; GO:0005829; GO:0006631; GO:0008474; GO:0046464; GO:1905344,acylglycerol catabolic process [GO:0046464]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleoplasm [GO:0005654],lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474],GO:0003824; GO:0005654; GO:0005829; GO:0006629; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; nucleoplasm; cytosol; lipid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03909,3.8837233981108494,FUN_015985-T1,Peve_00024008,Pocillopora_meandrina_HIv1___RNAseq.g21401.t1,three_way,57.967666666666666,,,,,,,,,,,,,,,,,
OG_03911,5.827105816923303,FUN_015990-T1,Peve_00023998,Pocillopora_meandrina_HIv1___RNAseq.g21387.t1,three_way,69.50233333333334,FUN_015990-T1,Q5BIM1,,,,,25.3,490.0,3.2e-30,135.2,sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1,,,,,,
OG_03912,1.0403005694138845,FUN_015993-T1,Peve_00023996,Pocillopora_meandrina_HIv1___RNAseq.g21382.t1,three_way,74.39133333333334,FUN_015993-T1,Q08AE8,SPIR1_HUMAN,,Protein spire homolog 1 (Spir-1),Homo sapiens (Human),29.2,627.0,3.7000000000000004e-48,194.5,sp|Q08AE8|SPIR1_HUMAN Protein spire homolog 1 OS=Homo sapiens OX=9606 GN=SPIRE1 PE=1 SV=3,GO:0003779; GO:0005654; GO:0005741; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0008017; GO:0015031; GO:0016192; GO:0030036; GO:0030659; GO:0036089; GO:0040038; GO:0045010; GO:0045087; GO:0046907; GO:0048193; GO:0048471; GO:0051295; GO:0051639; GO:0070649; GO:0090141; GO:2000781,actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; innate immune response [GO:0045087]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],actin binding [GO:0003779]; microtubule binding [GO:0008017],GO:0000910; GO:0002376; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016192; GO:0022414; GO:0043226; GO:0061024; GO:0098542,cytokinesis; immune system process; nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; reproductive process; organelle; membrane organization; defense response to other organism
OG_03916,1.5416315424528018,FUN_016002-T1,Peve_00004542,Pocillopora_meandrina_HIv1___RNAseq.g21371.t1,three_way,80.09833333333333,FUN_016002-T1,Q9D7A8,,,,,43.2,273.0,7.999999999999999e-53,208.8,sp|Q9D7A8|ARMC1_MOUSE Armadillo repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Armc1 PE=1 SV=1,,,,,,
OG_03918,1.1883633725064335,FUN_016014-T1,Peve_00004540,Pocillopora_meandrina_HIv1___RNAseq.g21369.t1,three_way,67.8095,FUN_016014-T1,B2RX88,CSPP1_MOUSE,,Centrosome and spindle pole associated protein 1,Mus musculus (Mouse),29.2,1240.0,2.1e-09,66.6,sp|B2RX88|CSPP1_MOUSE Centrosome and spindle pole associated protein 1 OS=Mus musculus OX=10090 GN=Cspp1 PE=1 SV=2,GO:0000922; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0005929; GO:0032467; GO:0034451; GO:0036064; GO:0051781,positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922],,GO:0005654; GO:0005815; GO:0005929; GO:0043226,nucleoplasm; microtubule organizing center; cilium; organelle
OG_03927,1.2353350864868131,FUN_016042-T1,Peve_00011805,Pocillopora_meandrina_HIv1___RNAseq.g21646.t1,three_way,79.87966666666667,FUN_016042-T1,A2VDP2,PCMD1_BOVIN,,Protein-L-isoaspartate O-methyltransferase domain-containing protein 1,Bos taurus (Bovine),58.8,255.0,6.599999999999997e-82,305.4,sp|A2VDP2|PCMD1_BOVIN Protein-L-isoaspartate O-methyltransferase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PCMTD1 PE=2 SV=1,GO:0004719; GO:0005737; GO:0016020; GO:0016567; GO:0031466; GO:1990756,protein ubiquitination [GO:0016567],Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; membrane [GO:0016020],protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0003824; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_03928,3.360435464964989,FUN_016043-T1,Peve_00011803,Pocillopora_meandrina_HIv1___RNAseq.g21644.t1,three_way,70.11666666666666,,,,,,,,,,,,,,,,,
OG_03929,2.0377423020050025,FUN_016044-T1,Peve_00011802,Pocillopora_meandrina_HIv1___RNAseq.g21643.t1,three_way,75.492,,,,,,,,,,,,,,,,,
OG_03930,1.4315194687615065,FUN_016045-T2,Peve_00011796,Pocillopora_meandrina_HIv1___RNAseq.g21638.t1,three_way,82.58033333333333,FUN_016045-T2,Q9V6X7,OFUT1_DROME,,GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1),Drosophila melanogaster (Fruit fly),46.1,380.0,1.5e-94,347.8,sp|Q9V6X7|OFUT1_DROME GDP-fucose protein O-fucosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=O-fut1 PE=1 SV=1,GO:0005112; GO:0005788; GO:0006004; GO:0007219; GO:0036066; GO:0045165; GO:0045747; GO:0045807; GO:0046922,cell fate commitment [GO:0045165]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066],endoplasmic reticulum lumen [GO:0005788],Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922],GO:0003824; GO:0005975; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03942,1.406426125659656,FUN_016077-T1,Peve_00021922,Pocillopora_meandrina_HIv1___RNAseq.g21615.t1,three_way,81.17833333333333,FUN_016077-T1,Q9V3D2,,,,,63.3,349.0,6.9e-134,478.4,sp|Q9V3D2|HEM6_DROME Oxygen-dependent coproporphyrinogen-III oxidase OS=Drosophila melanogaster OX=7227 GN=Coprox PE=2 SV=1,,,,,,
OG_03944,1.8966710219541068,FUN_016081-T1,Peve_00021927,Pocillopora_meandrina_HIv1___RNAseq.g21612.t1,three_way,72.43566666666666,,,,,,,,,,,,,,,,,
OG_03945,1.916654444733361,FUN_016082-T1,Peve_00021929,Pocillopora_meandrina_HIv1___RNAseq.g21611.t1,three_way,89.665,FUN_016082-T1,Q8CCB4,,,,,60.6,830.0,1.8000000000000002e-273,943.3,sp|Q8CCB4|VPS53_MOUSE Vacuolar protein sorting-associated protein 53 homolog OS=Mus musculus OX=10090 GN=Vps53 PE=1 SV=1,,,,,,
OG_03950,1.642463967701133,FUN_016089-T1,Peve_00013364,Pocillopora_meandrina_HIv1___RNAseq.g21562.t1,three_way,69.75566666666667,FUN_016089-T1,Q4V9Y5,,,,,40.3,201.0,9.1e-34,146.4,sp|Q4V9Y5|CRLD2_XENTR Cysteine-rich secretory protein LCCL domain-containing 2 OS=Xenopus tropicalis OX=8364 GN=crispld2 PE=2 SV=1,,,,,,
OG_03951,1.7998655663569405,FUN_016090-T1,Peve_00013365,Pocillopora_meandrina_HIv1___RNAseq.g21564.t1,three_way,74.69583333333334,FUN_016090-T1,Q9UDW3,ZMAT5_HUMAN,,Zinc finger matrin-type protein 5 (U11/U12 small nuclear ribonucleoprotein 20 kDa protein) (U11/U12 snRNP 20 kDa protein) (U11/U12-20K),Homo sapiens (Human),42.0,174.0,1.4e-31,137.5,sp|Q9UDW3|ZMAT5_HUMAN Zinc finger matrin-type protein 5 OS=Homo sapiens OX=9606 GN=ZMAT5 PE=1 SV=1,GO:0005654; GO:0005689; GO:0006397; GO:0008270; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689],zinc ion binding [GO:0008270],GO:0005654; GO:0016071,nucleoplasm; mRNA metabolic process
OG_03952,1.494626515929803,FUN_016091-T1,Peve_00013366,Pocillopora_meandrina_HIv1___RNAseq.g21574.t1,three_way,91.33766666666666,FUN_016091-T1,P63085,MK01_MOUSE,,Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2),Mus musculus (Mouse),85.7,349.0,1.0999999999999996e-177,624.0,sp|P63085|MK01_MOUSE Mitogen-activated protein kinase 1 OS=Mus musculus OX=10090 GN=Mapk1 PE=1 SV=3,GO:0000165; GO:0001784; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006351; GO:0006915; GO:0006974; GO:0007173; GO:0007507; GO:0008286; GO:0008353; GO:0009887; GO:0010759; GO:0014032; GO:0014044; GO:0016301; GO:0018105; GO:0018107; GO:0019858; GO:0019902; GO:0030278; GO:0030521; GO:0030641; GO:0030878; GO:0031143; GO:0031647; GO:0031663; GO:0032206; GO:0032496; GO:0032872; GO:0033598; GO:0034198; GO:0035094; GO:0036064; GO:0038133; GO:0042473; GO:0042552; GO:0042802; GO:0043330; GO:0045542; GO:0045596; GO:0048009; GO:0048538; GO:0050847; GO:0050852; GO:0050853; GO:0051090; GO:0051403; GO:0051493; GO:0060020; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0061514; GO:0070371; GO:0070849; GO:0071356; GO:0072584; GO:0072686; GO:0090170; GO:0106310; GO:0120041; GO:2000641,androgen receptor signaling pathway [GO:0030521]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cellular response to amino acid starvation [GO:0034198]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; DNA damage response [GO:0006974]; DNA-templated transcription [GO:0006351]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-34-mediated signaling pathway [GO:0061514]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; myelination [GO:0042552]; negative regulation of cell differentiation [GO:0045596]; neural crest cell development [GO:0014032]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of telomere maintenance [GO:0032206]; progesterone receptor signaling pathway [GO:0050847]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; Schwann cell development [GO:0014044]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440],caveola [GO:0005901]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005768; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0012501; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0055086; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; mitochondrion; endosome; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein"
OG_03953,2.1637029755191057,FUN_016093-T1,Peve_00018223,Pocillopora_meandrina_HIv1___RNAseq.g21576.t1,three_way,55.824333333333335,,,,,,,,,,,,,,,,,
OG_03955,1.579494597474136,FUN_016100-T1,Peve_00010771,Pocillopora_meandrina_HIv1___RNAseq.g21590.t1,three_way,83.7185,FUN_016100-T1,Q13948,,,,,48.2,676.0,4.2e-151,536.6,sp|Q13948|CASP_HUMAN Protein CASP OS=Homo sapiens OX=9606 GN=CUX1 PE=1 SV=2,,,,,,
OG_03960,1.1156885558082406,FUN_016106-T1,Peve_00010760,Pocillopora_meandrina_HIv1___TS.g26345.t1,three_way,78.27083333333333,FUN_016106-T1,P07314,GGT1_RAT,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Rattus norvegicus (Rat),45.9,536.0,3.6e-125,450.3,sp|P07314|GGT1_RAT Glutathione hydrolase 1 proenzyme OS=Rattus norvegicus OX=10116 GN=Ggt1 PE=1 SV=4,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982],aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_03961,2.31803541519023,FUN_016109-T1,Peve_00013354,Pocillopora_meandrina_HIv1___RNAseq.g21558.t1,three_way,89.81033333333333,FUN_016109-T1,O43709,,,,,62.1,282.0,2.9e-98,359.8,sp|O43709|BUD23_HUMAN 18S rRNA (guanine-N(7))-methyltransferase OS=Homo sapiens OX=9606 GN=BUD23 PE=1 SV=2,,,,,,
OG_03966,2.093139819786802,FUN_016115-T1,Peve_00013352,Pocillopora_meandrina_HIv1___RNAseq.g21556.t1,three_way,63.22466666666667,FUN_016115-T1,Q9H9H4,VP37B_HUMAN,,Vacuolar protein sorting-associated protein 37B (hVps37B) (ESCRT-I complex subunit VPS37B),Homo sapiens (Human),36.6,82.0,2.4e-06,53.1,sp|Q9H9H4|VP37B_HUMAN Vacuolar protein sorting-associated protein 37B OS=Homo sapiens OX=9606 GN=VPS37B PE=1 SV=1,GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0019076; GO:0030496; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043328; GO:0048306; GO:0070062; GO:0090148; GO:1903774,macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306],GO:0005768; GO:0005886; GO:0006886; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; plasma membrane; intracellular protein transport; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_03967,1.6350516602807146,FUN_016116-T1,Peve_00013351,Pocillopora_meandrina_HIv1___TS.g26292.t1a,three_way,59.283,FUN_016116-T1,Q01097,NMDE2_MOUSE,,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B)",Mus musculus (Mouse),22.8,689.0,2.1e-31,139.0,"sp|Q01097|NMDE2_MOUSE Glutamate receptor ionotropic, NMDA 2B OS=Mus musculus OX=10090 GN=Grin2b PE=1 SV=3",GO:0001662; GO:0001701; GO:0001964; GO:0001967; GO:0004972; GO:0005261; GO:0005262; GO:0005764; GO:0005770; GO:0005789; GO:0005856; GO:0005886; GO:0006812; GO:0006816; GO:0007268; GO:0007423; GO:0007611; GO:0007612; GO:0007613; GO:0008021; GO:0008270; GO:0009986; GO:0014069; GO:0016020; GO:0016595; GO:0017146; GO:0022849; GO:0030425; GO:0030658; GO:0035235; GO:0042596; GO:0042734; GO:0043005; GO:0045202; GO:0045211; GO:0045471; GO:0048167; GO:0048168; GO:0048266; GO:0050966; GO:0051290; GO:0051968; GO:0060078; GO:0060079; GO:0060291; GO:0097060; GO:0097553; GO:0098655; GO:0098794; GO:0098839; GO:0098978; GO:0141161; GO:1902951; GO:1904062; GO:2000463,"behavioral fear response [GO:0001662]; behavioral response to pain [GO:0048266]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; excitatory postsynaptic potential [GO:0060079]; fear response [GO:0042596]; in utero embryonic development [GO:0001701]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; negative regulation of dendritic spine maintenance [GO:1902951]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein heterotetramerization [GO:0051290]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; sensory organ development [GO:0007423]; startle response [GO:0001964]; suckling behavior [GO:0001967]",cell surface [GO:0009986]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; transport vesicle membrane [GO:0030658],calcium channel activity [GO:0005262]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; zinc ion binding [GO:0008270],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005856; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0060089; GO:0065003,transporter activity; lysosome; endosome; vacuole; cytoskeleton; plasma membrane; signaling; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly
OG_03968,1.189014810746614,FUN_016122-T1,Peve_00013455,Pocillopora_meandrina_HIv1___RNAseq.g21534.t1,three_way,49.625,,,,,,,,,,,,,,,,,
OG_03969,2.538325845066137,FUN_016123-T1,Peve_00013454,Pocillopora_meandrina_HIv1___RNAseq.g21533.t1,three_way,88.006,FUN_016123-T1,Q9YHZ6,,,,,47.3,566.0,1.3e-150,534.6,sp|Q9YHZ6|CDC45_XENLA Cell division control protein 45 homolog OS=Xenopus laevis OX=8355 GN=cdc45 PE=1 SV=2,,,,,,
OG_03970,1.248510441438813,FUN_016124-T1,Peve_00013453,Pocillopora_meandrina_HIv1___RNAseq.g21251.t1a,three_way,41.071333333333335,FUN_016124-T1,Q60774,,,,,30.0,273.0,3.3e-23,110.5,sp|Q60774|TM45A_MOUSE Transmembrane protein 45A OS=Mus musculus OX=10090 GN=Tmem45a PE=2 SV=1,,,,,,
OG_03978,2.7921187548012805,FUN_016132-T1,Peve_00022580,Pocillopora_meandrina_HIv1___RNAseq.g22029.t1,three_way,56.699000000000005,FUN_016132-T1,Q8N4B1,SESQ1_HUMAN,,Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase-interacting protein A) (IPIP27A) (PH domain-containing endocytic trafficking adaptor 1),Homo sapiens (Human),45.7,127.0,1.2000000000000001e-30,135.6,sp|Q8N4B1|SESQ1_HUMAN Sesquipedalian-1 OS=Homo sapiens OX=9606 GN=PHETA1 PE=1 SV=1,GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037,"endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],protein homodimerization activity [GO:0042803],GO:0005768; GO:0005829; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_03979,1.4992783809111747,FUN_016137-T1,Peve_00022581,Pocillopora_meandrina_HIv1___RNAseq.g22030.t1,three_way,83.41883333333334,FUN_016137-T1,Q810B6,ANFY1_MOUSE,,Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif),Mus musculus (Mouse),49.1,1329.0,3.3e-253,876.7,sp|Q810B6|ANFY1_MOUSE Rabankyrin-5 OS=Mus musculus OX=10090 GN=Ankfy1 PE=1 SV=2,GO:0005769; GO:0005829; GO:0006897; GO:0008270; GO:0010008; GO:0030904; GO:0031267; GO:0034058; GO:0042147; GO:0044354; GO:0048549; GO:0090160; GO:1901981,"endocytosis [GO:0006897]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; macropinosome [GO:0044354]; retromer complex [GO:0030904],phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0005768; GO:0005829; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; cytosol; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_03982,3.1300270007792745,FUN_016141-T1,Peve_00013437,Pocillopora_meandrina_HIv1___TS.g26796.t1c,three_way,79.88266666666667,FUN_016141-T1,O14578,,,,,35.7,1950.0,1.8999999999999999e-239,831.6,sp|O14578|CTRO_HUMAN Citron Rho-interacting kinase OS=Homo sapiens OX=9606 GN=CIT PE=1 SV=2,,,,,,
OG_03983,1.7345491396080237,FUN_016148-T1,Peve_00013425,Pocillopora_meandrina_HIv1___RNAseq.g22092.t1,three_way,82.95133333333334,FUN_016148-T1,P79987,HIRA_CHICK,,Protein HIRA (cHIRA) (TUP1-like enhancer of split protein 1),Gallus gallus (Chicken),44.1,1049.0,7.2e-216,752.3,sp|P79987|HIRA_CHICK Protein HIRA OS=Gallus gallus OX=9031 GN=HIRA PE=1 SV=2,GO:0000417; GO:0000785; GO:0005634; GO:0006338; GO:0006351; GO:0006355,chromatin remodeling [GO:0006338]; DNA-templated transcription [GO:0006351]; regulation of DNA-templated transcription [GO:0006355],chromatin [GO:0000785]; HIR complex [GO:0000417]; nucleus [GO:0005634],,GO:0005634; GO:0006325; GO:0006351; GO:0006355; GO:0043226,nucleus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; organelle
OG_03985,2.388079869258067,FUN_016150-T1,Peve_00013422,Pocillopora_meandrina_HIv1___RNAseq.g22094.t1,three_way,87.48066666666666,,,,,,,,,,,,,,,,,
OG_03988,3.791730262554478,FUN_016154-T1,Peve_00004478,Pocillopora_meandrina_HIv1___RNAseq.g21231.t1,three_way,69.62266666666667,,,,,,,,,,,,,,,,,
OG_03989,2.274223651675049,FUN_016156-T1,Peve_00022567,Pocillopora_meandrina_HIv1___RNAseq.g21232.t1,three_way,67.495,FUN_016156-T1,Q6GQN8,MECR_DANRE,,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial (EC 1.3.1.104) (2-enoyl thioester reductase)",Danio rerio (Zebrafish) (Brachydanio rerio),47.7,130.0,7.1e-31,134.8,"sp|Q6GQN8|MECR_DANRE Enoyl-[acyl-carrier-protein] reductase, mitochondrial OS=Danio rerio OX=7955 GN=mecr PE=2 SV=2",GO:0005739; GO:0006631; GO:0006633; GO:0141148,fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631],mitochondrion [GO:0005739],enoyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0141148],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle
OG_03991,3.443597457800351,FUN_016163-T1,Peve_00022617,Pocillopora_meandrina_HIv1___RNAseq.g21016.t1,three_way,65.033,FUN_016163-T1,Q9ULI0,ATD2B_HUMAN,,ATPase family AAA domain-containing protein 2B,Homo sapiens (Human),42.8,1254.0,1.0999999999999999e-249,865.1,sp|Q9ULI0|ATD2B_HUMAN ATPase family AAA domain-containing protein 2B OS=Homo sapiens OX=9606 GN=ATAD2B PE=1 SV=4,GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0016887; GO:0042393; GO:0045815; GO:0070577,nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; transcription initiation-coupled chromatin remodeling [GO:0045815],nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577],GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016787; GO:0042393; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; chromatin organization; hydrolase activity; histone binding; organelle; protein-containing complex assembly
OG_03992,1.106943928208393,FUN_016166-T1,Peve_00022615,Pocillopora_meandrina_HIv1___RNAseq.g21019.t1,three_way,80.89733333333334,FUN_016166-T1,Q8AY73,,,,,60.6,968.0,0.0,1147.1,sp|Q8AY73|XPO2_ORENI Exportin-2 OS=Oreochromis niloticus OX=8128 GN=cse1l PE=2 SV=1,,,,,,
OG_03994,1.5088756600780695,FUN_016262-T1,Peve_00019444,Pocillopora_meandrina_HIv1___RNAseq.g11083.t1,three_way,70.785,,,,,,,,,,,,,,,,,
OG_03996,2.355163403546947,FUN_016280-T2,Peve_00003392,Pocillopora_meandrina_HIv1___RNAseq.g403.t1,three_way,76.21483333333333,FUN_016280-T2,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),42.5,742.0,6.9e-166,585.9,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04000,1.504656247298829,FUN_016294-T1,Peve_00001309,Pocillopora_meandrina_HIv1___RNAseq.g23519.t1b,three_way,61.464,,,,,,,,,,,,,,,,,
OG_04004,1.0924790244333644,FUN_016302-T1,Peve_00032295,Pocillopora_meandrina_HIv1___RNAseq.g10043.t1,three_way,79.83366666666666,FUN_016302-T1,Q9UIU6,,,,,70.9,179.0,4.1e-71,269.6,sp|Q9UIU6|SIX4_HUMAN Homeobox protein SIX4 OS=Homo sapiens OX=9606 GN=SIX4 PE=1 SV=2,,,,,,
OG_04006,4.29699189977808,FUN_016305-T1,Peve_00032293,Pocillopora_meandrina_HIv1___RNAseq.g10040.t1,three_way,94.53566666666669,FUN_016305-T1,Q6NZ04,SIX1B_DANRE,,Homeobox protein six1b (Homeobox protein six1a) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,285.0,6.9e-92,338.6,sp|Q6NZ04|SIX1B_DANRE Homeobox protein six1b OS=Danio rerio OX=7955 GN=six1b PE=1 SV=1,GO:0000978; GO:0000981; GO:0002074; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0014857; GO:0021984; GO:0043282; GO:0048741; GO:0048839; GO:0048935; GO:0051146,adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; chordate pharyngeal muscle development [GO:0043282]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; peripheral nervous system neuron development [GO:0048935]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146],cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04013,1.117844945512596,FUN_016316-T1,Peve_00024694,Pocillopora_meandrina_HIv1___RNAseq.g9705.t1,three_way,71.514,FUN_016316-T1,Q80UJ7,RB3GP_MOUSE,,Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP),Mus musculus (Mouse),43.6,1103.0,1.8e-239,830.9,sp|Q80UJ7|RB3GP_MOUSE Rab3 GTPase-activating protein catalytic subunit OS=Mus musculus OX=10090 GN=Rab3gap1 PE=1 SV=4,GO:0005085; GO:0005096; GO:0005737; GO:0005801; GO:0010628; GO:0010807; GO:0031267; GO:0032483; GO:0032991; GO:0034389; GO:0043547; GO:0048172; GO:0048489; GO:0050821; GO:0060079; GO:0061646; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786,establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; protein stabilization [GO:0050821]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of Rab protein signal transduction [GO:0032483]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle transport [GO:0048489],cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; endoplasmic reticulum tubular network [GO:0071782]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0043226; GO:0098772,organelle; molecular function regulator activity
OG_04016,2.002650759776886,FUN_016320-T1,Peve_00000581,Pocillopora_meandrina_HIv1___RNAseq.g9711.t1,three_way,50.35866666666666,FUN_016320-T1,E7F6T8,UBP37_DANRE,,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),Danio rerio (Zebrafish) (Brachydanio rerio),36.6,361.0,7e-47,191.0,sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1,GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0021551; GO:0031647; GO:0035871; GO:0051301; GO:0071108; GO:1904888,cell division [GO:0051301]; central nervous system morphogenesis [GO:0021551]; cranial skeletal system development [GO:1904888]; G1/S transition of mitotic cell cycle [GO:0000082]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04016,2.002650759776886,FUN_016320-T1,Peve_00000581,Pocillopora_meandrina_HIv1___RNAseq.g9711.t1,three_way,50.35866666666666,FUN_016320-T1,E7F6T8,UBP37_DANRE,,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),Danio rerio (Zebrafish) (Brachydanio rerio),47.1,70.0,3e-13,79.3,sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1,GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0021551; GO:0031647; GO:0035871; GO:0051301; GO:0071108; GO:1904888,cell division [GO:0051301]; central nervous system morphogenesis [GO:0021551]; cranial skeletal system development [GO:1904888]; G1/S transition of mitotic cell cycle [GO:0000082]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04019,1.6552190864839067,FUN_016324-T1,Peve_00009565,Pocillopora_meandrina_HIv1___TS.g23223.t1,three_way,71.28433333333334,,,,,,,,,,,,,,,,,
OG_04020,1.3263770917004103,FUN_016325-T1,Peve_00032381,Pocillopora_meandrina_HIv1___RNAseq.g9684.t1,three_way,69.31866666666667,,,,,,,,,,,,,,,,,
OG_04023,1.206309364940889,FUN_016329-T1,Peve_00032382,Pocillopora_meandrina_HIv1___RNAseq.g9858.t1b,three_way,87.74166666666666,FUN_016329-T1,Q96EZ8,MCRS1_HUMAN,,Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2),Homo sapiens (Human),53.9,410.0,8.7e-113,408.7,sp|Q96EZ8|MCRS1_HUMAN Microspherule protein 1 OS=Homo sapiens OX=9606 GN=MCRS1 PE=1 SV=1,GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0008266; GO:0010521; GO:0016604; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0036211; GO:0043204; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051726; GO:0060382; GO:0071339; GO:1904357; GO:1904507; GO:1904751,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204],G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226; GO:0098772,RNA binding; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle; molecular function regulator activity
OG_04024,2.4263129761718827,FUN_016330-T1,Peve_00032370,Pocillopora_meandrina_HIv1___RNAseq.g9857.t2,three_way,82.74833333333333,FUN_016330-T1,Q9NRC6,SPTN5_HUMAN,,"Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)",Homo sapiens (Human),28.1,3578.0,0.0,1392.1,"sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2",GO:0002046; GO:0003779; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007030; GO:0007041; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030054; GO:0030507; GO:0030864; GO:0032029; GO:0032391; GO:0034452; GO:0042802; GO:0042995; GO:0045179; GO:0045505; GO:0051015; GO:0051693; GO:0097381,actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041],apical cortex [GO:0045179]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; spectrin [GO:0008091],actin binding [GO:0003779]; actin filament binding [GO:0051015]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; opsin binding [GO:0002046]; spectrin binding [GO:0030507],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_04025,1.704397810007895,FUN_016332-T1,Peve_00044544,Pocillopora_meandrina_HIv1___RNAseq.g9841.t1,three_way,43.75183333333334,,,,,,,,,,,,,,,,,
OG_04029,2.161034079407804,FUN_016337-T1,Peve_00044566,Pocillopora_meandrina_HIv1___RNAseq.g9732.t1,three_way,81.75833333333334,,,,,,,,,,,,,,,,,
OG_04030,1.1741407686201486,FUN_016338-T1,Peve_00044573,Pocillopora_meandrina_HIv1___RNAseq.g9726.t1,three_way,78.57166666666667,FUN_016338-T1,Q6NWF4,,,,,59.3,177.0,7.1e-61,235.0,sp|Q6NWF4|VPS25_DANRE Vacuolar protein-sorting-associated protein 25 OS=Danio rerio OX=7955 GN=vps25 PE=2 SV=2,,,,,,
OG_04035,1.9459147242276904,FUN_016343-T1,Peve_00044581,Pocillopora_meandrina_HIv1___RNAseq.g9724.t1,three_way,79.218,FUN_016343-T1,Q28DS0,,,,,49.7,342.0,5.4e-94,345.9,sp|Q28DS0|SAE1_XENTR SUMO-activating enzyme subunit 1 OS=Xenopus tropicalis OX=8364 GN=sae1 PE=2 SV=1,,,,,,
OG_04036,1.7963618203213825,FUN_016344-T1,Peve_00004330,Pocillopora_meandrina_HIv1___RNAseq.g9849.t1,three_way,55.79433333333333,FUN_016344-T1,Q28GL6,,,,,30.6,281.0,2.7e-14,80.9,sp|Q28GL6|S7A6O_XENTR Probable RNA polymerase II nuclear localization protein SLC7A6OS OS=Xenopus tropicalis OX=8364 GN=slc7a6os PE=2 SV=1,,,,,,
OG_04037,1.8112482147722773,FUN_016345-T1,Peve_00004334,Pocillopora_meandrina_HIv1___TS.g23380.t1,three_way,66.87283333333333,FUN_016345-T1,P63252,KCNJ2_HUMAN,,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",Homo sapiens (Human),42.7,328.0,8.2e-70,265.8,sp|P63252|KCNJ2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens OX=9606 GN=KCNJ2 PE=1 SV=1,GO:0005242; GO:0005546; GO:0005886; GO:0006813; GO:0008076; GO:0014704; GO:0014861; GO:0015693; GO:0016020; GO:0030007; GO:0030315; GO:0034765; GO:0042802; GO:0043025; GO:0043197; GO:0045211; GO:0051289; GO:0055119; GO:0060075; GO:0060306; GO:0071260; GO:0071805; GO:0086002; GO:0086004; GO:0086008; GO:0086011; GO:0086012; GO:0086013; GO:0086091; GO:0090076; GO:0098978; GO:1901381; GO:1990573,cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to mechanical stimulus [GO:0071260]; intracellular potassium ion homeostasis [GO:0030007]; magnesium ion transport [GO:0015693]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076],dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076],"identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]",GO:0003012; GO:0005215; GO:0005886; GO:0008289; GO:0055085; GO:0065003,muscle system process; transporter activity; plasma membrane; lipid binding; transmembrane transport; protein-containing complex assembly
OG_04038,2.677637803030074,FUN_016346-T2,Peve_00004339,Pocillopora_meandrina_HIv1___TS.g23215.t1,three_way,85.454,FUN_016346-T2,Q6NW96,SP9_DANRE,,Transcription factor Sp9,Danio rerio (Zebrafish) (Brachydanio rerio),39.6,341.0,1.2999999999999998e-43,178.7,sp|Q6NW96|SP9_DANRE Transcription factor Sp9 OS=Danio rerio OX=7955 GN=sp9 PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0030326; GO:0035118; GO:0045743,embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04039,3.080291482617411,FUN_016347-T1,Peve_00004355,Pocillopora_meandrina_HIv1___RNAseq.g9679.t1,three_way,82.813,FUN_016347-T1,Q9JHX2,,,,,31.5,321.0,1.9e-18,95.1,sp|Q9JHX2|SP5_MOUSE Transcription factor Sp5 OS=Mus musculus OX=10090 GN=Sp5 PE=2 SV=1,,,,,,
OG_04041,4.052989233817085,FUN_016350-T1,Peve_00004331,Pocillopora_meandrina_HIv1___RNAseq.16312_t,three_way,70.639,FUN_016350-T1,Q90WR8,SP3_CHICK,,Transcription factor Sp3,Gallus gallus (Chicken),48.7,117.0,7.9e-20,100.1,sp|Q90WR8|SP3_CHICK Transcription factor Sp3 OS=Gallus gallus OX=9031 GN=SP3 PE=1 SV=1,GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001779; GO:0001889; GO:0002318; GO:0003682; GO:0005829; GO:0006357; GO:0008270; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0043353; GO:0045944; GO:0048596; GO:0048706; GO:0060216; GO:0061629,B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; myeloid progenitor cell differentiation [GO:0002318]; natural killer cell differentiation [GO:0001779]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217],cytosol [GO:0005829]; PML body [GO:0016605]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04042,1.8569503658107072,FUN_016351-T1,Peve_00004332,Pocillopora_meandrina_HIv1___RNAseq.g9676.t1,three_way,80.54966666666667,FUN_016351-T1,Q6ZMI0,PPR21_HUMAN,,Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (Ferry endosomal RAB5 effector complex subunit 2) (Fy-2) (KLRAQ motif-containing protein 1),Homo sapiens (Human),40.8,787.0,5.8e-136,486.5,sp|Q6ZMI0|PPR21_HUMAN Protein phosphatase 1 regulatory subunit 21 OS=Homo sapiens OX=9606 GN=PPP1R21 PE=1 SV=1,GO:0003723; GO:0005769; GO:0016020,,early endosome [GO:0005769]; membrane [GO:0016020],RNA binding [GO:0003723],GO:0003723; GO:0005768; GO:0031410; GO:0043226,RNA binding; endosome; cytoplasmic vesicle; organelle
OG_04043,2.294324458643836,FUN_016352-T1,Peve_00004333,Pocillopora_meandrina_HIv1___RNAseq.g9675.t1,three_way,65.38916666666667,FUN_016352-T1,Q8CI75,DI3L2_MOUSE,,DIS3-like exonuclease 2 (EC 3.1.13.-),Mus musculus (Mouse),48.3,818.0,3.1e-212,740.7,sp|Q8CI75|DI3L2_MOUSE DIS3-like exonuclease 2 OS=Mus musculus OX=10090 GN=Dis3l2 PE=1 SV=1,GO:0000175; GO:0000278; GO:0000287; GO:0000932; GO:0000956; GO:0004540; GO:0005737; GO:0005829; GO:0008266; GO:0008285; GO:0010587; GO:0019827; GO:0051301; GO:0051306; GO:1990074,cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process [GO:0000956]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827],cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932],3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; RNA nuclease activity [GO:0004540],GO:0000278; GO:0003723; GO:0003824; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"mitotic cell cycle; RNA binding; catalytic activity; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_04047,1.0882795481231426,FUN_016361-T1,Peve_00004340,Pocillopora_meandrina_HIv1___RNAseq.g9671.t1,three_way,68.96966666666667,FUN_016361-T1,P56962,STX17_HUMAN,,Syntaxin-17,Homo sapiens (Human),33.8,272.0,8.5e-27,122.5,sp|P56962|STX17_HUMAN Syntaxin-17 OS=Homo sapiens OX=9606 GN=STX17 PE=1 SV=2,GO:0000149; GO:0000421; GO:0005484; GO:0005739; GO:0005776; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006888; GO:0006906; GO:0007030; GO:0012505; GO:0012507; GO:0016240; GO:0019901; GO:0019903; GO:0030134; GO:0030868; GO:0031201; GO:0033116; GO:0034497; GO:0044233; GO:0048278; GO:0061909; GO:0097111; GO:0097352; GO:0120281,autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; autophagosome-lysosome fusion [GO:0061909]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to phagophore assembly site [GO:0034497]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],autolysosome membrane [GO:0120281]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; SNARE complex [GO:0031201],protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],GO:0005739; GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090; GO:0061024,mitochondrion; vacuole; cytosol; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization
OG_04049,1.867241550102133,FUN_016365-T1,Peve_00004342,Pocillopora_meandrina_HIv1___RNAseq.g9605.t1,three_way,60.6625,FUN_016365-T1,Q58D84,,,,,40.3,72.0,1.4e-09,67.0,sp|Q58D84|FSTL1_BOVIN Follistatin-related protein 1 OS=Bos taurus OX=9913 GN=FSTL1 PE=2 SV=1,,,,,,
OG_04050,2.4243742543753246,FUN_016368-T2,Peve_00004346,Pocillopora_meandrina_HIv1___RNAseq.g9681.t1,three_way,71.802,FUN_016368-T2,Q8NEV4,MYO3A_HUMAN,,Myosin-IIIa (EC 2.7.11.1),Homo sapiens (Human),49.4,1096.0,9.1e-305,1048.1,sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2,GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310,cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003774; GO:0003824; GO:0008092; GO:0016740; GO:0016787; GO:0016853; GO:0050877; GO:0140096; GO:0140657,"cytoskeletal motor activity; catalytic activity; cytoskeletal protein binding; transferase activity; hydrolase activity; isomerase activity; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_04052,2.197658217731677,FUN_016371-T1,Peve_00022927,Pocillopora_meandrina_HIv1___RNAseq.g9747.t1,three_way,64.89166666666667,FUN_016371-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),56.4,133.0,4.6e-27,123.2,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04053,2.1397260941085787,FUN_016372-T1,Peve_00022926,Pocillopora_meandrina_HIv1___RNAseq.g9746.t1,three_way,60.034666666666666,FUN_016372-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,181.0,1.5e-16,88.2,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04054,2.581689821141442,FUN_016373-T1,Peve_00022923,Pocillopora_meandrina_HIv1___RNAseq.g9745.t1,three_way,73.565,FUN_016373-T1,P42587,,,,,58.7,75.0,4.2e-17,89.7,sp|P42587|HNK2_XENLA Homeobox protein XENK-2 OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_04055,2.2543419602215278,FUN_016374-T1,Peve_00022922,Pocillopora_meandrina_HIv1___RNAseq.g9744.t1,three_way,74.13233333333334,FUN_016374-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,207.0,5.3e-32,139.4,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04056,1.8747433273099567,FUN_016375-T1,Peve_00022921,Pocillopora_meandrina_HIv1___RNAseq.16382_t,three_way,83.09666666666666,FUN_016375-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),65.5,87.0,8.3e-25,115.5,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04057,1.345054767855983,FUN_016377-T1,Peve_00022920,Pocillopora_meandrina_HIv1___RNAseq.g9741.t1,three_way,46.54933333333334,FUN_016377-T1,Q03372,HMSH_DROME,,Muscle segmentation homeobox (Protein drop) (Protein msh),Drosophila melanogaster (Fruit fly),36.9,111.0,7e-08,59.3,sp|Q03372|HMSH_DROME Muscle segmentation homeobox OS=Drosophila melanogaster OX=7227 GN=Dr PE=1 SV=2,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007389; GO:0007398; GO:0007400; GO:0007417; GO:0007419; GO:0007420; GO:0007450; GO:0007476; GO:0007485; GO:0007517; GO:0009953; GO:0010629; GO:0021782; GO:0035222; GO:0035309; GO:0042659; GO:0043565; GO:0048598,"brain development [GO:0007420]; central nervous system development [GO:0007417]; dorsal/ventral pattern formation [GO:0009953]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic morphogenesis [GO:0048598]; glial cell development [GO:0021782]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing morphogenesis [GO:0007476]; muscle organ development [GO:0007517]; negative regulation of gene expression [GO:0010629]; neuroblast fate determination [GO:0007400]; pattern specification process [GO:0007389]; regulation of cell fate specification [GO:0042659]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; wing and notum subfield formation [GO:0035309]; wing disc pattern formation [GO:0035222]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04059,1.833163695982828,FUN_016379-T1,Peve_00022918,Pocillopora_meandrina_HIv1___RNAseq.g9739.t1,three_way,48.443333333333335,FUN_016379-T1,P02836,HMEN_DROME,,Segmentation polarity homeobox protein engrailed,Drosophila melanogaster (Fruit fly),42.7,96.0,4.6e-09,63.2,sp|P02836|HMEN_DROME Segmentation polarity homeobox protein engrailed OS=Drosophila melanogaster OX=7227 GN=en PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007367; GO:0007386; GO:0007388; GO:0007400; GO:0007411; GO:0007418; GO:0007472; GO:0007474; GO:0007487; GO:0008406; GO:0010468; GO:0010629; GO:0035215; GO:0035224; GO:0035277; GO:0035288; GO:0035289; GO:0035290; GO:0043524; GO:0043565; GO:0045944; GO:0048099; GO:0048100,"analia development [GO:0007487]; anterior head segmentation [GO:0035288]; anterior/posterior lineage restriction, imaginal disc [GO:0048099]; axon guidance [GO:0007411]; compartment pattern specification [GO:0007386]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc development [GO:0035215]; gonad development [GO:0008406]; imaginal disc-derived wing vein specification [GO:0007474]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior compartment specification [GO:0007388]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; trunk segmentation [GO:0035290]; ventral midline development [GO:0007418]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04061,1.845208946305088,FUN_016381-T1,Peve_00022915,Pocillopora_meandrina_HIv1___RNAseq.g9749.t1,three_way,68.01166666666667,,,,,,,,,,,,,,,,,
OG_04062,2.9625951846879586,FUN_016382-T1,Peve_00022906,Pocillopora_meandrina_HIv1___RNAseq.g9735.t1,three_way,83.83333333333333,FUN_016382-T1,Q3MHX1,,,,,50.0,200.0,4.0000000000000005e-49,196.1,sp|Q3MHX1|COMD7_BOVIN COMM domain-containing protein 7 OS=Bos taurus OX=9913 GN=COMMD7 PE=2 SV=1,,,,,,
OG_04064,2.144598338220046,FUN_016385-T1,Peve_00022914,Pocillopora_meandrina_HIv1___RNAseq.g9738.t1,three_way,70.09116666666667,FUN_016385-T1,Q15061,WDR43_HUMAN,,WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog),Homo sapiens (Human),40.4,599.0,7.9e-112,406.0,sp|Q15061|WDR43_HUMAN WD repeat-containing protein 43 OS=Homo sapiens OX=9606 GN=WDR43 PE=1 SV=3,GO:0000462; GO:0000785; GO:0000993; GO:0001650; GO:0003711; GO:0003723; GO:0005654; GO:0005730; GO:0032040; GO:0034243; GO:0042274; GO:0045943; GO:2000036; GO:2000234,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; ribosomal small subunit biogenesis [GO:0042274]",chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040],RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation factor activity [GO:0003711],GO:0003723; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0140110,RNA binding; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04065,1.9697210093053024,FUN_016386-T1,Peve_00030460,Pocillopora_meandrina_HIv1___RNAseq.g15065.t1,three_way,69.083,FUN_016386-T1,Q9UBD5,ORC3_HUMAN,,Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo),Homo sapiens (Human),40.6,729.0,7.2e-149,529.3,sp|Q9UBD5|ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens OX=9606 GN=ORC3 PE=1 SV=1,GO:0000781; GO:0000785; GO:0000808; GO:0003688; GO:0005634; GO:0005654; GO:0005656; GO:0005664; GO:0006260; GO:0006270; GO:0006275; GO:0014009; GO:0016604; GO:0031261; GO:0061351,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; glial cell proliferation [GO:0014009]; neural precursor cell proliferation [GO:0061351]; regulation of DNA replication [GO:0006275],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication preinitiation complex [GO:0031261]; nuclear body [GO:0016604]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]",DNA replication origin binding [GO:0003688],GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA replication; organelle
OG_04066,1.6300262837039057,FUN_016387-T1,Peve_00022900,Pocillopora_meandrina_HIv1___RNAseq.g9768.t1,three_way,79.809,FUN_016387-T1,O15229,KMO_HUMAN,,Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase),Homo sapiens (Human),57.1,417.0,7.7e-141,501.9,sp|O15229|KMO_HUMAN Kynurenine 3-monooxygenase OS=Homo sapiens OX=9606 GN=KMO PE=1 SV=2,GO:0004502; GO:0005615; GO:0005739; GO:0005741; GO:0005829; GO:0006569; GO:0009651; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1903296,"'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; L-tryptophan catabolic process [GO:0006569]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651]",cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174],GO:0003824; GO:0005615; GO:0005739; GO:0005829; GO:0006520; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; mitochondrion; cytosol; amino acid metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_04067,1.1568594209049303,FUN_016388-T1,Peve_00033767,Pocillopora_meandrina_HIv1___RNAseq.g9766.t1,three_way,44.09583333333333,,,,,,,,,,,,,,,,,
OG_04068,1.863318501369873,FUN_016389-T1,Peve_00033768,Pocillopora_meandrina_HIv1___RNAseq.g9765.t1,three_way,65.33466666666666,FUN_016389-T1,Q6DGB6,DAA19_DANRE,,Dynein axonemal assembly factor 19 (Coiled-coil domain-containing protein 103) (Protein schmalhans),Danio rerio (Zebrafish) (Brachydanio rerio),48.0,200.0,2.7e-41,170.2,sp|Q6DGB6|DAA19_DANRE Dynein axonemal assembly factor 19 OS=Danio rerio OX=7955 GN=dnaaf19 PE=1 SV=1,GO:0001947; GO:0003143; GO:0003146; GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007368; GO:0031514; GO:0036157; GO:0036159; GO:0060271; GO:0070286; GO:0090660,axonemal dynein complex assembly [GO:0070286]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159],axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],,GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0050877; GO:0065003,extracellular region; cilium; microtubule-based movement; organelle; cilium organization; nervous system process; protein-containing complex assembly
OG_04073,1.5750135926455422,FUN_016396-T1,Peve_00006415,Pocillopora_meandrina_HIv1___RNAseq.g9761.t1,three_way,59.46566666666667,FUN_016396-T1,Q9NXE8,CWC25_HUMAN,,Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25),Homo sapiens (Human),58.0,143.0,1.2e-36,156.0,sp|Q9NXE8|CWC25_HUMAN Pre-mRNA-splicing factor CWC25 homolog OS=Homo sapiens OX=9606 GN=CWC25 PE=1 SV=1,GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0016607; GO:0071006,"mRNA splicing, via spliceosome [GO:0000398]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684],,GO:0005634; GO:0005654; GO:0016071; GO:0043226,nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_04075,3.904012432317837,FUN_016400-T1,Peve_00006411,Pocillopora_meandrina_HIv1___RNAseq.g9752.t1,three_way,83.30466666666666,FUN_016400-T1,Q6NUP7,PP4R4_HUMAN,,Serine/threonine-protein phosphatase 4 regulatory subunit 4,Homo sapiens (Human),46.8,667.0,3.4e-166,587.0,sp|Q6NUP7|PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PPP4R4 PE=1 SV=1,GO:0001835; GO:0004864; GO:0004865; GO:0005737; GO:0005829; GO:0005929; GO:0008287; GO:0019888; GO:0036064; GO:0043231,blastocyst hatching [GO:0001835],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase complex [GO:0008287],protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],GO:0005815; GO:0005829; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; cilium; organelle; molecular function regulator activity
OG_04076,1.1976783719787096,FUN_016401-T1,Peve_00006412,Pocillopora_meandrina_HIv1___RNAseq.g9751.t1,three_way,88.60033333333332,FUN_016401-T1,Q7RYW6,,,,,62.5,333.0,7.300000000000001e-118,425.2,sp|Q7RYW6|CYSK_NEUCR Cysteine synthase 1 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=cys-17 PE=3 SV=1,,,,,,
OG_04080,1.8106524661868588,FUN_016410-T1,Peve_00018210,Pocillopora_meandrina_HIv1___RNAseq.g9784.t1,three_way,70.55316666666667,,,,,,,,,,,,,,,,,
OG_04087,1.5693151511319827,FUN_016423-T1,Peve_00004362,Pocillopora_meandrina_HIv1___RNAseq.g9805.t1,three_way,60.657833333333336,FUN_016423-T1,Q7ZWE3,LARP7_DANRE,,La-related protein 7 (La ribonucleoprotein domain family member 7),Danio rerio (Zebrafish) (Brachydanio rerio),31.0,568.0,1.3e-52,209.1,sp|Q7ZWE3|LARP7_DANRE La-related protein 7 OS=Danio rerio OX=7955 GN=larp7 PE=2 SV=1,GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0048024; GO:0060043; GO:0061026; GO:0097322; GO:1904871; GO:1905382; GO:1990438; GO:1990904,"box C/D sno(s)RNA 3'-end processing [GO:0000494]; cardiac muscle tissue regeneration [GO:0061026]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0016073; GO:0022414; GO:0030154; GO:0043226; GO:0048856,RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; snRNA metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development
OG_04088,1.7800484618978645,FUN_016425-T1,Peve_00004359,Pocillopora_meandrina_HIv1___TS.g23342.t4,three_way,52.22683333333333,,,,,,,,,,,,,,,,,
OG_04089,2.4923048956117757,FUN_016428-T1,Peve_00004356,Pocillopora_meandrina_HIv1___RNAseq.g9809.t1,three_way,74.45816666666666,FUN_016428-T1,Q15147,,,,,38.6,1257.0,9.2e-231,802.4,"sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3",,,,,,
OG_04091,2.3091461097397588,FUN_016430-T1,Peve_00004353,Pocillopora_meandrina_HIv1___RNAseq.g9811.t1,three_way,63.04533333333333,,,,,,,,,,,,,,,,,
OG_04092,1.3799782091598378,FUN_016432-T1,Peve_00004351,Pocillopora_meandrina_HIv1___RNAseq.g9813.t3,three_way,72.73966666666666,FUN_016432-T1,P10894,PLCB1_BOVIN,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1)",Bos taurus (Bovine),58.2,490.0,5.7e-156,553.1,"sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1",GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498,G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607],"calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]",GO:0003824; GO:0005829; GO:0006629; GO:0008289; GO:0016787; GO:0043226; GO:0050877; GO:0055085; GO:0098772,catalytic activity; cytosol; lipid metabolic process; lipid binding; hydrolase activity; organelle; nervous system process; transmembrane transport; molecular function regulator activity
OG_04093,1.598354839557379,FUN_016433-T1,Peve_00002890,Pocillopora_meandrina_HIv1___TS.g23394.t1,three_way,89.05133333333333,FUN_016433-T1,Q15542,TAF5_HUMAN,,Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100),Homo sapiens (Human),49.0,467.0,1.1000000000000001e-100,369.0,sp|Q15542|TAF5_HUMAN Transcription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3,GO:0000124; GO:0000785; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006352; GO:0006357; GO:0006367; GO:0015629; GO:0016251; GO:0033276; GO:0042789; GO:0042802; GO:0045893; GO:0051123; GO:0060261,DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276],identical protein binding [GO:0042802]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0005634; GO:0005654; GO:0005856; GO:0006351; GO:0006355; GO:0016071; GO:0043226; GO:0065003; GO:0140223,nucleus; nucleoplasm; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; organelle; protein-containing complex assembly; general transcription initiation factor activity
OG_04094,1.2237496727424673,FUN_016434-T1,Peve_00030461,Pocillopora_meandrina_HIv1___RNAseq.g9861.t1,three_way,81.31916666666666,FUN_016434-T1,B0S6T2,S15A2_DANRE,,Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2),Danio rerio (Zebrafish) (Brachydanio rerio),42.3,678.0,1.6999999999999998e-137,491.5,sp|B0S6T2|S15A2_DANRE Solute carrier family 15 member 2 OS=Danio rerio OX=7955 GN=slc15a2 PE=1 SV=1,GO:0001878; GO:0005886; GO:0015031; GO:0015333; GO:0015835; GO:0016324; GO:0030670; GO:0042937; GO:0045087; GO:0070424; GO:0071916; GO:0140206; GO:0140207,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; response to yeast [GO:0001878]; tripeptide import across plasma membrane [GO:0140207]",apical plasma membrane [GO:0016324]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886],dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; tripeptide transmembrane transporter activity [GO:0042937],GO:0002376; GO:0005215; GO:0005886; GO:0055085; GO:0098542,immune system process; transporter activity; plasma membrane; transmembrane transport; defense response to other organism
OG_04096,1.105569689055452,FUN_016436-T1,Peve_00002886,Pocillopora_meandrina_HIv1___TS.g23399.t2,three_way,66.57249999999999,FUN_016436-T1,P05455,LA_HUMAN,,Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B),Homo sapiens (Human),46.4,196.0,2.2e-38,160.6,sp|P05455|LA_HUMAN Lupus La protein OS=Homo sapiens OX=9606 GN=SSB PE=1 SV=2,GO:0000049; GO:0000781; GO:0001682; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006409; GO:0008033; GO:0008266; GO:0008334; GO:0010494; GO:0042780; GO:0045727; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904,histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; positive regulation of translation [GO:0045727]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]",mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005829; GO:0006399; GO:0006913; GO:0016071; GO:0043226,RNA binding; nucleus; cytosol; tRNA metabolic process; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_04100,1.2357852085339012,FUN_016446-T1,Peve_00032929,Pocillopora_meandrina_HIv1___RNAseq.g9835.t1,three_way,65.06700000000001,FUN_016446-T1,Q920N1,CMA1A_MOUSE,,Ciliary microtubule associated protein 1A (Outer dense fiber of sperm tails protein 3) (Outer dense fiber protein 3) (Sperm tail protein SHIPPO 1),Mus musculus (Mouse),42.8,236.0,4.9e-46,186.0,sp|Q920N1|CMA1A_MOUSE Ciliary microtubule associated protein 1A OS=Mus musculus OX=10090 GN=Cimap1a PE=1 SV=2,GO:0001520; GO:0005737; GO:0007283; GO:0030154; GO:0030317; GO:0036126,cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0030154; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; cell differentiation; organelle; cell motility
OG_04101,1.799256523160649,FUN_016452-T1,Peve_00016427,Pocillopora_meandrina_HIv1___RNAseq.g9832.t1,three_way,79.55466666666666,FUN_016452-T1,Q8TD10,MIPO1_HUMAN,,Mirror-image polydactyly gene 1 protein,Homo sapiens (Human),26.7,322.0,5.4e-17,90.5,sp|Q8TD10|MIPO1_HUMAN Mirror-image polydactyly gene 1 protein OS=Homo sapiens OX=9606 GN=MIPOL1 PE=1 SV=1,GO:0005634; GO:0042802,,nucleus [GO:0005634],identical protein binding [GO:0042802],GO:0005634; GO:0043226,nucleus; organelle
OG_04102,1.203267362367879,FUN_016453-T1,Peve_00040136,Pocillopora_meandrina_HIv1___RNAseq.g97.t1,three_way,59.23416666666667,FUN_016453-T1,Q0VF49,,,,,25.1,355.0,6.7e-07,58.5,sp|Q0VF49|K2012_HUMAN Uncharacterized protein KIAA2012 OS=Homo sapiens OX=9606 GN=KIAA2012 PE=1 SV=2,,,,,,
OG_04104,1.454457020698755,FUN_016468-T1,Peve_00015302,Pocillopora_meandrina_HIv1___RNAseq.g10226.t1,three_way,73.41266666666667,FUN_016468-T1,Q5ZHT1,ACD11_CHICK,,Acyl-CoA dehydrogenase family member 11 (ACAD-11) (EC 1.3.8.-),Gallus gallus (Chicken),58.0,769.0,2.3999999999999996e-243,843.2,sp|Q5ZHT1|ACD11_CHICK Acyl-CoA dehydrogenase family member 11 OS=Gallus gallus OX=9031 GN=ACAD11 PE=2 SV=1,GO:0003995; GO:0005737; GO:0005739; GO:0005777; GO:0031966; GO:0033539; GO:0050660,fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539],cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisome [GO:0005777],acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; oxidoreductase activity; organelle
OG_04106,2.397237365452637,FUN_016470-T1,Peve_00015304,Pocillopora_meandrina_HIv1___RNAseq.g101.t1,three_way,67.28366666666666,FUN_016470-T1,Q6P4F7,RHGBA_HUMAN,,Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A),Homo sapiens (Human),37.3,260.0,1.6999999999999996e-31,139.0,sp|Q6P4F7|RHGBA_HUMAN Rho GTPase-activating protein 11A OS=Homo sapiens OX=9606 GN=ARHGAP11A PE=1 SV=2,GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056,positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleus [GO:0005634],GTPase activator activity [GO:0005096],GO:0005634; GO:0005829; GO:0043226; GO:0098772,nucleus; cytosol; organelle; molecular function regulator activity
OG_04108,2.033615358376758,FUN_016473-T1,Peve_00015306,Pocillopora_meandrina_HIv1___RNAseq.g145.t1,three_way,60.1465,FUN_016473-T1,A7MB54,HLX_BOVIN,,H2.0-like homeobox protein (Homeobox protein HLX1),Bos taurus (Bovine),81.0,58.0,5e-21,102.8,sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1,GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679,embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0002376; GO:0003677; GO:0005634; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04109,3.3267882095063865,FUN_016475-T1,Peve_00040144,Pocillopora_meandrina_HIv1___RNAseq.g10194.t1,three_way,66.4755,FUN_016475-T1,P0C5Y8,ALS2_RAT,,Alsin (Amyotrophic lateral sclerosis 2 protein homolog),Rattus norvegicus (Rat),30.6,1765.0,3.8e-188,661.0,sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1,GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072,"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267],GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0016192; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,nucleus; endosome; microtubule organizing center; cytosol; vesicle-mediated transport; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_04110,1.0632538662116449,FUN_016476-T2,Peve_00024208,Pocillopora_meandrina_HIv1___RNAseq.g10193.t1,three_way,69.1025,FUN_016476-T2,P90666,,,,,48.6,638.0,6.4e-165,583.2,sp|P90666|TXND3_HELCR Thioredoxin domain-containing protein 3 homolog OS=Heliocidaris crassispina OX=1043166 GN=NME8 PE=1 SV=1,,,,,,
OG_04113,2.548510698350704,FUN_016489-T1,Peve_00001327,Pocillopora_meandrina_HIv1___RNAseq.g9629.t1,three_way,83.481,FUN_016489-T1,Q8R5L3,,,,,52.2,596.0,7.399999999999999e-171,602.1,sp|Q8R5L3|VPS39_MOUSE Vam6/Vps39-like protein OS=Mus musculus OX=10090 GN=Vps39 PE=1 SV=1,,,,,,
OG_04114,1.475884248107215,FUN_016490-T1,Peve_00001326,Pocillopora_meandrina_HIv1___RNAseq.g9508.t1,three_way,62.83783333333333,FUN_016490-T1,Q505F5,,,,,40.5,333.0,1.1e-45,186.0,sp|Q505F5|LRC47_MOUSE Leucine-rich repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Lrrc47 PE=1 SV=1,,,,,,
OG_04116,1.8268853191944616,FUN_016492-T1,Peve_00042752,Pocillopora_meandrina_HIv1___RNAseq.g179.t1,three_way,63.57866666666666,FUN_016492-T1,Q8L706,,,,,24.4,312.0,1.1e-15,87.4,sp|Q8L706|SYT5_ARATH Synaptotagmin-5 OS=Arabidopsis thaliana OX=3702 GN=SYT5 PE=2 SV=1,,,,,,
OG_04120,2.191640604578401,FUN_016496-T1,Peve_00010548,Pocillopora_meandrina_HIv1___RNAseq.g175.t1,three_way,69.93133333333333,FUN_016496-T1,Q5RFE6,,,,,48.9,474.0,3.5e-128,459.9,sp|Q5RFE6|THNS2_PONAB Threonine synthase-like 2 OS=Pongo abelii OX=9601 GN=THNSL2 PE=2 SV=1,,,,,,
OG_04121,1.1353956854673408,FUN_016502-T1,Peve_00002862,Pocillopora_meandrina_HIv1___RNAseq.g26039.t1,three_way,58.61033333333333,,,,,,,,,,,,,,,,,
OG_04122,1.4380400353117495,FUN_016503-T1,Peve_00016813,Pocillopora_meandrina_HIv1___RNAseq.g9722.t1,three_way,69.429,FUN_016503-T1,Q32LQ4,,,,,58.3,336.0,3.3e-117,422.9,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_04123,1.3847190380273142,FUN_016504-T1,Peve_00016812,Pocillopora_meandrina_HIv1___RNAseq.g9720.t1,three_way,88.1275,FUN_016504-T1,Q9Y2X3,NOP58_HUMAN,,Nucleolar protein 58 (Nucleolar protein 5),Homo sapiens (Human),71.5,445.0,1.6e-174,614.0,sp|Q9Y2X3|NOP58_HUMAN Nucleolar protein 58 OS=Homo sapiens OX=9606 GN=NOP58 PE=1 SV=1,GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0048254; GO:0051117; GO:0070761,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254],box C/D methylation guide snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732],ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0043226,RNA binding; nucleoplasm; nucleolus; cytosol; organelle
OG_04124,1.3050293430591962,FUN_016506-T1,Peve_00016809,Pocillopora_meandrina_HIv1___RNAseq.g9719.t1,three_way,60.988,FUN_016506-T1,Q6AX80,,,,,35.9,434.0,5.4e-76,286.6,sp|Q6AX80|ENPP4_XENLA Bis(5'-adenosyl)-triphosphatase enpp4 OS=Xenopus laevis OX=8355 GN=enpp4 PE=2 SV=1,,,,,,
OG_04125,1.801219853039324,FUN_016508-T1,Peve_00042768,Pocillopora_meandrina_HIv1___TS.g23255.t1,three_way,68.21666666666667,FUN_016508-T1,Q6PUF4,,,,,41.6,267.0,2.1e-49,197.6,sp|Q6PUF4|DHI1L_CHICK Hydroxysteroid 11-beta-dehydrogenase 1-like protein OS=Gallus gallus OX=9031 GN=HSD11B1L PE=2 SV=1,,,,,,
OG_04129,3.867098746842857,FUN_016578-T1,Peve_00002516,Pocillopora_meandrina_HIv1___RNAseq.g9694.t1,three_way,71.17683333333333,FUN_016578-T1,Q8K4Q6,NEIL1_MOUSE,,Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (Nei homolog 1) (NEH1) (Nei-like protein 1),Mus musculus (Mouse),49.5,307.0,1.9000000000000002e-80,301.2,sp|Q8K4Q6|NEIL1_MOUSE Endonuclease 8-like 1 OS=Mus musculus OX=10090 GN=Neil1 PE=2 SV=3,GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0006281; GO:0006284; GO:0006979; GO:0008270; GO:0016829; GO:0019104; GO:0140078,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; response to oxidative stress [GO:0006979],centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; lyase activity [GO:0016829]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0006281; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; microtubule organizing center; DNA repair; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_04131,2.172670930121317,FUN_016583-T1,Peve_00016678,Pocillopora_meandrina_HIv1___RNAseq.g418.t1,three_way,41.5285,,,,,,,,,,,,,,,,,
OG_04132,2.633103972473348,FUN_016586-T1,Peve_00015488,Pocillopora_meandrina_HIv1___RNAseq.g471.t1,three_way,72.66883333333334,FUN_016586-T1,Q08CH3,,,,,37.6,540.0,7.2e-91,336.3,sp|Q08CH3|MPND_DANRE MPN domain-containing protein OS=Danio rerio OX=7955 GN=mpnd PE=2 SV=1,,,,,,
OG_04133,3.764846119309457,FUN_016587-T1,Peve_00000800,Pocillopora_meandrina_HIv1___RNAseq.g2974.t1,three_way,65.638,FUN_016587-T1,Q92900,RENT1_HUMAN,,Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1),Homo sapiens (Human),38.4,440.0,3.5999999999999997e-69,265.8,sp|Q92900|RENT1_HUMAN Regulator of nonsense transcripts 1 OS=Homo sapiens OX=9606 GN=UPF1 PE=1 SV=2,GO:0000184; GO:0000781; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0016887; GO:0032201; GO:0032204; GO:0035145; GO:0036121; GO:0042162; GO:0044530; GO:0044770; GO:0044877; GO:0048471; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347; GO:1905746,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded DNA helicase activity [GO:0036121]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006913; GO:0016071; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA replication; DNA repair; nucleocytoplasmic transport; mRNA metabolic process; hydrolase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04134,2.187543864185054,FUN_016588-T1,Peve_00000798,Pocillopora_meandrina_HIv1___RNAseq.g2973.t1,three_way,71.725,,,,,,,,,,,,,,,,,
OG_04142,1.5120977393260744,FUN_016599-T1,Peve_00003402,Pocillopora_meandrina_HIv1___RNAseq.g414.t2,three_way,67.56366666666666,,,,,,,,,,,,,,,,,
OG_04146,3.1952299902674333,FUN_016608-T1,Peve_00010249,Pocillopora_meandrina_HIv1___RNAseq.g9623.t1b,three_way,79.465,FUN_016608-T1,P58465,,,,,63.3,270.0,1.5e-89,330.9,sp|P58465|CTDSL_MOUSE CTD small phosphatase-like protein OS=Mus musculus OX=10090 GN=Ctdspl PE=2 SV=3,,,,,,
OG_04153,1.1762219256033295,FUN_016617-T1,Peve_00008570,Pocillopora_meandrina_HIv1___RNAseq.g9622.t1,three_way,68.09433333333334,FUN_016617-T1,P18293,ANPRA_MOUSE,,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),Mus musculus (Mouse),32.4,786.0,9.3e-99,362.8,sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2,GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0007168; GO:0008217; GO:0010753; GO:0016020; GO:0016941; GO:0017046; GO:0019934; GO:0042417; GO:0043235; GO:0048662; GO:0097746; GO:1990620,blood vessel diameter maintenance [GO:0097746]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217],ANPR-A receptor complex [GO:1990620]; membrane [GO:0016020]; receptor complex [GO:0043235],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672],GO:0003013; GO:0003824; GO:0009975; GO:0016740; GO:0016829; GO:0060089; GO:0140096,"circulatory system process; catalytic activity; cyclase activity; transferase activity; lyase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_04156,1.751792569765569,FUN_016623-T1,Peve_00026347,Pocillopora_meandrina_HIv1___RNAseq.g9627.t1,three_way,60.69583333333333,FUN_016623-T1,P97718,ADA1A_MOUSE,,Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor),Mus musculus (Mouse),24.1,316.0,5.3e-23,110.2,sp|P97718|ADA1A_MOUSE Alpha-1A adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1a PE=1 SV=3,GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007512; GO:0008217; GO:0010507; GO:0010613; GO:0016020; GO:0019229; GO:0031965; GO:0035024; GO:0035265; GO:0043410; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0071875; GO:0097195; GO:0150099,adrenergic receptor signaling pathway [GO:0071875]; adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982],GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0060089,circulatory system process; nucleus; nucleoplasm; cytosol; plasma membrane; signaling; organelle; anatomical structure development; molecular transducer activity
OG_04157,1.722722786743352,FUN_016625-T1,Peve_00020325,Pocillopora_meandrina_HIv1___RNAseq.g148.t1,three_way,74.75966666666666,FUN_016625-T1,A0A8V1ABE9,DSD1_CHICK,,D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase),Gallus gallus (Chicken),46.1,310.0,9e-77,288.5,sp|A0A8V1ABE9|DSD1_CHICK D-serine dehydratase OS=Gallus gallus OX=9031 GN=DSD PE=1 SV=1,GO:0005737; GO:0008270; GO:0008721; GO:0030170; GO:0030425; GO:0036088,D-serine catabolic process [GO:0036088],cytoplasm [GO:0005737]; dendrite [GO:0030425],D-serine ammonia-lyase activity [GO:0008721]; pyridoxal phosphate binding [GO:0030170]; zinc ion binding [GO:0008270],GO:0003824; GO:0006520; GO:0016829,catalytic activity; amino acid metabolic process; lyase activity
OG_04158,1.406696950621381,FUN_016635-T1,Peve_00020323,Pocillopora_meandrina_HIv1___RNAseq.g104.t1,three_way,85.525,FUN_016635-T1,A5PKH3,,,,,68.4,415.0,2.5e-178,626.3,sp|A5PKH3|FAAA_BOVIN Fumarylacetoacetase OS=Bos taurus OX=9913 GN=FAH PE=2 SV=1,,,,,,
OG_04161,1.2533630593748608,FUN_016639-T1,Peve_00001325,Pocillopora_meandrina_HIv1___RNAseq.g10191.t1,three_way,64.88383333333333,FUN_016639-T1,O70249,OGG1_RAT,,N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)],Rattus norvegicus (Rat),47.5,335.0,6.7e-84,312.4,sp|O70249|OGG1_RAT N-glycosylase/DNA lyase OS=Rattus norvegicus OX=10116 GN=Ogg1 PE=2 SV=1,GO:0000978; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006285; GO:0006289; GO:0006355; GO:0006974; GO:0006979; GO:0008017; GO:0008534; GO:0009314; GO:0009410; GO:0009416; GO:0016363; GO:0016607; GO:0019104; GO:0019899; GO:0032355; GO:0032357; GO:0032991; GO:0034039; GO:0034614; GO:0043066; GO:0044029; GO:0045471; GO:0045944; GO:0051593; GO:0071276; GO:0140078; GO:1901291,"base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair [GO:0006289]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]",mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],"8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; enzyme binding [GO:0019899]; microtubule binding [GO:0008017]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006325; GO:0006355; GO:0008092; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; chromatin organization; regulation of DNA-templated transcription; cytoskeletal protein binding; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_04162,1.426419998193022,FUN_016640-T1,Peve_00042751,Pocillopora_meandrina_HIv1___TS.g6976.t1,three_way,78.45166666666667,FUN_016640-T1,Q86XK2,FBX11_HUMAN,,F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1),Homo sapiens (Human),39.9,286.0,3.6999999999999997e-54,214.9,sp|Q86XK2|FBX11_HUMAN F-box only protein 11 OS=Homo sapiens OX=9606 GN=FBXO11 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0036211; GO:0042981; GO:0043161; GO:1990756,negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0050877; GO:0060090; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; transferase activity; protein catabolic process; organelle; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_04167,3.185846652574785,FUN_016648-T1,Peve_00042742,Pocillopora_meandrina_HIv1___RNAseq.g197.t1,three_way,86.58166666666666,FUN_016648-T1,A8QCE4,,,,,45.3,64.0,6.8e-15,83.6,sp|A8QCE4|LST2_BRUMA Lateral signaling target protein 2 homolog OS=Brugia malayi OX=6279 GN=Bm5439 PE=3 SV=1,,,,,,
OG_04168,1.2467010922704325,FUN_016649-T1,Peve_00042740,Pocillopora_meandrina_HIv1___TS.g6963.t1,three_way,75.31400000000001,FUN_016649-T1,Q8TDX6,,,,,47.3,427.0,4.4e-103,376.7,sp|Q8TDX6|CGAT1_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=CSGALNACT1 PE=1 SV=2,,,,,,
OG_04170,5.513050299532886,FUN_016651-T1,Peve_00042780,Pocillopora_meandrina_HIv1___TS.g6961.t1,three_way,81.653,FUN_016651-T1,Q6TMK4,POXA_DICDI,,Peroxinectin A (EC 1.11.1.7),Dictyostelium discoideum (Social amoeba),34.7,521.0,3.3e-86,322.0,sp|Q6TMK4|POXA_DICDI Peroxinectin A OS=Dictyostelium discoideum OX=44689 GN=poxA PE=1 SV=1,GO:0004447; GO:0004601; GO:0005576; GO:0005783; GO:0006955; GO:0006979; GO:0020037; GO:0036393; GO:0042742; GO:0042744; GO:0140825,defense response to bacterium [GO:0042742]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; response to oxidative stress [GO:0006979],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; lactoperoxidase activity [GO:0140825]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393],GO:0002376; GO:0003824; GO:0005576; GO:0005783; GO:0016209; GO:0016491; GO:0043226,immune system process; catalytic activity; extracellular region; endoplasmic reticulum; antioxidant activity; oxidoreductase activity; organelle
OG_04171,2.209538824900974,FUN_016652-T1,Peve_00042777,Pocillopora_meandrina_HIv1___RNAseq.22127_t,three_way,89.431,FUN_016652-T1,Q2KIA2,TR112_BOVIN,,Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog),Bos taurus (Bovine),61.8,123.0,2.2e-37,156.4,sp|Q2KIA2|TR112_BOVIN Multifunctional methyltransferase subunit TRM112-like protein OS=Bos taurus OX=9913 GN=TRMT112 PE=2 SV=1,GO:0000470; GO:0005634; GO:0005654; GO:0005737; GO:0018364; GO:0030490; GO:0031167; GO:0043528; GO:0045815; GO:0046982; GO:0048471; GO:0070476; GO:0141106; GO:2000234,maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; transcription initiation-coupled chromatin remodeling [GO:0045815],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA (m2G10) methyltransferase complex [GO:0043528],protein heterodimerization activity [GO:0046982]; tRNA methyltransferase activator activity [GO:0141106],GO:0005634; GO:0005654; GO:0006325; GO:0043226; GO:0098772,nucleus; nucleoplasm; chromatin organization; organelle; molecular function regulator activity
OG_04173,3.1518068315466814,FUN_016657-T1,Peve_00020507,Pocillopora_meandrina_HIv1___RNAseq.g25312.t1a,three_way,54.83766666666666,FUN_016657-T1,Q5E9Q3,,,,,46.7,165.0,1.2e-34,149.1,sp|Q5E9Q3|MITOK_BOVIN Mitochondrial potassium channel OS=Bos taurus OX=9913 GN=CCDC51 PE=2 SV=1,,,,,,
OG_04175,1.7252446336948706,FUN_016660-T2,Peve_00032318,Pocillopora_meandrina_HIv1___RNAseq.g10087.t1,three_way,86.16333333333333,FUN_016660-T2,Q92047,,,,,58.3,223.0,3.4000000000000004e-74,279.6,sp|Q92047|PIMT_DANRE Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Danio rerio OX=7955 GN=pcmt PE=2 SV=3,,,,,,
OG_04176,1.8083017684651936,FUN_016661-T1,Peve_00032319,Pocillopora_meandrina_HIv1___RNAseq.g10086.t1,three_way,55.61933333333333,FUN_016661-T1,Q5RCI5,CSKMT_PONAB,,"Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial (CS-KMT) (EC 2.1.1.-) (Methyltransferase-like protein 12, mitochondrial)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),33.2,208.0,1.4e-17,91.7,"sp|Q5RCI5|CSKMT_PONAB Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial OS=Pongo abelii OX=9601 GN=CSKMT PE=2 SV=1",GO:0005739; GO:0006479; GO:0016278; GO:0016279; GO:0018023; GO:0018026; GO:0018027,peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479],mitochondrion [GO:0005739],lysine N-methyltransferase activity [GO:0016278]; protein-lysine N-methyltransferase activity [GO:0016279],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04177,1.0527118563240814,FUN_016662-T1,Peve_00032320,Pocillopora_meandrina_HIv1___RNAseq.g10085.t1,three_way,61.4985,FUN_016662-T1,P98088,MUC5A_HUMAN,,"Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM)",Homo sapiens (Human),29.1,998.0,1.2e-119,433.3,sp|P98088|MUC5A_HUMAN Mucin-5AC OS=Homo sapiens OX=9606 GN=MUC5AC PE=1 SV=4,GO:0005201; GO:0005615; GO:0005796; GO:0005886; GO:0031012; GO:0046872; GO:0070062; GO:0070701,,extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; plasma membrane [GO:0005886],extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872],GO:0005198; GO:0005615; GO:0005886; GO:0030312; GO:0031012; GO:0043226,structural molecule activity; extracellular space; plasma membrane; external encapsulating structure; extracellular matrix; organelle
OG_04178,1.3405311164110263,FUN_016668-T1,Peve_00002514,Pocillopora_meandrina_HIv1___RNAseq.g9697.t1,three_way,79.70833333333333,FUN_016668-T1,A0JNI5,CLASR_BOVIN,,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16)",Bos taurus (Bovine),51.1,309.0,1.2e-50,202.6,sp|A0JNI5|CLASR_BOVIN CLK4-associating serine/arginine rich protein OS=Bos taurus OX=9913 GN=CLASRP PE=2 SV=1,GO:0005634; GO:0006397; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nucleus [GO:0005634],,GO:0005634; GO:0016071; GO:0043226,nucleus; mRNA metabolic process; organelle
OG_04181,2.5681642894144203,FUN_016677-T1,Peve_00035082,Pocillopora_meandrina_HIv1___RNAseq.g388.t3,three_way,77.881,FUN_016677-T1,A2RUC4,TYW5_HUMAN,,tRNA wybutosine-synthesizing protein 5 (hTYW5) (tRNA yW-synthesizing protein 5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase),Homo sapiens (Human),64.9,302.0,2.1999999999999998e-116,420.2,sp|A2RUC4|TYW5_HUMAN tRNA wybutosine-synthesizing protein 5 OS=Homo sapiens OX=9606 GN=TYW5 PE=1 SV=1,GO:0000049; GO:0005506; GO:0005737; GO:0031591; GO:0042803; GO:0102524,wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524],GO:0003723; GO:0003824; GO:0006399; GO:0016491; GO:0140098; GO:1901135,"RNA binding; catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_04183,1.1949690897704583,FUN_016701-T1,Peve_00004837,Pocillopora_meandrina_HIv1___RNAseq.g279.t1,three_way,55.42366666666667,,,,,,,,,,,,,,,,,
OG_04185,2.529796134519806,FUN_016705-T1,Peve_00004831,Pocillopora_meandrina_HIv1___RNAseq.g281.t1,three_way,77.65433333333333,FUN_016705-T1,Q9SB50,,,,,48.3,292.0,1.1e-71,271.6,sp|Q9SB50|AP4M_ARATH AP-4 complex subunit mu OS=Arabidopsis thaliana OX=3702 GN=AP4M PE=2 SV=1,,,,,,
OG_04187,1.3999603648229777,FUN_016708-T1,Peve_00024196,Pocillopora_meandrina_HIv1___RNAseq.g277.t1,three_way,80.69266666666667,FUN_016708-T1,Q1RMM1,,,,,48.7,431.0,1.0999999999999999e-91,338.6,sp|Q1RMM1|ZC3HF_BOVIN Zinc finger CCCH domain-containing protein 15 OS=Bos taurus OX=9913 GN=ZC3H15 PE=2 SV=1,,,,,,
OG_04189,2.659481995468922,FUN_016710-T1,Peve_00024194,Pocillopora_meandrina_HIv1___RNAseq.g275.t1,three_way,50.513666666666666,,,,,,,,,,,,,,,,,
OG_04191,1.9656829278667327,FUN_016712-T1,Peve_00024209,Pocillopora_meandrina_HIv1___RNAseq.g273.t1,three_way,78.60933333333334,FUN_016712-T1,Q7ZUZ0,,,,,47.5,181.0,4.1e-40,166.0,sp|Q7ZUZ0|CSN8_DANRE COP9 signalosome complex subunit 8 OS=Danio rerio OX=7955 GN=cops8 PE=2 SV=1,,,,,,
OG_04196,1.3701571715856702,FUN_016722-T1,Peve_00014668,Pocillopora_meandrina_HIv1___RNAseq.g227.t1,three_way,81.29,FUN_016722-T1,P48630,,,,,50.0,372.0,8.000000000000002e-104,378.6,"sp|P48630|FD6E1_SOYBN Omega-6 fatty acid desaturase, endoplasmic reticulum isozyme 1 OS=Glycine max OX=3847 GN=FAD2-1 PE=2 SV=1",,,,,,
OG_04204,2.306288137229142,FUN_016759-T1,Peve_00003676,Pocillopora_meandrina_HIv1___RNAseq.g14956.t1,three_way,68.49566666666666,FUN_016759-T1,Q2QUN2,,,,,25.6,629.0,2.7e-41,172.6,sp|Q2QUN2|LAC24_ORYSJ Laccase-24 OS=Oryza sativa subsp. japonica OX=39947 GN=LAC24 PE=2 SV=1,,,,,,
OG_04206,1.3058051276328075,FUN_016778-T1,Peve_00032302,Pocillopora_meandrina_HIv1___RNAseq.g10030.t1,three_way,69.55216666666666,FUN_016778-T1,Q5TYQ8,,,,,28.0,640.0,5.1e-21,104.4,sp|Q5TYQ8|ZC3HE_DANRE Zinc finger CCCH domain-containing protein 14 OS=Danio rerio OX=7955 GN=zc3h14 PE=2 SV=1,,,,,,
OG_04207,2.3300726081082828,FUN_016779-T1,Peve_00032301,Pocillopora_meandrina_HIv1___RNAseq.g10031.t1,three_way,80.821,FUN_016779-T1,Q8BTW9,PAK4_MOUSE,,Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4),Mus musculus (Mouse),45.4,597.0,1.4e-119,431.4,sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus OX=10090 GN=Pak4 PE=1 SV=1,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006915; GO:0045766; GO:0060996; GO:0106310; GO:2000352,apoptotic process [GO:0006915]; dendritic spine development [GO:0060996]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766],cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0012501; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; programmed cell death; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04209,1.9599807290141693,FUN_016791-T1,Peve_00032297,Pocillopora_meandrina_HIv1___RNAseq.g10045.t1,three_way,78.91866666666667,FUN_016791-T1,Q65X23,,,,,26.7,292.0,1.5e-14,83.6,sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica OX=39947 GN=WNK2 PE=2 SV=1,,,,,,
OG_04210,1.807757236414174,FUN_016797-T1,Peve_00018601,Pocillopora_meandrina_HIv1___RNAseq.g241.t1,three_way,81.34166666666667,FUN_016797-T1,Q8TF09,DLRB2_HUMAN,,"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2)",Homo sapiens (Human),58.7,92.0,3.599999999999999e-24,112.8,sp|Q8TF09|DLRB2_HUMAN Dynein light chain roadblock-type 2 OS=Homo sapiens OX=9606 GN=DYNLRB2 PE=1 SV=1,GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0045505; GO:0097542,microtubule-based movement [GO:0007018],centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874],dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0005929; GO:0007018; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cilium; microtubule-based movement; isomerase activity; organelle; ATP-dependent activity
OG_04211,2.5230770595608254,FUN_016798-T1,Peve_00023973,Pocillopora_meandrina_HIv1___RNAseq.g242.t1,three_way,87.46816666666666,FUN_016798-T1,Q9Y2E4,,,,,56.7,1558.0,0.0,1701.0,sp|Q9Y2E4|DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens OX=9606 GN=DIP2C PE=1 SV=2,,,,,,
OG_04212,1.3987643371464376,FUN_016801-T1,Peve_00018618,Pocillopora_meandrina_HIv1___RNAseq.g243.t1,three_way,58.68683333333333,FUN_016801-T1,Q7Z5N4,SDK1_HUMAN,,Protein sidekick-1,Homo sapiens (Human),25.9,942.0,8.3e-57,224.2,sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998,behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_04215,1.3599467920407824,FUN_016868-T1,Peve_00020503,Pocillopora_meandrina_HIv1___RNAseq.g9928.t1,three_way,70.04816666666666,FUN_016868-T1,Q9P2K8,E2AK4_HUMAN,,eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein),Homo sapiens (Human),38.7,1721.0,1.3999999999999998e-256,888.3,sp|Q9P2K8|E2AK4_HUMAN eIF-2-alpha kinase GCN2 OS=Homo sapiens OX=9606 GN=EIF2AK4 PE=1 SV=3,GO:0000049; GO:0000077; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004674; GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006446; GO:0006468; GO:0007612; GO:0007616; GO:0010998; GO:0019081; GO:0022626; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0070417; GO:0071264; GO:0106310; GO:0140469; GO:1900273; GO:1990138,adaptive immune response [GO:0002250]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634],ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0005840; GO:0006355; GO:0016740; GO:0043226; GO:0050877; GO:0140096,"immune system process; RNA binding; catalytic activity; nucleus; cytosol; ribosome; regulation of DNA-templated transcription; transferase activity; organelle; nervous system process; catalytic activity, acting on a protein"
OG_04218,2.569139687112889,FUN_016968-T1,Peve_00025295,Pocillopora_meandrina_HIv1___RNAseq.g9906.t1,three_way,69.24583333333334,FUN_016968-T1,O13046,,,,,38.1,1161.0,8.099999999999999e-200,699.1,sp|O13046|WDHD1_XENLA WD repeat and HMG-box DNA-binding protein 1 OS=Xenopus laevis OX=8355 GN=wdhd1 PE=1 SV=1,,,,,,
OG_04224,1.6658106329057467,FUN_016988-T1,Peve_00025276,Pocillopora_meandrina_HIv1___RNAseq.g9895.t1,three_way,70.32283333333334,FUN_016988-T1,Q8CJ69,BMPER_MOUSE,,BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (mCV2),Mus musculus (Mouse),37.7,446.0,2.6e-92,340.9,sp|Q8CJ69|BMPER_MOUSE BMP-binding endothelial regulator protein OS=Mus musculus OX=10090 GN=Bmper PE=1 SV=1,GO:0001657; GO:0002043; GO:0005576; GO:0005615; GO:0010594; GO:0030509; GO:0030514; GO:0032880; GO:0042118; GO:0048839; GO:0060391; GO:0060395; GO:0062023; GO:0070374; GO:1903672,blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization [GO:0032880]; SMAD protein signal transduction [GO:0060395]; ureteric bud development [GO:0001657],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615],,GO:0005576; GO:0005615; GO:0048856,extracellular region; extracellular space; anatomical structure development
OG_04226,1.4195486670347903,FUN_017004-T1,Peve_00025258,Pocillopora_meandrina_HIv1___RNAseq.g9892.t1,three_way,79.81666666666666,FUN_017004-T1,Q9TTF0,,,,,43.8,393.0,4e-82,306.6,sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2,,,,,,
OG_04227,1.7717050876320706,FUN_017022-T1,Peve_00018298,Pocillopora_meandrina_HIv1___RNAseq.g20360.t1,three_way,58.69716666666667,FUN_017022-T1,Q8BV79,,,,,28.2,2731.0,2.9e-254,881.7,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_04231,2.2414157704199718,FUN_017708-T1,Peve_00026625,Pocillopora_meandrina_HIv1___RNAseq.g24801.t1,three_way,60.646,FUN_017708-T1,P0DXC0,,,,,51.6,337.0,7.8e-93,342.0,sp|P0DXC0|CGLR3_STYPI Cyclic GMP-AMP synthase-like receptor 3 OS=Stylophora pistillata OX=50429 PE=1 SV=1,,,,,,
OG_04232,2.51475341978161,FUN_017709-T1,Peve_00022746,Pocillopora_meandrina_HIv1___RNAseq.g19535.t1,three_way,68.68633333333334,FUN_017709-T1,Q12931,TRAP1_HUMAN,,"Heat shock protein 75 kDa, mitochondrial (HSP 75) (Heat shock protein family C member 5) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)",Homo sapiens (Human),50.5,661.0,7.799999999999998e-177,622.1,"sp|Q12931|TRAP1_HUMAN Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens OX=9606 GN=TRAP1 PE=1 SV=3",GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0016887; GO:0019901; GO:0051082; GO:0061077; GO:0140662; GO:1901856; GO:1903427; GO:1903751,chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0140657,RNA binding; catalytic activity; nucleoplasm; mitochondrion; protein folding; hydrolase activity; organelle; protein folding chaperone; ATP-dependent activity
OG_04236,1.1084459392774926,FUN_017757-T1,Peve_00033745,Pocillopora_meandrina_HIv1___RNAseq.g426.t1,three_way,66.6565,FUN_017757-T1,Q5SS90,,,,,34.7,245.0,5.6e-26,119.8,sp|Q5SS90|CG057_MOUSE Uncharacterized protein C7orf57 homolog OS=Mus musculus OX=10090 GN=Gm11992 PE=1 SV=1,,,,,,
OG_04243,3.7522609983734863,FUN_017765-T1,Peve_00003282,Pocillopora_meandrina_HIv1___RNAseq.g446.t1,three_way,79.75516666666667,FUN_017765-T1,Q5RD44,B3A2_PONAB,,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Solute carrier family 4 member 2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),43.1,1043.0,1.9e-207,724.5,sp|Q5RD44|B3A2_PONAB Anion exchange protein 2 OS=Pongo abelii OX=9601 GN=SLC4A2 PE=2 SV=2,GO:0016323; GO:0016324; GO:0030316; GO:0032956; GO:0043377; GO:0045124; GO:0051453; GO:0140900; GO:2000565,"negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]",apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323],chloride:bicarbonate antiporter activity [GO:0140900],GO:0005215; GO:0030154,transporter activity; cell differentiation
OG_04255,2.070565014895123,FUN_017786-T1,Peve_00040532,Pocillopora_meandrina_HIv1___RNAseq.g9521.t1,three_way,78.56866666666667,FUN_017786-T1,A0A455ZMR3,,,,,31.7,322.0,3.7999999999999996e-35,150.2,sp|A0A455ZMR3|PPZD_METMF 2-oxoglutarate-Fe(II) type oxidoreductase ppzD OS=Metarhizium majus (strain ARSEF 297) OX=1276143 GN=ppzD PE=1 SV=1,,,,,,
OG_04258,1.6091201736061471,FUN_017800-T1,Peve_00040758,Pocillopora_meandrina_HIv1___RNAseq.g9529.t1,three_way,80.79866666666666,FUN_017800-T1,Q32LC9,,,,,65.8,237.0,4e-99,362.8,sp|Q32LC9|ZN330_BOVIN Zinc finger protein 330 OS=Bos taurus OX=9913 GN=ZNF330 PE=2 SV=1,,,,,,
OG_04265,3.4669682774771,FUN_017815-T1,Peve_00006859,Pocillopora_meandrina_HIv1___RNAseq.g9541.t1,three_way,67.37566666666666,FUN_017815-T1,P22727,WNT6_MOUSE,,Protein Wnt-6,Mus musculus (Mouse),41.3,366.0,3e-82,307.0,sp|P22727|WNT6_MOUSE Protein Wnt-6 OS=Mus musculus OX=10090 GN=Wnt6 PE=1 SV=2,GO:0001658; GO:0005102; GO:0005576; GO:0005788; GO:0007165; GO:0007267; GO:0009798; GO:0009887; GO:0009986; GO:0010628; GO:0016055; GO:0031012; GO:0042475; GO:0045893; GO:0060684; GO:0070172; GO:0072079; GO:0072080,animal organ morphogenesis [GO:0009887]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell signaling [GO:0007267]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule development [GO:0072080]; nephron tubule formation [GO:0072079]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],signaling receptor binding [GO:0005102],GO:0005576; GO:0006355; GO:0023052; GO:0030312; GO:0031012; GO:0048856,extracellular region; regulation of DNA-templated transcription; signaling; external encapsulating structure; extracellular matrix; anatomical structure development
OG_04266,2.491465346120618,FUN_017816-T1,Peve_00006857,Pocillopora_meandrina_HIv1___RNAseq.g9540.t1,three_way,72.20233333333334,FUN_017816-T1,Q2LMP1,WNT3A_CHICK,,Protein Wnt-3a,Gallus gallus (Chicken),41.7,314.0,2.3000000000000002e-71,270.8,sp|Q2LMP1|WNT3A_CHICK Protein Wnt-3a OS=Gallus gallus OX=9031 GN=WNT3A PE=1 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0005640; GO:0005783; GO:0005829; GO:0005886; GO:0009953; GO:0010628; GO:0010831; GO:0030182; GO:0030509; GO:0035108; GO:0040036; GO:0042472; GO:0045165; GO:0045663; GO:0045743; GO:0045944; GO:0048263; GO:0050679; GO:0060070; GO:0060173; GO:0060828; GO:0061303; GO:0090263,BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cornea development in camera-type eye [GO:0061303]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0005783; GO:0005829; GO:0005886; GO:0006355; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; endoplasmic reticulum; cytosol; plasma membrane; regulation of DNA-templated transcription; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_04272,1.1759388677123863,FUN_017831-T1,Peve_00029496,Pocillopora_meandrina_HIv1___TS.g23177.t1,three_way,86.089,,,,,,,,,,,,,,,,,
OG_04273,1.3604131893997498,FUN_017832-T1,Peve_00009486,Pocillopora_meandrina_HIv1___RNAseq.g9637.t3,three_way,63.501,FUN_017832-T1,Q28EW0,TM87A_XENTR,,Transmembrane protein 87A (Elkin1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),53.1,388.0,5.7e-112,406.8,sp|Q28EW0|TM87A_XENTR Transmembrane protein 87A OS=Xenopus tropicalis OX=8364 GN=tmem87a PE=2 SV=1,GO:0000139; GO:0005886; GO:0032580; GO:0050976; GO:0071260,cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_04276,2.2744176734543737,FUN_017835-T1,Peve_00027711,Pocillopora_meandrina_HIv1___RNAseq.g9593.t1,three_way,65.258,FUN_017835-T1,E1C1L6,ENTP5_CHICK,,Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5),Gallus gallus (Chicken),47.1,380.0,1.0000000000000001e-88,328.6,sp|E1C1L6|ENTP5_CHICK Ectonucleoside triphosphate diphosphohydrolase 5 OS=Gallus gallus OX=9031 GN=ENTPD5 PE=3 SV=1,GO:0004382; GO:0005576; GO:0005783; GO:0006011; GO:0006256; GO:0006487; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003,'de novo' post-translational protein folding [GO:0051084]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-alpha-D-glucose metabolic process [GO:0006011],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],ADP phosphatase activity [GO:0043262]; CDP phosphatase activity [GO:0036384]; GDP phosphatase activity [GO:0004382]; IDP phosphatase activity [GO:1990003]; UDP phosphatase activity [GO:0045134],GO:0003824; GO:0005576; GO:0005783; GO:0006457; GO:0009101; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; extracellular region; endoplasmic reticulum; protein folding; glycoprotein biosynthetic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04279,1.2377759529094063,FUN_017840-T1,Peve_00011468,Pocillopora_meandrina_HIv1___RNAseq.g9633.t1,three_way,76.64583333333333,FUN_017840-T1,F4JYJ3,,,,,35.1,225.0,6.599999999999997e-29,129.8,sp|F4JYJ3|SFH11_ARATH Phosphatidylinositol/phosphatidylcholine transfer protein SFH11 OS=Arabidopsis thaliana OX=3702 GN=SFH11 PE=3 SV=1,,,,,,
OG_04281,2.526032815540661,FUN_017843-T1,Peve_00018632,Pocillopora_meandrina_HIv1___RNAseq.g9587.t3,three_way,50.5255,,,,,,,,,,,,,,,,,
OG_04282,2.1017256500159003,FUN_017845-T1,Peve_00018633,Pocillopora_meandrina_HIv1___RNAseq.g9586.t1,three_way,63.23116666666667,,,,,,,,,,,,,,,,,
OG_04286,2.84199265307187,FUN_017849-T1,Peve_00013266,Pocillopora_meandrina_HIv1___RNAseq.g9583.t1,three_way,76.97,FUN_017849-T1,P57788,,,,,32.0,419.0,1.8e-52,208.4,sp|P57788|MOT4_CHICK Monocarboxylate transporter 4 OS=Gallus gallus OX=9031 GN=SLC16A3 PE=2 SV=2,,,,,,
OG_04287,1.2837791126632427,FUN_017850-T1,Peve_00019991,Pocillopora_meandrina_HIv1___RNAseq.g9582.t1,three_way,53.20133333333334,FUN_017850-T1,C5FWH1,,,,,34.9,146.0,8.9e-14,79.7,sp|C5FWH1|LIS1_ARTOC Nuclear distribution protein PAC1 OS=Arthroderma otae (strain ATCC MYA-4605 / CBS 113480) OX=554155 GN=PAC1 PE=3 SV=1,,,,,,
OG_04292,1.35650934423851,FUN_017858-T1,Peve_00032944,Pocillopora_meandrina_HIv1___RNAseq.g9575.t1,three_way,75.3595,FUN_017858-T1,Q9GLM4,,,,,46.3,428.0,1.5e-111,404.8,sp|Q9GLM4|TENS1_BOVIN Tensin-1 OS=Bos taurus OX=9913 GN=TNS1 PE=2 SV=2,,,,,,
OG_04300,2.1303697569619966,FUN_017869-T1,Peve_00023912,Pocillopora_meandrina_HIv1___RNAseq.g9555.t1,three_way,85.59933333333333,FUN_017869-T1,P80205,OTX1_MOUSE,,Homeobox protein OTX1 (Orthodenticle homolog 1),Mus musculus (Mouse),69.2,91.0,2.4e-26,120.6,sp|P80205|OTX1_MOUSE Homeobox protein OTX1 OS=Mus musculus OX=10090 GN=Otx1 PE=2 SV=1,GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0009952; GO:0022037; GO:0030900; GO:0030901; GO:0042472; GO:0048852,anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; forebrain development [GO:0030900]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_04302,3.126362944607269,FUN_017878-T1,Peve_00021114,Pocillopora_meandrina_HIv1___TS.g7116.t1,three_way,74.763,FUN_017878-T1,P97259,,,,,45.1,587.0,8.600000000000001e-145,515.4,"sp|P97259|MGT5A_CRIGR Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Cricetulus griseus OX=10029 GN=MGAT5 PE=1 SV=1",,,,,,
OG_04305,1.4725814283887153,FUN_017890-T1,Peve_00019164,Pocillopora_meandrina_HIv1___RNAseq.g9666.t1,three_way,81.693,FUN_017890-T1,Q5EAB6,PMGT1_BOVIN,,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)",Bos taurus (Bovine),52.1,657.0,1.9e-201,703.7,"sp|Q5EAB6|PMGT1_BOVIN Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Bos taurus OX=9913 GN=POMGNT1 PE=2 SV=1",GO:0000139; GO:0006493; GO:0008375; GO:0016020; GO:0016266; GO:0030145; GO:0030246; GO:0047223,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi membrane [GO:0000139]; membrane [GO:0016020],"acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]",GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04306,1.1310572665045733,FUN_017891-T1,Peve_00019165,Pocillopora_meandrina_HIv1___TS.g23200.t2,three_way,53.3605,,,,,,,,,,,,,,,,,
OG_04309,1.1885787484507804,FUN_017897-T1,Peve_00000237,Pocillopora_meandrina_HIv1___RNAseq.g343.t1,three_way,80.214,FUN_017897-T1,Q6AXJ9,,,,,63.9,352.0,1.4000000000000001e-126,454.1,sp|Q6AXJ9|CDKL1_DANRE Cyclin-dependent kinase-like 1 OS=Danio rerio OX=7955 GN=cdkl1 PE=2 SV=1,,,,,,
OG_04311,1.0496848355579596,FUN_017899-T1,Peve_00000241,Pocillopora_meandrina_HIv1___RNAseq.g341.t1,three_way,85.13083333333333,FUN_017899-T1,Q8ND07,,,,,40.7,477.0,4.6e-76,287.0,sp|Q8ND07|BBOF1_HUMAN Basal body-orientation factor 1 OS=Homo sapiens OX=9606 GN=BBOF1 PE=1 SV=3,,,,,,
OG_04313,2.637682117726381,FUN_017901-T1,Peve_00000244,Pocillopora_meandrina_HIv1___RNAseq.g335.t1,three_way,71.97016666666667,FUN_017901-T1,A7J1T0,M313B_XENLA,,Mitogen-activated protein kinase kinase kinase 13-B (EC 2.7.11.25),Xenopus laevis (African clawed frog),67.4,387.0,1.3e-155,551.6,sp|A7J1T0|M313B_XENLA Mitogen-activated protein kinase kinase kinase 13-B OS=Xenopus laevis OX=8355 GN=map3k13-b PE=2 SV=1,GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0007254; GO:0016020; GO:0060255; GO:0080090; GO:0106310,JNK cascade [GO:0007254]; regulation of macromolecule metabolic process [GO:0060255]; regulation of primary metabolic process [GO:0080090],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04318,2.2435425242060405,FUN_017918-T1,Peve_00013068,Pocillopora_meandrina_HIv1___RNAseq.g326.t1,three_way,47.547,,,,,,,,,,,,,,,,,
OG_04321,1.550711086923341,FUN_017923-T1,Peve_00015799,Pocillopora_meandrina_HIv1___TS.g7057.t1,three_way,91.55833333333334,FUN_017923-T1,P63154,,,,,71.1,682.0,3e-184,646.7,sp|P63154|CRNL1_MOUSE Crooked neck-like protein 1 OS=Mus musculus OX=10090 GN=Crnkl1 PE=1 SV=1,,,,,,
OG_04322,1.2087579047783972,FUN_017924-T1,Peve_00035877,Pocillopora_meandrina_HIv1___TS.g7056.t1,three_way,80.122,FUN_017924-T1,Q1JQD7,MOCS1_BOVIN,,"Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]",Bos taurus (Bovine),70.1,344.0,5.9999999999999995e-142,505.4,sp|Q1JQD7|MOCS1_BOVIN Molybdenum cofactor biosynthesis protein 1 OS=Bos taurus OX=9913 GN=MOCS1 PE=2 SV=2,GO:0005525; GO:0006777; GO:0046872; GO:0051539; GO:0061798; GO:0061799,Mo-molybdopterin cofactor biosynthetic process [GO:0006777],,"4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]",GO:0003824; GO:0016829,catalytic activity; lyase activity
OG_04323,1.386910086152739,FUN_017925-T1,Peve_00001606,Pocillopora_meandrina_HIv1___RNAseq.g289.t1,three_way,96.3535,FUN_017925-T1,P30883,,,,,94.6,443.0,1.2e-250,866.7,sp|P30883|TBB4_XENLA Tubulin beta-4 chain OS=Xenopus laevis OX=8355 GN=tubb4 PE=1 SV=1,,,,,,
OG_04324,2.787827170689266,FUN_017926-T2,Peve_00001604,Pocillopora_meandrina_HIv1___RNAseq.g288.t1,three_way,71.02733333333333,FUN_017926-T2,Q7TNC6,KI26B_MOUSE,,Kinesin-like protein KIF26B,Mus musculus (Mouse),39.8,814.0,1.3e-130,469.9,sp|Q7TNC6|KI26B_MOUSE Kinesin-like protein KIF26B OS=Mus musculus OX=10090 GN=Kif26b PE=1 SV=3,GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017; GO:0022409; GO:0030010; GO:0072092,establishment of cell polarity [GO:0030010]; microtubule-based movement [GO:0007018]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092],cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0007018; GO:0007163; GO:0008092; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule-based movement; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_04326,2.015509378978224,FUN_017929-T1,Peve_00001599,Pocillopora_meandrina_HIv1___RNAseq.g283.t1,three_way,89.11483333333334,FUN_017929-T1,O75165,DJC13_HUMAN,,DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8),Homo sapiens (Human),66.3,1643.0,0.0,2240.3,sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5,GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0070062; GO:1902954; GO:2000641,endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667],,GO:0005829; GO:0005886; GO:0016192; GO:0030154; GO:0043226,cytosol; plasma membrane; vesicle-mediated transport; cell differentiation; organelle
OG_04329,1.6935434914742966,FUN_017936-T1,Peve_00001591,Pocillopora_meandrina_HIv1___RNAseq.g395.t1,three_way,80.378,FUN_017936-T1,Q9GKS9,,,,,39.4,797.0,9.999999999999998e-128,459.1,sp|Q9GKS9|DZAN1_MACFA Double zinc ribbon and ankyrin repeat-containing protein 1 OS=Macaca fascicularis OX=9541 GN=DZANK1 PE=2 SV=3,,,,,,
OG_04330,1.8195170376205927,FUN_017938-T1,Peve_00001589,Pocillopora_meandrina_HIv1___RNAseq.g218.t1,three_way,75.231,FUN_017938-T1,Q7TPM9,,,,,34.7,507.0,4.4e-71,270.8,sp|Q7TPM9|MTMRA_MOUSE Myotubularin-related protein 10 OS=Mus musculus OX=10090 GN=Mtmr10 PE=1 SV=2,,,,,,
OG_04331,1.9102096663972767,FUN_017939-T1,Peve_00001588,Pocillopora_meandrina_HIv1___RNAseq.g219.t1,three_way,53.27133333333334,FUN_017939-T1,Q6P0D7,,,,,42.1,449.0,7.2e-89,330.1,sp|Q6P0D7|MPP7_DANRE MAGUK p55 subfamily member 7 OS=Danio rerio OX=7955 GN=mpp7 PE=1 SV=1,,,,,,
OG_04335,3.4627566181436022,FUN_017947-T1,Peve_00000380,Pocillopora_meandrina_HIv1___RNAseq.g25233.t1,three_way,66.458,FUN_017947-T1,F1M0Z1,TRIO_RAT,,Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein),Rattus norvegicus (Rat),44.3,314.0,2.1999999999999998e-69,265.8,sp|F1M0Z1|TRIO_RAT Triple functional domain protein OS=Rattus norvegicus OX=10116 GN=Trio PE=1 SV=4,GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310,axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170],cell projection [GO:0042995]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04336,6.137564238648587,FUN_017948-T1,Peve_00000381,Pocillopora_meandrina_HIv1___RNAseq.g25232.t1,three_way,82.87233333333333,,,,,,,,,,,,,,,,,
OG_04337,1.6042044791656005,FUN_017950-T1,Peve_00000377,Pocillopora_meandrina_HIv1___RNAseq.g25230.t1,three_way,61.35916666666667,FUN_017950-T1,Q8T689,,,,,26.9,583.0,8.299999999999999e-46,188.0,sp|Q8T689|ABCG4_DICDI ABC transporter G family member 4 OS=Dictyostelium discoideum OX=44689 GN=abcG4 PE=3 SV=1,,,,,,
OG_04338,3.66783939892824,FUN_017952-T1,Peve_00001586,Pocillopora_meandrina_HIv1___RNAseq.g224.t1,three_way,96.399,FUN_017952-T1,Q7T1R4,,,,,91.5,117.0,8.8e-61,235.3,sp|Q7T1R4|FOXA2_XENTR Forkhead box protein A2 OS=Xenopus tropicalis OX=8364 GN=foxa2 PE=2 SV=1,,,,,,
OG_04342,1.0998580772763122,FUN_017959-T1,Peve_00000387,Pocillopora_meandrina_HIv1___RNAseq.g25237.t1,three_way,74.73633333333333,FUN_017959-T1,Q9H8Y8,,,,,65.2,282.0,9e-101,368.6,sp|Q9H8Y8|GORS2_HUMAN Golgi reassembly-stacking protein 2 OS=Homo sapiens OX=9606 GN=GORASP2 PE=1 SV=3,,,,,,
OG_04343,1.798800135434944,FUN_017964-T1,Peve_00000391,Pocillopora_meandrina_HIv1___TS.g25524.t1,three_way,75.0295,FUN_017964-T1,O00409,FOXN3_HUMAN,,Forkhead box protein N3 (Checkpoint suppressor 1),Homo sapiens (Human),44.8,281.0,4.799999999999999e-53,210.3,sp|O00409|FOXN3_HUMAN Forkhead box protein N3 OS=Homo sapiens OX=9606 GN=FOXN3 PE=1 SV=1,GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0006355; GO:0007095; GO:0045892; GO:0097094,craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],chromatin [GO:0000785]; nucleus [GO:0005634],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04346,2.360122940515301,FUN_017970-T1,Peve_00000395,Pocillopora_meandrina_HIv1___TS.g25528.t2,three_way,63.346833333333336,FUN_017970-T1,Q9VM21,,,,,33.0,624.0,2.1999999999999997e-53,212.2,sp|Q9VM21|GUDU_DROME Armadillo repeat-containing protein gudu OS=Drosophila melanogaster OX=7227 GN=gudu PE=2 SV=1,,,,,,
OG_04348,1.6237880091101216,FUN_017974-T1,Peve_00027236,Pocillopora_meandrina_HIv1___RNAseq.g25289.t1,three_way,57.09133333333333,,,,,,,,,,,,,,,,,
OG_04355,1.0899845003424904,FUN_018005-T1,Peve_00015726,Pocillopora_meandrina_HIv1___RNAseq.g25259.t1,three_way,82.79083333333334,FUN_018005-T1,A7E2Z2,,,,,48.1,736.0,9e-189,661.8,sp|A7E2Z2|EZH1_BOVIN Histone-lysine N-methyltransferase EZH1 OS=Bos taurus OX=9913 GN=EZH1 PE=2 SV=2,,,,,,
OG_04356,1.533658619554626,FUN_018006-T1,Peve_00015728,Pocillopora_meandrina_HIv1___RNAseq.g25258.t1,three_way,74.419,FUN_018006-T1,O43264,ZW10_HUMAN,,Centromere/kinetochore protein zw10 homolog,Homo sapiens (Human),38.4,787.0,2.2e-143,511.1,sp|O43264|ZW10_HUMAN Centromere/kinetochore protein zw10 homolog OS=Homo sapiens OX=9606 GN=ZW10 PE=1 SV=3,GO:0000070; GO:0000132; GO:0000776; GO:0000922; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0005828; GO:0005829; GO:0006888; GO:0006890; GO:0007030; GO:0007080; GO:0007094; GO:0007096; GO:0015031; GO:0016020; GO:0019237; GO:0034501; GO:0051301; GO:0051321; GO:0051988; GO:0065003; GO:0070939; GO:1990423,"cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922],centromeric DNA binding [GO:0019237],GO:0003677; GO:0005634; GO:0005783; GO:0005811; GO:0005829; GO:0007010; GO:0007059; GO:0016192; GO:0022414; GO:0043226; GO:0065003,DNA binding; nucleus; endoplasmic reticulum; lipid droplet; cytosol; cytoskeleton organization; chromosome segregation; vesicle-mediated transport; reproductive process; organelle; protein-containing complex assembly
OG_04361,1.917504988709512,FUN_018012-T1,Peve_00000401,Pocillopora_meandrina_HIv1___RNAseq.g25253.t1,three_way,51.12533333333333,,,,,,,,,,,,,,,,,
OG_04365,1.9597641578514773,FUN_018018-T2,Peve_00026633,Pocillopora_meandrina_HIv1___RNAseq.g25292.t1,three_way,78.64166666666667,FUN_018018-T2,P30260,CDC27_HUMAN,,Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC),Homo sapiens (Human),51.0,843.0,4.8e-117,423.7,sp|P30260|CDC27_HUMAN Cell division cycle protein 27 homolog OS=Homo sapiens OX=9606 GN=CDC27 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0019903; GO:0031145; GO:0031175; GO:0051301; GO:0051445; GO:0070936; GO:0070979; GO:0072686; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; neuron projection development [GO:0031175]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],protein phosphatase binding [GO:0019903],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; microtubule organizing center; cytosol; protein catabolic process; organelle
OG_04366,1.2484612459960427,FUN_018019-T1,Peve_00026634,Pocillopora_meandrina_HIv1___RNAseq.29613_t,three_way,80.27433333333333,FUN_018019-T1,Q9I3S3,,,,,66.9,314.0,3.5000000000000005e-125,449.5,sp|Q9I3S3|GBUA_PSEAE Guanidinobutyrase OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=gbuA PE=1 SV=1,,,,,,
OG_04367,2.093392553050196,FUN_018023-T1,Peve_00005730,Pocillopora_meandrina_HIv1___RNAseq.g25298.t1,three_way,70.57966666666667,FUN_018023-T1,Q9WU06,AVIL_RAT,,Advillin (Peripheral nervous system villin-like protein) (Pervin),Rattus norvegicus (Rat),40.0,834.0,9e-156,552.4,sp|Q9WU06|AVIL_RAT Advillin OS=Rattus norvegicus OX=10116 GN=Avil PE=2 SV=2,GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480,actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005856; GO:0008092; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeletal protein binding; lipid binding; organelle; cilium organization; anatomical structure development
OG_04368,1.6277617515968466,FUN_018026-T1,Peve_00005737,Pocillopora_meandrina_HIv1___RNAseq.g25300.t1,three_way,69.16366666666667,FUN_018026-T1,Q9Z0W3,,,,,33.6,1163.0,8.8e-181,636.0,sp|Q9Z0W3|NU160_MOUSE Nuclear pore complex protein Nup160 OS=Mus musculus OX=10090 GN=Nup160 PE=1 SV=2,,,,,,
OG_04372,2.003462664673958,FUN_018031-T1,Peve_00025689,Pocillopora_meandrina_HIv1___RNAseq.g25357.t1,three_way,55.23,FUN_018031-T1,O35206,COFA1_MOUSE,,Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV)],Mus musculus (Mouse),35.1,239.0,3.9999999999999994e-28,127.5,sp|O35206|COFA1_MOUSE Collagen alpha-1(XV) chain OS=Mus musculus OX=10090 GN=Col15a1 PE=1 SV=2,GO:0005581; GO:0005604; GO:0005615; GO:0005783; GO:0007155; GO:0062023,cell adhesion [GO:0007155],basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],,GO:0005615; GO:0005783; GO:0007155; GO:0030312; GO:0031012; GO:0043226,extracellular space; endoplasmic reticulum; cell adhesion; external encapsulating structure; extracellular matrix; organelle
OG_04374,1.0727416909969096,FUN_018035-T2,Peve_00020009,Pocillopora_meandrina_HIv1___RNAseq.g25361.t2,three_way,68.1825,FUN_018035-T2,Q6P121,,,,,35.6,303.0,6e-37,156.8,sp|Q6P121|HYCCI_DANRE Hyccin OS=Danio rerio OX=7955 GN=hycc1 PE=2 SV=1,,,,,,
OG_04376,1.4526328966554485,FUN_018042-T1,Peve_00021780,Pocillopora_meandrina_HIv1___RNAseq.g25354.t1,three_way,62.6125,FUN_018042-T1,P25931,,,,,24.0,263.0,3.1e-06,54.7,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_04378,3.216035492553276,FUN_018044-T1,Peve_00021778,Pocillopora_meandrina_HIv1___RNAseq.g25351.t1,three_way,82.307,FUN_018044-T1,Q3ZCH9,,,,,61.7,248.0,2.0000000000000001e-88,327.0,sp|Q3ZCH9|HDHD2_BOVIN Haloacid dehalogenase-like hydrolase domain-containing protein 2 OS=Bos taurus OX=9913 GN=HDHD2 PE=2 SV=1,,,,,,
OG_04379,1.7988219697964487,FUN_018045-T1,Peve_00021776,Pocillopora_meandrina_HIv1___RNAseq.g25350.t1,three_way,76.90433333333333,FUN_018045-T1,Q99741,CDC6_HUMAN,,Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6),Homo sapiens (Human),42.7,571.0,9.5e-109,395.6,sp|Q99741|CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens OX=9606 GN=CDC6 PE=1 SV=1,GO:0000076; GO:0000079; GO:0000166; GO:0000922; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0016887; GO:0030071; GO:0032467; GO:0033314; GO:0045171; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:0072686; GO:0120283; GO:1904117; GO:1904385,cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint signaling [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; traversing start control point of mitotic cell cycle [GO:0007089],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; protein serine/threonine kinase binding [GO:0120283],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226,DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle
OG_04380,2.299013606883315,FUN_018046-T1,Peve_00021796,Pocillopora_meandrina_HIv1___RNAseq.g25349.t2,three_way,79.40316666666666,FUN_018046-T1,C3YZ51,,,,,67.8,410.0,3e-144,513.1,sp|C3YZ51|UBA5_BRAFL Ubiquitin-like modifier-activating enzyme 5 OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_113714 PE=3 SV=1,,,,,,
OG_04381,2.3267968572988087,FUN_018086-T1,Peve_00021774,Pocillopora_meandrina_HIv1___RNAseq.g25348.t1,three_way,67.76233333333333,FUN_018086-T1,A0JM23,,,,,37.7,1131.0,2.1e-142,508.4,sp|A0JM23|NPHP3_XENTR Nephrocystin-3 OS=Xenopus tropicalis OX=8364 GN=nphp3 PE=2 SV=2,,,,,,
OG_04383,2.527715699032375,FUN_018089-T1,Peve_00034409,Pocillopora_meandrina_HIv1___RNAseq.g25344.t1,three_way,74.77966666666667,FUN_018089-T1,A6QQX9,TM163_BOVIN,,Transmembrane protein 163,Bos taurus (Bovine),35.8,215.0,2.7e-29,130.6,sp|A6QQX9|TM163_BOVIN Transmembrane protein 163 OS=Bos taurus OX=9913 GN=TMEM163 PE=2 SV=1,GO:0005765; GO:0005886; GO:0008270; GO:0030672; GO:0031901; GO:0031902; GO:0042552; GO:0140882,myelination [GO:0042552]; zinc export across plasma membrane [GO:0140882],early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],zinc ion binding [GO:0008270],GO:0005886; GO:0055085,plasma membrane; transmembrane transport
OG_04384,1.7917106072583815,FUN_018090-T1,Peve_00017613,Pocillopora_meandrina_HIv1___RNAseq.g25343.t1,three_way,84.46766666666666,FUN_018090-T1,Q64521,GPDM_MOUSE,,"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (Protein TISP38)",Mus musculus (Mouse),62.2,717.0,1.6999999999999998e-259,896.7,"sp|Q64521|GPDM_MOUSE Glycerol-3-phosphate dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Gpd2 PE=1 SV=2",GO:0004368; GO:0005509; GO:0005739; GO:0005743; GO:0006072; GO:0006094; GO:0006127; GO:0019563; GO:0035264; GO:0043010,camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate shuttle [GO:0006127]; multicellular organism growth [GO:0035264],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368],GO:0003824; GO:0005739; GO:0005975; GO:0016491; GO:0043226; GO:0048856; GO:0055086; GO:1901135,catalytic activity; mitochondrion; carbohydrate metabolic process; oxidoreductase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04385,2.443161463185981,FUN_018091-T1,Peve_00001666,Pocillopora_meandrina_HIv1___TS.g25577.t1,three_way,73.79583333333333,FUN_018091-T1,Q6ZS30,,,,,36.6,2500.0,0.0,1536.9,sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3,,,,,,
OG_04386,1.294400386189852,FUN_018124-T1,Peve_00001655,Pocillopora_meandrina_HIv1___RNAseq.g25306.t1,three_way,75.08200000000001,FUN_018124-T1,Q28ES4,,,,,39.0,492.0,4.8e-84,313.5,sp|Q28ES4|S22FL_XENTR Solute carrier family 22 member 15-like OS=Xenopus tropicalis OX=8364 GN=slc22a15b PE=2 SV=1,,,,,,
OG_04387,2.039450192337669,FUN_018138-T1,Peve_00001660,Pocillopora_meandrina_HIv1___RNAseq.g25310.t1,three_way,71.25666666666666,FUN_018138-T1,Q9Y6B7,AP4B1_HUMAN,,AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin),Homo sapiens (Human),38.5,748.0,2.7000000000000003e-133,477.6,sp|Q9Y6B7|AP4B1_HUMAN AP-4 complex subunit beta-1 OS=Homo sapiens OX=9606 GN=AP4B1 PE=1 SV=2,GO:0005802; GO:0005829; GO:0006605; GO:0006886; GO:0008104; GO:0016192; GO:0030124; GO:0030131; GO:0030276; GO:0031904; GO:0032588; GO:0061938; GO:0098541,intracellular protein transport [GO:0006886]; protein localization [GO:0008104]; protein localization to somatodendritic compartment [GO:0061938]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192],AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic side of trans-Golgi network transport vesicle membrane [GO:0098541]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],clathrin binding [GO:0030276],GO:0005829; GO:0006886; GO:0016192,cytosol; intracellular protein transport; vesicle-mediated transport
OG_04393,2.089466673329285,FUN_018395-T1,Peve_00031706,Pocillopora_meandrina_HIv1___RNAseq.16757_t,three_way,77.64733333333334,,,,,,,,,,,,,,,,,
OG_04395,2.17771205663381,FUN_018398-T1,Peve_00032288,Pocillopora_meandrina_HIv1___TS.g23627.t2,three_way,73.27966666666667,FUN_018398-T1,P70168,IMB1_MOUSE,,Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG),Mus musculus (Mouse),64.6,878.0,0.0,1105.5,sp|P70168|IMB1_MOUSE Importin subunit beta-1 OS=Mus musculus OX=10090 GN=Kpnb1 PE=1 SV=2,GO:0005654; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0010494; GO:0019904; GO:0030953; GO:0031267; GO:0031965; GO:0032991; GO:0040001; GO:0042564; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307,astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; protein domain specific binding [GO:0019904]; small GTPase binding [GO:0031267],GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0007010; GO:0007018; GO:0043226; GO:0140104,nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; microtubule-based movement; organelle; molecular carrier activity
OG_04396,2.512776486502905,FUN_018401-T1,Peve_00031702,Pocillopora_meandrina_HIv1___RNAseq.g10160.t1,three_way,68.175,FUN_018401-T1,Q6DIM3,TBD_XENTR,,Tubulin delta chain (Delta-tubulin),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),31.4,255.0,1.5e-26,122.5,sp|Q6DIM3|TBD_XENTR Tubulin delta chain OS=Xenopus tropicalis OX=8364 GN=tubd1 PE=2 SV=1,GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005814; GO:0005874; GO:0005929; GO:0007017; GO:0030030; GO:0045880,cell projection organization [GO:0030030]; microtubule-based process [GO:0007017]; positive regulation of smoothened signaling pathway [GO:0045880],centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634],GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005634; GO:0005929; GO:0043226,structural molecule activity; nucleus; cilium; organelle
OG_04397,2.894224081214256,FUN_018402-T1,Peve_00033494,Pocillopora_meandrina_HIv1___RNAseq.16819_t,three_way,58.857,FUN_018402-T1,Q8BVT6,,,,,27.0,429.0,2.6e-26,122.1,sp|Q8BVT6|PP2D1_MOUSE Protein phosphatase 2C-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pp2d1 PE=2 SV=1,,,,,,
OG_04403,2.55226591283864,FUN_018416-T1,Peve_00031691,Pocillopora_meandrina_HIv1___RNAseq.g10170.t1,three_way,54.97866666666667,FUN_018416-T1,Q49A88,CCD14_HUMAN,,Coiled-coil domain-containing protein 14,Homo sapiens (Human),29.7,229.0,3.1e-18,95.5,sp|Q49A88|CCD14_HUMAN Coiled-coil domain-containing protein 14 OS=Homo sapiens OX=9606 GN=CCDC14 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005929; GO:0015630; GO:0021762; GO:0034451; GO:0036064; GO:0071539,protein localization to centrosome [GO:0071539]; substantia nigra development [GO:0021762],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630],,GO:0005815; GO:0005856; GO:0005929; GO:0043226; GO:0048856,microtubule organizing center; cytoskeleton; cilium; organelle; anatomical structure development
OG_04404,1.0984017175967105,FUN_018418-T2,Peve_00031690,Pocillopora_meandrina_HIv1___RNAseq.g10175.t1,three_way,54.339,,,,,,,,,,,,,,,,,
OG_04405,1.6257623503825154,FUN_018423-T1,Peve_00031689,Pocillopora_meandrina_HIv1___RNAseq.g10176.t1,three_way,63.1915,,,,,,,,,,,,,,,,,
OG_04410,1.946361832183599,FUN_018429-T1,Peve_00007316,Pocillopora_meandrina_HIv1___RNAseq.g10178.t1,three_way,79.36266666666667,FUN_018429-T1,P20664,,,,,57.6,399.0,1.9e-133,477.2,sp|P20664|PRI1_MOUSE DNA primase small subunit OS=Mus musculus OX=10090 GN=Prim1 PE=1 SV=1,,,,,,
OG_04414,2.0650886594937745,FUN_018521-T1,Peve_00007312,Pocillopora_meandrina_HIv1___RNAseq.g10181.t1,three_way,76.60266666666666,FUN_018521-T1,Q90ZA1,PARN_XENLA,,Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease) (parn-A),Xenopus laevis (African clawed frog),46.5,563.0,2.4999999999999998e-139,497.3,sp|Q90ZA1|PARN_XENLA Poly(A)-specific ribonuclease PARN OS=Xenopus laevis OX=8355 GN=parn PE=1 SV=1,GO:0000175; GO:0000289; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0043169; GO:0046872; GO:0051321; GO:1990431; GO:1990432,meiotic cell cycle [GO:0051321]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; priRNA 3'-end processing [GO:1990431]; siRNA 3'-end processing [GO:1990432],cytoplasm [GO:0005737]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; reproductive process; organelle; catalytic activity, acting on RNA"
OG_04417,1.682838393516242,FUN_018525-T1,Peve_00039210,Pocillopora_meandrina_HIv1___RNAseq.g10001.t1,three_way,54.96333333333333,,,,,,,,,,,,,,,,,
OG_04420,1.5430016985875905,FUN_018529-T2,Peve_00039204,Pocillopora_meandrina_HIv1___RNAseq.g9995.t1,three_way,74.336,FUN_018529-T2,O15460,P4HA2_HUMAN,,"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)",Homo sapiens (Human),41.8,538.0,9.7e-114,412.1,sp|O15460|P4HA2_HUMAN Prolyl 4-hydroxylase subunit alpha-2 OS=Homo sapiens OX=9606 GN=P4HA2 PE=1 SV=1,GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0031418; GO:0043231,,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656],GO:0003824; GO:0005654; GO:0005783; GO:0005829; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; endoplasmic reticulum; cytosol; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_04421,2.112943901158401,FUN_018530-T2,Peve_00039202,Pocillopora_meandrina_HIv1___RNAseq.g9980.t1,three_way,91.0425,FUN_018530-T2,Q01082,SPTB2_HUMAN,,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",Homo sapiens (Human),49.4,2310.0,0.0,2035.0,"sp|Q01082|SPTB2_HUMAN Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTBN1 PE=1 SV=2",GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007009; GO:0007417; GO:0008091; GO:0014069; GO:0014731; GO:0021556; GO:0030036; GO:0030054; GO:0030506; GO:0030673; GO:0030864; GO:0031430; GO:0032437; GO:0032743; GO:0042995; GO:0043001; GO:0045296; GO:0051015; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:0098978; GO:1903076; GO:1903078,actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; central nervous system development [GO:0007417]; central nervous system formation [GO:0021556]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200],GO:0000910; GO:0003723; GO:0005198; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0061024; GO:0072659,cytokinesis; RNA binding; structural molecule activity; nucleolus; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; membrane organization; protein localization to plasma membrane
OG_04423,3.803634235040179,FUN_018532-T1,Peve_00039214,Pocillopora_meandrina_HIv1___RNAseq.g9982.t1,three_way,57.187333333333335,,,,,,,,,,,,,,,,,
OG_04425,1.5120031353008765,FUN_018536-T1,Peve_00006701,Pocillopora_meandrina_HIv1___RNAseq.g9988.t1,three_way,84.17433333333334,FUN_018536-T1,Q0P5W1,VPS8_MOUSE,,Vacuolar protein sorting-associated protein 8 homolog,Mus musculus (Mouse),43.1,1398.0,0.0,1083.2,sp|Q0P5W1|VPS8_MOUSE Vacuolar protein sorting-associated protein 8 homolog OS=Mus musculus OX=10090 GN=Vps8 PE=1 SV=1,GO:0005769; GO:0006623; GO:0008270; GO:0033263; GO:0034058,endosomal vesicle fusion [GO:0034058]; protein targeting to vacuole [GO:0006623],CORVET complex [GO:0033263]; early endosome [GO:0005769],zinc ion binding [GO:0008270],GO:0005768; GO:0006886; GO:0031410; GO:0043226; GO:0061024,endosome; intracellular protein transport; cytoplasmic vesicle; organelle; membrane organization
OG_04427,2.464592528754944,FUN_018550-T1,Peve_00032304,Pocillopora_meandrina_HIv1___RNAseq.g10049.t1,three_way,68.13333333333334,FUN_018550-T1,Q5BLD8,,,,,33.1,166.0,2.1e-17,90.9,sp|Q5BLD8|MT21A_DANRE Protein N-lysine methyltransferase METTL21A OS=Danio rerio OX=7955 GN=mettl21a PE=2 SV=1,,,,,,
OG_04430,1.9441551026561483,FUN_018596-T1,Peve_00043163,Pocillopora_meandrina_HIv1___RNAseq.g501.t1,three_way,71.55466666666666,,,,,,,,,,,,,,,,,
OG_04431,1.768443161829405,FUN_018598-T1,Peve_00043164,Pocillopora_meandrina_HIv1___RNAseq.g502.t1,three_way,68.94316666666667,FUN_018598-T1,Q7TQC7,,,,,26.4,538.0,1.9e-18,95.5,sp|Q7TQC7|GPTC2_MOUSE G patch domain-containing protein 2 OS=Mus musculus OX=10090 GN=Gpatch2 PE=1 SV=2,,,,,,
OG_04435,1.2971519798542122,FUN_018802-T1,Peve_00013887,Pocillopora_meandrina_HIv1___RNAseq.g9880.t1,three_way,68.601,,,,,,,,,,,,,,,,,
OG_04439,5.802102938962715,FUN_018835-T2,Peve_00035787,Pocillopora_meandrina_HIv1___RNAseq.g9856.t1,three_way,77.22033333333333,FUN_018835-T2,Q9C0G6,DYH6_HUMAN,,Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6),Homo sapiens (Human),37.1,4337.0,0.0,2654.0,sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_04444,1.1177364457185694,FUN_018865-T1,Peve_00035798,Pocillopora_meandrina_HIv1___RNAseq.g368.t1,three_way,68.708,FUN_018865-T1,Q1LZ78,NTPCR_BOVIN,,Cancer-related nucleoside-triphosphatase homolog (NTPase) (EC 3.6.1.15) (Nucleoside triphosphate phosphohydrolase),Bos taurus (Bovine),47.9,190.0,3.5e-42,172.9,sp|Q1LZ78|NTPCR_BOVIN Cancer-related nucleoside-triphosphatase homolog OS=Bos taurus OX=9913 GN=NTPCR PE=2 SV=1,GO:0003924; GO:0005524; GO:0016887; GO:0017111; GO:0043273,,,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CTPase activity [GO:0043273]; GTPase activity [GO:0003924]; ribonucleoside triphosphate phosphatase activity [GO:0017111],GO:0003824; GO:0003924; GO:0016787,catalytic activity; GTPase activity; hydrolase activity
OG_04445,1.4474817686528194,FUN_018866-T1,Peve_00035799,Pocillopora_meandrina_HIv1___RNAseq.g369.t1,three_way,72.44133333333333,FUN_018866-T1,Q6INV3,,,,,56.3,71.0,2.7e-16,87.0,sp|Q6INV3|LRC57_XENLA Leucine-rich repeat-containing protein 57 OS=Xenopus laevis OX=8355 GN=lrrc57 PE=2 SV=1,,,,,,
OG_04449,1.6880116405148529,FUN_019015-T1,Peve_00035805,Pocillopora_meandrina_HIv1___RNAseq.g384.t1,three_way,68.97266666666667,FUN_019015-T1,Q03336,RGN_RAT,,Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30),Rattus norvegicus (Rat),49.3,134.0,6.5e-34,145.6,sp|Q03336|RGN_RAT Regucalcin OS=Rattus norvegicus OX=10116 GN=Rgn PE=1 SV=3,GO:0001822; GO:0001889; GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0007283; GO:0008270; GO:0010558; GO:0010867; GO:0010907; GO:0019853; GO:0030234; GO:0032781; GO:0043066; GO:0045019; GO:0045723; GO:0050680; GO:0050848; GO:0097421; GO:1901318; GO:1902679; GO:1903011; GO:1903052; GO:1903625; GO:2000279,intracellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of macromolecule biosynthetic process [GO:0010558]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005975; GO:0006766; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; carbohydrate metabolic process; vitamin metabolic process; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_04450,2.086991423763421,FUN_019023-T1,Peve_00009450,Pocillopora_meandrina_HIv1___RNAseq.g9987.t1,three_way,68.78166666666667,,,,,,,,,,,,,,,,,
OG_04454,2.857106170414556,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,2.857106170414556,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04456,1.906577496563904,FUN_019139-T1,Peve_00032879,Pocillopora_meandrina_HIv1___RNAseq.g25379.t1,three_way,83.4905,FUN_019139-T1,P37287,PIGA_HUMAN,,Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A),Homo sapiens (Human),64.6,424.0,6.1e-154,545.4,sp|P37287|PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens OX=9606 GN=PIGA PE=1 SV=1,GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0016020; GO:0017176; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; membrane [GO:0016020],phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194],GO:0003824; GO:0006629; GO:0016740; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_04462,1.6617135442653086,FUN_019341-T1,Peve_00032918,Pocillopora_meandrina_HIv1___RNAseq.g20861.t1,three_way,61.333333333333336,FUN_019341-T1,Q8NHV4,NEDD1_HUMAN,,Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1),Homo sapiens (Human),34.3,697.0,4.2e-98,360.5,sp|Q8NHV4|NEDD1_HUMAN Protein NEDD1 OS=Homo sapiens OX=9606 GN=NEDD1 PE=1 SV=1,GO:0000242; GO:0000278; GO:0000922; GO:0001650; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007020; GO:0036064; GO:0043015; GO:0045177; GO:0051301,cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278],apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922],gamma-tubulin binding [GO:0043015],GO:0000278; GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0043226,mitotic cell cycle; nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_04465,2.2295276629482257,FUN_019382-T1,Peve_00031766,Pocillopora_meandrina_HIv1___RNAseq.g23704.t1,three_way,75.74716666666667,,,,,,,,,,,,,,,,,
OG_04474,2.629097995431957,FUN_020855-T1,Peve_00032916,Pocillopora_meandrina_HIv1___RNAseq.g20813.t1,three_way,66.00766666666667,,,,,,,,,,,,,,,,,
OG_04475,2.145619698847485,FUN_020917-T1,Peve_00041316,Pocillopora_meandrina_HIv1___RNAseq.g6156.t1,three_way,40.312333333333335,,,,,,,,,,,,,,,,,
OG_04476,1.2128196318033937,FUN_020920-T1,Peve_00017285,Pocillopora_meandrina_HIv1___RNAseq.g15907.t1a,three_way,47.4085,FUN_020920-T1,O95450,,,,,28.7,905.0,8.1e-97,356.7,sp|O95450|ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens OX=9606 GN=ADAMTS2 PE=1 SV=2,,,,,,
OG_04477,1.5615805899712003,FUN_021107-T1,Peve_00008862,Pocillopora_meandrina_HIv1___RNAseq.g4370.t1,three_way,74.41733333333333,FUN_021107-T1,Q5FVN8,,,,,34.2,325.0,2.8e-38,161.4,"sp|Q5FVN8|WSDU1_RAT WD repeat, SAM and U-box domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Wdsub1 PE=2 SV=1",,,,,,
OG_04479,2.065300936839108,FUN_021449-T1,Peve_00025992,Pocillopora_meandrina_HIv1___RNAseq.g2971.t1,three_way,68.957,FUN_021449-T1,Q13416,ORC2_HUMAN,,Origin recognition complex subunit 2,Homo sapiens (Human),43.0,505.0,6.2e-99,362.8,sp|Q13416|ORC2_HUMAN Origin recognition complex subunit 2 OS=Homo sapiens OX=9606 GN=ORC2 PE=1 SV=2,GO:0000122; GO:0000781; GO:0000792; GO:0000808; GO:0000939; GO:0003688; GO:0005634; GO:0005654; GO:0005664; GO:0005813; GO:0006270; GO:0016020,DNA replication initiation [GO:0006270]; negative regulation of transcription by RNA polymerase II [GO:0000122],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; inner kinetochore [GO:0000939]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]",DNA replication origin binding [GO:0003688],GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; microtubule organizing center; regulation of DNA-templated transcription; organelle
OG_04486,1.497944573385971,FUN_021479-T1,Peve_00013215,Pocillopora_meandrina_HIv1___RNAseq.g9419.t1,three_way,44.461333333333336,,,,,,,,,,,,,,,,,
OG_04489,3.454366043230296,FUN_021612-T1,Peve_00021567,Pocillopora_meandrina_HIv1___RNAseq.g4223.t1,three_way,65.06666666666666,FUN_021612-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),35.3,439.0,6.1e-64,246.5,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_04492,1.9425259701807769,FUN_021923-T1,Peve_00016339,Pocillopora_meandrina_HIv1___RNAseq.g2916.t1a,three_way,59.88366666666666,FUN_021923-T1,Q9CPS6,,,,,43.3,67.0,9.4e-10,64.3,sp|Q9CPS6|HINT3_MOUSE Adenosine 5'-monophosphoramidase HINT3 OS=Mus musculus OX=10090 GN=Hint3 PE=1 SV=1,,,,,,
OG_04494,1.5868336944756585,FUN_021926-T1,Peve_00000368,Pocillopora_meandrina_HIv1___RNAseq.g2915.t1,three_way,72.39533333333334,,,,,,,,,,,,,,,,,
OG_04496,4.08841061761188,FUN_021928-T1,Peve_00023935,Pocillopora_meandrina_HIv1___RNAseq.g2913.t1,three_way,79.017,FUN_021928-T1,O81884,,,,,44.3,316.0,7.099999999999999e-70,265.8,sp|O81884|GALDH_ARATH L-galactose dehydrogenase OS=Arabidopsis thaliana OX=3702 GN=LGALDH PE=1 SV=1,,,,,,
OG_04498,2.29533048560942,FUN_021934-T1,Peve_00023932,Pocillopora_meandrina_HIv1___RNAseq.g2962.t1,three_way,57.409666666666666,,,,,,,,,,,,,,,,,
OG_04500,3.4804419554854302,FUN_021938-T1,Peve_00023930,Pocillopora_meandrina_HIv1___RNAseq.g2960.t2,three_way,73.7475,FUN_021938-T1,Q4W5Z4,DNM3A_CHICK,,DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (Cysteine methyltransferase DNMT3A) (EC 2.1.1.-),Gallus gallus (Chicken),47.0,651.0,6.4e-174,612.5,sp|Q4W5Z4|DNM3A_CHICK DNA (cytosine-5)-methyltransferase 3A OS=Gallus gallus OX=9031 GN=DNMT3A PE=2 SV=1,GO:0000791; GO:0001046; GO:0003886; GO:0005634; GO:0005737; GO:0008270; GO:0009408; GO:0016363; GO:0032259; GO:0044027; GO:0045892; GO:0071774; GO:0106363,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; response to fibroblast growth factor [GO:0071774]; response to heat [GO:0009408],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],core promoter sequence-specific DNA binding [GO:0001046]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; protein-cysteine methyltransferase activity [GO:0106363]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0140096; GO:0140097,"DNA binding; catalytic activity; nucleus; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_04501,2.051264119918913,FUN_021939-T1,Peve_00022544,Pocillopora_meandrina_HIv1___RNAseq.g12977.t2,three_way,61.04866666666667,FUN_021939-T1,Q5M888,,,,,43.1,404.0,8.3e-83,308.9,sp|Q5M888|CG025_RAT UPF0415 protein C7orf25 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1,,,,,,
OG_04503,4.0589379299112585,FUN_022013-T1,Peve_00042673,Pocillopora_meandrina_HIv1___RNAseq.g3139.t1,three_way,74.30833333333334,FUN_022013-T1,Q05360,,,,,43.6,676.0,1.9e-149,531.2,sp|Q05360|WHITE_LUCCU Protein white OS=Lucilia cuprina OX=7375 GN=W PE=2 SV=2,,,,,,
OG_04509,1.9556065751297167,FUN_022038-T1,Peve_00016622,Pocillopora_meandrina_HIv1___RNAseq.g9268.t1,three_way,65.09233333333333,FUN_022038-T1,Q568B7,,,,,53.4,425.0,7.300000000000001e-125,448.7,sp|Q568B7|QTMAN_DANRE tRNA-queuosine alpha-mannosyltransferase OS=Danio rerio OX=7955 GN=gtdc1 PE=2 SV=2,,,,,,
OG_04512,1.7393118189813537,FUN_022044-T1,Peve_00007834,Pocillopora_meandrina_HIv1___RNAseq.g9290.t1,three_way,72.45516666666667,FUN_022044-T1,Q5T2R2,DPS1_HUMAN,,All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1) (EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1),Homo sapiens (Human),57.9,323.0,3e-102,373.6,sp|Q5T2R2|DPS1_HUMAN All trans-polyprenyl-diphosphate synthase PDSS1 OS=Homo sapiens OX=9606 GN=PDSS1 PE=1 SV=1,GO:0004659; GO:0005739; GO:0005759; GO:0006744; GO:0008299; GO:0032476; GO:0032478; GO:0046872; GO:0046982; GO:0052923; GO:0097269; GO:0110142,isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; polyprenyl diphosphate synthase complex [GO:0032476]; ubiquinone biosynthesis complex [GO:0110142],all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity [GO:0052923]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_04513,2.573032593347953,FUN_022046-T1,Peve_00007833,Pocillopora_meandrina_HIv1___RNAseq.g9288.t1,three_way,85.22166666666666,FUN_022046-T1,Q8WVP7,LMBR1_HUMAN,,Limb region 1 protein homolog (Differentiation-related gene 14 protein),Homo sapiens (Human),51.5,464.0,4.4000000000000006e-118,426.4,sp|Q8WVP7|LMBR1_HUMAN Limb region 1 protein homolog OS=Homo sapiens OX=9606 GN=LMBR1 PE=1 SV=1,GO:0004888; GO:0005886; GO:0007165; GO:0042733,embryonic digit morphogenesis [GO:0042733]; signal transduction [GO:0007165],plasma membrane [GO:0005886],transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_04515,1.442695539243626,FUN_022048-T1,Peve_00017132,Pocillopora_meandrina_HIv1___RNAseq.g4598.t1,three_way,56.047666666666665,FUN_022048-T1,Q7TN88,,,,,27.8,1834.0,3.2e-182,642.5,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_04519,1.1636342385150062,FUN_022053-T1,Peve_00014931,Pocillopora_meandrina_HIv1___TS.g22020.t1a,three_way,47.467333333333336,FUN_022053-T1,Q6P135,,,,,29.6,152.0,8.4e-08,59.3,sp|Q6P135|TMUB1_DANRE Transmembrane and ubiquitin-like domain-containing protein 1 OS=Danio rerio OX=7955 GN=tmub1 PE=2 SV=1,,,,,,
OG_04520,1.156160649617357,FUN_022054-T1,Peve_00014935,Pocillopora_meandrina_HIv1___TS.g22021.t1,three_way,85.77199999999999,FUN_022054-T1,A7RHL5,,,,,85.4,82.0,1.3000000000000001e-33,143.3,sp|A7RHL5|COSA_NEMVE Costars family protein v1g158749 OS=Nematostella vectensis OX=45351 GN=v1g158749 PE=3 SV=1,,,,,,
OG_04521,1.5412203541035805,FUN_022055-T1,Peve_00014937,Pocillopora_meandrina_HIv1___RNAseq.g4606.t1,three_way,77.94066666666666,FUN_022055-T1,Q9BVL4,SELO_HUMAN,,"Protein adenylyltransferase SelO, mitochondrial (EC 2.7.7.-) (EC 2.7.7.108) (Selenoprotein O) (SelO)",Homo sapiens (Human),55.3,631.0,1.3999999999999999e-191,671.0,"sp|Q9BVL4|SELO_HUMAN Protein adenylyltransferase SelO, mitochondrial OS=Homo sapiens OX=9606 GN=SELENOO PE=1 SV=3",GO:0005524; GO:0005694; GO:0005739; GO:0018117; GO:0046872; GO:0070733,protein adenylylation [GO:0018117],chromosome [GO:0005694]; mitochondrion [GO:0005739],AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],GO:0003824; GO:0005694; GO:0005739; GO:0016740; GO:0043226,catalytic activity; chromosome; mitochondrion; transferase activity; organelle
OG_04523,2.103428636362173,FUN_022057-T1,Peve_00014939,Pocillopora_meandrina_HIv1___RNAseq.g4608.t1,three_way,86.64366666666668,FUN_022057-T1,M0RDU0,,,,,37.1,350.0,4.3e-50,199.9,sp|M0RDU0|HAP40_RAT 40-kDa huntingtin-associated protein OS=Rattus norvegicus OX=10116 GN=F8a1 PE=1 SV=1,,,,,,
OG_04524,2.4699854530167418,FUN_022059-T1,Peve_00014932,Pocillopora_meandrina_HIv1___RNAseq.g4610.t1,three_way,48.778,FUN_022059-T1,Q9NVV4,PAPD1_HUMAN,,"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)",Homo sapiens (Human),35.3,292.0,4.3e-40,167.9,"sp|Q9NVV4|PAPD1_HUMAN Poly(A) RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=MTPAP PE=1 SV=1",GO:0000287; GO:0000965; GO:0002134; GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0006397; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0043231; GO:0071044; GO:1990817,histone mRNA catabolic process [GO:0071044]; mitochondrial RNA 3'-end processing [GO:0000965]; mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123],intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; poly(A) RNA polymerase activity [GO:1990817]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0016071; GO:0016740; GO:0043226; GO:0140053,RNA binding; catalytic activity; nucleoplasm; mitochondrion; mRNA metabolic process; transferase activity; organelle; mitochondrial gene expression
OG_04528,1.517930134202011,FUN_022072-T1,Peve_00025462,Pocillopora_meandrina_HIv1___RNAseq.g4582.t1,three_way,69.28633333333333,FUN_022072-T1,Q1MTN8,,,,,29.9,324.0,1.3e-27,125.6,sp|Q1MTN8|ACL4_SCHPO Probable assembly chaperone of rpl4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC16D10.01c PE=3 SV=2,,,,,,
OG_04529,1.9215157193980257,FUN_022073-T1,Peve_00012101,Pocillopora_meandrina_HIv1___RNAseq.g4581.t1,three_way,60.477,FUN_022073-T1,P58557,,,,,36.4,162.0,2.6e-19,97.1,sp|P58557|YBEY_HUMAN Endoribonuclease YbeY OS=Homo sapiens OX=9606 GN=YBEY PE=1 SV=2,,,,,,
OG_04531,3.598440061127337,FUN_022075-T1,Peve_00038290,Pocillopora_meandrina_HIv1___RNAseq.g9321.t1,three_way,59.58166666666667,,,,,,,,,,,,,,,,,
OG_04536,1.860674377685385,FUN_022092-T1,Peve_00038684,Pocillopora_meandrina_HIv1___RNAseq.g4111.t1,three_way,48.881,,,,,,,,,,,,,,,,,
OG_04538,4.443558048108953,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_04539,1.4058734166692537,FUN_022096-T1,Peve_00038680,Pocillopora_meandrina_HIv1___RNAseq.g4123.t1,three_way,44.281,,,,,,,,,,,,,,,,,
OG_04543,1.6152962696547857,FUN_022104-T2,Peve_00009726,Pocillopora_meandrina_HIv1___RNAseq.g4104.t1,three_way,90.09683333333334,FUN_022104-T2,Q9JHD2,KAT2A_MOUSE,,Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (MmGCN5) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A),Mus musculus (Mouse),63.9,758.0,4.4999999999999997e-293,1008.4,sp|Q9JHD2|KAT2A_MOUSE Histone acetyltransferase KAT2A OS=Mus musculus OX=10090 GN=Kat2a PE=1 SV=2,GO:0000122; GO:0000123; GO:0000124; GO:0001701; GO:0001756; GO:0001819; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005813; GO:0006094; GO:0006282; GO:0006355; GO:0006357; GO:0007399; GO:0007507; GO:0007616; GO:0008080; GO:0010484; GO:0016407; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035264; GO:0042826; GO:0043484; GO:0043992; GO:0043993; GO:0043997; GO:0045252; GO:0045589; GO:0045721; GO:0045722; GO:0045893; GO:0045944; GO:0045995; GO:0046600; GO:0048144; GO:0048167; GO:0048312; GO:0050863; GO:0051302; GO:0051726; GO:0060173; GO:0061035; GO:0071356; GO:0072686; GO:0106078; GO:0106227; GO:0106229; GO:0140297; GO:0140672; GO:1903010; GO:1990090; GO:2000036; GO:2000727,cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; fibroblast proliferation [GO:0048144]; gluconeogenesis [GO:0006094]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA splicing [GO:0043484]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537],ATAC complex [GO:0140672]; centrosome [GO:0005813]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K9 acetyltransferase activity [GO:0043992]; histone H4K12 acetyltransferase activity [GO:0043997]; histone succinyltransferase activity [GO:0106078]; N-acetyltransferase activity [GO:0008080]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005975; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; carbohydrate metabolic process; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_04544,1.8009535659332638,FUN_022106-T1,Peve_00025701,Pocillopora_meandrina_HIv1___RNAseq.g9229.t1,three_way,68.26433333333333,FUN_022106-T1,Q5E9J9,,,,,39.2,375.0,1.3e-70,268.5,sp|Q5E9J9|STRAA_BOVIN STE20-related kinase adapter protein alpha OS=Bos taurus OX=9913 GN=STRADA PE=2 SV=1,,,,,,
OG_04545,1.6515276757129955,FUN_022110-T1,Peve_00020403,Pocillopora_meandrina_HIv1___RNAseq.g9226.t1,three_way,64.77066666666667,FUN_022110-T1,Q9FN03,,,,,33.7,347.0,2.7e-51,204.9,sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1,,,,,,
OG_04546,1.576890817733145,FUN_022112-T1,Peve_00036606,Pocillopora_meandrina_HIv1___RNAseq.g4778.t1,three_way,74.535,FUN_022112-T1,Q8IZD6,S22AF_HUMAN,,Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1),Homo sapiens (Human),34.7,435.0,2.5000000000000002e-58,228.0,sp|Q8IZD6|S22AF_HUMAN Solute carrier family 22 member 15 OS=Homo sapiens OX=9606 GN=SLC22A15 PE=1 SV=1,GO:0005886; GO:0006811; GO:0006865; GO:0015199,amino acid transport [GO:0006865]; monoatomic ion transport [GO:0006811],plasma membrane [GO:0005886],amino-acid betaine transmembrane transporter activity [GO:0015199],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_04547,2.6966458806551423,FUN_022170-T1,Peve_00036602,Pocillopora_meandrina_HIv1___RNAseq.g4779.t1,three_way,50.17433333333334,FUN_022170-T1,B8UU78,,,,,90.7,1117.0,0.0,1992.2,sp|B8UU78|ELP_ACRMI EGF and laminin G domain-containing protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_04559,2.2183989702820632,FUN_022198-T1,Peve_00038010,Pocillopora_meandrina_HIv1___RNAseq.g4797.t1,three_way,68.02633333333333,,,,,,,,,,,,,,,,,
OG_04560,4.660687487271354,FUN_022199-T1,Peve_00041449,Pocillopora_meandrina_HIv1___RNAseq.g4798.t1,three_way,67.538,,,,,,,,,,,,,,,,,
OG_04565,1.904555863189254,FUN_022208-T1,Peve_00008602,Pocillopora_meandrina_HIv1___RNAseq.g4802.t1,three_way,72.70933333333333,FUN_022208-T1,A4QBI8,,,,,39.6,101.0,5.1e-13,75.9,sp|A4QBI8|RL16_CORGB Large ribosomal subunit protein uL16 OS=Corynebacterium glutamicum (strain R) OX=340322 GN=rplP PE=3 SV=1,,,,,,
OG_04567,2.35586345071696,FUN_022210-T1,Peve_00008600,Pocillopora_meandrina_HIv1___RNAseq.g4765.t1,three_way,84.062,FUN_022210-T1,Q8HYI9,,,,,45.7,138.0,1.9e-30,133.7,sp|Q8HYI9|PFD5_BOVIN Prefoldin subunit 5 OS=Bos taurus OX=9913 GN=PFDN5 PE=2 SV=1,,,,,,
OG_04569,1.343630444273326,FUN_022214-T1,Peve_00008606,Pocillopora_meandrina_HIv1___RNAseq.g4762.t1,three_way,80.757,FUN_022214-T1,Q0D2E8,,,,,49.6,544.0,3e-147,523.5,sp|Q0D2E8|RFT1_XENTR Man(5)GlcNAc(2)-PP-dolichol translocation protein RFT1 OS=Xenopus tropicalis OX=8364 GN=rft1 PE=2 SV=1,,,,,,
OG_04572,1.1686522307322995,FUN_022220-T1,Peve_00033928,Pocillopora_meandrina_HIv1___RNAseq.g4737.t1,three_way,78.52833333333334,FUN_022220-T1,A7SG73,NADC_NEMVE,,Nicotinate-nucleotide pyrophosphorylase [carboxylating] (EC 2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]) (QAPRTase),Nematostella vectensis (Starlet sea anemone),60.9,289.0,1.3e-95,350.9,sp|A7SG73|NADC_NEMVE Nicotinate-nucleotide pyrophosphorylase [carboxylating] (Fragment) OS=Nematostella vectensis OX=45351 GN=qprt PE=3 SV=1,GO:0004514; GO:0005737; GO:0009435; GO:0034213,NAD biosynthetic process [GO:0009435]; quinolinate catabolic process [GO:0034213],cytoplasm [GO:0005737],nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514],GO:0003824; GO:0016740; GO:0055086,catalytic activity; transferase activity; nucleobase-containing small molecule metabolic process
OG_04575,1.632647527724298,FUN_022225-T1,Peve_00008146,Pocillopora_meandrina_HIv1___RNAseq.g4746.t1b,three_way,48.185,FUN_022225-T1,P35448,,,,,39.9,158.0,7.7e-07,57.8,sp|P35448|TSP1_XENLA Thrombospondin-1 OS=Xenopus laevis OX=8355 GN=thbs1 PE=2 SV=1,,,,,,
OG_04576,2.173253278483985,FUN_022235-T2,Peve_00012432,Pocillopora_meandrina_HIv1___RNAseq.g4750.t1,three_way,76.53366666666666,FUN_022235-T2,Q0VCA7,OXSM_BOVIN,,"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase)",Bos taurus (Bovine),53.0,423.0,5.4000000000000006e-126,452.6,"sp|Q0VCA7|OXSM_BOVIN 3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial OS=Bos taurus OX=9913 GN=OXSM PE=2 SV=1",GO:0004315; GO:0005739; GO:0006633,fatty acid biosynthetic process [GO:0006633],mitochondrion [GO:0005739],3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_04578,1.6054687492513606,FUN_022241-T1,Peve_00037422,Pocillopora_meandrina_HIv1___RNAseq.g4756.t1,three_way,81.13533333333334,FUN_022241-T1,B8JKD7,RPA2_DANRE,,DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6),Danio rerio (Zebrafish) (Brachydanio rerio),56.1,1131.0,0.0,1315.1,sp|B8JKD7|RPA2_DANRE DNA-directed RNA polymerase I subunit RPA2 OS=Danio rerio OX=7955 GN=polr1b PE=3 SV=1,GO:0000428; GO:0003677; GO:0003899; GO:0005694; GO:0005730; GO:0005739; GO:0006351; GO:0008270; GO:0014029; GO:0032549,DNA-templated transcription [GO:0006351]; neural crest formation [GO:0014029],chromosome [GO:0005694]; DNA-directed RNA polymerase complex [GO:0000428]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; ribonucleoside binding [GO:0032549]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005694; GO:0005730; GO:0005739; GO:0006351; GO:0016740; GO:0030154; GO:0043226; GO:0140098,"DNA binding; catalytic activity; chromosome; nucleolus; mitochondrion; DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_04579,1.4015991850141298,FUN_022242-T1,Peve_00037424,Pocillopora_meandrina_HIv1___TS.g22171.t1,three_way,87.71433333333333,FUN_022242-T1,E7F590,VPS41_DANRE,,Vacuolar protein sorting-associated protein 41 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),53.6,823.0,8.099999999999999e-251,868.2,sp|E7F590|VPS41_DANRE Vacuolar protein sorting-associated protein 41 homolog OS=Danio rerio OX=7955 GN=vps41 PE=1 SV=1,GO:0005765; GO:0005770; GO:0005794; GO:0005829; GO:0006623; GO:0008270; GO:0008333; GO:0009267; GO:0016236; GO:0030136; GO:0030897; GO:0031901; GO:0031902; GO:0034058,cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623],clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765],zinc ion binding [GO:0008270],GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; Golgi apparatus; cytosol; intracellular protein transport; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_04580,1.5084844463433682,FUN_022243-T2,Peve_00037426,Pocillopora_meandrina_HIv1___RNAseq.g4758.t1,three_way,80.60083333333333,FUN_022243-T2,Q9H2F5,,,,,46.3,555.0,5.4e-117,423.3,sp|Q9H2F5|EPC1_HUMAN Enhancer of polycomb homolog 1 OS=Homo sapiens OX=9606 GN=EPC1 PE=1 SV=1,,,,,,
OG_04582,2.100727906003583,FUN_022245-T1,Peve_00037428,Pocillopora_meandrina_HIv1___RNAseq.g4760.t1,three_way,54.247166666666665,FUN_022245-T1,Q96DN6,MBD6_HUMAN,,Methyl-CpG-binding domain protein 6 (Methyl-CpG-binding protein MBD6),Homo sapiens (Human),41.4,99.0,6.5e-16,88.6,sp|Q96DN6|MBD6_HUMAN Methyl-CpG-binding domain protein 6 OS=Homo sapiens OX=9606 GN=MBD6 PE=1 SV=2,GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0010369,,chromocenter [GO:0010369]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005654; GO:0005694; GO:0043226,nucleus; nucleoplasm; chromosome; organelle
OG_04583,1.6421563254298983,FUN_022248-T1,Peve_00021274,Pocillopora_meandrina_HIv1___RNAseq.g4731.t1,three_way,77.724,FUN_022248-T1,P50171,,,,,54.1,259.0,1.3e-68,261.2,sp|P50171|DHB8_MOUSE (3R)-3-hydroxyacyl-CoA dehydrogenase OS=Mus musculus OX=10090 GN=Hsd17b8 PE=1 SV=2,,,,,,
OG_04584,2.772508906184455,FUN_022249-T1,Peve_00021283,Pocillopora_meandrina_HIv1___RNAseq.g4723.t1,three_way,79.9,FUN_022249-T1,Q1ECX4,TLK2_DANRE,,Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (PKU-alpha) (Tousled-like kinase 2),Danio rerio (Zebrafish) (Brachydanio rerio),51.9,697.0,1.7e-174,614.4,sp|Q1ECX4|TLK2_DANRE Serine/threonine-protein kinase tousled-like 2 OS=Danio rerio OX=7955 GN=tlk2 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0035556; GO:0048471; GO:0106310,chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556],cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytoskeleton; chromosome segregation; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04590,1.418870176498752,FUN_022265-T1,Peve_00043988,Pocillopora_meandrina_HIv1___RNAseq.g4716.t1,three_way,60.199,FUN_022265-T1,Q9BU76,,,,,46.3,134.0,3.5000000000000004e-28,127.1,sp|Q9BU76|MMTA2_HUMAN Multiple myeloma tumor-associated protein 2 OS=Homo sapiens OX=9606 GN=MMTAG2 PE=1 SV=1,,,,,,
OG_04594,1.522805322388488,FUN_022278-T1,Peve_00022094,Pocillopora_meandrina_HIv1___RNAseq.g4704.t1,three_way,78.5305,FUN_022278-T1,Q08CH6,CATIP_DANRE,,Ciliogenesis-associated TTC17-interacting protein,Danio rerio (Zebrafish) (Brachydanio rerio),43.1,341.0,9.5e-73,275.4,sp|Q08CH6|CATIP_DANRE Ciliogenesis-associated TTC17-interacting protein OS=Danio rerio OX=7955 GN=catip PE=1 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0060271; GO:0061371,actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005856; GO:0005886; GO:0043226; GO:0044782; GO:0065003,nucleus; cytoskeleton; plasma membrane; organelle; cilium organization; protein-containing complex assembly
OG_04596,3.54551295919017,FUN_022280-T1,Peve_00022092,Pocillopora_meandrina_HIv1___RNAseq.g4702.t1,three_way,79.605,FUN_022280-T1,Q0V9W6,,,,,40.9,423.0,5.6e-88,326.2,sp|Q0V9W6|BTBD6_XENTR BTB/POZ domain-containing protein 6 OS=Xenopus tropicalis OX=8364 GN=btbd6 PE=2 SV=2,,,,,,
OG_04600,3.759058614449691,FUN_022285-T1,Peve_00003591,Pocillopora_meandrina_HIv1___RNAseq.g4696.t1,three_way,62.73716666666667,FUN_022285-T1,A7MB54,HLX_BOVIN,,H2.0-like homeobox protein (Homeobox protein HLX1),Bos taurus (Bovine),69.0,58.0,3.8e-17,90.1,sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1,GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679,embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0002376; GO:0003677; GO:0005634; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04603,1.0349762564350768,FUN_022292-T1,Peve_00003687,Pocillopora_meandrina_HIv1___RNAseq.g4692.t1,three_way,84.67733333333334,FUN_022292-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),34.6,315.0,7.4e-50,199.1,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_04604,3.3375790809513277,FUN_022293-T1,Peve_00003688,Pocillopora_meandrina_HIv1___RNAseq.g4691.t1,three_way,65.73366666666666,,,,,,,,,,,,,,,,,
OG_04605,1.320384241349562,FUN_022295-T1,Peve_00003689,Pocillopora_meandrina_HIv1___RNAseq.g4689.t1,three_way,77.32466666666667,FUN_022295-T1,Q6P5U8,,,,,35.1,535.0,8e-40,166.8,sp|Q6P5U8|CC148_MOUSE Coiled-coil domain-containing protein 148 OS=Mus musculus OX=10090 GN=Ccdc148 PE=2 SV=1,,,,,,
OG_04606,1.640577993505942,FUN_022296-T1,Peve_00003691,Pocillopora_meandrina_HIv1___RNAseq.g4665.t1,three_way,63.23733333333333,FUN_022296-T1,Q5U4U4,,,,,31.4,574.0,6.7e-65,250.0,sp|Q5U4U4|DONS_XENLA Protein downstream neighbor of son homolog OS=Xenopus laevis OX=8355 GN=donson PE=1 SV=1,,,,,,
OG_04607,1.7140440482436363,FUN_022297-T1,Peve_00021643,Pocillopora_meandrina_HIv1___RNAseq.g4620.t1,three_way,54.49733333333333,FUN_022297-T1,Q6AXX1,,,,,37.6,178.0,1.2e-23,112.1,sp|Q6AXX1|SLNL1_RAT Schlafen-like protein 1 OS=Rattus norvegicus OX=10116 GN=Slfnl1 PE=2 SV=1,,,,,,
OG_04610,3.731955434163514,FUN_022307-T1,Peve_00021671,Pocillopora_meandrina_HIv1___RNAseq.g4623.t1,three_way,86.57633333333334,FUN_022307-T1,Q8VEE0,,,,,65.1,212.0,1e-75,284.6,sp|Q8VEE0|RPE_MOUSE Ribulose-phosphate 3-epimerase OS=Mus musculus OX=10090 GN=Rpe PE=1 SV=1,,,,,,
OG_04615,4.6396512596504405,FUN_022314-T1,Peve_00021691,Pocillopora_meandrina_HIv1___TS.g22047.t1,three_way,61.79866666666667,,,,,,,,,,,,,,,,,
OG_04616,2.0509075076318366,FUN_022315-T1,Peve_00021692,Pocillopora_meandrina_HIv1___RNAseq.g4632.t1,three_way,88.54166666666667,FUN_022315-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),67.0,218.0,3.2e-15,83.6,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_04617,1.301443082987713,FUN_022316-T1,Peve_00021693,Pocillopora_meandrina_HIv1___RNAseq.g4633.t1,three_way,36.72766666666666,,,,,,,,,,,,,,,,,
OG_04618,1.515497187998,FUN_022319-T1,Peve_00021701,Pocillopora_meandrina_HIv1___TS.g22054.t1,three_way,56.806333333333335,,,,,,,,,,,,,,,,,
OG_04619,1.199591960999631,FUN_022321-T1,Peve_00021706,Pocillopora_meandrina_HIv1___RNAseq.g4642.t1,three_way,52.955333333333336,,,,,,,,,,,,,,,,,
OG_04620,1.3711094084315465,FUN_022322-T1,Peve_00021644,Pocillopora_meandrina_HIv1___RNAseq.g4643.t1,three_way,86.02233333333332,,,,,,,,,,,,,,,,,
OG_04621,1.2469724675375198,FUN_022323-T1,Peve_00021645,Pocillopora_meandrina_HIv1___RNAseq.g4644.t1,three_way,86.14483333333334,,,,,,,,,,,,,,,,,
OG_04625,2.9510650189693983,FUN_022333-T1,Peve_00028601,Pocillopora_meandrina_HIv1___RNAseq.g4652.t1,three_way,61.93866666666667,FUN_022333-T1,Q92609,TBCD5_HUMAN,,TBC1 domain family member 5,Homo sapiens (Human),37.5,610.0,3.2e-104,381.3,sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1,GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:1905394,"autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]",autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904],AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394],GO:0005773; GO:0005794; GO:0005829; GO:0006914; GO:0016192; GO:0043226; GO:0098772,vacuole; Golgi apparatus; cytosol; autophagy; vesicle-mediated transport; organelle; molecular function regulator activity
OG_04626,1.8922139264195643,FUN_022334-T2,Peve_00028599,Pocillopora_meandrina_HIv1___RNAseq.g4653.t1,three_way,68.03833333333333,FUN_022334-T2,Q149M9,,,,,31.2,944.0,1.1e-108,397.1,sp|Q149M9|NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=NWD1 PE=1 SV=3,,,,,,
OG_04629,1.4688220363063735,FUN_022342-T1,Peve_00028600,Pocillopora_meandrina_HIv1___RNAseq.g4656.t1,three_way,74.125,,,,,,,,,,,,,,,,,
OG_04630,1.8378722018958509,FUN_022343-T1,Peve_00028597,Pocillopora_meandrina_HIv1___RNAseq.g4657.t1,three_way,58.79733333333333,,,,,,,,,,,,,,,,,
OG_04631,1.430620960306898,FUN_022344-T1,Peve_00018541,Pocillopora_meandrina_HIv1___TS.g22072.t1,three_way,53.583333333333336,FUN_022344-T1,Q3USZ8,,,,,32.1,358.0,3.1e-40,167.5,sp|Q3USZ8|DIK2A_MOUSE Divergent protein kinase domain 2A OS=Mus musculus OX=10090 GN=Dipk2a PE=1 SV=2,,,,,,
OG_04632,1.0332034270423425,FUN_022345-T1,Peve_00018540,Pocillopora_meandrina_HIv1___RNAseq.g4659.t1,three_way,72.2795,FUN_022345-T1,Q5R9X9,,,,,39.2,332.0,1.7e-45,185.7,sp|Q5R9X9|3BP5L_PONAB SH3 domain-binding protein 5-like OS=Pongo abelii OX=9601 GN=SH3BP5L PE=2 SV=1,,,,,,
OG_04635,3.80591392459236,FUN_022357-T1,Peve_00021682,Pocillopora_meandrina_HIv1___RNAseq.g4585.t1,three_way,74.13533333333334,FUN_022357-T1,P55011,S12A2_HUMAN,,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (hNKCC1),Homo sapiens (Human),45.9,1014.0,4e-238,826.2,sp|P55011|S12A2_HUMAN Solute carrier family 12 member 2 OS=Homo sapiens OX=9606 GN=SLC12A2 PE=1 SV=1,GO:0005886; GO:0006811; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0008511; GO:0008519; GO:0009925; GO:0010818; GO:0015079; GO:0015377; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030321; GO:0030644; GO:0030659; GO:0031253; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043005; GO:0043025; GO:0044297; GO:0044298; GO:0045795; GO:0046873; GO:0051087; GO:0051879; GO:0055064; GO:0055075; GO:0055078; GO:0061044; GO:0070062; GO:0070634; GO:0071944; GO:0072488; GO:0098658; GO:0098659; GO:0098719; GO:0150003; GO:0150104; GO:1902476; GO:1903561; GO:1904450; GO:1904464; GO:1990573; GO:1990869,ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; intracellular chloride ion homeostasis [GO:0030644]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of blood-brain barrier [GO:0035633]; monoatomic ion transport [GO:0006811]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],ammonium channel activity [GO:0008519]; chloride:monoatomic cation symporter activity [GO:0015377]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]; protein-folding chaperone binding [GO:0051087]; sodium:potassium:chloride symporter activity [GO:0008511],GO:0002376; GO:0003013; GO:0005215; GO:0005886; GO:0023052; GO:0043226; GO:0048870; GO:0055085,immune system process; circulatory system process; transporter activity; plasma membrane; signaling; organelle; cell motility; transmembrane transport
OG_04637,2.635871682895734,FUN_022363-T1,Peve_00021993,Pocillopora_meandrina_HIv1___RNAseq.g4594.t1,three_way,86.07533333333333,FUN_022363-T1,Q7Z5J8,,,,,48.0,1367.0,3.1e-212,740.7,sp|Q7Z5J8|ANKAR_HUMAN Ankyrin and armadillo repeat-containing protein OS=Homo sapiens OX=9606 GN=ANKAR PE=1 SV=3,,,,,,
OG_04639,2.1807068538290464,FUN_022365-T1,Peve_00021988,Pocillopora_meandrina_HIv1___TS.g22011.t1,three_way,64.79716666666667,FUN_022365-T1,A2RRU4,SCAP_RAT,,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),Rattus norvegicus (Rat),35.1,1375.0,2.4999999999999998e-147,525.0,sp|A2RRU4|SCAP_RAT Sterol regulatory element-binding protein cleavage-activating protein OS=Rattus norvegicus OX=10116 GN=Scap PE=2 SV=1,GO:0000139; GO:0001666; GO:0005789; GO:0006629; GO:0006955; GO:0008203; GO:0012507; GO:0019217; GO:0032868; GO:0032933; GO:0032934; GO:0032936; GO:0032991; GO:0033552; GO:0042304; GO:0044877; GO:0045540; GO:0045542; GO:0090110,cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; lipid metabolic process [GO:0006629]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to vitamin B3 [GO:0033552]; SREBP signaling pathway [GO:0032933],endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; protein-containing complex [GO:0032991]; SREBP-SCAP complex [GO:0032936],protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934],GO:0002376; GO:0006629; GO:0008289,immune system process; lipid metabolic process; lipid binding
OG_04641,1.5812278486662652,FUN_022367-T1,Peve_00013238,Pocillopora_meandrina_HIv1___TS.g19588.t1,three_way,84.17866666666667,FUN_022367-T1,P53603,,,,,60.6,543.0,4.5e-188,659.1,sp|P53603|FTCD_PIG Formimidoyltransferase-cyclodeaminase OS=Sus scrofa OX=9823 GN=FTCD PE=1 SV=1,,,,,,
OG_04642,3.515823825636782,FUN_022368-T1,Peve_00013237,Pocillopora_meandrina_HIv1___RNAseq.g9293.t2,three_way,55.12766666666666,FUN_022368-T1,B2GV47,,,,,31.2,523.0,1.9000000000000001e-66,255.8,sp|B2GV47|RADX_RAT RPA-related protein RADX OS=Rattus norvegicus OX=10116 GN=Radx PE=2 SV=1,,,,,,
OG_04643,2.6766776348254555,FUN_022369-T1,Peve_00013236,Pocillopora_meandrina_HIv1___RNAseq.g9295.t1,three_way,77.29733333333333,FUN_022369-T1,Q8NCL4,GALT6_HUMAN,,Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6),Homo sapiens (Human),52.4,450.0,6.6e-132,472.6,sp|Q8NCL4|GALT6_HUMAN Polypeptide N-acetylgalactosaminyltransferase 6 OS=Homo sapiens OX=9606 GN=GALNT6 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0018243; GO:0030246; GO:0046872; GO:0048471,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04644,2.318959407482327,FUN_022371-T1,Peve_00013234,Pocillopora_meandrina_HIv1___RNAseq.g9296.t1,three_way,87.35,FUN_022371-T1,Q6WV17,GALT5_DROME,,Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5),Drosophila melanogaster (Fruit fly),52.9,442.0,3.5e-128,460.3,sp|Q6WV17|GALT5_DROME Polypeptide N-acetylgalactosaminyltransferase 5 OS=Drosophila melanogaster OX=7227 GN=Pgant5 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006493; GO:0012505; GO:0030246; GO:0046872,protein O-linked glycosylation [GO:0006493],endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04646,1.381835931538097,FUN_022378-T1,Peve_00013226,Pocillopora_meandrina_HIv1___RNAseq.g9303.t1,three_way,49.90833333333334,,,,,,,,,,,,,,,,,
OG_04649,2.679790263223426,FUN_022382-T1,Peve_00013222,Pocillopora_meandrina_HIv1___RNAseq.g9307.t1,three_way,66.057,FUN_022382-T1,O93366,,,,,50.0,76.0,4.7e-14,79.7,sp|O93366|TLX1_CHICK T-cell leukemia homeobox protein 1 OS=Gallus gallus OX=9031 GN=TLX1 PE=2 SV=1,,,,,,
OG_04650,2.222165641156135,FUN_022383-T1,Peve_00013221,Pocillopora_meandrina_HIv1___RNAseq.g9308.t1,three_way,67.081,FUN_022383-T1,P20009,DLL_DROME,,Homeotic protein distal-less (Protein brista),Drosophila melanogaster (Fruit fly),47.1,174.0,6.900000000000001e-28,125.9,sp|P20009|DLL_DROME Homeotic protein distal-less OS=Drosophila melanogaster OX=7227 GN=Dll PE=2 SV=3,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007449; GO:0007469; GO:0007479; GO:0007480; GO:0007485; GO:0007487; GO:0008587; GO:0010092; GO:0010629; GO:0016319; GO:0030154; GO:0035114; GO:0035215; GO:0045893; GO:0048264; GO:0048728,"analia development [GO:0007487]; antennal development [GO:0007469]; cell differentiation [GO:0030154]; determination of ventral identity [GO:0048264]; genital disc development [GO:0035215]; imaginal disc-derived appendage morphogenesis [GO:0035114]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc proximal/distal pattern formation [GO:0007479]; mushroom body development [GO:0016319]; negative regulation of gene expression [GO:0010629]; positive regulation of DNA-templated transcription [GO:0045893]; proboscis development [GO:0048728]; proximal/distal pattern formation, imaginal disc [GO:0007449]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04652,2.5986689608911315,FUN_022389-T1,Peve_00037602,Pocillopora_meandrina_HIv1___TS.g19607.t1,three_way,66.46,FUN_022389-T1,D3Z2X2,DNHD1_MOUSE,,Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein),Mus musculus (Mouse),22.8,4456.0,4.4999999999999995e-257,891.3,sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3,GO:0005524; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0045505; GO:0051959; GO:0120316,flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316],dynein complex [GO:0030286]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; isomerase activity; reproductive process; organelle; cilium organization; cell motility; ATP-dependent activity
OG_04656,1.1876466957455425,FUN_022396-T1,Peve_00037596,Pocillopora_meandrina_HIv1___RNAseq.g9319.t1b,three_way,72.51733333333334,,,,,,,,,,,,,,,,,
OG_04662,2.8190548629756726,FUN_022408-T1,Peve_00037583,Pocillopora_meandrina_HIv1___RNAseq.g4541.t1,three_way,68.21366666666667,FUN_022408-T1,F1QJX5,UBR3_DANRE,,E3 ubiquitin-protein ligase ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase ubr3),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,844.0,4.4000000000000004e-125,451.1,sp|F1QJX5|UBR3_DANRE E3 ubiquitin-protein ligase ubr3 OS=Danio rerio OX=7955 GN=ubr3 PE=2 SV=2,GO:0000151; GO:0005737; GO:0008270; GO:0016567; GO:0048592; GO:0061630; GO:0071596,eye morphogenesis [GO:0048592]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04667,1.0555838794039132,FUN_022419-T1,Peve_00037625,Pocillopora_meandrina_HIv1___RNAseq.g4351.t2,three_way,41.7235,FUN_022419-T1,B2LT64,TLR2_GIRCA,,Toll-like receptor 2 (CD antigen CD282),Giraffa camelopardalis (Giraffe),32.1,134.0,7.3e-13,77.0,sp|B2LT64|TLR2_GIRCA Toll-like receptor 2 OS=Giraffa camelopardalis OX=9894 GN=TLR2 PE=3 SV=1,GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0042497; GO:0043235; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727,cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; transmembrane signaling receptor activity [GO:0004888]; triacyl lipopeptide binding [GO:0042497]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_04668,1.2695112618367983,FUN_022424-T1,Peve_00037614,Pocillopora_meandrina_HIv1___RNAseq.g4350.t1,three_way,87.994,FUN_022424-T1,P41250,GARS_HUMAN,,Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1),Homo sapiens (Human),62.3,673.0,6.6e-253,874.8,sp|P41250|GARS_HUMAN Glycine--tRNA ligase OS=Homo sapiens OX=9606 GN=GARS1 PE=1 SV=3,GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0015966; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150; GO:0141192,diadenosine tetraphosphate biosynthetic process [GO:0015966]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141],ATP binding [GO:0005524]; ATP:ATP adenylyltransferase activity [GO:0141192]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983],GO:0003824; GO:0005739; GO:0005829; GO:0006399; GO:0006520; GO:0016740; GO:0016787; GO:0016874; GO:0031410; GO:0043226; GO:0055086; GO:0140098,"catalytic activity; mitochondrion; cytosol; tRNA metabolic process; amino acid metabolic process; transferase activity; hydrolase activity; ligase activity; cytoplasmic vesicle; organelle; nucleobase-containing small molecule metabolic process; catalytic activity, acting on RNA"
OG_04669,2.625277118304775,FUN_022425-T1,Peve_00037613,Pocillopora_meandrina_HIv1___RNAseq.g4349.t1,three_way,66.758,,,,,,,,,,,,,,,,,
OG_04672,2.1960575218150384,FUN_022430-T1,Peve_00037605,Pocillopora_meandrina_HIv1___RNAseq.g4343.t1,three_way,55.87566666666667,FUN_022430-T1,P07106,,,,,46.6,131.0,5.1e-28,127.5,sp|P07106|ACBD5_BOVIN Acyl-CoA-binding domain-containing protein 5 OS=Bos taurus OX=9913 GN=ACBD5 PE=2 SV=2,,,,,,
OG_04675,2.184942962544336,FUN_022437-T1,Peve_00017892,Pocillopora_meandrina_HIv1___RNAseq.g4335.t1,three_way,81.93833333333333,FUN_022437-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),42.7,450.0,4.5e-92,340.1,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_04678,1.1583497961049811,FUN_022450-T1,Peve_00009225,Pocillopora_meandrina_HIv1___RNAseq.g4325.t1,three_way,62.3975,FUN_022450-T1,Q5RDB4,,,,,39.0,249.0,4.2000000000000004e-48,193.7,sp|Q5RDB4|NEMP1_PONAB Nuclear envelope integral membrane protein 1 OS=Pongo abelii OX=9601 GN=NEMP1 PE=2 SV=1,,,,,,
OG_04686,1.4386827642238704,FUN_022477-T1,Peve_00002918,Pocillopora_meandrina_HIv1___RNAseq.g4303.t1,three_way,85.38066666666667,FUN_022477-T1,Q32L53,LFG1_BOVIN,,Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit),Bos taurus (Bovine),46.4,220.0,5.999999999999997e-47,189.1,sp|Q32L53|LFG1_BOVIN Protein lifeguard 1 OS=Bos taurus OX=9913 GN=GRINA PE=2 SV=1,GO:0005262; GO:0005783; GO:0005794; GO:0016020; GO:0043524; GO:0097190; GO:1902042,apoptotic signaling pathway [GO:0097190]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524],endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],calcium channel activity [GO:0005262],GO:0005215; GO:0005783; GO:0005794; GO:0043226,transporter activity; endoplasmic reticulum; Golgi apparatus; organelle
OG_04688,1.6172079514334785,FUN_022479-T1,Peve_00002930,Pocillopora_meandrina_HIv1___RNAseq.g4300.t2,three_way,75.41633333333333,FUN_022479-T1,P52624,UPP1_MOUSE,,Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3),Mus musculus (Mouse),50.2,285.0,6.900000000000001e-78,292.4,sp|P52624|UPP1_MOUSE Uridine phosphorylase 1 OS=Mus musculus OX=10090 GN=Upp1 PE=1 SV=2,GO:0004850; GO:0005654; GO:0005829; GO:0006218; GO:0006220; GO:0006248; GO:0006249; GO:0009032; GO:0042149; GO:0042802; GO:0044206; GO:0046050; GO:0046074; GO:0046079; GO:0046108; GO:0047847,cellular response to glucose starvation [GO:0042149]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP catabolic process [GO:0046050]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108],cytosol [GO:0005829]; nucleoplasm [GO:0005654],deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; thymidine phosphorylase activity [GO:0009032]; uridine phosphorylase activity [GO:0004850],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04689,1.3179820576611117,FUN_022480-T1,Peve_00002919,Pocillopora_meandrina_HIv1___RNAseq.g4299.t1,three_way,73.78766666666667,FUN_022480-T1,Q9UH92,MLX_HUMAN,,Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4),Homo sapiens (Human),61.2,188.0,1.8e-56,220.7,sp|Q9UH92|MLX_HUMAN Max-like protein X OS=Homo sapiens OX=9606 GN=MLX PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:0061629; GO:1990837,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04692,3.002392771555136,FUN_022484-T1,Peve_00002924,Pocillopora_meandrina_HIv1___RNAseq.g4295.t1,three_way,86.47083333333333,FUN_022484-T1,Q8VID6,PDE11_RAT,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)",Rattus norvegicus (Rat),47.6,930.0,9.3e-242,838.2,"sp|Q8VID6|PDE11_RAT Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Rattus norvegicus OX=10116 GN=Pde11a PE=1 SV=1",GO:0004115; GO:0004118; GO:0005829; GO:0010754; GO:0019933; GO:0030553; GO:0043204; GO:0046872; GO:0047555; GO:0141162,cAMP-mediated signaling [GO:0019933]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754],cytosol [GO:0005829]; perikaryon [GO:0043204],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787,catalytic activity; cytosol; hydrolase activity
OG_04697,1.8865489423317552,FUN_022494-T1,Peve_00043030,Pocillopora_meandrina_HIv1___TS.18734_t,three_way,69.23266666666666,,,,,,,,,,,,,,,,,
OG_04698,1.4817183456501914,FUN_022495-T1,Peve_00043033,Pocillopora_meandrina_HIv1___TS.g21687.t1,three_way,47.8575,,,,,,,,,,,,,,,,,
OG_04699,2.948241340671264,FUN_022499-T1,Peve_00033031,Pocillopora_meandrina_HIv1___RNAseq.g4275.t1,three_way,69.74766666666667,FUN_022499-T1,A4IH82,,,,,29.7,290.0,3.3e-22,107.8,sp|A4IH82|3BP5L_XENTR SH3 domain-binding protein 5-like OS=Xenopus tropicalis OX=8364 GN=sh3bp5l PE=2 SV=1,,,,,,
OG_04700,1.133281797744328,FUN_022500-T1,Peve_00032397,Pocillopora_meandrina_HIv1___RNAseq.g4274.t2,three_way,58.830666666666666,,,,,,,,,,,,,,,,,
OG_04705,1.1112855309218417,FUN_022506-T1,Peve_00002460,Pocillopora_meandrina_HIv1___RNAseq.g4262.t1,three_way,76.27033333333334,FUN_022506-T1,P58742,AAAS_MOUSE,,Aladin (Adracalin),Mus musculus (Mouse),41.0,493.0,3.7e-115,416.8,sp|P58742|AAAS_MOUSE Aladin OS=Mus musculus OX=10090 GN=Aaas PE=1 SV=1,GO:0000922; GO:0001578; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006749; GO:0006913; GO:0006979; GO:0007612; GO:0009566; GO:0015031; GO:0031965; GO:0035264; GO:0051028; GO:0072686; GO:0090307,fertilization [GO:0009566]; glutathione metabolic process [GO:0006749]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; response to oxidative stress [GO:0006979],centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],,GO:0005635; GO:0005654; GO:0005815; GO:0005829; GO:0006575; GO:0006790; GO:0006913; GO:0007010; GO:0022414; GO:0043226; GO:0050877,nuclear envelope; nucleoplasm; microtubule organizing center; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; organelle; nervous system process
OG_04706,1.8550222693141,FUN_022507-T1,Peve_00002459,Pocillopora_meandrina_HIv1___RNAseq.g4261.t1,three_way,67.73566666666666,FUN_022507-T1,F1QDI9,,,,,65.5,640.0,6.4e-248,858.6,sp|F1QDI9|MCM9_DANRE DNA helicase MCM9 OS=Danio rerio OX=7955 GN=mcm9 PE=3 SV=2,,,,,,
OG_04707,1.7212872476533676,FUN_022509-T1,Peve_00031525,Pocillopora_meandrina_HIv1___RNAseq.g4259.t1,three_way,82.23083333333334,FUN_022509-T1,Q810A7,DDX42_MOUSE,,ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42),Mus musculus (Mouse),59.9,731.0,1.4000000000000001e-227,790.8,sp|Q810A7|DDX42_MOUSE ATP-dependent RNA helicase DDX42 OS=Mus musculus OX=10090 GN=Ddx42 PE=1 SV=3,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008104; GO:0016607; GO:0016887; GO:0042981; GO:0071004; GO:1903241,protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; U2-type prespliceosome assembly [GO:1903241],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type prespliceosome [GO:0071004],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0065003; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; cytosol; hydrolase activity; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04717,2.2984699545310128,FUN_022539-T2,Peve_00025372,Pocillopora_meandrina_HIv1___RNAseq.g4147.t1,three_way,68.20566666666667,,,,,,,,,,,,,,,,,
OG_04720,1.369691677825832,FUN_022569-T1,Peve_00000937,Pocillopora_meandrina_HIv1___RNAseq.g4156.t1,three_way,73.66833333333334,,,,,,,,,,,,,,,,,
OG_04723,2.208050751772785,FUN_022586-T1,Peve_00020593,Pocillopora_meandrina_HIv1___RNAseq.g4434.t2,three_way,67.00133333333333,FUN_022586-T1,Q9BE31,,,,,29.9,632.0,8e-77,289.7,sp|Q9BE31|RHG12_MACFA Rho GTPase-activating protein 12 OS=Macaca fascicularis OX=9541 GN=ARHGAP12 PE=2 SV=1,,,,,,
OG_04724,1.009879015884002,FUN_022589-T1,Peve_00020263,Pocillopora_meandrina_HIv1___RNAseq.g4431.t1,three_way,80.9065,FUN_022589-T1,O70172,,,,,50.9,450.0,7.000000000000003e-110,399.1,sp|O70172|PI42A_MOUSE Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha OS=Mus musculus OX=10090 GN=Pip4k2a PE=1 SV=1,,,,,,
OG_04726,1.2502858967149304,FUN_022591-T1,Peve_00020266,Pocillopora_meandrina_HIv1___RNAseq.g4429.t1,three_way,89.74766666666666,FUN_022591-T1,E2RG47,STT3B_CANLF,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18),Canis lupus familiaris (Dog) (Canis familiaris),69.7,700.0,4.4e-276,951.8,sp|E2RG47|STT3B_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B OS=Canis lupus familiaris OX=9615 GN=STT3B PE=1 SV=1,GO:0004579; GO:0006516; GO:0006986; GO:0008250; GO:0018279; GO:0036503; GO:0043686; GO:0043687; GO:0046872; GO:0160227,co-translational protein modification [GO:0043686]; ERAD pathway [GO:0036503]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986],oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex B [GO:0160227],dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872],GO:0003824; GO:0009101; GO:0016740; GO:0030163; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; protein catabolic process; carbohydrate derivative metabolic process
OG_04728,2.2906763386968096,FUN_022594-T1,Peve_00020268,Pocillopora_meandrina_HIv1___RNAseq.g4427.t1,three_way,86.208,FUN_022594-T1,Q969G3,SMCE1_HUMAN,,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57),Homo sapiens (Human),52.9,240.0,5.8e-47,189.5,sp|Q969G3|SMCE1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 OS=Homo sapiens OX=9606 GN=SMARCE1 PE=1 SV=2,GO:0000228; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0008080; GO:0016363; GO:0016514; GO:0016586; GO:0016922; GO:0022008; GO:0030071; GO:0032991; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],GO:0000228; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0060090; GO:0140110,nuclear chromosome; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_04731,3.2420763756313686,FUN_022599-T1,Peve_00012273,Pocillopora_meandrina_HIv1___RNAseq.g4424.t2,three_way,83.4855,FUN_022599-T1,F1LZW6,S2513_RAT,,"Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (Solute carrier family 25 member 13)",Rattus norvegicus (Rat),51.9,671.0,7.100000000000001e-186,652.1,"sp|F1LZW6|S2513_RAT Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial OS=Rattus norvegicus OX=10116 GN=Slc25a13 PE=3 SV=4",GO:0000514; GO:0000515; GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006094; GO:0006754; GO:0015172; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490; GO:0045333; GO:0051592,aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; response to calcium ion [GO:0051592],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],"3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]",GO:0005215; GO:0005739; GO:0005975; GO:0006091; GO:0043226; GO:0055085; GO:0055086; GO:1901135,transporter activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04736,1.027555700081518,FUN_022610-T1,Peve_00012255,Pocillopora_meandrina_HIv1___TS.g21808.t1,three_way,50.32066666666667,,,,,,,,,,,,,,,,,
OG_04737,7.401238143008154,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_04738,1.2514139103142752,FUN_022614-T1,Peve_00012265,Pocillopora_meandrina_HIv1___RNAseq.g4396.t1,three_way,66.271,,,,,,,,,,,,,,,,,
OG_04739,3.1427150515892857,FUN_022615-T1,Peve_00012268,Pocillopora_meandrina_HIv1___RNAseq.g4395.t1,three_way,62.804,FUN_022615-T1,P79691,SHH_CARAU,,Sonic hedgehog protein (SHHA) (EC 3.1.-.-) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) [Cleaved into: Sonic hedgehog protein A N-product (Shh N-terminal processed signaling domains) (ShhNp) (Sonic hedgehog protein N-product) (ShhN)],Carassius auratus (Goldfish),44.2,398.0,9.4e-82,305.4,sp|P79691|SHH_CARAU Sonic hedgehog protein OS=Carassius auratus OX=7957 GN=shha PE=3 SV=3,GO:0000139; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005789; GO:0005886; GO:0007224; GO:0007267; GO:0007389; GO:0008233; GO:0009888; GO:0010468; GO:0016539; GO:0016540; GO:0030182; GO:0035295; GO:0042127; GO:0045880; GO:0048468; GO:0048513; GO:0048709; GO:0050793; GO:0097264; GO:0140853,animal organ development [GO:0048513]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; pattern specification process [GO:0007389]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of cell population proliferation [GO:0042127]; regulation of developmental process [GO:0050793]; regulation of gene expression [GO:0010468]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888]; tube development [GO:0035295],endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233],GO:0003824; GO:0005615; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0030154; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; transferase activity; hydrolase activity; signaling; cell differentiation; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_04743,1.6556848745198811,FUN_022622-T1,Peve_00012274,Pocillopora_meandrina_HIv1___RNAseq.g4388.t1,three_way,79.17566666666667,FUN_022622-T1,Q58EB4,,,,,64.5,242.0,7.4e-80,298.5,"sp|Q58EB4|HIBCH_DANRE 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial OS=Danio rerio OX=7955 GN=hibch PE=2 SV=1",,,,,,
OG_04745,1.536500524714061,FUN_022626-T1,Peve_00012279,Pocillopora_meandrina_HIv1___RNAseq.g4386.t1,three_way,75.93066666666667,FUN_022626-T1,Q5U3U0,,,,,52.9,291.0,3.4e-89,329.7,sp|Q5U3U0|PHYD1_DANRE Phytanoyl-CoA dioxygenase domain-containing protein 1 OS=Danio rerio OX=7955 GN=phyhd1 PE=2 SV=1,,,,,,
OG_04749,1.4997470674937703,FUN_022632-T1,Peve_00012223,Pocillopora_meandrina_HIv1___RNAseq.g2906.t1,three_way,91.81466666666668,FUN_022632-T1,Q2NKW0,BL1S1_BOVIN,,Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC-1 subunit 1) (Protein acetyltransferase BLOC1S1) (EC 2.3.1.-),Bos taurus (Bovine),61.9,118.0,2.7000000000000004e-32,139.4,sp|Q2NKW0|BL1S1_BOVIN Biogenesis of lysosome-related organelles complex 1 subunit 1 OS=Bos taurus OX=9913 GN=BLOC1S1 PE=2 SV=1,GO:0005758; GO:0005759; GO:0005765; GO:0005829; GO:0008089; GO:0009060; GO:0016197; GO:0018394; GO:0031083; GO:0031175; GO:0032418; GO:0048490; GO:0061733; GO:0099078; GO:1904115,aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394],axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759],protein-lysine-acetyltransferase activity [GO:0061733],GO:0003824; GO:0005829; GO:0006091; GO:0007018; GO:0016192; GO:0016740; GO:0140096,"catalytic activity; cytosol; generation of precursor metabolites and energy; microtubule-based movement; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_04751,2.9475804128998457,FUN_022635-T1,Peve_00027026,Pocillopora_meandrina_HIv1___RNAseq.g9362.t1,three_way,80.95233333333333,FUN_022635-T1,Q8R344,,,,,58.0,162.0,1.2e-38,161.0,sp|Q8R344|CCD12_MOUSE Coiled-coil domain-containing protein 12 OS=Mus musculus OX=10090 GN=Ccdc12 PE=1 SV=2,,,,,,
OG_04755,3.669239822046791,FUN_022640-T1,Peve_00022140,Pocillopora_meandrina_HIv1___RNAseq.g9367.t1,three_way,76.032,FUN_022640-T1,P49356,FNTB_HUMAN,,Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta),Homo sapiens (Human),54.6,388.0,6.6e-122,438.7,sp|P49356|FNTB_HUMAN Protein farnesyltransferase subunit beta OS=Homo sapiens OX=9606 GN=FNTB PE=1 SV=1,GO:0004660; GO:0005829; GO:0005875; GO:0005965; GO:0006629; GO:0008270; GO:0008284; GO:0010698; GO:0018343; GO:0019899; GO:0042277; GO:0045787; GO:0060632,lipid metabolic process [GO:0006629]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; protein farnesylation [GO:0018343]; regulation of microtubule-based movement [GO:0060632],cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; protein farnesyltransferase complex [GO:0005965],acetyltransferase activator activity [GO:0010698]; enzyme binding [GO:0019899]; peptide binding [GO:0042277]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006629; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04756,1.5171399212934484,FUN_022642-T1,Peve_00044337,Pocillopora_meandrina_HIv1___RNAseq.g9369.t1,three_way,57.92616666666667,FUN_022642-T1,Q14517,,,,,26.9,334.0,2.4e-19,100.1,sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2,,,,,,
OG_04757,1.1493329146794729,FUN_022644-T2,Peve_00044335,Pocillopora_meandrina_HIv1___RNAseq.g9376.t1,three_way,70.68516666666667,FUN_022644-T2,Q9UNS1,TIM_HUMAN,,Protein timeless homolog (hTIM),Homo sapiens (Human),42.1,1053.0,1.1e-205,718.8,sp|Q9UNS1|TIM_HUMAN Protein timeless homolog OS=Homo sapiens OX=9606 GN=TIMELESS PE=1 SV=2,GO:0000076; GO:0000785; GO:0002009; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007623; GO:0008047; GO:0009582; GO:0030324; GO:0031297; GO:0031298; GO:0035861; GO:0042752; GO:0042802; GO:0043111; GO:0044770; GO:0045892; GO:0048754; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781,branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork processing [GO:0031297],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861],DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802],GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006355; GO:0043226; GO:0048856; GO:0098772,DNA binding; nucleus; nucleoplasm; DNA repair; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular function regulator activity
OG_04758,2.981787807820932,FUN_022647-T1,Peve_00036577,Pocillopora_meandrina_HIv1___RNAseq.g4454.t1,three_way,72.587,FUN_022647-T1,Q15434,,,,,61.2,232.0,9.8e-69,262.7,"sp|Q15434|RBMS2_HUMAN RNA-binding motif, single-stranded-interacting protein 2 OS=Homo sapiens OX=9606 GN=RBMS2 PE=1 SV=1",,,,,,
OG_04760,2.2157855185439748,FUN_022656-T1,Peve_00019498,Pocillopora_meandrina_HIv1___RNAseq.g21258.t1,three_way,47.02216666666666,,,,,,,,,,,,,,,,,
OG_04761,1.469154826674024,FUN_022659-T1,Peve_00020231,Pocillopora_meandrina_HIv1___RNAseq.g3028.t1,three_way,39.47416666666667,,,,,,,,,,,,,,,,,
OG_04762,2.62766770230131,FUN_022662-T1,Peve_00027940,Pocillopora_meandrina_HIv1___RNAseq.g3157.t1b,three_way,84.34933333333333,FUN_022662-T1,Q5ZLC8,,,,,47.4,137.0,1.4e-25,120.2,sp|Q5ZLC8|ANR52_CHICK Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Gallus gallus OX=9031 GN=ANKRD52 PE=2 SV=1,,,,,,
OG_04764,1.2588023679851597,FUN_022664-T2,Peve_00027942,Pocillopora_meandrina_HIv1___RNAseq.g3154.t1,three_way,68.32866666666666,FUN_022664-T2,O19094,OCTC_BOVIN,,Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137),Bos taurus (Bovine),42.1,598.0,9.4e-137,488.8,sp|O19094|OCTC_BOVIN Peroxisomal carnitine O-octanoyltransferase OS=Bos taurus OX=9913 GN=CROT PE=1 SV=1,GO:0005777; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009437; GO:0015936; GO:0051791,carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791],peroxisome [GO:0005777],carnitine O-octanoyltransferase activity [GO:0008458],GO:0003824; GO:0005777; GO:0006091; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; peroxisome; generation of precursor metabolites and energy; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_04771,1.5037830109171633,FUN_022673-T1,Peve_00010102,Pocillopora_meandrina_HIv1___RNAseq.g4124.t2,three_way,59.6315,FUN_022673-T1,Q3U821,,,,,33.9,785.0,7.1e-103,376.7,sp|Q3U821|WDR75_MOUSE WD repeat-containing protein 75 OS=Mus musculus OX=10090 GN=Wdr75 PE=1 SV=1,,,,,,
OG_04774,1.9456692886201616,FUN_022678-T1,Peve_00018003,Pocillopora_meandrina_HIv1___RNAseq.g4841.t1,three_way,59.595666666666666,FUN_022678-T1,Q91175,,,,,25.1,323.0,3.9e-15,84.3,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_04777,1.4532196386212424,FUN_022683-T1,Peve_00018006,Pocillopora_meandrina_HIv1___RNAseq.g4838.t1,three_way,79.14633333333333,FUN_022683-T1,Q5RFD3,,,,,50.6,245.0,8.2e-65,248.4,sp|Q5RFD3|PSME3_PONAB Proteasome activator complex subunit 3 OS=Pongo abelii OX=9601 GN=PSME3 PE=2 SV=1,,,,,,
OG_04779,1.2153564658170013,FUN_022688-T1,Peve_00045105,Pocillopora_meandrina_HIv1___RNAseq.19135_t,three_way,60.34033333333333,FUN_022688-T1,Q4ZQC6,,,,,55.3,123.0,3.1000000000000002e-34,146.7,sp|Q4ZQC6|MSRB_PSEU2 Peptide methionine sulfoxide reductase MsrB OS=Pseudomonas syringae pv. syringae (strain B728a) OX=205918 GN=msrB PE=3 SV=1,,,,,,
OG_04780,2.3506493563063096,FUN_022689-T1,Peve_00045106,Pocillopora_meandrina_HIv1___RNAseq.g4835.t1,three_way,78.04266666666666,FUN_022689-T1,Q8NKE2,,,,,44.2,278.0,4.999999999999999e-62,239.6,"sp|Q8NKE2|AOX_CRYNH Alternative oxidase, mitochondrial OS=Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) OX=235443 GN=AOX1 PE=3 SV=2",,,,,,
OG_04786,1.6180330518322992,FUN_022700-T1,Peve_00018683,Pocillopora_meandrina_HIv1___RNAseq.g4826.t1,three_way,70.454,FUN_022700-T1,Q9NS86,LANC2_HUMAN,,LanC-like protein 2 (Testis-specific adriamycin sensitivity protein),Homo sapiens (Human),49.2,386.0,2.1e-89,330.9,sp|Q9NS86|LANC2_HUMAN LanC-like protein 2 OS=Homo sapiens OX=9606 GN=LANCL2 PE=1 SV=1,GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0009789; GO:0010314; GO:0030864; GO:0031179; GO:0032266; GO:0045892; GO:0070273,carbohydrate metabolic process [GO:0005975]; negative regulation of DNA-templated transcription [GO:0045892]; peptide modification [GO:0031179]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789],cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314],GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005975; GO:0006355; GO:0008289; GO:0043226,nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; carbohydrate metabolic process; regulation of DNA-templated transcription; lipid binding; organelle
OG_04796,1.413626012112527,FUN_022715-T1,Peve_00016563,Pocillopora_meandrina_HIv1___RNAseq.g3160.t1,three_way,74.70833333333333,FUN_022715-T1,O88794,,,,,52.1,234.0,1.4e-65,251.1,sp|O88794|PNPO_RAT Pyridoxine-5'-phosphate oxidase OS=Rattus norvegicus OX=10116 GN=Pnpo PE=1 SV=1,,,,,,
OG_04797,1.2044730553088774,FUN_022716-T1,Peve_00016561,Pocillopora_meandrina_HIv1___RNAseq.g3161.t1,three_way,88.14033333333333,FUN_022716-T1,A7RG82,,,,,77.2,338.0,3.5e-154,545.8,sp|A7RG82|CLP1_NEMVE Protein CLP1 homolog OS=Nematostella vectensis OX=45351 GN=v1g236308 PE=3 SV=1,,,,,,
OG_04802,1.602437780204078,FUN_022761-T1,Peve_00006882,Pocillopora_meandrina_HIv1___RNAseq.g4814.t1,three_way,80.2745,,,,,,,,,,,,,,,,,
OG_04803,1.1687670169235622,FUN_022762-T1,Peve_00006888,Pocillopora_meandrina_HIv1___RNAseq.g4810.t1,three_way,52.281666666666666,,,,,,,,,,,,,,,,,
OG_04804,1.0209333602637272,FUN_022763-T1,Peve_00006881,Pocillopora_meandrina_HIv1___RNAseq.g4809.t1,three_way,71.97783333333334,FUN_022763-T1,Q96RJ6,FER3L_HUMAN,,Fer3-like protein (Basic helix-loop-helix protein N-twist) (Class A basic helix-loop-helix protein 31) (bHLHa31) (Nephew of atonal 3) (Neuronal twist),Homo sapiens (Human),46.4,56.0,7.9e-07,55.1,sp|Q96RJ6|FER3L_HUMAN Fer3-like protein OS=Homo sapiens OX=9606 GN=FERD3L PE=1 SV=1,GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0032502; GO:0033504; GO:0045892; GO:0046983; GO:0048468; GO:0050767; GO:1904338; GO:1990837,cell development [GO:0048468]; developmental process [GO:0032502]; floor plate development [GO:0033504]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_04805,1.6546005118787557,FUN_022764-T1,Peve_00014654,Pocillopora_meandrina_HIv1___RNAseq.g4808.t1,three_way,73.40683333333334,FUN_022764-T1,Q6QHK4,FIGLA_HUMAN,,Factor in the germline alpha (FIGalpha) (Class C basic helix-loop-helix protein 8) (bHLHc8) (Folliculogenesis-specific basic helix-loop-helix protein) (Transcription factor FIGa),Homo sapiens (Human),45.3,64.0,1.6e-08,61.2,sp|Q6QHK4|FIGLA_HUMAN Factor in the germline alpha OS=Homo sapiens OX=9606 GN=FIGLA PE=1 SV=2,GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0032502; GO:0043425; GO:0046983; GO:0048599; GO:1990837,developmental process [GO:0032502]; oocyte development [GO:0048599]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04806,2.932711632105307,FUN_022765-T1,Peve_00014656,Pocillopora_meandrina_HIv1___RNAseq.g4805.t1,three_way,83.05433333333333,FUN_022765-T1,P13903,,,,,77.5,89.0,1.1e-31,137.5,sp|P13903|TWIST_XENLA Twist-related protein OS=Xenopus laevis OX=8355 GN=twist1 PE=2 SV=1,,,,,,
OG_04807,2.1956388610166053,FUN_022766-T1,Peve_00014657,Pocillopora_meandrina_HIv1___RNAseq.g4730.t1,three_way,58.63033333333333,,,,,,,,,,,,,,,,,
OG_04808,2.7718703329359147,FUN_022767-T1,Peve_00014658,Pocillopora_meandrina_HIv1___RNAseq.g4729.t1,three_way,73.63166666666666,FUN_022767-T1,Q7ZX22,WDR24_XENLA,,GATOR2 complex protein WDR24 (EC 2.3.2.27),Xenopus laevis (African clawed frog),38.4,799.0,4.6e-160,566.6,sp|Q7ZX22|WDR24_XENLA GATOR2 complex protein WDR24 OS=Xenopus laevis OX=8355 GN=wdr24 PE=2 SV=1,GO:0005765; GO:0005774; GO:0005829; GO:0006914; GO:0008270; GO:0016239; GO:0031669; GO:0034198; GO:0061630; GO:0061700; GO:0085020; GO:1904263,autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; protein K6-linked ubiquitination [GO:0085020],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006914; GO:0016740; GO:0140096,"catalytic activity; cytosol; autophagy; transferase activity; catalytic activity, acting on a protein"
OG_04809,2.231494320169292,FUN_022771-T1,Peve_00043386,Pocillopora_meandrina_HIv1___RNAseq.g4766.t1,three_way,62.87,FUN_022771-T1,P49442,,,,,39.7,393.0,1.5e-66,255.0,sp|P49442|INPP_MOUSE Inositol polyphosphate 1-phosphatase OS=Mus musculus OX=10090 GN=Inpp1 PE=1 SV=2,,,,,,
OG_04810,1.743119523288164,FUN_022772-T1,Peve_00043388,Pocillopora_meandrina_HIv1___RNAseq.g4767.t1,three_way,97.277,FUN_022772-T1,P23258,TBG1_HUMAN,,Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1),Homo sapiens (Human),81.6,451.0,5.9e-221,768.1,sp|P23258|TBG1_HUMAN Tubulin gamma-1 chain OS=Homo sapiens OX=9606 GN=TUBG1 PE=1 SV=2,GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0000931; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005881; GO:0007020; GO:0007052; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0043005; GO:0045177; GO:0055037; GO:0097730; GO:0140490; GO:1990498,cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052],apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; mitotic spindle microtubule [GO:1990498]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819],GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule nucleator activity [GO:0140490]; structural constituent of cytoskeleton [GO:0005200],GO:0000228; GO:0000278; GO:0005198; GO:0005634; GO:0005694; GO:0005768; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0007059; GO:0022414; GO:0031410; GO:0043226,nuclear chromosome; mitotic cell cycle; structural molecule activity; nucleus; chromosome; endosome; microtubule organizing center; cytosol; cilium; cytoskeleton organization; chromosome segregation; reproductive process; cytoplasmic vesicle; organelle
OG_04817,1.5147929434173344,FUN_022803-T1,Peve_00024730,Pocillopora_meandrina_HIv1___RNAseq.g3482.t1,three_way,64.24266666666666,,,,,,,,,,,,,,,,,
OG_04818,2.3846598576130758,FUN_022804-T1,Peve_00024731,Pocillopora_meandrina_HIv1___RNAseq.g3480.t1,three_way,66.91633333333334,FUN_022804-T1,Q9NQZ5,STAR7_HUMAN,,"StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7) (StARD7)",Homo sapiens (Human),44.1,247.0,7.6000000000000005e-59,229.2,"sp|Q9NQZ5|STAR7_HUMAN StAR-related lipid transfer protein 7, mitochondrial OS=Homo sapiens OX=9606 GN=STARD7 PE=1 SV=2",GO:0001773; GO:0005576; GO:0005739; GO:0005741; GO:0006744; GO:0006954; GO:0008289; GO:0042092; GO:0061436; GO:0120013; GO:0120197; GO:0140104,establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; mucociliary clearance [GO:0120197]; myeloid dendritic cell activation [GO:0001773]; type 2 immune response [GO:0042092]; ubiquinone biosynthetic process [GO:0006744],extracellular region [GO:0005576]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; lipid transfer activity [GO:0120013]; molecular carrier activity [GO:0140104],GO:0002376; GO:0003016; GO:0005215; GO:0005576; GO:0005739; GO:0006954; GO:0007018; GO:0008289; GO:0043226; GO:0048856; GO:0140104,immune system process; respiratory system process; transporter activity; extracellular region; mitochondrion; inflammatory response; microtubule-based movement; lipid binding; organelle; anatomical structure development; molecular carrier activity
OG_04822,1.69539717162491,FUN_022812-T1,Peve_00031630,Pocillopora_meandrina_HIv1___RNAseq.g3465.t1,three_way,78.11,FUN_022812-T1,P00504,,,,,54.6,368.0,1e-114,414.8,"sp|P00504|AATC_CHICK Aspartate aminotransferase, cytoplasmic OS=Gallus gallus OX=9031 GN=GOT1 PE=1 SV=3",,,,,,
OG_04825,1.5479650386831156,FUN_022817-T1,Peve_00014997,Pocillopora_meandrina_HIv1___TS.g9632.t1,three_way,48.804,,,,,,,,,,,,,,,,,
OG_04827,1.1480246000342889,FUN_022821-T1,Peve_00016085,Pocillopora_meandrina_HIv1___RNAseq.g3443.t1,three_way,74.968,FUN_022821-T1,B3S3D5,,,,,72.1,104.0,1.5e-34,148.3,sp|B3S3D5|DDRGK_TRIAD DDRGK domain-containing protein 1 OS=Trichoplax adhaerens OX=10228 GN=TRIADDRAFT_58679 PE=3 SV=1,,,,,,
OG_04829,2.422236271828486,FUN_022823-T1,Peve_00027665,Pocillopora_meandrina_HIv1___RNAseq.g3439.t1,three_way,69.43183333333333,FUN_022823-T1,A8MU46,SMTL1_HUMAN,,Smoothelin-like protein 1,Homo sapiens (Human),49.5,101.0,9.6e-22,106.7,sp|A8MU46|SMTL1_HUMAN Smoothelin-like protein 1 OS=Homo sapiens OX=9606 GN=SMTNL1 PE=1 SV=2,GO:0005516; GO:0005523; GO:0005634; GO:0005737; GO:0008157; GO:0009410; GO:0014823; GO:0031430; GO:0031674; GO:0042310; GO:0043292; GO:0045892; GO:0045907; GO:0048644; GO:0051401; GO:0097718,muscle organ morphogenesis [GO:0048644]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310],contractile muscle fiber [GO:0043292]; cytoplasm [GO:0005737]; I band [GO:0031674]; M band [GO:0031430]; nucleus [GO:0005634],calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523],GO:0003013; GO:0005634; GO:0006355; GO:0008092; GO:0043226,circulatory system process; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; organelle
OG_04831,2.510273873044218,FUN_022825-T1,Peve_00028904,Pocillopora_meandrina_HIv1___RNAseq.g3433.t1,three_way,66.04366666666667,FUN_022825-T1,O43156,TTI1_HUMAN,,TELO2-interacting protein 1 homolog (Protein SMG10),Homo sapiens (Human),33.4,1144.0,2.5e-172,607.8,sp|O43156|TTI1_HUMAN TELO2-interacting protein 1 homolog OS=Homo sapiens OX=9606 GN=TTI1 PE=1 SV=3,GO:0005634; GO:0005737; GO:0031931; GO:0031932; GO:0032006; GO:0050821; GO:0110078; GO:2000003,positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006],cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT Hsp90 cochaperone complex [GO:0110078],,GO:0005634; GO:0043226,nucleus; organelle
OG_04834,1.5377400040789568,FUN_022832-T1,Peve_00028897,Pocillopora_meandrina_HIv1___RNAseq.g3430.t1,three_way,80.637,FUN_022832-T1,Q8WXB1,MT21A_HUMAN,,Protein N-lysine methyltransferase METTL21A (EC 2.1.1.-) (HSPA lysine methyltransferase) (HSPA-KMT) (Hepatocellular carcinoma-associated antigen 557b) (Methyltransferase-like protein 21A),Homo sapiens (Human),53.4,161.0,2.2e-38,160.2,sp|Q8WXB1|MT21A_HUMAN Protein N-lysine methyltransferase METTL21A OS=Homo sapiens OX=9606 GN=METTL21A PE=1 SV=2,GO:0005654; GO:0005829; GO:0006479; GO:0008276; GO:0016279; GO:0030544; GO:0031072; GO:0032991; GO:0051117; GO:1903645,negative regulation of chaperone-mediated protein folding [GO:1903645]; protein methylation [GO:0006479],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],ATPase binding [GO:0051117]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_04841,1.1389707283717991,FUN_022850-T2,Peve_00028882,Pocillopora_meandrina_HIv1___RNAseq.g3395.t1,three_way,55.903,FUN_022850-T2,Q9I8N6,CSF1R_DANRE,,Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms homolog),Danio rerio (Zebrafish) (Brachydanio rerio),27.4,431.0,2.4000000000000002e-30,135.6,sp|Q9I8N6|CSF1R_DANRE Macrophage colony-stimulating factor 1 receptor OS=Danio rerio OX=7955 GN=csf1r PE=2 SV=1,GO:0002383; GO:0005011; GO:0005524; GO:0005886; GO:0006629; GO:0006954; GO:0007169; GO:0008284; GO:0010759; GO:0014004; GO:0014005; GO:0016477; GO:0019838; GO:0019955; GO:0030100; GO:0030316; GO:0030318; GO:0030335; GO:0031641; GO:0036035; GO:0036179; GO:0036269; GO:0042481; GO:0043235; GO:0043408; GO:0043473; GO:0045087; GO:0048066; GO:0048070; GO:0048246; GO:0050936; GO:0050938; GO:0061075; GO:0097324; GO:1990682; GO:2001204,cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; developmental pigmentation [GO:0048066]; immune response in brain or nervous system [GO:0002383]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipid metabolic process [GO:0006629]; macrophage chemotaxis [GO:0048246]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; microglia development [GO:0014005]; microglia differentiation [GO:0014004]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast maturation [GO:0036179]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neural retina development [GO:0061075]; regulation of developmental pigmentation [GO:0048070]; regulation of endocytosis [GO:0030100]; regulation of MAPK cascade [GO:0043408]; regulation of myelination [GO:0031641]; regulation of odontogenesis [GO:0042481]; regulation of osteoclast development [GO:2001204]; regulation of xanthophore differentiation [GO:0050938]; swimming behavior [GO:0036269]; xanthophore differentiation [GO:0050936],CSF1-CSF1R complex [GO:1990682]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; macrophage colony-stimulating factor receptor activity [GO:0005011],GO:0002376; GO:0003824; GO:0005886; GO:0006629; GO:0006954; GO:0016740; GO:0030154; GO:0048856; GO:0048870; GO:0060089; GO:0098542; GO:0140096,"immune system process; catalytic activity; plasma membrane; lipid metabolic process; inflammatory response; transferase activity; cell differentiation; anatomical structure development; cell motility; molecular transducer activity; defense response to other organism; catalytic activity, acting on a protein"
OG_04845,1.3887574494976516,FUN_022855-T1,Peve_00004027,Pocillopora_meandrina_HIv1___RNAseq.g3390.t1,three_way,86.75766666666667,FUN_022855-T1,P0AF49,,,,,51.4,138.0,8.000000000000001e-39,161.4,sp|P0AF49|YJBQ_ECO57 UPF0047 protein YjbQ OS=Escherichia coli O157:H7 OX=83334 GN=yjbQ PE=3 SV=1,,,,,,
OG_04846,2.4846297630352323,FUN_022856-T1,Peve_00004026,Pocillopora_meandrina_HIv1___RNAseq.g3389.t1,three_way,83.74,FUN_022856-T1,A2TLM1,,,,,67.5,194.0,8.9e-66,251.5,sp|A2TLM1|RPIA_PIG Ribose-5-phosphate isomerase OS=Sus scrofa OX=9823 GN=RPIA PE=2 SV=1,,,,,,
OG_04847,1.1734874290887891,FUN_022857-T1,Peve_00004025,Pocillopora_meandrina_HIv1___TS.g9560.t1,three_way,73.97733333333333,FUN_022857-T1,Q75Z89,5HT2A_BOVIN,,5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A),Bos taurus (Bovine),28.6,318.0,4.5e-26,120.2,sp|Q75Z89|5HT2A_BOVIN 5-hydroxytryptamine receptor 2A OS=Bos taurus OX=9913 GN=HTR2A PE=2 SV=1,GO:0001587; GO:0004993; GO:0005886; GO:0005901; GO:0006096; GO:0006874; GO:0007187; GO:0007208; GO:0007210; GO:0007268; GO:0009410; GO:0010513; GO:0030296; GO:0030424; GO:0030425; GO:0030594; GO:0031410; GO:0042802; GO:0044380; GO:0045600; GO:0045821; GO:0051209; GO:0051378; GO:0070374; GO:0071886; GO:0098666; GO:0098793; GO:0099589,"chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glycolytic process [GO:0006096]; intracellular calcium ion homeostasis [GO:0006874]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glycolytic process [GO:0045821]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein localization to cytoskeleton [GO:0044380]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; serotonin receptor signaling pathway [GO:0007210]",axon [GO:0030424]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; G protein-coupled serotonin receptor complex [GO:0098666]; plasma membrane [GO:0005886]; presynapse [GO:0098793],"1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; G protein-coupled serotonin receptor activity [GO:0004993]; Gq/11-coupled serotonin receptor activity [GO:0001587]; identical protein binding [GO:0042802]; neurotransmitter receptor activity [GO:0030594]; protein tyrosine kinase activator activity [GO:0030296]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589]",GO:0005886; GO:0005975; GO:0006091; GO:0023052; GO:0031410; GO:0043226; GO:0055085; GO:0055086; GO:0060089; GO:0098772; GO:1901135,plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; signaling; cytoplasmic vesicle; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process; molecular transducer activity; molecular function regulator activity; carbohydrate derivative metabolic process
OG_04851,2.3548491301377137,FUN_022863-T1,Peve_00025604,Pocillopora_meandrina_HIv1___RNAseq.g3607.t1,three_way,83.18433333333333,FUN_022863-T1,Q5F450,PAN2_CHICK,,PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2),Gallus gallus (Chicken),51.1,1129.0,0.0,1086.6,sp|Q5F450|PAN2_CHICK PAN2-PAN3 deadenylation complex catalytic subunit PAN2 OS=Gallus gallus OX=9031 GN=PAN2 PE=2 SV=1,GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872,mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535],GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_04852,2.1676988998853237,FUN_022864-T1,Peve_00025619,Pocillopora_meandrina_HIv1___TS.g9783.t1,three_way,69.89,FUN_022864-T1,Q9BSG0,,,,,43.6,165.0,7.2e-38,158.7,sp|Q9BSG0|PADC1_HUMAN Protease-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PRADC1 PE=1 SV=1,,,,,,
OG_04853,1.1552136482436095,FUN_022865-T1,Peve_00025617,Pocillopora_meandrina_HIv1___RNAseq.g3609.t1,three_way,84.65799999999999,FUN_022865-T1,Q7T321,KCMF1_DANRE,,E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27),Danio rerio (Zebrafish) (Brachydanio rerio),62.8,333.0,2.6e-92,340.5,sp|Q7T321|KCMF1_DANRE E3 ubiquitin-protein ligase KCMF1 OS=Danio rerio OX=7955 GN=kcmf1 PE=2 SV=1,GO:0005764; GO:0005770; GO:0005886; GO:0008270; GO:0016740; GO:0045202; GO:0070534; GO:0099536; GO:0141191,negative regulation of HRI-mediated signaling [GO:0141191]; protein K63-linked ubiquitination [GO:0070534]; synaptic signaling [GO:0099536],late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synapse [GO:0045202],transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0016740; GO:0023052; GO:0031410; GO:0043226,catalytic activity; lysosome; endosome; vacuole; plasma membrane; transferase activity; signaling; cytoplasmic vesicle; organelle
OG_04854,2.015535674857313,FUN_022868-T1,Peve_00012303,Pocillopora_meandrina_HIv1___RNAseq.g3613.t1,three_way,73.38633333333333,FUN_022868-T1,Q804R0,LBX2_DANRE,,Transcription factor LBX2 (Ladybird homeobox 2) (Ladybird homeobox protein homolog 2),Danio rerio (Zebrafish) (Brachydanio rerio),46.3,177.0,4.2e-30,132.9,sp|Q804R0|LBX2_DANRE Transcription factor LBX2 OS=Danio rerio OX=7955 GN=lbx2 PE=1 SV=1,GO:0000578; GO:0000981; GO:0005634; GO:0006357; GO:0042692; GO:0048920; GO:0048922; GO:0055001; GO:0060828; GO:1904105; GO:1990837; GO:2000052,embryonic axis specification [GO:0000578]; muscle cell development [GO:0055001]; muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; posterior lateral line neuromast deposition [GO:0048922]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04857,2.702014158640155,FUN_022871-T1,Peve_00012299,Pocillopora_meandrina_HIv1___RNAseq.g3616.t1,three_way,89.286,FUN_022871-T1,Q90788,NKX25_CHICK,,Homeobox protein Nkx-2.5 (cNKx-2.5) (Homeobox protein NK-2 homolog E),Gallus gallus (Chicken),52.2,159.0,1.2e-33,145.2,sp|Q90788|NKX25_CHICK Homeobox protein Nkx-2.5 OS=Gallus gallus OX=9031 GN=NKX-2.5 PE=2 SV=1,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001947; GO:0003148; GO:0003166; GO:0003168; GO:0003211; GO:0003221; GO:0003222; GO:0003228; GO:0003278; GO:0003285; GO:0003342; GO:0003350; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007512; GO:0010628; GO:0010667; GO:0010765; GO:0010832; GO:0030097; GO:0030154; GO:0030855; GO:0030878; GO:0032991; GO:0032993; GO:0042803; GO:0045666; GO:0045823; GO:0048536; GO:0050673; GO:0050679; GO:0051891; GO:0055005; GO:0055117; GO:0060037; GO:0060038; GO:0060043; GO:0060048; GO:0060261; GO:0060347; GO:0060412; GO:0060413; GO:0060928; GO:0060929; GO:0060971; GO:0061629; GO:0071772; GO:0090090; GO:1903779; GO:1904019; GO:1904036; GO:1990664,adult heart development [GO:0007512]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial cardiac muscle tissue development [GO:0003228]; atrial septum morphogenesis [GO:0060413]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; bundle of His development [GO:0003166]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle contraction [GO:0060048]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; embryonic heart tube left/right pattern formation [GO:0060971]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of heart contraction [GO:0045823]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; proepicardium development [GO:0003342]; pulmonary myocardium development [GO:0003350]; Purkinje myocyte differentiation [GO:0003168]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cardiac muscle contraction [GO:0055117]; regulation of transcription by RNA polymerase II [GO:0006357]; response to BMP [GO:0071772]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; septum secundum development [GO:0003285]; spleen development [GO:0048536]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],cytosol [GO:0005829]; Nkx-2.5 complex [GO:1990664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0007010; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04858,3.5357925456699038,FUN_022873-T1,Peve_00012298,Pocillopora_meandrina_HIv1___RNAseq.g3617.t1,three_way,80.57066666666667,FUN_022873-T1,P13297,MSX1_MOUSE,,Homeobox protein MSX-1 (Homeobox protein Hox-7) (Hox-7.1) (Msh homeobox 1-like protein),Mus musculus (Mouse),65.8,149.0,1e-41,171.8,sp|P13297|MSX1_MOUSE Homeobox protein MSX-1 OS=Mus musculus OX=10090 GN=Msx1 PE=1 SV=4,GO:0000122; GO:0000902; GO:0000976; GO:0000977; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001701; GO:0001837; GO:0002039; GO:0003007; GO:0003198; GO:0005634; GO:0005654; GO:0005667; GO:0006366; GO:0007507; GO:0007517; GO:0008285; GO:0009952; GO:0010463; GO:0010629; GO:0021983; GO:0023019; GO:0030308; GO:0030326; GO:0030509; GO:0030513; GO:0030900; GO:0030901; GO:0034399; GO:0034504; GO:0035115; GO:0035116; GO:0035880; GO:0042474; GO:0042475; GO:0042476; GO:0042481; GO:0042482; GO:0042733; GO:0043066; GO:0043565; GO:0043584; GO:0045787; GO:0045892; GO:0045944; GO:0048839; GO:0048863; GO:0050821; GO:0051154; GO:0060021; GO:0060325; GO:0060349; GO:0060536; GO:0061180; GO:0061311; GO:0071316; GO:0090427; GO:0097152; GO:1901330; GO:1902255; GO:2001055,activation of meiosis [GO:0090427]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; bone morphogenesis [GO:0060349]; cartilage morphogenesis [GO:0060536]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway involved in heart development [GO:0061311]; cellular response to nicotine [GO:0071316]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic nail plate morphogenesis [GO:0035880]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; mammary gland epithelium development [GO:0061180]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of odontoblast differentiation [GO:1901330]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nose development [GO:0043584]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; pituitary gland development [GO:0021983]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell cycle [GO:0045787]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of odontogenesis [GO:0042482]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of odontogenesis [GO:0042481]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366],nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04859,1.4597947390802095,FUN_022876-T1,Peve_00012294,Pocillopora_meandrina_HIv1___RNAseq.g3619.t2,three_way,78.97766666666666,FUN_022876-T1,Q5SNQ7,,,,,44.6,489.0,1.9999999999999999e-115,417.9,sp|Q5SNQ7|SRAC1_DANRE Protein SERAC1 OS=Danio rerio OX=7955 GN=serac1 PE=3 SV=1,,,,,,
OG_04860,2.495408383964636,FUN_022877-T1,Peve_00012293,Pocillopora_meandrina_HIv1___RNAseq.g3620.t1,three_way,78.91933333333333,FUN_022877-T1,Q9BRF8,CPPED_HUMAN,,Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1),Homo sapiens (Human),48.3,294.0,1.3e-80,301.2,sp|Q9BRF8|CPPED_HUMAN Serine/threonine-protein phosphatase CPPED1 OS=Homo sapiens OX=9606 GN=CPPED1 PE=1 SV=3,GO:0004722; GO:0005576; GO:0005829; GO:0005886; GO:0035578; GO:0046872,,azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005576; GO:0005829; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular region; cytosol; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_04864,2.282216714900398,FUN_022888-T1,Peve_00001730,Pocillopora_meandrina_HIv1___RNAseq.g3687.t1,three_way,82.29666666666667,FUN_022888-T1,Q8TCE6,,,,,48.3,263.0,1.1e-72,275.0,sp|Q8TCE6|DEN10_HUMAN DENN domain-containing protein 10 OS=Homo sapiens OX=9606 GN=DENND10 PE=1 SV=1,,,,,,
OG_04865,1.6550195916286057,FUN_022890-T1,Peve_00001724,Pocillopora_meandrina_HIv1___RNAseq.g3688.t1,three_way,77.9365,FUN_022890-T1,Q14147,DHX34_HUMAN,,Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34) (DExH-box helicase 34),Homo sapiens (Human),53.8,1013.0,2.4e-288,993.0,sp|Q14147|DHX34_HUMAN Probable ATP-dependent RNA helicase DHX34 OS=Homo sapiens OX=9606 GN=DHX34 PE=1 SV=2,GO:0000956; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0016020; GO:0016887; GO:0042327; GO:0044877; GO:2000623,"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of phosphorylation [GO:0042327]",membrane [GO:0016020],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0016071; GO:0016787; GO:0016853; GO:0140098; GO:0140657,"RNA binding; catalytic activity; mRNA metabolic process; hydrolase activity; isomerase activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04868,4.071699282749832,FUN_022895-T1,Peve_00001718,Pocillopora_meandrina_HIv1___RNAseq.g3694.t1,three_way,68.29366666666667,FUN_022895-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),39.7,715.0,1.4e-142,508.4,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04869,2.1559082288472378,FUN_022896-T1,Peve_00001719,Pocillopora_meandrina_HIv1___RNAseq.g3697.t1,three_way,53.845,,,,,,,,,,,,,,,,,
OG_04870,1.6092878563011657,FUN_022897-T1,Peve_00001717,Pocillopora_meandrina_HIv1___RNAseq.g3698.t1,three_way,60.53266666666666,FUN_022897-T1,Q0VCR4,PPR3C_BOVIN,,Protein phosphatase 1 regulatory subunit 3C (Protein phosphatase 1 regulatory subunit 5) (PP1 subunit R5) (Protein targeting to glycogen) (PTG),Bos taurus (Bovine),35.8,176.0,3e-26,120.2,sp|Q0VCR4|PPR3C_BOVIN Protein phosphatase 1 regulatory subunit 3C OS=Bos taurus OX=9913 GN=PPP1R3C PE=2 SV=1,GO:0000164; GO:0005829; GO:0005977; GO:0005978; GO:0005979; GO:0008157; GO:0019903; GO:0060090; GO:2001069,glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979],cytosol [GO:0005829]; protein phosphatase type 1 complex [GO:0000164],glycogen binding [GO:2001069]; molecular adaptor activity [GO:0060090]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903],GO:0005829; GO:0005975; GO:0006091; GO:0060090,cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; molecular adaptor activity
OG_04872,1.5038123225777302,FUN_022900-T1,Peve_00001844,Pocillopora_meandrina_HIv1___TS.g9874.t2,three_way,78.98066666666666,FUN_022900-T1,P14735,IDE_HUMAN,,Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin),Homo sapiens (Human),57.6,531.0,2.7e-191,669.8,sp|P14735|IDE_HUMAN Insulin-degrading enzyme OS=Homo sapiens OX=9606 GN=IDE PE=1 SV=4,GO:0001540; GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044877; GO:0045732; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0150094; GO:1901142; GO:1901143; GO:1903715,amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270],GO:0001618; GO:0002376; GO:0003824; GO:0005615; GO:0005634; GO:0005739; GO:0005777; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"virus receptor activity; immune system process; catalytic activity; extracellular space; nucleus; mitochondrion; peroxisome; cytosol; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_04873,1.8161568721799293,FUN_022902-T1,Peve_00001843,Pocillopora_meandrina_HIv1___RNAseq.g3701.t1,three_way,79.475,FUN_022902-T1,Q2KIG5,THAS_BOVIN,,Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),Bos taurus (Bovine),36.2,116.0,1.9e-13,78.6,sp|Q2KIG5|THAS_BOVIN Thromboxane-A synthase OS=Bos taurus OX=9913 GN=TBXAS1 PE=2 SV=1,GO:0001516; GO:0004497; GO:0004796; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0036134; GO:0106256,icosanoid metabolic process [GO:0006690]; prostaglandin biosynthetic process [GO:0001516],endoplasmic reticulum membrane [GO:0005789],"12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; thromboxane-A synthase activity [GO:0004796]",GO:0003824; GO:0006629; GO:0016491; GO:0016829; GO:0016853,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity; isomerase activity
OG_04875,2.367589316625261,FUN_022906-T1,Peve_00001841,Pocillopora_meandrina_HIv1___RNAseq.g3703.t1,three_way,76.03683333333333,,,,,,,,,,,,,,,,,
OG_04877,2.4402794039227347,FUN_022908-T1,Peve_00001834,Pocillopora_meandrina_HIv1___RNAseq.g3705.t1,three_way,83.53733333333334,FUN_022908-T1,Q08DA5,,,,,59.4,360.0,8.9e-119,428.3,sp|Q08DA5|PANK3_BOVIN Pantothenate kinase 3 OS=Bos taurus OX=9913 GN=PANK3 PE=2 SV=1,,,,,,
OG_04878,1.1320016167350389,FUN_022909-T1,Peve_00001833,Pocillopora_meandrina_HIv1___RNAseq.g3706.t1,three_way,71.17616666666667,FUN_022909-T1,A2RSY1,KANL3_MOUSE,,KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog),Mus musculus (Mouse),49.6,516.0,4.3000000000000004e-134,480.7,sp|A2RSY1|KANL3_MOUSE KAT8 regulatory NSL complex subunit 3 OS=Mus musculus OX=10090 GN=Kansl3 PE=1 SV=1,GO:0000123; GO:0000922; GO:0005654; GO:0005739; GO:0006325; GO:0044545; GO:0045893; GO:0051011; GO:0090307; GO:1903108,chromatin organization [GO:0006325]; mitotic spindle assembly [GO:0090307]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitochondrial transcription [GO:1903108],histone acetyltransferase complex [GO:0000123]; mitochondrion [GO:0005739]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],microtubule minus-end binding [GO:0051011],GO:0005654; GO:0005739; GO:0006325; GO:0006355; GO:0007010; GO:0008092; GO:0043226,nucleoplasm; mitochondrion; chromatin organization; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_04879,1.3731387478425192,FUN_022913-T1,Peve_00038541,Pocillopora_meandrina_HIv1___RNAseq.g3709.t1,three_way,75.51899999999999,FUN_022913-T1,Q5M990,,,,,44.1,179.0,4.1e-37,156.4,sp|Q5M990|TTC33_XENLA Tetratricopeptide repeat protein 33 OS=Xenopus laevis OX=8355 GN=ttc33 PE=2 SV=1,,,,,,
OG_04884,1.8163797676873168,FUN_022918-T1,Peve_00001740,Pocillopora_meandrina_HIv1___RNAseq.g3714.t1,three_way,73.348,FUN_022918-T1,O94903,,,,,58.6,239.0,4.2e-77,289.3,sp|O94903|PLPHP_HUMAN Pyridoxal phosphate homeostasis protein OS=Homo sapiens OX=9606 GN=PLPBP PE=1 SV=1,,,,,,
OG_04886,1.2021134586480915,FUN_022926-T1,Peve_00008664,Pocillopora_meandrina_HIv1___RNAseq.g3725.t1,three_way,76.998,FUN_022926-T1,Q9UBJ2,ABCD2_HUMAN,,ATP-binding cassette sub-family D member 2 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR),Homo sapiens (Human),58.7,717.0,1.5e-234,813.9,sp|Q9UBJ2|ABCD2_HUMAN ATP-binding cassette sub-family D member 2 OS=Homo sapiens OX=9606 GN=ABCD2 PE=1 SV=1,GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0006636; GO:0007031; GO:0009617; GO:0015605; GO:0015910; GO:0015932; GO:0016887; GO:0032000; GO:0036109; GO:0042626; GO:0042759; GO:0042760; GO:0042803; GO:0042887; GO:0043217; GO:0043651; GO:0046982; GO:0047617; GO:0140359; GO:1900016; GO:1901570; GO:1901682; GO:1903427; GO:1990535; GO:2001280,alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation [GO:0006635]; fatty acid derivative biosynthetic process [GO:1901570]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; response to bacterium [GO:0009617]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038],cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; nucleobase-containing compound transmembrane transporter activity [GO:0015932]; organophosphate ester transmembrane transporter activity [GO:0015605]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sulfur compound transmembrane transporter activity [GO:1901682],GO:0003824; GO:0005215; GO:0005777; GO:0005829; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; peroxisome; cytosol; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
OG_04889,1.8246808961330496,FUN_022930-T1,Peve_00032135,Pocillopora_meandrina_HIv1___RNAseq.g3729.t1,three_way,70.59166666666667,,,,,,,,,,,,,,,,,
OG_04893,1.1783892061850885,FUN_022937-T1,Peve_00026752,Pocillopora_meandrina_HIv1___RNAseq.g3737.t1,three_way,87.12,FUN_022937-T1,P67827,KC1A_BOVIN,,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),Bos taurus (Bovine),87.7,277.0,5.1000000000000005e-145,515.4,sp|P67827|KC1A_BOVIN Casein kinase I isoform alpha OS=Bos taurus OX=9913 GN=CSNK1A1 PE=1 SV=1,GO:0000139; GO:0000776; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007165; GO:0016055; GO:0016607; GO:0018105; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1900226,cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04894,1.342279873217994,FUN_022938-T1,Peve_00026754,Pocillopora_meandrina_HIv1___RNAseq.g3738.t1,three_way,80.67833333333333,FUN_022938-T1,Q9HAN9,NMNA1_HUMAN,,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide-nucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1),Homo sapiens (Human),53.8,251.0,1.9e-71,270.4,sp|Q9HAN9|NMNA1_HUMAN Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 OS=Homo sapiens OX=9606 GN=NMNAT1 PE=1 SV=1,GO:0000309; GO:0000785; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0009165; GO:0009435; GO:0009611; GO:0016604; GO:0042802; GO:0043410; GO:0043524; GO:0045892; GO:0140768; GO:1902511; GO:1990535; GO:1990966,ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection maintenance [GO:1990535]; nucleotide biosynthetic process [GO:0009165]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611],chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0043226; GO:0055086; GO:0060090; GO:1901135,catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; organelle; nucleobase-containing small molecule metabolic process; molecular adaptor activity; carbohydrate derivative metabolic process
OG_04896,2.360998547602926,FUN_022940-T1,Peve_00001686,Pocillopora_meandrina_HIv1___RNAseq.g3744.t1,three_way,83.253,FUN_022940-T1,Q9JJX8,,,,,59.5,375.0,1.900000000000001e-130,467.2,sp|Q9JJX8|ST32B_MOUSE Serine/threonine-protein kinase 32B OS=Mus musculus OX=10090 GN=Stk32b PE=2 SV=2,,,,,,
OG_04897,2.0342775056643165,FUN_022941-T1,Peve_00001690,Pocillopora_meandrina_HIv1___RNAseq.g3745.t1,three_way,72.69833333333334,FUN_022941-T1,Q9HDY1,,,,,24.5,575.0,2.9e-24,115.2,sp|Q9HDY1|ASE1_SCHPO Anaphase spindle elongation protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ase1 PE=1 SV=1,,,,,,
OG_04898,2.0790227165774846,FUN_022942-T2,Peve_00001683,Pocillopora_meandrina_HIv1___RNAseq.g3746.t1,three_way,53.5425,FUN_022942-T2,Q76NI1,KNDC1_HUMAN,,Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Cerebral protein 9) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2),Homo sapiens (Human),29.4,901.0,7e-79,298.5,sp|Q76NI1|KNDC1_HUMAN Kinase non-catalytic C-lobe domain-containing protein 1 OS=Homo sapiens OX=9606 GN=KNDC1 PE=1 SV=2,GO:0001934; GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773,cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase-mediated signal transduction [GO:0007264],dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0030154; GO:0098772,cell differentiation; molecular function regulator activity
OG_04899,1.0011185934190927,FUN_022944-T1,Peve_00015104,Pocillopora_meandrina_HIv1___RNAseq.g3747.t2,three_way,69.95933333333333,FUN_022944-T1,Q8BRU6,VMAT2_MOUSE,,Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2) (Vesicular monoamine transporter 2),Mus musculus (Mouse),48.6,247.0,1.4e-60,234.6,sp|Q8BRU6|VMAT2_MOUSE Synaptic vesicular amine transporter OS=Mus musculus OX=10090 GN=Slc18a2 PE=1 SV=1,GO:0001975; GO:0002552; GO:0002553; GO:0005813; GO:0007626; GO:0009636; GO:0009791; GO:0015311; GO:0030424; GO:0030425; GO:0030667; GO:0030672; GO:0042910; GO:0051610; GO:0051615; GO:0098691; GO:0098700; GO:0099123,histamine secretion by mast cell [GO:0002553]; histamine uptake [GO:0051615]; locomotory behavior [GO:0007626]; neurotransmitter loading into synaptic vesicle [GO:0098700]; post-embryonic development [GO:0009791]; response to amphetamine [GO:0001975]; response to toxic substance [GO:0009636]; serotonin secretion by mast cell [GO:0002552]; serotonin uptake [GO:0051610]; somato-dendritic dopamine secretion [GO:0099123],axon [GO:0030424]; centrosome [GO:0005813]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672],monoamine:proton antiporter activity [GO:0015311]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005815,transporter activity; microtubule organizing center
OG_04900,3.01945110821681,FUN_022945-T1,Peve_00015105,Pocillopora_meandrina_HIv1___RNAseq.g3748.t1,three_way,90.02333333333334,FUN_022945-T1,E7FDB3,,,,,59.2,76.0,2e-20,100.9,sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1,,,,,,
OG_04901,1.234902262946743,FUN_022946-T1,Peve_00015106,Pocillopora_meandrina_HIv1___RNAseq.g3749.t1a,three_way,71.6855,FUN_022946-T1,Q5RA03,SHOT1_PONAB,,Shootin-1 (Shootin1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.6,289.0,2e-21,105.5,sp|Q5RA03|SHOT1_PONAB Shootin-1 OS=Pongo abelii OX=9601 GN=SHTN1 PE=2 SV=2,GO:0005875; GO:0006930; GO:0007265; GO:0007409; GO:0015630; GO:0030027; GO:0030175; GO:0030424; GO:0030426; GO:0031252; GO:0032488; GO:0038007; GO:0043204; GO:0044295; GO:0045773; GO:0048471; GO:0048812; GO:0051015; GO:0060327; GO:0061163; GO:0061573; GO:2000114; GO:2001224,"actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration, cell extension [GO:0006930]",axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471],actin filament binding [GO:0051015],GO:0005856; GO:0008092; GO:0043226,cytoskeleton; cytoskeletal protein binding; organelle
OG_04902,2.1071725127215384,FUN_022948-T1,Peve_00005141,Pocillopora_meandrina_HIv1___RNAseq.g3749.t1b,three_way,55.449,FUN_022948-T1,O16374,GALT1_CAEEL,,"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)",Caenorhabditis elegans,26.7,303.0,1.7e-26,121.7,"sp|O16374|GALT1_CAEEL Beta-1,4-galactosyltransferase galt-1 OS=Caenorhabditis elegans OX=6239 GN=galt-1 PE=1 SV=4",GO:0003831; GO:0005737; GO:0006491; GO:0016757; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872; GO:0070085,glycosylation [GO:0070085]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125],cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; intracellular organelle [GO:0043229],"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]",GO:0003824; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_04903,3.369201836257107,FUN_022949-T1,Peve_00005144,Pocillopora_meandrina_HIv1___TS.g9923.t1,three_way,70.34633333333333,FUN_022949-T1,Q9JIP0,TRPV5_RAT,,Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transporter 2) (CaT2) (Epithelial calcium channel 1) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3),Rattus norvegicus (Rat),27.3,598.0,1.4999999999999998e-43,179.5,sp|Q9JIP0|TRPV5_RAT Transient receptor potential cation channel subfamily V member 5 OS=Rattus norvegicus OX=10116 GN=Trpv5 PE=1 SV=1,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016324; GO:0034704; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809],apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003014; GO:0005215; GO:0005886; GO:0055085; GO:0065003,renal system process; transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_04912,1.487980564935267,FUN_022965-T1,Peve_00011899,Pocillopora_meandrina_HIv1___RNAseq.g3764.t1,three_way,81.05166666666666,FUN_022965-T1,Q6NTV9,,,,,55.1,98.0,1.2e-22,107.5,sp|Q6NTV9|NHP2_XENLA H/ACA ribonucleoprotein complex subunit 2-like protein OS=Xenopus laevis OX=8355 GN=nhp2 PE=2 SV=1,,,,,,
OG_04914,1.8088256147711148,FUN_022968-T1,Peve_00011901,Pocillopora_meandrina_HIv1___RNAseq.g3762.t1,three_way,74.65283333333333,FUN_022968-T1,Q14185,,,,,47.2,1635.0,0.0,1488.4,sp|Q14185|DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=2,,,,,,
OG_04916,1.890351784411159,FUN_022970-T1,Peve_00011906,Pocillopora_meandrina_HIv1___RNAseq.17380_t,three_way,66.845,FUN_022970-T1,Q9QYC0,ADDA_MOUSE,,Alpha-adducin (Erythrocyte adducin subunit alpha),Mus musculus (Mouse),34.7,395.0,3.5e-58,227.6,sp|Q9QYC0|ADDA_MOUSE Alpha-adducin OS=Mus musculus OX=10090 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0003779; GO:0005200; GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006884; GO:0016020; GO:0016604; GO:0020027; GO:0030218; GO:0035264; GO:0045202; GO:0048873; GO:0071277; GO:1903142; GO:1903393,cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; synapse [GO:0045202],actin binding [GO:0003779]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005856; GO:0005886; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_04922,2.7559373711769792,FUN_022980-T1,Peve_00043402,Pocillopora_meandrina_HIv1___RNAseq.g3752.t1,three_way,86.49766666666666,FUN_022980-T1,O00567,NOP56_HUMAN,,Nucleolar protein 56 (Nucleolar protein 5A),Homo sapiens (Human),69.4,431.0,3.2000000000000003e-170,599.7,sp|O00567|NOP56_HUMAN Nucleolar protein 56 OS=Homo sapiens OX=9606 GN=NOP56 PE=1 SV=4,GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0045296; GO:0070761; GO:1990226,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],box C/D methylation guide snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732],cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515],GO:0003723; GO:0005654; GO:0005730; GO:0043226,RNA binding; nucleoplasm; nucleolus; organelle
OG_04923,2.0082772070343333,FUN_022981-T1,Peve_00043401,Pocillopora_meandrina_HIv1___RNAseq.g3751.t1,three_way,84.266,FUN_022981-T1,Q6GLT8,,,,,64.8,287.0,5.1e-114,412.1,"sp|Q6GLT8|FAHD2_XENLA Oxaloacetate tautomerase fahd2, mitochondrial OS=Xenopus laevis OX=8355 GN=fahd2 PE=2 SV=1",,,,,,
OG_04928,2.4814703953750885,FUN_022993-T1,Peve_00043404,Pocillopora_meandrina_HIv1___RNAseq.g3789.t1,three_way,71.83366666666667,,,,,,,,,,,,,,,,,
OG_04929,1.1947579522182497,FUN_022996-T2,Peve_00006906,Pocillopora_meandrina_HIv1___RNAseq.17418_t,three_way,53.84466666666667,FUN_022996-T2,Q8BTU7,,,,,30.2,400.0,1.5999999999999998e-41,171.8,sp|Q8BTU7|RCCD1_MOUSE RCC1 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rccd1 PE=2 SV=2,,,,,,
OG_04930,1.581612781679472,FUN_022997-T1,Peve_00006903,Pocillopora_meandrina_HIv1___RNAseq.g3793.t1,three_way,49.0015,,,,,,,,,,,,,,,,,
OG_04931,2.602271969248332,FUN_022998-T1,Peve_00006898,Pocillopora_meandrina_HIv1___RNAseq.g3792.t1,three_way,50.482,,,,,,,,,,,,,,,,,
OG_04937,1.3342793206796162,FUN_023008-T1,Peve_00009991,Pocillopora_meandrina_HIv1___RNAseq.g3821.t1,three_way,76.93366666666667,FUN_023008-T1,O13067,,,,,36.1,757.0,6.9e-94,346.7,sp|O13067|CND2_XENLA Condensin complex subunit 2 OS=Xenopus laevis OX=8355 GN=ncaph PE=1 SV=1,,,,,,
OG_04941,1.0461332959602727,FUN_023015-T1,Peve_00010017,Pocillopora_meandrina_HIv1___RNAseq.17453_t,three_way,39.771166666666666,,,,,,,,,,,,,,,,,
OG_04942,1.8305563274128536,FUN_023017-T1,Peve_00010018,Pocillopora_meandrina_HIv1___RNAseq.g3833.t1,three_way,60.31033333333333,FUN_023017-T1,Q1PSW8,LIN41_MOUSE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Mus musculus (Mouse),21.1,313.0,9.5e-09,63.2,sp|Q1PSW8|LIN41_MOUSE E3 ubiquitin-protein ligase TRIM71 OS=Mus musculus OX=10090 GN=Trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637,3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04944,1.52785331473163,FUN_023023-T1,Peve_00010022,Pocillopora_meandrina_HIv1___RNAseq.g3837.t1,three_way,74.59233333333333,FUN_023023-T1,Q91175,,,,,31.2,333.0,6e-37,156.4,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_04948,2.2730211013737347,FUN_023038-T1,Peve_00008502,Pocillopora_meandrina_HIv1___RNAseq.17481_t,three_way,82.503,,,,,,,,,,,,,,,,,
OG_04949,1.4479034853474655,FUN_023039-T1,Peve_00008503,Pocillopora_meandrina_HIv1___RNAseq.g3858.t1,three_way,73.10366666666667,FUN_023039-T1,B5FYQ0,ARL3_TAEGU,,ADP-ribosylation factor-like protein 3,Taeniopygia guttata (Zebra finch) (Poephila guttata),70.2,181.0,1.6e-68,260.4,sp|B5FYQ0|ARL3_TAEGU ADP-ribosylation factor-like protein 3 OS=Taeniopygia guttata OX=59729 GN=ARL3 PE=2 SV=1,GO:0000139; GO:0000281; GO:0000287; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0006893; GO:0007224; GO:0007264; GO:0008017; GO:0015031; GO:0019003; GO:0030496; GO:0032391; GO:0036064; GO:0042073; GO:0042461; GO:0060271; GO:1903441,cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017],GO:0000910; GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005929; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0043226; GO:0044782; GO:0048856,cytokinesis; catalytic activity; GTPase activity; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; cilium; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; organelle; cilium organization; anatomical structure development
OG_04950,1.1880421907122307,FUN_023040-T1,Peve_00008504,Pocillopora_meandrina_HIv1___RNAseq.g3859.t1,three_way,86.40083333333334,FUN_023040-T1,Q28479,IDH3B_MACFA,,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),57.6,337.0,1.3e-112,407.9,"sp|Q28479|IDH3B_MACFA Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial OS=Macaca fascicularis OX=9541 GN=IDH3B PE=2 SV=2",GO:0000287; GO:0005739; GO:0006099; GO:0006102; GO:0016616; GO:0051287,isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],mitochondrion [GO:0005739],"magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_04951,2.442065378070341,FUN_023041-T1,Peve_00008505,Pocillopora_meandrina_HIv1___RNAseq.g3860.t1,three_way,73.58200000000001,FUN_023041-T1,P40692,MLH1_HUMAN,,DNA mismatch repair protein Mlh1 (MutL protein homolog 1),Homo sapiens (Human),53.6,813.0,1.3e-236,820.8,sp|P40692|MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens OX=9606 GN=MLH1 PE=1 SV=1,GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008047; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257; GO:0140664,double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I homologous chromosome alignment [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283],chiasma [GO:0005712]; chromosome [GO:0005694]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0007059; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; DNA repair; DNA recombination; chromosome segregation; mRNA metabolic process; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_04953,2.327254395932533,FUN_023043-T1,Peve_00008509,Pocillopora_meandrina_HIv1___RNAseq.g3862.t1,three_way,69.66266666666667,FUN_023043-T1,Q6DCF2,,,,,35.5,991.0,7.2e-163,576.2,sp|Q6DCF2|MMS19_XENLA MMS19 nucleotide excision repair protein homolog OS=Xenopus laevis OX=8355 GN=mms19 PE=2 SV=1,,,,,,
OG_04957,1.5597150623786749,FUN_023047-T1,Peve_00008514,Pocillopora_meandrina_HIv1___RNAseq.g3871.t1,three_way,45.82666666666667,FUN_023047-T1,Q6NUJ5,PWP2B_HUMAN,,PWWP domain-containing protein 2B,Homo sapiens (Human),48.9,92.0,3.3e-17,91.7,sp|Q6NUJ5|PWP2B_HUMAN PWWP domain-containing protein 2B OS=Homo sapiens OX=9606 GN=PWWP2B PE=1 SV=3,GO:0005634; GO:0005654; GO:0006338; GO:0032968; GO:0120161; GO:0120325,chromatin remodeling [GO:0006338]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of cold-induced thermogenesis [GO:0120161],nucleoplasm [GO:0005654]; nucleus [GO:0005634],NuRD complex binding [GO:0120325],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_04959,1.3836100699802991,FUN_023050-T1,Peve_00008516,Pocillopora_meandrina_HIv1___RNAseq.g3873.t1,three_way,85.382,FUN_023050-T1,Q7M760,ZRAN1_MOUSE,,Ubiquitin thioesterase Zranb1 (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1),Mus musculus (Mouse),46.4,724.0,1.2e-185,651.4,sp|Q7M760|ZRAN1_MOUSE Ubiquitin thioesterase Zranb1 OS=Mus musculus OX=10090 GN=Zranb1 PE=2 SV=1,GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007010; GO:0008270; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0035523; GO:0070530; GO:0070536; GO:0071947; GO:1990168,cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0007010; GO:0016787; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton organization; hydrolase activity; organelle; cell motility; catalytic activity, acting on a protein"
OG_04960,2.6519059527122018,FUN_023051-T1,Peve_00008518,Pocillopora_meandrina_HIv1___TS.g10046.t1,three_way,59.464666666666666,FUN_023051-T1,Q99ME2,,,,,28.8,1022.0,2.5e-109,398.7,sp|Q99ME2|WDR6_MOUSE tRNA (34-2'-O)-methyltransferase regulator WDR6 OS=Mus musculus OX=10090 GN=Wdr6 PE=1 SV=1,,,,,,
OG_04962,2.938961279729809,FUN_023054-T2,Peve_00008519,Pocillopora_meandrina_HIv1___RNAseq.g3877.t1,three_way,70.94933333333334,FUN_023054-T2,Q9BPW9,DHRS9_HUMAN,,Dehydrogenase/reductase SDR family member 9 (EC 1.1.1.209) (EC 1.1.1.53) (3-alpha hydroxysteroid dehydrogenase) (3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Retinol dehydrogenase 15) (EC 1.1.1.105) (Short chain dehydrogenase/reductase family 9C member 4) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase) (RDH-TBE),Homo sapiens (Human),45.9,305.0,1.2e-66,255.0,sp|Q9BPW9|DHRS9_HUMAN Dehydrogenase/reductase SDR family member 9 OS=Homo sapiens OX=9606 GN=DHRS9 PE=1 SV=1,GO:0004022; GO:0004745; GO:0005789; GO:0008202; GO:0008209; GO:0016491; GO:0016854; GO:0030855; GO:0042448; GO:0042572; GO:0042904; GO:0043231; GO:0047023; GO:0047035; GO:0047044,9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"alcohol dehydrogenase (NAD+) activity [GO:0004022]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; oxidoreductase activity [GO:0016491]; racemase and epimerase activity [GO:0016854]; testosterone dehydrogenase (NAD+) activity [GO:0047035]",GO:0003824; GO:0006629; GO:0016491; GO:0016853; GO:0030154; GO:0043226,catalytic activity; lipid metabolic process; oxidoreductase activity; isomerase activity; cell differentiation; organelle
OG_04963,1.0880962794252598,FUN_023062-T1,Peve_00024671,Pocillopora_meandrina_HIv1___RNAseq.g3881.t1,three_way,72.876,,,,,,,,,,,,,,,,,
OG_04964,1.824173927241816,FUN_023063-T1,Peve_00024670,Pocillopora_meandrina_HIv1___RNAseq.g3882.t1,three_way,80.55416666666666,FUN_023063-T1,Q66L33,,,,,68.8,192.0,2e-75,283.9,sp|Q66L33|MK16A_XENLA Protein MAK16 homolog A OS=Xenopus laevis OX=8355 GN=mak16-a PE=2 SV=1,,,,,,
OG_04965,3.090170222672975,FUN_023064-T1,Peve_00024668,Pocillopora_meandrina_HIv1___RNAseq.g3883.t1,three_way,87.05566666666667,FUN_023064-T1,P43249,,,,,62.2,566.0,1.8e-203,710.3,sp|P43249|GRK5_BOVIN G protein-coupled receptor kinase 5 OS=Bos taurus OX=9913 GN=GRK5 PE=1 SV=1,,,,,,
OG_04974,2.01172507019288,FUN_023081-T1,Peve_00038942,Pocillopora_meandrina_HIv1___RNAseq.g1656.t1,three_way,77.20400000000001,,,,,,,,,,,,,,,,,
OG_04976,2.5421004844086488,FUN_023085-T1,Peve_00027837,Pocillopora_meandrina_HIv1___RNAseq.g1661.t1,three_way,55.247166666666665,FUN_023085-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),30.7,313.0,4.7e-31,137.1,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_04977,1.8029315083761912,FUN_023086-T1,Peve_00037477,Pocillopora_meandrina_HIv1___TS.g4174.t3,three_way,63.9085,FUN_023086-T1,Q9Y251,HPSE_HUMAN,,Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit],Homo sapiens (Human),40.4,498.0,6.5999999999999994e-93,342.8,sp|Q9Y251|HPSE_HUMAN Heparanase OS=Homo sapiens OX=9606 GN=HPSE PE=1 SV=2,GO:0004566; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005765; GO:0006029; GO:0007160; GO:0010575; GO:0030194; GO:0030200; GO:0030202; GO:0030305; GO:0031012; GO:0033690; GO:0035580; GO:0043202; GO:0043231; GO:0045121; GO:0045545; GO:0046677; GO:0051797; GO:0051798; GO:0051897; GO:0060055; GO:0061028; GO:0061042; GO:0071806,angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; establishment of endothelial barrier [GO:0061028]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; positive regulation of blood coagulation [GO:0030194]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein transmembrane transport [GO:0071806]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; response to antibiotic [GO:0046677]; vascular wound healing [GO:0061042],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580],beta-glucuronidase activity [GO:0004566]; heparanase activity [GO:0030305]; syndecan binding [GO:0045545],GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0007155; GO:0016787; GO:0030163; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0055085; GO:1901135,catalytic activity; extracellular region; extracellular space; nucleus; nucleoplasm; lysosome; vacuole; cell adhesion; hydrolase activity; protein catabolic process; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; transmembrane transport; carbohydrate derivative metabolic process
OG_04979,1.0368877160447876,FUN_023099-T1,Peve_00006979,Pocillopora_meandrina_HIv1___TS.g4182.t1,three_way,64.4485,FUN_023099-T1,P55115,,,,,34.9,278.0,7e-41,171.0,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_04980,2.530380921333346,FUN_023100-T1,Peve_00006982,Pocillopora_meandrina_HIv1___RNAseq.g1675.t1,three_way,70.84949999999999,FUN_023100-T1,Q32L68,,,,,52.3,109.0,1.1e-22,109.4,sp|Q32L68|HM20B_BOVIN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related OS=Bos taurus OX=9913 GN=HMG20B PE=2 SV=1,,,,,,
OG_04981,1.7517805952854997,FUN_023108-T1,Peve_00038931,Pocillopora_meandrina_HIv1___RNAseq.g1687.t1,three_way,51.39366666666667,FUN_023108-T1,Q9JME2,CHSTB_MOUSE,,Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1),Mus musculus (Mouse),37.0,265.0,1.1e-43,178.7,sp|Q9JME2|CHSTB_MOUSE Carbohydrate sulfotransferase 11 OS=Mus musculus OX=10090 GN=Chst11 PE=2 SV=1,GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216,apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179],Golgi membrane [GO:0000139],chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005975; GO:0009101; GO:0012501; GO:0016740; GO:0048856; GO:1901135,catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; programmed cell death; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_04982,1.501978199919637,FUN_023109-T1,Peve_00001973,Pocillopora_meandrina_HIv1___RNAseq.g1688.t1,three_way,60.158,FUN_023109-T1,Q5VV63,ATRN1_HUMAN,,Attractin-like protein 1,Homo sapiens (Human),32.3,1320.0,4.1e-183,643.7,sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2,GO:0005112; GO:0007186; GO:0016020; GO:0030246,G protein-coupled receptor signaling pathway [GO:0007186],membrane [GO:0016020],carbohydrate binding [GO:0030246]; Notch binding [GO:0005112],,
OG_04984,2.308009242925832,FUN_023111-T1,Peve_00045023,Pocillopora_meandrina_HIv1___RNAseq.g1700.t1,three_way,62.512,FUN_023111-T1,A7MB10,,,,,36.0,1929.0,1.9e-291,1004.2,sp|A7MB10|RRP5_BOVIN Protein RRP5 homolog OS=Bos taurus OX=9913 GN=PDCD11 PE=2 SV=1,,,,,,
OG_04985,1.238615303970641,FUN_023112-T1,Peve_00045022,Pocillopora_meandrina_HIv1___RNAseq.g1699.t1,three_way,49.251,,,,,,,,,,,,,,,,,
OG_04986,1.3795552736345778,FUN_023113-T1,Peve_00045019,Pocillopora_meandrina_HIv1___RNAseq.g1698.t1,three_way,71.10633333333334,FUN_023113-T1,Q5ZJN2,RB11A_CHICK,,Ras-related protein Rab-11A (EC 3.6.5.2),Gallus gallus (Chicken),52.4,233.0,3.7999999999999996e-62,239.6,sp|Q5ZJN2|RB11A_CHICK Ras-related protein Rab-11A OS=Gallus gallus OX=9031 GN=RAB11A PE=2 SV=1,GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0006887; GO:0030133; GO:0030666; GO:0032154; GO:0032402; GO:0032588; GO:0045335; GO:0055038; GO:0061512; GO:0098837; GO:0098887; GO:1902017; GO:1902954; GO:1904779; GO:2001135,"exocytosis [GO:0006887]; melanosome transport [GO:0032402]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of early endosome to recycling endosome transport [GO:1902954]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to centrosome [GO:1904779]",cleavage furrow [GO:0032154]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005794; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0072659; GO:0098772,catalytic activity; GTPase activity; endosome; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; protein localization to plasma membrane; molecular function regulator activity
OG_04987,1.4789794577147708,FUN_023115-T1,Peve_00045026,Pocillopora_meandrina_HIv1___RNAseq.g1697.t1,three_way,82.82133333333333,,,,,,,,,,,,,,,,,
OG_04988,2.379345855740355,FUN_023118-T1,Peve_00045010,Pocillopora_meandrina_HIv1___RNAseq.g1695.t1,three_way,60.8045,FUN_023118-T1,Q80UN9,MOD5_MOUSE,,tRNA dimethylallyltransferase (EC 2.5.1.75) (Isopentenyl-diphosphate:tRNA isopentenyltransferase) (IPP transferase) (IPPT) (tRNA isopentenyltransferase) (IPTase),Mus musculus (Mouse),39.0,516.0,1.6e-92,341.7,sp|Q80UN9|MOD5_MOUSE tRNA dimethylallyltransferase OS=Mus musculus OX=10090 GN=Trit1 PE=1 SV=2,GO:0005524; GO:0005634; GO:0005739; GO:0006400; GO:0008270; GO:0052381; GO:0070900,mitochondrial tRNA modification [GO:0070900]; tRNA modification [GO:0006400],mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; tRNA dimethylallyltransferase activity [GO:0052381]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005739; GO:0006399; GO:0016740; GO:0043226; GO:0140053; GO:0140098,"catalytic activity; nucleus; mitochondrion; tRNA metabolic process; transferase activity; organelle; mitochondrial gene expression; catalytic activity, acting on RNA"
OG_04989,2.7198382281316347,FUN_023119-T1,Peve_00021102,Pocillopora_meandrina_HIv1___RNAseq.g1692.t1,three_way,61.756166666666665,FUN_023119-T1,Q92547,TOPB1_HUMAN,,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),Homo sapiens (Human),33.8,1669.0,2e-207,724.9,sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens OX=9606 GN=TOPBP1 PE=1 SV=3,GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166,broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212],actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922],chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0000228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0005856; GO:0005886; GO:0006281; GO:0006310; GO:0043226; GO:0060090; GO:0098772,nuclear chromosome; DNA binding; nucleus; nucleoplasm; chromosome; microtubule organizing center; cytoskeleton; plasma membrane; DNA repair; DNA recombination; organelle; molecular adaptor activity; molecular function regulator activity
OG_04991,1.4983509489330888,FUN_023121-T1,Peve_00021100,Pocillopora_meandrina_HIv1___RNAseq.g1690.t1,three_way,75.82333333333334,FUN_023121-T1,Q4VBI7,STX18_DANRE,,Syntaxin-18,Danio rerio (Zebrafish) (Brachydanio rerio),56.5,322.0,4.9000000000000004e-86,319.3,sp|Q4VBI7|STX18_DANRE Syntaxin-18 OS=Danio rerio OX=7955 GN=stx18 PE=2 SV=1,GO:0005484; GO:0005783; GO:0005789; GO:0006886; GO:0006890; GO:0031201,"intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SNARE complex [GO:0031201],SNAP receptor activity [GO:0005484],GO:0005783; GO:0006886; GO:0016192; GO:0043226; GO:0060090,endoplasmic reticulum; intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity
OG_04995,2.276924763921617,FUN_023127-T1,Peve_00011778,Pocillopora_meandrina_HIv1___RNAseq.g1757.t1,three_way,70.8965,FUN_023127-T1,P42859,,,,,34.8,3196.0,0.0,1587.0,sp|P42859|HD_MOUSE Huntingtin OS=Mus musculus OX=10090 GN=Htt PE=1 SV=2,,,,,,
OG_04996,2.654793141227526,FUN_023129-T1,Peve_00011777,Pocillopora_meandrina_HIv1___RNAseq.g1756.t1,three_way,68.69866666666667,,,,,,,,,,,,,,,,,
OG_04998,2.445010173236567,FUN_023133-T1,Peve_00008525,Pocillopora_meandrina_HIv1___RNAseq.g1754.t1,three_way,68.886,FUN_023133-T1,Q9EPZ8,,,,,36.0,663.0,6.6e-106,386.3,sp|Q9EPZ8|RN103_RAT E3 ubiquitin-protein ligase RNF103 OS=Rattus norvegicus OX=10116 GN=Rnf103 PE=2 SV=1,,,,,,
OG_05000,3.347928336743553,FUN_023136-T1,Peve_00008523,Pocillopora_meandrina_HIv1___RNAseq.g1752.t1,three_way,64.003,,,,,,,,,,,,,,,,,
OG_05002,1.2288549287419706,FUN_023138-T1,Peve_00042474,Pocillopora_meandrina_HIv1___RNAseq.g1750.t1,three_way,71.85766666666667,,,,,,,,,,,,,,,,,
OG_05003,2.2225070502507034,FUN_023139-T1,Peve_00042477,Pocillopora_meandrina_HIv1___RNAseq.g1749.t1,three_way,49.72316666666666,FUN_023139-T1,P70399,TP53B_MOUSE,,TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),Mus musculus (Mouse),27.4,559.0,4.7999999999999996e-43,179.1,sp|P70399|TP53B_MOUSE TP53-binding protein 1 OS=Mus musculus OX=10090 GN=Tp53bp1 PE=1 SV=3,GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0005634; GO:0005657; GO:0005737; GO:0006281; GO:0006303; GO:0006355; GO:0006974; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0043565; GO:0045830; GO:0045944; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:0097680; GO:0140005; GO:0140941; GO:1990166; GO:1990391; GO:2000042,cellular response to X-ray [GO:0071481]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; protein localization to site of double-strand break [GO:1990166]; regulation of DNA-templated transcription [GO:0006355],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",damaged DNA binding [GO:0003684]; histone H4K20me methyltransferase activity [GO:0140941]; histone H4K20me2 reader activity [GO:0140005]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin-modified histone reader activity [GO:0061649],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; DNA repair; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_05005,2.9555411236263684,FUN_023153-T1,Peve_00014158,Pocillopora_meandrina_HIv1___RNAseq.g17694.t1,three_way,72.7995,FUN_023153-T1,Q9Y2H2,SAC2_HUMAN,,Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2),Homo sapiens (Human),48.1,774.0,2e-204,714.5,sp|Q9Y2H2|SAC2_HUMAN Phosphatidylinositide phosphatase SAC2 OS=Homo sapiens OX=9606 GN=INPP5F PE=1 SV=3,GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0043231; GO:0043491; GO:0043812; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135,adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135],axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037],inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803],GO:0003012; GO:0003824; GO:0005768; GO:0006629; GO:0016192; GO:0016787; GO:0031410; GO:0043226,muscle system process; catalytic activity; endosome; lipid metabolic process; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_05009,2.494562421063624,FUN_023160-T2,Peve_00018797,Pocillopora_meandrina_HIv1___RNAseq.g641.t1,three_way,62.85266666666667,,,,,,,,,,,,,,,,,
OG_05013,1.1919399794392815,FUN_023172-T1,Peve_00009974,Pocillopora_meandrina_HIv1___TS.g25349.t1,three_way,75.821,,,,,,,,,,,,,,,,,
OG_05014,2.286618292554354,FUN_023173-T1,Peve_00009976,Pocillopora_meandrina_HIv1___TS.g25350.t1,three_way,83.18433333333333,FUN_023173-T1,O93309,SMC3_XENLA,,Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3),Xenopus laevis (African clawed frog),50.2,630.0,2.6e-150,533.9,sp|O93309|SMC3_XENLA Structural maintenance of chromosomes protein 3 OS=Xenopus laevis OX=8355 GN=smc3 PE=1 SV=2,GO:0000775; GO:0000785; GO:0003690; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0007064; GO:0016887; GO:0030892; GO:0030893; GO:0051301; GO:0051321,cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; regulation of DNA replication [GO:0006275],"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0022414; GO:0043226,DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; reproductive process; organelle
OG_05015,3.3276067687480064,FUN_023177-T1,Peve_00009975,Pocillopora_meandrina_HIv1___RNAseq.g656.t1,three_way,61.85766666666667,FUN_023177-T1,Q9LJR3,SPA3_ARATH,,Protein SPA1-RELATED 3,Arabidopsis thaliana (Mouse-ear cress),24.5,143.0,4.2e-06,53.9,sp|Q9LJR3|SPA3_ARATH Protein SPA1-RELATED 3 OS=Arabidopsis thaliana OX=3702 GN=SPA3 PE=1 SV=1,GO:0004672; GO:0005524; GO:0005634; GO:0009585; GO:0009640; GO:0042802,"photomorphogenesis [GO:0009640]; red, far-red light phototransduction [GO:0009585]",nucleus [GO:0005634],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05021,1.2749768040867313,FUN_023184-T1,Peve_00027670,Pocillopora_meandrina_HIv1___RNAseq.g665.t1,three_way,47.4835,,,,,,,,,,,,,,,,,
OG_05023,1.1062635573931503,FUN_023186-T1,Peve_00009988,Pocillopora_meandrina_HIv1___RNAseq.g668.t1,three_way,64.46583333333334,FUN_023186-T1,Q6NXT6,TAPT1_HUMAN,,Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor),Homo sapiens (Human),52.5,503.0,7.099999999999999e-135,482.6,sp|Q6NXT6|TAPT1_HUMAN Transmembrane anterior posterior transformation protein 1 homolog OS=Homo sapiens OX=9606 GN=TAPT1 PE=1 SV=1,GO:0001503; GO:0005654; GO:0005789; GO:0005813; GO:0005829; GO:0014032; GO:0016020; GO:0016520; GO:0030030; GO:0036064; GO:0045724; GO:0048706; GO:0051216; GO:0061036; GO:1903012,cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleoplasm [GO:0005654],growth hormone-releasing hormone receptor activity [GO:0016520],GO:0005654; GO:0005815; GO:0005829; GO:0048856; GO:0060089,nucleoplasm; microtubule organizing center; cytosol; anatomical structure development; molecular transducer activity
OG_05024,1.8377732346156264,FUN_023187-T1,Peve_00009989,Pocillopora_meandrina_HIv1___RNAseq.g669.t1,three_way,73.152,FUN_023187-T1,F1Q8J0,RNPC3_DANRE,,RNA-binding region-containing protein 3 (RNA-binding protein 40),Danio rerio (Zebrafish) (Brachydanio rerio),44.0,489.0,1.1999999999999999e-75,285.4,sp|F1Q8J0|RNPC3_DANRE RNA-binding region-containing protein 3 OS=Danio rerio OX=7955 GN=rnpc3 PE=2 SV=1,GO:0000398; GO:0001889; GO:0005689; GO:0030626; GO:0031016; GO:0048565; GO:0097157,"digestive tract development [GO:0048565]; liver development [GO:0001889]; mRNA splicing, via spliceosome [GO:0000398]; pancreas development [GO:0031016]",U12-type spliceosomal complex [GO:0005689],pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626],GO:0003723; GO:0016071; GO:0048856,RNA binding; mRNA metabolic process; anatomical structure development
OG_05025,1.5296649480476416,FUN_023188-T1,Peve_00009990,Pocillopora_meandrina_HIv1___RNAseq.g670.t1,three_way,70.7675,,,,,,,,,,,,,,,,,
OG_05029,1.2051305709478584,FUN_023194-T1,Peve_00027171,Pocillopora_meandrina_HIv1___RNAseq.g674.t1,three_way,56.34633333333333,FUN_023194-T1,Q76EC5,,,,,37.2,172.0,7.8e-24,112.1,sp|Q76EC5|CHST9_MOUSE Carbohydrate sulfotransferase 9 OS=Mus musculus OX=10090 GN=Chst9 PE=2 SV=1,,,,,,
OG_05030,3.142832057580432,FUN_023202-T1,Peve_00010001,Pocillopora_meandrina_HIv1___RNAseq.g680.t1,three_way,51.176,FUN_023202-T1,Q9Z0R0,,,,,46.0,339.0,2e-82,308.5,sp|Q9Z0R0|HASP_MOUSE Serine/threonine-protein kinase haspin OS=Mus musculus OX=10090 GN=Haspin PE=1 SV=3,,,,,,
OG_05033,1.93345054107125,FUN_023213-T1,Peve_00010009,Pocillopora_meandrina_HIv1___RNAseq.g689.t1,three_way,68.199,FUN_023213-T1,Q8IUR5,,,,,44.5,456.0,6e-86,320.9,sp|Q8IUR5|TMTC1_HUMAN Protein O-mannosyl-transferase TMTC1 OS=Homo sapiens OX=9606 GN=TMTC1 PE=1 SV=3,,,,,,
OG_05034,2.2358133663812048,FUN_023215-T1,Peve_00029821,Pocillopora_meandrina_HIv1___RNAseq.g690.t1,three_way,75.65683333333334,FUN_023215-T1,Q75W95,,,,,43.3,224.0,6.5e-31,136.0,sp|Q75W95|NKX11_DANRE NK1 transcription factor-related protein 1 OS=Danio rerio OX=7955 GN=nkx1.2lb PE=2 SV=1,,,,,,
OG_05035,3.226219900507904,FUN_023216-T1,Peve_00029820,Pocillopora_meandrina_HIv1___RNAseq.g691.t1,three_way,77.107,FUN_023216-T1,Q90XN9,,,,,68.3,126.0,2e-36,154.1,sp|Q90XN9|HMX3B_ORYLA Homeobox protein HMX3-B OS=Oryzias latipes OX=8090 GN=hmx3b PE=2 SV=1,,,,,,
OG_05037,1.0585790082077602,FUN_023219-T1,Peve_00029815,Pocillopora_meandrina_HIv1___RNAseq.g695.t1,three_way,62.362,FUN_023219-T1,P53454,,,,,31.2,327.0,5.3e-29,130.6,sp|P53454|DRD5L_TAKRU D(5)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=dl PE=3 SV=1,,,,,,
OG_05040,1.154220034771388,FUN_023224-T1,Peve_00029811,Pocillopora_meandrina_HIv1___RNAseq.g708.t1,three_way,94.295,FUN_023224-T1,Q5ZJK8,,,,,81.7,531.0,3.7e-254,878.6,sp|Q5ZJK8|TCPH_CHICK T-complex protein 1 subunit eta OS=Gallus gallus OX=9031 GN=CCT7 PE=1 SV=1,,,,,,
OG_05042,1.4369172157826935,FUN_023226-T1,Peve_00029805,Pocillopora_meandrina_HIv1___TS.g25414.t1,three_way,82.15833333333333,FUN_023226-T1,A1A4R8,,,,,53.7,294.0,1e-84,315.8,sp|A1A4R8|CDC23_BOVIN Cell division cycle protein 23 homolog OS=Bos taurus OX=9913 GN=CDC23 PE=2 SV=1,,,,,,
OG_05044,1.361941788296085,FUN_023228-T1,Peve_00029803,Pocillopora_meandrina_HIv1___RNAseq.g718.t1,three_way,84.18599999999999,FUN_023228-T1,Q5U4F6,DC2I2_MOUSE,,Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34),Mus musculus (Mouse),45.9,492.0,1.2e-121,438.3,sp|Q5U4F6|DC2I2_MOUSE Cytoplasmic dynein 2 intermediate chain 2 OS=Mus musculus OX=10090 GN=Dync2i2 PE=1 SV=3,GO:0005730; GO:0005813; GO:0005814; GO:0005829; GO:0005868; GO:0005929; GO:0005930; GO:0016604; GO:0030175; GO:0031965; GO:0035721; GO:0036064; GO:0045503; GO:0060271,cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721],axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; filopodium [GO:0030175]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730],dynein light chain binding [GO:0045503],GO:0005730; GO:0005815; GO:0005829; GO:0005929; GO:0007018; GO:0043226; GO:0044782,nucleolus; microtubule organizing center; cytosol; cilium; microtubule-based movement; organelle; cilium organization
OG_05045,1.1902850196527317,FUN_023231-T1,Peve_00029854,Pocillopora_meandrina_HIv1___RNAseq.g17040.t1,three_way,64.61666666666667,FUN_023231-T1,Q9WU56,PUS1_MOUSE,,Pseudouridylate synthase 1 homolog (EC 5.4.99.-) (tRNA pseudouridine synthase 1) (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I),Mus musculus (Mouse),44.1,338.0,8.4e-74,279.3,sp|Q9WU56|PUS1_MOUSE Pseudouridylate synthase 1 homolog OS=Mus musculus OX=10090 GN=Pus1 PE=1 SV=2,GO:0000049; GO:0002153; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006397; GO:0008380; GO:0009982; GO:0031119; GO:0045944; GO:0106029; GO:0160147; GO:1990481,mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119],mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],chromatin binding [GO:0003682]; pseudouridine synthase activity [GO:0009982]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; tRNA pseudouridine(38-40) synthase activity [GO:0160147],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006355; GO:0006399; GO:0016071; GO:0016853; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; regulation of DNA-templated transcription; tRNA metabolic process; mRNA metabolic process; isomerase activity; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_05046,1.6837476460095884,FUN_023233-T1,Peve_00029853,Pocillopora_meandrina_HIv1___RNAseq.g727.t1,three_way,79.16716666666666,FUN_023233-T1,Q08DG6,,,,,57.5,219.0,3.8e-65,249.6,sp|Q08DG6|COX15_BOVIN Heme A synthase COX15 OS=Bos taurus OX=9913 GN=COX15 PE=2 SV=1,,,,,,
OG_05048,1.3153411264000463,FUN_023237-T1,Peve_00029851,Pocillopora_meandrina_HIv1___RNAseq.g17389.t1,three_way,74.06716666666667,FUN_023237-T1,B9FHF3,DJB6_ORYSJ,,DnaJ protein ERDJ3B (Chaperone protein dnaJ B6) (OsDjB6) (Endoplasmic reticulum dnaJ domain-containing protein 3B) (OsERdj3B),Oryza sativa subsp. japonica (Rice),47.3,55.0,6.4e-09,64.3,sp|B9FHF3|DJB6_ORYSJ DnaJ protein ERDJ3B OS=Oryza sativa subsp. japonica OX=39947 GN=ERDJ3B PE=1 SV=1,GO:0005737; GO:0005788; GO:0042026; GO:0051082; GO:0051087,protein refolding [GO:0042026],cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788],protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0006457,protein folding
OG_05050,2.3635809025972407,FUN_023240-T1,Peve_00029849,Pocillopora_meandrina_HIv1___RNAseq.g17391.t1,three_way,69.214,FUN_023240-T1,Q6Y685,TACC1_MOUSE,,Transforming acidic coiled-coil-containing protein 1,Mus musculus (Mouse),43.0,193.0,1.1e-29,133.3,sp|Q6Y685|TACC1_MOUSE Transforming acidic coiled-coil-containing protein 1 OS=Mus musculus OX=10090 GN=Tacc1 PE=1 SV=1,GO:0000226; GO:0003713; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0008283; GO:0019904; GO:0021987; GO:0022008; GO:0022027; GO:0030331; GO:0030496; GO:0032886; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301,cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; regulation of microtubule-based process [GO:0032886],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634],nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005815; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; microtubule organizing center; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_05051,1.2296177544975369,FUN_023247-T1,Peve_00019237,Pocillopora_meandrina_HIv1___RNAseq.g17396.t1,three_way,62.26833333333333,FUN_023247-T1,P56407,,,,,64.5,76.0,6.2e-19,95.9,sp|P56407|HM09_CAEEL Homeobox protein ceh-9 OS=Caenorhabditis elegans OX=6239 GN=ceh-9 PE=3 SV=2,,,,,,
OG_05052,2.291952202872261,FUN_023248-T1,Peve_00019246,Pocillopora_meandrina_HIv1___RNAseq.g17397.t1,three_way,77.48166666666667,FUN_023248-T1,Q5ZIZ2,SMYD5_CHICK,,Protein-lysine N-trimethyltransferase SMYD5 (EC 2.1.1.-) (SET and MYND domain-containing protein 5) ([histone H3]-lysine20 N-trimethyltransferase SMYD5) (EC 2.1.1.372) ([histone H4]-lysine36 N-trimethyltransferase SMYD5) (EC 2.1.1.359),Gallus gallus (Chicken),55.4,381.0,2.800000000000001e-118,426.8,sp|Q5ZIZ2|SMYD5_CHICK Protein-lysine N-trimethyltransferase SMYD5 OS=Gallus gallus OX=9031 GN=SMYD5 PE=2 SV=1,GO:0005737; GO:0008270; GO:0016279; GO:0032259; GO:0042799; GO:0045814; GO:0140943; GO:0140955; GO:1900249; GO:2000035; GO:2000736,"methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of cytoplasmic translational elongation [GO:1900249]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035]",cytoplasm [GO:0005737],histone H3K36 trimethyltransferase activity [GO:0140955]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 trimethyltransferase activity [GO:0140943]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270],GO:0003824; GO:0006325; GO:0016740; GO:0140096,"catalytic activity; chromatin organization; transferase activity; catalytic activity, acting on a protein"
OG_05055,1.2132740607531198,FUN_023251-T1,Peve_00019255,Pocillopora_meandrina_HIv1___RNAseq.g1743.t1,three_way,82.61816666666667,FUN_023251-T1,Q6PCJ1,DCTN1_XENLA,,Dynactin subunit 1,Xenopus laevis (African clawed frog),41.7,763.0,1.9e-112,409.1,sp|Q6PCJ1|DCTN1_XENLA Dynactin subunit 1 OS=Xenopus laevis OX=8355 GN=dctn1 PE=2 SV=1,GO:0000132; GO:0000776; GO:0000922; GO:0005813; GO:0005814; GO:0005874; GO:0005875; GO:0005938; GO:0007097; GO:0008017; GO:0030286; GO:0030424; GO:0031122; GO:0035371; GO:0051301; GO:0060236; GO:0090316; GO:0099738,cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; nuclear migration [GO:0007097]; positive regulation of intracellular protein transport [GO:0090316]; regulation of mitotic spindle organization [GO:0060236],axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_05056,1.7782721407556188,FUN_023252-T1,Peve_00019257,Pocillopora_meandrina_HIv1___RNAseq.g1747.t1,three_way,87.91333333333333,FUN_023252-T1,Q155U0,,,,,55.4,819.0,1.3e-228,794.3,sp|Q155U0|VPS51_DANRE Vacuolar protein sorting-associated protein 51 homolog OS=Danio rerio OX=7955 GN=vps51 PE=2 SV=1,,,,,,
OG_05059,2.2749264414555044,FUN_023256-T1,Peve_00019260,Pocillopora_meandrina_HIv1___TS.g25273.t1,three_way,37.922666666666665,,,,,,,,,,,,,,,,,
OG_05060,1.817415289351044,FUN_023257-T1,Peve_00019264,Pocillopora_meandrina_HIv1___RNAseq.g573.t1,three_way,65.63666666666667,FUN_023257-T1,Q9BT09,CNPY3_HUMAN,,Protein canopy homolog 3 (CTG repeat protein 4a) (Expanded repeat-domain protein CAG/CTG 5) (Protein associated with TLR4) (Trinucleotide repeat-containing gene 5 protein),Homo sapiens (Human),40.1,182.0,2.1e-34,148.3,sp|Q9BT09|CNPY3_HUMAN Protein canopy homolog 3 OS=Homo sapiens OX=9606 GN=CNPY3 PE=1 SV=1,GO:0005102; GO:0005788; GO:0045087,innate immune response [GO:0045087],endoplasmic reticulum lumen [GO:0005788],signaling receptor binding [GO:0005102],GO:0002376; GO:0098542,immune system process; defense response to other organism
OG_05061,2.028678839002847,FUN_023258-T1,Peve_00019265,Pocillopora_meandrina_HIv1___RNAseq.g29203.t1,three_way,59.568333333333335,FUN_023258-T1,Q057J1,,,,,53.5,71.0,4.5e-13,75.9,sp|Q057J1|RL27_BUCCC Large ribosomal subunit protein bL27 OS=Buchnera aphidicola subsp. Cinara cedri (strain Cc) OX=372461 GN=rpmA PE=3 SV=1,,,,,,
OG_05063,2.9196774282763256,FUN_023260-T1,Peve_00019268,Pocillopora_meandrina_HIv1___RNAseq.g578.t1,three_way,89.18833333333333,FUN_023260-T1,Q9W676,,,,,61.8,382.0,2.4e-114,413.7,sp|Q9W676|LDB2_CHICK LIM domain-binding protein 2 OS=Gallus gallus OX=9031 GN=LDB2 PE=2 SV=1,,,,,,
OG_05064,2.6535425105708765,FUN_023262-T2,Peve_00019267,Pocillopora_meandrina_HIv1___RNAseq.g576.t2,three_way,62.084,FUN_023262-T2,A4IG62,SUV3_DANRE,,"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)",Danio rerio (Zebrafish) (Brachydanio rerio),45.3,583.0,4.8e-149,530.0,"sp|A4IG62|SUV3_DANRE ATP-dependent RNA helicase SUPV3L1, mitochondrial OS=Danio rerio OX=7955 GN=supv3l1 PE=2 SV=1",GO:0000958; GO:0000962; GO:0000965; GO:0001889; GO:0003677; GO:0003678; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0007005; GO:0016887; GO:0030307; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0043066; GO:0045025; GO:2000827,DNA recombination [GO:0006310]; liver development [GO:0001889]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401],mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0006310; GO:0007005; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0140053; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; DNA recombination; mitochondrion organization; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; anatomical structure development; mitochondrial gene expression; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05065,1.4753701741965048,FUN_023268-T1,Peve_00018794,Pocillopora_meandrina_HIv1___TS.g17377.t1b,three_way,60.35533333333333,FUN_023268-T1,Q96N46,,,,,35.8,433.0,8.1e-59,230.3,sp|Q96N46|TTC14_HUMAN Tetratricopeptide repeat protein 14 OS=Homo sapiens OX=9606 GN=TTC14 PE=1 SV=1,,,,,,
OG_05066,1.5267178298541448,FUN_023269-T1,Peve_00019482,Pocillopora_meandrina_HIv1___TS.g17377.t1a,three_way,74.93916666666667,FUN_023269-T1,Q9PVF8,CTNA1_DANRE,,Catenin alpha-1 (Alpha E-catenin),Danio rerio (Zebrafish) (Brachydanio rerio),23.7,628.0,5.3e-38,162.2,sp|Q9PVF8|CTNA1_DANRE Catenin alpha-1 OS=Danio rerio OX=7955 GN=ctnna1 PE=1 SV=1,GO:0001894; GO:0005198; GO:0005634; GO:0005902; GO:0005911; GO:0005912; GO:0005938; GO:0008013; GO:0015629; GO:0016342; GO:0016477; GO:0034334; GO:0043009; GO:0045296; GO:0051015; GO:0098609,adherens junction maintenance [GO:0034334]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; chordate embryonic development [GO:0043009]; tissue homeostasis [GO:0001894],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; microvillus [GO:0005902]; nucleus [GO:0005634],actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198],GO:0005198; GO:0005634; GO:0005856; GO:0007155; GO:0008092; GO:0034330; GO:0043226; GO:0048856; GO:0048870,structural molecule activity; nucleus; cytoskeleton; cell adhesion; cytoskeletal protein binding; cell junction organization; organelle; anatomical structure development; cell motility
OG_05068,1.3277297345221148,FUN_023271-T1,Peve_00019479,Pocillopora_meandrina_HIv1___RNAseq.g17804.t1,three_way,65.41499999999999,,,,,,,,,,,,,,,,,
OG_05069,3.262557088042769,FUN_023272-T1,Peve_00031864,Pocillopora_meandrina_HIv1___RNAseq.g17803.t1,three_way,64.60916666666667,FUN_023272-T1,Q9Z1Z1,E2AK3_RAT,,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2),Rattus norvegicus (Rat),35.6,1035.0,9.7e-144,512.7,sp|Q9Z1Z1|E2AK3_RAT Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Rattus norvegicus OX=10116 GN=Eif2ak3 PE=1 SV=1,GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006412; GO:0006446; GO:0006983; GO:0007029; GO:0007595; GO:0009967; GO:0010575; GO:0010628; GO:0010629; GO:0017148; GO:0019217; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031016; GO:0031018; GO:0031642; GO:0032055; GO:0032933; GO:0034198; GO:0034976; GO:0036499; GO:0036503; GO:0042149; GO:0042802; GO:0043066; GO:0044233; GO:0044322; GO:0045444; GO:0045943; GO:0048009; GO:0048471; GO:0051787; GO:0051879; GO:0060734; GO:0070059; GO:0070417; GO:0106310; GO:1900182; GO:1902010; GO:1902235; GO:1902237; GO:1903788; GO:1990737,angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation [GO:0006446]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005783; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05070,1.238311196527945,FUN_023276-T1,Peve_00041312,Pocillopora_meandrina_HIv1___RNAseq.g17800.t1,three_way,81.05266666666667,FUN_023276-T1,Q6AYQ8,FAHD1_RAT,,"Oxaloacetate tautomerase FAHD1, mitochondrial (EC 5.3.2.2) (Acylpyruvase FAHD1) (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112)",Rattus norvegicus (Rat),53.5,215.0,5.4999999999999994e-68,258.8,"sp|Q6AYQ8|FAHD1_RAT Oxaloacetate tautomerase FAHD1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Fahd1 PE=1 SV=1",GO:0005654; GO:0005739; GO:0005829; GO:0006090; GO:0006107; GO:0008948; GO:0018773; GO:0034545; GO:0046872; GO:0047621; GO:0050163,oxaloacetate metabolic process [GO:0006107]; pyruvate metabolic process [GO:0006090],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]; oxaloacetate tautomerase activity [GO:0050163],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016787; GO:0016829; GO:0016853; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; cytosol; hydrolase activity; lyase activity; isomerase activity; organelle
OG_05071,1.289526554562436,FUN_023293-T1,Peve_00003652,Pocillopora_meandrina_HIv1___RNAseq.g23035.t1,three_way,68.382,,,,,,,,,,,,,,,,,
OG_05072,3.46658062778549,FUN_023298-T1,Peve_00041305,Pocillopora_meandrina_HIv1___RNAseq.g17780.t1,three_way,76.65966666666667,FUN_023298-T1,Q5XIH9,HPDL_RAT,,4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) (EC 1.13.11.46) (Glyoxalase domain-containing protein 1),Rattus norvegicus (Rat),32.8,390.0,1.4e-48,195.3,sp|Q5XIH9|HPDL_RAT 4-hydroxyphenylpyruvate dioxygenase-like protein OS=Rattus norvegicus OX=10116 GN=Hpdl PE=2 SV=1,GO:0003868; GO:0005739; GO:0009072; GO:0046872; GO:0050585,aromatic amino acid metabolic process [GO:0009072],mitochondrion [GO:0005739],4-hydroxymandelate synthase activity [GO:0050585]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; organelle
OG_05075,3.329609305176877,FUN_023301-T1,Peve_00041311,Pocillopora_meandrina_HIv1___RNAseq.g17777.t1,three_way,77.84916666666666,FUN_023301-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),31.5,371.0,1.6000000000000001e-38,162.5,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_05077,1.9602915378430823,FUN_023306-T1,Peve_00041314,Pocillopora_meandrina_HIv1___RNAseq.g17775.t2,three_way,73.69766666666666,FUN_023306-T1,Q9H008,,,,,58.0,257.0,3.1e-84,313.2,sp|Q9H008|LHPP_HUMAN Phospholysine phosphohistidine inorganic pyrophosphate phosphatase OS=Homo sapiens OX=9606 GN=LHPP PE=1 SV=2,,,,,,
OG_05078,3.1077001416828822,FUN_023307-T1,Peve_00041315,Pocillopora_meandrina_HIv1___RNAseq.g17774.t1,three_way,62.178,FUN_023307-T1,Q9QXT1,,,,,36.0,86.0,3.4e-10,67.4,sp|Q9QXT1|DAPP1_MOUSE Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide OS=Mus musculus OX=10090 GN=Dapp1 PE=1 SV=1,,,,,,
OG_05079,2.753683598293511,FUN_023308-T1,Peve_00041319,Pocillopora_meandrina_HIv1___RNAseq.g17773.t1,three_way,65.986,FUN_023308-T1,Q80YG3,,,,,38.9,378.0,3.6e-73,276.9,sp|Q80YG3|KLDC1_MOUSE Kelch domain-containing protein 1 OS=Mus musculus OX=10090 GN=Klhdc1 PE=2 SV=1,,,,,,
OG_05080,2.9651048688387105,FUN_023309-T1,Peve_00041320,Pocillopora_meandrina_HIv1___RNAseq.g17772.t1,three_way,73.30616666666667,FUN_023309-T1,P52732,KIF11_HUMAN,,Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5) (TR-interacting protein 5) (TRIP-5),Homo sapiens (Human),51.0,755.0,1.2e-171,605.5,sp|P52732|KIF11_HUMAN Kinesin-like protein KIF11 OS=Homo sapiens OX=9606 GN=KIF11 PE=1 SV=2,GO:0000278; GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007051; GO:0007052; GO:0007100; GO:0008017; GO:0008574; GO:0016020; GO:0019901; GO:0032991; GO:0036064; GO:0043231; GO:0046602; GO:0051231; GO:0051301; GO:0072686; GO:0090307,cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; spindle elongation [GO:0051231]; spindle organization [GO:0007051],ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901],GO:0000278; GO:0003774; GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0140657,mitotic cell cycle; cytoskeletal motor activity; catalytic activity; nucleus; microtubule organizing center; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; ATP-dependent activity
OG_05081,1.14572052726259,FUN_023311-T1,Peve_00011528,Pocillopora_meandrina_HIv1___RNAseq.g17770.t1,three_way,61.54116666666667,FUN_023311-T1,Q13332,,,,,29.5,742.0,1.1999999999999999e-61,240.4,sp|Q13332|PTPRS_HUMAN Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens OX=9606 GN=PTPRS PE=1 SV=3,,,,,,
OG_05082,1.4950579989247166,FUN_023314-T1,Peve_00017882,Pocillopora_meandrina_HIv1___RNAseq.g17767.t1,three_way,79.65150000000001,FUN_023314-T1,P47870,GBRB2_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Homo sapiens (Human),40.5,321.0,5.9e-61,236.5,sp|P47870|GBRB2_HUMAN Gamma-aminobutyric acid receptor subunit beta-2 OS=Homo sapiens OX=9606 GN=GABRB2 PE=1 SV=2,GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0022851; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0051932; GO:0060119; GO:0060384; GO:0070062; GO:0071420; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05083,1.857600928761607,FUN_023316-T2,Peve_00017883,Pocillopora_meandrina_HIv1___RNAseq.g17768.t1,three_way,78.326,FUN_023316-T2,P63138,GBRB2_RAT,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Rattus norvegicus (Rat),32.2,391.0,1.6000000000000002e-48,194.9,sp|P63138|GBRB2_RAT Gamma-aminobutyric acid receptor subunit beta-2 OS=Rattus norvegicus OX=10116 GN=Gabrb2 PE=1 SV=1,GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0007214; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0048666; GO:0048787; GO:0051932; GO:0060119; GO:0060384; GO:0071420; GO:0090102; GO:0098978; GO:0098982; GO:0099507; GO:0099634; GO:1902476; GO:1902710; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; neuron development [GO:0048666]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynaptic active zone membrane [GO:0048787],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; inhibitory extracellular ligand-gated monoatomic ion channel activity [GO:0005237]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05091,1.8702614445006325,FUN_023336-T1,Peve_00001907,Pocillopora_meandrina_HIv1___RNAseq.g17418.t1,three_way,88.16199999999999,FUN_023336-T1,Q9NX55,HYPK_HUMAN,,Huntingtin-interacting protein K (Huntingtin yeast partner K),Homo sapiens (Human),59.6,104.0,1.5e-23,110.2,sp|Q9NX55|HYPK_HUMAN Huntingtin-interacting protein K OS=Homo sapiens OX=9606 GN=HYPK PE=1 SV=3,GO:0005634; GO:0005654; GO:0005737; GO:0015630; GO:0032991; GO:0043066; GO:0044183; GO:0050821,negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],protein folding chaperone [GO:0044183],GO:0005634; GO:0005654; GO:0005856; GO:0043226; GO:0044183,nucleus; nucleoplasm; cytoskeleton; organelle; protein folding chaperone
OG_05094,2.6211952250886963,FUN_023341-T1,Peve_00023294,Pocillopora_meandrina_HIv1___RNAseq.g17422.t2,three_way,63.56933333333334,FUN_023341-T1,O15066,KIF3B_HUMAN,,"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]",Homo sapiens (Human),28.9,557.0,1.3000000000000002e-44,183.7,sp|O15066|KIF3B_HUMAN Kinesin-like protein KIF3B OS=Homo sapiens OX=9606 GN=KIF3B PE=1 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016192; GO:0016887; GO:0016939; GO:0030425; GO:0030496; GO:0031267; GO:0032467; GO:0032839; GO:0036372; GO:0042073; GO:0043197; GO:0060271; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0098971; GO:0098978; GO:0120170; GO:1904115,anterograde axonal transport [GO:0008089]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; opsin transport [GO:0036372]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; vesicle-mediated transport [GO:0016192],axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_05095,1.2154235764953278,FUN_023342-T1,Peve_00023292,Pocillopora_meandrina_HIv1___RNAseq.g17423.t1,three_way,64.36,,,,,,,,,,,,,,,,,
OG_05096,1.986954988036071,FUN_023343-T1,Peve_00023293,Pocillopora_meandrina_HIv1___RNAseq.g17424.t1,three_way,72.48533333333333,FUN_023343-T1,Q05AM5,,,,,45.9,854.0,2.9e-210,733.4,sp|Q05AM5|ELP2_DANRE Elongator complex protein 2 OS=Danio rerio OX=7955 GN=elp2 PE=2 SV=1,,,,,,
OG_05103,2.43487192798304,FUN_023358-T2,Peve_00005335,Pocillopora_meandrina_HIv1___TS.g17018.t1,three_way,80.87916666666666,FUN_023358-T2,Q96A58,RERG_HUMAN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Homo sapiens (Human),36.9,160.0,2.8000000000000002e-28,127.1,sp|Q96A58|RERG_HUMAN Ras-related and estrogen-regulated growth inhibitor OS=Homo sapiens OX=9606 GN=RERG PE=1 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007264; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear estrogen receptor binding [GO:0030331],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; nucleus; nucleoplasm; cytosol; plasma membrane; hydrolase activity; organelle; molecular function regulator activity
OG_05104,2.299187030655892,FUN_023360-T1,Peve_00005336,Pocillopora_meandrina_HIv1___TS.g17019.t1,three_way,64.49333333333334,FUN_023360-T1,Q0VCJ7,RERG_BOVIN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Bos taurus (Bovine),38.9,193.0,1.5999999999999999e-29,131.3,sp|Q0VCJ7|RERG_BOVIN Ras-related and estrogen-regulated growth inhibitor OS=Bos taurus OX=9913 GN=RERG PE=2 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005829; GO:0005886; GO:0008285; GO:0009725; GO:0019003; GO:0030308,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; nucleoplasm; cytosol; plasma membrane; hydrolase activity; molecular function regulator activity
OG_05106,3.3150918704141703,FUN_023364-T2,Peve_00005343,Pocillopora_meandrina_HIv1___RNAseq.g17540.t1,three_way,47.92916666666667,,,,,,,,,,,,,,,,,
OG_05110,4.409400563141467,FUN_023369-T2,Peve_00005354,Pocillopora_meandrina_HIv1___TS.g17121.t2,three_way,69.55983333333333,FUN_023369-T2,O96028,NSD2_HUMAN,,Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein),Homo sapiens (Human),41.5,1229.0,2.6e-223,777.3,sp|O96028|NSD2_HUMAN Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens OX=9606 GN=NSD2 PE=1 SV=1,GO:0000122; GO:0000785; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006355; GO:0008270; GO:0032259; GO:0042799; GO:0043565; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:0140938; GO:0140954; GO:0140955; GO:2001032,atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; double-strand break repair [GO:0006302]; membranous septum morphogenesis [GO:0003149]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H4K20 methyltransferase activity [GO:0042799]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05112,1.7455183717565446,FUN_023371-T1,Peve_00005356,Pocillopora_meandrina_HIv1___RNAseq.g17531.t1,three_way,86.89033333333333,FUN_023371-T1,Q8TD22,SFXN5_HUMAN,,Sideroflexin-5,Homo sapiens (Human),56.9,318.0,1.6e-103,377.5,sp|Q8TD22|SFXN5_HUMAN Sideroflexin-5 OS=Homo sapiens OX=9606 GN=SFXN5 PE=1 SV=1,GO:0005739; GO:0005743; GO:0006865; GO:0015075; GO:0015137; GO:0015746; GO:0120162; GO:1990542,amino acid transport [GO:0006865]; citrate transport [GO:0015746]; mitochondrial transmembrane transport [GO:1990542]; positive regulation of cold-induced thermogenesis [GO:0120162],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],citrate transmembrane transporter activity [GO:0015137]; monoatomic ion transmembrane transporter activity [GO:0015075],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_05114,1.57528782546242,FUN_023373-T1,Peve_00005360,Pocillopora_meandrina_HIv1___RNAseq.g17529.t1,three_way,56.03366666666667,,,,,,,,,,,,,,,,,
OG_05116,2.28801920717326,FUN_023376-T1,Peve_00005364,Pocillopora_meandrina_HIv1___RNAseq.g17526.t1,three_way,65.55333333333333,FUN_023376-T1,Q54PR9,CF60_DICDI,,Counting factor 60,Dictyostelium discoideum (Social amoeba),31.2,404.0,3.9e-42,174.1,sp|Q54PR9|CF60_DICDI Counting factor 60 OS=Dictyostelium discoideum OX=44689 GN=cf60 PE=1 SV=1,GO:0005576; GO:0016791; GO:0031158,negative regulation of aggregate size involved in sorocarp development [GO:0031158],extracellular region [GO:0005576],phosphatase activity [GO:0016791],GO:0003824; GO:0005576; GO:0016787,catalytic activity; extracellular region; hydrolase activity
OG_05119,3.876455853381448,FUN_023381-T1,Peve_00030697,Pocillopora_meandrina_HIv1___RNAseq.g17515.t1,three_way,64.44500000000001,FUN_023381-T1,Q7ZWG6,PCFT_DANRE,,Proton-coupled folate transporter (Solute carrier family 46 member 1),Danio rerio (Zebrafish) (Brachydanio rerio),32.7,428.0,4.3e-52,207.2,sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1,GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085,transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05120,1.3414553640916007,FUN_023382-T1,Peve_00014629,Pocillopora_meandrina_HIv1___RNAseq.g17514.t1,three_way,70.77666666666667,FUN_023382-T1,Q7ZWG6,PCFT_DANRE,,Proton-coupled folate transporter (Solute carrier family 46 member 1),Danio rerio (Zebrafish) (Brachydanio rerio),27.7,411.0,1.6e-37,158.7,sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1,GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085,transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05123,1.687606983047598,FUN_023386-T1,Peve_00004633,Pocillopora_meandrina_HIv1___RNAseq.g17450.t1,three_way,75.50966666666666,FUN_023386-T1,Q8R367,,,,,33.6,137.0,4.7e-16,85.9,sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1,,,,,,
OG_05127,1.3272436982605151,FUN_023392-T1,Peve_00038659,Pocillopora_meandrina_HIv1___RNAseq.g17625.t2,three_way,55.8355,FUN_023392-T1,Q96LW4,PRIPO_HUMAN,,DNA-directed primase/polymerase protein (hPrimpol1) (EC 2.7.7.102) (EC 2.7.7.7) (Coiled-coil domain-containing protein 111),Homo sapiens (Human),42.4,507.0,8.4e-97,356.3,sp|Q96LW4|PRIPO_HUMAN DNA-directed primase/polymerase protein OS=Homo sapiens OX=9606 GN=PRIMPOL PE=1 SV=3,GO:0000428; GO:0003682; GO:0003887; GO:0003899; GO:0005634; GO:0005657; GO:0005739; GO:0005759; GO:0006264; GO:0006269; GO:0008270; GO:0009411; GO:0019985; GO:0030145; GO:0031297; GO:0042276; GO:0043504; GO:0062176,"DNA replication, synthesis of primer [GO:0006269]; error-prone translesion synthesis [GO:0042276]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; R-loop processing [GO:0062176]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]",DNA-directed RNA polymerase complex [GO:0000428]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; replication fork [GO:0005657],chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-directed RNA polymerase activity [GO:0003899]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005739; GO:0006260; GO:0006281; GO:0006325; GO:0016740; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; mitochondrion; DNA replication; DNA repair; chromatin organization; transferase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_05129,1.275148283517519,FUN_023394-T2,Peve_00038661,Pocillopora_meandrina_HIv1___RNAseq.g17627.t1,three_way,62.523,FUN_023394-T2,P10746,HEM4_HUMAN,,Uroporphyrinogen-III synthase (UROIIIS) (UROS) (EC 4.2.1.75) (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase),Homo sapiens (Human),36.3,262.0,2.3e-39,164.1,sp|P10746|HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens OX=9606 GN=Mgu PE=1 SV=1,GO:0004852; GO:0005542; GO:0005739; GO:0005829; GO:0006780; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0048034; GO:0070541; GO:0071243; GO:0071418,cellular response to amine stimulus [GO:0071418]; cellular response to arsenic-containing substance [GO:0071243]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to platinum ion [GO:0070541]; uroporphyrinogen III biosynthetic process [GO:0006780],cytosol [GO:0005829]; mitochondrion [GO:0005739],folic acid binding [GO:0005542]; uroporphyrinogen-III synthase activity [GO:0004852],GO:0003824; GO:0005739; GO:0005829; GO:0016829; GO:0043226,catalytic activity; mitochondrion; cytosol; lyase activity; organelle
OG_05131,1.3568245503179863,FUN_023399-T1,Peve_00004637,Pocillopora_meandrina_HIv1___RNAseq.g17446.t1,three_way,47.458,,,,,,,,,,,,,,,,,
OG_05134,2.831353607047622,FUN_023405-T1,Peve_00016099,Pocillopora_meandrina_HIv1___RNAseq.g17555.t1,three_way,68.52166666666666,,,,,,,,,,,,,,,,,
OG_05135,2.4772876311818672,FUN_023406-T1,Peve_00016101,Pocillopora_meandrina_HIv1___RNAseq.g17553.t1,three_way,88.30066666666667,FUN_023406-T1,P24844,MYL9_HUMAN,,"Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)",Homo sapiens (Human),59.1,171.0,2.5e-52,206.5,sp|P24844|MYL9_HUMAN Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4,GO:0001725; GO:0005200; GO:0005509; GO:0005737; GO:0005829; GO:0005859; GO:0005938; GO:0006937; GO:0008307; GO:0016460; GO:0030016; GO:0030018; GO:0030239; GO:0032036; GO:0043149; GO:0070527,myofibril assembly [GO:0030239]; platelet aggregation [GO:0070527]; regulation of muscle contraction [GO:0006937]; stress fiber assembly [GO:0043149],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307],GO:0005198; GO:0005829; GO:0007010; GO:0007155; GO:0008092; GO:0043226,structural molecule activity; cytosol; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; organelle
OG_05136,2.6073320916395253,FUN_023407-T1,Peve_00016102,Pocillopora_meandrina_HIv1___RNAseq.g17552.t1,three_way,89.46416666666667,FUN_023407-T1,P24032,,,,,63.5,170.0,1.6e-54,213.8,"sp|P24032|MLRN_CHICK Myosin regulatory light chain 2, smooth muscle minor isoform OS=Gallus gallus OX=9031 PE=1 SV=2",,,,,,
OG_05142,1.2497065471092168,FUN_023418-T1,Peve_00019270,Pocillopora_meandrina_HIv1___RNAseq.g579.t1,three_way,56.60016666666667,FUN_023418-T1,Q5ZJR9,,,,,27.2,383.0,7.6e-21,103.6,sp|Q5ZJR9|TAF1B_CHICK TATA box-binding protein-associated factor RNA polymerase I subunit B OS=Gallus gallus OX=9031 GN=TAF1B PE=2 SV=2,,,,,,
OG_05143,1.7837500584804722,FUN_023419-T2,Peve_00019272,Pocillopora_meandrina_HIv1___RNAseq.g580.t1,three_way,70.67533333333334,FUN_023419-T2,Q8N9I5,FADS6_HUMAN,,Fatty acid desaturase 6 (EC 1.14.19.-),Homo sapiens (Human),45.8,330.0,2.4e-77,290.8,sp|Q8N9I5|FADS6_HUMAN Fatty acid desaturase 6 OS=Homo sapiens OX=9606 GN=FADS6 PE=1 SV=2,GO:0006629; GO:0006633; GO:0016020; GO:0016717,fatty acid biosynthetic process [GO:0006633]; lipid metabolic process [GO:0006629],membrane [GO:0016020],"oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_05150,1.9894855595313063,FUN_023433-T1,Peve_00019225,Pocillopora_meandrina_HIv1___TS.g25287.t1,three_way,71.47266666666667,FUN_023433-T1,Q9UBG0,MRC2_HUMAN,,C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280),Homo sapiens (Human),32.6,132.0,8.5e-14,80.5,sp|Q9UBG0|MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens OX=9606 GN=MRC2 PE=1 SV=2,GO:0001649; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0030246; GO:0030574; GO:0038023,collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649],focal adhesion [GO:0005925]; membrane [GO:0016020],carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; signaling receptor activity [GO:0038023],GO:0016192; GO:0030154; GO:0060089,vesicle-mediated transport; cell differentiation; molecular transducer activity
OG_05151,2.5036379889896825,FUN_023434-T1,Peve_00019227,Pocillopora_meandrina_HIv1___RNAseq.g550.t1,three_way,80.48166666666667,FUN_023434-T1,Q7L273,KCTD9_HUMAN,,BTB/POZ domain-containing protein KCTD9,Homo sapiens (Human),53.6,235.0,1.4000000000000001e-59,231.9,sp|Q7L273|KCTD9_HUMAN BTB/POZ domain-containing protein KCTD9 OS=Homo sapiens OX=9606 GN=KCTD9 PE=1 SV=1,GO:0016567; GO:0035556; GO:0042802; GO:0051260; GO:0097602,intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567],,cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802],GO:0065003,protein-containing complex assembly
OG_05152,1.5425934369550949,FUN_023435-T1,Peve_00019228,Pocillopora_meandrina_HIv1___RNAseq.g549.t1a,three_way,81.44566666666667,FUN_023435-T1,Q9NQW7,XPP1_HUMAN,,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",Homo sapiens (Human),56.8,620.0,1.9e-203,710.3,sp|Q9NQW7|XPP1_HUMAN Xaa-Pro aminopeptidase 1 OS=Homo sapiens OX=9606 GN=XPNPEP1 PE=1 SV=3,GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006; GO:0070062,bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05157,1.8233581050618253,FUN_023446-T1,Peve_00019244,Pocillopora_meandrina_HIv1___RNAseq.g17636.t1,three_way,73.13333333333333,FUN_023446-T1,Q708S6,ASI1C_DANRE,,"Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3)",Danio rerio (Zebrafish) (Brachydanio rerio),32.2,457.0,5.9999999999999996e-55,216.9,sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1,GO:0005261; GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128,cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725],dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05158,1.3745129691933804,FUN_023447-T1,Peve_00019245,Pocillopora_meandrina_HIv1___RNAseq.g17633.t1,three_way,62.09233333333333,FUN_023447-T1,Q708S6,ASI1C_DANRE,,"Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3)",Danio rerio (Zebrafish) (Brachydanio rerio),26.3,457.0,1.1e-37,159.5,sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1,GO:0005261; GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128,cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725],dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05159,1.9861463175837368,FUN_023449-T1,Peve_00037222,Pocillopora_meandrina_HIv1___RNAseq.g17631.t2,three_way,40.68716666666667,,,,,,,,,,,,,,,,,
OG_05160,2.3381270217520056,FUN_023450-T1,Peve_00037237,Pocillopora_meandrina_HIv1___RNAseq.g17630.t1,three_way,87.68333333333334,FUN_023450-T1,Q9JI08,,,,,42.9,254.0,5.1999999999999996e-46,186.0,sp|Q9JI08|BIN3_MOUSE Bridging integrator 3 OS=Mus musculus OX=10090 GN=Bin3 PE=1 SV=1,,,,,,
OG_05161,2.422344802253137,FUN_023459-T1,Peve_00037224,Pocillopora_meandrina_HIv1___RNAseq.g17544.t1,three_way,95.354,FUN_023459-T1,O75643,U520_HUMAN,,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),Homo sapiens (Human),74.1,2143.0,0.0,3215.6,sp|O75643|U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens OX=9606 GN=SNRNP200 PE=1 SV=2,GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005886; GO:0005929; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013,"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]",catalytic step 2 spliceosome [GO:0071013]; cilium [GO:0005929]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005886; GO:0005929; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0065003; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; plasma membrane; cilium; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; protein-containing complex assembly; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05163,1.012475646632652,FUN_023461-T1,Peve_00004657,Pocillopora_meandrina_HIv1___RNAseq.g17546.t1,three_way,73.69733333333333,FUN_023461-T1,G3M4F8,,,,,34.4,323.0,4.200000000000001e-36,153.7,sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1,,,,,,
OG_05170,1.882278517171177,FUN_023498-T1,Peve_00017458,Pocillopora_meandrina_HIv1___RNAseq.g538.t1,three_way,71.93366666666667,FUN_023498-T1,Q9DAM9,FANK1_MOUSE,,Fibronectin type 3 and ankyrin repeat domains 1 protein (Germ cell-specific gene 1 protein) (GSG1),Mus musculus (Mouse),40.9,149.0,1.5999999999999999e-24,115.2,sp|Q9DAM9|FANK1_MOUSE Fibronectin type 3 and ankyrin repeat domains 1 protein OS=Mus musculus OX=10090 GN=Fank1 PE=1 SV=1,GO:0000785; GO:0005634; GO:0005654; GO:0005829; GO:0005929; GO:0036064; GO:0045893; GO:0051091; GO:0097546,positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893],chromatin [GO:0000785]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0006355; GO:0043226,nucleus; nucleoplasm; microtubule organizing center; cytosol; cilium; regulation of DNA-templated transcription; organelle
OG_05171,1.54969609229763,FUN_023499-T1,Peve_00017457,Pocillopora_meandrina_HIv1___RNAseq.g537.t1,three_way,81.41233333333334,FUN_023499-T1,Q8K1X1,WDR11_MOUSE,,WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2),Mus musculus (Mouse),43.1,1285.0,1.3e-299,1030.8,sp|Q8K1X1|WDR11_MOUSE WD repeat-containing protein 11 OS=Mus musculus OX=10090 GN=Wdr11 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005802; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041,cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041],axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802],,GO:0005634; GO:0005815; GO:0005929; GO:0006886; GO:0031410; GO:0043226; GO:0044782; GO:0048856,nucleus; microtubule organizing center; cilium; intracellular protein transport; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development
OG_05173,2.882448319080779,FUN_023501-T1,Peve_00017454,Pocillopora_meandrina_HIv1___RNAseq.g534.t1,three_way,56.98533333333334,,,,,,,,,,,,,,,,,
OG_05175,2.9934465994209134,FUN_023503-T1,Peve_00017430,Pocillopora_meandrina_HIv1___RNAseq.g531.t2,three_way,72.32416666666667,FUN_023503-T1,Q3UUG6,TBC24_MOUSE,,TBC1 domain family member 24,Mus musculus (Mouse),28.8,539.0,1.3e-52,209.1,sp|Q3UUG6|TBC24_MOUSE TBC1 domain family member 24 OS=Mus musculus OX=10090 GN=Tbc1d24 PE=1 SV=2,GO:0005096; GO:0005886; GO:0016358; GO:0030659; GO:0031175; GO:0031594; GO:0034599; GO:0043195; GO:0048488; GO:0050775; GO:0061564; GO:1900408; GO:2000463; GO:2001224,axon development [GO:0061564]; cellular response to oxidative stress [GO:0034599]; dendrite development [GO:0016358]; negative regulation of cellular response to oxidative stress [GO:1900408]; neuron projection development [GO:0031175]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron migration [GO:2001224]; synaptic vesicle endocytosis [GO:0048488],cytoplasmic vesicle membrane [GO:0030659]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195],GTPase activator activity [GO:0005096],GO:0005886; GO:0016192; GO:0048856; GO:0098772,plasma membrane; vesicle-mediated transport; anatomical structure development; molecular function regulator activity
OG_05178,2.172463571086816,FUN_023509-T1,Peve_00018237,Pocillopora_meandrina_HIv1___RNAseq.g567.t1,three_way,69.6595,FUN_023509-T1,Q60554,NKX61_MESAU,,Homeobox protein Nkx-6.1 (Homeobox protein NK-6 homolog A),Mesocricetus auratus (Golden hamster),67.6,108.0,1.9e-31,137.5,sp|Q60554|NKX61_MESAU Homeobox protein Nkx-6.1 OS=Mesocricetus auratus OX=10036 GN=NKX6-1 PE=1 SV=1,GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0010255; GO:0031016; GO:0044342; GO:0045944; GO:0061629; GO:0072560; GO:2000078,glucose mediated signaling pathway [GO:0010255]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell development [GO:2000078]; type B pancreatic cell maturation [GO:0072560]; type B pancreatic cell proliferation [GO:0044342],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05181,2.02205640005085,FUN_023522-T1,Peve_00009063,Pocillopora_meandrina_HIv1___RNAseq.g3599.t1,three_way,72.77533333333334,FUN_023522-T1,Q8BH74,,,,,43.7,948.0,3.4e-215,750.0,sp|Q8BH74|NU107_MOUSE Nuclear pore complex protein Nup107 OS=Mus musculus OX=10090 GN=Nup107 PE=1 SV=1,,,,,,
OG_05182,1.7928403208987285,FUN_023523-T1,Peve_00009062,Pocillopora_meandrina_HIv1___RNAseq.g3600.t2,three_way,64.48166666666667,FUN_023523-T1,Q4SQ06,,,,,35.9,78.0,1e-06,54.3,sp|Q4SQ06|NOP16_TETNG Nucleolar protein 16 OS=Tetraodon nigroviridis OX=99883 GN=nop16 PE=3 SV=1,,,,,,
OG_05184,1.6220103383861102,FUN_023550-T1,Peve_00041532,Pocillopora_meandrina_HIv1___RNAseq.g11206.t1a,three_way,67.22466666666666,FUN_023550-T1,Q5SSH8,NEUFC_MOUSE,,Neuferricin (Cytochrome b5 domain-containing protein 2),Mus musculus (Mouse),43.9,223.0,2.5000000000000002e-58,227.3,sp|Q5SSH8|NEUFC_MOUSE Neuferricin OS=Mus musculus OX=10090 GN=Cyb5d2 PE=1 SV=1,GO:0005576; GO:0020037; GO:0030182; GO:0045666,neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666],extracellular region [GO:0005576],heme binding [GO:0020037],GO:0005576; GO:0030154,extracellular region; cell differentiation
OG_05186,2.0489028351607788,FUN_023552-T1,Peve_00009071,Pocillopora_meandrina_HIv1___RNAseq.g3591.t2,three_way,74.04033333333334,FUN_023552-T1,Q9NXH9,TRM1_HUMAN,,"tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA methyltransferase 1) (hTRM1) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase)",Homo sapiens (Human),51.0,590.0,4.2e-163,576.2,sp|Q9NXH9|TRM1_HUMAN tRNA (guanine(26)-N(2))-dimethyltransferase OS=Homo sapiens OX=9606 GN=TRMT1 PE=1 SV=1,GO:0000049; GO:0002940; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006400; GO:0008270; GO:0160104,tRNA modification [GO:0006400]; tRNA N2-guanine methylation [GO:0002940],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; tRNA (guanine(26)-N2)-dimethyltransferase activity [GO:0160104]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_05187,1.722149756293483,FUN_023553-T1,Peve_00009074,Pocillopora_meandrina_HIv1___RNAseq.g3589.t1,three_way,89.21216666666666,FUN_023553-T1,Q8NE35,CPEB3_HUMAN,,Cytoplasmic polyadenylation element-binding protein 3 (CPE-BP3) (CPE-binding protein 3) (hCPEB-3),Homo sapiens (Human),70.5,369.0,1.6e-146,521.2,sp|Q8NE35|CPEB3_HUMAN Cytoplasmic polyadenylation element-binding protein 3 OS=Homo sapiens OX=9606 GN=CPEB3 PE=1 SV=2,GO:0000122; GO:0000900; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007616; GO:0008135; GO:0014069; GO:0017148; GO:0030014; GO:0030425; GO:0030496; GO:0035613; GO:0035925; GO:0043005; GO:0043022; GO:0045202; GO:0045727; GO:0048167; GO:0060213; GO:0060998; GO:0060999; GO:0061158; GO:0071230; GO:0097440; GO:1900153; GO:1900248; GO:2000766,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; long-term memory [GO:0007616]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; regulation of dendritic spine development [GO:0060998]; regulation of synaptic plasticity [GO:0048167]",apical dendrite [GO:0097440]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],"mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; translation factor activity, RNA binding [GO:0008135]",GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0045182; GO:0050877,RNA binding; nucleus; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; translation regulator activity; nervous system process
OG_05188,3.147234388374983,FUN_023554-T1,Peve_00024945,Pocillopora_meandrina_HIv1___RNAseq.g3590.t1,three_way,88.87966666666667,FUN_023554-T1,Q6GM44,,,,,63.3,275.0,7.8e-104,378.3,sp|Q6GM44|MARH5_XENLA E3 ubiquitin-protein ligase MARCHF5 OS=Xenopus laevis OX=8355 GN=marchf5 PE=2 SV=1,,,,,,
OG_05189,2.73560377105328,FUN_023555-T1,Peve_00009058,Pocillopora_meandrina_HIv1___RNAseq.g3555.t1,three_way,64.18966666666667,FUN_023555-T1,Q9UIF7,MUTYH_HUMAN,,Adenine DNA glycosylase (EC 3.2.2.31) (MutY homolog) (hMYH),Homo sapiens (Human),47.7,472.0,1.2e-110,401.7,sp|Q9UIF7|MUTYH_HUMAN Adenine DNA glycosylase OS=Homo sapiens OX=9606 GN=MUTYH PE=1 SV=1,GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0045007; GO:0046872; GO:0051539; GO:0060546,base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; negative regulation of necroptotic process [GO:0060546],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_05191,1.7911446605384649,FUN_023557-T1,Peve_00037255,Pocillopora_meandrina_HIv1___RNAseq.g520.t1,three_way,63.37466666666667,FUN_023557-T1,Q5TEA3,,,,,35.3,1191.0,5.8e-204,713.0,sp|Q5TEA3|DAAF9_HUMAN Dynein axonemal assembly factor 9 OS=Homo sapiens OX=9606 GN=DNAAF9 PE=1 SV=1,,,,,,
OG_05200,2.5010649959393585,FUN_023581-T1,Peve_00035146,Pocillopora_meandrina_HIv1___RNAseq.g3529.t1,three_way,51.781333333333336,,,,,,,,,,,,,,,,,
OG_05201,1.180203652524226,FUN_023582-T1,Peve_00035145,Pocillopora_meandrina_HIv1___RNAseq.g3528.t1,three_way,65.47666666666666,FUN_023582-T1,Q91770,,,,,56.1,82.0,6.3e-16,85.9,sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1,,,,,,
OG_05202,2.1691323358865904,FUN_023586-T1,Peve_00039436,Pocillopora_meandrina_HIv1___RNAseq.g3307.t1,three_way,72.94,,,,,,,,,,,,,,,,,
OG_05204,2.1762290644263733,FUN_023588-T1,Peve_00028963,Pocillopora_meandrina_HIv1___TS.g17411.t1,three_way,68.98,FUN_023588-T1,Q5ZK33,LETM1_CHICK,,Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1),Gallus gallus (Chicken),40.7,644.0,2.9999999999999997e-105,384.4,sp|Q5ZK33|LETM1_CHICK Mitochondrial proton/calcium exchanger protein OS=Gallus gallus OX=9031 GN=LETM1 PE=2 SV=1,GO:0005509; GO:0005739; GO:0005743; GO:0006813; GO:0006816; GO:0006851; GO:0007005; GO:0007007; GO:0015369; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093,calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; potassium ion transport [GO:0006813]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022],GO:0005215; GO:0005739; GO:0007005; GO:0043226; GO:0055085; GO:0061024; GO:0065003,transporter activity; mitochondrion; mitochondrion organization; organelle; transmembrane transport; membrane organization; protein-containing complex assembly
OG_05206,1.1455963085435117,FUN_023590-T1,Peve_00026477,Pocillopora_meandrina_HIv1___RNAseq.16918_t,three_way,48.98133333333333,,,,,,,,,,,,,,,,,
OG_05208,5.2822628210610985,FUN_023592-T1,Peve_00023919,Pocillopora_meandrina_HIv1___RNAseq.g3311.t1,three_way,44.60383333333333,FUN_023592-T1,E9PVX6,KI67_MOUSE,,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog),Mus musculus (Mouse),42.2,135.0,5.7e-18,95.9,sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1,GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072089; GO:0072574; GO:0140693; GO:1902275; GO:1990705,cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088]; stem cell proliferation [GO:0072089],"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0007059; GO:0022414; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; chromosome; nucleolus; chromosome segregation; reproductive process; organelle; molecular adaptor activity
OG_05212,1.841517926019663,FUN_023619-T1,Peve_00018316,Pocillopora_meandrina_HIv1___RNAseq.g3522.t2,three_way,51.43366666666667,,,,,,,,,,,,,,,,,
OG_05215,3.962264387336371,FUN_023623-T1,Peve_00010900,Pocillopora_meandrina_HIv1___RNAseq.g3525.t1,three_way,73.34016666666666,FUN_023623-T1,Q90W58,,,,,46.8,308.0,4.4e-68,260.0,sp|Q90W58|DUS1B_XENLA Dual specificity protein phosphatase 1-B OS=Xenopus laevis OX=8355 GN=dusp1-b PE=2 SV=1,,,,,,
OG_05217,2.9455634645069084,FUN_023627-T2,Peve_00037251,Pocillopora_meandrina_HIv1___RNAseq.g523.t1,three_way,55.51683333333334,FUN_023627-T2,Q9JIC3,,,,,30.6,1016.0,8.3e-114,412.9,sp|Q9JIC3|DCR1A_MOUSE DNA cross-link repair 1A protein OS=Mus musculus OX=10090 GN=Dclre1a PE=1 SV=2,,,,,,
OG_05219,1.3223665095235917,FUN_023631-T1,Peve_00017456,Pocillopora_meandrina_HIv1___RNAseq.g526.t1,three_way,75.54283333333333,FUN_023631-T1,P57073,SOX8_HUMAN,,Transcription factor SOX-8,Homo sapiens (Human),59.1,110.0,6.7e-28,126.7,sp|P57073|SOX8_HUMAN Transcription factor SOX-8 OS=Homo sapiens OX=9606 GN=SOX8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001649; GO:0001701; GO:0001755; GO:0002009; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0007165; GO:0007283; GO:0007422; GO:0008584; GO:0010628; GO:0010817; GO:0014015; GO:0014032; GO:0033690; GO:0035914; GO:0043066; GO:0045165; GO:0045444; GO:0045662; GO:0045892; GO:0045893; GO:0045944; GO:0046533; GO:0048469; GO:0048484; GO:0048709; GO:0060009; GO:0060018; GO:0060041; GO:0060221; GO:0060612; GO:0061138; GO:0072034; GO:0072197; GO:0072289; GO:0090184; GO:0090190; GO:0140297; GO:1990837,adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hormone levels [GO:0010817]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_05230,1.6197191954927908,FUN_023643-T1,Peve_00027825,Pocillopora_meandrina_HIv1___RNAseq.g17818.t1,three_way,90.502,FUN_023643-T1,Q9DAA6,EXOS1_MOUSE,,Exosome complex component CSL4 (Exosome component 1),Mus musculus (Mouse),64.6,147.0,2.7000000000000004e-44,179.9,sp|Q9DAA6|EXOS1_MOUSE Exosome complex component CSL4 OS=Mus musculus OX=10090 GN=Exosc1 PE=1 SV=1,GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0101019,RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364],cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0043226,RNA binding; nucleus; nucleolus; cytosol; organelle
OG_05231,1.6332026330668274,FUN_023644-T1,Peve_00027824,Pocillopora_meandrina_HIv1___RNAseq.g17819.t1,three_way,74.502,,,,,,,,,,,,,,,,,
OG_05234,1.2199629620158583,FUN_023649-T1,Peve_00027829,Pocillopora_meandrina_HIv1___RNAseq.g19794.t1,three_way,56.414,FUN_023649-T1,O96790,,,,,33.2,277.0,5.8e-27,123.2,sp|O96790|DPGN_DIPMA Serine protease inhibitor dipetalogastin (Fragment) OS=Dipetalogaster maximus OX=72496 PE=1 SV=2,,,,,,
OG_05239,1.243429041163147,FUN_023676-T1,Peve_00020274,Pocillopora_meandrina_HIv1___RNAseq.g17755.t1,three_way,66.76166666666667,FUN_023676-T1,G1T7U7,,,,,48.8,326.0,2.5e-83,310.5,sp|G1T7U7|NAAA_RABIT N-acylethanolamine-hydrolyzing acid amidase OS=Oryctolagus cuniculus OX=9986 GN=NAAA PE=1 SV=2,,,,,,
OG_05242,2.0141345758684777,FUN_023683-T2,Peve_00014143,Pocillopora_meandrina_HIv1___RNAseq.g17734.t1,three_way,51.321,,,,,,,,,,,,,,,,,
OG_05244,1.465192317630306,FUN_023689-T1,Peve_00014149,Pocillopora_meandrina_HIv1___RNAseq.g17728.t1,three_way,68.89233333333334,FUN_023689-T1,F6S215,,,,,25.8,979.0,3.2e-75,285.0,sp|F6S215|AP5B1_XENTR AP-5 complex subunit beta-1 OS=Xenopus tropicalis OX=8364 GN=ap5b1 PE=3 SV=1,,,,,,
OG_05247,3.5445691555547043,FUN_023693-T1,Peve_00014155,Pocillopora_meandrina_HIv1___RNAseq.g17720.t1,three_way,64.13166666666666,FUN_023693-T1,Q5YCC5,,,,,29.7,660.0,6.2e-79,297.0,sp|Q5YCC5|TMC7_CHICK Transmembrane channel-like protein 7 OS=Gallus gallus OX=9031 GN=Tmc7 PE=2 SV=1,,,,,,
OG_05252,1.3449863585163753,FUN_023700-T1,Peve_00017416,Pocillopora_meandrina_HIv1___RNAseq.g17595.t2b,three_way,81.831,FUN_023700-T1,O14776,TCRG1_HUMAN,,Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150),Homo sapiens (Human),60.9,274.0,1.7000000000000001e-65,251.1,sp|O14776|TCRG1_HUMAN Transcription elongation regulator 1 OS=Homo sapiens OX=9606 GN=TCERG1 PE=1 SV=2,GO:0000122; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0061629; GO:0070063,mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation factor activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390],GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0140110,RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_05254,3.709738926347288,FUN_023702-T1,Peve_00017411,Pocillopora_meandrina_HIv1___RNAseq.g17589.t1,three_way,69.48033333333333,FUN_023702-T1,Q3KP44,ANR55_HUMAN,,Ankyrin repeat domain-containing protein 55,Homo sapiens (Human),25.1,259.0,1.5e-16,89.0,sp|Q3KP44|ANR55_HUMAN Ankyrin repeat domain-containing protein 55 OS=Homo sapiens OX=9606 GN=ANKRD55 PE=1 SV=3,,,,,,
OG_05258,1.0575922495942696,FUN_023762-T1,Peve_00044465,Pocillopora_meandrina_HIv1___TS.g9665.t1,three_way,75.69,FUN_023762-T1,P00727,AMPL_BOVIN,,Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (LAP) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase),Bos taurus (Bovine),60.9,294.0,8.999999999999999e-96,351.7,sp|P00727|AMPL_BOVIN Cytosol aminopeptidase OS=Bos taurus OX=9913 GN=LAP3 PE=1 SV=3,GO:0004180; GO:0005737; GO:0005739; GO:0006508; GO:0008233; GO:0016805; GO:0030145; GO:0070006; GO:0097718,proteolysis [GO:0006508],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; disordered domain specific binding [GO:0097718]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05259,2.377949413535288,FUN_023765-T1,Peve_00030839,Pocillopora_meandrina_HIv1___TS.g9692.t1a,three_way,65.00833333333333,FUN_023765-T1,P17453,,,,,32.3,473.0,4.500000000000001e-65,250.4,sp|P17453|BPI_BOVIN Bactericidal permeability-increasing protein OS=Bos taurus OX=9913 GN=BPI PE=2 SV=2,,,,,,
OG_05261,1.505159661959942,FUN_023772-T1,Peve_00039442,Pocillopora_meandrina_HIv1___RNAseq.g3603.t1,three_way,71.67933333333333,FUN_023772-T1,Q4JIM5,ABL2_MOUSE,,Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG),Mus musculus (Mouse),40.5,74.0,4.7e-08,60.8,sp|Q4JIM5|ABL2_MOUSE Tyrosine-protein kinase ABL2 OS=Mus musculus OX=10090 GN=Abl2 PE=1 SV=1,GO:0000287; GO:0001843; GO:0001891; GO:0002118; GO:0004713; GO:0004715; GO:0005524; GO:0006468; GO:0006909; GO:0006930; GO:0007015; GO:0007173; GO:0007200; GO:0007204; GO:0007249; GO:0007266; GO:0007612; GO:0007628; GO:0008104; GO:0008542; GO:0009791; GO:0010976; GO:0015629; GO:0016322; GO:0018108; GO:0021587; GO:0022408; GO:0030027; GO:0030036; GO:0030145; GO:0030182; GO:0031223; GO:0031410; GO:0032729; GO:0032743; GO:0035024; GO:0035264; GO:0035640; GO:0043123; GO:0043197; GO:0046632; GO:0048008; GO:0048813; GO:0050885; GO:0051017; GO:0051649; GO:0060020; GO:0060074; GO:0060563; GO:0070374; GO:0072359; GO:0097062; GO:0098609; GO:0098794; GO:0098978; GO:1903053; GO:1903905; GO:1904157; GO:2000096; GO:2000352; GO:2000406,"actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; adult walking behavior [GO:0007628]; aggressive behavior [GO:0002118]; alpha-beta T cell differentiation [GO:0046632]; auditory behavior [GO:0031223]; Bergmann glial cell differentiation [GO:0060020]; canonical NF-kappaB signal transduction [GO:0007249]; cell-cell adhesion [GO:0098609]; cerebellum morphogenesis [GO:0021587]; circulatory system development [GO:0072359]; dendrite morphogenesis [GO:0048813]; dendritic spine maintenance [GO:0097062]; DN4 thymocyte differentiation [GO:1904157]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of localization in cell [GO:0051649]; exploration behavior [GO:0035640]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of Rho protein signal transduction [GO:0035024]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuron remodeling [GO:0016322]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell migration [GO:2000406]; positive regulation of type II interferon production [GO:0032729]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of extracellular matrix organization [GO:1903053]; Rho protein signal transduction [GO:0007266]; substrate-dependent cell migration, cell extension [GO:0006930]; synapse maturation [GO:0060074]; visual learning [GO:0008542]",actin cytoskeleton [GO:0015629]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; postsynapse [GO:0098794],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713],GO:0002376; GO:0003824; GO:0005856; GO:0007010; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"immune system process; catalytic activity; cytoskeleton; cytoskeleton organization; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05265,1.808091272360334,FUN_023795-T1,Peve_00039445,Pocillopora_meandrina_HIv1___RNAseq.g5766.t1,three_way,90.22266666666668,FUN_023795-T1,Q91VN6,DDX41_MOUSE,,Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41),Mus musculus (Mouse),76.5,548.0,1.1e-243,844.0,sp|Q91VN6|DDX41_MOUSE Probable ATP-dependent RNA helicase DDX41 OS=Mus musculus OX=10090 GN=Ddx41 PE=1 SV=2,GO:0000398; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005783; GO:0005829; GO:0008270; GO:0008283; GO:0016887; GO:0030154; GO:0035458; GO:0045944; GO:0051607; GO:0071013; GO:0140896,"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005783; GO:0005829; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; endoplasmic reticulum; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05268,3.38496014809554,FUN_023921-T1,Peve_00026572,Pocillopora_meandrina_HIv1___TS.g27910.t1,three_way,65.93933333333332,,,,,,,,,,,,,,,,,
OG_05269,2.4296366182573186,FUN_023922-T1,Peve_00017665,Pocillopora_meandrina_HIv1___TS.g28130.t1a,three_way,66.8095,FUN_023922-T1,Q3UMC0,AFG2A_MOUSE,,ATPase family gene 2 protein homolog A (EC 3.6.4.10) (AFG2 AAA ATPase homolog A) (Ribosome biogenesis protein SPATA5) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5),Mus musculus (Mouse),47.8,856.0,3.2e-207,723.4,sp|Q3UMC0|AFG2A_MOUSE ATPase family gene 2 protein homolog A OS=Mus musculus OX=10090 GN=Afg2a PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0007283; GO:0007420; GO:0016887; GO:0030154; GO:0042273; GO:1990275,brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856,catalytic activity; mitochondrion; cytosol; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development
OG_05270,1.3661981018145382,FUN_023923-T1,Peve_00010790,Pocillopora_meandrina_HIv1___RNAseq.g18865.t1,three_way,53.831,FUN_023923-T1,P59672,ANS1A_MOUSE,,Ankyrin repeat and SAM domain-containing protein 1A (Odin),Mus musculus (Mouse),30.1,133.0,2.6e-08,60.8,sp|P59672|ANS1A_MOUSE Ankyrin repeat and SAM domain-containing protein 1A OS=Mus musculus OX=10090 GN=Anks1a PE=1 SV=3,GO:0005737; GO:0006929; GO:0016322; GO:0043005; GO:0046875; GO:0048013; GO:1901187; GO:2000059,ephrin receptor signaling pathway [GO:0048013]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929],cytoplasm [GO:0005737]; neuron projection [GO:0043005],ephrin receptor binding [GO:0046875],GO:0048870,cell motility
OG_05272,1.062484251270996,FUN_023925-T1,Peve_00026567,Pocillopora_meandrina_HIv1___RNAseq.g18510.t1,three_way,82.92366666666666,FUN_023925-T1,P61085,UBE2K_BOVIN,,Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase),Bos taurus (Bovine),69.2,201.0,1.2000000000000001e-74,280.8,sp|P61085|UBE2K_BOVIN Ubiquitin-conjugating enzyme E2 K OS=Bos taurus OX=9913 GN=UBE2K PE=1 SV=3,GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0031625; GO:0061631; GO:0070936,protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05275,2.59062438288369,FUN_023933-T1,Peve_00017668,Pocillopora_meandrina_HIv1___TS.g28130.t1b,three_way,81.382,FUN_023933-T1,Q6P0U0,,,,,51.3,398.0,7.3e-117,422.2,sp|Q6P0U0|NAGA_DANRE N-acetylglucosamine-6-phosphate deacetylase OS=Danio rerio OX=7955 GN=amdhd2 PE=2 SV=1,,,,,,
OG_05281,1.5080393235491114,FUN_023943-T2,Peve_00023222,Pocillopora_meandrina_HIv1___RNAseq.g18860.t1,three_way,70.39283333333333,FUN_023943-T2,Q9JHI7,EXOS9_MOUSE,,Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75),Mus musculus (Mouse),48.0,452.0,3.4e-104,380.2,sp|Q9JHI7|EXOS9_MOUSE Exosome complex component RRP45 OS=Mus musculus OX=10090 GN=Exosc9 PE=1 SV=1,GO:0000176; GO:0000177; GO:0000178; GO:0000228; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0030307; GO:0035925; GO:0045944; GO:0061629; GO:0071028; GO:0071035; GO:0101019,nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364],cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0000228; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006355; GO:0016071; GO:0043226,nuclear chromosome; RNA binding; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_05283,2.5240180859782493,FUN_023945-T1,Peve_00010787,Pocillopora_meandrina_HIv1___RNAseq.g18863.t1,three_way,91.15233333333332,FUN_023945-T1,Q6NYV5,SP30L_DANRE,,Histone deacetylase complex subunit SAP30L (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like),Danio rerio (Zebrafish) (Brachydanio rerio),62.1,174.0,1.5e-54,213.8,sp|Q6NYV5|SP30L_DANRE Histone deacetylase complex subunit SAP30L OS=Danio rerio OX=7955 GN=sap30l PE=1 SV=1,GO:0000118; GO:0000122; GO:0001947; GO:0003677; GO:0003712; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273,heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355],histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005730; GO:0006355; GO:0008289; GO:0042393; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleolus; regulation of DNA-templated transcription; lipid binding; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_05285,1.3906366041928837,FUN_023948-T1,Peve_00016130,Pocillopora_meandrina_HIv1___RNAseq.g18526.t1,three_way,94.61833333333334,FUN_023948-T1,Q176V0,,,,,94.0,83.0,2.8e-37,155.6,sp|Q176V0|UFM1_AEDAE Ubiquitin-fold modifier 1 OS=Aedes aegypti OX=7159 GN=AAEL006251 PE=3 SV=1,,,,,,
OG_05289,1.3152256370191888,FUN_023954-T1,Peve_00016132,Pocillopora_meandrina_HIv1___RNAseq.g18528.t1,three_way,73.87133333333334,,,,,,,,,,,,,,,,,
OG_05290,2.214239323466739,FUN_023956-T1,Peve_00017997,Pocillopora_meandrina_HIv1___RNAseq.g18522.t1,three_way,84.48,FUN_023956-T1,O60271,,,,,49.1,642.0,1.4e-149,531.2,sp|O60271|JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4,,,,,,
OG_05291,1.8468212435170035,FUN_023958-T1,Peve_00017996,Pocillopora_meandrina_HIv1___RNAseq.g18521.t1,three_way,58.741,,,,,,,,,,,,,,,,,
OG_05292,2.637853055419733,FUN_023959-T1,Peve_00017995,Pocillopora_meandrina_HIv1___RNAseq.g18520.t1,three_way,96.22633333333332,FUN_023959-T1,Q5XGI0,PRPS2_XENTR,,Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),81.8,318.0,5.6e-146,518.5,sp|Q5XGI0|PRPS2_XENTR Ribose-phosphate pyrophosphokinase 2 OS=Xenopus tropicalis OX=8364 GN=prps2 PE=2 SV=1,GO:0000287; GO:0004749; GO:0005524; GO:0006015; GO:0009156; GO:0009165; GO:0016301; GO:0042803,5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156],,ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749],GO:0003824; GO:0016740; GO:0055086; GO:1901135,catalytic activity; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05301,2.5818498840789195,FUN_023971-T1,Peve_00025477,Pocillopora_meandrina_HIv1___RNAseq.g18534.t1,three_way,57.55416666666667,FUN_023971-T1,P15384,,,,,33.7,395.0,9.300000000000001e-57,222.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_05302,1.1100842627856136,FUN_023972-T1,Peve_00025484,Pocillopora_meandrina_HIv1___RNAseq.g18530.t1,three_way,91.074,FUN_023972-T1,Q8K2G4,BBS7_MOUSE,,BBSome complex member BBS7 (BBS2-like protein 1) (Bardet-Biedl syndrome 7 protein homolog),Mus musculus (Mouse),68.9,718.0,1.8e-293,1009.6,sp|Q8K2G4|BBS7_MOUSE BBSome complex member BBS7 OS=Mus musculus OX=10090 GN=Bbs7 PE=1 SV=1,GO:0001654; GO:0001750; GO:0005634; GO:0005813; GO:0005930; GO:0006357; GO:0007224; GO:0007420; GO:0007507; GO:0008104; GO:0015031; GO:0016020; GO:0032436; GO:0034451; GO:0034464; GO:0036064; GO:0045444; GO:0060170; GO:0060173; GO:0060271; GO:0061629; GO:1903929; GO:1905515,brain development [GO:0007420]; cilium assembly [GO:0060271]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; limb development [GO:0060173]; non-motile cilium assembly [GO:1905515]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224],axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; membrane [GO:0016020]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0005634; GO:0005815; GO:0006355; GO:0030154; GO:0043226; GO:0044782; GO:0048856,nucleus; microtubule organizing center; regulation of DNA-templated transcription; cell differentiation; organelle; cilium organization; anatomical structure development
OG_05305,2.660091825364097,FUN_023978-T1,Peve_00020874,Pocillopora_meandrina_HIv1___RNAseq.g19435.t1,three_way,47.72816666666667,,,,,,,,,,,,,,,,,
OG_05308,2.214187104546064,FUN_023982-T1,Peve_00020888,Pocillopora_meandrina_HIv1___RNAseq.g19411.t1,three_way,76.62366666666667,FUN_023982-T1,Q8N264,RHG24_HUMAN,,Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP),Homo sapiens (Human),47.5,341.0,3.3e-91,337.0,sp|Q8N264|RHG24_HUMAN Rho GTPase-activating protein 24 OS=Homo sapiens OX=9606 GN=ARHGAP24 PE=1 SV=2,GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:1900028,"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]",adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925],GTPase activator activity [GO:0005096],GO:0005856; GO:0030154; GO:0043226; GO:0048870; GO:0098772,cytoskeleton; cell differentiation; organelle; cell motility; molecular function regulator activity
OG_05311,1.050527296770041,FUN_023988-T1,Peve_00020894,Pocillopora_meandrina_HIv1___RNAseq.g19364.t1,three_way,63.86633333333334,,,,,,,,,,,,,,,,,
OG_05316,2.002010655512987,FUN_024001-T1,Peve_00034187,Pocillopora_meandrina_HIv1___RNAseq.g19350.t1,three_way,77.74116666666666,FUN_024001-T1,P15056,BRAF_HUMAN,,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),Homo sapiens (Human),47.0,743.0,1.8999999999999998e-173,610.9,sp|P15056|BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens OX=9606 GN=BRAF PE=1 SV=4,GO:0000165; GO:0002318; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006468; GO:0007173; GO:0008270; GO:0008542; GO:0009887; GO:0010628; GO:0010764; GO:0010828; GO:0016079; GO:0030878; GO:0033077; GO:0033138; GO:0034446; GO:0034451; GO:0035019; GO:0036064; GO:0042127; GO:0042802; GO:0043005; GO:0043066; GO:0043149; GO:0043231; GO:0043367; GO:0043369; GO:0043524; GO:0044297; GO:0045580; GO:0048538; GO:0048680; GO:0050772; GO:0050852; GO:0051496; GO:0060291; GO:0060323; GO:0060324; GO:0070371; GO:0070374; GO:0071277; GO:0071466; GO:0072577; GO:0090150; GO:0097110; GO:0098793; GO:0098794; GO:0098978; GO:0099170; GO:0106310; GO:1900026; GO:2000301; GO:2000352,"animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; visual learning [GO:0008542]",cell body [GO:0044297]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0007155; GO:0012501; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; cell adhesion; programmed cell death; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05317,1.181217500028027,FUN_024002-T1,Peve_00034192,Pocillopora_meandrina_HIv1___RNAseq.g19348.t1,three_way,47.63516666666667,FUN_024002-T1,A4D0V7,CPED1_HUMAN,,Cadherin-like and PC-esterase domain-containing protein 1,Homo sapiens (Human),33.3,771.0,3.9e-108,394.4,sp|A4D0V7|CPED1_HUMAN Cadherin-like and PC-esterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CPED1 PE=1 SV=1,GO:0005783,,endoplasmic reticulum [GO:0005783],,GO:0005783; GO:0043226,endoplasmic reticulum; organelle
OG_05320,1.4763497252697524,FUN_024005-T1,Peve_00040411,Pocillopora_meandrina_HIv1___RNAseq.g19345.t1,three_way,78.31733333333334,FUN_024005-T1,Q68EH9,CRBN_DANRE,,Protein cereblon (zcrbn),Danio rerio (Zebrafish) (Brachydanio rerio),48.4,382.0,3.4e-97,356.7,sp|Q68EH9|CRBN_DANRE Protein cereblon OS=Danio rerio OX=7955 GN=crbn PE=1 SV=1,GO:0000151; GO:0005634; GO:0005737; GO:0008283; GO:0016567; GO:0031464; GO:0033333; GO:0035118; GO:0043161; GO:0046872; GO:0060173; GO:0071599; GO:0071600,cell population proliferation [GO:0008283]; embryonic pectoral fin morphogenesis [GO:0035118]; fin development [GO:0033333]; limb development [GO:0060173]; otic vesicle development [GO:0071599]; otic vesicle morphogenesis [GO:0071600]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872],GO:0005634; GO:0030163; GO:0043226; GO:0048856,nucleus; protein catabolic process; organelle; anatomical structure development
OG_05322,1.6899993999701468,FUN_024011-T1,Peve_00040413,Pocillopora_meandrina_HIv1___RNAseq.g19343.t1,three_way,89.23066666666666,FUN_024011-T1,Q5ZMV7,,,,,70.6,313.0,3.3e-138,492.7,sp|Q5ZMV7|WDR82_CHICK WD repeat-containing protein 82 OS=Gallus gallus OX=9031 GN=WDR82 PE=2 SV=1,,,,,,
OG_05325,1.33841881824482,FUN_024017-T1,Peve_00023794,Pocillopora_meandrina_HIv1___RNAseq.g19284.t1,three_way,80.70366666666666,FUN_024017-T1,F6UA42,,,,,57.2,797.0,4.3e-248,859.0,sp|F6UA42|UHRF1_XENTR E3 ubiquitin-protein ligase UHRF1 OS=Xenopus tropicalis OX=8364 GN=uhrf1 PE=3 SV=2,,,,,,
OG_05329,1.7519077394994824,FUN_024032-T1,Peve_00020332,Pocillopora_meandrina_HIv1___RNAseq.g19275.t1,three_way,51.3095,FUN_024032-T1,Q6A548,TERT_CANLF,,Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit),Canis lupus familiaris (Dog) (Canis familiaris),32.1,831.0,2.7e-107,392.1,sp|Q6A548|TERT_CANLF Telomerase reverse transcriptase OS=Canis lupus familiaris OX=9615 GN=TERT PE=2 SV=1,GO:0000333; GO:0000781; GO:0003720; GO:0005697; GO:0005730; GO:0005737; GO:0007004; GO:0016605; GO:0042162; GO:0046872; GO:0070034,telomere maintenance via telomerase [GO:0007004],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; PML body [GO:0016605]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697]",metal ion binding [GO:0046872]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005730; GO:0016740; GO:0032200; GO:0043226; GO:0140097,"DNA binding; RNA binding; catalytic activity; nucleolus; transferase activity; telomere organization; organelle; catalytic activity, acting on DNA"
OG_05331,1.7054485603443867,FUN_024037-T1,Peve_00020333,Pocillopora_meandrina_HIv1___RNAseq.g19274.t1,three_way,74.21233333333333,FUN_024037-T1,O00462,MANBA_HUMAN,,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase),Homo sapiens (Human),47.2,885.0,1.1999999999999998e-243,844.3,sp|O00462|MANBA_HUMAN Beta-mannosidase OS=Homo sapiens OX=9606 GN=MANBA PE=1 SV=3,GO:0004567; GO:0005886; GO:0006516; GO:0009313; GO:0035577; GO:0036211; GO:0043202; GO:0043231,glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]; protein modification process [GO:0036211],azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886],beta-mannosidase activity [GO:0004567],GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_05332,2.263190300824869,FUN_024041-T2,Peve_00020339,Pocillopora_meandrina_HIv1___RNAseq.g19271.t1,three_way,87.892,FUN_024041-T2,P11024,NNTM_BOVIN,,"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)",Bos taurus (Bovine),63.4,1036.0,0.0,1258.0,"sp|P11024|NNTM_BOVIN NAD(P) transhydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=NNT PE=1 SV=3",GO:0005743; GO:0006740; GO:0008750; GO:0016491; GO:0050661; GO:0072593,NADPH regeneration [GO:0006740]; reactive oxygen species metabolic process [GO:0072593],mitochondrial inner membrane [GO:0005743],NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; proton-translocating NAD(P)+ transhydrogenase activity [GO:0008750],GO:0003824; GO:0005215; GO:0006091; GO:0016491; GO:0055086,catalytic activity; transporter activity; generation of precursor metabolites and energy; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_05334,2.078143648910361,FUN_024044-T4,Peve_00020349,Pocillopora_meandrina_HIv1___RNAseq.g19263.t1,three_way,44.71333333333334,,,,,,,,,,,,,,,,,
OG_05335,2.841086424226191,FUN_024047-T1,Peve_00020347,Pocillopora_meandrina_HIv1___RNAseq.g19265.t1,three_way,76.87566666666666,FUN_024047-T1,Q99MB5,,,,,60.5,124.0,1.3000000000000002e-44,180.6,sp|Q99MB5|LMO3_RAT LIM domain only protein 3 OS=Rattus norvegicus OX=10116 GN=Lmo3 PE=2 SV=2,,,,,,
OG_05336,1.281941620751502,FUN_024051-T1,Peve_00020343,Pocillopora_meandrina_HIv1___RNAseq.g19268.t1a,three_way,33.204166666666666,,,,,,,,,,,,,,,,,
OG_05340,1.1564019235361815,FUN_024063-T1,Peve_00000155,Pocillopora_meandrina_HIv1___RNAseq.g19256.t1,three_way,75.40483333333333,FUN_024063-T1,Q9P241,AT10D_HUMAN,,Phospholipid-transporting ATPase VD (EC 7.6.2.1) (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D),Homo sapiens (Human),43.6,1316.0,3.3999999999999998e-279,963.0,sp|Q9P241|AT10D_HUMAN Phospholipid-transporting ATPase VD OS=Homo sapiens OX=9606 GN=ATP10D PE=1 SV=3,GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0016020; GO:0016887; GO:0034220; GO:0045332; GO:0140326; GO:0140351; GO:1990531,monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287],GO:0003824; GO:0005215; GO:0005654; GO:0005783; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleoplasm; endoplasmic reticulum; plasma membrane; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
OG_05342,2.17876396226128,FUN_024071-T1,Peve_00014630,Pocillopora_meandrina_HIv1___RNAseq.23622_t,three_way,47.72133333333333,,,,,,,,,,,,,,,,,
OG_05343,1.201745119613199,FUN_024074-T1,Peve_00000137,Pocillopora_meandrina_HIv1___RNAseq.g19216.t1,three_way,88.08233333333334,FUN_024074-T1,Q3UGF1,,,,,63.3,1342.0,0.0,1771.9,sp|Q3UGF1|WDR19_MOUSE WD repeat-containing protein 19 OS=Mus musculus OX=10090 GN=Wdr19 PE=1 SV=1,,,,,,
OG_05346,1.158890944537844,FUN_024106-T1,Peve_00000192,Pocillopora_meandrina_HIv1___RNAseq.g19200.t1,three_way,44.25,,,,,,,,,,,,,,,,,
OG_05350,3.200714149320379,FUN_024113-T1,Peve_00000184,Pocillopora_meandrina_HIv1___RNAseq.g19187.t1,three_way,78.90166666666667,FUN_024113-T1,Q9UI95,MD2L2_HUMAN,,Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2) (REV7 homolog) (hREV7),Homo sapiens (Human),55.6,160.0,4.5e-44,179.1,sp|Q9UI95|MD2L2_HUMAN Mitotic spindle assembly checkpoint protein MAD2B OS=Homo sapiens OX=9606 GN=MAD2L2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0001558; GO:0002208; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0006302; GO:0007015; GO:0007094; GO:0008432; GO:0010719; GO:0010944; GO:0016035; GO:0033138; GO:0035861; GO:0042177; GO:0042276; GO:0042772; GO:0043247; GO:0045830; GO:0045893; GO:0051301; GO:0061629; GO:0090090; GO:1904667; GO:2000042; GO:2000048; GO:2001034,"actin filament organization [GO:0007015]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; error-prone translesion synthesis [GO:0042276]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell growth [GO:0001558]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247]",chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035],JUN kinase binding [GO:0008432]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006355; GO:0032200; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; nucleoplasm; chromosome; DNA repair; regulation of DNA-templated transcription; telomere organization; organelle; molecular adaptor activity; transcription regulator activity
OG_05355,1.0803030647464005,FUN_024127-T1,Peve_00000138,Pocillopora_meandrina_HIv1___RNAseq.g19898.t1,three_way,68.97566666666667,FUN_024127-T1,Q8N5I4,DHRSX_HUMAN,,Polyprenol dehydrogenase (EC 1.1.1.441) (DHRSXY) (Dehydrogenase/reductase SDR family member on chromosome X) (Dolichal reductase),Homo sapiens (Human),44.9,321.0,1.2000000000000001e-74,281.6,sp|Q8N5I4|DHRSX_HUMAN Polyprenol dehydrogenase OS=Homo sapiens OX=9606 GN=DHRSX PE=1 SV=2,GO:0005576; GO:0005811; GO:0010508; GO:0019408; GO:0160196; GO:0160197,dolichol biosynthetic process [GO:0019408]; positive regulation of autophagy [GO:0010508],extracellular region [GO:0005576]; lipid droplet [GO:0005811],dolichal reductase [NAD(P)+] activity [GO:0160197]; polyprenol dehydrogenase activity [GO:0160196],GO:0003824; GO:0005576; GO:0005811; GO:0016491; GO:0043226,catalytic activity; extracellular region; lipid droplet; oxidoreductase activity; organelle
OG_05362,1.6635438977133954,FUN_024140-T1,Peve_00036827,Pocillopora_meandrina_HIv1___RNAseq.g19870.t1,three_way,70.87366666666667,FUN_024140-T1,Q96IZ5,,,,,33.3,381.0,5.6e-48,193.4,sp|Q96IZ5|RBM41_HUMAN RNA-binding protein 41 OS=Homo sapiens OX=9606 GN=RBM41 PE=1 SV=2,,,,,,
OG_05373,1.1055580122298834,FUN_024176-T1,Peve_00005152,Pocillopora_meandrina_HIv1___RNAseq.g18889.t1,three_way,53.38816666666667,FUN_024176-T1,P62597,,,,,25.5,368.0,7.5e-19,97.1,sp|P62597|POTE1_CHICK Protection of telomeres protein 1 OS=Gallus gallus OX=9031 GN=POT1 PE=1 SV=1,,,,,,
OG_05378,2.0337745716096127,FUN_024195-T1,Peve_00018698,Pocillopora_meandrina_HIv1___RNAseq.g18880.t1,three_way,77.08933333333333,FUN_024195-T1,Q96NL6,SCLT1_HUMAN,,Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1),Homo sapiens (Human),27.6,613.0,2.3999999999999998e-54,215.3,sp|Q96NL6|SCLT1_HUMAN Sodium channel and clathrin linker 1 OS=Homo sapiens OX=9606 GN=SCLT1 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005829; GO:0015630; GO:0017080; GO:0030276; GO:0036064; GO:0045162; GO:0060271; GO:0071439; GO:0097539,cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630],clathrin binding [GO:0030276]; sodium channel regulator activity [GO:0017080],GO:0005815; GO:0005829; GO:0005856; GO:0043226; GO:0044782; GO:0061024; GO:0098772,microtubule organizing center; cytosol; cytoskeleton; organelle; cilium organization; membrane organization; molecular function regulator activity
OG_05380,1.4129133174431456,FUN_024197-T1,Peve_00025330,Pocillopora_meandrina_HIv1___RNAseq.g3316.t1,three_way,57.18566666666667,FUN_024197-T1,Q6PBQ2,,,,,33.5,388.0,6.1e-54,213.4,sp|Q6PBQ2|CHMP7_DANRE Charged multivesicular body protein 7 OS=Danio rerio OX=7955 GN=chmp7 PE=2 SV=1,,,,,,
OG_05384,2.606215167274484,FUN_024201-T1,Peve_00031885,Pocillopora_meandrina_HIv1___RNAseq.g18895.t1,three_way,52.33616666666667,FUN_024201-T1,Q5RG49,,,,,28.2,1294.0,6.1e-121,437.2,sp|Q5RG49|ACSF4_DANRE Beta-alanine-activating enzyme OS=Danio rerio OX=7955 GN=aasdh PE=3 SV=1,,,,,,
OG_05388,1.4181622782208834,FUN_024214-T1,Peve_00031909,Pocillopora_meandrina_HIv1___RNAseq.g18908.t1,three_way,69.09233333333334,,,,,,,,,,,,,,,,,
OG_05397,2.3121999253820062,FUN_024224-T1,Peve_00031887,Pocillopora_meandrina_HIv1___TS.g28304.t1,three_way,65.771,FUN_024224-T1,O60343,TBCD4_HUMAN,,TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160),Homo sapiens (Human),33.6,1274.0,8.199999999999999e-148,526.6,sp|O60343|TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens OX=9606 GN=TBC1D4 PE=1 SV=2,GO:0005096; GO:0005794; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869,cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],GTPase activator activity [GO:0005096],GO:0005794; GO:0005829; GO:0016192; GO:0043226; GO:0098772,Golgi apparatus; cytosol; vesicle-mediated transport; organelle; molecular function regulator activity
OG_05398,1.7388813178197695,FUN_024327-T2,Peve_00016300,Pocillopora_meandrina_HIv1___RNAseq.g18921.t1,three_way,43.888,FUN_024327-T2,O60494,CUBN_HUMAN,,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Homo sapiens (Human),38.0,108.0,1.7e-11,71.6,sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5,GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_05399,2.352877389042982,FUN_024328-T1,Peve_00016318,Pocillopora_meandrina_HIv1___RNAseq.g18924.t1,three_way,71.84100000000001,FUN_024328-T1,Q21565,,,,,49.4,419.0,7.6e-111,402.5,sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2,,,,,,
OG_05400,5.572545677756982,FUN_024330-T1,Peve_00016319,Pocillopora_meandrina_HIv1___RNAseq.g18926.t1,three_way,76.277,FUN_024330-T1,O89023,TPP1_MOUSE,,Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I),Mus musculus (Mouse),50.2,562.0,2.3e-155,550.4,sp|O89023|TPP1_MOUSE Tripeptidyl-peptidase 1 OS=Mus musculus OX=10090 GN=Tpp1 PE=1 SV=2,GO:0004175; GO:0004252; GO:0005739; GO:0005764; GO:0005794; GO:0006508; GO:0007040; GO:0007399; GO:0008233; GO:0008236; GO:0008240; GO:0030855; GO:0035727; GO:0042470; GO:0043171; GO:0045121; GO:0045453; GO:0046872; GO:0050885; GO:0055037; GO:0070198; GO:0120146; GO:1905146,"bone resorption [GO:0045453]; epithelial cell differentiation [GO:0030855]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]",Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; recycling endosome [GO:0055037],endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240],GO:0003824; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0007040; GO:0008289; GO:0016787; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; mitochondrion; lysosome; endosome; vacuole; Golgi apparatus; lysosome organization; lipid binding; hydrolase activity; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05401,1.433127893947237,FUN_024332-T1,Peve_00016315,Pocillopora_meandrina_HIv1___RNAseq.g18928.t1,three_way,91.02566666666668,FUN_024332-T1,A7S3J7,,,,,82.1,263.0,2.4e-123,443.0,sp|A7S3J7|RS3A_NEMVE Small ribosomal subunit protein eS1 OS=Nematostella vectensis OX=45351 GN=v1g242621 PE=3 SV=1,,,,,,
OG_05402,1.997804356041732,FUN_024333-T1,Peve_00016310,Pocillopora_meandrina_HIv1___RNAseq.g18942.t1,three_way,73.826,FUN_024333-T1,Q8BFR4,,,,,53.1,490.0,1.6e-153,544.3,sp|Q8BFR4|GNS_MOUSE N-acetylglucosamine-6-sulfatase OS=Mus musculus OX=10090 GN=Gns PE=1 SV=1,,,,,,
OG_05407,2.2740378995490858,FUN_024339-T1,Peve_00016804,Pocillopora_meandrina_HIv1___RNAseq.g18936.t1,three_way,66.383,FUN_024339-T1,Q96H96,COQ2_HUMAN,,"4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase)",Homo sapiens (Human),66.2,305.0,3.4e-116,419.9,"sp|Q96H96|COQ2_HUMAN 4-hydroxybenzoate polyprenyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=COQ2 PE=1 SV=2",GO:0004659; GO:0005739; GO:0005743; GO:0006071; GO:0006744; GO:0008299; GO:0008412; GO:0031314,glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],4-hydroxybenzoate polyprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659],GO:0003824; GO:0005739; GO:0005975; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lipid metabolic process; transferase activity; organelle
OG_05410,1.6728181911412292,FUN_024344-T1,Peve_00016805,Pocillopora_meandrina_HIv1___RNAseq.g18930.t1,three_way,83.4915,FUN_024344-T1,F1QN74,,,,,50.1,435.0,4.5e-125,449.5,sp|F1QN74|ZMY10_DANRE Zinc finger MYND domain-containing protein 10 OS=Danio rerio OX=7955 GN=zmynd10 PE=2 SV=1,,,,,,
OG_05411,1.861394728130653,FUN_024348-T1,Peve_00021946,Pocillopora_meandrina_HIv1___RNAseq.g18670.t1,three_way,69.60533333333333,FUN_024348-T1,A9LIW2,,,,,30.1,615.0,8.1e-64,246.5,sp|A9LIW2|CSC1L_BRAJU CSC1-like protein ERD4 OS=Brassica juncea OX=3707 GN=ERD4 PE=3 SV=2,,,,,,
OG_05414,1.3708731142617565,FUN_024351-T1,Peve_00024494,Pocillopora_meandrina_HIv1___RNAseq.g18673.t1,three_way,45.65566666666666,,,,,,,,,,,,,,,,,
OG_05415,1.3953158181657352,FUN_024353-T1,Peve_00024188,Pocillopora_meandrina_HIv1___RNAseq.g18689.t1,three_way,83.83233333333334,FUN_024353-T1,A6NFE3,,,,,36.8,117.0,2.2e-15,83.2,sp|A6NFE3|EFC10_HUMAN EF-hand calcium-binding domain-containing protein 10 OS=Homo sapiens OX=9606 GN=EFCAB10 PE=1 SV=2,,,,,,
OG_05416,2.2956132749817595,FUN_024354-T1,Peve_00024185,Pocillopora_meandrina_HIv1___RNAseq.g18690.t1,three_way,66.696,FUN_024354-T1,Q5I0M0,SETMR_RAT,,Histone-lysine N-methyltransferase SETMAR (EC 2.1.1.357) (SET domain and mariner transposase fusion protein homolog),Rattus norvegicus (Rat),46.7,289.0,3.1000000000000003e-66,253.4,sp|Q5I0M0|SETMR_RAT Histone-lysine N-methyltransferase SETMAR OS=Rattus norvegicus OX=10116 GN=Setmar PE=2 SV=1,GO:0000014; GO:0000729; GO:0000793; GO:0003677; GO:0003690; GO:0003697; GO:0004519; GO:0005634; GO:0006303; GO:0006308; GO:0008270; GO:0008283; GO:0015074; GO:0031297; GO:0032259; GO:0035861; GO:0042054; GO:0042800; GO:0042803; GO:0044547; GO:0044774; GO:0045814; GO:0045892; GO:0046975; GO:0140954; GO:2001034; GO:2001251,"cell population proliferation [GO:0008283]; DNA catabolic process [GO:0006308]; DNA double-strand break processing [GO:0000729]; DNA integration [GO:0015074]; double-strand break repair via nonhomologous end joining [GO:0006303]; methylation [GO:0032259]; mitotic DNA integrity checkpoint signaling [GO:0044774]; negative regulation of chromosome organization [GO:2001251]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; replication fork processing [GO:0031297]",condensed chromosome [GO:0000793]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 methyltransferase activity [GO:0042800]; histone methyltransferase activity [GO:0042054]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0043226; GO:0140096; GO:0140097,"DNA binding; catalytic activity; nucleus; chromosome; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_05420,1.3415386172143404,FUN_024365-T1,Peve_00034596,Pocillopora_meandrina_HIv1___RNAseq.g15262.t1,three_way,59.11716666666667,,,,,,,,,,,,,,,,,
OG_05422,1.6584876161551174,FUN_024367-T1,Peve_00003572,Pocillopora_meandrina_HIv1___RNAseq.g18652.t1,three_way,79.83883333333333,FUN_024367-T1,Q8BM85,,,,,51.3,905.0,2.2e-245,850.1,sp|Q8BM85|TBCK_MOUSE TBC domain-containing protein kinase-like protein OS=Mus musculus OX=10090 GN=Tbck PE=1 SV=2,,,,,,
OG_05423,1.2161229300778051,FUN_024368-T1,Peve_00003573,Pocillopora_meandrina_HIv1___RNAseq.g19083.t1,three_way,88.05250000000001,FUN_024368-T1,Q9Y496,KIF3A_HUMAN,,Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A),Homo sapiens (Human),71.0,648.0,6.800000000000001e-216,751.9,sp|Q9Y496|KIF3A_HUMAN Kinesin-like protein KIF3A OS=Homo sapiens OX=9606 GN=KIF3A PE=1 SV=4,GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0006996; GO:0008017; GO:0008089; GO:0008574; GO:0010457; GO:0015031; GO:0015630; GO:0016887; GO:0016939; GO:0019903; GO:0030507; GO:0031267; GO:0034454; GO:0060271; GO:0070062; GO:0072383; GO:0097542; GO:1902414; GO:1904115,anterograde axonal transport [GO:0008089]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031],axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein phosphatase binding [GO:0019903]; small GTPase binding [GO:0031267]; spectrin binding [GO:0030507],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_05425,1.438057595954612,FUN_024370-T1,Peve_00003575,Pocillopora_meandrina_HIv1___RNAseq.g19085.t1,three_way,79.644,FUN_024370-T1,Q02040,AK17A_HUMAN,,"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)",Homo sapiens (Human),58.5,275.0,1.9e-87,324.7,sp|Q02040|AK17A_HUMAN A-kinase anchor protein 17A OS=Homo sapiens OX=9606 GN=AKAP17A PE=1 SV=2,GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018,B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; signal transduction [GO:0007165],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],protein kinase A binding [GO:0051018]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0043226,immune system process; RNA binding; nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_05428,1.2409716125092127,FUN_024373-T1,Peve_00020237,Pocillopora_meandrina_HIv1___RNAseq.g18595.t1,three_way,71.70833333333333,FUN_024373-T1,A0JMY5,,,,,42.7,560.0,4.7999999999999995e-92,340.1,sp|A0JMY5|NFXL1_XENLA NF-X1-type zinc finger protein NFXL1 OS=Xenopus laevis OX=8355 GN=nfxl1 PE=2 SV=1,,,,,,
OG_05429,1.2551588063267236,FUN_024375-T1,Peve_00020238,Pocillopora_meandrina_HIv1___RNAseq.g18600.t1,three_way,67.935,,,,,,,,,,,,,,,,,
OG_05432,1.2764884628127695,FUN_024378-T1,Peve_00020233,Pocillopora_meandrina_HIv1___RNAseq.g18603.t1,three_way,84.493,FUN_024378-T1,P94598,,,,,60.0,440.0,7.3e-161,568.5,sp|P94598|DHE3_BACTN Glutamate dehydrogenase OS=Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50) OX=226186 GN=gdhA PE=3 SV=2,,,,,,
OG_05433,1.1004606774383936,FUN_024382-T1,Peve_00021903,Pocillopora_meandrina_HIv1___RNAseq.g18604.t1,three_way,82.13216666666666,FUN_024382-T1,Q5E9N5,CLPB_BOVIN,,"Mitochondrial disaggregase (EC 3.6.1.-) (Suppressor of potassium transport defect 3) [Cleaved into: Mitochondrial disaggregase, cleaved form]",Bos taurus (Bovine),57.9,534.0,1.3e-179,630.9,sp|Q5E9N5|CLPB_BOVIN Mitochondrial disaggregase OS=Bos taurus OX=9913 GN=CLPB PE=2 SV=1,GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0016887; GO:0034605,cellular response to heat [GO:0034605],cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005739; GO:0016787; GO:0043226,catalytic activity; mitochondrion; hydrolase activity; organelle
OG_05436,4.303823710659944,FUN_024389-T1,Peve_00018044,Pocillopora_meandrina_HIv1___RNAseq.g18620.t1,three_way,74.58266666666667,FUN_024389-T1,O70433,,,,,39.0,269.0,1.3e-68,262.3,sp|O70433|FHL2_MOUSE Four and a half LIM domains protein 2 OS=Mus musculus OX=10090 GN=Fhl2 PE=1 SV=1,,,,,,
OG_05437,4.255529135317211,FUN_024390-T2,Peve_00018042,Pocillopora_meandrina_HIv1___RNAseq.g18621.t1,three_way,74.62266666666667,FUN_024390-T2,Q80VL3,,,,,50.8,413.0,3e-126,454.1,sp|Q80VL3|PRIC3_MOUSE Prickle planar cell polarity protein 3 OS=Mus musculus OX=10090 GN=Prickle3 PE=1 SV=1,,,,,,
OG_05441,1.138700910923453,FUN_024394-T1,Peve_00005019,Pocillopora_meandrina_HIv1___RNAseq.g18627.t1,three_way,70.47866666666667,FUN_024394-T1,Q8UW76,TBX20_CHICK,,T-box transcription factor TBX20 (T-box protein 20) (cTbx20),Gallus gallus (Chicken),48.6,294.0,3.4e-67,256.9,sp|Q8UW76|TBX20_CHICK T-box transcription factor TBX20 OS=Gallus gallus OX=9031 GN=TBX20 PE=2 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001569; GO:0001708; GO:0001947; GO:0003148; GO:0003175; GO:0003180; GO:0003193; GO:0003207; GO:0003215; GO:0003272; GO:0003344; GO:0005634; GO:0005737; GO:0006357; GO:0006936; GO:0008015; GO:0009953; GO:0010628; GO:0010629; GO:0010718; GO:0014031; GO:0021524; GO:0030335; GO:0030513; GO:0035922; GO:0036302; GO:0036306; GO:0055008; GO:0060045; GO:0060392; GO:0060413; GO:0060577; GO:0060973; GO:0061629; GO:0097475; GO:2000793,aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; mesenchymal cell development [GO:0014031]; motor neuron migration [GO:0097475]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; regulation of transcription by RNA polymerase II [GO:0006357]; tricuspid valve development [GO:0003175]; visceral motor neuron differentiation [GO:0021524],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003013; GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; circulatory system process; DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_05442,4.234947576717819,FUN_024395-T1,Peve_00005021,Pocillopora_meandrina_HIv1___RNAseq.g18630.t1,three_way,66.315,FUN_024395-T1,P57102,HAND2_DANRE,,"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)",Danio rerio (Zebrafish) (Brachydanio rerio),43.6,140.0,1.8e-16,87.4,sp|P57102|HAND2_DANRE Heart- and neural crest derivatives-expressed protein 2 OS=Danio rerio OX=7955 GN=hand2 PE=2 SV=1,GO:0000977; GO:0000981; GO:0001947; GO:0003007; GO:0003142; GO:0003144; GO:0003342; GO:0003357; GO:0005634; GO:0006357; GO:0007507; GO:0010002; GO:0030859; GO:0030878; GO:0035051; GO:0035118; GO:0046983; GO:0048485; GO:0048703; GO:0055007; GO:0060047; GO:0071908; GO:0072015,cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; podocyte development [GO:0072015]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription by RNA polymerase II [GO:0006357]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003013; GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,circulatory system process; DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05443,3.802235820780109,FUN_024398-T2,Peve_00021812,Pocillopora_meandrina_HIv1___RNAseq.g18631.t1,three_way,82.838,FUN_024398-T2,Q66GS9,CP135_HUMAN,,Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4),Homo sapiens (Human),37.8,566.0,6.9e-91,337.4,sp|Q66GS9|CP135_HUMAN Centrosomal protein of 135 kDa OS=Homo sapiens OX=9606 GN=CEP135 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008017; GO:0010457; GO:0015631; GO:0042802; GO:0042803; GO:1902857; GO:1904951,centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829],identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631],GO:0005815; GO:0005829; GO:0008092; GO:0043226,microtubule organizing center; cytosol; cytoskeletal protein binding; organelle
OG_05444,2.258770876275303,FUN_024399-T1,Peve_00021813,Pocillopora_meandrina_HIv1___RNAseq.g18632.t1,three_way,82.354,FUN_024399-T1,Q9QZN3,,,,,52.8,267.0,1.5e-81,304.3,sp|Q9QZN3|FBX8_MOUSE F-box only protein 8 OS=Mus musculus OX=10090 GN=Fbxo8 PE=2 SV=2,,,,,,
OG_05445,4.572233486494011,FUN_024401-T1,Peve_00033232,Pocillopora_meandrina_HIv1___RNAseq.g18633.t1,three_way,75.52233333333334,FUN_024401-T1,P20595,GCYB1_RAT,,Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit),Rattus norvegicus (Rat),46.0,620.0,2.1e-138,494.6,sp|P20595|GCYB1_RAT Guanylate cyclase soluble subunit beta-1 OS=Rattus norvegicus OX=10116 GN=Gucy1b1 PE=1 SV=2,GO:0004383; GO:0005525; GO:0005829; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0032991; GO:0038060; GO:0044877; GO:0046872; GO:0051879; GO:0070026; GO:0070482; GO:0071732; GO:0098831; GO:0098978,cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482],"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone cytoplasmic component [GO:0098831]; protein-containing complex [GO:0032991]",GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005829; GO:0009975; GO:0016829; GO:0055086; GO:1901135,catalytic activity; cytosol; cyclase activity; lyase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05446,4.495645350505545,FUN_024402-T1,Peve_00007147,Pocillopora_meandrina_HIv1___RNAseq.g18634.t1,three_way,78.25166666666667,FUN_024402-T1,O54865,,,,,51.5,532.0,1.4e-146,521.2,sp|O54865|GCYB1_MOUSE Guanylate cyclase soluble subunit beta-1 OS=Mus musculus OX=10090 GN=Gucy1b1 PE=1 SV=1,,,,,,
OG_05453,1.7875592908925906,FUN_024411-T1,Peve_00011775,Pocillopora_meandrina_HIv1___RNAseq.g18636.t1,three_way,77.30883333333334,FUN_024411-T1,Q7T163,KDISB_DANRE,,Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B),Danio rerio (Zebrafish) (Brachydanio rerio),35.3,893.0,4.3999999999999996e-141,504.6,sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3,GO:0005770; GO:0007399; GO:0019887; GO:0030165; GO:0031902; GO:0038180,nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399],late endosome [GO:0005770]; late endosome membrane [GO:0031902],PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887],GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0098772,endosome; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_05454,1.328283447241192,FUN_024412-T1,Peve_00007146,Pocillopora_meandrina_HIv1___RNAseq.g18635.t1,three_way,68.411,FUN_024412-T1,Q6ZQ58,,,,,38.2,878.0,1.9e-105,385.6,sp|Q6ZQ58|LARP1_MOUSE La-related protein 1 OS=Mus musculus OX=10090 GN=Larp1 PE=1 SV=3,,,,,,
OG_05460,1.127407340660255,FUN_024439-T1,Peve_00004162,Pocillopora_meandrina_HIv1___RNAseq.g18714.t1,three_way,80.35366666666667,FUN_024439-T1,Q9Z206,ARHG8_MOUSE,,Neuroepithelial cell-transforming gene 1 protein (Rho guanine nucleotide exchange factor 8),Mus musculus (Mouse),45.5,444.0,1.8000000000000002e-104,381.3,sp|Q9Z206|ARHG8_MOUSE Neuroepithelial cell-transforming gene 1 protein OS=Mus musculus OX=10090 GN=Net1 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005737; GO:0005886; GO:0031267; GO:0035556; GO:0043065; GO:0043547; GO:0051451; GO:0070301; GO:0071479; GO:1900026,cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005634; GO:0005886; GO:0043226; GO:0048870; GO:0098772,nucleus; plasma membrane; organelle; cell motility; molecular function regulator activity
OG_05461,1.3312990126284308,FUN_024444-T1,Peve_00025480,Pocillopora_meandrina_HIv1___RNAseq.g18709.t1,three_way,69.896,FUN_024444-T1,Q08BL7,,,,,41.6,507.0,2e-95,351.3,sp|Q08BL7|GLCTK_DANRE Glycerate kinase OS=Danio rerio OX=7955 GN=glyctk PE=2 SV=1,,,,,,
OG_05462,2.9050761063584134,FUN_024445-T1,Peve_00025478,Pocillopora_meandrina_HIv1___RNAseq.g18708.t1,three_way,87.55799999999999,FUN_024445-T1,Q14643,,,,,59.9,2841.0,0.0,3137.1,"sp|Q14643|ITPR1_HUMAN Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1 OS=Homo sapiens OX=9606 GN=ITPR1 PE=1 SV=3",,,,,,
OG_05464,1.015754642095639,FUN_024447-T1,Peve_00025475,Pocillopora_meandrina_HIv1___TS.g28098.t1,three_way,82.643,FUN_024447-T1,Q9CQ79,,,,,47.0,202.0,9.5e-52,204.9,sp|Q9CQ79|TXND9_MOUSE Thioredoxin domain-containing protein 9 OS=Mus musculus OX=10090 GN=Txndc9 PE=1 SV=1,,,,,,
OG_05465,3.378495666775186,FUN_024448-T1,Peve_00025474,Pocillopora_meandrina_HIv1___RNAseq.g18705.t1,three_way,56.5495,FUN_024448-T1,Q96RY5,,,,,49.1,228.0,3.2e-52,208.8,sp|Q96RY5|CRML_HUMAN Protein cramped-like OS=Homo sapiens OX=9606 GN=CRAMP1 PE=1 SV=3,,,,,,
OG_05468,2.065545424435939,FUN_024451-T1,Peve_00003482,Pocillopora_meandrina_HIv1___RNAseq.g18852.t1,three_way,84.42533333333333,FUN_024451-T1,Q6P5I8,,,,,47.8,228.0,1.8e-45,184.1,sp|Q6P5I8|YIPF5_DANRE Protein YIPF5 OS=Danio rerio OX=7955 GN=yipf5 PE=2 SV=1,,,,,,
OG_05473,4.317078722838095,FUN_024456-T1,Peve_00010312,Pocillopora_meandrina_HIv1___RNAseq.g18574.t1,three_way,77.98883333333333,FUN_024456-T1,A7S6A1,,,,,59.2,903.0,2.2000000000000002e-272,939.9,sp|A7S6A1|U518_NEMVE FHIP family protein v1g243165 OS=Nematostella vectensis OX=45351 GN=v1g243165 PE=3 SV=1,,,,,,
OG_05475,2.1005122779564123,FUN_024460-T1,Peve_00032923,Pocillopora_meandrina_HIv1___RNAseq.g14859.t1,three_way,88.63699999999999,FUN_024460-T1,Q2M389,WASC4_HUMAN,,WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP),Homo sapiens (Human),64.5,920.0,0.0,1206.8,sp|Q2M389|WASC4_HUMAN WASH complex subunit 4 OS=Homo sapiens OX=9606 GN=WASHC4 PE=1 SV=2,GO:0005654; GO:0005768; GO:0007032; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0050890; GO:0050905; GO:0061635; GO:0071203; GO:0140591; GO:0140894,cognition [GO:0050890]; endolysosomal toll-like receptor signaling pathway [GO:0140894]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; neuromuscular process [GO:0050905]; nuclear envelope budding [GO:0140591]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of protein complex stability [GO:0061635],early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203],,GO:0002376; GO:0005654; GO:0005768; GO:0006913; GO:0016192; GO:0031410; GO:0043226; GO:0050877,immune system process; nucleoplasm; endosome; nucleocytoplasmic transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; nervous system process
OG_05476,2.7967553425104352,FUN_024466-T1,Peve_00026420,Pocillopora_meandrina_HIv1___RNAseq.g18562.t1,three_way,72.03833333333334,FUN_024466-T1,J7GQ11,,,,,35.2,495.0,1e-70,270.0,sp|J7GQ11|TYRDC_LEVBR L-tyrosine decarboxylase OS=Levilactobacillus brevis OX=1580 GN=tdc PE=1 SV=1,,,,,,
OG_05477,1.2495192369322838,FUN_024467-T1,Peve_00026395,Pocillopora_meandrina_HIv1___RNAseq.g18560.t1,three_way,49.363166666666665,,,,,,,,,,,,,,,,,
OG_05479,2.297810885645508,FUN_024473-T1,Peve_00002830,Pocillopora_meandrina_HIv1___RNAseq.g18567.t1,three_way,52.34666666666666,FUN_024473-T1,P97460,NPAS2_MOUSE,,Neuronal PAS domain-containing protein 2 (Neuronal PAS2),Mus musculus (Mouse),34.6,413.0,1.1999999999999999e-46,190.7,sp|P97460|NPAS2_MOUSE Neuronal PAS domain-containing protein 2 OS=Mus musculus OX=10090 GN=Npas2 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006974; GO:0007623; GO:0009410; GO:0032922; GO:0042745; GO:0042752; GO:0045475; GO:0045739; GO:0045893; GO:0045944; GO:0046872; GO:0046983; GO:0051775; GO:2000987,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; DNA damage response [GO:0006974]; locomotor rhythm [GO:0045475]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; response to redox state [GO:0051775]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_05484,1.2442527635435834,FUN_024481-T1,Peve_00016898,Pocillopora_meandrina_HIv1___RNAseq.g19066.t2,three_way,65.00099999999999,FUN_024481-T1,Q92870,APBB2_HUMAN,,Amyloid beta precursor protein binding family B member 2 (Amyloid-beta (A4) precursor protein-binding family B member 2) (Protein Fe65-like 1),Homo sapiens (Human),36.6,331.0,3.8e-55,218.8,sp|Q92870|APBB2_HUMAN Amyloid beta precursor protein binding family B member 2 OS=Homo sapiens OX=9606 GN=APBB2 PE=1 SV=3,GO:0000122; GO:0001540; GO:0001764; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0006355; GO:0006939; GO:0007411; GO:0016020; GO:0030027; GO:0030198; GO:0030426; GO:0035556; GO:0036438; GO:0043065; GO:0043066; GO:0045202; GO:0045944; GO:0050808; GO:0060090; GO:1901988,axon guidance [GO:0007411]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; maintenance of lens transparency [GO:0036438]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle phase transition [GO:1901988]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; smooth muscle contraction [GO:0006939]; synapse organization [GO:0050808],cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202],amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090],GO:0003012; GO:0005634; GO:0005768; GO:0005783; GO:0005794; GO:0006355; GO:0030198; GO:0031410; GO:0034330; GO:0043226; GO:0048870; GO:0060090,muscle system process; nucleus; endosome; endoplasmic reticulum; Golgi apparatus; regulation of DNA-templated transcription; extracellular matrix organization; cytoplasmic vesicle; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_05485,3.1662533324654083,FUN_024482-T1,Peve_00010582,Pocillopora_meandrina_HIv1___RNAseq.g19067.t1,three_way,60.68966666666667,,,,,,,,,,,,,,,,,
OG_05488,1.7680610823110003,FUN_024485-T1,Peve_00010581,Pocillopora_meandrina_HIv1___RNAseq.g19070.t1,three_way,78.75466666666667,,,,,,,,,,,,,,,,,
OG_05492,1.2526040281802393,FUN_024524-T1,Peve_00034558,Pocillopora_meandrina_HIv1___RNAseq.g18542.t1,three_way,74.3655,FUN_024524-T1,Q96PY6,NEK1_HUMAN,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55),Homo sapiens (Human),32.6,1424.0,3.4000000000000003e-128,461.5,sp|Q96PY6|NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens OX=9606 GN=NEK1 PE=1 SV=2,GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310,cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_05493,1.7646520376713926,FUN_024525-T1,Peve_00015355,Pocillopora_meandrina_HIv1___RNAseq.g18543.t1,three_way,64.36533333333333,FUN_024525-T1,Q08DR9,SPDLY_BOVIN,,Protein Spindly (Coiled-coil domain-containing protein 99) (Spindle apparatus coiled-coil domain-containing protein 1),Bos taurus (Bovine),30.0,227.0,5e-19,97.8,sp|Q08DR9|SPDLY_BOVIN Protein Spindly OS=Bos taurus OX=9913 GN=SPDL1 PE=2 SV=1,GO:0000132; GO:0000922; GO:0000940; GO:0005634; GO:0005737; GO:0005813; GO:0007080; GO:0007094; GO:0016477; GO:0034501; GO:0043515; GO:0051301,cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922],kinetochore binding [GO:0043515],GO:0005634; GO:0005815; GO:0007010; GO:0043226; GO:0048870,nucleus; microtubule organizing center; cytoskeleton organization; organelle; cell motility
OG_05503,2.278846829622131,FUN_024567-T1,Peve_00036070,Pocillopora_meandrina_HIv1___RNAseq.g19088.t1,three_way,78.1325,FUN_024567-T1,Q8WXW3,PIBF1_HUMAN,,Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90),Homo sapiens (Human),39.1,713.0,3.8000000000000003e-119,430.6,sp|Q8WXW3|PIBF1_HUMAN Progesterone-induced-blocking factor 1 OS=Homo sapiens OX=9606 GN=PIBF1 PE=1 SV=2,GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0036064; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515,activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],interleukin-4 receptor binding [GO:0005136],GO:0002376; GO:0005615; GO:0005634; GO:0005815; GO:0007010; GO:0043226; GO:0044782,immune system process; extracellular space; nucleus; microtubule organizing center; cytoskeleton organization; organelle; cilium organization
OG_05504,1.2568529964513386,FUN_024574-T1,Peve_00026364,Pocillopora_meandrina_HIv1___RNAseq.g23152.t1,three_way,48.51866666666667,,,,,,,,,,,,,,,,,
OG_05507,1.1942924079222823,FUN_024588-T1,Peve_00007644,Pocillopora_meandrina_HIv1___RNAseq.g19109.t1,three_way,76.148,FUN_024588-T1,P42785,PCP_HUMAN,,Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP),Homo sapiens (Human),59.5,444.0,2.2e-157,557.0,sp|P42785|PCP_HUMAN Lysosomal Pro-X carboxypeptidase OS=Homo sapiens OX=9606 GN=PRCP PE=1 SV=1,GO:0002003; GO:0002155; GO:0002353; GO:0003085; GO:0004181; GO:0004185; GO:0005886; GO:0008239; GO:0035577; GO:0042593; GO:0043231; GO:0043535; GO:0045178; GO:0060055; GO:0070062; GO:0097009; GO:0101003; GO:2000377,angiogenesis involved in wound healing [GO:0060055]; angiotensin maturation [GO:0002003]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone receptor signaling pathway [GO:0002155],azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],dipeptidyl-peptidase activity [GO:0008239]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185],GO:0003824; GO:0005886; GO:0006954; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; inflammatory response; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_05509,1.2614839896462775,FUN_024592-T1,Peve_00037916,Pocillopora_meandrina_HIv1___RNAseq.g19122.t1,three_way,65.791,FUN_024592-T1,Q2KIK0,,,,,38.3,397.0,1.2e-68,261.9,sp|Q2KIK0|SGT1_BOVIN Protein SGT1 homolog OS=Bos taurus OX=9913 GN=SUGT1 PE=2 SV=1,,,,,,
OG_05511,1.593150903930544,FUN_024594-T1,Peve_00037923,Pocillopora_meandrina_HIv1___RNAseq.g19124.t1,three_way,73.8495,FUN_024594-T1,Q8R0F3,SUMF1_MOUSE,,Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1),Mus musculus (Mouse),69.0,281.0,4.5e-123,442.6,sp|Q8R0F3|SUMF1_MOUSE Formylglycine-generating enzyme OS=Mus musculus OX=10090 GN=Sumf1 PE=1 SV=2,GO:0005783; GO:0005788; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135,post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],cupric ion binding [GO:1903135]; formylglycine-generating oxidase activity [GO:0120147]; identical protein binding [GO:0042802],GO:0003824; GO:0005783; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; oxidoreductase activity; organelle
OG_05513,1.3272513525135134,FUN_024596-T1,Peve_00037922,Pocillopora_meandrina_HIv1___TS.g28511.t1,three_way,92.383,FUN_024596-T1,P60122,,,,,86.6,456.0,2.1000000000000002e-223,776.2,sp|P60122|RUVB1_MOUSE RuvB-like 1 OS=Mus musculus OX=10090 GN=Ruvbl1 PE=1 SV=1,,,,,,
OG_05514,2.620446337348378,FUN_024614-T1,Peve_00041134,Pocillopora_meandrina_HIv1___RNAseq.g19147.t1,three_way,72.74433333333333,FUN_024614-T1,B3EWZ9,HEPHL_ACRMI,,Hephaestin-like protein (EC 1.-.-.-),Acropora millepora (Staghorn coral) (Heteropora millepora),96.7,1114.0,0.0,2249.2,sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491,copper ion transport [GO:0006825]; iron ion transport [GO:0006826],plasma membrane [GO:0005886],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005886; GO:0016491,catalytic activity; plasma membrane; oxidoreductase activity
OG_05517,1.123313301263232,FUN_024617-T1,Peve_00041139,Pocillopora_meandrina_HIv1___RNAseq.g19150.t1,three_way,79.05566666666667,FUN_024617-T1,Q2TA01,,,,,42.7,143.0,3e-17,89.7,sp|Q2TA01|TM216_BOVIN Transmembrane protein 216 OS=Bos taurus OX=9913 GN=TMEM216 PE=2 SV=2,,,,,,
OG_05518,2.601492508445597,FUN_024618-T1,Peve_00027329,Pocillopora_meandrina_HIv1___RNAseq.g19153.t1,three_way,82.87033333333333,FUN_024618-T1,Q9VJ79,PDE11_DROME,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11) (PDE11)",Drosophila melanogaster (Fruit fly),51.3,915.0,3.4e-254,879.4,"sp|Q9VJ79|PDE11_DROME Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 OS=Drosophila melanogaster OX=7227 GN=Pde11 PE=1 SV=4",GO:0004115; GO:0005829; GO:0019933; GO:0046058; GO:0046068; GO:0046872; GO:0047555,cAMP metabolic process [GO:0046058]; cAMP-mediated signaling [GO:0019933]; cGMP metabolic process [GO:0046068],cytosol [GO:0005829],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05522,3.725915468409025,FUN_024625-T1,Peve_00012720,Pocillopora_meandrina_HIv1___TS.g28341.t1,three_way,37.063,,,,,,,,,,,,,,,,,
OG_05523,1.6556692744734065,FUN_024629-T1,Peve_00012710,Pocillopora_meandrina_HIv1___RNAseq.g18959.t1,three_way,61.03916666666667,,,,,,,,,,,,,,,,,
OG_05524,2.4169516450223627,FUN_024632-T1,Peve_00012707,Pocillopora_meandrina_HIv1___RNAseq.g18962.t1,three_way,81.95866666666667,FUN_024632-T1,P07742,,,,,75.2,793.0,0.0,1231.5,sp|P07742|RIR1_MOUSE Ribonucleoside-diphosphate reductase large subunit OS=Mus musculus OX=10090 GN=Rrm1 PE=1 SV=2,,,,,,
OG_05525,1.3608187098857794,FUN_024633-T1,Peve_00012726,Pocillopora_meandrina_HIv1___RNAseq.g18963.t1,three_way,42.951166666666666,,,,,,,,,,,,,,,,,
OG_05528,1.034400346856286,FUN_024671-T1,Peve_00032976,Pocillopora_meandrina_HIv1___RNAseq.g18966.t1,three_way,60.04133333333333,FUN_024671-T1,Q5BK09,,,,,25.9,263.0,2.8e-13,77.4,sp|Q5BK09|DRAM2_RAT DNA damage-regulated autophagy modulator protein 2 OS=Rattus norvegicus OX=10116 GN=Dram2 PE=2 SV=1,,,,,,
OG_05529,1.027287847190533,FUN_024672-T1,Peve_00027344,Pocillopora_meandrina_HIv1___RNAseq.g19161.t1,three_way,74.23133333333334,,,,,,,,,,,,,,,,,
OG_05530,1.0377035274411082,FUN_024677-T1,Peve_00012721,Pocillopora_meandrina_HIv1___RNAseq.g18952.t1,three_way,50.53216666666667,FUN_024677-T1,Q6ZVD7,STOX1_HUMAN,,Storkhead-box protein 1 (Winged-helix domain-containing protein),Homo sapiens (Human),39.2,158.0,6.199999999999999e-24,114.4,sp|Q6ZVD7|STOX1_HUMAN Storkhead-box protein 1 OS=Homo sapiens OX=9606 GN=STOX1 PE=1 SV=2,GO:0000977; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0006357; GO:0010468; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0048839; GO:0051301; GO:0051881; GO:0051897; GO:0071500; GO:1900087; GO:1901858; GO:1902882; GO:1904031; GO:1904120,cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription by RNA polymerase II [GO:0006357],cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977],GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05533,3.3185877809445268,FUN_024719-T1,Peve_00012704,Pocillopora_meandrina_HIv1___RNAseq.g18947.t1,three_way,64.05266666666667,FUN_024719-T1,A7MBB3,,,,,31.4,175.0,8.8e-10,65.9,sp|A7MBB3|T150B_BOVIN Modulator of macroautophagy TMEM150B OS=Bos taurus OX=9913 GN=TMEM150B PE=2 SV=1,,,,,,
OG_05535,2.178673690972761,FUN_024724-T1,Peve_00012714,Pocillopora_meandrina_HIv1___RNAseq.g18835.t1,three_way,82.242,FUN_024724-T1,Q9EPW0,INP4A_MOUSE,,"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Inositol polyphosphate 4-phosphatase-1) (4-Ptase-1) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)",Mus musculus (Mouse),37.1,911.0,3.5e-154,547.4,sp|Q9EPW0|INP4A_MOUSE Inositol polyphosphate-4-phosphatase type I A OS=Mus musculus OX=10090 GN=Inpp4a PE=1 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0006798; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0052828; GO:0055038; GO:0098978; GO:0099072,polyphosphate catabolic process [GO:0006798]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038],"inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]",GO:0003824; GO:0005634; GO:0005886; GO:0016787; GO:0043226,catalytic activity; nucleus; plasma membrane; hydrolase activity; organelle
OG_05537,3.0637499719355805,FUN_024726-T1,Peve_00029154,Pocillopora_meandrina_HIv1___RNAseq.g18837.t1,three_way,72.15833333333333,FUN_024726-T1,A0A1J6KGJ9,,,,,30.6,563.0,1e-55,219.5,sp|A0A1J6KGJ9|JAR4_NICAT Jasmonoyl--L-amino acid synthetase JAR4 OS=Nicotiana attenuata OX=49451 GN=JAR4 PE=1 SV=1,,,,,,
OG_05538,1.3560707275193955,FUN_024740-T1,Peve_00026310,Pocillopora_meandrina_HIv1___RNAseq.g18838.t1,three_way,80.97633333333333,FUN_024740-T1,O15067,PUR4_HUMAN,,Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase) (Phosphoribosylformylglycineamide amidotransferase),Homo sapiens (Human),58.8,1323.0,0.0,1520.8,sp|O15067|PUR4_HUMAN Phosphoribosylformylglycinamidine synthase OS=Homo sapiens OX=9606 GN=PFAS PE=1 SV=4,GO:0004642; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006541; GO:0009168; GO:0009410; GO:0044208; GO:0046872; GO:0070062; GO:0097065; GO:0097294,'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to xenobiotic stimulus [GO:0009410],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642],GO:0003824; GO:0005829; GO:0006520; GO:0016874; GO:0043226; GO:0048856; GO:0055086; GO:1901135,catalytic activity; cytosol; amino acid metabolic process; ligase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05539,2.3526538926890845,FUN_024741-T1,Peve_00026308,Pocillopora_meandrina_HIv1___RNAseq.g18839.t1,three_way,45.45766666666667,FUN_024741-T1,Q8NB91,FANCB_HUMAN,,Fanconi anemia group B protein (Protein FACB) (Fanconi anemia-associated polypeptide of 95 kDa) (FAAP95),Homo sapiens (Human),20.2,643.0,3.7e-10,68.6,sp|Q8NB91|FANCB_HUMAN Fanconi anemia group B protein OS=Homo sapiens OX=9606 GN=FANCB PE=1 SV=1,GO:0000785; GO:0005654; GO:0005829; GO:0036297; GO:0043240; GO:1905168; GO:1990414; GO:2000042,interstrand cross-link repair [GO:0036297]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829; GO:0006281; GO:0006310,nucleoplasm; cytosol; DNA repair; DNA recombination
OG_05540,2.715511049934127,FUN_024742-T1,Peve_00005934,Pocillopora_meandrina_HIv1___TS.g28230.t1,three_way,61.432,FUN_024742-T1,Q865W2,,,,,26.7,217.0,2e-10,69.3,sp|Q865W2|TRI50_PIG E3 ubiquitin-protein ligase TRIM50 OS=Sus scrofa OX=9823 GN=TRIM50 PE=2 SV=1,,,,,,
OG_05542,2.155799293688233,FUN_024748-T1,Peve_00005930,Pocillopora_meandrina_HIv1___RNAseq.g18844.t2,three_way,45.1395,,,,,,,,,,,,,,,,,
OG_05549,1.5353758996802649,FUN_024756-T1,Peve_00027351,Pocillopora_meandrina_HIv1___RNAseq.g18828.t1,three_way,51.74283333333333,FUN_024756-T1,Q9P0M2,AKA7G_HUMAN,,A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma),Homo sapiens (Human),39.0,205.0,7.9e-36,153.3,sp|Q9P0M2|AKA7G_HUMAN A-kinase anchor protein 7 isoform gamma OS=Homo sapiens OX=9606 GN=AKAP7 PE=1 SV=2,GO:0000166; GO:0005634; GO:0005829; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686,modulation of chemical synaptic transmission [GO:0050804],cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901],GO:0005634; GO:0005829; GO:0043226,nucleus; cytosol; organelle
OG_05551,4.339647014937423,FUN_024758-T1,Peve_00027326,Pocillopora_meandrina_HIv1___RNAseq.g18826.t1,three_way,87.74933333333333,,,,,,,,,,,,,,,,,
OG_05558,1.3404566999109713,FUN_024776-T1,Peve_00036224,Pocillopora_meandrina_HIv1___RNAseq.g18814.t1,three_way,89.42866666666667,FUN_024776-T1,Q8BTV1,TUSC3_MOUSE,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33) (Tumor suppressor candidate 3),Mus musculus (Mouse),65.9,299.0,8.100000000000001e-124,444.9,sp|Q8BTV1|TUSC3_MOUSE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 OS=Mus musculus OX=10090 GN=Tusc3 PE=1 SV=1,GO:0005739; GO:0008250; GO:0015693; GO:0018279; GO:0050890; GO:0062062,cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279],mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250],oligosaccharyltransferase complex binding [GO:0062062],GO:0005739; GO:0009101; GO:0043226; GO:0050877; GO:1901135,mitochondrion; glycoprotein biosynthetic process; organelle; nervous system process; carbohydrate derivative metabolic process
OG_05559,2.439434678596112,FUN_024777-T1,Peve_00029133,Pocillopora_meandrina_HIv1___RNAseq.g18813.t1,three_way,71.3975,FUN_024777-T1,Q5T8P6,RBM26_HUMAN,,RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26),Homo sapiens (Human),31.9,1043.0,1e-47,193.7,sp|Q5T8P6|RBM26_HUMAN RNA-binding protein 26 OS=Homo sapiens OX=9606 GN=RBM26 PE=1 SV=3,GO:0003723; GO:0005634; GO:0008270,,nucleus [GO:0005634],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005634; GO:0043226,RNA binding; nucleus; organelle
OG_05560,1.0790304023187829,FUN_024778-T1,Peve_00016140,Pocillopora_meandrina_HIv1___RNAseq.g18804.t1,three_way,93.01066666666668,FUN_024778-T1,Q91ZW3,,,,,72.6,999.0,0.0,1404.0,sp|Q91ZW3|SMCA5_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 OS=Mus musculus OX=10090 GN=Smarca5 PE=1 SV=1,,,,,,
OG_05562,2.705476933936555,FUN_024781-T1,Peve_00015076,Pocillopora_meandrina_HIv1___TS.g28189.t2,three_way,75.94966666666666,FUN_024781-T1,Q5F3U9,,,,,42.0,1148.0,3.5999999999999997e-242,840.1,sp|Q5F3U9|PDS5B_CHICK Sister chromatid cohesion protein PDS5 homolog B OS=Gallus gallus OX=9031 GN=PDS5B PE=2 SV=3,,,,,,
OG_05563,2.495261114224527,FUN_024783-T1,Peve_00007043,Pocillopora_meandrina_HIv1___TS.g28188.t1,three_way,49.95166666666667,FUN_024783-T1,Q3U481,MFS12_MOUSE,,Major facilitator superfamily domain-containing protein 12 (Protein grizzled),Mus musculus (Mouse),32.5,206.0,9e-19,96.7,sp|Q3U481|MFS12_MOUSE Major facilitator superfamily domain-containing protein 12 OS=Mus musculus OX=10090 GN=Mfsd12 PE=1 SV=1,GO:0005764; GO:0005765; GO:0005770; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; cytoplasmic vesicle; organelle; transmembrane transport
OG_05568,1.0585594838758077,FUN_024804-T1,Peve_00026081,Pocillopora_meandrina_HIv1___RNAseq.g18778.t2,three_way,85.261,FUN_024804-T1,Q64332,SYN2_MOUSE,,Synapsin-2 (Synapsin II),Mus musculus (Mouse),58.6,326.0,4.6e-111,402.9,sp|Q64332|SYN2_MOUSE Synapsin-2 OS=Mus musculus OX=10090 GN=Syn2 PE=1 SV=2,GO:0005524; GO:0005886; GO:0007269; GO:0014069; GO:0017156; GO:0030672; GO:0031201; GO:0042802; GO:0043209; GO:0045202; GO:0097091; GO:0098685; GO:0098978; GO:0099504,calcium-ion regulated exocytosis [GO:0017156]; neurotransmitter secretion [GO:0007269]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle cycle [GO:0099504],glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],ATP binding [GO:0005524]; identical protein binding [GO:0042802],GO:0005886; GO:0016192; GO:0043226,plasma membrane; vesicle-mediated transport; organelle
OG_05572,3.9510613341832586,FUN_024815-T1,Peve_00026076,Pocillopora_meandrina_HIv1___RNAseq.g18772.t1,three_way,69.34433333333334,FUN_024815-T1,Q96PE2,ARHGH_HUMAN,,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),Homo sapiens (Human),40.1,1066.0,9.2e-179,630.2,sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056,actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0007010; GO:0098772,cytosol; cytoskeleton organization; molecular function regulator activity
OG_05574,1.4612850825819068,FUN_024863-T1,Peve_00026086,Pocillopora_meandrina_HIv1___TS.g28157.t1,three_way,75.19033333333333,FUN_024863-T1,Q9NVM9,INT13_HUMAN,,Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95),Homo sapiens (Human),42.6,698.0,1.3000000000000002e-145,518.5,sp|Q9NVM9|INT13_HUMAN Integrator complex subunit 13 OS=Homo sapiens OX=9606 GN=INTS13 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007346; GO:0016180; GO:0016604; GO:0030317; GO:0032039; GO:0034243; GO:0043231; GO:0051301; GO:0051642; GO:0080154; GO:0090435; GO:0140297; GO:0160232; GO:0160240,cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180],cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA-binding transcription factor binding [GO:0140297],GO:0005634; GO:0005654; GO:0006355; GO:0007010; GO:0007018; GO:0016073; GO:0022414; GO:0043226; GO:0048870,nucleus; nucleoplasm; regulation of DNA-templated transcription; cytoskeleton organization; microtubule-based movement; snRNA metabolic process; reproductive process; organelle; cell motility
OG_05575,1.7111361583087428,FUN_024865-T1,Peve_00016133,Pocillopora_meandrina_HIv1___RNAseq.g18765.t1,three_way,72.15233333333333,FUN_024865-T1,Q9WV52,PLEK2_MOUSE,,Pleckstrin-2,Mus musculus (Mouse),32.3,378.0,2.5e-47,191.0,sp|Q9WV52|PLEK2_MOUSE Pleckstrin-2 OS=Mus musculus OX=10090 GN=Plek2 PE=1 SV=1,GO:0005737; GO:0005856; GO:0005886; GO:0016020; GO:0030036; GO:0031258; GO:0031346; GO:0032266; GO:0035556; GO:0043325; GO:0080025; GO:0120034,actin cytoskeleton organization [GO:0030036]; intracellular signal transduction [GO:0035556]; positive regulation of cell projection organization [GO:0031346]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886],"phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]",GO:0005856; GO:0005886; GO:0007010; GO:0008289; GO:0043226,cytoskeleton; plasma membrane; cytoskeleton organization; lipid binding; organelle
OG_05576,1.8253738924293488,FUN_024871-T1,Peve_00016134,Pocillopora_meandrina_HIv1___RNAseq.g18750.t1,three_way,55.18966666666667,FUN_024871-T1,P39022,,,,,68.3,161.0,3.8e-60,233.8,sp|P39022|RAD52_CHICK DNA repair protein RAD52 homolog OS=Gallus gallus OX=9031 GN=RAD52 PE=2 SV=1,,,,,,
OG_05579,1.3675440370003689,FUN_024900-T1,Peve_00016136,Pocillopora_meandrina_HIv1___RNAseq.g18747.t1a,three_way,92.683,FUN_024900-T1,A0A1B0GTI8,,,,,32.9,170.0,4.6000000000000015e-22,106.3,sp|A0A1B0GTI8|TM272_HUMAN Transmembrane protein 272 OS=Homo sapiens OX=9606 GN=TMEM272 PE=2 SV=3,,,,,,
OG_05582,3.5882641527037187,FUN_024906-T1,Peve_00038387,Pocillopora_meandrina_HIv1___RNAseq.g19419.t1,three_way,66.53216666666667,FUN_024906-T1,P23359,BMP7_MOUSE,,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1),Mus musculus (Mouse),24.3,382.0,1.2000000000000001e-30,135.6,sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2,GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0036305; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312,allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; vesicle [GO:0031982],BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005615; GO:0006355; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell adhesion; programmed cell death; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05584,1.6032633397427625,FUN_024912-T1,Peve_00020857,Pocillopora_meandrina_HIv1___RNAseq.g19413.t1,three_way,77.491,FUN_024912-T1,P32320,CDD_HUMAN,,Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase),Homo sapiens (Human),52.2,134.0,1.2e-32,141.0,sp|P32320|CDD_HUMAN Cytidine deaminase OS=Homo sapiens OX=9606 GN=CDA PE=1 SV=2,GO:0001882; GO:0004126; GO:0005576; GO:0005829; GO:0007166; GO:0008270; GO:0008655; GO:0009972; GO:0019858; GO:0030308; GO:0034774; GO:0042802; GO:0042803; GO:0044206; GO:0045980; GO:0046898; GO:0071217; GO:1904724; GO:1904813,cell surface receptor signaling pathway [GO:0007166]; cellular response to external biotic stimulus [GO:0071217]; cytidine deamination [GO:0009972]; cytosine metabolic process [GO:0019858]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; pyrimidine-containing compound salvage [GO:0008655]; response to cycloheximide [GO:0046898]; UMP salvage [GO:0044206],cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724],cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; extracellular region; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05586,3.183073172429001,FUN_024942-T1,Peve_00038386,Pocillopora_meandrina_HIv1___RNAseq.g19445.t1,three_way,68.45700000000001,FUN_024942-T1,A8MXD5,GRCR1_HUMAN,,Glutaredoxin domain-containing cysteine-rich protein 1,Homo sapiens (Human),35.3,190.0,2.1e-28,127.5,sp|A8MXD5|GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens OX=9606 GN=GRXCR1 PE=1 SV=1,GO:0005902; GO:0006887; GO:0007009; GO:0007605; GO:0032420; GO:0051592; GO:0051649; GO:0060088; GO:0060091; GO:0060118; GO:0060119; GO:0060122; GO:0070588; GO:0090102; GO:1905144,auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transmembrane transport [GO:0070588]; cochlea development [GO:0090102]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; plasma membrane organization [GO:0007009]; response to acetylcholine [GO:1905144]; response to calcium ion [GO:0051592]; sensory perception of sound [GO:0007605]; vestibular receptor cell development [GO:0060118],kinocilium [GO:0060091]; microvillus [GO:0005902]; stereocilium [GO:0032420],,GO:0005929; GO:0016192; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0061024,cilium; vesicle-mediated transport; organelle; anatomical structure development; nervous system process; transmembrane transport; membrane organization
OG_05589,2.4458013300524484,FUN_025035-T1,Peve_00038379,Pocillopora_meandrina_HIv1___RNAseq.g19423.t1,three_way,84.7295,FUN_025035-T1,Q6DCE3,ZNT9_XENLA,,"Proton-coupled zinc antiporter SLC30A9, mitochondrial (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9)",Xenopus laevis (African clawed frog),48.4,517.0,2.8e-121,437.2,"sp|Q6DCE3|ZNT9_XENLA Proton-coupled zinc antiporter SLC30A9, mitochondrial OS=Xenopus laevis OX=8355 GN=slc30a9 PE=2 SV=1",GO:0005385; GO:0005634; GO:0005783; GO:0006829; GO:0006882; GO:0010821; GO:0015297; GO:0031410; GO:0031966,intracellular zinc ion homeostasis [GO:0006882]; regulation of mitochondrion organization [GO:0010821]; zinc ion transport [GO:0006829],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634],antiporter activity [GO:0015297]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005634; GO:0005783; GO:0031410; GO:0043226,transporter activity; nucleus; endoplasmic reticulum; cytoplasmic vesicle; organelle
OG_05594,1.2199540189642537,FUN_025108-T1,Peve_00038376,Pocillopora_meandrina_HIv1___RNAseq.g19430.t1,three_way,83.12366666666667,FUN_025108-T1,P41252,SYIC_HUMAN,,"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)",Homo sapiens (Human),62.5,1157.0,0.0,1500.3,"sp|P41252|SYIC_HUMAN Isoleucine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=IARS1 PE=1 SV=2",GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062,isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654],aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005654; GO:0005829; GO:0006399; GO:0006520; GO:0016874; GO:0030154; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; cytosol; tRNA metabolic process; amino acid metabolic process; ligase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_05601,1.907024766531395,FUN_025233-T1,Peve_00034838,Pocillopora_meandrina_HIv1___RNAseq.g13605.t1,three_way,74.29116666666667,FUN_025233-T1,P49916,DNLI3_HUMAN,,DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3),Homo sapiens (Human),56.4,922.0,2.1e-265,916.8,sp|P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2,GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006273; GO:0006284; GO:0006287; GO:0006302; GO:0007005; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681,"base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]",DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006310; GO:0007005; GO:0016874; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; DNA recombination; mitochondrion organization; ligase activity; organelle; catalytic activity, acting on DNA"
OG_05602,1.916954942841107,FUN_025259-T1,Peve_00031195,Pocillopora_meandrina_HIv1___TS.g2586.t1,three_way,76.54266666666668,FUN_025259-T1,Q8NCX0,,,,,27.3,956.0,1.9e-10,70.1,sp|Q8NCX0|CC150_HUMAN Coiled-coil domain-containing protein 150 OS=Homo sapiens OX=9606 GN=CCDC150 PE=1 SV=2,,,,,,
OG_05603,1.5298922203086234,FUN_025260-T1,Peve_00031287,Pocillopora_meandrina_HIv1___RNAseq.g13591.t1,three_way,87.201,FUN_025260-T1,Q5W041,ARMC3_HUMAN,,Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1),Homo sapiens (Human),51.8,871.0,3.1e-103,377.9,sp|Q5W041|ARMC3_HUMAN Armadillo repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=ARMC3 PE=1 SV=2,GO:0007286; GO:0030317; GO:0034517; GO:0070062,flagellated sperm motility [GO:0030317]; ribophagy [GO:0034517]; spermatid development [GO:0007286],extracellular exosome [GO:0070062],,GO:0006914; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,autophagy; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_05605,1.1377868901776276,FUN_025263-T1,Peve_00014011,Pocillopora_meandrina_HIv1___RNAseq.g13585.t1,three_way,79.685,FUN_025263-T1,Q12962,TAF10_HUMAN,,Transcription initiation factor TFIID subunit 10 (STAF28) (Transcription initiation factor TFIID 30 kDa subunit) (TAF(II)30) (TAFII-30) (TAFII30),Homo sapiens (Human),68.4,117.0,2e-40,166.8,sp|Q12962|TAF10_HUMAN Transcription initiation factor TFIID subunit 10 OS=Homo sapiens OX=9606 GN=TAF10 PE=1 SV=1,GO:0000082; GO:0000124; GO:0001673; GO:0001756; GO:0001892; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005737; GO:0006282; GO:0006338; GO:0006352; GO:0006355; GO:0006357; GO:0006366; GO:0006367; GO:0006915; GO:0016251; GO:0019899; GO:0030331; GO:0033276; GO:0035264; GO:0036285; GO:0042789; GO:0042802; GO:0043484; GO:0045893; GO:0048371; GO:0048471; GO:0051123; GO:0060173; GO:0060261; GO:0070063; GO:0070365; GO:0097550; GO:1905069; GO:1990841,allantois development [GO:1905069]; apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; embryonic placenta development [GO:0001892]; G1/S transition of mitotic cell cycle [GO:0000082]; hepatocyte differentiation [GO:0070365]; lateral mesodermal cell differentiation [GO:0048371]; limb development [GO:0060173]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organism growth [GO:0035264]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; SAGA complex assembly [GO:0036285]; somitogenesis [GO:0001756]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; transcription preinitiation complex [GO:0097550],DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; nuclear estrogen receptor binding [GO:0030331]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase binding [GO:0070063]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006351; GO:0006355; GO:0012501; GO:0016071; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0140223,DNA binding; nucleus; nucleoplasm; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; mRNA metabolic process; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; general transcription initiation factor activity
OG_05608,2.4483555747474623,FUN_025291-T1,Peve_00040962,Pocillopora_meandrina_HIv1___RNAseq.g13475.t1,three_way,54.800666666666665,,,,,,,,,,,,,,,,,
OG_05609,3.1042269215278,FUN_025294-T1,Peve_00040955,Pocillopora_meandrina_HIv1___RNAseq.g13469.t1,three_way,53.38583333333333,,,,,,,,,,,,,,,,,
OG_05610,1.8609365863015308,FUN_025295-T1,Peve_00040954,Pocillopora_meandrina_HIv1___RNAseq.g13468.t1,three_way,62.326,,,,,,,,,,,,,,,,,
OG_05613,2.102650456737111,FUN_025299-T1,Peve_00040950,Pocillopora_meandrina_HIv1___RNAseq.g13465.t1,three_way,63.21666666666667,,,,,,,,,,,,,,,,,
OG_05614,1.455132308920911,FUN_025302-T1,Peve_00040947,Pocillopora_meandrina_HIv1___RNAseq.g13462.t1,three_way,63.404,FUN_025302-T1,Q08DT6,,,,,55.0,109.0,1.1e-22,108.2,sp|Q08DT6|RM47_BOVIN Large ribosomal subunit protein uL29m OS=Bos taurus OX=9913 GN=MRPL47 PE=2 SV=1,,,,,,
OG_05616,2.091623099505109,FUN_025304-T1,Peve_00040949,Pocillopora_meandrina_HIv1___RNAseq.g13460.t1,three_way,85.93833333333333,FUN_025304-T1,Q9I7S6,,,,,53.0,372.0,3.1e-112,407.1,"sp|Q9I7S6|PDE9A_DROME High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A OS=Drosophila melanogaster OX=7227 GN=Pde9 PE=2 SV=2",,,,,,
OG_05617,1.251516983684823,FUN_025306-T1,Peve_00027097,Pocillopora_meandrina_HIv1___RNAseq.g13454.t1,three_way,78.10933333333332,FUN_025306-T1,Q95R48,,,,,28.5,396.0,5.8e-38,159.8,sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2,,,,,,
OG_05618,2.439013363859265,FUN_025308-T1,Peve_00027048,Pocillopora_meandrina_HIv1___RNAseq.g13453.t1,three_way,61.894,,,,,,,,,,,,,,,,,
OG_05620,2.5582133273863388,FUN_025310-T1,Peve_00027063,Pocillopora_meandrina_HIv1___RNAseq.g13451.t1,three_way,53.777,,,,,,,,,,,,,,,,,
OG_05621,1.5866225177916566,FUN_025314-T1,Peve_00027075,Pocillopora_meandrina_HIv1___RNAseq.g13449.t1,three_way,74.45566666666667,FUN_025314-T1,Q5U458,DJC11_MOUSE,,DnaJ homolog subfamily C member 11,Mus musculus (Mouse),47.5,558.0,2e-135,484.2,sp|Q5U458|DJC11_MOUSE DnaJ homolog subfamily C member 11 OS=Mus musculus OX=10090 GN=Dnajc11 PE=1 SV=2,GO:0001401; GO:0005739; GO:0005743; GO:0016607; GO:0042407; GO:0061617,cristae formation [GO:0042407],MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; SAM complex [GO:0001401],,GO:0005739; GO:0007005; GO:0043226; GO:0061024,mitochondrion; mitochondrion organization; organelle; membrane organization
OG_05624,2.0667154762666726,FUN_025318-T1,Peve_00027086,Pocillopora_meandrina_HIv1___RNAseq.14712_t,three_way,59.059000000000005,,,,,,,,,,,,,,,,,
OG_05627,2.123461594347212,FUN_025322-T1,Peve_00027091,Pocillopora_meandrina_HIv1___RNAseq.g13422.t1,three_way,87.86033333333333,FUN_025322-T1,Q6PAX2,,,,,62.0,574.0,2.0000000000000005e-165,583.9,sp|Q6PAX2|ATD3B_XENLA ATPase family AAA domain-containing protein 3-B OS=Xenopus laevis OX=8355 GN=atad3-b PE=2 SV=1,,,,,,
OG_05629,2.53861693943717,FUN_025324-T1,Peve_00027096,Pocillopora_meandrina_HIv1___RNAseq.g13420.t1,three_way,68.96249999999999,FUN_025324-T1,Q9Y6Y1,CMTA1_HUMAN,,Calmodulin-binding transcription activator 1,Homo sapiens (Human),29.5,1137.0,2.1e-90,335.9,sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4,GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886,neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712],GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; nervous system process; molecular adaptor activity; transcription regulator activity
OG_05631,3.0219283630445024,FUN_025328-T1,Peve_00027062,Pocillopora_meandrina_HIv1___RNAseq.g13406.t1,three_way,70.02683333333333,FUN_025328-T1,Q9H3D4,,,,,34.9,272.0,1.1999999999999999e-35,152.5,sp|Q9H3D4|P63_HUMAN Tumor protein 63 OS=Homo sapiens OX=9606 GN=TP63 PE=1 SV=1,,,,,,
OG_05632,1.9027089336831,FUN_025330-T1,Peve_00027061,Pocillopora_meandrina_HIv1___RNAseq.g13405.t1,three_way,58.849,,,,,,,,,,,,,,,,,
OG_05633,1.018754198475016,FUN_025331-T1,Peve_00027057,Pocillopora_meandrina_HIv1___RNAseq.g13404.t2,three_way,84.81166666666667,FUN_025331-T1,Q5F499,OPA1_CHICK,,"Dynamin-like GTPase OPA1, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like GTPase OPA1, long form (L-OPA1); Dynamin-like GTPase OPA1, short form (S-OPA1)]",Gallus gallus (Chicken),53.5,939.0,5.1999999999999995e-264,912.1,"sp|Q5F499|OPA1_CHICK Dynamin-like GTPase OPA1, mitochondrial OS=Gallus gallus OX=9031 GN=OPA1 PE=2 SV=1",GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005743; GO:0005758; GO:0005874; GO:0006897; GO:0006915; GO:0008017; GO:0008053; GO:0016559; GO:0031966; GO:0032740; GO:0046039; GO:0046872; GO:0048312; GO:0070300; GO:0097749; GO:0140523; GO:0180020; GO:1901612; GO:1990627; GO:2000330,apoptotic process [GO:0006915]; endocytosis [GO:0006897]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrial inner membrane fusion [GO:1990627]; peroxisome fission [GO:0016559]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330],cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966],cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; membrane bending activity [GO:0180020]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300],GO:0003824; GO:0003924; GO:0007005; GO:0008092; GO:0008289; GO:0012501; GO:0016192; GO:0016787; GO:0055086; GO:0061024; GO:1901135,catalytic activity; GTPase activity; mitochondrion organization; cytoskeletal protein binding; lipid binding; programmed cell death; vesicle-mediated transport; hydrolase activity; nucleobase-containing small molecule metabolic process; membrane organization; carbohydrate derivative metabolic process
OG_05639,1.0270372904749467,FUN_025343-T1,Peve_00027051,Pocillopora_meandrina_HIv1___RNAseq.g13379.t1,three_way,83.50133333333333,FUN_025343-T1,P13732,,,,,66.7,93.0,9.900000000000001e-30,130.6,sp|P13732|RL22_TRIGR Large ribosomal subunit protein eL22 OS=Tripneustes gratilla OX=7673 GN=RPL22 PE=2 SV=1,,,,,,
OG_05640,3.126116909800729,FUN_025348-T1,Peve_00004327,Pocillopora_meandrina_HIv1___TS.g2360.t1a,three_way,40.693666666666665,,,,,,,,,,,,,,,,,
OG_05649,2.751904438584869,FUN_025372-T1,Peve_00040522,Pocillopora_meandrina_HIv1___RNAseq.g13329.t1,three_way,85.562,FUN_025372-T1,Q92997,DVL3_HUMAN,,Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3),Homo sapiens (Human),61.0,485.0,3.2e-124,447.2,sp|Q92997|DVL3_HUMAN Segment polarity protein dishevelled homolog DVL-3 OS=Homo sapiens OX=9606 GN=DVL3 PE=1 SV=2,GO:0000785; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0009410; GO:0031267; GO:0032880; GO:0032956; GO:0035556; GO:0035567; GO:0043547; GO:0045893; GO:0045944; GO:0046330; GO:0050821; GO:0060070; GO:0060071; GO:0150012,"canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein localization [GO:0032880]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",chromatin [GO:0000785]; cytosol [GO:0005829],beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267],GO:0005829; GO:0006355,cytosol; regulation of DNA-templated transcription
OG_05650,2.23130590635078,FUN_025373-T1,Peve_00040523,Pocillopora_meandrina_HIv1___RNAseq.g13328.t1,three_way,60.128166666666665,FUN_025373-T1,A1L0Y2,,,,,39.5,1520.0,7.3e-307,1055.0,sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1,,,,,,
OG_05654,1.8453974445522736,FUN_025403-T1,Peve_00026689,Pocillopora_meandrina_HIv1___RNAseq.g13308.t1,three_way,71.69633333333334,FUN_025403-T1,Q7SXN5,DNM1L_DANRE,,Dynamin-1-like protein (EC 3.6.5.5),Danio rerio (Zebrafish) (Brachydanio rerio),21.1,701.0,1.2e-07,60.1,sp|Q7SXN5|DNM1L_DANRE Dynamin-1-like protein OS=Danio rerio OX=7955 GN=dnm1l PE=2 SV=1,GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0008017; GO:0008289; GO:0016020; GO:0016559; GO:0030672; GO:0042803; GO:0043653; GO:0048312; GO:0048511; GO:0051259,endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; rhythmic process [GO:0048511],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0065003,catalytic activity; GTPase activity; mitochondrion; peroxisome; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; protein-containing complex assembly
OG_05656,2.778277321500414,FUN_025411-T1,Peve_00017349,Pocillopora_meandrina_HIv1___RNAseq.g13310.t1,three_way,63.414,FUN_025411-T1,C3ZQF9,,,,,24.0,313.0,5e-17,90.1,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_05661,2.5656691310643622,FUN_025430-T2,Peve_00030583,Pocillopora_meandrina_HIv1___RNAseq.g13324.t1,three_way,80.823,FUN_025430-T2,Q3ZBV2,DD19A_BOVIN,,ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box protein 19A),Bos taurus (Bovine),64.6,418.0,8.7e-162,571.6,sp|Q3ZBV2|DD19A_BOVIN ATP-dependent RNA helicase DDX19A OS=Bos taurus OX=9913 GN=DDX19A PE=2 SV=1,GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016887; GO:0016973,poly(A)+ mRNA export from nucleus [GO:0016973],cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006913; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleocytoplasmic transport; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05663,1.807112370089827,FUN_025432-T1,Peve_00029489,Pocillopora_meandrina_HIv1___RNAseq.g13327.t1,three_way,51.88183333333333,,,,,,,,,,,,,,,,,
OG_05666,2.3256408293946027,FUN_025441-T1,Peve_00029478,Pocillopora_meandrina_HIv1___RNAseq.g13294.t1,three_way,72.48916666666666,FUN_025441-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),45.7,361.0,2.8e-94,349.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_05668,1.543138613277863,FUN_025458-T1,Peve_00034350,Pocillopora_meandrina_HIv1___RNAseq.g13247.t1,three_way,91.296,FUN_025458-T1,Q6DFH9,,,,,71.7,180.0,1.4000000000000001e-80,300.4,sp|Q6DFH9|NIP7_XENLA 60S ribosome subunit biogenesis protein NIP7 homolog OS=Xenopus laevis OX=8355 GN=nip7 PE=2 SV=1,,,,,,
OG_05671,2.3059887775495778,FUN_025464-T1,Peve_00043839,Pocillopora_meandrina_HIv1___RNAseq.g13242.t1,three_way,70.53633333333333,FUN_025464-T1,P60763,RAC3_HUMAN,,Ras-related C3 botulinum toxin substrate 3 (EC 3.6.5.2) (p21-Rac3),Homo sapiens (Human),39.2,153.0,6.8e-23,111.7,sp|P60763|RAC3_HUMAN Ras-related C3 botulinum toxin substrate 3 OS=Homo sapiens OX=9606 GN=RAC3 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0012505; GO:0014041; GO:0016055; GO:0016601; GO:0019901; GO:0021894; GO:0030027; GO:0030031; GO:0030036; GO:0030426; GO:0030865; GO:0031410; GO:0031941; GO:0032956; GO:0033630; GO:0035556; GO:0043005; GO:0043020; GO:0043025; GO:0045730; GO:0048306; GO:0048471; GO:0048873; GO:0050885; GO:0051932; GO:0060326; GO:0070062; GO:0071944; GO:0098794; GO:0098974; GO:0098978; GO:0150052; GO:1900026; GO:1902622,"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell chemotaxis [GO:0060326]; cell projection assembly [GO:0030031]; cerebral cortex GABAergic interneuron development [GO:0021894]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neuron maturation [GO:0014041]; regulation of neutrophil migration [GO:1902622]; regulation of postsynapse assembly [GO:0150052]; respiratory burst [GO:0045730]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway [GO:0016055]",cell periphery [GO:0071944]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; NADPH oxidase complex [GO:0043020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],calcium-dependent protein binding [GO:0048306]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0016787; GO:0023052; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0098772,catalytic activity; GTPase activity; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; hydrolase activity; signaling; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; nervous system process; molecular function regulator activity
OG_05673,1.789589675510647,FUN_025503-T1,Peve_00016401,Pocillopora_meandrina_HIv1___RNAseq.g13229.t1,three_way,45.6685,,,,,,,,,,,,,,,,,
OG_05677,1.647902433600105,FUN_025510-T1,Peve_00002253,Pocillopora_meandrina_HIv1___RNAseq.g13213.t1,three_way,72.42949999999999,,,,,,,,,,,,,,,,,
OG_05678,2.634079834342037,FUN_025511-T1,Peve_00002249,Pocillopora_meandrina_HIv1___RNAseq.g13212.t1,three_way,56.655,FUN_025511-T1,Q8TCQ1,MARH1_HUMAN,,E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING finger protein 171) (RING-type E3 ubiquitin transferase MARCHF1),Homo sapiens (Human),28.2,206.0,7.7e-14,79.7,sp|Q8TCQ1|MARH1_HUMAN E3 ubiquitin-protein ligase MARCHF1 OS=Homo sapiens OX=9606 GN=MARCHF1 PE=1 SV=1,GO:0000209; GO:0002495; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0043231; GO:0061630,antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"immune system process; catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05679,3.221962116223068,FUN_025516-T1,Peve_00002247,Pocillopora_meandrina_HIv1___RNAseq.g13210.t1,three_way,89.46916666666667,,,,,,,,,,,,,,,,,
OG_05681,2.4250298840538047,FUN_025518-T1,Peve_00031512,Pocillopora_meandrina_HIv1___RNAseq.g13207.t1,three_way,87.27499999999999,FUN_025518-T1,O95140,,,,,51.6,744.0,3.3999999999999997e-205,716.5,sp|O95140|MFN2_HUMAN Mitofusin-2 OS=Homo sapiens OX=9606 GN=MFN2 PE=1 SV=3,,,,,,
OG_05684,1.134189115019896,FUN_025527-T1,Peve_00009002,Pocillopora_meandrina_HIv1___RNAseq.g23047.t1,three_way,85.454,FUN_025527-T1,Q9D2N4,DTNA_MOUSE,,Dystrobrevin alpha (DTN-A) (Alpha-dystrobrevin),Mus musculus (Mouse),46.0,554.0,2.5e-117,424.1,sp|Q9D2N4|DTNA_MOUSE Dystrobrevin alpha OS=Mus musculus OX=10090 GN=Dtna PE=1 SV=2,GO:0005737; GO:0008270; GO:0016014; GO:0032991; GO:0042383; GO:0045202,,cytoplasm [GO:0005737]; dystrobrevin complex [GO:0016014]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005886,plasma membrane
OG_05685,2.7791624630795964,FUN_025530-T1,Peve_00009476,Pocillopora_meandrina_HIv1___TS.g2807.t1,three_way,91.53566666666669,FUN_025530-T1,Q5U395,,,,,73.8,244.0,2.7000000000000002e-104,379.8,sp|Q5U395|CNEPA_DANRE CTD nuclear envelope phosphatase 1A OS=Danio rerio OX=7955 GN=ctdnep1a PE=2 SV=1,,,,,,
OG_05691,4.582920090561175,FUN_025542-T1,Peve_00032958,Pocillopora_meandrina_HIv1___RNAseq.g13798.t1,three_way,69.249,,,,,,,,,,,,,,,,,
OG_05692,1.6239836008732091,FUN_025543-T1,Peve_00002302,Pocillopora_meandrina_HIv1___RNAseq.g13797.t1,three_way,76.96466666666667,FUN_025543-T1,A2A825,CPLN2_MOUSE,,Ciliogenesis and planar polarity effector 2 (REM2- and Rab-like small GTPase 1),Mus musculus (Mouse),54.1,181.0,2.6999999999999997e-55,216.5,sp|A2A825|CPLN2_MOUSE Ciliogenesis and planar polarity effector 2 OS=Mus musculus OX=10090 GN=Cplane2 PE=1 SV=1,GO:0003274; GO:0003924; GO:0005525; GO:0005737; GO:0005814; GO:0006887; GO:0007224; GO:0008104; GO:0008589; GO:0015031; GO:0016485; GO:0017157; GO:0031338; GO:0035082; GO:0035869; GO:0036064; GO:0060173; GO:0060271; GO:0097546; GO:1904888,axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cranial skeletal system development [GO:1904888]; endocardial cushion fusion [GO:0003274]; exocytosis [GO:0006887]; limb development [GO:0060173]; protein localization [GO:0008104]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of smoothened signaling pathway [GO:0008589]; regulation of vesicle fusion [GO:0031338]; smoothened signaling pathway [GO:0007224],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005815; GO:0007010; GO:0007155; GO:0016192; GO:0016787; GO:0043226; GO:0044782; GO:0048856; GO:0051604,catalytic activity; GTPase activity; microtubule organizing center; cytoskeleton organization; cell adhesion; vesicle-mediated transport; hydrolase activity; organelle; cilium organization; anatomical structure development; protein maturation
OG_05693,1.8238071658792845,FUN_025544-T1,Peve_00032952,Pocillopora_meandrina_HIv1___TS.g2798.t1,three_way,69.56033333333333,FUN_025544-T1,O60308,CE104_HUMAN,,Centrosomal protein of 104 kDa (Cep104),Homo sapiens (Human),38.5,925.0,9.3e-159,562.4,sp|O60308|CE104_HUMAN Centrosomal protein of 104 kDa OS=Homo sapiens OX=9606 GN=CEP104 PE=1 SV=1,GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0005929,,centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_05695,2.137635011131817,FUN_025556-T1,Peve_00017520,Pocillopora_meandrina_HIv1___RNAseq.g13790.t1,three_way,77.30333333333333,FUN_025556-T1,Q5SRE5,NU188_HUMAN,,Nucleoporin NUP188 (hNup188),Homo sapiens (Human),37.0,1762.0,5.6e-296,1019.2,sp|Q5SRE5|NU188_HUMAN Nucleoporin NUP188 OS=Homo sapiens OX=9606 GN=NUP188 PE=1 SV=1,GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006606; GO:0006913; GO:0016020; GO:0017056; GO:0044611; GO:0051028,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005829; GO:0006886; GO:0006913,structural molecule activity; nuclear envelope; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_05698,4.168551249593483,FUN_025561-T1,Peve_00019806,Pocillopora_meandrina_HIv1___TS.g2789.t1,three_way,87.92233333333333,FUN_025561-T1,Q6VFT7,FOXL2_BOVIN,,Forkhead box protein L2,Bos taurus (Bovine),89.7,107.0,1.9e-52,207.6,sp|Q6VFT7|FOXL2_BOVIN Forkhead box protein L2 OS=Bos taurus OX=9913 GN=FOXL2 PE=2 SV=1,GO:0000978; GO:0000981; GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006309; GO:0006357; GO:0009653; GO:0019101; GO:0030154; GO:0031624; GO:0043028; GO:0043065; GO:0045892; GO:0045893; GO:0045944; GO:0048048; GO:0060014; GO:0090543,anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of DNA-templated transcription [GO:0045892]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin conjugating enzyme binding [GO:0031624]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_05701,1.2042301447288346,FUN_025571-T1,Peve_00001252,Pocillopora_meandrina_HIv1___TS.g2769.t1,three_way,65.26633333333334,FUN_025571-T1,Q7ZUC2,CAB45_DANRE,,45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,159.0,6.8e-20,99.0,sp|Q7ZUC2|CAB45_DANRE 45 kDa calcium-binding protein OS=Danio rerio OX=7955 GN=sdf4 PE=2 SV=1,GO:0002040; GO:0005509; GO:0005783; GO:0005796; GO:0017156,calcium-ion regulated exocytosis [GO:0017156]; sprouting angiogenesis [GO:0002040],endoplasmic reticulum [GO:0005783]; Golgi lumen [GO:0005796],calcium ion binding [GO:0005509],GO:0005783; GO:0016192; GO:0043226,endoplasmic reticulum; vesicle-mediated transport; organelle
OG_05702,1.2881145219902923,FUN_025572-T1,Peve_00001254,Pocillopora_meandrina_HIv1___RNAseq.g13766.t1,three_way,87.75500000000001,FUN_025572-T1,Q9P2S5,WRP73_HUMAN,,WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene),Homo sapiens (Human),60.9,443.0,3.9e-166,585.9,sp|Q9P2S5|WRP73_HUMAN WD repeat-containing protein WRAP73 OS=Homo sapiens OX=9606 GN=WRAP73 PE=1 SV=1,GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0030030; GO:0034451; GO:0036064; GO:0090307; GO:1902857; GO:1990811,cell projection organization [GO:0030030]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; MWP complex [GO:1990811],,GO:0005815; GO:0007010; GO:0043226,microtubule organizing center; cytoskeleton organization; organelle
OG_05706,1.6079904808222765,FUN_025579-T1,Peve_00022366,Pocillopora_meandrina_HIv1___RNAseq.g13759.t1,three_way,85.93933333333334,FUN_025579-T1,Q9CZ04,CSN7A_MOUSE,,COP9 signalosome complex subunit 7a (SGN7a) (Signalosome subunit 7a) (JAB1-containing signalosome subunit 7a),Mus musculus (Mouse),48.7,271.0,6.5e-66,252.3,sp|Q9CZ04|CSN7A_MOUSE COP9 signalosome complex subunit 7a OS=Mus musculus OX=10090 GN=Cops7a PE=1 SV=2,GO:0000338; GO:0005654; GO:0005829; GO:0008180; GO:0010387,COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338],COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829; GO:0065003,nucleoplasm; cytosol; protein-containing complex assembly
OG_05707,1.4286558193503511,FUN_025580-T1,Peve_00010640,Pocillopora_meandrina_HIv1___RNAseq.g13742.t1,three_way,70.19,FUN_025580-T1,B1AUE5,PEX10_MOUSE,,Peroxisome biogenesis factor 10 (EC 2.3.2.27) (Peroxin-10) (Peroxisomal biogenesis factor 10) (Peroxisome assembly protein 10),Mus musculus (Mouse),43.1,313.0,1.7e-62,241.5,sp|B1AUE5|PEX10_MOUSE Peroxisome biogenesis factor 10 OS=Mus musculus OX=10090 GN=Pex10 PE=2 SV=1,GO:0000209; GO:0005777; GO:0005778; GO:0008270; GO:0016562; GO:0034614; GO:0061630,"cellular response to reactive oxygen species [GO:0034614]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein polyubiquitination [GO:0000209]",peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005777; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; peroxisome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05710,1.0822189635715078,FUN_025585-T1,Peve_00038692,Pocillopora_meandrina_HIv1___TS.g2735.t1,three_way,75.33333333333333,,,,,,,,,,,,,,,,,
OG_05713,1.5660873615011237,FUN_025598-T1,Peve_00041095,Pocillopora_meandrina_HIv1___RNAseq.g23146.t1,three_way,72.71566666666666,FUN_025598-T1,B2RQR8,ECE2_MOUSE,,Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71),Mus musculus (Mouse),41.2,639.0,5.8e-142,506.1,sp|B2RQR8|ECE2_MOUSE Endothelin-converting enzyme 2 OS=Mus musculus OX=10090 GN=Ece2 PE=1 SV=1,GO:0000139; GO:0004222; GO:0005802; GO:0016486; GO:0030658; GO:0046872,peptide hormone processing [GO:0016486],Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_05715,1.5144871487367046,FUN_025600-T1,Peve_00006554,Pocillopora_meandrina_HIv1___RNAseq.g23141.t1,three_way,73.26283333333333,FUN_025600-T1,A1A4J7,,,,,31.7,819.0,5.300000000000001e-100,367.1,sp|A1A4J7|SMG8_BOVIN Nonsense-mediated mRNA decay factor SMG8 OS=Bos taurus OX=9913 GN=SMG8 PE=2 SV=2,,,,,,
OG_05716,1.3157812232334445,FUN_025604-T1,Peve_00006549,Pocillopora_meandrina_HIv1___RNAseq.g23137.t1,three_way,68.401,FUN_025604-T1,P29274,AA2AR_HUMAN,,Adenosine receptor A2a,Homo sapiens (Human),29.1,313.0,7.5e-17,90.5,sp|P29274|AA2AR_HUMAN Adenosine receptor A2a OS=Homo sapiens OX=9606 GN=ADORA2A PE=1 SV=2,GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005882; GO:0005886; GO:0006355; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007188; GO:0007189; GO:0007200; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0008289; GO:0009410; GO:0014049; GO:0014057; GO:0014061; GO:0014074; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0042311; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0070374; GO:0097190; GO:0098978; GO:0099171; GO:1900273; GO:2001235,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of calcium ion transport [GO:0051924]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]",asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734],alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802],GO:0003013; GO:0003014; GO:0005886; GO:0006355; GO:0006954; GO:0008092; GO:0008289; GO:0012501; GO:0016192; GO:0023052; GO:0048856; GO:0050877; GO:0060089,circulatory system process; renal system process; plasma membrane; regulation of DNA-templated transcription; inflammatory response; cytoskeletal protein binding; lipid binding; programmed cell death; vesicle-mediated transport; signaling; anatomical structure development; nervous system process; molecular transducer activity
OG_05719,1.9570446767544016,FUN_025624-T1,Peve_00009538,Pocillopora_meandrina_HIv1___RNAseq.g23127.t1,three_way,56.78766666666667,,,,,,,,,,,,,,,,,
OG_05723,2.600139269446613,FUN_025642-T1,Peve_00039651,Pocillopora_meandrina_HIv1___RNAseq.g23097.t1,three_way,81.889,FUN_025642-T1,Q5I598,MTHR_BOVIN,,Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53),Bos taurus (Bovine),63.3,602.0,5.7e-238,825.1,sp|Q5I598|MTHR_BOVIN Methylenetetrahydrofolate reductase (NADPH) OS=Bos taurus OX=9913 GN=MTHFR PE=2 SV=1,GO:0004489; GO:0009086; GO:0035999; GO:0071949; GO:0106313,methionine biosynthetic process [GO:0009086]; tetrahydrofolate interconversion [GO:0035999],,FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase (NADPH) activity [GO:0106313],GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0016491,catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity
OG_05726,2.6977729326396025,FUN_025649-T1,Peve_00039652,Pocillopora_meandrina_HIv1___RNAseq.g23087.t2c,three_way,52.45816666666667,,,,,,,,,,,,,,,,,
OG_05727,3.097994103025519,FUN_025650-T1,Peve_00002528,Pocillopora_meandrina_HIv1___RNAseq.g23087.t2a,three_way,85.454,,,,,,,,,,,,,,,,,
OG_05728,2.305499120102275,FUN_025651-T1,Peve_00002530,Pocillopora_meandrina_HIv1___RNAseq.g23086.t1,three_way,78.245,FUN_025651-T1,Q9Z1L0,PK3CB_RAT,,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1)",Rattus norvegicus (Rat),46.3,1059.0,4.4e-264,912.5,"sp|Q9Z1L0|PK3CB_RAT Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform OS=Rattus norvegicus OX=10116 GN=Pik3cb PE=2 SV=1",GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0007156; GO:0010595; GO:0010628; GO:0016303; GO:0016477; GO:0030168; GO:0031526; GO:0033031; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0042267; GO:0043409; GO:0043491; GO:0043560; GO:0045429; GO:0046854; GO:0046934; GO:0048015; GO:0051898; GO:0060055; GO:0106310; GO:1900747; GO:1903298; GO:1903671,angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intracellular calcium ion homeostasis [GO:0006874]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; response to ischemia [GO:0002931]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376],"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]","1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; protein serine kinase activity [GO:0106310]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006629; GO:0006914; GO:0007155; GO:0016192; GO:0016740; GO:0043226; GO:0048870; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; lipid metabolic process; autophagy; cell adhesion; vesicle-mediated transport; transferase activity; organelle; cell motility; defense response to other organism; catalytic activity, acting on a protein"
OG_05729,1.9663134194928384,FUN_025654-T1,Peve_00002534,Pocillopora_meandrina_HIv1___RNAseq.g23083.t1,three_way,64.02466666666666,FUN_025654-T1,A4IH36,,,,,33.0,203.0,3.6e-23,110.5,sp|A4IH36|ADIPL_XENTR Adipolin OS=Xenopus tropicalis OX=8364 GN=c1qtnf12 PE=2 SV=1,,,,,,
OG_05730,1.594062694005801,FUN_025656-T1,Peve_00042177,Pocillopora_meandrina_HIv1___RNAseq.g23077.t1,three_way,71.13966666666667,FUN_025656-T1,Q96LK0,,,,,39.9,158.0,9.6e-25,114.8,sp|Q96LK0|CEP19_HUMAN Centrosomal protein of 19 kDa OS=Homo sapiens OX=9606 GN=CEP19 PE=1 SV=2,,,,,,
OG_05731,5.430032311701793,FUN_025657-T1,Peve_00042176,Pocillopora_meandrina_HIv1___RNAseq.g23075.t1,three_way,71.07683333333333,FUN_025657-T1,P17863,,,,,33.1,341.0,1.1e-45,186.4,sp|P17863|SKI_AVIES Transforming protein Ski OS=Avian erythroblastosis virus (strain Sloan-Kettering) OX=11862 GN=V-SKI PE=1 SV=1,,,,,,
OG_05732,3.48283522975374,FUN_025658-T1,Peve_00042175,Pocillopora_meandrina_HIv1___RNAseq.g23074.t1,three_way,65.081,FUN_025658-T1,Q8C033,ARHGA_MOUSE,,Rho guanine nucleotide exchange factor 10,Mus musculus (Mouse),34.0,920.0,1.1e-133,479.9,sp|Q8C033|ARHGA_MOUSE Rho guanine nucleotide exchange factor 10 OS=Mus musculus OX=10090 GN=Arhgef10 PE=1 SV=2,GO:0005085; GO:0005813; GO:0019894; GO:0022011; GO:0035025; GO:0051298; GO:0051496; GO:0090307,centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496],centrosome [GO:0005813],guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894],GO:0005815; GO:0007010; GO:0008092; GO:0098772,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; molecular function regulator activity
OG_05734,1.5970404820636668,FUN_025660-T1,Peve_00042171,Pocillopora_meandrina_HIv1___RNAseq.g23068.t1,three_way,78.61866666666667,FUN_025660-T1,B0DOB4,NPHP4_XENLA,,Nephrocystin-4,Xenopus laevis (African clawed frog),41.9,1048.0,1.8e-222,774.2,sp|B0DOB4|NPHP4_XENLA Nephrocystin-4 OS=Xenopus laevis OX=8355 GN=nphp4 PE=2 SV=1,GO:0005737; GO:0035869; GO:0036064; GO:0090090; GO:0097546; GO:0097730; GO:1904491,negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein localization to ciliary transition zone [GO:1904491],ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_05741,1.100431606877734,FUN_025668-T1,Peve_00042161,Pocillopora_meandrina_HIv1___RNAseq.g23059.t1,three_way,84.68433333333333,,,,,,,,,,,,,,,,,
OG_05745,1.446465074703319,FUN_025672-T1,Peve_00042189,Pocillopora_meandrina_HIv1___RNAseq.g23055.t1,three_way,85.41666666666667,FUN_025672-T1,Q7F0J0,,,,,45.2,146.0,7.6e-31,135.6,sp|Q7F0J0|CML13_ORYSJ Probable calcium-binding protein CML13 OS=Oryza sativa subsp. japonica OX=39947 GN=CML13 PE=2 SV=1,,,,,,
OG_05746,1.7337928479127505,FUN_025673-T1,Peve_00023389,Pocillopora_meandrina_HIv1___RNAseq.g1882.t1,three_way,79.89666666666666,FUN_025673-T1,C3YWU0,FUCO_BRAFL,,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),Branchiostoma floridae (Florida lancelet) (Amphioxus),62.1,449.0,3.8000000000000004e-180,632.5,sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2,GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139,fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],extracellular region [GO:0005576]; lysosome [GO:0005764],alpha-L-fucosidase activity [GO:0004560],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0005975; GO:0016787; GO:0043226; GO:1901135,catalytic activity; extracellular region; lysosome; vacuole; carbohydrate metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_05751,1.720564488418744,FUN_025683-T2,Peve_00000457,Pocillopora_meandrina_HIv1___RNAseq.g13113.t1,three_way,56.72566666666667,FUN_025683-T2,O57460,TLL1_DANRE,,Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein),Danio rerio (Zebrafish) (Brachydanio rerio),34.0,141.0,1.2e-16,89.7,sp|O57460|TLL1_DANRE Dorsal-ventral patterning tolloid-like protein 1 OS=Danio rerio OX=7955 GN=tll1 PE=2 SV=1,GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264,blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular region [GO:0005576]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_05752,1.5892187630013153,FUN_025684-T1,Peve_00000458,Pocillopora_meandrina_HIv1___RNAseq.g13117.t1,three_way,62.62833333333333,,,,,,,,,,,,,,,,,
OG_05753,3.846272403737152,FUN_025686-T1,Peve_00022755,Pocillopora_meandrina_HIv1___RNAseq.g13112.t1,three_way,71.20066666666666,FUN_025686-T1,O76075,,,,,35.7,328.0,1.5999999999999999e-55,218.0,sp|O76075|DFFB_HUMAN DNA fragmentation factor subunit beta OS=Homo sapiens OX=9606 GN=DFFB PE=1 SV=1,,,,,,
OG_05754,1.2155003838086111,FUN_025689-T1,Peve_00005582,Pocillopora_meandrina_HIv1___RNAseq.g13163.t2a,three_way,81.69233333333334,FUN_025689-T1,P58058,,,,,53.0,389.0,1.3999999999999999e-112,407.9,sp|P58058|NADK_MOUSE NAD kinase OS=Mus musculus OX=10090 GN=Nadk PE=1 SV=2,,,,,,
OG_05757,5.208677974653829,FUN_025692-T1,Peve_00005578,Pocillopora_meandrina_HIv1___RNAseq.g13161.t2,three_way,54.39333333333333,,,,,,,,,,,,,,,,,
OG_05761,3.219014411934966,FUN_025702-T1,Peve_00004694,Pocillopora_meandrina_HIv1___RNAseq.g13827.t1,three_way,44.88766666666667,FUN_025702-T1,Q08D19,,,,,43.6,110.0,8.7e-14,80.1,sp|Q08D19|GOLI4_XENTR Golgi integral membrane protein 4 OS=Xenopus tropicalis OX=8364 GN=golim4 PE=2 SV=2,,,,,,
OG_05763,1.010538860713352,FUN_025720-T1,Peve_00014084,Pocillopora_meandrina_HIv1___RNAseq.g10451.t1,three_way,60.96366666666667,,,,,,,,,,,,,,,,,
OG_05765,3.996102392797824,FUN_025723-T1,Peve_00001126,Pocillopora_meandrina_HIv1___RNAseq.g10454.t2,three_way,89.69200000000001,FUN_025723-T1,Q14566,MCM6_HUMAN,,DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM),Homo sapiens (Human),70.7,808.0,0.0,1134.0,sp|Q14566|MCM6_HUMAN DNA replication licensing factor MCM6 OS=Homo sapiens OX=9606 GN=MCM6 PE=1 SV=1,GO:0000727; GO:0000781; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0042802; GO:0071162; GO:1902969,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; regulation of DNA-templated DNA replication initiation [GO:0030174],"chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_05766,1.2049948189626247,FUN_025724-T1,Peve_00001160,Pocillopora_meandrina_HIv1___RNAseq.g10456.t1,three_way,61.71366666666667,FUN_025724-T1,Q5NUA6,NF2L2_BOVIN,,"Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2)",Bos taurus (Bovine),43.4,122.0,1e-17,93.2,sp|Q5NUA6|NF2L2_BOVIN Nuclear factor erythroid 2-related factor 2 OS=Bos taurus OX=9913 GN=NFE2L2 PE=2 SV=2,GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0010499; GO:0016567; GO:0034599; GO:0043161; GO:0043565; GO:0045088; GO:0045454; GO:0045944; GO:0071498; GO:0110076,cell redox homeostasis [GO:0045454]; cellular response to fluid shear stress [GO:0071498]; cellular response to oxidative stress [GO:0034599]; negative regulation of ferroptosis [GO:0110076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of innate immune response [GO:0045088]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; transcription regulator activity
OG_05770,1.1745146437516298,FUN_025730-T1,Peve_00035630,Pocillopora_meandrina_HIv1___RNAseq.g10436.t1,three_way,81.93766666666667,FUN_025730-T1,A5D8W1,CFA69_HUMAN,,Cilia- and flagella-associated protein 69,Homo sapiens (Human),40.2,895.0,9.3e-194,678.7,sp|A5D8W1|CFA69_HUMAN Cilia- and flagella-associated protein 69 OS=Homo sapiens OX=9606 GN=CFAP69 PE=1 SV=3,GO:0005737; GO:0007288; GO:0007608; GO:0030317; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834,flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288],cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225],,GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_05772,2.3014884712085366,FUN_025734-T1,Peve_00013274,Pocillopora_meandrina_HIv1___TS.g13847.t1,three_way,69.05016666666667,FUN_025734-T1,Q68DK7,MSL1_HUMAN,,Male-specific lethal 1 homolog (MSL-1) (Male-specific lethal 1-like 1) (MSL1-like 1) (Male-specific lethal-1 homolog 1),Homo sapiens (Human),39.4,127.0,1.1e-14,82.8,sp|Q68DK7|MSL1_HUMAN Male-specific lethal 1 homolog OS=Homo sapiens OX=9606 GN=MSL1 PE=1 SV=3,GO:0005634; GO:0005654; GO:0006338; GO:0016607; GO:0030674; GO:0045893; GO:0072487,chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893],MSL complex [GO:0072487]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],protein-macromolecule adaptor activity [GO:0030674],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0060090,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_05775,1.8255418822794205,FUN_025738-T1,Peve_00008539,Pocillopora_meandrina_HIv1___RNAseq.g30315.t1,three_way,59.97833333333333,,,,,,,,,,,,,,,,,
OG_05776,3.270506701764796,FUN_025745-T1,Peve_00008538,Pocillopora_meandrina_HIv1___TS.g13844.t2,three_way,50.434333333333335,FUN_025745-T1,Q86XL3,ANKL2_HUMAN,,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),Homo sapiens (Human),28.6,889.0,7.4e-84,313.5,sp|Q86XL3|ANKL2_HUMAN Ankyrin repeat and LEM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ANKLE2 PE=1 SV=4,GO:0004860; GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0016020; GO:0019888; GO:0042326; GO:0043066; GO:0050790; GO:0051301; GO:0051721,cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; regulation of catalytic activity [GO:0050790],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],protein kinase inhibitor activity [GO:0004860]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888],GO:0005783; GO:0043226; GO:0048856; GO:0061024; GO:0098772,endoplasmic reticulum; organelle; anatomical structure development; membrane organization; molecular function regulator activity
OG_05779,3.5996296263960184,FUN_025750-T1,Peve_00007726,Pocillopora_meandrina_HIv1___RNAseq.g10411.t1,three_way,86.325,FUN_025750-T1,O57656,,,,,52.3,392.0,2.1999999999999998e-107,390.6,"sp|O57656|GPDA_TAKRU Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic OS=Takifugu rubripes OX=31033 GN=gpd1 PE=3 SV=1",,,,,,
OG_05780,3.875533798353412,FUN_025751-T1,Peve_00007731,Pocillopora_meandrina_HIv1___RNAseq.g10407.t1,three_way,81.0305,FUN_025751-T1,A2A935,PRD16_MOUSE,,Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.367) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1),Mus musculus (Mouse),24.8,298.0,1.1e-20,103.2,sp|A2A935|PRD16_MOUSE Histone-lysine N-methyltransferase PRDM16 OS=Mus musculus OX=10090 GN=Prdm16 PE=1 SV=1,GO:0000122; GO:0001228; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0008270; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0032259; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162; GO:0140947; GO:0140948,brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; histone H3K9me2 methyltransferase activity [GO:0140947]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_05782,1.6263632347580108,FUN_025756-T1,Peve_00040609,Pocillopora_meandrina_HIv1___RNAseq.26310_t,three_way,71.92066666666666,FUN_025756-T1,Q91ZS8,RED1_MOUSE,,Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase),Mus musculus (Mouse),46.2,643.0,3.6e-145,516.9,sp|Q91ZS8|RED1_MOUSE Double-stranded RNA-specific editase 1 OS=Mus musculus OX=10090 GN=Adarb1 PE=1 SV=1,GO:0003723; GO:0003725; GO:0003726; GO:0004000; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008285; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049,adenosine to inosine editing [GO:0006382]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202],adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0012501; GO:0016071; GO:0016787; GO:0023052; GO:0043226; GO:0050877,RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; programmed cell death; mRNA metabolic process; hydrolase activity; signaling; organelle; nervous system process
OG_05783,3.8773203866595134,FUN_025757-T1,Peve_00029936,Pocillopora_meandrina_HIv1___RNAseq.g10418.t1,three_way,73.75783333333334,FUN_025757-T1,Q5R4D6,LEO1_PONAB,,RNA polymerase-associated protein LEO1,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),67.6,256.0,2.5000000000000002e-89,330.9,sp|Q5R4D6|LEO1_PONAB RNA polymerase-associated protein LEO1 OS=Pongo abelii OX=9601 GN=LEO1 PE=2 SV=1,GO:0001711; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:0031124; GO:0032968; GO:0045638; GO:1990269,endodermal cell fate commitment [GO:0001711]; mRNA 3'-end processing [GO:0031124]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593],RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269],GO:0006355; GO:0016071,regulation of DNA-templated transcription; mRNA metabolic process
OG_05784,1.5615014043890154,FUN_025758-T1,Peve_00040618,Pocillopora_meandrina_HIv1___RNAseq.g10419.t1,three_way,66.84783333333333,FUN_025758-T1,Q3TVI4,,,,,39.1,169.0,3.4e-16,87.4,sp|Q3TVI4|HEXI2_MOUSE Protein HEXIM2 OS=Mus musculus OX=10090 GN=Hexim2 PE=1 SV=1,,,,,,
OG_05790,1.312127505474202,FUN_025768-T1,Peve_00021329,Pocillopora_meandrina_HIv1___RNAseq.g10371.t1,three_way,68.259,FUN_025768-T1,Q6GL69,,,,,49.5,192.0,2.9e-44,180.3,sp|Q6GL69|MK67I_XENTR MKI67 FHA domain-interacting nucleolar phosphoprotein-like OS=Xenopus tropicalis OX=8364 GN=nifk PE=2 SV=1,,,,,,
OG_05793,1.2537872429372638,FUN_025774-T1,Peve_00016582,Pocillopora_meandrina_HIv1___RNAseq.g10364.t1,three_way,67.209,FUN_025774-T1,Q66IB8,,,,,55.5,119.0,2.600000000000001e-33,142.9,sp|Q66IB8|CB076_DANRE UPF0538 protein C2orf76 homolog OS=Danio rerio OX=7955 GN=zgc:101851 PE=2 SV=1,,,,,,
OG_05796,1.102646133324735,FUN_025778-T1,Peve_00009659,Pocillopora_meandrina_HIv1___RNAseq.g10360.t1,three_way,63.86666666666667,,,,,,,,,,,,,,,,,
OG_05800,1.6796180902095403,FUN_025786-T1,Peve_00003054,Pocillopora_meandrina_HIv1___RNAseq.g10392.t1,three_way,81.36866666666667,FUN_025786-T1,Q8VHI3,OFUT2_MOUSE,,GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2),Mus musculus (Mouse),56.2,390.0,3.200000000000001e-130,467.2,sp|Q8VHI3|OFUT2_MOUSE GDP-fucose protein O-fucosyltransferase 2 OS=Mus musculus OX=10090 GN=Pofut2 PE=1 SV=1,GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0008417; GO:0010468; GO:0010717; GO:0036065; GO:0036066; GO:0046922; GO:0051046; GO:1903334,fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; mesoderm formation [GO:0001707]; positive regulation of protein folding [GO:1903334]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922],GO:0003824; GO:0005794; GO:0005975; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_05803,2.003184497606008,FUN_025793-T1,Peve_00021012,Pocillopora_meandrina_HIv1___RNAseq.g10402.t1,three_way,55.269666666666666,FUN_025793-T1,Q6R3M4,POLI_MOUSE,,DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B),Mus musculus (Mouse),40.9,541.0,1.2e-94,349.0,sp|Q6R3M4|POLI_MOUSE DNA polymerase iota OS=Mus musculus OX=10090 GN=Poli PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0019985; GO:0046872; GO:0071494,cellular response to UV-C [GO:0071494]; DNA replication [GO:0006260]; translesion synthesis [GO:0019985],nucleus [GO:0005634],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_05805,2.9450203845140037,FUN_025800-T1,Peve_00017926,Pocillopora_meandrina_HIv1___RNAseq.g10386.t2,three_way,84.613,FUN_025800-T1,Q8VDT1,,,,,52.0,666.0,8.599999999999999e-189,661.8,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_05810,1.9862150867694333,FUN_025810-T1,Peve_00002517,Pocillopora_meandrina_HIv1___RNAseq.g9333.t1,three_way,83.25233333333333,FUN_025810-T1,Q9Y6W3,CAN7_HUMAN,,Calpain-7 (EC 3.4.22.-) (PalB homolog) (PalBH),Homo sapiens (Human),52.7,522.0,7.499999999999999e-143,508.8,sp|Q9Y6W3|CAN7_HUMAN Calpain-7 OS=Homo sapiens OX=9606 GN=CAPN7 PE=1 SV=1,GO:0004175; GO:0004197; GO:0004198; GO:0005634; GO:0005813; GO:0005829; GO:0006508; GO:0010634; GO:0070062; GO:0090541; GO:0097264,positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264],centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; MIT domain binding [GO:0090541],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05814,1.891780409300009,FUN_025820-T1,Peve_00033995,Pocillopora_meandrina_HIv1___RNAseq.g9340.t1,three_way,77.072,FUN_025820-T1,A7RHG8,,,,,52.2,429.0,1.1e-131,471.5,sp|A7RHG8|WDR12_NEMVE Ribosome biogenesis protein WDR12 homolog (Fragment) OS=Nematostella vectensis OX=45351 GN=v1g82024 PE=3 SV=1,,,,,,
OG_05817,2.039566554345416,FUN_025824-T1,Peve_00036284,Pocillopora_meandrina_HIv1___RNAseq.g9344.t1,three_way,88.77216666666666,FUN_025824-T1,Q9GM70,,,,,50.4,282.0,9e-78,292.0,sp|Q9GM70|ST17A_RABIT Serine/threonine-protein kinase 17A OS=Oryctolagus cuniculus OX=9986 GN=STK17A PE=2 SV=1,,,,,,
OG_05818,1.4613516144695755,FUN_025825-T2,Peve_00036287,Pocillopora_meandrina_HIv1___RNAseq.g9345.t1,three_way,78.706,FUN_025825-T2,P54513,,,,,32.3,195.0,9.9e-15,83.6,sp|P54513|YQHO_BACSU Uncharacterized protein YqhO OS=Bacillus subtilis (strain 168) OX=224308 GN=yqhO PE=3 SV=1,,,,,,
OG_05820,1.7658270665941034,FUN_025835-T1,Peve_00028303,Pocillopora_meandrina_HIv1___RNAseq.g9347.t1,three_way,68.652,FUN_025835-T1,P08684,CP3A4_HUMAN,,"Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)",Homo sapiens (Human),36.3,482.0,3.3000000000000003e-78,293.9,sp|P08684|CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens OX=9606 GN=CYP3A4 PE=1 SV=4,GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006629; GO:0006706; GO:0006805; GO:0008202; GO:0008203; GO:0008209; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016098; GO:0016491; GO:0019825; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0042759; GO:0043231; GO:0046222; GO:0050591; GO:0050649; GO:0062181; GO:0062187; GO:0062188; GO:0062189; GO:0070576; GO:0070989; GO:0101020; GO:0101021; GO:0102320,aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; androgen metabolic process [GO:0008209]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"1,8-cineole 2-exo-monooxygenase activity [GO:0102320]; 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; quinine 3-monooxygenase activity [GO:0050591]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491; GO:0043226,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity; organelle
OG_05821,2.20063059186339,FUN_025836-T1,Peve_00028304,Pocillopora_meandrina_HIv1___RNAseq.g10325.t1b,three_way,67.41033333333334,FUN_025836-T1,Q9DBC0,SELO_MOUSE,,"Protein adenylyltransferase SelO, mitochondrial (EC 2.7.7.-) (EC 2.7.7.108) (Selenoprotein O) (SelO)",Mus musculus (Mouse),46.7,642.0,4.0999999999999995e-148,526.6,"sp|Q9DBC0|SELO_MOUSE Protein adenylyltransferase SelO, mitochondrial OS=Mus musculus OX=10090 GN=Selenoo PE=1 SV=4",GO:0005524; GO:0005694; GO:0005739; GO:0046872; GO:0070733,,chromosome [GO:0005694]; mitochondrion [GO:0005739],AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],GO:0003824; GO:0005694; GO:0005739; GO:0016740; GO:0043226,catalytic activity; chromosome; mitochondrion; transferase activity; organelle
OG_05822,2.1253519033735504,FUN_025838-T1,Peve_00028309,Pocillopora_meandrina_HIv1___RNAseq.g10332.t1,three_way,68.98100000000001,FUN_025838-T1,Q14957,NMDE3_HUMAN,,"Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C)",Homo sapiens (Human),25.0,472.0,4.799999999999997e-41,171.4,"sp|Q14957|NMDE3_HUMAN Glutamate receptor ionotropic, NMDA 2C OS=Homo sapiens OX=9606 GN=GRIN2C PE=1 SV=3",GO:0004972; GO:0005261; GO:0005789; GO:0005886; GO:0007215; GO:0007420; GO:0009611; GO:0017146; GO:0033058; GO:0035235; GO:0035249; GO:0042177; GO:0045211; GO:0048167; GO:0048168; GO:0050885; GO:0051968; GO:0060079; GO:0060291; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:0098978; GO:1903539; GO:1904062; GO:1904315; GO:2000463,"brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; directional locomotion [GO:0033058]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic potentiation [GO:0060291]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process controlling balance [GO:0050885]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein localization to postsynaptic membrane [GO:1903539]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611]; synaptic transmission, glutamatergic [GO:0035249]",endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211],monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_05825,1.851685802737134,FUN_025842-T1,Peve_00028315,Pocillopora_meandrina_HIv1___TS.g13751.t1,three_way,74.87866666666667,FUN_025842-T1,Q91WG5,AAKG2_MOUSE,,5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2),Mus musculus (Mouse),61.1,314.0,5.6e-108,392.9,sp|Q91WG5|AAKG2_MOUSE 5'-AMP-activated protein kinase subunit gamma-2 OS=Mus musculus OX=10090 GN=Prkag2 PE=1 SV=2,GO:0004679; GO:0004862; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0006110; GO:0006633; GO:0008607; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0031669; GO:0035556; GO:0043531,cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588],ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887],GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0006629; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; lipid metabolic process; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05827,1.122319694164881,FUN_025844-T1,Peve_00028317,Pocillopora_meandrina_HIv1___RNAseq.g10340.t2a,three_way,92.42766666666668,FUN_025844-T1,Q60HG1,,,,,68.5,771.0,6e-298,1024.6,sp|Q60HG1|ERCC3_MACFA General transcription and DNA repair factor IIH helicase/translocase subunit XPB OS=Macaca fascicularis OX=9541 GN=ERCC3 PE=2 SV=1,,,,,,
OG_05828,1.677440181656086,FUN_025845-T1,Peve_00012183,Pocillopora_meandrina_HIv1___RNAseq.g10340.t2b,three_way,73.04216666666667,FUN_025845-T1,P42768,WASP_HUMAN,,Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp),Homo sapiens (Human),38.9,293.0,2.1000000000000005e-44,181.8,sp|P42768|WASP_HUMAN Actin nucleation-promoting factor WAS OS=Homo sapiens OX=9606 GN=WAS PE=1 SV=4,GO:0002625; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0051492; GO:0051497; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146,actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to type II interferon [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506],actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267],GO:0002376; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0048856; GO:0065003; GO:0098772,immune system process; nucleus; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_05829,1.979644360075352,FUN_025847-T1,Peve_00012182,Pocillopora_meandrina_HIv1___TS.g13754.t1,three_way,63.074,FUN_025847-T1,Q9NZA1,CLIC5_HUMAN,,Chloride intracellular channel protein 5 (Glutaredoxin-like oxidoreductase CLIC5) (EC 1.8.-.-),Homo sapiens (Human),34.1,223.0,1.5e-20,101.3,sp|Q9NZA1|CLIC5_HUMAN Chloride intracellular channel protein 5 OS=Homo sapiens OX=9606 GN=CLIC5 PE=1 SV=3,GO:0005254; GO:0005739; GO:0005794; GO:0005813; GO:0005938; GO:0006821; GO:0007565; GO:0007601; GO:0007605; GO:0015629; GO:0016324; GO:0016491; GO:0032420; GO:0034707; GO:0070062,chloride transport [GO:0006821]; female pregnancy [GO:0007565]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; stereocilium [GO:0032420],chloride channel activity [GO:0005254]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005215; GO:0005739; GO:0005794; GO:0005815; GO:0005856; GO:0016491; GO:0022414; GO:0043226; GO:0050877,catalytic activity; transporter activity; mitochondrion; Golgi apparatus; microtubule organizing center; cytoskeleton; oxidoreductase activity; reproductive process; organelle; nervous system process
OG_05833,1.0409144033017128,FUN_025877-T1,Peve_00006434,Pocillopora_meandrina_HIv1___RNAseq.g9351.t1c,three_way,59.905,FUN_025877-T1,Q91ZV7,PLDX1_MOUSE,,Plexin domain-containing protein 1 (Tumor endothelial marker 7),Mus musculus (Mouse),38.3,295.0,4.2e-53,210.3,sp|Q91ZV7|PLDX1_MOUSE Plexin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Plxdc1 PE=1 SV=2,GO:0005576; GO:0005737; GO:0005886; GO:0005923; GO:0021510; GO:0030425; GO:0043025; GO:0043235,spinal cord development [GO:0021510],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],,GO:0005576; GO:0005886; GO:0048856,extracellular region; plasma membrane; anatomical structure development
OG_05834,2.0355674207366583,FUN_025878-T1,Peve_00006435,Pocillopora_meandrina_HIv1___RNAseq.g3176.t1,three_way,82.42066666666666,FUN_025878-T1,Q61753,,,,,53.8,463.0,7.000000000000002e-130,465.7,sp|Q61753|SERA_MOUSE D-3-phosphoglycerate dehydrogenase OS=Mus musculus OX=10090 GN=Phgdh PE=1 SV=3,,,,,,
OG_05835,1.1888537045448675,FUN_025879-T1,Peve_00006436,Pocillopora_meandrina_HIv1___RNAseq.g3178.t1,three_way,64.36766666666666,,,,,,,,,,,,,,,,,
OG_05837,1.5394170821914703,FUN_025883-T1,Peve_00018900,Pocillopora_meandrina_HIv1___TS.g13938.t2,three_way,66.98766666666667,,,,,,,,,,,,,,,,,
OG_05841,3.1996417070425487,FUN_025889-T1,Peve_00024284,Pocillopora_meandrina_HIv1___RNAseq.g10542.t1,three_way,53.60116666666666,FUN_025889-T1,Q5ZM41,,,,,29.0,728.0,7.4e-64,247.3,sp|Q5ZM41|TEX10_CHICK Testis-expressed protein 10 homolog OS=Gallus gallus OX=9031 GN=TEX10 PE=2 SV=1,,,,,,
OG_05842,1.024317083872611,FUN_025911-T2,Peve_00018892,Pocillopora_meandrina_HIv1___RNAseq.g10543.t1,three_way,87.18599999999999,FUN_025911-T2,Q9Y4A5,TRRAP_HUMAN,,Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog),Homo sapiens (Human),57.4,3490.0,0.0,3867.8,sp|Q9Y4A5|TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens OX=9606 GN=TRRAP PE=1 SV=3,GO:0000124; GO:0000786; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006282; GO:0006355; GO:0006357; GO:0033276; GO:0035267; GO:0042981; GO:0043484; GO:0045893; GO:0051726; GO:0140861; GO:1905168; GO:2000779,DNA repair-dependent chromatin remodeling [GO:0140861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357],Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276],transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0005794; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; Golgi apparatus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_05846,1.5834359754834002,FUN_025915-T1,Peve_00010172,Pocillopora_meandrina_HIv1___RNAseq.g10468.t1,three_way,86.59700000000001,FUN_025915-T1,Q6DDF0,,,,,41.7,489.0,1.6999999999999998e-96,354.8,sp|Q6DDF0|WDR37_XENLA WD repeat-containing protein 37 OS=Xenopus laevis OX=8355 GN=wdr37 PE=2 SV=1,,,,,,
OG_05848,2.361338132820903,FUN_025917-T1,Peve_00001158,Pocillopora_meandrina_HIv1___RNAseq.g10466.t1,three_way,67.06833333333333,FUN_025917-T1,Q8C6G1,CF410_MOUSE,,Cilia- and flagella-associated protein 410,Mus musculus (Mouse),38.9,265.0,4.6e-38,159.8,sp|Q8C6G1|CF410_MOUSE Cilia- and flagella-associated protein 410 OS=Mus musculus OX=10090 GN=Cfap410 PE=1 SV=1,GO:0001750; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006974; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0036064; GO:0060271; GO:0097733,cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886],,GO:0005654; GO:0005739; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0043226; GO:0044782,nucleoplasm; mitochondrion; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; organelle; cilium organization
OG_05856,2.7787679105935226,FUN_025935-T1,Peve_00027752,Pocillopora_meandrina_HIv1___RNAseq.g13629.t2,three_way,63.209,FUN_025935-T1,Q4PZA2,ECE1_MOUSE,,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),Mus musculus (Mouse),35.1,701.0,2.4e-126,454.5,sp|Q4PZA2|ECE1_MOUSE Endothelin-converting enzyme 1 OS=Mus musculus OX=10090 GN=Ece1 PE=1 SV=1,GO:0001921; GO:0004222; GO:0005768; GO:0005794; GO:0007411; GO:0008270; GO:0009897; GO:0009986; GO:0010467; GO:0010814; GO:0010815; GO:0010816; GO:0016486; GO:0031175; GO:0033093; GO:0034959; GO:0035050; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0060385; GO:0097492; GO:1902287,axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492],cell surface [GO:0009986]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Weibel-Palade body [GO:0033093],metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005794; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; endosome; Golgi apparatus; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_05857,1.3877160029051163,FUN_025940-T1,Peve_00027756,Pocillopora_meandrina_HIv1___RNAseq.g10537.t1a,three_way,54.245666666666665,,,,,,,,,,,,,,,,,
OG_05858,1.7749389910150792,FUN_025943-T1,Peve_00003741,Pocillopora_meandrina_HIv1___RNAseq.g10538.t1,three_way,71.72466666666666,FUN_025943-T1,B2RZ86,,,,,31.3,355.0,1.8000000000000002e-28,128.3,sp|B2RZ86|CCD89_RAT Coiled-coil domain-containing protein 89 OS=Rattus norvegicus OX=10116 GN=Ccdc89 PE=2 SV=2,,,,,,
OG_05860,2.456817966282776,FUN_025963-T1,Peve_00015816,Pocillopora_meandrina_HIv1___RNAseq.g10514.t1,three_way,62.4445,,,,,,,,,,,,,,,,,
OG_05861,2.2968821722643424,FUN_025968-T1,Peve_00015812,Pocillopora_meandrina_HIv1___RNAseq.g10513.t1,three_way,76.54333333333334,FUN_025968-T1,Q8IZ52,CHSS2_HUMAN,,Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2),Homo sapiens (Human),31.2,794.0,3.2e-100,367.9,sp|Q8IZ52|CHSS2_HUMAN Chondroitin sulfate synthase 2 OS=Homo sapiens OX=9606 GN=CHPF PE=1 SV=2,GO:0000139; GO:0005759; GO:0005829; GO:0032580; GO:0046872; GO:0047238; GO:0050510; GO:0050650,chondroitin sulfate proteoglycan biosynthetic process [GO:0050650],cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; mitochondrial matrix [GO:0005759],glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510],GO:0003824; GO:0005829; GO:0009101; GO:0016740; GO:1901135,catalytic activity; cytosol; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_05863,1.142653428117994,FUN_025970-T1,Peve_00002912,Pocillopora_meandrina_HIv1___RNAseq.g10511.t1,three_way,65.593,FUN_025970-T1,Q6XYQ8,SYT10_HUMAN,,Synaptotagmin-10 (Synaptotagmin X) (SytX),Homo sapiens (Human),44.2,113.0,7e-19,95.9,sp|Q6XYQ8|SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens OX=9606 GN=SYT10 PE=1 SV=1,GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0006887; GO:0007268; GO:0007608; GO:0016192; GO:0017158; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0061891; GO:0070382; GO:0098793; GO:0098978,chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192],exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658],"calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]",GO:0005886; GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0050877; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; nervous system process; molecular function regulator activity; molecular sensor activity
OG_05864,2.163018227681837,FUN_025971-T1,Peve_00002910,Pocillopora_meandrina_HIv1___RNAseq.g10510.t1,three_way,71.926,FUN_025971-T1,Q6XYQ8,SYT10_HUMAN,,Synaptotagmin-10 (Synaptotagmin X) (SytX),Homo sapiens (Human),34.1,229.0,9.900000000000001e-28,125.2,sp|Q6XYQ8|SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens OX=9606 GN=SYT10 PE=1 SV=1,GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0006887; GO:0007268; GO:0007608; GO:0016192; GO:0017158; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0061891; GO:0070382; GO:0098793; GO:0098978,chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192],exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658],"calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]",GO:0005886; GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0050877; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; nervous system process; molecular function regulator activity; molecular sensor activity
OG_05865,1.7339621033022707,FUN_025974-T1,Peve_00002327,Pocillopora_meandrina_HIv1___RNAseq.g10508.t1,three_way,78.03366666666666,,,,,,,,,,,,,,,,,
OG_05868,2.489641805197478,FUN_025977-T1,Peve_00002324,Pocillopora_meandrina_HIv1___RNAseq.g10505.t1,three_way,91.186,FUN_025977-T1,P43450,,,,,76.2,294.0,7.8e-134,478.0,sp|P43450|CDK2_CARAU Cyclin-dependent kinase 2 OS=Carassius auratus OX=7957 GN=cdk2 PE=1 SV=1,,,,,,
OG_05872,3.115776485185642,FUN_026014-T1,Peve_00004062,Pocillopora_meandrina_HIv1___RNAseq.g10490.t1,three_way,68.83616666666667,FUN_026014-T1,Q61122,,,,,30.6,317.0,1.0999999999999998e-24,116.3,sp|Q61122|NAB1_MOUSE NGFI-A-binding protein 1 OS=Mus musculus OX=10090 GN=Nab1 PE=1 SV=2,,,,,,
OG_05873,1.512817260247395,FUN_026015-T1,Peve_00004071,Pocillopora_meandrina_HIv1___RNAseq.g10491.t1,three_way,88.20066666666666,FUN_026015-T1,B0G143,,,,,47.0,298.0,1.8e-72,274.2,sp|B0G143|UCPB_DICDI Mitochondrial substrate carrier family protein ucpB OS=Dictyostelium discoideum OX=44689 GN=ucpB PE=3 SV=1,,,,,,
OG_05874,3.658251402269678,FUN_026023-T1,Peve_00026728,Pocillopora_meandrina_HIv1___RNAseq.g10495.t1,three_way,61.43916666666667,FUN_026023-T1,Q91717,,,,,31.0,277.0,2.3e-26,123.6,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_05875,3.4255905187375264,FUN_026024-T1,Peve_00026729,Pocillopora_meandrina_HIv1___RNAseq.g10496.t1,three_way,59.858,FUN_026024-T1,O46392,,,,,37.0,216.0,5.4e-35,152.1,sp|O46392|CO1A2_CANLF Collagen alpha-2(I) chain OS=Canis lupus familiaris OX=9615 GN=COL1A2 PE=2 SV=2,,,,,,
OG_05877,1.10251778361271,FUN_026027-T1,Peve_00026727,Pocillopora_meandrina_HIv1___RNAseq.g10474.t1,three_way,56.87566666666667,FUN_026027-T1,P32442,MEOX1_MOUSE,,Homeobox protein MOX-1 (Mesenchyme homeobox 1),Mus musculus (Mouse),78.8,66.0,1.8e-23,110.9,sp|P32442|MEOX1_MOUSE Homeobox protein MOX-1 OS=Mus musculus OX=10090 GN=Meox1 PE=1 SV=1,GO:0000978; GO:0001228; GO:0001757; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0043565; GO:0045944; GO:0060218; GO:0061053; GO:0061056; GO:0071837,hematopoietic stem cell differentiation [GO:0060218]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sclerotome development [GO:0061056]; somite development [GO:0061053]; somite specification [GO:0001757],cytoplasm [GO:0005737]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05878,2.508913598635495,FUN_026029-T1,Peve_00003815,Pocillopora_meandrina_HIv1___RNAseq.26365_t,three_way,69.68616666666667,FUN_026029-T1,F1Q4R9,MEOX1_DANRE,,Homeobox protein MOX-1 (Mesenchyme homeobox 1) (Protein choker),Danio rerio (Zebrafish) (Brachydanio rerio),89.1,55.0,6.3e-20,99.4,sp|F1Q4R9|MEOX1_DANRE Homeobox protein MOX-1 OS=Danio rerio OX=7955 GN=meox1 PE=2 SV=1,GO:0000978; GO:0000981; GO:0001501; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0030097; GO:0043565; GO:0045944; GO:0048066; GO:0055001; GO:0060218; GO:0061053; GO:0061056,developmental pigmentation [GO:0048066]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; muscle cell development [GO:0055001]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; skeletal system development [GO:0001501]; somite development [GO:0061053],cytoplasm [GO:0005737]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05879,1.9694402612078827,FUN_026032-T1,Peve_00003809,Pocillopora_meandrina_HIv1___RNAseq.g10470.t1,three_way,63.20466666666667,FUN_026032-T1,P05205,HP1_DROME,,Heterochromatin protein 1 (HP1) (Non-histone chromosomal protein C1A9 antigen),Drosophila melanogaster (Fruit fly),49.7,191.0,4.3e-25,116.3,sp|P05205|HP1_DROME Heterochromatin protein 1 OS=Drosophila melanogaster OX=7227 GN=Su(var)205 PE=1 SV=2,GO:0000182; GO:0000278; GO:0000723; GO:0000775; GO:0000779; GO:0000781; GO:0000791; GO:0000792; GO:0000793; GO:0003682; GO:0003696; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005694; GO:0005700; GO:0005701; GO:0005703; GO:0005721; GO:0006355; GO:0010369; GO:0030544; GO:0030674; GO:0031507; GO:0031508; GO:0035064; GO:0042393; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0051276; GO:0070063; GO:0099122; GO:0141006; GO:0141194; GO:1905632; GO:1905634; GO:1905646,chromosome organization [GO:0051276]; heterochromatin formation [GO:0031507]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-templated transcription [GO:0045892]; pericentric heterochromatin formation [GO:0031508]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to euchromatin [GO:1905632]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization to chromatin [GO:1905634]; siRNA-mediated heterochromatin formation [GO:0141194]; telomere maintenance [GO:0000723]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],"chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696],GO:0000278; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0031047; GO:0032200; GO:0042393; GO:0043226; GO:0060090,mitotic cell cycle; DNA binding; RNA binding; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; regulatory ncRNA-mediated gene silencing; telomere organization; histone binding; organelle; molecular adaptor activity
OG_05880,1.7405852095503866,FUN_026033-T1,Peve_00003810,Pocillopora_meandrina_HIv1___RNAseq.g10469.t1,three_way,72.66566666666667,FUN_026033-T1,Q8BP00,IQCB1_MOUSE,,IQ calmodulin-binding motif-containing protein 1,Mus musculus (Mouse),32.5,569.0,6.2e-74,280.0,sp|Q8BP00|IQCB1_MOUSE IQ calmodulin-binding motif-containing protein 1 OS=Mus musculus OX=10090 GN=Iqcb1 PE=1 SV=2,GO:0001750; GO:0005516; GO:0005737; GO:0005813; GO:0019899; GO:0030674; GO:0032391; GO:0045494; GO:0048496; GO:0060271; GO:0061824; GO:0062063,cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494],centrosome [GO:0005813]; cytoplasm [GO:0005737]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750],BBSome binding [GO:0062063]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674],GO:0005815; GO:0044782; GO:0060090,microtubule organizing center; cilium organization; molecular adaptor activity
OG_05884,2.2287765205614303,FUN_026037-T1,Peve_00025183,Pocillopora_meandrina_HIv1___RNAseq.g10550.t1,three_way,71.07133333333333,FUN_026037-T1,P47727,CBR1_RAT,,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)",Rattus norvegicus (Rat),45.3,278.0,2.3e-66,253.8,sp|P47727|CBR1_RAT Carbonyl reductase [NADPH] 1 OS=Rattus norvegicus OX=10116 GN=Cbr1 PE=1 SV=2,GO:0001542; GO:0004090; GO:0005737; GO:0005902; GO:0006706; GO:0006805; GO:0008211; GO:0016616; GO:0016655; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0047020; GO:0047021; GO:0050221; GO:0160163; GO:1905344; GO:2000379,epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; microvillus [GO:0005902],"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E2 9-reductase activity [GO:0050221]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163]",GO:0003824; GO:0006629; GO:0006766; GO:0016491; GO:0022414; GO:0030154,catalytic activity; lipid metabolic process; vitamin metabolic process; oxidoreductase activity; reproductive process; cell differentiation
OG_05886,1.9740788666702889,FUN_026049-T1,Peve_00022189,Pocillopora_meandrina_HIv1___TS.g13972.t1,three_way,66.42933333333333,FUN_026049-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),35.0,537.0,5.4e-80,300.1,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_05887,2.274859738636232,FUN_026051-T1,Peve_00022190,Pocillopora_meandrina_HIv1___RNAseq.g10553.t1,three_way,59.20016666666667,FUN_026051-T1,Q8NFZ3,,,,,33.3,631.0,7.6e-91,336.3,"sp|Q8NFZ3|NLGNY_HUMAN Neuroligin-4, Y-linked OS=Homo sapiens OX=9606 GN=NLGN4Y PE=1 SV=1",,,,,,
OG_05888,1.3870258310522952,FUN_026052-T1,Peve_00022191,Pocillopora_meandrina_HIv1___RNAseq.g10554.t1,three_way,94.17266666666669,,,,,,,,,,,,,,,,,
OG_05891,2.5688782028718578,FUN_026057-T1,Peve_00022193,Pocillopora_meandrina_HIv1___RNAseq.g10569.t1,three_way,81.50766666666667,FUN_026057-T1,Q66I12,CCD47_DANRE,,PAT complex subunit CCDC47 (Coiled-coil domain-containing protein 47),Danio rerio (Zebrafish) (Brachydanio rerio),44.5,321.0,3.9e-74,280.4,sp|Q66I12|CCD47_DANRE PAT complex subunit CCDC47 OS=Danio rerio OX=7955 GN=ccdc47 PE=2 SV=1,GO:0005509; GO:0005783; GO:0005789; GO:0030867; GO:0032469; GO:0043022; GO:0044183; GO:0045048; GO:0160063; GO:0160064,endoplasmic reticulum calcium ion homeostasis [GO:0032469]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; protein insertion into ER membrane [GO:0045048],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; multi-pass translocon complex [GO:0160064]; rough endoplasmic reticulum membrane [GO:0030867],calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022],GO:0005783; GO:0043226; GO:0044183,endoplasmic reticulum; organelle; protein folding chaperone
OG_05892,1.4552586759773742,FUN_026058-T1,Peve_00022194,Pocillopora_meandrina_HIv1___RNAseq.g10568.t1,three_way,87.0575,FUN_026058-T1,Q9BUQ8,,,,,74.4,575.0,3.3e-256,885.9,sp|Q9BUQ8|DDX23_HUMAN Probable ATP-dependent RNA helicase DDX23 OS=Homo sapiens OX=9606 GN=DDX23 PE=1 SV=3,,,,,,
OG_05897,1.259256282285107,FUN_026073-T1,Peve_00002028,Pocillopora_meandrina_HIv1___RNAseq.g10563.t1a,three_way,88.83766666666666,FUN_026073-T1,Q5F495,,,,,81.9,204.0,3.4000000000000003e-100,365.9,sp|Q5F495|PHOCN_CHICK MOB-like protein phocein OS=Gallus gallus OX=9031 GN=MOB4 PE=2 SV=1,,,,,,
OG_05899,3.037153669808634,FUN_026076-T1,Peve_00002022,Pocillopora_meandrina_HIv1___RNAseq.g10561.t1,three_way,58.79216666666667,FUN_026076-T1,Q9NVE5,,,,,35.0,1254.0,1.6e-196,688.3,sp|Q9NVE5|UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens OX=9606 GN=USP40 PE=1 SV=3,,,,,,
OG_05900,1.3120790402836244,FUN_026078-T1,Peve_00016849,Pocillopora_meandrina_HIv1___RNAseq.g10560.t1,three_way,71.18333333333334,FUN_026078-T1,Q9D1Z3,ACKMT_MOUSE,,ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B) (mFam173b),Mus musculus (Mouse),53.5,187.0,2.9e-50,199.9,sp|Q9D1Z3|ACKMT_MOUSE ATP synthase subunit C lysine N-methyltransferase OS=Mus musculus OX=10090 GN=Atpsckmt PE=1 SV=1,GO:0005739; GO:0016279; GO:0018022; GO:0018023; GO:0030061; GO:1904058; GO:1905273; GO:1905706,"peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]",mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739],protein-lysine N-methyltransferase activity [GO:0016279],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05903,1.4600218448354056,FUN_026088-T1,Peve_00004126,Pocillopora_meandrina_HIv1___RNAseq.g10571.t1,three_way,73.563,FUN_026088-T1,Q5FVG2,E41L5_RAT,,Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5),Rattus norvegicus (Rat),47.5,358.0,2.8e-86,321.6,sp|Q5FVG2|E41L5_RAT Band 4.1-like protein 5 OS=Rattus norvegicus OX=10116 GN=Epb41l5 PE=1 SV=2,GO:0000902; GO:0001701; GO:0001756; GO:0001837; GO:0001839; GO:0001917; GO:0001954; GO:0003382; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007498; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0030036; GO:0031032; GO:0031252; GO:0032525; GO:0032587; GO:0048318; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560,"actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis [GO:0000902]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]",adherens junction [GO:0005912]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904],GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0048870,nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; cell motility
OG_05910,1.8429094413689835,FUN_026101-T1,Peve_00013338,Pocillopora_meandrina_HIv1___RNAseq.g10579.t1,three_way,87.09166666666667,FUN_026101-T1,Q96JG6,,,,,51.6,965.0,9.3e-269,927.9,sp|Q96JG6|VPS50_HUMAN Syndetin OS=Homo sapiens OX=9606 GN=VPS50 PE=1 SV=3,,,,,,
OG_05912,1.0360071843277814,FUN_026103-T1,Peve_00044189,Pocillopora_meandrina_HIv1___RNAseq.g10325.t1a,three_way,77.14266666666667,FUN_026103-T1,Q2TA12,,,,,45.4,207.0,1.9e-44,181.0,sp|Q2TA12|RM02_BOVIN Large ribosomal subunit protein uL2m OS=Bos taurus OX=9913 GN=MRPL2 PE=1 SV=2,,,,,,
OG_05913,1.379270096408472,FUN_026104-T1,Peve_00044188,Pocillopora_meandrina_HIv1___RNAseq.g10324.t1,three_way,89.33133333333333,FUN_026104-T1,P15690,,,,,68.5,695.0,7.7e-284,977.6,"sp|P15690|NDUS1_BOVIN NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS1 PE=1 SV=1",,,,,,
OG_05915,1.5449353318542691,FUN_026107-T1,Peve_00044186,Pocillopora_meandrina_HIv1___RNAseq.g10322.t1,three_way,90.69366666666669,FUN_026107-T1,P22033,MUTA_HUMAN,,"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)",Homo sapiens (Human),74.7,732.0,0.0,1115.5,"sp|P22033|MUTA_HUMAN Methylmalonyl-CoA mutase, mitochondrial OS=Homo sapiens OX=9606 GN=MMUT PE=1 SV=4",GO:0003924; GO:0004494; GO:0005737; GO:0005739; GO:0005759; GO:0009791; GO:0019678; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0050667; GO:0072341; GO:1901290,"homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; propionate metabolic process, methylmalonyl pathway [GO:0019678]; succinyl-CoA biosynthetic process [GO:1901290]",cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0006520; GO:0006629; GO:0006790; GO:0016787; GO:0016853; GO:0043226; GO:0055086,catalytic activity; GTPase activity; mitochondrion; amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; hydrolase activity; isomerase activity; organelle; nucleobase-containing small molecule metabolic process
OG_05916,1.4442976879179,FUN_026108-T1,Peve_00014996,Pocillopora_meandrina_HIv1___RNAseq.g10317.t1,three_way,87.78083333333333,FUN_026108-T1,Q9HD67,MYO10_HUMAN,,Unconventional myosin-X (Unconventional myosin-10),Homo sapiens (Human),45.4,2065.0,0.0,1582.8,sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3,GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002,cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165],cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]",GO:0003774; GO:0003824; GO:0005730; GO:0005829; GO:0005886; GO:0008092; GO:0008289; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleolus; cytosol; plasma membrane; cytoskeletal protein binding; lipid binding; isomerase activity; organelle; ATP-dependent activity
OG_05917,1.461105005833295,FUN_026112-T1,Peve_00014998,Pocillopora_meandrina_HIv1___TS.g13728.t1,three_way,36.16533333333333,,,,,,,,,,,,,,,,,
OG_05919,1.0106425529561207,FUN_026115-T1,Peve_00013997,Pocillopora_meandrina_HIv1___RNAseq.20147_t,three_way,55.01466666666666,,,,,,,,,,,,,,,,,
OG_05924,1.1396289370508372,FUN_026147-T1,Peve_00014874,Pocillopora_meandrina_HIv1___RNAseq.g3231.t1,three_way,62.565,FUN_026147-T1,Q24K03,,,,,39.3,336.0,1.8e-52,208.0,sp|Q24K03|THUM1_BOVIN THUMP domain-containing protein 1 OS=Bos taurus OX=9913 GN=THUMPD1 PE=2 SV=1,,,,,,
OG_05925,2.2899651435711657,FUN_026148-T1,Peve_00014875,Pocillopora_meandrina_HIv1___RNAseq.g3232.t1,three_way,87.95866666666667,FUN_026148-T1,Q64261,CDK6_MOUSE,,Cyclin-dependent kinase 6 (EC 2.7.11.22) (CR2 protein kinase) (CRK2) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE),Mus musculus (Mouse),68.0,222.0,6.7e-85,315.1,sp|Q64261|CDK6_MOUSE Cyclin-dependent kinase 6 OS=Mus musculus OX=10090 GN=Cdk6 PE=1 SV=2,GO:0000082; GO:0000122; GO:0001726; GO:0001954; GO:0002244; GO:0003323; GO:0004693; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0006974; GO:0007219; GO:0009615; GO:0010628; GO:0016301; GO:0030097; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0050680; GO:0051301; GO:0060218; GO:0097131; GO:0097132; GO:0097133; GO:0098770; GO:0106310; GO:1902036; GO:2000773,cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; DNA damage response [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; regulation of erythrocyte differentiation [GO:0045646]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],centrosome [GO:0005813]; cyclin D1-CDK6 complex [GO:0097131]; cyclin D2-CDK6 complex [GO:0097132]; cyclin D3-CDK6 complex [GO:0097133]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ruffle [GO:0001726],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310],GO:0002376; GO:0003824; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0016740; GO:0030154; GO:0048856; GO:0140096,"immune system process; catalytic activity; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; transferase activity; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_05926,3.3008874946046967,FUN_026150-T1,Peve_00020731,Pocillopora_meandrina_HIv1___RNAseq.g3216.t1,three_way,83.78333333333333,FUN_026150-T1,Q9UJ83,HACL1_HUMAN,,2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.63) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2),Homo sapiens (Human),60.0,578.0,2.3e-206,719.9,sp|Q9UJ83|HACL1_HUMAN 2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2,GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:0106359; GO:0106376; GO:1903512,fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],2-hydroxyacyl-CoA lyase activity [GO:0106359]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0005654; GO:0005777; GO:0005829; GO:0006629; GO:0016829; GO:0043226,catalytic activity; nucleoplasm; peroxisome; cytosol; lipid metabolic process; lyase activity; organelle
OG_05928,2.232934953045409,FUN_026154-T1,Peve_00000925,Pocillopora_meandrina_HIv1___RNAseq.g3213.t1,three_way,86.743,FUN_026154-T1,O60921,HUS1_HUMAN,,Checkpoint protein HUS1 (hHUS1),Homo sapiens (Human),53.2,282.0,1.7e-82,307.4,sp|O60921|HUS1_HUMAN Checkpoint protein HUS1 OS=Homo sapiens OX=9606 GN=HUS1 PE=1 SV=1,GO:0000077; GO:0000723; GO:0000724; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006289; GO:0006974; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479,cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; response to UV [GO:0009411]; telomere maintenance [GO:0000723],checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006310; GO:0022414; GO:0032200; GO:0043226; GO:0048856,nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; DNA recombination; reproductive process; telomere organization; organelle; anatomical structure development
OG_05933,2.164252360567733,FUN_026161-T1,Peve_00006892,Pocillopora_meandrina_HIv1___RNAseq.g3202.t1,three_way,65.80033333333333,FUN_026161-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),33.2,564.0,2.7999999999999997e-82,307.8,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_05935,2.3208343719277287,FUN_026165-T1,Peve_00008133,Pocillopora_meandrina_HIv1___RNAseq.g3173.t1,three_way,63.327666666666666,FUN_026165-T1,Q5NU32,AOFA_HORSE,,Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A),Equus caballus (Horse),37.2,468.0,2.9e-77,290.8,sp|Q5NU32|AOFA_HORSE Amine oxidase [flavin-containing] A OS=Equus caballus OX=9796 GN=MAOA PE=2 SV=1,GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0050660; GO:0097621,catecholamine metabolic process [GO:0006584],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_05943,1.1011602381785042,FUN_026181-T1,Peve_00022313,Pocillopora_meandrina_HIv1___RNAseq.g3036.t1,three_way,74.56566666666667,FUN_026181-T1,Q9H0H5,RGAP1_HUMAN,,Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4),Homo sapiens (Human),42.3,636.0,4.8e-117,423.3,sp|Q9H0H5|RGAP1_HUMAN Rac GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RACGAP1 PE=1 SV=1,GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005739; GO:0005819; GO:0005829; GO:0005874; GO:0006811; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008270; GO:0009898; GO:0019901; GO:0030218; GO:0030496; GO:0030674; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149; GO:1902358,actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358],acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233],"alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270]",GO:0000910; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0007010; GO:0008092; GO:0008289; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0055085; GO:0060090; GO:0098772,cytokinesis; nucleus; nucleoplasm; mitochondrion; cytosol; cytoskeleton organization; cytoskeletal protein binding; lipid binding; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; transmembrane transport; molecular adaptor activity; molecular function regulator activity
OG_05945,2.681399865703404,FUN_026188-T1,Peve_00007220,Pocillopora_meandrina_HIv1___RNAseq.g9603.t1,three_way,49.890166666666666,,,,,,,,,,,,,,,,,
OG_05947,3.2733660591317384,FUN_026194-T1,Peve_00016690,Pocillopora_meandrina_HIv1___TS.g18158.t1,three_way,54.12983333333333,,,,,,,,,,,,,,,,,
OG_05952,1.924885960921204,FUN_026214-T1,Peve_00004859,Pocillopora_meandrina_HIv1___TS.g18166.t1,three_way,63.017,FUN_026214-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,371.0,3.5e-20,102.4,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_05956,2.347901728269848,FUN_026300-T1,Peve_00030624,Pocillopora_meandrina_HIv1___RNAseq.g3055.t1,three_way,48.91783333333333,,,,,,,,,,,,,,,,,
OG_05957,1.3035143147271588,FUN_026303-T1,Peve_00017107,Pocillopora_meandrina_HIv1___RNAseq.g3057.t1,three_way,75.509,FUN_026303-T1,Q9PRL8,,,,,69.2,78.0,2.1999999999999997e-25,115.9,sp|Q9PRL8|ACBP_CHICK Acyl-CoA-binding protein OS=Gallus gallus OX=9031 GN=DBI PE=1 SV=1,,,,,,
OG_05958,1.7601756674573794,FUN_026305-T1,Peve_00025709,Pocillopora_meandrina_HIv1___RNAseq.g3058.t1,three_way,89.43866666666666,FUN_026305-T1,P21613,,,,,58.8,972.0,2.4e-239,830.5,sp|P21613|KINH_DORPE Kinesin heavy chain OS=Doryteuthis pealeii OX=1051067 PE=1 SV=1,,,,,,
OG_05959,1.433681177124023,FUN_026306-T1,Peve_00025710,Pocillopora_meandrina_HIv1___RNAseq.g3061.t1,three_way,81.67766666666667,FUN_026306-T1,P40757,,,,,57.9,375.0,1.6000000000000006e-130,467.6,"sp|P40757|ALN_AQUCT Allantoinase, mitochondrial OS=Aquarana catesbeiana OX=8400 GN=ALN PE=1 SV=1",,,,,,
OG_05962,1.3101781733068243,FUN_026309-T1,Peve_00036856,Pocillopora_meandrina_HIv1___RNAseq.g3064.t1,three_way,88.59666666666666,FUN_026309-T1,Q6X1Y6,ASIC3_MOUSE,,Acid-sensing ion channel 3 (ASIC3) (Amiloride-sensitive cation channel 3) (Dorsal root ASIC) (DRASIC),Mus musculus (Mouse),31.1,453.0,2.4e-56,222.2,sp|Q6X1Y6|ASIC3_MOUSE Acid-sensing ion channel 3 OS=Mus musculus OX=10090 GN=Asic3 PE=1 SV=2,GO:0005261; GO:0005737; GO:0005886; GO:0006812; GO:0006814; GO:0009408; GO:0009612; GO:0010447; GO:0015280; GO:0034220; GO:0042931; GO:0050907; GO:0050915; GO:0050961; GO:0050965; GO:0050966; GO:0050968; GO:0050974; GO:0051649; GO:0051899; GO:0160125,detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception [GO:0050961]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; establishment of localization in cell [GO:0051649]; membrane depolarization [GO:0051899]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of sour taste [GO:0050915]; sodium ion transport [GO:0006814],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],enterobactin transmembrane transporter activity [GO:0042931]; ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated sodium channel activity [GO:0160125],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_05963,1.4897428292260335,FUN_026310-T1,Peve_00036855,Pocillopora_meandrina_HIv1___RNAseq.g3065.t1,three_way,55.12266666666667,FUN_026310-T1,A0A1L8F5J9,NMDZ1_XENLA,,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",Xenopus laevis (African clawed frog),26.6,549.0,1.2e-49,199.9,"sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1",GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839,calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725],neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_05966,1.5539460513166583,FUN_026369-T2,Peve_00027912,Pocillopora_meandrina_HIv1___RNAseq.g3119.t1,three_way,54.78633333333333,FUN_026369-T2,Q9H8Y5,ANKZ1_HUMAN,,tRNA endonuclease ANKZF1 (EC 3.1.-.-) (Ankyrin repeat and zinc finger domain-containing protein 1) (Zinc finger protein 744),Homo sapiens (Human),36.6,711.0,4.3e-67,257.7,sp|Q9H8Y5|ANKZ1_HUMAN tRNA endonuclease ANKZF1 OS=Homo sapiens OX=9606 GN=ANKZF1 PE=1 SV=1,GO:0004521; GO:0005737; GO:0006515; GO:0008270; GO:0016020; GO:0036503; GO:0070301; GO:0072344; GO:0140101,cellular response to hydrogen peroxide [GO:0070301]; ERAD pathway [GO:0036503]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; rescue of stalled ribosome [GO:0072344],cytoplasm [GO:0005737]; membrane [GO:0016020],"catalytic activity, acting on a tRNA [GO:0140101]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270]",GO:0003824; GO:0030163; GO:0140098,"catalytic activity; protein catabolic process; catalytic activity, acting on RNA"
OG_05973,2.3730187295493903,FUN_026389-T1,Peve_00032417,Pocillopora_meandrina_HIv1___RNAseq.g2951.t1,three_way,65.594,FUN_026389-T1,Q54UT2,DGK_DICDI,,Deoxyguanosine kinase (dGK) (EC 2.7.1.113) (DddGK),Dictyostelium discoideum (Social amoeba),46.5,217.0,9e-51,202.2,sp|Q54UT2|DGK_DICDI Deoxyguanosine kinase OS=Dictyostelium discoideum OX=44689 GN=dgk PE=1 SV=2,GO:0004138; GO:0005524; GO:0005737; GO:0005739; GO:0006120; GO:0006180; GO:0045271,"deoxyguanosine salvage [GO:0006180]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]",cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271],ATP binding [GO:0005524]; deoxyguanosine kinase activity [GO:0004138],GO:0003824; GO:0005739; GO:0006091; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; generation of precursor metabolites and energy; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05974,1.1295936343634454,FUN_026394-T1,Peve_00032420,Pocillopora_meandrina_HIv1___RNAseq.g2941.t1,three_way,86.70166666666667,FUN_026394-T1,Q01583,DGK1_DROME,,Diacylglycerol kinase 1 (DAG kinase 1) (DGK 1) (Diglyceride kinase 1) (EC 2.7.1.107),Drosophila melanogaster (Fruit fly),39.6,450.0,3.8e-71,270.4,sp|Q01583|DGK1_DROME Diacylglycerol kinase 1 OS=Drosophila melanogaster OX=7227 GN=Dgk PE=2 SV=5,GO:0004143; GO:0005509; GO:0005524; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0035556; GO:0046339,diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0006629; GO:0016740,catalytic activity; plasma membrane; lipid metabolic process; transferase activity
OG_05975,1.2315676998588598,FUN_026395-T1,Peve_00028957,Pocillopora_meandrina_HIv1___RNAseq.g2940.t1,three_way,69.13300000000001,FUN_026395-T1,A7S1H9,,,,,55.6,90.0,2.5e-21,102.8,"sp|A7S1H9|SDHF3_NEMVE Succinate dehydrogenase assembly factor 3, mitochondrial OS=Nematostella vectensis OX=45351 GN=acn9 PE=3 SV=1",,,,,,
OG_05976,1.5006640983928754,FUN_026399-T1,Peve_00028956,Pocillopora_meandrina_HIv1___TS.g18054.t2,three_way,70.44033333333333,FUN_026399-T1,P02720,,,,,49.0,206.0,3.5e-53,209.9,sp|P02720|PPCT_BOVIN Phosphatidylcholine transfer protein OS=Bos taurus OX=9913 GN=PCTP PE=1 SV=1,,,,,,
OG_05977,2.86374939333976,FUN_026406-T1,Peve_00000795,Pocillopora_meandrina_HIv1___RNAseq.g2938.t1,three_way,71.30283333333334,,,,,,,,,,,,,,,,,
OG_05979,1.91486965122876,FUN_026410-T1,Peve_00000792,Pocillopora_meandrina_HIv1___TS.g18090.t2,three_way,66.82866666666666,,,,,,,,,,,,,,,,,
OG_05983,1.9456667827332816,FUN_026415-T1,Peve_00006089,Pocillopora_meandrina_HIv1___RNAseq.g3014.t1,three_way,79.76233333333333,FUN_026415-T1,Q9EPR4,S23A2_MOUSE,,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2),Mus musculus (Mouse),54.1,549.0,1.1e-163,578.2,sp|Q9EPR4|S23A2_MOUSE Solute carrier family 23 member 2 OS=Mus musculus OX=10090 GN=Slc23a2 PE=1 SV=2,GO:0005737; GO:0006979; GO:0007155; GO:0008015; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0071361; GO:1903861,blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229],GO:0003013; GO:0005215; GO:0005975; GO:0007155; GO:0055085,circulatory system process; transporter activity; carbohydrate metabolic process; cell adhesion; transmembrane transport
OG_05985,1.16981607773702,FUN_026471-T1,Peve_00030192,Pocillopora_meandrina_HIv1___RNAseq.g4186.t1,three_way,66.35833333333333,FUN_026471-T1,F4JZ24,,,,,31.6,177.0,5e-17,90.5,sp|F4JZ24|P4H10_ARATH Probable prolyl 4-hydroxylase 10 OS=Arabidopsis thaliana OX=3702 GN=P4H10 PE=3 SV=1,,,,,,
OG_05989,2.108806889666478,FUN_026475-T1,Peve_00002335,Pocillopora_meandrina_HIv1___RNAseq.g4182.t1,three_way,75.23366666666666,FUN_026475-T1,Q802U2,MIOS_DANRE,,GATOR2 complex protein MIOS,Danio rerio (Zebrafish) (Brachydanio rerio),45.1,443.0,7.2e-107,389.0,sp|Q802U2|MIOS_DANRE GATOR2 complex protein MIOS OS=Danio rerio OX=7955 GN=mios PE=2 SV=1,GO:0005737; GO:0005765; GO:0008270; GO:0031669; GO:0034198; GO:0060047; GO:0060841; GO:0061700; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; heart contraction [GO:0060047]; positive regulation of TORC1 signaling [GO:1904263]; venous blood vessel development [GO:0060841],cytoplasm [GO:0005737]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765],zinc ion binding [GO:0008270],GO:0003013; GO:0048856,circulatory system process; anatomical structure development
OG_05990,1.8515366379860527,FUN_026477-T1,Peve_00002334,Pocillopora_meandrina_HIv1___RNAseq.g4181.t1,three_way,66.879,,,,,,,,,,,,,,,,,
OG_05991,1.048075140207971,FUN_026480-T1,Peve_00002343,Pocillopora_meandrina_HIv1___RNAseq.g4178.t1,three_way,72.6325,FUN_026480-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),31.4,408.0,9.999999999999999e-54,212.6,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_05992,2.991012147659278,FUN_026481-T1,Peve_00002333,Pocillopora_meandrina_HIv1___RNAseq.g4177.t1,three_way,82.02083333333333,FUN_026481-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),34.3,414.0,6.6e-58,226.5,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_05993,3.0109006278821364,FUN_026482-T1,Peve_00002332,Pocillopora_meandrina_HIv1___RNAseq.g4176.t1,three_way,69.22866666666667,FUN_026482-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),30.8,402.0,2.2999999999999998e-55,218.0,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_06006,1.846530889882856,FUN_026511-T1,Peve_00034433,Pocillopora_meandrina_HIv1___RNAseq.g4202.t1,three_way,85.81833333333333,FUN_026511-T1,Q9H269,VPS16_HUMAN,,Vacuolar protein sorting-associated protein 16 homolog (hVPS16),Homo sapiens (Human),48.9,630.0,2.5e-166,587.0,sp|Q9H269|VPS16_HUMAN Vacuolar protein sorting-associated protein 16 homolog OS=Homo sapiens OX=9606 GN=VPS16 PE=1 SV=2,GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0010008; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0042144; GO:0043025; GO:0051015; GO:0055037; GO:0097352; GO:0098793,"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]",autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; recycling endosome [GO:0055037],actin binding [GO:0003779]; actin filament binding [GO:0051015],GO:0005764; GO:0005768; GO:0005773; GO:0006886; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0061024,lysosome; endosome; vacuole; intracellular protein transport; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_06008,1.1457102002512087,FUN_026528-T1,Peve_00040219,Pocillopora_meandrina_HIv1___RNAseq.g4218.t1,three_way,81.22200000000001,FUN_026528-T1,Q08DM8,,,,,59.9,212.0,1.3000000000000001e-67,257.7,sp|Q08DM8|TSN_BOVIN Translin OS=Bos taurus OX=9913 GN=TSN PE=2 SV=1,,,,,,
OG_06009,2.8637326660859723,FUN_026529-T1,Peve_00021569,Pocillopora_meandrina_HIv1___RNAseq.g4217.t1,three_way,74.87133333333334,FUN_026529-T1,Q9JIT1,,,,,47.4,369.0,1.4000000000000001e-89,331.3,sp|Q9JIT1|RNF32_MOUSE RING finger protein 32 OS=Mus musculus OX=10090 GN=Rnf32 PE=1 SV=1,,,,,,
OG_06014,2.124683791020167,FUN_026541-T1,Peve_00020321,Pocillopora_meandrina_HIv1___RNAseq.g4240.t1,three_way,62.72516666666667,FUN_026541-T1,P55197,AF10_HUMAN,,Protein AF-10 (ALL1-fused gene from chromosome 10 protein),Homo sapiens (Human),78.8,184.0,1.1999999999999999e-90,336.3,sp|P55197|AF10_HUMAN Protein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0031491; GO:0032991; GO:0042393; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; histone binding; organelle
OG_06014,2.124683791020167,FUN_026541-T1,Peve_00020321,Pocillopora_meandrina_HIv1___RNAseq.g4240.t1,three_way,62.72516666666667,FUN_026541-T1,P55197,AF10_HUMAN,,Protein AF-10 (ALL1-fused gene from chromosome 10 protein),Homo sapiens (Human),46.3,67.0,7.8e-10,67.8,sp|P55197|AF10_HUMAN Protein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0031491; GO:0032991; GO:0042393; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; histone binding; organelle
OG_06015,2.4622168196769225,FUN_026542-T1,Peve_00020320,Pocillopora_meandrina_HIv1___RNAseq.g4239.t1,three_way,82.803,FUN_026542-T1,Q8BHN5,,,,,39.6,493.0,2.8000000000000003e-80,300.8,sp|Q8BHN5|RBM45_MOUSE RNA-binding protein 45 OS=Mus musculus OX=10090 GN=Rbm45 PE=1 SV=1,,,,,,
OG_06016,2.1328715456165788,FUN_026543-T1,Peve_00020319,Pocillopora_meandrina_HIv1___RNAseq.g4238.t1,three_way,56.20633333333333,,,,,,,,,,,,,,,,,
OG_06017,1.3499477190819729,FUN_026545-T1,Peve_00002360,Pocillopora_meandrina_HIv1___RNAseq.g4236.t1,three_way,91.02066666666668,FUN_026545-T1,Q7ZSX3,PTF1A_DANRE,,Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48),Danio rerio (Zebrafish) (Brachydanio rerio),66.7,102.0,9.8e-28,124.4,sp|Q7ZSX3|PTF1A_DANRE Pancreas transcription factor 1 subunit alpha OS=Danio rerio OX=7955 GN=ptf1a PE=2 SV=1,GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0032502; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048666; GO:0048699,amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; developmental process [GO:0032502]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; neuron development [GO:0048666]; pancreas development [GO:0031016]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888],cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06018,1.066480727844188,FUN_026546-T1,Peve_00033713,Pocillopora_meandrina_HIv1___RNAseq.g4237.t1,three_way,64.72766666666666,FUN_026546-T1,Q96KC8,DNJC1_HUMAN,,DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1),Homo sapiens (Human),40.8,525.0,4.4e-84,313.5,sp|Q96KC8|DNJC1_HUMAN DnaJ homolog subfamily C member 1 OS=Homo sapiens OX=9606 GN=DNAJC1 PE=1 SV=1,GO:0001671; GO:0003677; GO:0005783; GO:0005789; GO:0005886; GO:0006417; GO:0006457; GO:0012505; GO:0016020; GO:0031965; GO:0045861; GO:0050708; GO:0051087,negative regulation of proteolysis [GO:0045861]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],ATPase activator activity [GO:0001671]; DNA binding [GO:0003677]; protein-folding chaperone binding [GO:0051087],GO:0003677; GO:0005783; GO:0005886; GO:0006457; GO:0043226; GO:0098772,DNA binding; endoplasmic reticulum; plasma membrane; protein folding; organelle; molecular function regulator activity
OG_06019,2.27696477377101,FUN_026547-T1,Peve_00002361,Pocillopora_meandrina_HIv1___RNAseq.g4233.t1,three_way,71.54266666666666,,,,,,,,,,,,,,,,,
OG_06020,1.38627080997116,FUN_026548-T1,Peve_00002362,Pocillopora_meandrina_HIv1___RNAseq.g4232.t1,three_way,67.98133333333332,FUN_026548-T1,Q8IYJ2,CJ067_HUMAN,,"Uncharacterized protein C10orf67, mitochondrial",Homo sapiens (Human),25.5,216.0,5.9e-14,80.9,"sp|Q8IYJ2|CJ067_HUMAN Uncharacterized protein C10orf67, mitochondrial OS=Homo sapiens OX=9606 GN=C10orf67 PE=1 SV=3",GO:0005739,,mitochondrion [GO:0005739],,GO:0005739; GO:0043226,mitochondrion; organelle
OG_06023,1.608122420859878,FUN_026579-T1,Peve_00040668,Pocillopora_meandrina_HIv1___RNAseq.g30115.t1,three_way,59.54333333333334,FUN_026579-T1,Q5R868,,,,,28.9,377.0,1.5999999999999999e-29,132.1,sp|Q5R868|PGAP4_PONAB GPI-N-acetylgalactosamine transferase PGAP4 OS=Pongo abelii OX=9601 GN=PGAP4 PE=2 SV=1,,,,,,
OG_06024,1.1059434823870702,FUN_026582-T1,Peve_00006460,Pocillopora_meandrina_HIv1___RNAseq.g4513.t1,three_way,81.87833333333333,FUN_026582-T1,Q8TAQ2,SMRC2_HUMAN,,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),Homo sapiens (Human),51.1,991.0,1.4e-241,837.8,sp|Q8TAQ2|SMRC2_HUMAN SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2 PE=1 SV=1,GO:0000776; GO:0000785; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514],histone binding [GO:0042393]; transcription coactivator activity [GO:0003713],GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06026,2.5732095048320365,FUN_026585-T1,Peve_00006457,Pocillopora_meandrina_HIv1___TS.g21922.t2,three_way,56.837,,,,,,,,,,,,,,,,,
OG_06027,1.3282596384837924,FUN_026586-T1,Peve_00006458,Pocillopora_meandrina_HIv1___RNAseq.g4506.t1,three_way,78.36933333333333,,,,,,,,,,,,,,,,,
OG_06028,1.3581597789352473,FUN_026589-T1,Peve_00043907,Pocillopora_meandrina_HIv1___TS.g21913.t2,three_way,75.30533333333334,FUN_026589-T1,F8WLE0,,,,,39.4,864.0,1.9e-152,541.6,sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1,,,,,,
OG_06029,1.805405110672203,FUN_026590-T1,Peve_00043908,Pocillopora_meandrina_HIv1___RNAseq.g4497.t1,three_way,58.6655,FUN_026590-T1,A4D1E9,GTPBA_HUMAN,,GTP-binding protein 10 (Protein obg homolog 2) (ObgH2),Homo sapiens (Human),46.9,286.0,1.5e-65,252.3,sp|A4D1E9|GTPBA_HUMAN GTP-binding protein 10 OS=Homo sapiens OX=9606 GN=GTPBP10 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003924; GO:0005525; GO:0005694; GO:0005730; GO:0005739; GO:0042254,ribosome biogenesis [GO:0042254],chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0003924; GO:0005694; GO:0005730; GO:0005739; GO:0016787; GO:0042254; GO:0043226,RNA binding; catalytic activity; GTPase activity; chromosome; nucleolus; mitochondrion; hydrolase activity; ribosome biogenesis; organelle
OG_06031,1.311187590090678,FUN_026597-T1,Peve_00035402,Pocillopora_meandrina_HIv1___RNAseq.g4485.t1,three_way,53.672666666666665,,,,,,,,,,,,,,,,,
OG_06032,2.0039041632549983,FUN_026617-T1,Peve_00043915,Pocillopora_meandrina_HIv1___RNAseq.g4482.t1,three_way,86.23883333333333,FUN_026617-T1,A0A8I5ZNK2,OXSR1_RAT,,Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein),Rattus norvegicus (Rat),54.0,522.0,8.8e-151,535.0,sp|A0A8I5ZNK2|OXSR1_RAT Serine/threonine-protein kinase OSR1 OS=Rattus norvegicus OX=10116 GN=Oxsr1 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006884; GO:0006979; GO:0007165; GO:0007231; GO:0009410; GO:0010820; GO:0019901; GO:0035556; GO:0038116; GO:0038146; GO:0042802; GO:0070294; GO:0071474; GO:0071476; GO:1901380; GO:1990869,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; osmosensory signaling pathway [GO:0007231]; positive regulation of T cell chemotaxis [GO:0010820]; renal sodium ion absorption [GO:0070294]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674],GO:0003014; GO:0003824; GO:0005829; GO:0016740; GO:0140096,"renal system process; catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_06033,4.149444261688954,FUN_026619-T1,Peve_00043889,Pocillopora_meandrina_HIv1___RNAseq.g4478.t1a,three_way,66.35766666666667,FUN_026619-T1,Q8BHC4,,,,,46.8,222.0,1.7e-51,204.1,sp|Q8BHC4|DCAKD_MOUSE Dephospho-CoA kinase domain-containing protein OS=Mus musculus OX=10090 GN=Dcakd PE=1 SV=1,,,,,,
OG_06034,3.3482400285077785,FUN_026626-T1,Peve_00030694,Pocillopora_meandrina_HIv1___RNAseq.g4478.t1b,three_way,49.834833333333336,FUN_026626-T1,P23785,GRN_RAT,,Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Granulin precursor) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)],Rattus norvegicus (Rat),31.6,510.0,1.8999999999999998e-62,243.0,sp|P23785|GRN_RAT Progranulin OS=Rattus norvegicus OX=10116 GN=Grn PE=1 SV=3,GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905671; GO:1905673,astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488]; trophectodermal cell proliferation [GO:0001834],cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982],cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087],GO:0002376; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0007040; GO:0016192; GO:0022414; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048018; GO:0048856; GO:0098772,immune system process; extracellular region; extracellular space; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; lysosome organization; vesicle-mediated transport; reproductive process; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06038,1.4407630505052809,FUN_026685-T1,Peve_00036589,Pocillopora_meandrina_HIv1___RNAseq.g4459.t1,three_way,71.81433333333334,FUN_026685-T1,Q8IYE1,CCD13_HUMAN,,Coiled-coil domain-containing protein 13,Homo sapiens (Human),29.4,697.0,4.1e-46,188.0,sp|Q8IYE1|CCD13_HUMAN Coiled-coil domain-containing protein 13 OS=Homo sapiens OX=9606 GN=CCDC13 PE=1 SV=2,GO:0005737; GO:0005813; GO:0006974; GO:0031122; GO:0034451; GO:0042995; GO:1905515,cytoplasmic microtubule organization [GO:0031122]; DNA damage response [GO:0006974]; non-motile cilium assembly [GO:1905515],cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737],,GO:0005815; GO:0007010; GO:0044782,microtubule organizing center; cytoskeleton organization; cilium organization
OG_06039,2.377447277799071,FUN_026686-T1,Peve_00036588,Pocillopora_meandrina_HIv1___RNAseq.g4458.t1,three_way,77.316,FUN_026686-T1,Q91ZR4,NEK8_MOUSE,,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8),Mus musculus (Mouse),53.2,710.0,1.2e-204,714.5,sp|Q91ZR4|NEK8_MOUSE Serine/threonine-protein kinase Nek8 OS=Mus musculus OX=10090 GN=Nek8 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310,animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330],centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06044,2.078589265936482,FUN_026709-T1,Peve_00018525,Pocillopora_meandrina_HIv1___RNAseq.g9380.t1,three_way,64.574,,,,,,,,,,,,,,,,,
OG_06049,1.3906429840207453,FUN_026721-T1,Peve_00018533,Pocillopora_meandrina_HIv1___RNAseq.g9388.t1,three_way,45.75816666666667,,,,,,,,,,,,,,,,,
OG_06056,1.917287626603137,FUN_026739-T2,Peve_00021666,Pocillopora_meandrina_HIv1___RNAseq.g9411.t1,three_way,70.781,FUN_026739-T2,P42232,STA5B_MOUSE,,Signal transducer and activator of transcription 5B,Mus musculus (Mouse),32.8,729.0,1e-96,356.3,sp|P42232|STA5B_MOUSE Signal transducer and activator of transcription 5B OS=Mus musculus OX=10090 GN=Stat5b PE=1 SV=1,GO:0000278; GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0001787; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0007259; GO:0007548; GO:0007565; GO:0007595; GO:0008283; GO:0008284; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030098; GO:0030155; GO:0030183; GO:0030218; GO:0030856; GO:0032355; GO:0032743; GO:0032819; GO:0032825; GO:0033028; GO:0033033; GO:0033077; GO:0035259; GO:0038162; GO:0040014; GO:0040018; GO:0042104; GO:0042267; GO:0042448; GO:0042492; GO:0042803; GO:0043029; GO:0045579; GO:0045588; GO:0045621; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0050729; GO:0050798; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0097531,activated T cell proliferation [GO:0050798]; B cell differentiation [GO:0030183]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; female pregnancy [GO:0007565]; gamma-delta T cell differentiation [GO:0042492]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; lymphocyte differentiation [GO:0030098]; mast cell migration [GO:0097531]; mitotic cell cycle [GO:0000278]; myeloid cell apoptotic process [GO:0033028]; natural killer cell differentiation [GO:0001779]; natural killer cell mediated cytotoxicity [GO:0042267]; natural killer cell proliferation [GO:0001787]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of myeloid cell apoptotic process [GO:0033033]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0000278; GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0006629; GO:0006790; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0098542; GO:0140110,mitotic cell cycle; immune system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; lipid metabolic process; sulfur compound metabolic process; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; defense response to other organism; transcription regulator activity
OG_06058,1.216867352712457,FUN_026758-T1,Peve_00011338,Pocillopora_meandrina_HIv1___RNAseq.g9118.t1,three_way,49.97033333333333,,,,,,,,,,,,,,,,,
OG_06065,1.1359715201115628,FUN_026899-T1,Peve_00021656,Pocillopora_meandrina_HIv1___RNAseq.g9422.t1,three_way,59.486,FUN_026899-T1,Q5C9Z4,NOM1_HUMAN,,Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog),Homo sapiens (Human),48.6,664.0,3.3e-126,454.1,sp|Q5C9Z4|NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NOM1 PE=1 SV=1,GO:0003723; GO:0005730; GO:0042274; GO:0048820,hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274],nucleolus [GO:0005730],RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0043226,RNA binding; nucleolus; organelle
OG_06066,3.2922501263160826,FUN_026909-T1,Peve_00021653,Pocillopora_meandrina_HIv1___TS.g19726.t1,three_way,61.72833333333333,FUN_026909-T1,Q66J01,,,,,30.8,910.0,4e-101,370.9,sp|Q66J01|PGAP1_XENLA GPI inositol-deacylase OS=Xenopus laevis OX=8355 GN=pgap1 PE=2 SV=1,,,,,,
OG_06068,3.7603079790450624,FUN_026916-T1,Peve_00014703,Pocillopora_meandrina_HIv1___RNAseq.g11017.t1,three_way,54.9965,,,,,,,,,,,,,,,,,
OG_06072,2.4523663314844883,FUN_026981-T1,Peve_00013217,Pocillopora_meandrina_HIv1___RNAseq.g9421.t1,three_way,51.642,,,,,,,,,,,,,,,,,
OG_06078,1.844334277371589,FUN_026989-T1,Peve_00012936,Pocillopora_meandrina_HIv1___RNAseq.g10353.t1,three_way,77.742,FUN_026989-T1,Q6UW02,,,,,30.3,472.0,2.6e-70,267.7,sp|Q6UW02|CP20A_HUMAN Cytochrome P450 20A1 OS=Homo sapiens OX=9606 GN=CYP20A1 PE=1 SV=1,,,,,,
OG_06082,1.68359209252084,FUN_027067-T1,Peve_00012228,Pocillopora_meandrina_HIv1___RNAseq.g2815.t1,three_way,77.89,FUN_027067-T1,Q6DHC3,,,,,51.8,336.0,2.1e-90,334.0,sp|Q6DHC3|S2540_DANRE Mitochondrial glutathione transporter SLC25A40 OS=Danio rerio OX=7955 GN=slc25a40 PE=2 SV=1,,,,,,
OG_06083,1.008790271438748,FUN_027071-T1,Peve_00012230,Pocillopora_meandrina_HIv1___RNAseq.23069_t,three_way,84.827,FUN_027071-T1,Q1L8G7,,,,,40.0,210.0,3.4e-36,153.3,sp|Q1L8G7|GATD1_DANRE GATA zinc finger domain-containing protein 1 OS=Danio rerio OX=7955 GN=gatad1 PE=2 SV=1,,,,,,
OG_06084,2.109333079355657,FUN_027072-T1,Peve_00012231,Pocillopora_meandrina_HIv1___RNAseq.g2813.t1,three_way,68.39233333333333,FUN_027072-T1,P26797,,,,,38.5,91.0,5.9e-11,69.3,sp|P26797|HM19_CAEEL Homeobox protein ceh-19 OS=Caenorhabditis elegans OX=6239 GN=ceh-19 PE=2 SV=2,,,,,,
OG_06085,1.6568947433089642,FUN_027075-T1,Peve_00012235,Pocillopora_meandrina_HIv1___RNAseq.g2812.t1,three_way,70.49183333333333,FUN_027075-T1,Q14549,,,,,69.1,97.0,4.5000000000000004e-30,132.9,sp|Q14549|GBX1_HUMAN Homeobox protein GBX-1 OS=Homo sapiens OX=9606 GN=GBX1 PE=1 SV=2,,,,,,
OG_06087,1.2295238321675153,FUN_027086-T1,Peve_00012245,Pocillopora_meandrina_HIv1___TS.g17920.t1,three_way,91.32083333333333,FUN_027086-T1,Q14562,DHX8_HUMAN,,ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1),Homo sapiens (Human),75.5,1179.0,0.0,1576.2,sp|Q14562|DHX8_HUMAN ATP-dependent RNA helicase DHX8 OS=Homo sapiens OX=9606 GN=DHX8 PE=1 SV=1,GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008186; GO:0008380; GO:0016604; GO:0016887; GO:0042802; GO:0071007; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]",GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06088,1.3049745813150042,FUN_027087-T1,Peve_00012239,Pocillopora_meandrina_HIv1___RNAseq.g24966.t1,three_way,81.16233333333334,FUN_027087-T1,E9Q3T6,PRD14_MOUSE,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Mus musculus (Mouse),53.8,234.0,2.2e-67,257.7,sp|E9Q3T6|PRD14_MOUSE PR domain zinc finger protein 14 OS=Mus musculus OX=10090 GN=Prdm14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0032259; GO:0040029; GO:0040037; GO:0045814; GO:0048873; GO:0060818; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of gene expression [GO:0010468]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_06090,1.7699027218922956,FUN_027128-T1,Peve_00039620,Pocillopora_meandrina_HIv1___TS.g10360.t2,three_way,69.8775,FUN_027128-T1,O60244,MED14_HUMAN,,Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150),Homo sapiens (Human),36.0,1532.0,7.500000000000001e-225,782.7,sp|O60244|MED14_HUMAN Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens OX=9606 GN=MED14 PE=1 SV=2,GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0032968; GO:0035019; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847,positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019],core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_06092,3.0517588445172623,FUN_027218-T1,Peve_00018289,Pocillopora_meandrina_HIv1___RNAseq.g15249.t1,three_way,69.15166666666667,FUN_027218-T1,Q8IW92,,,,,43.8,665.0,4.3e-148,526.6,sp|Q8IW92|GLBL2_HUMAN Beta-galactosidase-1-like protein 2 OS=Homo sapiens OX=9606 GN=GLB1L2 PE=1 SV=1,,,,,,
OG_06098,2.553154068604635,FUN_027734-T1,Peve_00036493,Pocillopora_meandrina_HIv1___RNAseq.g13905.t1,three_way,66.03566666666666,FUN_027734-T1,Q86YF9,DZIP1_HUMAN,,Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1),Homo sapiens (Human),28.4,334.0,1.3e-27,127.1,sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0043231; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140706; GO:1903566,ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0060090,nucleus; nucleoplasm; microtubule organizing center; cytosol; reproductive process; organelle; cilium organization; anatomical structure development; molecular adaptor activity
OG_06099,2.403779654168638,FUN_027735-T1,Peve_00036492,Pocillopora_meandrina_HIv1___RNAseq.g13904.t1,three_way,70.82816666666666,FUN_027735-T1,O94888,UBXN7_HUMAN,,UBX domain-containing protein 7,Homo sapiens (Human),41.6,500.0,1e-93,345.5,sp|O94888|UBXN7_HUMAN UBX domain-containing protein 7 OS=Homo sapiens OX=9606 GN=UBXN7 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005829; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_06104,1.9443522783554432,FUN_027805-T1,Peve_00036485,Pocillopora_meandrina_HIv1___RNAseq.g13898.t1,three_way,81.17733333333334,FUN_027805-T1,Q8BHJ5,TBL1R_MOUSE,,F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1),Mus musculus (Mouse),58.4,514.0,4.8e-120,433.0,sp|Q8BHJ5|TBL1R_MOUSE F-box-like/WD repeat-containing protein TBL1XR1 OS=Mus musculus OX=10090 GN=Tbl1xr1 PE=1 SV=1,GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0008013; GO:0010468; GO:0016042; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0045892; GO:0045944; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263,adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; fat pad development [GO:0060613]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872],histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0006629; GO:0030154; GO:0030163; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; cell differentiation; protein catabolic process; histone binding; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06107,1.0510683891337584,FUN_027811-T1,Peve_00036479,Pocillopora_meandrina_HIv1___RNAseq.g13893.t1,three_way,68.13966666666667,,,,,,,,,,,,,,,,,
OG_06114,2.9871262701141768,FUN_027831-T1,Peve_00020551,Pocillopora_meandrina_HIv1___RNAseq.g13868.t1,three_way,74.62966666666667,FUN_027831-T1,Q9H892,,,,,27.8,753.0,8.2e-63,243.4,sp|Q9H892|TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens OX=9606 GN=TTC12 PE=1 SV=2,,,,,,
OG_06115,3.3674527554257185,FUN_027832-T1,Peve_00020550,Pocillopora_meandrina_HIv1___TS.g11651.t1a,three_way,84.66816666666666,FUN_027832-T1,Q6NRH1,,,,,58.3,408.0,3.2e-139,496.5,sp|Q6NRH1|DCAF8_XENLA DDB1- and CUL4-associated factor 8 OS=Xenopus laevis OX=8355 GN=dcaf8 PE=2 SV=1,,,,,,
OG_06116,1.4826764526219516,FUN_027847-T1,Peve_00020549,Pocillopora_meandrina_HIv1___TS.g11651.t1b,three_way,53.05566666666667,FUN_027847-T1,P57052,RBM11_HUMAN,,Splicing regulator RBM11 (RNA-binding motif protein 11),Homo sapiens (Human),61.7,94.0,6.400000000000001e-23,109.0,sp|P57052|RBM11_HUMAN Splicing regulator RBM11 OS=Homo sapiens OX=9606 GN=RBM11 PE=1 SV=1,GO:0000381; GO:0003727; GO:0005634; GO:0005654; GO:0006397; GO:0008266; GO:0008380; GO:0016607; GO:0030154; GO:0034599; GO:0042803,"cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],poly(U) RNA binding [GO:0008266]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0030154; GO:0043226,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; cell differentiation; organelle
OG_06117,2.052970363478025,FUN_027848-T1,Peve_00023422,Pocillopora_meandrina_HIv1___RNAseq.g29757.t1,three_way,50.14816666666667,,,,,,,,,,,,,,,,,
OG_06121,1.8238822940903416,FUN_027853-T1,Peve_00020102,Pocillopora_meandrina_HIv1___RNAseq.g13886.t1,three_way,89.03033333333333,FUN_027853-T1,Q8CI04,,,,,48.8,818.0,1.5000000000000002e-211,737.6,sp|Q8CI04|COG3_MOUSE Conserved oligomeric Golgi complex subunit 3 OS=Mus musculus OX=10090 GN=Cog3 PE=1 SV=3,,,,,,
OG_06122,2.083615151091666,FUN_027899-T1,Peve_00020103,Pocillopora_meandrina_HIv1___RNAseq.g13885.t1,three_way,50.3325,,,,,,,,,,,,,,,,,
OG_06123,2.6330659222595805,FUN_027900-T1,Peve_00020104,Pocillopora_meandrina_HIv1___RNAseq.g13884.t1,three_way,58.21116666666667,FUN_027900-T1,B2RYR0,RN168_RAT,,E3 ubiquitin-protein ligase RNF168 (EC 2.3.2.27) (RING finger protein 168) (RING-type E3 ubiquitin transferase RNF168),Rattus norvegicus (Rat),47.5,122.0,2.4000000000000002e-30,134.4,sp|B2RYR0|RN168_RAT E3 ubiquitin-protein ligase RNF168 OS=Rattus norvegicus OX=10116 GN=Rnf168 PE=1 SV=1,GO:0000151; GO:0003682; GO:0004842; GO:0005634; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0016567; GO:0031491; GO:0032880; GO:0032991; GO:0034244; GO:0034644; GO:0035861; GO:0040029; GO:0042393; GO:0043130; GO:0045190; GO:0045739; GO:0070530; GO:0070534; GO:0097680; GO:0140852; GO:0140858; GO:0140861; GO:1990391,cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of protein localization [GO:0032880]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511],DNA repair complex [GO:1990391]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151],chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone H2AK15 ubiquitin ligase activity [GO:0140858]; histone ubiquitin ligase activity [GO:0140852]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_06126,2.0137060131392817,FUN_027923-T1,Peve_00020108,Pocillopora_meandrina_HIv1___RNAseq.g13880.t1,three_way,62.48633333333333,FUN_027923-T1,Q2KHV4,,,,,42.6,298.0,1.4999999999999999e-61,238.0,"sp|Q2KHV4|PARL_BOVIN Presenilin-associated rhomboid-like protein, mitochondrial OS=Bos taurus OX=9913 GN=PARL PE=2 SV=1",,,,,,
OG_06128,1.684211042024646,FUN_027932-T1,Peve_00020113,Pocillopora_meandrina_HIv1___RNAseq.g13876.t1,three_way,75.51033333333334,FUN_027932-T1,P49848,TAF6_HUMAN,,Transcription initiation factor TFIID subunit 6 (RNA polymerase II TBP-associated factor subunit E) (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70) (Transcription initiation factor TFIID 80 kDa subunit) (TAF(II)80) (TAFII-80) (TAFII80),Homo sapiens (Human),53.7,456.0,1.8e-142,507.7,sp|P49848|TAF6_HUMAN Transcription initiation factor TFIID subunit 6 OS=Homo sapiens OX=9606 GN=TAF6 PE=1 SV=1,GO:0000124; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0006915; GO:0008285; GO:0016251; GO:0017162; GO:0032991; GO:0033276; GO:0042789; GO:0043065; GO:0045786; GO:0045893; GO:0046695; GO:0046982; GO:0051123; GO:0060261; GO:0071339; GO:2001244,apoptotic process [GO:0006915]; DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276],aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0012501; GO:0016071; GO:0043226; GO:0060090; GO:0065003; GO:0140110; GO:0140223,DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; mRNA metabolic process; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity; general transcription initiation factor activity
OG_06133,2.3057352131003426,FUN_027939-T1,Peve_00023148,Pocillopora_meandrina_HIv1___RNAseq.g14031.t1,three_way,77.95766666666667,FUN_027939-T1,Q18120,TWK18_CAEEL,,TWiK family of potassium channels protein 18,Caenorhabditis elegans,35.9,192.0,7.4e-23,109.8,sp|Q18120|TWK18_CAEEL TWiK family of potassium channels protein 18 OS=Caenorhabditis elegans OX=6239 GN=twk-18 PE=1 SV=2,GO:0005886; GO:0006813; GO:0006936; GO:0015271; GO:0016020; GO:0022841; GO:0040011; GO:0071805,locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813],membrane [GO:0016020]; plasma membrane [GO:0005886],outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841],GO:0003012; GO:0005215; GO:0005886; GO:0055085,muscle system process; transporter activity; plasma membrane; transmembrane transport
OG_06135,1.2240455159175934,FUN_027946-T1,Peve_00034208,Pocillopora_meandrina_HIv1___RNAseq.g14033.t1,three_way,60.9715,FUN_027946-T1,Q0V9T8,,,,,63.8,229.0,1e-86,322.4,sp|Q0V9T8|BIVM_XENTR Basic immunoglobulin-like variable motif-containing protein OS=Xenopus tropicalis OX=8364 GN=bivm PE=2 SV=1,,,,,,
OG_06137,1.0767506481984075,FUN_027950-T1,Peve_00021880,Pocillopora_meandrina_HIv1___RNAseq.g14040.t1,three_way,82.44316666666667,FUN_027950-T1,Q58EK3,,,,,36.9,306.0,1.3e-53,211.8,sp|Q58EK3|PLCX3_DANRE PI-PLC X domain-containing protein 3 OS=Danio rerio OX=7955 GN=plcxd3 PE=2 SV=1,,,,,,
OG_06138,1.5115311900070096,FUN_027960-T1,Peve_00017205,Pocillopora_meandrina_HIv1___RNAseq.g14049.t1,three_way,88.88733333333333,,,,,,,,,,,,,,,,,
OG_06139,1.386558854966581,FUN_027961-T1,Peve_00021881,Pocillopora_meandrina_HIv1___RNAseq.g14050.t1,three_way,83.93933333333334,FUN_027961-T1,P47791,,,,,60.3,461.0,1.9e-158,560.5,"sp|P47791|GSHR_MOUSE Glutathione reductase, mitochondrial OS=Mus musculus OX=10090 GN=Gsr PE=1 SV=3",,,,,,
OG_06145,1.2899887754373949,FUN_027975-T1,Peve_00031359,Pocillopora_meandrina_HIv1___RNAseq.g14056.t1,three_way,65.946,,,,,,,,,,,,,,,,,
OG_06147,3.094293761022958,FUN_027977-T1,Peve_00031366,Pocillopora_meandrina_HIv1___RNAseq.g14058.t1,three_way,74.97666666666666,FUN_027977-T1,Q9Z2F6,,,,,44.0,175.0,4.2000000000000005e-33,143.7,sp|Q9Z2F6|BCL3_MOUSE B-cell lymphoma 3 protein homolog OS=Mus musculus OX=10090 GN=Bcl3 PE=1 SV=2,,,,,,
OG_06155,1.3349572874864215,FUN_027992-T1,Peve_00023124,Pocillopora_meandrina_HIv1___RNAseq.g14020.t1,three_way,64.479,,,,,,,,,,,,,,,,,
OG_06157,1.3062823853950711,FUN_028000-T1,Peve_00023138,Pocillopora_meandrina_HIv1___RNAseq.g14071.t1,three_way,85.642,FUN_028000-T1,Q80W32,DRC9_MOUSE,,Dynein regulatory complex protein 9 (IQ domain-containing protein G),Mus musculus (Mouse),40.1,357.0,2.6999999999999998e-62,240.7,sp|Q80W32|DRC9_MOUSE Dynein regulatory complex protein 9 OS=Mus musculus OX=10090 GN=Iqcg PE=1 SV=1,GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0015629; GO:0030544; GO:0031514; GO:0036126,sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544],GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0048856,cytosol; cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; anatomical structure development
OG_06160,2.0433623704041057,FUN_028005-T1,Peve_00032127,Pocillopora_meandrina_HIv1___RNAseq.g14075.t1,three_way,71.60433333333333,FUN_028005-T1,Q28678,ICLN_RABIT,,"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln))",Oryctolagus cuniculus (Rabbit),42.4,236.0,4.4999999999999996e-35,149.4,sp|Q28678|ICLN_RABIT Methylosome subunit pICln OS=Oryctolagus cuniculus OX=9986 GN=CLNS1A PE=2 SV=2,GO:0000387; GO:0005634; GO:0005681; GO:0005829; GO:0005856; GO:0005886; GO:0006821; GO:0006884; GO:0034709; GO:0034715; GO:0045292,"cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; mRNA cis splicing, via spliceosome [GO:0045292]; spliceosomal snRNP assembly [GO:0000387]",cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681],,GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0016071; GO:0043226; GO:0065003,nucleus; cytosol; cytoskeleton; plasma membrane; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06161,1.3836791810217677,FUN_028007-T1,Peve_00040331,Pocillopora_meandrina_HIv1___TS.g11855.t1,three_way,82.549,FUN_028007-T1,Q923S8,PANK4_RAT,,4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (rPanK4),Rattus norvegicus (Rat),57.3,640.0,9.400000000000001e-209,728.0,sp|Q923S8|PANK4_RAT 4'-phosphopantetheine phosphatase OS=Rattus norvegicus OX=10116 GN=Pank4 PE=1 SV=1,GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016791; GO:0046872,coenzyme A biosynthetic process [GO:0015937],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; phosphatase activity [GO:0016791],GO:0003824; GO:0005634; GO:0005829; GO:0006790; GO:0016740; GO:0016787; GO:0043226; GO:0055086,catalytic activity; nucleus; cytosol; sulfur compound metabolic process; transferase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_06166,3.028265634374399,FUN_028019-T1,Peve_00036500,Pocillopora_meandrina_HIv1___RNAseq.g13910.t1,three_way,60.98683333333333,FUN_028019-T1,Q6DCD5,TMTC2_XENLA,,Protein O-mannosyl-transferase tmtc2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2),Xenopus laevis (African clawed frog),36.7,581.0,5.800000000000001e-86,320.5,sp|Q6DCD5|TMTC2_XENLA Protein O-mannosyl-transferase tmtc2 OS=Xenopus laevis OX=8355 GN=tmtc2 PE=2 SV=1,GO:0000030; GO:0004169; GO:0005789; GO:0035269,protein O-linked mannosylation [GO:0035269],endoplasmic reticulum membrane [GO:0005789],dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030],GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06168,1.1253551687179268,FUN_028021-T1,Peve_00036502,Pocillopora_meandrina_HIv1___RNAseq.g13912.t1,three_way,65.23266666666666,FUN_028021-T1,A8XKV0,,,,,37.1,245.0,3.3e-40,166.8,sp|A8XKV0|BCA1_CAEBR Beta carbonic anhydrase 1 OS=Caenorhabditis briggsae OX=6238 GN=bca-1 PE=3 SV=2,,,,,,
OG_06169,2.482075603717807,FUN_028022-T1,Peve_00010821,Pocillopora_meandrina_HIv1___RNAseq.g13913.t1,three_way,64.496,FUN_028022-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),32.9,434.0,7.4999999999999994e-62,239.6,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_06171,1.670672138229552,FUN_028024-T1,Peve_00010827,Pocillopora_meandrina_HIv1___RNAseq.g13915.t1,three_way,86.50533333333333,,,,,,,,,,,,,,,,,
OG_06175,1.4844511133802454,FUN_028032-T1,Peve_00020106,Pocillopora_meandrina_HIv1___RNAseq.g13935.t1,three_way,50.176,,,,,,,,,,,,,,,,,
OG_06176,1.4688625825587844,FUN_028039-T1,Peve_00020116,Pocillopora_meandrina_HIv1___RNAseq.g13937.t1,three_way,86.83566666666667,FUN_028039-T1,Q9VCA2,,,,,36.3,521.0,4.5e-84,313.5,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_06181,3.400940468644846,FUN_028088-T1,Peve_00031660,Pocillopora_meandrina_HIv1___TS.g11574.t1,three_way,88.21483333333333,FUN_028088-T1,P18907,,,,,76.6,988.0,0.0,1502.3,sp|P18907|AT1A1_HORSE Sodium/potassium-transporting ATPase subunit alpha-1 OS=Equus caballus OX=9796 GN=ATP1A1 PE=3 SV=1,,,,,,
OG_06183,1.634069072874101,FUN_028093-T1,Peve_00022235,Pocillopora_meandrina_HIv1___RNAseq.g15583.t1,three_way,71.7505,FUN_028093-T1,Q6DDH6,,,,,27.4,394.0,2.4e-21,105.9,sp|Q6DDH6|SP13A_XENLA Histone deacetylase complex subunit SAP130-A OS=Xenopus laevis OX=8355 GN=sap130-a PE=2 SV=1,,,,,,
OG_06187,1.1481241169160048,FUN_028099-T2,Peve_00004894,Pocillopora_meandrina_HIv1___RNAseq.g15574.t1,three_way,79.82566666666666,FUN_028099-T2,Q7ZUW2,,,,,57.3,913.0,4.6e-213,743.0,sp|Q7ZUW2|HYOU1_DANRE Hypoxia up-regulated protein 1 OS=Danio rerio OX=7955 GN=hyou1 PE=2 SV=1,,,,,,
OG_06188,3.22112898099472,FUN_028103-T1,Peve_00032588,Pocillopora_meandrina_HIv1___RNAseq.g15573.t1,three_way,47.289,,,,,,,,,,,,,,,,,
OG_06190,1.601346296797152,FUN_028105-T1,Peve_00004887,Pocillopora_meandrina_HIv1___RNAseq.g15571.t1,three_way,74.17699999999999,FUN_028105-T1,Q86UT8,CATAC_HUMAN,,Centrosomal AT-AC splicing factor (Coiled-coil domain-containing protein 84),Homo sapiens (Human),33.2,355.0,3.3e-44,180.6,sp|Q86UT8|CATAC_HUMAN Centrosomal AT-AC splicing factor OS=Homo sapiens OX=9606 GN=CENATAC PE=1 SV=1,GO:0000398; GO:0005737; GO:0005813; GO:0010826; GO:0042176; GO:0051304,"chromosome separation [GO:0051304]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centrosome duplication [GO:0010826]; regulation of protein catabolic process [GO:0042176]",centrosome [GO:0005813]; cytoplasm [GO:0005737],,GO:0005815; GO:0016071,microtubule organizing center; mRNA metabolic process
OG_06191,1.1966962479326697,FUN_028111-T1,Peve_00019693,Pocillopora_meandrina_HIv1___RNAseq.g15567.t1,three_way,64.035,,,,,,,,,,,,,,,,,
OG_06192,1.3955488447414863,FUN_028114-T1,Peve_00019695,Pocillopora_meandrina_HIv1___RNAseq.g15565.t1,three_way,50.1775,FUN_028114-T1,P56182,RRP1_HUMAN,,Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein),Homo sapiens (Human),33.4,347.0,2.3e-47,191.8,sp|P56182|RRP1_HUMAN Ribosomal RNA processing protein 1 homolog A OS=Homo sapiens OX=9606 GN=RRP1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0006364; GO:0030688,rRNA processing [GO:0006364],"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]",RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0043226,RNA binding; nucleus; chromosome; nucleolus; organelle
OG_06193,2.01344564472489,FUN_028115-T1,Peve_00030850,Pocillopora_meandrina_HIv1___RNAseq.g15564.t1,three_way,78.04,FUN_028115-T1,A1A4P5,,,,,54.7,137.0,1.4e-32,141.0,sp|A1A4P5|PFD2_BOVIN Prefoldin subunit 2 OS=Bos taurus OX=9913 GN=PFDN2 PE=2 SV=1,,,,,,
OG_06195,2.364359200841112,FUN_028120-T1,Peve_00033839,Pocillopora_meandrina_HIv1___TS.g10588.t1b,three_way,59.40266666666667,,,,,,,,,,,,,,,,,
OG_06197,2.164313172506418,FUN_028122-T1,Peve_00004261,Pocillopora_meandrina_HIv1___RNAseq.g15557.t2,three_way,43.58133333333333,FUN_028122-T1,P36335,,,,,26.3,598.0,1.3e-35,152.9,sp|P36335|NCA12_XENLA Neural cell adhesion molecule 1-B OS=Xenopus laevis OX=8355 GN=ncam1-b PE=2 SV=1,,,,,,
OG_06198,3.590593927256582,FUN_028130-T1,Peve_00004260,Pocillopora_meandrina_HIv1___RNAseq.g15556.t1,three_way,59.60266666666666,FUN_028130-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),26.8,276.0,4.9e-14,81.6,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_06202,1.2577116548497835,FUN_028138-T1,Peve_00042833,Pocillopora_meandrina_HIv1___RNAseq.g15552.t1,three_way,60.35533333333333,FUN_028138-T1,Q6DRI7,DDX51_DANRE,,ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51),Danio rerio (Zebrafish) (Brachydanio rerio),46.6,528.0,1.1000000000000001e-125,452.2,sp|Q6DRI7|DDX51_DANRE ATP-dependent RNA helicase DDX51 OS=Danio rerio OX=7955 GN=ddx51 PE=2 SV=1,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016887,rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleolus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06206,1.5316459269691711,FUN_028142-T1,Peve_00037719,Pocillopora_meandrina_HIv1___RNAseq.g16428.t1,three_way,69.77866666666667,FUN_028142-T1,Q53RE8,,,,,50.8,65.0,6.8e-11,68.9,sp|Q53RE8|ANR39_HUMAN Ankyrin repeat domain-containing protein 39 OS=Homo sapiens OX=9606 GN=ANKRD39 PE=1 SV=1,,,,,,
OG_06207,1.278130795623713,FUN_028143-T1,Peve_00037720,Pocillopora_meandrina_HIv1___TS.g11444.t1,three_way,74.73266666666667,FUN_028143-T1,Q5SZT7,NKAPL_MOUSE,,NKAP-like protein,Mus musculus (Mouse),72.4,123.0,4.9e-41,169.9,sp|Q5SZT7|NKAPL_MOUSE NKAP-like protein OS=Mus musculus OX=10090 GN=Nkapl PE=1 SV=1,GO:0003682; GO:0005634; GO:0007283; GO:0030154,cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0022414; GO:0030154; GO:0043226,nucleus; reproductive process; cell differentiation; organelle
OG_06208,1.5691009622017096,FUN_028145-T1,Peve_00037725,Pocillopora_meandrina_HIv1___RNAseq.g16425.t1,three_way,84.72733333333333,FUN_028145-T1,A0JPE9,,,,,53.0,513.0,8.6e-160,565.1,sp|A0JPE9|GLPK5_DANRE Glycerol kinase 5 OS=Danio rerio OX=7955 GN=gk5 PE=2 SV=2,,,,,,
OG_06211,2.137285057553141,FUN_028150-T1,Peve_00042832,Pocillopora_meandrina_HIv1___RNAseq.g15551.t1,three_way,65.80033333333333,FUN_028150-T1,Q68J42,LIPS_PIG,,Hormone-sensitive lipase (HSL) (EC 3.1.1.79) (Monoacylglycerol lipase LIPE) (EC 3.1.1.23) (Retinyl ester hydrolase) (REH),Sus scrofa (Pig),33.3,816.0,3.4e-115,417.5,sp|Q68J42|LIPS_PIG Hormone-sensitive lipase OS=Sus scrofa OX=9823 GN=LIPE PE=2 SV=1,GO:0004771; GO:0004806; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0008203; GO:0016020; GO:0016042; GO:0019433; GO:0042134; GO:0046340; GO:0046485; GO:0047372; GO:0047376; GO:0050253; GO:0120516,cholesterol metabolic process [GO:0008203]; diacylglycerol catabolic process [GO:0046340]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation at RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],"all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diacylglycerol lipase activity [GO:0120516]; monoacylglycerol lipase activity [GO:0047372]; retinyl-palmitate esterase activity [GO:0050253]; rRNA primary transcript binding [GO:0042134]; sterol ester esterase activity [GO:0004771]; triacylglycerol lipase activity [GO:0004806]",GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016787; GO:0043226,RNA binding; catalytic activity; nucleus; mitochondrion; lipid droplet; cytosol; lipid metabolic process; hydrolase activity; organelle
OG_06216,1.2828808699919725,FUN_028157-T1,Peve_00010295,Pocillopora_meandrina_HIv1___RNAseq.g16467.t1,three_way,45.73066666666666,,,,,,,,,,,,,,,,,
OG_06219,1.9155299391646703,FUN_028162-T1,Peve_00018136,Pocillopora_meandrina_HIv1___RNAseq.g16500.t1,three_way,57.34316666666667,FUN_028162-T1,Q96T23,RSF1_HUMAN,,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),Homo sapiens (Human),42.2,154.0,6.7e-24,114.0,sp|Q96T23|RSF1_HUMAN Remodeling and spacing factor 1 OS=Homo sapiens OX=9606 GN=RSF1 PE=1 SV=2,GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0008270; GO:0031213; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0050434; GO:0140751,chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213],histone binding [GO:0042393]; histone octamer slider activity [GO:0140751]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0065003; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; protein-containing complex assembly; catalytic activity, acting on DNA; ATP-dependent activity"
OG_06221,1.2040056292812158,FUN_028164-T1,Peve_00044586,Pocillopora_meandrina_HIv1___TS.g11490.t1,three_way,71.51433333333334,,,,,,,,,,,,,,,,,
OG_06223,1.6347810928245914,FUN_028167-T1,Peve_00029326,Pocillopora_meandrina_HIv1___RNAseq.g16473.t1,three_way,78.41499999999999,FUN_028167-T1,Q8VDI9,,,,,56.0,563.0,3.4e-184,646.4,"sp|Q8VDI9|ALG9_MOUSE Alpha-1,2-mannosyltransferase ALG9 OS=Mus musculus OX=10090 GN=Alg9 PE=2 SV=1",,,,,,
OG_06225,2.531975519879457,FUN_028170-T1,Peve_00044582,Pocillopora_meandrina_HIv1___RNAseq.g16470.t1,three_way,67.04516666666666,,,,,,,,,,,,,,,,,
OG_06227,3.141818999269491,FUN_028173-T1,Peve_00024812,Pocillopora_meandrina_HIv1___RNAseq.g16502.t1,three_way,60.945166666666665,FUN_028173-T1,P50534,MSL2_DROME,,E3 ubiquitin-protein ligase msl-2 (EC 2.3.2.27) (Protein male-specific lethal-2),Drosophila melanogaster (Fruit fly),40.9,88.0,2.8e-11,71.2,sp|P50534|MSL2_DROME E3 ubiquitin-protein ligase msl-2 OS=Drosophila melanogaster OX=7227 GN=msl-2 PE=1 SV=2,GO:0000209; GO:0000228; GO:0000805; GO:0003677; GO:0003682; GO:0005694; GO:0007549; GO:0008270; GO:0009047; GO:0016456; GO:0016567; GO:0046536; GO:0061630; GO:0071168; GO:0072487; GO:0106222; GO:0140463; GO:0140517; GO:0140693; GO:0141054; GO:1990837,dosage compensation by hyperactivation of X chromosome [GO:0009047]; protein localization to chromatin [GO:0071168]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sex-chromosome dosage compensation [GO:0007549],"chromosome [GO:0005694]; dosage compensation complex [GO:0046536]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]",chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; histone H2B ubiquitin ligase activity [GO:0141054]; lncRNA binding [GO:0106222]; molecular condensate scaffold activity [GO:0140693]; protein-RNA adaptor activity [GO:0140517]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0000228; GO:0003677; GO:0003723; GO:0003824; GO:0005694; GO:0006325; GO:0016740; GO:0043226; GO:0060090; GO:0140096,"nuclear chromosome; DNA binding; RNA binding; catalytic activity; chromosome; chromatin organization; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein"
OG_06228,1.405471534047695,FUN_028174-T1,Peve_00024810,Pocillopora_meandrina_HIv1___RNAseq.g16503.t1,three_way,89.96966666666667,FUN_028174-T1,P79384,,,,,77.6,510.0,8.2e-238,824.3,"sp|P79384|PCCB_PIG Propionyl-CoA carboxylase beta chain, mitochondrial OS=Sus scrofa OX=9823 GN=PCCB PE=1 SV=1",,,,,,
OG_06230,1.6252918909696328,FUN_028180-T1,Peve_00001282,Pocillopora_meandrina_HIv1___RNAseq.g16511.t1,three_way,66.941,FUN_028180-T1,Q8BLN6,UNC80_MOUSE,,Protein unc-80 homolog (mUNC-80),Mus musculus (Mouse),29.5,3133.0,7.3e-307,1056.2,sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3,GO:0005886; GO:0030425; GO:0034706,,dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706],,GO:0005886,plasma membrane
OG_06232,1.6752537936149092,FUN_028185-T1,Peve_00001293,Pocillopora_meandrina_HIv1___TS.g11524.t1,three_way,76.6565,FUN_028185-T1,Q86YW9,MD12L_HUMAN,,Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like),Homo sapiens (Human),39.9,1865.0,0.0,1122.5,sp|Q86YW9|MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens OX=9606 GN=MED12L PE=1 SV=2,GO:0003713; GO:0008013; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592],beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713],GO:0006355; GO:0060090; GO:0140110,regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_06234,1.661488006582746,FUN_028187-T1,Peve_00000861,Pocillopora_meandrina_HIv1___RNAseq.g16542.t1,three_way,56.39333333333333,FUN_028187-T1,Q9YH85,,,,,27.1,284.0,4.2e-15,84.0,sp|Q9YH85|TECTA_CHICK Alpha-tectorin OS=Gallus gallus OX=9031 GN=TECTA PE=1 SV=1,,,,,,
OG_06236,1.886912938629055,FUN_028192-T1,Peve_00001297,Pocillopora_meandrina_HIv1___TS.g11527.t1,three_way,50.75,FUN_028192-T1,Q91X17,UROM_MOUSE,,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",Mus musculus (Mouse),37.5,144.0,6.5e-21,104.0,sp|Q91X17|UROM_MOUSE Uromodulin OS=Mus musculus OX=10090 GN=Umod PE=1 SV=1,GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033554; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266,antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to stress [GO:0033554]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509]; IgG binding [GO:0019864],GO:0002376; GO:0003014; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007155; GO:0012501; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0061024; GO:0098542,immune system process; renal system process; extracellular space; endoplasmic reticulum; plasma membrane; cilium; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; cell adhesion; programmed cell death; protein catabolic process; organelle; anatomical structure development; cell motility; transmembrane transport; membrane organization; defense response to other organism
OG_06241,2.4849228254472706,FUN_028229-T1,Peve_00015265,Pocillopora_meandrina_HIv1___TS.g10556.t1,three_way,86.2135,FUN_028229-T1,Q9H172,ABCG4_HUMAN,,ATP-binding cassette sub-family G member 4 (EC 7.6.2.-),Homo sapiens (Human),58.5,602.0,8.9e-191,668.3,sp|Q9H172|ABCG4_HUMAN ATP-binding cassette sub-family G member 4 OS=Homo sapiens OX=9606 GN=ABCG4 PE=1 SV=2,GO:0005524; GO:0005886; GO:0006355; GO:0010008; GO:0010875; GO:0016887; GO:0031410; GO:0033344; GO:0034041; GO:0042632; GO:0042802; GO:0042803; GO:0045542; GO:0046982; GO:0055085; GO:0071403; GO:1990830,cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of DNA-templated transcription [GO:0006355]; transmembrane transport [GO:0055085],cytoplasmic vesicle [GO:0031410]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005886; GO:0006355; GO:0016787; GO:0031410; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_06244,2.088102745506504,FUN_028236-T1,Peve_00015260,Pocillopora_meandrina_HIv1___TS.g10553.t1,three_way,56.52033333333333,,,,,,,,,,,,,,,,,
OG_06246,3.345889768471185,FUN_028241-T1,Peve_00019542,Pocillopora_meandrina_HIv1___RNAseq.g15522.t1,three_way,71.78316666666666,FUN_028241-T1,Q155Q3,DIXC1_HUMAN,,Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1),Homo sapiens (Human),41.1,725.0,4.900000000000001e-71,270.8,sp|Q155Q3|DIXC1_HUMAN Dixin OS=Homo sapiens OX=9606 GN=DIXDC1 PE=1 SV=2,GO:0001725; GO:0003779; GO:0005829; GO:0005925; GO:0019904; GO:0021799; GO:0021869; GO:0030177; GO:0032956; GO:0043015; GO:0045665; GO:0060070; GO:0070507; GO:0098794; GO:0098885; GO:0098978,canonical Wnt signaling pathway [GO:0060070]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; stress fiber [GO:0001725],actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904],GO:0005829; GO:0008092; GO:0034330; GO:0048870,cytosol; cytoskeletal protein binding; cell junction organization; cell motility
OG_06258,1.2752057591225674,FUN_028276-T1,Peve_00018995,Pocillopora_meandrina_HIv1___RNAseq.g15501.t1,three_way,50.34283333333333,,,,,,,,,,,,,,,,,
OG_06261,1.3991067312887462,FUN_028279-T1,Peve_00003674,Pocillopora_meandrina_HIv1___RNAseq.g15496.t1,three_way,60.25483333333333,FUN_028279-T1,Q1L8I0,,,,,35.2,687.0,2.8e-90,334.7,sp|Q1L8I0|PUS7L_DANRE Pseudouridylate synthase PUS7L OS=Danio rerio OX=7955 GN=pus7l PE=2 SV=1,,,,,,
OG_06262,2.06311202497978,FUN_028287-T1,Peve_00003672,Pocillopora_meandrina_HIv1___RNAseq.g15495.t1,three_way,73.47366666666667,FUN_028287-T1,Q8K1K9,HINFP_MOUSE,,Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein),Mus musculus (Mouse),50.1,413.0,4.2e-106,386.7,sp|Q8K1K9|HINFP_MOUSE Histone H4 transcription factor OS=Mus musculus OX=10090 GN=Hinfp PE=2 SV=3,GO:0000077; GO:0000082; GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0008270; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044843; GO:0045184; GO:0045445; GO:0045892; GO:0045893,cell cycle G1/S phase transition [GO:0044843]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355],Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; anatomical structure development; transcription regulator activity
OG_06266,3.040280893496364,FUN_028293-T1,Peve_00000716,Pocillopora_meandrina_HIv1___TS.g10567.t1,three_way,55.41733333333333,FUN_028293-T1,G5EBF1,SAX3_CAEEL,,Protein sax-3 (Sensory axon guidance 3),Caenorhabditis elegans,24.9,887.0,4.3e-42,175.6,sp|G5EBF1|SAX3_CAEEL Protein sax-3 OS=Caenorhabditis elegans OX=6239 GN=sax-3 PE=2 SV=1,GO:0001764; GO:0005829; GO:0005886; GO:0007411; GO:0008046; GO:0030424; GO:0033563; GO:0035385; GO:0097374; GO:0098609; GO:1905489,axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; dorsal/ventral axon guidance [GO:0033563]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; Roundabout signaling pathway [GO:0035385]; sensory neuron axon guidance [GO:0097374],axon [GO:0030424]; cytosol [GO:0005829]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046],GO:0005829; GO:0005886; GO:0007155; GO:0048870; GO:0060089,cytosol; plasma membrane; cell adhesion; cell motility; molecular transducer activity
OG_06268,1.7914811577145808,FUN_028299-T1,Peve_00000718,Pocillopora_meandrina_HIv1___RNAseq.g15542.t2,three_way,70.94366666666667,,,,,,,,,,,,,,,,,
OG_06269,1.66737658701721,FUN_028300-T1,Peve_00000713,Pocillopora_meandrina_HIv1___RNAseq.g15543.t1,three_way,84.12116666666667,FUN_028300-T1,Q80Z96,,,,,42.7,461.0,2.0999999999999998e-94,347.8,sp|Q80Z96|VANG1_MOUSE Vang-like protein 1 OS=Mus musculus OX=10090 GN=Vangl1 PE=1 SV=2,,,,,,
OG_06270,1.6435357553574814,FUN_028301-T1,Peve_00000714,Pocillopora_meandrina_HIv1___TS.g10572.t1,three_way,51.42816666666666,FUN_028301-T1,D3ZSP7,TTC3_RAT,,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D),Rattus norvegicus (Rat),27.5,741.0,7.4e-62,241.5,sp|D3ZSP7|TTC3_RAT E3 ubiquitin-protein ligase TTC3 OS=Rattus norvegicus OX=10116 GN=Ttc3 PE=3 SV=3,GO:0004842; GO:0005634; GO:0005773; GO:0005794; GO:0006511; GO:0008270; GO:0030517; GO:0045665; GO:0070936,negative regulation of axon extension [GO:0030517]; negative regulation of neuron differentiation [GO:0045665]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; vacuole [GO:0005773],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005773; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vacuole; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06271,1.3876839030971355,FUN_028303-T1,Peve_00027867,Pocillopora_meandrina_HIv1___RNAseq.g15547.t1,three_way,85.15633333333334,FUN_028303-T1,Q32LN4,CFA45_BOVIN,,Cilia- and flagella-associated protein 45,Bos taurus (Bovine),35.3,547.0,1e-17,93.2,sp|Q32LN4|CFA45_BOVIN Cilia- and flagella-associated protein 45 OS=Bos taurus OX=9913 GN=CFAP45 PE=1 SV=2,GO:0005576; GO:0005879; GO:0016208; GO:0030317; GO:0036126; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0160112,cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],9+0 motile cilium [GO:0097728]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126],AMP binding [GO:0016208],GO:0005576; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,extracellular region; cilium; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_06280,2.31914722915026,FUN_028449-T1,Peve_00031080,Pocillopora_meandrina_HIv1___TS.g11207.t1,three_way,39.0405,FUN_028449-T1,Q62718,NTRI_RAT,,Neurotrimin (GP65),Rattus norvegicus (Rat),31.4,204.0,2.4e-18,95.9,sp|Q62718|NTRI_RAT Neurotrimin OS=Rattus norvegicus OX=10116 GN=Ntm PE=1 SV=1,GO:0005615; GO:0007155; GO:0009986; GO:0010976; GO:0010977; GO:0021549; GO:0030424; GO:0032355; GO:0042802; GO:0048471; GO:0048787; GO:0060076; GO:0060253; GO:0071392; GO:0098552; GO:0098686; GO:0098839; GO:1900149,cell adhesion [GO:0007155]; cellular response to estradiol stimulus [GO:0071392]; cerebellum development [GO:0021549]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron projection development [GO:0010977]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Schwann cell migration [GO:1900149]; response to estradiol [GO:0032355],axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; side of membrane [GO:0098552],identical protein binding [GO:0042802],GO:0005615; GO:0007155; GO:0048856,extracellular space; cell adhesion; anatomical structure development
OG_06284,2.7519324876160667,FUN_028470-T1,Peve_00036788,Pocillopora_meandrina_HIv1___RNAseq.g16126.t1,three_way,85.66233333333334,FUN_028470-T1,Q17LW0,,,,,59.3,1107.0,1.4e-292,1007.3,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_06285,1.503473250862997,FUN_028472-T1,Peve_00036790,Pocillopora_meandrina_HIv1___RNAseq.g16124.t1,three_way,53.61833333333333,,,,,,,,,,,,,,,,,
OG_06287,2.0707224688350503,FUN_028477-T1,Peve_00039732,Pocillopora_meandrina_HIv1___RNAseq.6804_t,three_way,81.0705,FUN_028477-T1,Q9H3P2,NELFA_HUMAN,,Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 protein),Homo sapiens (Human),41.4,534.0,1.3999999999999999e-61,238.8,sp|Q9H3P2|NELFA_HUMAN Negative elongation factor A OS=Homo sapiens OX=9606 GN=NELFA PE=1 SV=3,GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0016604; GO:0032021; GO:0034244; GO:0045944; GO:0060090,negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytosol [GO:0005829]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090],GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0060090,nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_06288,2.550846840541261,FUN_028482-T1,Peve_00039731,Pocillopora_meandrina_HIv1___RNAseq.11963_t,three_way,70.764,FUN_028482-T1,Q9NYR8,,,,,45.3,287.0,1.1000000000000001e-60,235.0,sp|Q9NYR8|RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens OX=9606 GN=RDH8 PE=1 SV=1,,,,,,
OG_06289,1.7963205179294957,FUN_028484-T1,Peve_00023662,Pocillopora_meandrina_HIv1___RNAseq.g16115.t1,three_way,73.85666666666667,FUN_028484-T1,Q9NYR8,,,,,33.7,264.0,2.2e-31,137.9,sp|Q9NYR8|RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens OX=9606 GN=RDH8 PE=1 SV=1,,,,,,
OG_06293,1.2801179589370473,FUN_028491-T1,Peve_00015137,Pocillopora_meandrina_HIv1___RNAseq.g20858.t1,three_way,70.98166666666667,FUN_028491-T1,Q6P4R8,NFRKB_HUMAN,,Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G),Homo sapiens (Human),75.4,167.0,3.6999999999999996e-68,260.4,sp|Q6P4R8|NFRKB_HUMAN Nuclear factor related to kappa-B-binding protein OS=Homo sapiens OX=9606 GN=NFRKB PE=1 SV=2,GO:0000723; GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; protease binding [GO:0002020],GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle
OG_06294,1.1547417164275928,FUN_028494-T1,Peve_00015135,Pocillopora_meandrina_HIv1___RNAseq.g16087.t1,three_way,73.79483333333333,FUN_028494-T1,Q96MW5,COG8_HUMAN,,Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8),Homo sapiens (Human),53.1,499.0,7.300000000000001e-145,515.8,sp|Q96MW5|COG8_HUMAN Conserved oligomeric Golgi complex subunit 8 OS=Homo sapiens OX=9606 GN=COG8 PE=1 SV=2,GO:0000139; GO:0000301; GO:0005794; GO:0006891; GO:0007030; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0070085,"glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588],,GO:0005794; GO:0016192; GO:0043226,Golgi apparatus; vesicle-mediated transport; organelle
OG_06298,1.6645806265592211,FUN_028498-T2,Peve_00019598,Pocillopora_meandrina_HIv1___RNAseq.g15238.t2,three_way,79.519,FUN_028498-T2,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),35.8,617.0,1e-97,360.1,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_06304,1.0670524194770754,FUN_028510-T1,Peve_00008103,Pocillopora_meandrina_HIv1___TS.g11897.t1,three_way,78.13066666666667,FUN_028510-T1,Q96RQ3,MCCA_HUMAN,,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)",Homo sapiens (Human),60.7,687.0,8.1e-238,824.7,"sp|Q96RQ3|MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=MCCC1 PE=1 SV=3",GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:1905202,biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; L-leucine catabolic process [GO:0006552],cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0006790; GO:0016874; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; sulfur compound metabolic process; ligase activity; organelle
OG_06308,1.247341574361847,FUN_028547-T1,Peve_00012988,Pocillopora_meandrina_HIv1___RNAseq.g16675.t1,three_way,72.68233333333333,FUN_028547-T1,Q9CR50,ZN363_MOUSE,,RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363),Mus musculus (Mouse),55.2,241.0,1.8999999999999998e-82,307.4,sp|Q9CR50|ZN363_MOUSE RING finger and CHY zinc finger domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rchy1 PE=1 SV=1,GO:0000151; GO:0002039; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0051865; GO:0061630; GO:0072344,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06310,3.762979629380614,FUN_028549-T1,Peve_00000746,Pocillopora_meandrina_HIv1___RNAseq.g6218.t1,three_way,56.03633333333333,FUN_028549-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),30.5,285.0,4.8e-29,131.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_06312,1.0880790341233737,FUN_028552-T1,Peve_00000749,Pocillopora_meandrina_HIv1___RNAseq.g9164.t1,three_way,47.18,,,,,,,,,,,,,,,,,
OG_06313,2.595131596980179,FUN_028553-T1,Peve_00000750,Pocillopora_meandrina_HIv1___TS.g15553.t2,three_way,74.64583333333333,FUN_028553-T1,A2AT37,RENT2_MOUSE,,Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog) (Upf2),Mus musculus (Mouse),48.4,1041.0,5e-267,922.5,sp|A2AT37|RENT2_MOUSE Regulator of nonsense transcripts 2 OS=Mus musculus OX=10090 GN=Upf2 PE=1 SV=1,GO:0000184; GO:0001889; GO:0003723; GO:0005737; GO:0005829; GO:0006986; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471,"animal organ regeneration [GO:0031100]; liver development [GO:0001889]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to unfolded protein [GO:0006986]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; perinuclear region of cytoplasm [GO:0048471],RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0005829; GO:0016071; GO:0043226; GO:0048856,DNA binding; RNA binding; cytosol; mRNA metabolic process; organelle; anatomical structure development
OG_06318,2.4817041474381893,FUN_028794-T1,Peve_00000751,Pocillopora_meandrina_HIv1___RNAseq.g20732.t1,three_way,77.11333333333333,FUN_028794-T1,Q9W352,,,,,39.9,313.0,1.9e-21,104.8,sp|Q9W352|CXXC1_DROME CXXC-type zinc finger protein 1 OS=Drosophila melanogaster OX=7227 GN=Cfp1 PE=1 SV=1,,,,,,
OG_06320,1.1635631955515633,FUN_028803-T1,Peve_00018546,Pocillopora_meandrina_HIv1___RNAseq.g20705.t1,three_way,75.81733333333334,FUN_028803-T1,Q6P4A8,PLBL1_HUMAN,,Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C],Homo sapiens (Human),51.0,529.0,1.9e-146,520.8,sp|Q6P4A8|PLBL1_HUMAN Phospholipase B-like 1 OS=Homo sapiens OX=9606 GN=PLBD1 PE=1 SV=2,GO:0004620; GO:0005576; GO:0005615; GO:0005764; GO:0005829; GO:0009395,phospholipid catabolic process [GO:0009395],cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764],phospholipase activity [GO:0004620],GO:0003824; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005829; GO:0006629; GO:0016787; GO:0043226,catalytic activity; extracellular region; extracellular space; lysosome; vacuole; cytosol; lipid metabolic process; hydrolase activity; organelle
OG_06323,2.160159364136775,FUN_028831-T1,Peve_00024573,Pocillopora_meandrina_HIv1___RNAseq.g20708.t1,three_way,60.382666666666665,FUN_028831-T1,Q9NVH0,EXD2_HUMAN,,Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2),Homo sapiens (Human),34.2,669.0,3.8e-100,367.5,sp|Q9NVH0|EXD2_HUMAN Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EXD2 PE=1 SV=2,GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090304; GO:0090734,DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid metabolic process [GO:0090304]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310],GO:0003824; GO:0005634; GO:0005739; GO:0005856; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; mitochondrion; cytoskeleton; DNA repair; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_06327,1.5072560473049448,FUN_028847-T1,Peve_00044608,Pocillopora_meandrina_HIv1___RNAseq.g12800.t1,three_way,69.94233333333334,,,,,,,,,,,,,,,,,
OG_06338,1.9846601062719844,FUN_028897-T1,Peve_00027290,Pocillopora_meandrina_HIv1___RNAseq.g25674.t1,three_way,93.493,FUN_028897-T1,A8WIP6,CDK20_DANRE,,Cyclin-dependent kinase 20 (EC 2.7.11.22) (Cell cycle-related kinase) (Cell division protein kinase 20),Danio rerio (Zebrafish) (Brachydanio rerio),79.6,334.0,1.2e-152,540.8,sp|A8WIP6|CDK20_DANRE Cyclin-dependent kinase 20 OS=Danio rerio OX=7955 GN=cdk20 PE=2 SV=1,GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0051301; GO:0060271; GO:0106310,cell division [GO:0051301]; cilium assembly [GO:0060271],cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; cilium; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_06340,3.3808597789157404,FUN_028905-T1,Peve_00042688,Pocillopora_meandrina_HIv1___RNAseq.g25682.t1,three_way,65.59266666666667,,,,,,,,,,,,,,,,,
OG_06342,1.367622733385516,FUN_028907-T1,Peve_00031954,Pocillopora_meandrina_HIv1___RNAseq.g25671.t1,three_way,81.73166666666667,FUN_028907-T1,P48728,GCST_HUMAN,,"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)",Homo sapiens (Human),59.4,374.0,2.6e-119,430.3,"sp|P48728|GCST_HUMAN Aminomethyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=AMT PE=1 SV=1",GO:0004047; GO:0005654; GO:0005739; GO:0005759; GO:0005960; GO:0006546; GO:0008483; GO:0019464,glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464],glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483],GO:0003824; GO:0005654; GO:0005739; GO:0006520; GO:0016740; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; amino acid metabolic process; transferase activity; organelle
OG_06348,1.950479627143497,FUN_028918-T1,Peve_00028028,Pocillopora_meandrina_HIv1___TS.g9367.t1,three_way,84.30666666666667,FUN_028918-T1,A7RX26,HUTI_NEMVE,,Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog),Nematostella vectensis (Starlet sea anemone),71.0,317.0,6.6e-131,468.4,sp|A7RX26|HUTI_NEMVE Probable imidazolonepropionase OS=Nematostella vectensis OX=45351 GN=amdhd1 PE=3 SV=1,GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480,L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557],cytoplasm [GO:0005737],imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872],GO:0003824; GO:0006520; GO:0016787,catalytic activity; amino acid metabolic process; hydrolase activity
OG_06349,1.3062120894959002,FUN_028919-T1,Peve_00028034,Pocillopora_meandrina_HIv1___RNAseq.g20741.t2b,three_way,74.77233333333334,FUN_028919-T1,Q28107,FA5_BOVIN,,Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain],Bos taurus (Bovine),36.2,160.0,5e-24,112.5,sp|Q28107|FA5_BOVIN Coagulation factor V OS=Bos taurus OX=9913 GN=F5 PE=1 SV=1,GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091,blood circulation [GO:0008015]; blood coagulation [GO:0007596],extracellular region [GO:0005576]; platelet alpha granule [GO:0031091],copper ion binding [GO:0005507],GO:0003013; GO:0005576; GO:0031410; GO:0043226,circulatory system process; extracellular region; cytoplasmic vesicle; organelle
OG_06351,2.5896533963037878,FUN_028927-T1,Peve_00028043,Pocillopora_meandrina_HIv1___RNAseq.g25556.t1,three_way,63.5355,FUN_028927-T1,Q6NU95,,,,,47.6,391.0,1.4e-25,119.0,sp|Q6NU95|RPAP3_XENLA RNA polymerase II-associated protein 3 OS=Xenopus laevis OX=8355 GN=rpap3 PE=2 SV=1,,,,,,
OG_06352,1.3873438668973088,FUN_028939-T1,Peve_00026871,Pocillopora_meandrina_HIv1___TS.g9025.t1,three_way,60.138,FUN_028939-T1,P16305,,,,,34.0,418.0,2.2e-52,208.0,sp|P16305|GBRA6_MOUSE Gamma-aminobutyric acid receptor subunit alpha-6 OS=Mus musculus OX=10090 GN=Gabra6 PE=1 SV=3,,,,,,
OG_06354,2.361920718654959,FUN_028947-T1,Peve_00026866,Pocillopora_meandrina_HIv1___RNAseq.g25582.t1,three_way,71.633,FUN_028947-T1,Q9NSA2,KCND1_HUMAN,,A-type voltage-gated potassium channel KCND1 (Potassium voltage-gated channel subfamily D member 1) (Shal-type potassium channel KCND1) (Voltage-gated potassium channel subunit Kv4.1),Homo sapiens (Human),39.5,390.0,6.4e-67,256.1,sp|Q9NSA2|KCND1_HUMAN A-type voltage-gated potassium channel KCND1 OS=Homo sapiens OX=9606 GN=KCND1 PE=1 SV=2,GO:0001508; GO:0005250; GO:0005886; GO:0008076; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260],dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_06355,1.1814378404461354,FUN_028950-T1,Peve_00026877,Pocillopora_meandrina_HIv1___RNAseq.g25581.t1,three_way,65.13466666666667,FUN_028950-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),33.6,450.0,1.2e-56,222.2,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06357,1.9799450639799665,FUN_028953-T1,Peve_00025108,Pocillopora_meandrina_HIv1___RNAseq.g25579.t1,three_way,77.653,FUN_028953-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),43.3,395.0,4.900000000000001e-71,270.0,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06359,1.051687362461479,FUN_028961-T1,Peve_00029299,Pocillopora_meandrina_HIv1___TS.g8998.t1,three_way,54.599,,,,,,,,,,,,,,,,,
OG_06360,3.161826504115975,FUN_028963-T1,Peve_00025110,Pocillopora_meandrina_HIv1___RNAseq.g25566.t1,three_way,55.882666666666665,,,,,,,,,,,,,,,,,
OG_06361,1.8339035013092368,FUN_028965-T1,Peve_00020162,Pocillopora_meandrina_HIv1___RNAseq.g25571.t1,three_way,72.39466666666667,FUN_028965-T1,Q9Y2M2,SSUH2_HUMAN,,Protein SSUH2 homolog (Protein ssu-2 homolog),Homo sapiens (Human),38.1,357.0,7.200000000000001e-44,179.5,sp|Q9Y2M2|SSUH2_HUMAN Protein SSUH2 homolog OS=Homo sapiens OX=9606 GN=SSUH2 PE=1 SV=2,GO:0005634; GO:0005737; GO:0031072; GO:0042476; GO:0051082,odontogenesis [GO:0042476],cytoplasm [GO:0005737]; nucleus [GO:0005634],heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082],GO:0005634; GO:0043226,nucleus; organelle
OG_06362,1.6486666805170096,FUN_028966-T1,Peve_00020164,Pocillopora_meandrina_HIv1___RNAseq.g25572.t1,three_way,56.937333333333335,,,,,,,,,,,,,,,,,
OG_06364,1.1154843399355796,FUN_028968-T1,Peve_00029303,Pocillopora_meandrina_HIv1___RNAseq.g25575.t1,three_way,71.739,FUN_028968-T1,O97725,,,,,53.4,133.0,5.799999999999999e-31,135.2,sp|O97725|NDUAC_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 OS=Bos taurus OX=9913 GN=NDUFA12 PE=1 SV=1,,,,,,
OG_06365,1.8803118352481616,FUN_028969-T1,Peve_00029302,Pocillopora_meandrina_HIv1___TS.g9014.t1a,three_way,92.622,FUN_028969-T1,Q69ZQ2,ISY1_MOUSE,,Pre-mRNA-splicing factor ISY1 homolog,Mus musculus (Mouse),65.4,286.0,9.199999999999999e-92,338.2,sp|Q69ZQ2|ISY1_MOUSE Pre-mRNA-splicing factor ISY1 homolog OS=Mus musculus OX=10090 GN=Isy1 PE=1 SV=2,GO:0000350; GO:0000398; GO:0005634; GO:0071006; GO:0071013,"generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006],,GO:0005634; GO:0016071; GO:0043226; GO:0065003,nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06367,2.408933248456404,FUN_028971-T1,Peve_00006112,Pocillopora_meandrina_HIv1___RNAseq.g25601.t1,three_way,69.34566666666667,FUN_028971-T1,Q80TM9,NISCH_MOUSE,,Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor I-1-like protein) (Imidazoline-1 receptor) (I1R),Mus musculus (Mouse),25.1,343.0,6e-15,85.5,sp|Q80TM9|NISCH_MOUSE Nischarin OS=Mus musculus OX=10090 GN=Nisch PE=1 SV=2,GO:0005178; GO:0005654; GO:0005769; GO:0005829; GO:0005886; GO:0006915; GO:0015630; GO:0016601; GO:0030036; GO:0030336; GO:0035091; GO:0042802; GO:0045171; GO:0055037,actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; negative regulation of cell migration [GO:0030336]; Rac protein signal transduction [GO:0016601],cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091],GO:0005654; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008289; GO:0012501; GO:0031410; GO:0043226,nucleoplasm; endosome; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; lipid binding; programmed cell death; cytoplasmic vesicle; organelle
OG_06368,1.4641314562349803,FUN_028972-T1,Peve_00016206,Pocillopora_meandrina_HIv1___RNAseq.g25602.t1,three_way,75.99566666666666,FUN_028972-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),30.6,402.0,1.2e-51,205.7,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_06369,1.8565970770459943,FUN_028973-T1,Peve_00031293,Pocillopora_meandrina_HIv1___RNAseq.g25606.t1,three_way,43.651833333333336,,,,,,,,,,,,,,,,,
OG_06373,3.8124000852527256,FUN_028978-T1,Peve_00029291,Pocillopora_meandrina_HIv1___RNAseq.g25600.t1,three_way,57.49583333333333,FUN_028978-T1,P35331,,,,,29.0,978.0,1.4e-95,352.8,sp|P35331|NRCAM_CHICK Neuronal cell adhesion molecule OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06374,1.5879003305107204,FUN_028979-T1,Peve_00015447,Pocillopora_meandrina_HIv1___TS.g9074.t2,three_way,83.00766666666667,FUN_028979-T1,Q803T2,,,,,52.2,795.0,2.5999999999999997e-221,770.0,sp|Q803T2|STRP1_DANRE Striatin-interacting protein 1 homolog OS=Danio rerio OX=7955 GN=strip1 PE=1 SV=1,,,,,,
OG_06376,1.4052232494862538,FUN_028981-T1,Peve_00014491,Pocillopora_meandrina_HIv1___RNAseq.g25619.t1,three_way,69.54766666666667,FUN_028981-T1,A7WM73,HEXO1_ARATH,,Beta-hexosaminidase 1 (EC 3.2.1.52) (Beta-GlcNAcase 1) (Beta-N-acetylhexosaminidase 1) (Beta-hexosaminidase 2) (AtHEX2) (N-acetyl-beta-glucosaminidase 1),Arabidopsis thaliana (Mouse-ear cress),27.5,534.0,4.1e-45,184.1,sp|A7WM73|HEXO1_ARATH Beta-hexosaminidase 1 OS=Arabidopsis thaliana OX=3702 GN=HEXO1 PE=1 SV=1,GO:0000325; GO:0004563; GO:0005773; GO:0005975; GO:0015929; GO:0099503,carbohydrate metabolic process [GO:0005975],plant-type vacuole [GO:0000325]; secretory vesicle [GO:0099503]; vacuole [GO:0005773],beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929],GO:0003824; GO:0005773; GO:0005975; GO:0016787; GO:0031410; GO:0043226,catalytic activity; vacuole; carbohydrate metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_06381,1.679868885476182,FUN_028993-T1,Peve_00034527,Pocillopora_meandrina_HIv1___TS.g9080.t1b,three_way,53.91833333333334,FUN_028993-T1,A2AVA0,SVEP1_MOUSE,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)",Mus musculus (Mouse),33.5,191.0,1e-20,102.4,"sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1",GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193,cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0007155; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell adhesion; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; cell motility; cell adhesion mediator activity
OG_06384,2.818109928989019,FUN_029014-T1,Peve_00003118,Pocillopora_meandrina_HIv1___TS.g9087.t1,three_way,52.617,FUN_029014-T1,B8VIW9,,,,,40.2,1040.0,3.2999999999999996e-188,660.6,sp|B8VIW9|FP_ACRMI Fibronectin type III domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_06385,2.5319996180767945,FUN_029018-T1,Peve_00028035,Pocillopora_meandrina_HIv1___TS.g9259.t2,three_way,56.882666666666665,FUN_029018-T1,Q6IC98,GRAM4_HUMAN,,GRAM domain-containing protein 4 (Death-inducing protein),Homo sapiens (Human),33.6,429.0,2.2e-54,215.3,sp|Q6IC98|GRAM4_HUMAN GRAM domain-containing protein 4 OS=Homo sapiens OX=9606 GN=GRAMD4 PE=1 SV=1,GO:0005739; GO:0005789; GO:0006915; GO:0031966; GO:0034164; GO:0043065,apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of apoptotic process [GO:0043065],endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],,GO:0005739; GO:0012501; GO:0043226,mitochondrion; programmed cell death; organelle
OG_06392,1.443620134938961,FUN_029040-T1,Peve_00026015,Pocillopora_meandrina_HIv1___RNAseq.g20769.t1,three_way,90.76433333333334,FUN_029040-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),57.2,568.0,1.8000000000000004e-164,580.9,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06395,1.19509024393967,FUN_029056-T1,Peve_00040055,Pocillopora_meandrina_HIv1___RNAseq.g25438.t1,three_way,34.492,,,,,,,,,,,,,,,,,
OG_06398,1.368260198630069,FUN_029059-T2,Peve_00002500,Pocillopora_meandrina_HIv1___RNAseq.g25824.t1,three_way,47.455333333333336,FUN_029059-T2,Q6PJN8,,,,,34.8,267.0,4.9e-39,164.1,sp|Q6PJN8|DALD3_MOUSE DALR anticodon-binding domain-containing protein 3 OS=Mus musculus OX=10090 GN=Dalrd3 PE=2 SV=1,,,,,,
OG_06400,3.4458432683657447,FUN_029061-T1,Peve_00043258,Pocillopora_meandrina_HIv1___RNAseq.g25810.t1,three_way,65.944,FUN_029061-T1,A8MTJ6,FOXI3_HUMAN,,Forkhead box protein I3,Homo sapiens (Human),42.1,145.0,1.6e-20,101.7,sp|A8MTJ6|FOXI3_HUMAN Forkhead box protein I3 OS=Homo sapiens OX=9606 GN=FOXI3 PE=1 SV=3,GO:0000978; GO:0000981; GO:0001942; GO:0005634; GO:0006357; GO:0009653; GO:0009957; GO:0030154; GO:0042475; GO:0048538; GO:0060017; GO:0060037; GO:1905040,anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; epidermal cell fate specification [GO:0009957]; hair follicle development [GO:0001942]; odontogenesis of dentin-containing tooth [GO:0042475]; otic placode development [GO:1905040]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; regulation of transcription by RNA polymerase II [GO:0006357]; thymus development [GO:0048538],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06401,1.7605822348563531,FUN_029062-T1,Peve_00043257,Pocillopora_meandrina_HIv1___RNAseq.g25809.t1,three_way,72.04133333333333,FUN_029062-T1,Q02360,,,,,47.4,114.0,6.8e-21,104.0,sp|Q02360|FOXL1_DROME Fork head domain-containing protein L1 OS=Drosophila melanogaster OX=7227 GN=FoxL1 PE=1 SV=2,,,,,,
OG_06403,4.548179775653479,FUN_029065-T1,Peve_00043255,Pocillopora_meandrina_HIv1___RNAseq.g25804.t1,three_way,71.726,,,,,,,,,,,,,,,,,
OG_06406,1.9465823575054837,FUN_029080-T1,Peve_00012860,Pocillopora_meandrina_HIv1___RNAseq.g25461.t1,three_way,67.50433333333334,FUN_029080-T1,Q6IQ20,NAPEP_HUMAN,,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54),Homo sapiens (Human),54.1,344.0,7.000000000000003e-110,398.7,sp|Q6IQ20|NAPEP_HUMAN N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Homo sapiens OX=9606 GN=NAPEPLD PE=1 SV=2,GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0030868; GO:0031901; GO:0032052; GO:0035900; GO:0042622; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0098686; GO:1903999,host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; temperature homeostasis [GO:0001659],cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; smooth endoplasmic reticulum membrane [GO:0030868],bile acid binding [GO:0032052]; identical protein binding [GO:0042802]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270],GO:0003824; GO:0005635; GO:0005654; GO:0005768; GO:0005794; GO:0006629; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nuclear envelope; nucleoplasm; endosome; Golgi apparatus; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_06412,1.693974127054574,FUN_029095-T1,Peve_00007830,Pocillopora_meandrina_HIv1___RNAseq.g25749.t1,three_way,83.04316666666666,FUN_029095-T1,Q6PDC8,,,,,35.7,487.0,2.5000000000000003e-67,258.1,sp|Q6PDC8|MFD4A_MOUSE Major facilitator superfamily domain-containing protein 4A OS=Mus musculus OX=10090 GN=Mfsd4a PE=2 SV=2,,,,,,
OG_06418,1.45358582377979,FUN_029105-T1,Peve_00029018,Pocillopora_meandrina_HIv1___RNAseq.g25494.t1,three_way,84.80216666666666,FUN_029105-T1,Q6GP04,,,,,50.3,1768.0,0.0,1569.7,sp|Q6GP04|MON2_XENLA Protein MON2 homolog OS=Xenopus laevis OX=8355 GN=mon2 PE=2 SV=1,,,,,,
OG_06420,1.5109982754200022,FUN_029108-T1,Peve_00017655,Pocillopora_meandrina_HIv1___RNAseq.g25465.t1,three_way,91.391,FUN_029108-T1,Q3SZ71,MPPB_BOVIN,,Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP),Bos taurus (Bovine),69.1,469.0,1.3000000000000006e-186,654.1,sp|Q3SZ71|MPPB_BOVIN Mitochondrial-processing peptidase subunit beta OS=Bos taurus OX=9913 GN=PMPCB PE=2 SV=1,GO:0004222; GO:0005739; GO:0005759; GO:0006627; GO:0046872,protein processing involved in protein targeting to mitochondrion [GO:0006627],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_06422,2.366048851336305,FUN_029111-T1,Peve_00004671,Pocillopora_meandrina_HIv1___TS.g9201.t1,three_way,50.54466666666666,FUN_029111-T1,Q9NS91,RAD18_HUMAN,,E3 ubiquitin-protein ligase RAD18 (EC 2.3.2.27) (Postreplication repair protein RAD18) (hHR18) (hRAD18) (RING finger protein 73) (RING-type E3 ubiquitin transferase RAD18),Homo sapiens (Human),32.9,523.0,3.6999999999999998e-56,221.1,sp|Q9NS91|RAD18_HUMAN E3 ubiquitin-protein ligase RAD18 OS=Homo sapiens OX=9606 GN=RAD18 PE=1 SV=2,GO:0000403; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0006301; GO:0006513; GO:0006974; GO:0008270; GO:0016604; GO:0031593; GO:0031625; GO:0035861; GO:0042405; GO:0042802; GO:0044877; GO:0051865; GO:0051984; GO:0061630; GO:0097505,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861],damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0016740; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06426,1.2115788878352591,FUN_029115-T1,Peve_00013132,Pocillopora_meandrina_HIv1___RNAseq.g25772.t1,three_way,35.194,,,,,,,,,,,,,,,,,
OG_06427,2.204294334295456,FUN_029117-T1,Peve_00013133,Pocillopora_meandrina_HIv1___RNAseq.g25773.t1,three_way,89.271,FUN_029117-T1,Q6NYH1,IF122_DANRE,,Intraflagellar transport protein 122 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),70.9,1191.0,0.0,1824.3,sp|Q6NYH1|IF122_DANRE Intraflagellar transport protein 122 homolog OS=Danio rerio OX=7955 GN=ift122 PE=2 SV=1,GO:0001823; GO:0005737; GO:0005929; GO:0007507; GO:0008589; GO:0008594; GO:0030991; GO:0032402; GO:0035721; GO:0036064; GO:0036372; GO:0042073; GO:0045494; GO:0045879; GO:0048593; GO:0060271; GO:0061512; GO:0097730; GO:1905515,camera-type eye morphogenesis [GO:0048593]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; melanosome transport [GO:0032402]; mesonephros development [GO:0001823]; negative regulation of smoothened signaling pathway [GO:0045879]; non-motile cilium assembly [GO:1905515]; opsin transport [GO:0036372]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; regulation of smoothened signaling pathway [GO:0008589],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730],,GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_06431,2.3297594218422426,FUN_029125-T1,Peve_00024870,Pocillopora_meandrina_HIv1___RNAseq.g25775.t1,three_way,64.52616666666667,FUN_029125-T1,A4IHD2,,,,,50.8,846.0,7.7e-237,822.4,sp|A4IHD2|ARIP4_XENTR Helicase ARIP4 OS=Xenopus tropicalis OX=8364 GN=rad54l2 PE=2 SV=1,,,,,,
OG_06433,2.5295166256746917,FUN_029127-T1,Peve_00004665,Pocillopora_meandrina_HIv1___RNAseq.g25779.t1,three_way,50.135333333333335,,,,,,,,,,,,,,,,,
OG_06438,1.9965626052030088,FUN_029139-T1,Peve_00041022,Pocillopora_meandrina_HIv1___TS.g9187.t2,three_way,76.01066666666667,FUN_029139-T1,Q9H1D0,TRPV6_HUMAN,,Transient receptor potential cation channel subfamily V member 6 (TrpV6) (CaT-like) (CaT-L) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2),Homo sapiens (Human),27.6,566.0,5.5e-48,194.1,sp|Q9H1D0|TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens OX=9606 GN=TRPV6 PE=1 SV=3,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0017158; GO:0034704; GO:0035898; GO:0042802; GO:0046872; GO:0051592; GO:0055074; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592],calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06440,1.48263865798817,FUN_029144-T1,Peve_00000512,Pocillopora_meandrina_HIv1___RNAseq.g25729.t1,three_way,75.978,FUN_029144-T1,Q14BN4,,,,,59.9,289.0,1.6e-89,332.4,sp|Q14BN4|SLMAP_HUMAN Sarcolemmal membrane-associated protein OS=Homo sapiens OX=9606 GN=SLMAP PE=1 SV=1,,,,,,
OG_06442,2.123598130480851,FUN_029149-T1,Peve_00000508,Pocillopora_meandrina_HIv1___RNAseq.g25732.t1,three_way,83.18866666666666,FUN_029149-T1,Q62717,,,,,54.3,1182.0,0.0,1248.0,sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1,,,,,,
OG_06443,1.234823704564198,FUN_029154-T1,Peve_00041026,Pocillopora_meandrina_HIv1___RNAseq.g25735.t1,three_way,90.00566666666667,FUN_029154-T1,Q86XH1,,,,,57.3,820.0,1.7000000000000002e-218,760.8,sp|Q86XH1|DRC11_HUMAN Dynein regulatory complex protein 11 OS=Homo sapiens OX=9606 GN=IQCA1 PE=1 SV=1,,,,,,
OG_06447,3.055006070356677,FUN_029166-T1,Peve_00027805,Pocillopora_meandrina_HIv1___RNAseq.g25481.t1,three_way,75.72866666666667,FUN_029166-T1,P50395,GDIB_HUMAN,,Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2),Homo sapiens (Human),62.2,442.0,6.8e-166,585.1,sp|P50395|GDIB_HUMAN Rab GDP dissociation inhibitor beta OS=Homo sapiens OX=9606 GN=GDI2 PE=1 SV=2,GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0031267; GO:0031982; GO:0034774; GO:0035578; GO:0045202; GO:0070062; GO:1902018; GO:1903565,negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0003723; GO:0005576; GO:0005794; GO:0005829; GO:0016192; GO:0043226; GO:0098772,RNA binding; extracellular region; Golgi apparatus; cytosol; vesicle-mediated transport; organelle; molecular function regulator activity
OG_06448,2.656752403026524,FUN_029167-T1,Peve_00000513,Pocillopora_meandrina_HIv1___RNAseq.g25650.t1,three_way,55.28533333333333,,,,,,,,,,,,,,,,,
OG_06450,1.406203783345725,FUN_029170-T1,Peve_00042457,Pocillopora_meandrina_HIv1___RNAseq.g25479.t1,three_way,70.12,FUN_029170-T1,P40580,,,,,26.6,229.0,3.1e-06,54.3,sp|P40580|BZRD_YEAST Benzil reductase ((S)-benzoin forming) IRC24 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=IRC24 PE=1 SV=1,,,,,,
OG_06453,2.335751034811276,FUN_029174-T1,Peve_00015171,Pocillopora_meandrina_HIv1___TS.g8934.t1,three_way,64.79366666666667,FUN_029174-T1,Q62277,SYPH_MOUSE,,Synaptophysin (BM89 antigen) (Major synaptic vesicle protein p38),Mus musculus (Mouse),30.8,240.0,2.2000000000000004e-28,127.5,sp|Q62277|SYPH_MOUSE Synaptophysin OS=Mus musculus OX=10090 GN=Syp PE=1 SV=2,GO:0006897; GO:0007268; GO:0008021; GO:0010807; GO:0015485; GO:0016020; GO:0017075; GO:0030672; GO:0031594; GO:0042169; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044306; GO:0045202; GO:0048169; GO:0048172; GO:0048471; GO:0048786; GO:0050804; GO:0060076; GO:0060203; GO:0098685; GO:0098793; GO:2000474,chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; modulation of chemical synaptic transmission [GO:0050804]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807],clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; excitatory synapse [GO:0060076]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195],cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; SH2 domain binding [GO:0042169]; syntaxin-1 binding [GO:0017075],GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226,lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle
OG_06465,2.592774899982626,FUN_029196-T1,Peve_00004309,Pocillopora_meandrina_HIv1___RNAseq.g25522.t1,three_way,39.9695,FUN_029196-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),29.6,213.0,2.1e-13,79.3,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_06466,1.7213745050834464,FUN_029197-T1,Peve_00004308,Pocillopora_meandrina_HIv1___RNAseq.g25524.t1,three_way,73.50966666666666,FUN_029197-T1,P0AGF8,,,,,30.2,235.0,9.5e-21,102.1,sp|P0AGF8|TDCB_ECO57 L-threonine dehydratase catabolic TdcB OS=Escherichia coli O157:H7 OX=83334 GN=tdcB PE=3 SV=1,,,,,,
OG_06467,1.9372305105191228,FUN_029198-T1,Peve_00004307,Pocillopora_meandrina_HIv1___RNAseq.g25525.t1,three_way,50.453833333333336,,,,,,,,,,,,,,,,,
OG_06469,2.766866303279619,FUN_029208-T1,Peve_00013633,Pocillopora_meandrina_HIv1___RNAseq.g25538.t1,three_way,48.8415,,,,,,,,,,,,,,,,,
OG_06470,1.5544943367564574,FUN_029211-T1,Peve_00024515,Pocillopora_meandrina_HIv1___RNAseq.g25545.t1,three_way,61.35433333333333,,,,,,,,,,,,,,,,,
OG_06472,3.639563488316901,FUN_029234-T1,Peve_00045061,Pocillopora_meandrina_HIv1___RNAseq.g25553.t1,three_way,64.42733333333334,FUN_029234-T1,O15427,MOT4_HUMAN,,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),Homo sapiens (Human),27.4,398.0,5.9999999999999996e-40,166.8,sp|O15427|MOT4_HUMAN Monocarboxylate transporter 4 OS=Homo sapiens OX=9606 GN=SLC16A3 PE=1 SV=1,GO:0003723; GO:0005886; GO:0008028; GO:0015650; GO:0015718; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0031965; GO:0035873; GO:0035879; GO:0042867; GO:0050833; GO:1901475,lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate catabolic process [GO:0042867]; pyruvate transmembrane transport [GO:1901475],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],lactate:proton symporter activity [GO:0015650]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; RNA binding [GO:0003723],GO:0003723; GO:0005215; GO:0005886; GO:0055085,RNA binding; transporter activity; plasma membrane; transmembrane transport
OG_06473,1.5391904623327528,FUN_029239-T1,Peve_00013754,Pocillopora_meandrina_HIv1___RNAseq.g25411.t1,three_way,73.07666666666667,FUN_029239-T1,Q5R9S8,,,,,37.6,226.0,8.300000000000001e-38,158.7,sp|Q5R9S8|TMM43_PONAB Transmembrane protein 43 OS=Pongo abelii OX=9601 GN=TMEM43 PE=2 SV=1,,,,,,
OG_06476,1.1781662083640063,FUN_029243-T1,Peve_00013751,Pocillopora_meandrina_HIv1___TS.g8847.t1a,three_way,61.89633333333333,,,,,,,,,,,,,,,,,
OG_06478,3.447633723171127,FUN_029246-T1,Peve_00013747,Pocillopora_meandrina_HIv1___RNAseq.g25404.t1,three_way,78.42166666666667,FUN_029246-T1,Q9Y2I9,TBC30_HUMAN,,TBC1 domain family member 30,Homo sapiens (Human),49.0,569.0,8.899999999999999e-139,496.1,sp|Q9Y2I9|TBC30_HUMAN TBC1 domain family member 30 OS=Homo sapiens OX=9606 GN=TBC1D30 PE=1 SV=2,GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0016604; GO:0031267; GO:0036064; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; nuclear body [GO:0016604]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; plasma membrane; cilium; organelle; molecular function regulator activity
OG_06479,2.644220944108506,FUN_029247-T1,Peve_00013745,Pocillopora_meandrina_HIv1___TS.g9395.t1,three_way,61.76716666666667,FUN_029247-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),37.3,496.0,4.5e-84,314.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_06482,1.5942099050034102,FUN_029254-T1,Peve_00024374,Pocillopora_meandrina_HIv1___RNAseq.g15019.t1,three_way,65.14966666666666,,,,,,,,,,,,,,,,,
OG_06483,1.3861670709027043,FUN_029255-T1,Peve_00024372,Pocillopora_meandrina_HIv1___RNAseq.g15020.t1,three_way,52.675,,,,,,,,,,,,,,,,,
OG_06487,1.915147218717856,FUN_029261-T1,Peve_00024370,Pocillopora_meandrina_HIv1___RNAseq.g15021.t1,three_way,68.45433333333334,FUN_029261-T1,F1QZ15,,,,,40.9,164.0,3.1e-32,139.8,sp|F1QZ15|TPRKB_DANRE EKC/KEOPS complex subunit TPRKB OS=Danio rerio OX=7955 GN=tprkb PE=2 SV=1,,,,,,
OG_06488,1.0898205848481943,FUN_029262-T1,Peve_00030746,Pocillopora_meandrina_HIv1___RNAseq.g15033.t1,three_way,67.793,FUN_029262-T1,Q9Y222,DMTF1_HUMAN,,Cyclin-D-binding Myb-like transcription factor 1 (hDMTF1) (Cyclin-D-interacting Myb-like protein 1) (hDMP1),Homo sapiens (Human),40.9,599.0,2e-107,391.7,sp|Q9Y222|DMTF1_HUMAN Cyclin-D-binding Myb-like transcription factor 1 OS=Homo sapiens OX=9606 GN=DMTF1 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357,regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_06489,2.3313907017722504,FUN_029264-T1,Peve_00030745,Pocillopora_meandrina_HIv1___RNAseq.g15034.t1,three_way,71.40766666666667,,,,,,,,,,,,,,,,,
OG_06494,2.81244225942997,FUN_029275-T1,Peve_00030743,Pocillopora_meandrina_HIv1___RNAseq.g15044.t1,three_way,76.801,FUN_029275-T1,Q9SLX0,,,,,29.3,188.0,5.7e-16,86.7,sp|Q9SLX0|IMA1B_ORYSJ Importin subunit alpha-1b OS=Oryza sativa subsp. japonica OX=39947 GN=Os05g0155601 PE=1 SV=2,,,,,,
OG_06495,1.2076542889295927,FUN_029276-T1,Peve_00030742,Pocillopora_meandrina_HIv1___RNAseq.g15045.t1,three_way,92.86866666666668,FUN_029276-T1,Q28I85,,,,,74.1,54.0,4.6e-16,87.4,sp|Q28I85|POC1A_XENTR POC1 centriolar protein homolog A OS=Xenopus tropicalis OX=8364 GN=poc1a PE=2 SV=1,,,,,,
OG_06497,1.0924308524101063,FUN_029286-T1,Peve_00018583,Pocillopora_meandrina_HIv1___RNAseq.g16621.t1,three_way,73.06333333333333,,,,,,,,,,,,,,,,,
OG_06498,1.2523419509401714,FUN_029288-T1,Peve_00036556,Pocillopora_meandrina_HIv1___RNAseq.g11161.t1,three_way,72.14083333333333,FUN_029288-T1,A8EZG1,,,,,38.9,478.0,1e-82,308.9,sp|A8EZG1|MUTS_RICCK DNA mismatch repair protein MutS OS=Rickettsia canadensis (strain McKiel) OX=293613 GN=mutS PE=3 SV=1,,,,,,
OG_06499,2.364595162629554,FUN_029290-T1,Peve_00036558,Pocillopora_meandrina_HIv1___RNAseq.g11162.t1,three_way,72.6425,FUN_029290-T1,O95602,RPA1_HUMAN,,DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194),Homo sapiens (Human),50.1,1092.0,2e-264,913.7,sp|O95602|RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens OX=9606 GN=POLR1A PE=1 SV=2,GO:0000287; GO:0000785; GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005739; GO:0006360; GO:0008270; GO:0071667; GO:1904750,negative regulation of protein localization to nucleolus [GO:1904750]; transcription by RNA polymerase I [GO:0006360],chromatin [GO:0000785]; chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005694; GO:0005739; GO:0006351; GO:0016740; GO:0043226; GO:0140098,"DNA binding; catalytic activity; nucleoplasm; chromosome; mitochondrion; DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on RNA"
OG_06502,1.0751038321196813,FUN_029296-T1,Peve_00040801,Pocillopora_meandrina_HIv1___RNAseq.g12593.t1,three_way,55.744,FUN_029296-T1,Q8TE60,,,,,30.5,1022.0,6.6e-110,401.0,sp|Q8TE60|ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens OX=9606 GN=ADAMTS18 PE=1 SV=3,,,,,,
OG_06505,1.505804987663584,FUN_029299-T1,Peve_00040810,Pocillopora_meandrina_HIv1___RNAseq.g12587.t1,three_way,89.47666666666666,FUN_029299-T1,Q90511,,,,,60.5,357.0,3.9e-116,419.5,sp|Q90511|EI2BB_TAKRU Translation initiation factor eIF2B subunit beta OS=Takifugu rubripes OX=31033 GN=eif2b2 PE=3 SV=1,,,,,,
OG_06506,1.3589575768168116,FUN_029300-T2,Peve_00040809,Pocillopora_meandrina_HIv1___RNAseq.g12586.t1,three_way,47.71066666666667,FUN_029300-T2,Q3SZD5,,,,,32.8,244.0,4.5e-29,131.3,sp|Q3SZD5|DCA15_BOVIN DDB1- and CUL4-associated factor 15 OS=Bos taurus OX=9913 GN=DCAF15 PE=2 SV=1,,,,,,
OG_06507,2.110991818648788,FUN_029301-T1,Peve_00040808,Pocillopora_meandrina_HIv1___RNAseq.g12585.t1,three_way,51.386,FUN_029301-T1,Q01974,ROR2_HUMAN,,"Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)",Homo sapiens (Human),27.3,264.0,1.5e-16,90.5,sp|Q01974|ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens OX=9606 GN=ROR2 PE=1 SV=2,GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0015026; GO:0016055; GO:0017147; GO:0030335; GO:0030424; GO:0030669; GO:0031435; GO:0043235; GO:0046872,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; positive regulation of cell migration [GO:0030335]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; clathrin-coated endocytic vesicle membrane [GO:0030669]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0016740; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; transferase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_06510,1.0655705552402253,FUN_029307-T1,Peve_00035000,Pocillopora_meandrina_HIv1___RNAseq.g12580.t1,three_way,72.083,FUN_029307-T1,Q9H867,,,,,44.6,224.0,7.799999999999999e-46,185.3,sp|Q9H867|MT21D_HUMAN Protein N-lysine methyltransferase METTL21D OS=Homo sapiens OX=9606 GN=VCPKMT PE=1 SV=2,,,,,,
OG_06511,1.106473998923301,FUN_029308-T1,Peve_00038266,Pocillopora_meandrina_HIv1___RNAseq.g12581.t1,three_way,73.26783333333334,FUN_029308-T1,P14314,GLU2B_HUMAN,,Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH),Homo sapiens (Human),42.0,512.0,3.2999999999999996e-53,211.1,sp|P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens OX=9606 GN=PRKCSH PE=1 SV=2,GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0044325; GO:0051219,intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231],calcium ion binding [GO:0005509]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; transmembrane transporter binding [GO:0044325],GO:0005783; GO:0009101; GO:0043226; GO:0048856; GO:1901135,endoplasmic reticulum; glycoprotein biosynthetic process; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_06515,1.3137314185580322,FUN_029315-T1,Peve_00038260,Pocillopora_meandrina_HIv1___RNAseq.g12576.t1,three_way,59.641666666666666,FUN_029315-T1,Q6RI86,TRPA1_RAT,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Rattus norvegicus (Rat),28.2,181.0,5e-07,57.0,sp|Q6RI86|TRPA1_RAT Transient receptor potential cation channel subfamily A member 1 OS=Rattus norvegicus OX=10116 GN=Trpa1 PE=1 SV=2,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_06516,2.285384449597556,FUN_029317-T1,Peve_00038259,Pocillopora_meandrina_HIv1___RNAseq.g12575.t1,three_way,56.52,FUN_029317-T1,Q8IY67,,,,,37.9,269.0,1.4e-40,169.9,sp|Q8IY67|RAVR1_HUMAN Ribonucleoprotein PTB-binding 1 OS=Homo sapiens OX=9606 GN=RAVER1 PE=1 SV=1,,,,,,
OG_06521,1.3555412733469343,FUN_029337-T1,Peve_00023376,Pocillopora_meandrina_HIv1___RNAseq.g17303.t1,three_way,76.86833333333334,FUN_029337-T1,Q5ZLN0,,,,,59.5,608.0,8.6e-57,223.8,sp|Q5ZLN0|LRC40_CHICK Leucine-rich repeat-containing protein 40 OS=Gallus gallus OX=9031 GN=LRRC40 PE=2 SV=1,,,,,,
OG_06522,5.820074065640641,FUN_029339-T1,Peve_00023361,Pocillopora_meandrina_HIv1___RNAseq.g17301.t1,three_way,61.434333333333335,FUN_029339-T1,Q01973,ROR1_HUMAN,,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",Homo sapiens (Human),31.6,773.0,1.1000000000000001e-118,429.1,sp|Q01973|ROR1_HUMAN Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens OX=9606 GN=ROR1 PE=1 SV=2,GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0015026; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092,astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0006355; GO:0016740; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_06525,1.0544366838072852,FUN_029343-T1,Peve_00023373,Pocillopora_meandrina_HIv1___RNAseq.g17296.t1,three_way,74.304,FUN_029343-T1,Q3ZBN6,GA45A_BOVIN,,Growth arrest and DNA damage-inducible protein GADD45 alpha,Bos taurus (Bovine),38.4,112.0,6.2e-10,65.5,sp|Q3ZBN6|GA45A_BOVIN Growth arrest and DNA damage-inducible protein GADD45 alpha OS=Bos taurus OX=9913 GN=GADD45A PE=2 SV=1,GO:0000122; GO:0005634; GO:0005737; GO:0016607; GO:0019900; GO:0042770; GO:0042803; GO:0043065; GO:0043537; GO:0046330; GO:0046982; GO:0051726; GO:0071260; GO:0071479; GO:1900745; GO:2000379,cellular response to ionizing radiation [GO:0071479]; cellular response to mechanical stimulus [GO:0071260]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of cell cycle [GO:0051726]; signal transduction in response to DNA damage [GO:0042770],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_06526,3.705113781363156,FUN_029345-T1,Peve_00023375,Pocillopora_meandrina_HIv1___RNAseq.g17294.t1,three_way,65.33866666666667,FUN_029345-T1,Q6PB03,PLD3_XENLA,,5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3),Xenopus laevis (African clawed frog),48.3,445.0,6.4e-117,422.5,sp|Q6PB03|PLD3_XENLA 5'-3' exonuclease PLD3 OS=Xenopus laevis OX=8355 GN=pld3 PE=2 SV=1,GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0014902; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015,immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015],early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202],single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145],GO:0002376; GO:0003824; GO:0006954; GO:0016787; GO:0030154; GO:0140097,"immune system process; catalytic activity; inflammatory response; hydrolase activity; cell differentiation; catalytic activity, acting on DNA"
OG_06527,1.1058140903812923,FUN_029356-T1,Peve_00023383,Pocillopora_meandrina_HIv1___RNAseq.g17292.t1,three_way,73.16533333333334,FUN_029356-T1,Q15397,,,,,44.1,424.0,5.2e-92,339.7,sp|Q15397|PUM3_HUMAN Pumilio homolog 3 OS=Homo sapiens OX=9606 GN=PUM3 PE=1 SV=3,,,,,,
OG_06528,2.8470142404366388,FUN_029357-T1,Peve_00023328,Pocillopora_meandrina_HIv1___RNAseq.g17291.t1,three_way,87.65433333333334,FUN_029357-T1,Q9UIJ7,KAD3_HUMAN,,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)",Homo sapiens (Human),57.9,209.0,2.1e-67,256.9,"sp|Q9UIJ7|KAD3_HUMAN GTP:AMP phosphotransferase AK3, mitochondrial OS=Homo sapiens OX=9606 GN=AK3 PE=1 SV=4",GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0016874; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899,ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; ligase activity [GO:0016874]; nucleoside triphosphate adenylate kinase activity [GO:0046899],GO:0003824; GO:0005739; GO:0016740; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; transferase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_06529,1.3064402045396866,FUN_029359-T1,Peve_00023331,Pocillopora_meandrina_HIv1___RNAseq.g17289.t1,three_way,79.39766666666667,FUN_029359-T1,Q802T2,,,,,53.4,489.0,4.4999999999999995e-139,496.1,"sp|Q802T2|ALG6_CHICK Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Gallus gallus OX=9031 GN=ALG6 PE=2 SV=1",,,,,,
OG_06533,3.4375412199896127,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,55.2,87.0,8.5e-18,94.4,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06533,3.4375412199896127,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,56.2,48.0,2e-06,56.6,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06536,2.4009359076402306,FUN_029396-T1,Peve_00044520,Pocillopora_meandrina_HIv1___RNAseq.g17138.t1,three_way,63.98033333333333,FUN_029396-T1,Q7SZC5,,,,,32.8,673.0,7.2e-84,313.2,sp|Q7SZC5|NDC1_DANRE Nucleoporin NDC1 OS=Danio rerio OX=7955 GN=ndc1 PE=2 SV=1,,,,,,
OG_06537,1.5373548025487846,FUN_029397-T1,Peve_00044519,Pocillopora_meandrina_HIv1___RNAseq.g17139.t1,three_way,75.86833333333334,FUN_029397-T1,Q5ZL00,EMC1_CHICK,,ER membrane protein complex subunit 1,Gallus gallus (Chicken),39.0,1036.0,1e-185,652.1,sp|Q5ZL00|EMC1_CHICK ER membrane protein complex subunit 1 OS=Gallus gallus OX=9031 GN=EMC1 PE=2 SV=1,GO:0005789; GO:0016020; GO:0045050; GO:0071816; GO:0072546,protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],,,
OG_06540,2.160844976062733,FUN_029404-T2,Peve_00044518,Pocillopora_meandrina_HIv1___RNAseq.g17143.t1,three_way,73.2395,FUN_029404-T2,Q5ZLX5,,,,,66.9,136.0,1.8e-50,200.7,sp|Q5ZLX5|ZRAB2_CHICK Zinc finger Ran-binding domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ZRANB2 PE=2 SV=1,,,,,,
OG_06541,2.790486470490006,FUN_029405-T1,Peve_00035059,Pocillopora_meandrina_HIv1___RNAseq.g17144.t1,three_way,85.84700000000001,FUN_029405-T1,Q3MHG1,SPTC1_BOVIN,,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),Bos taurus (Bovine),57.5,463.0,4.2e-156,552.7,sp|Q3MHG1|SPTC1_BOVIN Serine palmitoyltransferase 1 OS=Bos taurus OX=9913 GN=SPTLC1 PE=2 SV=1,GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0017059; GO:0030170; GO:0046512; GO:0046513; GO:1904649,ceramide biosynthetic process [GO:0046513]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059],pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_06542,1.9105538934963444,FUN_029410-T1,Peve_00004978,Pocillopora_meandrina_HIv1___RNAseq.g19537.t1,three_way,82.68033333333334,FUN_029410-T1,Q3T0P6,PGK1_BOVIN,,Phosphoglycerate kinase 1 (EC 2.7.11.1) (EC 2.7.2.3),Bos taurus (Bovine),69.6,411.0,1.9e-162,573.5,sp|Q3T0P6|PGK1_BOVIN Phosphoglycerate kinase 1 OS=Bos taurus OX=9913 GN=PGK1 PE=2 SV=3,GO:0004618; GO:0004674; GO:0005524; GO:0005615; GO:0005759; GO:0005829; GO:0006094; GO:0006096; GO:0016525; GO:0030855; GO:0031639; GO:0043531; GO:0044325; GO:0045121; GO:0046872; GO:0047134; GO:0061621; GO:0071456; GO:0106310; GO:0160218,canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0160218]; negative regulation of angiogenesis [GO:0016525]; plasminogen activation [GO:0031639],cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; mitochondrial matrix [GO:0005759],ADP binding [GO:0043531]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoglycerate kinase activity [GO:0004618]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-disulfide reductase [NAD(P)H] activity [GO:0047134]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005615; GO:0005829; GO:0005975; GO:0006091; GO:0016491; GO:0016740; GO:0030154; GO:0051604; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; extracellular space; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; transferase activity; cell differentiation; protein maturation; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06543,1.0694151860214065,FUN_029412-T1,Peve_00028187,Pocillopora_meandrina_HIv1___TS.g2914.t1,three_way,80.83733333333333,FUN_029412-T1,Q9HBH9,,,,,65.3,242.0,6.9e-94,345.5,sp|Q9HBH9|MKNK2_HUMAN MAP kinase-interacting serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MKNK2 PE=1 SV=3,,,,,,
OG_06545,1.569412724615297,FUN_029414-T3,Peve_00018038,Pocillopora_meandrina_HIv1___RNAseq.g17125.t1,three_way,87.62133333333334,FUN_029414-T3,Q9CZU3,MTREX_MOUSE,,Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase),Mus musculus (Mouse),70.0,1040.0,0.0,1463.0,sp|Q9CZU3|MTREX_MOUSE Exosome RNA helicase MTR4 OS=Mus musculus OX=10090 GN=Mtrex PE=1 SV=1,GO:0000176; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006397; GO:0006401; GO:0006974; GO:0008380; GO:0016607; GO:0016887; GO:0031499; GO:0071013,DNA damage response [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06549,2.4320505431215445,FUN_029421-T1,Peve_00005727,Pocillopora_meandrina_HIv1___RNAseq.g17180.t1,three_way,63.6955,,,,,,,,,,,,,,,,,
OG_06550,3.1669685259204488,FUN_029422-T1,Peve_00005721,Pocillopora_meandrina_HIv1___RNAseq.g17177.t2,three_way,42.010666666666665,,,,,,,,,,,,,,,,,
OG_06556,3.695056037232264,FUN_029438-T1,Peve_00028188,Pocillopora_meandrina_HIv1___RNAseq.g17152.t1,three_way,76.8055,FUN_029438-T1,Q8IZF0,NALCN_HUMAN,,Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1),Homo sapiens (Human),41.8,1604.0,0.0,1137.9,sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1,GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805,"calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]",monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06557,3.9332814529755593,FUN_029439-T1,Peve_00028189,Pocillopora_meandrina_HIv1___RNAseq.g17153.t1,three_way,82.17283333333333,FUN_029439-T1,Q91X83,,,,,67.5,381.0,1.1e-154,547.7,sp|Q91X83|METK1_MOUSE S-adenosylmethionine synthase isoform type-1 OS=Mus musculus OX=10090 GN=Mat1a PE=1 SV=1,,,,,,
OG_06560,1.2449830270704711,FUN_029443-T1,Peve_00034541,Pocillopora_meandrina_HIv1___RNAseq.g17168.t1,three_way,63.576,FUN_029443-T1,Q92179,,,,,26.6,331.0,1.7e-20,102.1,sp|Q92179|CHST3_CHICK Carbohydrate sulfotransferase 3 OS=Gallus gallus OX=9031 GN=CHST3 PE=1 SV=1,,,,,,
OG_06566,1.4375183258115554,FUN_029473-T1,Peve_00028195,Pocillopora_meandrina_HIv1___RNAseq.g17147.t1,three_way,66.37633333333333,FUN_029473-T1,Q8IWX8,CHERP_HUMAN,,Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6),Homo sapiens (Human),43.1,933.0,6.6e-63,243.8,sp|Q8IWX8|CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3,GO:0003723; GO:0005654; GO:0005737; GO:0006396; GO:0006874; GO:0007399; GO:0008285; GO:0016020; GO:0033017; GO:0044325; GO:0048471; GO:0051209; GO:0070886,intracellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396],cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017],RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325],GO:0003723; GO:0005654; GO:0048856; GO:0055085,RNA binding; nucleoplasm; anatomical structure development; transmembrane transport
OG_06572,1.4901365728158742,FUN_029487-T1,Peve_00017244,Pocillopora_meandrina_HIv1___RNAseq.g17129.t1,three_way,53.333666666666666,FUN_029487-T1,Q0V9Y8,,,,,32.0,331.0,1.5e-32,142.1,sp|Q0V9Y8|LRC42_XENTR Leucine-rich repeat-containing protein 42 OS=Xenopus tropicalis OX=8364 GN=lrrc42 PE=2 SV=2,,,,,,
OG_06573,1.9257843930424368,FUN_029518-T1,Peve_00008555,Pocillopora_meandrina_HIv1___RNAseq.g17117.t1,three_way,79.40516666666666,FUN_029518-T1,Q00438,,,,,47.7,558.0,2.7e-132,473.8,sp|Q00438|PTBP1_RAT Polypyrimidine tract-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Ptbp1 PE=1 SV=2,,,,,,
OG_06574,1.5233232120984883,FUN_029519-T1,Peve_00022876,Pocillopora_meandrina_HIv1___TS.g2888.t1,three_way,93.70616666666666,FUN_029519-T1,Q9JHU4,DYHC1_MOUSE,,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",Mus musculus (Mouse),73.3,4665.0,0.0,6825.7,sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2,GO:0003341; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0008569; GO:0016887; GO:0030175; GO:0030286; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1905832,cell division [GO:0051301]; cilium movement [GO:0003341]; establishment of spindle localization [GO:0051293]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; filopodium [GO:0030175]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0016787; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; hydrolase activity; isomerase activity; ATP-dependent activity
OG_06576,1.8889213556940727,FUN_029521-T2,Peve_00028580,Pocillopora_meandrina_HIv1___RNAseq.g17111.t1,three_way,61.62799999999999,FUN_029521-T2,P0DN10,,,,,63.5,52.0,2.7e-14,83.6,sp|P0DN10|VKT6_ANEVI U-actitoxin-Avd3i OS=Anemonia viridis OX=51769 PE=3 SV=1,,,,,,
OG_06577,2.110435460317136,FUN_029524-T1,Peve_00010676,Pocillopora_meandrina_HIv1___RNAseq.g17110.t1,three_way,64.472,,,,,,,,,,,,,,,,,
OG_06578,2.0385365403817928,FUN_029525-T1,Peve_00010677,Pocillopora_meandrina_HIv1___RNAseq.g17107.t1,three_way,53.90266666666667,FUN_029525-T1,A8Y5U1,,,,,35.4,285.0,9.9e-41,168.7,sp|A8Y5U1|RIMC1_DANRE RAB7A-interacting MON1-CCZ1 complex subunit 1 OS=Danio rerio OX=7955 GN=rimoc1 PE=2 SV=1,,,,,,
OG_06579,1.1705125451525475,FUN_029536-T1,Peve_00023332,Pocillopora_meandrina_HIv1___RNAseq.g17287.t1,three_way,88.79033333333334,,,,,,,,,,,,,,,,,
OG_06581,1.8618291060689864,FUN_029538-T1,Peve_00012818,Pocillopora_meandrina_HIv1___RNAseq.g2589.t1,three_way,73.36083333333333,,,,,,,,,,,,,,,,,
OG_06582,1.3321366081278798,FUN_029550-T1,Peve_00023351,Pocillopora_meandrina_HIv1___RNAseq.g17268.t1,three_way,83.60266666666666,FUN_029550-T1,O62742,,,,,65.4,540.0,9.5e-207,721.1,sp|O62742|SCP2_RABIT Sterol carrier protein 2 OS=Oryctolagus cuniculus OX=9986 GN=SCP2 PE=1 SV=1,,,,,,
OG_06583,1.5506092387657493,FUN_029554-T1,Peve_00023354,Pocillopora_meandrina_HIv1___RNAseq.g17263.t1,three_way,73.25566666666667,FUN_029554-T1,Q6NRK1,ADIPA_XENLA,,Afadin- and alpha-actinin-binding protein A (ADIP-A) (Afadin DIL domain-interacting protein A) (SSX2-interacting protein A) (XSSX2IP),Xenopus laevis (African clawed frog),33.5,424.0,5.9e-51,203.8,sp|Q6NRK1|ADIPA_XENLA Afadin- and alpha-actinin-binding protein A OS=Xenopus laevis OX=8355 GN=ssx2ip-a PE=1 SV=1,GO:0005737; GO:0005874; GO:0005912; GO:0007098; GO:0007155; GO:0034451; GO:0035735; GO:0036064; GO:0051011,cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; intraciliary transport involved in cilium assembly [GO:0035735],adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874],microtubule minus-end binding [GO:0051011],GO:0005815; GO:0007018; GO:0007155; GO:0008092,microtubule organizing center; microtubule-based movement; cell adhesion; cytoskeletal protein binding
OG_06584,3.413008996976441,FUN_029556-T1,Peve_00023360,Pocillopora_meandrina_HIv1___TS.g3028.t1,three_way,49.354,,,,,,,,,,,,,,,,,
OG_06586,1.4936927464004723,FUN_029567-T1,Peve_00018825,Pocillopora_meandrina_HIv1___RNAseq.g17258.t1,three_way,57.566,FUN_029567-T1,P58307,,,,,28.8,340.0,2.2000000000000004e-28,128.6,sp|P58307|OX1R_MOUSE Orexin/Hypocretin receptor type 1 OS=Mus musculus OX=10090 GN=Hcrtr1 PE=2 SV=3,,,,,,
OG_06588,3.4311674232004528,FUN_029570-T1,Peve_00018824,Pocillopora_meandrina_HIv1___RNAseq.g17256.t1,three_way,51.34166666666667,,,,,,,,,,,,,,,,,
OG_06590,1.0399111998736867,FUN_029616-T1,Peve_00037897,Pocillopora_meandrina_HIv1___RNAseq.28516_t,three_way,77.36733333333333,FUN_029616-T1,D4ACN8,,,,,47.0,134.0,1.9e-26,120.2,sp|D4ACN8|PLRKT_RAT Plasminogen receptor (KT) OS=Rattus norvegicus OX=10116 GN=Plgrkt PE=1 SV=1,,,,,,
OG_06591,1.2833708616406665,FUN_029639-T1,Peve_00037896,Pocillopora_meandrina_HIv1___RNAseq.g17203.t2,three_way,75.95783333333334,FUN_029639-T1,Q3SZZ0,,,,,63.1,249.0,3.3e-95,349.7,sp|Q3SZZ0|BRX1_BOVIN Ribosome biogenesis protein BRX1 homolog OS=Bos taurus OX=9913 GN=BRIX1 PE=2 SV=1,,,,,,
OG_06598,1.8009697477193196,FUN_029671-T2,Peve_00038757,Pocillopora_meandrina_HIv1___RNAseq.g17306.t1,three_way,45.8935,FUN_029671-T2,Q8N3J2,METL4_HUMAN,,N(6)-adenine-specific methyltransferase METTL4 (Methyltransferase-like protein 4) (N(6)-adenine-specific DNA methyltransferase METTL4) (EC 2.1.1.72) (snRNA (2'-O-methyladenosine-N(6)-)-methyltransferase METTL4) (EC 2.1.1.-),Homo sapiens (Human),28.4,507.0,6.9e-56,219.9,sp|Q8N3J2|METL4_HUMAN N(6)-adenine-specific methyltransferase METTL4 OS=Homo sapiens OX=9606 GN=METTL4 PE=1 SV=3,GO:0003676; GO:0005634; GO:0005759; GO:0005829; GO:0008173; GO:0009007; GO:0032259; GO:0036396; GO:0043484; GO:0045814; GO:0090296; GO:0106347; GO:0120049; GO:1903108; GO:1990204,"methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]",cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity [GO:0106347],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006355; GO:0016073; GO:0016740; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; cytosol; chromatin organization; regulation of DNA-templated transcription; snRNA metabolic process; transferase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_06601,1.133520106875757,FUN_029708-T1,Peve_00020456,Pocillopora_meandrina_HIv1___RNAseq.g17310.t1,three_way,74.966,FUN_029708-T1,Q7ZW86,,,,,47.2,462.0,8.399999999999999e-95,349.0,sp|Q7ZW86|CWC27_DANRE Spliceosome-associated protein CWC27 homolog OS=Danio rerio OX=7955 GN=cwc27 PE=2 SV=1,,,,,,
OG_06603,1.204856039927963,FUN_029710-T1,Peve_00018724,Pocillopora_meandrina_HIv1___RNAseq.g17312.t1,three_way,68.5275,FUN_029710-T1,Q8N9Q2,SR1IP_HUMAN,,Protein SREK1IP1 (SFRS12-interacting protein 1) (SREK1-interacting protein 1) (Splicing regulatory protein of 18 kDa) (p18SRP),Homo sapiens (Human),75.7,37.0,1.6e-11,70.9,sp|Q8N9Q2|SR1IP_HUMAN Protein SREK1IP1 OS=Homo sapiens OX=9606 GN=SREK1IP1 PE=1 SV=1,GO:0003676; GO:0006397; GO:0008270; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],,nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0016071,mRNA metabolic process
OG_06605,1.3942722176765543,FUN_029753-T1,Peve_00031236,Pocillopora_meandrina_HIv1___RNAseq.g17314.t1,three_way,79.57516666666666,FUN_029753-T1,Q5U2Z0,,,,,57.1,205.0,1.3999999999999998e-29,131.7,sp|Q5U2Z0|ZN367_RAT Zinc finger protein 367 OS=Rattus norvegicus OX=10116 GN=Znf367 PE=2 SV=1,,,,,,
OG_06606,2.652818144655874,FUN_029754-T1,Peve_00019513,Pocillopora_meandrina_HIv1___RNAseq.g17315.t1,three_way,73.25083333333333,FUN_029754-T1,D3ZYR1,FCHO2_RAT,,F-BAR domain only protein 2,Rattus norvegicus (Rat),35.2,1026.0,1.2e-117,426.0,sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1,GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793,clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]",GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0065003; GO:0072659,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; protein-containing complex assembly; protein localization to plasma membrane
OG_06607,1.432896935436937,FUN_029756-T1,Peve_00019493,Pocillopora_meandrina_HIv1___RNAseq.g17316.t1,three_way,54.69416666666667,,,,,,,,,,,,,,,,,
OG_06610,1.8415634796150333,FUN_029760-T1,Peve_00019501,Pocillopora_meandrina_HIv1___RNAseq.g17234.t1,three_way,80.53166666666667,FUN_029760-T1,Q8NBS3,,,,,44.5,815.0,1.7000000000000001e-178,627.9,sp|Q8NBS3|S4A11_HUMAN Solute carrier family 4 member 11 OS=Homo sapiens OX=9606 GN=SLC4A11 PE=1 SV=3,,,,,,
OG_06612,2.093336040970117,FUN_029763-T1,Peve_00019504,Pocillopora_meandrina_HIv1___RNAseq.g17323.t1,three_way,61.1925,FUN_029763-T1,Q6PCS4,,,,,36.2,716.0,2.9e-92,342.0,sp|Q6PCS4|RHG29_DANRE Rho GTPase-activating protein 29 OS=Danio rerio OX=7955 GN=arhgap29 PE=2 SV=1,,,,,,
OG_06613,1.6991279913394135,FUN_029767-T1,Peve_00019505,Pocillopora_meandrina_HIv1___RNAseq.g17324.t1,three_way,60.8995,,,,,,,,,,,,,,,,,
OG_06621,3.124687576753011,FUN_029882-T1,Peve_00024289,Pocillopora_meandrina_HIv1___RNAseq.g17341.t1,three_way,72.087,FUN_029882-T1,Q9BT73,,,,,34.5,119.0,2.2e-13,76.6,sp|Q9BT73|PSMG3_HUMAN Proteasome assembly chaperone 3 OS=Homo sapiens OX=9606 GN=PSMG3 PE=1 SV=1,,,,,,
OG_06623,1.6615574013737675,FUN_030045-T1,Peve_00008453,Pocillopora_meandrina_HIv1___RNAseq.g17344.t1,three_way,83.89533333333333,FUN_030045-T1,Q5PPX5,,,,,45.9,257.0,1.7e-61,237.7,sp|Q5PPX5|RN170_XENLA E3 ubiquitin-protein ligase RNF170 OS=Xenopus laevis OX=8355 GN=rnf170 PE=2 SV=1,,,,,,
OG_06625,1.401910170332768,FUN_030048-T1,Peve_00008446,Pocillopora_meandrina_HIv1___RNAseq.g17347.t1,three_way,81.524,FUN_030048-T1,Q5RBL0,,,,,58.5,229.0,6.200000000000001e-73,275.8,sp|Q5RBL0|YIPF1_PONAB Protein YIPF1 OS=Pongo abelii OX=9601 GN=YIPF1 PE=2 SV=1,,,,,,
OG_06634,2.100331403147952,FUN_030182-T1,Peve_00004650,Pocillopora_meandrina_HIv1___RNAseq.g17358.t1,three_way,61.07183333333333,FUN_030182-T1,Q6ZNA5,,,,,30.9,330.0,1.2e-40,169.1,sp|Q6ZNA5|FRRS1_HUMAN Ferric-chelate reductase 1 OS=Homo sapiens OX=9606 GN=FRRS1 PE=1 SV=2,,,,,,
OG_06636,1.2392068408855372,FUN_030184-T1,Peve_00004643,Pocillopora_meandrina_HIv1___TS.g3120.t1,three_way,72.65866666666666,FUN_030184-T1,O64411,,,,,40.5,481.0,3.3e-94,347.1,sp|O64411|PAO1_MAIZE Polyamine oxidase 1 OS=Zea mays OX=4577 GN=MPAO1 PE=1 SV=1,,,,,,
OG_06637,2.219599608194988,FUN_030185-T1,Peve_00000773,Pocillopora_meandrina_HIv1___RNAseq.g23592.t1,three_way,64.50933333333333,,,,,,,,,,,,,,,,,
OG_06643,2.9938660471515792,FUN_030655-T1,Peve_00043685,Pocillopora_meandrina_HIv1___RNAseq.g30310.t1,three_way,62.553666666666665,FUN_030655-T1,Q80T85,DCAF5_MOUSE,,DDB1- and CUL4-associated factor 5 (WD repeat-containing protein 22),Mus musculus (Mouse),49.2,445.0,8.699999999999999e-107,389.4,sp|Q80T85|DCAF5_MOUSE DDB1- and CUL4-associated factor 5 OS=Mus musculus OX=10090 GN=Dcaf5 PE=1 SV=2,GO:0005739; GO:0016567; GO:0080008,protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; mitochondrion [GO:0005739],,GO:0005739; GO:0043226,mitochondrion; organelle
OG_06647,1.7477296764807952,FUN_030663-T1,Peve_00043681,Pocillopora_meandrina_HIv1___RNAseq.g30304.t1,three_way,83.89,FUN_030663-T1,P20650,PPM1A_RAT,,Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA),Rattus norvegicus (Rat),54.7,369.0,2.6e-114,413.7,sp|P20650|PPM1A_RAT Protein phosphatase 1A OS=Rattus norvegicus OX=10116 GN=Ppm1a PE=1 SV=1,GO:0000287; GO:0004721; GO:0004722; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0006611; GO:0016020; GO:0030145; GO:0030512; GO:0030514; GO:0033192; GO:0043005; GO:0043122; GO:0043124; GO:0044325; GO:0045893; GO:0046827; GO:0070412; GO:0071560; GO:0090263; GO:1901223,cellular response to transforming growth factor beta stimulus [GO:0071560]; N-terminal protein myristoylation [GO:0006499]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein export from nucleus [GO:0046827]; protein dephosphorylation [GO:0006470]; protein export from nucleus [GO:0006611]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634],calmodulin-dependent protein phosphatase activity [GO:0033192]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; R-SMAD binding [GO:0070412]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06649,1.7700969049396338,FUN_030670-T1,Peve_00028183,Pocillopora_meandrina_HIv1___RNAseq.g30312.t1,three_way,72.44566666666667,,,,,,,,,,,,,,,,,
OG_06650,1.837594118434812,FUN_030671-T1,Peve_00028182,Pocillopora_meandrina_HIv1___RNAseq.g30313.t1,three_way,75.83566666666667,FUN_030671-T1,Q9Y6R9,CCD61_HUMAN,,Centrosomal protein CCDC61 (Coiled-coil domain-containing protein 61) (VFL3 homolog),Homo sapiens (Human),47.6,296.0,1.5e-58,228.8,sp|Q9Y6R9|CCD61_HUMAN Centrosomal protein CCDC61 OS=Homo sapiens OX=9606 GN=CCDC61 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005815; GO:0008017; GO:0030030; GO:0034451; GO:0036064; GO:0042802; GO:0090307; GO:0098534; GO:0120103,cell projection organization [GO:0030030]; centriole assembly [GO:0098534]; mitotic spindle assembly [GO:0090307],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],identical protein binding [GO:0042802]; microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0008092,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding
OG_06651,2.9575728879302527,FUN_030672-T1,Peve_00028178,Pocillopora_meandrina_HIv1___RNAseq.g30294.t1,three_way,67.33333333333333,FUN_030672-T1,P55345,ANM2_HUMAN,,Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2),Homo sapiens (Human),46.5,409.0,6.200000000000001e-106,386.0,sp|P55345|ANM2_HUMAN Protein arginine N-methyltransferase 2 OS=Homo sapiens OX=9606 GN=PRMT2 PE=1 SV=1,GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0007165; GO:0016274; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:0140592; GO:0140938; GO:2000134,chromatin remodeling [GO:0006338]; developmental cell growth [GO:0048588]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone H3 methyltransferase activity [GO:0140938]; histone H3R8 methyltransferase activity [GO:0140592]; histone methyltransferase activity [GO:0042054]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear progesterone receptor binding [GO:0033142]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_06654,1.353560865269246,FUN_030679-T1,Peve_00028159,Pocillopora_meandrina_HIv1___RNAseq.g30326.t1,three_way,92.19966666666669,FUN_030679-T1,Q7TN83,SYT16_MOUSE,,Synaptotagmin-16 (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein),Mus musculus (Mouse),44.2,303.0,5.6e-64,246.5,sp|Q7TN83|SYT16_MOUSE Synaptotagmin-16 OS=Mus musculus OX=10090 GN=Syt16 PE=1 SV=1,GO:0005543; GO:0016020; GO:0042802,,membrane [GO:0016020],identical protein binding [GO:0042802]; phospholipid binding [GO:0005543],GO:0008289,lipid binding
OG_06658,1.4185067057172782,FUN_030874-T1,Peve_00043625,Pocillopora_meandrina_HIv1___RNAseq.g30289.t1,three_way,83.54933333333334,FUN_030874-T1,Q9P2D3,HTR5B_HUMAN,,HEAT repeat-containing protein 5B,Homo sapiens (Human),50.9,2060.0,0.0,1933.7,sp|Q9P2D3|HTR5B_HUMAN HEAT repeat-containing protein 5B OS=Homo sapiens OX=9606 GN=HEATR5B PE=1 SV=2,GO:0005654; GO:0005794; GO:0005829; GO:0006897; GO:0008104; GO:0015031; GO:0016020; GO:0030136; GO:0030139; GO:0042147; GO:0043231; GO:0048471,"endocytosis [GO:0006897]; protein localization [GO:0008104]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],,GO:0005654; GO:0005794; GO:0005829; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; Golgi apparatus; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06664,1.5983134096191531,FUN_031056-T1,Peve_00028186,Pocillopora_meandrina_HIv1___RNAseq.g30325.t1a,three_way,64.37166666666667,FUN_031056-T1,Q8R0G9,NU133_MOUSE,,Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133),Mus musculus (Mouse),36.7,1120.0,3e-178,627.5,sp|Q8R0G9|NU133_MOUSE Nuclear pore complex protein Nup133 OS=Mus musculus OX=10090 GN=Nup133 PE=1 SV=2,GO:0000776; GO:0005635; GO:0005643; GO:0006406; GO:0006913; GO:0006999; GO:0015031; GO:0017056; GO:0021915; GO:0022008; GO:0031080; GO:0031965; GO:0048339; GO:0061053; GO:0072006,mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; paraxial mesoderm development [GO:0048339]; protein transport [GO:0015031]; somite development [GO:0061053],kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0006913; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; nuclear envelope; nucleocytoplasmic transport; cell differentiation; organelle; anatomical structure development
OG_06665,2.109396913567335,FUN_031057-T1,Peve_00028131,Pocillopora_meandrina_HIv1___RNAseq.g30324.t1,three_way,60.543,FUN_031057-T1,P56873,,,,,36.3,171.0,2.2e-18,93.6,sp|P56873|ZNRD2_MOUSE Protein ZNRD2 OS=Mus musculus OX=10090 GN=Znrd2 PE=1 SV=1,,,,,,
OG_06667,1.592438240932486,FUN_031066-T1,Peve_00013555,Pocillopora_meandrina_HIv1___RNAseq.g5922.t1,three_way,79.245,FUN_031066-T1,Q7TSU0,,,,,52.1,121.0,5.5e-31,135.6,sp|Q7TSU0|C1D_CRIGR Nuclear nucleic acid-binding protein C1D OS=Cricetulus griseus OX=10029 GN=C1D PE=2 SV=1,,,,,,
OG_06668,1.4082972757758836,FUN_031067-T1,Peve_00028134,Pocillopora_meandrina_HIv1___RNAseq.g30320.t1,three_way,70.354,FUN_031067-T1,O89043,,,,,41.5,619.0,1.5e-126,454.9,sp|O89043|DPOA2_RAT DNA polymerase alpha subunit B OS=Rattus norvegicus OX=10116 GN=Pola2 PE=1 SV=2,,,,,,
OG_06669,2.9377696857165927,FUN_031068-T1,Peve_00028133,Pocillopora_meandrina_HIv1___RNAseq.g30321.t1,three_way,84.0175,FUN_031068-T1,P05094,,,,,65.8,876.0,0.0,1176.4,sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3,,,,,,
OG_06670,2.586797866192577,FUN_031070-T1,Peve_00025081,Pocillopora_meandrina_HIv1___RNAseq.g6195.t1,three_way,68.65666666666667,FUN_031070-T1,Q93VC9,,,,,40.9,320.0,1.6e-60,234.6,sp|Q93VC9|CATB2_ARATH Cathepsin B-like protease 2 OS=Arabidopsis thaliana OX=3702 GN=CATHB2 PE=2 SV=1,,,,,,
OG_06673,1.0749899606228177,FUN_031076-T1,Peve_00028143,Pocillopora_meandrina_HIv1___RNAseq.g30318.t1,three_way,70.30116666666667,FUN_031076-T1,Q14919,NC2A_HUMAN,,Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha),Homo sapiens (Human),77.4,93.0,4.2e-34,146.4,sp|Q14919|NC2A_HUMAN Dr1-associated corepressor OS=Homo sapiens OX=9606 GN=DRAP1 PE=1 SV=3,GO:0000122; GO:0001046; GO:0001091; GO:0005634; GO:0006366; GO:0016251; GO:0017025; GO:0017054; GO:0042802; GO:0046982; GO:0090575,negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366],negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],core promoter sequence-specific DNA binding [GO:0001046]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025],GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0043226; GO:0140223,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_06675,1.7663966488478895,FUN_031078-T1,Peve_00028145,Pocillopora_meandrina_HIv1___RNAseq.g30316.t1,three_way,77.07333333333334,FUN_031078-T1,Q7L8A9,VASH1_HUMAN,,Tubulinyl-Tyr carboxypeptidase 1 (EC 3.4.17.17) (Tubulin carboxypeptidase 1) (Tyrosine carboxypeptidase 1) (TTCP 1) (Vasohibin-1),Homo sapiens (Human),50.2,273.0,1.2000000000000001e-74,281.6,sp|Q7L8A9|VASH1_HUMAN Tubulinyl-Tyr carboxypeptidase 1 OS=Homo sapiens OX=9606 GN=VASH1 PE=1 SV=1,GO:0001525; GO:0001937; GO:0003779; GO:0004181; GO:0005615; GO:0005737; GO:0005783; GO:0006508; GO:0009611; GO:0016525; GO:0043537; GO:0045177; GO:0045765; GO:0051726; GO:0060716; GO:0106423; GO:1901491; GO:2000772,angiogenesis [GO:0001525]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of lymphangiogenesis [GO:1901491]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; response to wounding [GO:0009611],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; tubulin-tyrosine carboxypeptidase [GO:0106423],GO:0003824; GO:0005615; GO:0005783; GO:0008092; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; endoplasmic reticulum; cytoskeletal protein binding; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06676,3.2952961684279147,FUN_031079-T1,Peve_00028146,Pocillopora_meandrina_HIv1___RNAseq.27627_t,three_way,61.867666666666665,,,,,,,,,,,,,,,,,
OG_06681,1.88786801510058,FUN_031184-T1,Peve_00016090,Pocillopora_meandrina_HIv1___RNAseq.g5221.t1,three_way,48.904,,,,,,,,,,,,,,,,,
OG_06683,1.75492508364234,FUN_031186-T1,Peve_00041875,Pocillopora_meandrina_HIv1___RNAseq.g5214.t1,three_way,69.12466666666667,FUN_031186-T1,P25500,,,,,64.8,491.0,5.8e-181,636.0,sp|P25500|PAPOA_BOVIN Poly(A) polymerase alpha OS=Bos taurus OX=9913 GN=PAPOLA PE=1 SV=3,,,,,,
OG_06686,2.2265869824886217,FUN_031212-T1,Peve_00041872,Pocillopora_meandrina_HIv1___RNAseq.g5200.t1,three_way,90.47633333333332,FUN_031212-T1,P36954,RPB9_HUMAN,,DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II subunit I) (RNA polymerase II 14.5 kDa subunit) (RPB14.5),Homo sapiens (Human),79.2,125.0,3.3e-55,216.1,sp|P36954|RPB9_HUMAN DNA-directed RNA polymerase II subunit RPB9 OS=Homo sapiens OX=9606 GN=POLR2I PE=1 SV=1,GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0008270,maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II [GO:0001193]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]",DNA-directed RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006351; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on RNA"
OG_06688,1.684926084507188,FUN_031220-T1,Peve_00032142,Pocillopora_meandrina_HIv1___RNAseq.g5199.t1,three_way,54.43183333333333,,,,,,,,,,,,,,,,,
OG_06691,2.0655968282673807,FUN_031236-T1,Peve_00043063,Pocillopora_meandrina_HIv1___RNAseq.g5195.t1,three_way,57.85166666666667,FUN_031236-T1,Q8NA75,,,,,33.1,278.0,1.8999999999999998e-39,164.9,sp|Q8NA75|DC4L2_HUMAN DDB1- and CUL4-associated factor 4-like protein 2 OS=Homo sapiens OX=9606 GN=DCAF4L2 PE=1 SV=1,,,,,,
OG_06694,1.19393567561291,FUN_031242-T1,Peve_00043062,Pocillopora_meandrina_HIv1___RNAseq.g5191.t1,three_way,62.47316666666666,FUN_031242-T1,A0A0G2L7I0,SPRTN_DANRE,,DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (Protein with SprT-like domain at the N terminus) (Spartan),Danio rerio (Zebrafish) (Brachydanio rerio),60.6,279.0,7.3e-94,345.9,sp|A0A0G2L7I0|SPRTN_DANRE DNA-dependent metalloprotease SPRTN OS=Danio rerio OX=7955 GN=sprtn PE=3 SV=1,GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0006508; GO:0006974; GO:0008270; GO:0016540; GO:0031593; GO:0106300,DNA damage response [GO:0006974]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508],chromatin [GO:0000785]; nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_06696,1.96214157887734,FUN_031251-T1,Peve_00015904,Pocillopora_meandrina_HIv1___RNAseq.g5188.t1,three_way,77.20766666666667,FUN_031251-T1,Q9D0L4,,,,,54.6,476.0,2.1999999999999998e-147,523.9,sp|Q9D0L4|ADCK1_MOUSE AarF domain-containing protein kinase 1 OS=Mus musculus OX=10090 GN=Adck1 PE=1 SV=1,,,,,,
OG_06698,1.8044969987020112,FUN_031263-T1,Peve_00001470,Pocillopora_meandrina_HIv1___RNAseq.g5187.t1,three_way,67.0335,,,,,,,,,,,,,,,,,
OG_06702,3.9422326619440646,FUN_031269-T1,Peve_00036737,Pocillopora_meandrina_HIv1___TS.g23896.t1,three_way,69.62383333333334,FUN_031269-T1,Q3T906,GNPTA_HUMAN,,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta],Homo sapiens (Human),39.7,1334.0,1e-257,891.7,sp|Q3T906|GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens OX=9606 GN=GNPTAB PE=1 SV=1,GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0033299; GO:0046835,carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976],GO:0003824; GO:0005794; GO:0005975; GO:0007040; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; carbohydrate metabolic process; lysosome organization; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_06703,1.2306184235282849,FUN_031274-T1,Peve_00036739,Pocillopora_meandrina_HIv1___TS.g23895.t1,three_way,65.17633333333333,FUN_031274-T1,Q09470,KCNA1_HUMAN,,Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1),Homo sapiens (Human),40.3,385.0,2.9e-73,277.3,sp|Q09470|KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens OX=9606 GN=KCNA1 PE=1 SV=2,GO:0001508; GO:0001964; GO:0005249; GO:0005251; GO:0005783; GO:0005829; GO:0005886; GO:0006937; GO:0007405; GO:0008076; GO:0009986; GO:0010644; GO:0010960; GO:0016020; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0070161; GO:0071286; GO:0071805; GO:0086011; GO:0097718,action potential [GO:0001508]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; membrane repolarization during action potential [GO:0086011]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],anchoring junction [GO:0070161]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06705,2.7694392367573744,FUN_031276-T1,Peve_00036741,Pocillopora_meandrina_HIv1___RNAseq.g5175.t1,three_way,49.56583333333333,FUN_031276-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),47.1,70.0,5.9e-10,67.8,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_06706,2.0647714037400138,FUN_031286-T1,Peve_00036747,Pocillopora_meandrina_HIv1___RNAseq.g5173.t1,three_way,73.2735,FUN_031286-T1,Q8CHB8,TTLL5_MOUSE,,Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 5),Mus musculus (Mouse),44.1,870.0,1.4999999999999998e-189,665.2,sp|Q8CHB8|TTLL5_MOUSE Tubulin polyglutamylase TTLL5 OS=Mus musculus OX=10090 GN=Ttll5 PE=1 SV=3,GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0030317; GO:0036064; GO:0036211; GO:0046872; GO:0060041; GO:0070740; GO:0097731; GO:0106437; GO:0106438,fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283],9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005634; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0016874; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; ligase activity; reproductive process; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_06707,1.4158569189363115,FUN_031287-T1,Peve_00036748,Pocillopora_meandrina_HIv1___RNAseq.g5172.t1,three_way,87.3345,FUN_031287-T1,Q8BFX3,,,,,64.2,653.0,1.1999999999999999e-235,817.4,sp|Q8BFX3|KCTD3_MOUSE BTB/POZ domain-containing protein KCTD3 OS=Mus musculus OX=10090 GN=Kctd3 PE=1 SV=1,,,,,,
OG_06711,1.2943387389298808,FUN_031299-T1,Peve_00026517,Pocillopora_meandrina_HIv1___TS.g23878.t1,three_way,71.31383333333333,FUN_031299-T1,Q20JQ7,SC4AB_DANRE,,Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b),Danio rerio (Zebrafish) (Brachydanio rerio),37.8,1295.0,2.4e-184,647.9,sp|Q20JQ7|SC4AB_DANRE Sodium channel protein type 4 subunit alpha B OS=Danio rerio OX=7955 GN=scn4ab PE=2 SV=1,GO:0001518; GO:0005248; GO:0019228; GO:0030424; GO:0086010,membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228],axon [GO:0030424]; voltage-gated sodium channel complex [GO:0001518],voltage-gated sodium channel activity [GO:0005248],GO:0005215,transporter activity
OG_06712,2.2824456399433064,FUN_031304-T1,Peve_00026516,Pocillopora_meandrina_HIv1___TS.g23876.t1,three_way,80.76050000000001,FUN_031304-T1,Q2XVR6,SC4AB_TAKRU,,Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b),Takifugu rubripes (Japanese pufferfish) (Fugu rubripes),36.0,1773.0,3.2e-262,907.1,sp|Q2XVR6|SC4AB_TAKRU Sodium channel protein type 4 subunit alpha B OS=Takifugu rubripes OX=31033 GN=scn4ab PE=3 SV=1,GO:0001518; GO:0005248; GO:0019228; GO:0086010,membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228],voltage-gated sodium channel complex [GO:0001518],voltage-gated sodium channel activity [GO:0005248],GO:0005215,transporter activity
OG_06714,2.4763388591775497,FUN_031307-T1,Peve_00026514,Pocillopora_meandrina_HIv1___TS.g23874.t1,three_way,75.132,FUN_031307-T1,Q9CWG8,NDUF7_MOUSE,,"Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)",Mus musculus (Mouse),50.9,407.0,7.8e-106,385.6,"sp|Q9CWG8|NDUF7_MOUSE Protein arginine methyltransferase NDUFAF7, mitochondrial OS=Mus musculus OX=10090 GN=Ndufaf7 PE=1 SV=4",GO:0005739; GO:0019899; GO:0019918; GO:0032981; GO:0035243,"mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]",mitochondrion [GO:0005739],enzyme binding [GO:0019899]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_06715,1.7145009198681835,FUN_031465-T1,Peve_00026560,Pocillopora_meandrina_HIv1___RNAseq.g5151.t1,three_way,70.29766666666667,FUN_031465-T1,Q8VYR2,,,,,33.4,287.0,5.599999999999997e-29,129.8,sp|Q8VYR2|NUDT9_ARATH Nudix hydrolase 9 OS=Arabidopsis thaliana OX=3702 GN=NUDT9 PE=2 SV=1,,,,,,
OG_06717,2.8698784934586983,FUN_031467-T1,Peve_00026558,Pocillopora_meandrina_HIv1___RNAseq.g5084.t2,three_way,78.09566666666667,FUN_031467-T1,Q5RDQ2,PALS1_PONAB,,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),46.4,576.0,2.3e-140,501.5,sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1,GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204,central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204],ATP binding [GO:0005524],GO:0005794; GO:0043226; GO:0048856,Golgi apparatus; organelle; anatomical structure development
OG_06720,1.8001461132462782,FUN_031471-T1,Peve_00026551,Pocillopora_meandrina_HIv1___RNAseq.g5081.t1,three_way,81.32666666666667,FUN_031471-T1,P97376,,,,,43.9,214.0,1.7e-44,181.0,sp|P97376|FRG1_MOUSE Protein FRG1 OS=Mus musculus OX=10090 GN=Frg1 PE=1 SV=2,,,,,,
OG_06721,1.8977052353956607,FUN_031472-T1,Peve_00026549,Pocillopora_meandrina_HIv1___RNAseq.g5080.t1,three_way,65.82266666666666,FUN_031472-T1,Q5F4B8,,,,,30.9,444.0,3.9e-40,167.5,sp|Q5F4B8|S46A3_CHICK Lysosomal proton-coupled steroid conjugate and bile acid symporter SLC46A3 OS=Gallus gallus OX=9031 GN=SLC46A3 PE=2 SV=1,,,,,,
OG_06726,1.0693282668674284,FUN_031499-T1,Peve_00026541,Pocillopora_meandrina_HIv1___RNAseq.g5100.t1,three_way,66.92466666666667,FUN_031499-T1,Q0VFR9,,,,,41.0,641.0,2e-118,427.9,sp|Q0VFR9|MED17_XENTR Mediator of RNA polymerase II transcription subunit 17 OS=Xenopus tropicalis OX=8364 GN=med17 PE=2 SV=1,,,,,,
OG_06728,2.4043720400843824,FUN_031501-T1,Peve_00044288,Pocillopora_meandrina_HIv1___RNAseq.g5104.t1,three_way,66.48166666666667,FUN_031501-T1,O58320,,,,,47.3,292.0,1.0000000000000001e-60,235.3,sp|O58320|GYAR_PYRHO Glyoxylate reductase OS=Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) OX=70601 GN=gyaR PE=1 SV=2,,,,,,
OG_06730,2.813620349060427,FUN_031507-T1,Peve_00004813,Pocillopora_meandrina_HIv1___RNAseq.g5114.t1,three_way,62.814,FUN_031507-T1,H3ZPL1,,,,,29.4,394.0,3.1e-48,194.1,sp|H3ZPL1|ARAT1_THELN Aromatic-amino-acid aminotransferase 1 OS=Thermococcus litoralis (strain ATCC 51850 / DSM 5473 / JCM 8560 / NS-C) OX=523849 GN=OCC_04335 PE=1 SV=1,,,,,,
OG_06731,1.811780422772164,FUN_031508-T1,Peve_00004814,Pocillopora_meandrina_HIv1___RNAseq.g5115.t1,three_way,90.06433333333334,FUN_031508-T1,Q86TJ2,TAD2B_HUMAN,,Transcriptional adapter 2-beta (ADA2-like protein beta) (ADA2-beta),Homo sapiens (Human),45.8,432.0,9.7e-101,368.6,sp|Q86TJ2|TAD2B_HUMAN Transcriptional adapter 2-beta OS=Homo sapiens OX=9606 GN=TADA2B PE=1 SV=2,GO:0000124; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0006338; GO:0006357; GO:0008270; GO:0043484; GO:0045893; GO:0070461,chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461],chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_06734,2.916522306563448,FUN_031518-T1,Peve_00045248,Pocillopora_meandrina_HIv1___RNAseq.g5120.t1,three_way,47.7075,FUN_031518-T1,D0PRN3,,,,,27.2,463.0,3.3000000000000003e-34,148.3,sp|D0PRN3|NRX3A_CHICK Neurexin-3 OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06735,1.961666554954368,FUN_031519-T1,Peve_00045247,Pocillopora_meandrina_HIv1___RNAseq.g5126.t1,three_way,70.90833333333333,,,,,,,,,,,,,,,,,
OG_06736,1.33488000244086,FUN_031523-T1,Peve_00045246,Pocillopora_meandrina_HIv1___RNAseq.g5128.t1,three_way,77.84,FUN_031523-T1,Q5RF14,,,,,51.4,693.0,1.8e-197,690.6,sp|Q5RF14|MIPEP_PONAB Mitochondrial intermediate peptidase OS=Pongo abelii OX=9601 GN=MIPEP PE=2 SV=1,,,,,,
OG_06737,1.585016662621276,FUN_031524-T1,Peve_00022781,Pocillopora_meandrina_HIv1___RNAseq.g5130.t1,three_way,58.0995,FUN_031524-T1,Q4KLN4,GLE1_RAT,,mRNA export factor GLE1 (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1),Rattus norvegicus (Rat),41.9,329.0,2.3e-70,268.5,sp|Q4KLN4|GLE1_RAT mRNA export factor GLE1 OS=Rattus norvegicus OX=10116 GN=Gle1 PE=2 SV=1,GO:0000822; GO:0005543; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0015031; GO:0016973; GO:0031369; GO:0036064; GO:0042802; GO:0044614,poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear pore cytoplasmic filaments [GO:0044614],identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369],GO:0005635; GO:0005815; GO:0006913; GO:0008289; GO:0043226,nuclear envelope; microtubule organizing center; nucleocytoplasmic transport; lipid binding; organelle
OG_06739,2.151075730921446,FUN_031526-T1,Peve_00022762,Pocillopora_meandrina_HIv1___RNAseq.g5133.t1,three_way,69.272,FUN_031526-T1,Q99N57,RAF1_MOUSE,,RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1),Mus musculus (Mouse),31.8,283.0,3.3e-28,127.9,sp|Q99N57|RAF1_MOUSE RAF proto-oncogene serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Raf1 PE=1 SV=2,GO:0000165; GO:0001678; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0008270; GO:0008285; GO:0008286; GO:0008625; GO:0010856; GO:0014044; GO:0030154; GO:0030878; GO:0031143; GO:0031267; GO:0031333; GO:0035019; GO:0035556; GO:0035773; GO:0035994; GO:0038133; GO:0042552; GO:0042802; GO:0043410; GO:0044342; GO:0045104; GO:0045944; GO:0048009; GO:0048011; GO:0048538; GO:0060324; GO:0071550; GO:0106310; GO:1902042,cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; ERBB2-ERBB3 signaling pathway [GO:0038133]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; face development [GO:0060324]; insulin receptor signaling pathway [GO:0008286]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular glucose homeostasis [GO:0001678]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; myelination [GO:0042552]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to muscle stretch [GO:0035994]; Schwann cell development [GO:0014044]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; type B pancreatic cell proliferation [GO:0044342],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],adenylate cyclase activator activity [GO:0010856]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0007010; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"catalytic activity; nucleus; mitochondrion; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; transferase activity; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06740,2.12403899222017,FUN_031528-T2,Peve_00022765,Pocillopora_meandrina_HIv1___RNAseq.g5137.t1,three_way,65.17133333333334,FUN_031528-T2,Q54H46,DRKA_DICDI,,Probable serine/threonine-protein kinase drkA (EC 2.7.11.1) (Receptor-like kinase 1) (Receptor-like kinase A) (Vesicle-associated receptor tyrosine kinase-like protein 1),Dictyostelium discoideum (Social amoeba),28.8,302.0,9.300000000000001e-27,123.2,sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum OX=44689 GN=drkA PE=3 SV=1,GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0097677; GO:0097696; GO:0106310,cell surface receptor signaling pathway via STAT [GO:0097696]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; STAT family protein binding [GO:0097677],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_06741,1.0660999059199323,FUN_031540-T1,Peve_00022767,Pocillopora_meandrina_HIv1___RNAseq.g5140.t2,three_way,78.98833333333333,FUN_031540-T1,Q0KK59,UNC79_MOUSE,,Protein unc-79 homolog,Mus musculus (Mouse),28.5,2723.0,7.2e-267,922.9,sp|Q0KK59|UNC79_MOUSE Protein unc-79 homolog OS=Mus musculus OX=10090 GN=Unc79 PE=1 SV=1,GO:0001967; GO:0005886; GO:0030534; GO:0035264; GO:0048149,adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]; suckling behavior [GO:0001967],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_06742,2.9015814715227184,FUN_031548-T1,Peve_00022768,Pocillopora_meandrina_HIv1___RNAseq.g5141.t1,three_way,49.17633333333333,FUN_031548-T1,A3KMW7,,,,,26.0,519.0,1.2e-11,73.6,sp|A3KMW7|MAP10_BOVIN Microtubule-associated protein 10 OS=Bos taurus OX=9913 GN=MAP10 PE=2 SV=1,,,,,,
OG_06744,1.052510880075165,FUN_031550-T1,Peve_00022772,Pocillopora_meandrina_HIv1___RNAseq.g5143.t1,three_way,67.64183333333334,,,,,,,,,,,,,,,,,
OG_06745,1.1608784172576108,FUN_031552-T1,Peve_00022775,Pocillopora_meandrina_HIv1___TS.g23806.t2,three_way,57.309,,,,,,,,,,,,,,,,,
OG_06746,1.1131171251212553,FUN_031553-T1,Peve_00022777,Pocillopora_meandrina_HIv1___TS.g23807.t1,three_way,61.806333333333335,,,,,,,,,,,,,,,,,
OG_06750,2.516012626246969,FUN_031559-T1,Peve_00032865,Pocillopora_meandrina_HIv1___RNAseq.g5076.t1,three_way,48.826166666666666,FUN_031559-T1,Q8WXE1,ATRIP_HUMAN,,ATR-interacting protein (ATM and Rad3-related-interacting protein),Homo sapiens (Human),30.7,153.0,1.1e-07,60.8,sp|Q8WXE1|ATRIP_HUMAN ATR-interacting protein OS=Homo sapiens OX=9606 GN=ATRIP PE=1 SV=1,GO:0000077; GO:0005634; GO:0005654; GO:0006139; GO:0006281; GO:0070310; GO:0070530; GO:2000779,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779],ATR-ATRIP complex [GO:0070310]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530],GO:0005634; GO:0005654; GO:0006281; GO:0043226,nucleus; nucleoplasm; DNA repair; organelle
OG_06751,3.0087110409531124,FUN_031560-T1,Peve_00032864,Pocillopora_meandrina_HIv1___TS.g23795.t1,three_way,47.11333333333334,FUN_031560-T1,B1H349,,,,,42.6,68.0,1.3e-06,57.4,sp|B1H349|SOX6_XENTR Transcription factor Sox-6 OS=Xenopus tropicalis OX=8364 GN=sox6 PE=2 SV=1,,,,,,
OG_06752,1.7498369798320677,FUN_031561-T1,Peve_00025442,Pocillopora_meandrina_HIv1___RNAseq.g5074.t2,three_way,66.97466666666666,FUN_031561-T1,Q8TCS8,PNPT1_HUMAN,,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)",Homo sapiens (Human),44.5,366.0,1e-83,312.0,"sp|Q8TCS8|PNPT1_HUMAN Polyribonucleotide nucleotidyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PNPT1 PE=1 SV=2",GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0005840; GO:0006397; GO:0006401; GO:0006402; GO:0007005; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042802; GO:0043457; GO:0045025; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0071042; GO:0097222; GO:0097421; GO:2000627; GO:2000772,cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion organization [GO:0007005]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; rRNA import into mitochondrion [GO:0035928],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosome [GO:0005840],3'-5'-RNA exonuclease activity [GO:0000175]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0005829; GO:0005840; GO:0007005; GO:0016071; GO:0016740; GO:0016787; GO:0043226; GO:0048856; GO:0055085; GO:0065003; GO:0140053; GO:0140098,"RNA binding; catalytic activity; mitochondrion; cytosol; ribosome; mitochondrion organization; mRNA metabolic process; transferase activity; hydrolase activity; organelle; anatomical structure development; transmembrane transport; protein-containing complex assembly; mitochondrial gene expression; catalytic activity, acting on RNA"
OG_06753,1.0460676775619733,FUN_031564-T1,Peve_00021506,Pocillopora_meandrina_HIv1___RNAseq.g5073.t1,three_way,72.53333333333333,FUN_031564-T1,Q8TBA6,GOGA5_HUMAN,,Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein),Homo sapiens (Human),36.0,745.0,2.7e-63,245.0,sp|Q8TBA6|GOGA5_HUMAN Golgin subfamily A member 5 OS=Homo sapiens OX=9606 GN=GOLGA5 PE=1 SV=3,GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0030133; GO:0031267; GO:0031985; GO:0042803; GO:0048193,"Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133],protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],GO:0005794; GO:0016192; GO:0031410; GO:0043226,Golgi apparatus; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06754,3.2659499635326323,FUN_031565-T1,Peve_00021513,Pocillopora_meandrina_HIv1___RNAseq.g5072.t1,three_way,87.24600000000001,FUN_031565-T1,Q01728,,,,,54.5,932.0,1.8e-266,920.2,sp|Q01728|NAC1_RAT Sodium/calcium exchanger 1 OS=Rattus norvegicus OX=10116 GN=Slc8a1 PE=1 SV=3,,,,,,
OG_06756,1.1111927249838824,FUN_031567-T1,Peve_00021502,Pocillopora_meandrina_HIv1___TS.g23790.t1,three_way,75.33816666666667,FUN_031567-T1,Q86UY6,NAA40_HUMAN,,N-alpha-acetyltransferase 40 (EC 2.3.1.257) (N-acetyltransferase 11) (N-alpha-acetyltransferase D) (NatD) (hNatD) (Protein acetyltransferase 1),Homo sapiens (Human),56.2,217.0,9.4e-63,241.5,sp|Q86UY6|NAA40_HUMAN N-alpha-acetyltransferase 40 OS=Homo sapiens OX=9606 GN=NAA40 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0010485; GO:0034451; GO:0043998; GO:1990189,lipid metabolic process [GO:0006629],centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone H2A acetyltransferase activity [GO:0043998]; histone H4 acetyltransferase activity [GO:0010485]; protein N-terminal-serine acetyltransferase activity [GO:1990189],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; lipid metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06757,2.0265314199400817,FUN_031570-T1,Peve_00021507,Pocillopora_meandrina_HIv1___RNAseq.g5065.t1,three_way,57.521,FUN_031570-T1,D4A218,,,,,32.0,303.0,1.1e-26,122.5,sp|D4A218|DMRT3_RAT Doublesex and mab-3 related transcription factor 3 OS=Rattus norvegicus OX=10116 GN=Dmrt3 PE=3 SV=1,,,,,,
OG_06758,1.6655619589481463,FUN_031589-T1,Peve_00021514,Pocillopora_meandrina_HIv1___RNAseq.g5069.t1,three_way,86.82000000000001,FUN_031589-T1,Q561L1,,,,,61.0,438.0,3.8e-161,569.3,sp|Q561L1|PUA1A_XENLA Adenylosuccinate synthetase isozyme 1 A OS=Xenopus laevis OX=8355 GN=adss1-a PE=2 SV=1,,,,,,
OG_06763,1.22551747994148,FUN_031595-T1,Peve_00012520,Pocillopora_meandrina_HIv1___RNAseq.g5058.t1,three_way,67.68833333333333,FUN_031595-T1,A2CG63,ARI4B_MOUSE,,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180),Mus musculus (Mouse),27.0,562.0,3e-13,79.0,sp|A2CG63|ARI4B_MOUSE AT-rich interactive domain-containing protein 4B OS=Mus musculus OX=10090 GN=Arid4b PE=1 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006366; GO:0007283; GO:0030336; GO:0030512; GO:0045944; GO:0070822; GO:0071514; GO:0097368; GO:1902455; GO:1902459,chromatin organization [GO:0006325]; establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleus; mitochondrion; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development
OG_06764,1.360890006679775,FUN_031596-T1,Peve_00012519,Pocillopora_meandrina_HIv1___RNAseq.g5057.t1,three_way,58.190333333333335,FUN_031596-T1,P42696,,,,,40.8,314.0,1.3000000000000002e-44,181.8,sp|P42696|RBM34_HUMAN RNA-binding protein 34 OS=Homo sapiens OX=9606 GN=RBM34 PE=1 SV=2,,,,,,
OG_06774,1.8101572030707944,FUN_031639-T1,Peve_00032679,Pocillopora_meandrina_HIv1___TS.g24410.t3b,three_way,82.65466666666667,FUN_031639-T1,Q6NWD4,TIM50_DANRE,,Mitochondrial import inner membrane translocase subunit TIM50,Danio rerio (Zebrafish) (Brachydanio rerio),50.0,268.0,1.1e-68,261.9,sp|Q6NWD4|TIM50_DANRE Mitochondrial import inner membrane translocase subunit TIM50 OS=Danio rerio OX=7955 GN=timm50 PE=2 SV=2,GO:0004722; GO:0004725; GO:0005743; GO:0005744; GO:0006470; GO:0006915; GO:0007006; GO:0030150,apoptotic process [GO:0006915]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150],mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744],protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0007005; GO:0012501; GO:0016787; GO:0055085; GO:0061024; GO:0140096,"catalytic activity; mitochondrion organization; programmed cell death; hydrolase activity; transmembrane transport; membrane organization; catalytic activity, acting on a protein"
OG_06777,2.230000864621291,FUN_031643-T1,Peve_00043580,Pocillopora_meandrina_HIv1___RNAseq.g5686.t1,three_way,83.8815,FUN_031643-T1,Q14738,2A5D_HUMAN,,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta),Homo sapiens (Human),65.9,548.0,3.3e-205,716.1,sp|Q14738|2A5D_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform OS=Homo sapiens OX=9606 GN=PPP2R5D PE=1 SV=1,GO:0000159; GO:0005634; GO:0005654; GO:0005829; GO:0007165; GO:0007399; GO:0019888; GO:0051177; GO:0072542,meiotic sister chromatid cohesion [GO:0051177]; nervous system development [GO:0007399]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159],protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888],GO:0005634; GO:0005654; GO:0005829; GO:0043226; GO:0048856; GO:0098772,nucleus; nucleoplasm; cytosol; organelle; anatomical structure development; molecular function regulator activity
OG_06778,4.003234895133202,FUN_031644-T1,Peve_00043582,Pocillopora_meandrina_HIv1___RNAseq.g5685.t1,three_way,76.86,FUN_031644-T1,Q3EBF7,SLD2_ARATH,,Delta(8)-fatty-acid desaturase 2 (EC 1.14.19.29) (Delta(8)-sphingolipid desaturase 2) (Sphingoid long-chain base desaturase 2) (Sphingoid LCB desaturase 2) (Sphingolipid 8-(E/Z)-desaturase 2),Arabidopsis thaliana (Mouse-ear cress),41.9,451.0,8.5e-100,365.5,sp|Q3EBF7|SLD2_ARATH Delta(8)-fatty-acid desaturase 2 OS=Arabidopsis thaliana OX=3702 GN=SLD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0030148; GO:0046872; GO:0052631; GO:0070417,cellular response to cold [GO:0070417]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; sphingolipid 8-(E/Z)-desaturase activity [GO:0052631],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle
OG_06780,1.6533671761225073,FUN_031647-T1,Peve_00043573,Pocillopora_meandrina_HIv1___RNAseq.g5682.t1,three_way,73.94383333333333,FUN_031647-T1,A0A1L8G016,,,,,52.6,485.0,1e-89,332.0,sp|A0A1L8G016|DAA11_XENLA Dynein axonemal assembly factor 11 OS=Xenopus laevis OX=8355 GN=dnaaf11 PE=3 SV=1,,,,,,
OG_06781,1.2365971520582737,FUN_031648-T1,Peve_00043574,Pocillopora_meandrina_HIv1___RNAseq.g5681.t1,three_way,93.75783333333334,FUN_031648-T1,Q6PD03,2A5A_MOUSE,,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha),Mus musculus (Mouse),75.4,443.0,6.199999999999999e-189,661.8,sp|Q6PD03|2A5A_MOUSE Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform OS=Mus musculus OX=10090 GN=Ppp2r5a PE=1 SV=1,GO:0000159; GO:0000775; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0007165; GO:0019210; GO:0019900; GO:0030018; GO:0031430; GO:0072542; GO:1903077,negative regulation of protein localization to plasma membrane [GO:1903077]; signal transduction [GO:0007165],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]",kinase binding [GO:0019900]; kinase inhibitor activity [GO:0019210]; protein phosphatase activator activity [GO:0072542],GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; plasma membrane; organelle; molecular function regulator activity
OG_06783,2.701083978093584,FUN_031650-T1,Peve_00043578,Pocillopora_meandrina_HIv1___TS.g24400.t2b,three_way,70.58166666666666,FUN_031650-T1,Q5R5D8,BODG_PONAB,,"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),35.3,380.0,3e-73,277.3,sp|Q5R5D8|BODG_PONAB Gamma-butyrobetaine dioxygenase OS=Pongo abelii OX=9601 GN=BBOX1 PE=2 SV=1,GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0045329,carnitine biosynthetic process [GO:0045329],mitochondrion [GO:0005739],gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_06784,2.9472286810034194,FUN_031651-T1,Peve_00017754,Pocillopora_meandrina_HIv1___RNAseq.g5677.t1,three_way,75.48266666666667,FUN_031651-T1,Q9NQX3,GEPH_HUMAN,,Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)],Homo sapiens (Human),46.9,721.0,2.5e-174,614.4,sp|Q9NQX3|GEPH_HUMAN Gephyrin OS=Homo sapiens OX=9606 GN=GPHN PE=1 SV=1,GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006777; GO:0007416; GO:0007529; GO:0008940; GO:0009898; GO:0010038; GO:0014069; GO:0030425; GO:0030674; GO:0032324; GO:0042802; GO:0043197; GO:0043546; GO:0045184; GO:0045211; GO:0046872; GO:0060077; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098982; GO:0099091; GO:0099572; GO:0099645,establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; response to metal ion [GO:0010038]; synapse assembly [GO:0007416],"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization, intracellular component [GO:0099091]; synaptic membrane [GO:0097060]",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005856; GO:0005886; GO:0016491; GO:0016740; GO:0034330; GO:0043226; GO:0060090,catalytic activity; cytosol; cytoskeleton; plasma membrane; oxidoreductase activity; transferase activity; cell junction organization; organelle; molecular adaptor activity
OG_06785,1.5496179732582316,FUN_031652-T1,Peve_00017753,Pocillopora_meandrina_HIv1___RNAseq.g5676.t1,three_way,63.12333333333333,FUN_031652-T1,Q642T7,,,,,48.6,366.0,1.9e-91,338.2,sp|Q642T7|UTP25_XENTR U3 small nucleolar RNA-associated protein 25 homolog OS=Xenopus tropicalis OX=8364 GN=utp25 PE=2 SV=1,,,,,,
OG_06786,1.554388716306681,FUN_031653-T1,Peve_00017752,Pocillopora_meandrina_HIv1___RNAseq.g5674.t1a,three_way,77.49199999999999,FUN_031653-T1,A7RIT9,3HAO_NEMVE,,"3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6) (3-hydroxyanthranilate oxygenase) (3-HAO) (3-hydroxyanthranilic acid dioxygenase) (HAD)",Nematostella vectensis (Starlet sea anemone),59.1,274.0,5.1e-96,352.4,"sp|A7RIT9|3HAO_NEMVE 3-hydroxyanthranilate 3,4-dioxygenase OS=Nematostella vectensis OX=45351 GN=v1g178517 PE=3 SV=1",GO:0000334; GO:0005737; GO:0006569; GO:0008198; GO:0019805; GO:0034354; GO:0043420; GO:0046874,'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-tryptophan catabolic process [GO:0006569]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874],cytoplasm [GO:0005737],"3-hydroxyanthranilate 3,4-dioxygenase activity [GO:0000334]; ferrous iron binding [GO:0008198]",GO:0003824; GO:0006520; GO:0016491; GO:0055086,catalytic activity; amino acid metabolic process; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_06787,2.267876659128693,FUN_031665-T2,Peve_00015111,Pocillopora_meandrina_HIv1___RNAseq.g5666.t1,three_way,79.292,FUN_031665-T2,Q86TV6,TTC7B_HUMAN,,Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1),Homo sapiens (Human),41.4,751.0,1.1e-137,492.3,sp|Q86TV6|TTC7B_HUMAN Tetratricopeptide repeat protein 7B OS=Homo sapiens OX=9606 GN=TTC7B PE=1 SV=3,GO:0005829; GO:0005886; GO:0046854; GO:0072659,phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659],cytosol [GO:0005829]; plasma membrane [GO:0005886],,GO:0005829; GO:0005886; GO:0006629; GO:0072659,cytosol; plasma membrane; lipid metabolic process; protein localization to plasma membrane
OG_06790,1.1420037312925566,FUN_031669-T1,Peve_00026337,Pocillopora_meandrina_HIv1___RNAseq.g5726.t1,three_way,88.93966666666667,,,,,,,,,,,,,,,,,
OG_06792,2.5835360708862223,FUN_031678-T1,Peve_00012833,Pocillopora_meandrina_HIv1___RNAseq.g5745.t1,three_way,69.84783333333333,FUN_031678-T1,Q5R4I2,RNF8_PONAB,,E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),29.4,446.0,2.1e-21,105.5,sp|Q5R4I2|RNF8_PONAB E3 ubiquitin-protein ligase RNF8 OS=Pongo abelii OX=9601 GN=RNF8 PE=2 SV=1,GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168,cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_06794,2.03894531995564,FUN_031681-T1,Peve_00012830,Pocillopora_meandrina_HIv1___RNAseq.g5749.t1,three_way,56.66333333333333,,,,,,,,,,,,,,,,,
OG_06796,2.6275712665668034,FUN_031684-T1,Peve_00013836,Pocillopora_meandrina_HIv1___RNAseq.g5778.t1,three_way,57.97633333333333,,,,,,,,,,,,,,,,,
OG_06798,1.2744201986173274,FUN_031686-T1,Peve_00013838,Pocillopora_meandrina_HIv1___RNAseq.g5776.t1,three_way,76.2835,FUN_031686-T1,Q9D2G2,ODO2_MOUSE,,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K)",Mus musculus (Mouse),73.2,396.0,8.5e-127,455.3,"sp|Q9D2G2|ODO2_MOUSE Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial OS=Mus musculus OX=10090 GN=Dlst PE=1 SV=1",GO:0004149; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006103; GO:0006104; GO:0016746; GO:0033512; GO:0043209; GO:0045252; GO:0160167,2-oxoglutarate metabolic process [GO:0006103]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoadipate dehydrogenase complex [GO:0160167]; oxoglutarate dehydrogenase complex [GO:0045252],acyltransferase activity [GO:0016746]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006520; GO:0006790; GO:0016740; GO:0043226; GO:0055086; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein"
OG_06806,1.2575080543207764,FUN_031705-T1,Peve_00018220,Pocillopora_meandrina_HIv1___TS.g24476.t1a,three_way,84.14866666666667,FUN_031705-T1,A7YWS7,,,,,56.9,524.0,9.7e-180,631.3,sp|A7YWS7|DPOE2_BOVIN DNA polymerase epsilon subunit 2 OS=Bos taurus OX=9913 GN=POLE2 PE=2 SV=1,,,,,,
OG_06811,3.229431637746529,FUN_031711-T1,Peve_00002662,Pocillopora_meandrina_HIv1___RNAseq.g5753.t1a,three_way,72.13733333333333,FUN_031711-T1,Q5RGU1,COQ8A_DANRE,,"Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)",Danio rerio (Zebrafish) (Brachydanio rerio),57.9,494.0,3.7e-159,563.1,"sp|Q5RGU1|COQ8A_DANRE Atypical kinase COQ8A, mitochondrial OS=Danio rerio OX=7955 GN=coq8a PE=2 SV=2",GO:0004672; GO:0005524; GO:0005739; GO:0006744; GO:0016301; GO:0016310; GO:0031966; GO:0043531,phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744],mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06812,3.511583763487939,FUN_031712-T1,Peve_00002661,Pocillopora_meandrina_HIv1___RNAseq.g5450.t1,three_way,83.29866666666666,FUN_031712-T1,M9PH32,,,,,46.4,69.0,3.2e-08,62.0,sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1,,,,,,
OG_06817,4.07908768574916,FUN_031723-T1,Peve_00040627,Pocillopora_meandrina_HIv1___RNAseq.g5482.t1,three_way,60.10466666666667,FUN_031723-T1,Q8BH86,,,,,37.3,510.0,3.3e-76,287.3,"sp|Q8BH86|GLUCM_MOUSE D-glutamate cyclase, mitochondrial OS=Mus musculus OX=10090 GN=Dglucy PE=1 SV=1",,,,,,
OG_06821,1.1126156266568543,FUN_031731-T1,Peve_00029895,Pocillopora_meandrina_HIv1___RNAseq.g5508.t1,three_way,58.312,FUN_031731-T1,Q6IUR5,NENF_RAT,,Neudesin (Neuron-derived neurotrophic factor) (SCIRP10-related protein) (Spinal cord injury-related protein 10),Rattus norvegicus (Rat),44.3,106.0,1.2e-22,107.8,sp|Q6IUR5|NENF_RAT Neudesin OS=Rattus norvegicus OX=10116 GN=Nenf PE=1 SV=1,GO:0000165; GO:0005615; GO:0005739; GO:0005783; GO:0008083; GO:0012505; GO:0016020; GO:0032099; GO:0043410; GO:0046872,MAPK cascade [GO:0000165]; negative regulation of appetite [GO:0032099]; positive regulation of MAPK cascade [GO:0043410],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739],growth factor activity [GO:0008083]; metal ion binding [GO:0046872],GO:0005615; GO:0005739; GO:0005783; GO:0043226; GO:0048018; GO:0098772,extracellular space; mitochondrion; endoplasmic reticulum; organelle; receptor ligand activity; molecular function regulator activity
OG_06822,1.7385106485353556,FUN_031732-T1,Peve_00029894,Pocillopora_meandrina_HIv1___RNAseq.g5509.t1,three_way,63.61333333333334,FUN_031732-T1,Q56P03,EAPP_HUMAN,,E2F-associated phosphoprotein (EAPP),Homo sapiens (Human),39.8,249.0,2e-37,157.5,sp|Q56P03|EAPP_HUMAN E2F-associated phosphoprotein OS=Homo sapiens OX=9606 GN=EAPP PE=1 SV=4,GO:0005634; GO:0005654; GO:0005737; GO:0008284; GO:0016607; GO:0032968; GO:0034244,negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0006355; GO:0043226,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle
OG_06826,1.051758504149824,FUN_031736-T1,Peve_00043414,Pocillopora_meandrina_HIv1___RNAseq.g5512.t1a,three_way,84.65166666666667,FUN_031736-T1,Q2NKU6,DPY30_BOVIN,,Protein dpy-30 homolog (Dpy-30-like protein) (Dpy-30L),Bos taurus (Bovine),62.5,96.0,2.1e-26,119.8,sp|Q2NKU6|DPY30_BOVIN Protein dpy-30 homolog OS=Bos taurus OX=9913 GN=DPY30 PE=3 SV=1,GO:0005634; GO:0005802; GO:0016197; GO:0035097; GO:0042803; GO:0044666; GO:0045815; GO:0048188; GO:0071339,endosomal transport [GO:0016197]; transcription initiation-coupled chromatin remodeling [GO:0045815],histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; trans-Golgi network [GO:0005802],protein homodimerization activity [GO:0042803],GO:0005634; GO:0006325; GO:0016192; GO:0043226,nucleus; chromatin organization; vesicle-mediated transport; organelle
OG_06827,1.2232890077183436,FUN_031738-T1,Peve_00043413,Pocillopora_meandrina_HIv1___RNAseq.g5513.t1,three_way,87.03966666666666,FUN_031738-T1,Q6P8X1,SNX6_MOUSE,,"Sorting nexin-6 [Cleaved into: Sorting nexin-6, N-terminally processed]",Mus musculus (Mouse),65.9,396.0,6.2e-142,505.4,sp|Q6P8X1|SNX6_MOUSE Sorting nexin-6 OS=Mus musculus OX=10090 GN=Snx6 PE=1 SV=2,GO:0005634; GO:0005764; GO:0005829; GO:0006886; GO:0030512; GO:0030904; GO:0031901; GO:0034452; GO:0034713; GO:0035091; GO:0042147; GO:0042803; GO:0043524; GO:0045892; GO:0071364; GO:0097422; GO:0098842; GO:0098978; GO:0099072; GO:1904646,"cellular response to amyloid-beta [GO:1904646]; cellular response to epidermal growth factor stimulus [GO:0071364]; intracellular protein transport [GO:0006886]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; lysosome [GO:0005764]; nucleus [GO:0005634]; postsynaptic early endosome [GO:0098842]; retromer complex [GO:0030904]; tubular endosome [GO:0097422],dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006355; GO:0006886; GO:0008092; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleus; lysosome; endosome; vacuole; cytosol; regulation of DNA-templated transcription; intracellular protein transport; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06828,2.1704859525150626,FUN_031739-T1,Peve_00043412,Pocillopora_meandrina_HIv1___RNAseq.g5514.t1,three_way,71.18233333333333,,,,,,,,,,,,,,,,,
OG_06830,2.4565167487094746,FUN_031742-T1,Peve_00043409,Pocillopora_meandrina_HIv1___RNAseq.g5526.t1,three_way,96.30366666666669,FUN_031742-T1,P36404,ARL2_HUMAN,,ADP-ribosylation factor-like protein 2,Homo sapiens (Human),81.5,162.0,7.5e-76,284.6,sp|P36404|ARL2_HUMAN ADP-ribosylation factor-like protein 2 OS=Homo sapiens OX=9606 GN=ARL2 PE=1 SV=4,GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005813; GO:0005829; GO:0006110; GO:0006457; GO:0007098; GO:0010811; GO:0015630; GO:0016328; GO:0019003; GO:0031113; GO:0031116; GO:0034260; GO:0036064; GO:0051457; GO:0070830; GO:1903715,bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; protein folding [GO:0006457]; regulation of aerobic respiration [GO:1903715]; regulation of glycolytic process [GO:0006110]; regulation of microtubule polymerization [GO:0031113],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005815; GO:0005829; GO:0005856; GO:0006457; GO:0016787; GO:0034330; GO:0043226,catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; mitochondrion; microtubule organizing center; cytosol; cytoskeleton; protein folding; hydrolase activity; cell junction organization; organelle
OG_06832,1.2133878487810643,FUN_031748-T1,Peve_00045071,Pocillopora_meandrina_HIv1___RNAseq.g5531.t1,three_way,67.169,,,,,,,,,,,,,,,,,
OG_06834,1.575573251535971,FUN_031752-T1,Peve_00023214,Pocillopora_meandrina_HIv1___RNAseq.g5535.t1,three_way,68.37466666666667,,,,,,,,,,,,,,,,,
OG_06835,1.540615687928323,FUN_031753-T1,Peve_00023213,Pocillopora_meandrina_HIv1___RNAseq.g5536.t1,three_way,55.97633333333333,,,,,,,,,,,,,,,,,
OG_06836,1.4920682281072812,FUN_031754-T1,Peve_00023210,Pocillopora_meandrina_HIv1___RNAseq.g5542.t1,three_way,70.37316666666666,FUN_031754-T1,Q8R9T6,,,,,32.9,246.0,1.1e-20,104.0,sp|Q8R9T6|PKN1_CALS4 Probable serine/threonine-protein kinase Sps1 OS=Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) OX=273068 GN=sps1 PE=3 SV=1,,,,,,
OG_06837,2.0519668600632865,FUN_031756-T1,Peve_00010432,Pocillopora_meandrina_HIv1___RNAseq.11794_t,three_way,33.38433333333333,,,,,,,,,,,,,,,,,
OG_06839,1.792246867700233,FUN_031779-T1,Peve_00026557,Pocillopora_meandrina_HIv1___RNAseq.g5548.t1a,three_way,38.97683333333333,,,,,,,,,,,,,,,,,
OG_06841,1.4557578264338396,FUN_031781-T1,Peve_00010425,Pocillopora_meandrina_HIv1___TS.g24284.t1,three_way,64.70833333333333,,,,,,,,,,,,,,,,,
OG_06846,3.058445804876376,FUN_031787-T1,Peve_00019324,Pocillopora_meandrina_HIv1___RNAseq.g5568.t1,three_way,65.77866666666667,FUN_031787-T1,A7Z026,,,,,44.6,294.0,6.300000000000001e-65,250.4,sp|A7Z026|PPR37_BOVIN Protein phosphatase 1 regulatory subunit 37 OS=Bos taurus OX=9913 GN=PPP1R37 PE=2 SV=1,,,,,,
OG_06849,3.3092933224418544,FUN_031790-T1,Peve_00019330,Pocillopora_meandrina_HIv1___TS.g24291.t1,three_way,72.05833333333334,,,,,,,,,,,,,,,,,
OG_06850,4.351197612947711,FUN_031791-T1,Peve_00019321,Pocillopora_meandrina_HIv1___RNAseq.g5572.t1,three_way,73.44166666666666,FUN_031791-T1,K7VCB9,,,,,43.1,232.0,1e-38,161.8,sp|K7VCB9|THIM_MAIZE Hydroxyethylthiazole kinase OS=Zea mays OX=4577 GN=THIM PE=1 SV=1,,,,,,
OG_06851,4.103888714068167,FUN_031800-T1,Peve_00019322,Pocillopora_meandrina_HIv1___RNAseq.g5573.t1,three_way,74.092,FUN_031800-T1,Q99986,VRK1_HUMAN,,Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1),Homo sapiens (Human),53.3,336.0,1.4000000000000001e-101,371.3,sp|Q99986|VRK1_HUMAN Serine/threonine-protein kinase VRK1 OS=Homo sapiens OX=9606 GN=VRK1 PE=1 SV=1,GO:0000785; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005829; GO:0006338; GO:0006468; GO:0006974; GO:0007077; GO:0007165; GO:0015030; GO:0016301; GO:0019901; GO:0030576; GO:0031175; GO:0031492; GO:0035175; GO:0042393; GO:0046777; GO:0051301; GO:0072354; GO:0090166; GO:0106310; GO:0120187; GO:0141003; GO:2001222,Cajal body organization [GO:0030576]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; Golgi disassembly [GO:0090166]; mitotic nuclear membrane disassembly [GO:0007077]; neuron projection development [GO:0031175]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of neuron migration [GO:2001222]; signal transduction [GO:0007165],Cajal body [GO:0015030]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone binding [GO:0042393]; histone H2AX kinase activity [GO:0141003]; histone H3S10 kinase activity [GO:0035175]; histone H3T3 kinase activity [GO:0072354]; kinase activity [GO:0016301]; nucleosomal DNA binding [GO:0031492]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0016740; GO:0042393; GO:0043226; GO:0061024; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; transferase activity; histone binding; organelle; membrane organization; catalytic activity, acting on a protein"
OG_06854,1.0743010672678588,FUN_031819-T1,Peve_00030275,Pocillopora_meandrina_HIv1___RNAseq.g5595.t1,three_way,82.48433333333334,FUN_031819-T1,Q2YDI0,,,,,60.6,142.0,4.199999999999999e-43,175.6,sp|Q2YDI0|RM11_BOVIN Large ribosomal subunit protein uL11m OS=Bos taurus OX=9913 GN=MRPL11 PE=1 SV=2,,,,,,
OG_06856,1.6357093302553125,FUN_031834-T1,Peve_00030278,Pocillopora_meandrina_HIv1___TS.g24318.t1,three_way,70.685,FUN_031834-T1,Q29RY4,RNZ1_BOVIN,,Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1),Bos taurus (Bovine),47.7,329.0,4e-78,293.1,sp|Q29RY4|RNZ1_BOVIN Zinc phosphodiesterase ELAC protein 1 OS=Bos taurus OX=9913 GN=ELAC1 PE=2 SV=1,GO:0004549; GO:0005634; GO:0005654; GO:0005829; GO:0042780; GO:0042781; GO:0046872; GO:0072344,rescue of stalled ribosome [GO:0072344]; tRNA 3'-end processing [GO:0042780],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]; tRNA-specific ribonuclease activity [GO:0004549],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; nucleus; nucleoplasm; cytosol; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_06858,1.8124012986640223,FUN_031848-T1,Peve_00030290,Pocillopora_meandrina_HIv1___RNAseq.g5607.t1,three_way,63.642,FUN_031848-T1,A6QNR1,,,,,44.3,219.0,1.2e-29,131.7,sp|A6QNR1|RRP36_BOVIN Ribosomal RNA processing protein 36 homolog OS=Bos taurus OX=9913 GN=RRP36 PE=2 SV=1,,,,,,
OG_06859,1.8588220587880435,FUN_031849-T1,Peve_00030292,Pocillopora_meandrina_HIv1___RNAseq.g5608.t1,three_way,82.18233333333333,FUN_031849-T1,Q8BX37,,,,,55.5,402.0,4.6e-141,502.7,sp|Q8BX37|ACP7_MOUSE Acid phosphatase type 7 OS=Mus musculus OX=10090 GN=Acp7 PE=2 SV=2,,,,,,
OG_06861,1.0386097524171112,FUN_031852-T2,Peve_00030298,Pocillopora_meandrina_HIv1___RNAseq.g5614.t1,three_way,88.76,FUN_031852-T2,P62861,RS30_HUMAN,,Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein (FAU ubiquitin like and ribosomal protein S30 fusion) [Cleaved into: Ubiquitin-like protein FUBI; Small ribosomal subunit protein eS30 (40S ribosomal protein S30)],Homo sapiens (Human),66.9,133.0,1.8999999999999998e-39,163.3,sp|P62861|RS30_HUMAN Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein OS=Homo sapiens OX=9606 GN=FAU PE=1 SV=2,GO:0002181; GO:0002227; GO:0003723; GO:0003735; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0015935; GO:0016567; GO:0019731; GO:0019941; GO:0022626; GO:0022627; GO:0031386; GO:0031625; GO:0050830; GO:0061844,antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small ribosomal subunit [GO:0015935],protein tag activity [GO:0031386]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625],GO:0002181; GO:0002376; GO:0003723; GO:0005198; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0005840; GO:0031386; GO:0043226; GO:0098542,cytoplasmic translation; immune system process; RNA binding; structural molecule activity; extracellular space; nucleus; nucleoplasm; cytosol; ribosome; protein tag activity; organelle; defense response to other organism
OG_06866,1.922435503235379,FUN_031862-T1,Peve_00011064,Pocillopora_meandrina_HIv1___RNAseq.g5635.t1,three_way,61.84783333333333,,,,,,,,,,,,,,,,,
OG_06868,1.6436017680094177,FUN_031868-T1,Peve_00010189,Pocillopora_meandrina_HIv1___RNAseq.g5646.t1b,three_way,72.2535,FUN_031868-T1,P50748,KNTC1_HUMAN,,Kinetochore-associated protein 1 (Rough deal homolog) (HsROD) (Rod) (hRod),Homo sapiens (Human),32.2,2261.0,3.3999999999999998e-301,1036.9,sp|P50748|KNTC1_HUMAN Kinetochore-associated protein 1 OS=Homo sapiens OX=9606 GN=KNTC1 PE=1 SV=1,GO:0000070; GO:0000922; GO:0005634; GO:0005737; GO:0005828; GO:0005829; GO:0005886; GO:0007094; GO:0007096; GO:0015629; GO:0031267; GO:0051301; GO:0051988; GO:0065003; GO:1903394; GO:1990423,cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922],small GTPase binding [GO:0031267],GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007059; GO:0043226; GO:0065003,nucleus; cytosol; cytoskeleton; plasma membrane; chromosome segregation; organelle; protein-containing complex assembly
OG_06869,1.6212424434585817,FUN_031869-T1,Peve_00010191,Pocillopora_meandrina_HIv1___RNAseq.g5647.t1,three_way,60.89966666666667,,,,,,,,,,,,,,,,,
OG_06873,1.231796549694024,FUN_031876-T1,Peve_00012647,Pocillopora_meandrina_HIv1___RNAseq.g5446.t1,three_way,98.995,FUN_031876-T1,P63099,CANB1_BOVIN,,Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1),Bos taurus (Bovine),88.2,170.0,7.999999999999999e-83,307.8,sp|P63099|CANB1_BOVIN Calcineurin subunit B type 1 OS=Bos taurus OX=9913 GN=PPP3R1 PE=1 SV=2,GO:0005509; GO:0005829; GO:0005955; GO:0008597; GO:0019902; GO:0033173; GO:0042383,calcineurin-NFAT signaling cascade [GO:0033173],calcineurin complex [GO:0005955]; cytosol [GO:0005829]; sarcolemma [GO:0042383],calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; phosphatase binding [GO:0019902],GO:0005829; GO:0005886; GO:0098772,cytosol; plasma membrane; molecular function regulator activity
OG_06874,3.3952838937600083,FUN_031877-T1,Peve_00012644,Pocillopora_meandrina_HIv1___RNAseq.g5447.t1,three_way,82.98033333333333,FUN_031877-T1,Q9VT65,CANB_DROME,,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],Drosophila melanogaster (Fruit fly),40.7,685.0,5.4e-154,546.2,sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2,GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; membrane [GO:0016020],calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198],GO:0003824; GO:0016787; GO:0048870; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_06876,1.97426425264808,FUN_031888-T1,Peve_00031832,Pocillopora_meandrina_HIv1___RNAseq.g6051.t1,three_way,66.68083333333333,FUN_031888-T1,P23913,,,,,45.3,417.0,4.9e-103,376.7,sp|P23913|LBR_CHICK Delta(14)-sterol reductase LBR OS=Gallus gallus OX=9031 GN=LBR PE=1 SV=1,,,,,,
OG_06884,1.9252622258198209,FUN_031907-T1,Peve_00037699,Pocillopora_meandrina_HIv1___RNAseq.g30042.t1,three_way,82.0565,,,,,,,,,,,,,,,,,
OG_06885,2.123923518066721,FUN_031908-T1,Peve_00037696,Pocillopora_meandrina_HIv1___RNAseq.g30045.t1,three_way,57.48116666666667,FUN_031908-T1,Q9Z2E9,,,,,45.7,221.0,1.5e-52,209.1,sp|Q9Z2E9|BSCL2_MOUSE Seipin OS=Mus musculus OX=10090 GN=Bscl2 PE=1 SV=2,,,,,,
OG_06886,1.495562819045105,FUN_031920-T1,Peve_00040655,Pocillopora_meandrina_HIv1___RNAseq.g30047.t1,three_way,68.389,FUN_031920-T1,Q07326,PIGF_HUMAN,,"GPI ethanolamine phosphate transferase, stabilizing subunit (GPI ethanolamine phosphate transferase 2, stabilizing subunit) (GPI ethanolamine phosphate transferase 3, stabilizing subunit) (GPI11 homolog) (Phosphatidylinositol-glycan biosynthesis class F protein) (PIG-F)",Homo sapiens (Human),38.3,162.0,4.8e-24,112.8,"sp|Q07326|PIGF_HUMAN GPI ethanolamine phosphate transferase, stabilizing subunit OS=Homo sapiens OX=9606 GN=PIGF PE=1 SV=1",GO:0004307; GO:0005789; GO:0006506,GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum membrane [GO:0005789],ethanolaminephosphotransferase activity [GO:0004307],GO:0003824; GO:0006629; GO:0016740; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_06887,2.0484978825471933,FUN_031921-T1,Peve_00040661,Pocillopora_meandrina_HIv1___RNAseq.g30046.t1,three_way,57.22266666666666,FUN_031921-T1,Q3LU38,,,,,36.1,183.0,3.9e-15,83.6,sp|Q3LU38|PROP1_ALOBE Homeobox protein prophet of Pit-1 OS=Alouatta belzebul OX=30590 GN=PROP1 PE=3 SV=1,,,,,,
OG_06888,1.685063183377967,FUN_031925-T1,Peve_00004245,Pocillopora_meandrina_HIv1___TS.g21220.t1,three_way,43.71983333333333,,,,,,,,,,,,,,,,,
OG_06889,3.2609636246280025,FUN_031927-T1,Peve_00004242,Pocillopora_meandrina_HIv1___RNAseq.g18295.t1,three_way,59.02133333333333,FUN_031927-T1,Q9C907,,,,,36.2,257.0,4.8e-40,166.4,sp|Q9C907|GDPD5_ARATH Glycerophosphodiester phosphodiesterase GDPD5 OS=Arabidopsis thaliana OX=3702 GN=GDPD5 PE=2 SV=1,,,,,,
OG_06890,2.1277605099581764,FUN_031929-T1,Peve_00004239,Pocillopora_meandrina_HIv1___RNAseq.g18236.t1,three_way,51.3345,FUN_031929-T1,A0A061IR73,,,,,46.3,749.0,3.1e-175,617.5,sp|A0A061IR73|PEX6_CRIGR Peroxisomal ATPase PEX6 OS=Cricetulus griseus OX=10029 GN=PEX6 PE=3 SV=1,,,,,,
OG_06892,1.5698769265564996,FUN_031931-T1,Peve_00004235,Pocillopora_meandrina_HIv1___RNAseq.g18238.t1,three_way,59.82666666666667,FUN_031931-T1,Q498L0,,,,,51.9,104.0,1.7000000000000002e-22,110.2,sp|Q498L0|C170B_XENLA Centrosomal protein of 170 kDa protein B OS=Xenopus laevis OX=8355 GN=cep170b PE=2 SV=1,,,,,,
OG_06893,1.0379801051923334,FUN_031934-T1,Peve_00035174,Pocillopora_meandrina_HIv1___RNAseq.g18219.t1,three_way,62.78816666666666,FUN_031934-T1,Q9DAZ9,ANCHR_MOUSE,,Abscission/NoCut checkpoint regulator (ANCHR) (Zinc finger FYVE domain-containing protein 19),Mus musculus (Mouse),27.1,414.0,1.2000000000000001e-30,135.6,sp|Q9DAZ9|ANCHR_MOUSE Abscission/NoCut checkpoint regulator OS=Mus musculus OX=10090 GN=Zfyve19 PE=1 SV=2,GO:0005737; GO:0005813; GO:0008270; GO:0030496; GO:0032154; GO:0032266; GO:0032466; GO:0044878; GO:0061952; GO:0090543,midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; negative regulation of cytokinesis [GO:0032466],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496],phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270],GO:0005815; GO:0008289; GO:0061024,microtubule organizing center; lipid binding; membrane organization
OG_06896,1.805039602755545,FUN_031938-T1,Peve_00024799,Pocillopora_meandrina_HIv1___RNAseq.g18210.t1,three_way,53.64366666666667,,,,,,,,,,,,,,,,,
OG_06899,1.667871429053762,FUN_031942-T1,Peve_00031841,Pocillopora_meandrina_HIv1___RNAseq.g18206.t1,three_way,81.319,FUN_031942-T1,Q9UKY4,,,,,52.4,687.0,1.1e-208,728.0,sp|Q9UKY4|POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens OX=9606 GN=POMT2 PE=1 SV=2,,,,,,
OG_06901,1.8798955202039047,FUN_031944-T1,Peve_00031843,Pocillopora_meandrina_HIv1___RNAseq.g18204.t2,three_way,92.98266666666666,FUN_031944-T1,Q7ZT47,PSF1_XENLA,,DNA replication complex GINS protein PSF1 (GINS complex subunit 1),Xenopus laevis (African clawed frog),59.0,195.0,4.900000000000001e-65,248.8,sp|Q7ZT47|PSF1_XENLA DNA replication complex GINS protein PSF1 OS=Xenopus laevis OX=8355 GN=gins1 PE=1 SV=1,GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902983,DNA replication [GO:0006260]; DNA strand elongation involved in mitotic DNA replication [GO:1902983],CMG complex [GO:0071162]; GINS complex [GO:0000811],chromatin binding [GO:0003682],GO:0006260,DNA replication
OG_06902,2.44817946983152,FUN_031945-T1,Peve_00031844,Pocillopora_meandrina_HIv1___RNAseq.g6066.t1,three_way,66.55733333333333,FUN_031945-T1,Q08C93,ABD12_DANRE,,Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-),Danio rerio (Zebrafish) (Brachydanio rerio),41.7,326.0,3.9999999999999997e-63,243.4,sp|Q08C93|ABD12_DANRE Lysophosphatidylserine lipase ABHD12 OS=Danio rerio OX=7955 GN=abhd12 PE=2 SV=1,GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0010842; GO:0016020; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651,acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],lysophospholipase activity [GO:0004622]; monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620],GO:0003824; GO:0006575; GO:0006629; GO:0016787; GO:0048856,catalytic activity; modified amino acid metabolic process; lipid metabolic process; hydrolase activity; anatomical structure development
OG_06903,2.7404894441408167,FUN_031949-T1,Peve_00031822,Pocillopora_meandrina_HIv1___RNAseq.g6063.t2,three_way,64.09533333333334,FUN_031949-T1,P81439,,,,,40.1,187.0,5.8e-32,141.7,sp|P81439|EQSTC_ACTEQ Equistatin OS=Actinia equina OX=6106 PE=1 SV=2,,,,,,
OG_06908,1.3042479826737745,FUN_031966-T1,Peve_00043673,Pocillopora_meandrina_HIv1___RNAseq.g30203.t1,three_way,76.01766666666667,FUN_031966-T1,Q8UWA5,,,,,36.9,274.0,3.3e-36,153.7,sp|Q8UWA5|CAH2_PSEHK Carbonic anhydrase 2 OS=Pseudaspius hakonensis OX=3004147 GN=ca2 PE=2 SV=3,,,,,,
OG_06909,1.2408401459118197,FUN_031967-T1,Peve_00013260,Pocillopora_meandrina_HIv1___RNAseq.g17806.t1,three_way,83.551,FUN_031967-T1,Q95M17,CHIA_BOVIN,,Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04),Bos taurus (Bovine),46.4,390.0,4.3999999999999996e-91,336.7,sp|Q95M17|CHIA_BOVIN Acidic mammalian chitinase OS=Bos taurus OX=9913 GN=CHIA PE=1 SV=1,GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0008843; GO:0032722,apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005975; GO:0012501; GO:0016787; GO:1901135,immune system process; catalytic activity; extracellular region; extracellular space; carbohydrate metabolic process; programmed cell death; hydrolase activity; carbohydrate derivative metabolic process
OG_06910,2.7900670369415725,FUN_031970-T1,Peve_00043666,Pocillopora_meandrina_HIv1___RNAseq.g30204.t1,three_way,57.15116666666666,FUN_031970-T1,Q96J02,,,,,37.4,270.0,1.6e-43,180.3,sp|Q96J02|ITCH_HUMAN E3 ubiquitin-protein ligase Itchy homolog OS=Homo sapiens OX=9606 GN=ITCH PE=1 SV=2,,,,,,
OG_06912,1.1396853753793172,FUN_031972-T1,Peve_00043663,Pocillopora_meandrina_HIv1___TS.g22502.t1,three_way,81.21033333333332,FUN_031972-T1,C6EUD4,,,,,58.3,338.0,4.9000000000000003e-110,399.4,sp|C6EUD4|APSCT_FASHE Succinyl-CoA:acetate/propanoyl-CoA:succinate CoA transferase OS=Fasciola hepatica OX=6192 PE=1 SV=1,,,,,,
OG_06913,1.1525698105096367,FUN_031974-T2,Peve_00043636,Pocillopora_meandrina_HIv1___TS.g22504.t1,three_way,69.29716666666667,FUN_031974-T2,Q866F4,,,,,31.2,818.0,1.2e-97,360.5,sp|Q866F4|ADCYA_RABIT Adenylate cyclase type 10 OS=Oryctolagus cuniculus OX=9986 GN=ADCY10 PE=2 SV=1,,,,,,
OG_06915,1.131424551904985,FUN_031976-T1,Peve_00043633,Pocillopora_meandrina_HIv1___RNAseq.g30254.t1,three_way,69.245,FUN_031976-T1,Q54CI5,,,,,40.9,154.0,3.3e-23,109.8,sp|Q54CI5|DPH4_DICDI DPH4 homolog OS=Dictyostelium discoideum OX=44689 GN=dph4 PE=3 SV=1,,,,,,
OG_06917,1.812618809865003,FUN_031981-T1,Peve_00028816,Pocillopora_meandrina_HIv1___RNAseq.g30256.t2,three_way,80.43633333333334,FUN_031981-T1,A7RZW4,DPP3_NEMVE,,Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III),Nematostella vectensis (Starlet sea anemone),69.4,731.0,1.7e-302,1039.6,sp|A7RZW4|DPP3_NEMVE Dipeptidyl peptidase 3 OS=Nematostella vectensis OX=45351 GN=dpp3 PE=3 SV=1,GO:0004177; GO:0005737; GO:0006508; GO:0008235; GO:0008239; GO:0046872,proteolysis [GO:0006508],cytoplasm [GO:0005737],aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_06919,3.503538655891549,FUN_031983-T1,Peve_00028814,Pocillopora_meandrina_HIv1___RNAseq.g30258.t1,three_way,74.83933333333334,FUN_031983-T1,Q8NBN7,RDH13_HUMAN,,Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3),Homo sapiens (Human),55.7,298.0,1e-85,318.2,sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2,GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650,eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226; GO:0048856,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle; anatomical structure development
OG_06920,1.2352148641386516,FUN_032004-T1,Peve_00028811,Pocillopora_meandrina_HIv1___TS.g22558.t1,three_way,74.84166666666667,FUN_032004-T1,Q5ZME2,,,,,69.8,331.0,8.9e-126,451.4,"sp|Q5ZME2|MDHC_CHICK Malate dehydrogenase, cytoplasmic OS=Gallus gallus OX=9031 GN=MDH1 PE=2 SV=1",,,,,,
OG_06923,1.4726420271392688,FUN_032013-T1,Peve_00028828,Pocillopora_meandrina_HIv1___RNAseq.g30268.t1,three_way,59.529,FUN_032013-T1,Q49LS6,,,,,25.3,359.0,1.5e-12,76.3,sp|Q49LS6|XKR9_TETNG XK-related protein 9 OS=Tetraodon nigroviridis OX=99883 GN=xkr9 PE=2 SV=1,,,,,,
OG_06926,1.516044050963895,FUN_032016-T2,Peve_00041123,Pocillopora_meandrina_HIv1___RNAseq.27584_t,three_way,52.10083333333333,FUN_032016-T2,Q1G7G9,TALD3_CHICK,,TALPID3 protein,Gallus gallus (Chicken),25.3,663.0,1.1000000000000002e-28,131.3,sp|Q1G7G9|TALD3_CHICK TALPID3 protein OS=Gallus gallus OX=9031 GN=TALPID3 PE=2 SV=2,GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0044458; GO:0051642; GO:0060271,centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; smoothened signaling pathway [GO:0007224],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737],,GO:0005815; GO:0043226; GO:0044782,microtubule organizing center; organelle; cilium organization
OG_06930,2.121637895905592,FUN_032021-T1,Peve_00041120,Pocillopora_meandrina_HIv1___RNAseq.g25906.t1,three_way,45.036,,,,,,,,,,,,,,,,,
OG_06932,1.5215033667655244,FUN_032024-T1,Peve_00001041,Pocillopora_meandrina_HIv1___RNAseq.g5695.t1,three_way,95.975,FUN_032024-T1,Q3SZF8,SMD2_BOVIN,,Small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2),Bos taurus (Bovine),89.0,118.0,5.1e-52,204.9,sp|Q3SZF8|SMD2_BOVIN Small nuclear ribonucleoprotein Sm D2 OS=Bos taurus OX=9913 GN=SNRPD2 PE=3 SV=1,GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06933,1.2138315448866264,FUN_032025-T1,Peve_00001044,Pocillopora_meandrina_HIv1___RNAseq.g5696.t1a,three_way,85.64333333333333,FUN_032025-T1,Q5U5C5,PRP31_XENLA,,U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31),Xenopus laevis (African clawed frog),62.3,496.0,2.4e-156,553.5,sp|Q5U5C5|PRP31_XENLA U4/U6 small nuclear ribonucleoprotein Prp31 OS=Xenopus laevis OX=8355 GN=prpf31 PE=2 SV=1,GO:0000244; GO:0000398; GO:0005634; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030622; GO:0046540; GO:0071005; GO:0071011; GO:0071339; GO:0097526,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]",Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690],U4atac snRNA binding [GO:0030622],GO:0003723; GO:0005634; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06934,1.4095711565832756,FUN_032038-T1,Peve_00013548,Pocillopora_meandrina_HIv1___RNAseq.g5928.t1b,three_way,59.332,,,,,,,,,,,,,,,,,
OG_06936,2.174245177870314,FUN_032043-T1,Peve_00013570,Pocillopora_meandrina_HIv1___RNAseq.g5943.t1,three_way,65.27933333333333,FUN_032043-T1,Q99N87,,,,,51.2,215.0,7.9999999999999985e-56,219.2,sp|Q99N87|RT05_MOUSE Small ribosomal subunit protein uS5m OS=Mus musculus OX=10090 GN=Mrps5 PE=1 SV=1,,,,,,
OG_06941,1.4655887389550364,FUN_032051-T1,Peve_00012446,Pocillopora_meandrina_HIv1___RNAseq.g6025.t1,three_way,90.203,FUN_032051-T1,Q91918,,,,,83.3,335.0,2.3000000000000003e-158,559.7,sp|Q91918|RA51A_XENLA DNA repair protein RAD51 homolog A OS=Xenopus laevis OX=8355 GN=rad51-a PE=2 SV=1,,,,,,
OG_06942,4.320022907735928,FUN_032052-T1,Peve_00012445,Pocillopora_meandrina_HIv1___RNAseq.g6026.t1,three_way,72.548,FUN_032052-T1,Q96NT5,,,,,28.5,445.0,2.6e-38,161.4,sp|Q96NT5|PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens OX=9606 GN=SLC46A1 PE=1 SV=1,,,,,,
OG_06943,2.290945272166369,FUN_032053-T1,Peve_00012451,Pocillopora_meandrina_HIv1___RNAseq.g6027.t1,three_way,65.46633333333334,FUN_032053-T1,Q68DK2,ZFY26_HUMAN,,Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein) (FYVE-CENT) (Spastizin),Homo sapiens (Human),31.7,1223.0,2.8e-168,595.9,sp|Q68DK2|ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ZFYVE26 PE=1 SV=4,GO:0000281; GO:0000724; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0008270; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:1905037,autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496],phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270],GO:0000910; GO:0005764; GO:0005768; GO:0005773; GO:0005815; GO:0006281; GO:0006310; GO:0007040; GO:0008289; GO:0031410; GO:0043226,cytokinesis; lysosome; endosome; vacuole; microtubule organizing center; DNA repair; DNA recombination; lysosome organization; lipid binding; cytoplasmic vesicle; organelle
OG_06945,1.6069937928182347,FUN_032055-T1,Peve_00012449,Pocillopora_meandrina_HIv1___RNAseq.g6020.t1,three_way,62.906666666666666,,,,,,,,,,,,,,,,,
OG_06946,1.1306811892807165,FUN_032056-T1,Peve_00011274,Pocillopora_meandrina_HIv1___RNAseq.g6021.t1,three_way,60.78183333333333,,,,,,,,,,,,,,,,,
OG_06948,2.896688239908992,FUN_032061-T2,Peve_00040453,Pocillopora_meandrina_HIv1___RNAseq.g6047.t1,three_way,65.65933333333334,FUN_032061-T2,P39428,TRAF1_MOUSE,,TNF receptor-associated factor 1,Mus musculus (Mouse),31.4,264.0,1.1000000000000001e-27,125.9,sp|P39428|TRAF1_MOUSE TNF receptor-associated factor 1 OS=Mus musculus OX=10090 GN=Traf1 PE=1 SV=2,GO:0005164; GO:0005737; GO:0006915; GO:0007165; GO:0008270; GO:0031625; GO:0031996; GO:0042802; GO:2001236,apoptotic process [GO:0006915]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; signal transduction [GO:0007165],cytoplasm [GO:0005737],identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0012501,programmed cell death
OG_06953,1.241333487172004,FUN_032067-T1,Peve_00024741,Pocillopora_meandrina_HIv1___RNAseq.g6039.t1,three_way,74.31583333333334,FUN_032067-T1,Q8N128,,,,,48.1,52.0,4e-10,67.0,sp|Q8N128|F177A_HUMAN Protein FAM177A1 OS=Homo sapiens OX=9606 GN=FAM177A1 PE=1 SV=1,,,,,,
OG_06955,1.9492816263632549,FUN_032074-T1,Peve_00018829,Pocillopora_meandrina_HIv1___RNAseq.g6016.t1,three_way,67.94316666666667,FUN_032074-T1,P78504,JAG1_HUMAN,,Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339),Homo sapiens (Human),41.2,204.0,9.5e-42,174.5,sp|P78504|JAG1_HUMAN Protein jagged-1 OS=Homo sapiens OX=9606 GN=JAG1 PE=1 SV=3,GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737,angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; molecular adaptor activity [GO:0060090]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198],GO:0002376; GO:0005198; GO:0005576; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0048018; GO:0048856; GO:0060090; GO:0098772,immune system process; structural molecule activity; extracellular region; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; receptor ligand activity; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_06956,2.121964678391418,FUN_032081-T1,Peve_00039910,Pocillopora_meandrina_HIv1___RNAseq.g5227.t1,three_way,79.99466666666666,FUN_032081-T1,Q5RE98,AOFB_PONAB,,Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),47.7,486.0,1.1000000000000001e-130,468.4,sp|Q5RE98|AOFB_PONAB Amine oxidase [flavin-containing] B OS=Pongo abelii OX=9601 GN=MAOB PE=2 SV=3,GO:0005739; GO:0005741; GO:0008131; GO:0050660; GO:0097621,,mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_06958,2.4190397381061186,FUN_032087-T1,Peve_00026034,Pocillopora_meandrina_HIv1___RNAseq.g5298.t1,three_way,38.37983333333334,,,,,,,,,,,,,,,,,
OG_06959,1.5165440792475005,FUN_032088-T1,Peve_00026033,Pocillopora_meandrina_HIv1___RNAseq.g5297.t1,three_way,66.52333333333334,FUN_032088-T1,Q5RBF1,SIR2_PONAB,,NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),59.6,297.0,1.9e-105,384.0,sp|Q5RBF1|SIR2_PONAB NAD-dependent protein deacetylase sirtuin-2 OS=Pongo abelii OX=9601 GN=SIRT2 PE=1 SV=1,GO:0000122; GO:0000792; GO:0003682; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006476; GO:0010507; GO:0010801; GO:0016042; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0040029; GO:0042177; GO:0042903; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0044224; GO:0045599; GO:0045836; GO:0045944; GO:0046872; GO:0046970; GO:0048471; GO:0051301; GO:0051726; GO:0051781; GO:0051987; GO:0061433; GO:0070403; GO:0070446; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0140773; GO:0140774; GO:1900119; GO:1900195; GO:2000378,cell division [GO:0051301]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; epigenetic regulation of gene expression [GO:0040029]; lipid catabolic process [GO:0016042]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; regulation of myelination [GO:0031641]; tubulin deacetylation [GO:0090042],centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819],"chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; protein lysine deacetylase activity [GO:0033558]; tubulin deacetylase activity [GO:0042903]",GO:0003824; GO:0005634; GO:0005694; GO:0005815; GO:0005829; GO:0005886; GO:0006325; GO:0006355; GO:0006629; GO:0016740; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; microtubule organizing center; cytosol; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_06964,1.200583984641746,FUN_032095-T1,Peve_00012823,Pocillopora_meandrina_HIv1___RNAseq.g5274.t1,three_way,65.23833333333333,,,,,,,,,,,,,,,,,
OG_06967,3.456705457517794,FUN_032099-T1,Peve_00035662,Pocillopora_meandrina_HIv1___RNAseq.g5303.t1,three_way,74.34366666666666,FUN_032099-T1,P98192,GNPAT_MOUSE,,Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase),Mus musculus (Mouse),36.0,659.0,1.3e-94,349.0,sp|P98192|GNPAT_MOUSE Dihydroxyacetone phosphate acyltransferase OS=Mus musculus OX=10090 GN=Gnpat PE=1 SV=1,GO:0003824; GO:0005777; GO:0005778; GO:0005782; GO:0006650; GO:0007416; GO:0008611; GO:0016287; GO:0021587; GO:0030054; GO:0030913; GO:0042552; GO:0061024,cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; synapse assembly [GO:0007416],cell junction [GO:0030054]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287],GO:0003824; GO:0005777; GO:0006629; GO:0016740; GO:0034330; GO:0043226; GO:0061024,catalytic activity; peroxisome; lipid metabolic process; transferase activity; cell junction organization; organelle; membrane organization
OG_06972,1.7704174377634063,FUN_032106-T1,Peve_00030222,Pocillopora_meandrina_HIv1___RNAseq.g5395.t1,three_way,94.85066666666668,FUN_032106-T1,P53451,,,,,75.0,539.0,3.9000000000000003e-224,778.9,sp|P53451|TCPD_TAKRU T-complex protein 1 subunit delta OS=Takifugu rubripes OX=31033 GN=cct4 PE=2 SV=1,,,,,,
OG_06974,2.5099823106552708,FUN_032109-T1,Peve_00030225,Pocillopora_meandrina_HIv1___RNAseq.g5392.t1,three_way,77.26299999999999,FUN_032109-T1,F1RAX8,,,,,55.6,444.0,2.5e-134,480.3,"sp|F1RAX8|COQ6_DANRE Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial OS=Danio rerio OX=7955 GN=coq6 PE=2 SV=1",,,,,,
OG_06979,2.6226224655216006,FUN_032115-T1,Peve_00030231,Pocillopora_meandrina_HIv1___RNAseq.g5383.t1,three_way,75.76333333333334,,,,,,,,,,,,,,,,,
OG_06981,2.6472317288495435,FUN_032118-T1,Peve_00030238,Pocillopora_meandrina_HIv1___RNAseq.g5380.t1,three_way,76.23633333333333,FUN_032118-T1,Q5ZL91,INT7_CHICK,,Integrator complex subunit 7 (Int7),Gallus gallus (Chicken),45.5,927.0,3.2e-212,740.3,sp|Q5ZL91|INT7_CHICK Integrator complex subunit 7 OS=Gallus gallus OX=9031 GN=INTS7 PE=2 SV=1,GO:0005634; GO:0005694; GO:0005737; GO:0006974; GO:0032039; GO:0034472; GO:0160232; GO:0160240,DNA damage response [GO:0006974]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472],chromosome [GO:0005694]; cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634],,GO:0005634; GO:0005694; GO:0016073; GO:0043226,nucleus; chromosome; snRNA metabolic process; organelle
OG_06986,2.455674114341574,FUN_032125-T1,Peve_00040713,Pocillopora_meandrina_HIv1___RNAseq.g5366.t1,three_way,78.05966666666667,FUN_032125-T1,Q6DF57,,,,,46.3,95.0,4e-16,85.9,sp|Q6DF57|GPT11_XENTR G patch domain-containing protein 11 OS=Xenopus tropicalis OX=8364 GN=gpatch11 PE=2 SV=1,,,,,,
OG_06987,2.535693075480684,FUN_032128-T1,Peve_00040717,Pocillopora_meandrina_HIv1___RNAseq.g5363.t1,three_way,49.11266666666667,,,,,,,,,,,,,,,,,
OG_06988,1.5949421979495024,FUN_032129-T1,Peve_00040715,Pocillopora_meandrina_HIv1___RNAseq.g5362.t1,three_way,64.65516666666666,FUN_032129-T1,Q9BWU0,NADAP_HUMAN,,Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein),Homo sapiens (Human),37.0,637.0,3.2000000000000002e-87,324.3,sp|Q9BWU0|NADAP_HUMAN Kanadaptin OS=Homo sapiens OX=9606 GN=SLC4A1AP PE=1 SV=2,GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231,,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],mRNA binding [GO:0003729],GO:0003723; GO:0005654; GO:0005886; GO:0043226,RNA binding; nucleoplasm; plasma membrane; organelle
OG_06991,3.116392325518775,FUN_032133-T1,Peve_00029139,Pocillopora_meandrina_HIv1___RNAseq.g5353.t1,three_way,78.61566666666667,FUN_032133-T1,Q9ULQ1,,,,,28.8,552.0,2.7000000000000004e-44,181.8,sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3,,,,,,
OG_06992,3.295082927543161,FUN_032137-T1,Peve_00007914,Pocillopora_meandrina_HIv1___RNAseq.g5357.t1,three_way,65.0305,FUN_032137-T1,Q3MIT2,PUS10_HUMAN,,tRNA pseudouridine synthase Pus10 (Hup10) (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase),Homo sapiens (Human),46.1,347.0,1.3e-77,291.6,sp|Q3MIT2|PUS10_HUMAN tRNA pseudouridine synthase Pus10 OS=Homo sapiens OX=9606 GN=PUS10 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005739; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029; GO:0160148,primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine synthase activity [GO:0106029]; tRNA pseudouridine(55) synthase activity [GO:0160148],GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0006399; GO:0016853; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mitochondrion; tRNA metabolic process; isomerase activity; organelle; catalytic activity, acting on RNA"
OG_06993,4.946359068462943,FUN_032139-T1,Peve_00007913,Pocillopora_meandrina_HIv1___TS.g24062.t1,three_way,49.26766666666666,,,,,,,,,,,,,,,,,
OG_06995,2.7860537445864466,FUN_032143-T1,Peve_00007909,Pocillopora_meandrina_HIv1___RNAseq.g5346.t1,three_way,75.438,FUN_032143-T1,Q9H0R1,AP5M1_HUMAN,,AP-5 complex subunit mu-1 (Adaptor-related protein complex 5 subunit mu-1) (Mu5) (Mu-2-related death-inducing protein) (MuD) (Putative HIV-1 infection-related protein),Homo sapiens (Human),34.8,515.0,1.2e-78,295.4,sp|Q9H0R1|AP5M1_HUMAN AP-5 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP5M1 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016020; GO:0016192; GO:0016197; GO:0030119; GO:0031902; GO:0044599,endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],,GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_07002,1.9279167351184208,FUN_032154-T1,Peve_00003238,Pocillopora_meandrina_HIv1___RNAseq.g5326.t1,three_way,41.39083333333333,,,,,,,,,,,,,,,,,
OG_07005,2.2359665183572206,FUN_032157-T1,Peve_00003243,Pocillopora_meandrina_HIv1___RNAseq.11552_t,three_way,70.325,,,,,,,,,,,,,,,,,
OG_07007,3.5067188049442666,FUN_032160-T1,Peve_00005389,Pocillopora_meandrina_HIv1___RNAseq.g5308.t1,three_way,84.28083333333333,FUN_032160-T1,Q9BX10,GTPB2_HUMAN,,GTP-binding protein 2,Homo sapiens (Human),61.1,535.0,2.7e-191,669.8,sp|Q9BX10|GTPB2_HUMAN GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=GTPBP2 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802; GO:0070966; GO:0072344; GO:1904678,"nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]",extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093],alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802],GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0016071; GO:0016787,RNA binding; catalytic activity; GTPase activity; extracellular region; mRNA metabolic process; hydrolase activity
OG_07009,2.454959538853502,FUN_032162-T1,Peve_00038631,Pocillopora_meandrina_HIv1___RNAseq.g5313.t1,three_way,99.18466666666669,FUN_032162-T1,Q6GQL2,PP1B_XENLA,,Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16),Xenopus laevis (African clawed frog),94.5,325.0,3.300000000000001e-186,652.1,sp|Q6GQL2|PP1B_XENLA Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Xenopus laevis OX=8355 GN=ppp1cb PE=2 SV=1,GO:0004722; GO:0005634; GO:0005737; GO:0005977; GO:0030155; GO:0032922; GO:0042752; GO:0046872; GO:0050115; GO:0051301; GO:0072357,cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752],cytoplasm [GO:0005737]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357],metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005975; GO:0006091; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; carbohydrate metabolic process; generation of precursor metabolites and energy; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07010,3.34881803296061,FUN_032163-T1,Peve_00038632,Pocillopora_meandrina_HIv1___RNAseq.g5314.t1,three_way,95.89,FUN_032163-T1,Q561P5,MCM5_XENTR,,DNA replication licensing factor mcm5 (EC 3.6.4.12),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),72.9,735.0,0.0,1084.7,sp|Q561P5|MCM5_XENTR DNA replication licensing factor mcm5 OS=Xenopus tropicalis OX=8364 GN=mcm5 PE=2 SV=1,GO:0000785; GO:0003688; GO:0004386; GO:0005524; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0044786; GO:0071162,cell cycle DNA replication [GO:0044786]; DNA replication initiation [GO:0006270]; regulation of DNA-templated DNA replication initiation [GO:0030174],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA replication origin binding [GO:0003688]; helicase activity [GO:0004386],GO:0003677; GO:0003824; GO:0006260; GO:0016787; GO:0016853; GO:0140657,DNA binding; catalytic activity; DNA replication; hydrolase activity; isomerase activity; ATP-dependent activity
OG_07015,2.802850465679308,FUN_032191-T1,Peve_00020048,Pocillopora_meandrina_HIv1___RNAseq.g24664.t1,three_way,75.42333333333333,FUN_032191-T1,Q0V9A9,,,,,59.2,284.0,1.1e-90,334.7,sp|Q0V9A9|LACB2_XENTR Endoribonuclease LACTB2 OS=Xenopus tropicalis OX=8364 GN=lactb2 PE=2 SV=1,,,,,,
OG_07020,1.0951054983124342,FUN_032196-T1,Peve_00017487,Pocillopora_meandrina_HIv1___RNAseq.g24408.t1,three_way,64.211,FUN_032196-T1,D3ZAT9,,,,,33.5,239.0,5.8e-38,159.5,sp|D3ZAT9|FAXC_RAT Failed axon connections homolog OS=Rattus norvegicus OX=10116 GN=Faxc PE=3 SV=1,,,,,,
OG_07021,2.07935183432773,FUN_032200-T2,Peve_00017491,Pocillopora_meandrina_HIv1___RNAseq.g24414.t1,three_way,73.51166666666667,FUN_032200-T2,Q6DDS9,XRCC5_XENLA,,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (Ku80),Xenopus laevis (African clawed frog),38.2,744.0,6.100000000000001e-130,466.5,sp|Q6DDS9|XRCC5_XENLA X-ray repair cross-complementing protein 5 OS=Xenopus laevis OX=8355 GN=xrcc5.L PE=1 SV=1,GO:0000723; GO:0003678; GO:0003684; GO:0003690; GO:0005524; GO:0006303; GO:0006310; GO:0016787; GO:0042162; GO:0043564,DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; telomere maintenance [GO:0000723],Ku70:Ku80 complex [GO:0043564],ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; hydrolase activity [GO:0016787]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0032200; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA repair; DNA recombination; hydrolase activity; isomerase activity; telomere organization; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07022,1.778960400753245,FUN_032201-T1,Peve_00017492,Pocillopora_meandrina_HIv1___RNAseq.g24415.t1,three_way,62.11133333333333,,,,,,,,,,,,,,,,,
OG_07023,2.24920054967364,FUN_032204-T1,Peve_00013799,Pocillopora_meandrina_HIv1___RNAseq.g24269.t1,three_way,60.29666666666667,FUN_032204-T1,Q9UBU6,,,,,33.3,201.0,1.1e-22,109.0,sp|Q9UBU6|FA8A1_HUMAN Protein FAM8A1 OS=Homo sapiens OX=9606 GN=FAM8A1 PE=1 SV=1,,,,,,
OG_07025,2.59146470682048,FUN_032217-T1,Peve_00015500,Pocillopora_meandrina_HIv1___RNAseq.g24278.t1,three_way,88.01366666666667,,,,,,,,,,,,,,,,,
OG_07026,1.1334865796302471,FUN_032218-T1,Peve_00015505,Pocillopora_meandrina_HIv1___RNAseq.g24279.t1,three_way,81.62233333333333,FUN_032218-T1,Q5F477,,,,,37.9,285.0,3.4e-45,183.7,sp|Q5F477|LDAH_CHICK Lipid droplet-associated hydrolase OS=Gallus gallus OX=9031 GN=LDAH PE=2 SV=2,,,,,,
OG_07027,2.260961097537293,FUN_032219-T1,Peve_00015512,Pocillopora_meandrina_HIv1___RNAseq.g24280.t1,three_way,65.81,FUN_032219-T1,A3KP40,,,,,24.7,461.0,2.2e-09,65.5,sp|A3KP40|CH034_DANRE Uncharacterized protein C8orf34 homolog OS=Danio rerio OX=7955 GN=zgc:162928 PE=2 SV=1,,,,,,
OG_07028,3.213984319383059,FUN_032220-T1,Peve_00015518,Pocillopora_meandrina_HIv1___RNAseq.g24281.t1,three_way,76.94216666666667,FUN_032220-T1,P08461,,,,,60.7,443.0,2.7e-132,473.8,"sp|P08461|ODP2_RAT Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial OS=Rattus norvegicus OX=10116 GN=Dlat PE=1 SV=3",,,,,,
OG_07030,1.6787288026700569,FUN_032222-T1,Peve_00015538,Pocillopora_meandrina_HIv1___RNAseq.g24283.t1,three_way,63.73566666666667,FUN_032222-T1,Q8BVA5,LDAH_MOUSE,,Lipid droplet-associated hydrolase (EC 3.1.1.13) (Lipid droplet-associated serine hydrolase) (mLDAH),Mus musculus (Mouse),39.9,288.0,2.1e-50,201.1,sp|Q8BVA5|LDAH_MOUSE Lipid droplet-associated hydrolase OS=Mus musculus OX=10090 GN=Ldah PE=1 SV=1,GO:0004771; GO:0005783; GO:0005811; GO:0019915; GO:0035356; GO:0042632; GO:0090077; GO:0160077,cholesterol homeostasis [GO:0042632]; foam cell differentiation [GO:0090077]; intracellular triglyceride homeostasis [GO:0035356]; lipid droplet fusion [GO:0160077]; lipid storage [GO:0019915],endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811],sterol ester esterase activity [GO:0004771],GO:0003824; GO:0005783; GO:0005811; GO:0016787; GO:0030154; GO:0043226,catalytic activity; endoplasmic reticulum; lipid droplet; hydrolase activity; cell differentiation; organelle
OG_07033,3.016859026481089,FUN_032225-T1,Peve_00043436,Pocillopora_meandrina_HIv1___RNAseq.g24827.t1,three_way,72.54,FUN_032225-T1,Q5HZI9,S2551_MOUSE,,Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 (Mitochondrial NAD(+) transporter SLC25A51) (Mitochondrial carrier triple repeat protein 1) (Solute carrier family 25 member 51),Mus musculus (Mouse),51.1,266.0,4.2e-74,279.6,sp|Q5HZI9|S2551_MOUSE Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 OS=Mus musculus OX=10090 GN=Slc25a51 PE=1 SV=1,GO:0005739; GO:0005743; GO:0006741; GO:0008514; GO:0019646; GO:0051724; GO:1990549,aerobic electron transport chain [GO:0019646]; mitochondrial NAD transmembrane transport [GO:1990549]; NADP biosynthetic process [GO:0006741],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],NAD transmembrane transporter activity [GO:0051724]; organic anion transmembrane transporter activity [GO:0008514],GO:0005215; GO:0005739; GO:0006091; GO:0043226; GO:0055085; GO:0055086,transporter activity; mitochondrion; generation of precursor metabolites and energy; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process
OG_07035,1.9383816153449471,FUN_032229-T1,Peve_00027503,Pocillopora_meandrina_HIv1___RNAseq.g24831.t1,three_way,71.70400000000001,FUN_032229-T1,Q66GV0,,,,,49.1,175.0,1.7e-41,170.6,sp|Q66GV0|MPV17_XENLA Mitochondrial inner membrane protein Mpv17 OS=Xenopus laevis OX=8355 GN=mpv17 PE=2 SV=2,,,,,,
OG_07037,1.5983160037148436,FUN_032232-T1,Peve_00043437,Pocillopora_meandrina_HIv1___RNAseq.g24836.t1,three_way,68.60266666666666,FUN_032232-T1,Q6DG22,ADA_DANRE,,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),Danio rerio (Zebrafish) (Brachydanio rerio),48.0,350.0,3.3e-91,336.7,sp|Q6DG22|ADA_DANRE Adenosine deaminase OS=Danio rerio OX=7955 GN=ada PE=2 SV=2,GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0042110; GO:0043103; GO:0046103; GO:0046936; GO:0060169; GO:0060205; GO:0070161,adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110],anchoring junction [GO:0070161]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764],2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07042,1.841947805768388,FUN_032241-T1,Peve_00023301,Pocillopora_meandrina_HIv1___TS.g12785.t1,three_way,77.97733333333333,FUN_032241-T1,Q9JLT4,TRXR2_MOUSE,,"Thioredoxin reductase 2, mitochondrial (EC 1.8.1.9) (Thioredoxin reductase TR3)",Mus musculus (Mouse),64.1,493.0,1.2e-193,677.6,"sp|Q9JLT4|TRXR2_MOUSE Thioredoxin reductase 2, mitochondrial OS=Mus musculus OX=10090 GN=Txnrd2 PE=1 SV=4",GO:0000305; GO:0004791; GO:0005739; GO:0007507; GO:0030097; GO:0042803; GO:0045454; GO:0050660,cell redox homeostasis [GO:0045454]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; response to oxygen radical [GO:0000305],mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005739; GO:0016209; GO:0016491; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; antioxidant activity; oxidoreductase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07045,1.4712874474976458,FUN_032247-T1,Peve_00036304,Pocillopora_meandrina_HIv1___RNAseq.g24869.t1,three_way,75.44666666666667,FUN_032247-T1,Q5PQN1,HERC4_RAT,,Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4),Rattus norvegicus (Rat),48.8,1069.0,3.5000000000000003e-274,946.0,sp|Q5PQN1|HERC4_RAT Probable E3 ubiquitin-protein ligase HERC4 OS=Rattus norvegicus OX=10116 GN=Herc4 PE=2 SV=1,GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630,cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0140096,"catalytic activity; cytosol; transferase activity; reproductive process; cell differentiation; catalytic activity, acting on a protein"
OG_07048,2.381177800549767,FUN_032253-T1,Peve_00014265,Pocillopora_meandrina_HIv1___RNAseq.g24907.t1c,three_way,69.48400000000001,FUN_032253-T1,Q1LY51,,,,,29.0,544.0,4.2e-30,134.0,sp|Q1LY51|ZN704_DANRE Zinc finger protein 704 OS=Danio rerio OX=7955 GN=znf704 PE=3 SV=2,,,,,,
OG_07049,2.017068630756044,FUN_032255-T1,Peve_00014264,Pocillopora_meandrina_HIv1___RNAseq.g24905.t1,three_way,70.49433333333333,FUN_032255-T1,O43909,EXTL3_HUMAN,,Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3),Homo sapiens (Human),46.1,855.0,2.3e-207,723.8,sp|O43909|EXTL3_HUMAN Exostosin-like 3 OS=Homo sapiens OX=9606 GN=EXTL3 PE=1 SV=1,GO:0000287; GO:0001888; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006486; GO:0010838; GO:0015012; GO:0016500; GO:0016757; GO:0030307; GO:0045617; GO:0050728; GO:0051897; GO:0106015; GO:1900016; GO:2000972,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of keratinocyte differentiation [GO:0045617]; positive regulation of cell growth [GO:0030307]; positive regulation of detection of glucose [GO:2000972]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein glycosylation [GO:0006486],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886],glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; magnesium ion binding [GO:0000287]; protein-hormone receptor activity [GO:0016500],GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0006486; GO:0009101; GO:0016740; GO:0043226; GO:0060089; GO:1901135,catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; plasma membrane; protein glycosylation; glycoprotein biosynthetic process; transferase activity; organelle; molecular transducer activity; carbohydrate derivative metabolic process
OG_07051,3.2969632866187912,FUN_032271-T1,Peve_00030007,Pocillopora_meandrina_HIv1___RNAseq.g24973.t1,three_way,77.01566666666666,FUN_032271-T1,A5PJJ7,,,,,49.8,301.0,1.8999999999999998e-82,307.8,sp|A5PJJ7|S16C6_BOVIN Short-chain dehydrogenase/reductase family 16C member 6 OS=Bos taurus OX=9913 GN=SDR16C6 PE=2 SV=1,,,,,,
OG_07052,4.692576473515211,FUN_032274-T1,Peve_00011763,Pocillopora_meandrina_HIv1___RNAseq.g24974.t1,three_way,68.399,FUN_032274-T1,A8E7N9,,,,,31.6,370.0,2.9e-44,181.0,sp|A8E7N9|GDF6B_DANRE Growth/differentiation factor 6-B OS=Danio rerio OX=7955 GN=gdf6b PE=2 SV=1,,,,,,
OG_07053,1.833290051565739,FUN_032276-T1,Peve_00011761,Pocillopora_meandrina_HIv1___RNAseq.g24976.t1,three_way,83.19833333333334,FUN_032276-T1,Q8QZZ8,RAB38_MOUSE,,Ras-related protein Rab-38 (EC 3.6.5.2),Mus musculus (Mouse),70.5,129.0,3.4e-52,205.7,sp|Q8QZZ8|RAB38_MOUSE Ras-related protein Rab-38 OS=Mus musculus OX=10090 GN=Rab38 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005739; GO:0005764; GO:0005769; GO:0005802; GO:0005886; GO:0007005; GO:0015031; GO:0016192; GO:0030670; GO:0030742; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0044297; GO:0045335; GO:0048023; GO:0048471; GO:0060155; GO:0072657; GO:0090383; GO:1903232; GO:1904377; GO:2001247,endosome to melanosome transport [GO:0035646]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of protein localization to cell periphery [GO:1904377]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],cell body [GO:0044297]; early endosome [GO:0005769]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0007005; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; mitochondrion; lysosome; endosome; vacuole; plasma membrane; mitochondrion organization; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_07055,3.152483004278587,FUN_032278-T1,Peve_00011758,Pocillopora_meandrina_HIv1___RNAseq.g24978.t1,three_way,81.38966666666667,FUN_032278-T1,Q8N584,,,,,40.9,587.0,4.1e-121,436.8,sp|Q8N584|TT39C_HUMAN Tetratricopeptide repeat protein 39C OS=Homo sapiens OX=9606 GN=TTC39C PE=1 SV=2,,,,,,
OG_07057,1.1740264570823198,FUN_032282-T1,Peve_00015548,Pocillopora_meandrina_HIv1___RNAseq.g24294.t1,three_way,60.5455,FUN_032282-T1,Q0IJ01,,,,,26.5,567.0,1.5e-33,146.0,sp|Q0IJ01|ZWILC_XENTR Protein zwilch homolog OS=Xenopus tropicalis OX=8364 GN=zwilch PE=2 SV=1,,,,,,
OG_07059,2.5369807764570766,FUN_032285-T1,Peve_00015515,Pocillopora_meandrina_HIv1___RNAseq.g3787.t1,three_way,65.661,FUN_032285-T1,P26186,,,,,39.3,168.0,1.8e-27,124.0,sp|P26186|MGMT_CRIGR Methylated-DNA--protein-cysteine methyltransferase OS=Cricetulus griseus OX=10029 GN=MGMT PE=2 SV=1,,,,,,
OG_07061,2.1332698159813326,FUN_032287-T1,Peve_00015513,Pocillopora_meandrina_HIv1___RNAseq.g24298.t1,three_way,80.58466666666666,FUN_032287-T1,O60942,MCE1_HUMAN,,mRNA-capping enzyme (HCAP1) (HCE) [Includes: mRNA 5'-triphosphate monophosphatase (EC 3.6.1.74) (mRNA 5'-phosphatase); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)],Homo sapiens (Human),49.5,566.0,5.900000000000001e-162,572.4,sp|O60942|MCE1_HUMAN mRNA-capping enzyme OS=Homo sapiens OX=9606 GN=RNGTT PE=1 SV=1,GO:0004484; GO:0004651; GO:0004721; GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0006370; GO:0006396; GO:0008192; GO:0050355; GO:0140818,7-methylguanosine mRNA capping [GO:0006370]; RNA processing [GO:0006396],nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; GTP binding [GO:0005525]; inorganic triphosphate phosphatase activity [GO:0050355]; mRNA 5'-triphosphate monophosphatase activity [GO:0140818]; mRNA guanylyltransferase activity [GO:0004484]; phosphoprotein phosphatase activity [GO:0004721]; polynucleotide 5'-phosphatase activity [GO:0004651]; RNA guanylyltransferase activity [GO:0008192],GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016740; GO:0016787; GO:0043226; GO:0140096; GO:0140098,"catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_07064,1.931254864942723,FUN_032290-T1,Peve_00015509,Pocillopora_meandrina_HIv1___RNAseq.g24318.t1,three_way,80.926,FUN_032290-T1,Q9BV90,SNR25_HUMAN,,U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein),Homo sapiens (Human),56.0,134.0,9.9e-35,147.9,sp|Q9BV90|SNR25_HUMAN U11/U12 small nuclear ribonucleoprotein 25 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP25 PE=1 SV=1,GO:0000398; GO:0005634; GO:0005654; GO:0005689; GO:0005829; GO:0008380; GO:0045171,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689],,GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0043226,nucleus; nucleoplasm; cytosol; mRNA metabolic process; organelle
OG_07069,1.0035727660127214,FUN_032304-T1,Peve_00029762,Pocillopora_meandrina_HIv1___RNAseq.g24893.t1,three_way,84.42699999999999,FUN_032304-T1,Q99470,,,,,60.9,115.0,4.5e-38,158.7,sp|Q99470|SDF2_HUMAN Stromal cell-derived factor 2 OS=Homo sapiens OX=9606 GN=SDF2 PE=1 SV=2,,,,,,
OG_07070,1.0296511138461728,FUN_032305-T1,Peve_00027302,Pocillopora_meandrina_HIv1___RNAseq.g24891.t1,three_way,48.758833333333335,,,,,,,,,,,,,,,,,
OG_07073,2.137766726254055,FUN_032309-T1,Peve_00009101,Pocillopora_meandrina_HIv1___RNAseq.g24764.t1,three_way,78.17133333333334,FUN_032309-T1,A7RZS0,BL1S2_NEMVE,,Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC-1 subunit 2),Nematostella vectensis (Starlet sea anemone),53.8,104.0,2.7e-21,103.2,sp|A7RZS0|BL1S2_NEMVE Biogenesis of lysosome-related organelles complex 1 subunit 2 OS=Nematostella vectensis OX=45351 GN=bloc1s2 PE=3 SV=1,GO:0000930; GO:0005765; GO:0005813; GO:0016197; GO:0031083; GO:0032418; GO:0043015; GO:0099078,endosomal transport [GO:0016197]; lysosome localization [GO:0032418],BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; centrosome [GO:0005813]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765],gamma-tubulin binding [GO:0043015],GO:0005815; GO:0008092; GO:0016192,microtubule organizing center; cytoskeletal protein binding; vesicle-mediated transport
OG_07075,2.2640153645669816,FUN_032312-T1,Peve_00002566,Pocillopora_meandrina_HIv1___RNAseq.g24785.t1,three_way,58.21183333333333,,,,,,,,,,,,,,,,,
OG_07086,1.47281322234094,FUN_032343-T1,Peve_00043851,Pocillopora_meandrina_HIv1___RNAseq.g29795.t1,three_way,70.73383333333334,FUN_032343-T1,Q9VCA2,,,,,31.8,528.0,2.3999999999999997e-61,238.0,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_07087,2.000767233997113,FUN_032344-T1,Peve_00021401,Pocillopora_meandrina_HIv1___RNAseq.g29796.t1,three_way,74.12733333333334,FUN_032344-T1,Q9H3R1,,,,,40.3,749.0,4.3000000000000005e-161,570.1,sp|Q9H3R1|NDST4_HUMAN Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 OS=Homo sapiens OX=9606 GN=NDST4 PE=1 SV=1,,,,,,
OG_07090,2.090947747718896,FUN_032347-T1,Peve_00032203,Pocillopora_meandrina_HIv1___RNAseq.g29799.t1,three_way,82.527,,,,,,,,,,,,,,,,,
OG_07091,1.378479179342652,FUN_032348-T1,Peve_00012753,Pocillopora_meandrina_HIv1___TS.g25052.t1,three_way,72.73100000000001,FUN_032348-T1,Q9PT60,,,,,44.5,263.0,4.7e-52,207.2,sp|Q9PT60|RBP1A_XENLA RalA-binding protein 1-A OS=Xenopus laevis OX=8355 GN=ralbp1-a PE=1 SV=3,,,,,,
OG_07101,3.142049531755539,FUN_032361-T1,Peve_00045028,Pocillopora_meandrina_HIv1___RNAseq.g29818.t1,three_way,57.91883333333333,FUN_032361-T1,Q8C3S2,,,,,33.1,1162.0,1.7e-147,525.4,sp|Q8C3S2|TNG6_MOUSE Transport and Golgi organization protein 6 homolog OS=Mus musculus OX=10090 GN=Tango6 PE=1 SV=1,,,,,,
OG_07102,3.977741889375883,FUN_032363-T1,Peve_00045030,Pocillopora_meandrina_HIv1___RNAseq.g29819.t1,three_way,59.871500000000005,FUN_032363-T1,Q6N021,TET2_HUMAN,,Methylcytosine dioxygenase TET2 (EC 1.14.11.80),Homo sapiens (Human),32.8,825.0,5.8e-99,364.4,sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3,GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579; GO:0141167,"chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]",chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0009101; GO:0016491; GO:0030154; GO:0043226; GO:0140097; GO:1901135,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; glycoprotein biosynthetic process; oxidoreductase activity; cell differentiation; organelle; catalytic activity, acting on DNA; carbohydrate derivative metabolic process"
OG_07103,6.542782769045913,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_07104,1.0712413874993616,FUN_032371-T1,Peve_00036465,Pocillopora_meandrina_HIv1___RNAseq.g24259.t1,three_way,67.01666666666667,FUN_032371-T1,Q04786,,,,,38.5,881.0,3.5e-156,553.9,sp|Q04786|HEX_VIBVL Beta-hexosaminidase OS=Vibrio vulnificus OX=672 GN=hex PE=3 SV=1,,,,,,
OG_07107,1.1535862722227797,FUN_032377-T1,Peve_00041775,Pocillopora_meandrina_HIv1___RNAseq.g24363.t1,three_way,75.99600000000001,FUN_032377-T1,Q3SX30,,,,,27.7,285.0,4.5e-20,100.1,sp|Q3SX30|PSMF1_BOVIN Proteasome inhibitor PI31 subunit OS=Bos taurus OX=9913 GN=PSMF1 PE=2 SV=2,,,,,,
OG_07109,1.1153552101504762,FUN_032379-T1,Peve_00041779,Pocillopora_meandrina_HIv1___TS.g12307.t1,three_way,82.202,FUN_032379-T1,Q66I21,,,,,63.8,442.0,3.4e-165,582.8,sp|Q66I21|AL8A1_DANRE 2-aminomuconic semialdehyde dehydrogenase OS=Danio rerio OX=7955 GN=aldh8a1 PE=2 SV=1,,,,,,
OG_07110,2.53481874094384,FUN_032381-T1,Peve_00041787,Pocillopora_meandrina_HIv1___RNAseq.g24369.t2,three_way,58.79066666666667,FUN_032381-T1,Q0VGT4,ZGRF1_MOUSE,,5'-3' DNA helicase ZGRF1 (EC 5.6.2.3) (GRF-type zinc finger domain-containing protein 1),Mus musculus (Mouse),49.1,846.0,3.2e-210,734.2,sp|Q0VGT4|ZGRF1_MOUSE 5'-3' DNA helicase ZGRF1 OS=Mus musculus OX=10090 GN=Zgrf1 PE=1 SV=2,GO:0000725; GO:0005524; GO:0005634; GO:0008270; GO:0016787; GO:0043139,recombinational repair [GO:0000725],nucleus [GO:0005634],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07111,1.3955204998461803,FUN_032384-T1,Peve_00041789,Pocillopora_meandrina_HIv1___RNAseq.g24371.t1,three_way,71.52466666666666,FUN_032384-T1,Q92113,,,,,35.0,472.0,2.7e-81,304.3,"sp|Q92113|CP17A_SQUAC Steroid 17-alpha-hydroxylase/17,20 lyase OS=Squalus acanthias OX=7797 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_07113,1.6401949104771936,FUN_032386-T1,Peve_00032594,Pocillopora_meandrina_HIv1___RNAseq.g29750.t1,three_way,46.69566666666667,FUN_032386-T1,Q5ZI22,NUP42_CHICK,,Nucleoporin NUP42 (Nucleoporin-like protein 2),Gallus gallus (Chicken),28.6,259.0,9.2e-15,82.8,sp|Q5ZI22|NUP42_CHICK Nucleoporin NUP42 OS=Gallus gallus OX=9031 GN=NUP42 PE=2 SV=1,GO:0005049; GO:0005643; GO:0008270; GO:0015031; GO:0031965; GO:0051028,mRNA transport [GO:0051028]; protein transport [GO:0015031],nuclear membrane [GO:0031965]; nuclear pore [GO:0005643],nuclear export signal receptor activity [GO:0005049]; zinc ion binding [GO:0008270],GO:0140104,molecular carrier activity
OG_07122,1.3579579114592848,FUN_032421-T1,Peve_00009160,Pocillopora_meandrina_HIv1___RNAseq.g29847.t1,three_way,76.65833333333333,FUN_032421-T1,Q6DEY1,,,,,33.8,240.0,8.100000000000001e-28,125.6,sp|Q6DEY1|SPF30_XENTR Survival of motor neuron-related-splicing factor 30 OS=Xenopus tropicalis OX=8364 GN=smndc1 PE=2 SV=1,,,,,,
OG_07123,2.619230789383939,FUN_032422-T1,Peve_00009161,Pocillopora_meandrina_HIv1___RNAseq.g21126.t1,three_way,56.91133333333333,,,,,,,,,,,,,,,,,
OG_07124,2.9538963649486685,FUN_032423-T1,Peve_00009162,Pocillopora_meandrina_HIv1___RNAseq.g29841.t1,three_way,74.066,FUN_032423-T1,Q8N3Y7,RDHE2_HUMAN,,Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5),Homo sapiens (Human),43.0,284.0,2.1e-62,240.7,sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2,GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297,"keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]",chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005811; GO:0006325; GO:0006355; GO:0006629; GO:0016491; GO:0043226; GO:0060090; GO:0140110,catalytic activity; nucleus; lipid droplet; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; oxidoreductase activity; organelle; molecular adaptor activity; transcription regulator activity
OG_07125,1.7647968072058144,FUN_032425-T1,Peve_00007852,Pocillopora_meandrina_HIv1___RNAseq.g29732.t1,three_way,72.82133333333334,FUN_032425-T1,Q90YB1,,,,,48.1,909.0,1.2000000000000002e-246,854.4,sp|Q90YB1|DNLI4_CHICK DNA ligase 4 OS=Gallus gallus OX=9031 GN=LIG4 PE=2 SV=2,,,,,,
OG_07130,1.213770600595574,FUN_032431-T1,Peve_00038720,Pocillopora_meandrina_HIv1___TS.g12074.t1,three_way,81.645,FUN_032431-T1,Q61749,,,,,59.4,377.0,9.999999999999999e-116,418.7,sp|Q61749|EI2BD_MOUSE Translation initiation factor eIF2B subunit delta OS=Mus musculus OX=10090 GN=Eif2b4 PE=1 SV=2,,,,,,
OG_07131,1.909980042274726,FUN_032432-T1,Peve_00038723,Pocillopora_meandrina_HIv1___RNAseq.g24125.t1,three_way,82.28133333333334,FUN_032432-T1,Q7ZWG6,PCFT_DANRE,,Proton-coupled folate transporter (Solute carrier family 46 member 1),Danio rerio (Zebrafish) (Brachydanio rerio),32.3,431.0,5.6e-52,206.8,sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1,GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085,transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_07132,3.006313565906252,FUN_032433-T1,Peve_00038721,Pocillopora_meandrina_HIv1___RNAseq.g20796.t1b,three_way,50.24216666666667,FUN_032433-T1,Q12789,TF3C1_HUMAN,,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),Homo sapiens (Human),25.0,1605.0,2.7e-101,372.9,sp|Q12789|TF3C1_HUMAN General transcription factor 3C polypeptide 1 OS=Homo sapiens OX=9606 GN=GTF3C1 PE=1 SV=4,GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904,5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797],membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127],DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995],GO:0003677; GO:0005654; GO:0005730; GO:0006351; GO:0006399; GO:0043226; GO:0140223,DNA binding; nucleoplasm; nucleolus; DNA-templated transcription; tRNA metabolic process; organelle; general transcription initiation factor activity
OG_07138,3.51346787090541,FUN_032464-T1,Peve_00009180,Pocillopora_meandrina_HIv1___TS.g12111.t1,three_way,65.44783333333334,FUN_032464-T1,E1BB03,ZRAB3_BOVIN,,DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)],Bos taurus (Bovine),45.5,521.0,7.4999999999999995e-115,416.0,sp|E1BB03|ZRAB3_BOVIN DNA annealing helicase and endonuclease ZRANB3 OS=Bos taurus OX=9913 GN=ZRANB3 PE=3 SV=3,GO:0004386; GO:0004520; GO:0005524; GO:0006281; GO:0006974; GO:0008270; GO:0009411; GO:0031297; GO:0036310; GO:0043596; GO:0070530,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; replication fork processing [GO:0031297]; response to UV [GO:0009411],nuclear replication fork [GO:0043596],ATP binding [GO:0005524]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA endonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0006281; GO:0016853; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA repair; isomerase activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07139,1.407087183978578,FUN_032467-T1,Peve_00009179,Pocillopora_meandrina_HIv1___RNAseq.g24169.t1,three_way,67.812,,,,,,,,,,,,,,,,,
OG_07143,1.087752657752138,FUN_032471-T1,Peve_00009175,Pocillopora_meandrina_HIv1___RNAseq.g24174.t1,three_way,40.74066666666667,,,,,,,,,,,,,,,,,
OG_07145,2.120110025511346,FUN_032477-T1,Peve_00041760,Pocillopora_meandrina_HIv1___RNAseq.g24343.t1,three_way,81.312,FUN_032477-T1,Q6DGE9,UN45B_DANRE,,Protein unc-45 homolog B (Unc-45B) (UNC45-related protein),Danio rerio (Zebrafish) (Brachydanio rerio),36.6,929.0,1.9e-165,584.7,sp|Q6DGE9|UN45B_DANRE Protein unc-45 homolog B OS=Danio rerio OX=7955 GN=unc45b PE=1 SV=2,GO:0002088; GO:0005737; GO:0007519; GO:0030018; GO:0030239; GO:0031672; GO:0048471; GO:0048738; GO:0051879; GO:0055001; GO:0055002; GO:0060538; GO:0061077,cardiac muscle tissue development [GO:0048738]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle cell development [GO:0055001]; myofibril assembly [GO:0030239]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue development [GO:0007519]; striated muscle cell development [GO:0055002],A band [GO:0031672]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018],Hsp90 protein binding [GO:0051879],GO:0007010; GO:0048856,cytoskeleton organization; anatomical structure development
OG_07147,1.364257847258033,FUN_032482-T1,Peve_00045320,Pocillopora_meandrina_HIv1___RNAseq.g24339.t1,three_way,75.098,FUN_032482-T1,Q866A2,,,,,39.7,312.0,4.7e-52,206.5,sp|Q866A2|ACHA7_MACMU Neuronal acetylcholine receptor subunit alpha-7 OS=Macaca mulatta OX=9544 GN=CHRNA7 PE=2 SV=1,,,,,,
OG_07149,1.1289468363611186,FUN_032502-T1,Peve_00042406,Pocillopora_meandrina_HIv1___RNAseq.g24323.t1,three_way,42.0895,,,,,,,,,,,,,,,,,
OG_07153,1.582722781880945,FUN_032526-T1,Peve_00000682,Pocillopora_meandrina_HIv1___RNAseq.g24734.t1,three_way,53.52583333333333,,,,,,,,,,,,,,,,,
OG_07154,2.9345921117508222,FUN_032533-T1,Peve_00000693,Pocillopora_meandrina_HIv1___RNAseq.g24729.t1,three_way,83.166,FUN_032533-T1,Q55CD9,,,,,47.7,413.0,1.2e-101,371.7,sp|Q55CD9|NDH_DICDI Probable NADH dehydrogenase OS=Dictyostelium discoideum OX=44689 GN=DDB_G0270104 PE=3 SV=2,,,,,,
OG_07155,1.094773268788118,FUN_032535-T1,Peve_00000696,Pocillopora_meandrina_HIv1___RNAseq.g24726.t1,three_way,79.178,FUN_032535-T1,Q8K4L0,,,,,50.9,807.0,2.500000000000001e-201,703.7,sp|Q8K4L0|DDX54_MOUSE ATP-dependent RNA helicase DDX54 OS=Mus musculus OX=10090 GN=Ddx54 PE=1 SV=1,,,,,,
OG_07159,2.540350186982871,FUN_032569-T1,Peve_00000700,Pocillopora_meandrina_HIv1___RNAseq.g24716.t1a,three_way,75.09,FUN_032569-T1,Q5FWL4,EST2A_XENLA,,Extended synaptotagmin-2-A (E-Syt2-A),Xenopus laevis (African clawed frog),28.4,855.0,1.4000000000000001e-89,332.4,sp|Q5FWL4|EST2A_XENLA Extended synaptotagmin-2-A OS=Xenopus laevis OX=8355 GN=esyt2-a PE=2 SV=1,GO:0005509; GO:0005544; GO:0005789; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0044232; GO:0061817; GO:0140268,endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091],GO:0008289; GO:0016192,lipid binding; vesicle-mediated transport
OG_07161,3.9253527466999234,FUN_032573-T1,Peve_00020057,Pocillopora_meandrina_HIv1___RNAseq.g24657.t1,three_way,46.22766666666666,FUN_032573-T1,Q90876,,,,,34.0,153.0,5.600000000000001e-23,109.4,sp|Q90876|IRF1_CHICK Interferon regulatory factor 1 OS=Gallus gallus OX=9031 GN=IRF1 PE=2 SV=1,,,,,,
OG_07165,2.962726807764342,FUN_032583-T1,Peve_00026847,Pocillopora_meandrina_HIv1___RNAseq.g24648.t1,three_way,42.123333333333335,,,,,,,,,,,,,,,,,
OG_07166,2.7251856198915667,FUN_032584-T1,Peve_00024132,Pocillopora_meandrina_HIv1___TS.g12593.t1,three_way,79.44666666666666,FUN_032584-T1,A3KPN8,,,,,50.9,456.0,4.1e-137,489.6,sp|A3KPN8|TTC38_DANRE Tetratricopeptide repeat protein 38 OS=Danio rerio OX=7955 GN=ttc38 PE=3 SV=1,,,,,,
OG_07167,3.091773646588094,FUN_032602-T1,Peve_00001527,Pocillopora_meandrina_HIv1___RNAseq.g24628.t1,three_way,85.47983333333333,FUN_032602-T1,Q9Y2J2,E41L3_HUMAN,,"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]",Homo sapiens (Human),51.7,348.0,4e-95,349.7,sp|Q9Y2J2|E41L3_HUMAN Band 4.1-like protein 3 OS=Homo sapiens OX=9606 GN=EPB41L3 PE=1 SV=2,GO:0002175; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005929; GO:0006915; GO:0008360; GO:0030054; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0036064; GO:0043217; GO:0044224; GO:0048812; GO:0071205; GO:0072659; GO:0098696; GO:0098794; GO:0098978; GO:0106006,actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696],cell junction [GO:0030054]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],actin binding [GO:0003779]; cytoskeletal protein-membrane anchor activity [GO:0106006]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007010; GO:0008092; GO:0012501; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659,structural molecule activity; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeleton organization; cytoskeletal protein binding; programmed cell death; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane
OG_07168,1.5792190849087493,FUN_032603-T1,Peve_00001522,Pocillopora_meandrina_HIv1___RNAseq.g24627.t1,three_way,61.717666666666666,FUN_032603-T1,Q8NFZ3,,,,,34.2,588.0,2.8e-77,291.2,"sp|Q8NFZ3|NLGNY_HUMAN Neuroligin-4, Y-linked OS=Homo sapiens OX=9606 GN=NLGN4Y PE=1 SV=1",,,,,,
OG_07170,1.8887516900152723,FUN_032605-T1,Peve_00028661,Pocillopora_meandrina_HIv1___RNAseq.g24618.t1,three_way,77.81633333333333,FUN_032605-T1,Q13535,,,,,40.7,2731.0,0.0,1912.9,sp|Q13535|ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens OX=9606 GN=ATR PE=1 SV=3,,,,,,
OG_07172,1.1937721168934696,FUN_032609-T1,Peve_00030642,Pocillopora_meandrina_HIv1___RNAseq.g29786.t1,three_way,72.363,FUN_032609-T1,P52272,HNRPM_HUMAN,,Heterogeneous nuclear ribonucleoprotein M (hnRNP M),Homo sapiens (Human),36.5,255.0,1e-34,149.4,sp|P52272|HNRPM_HUMAN Heterogeneous nuclear ribonucleoprotein M OS=Homo sapiens OX=9606 GN=HNRNPM PE=1 SV=3,GO:0000380; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0016020; GO:0016363; GO:0019904; GO:0042382; GO:0045202; GO:0062023; GO:0070062; GO:0071013,"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; spliceosomal complex [GO:0005681]; synapse [GO:0045202],mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; nucleolus; mRNA metabolic process; organelle
OG_07173,2.84994778928983,FUN_032611-T1,Peve_00026810,Pocillopora_meandrina_HIv1___RNAseq.g29794.t1,three_way,66.65333333333334,FUN_032611-T1,P23359,BMP7_MOUSE,,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1),Mus musculus (Mouse),42.2,393.0,4.2e-78,293.5,sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2,GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0036305; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312,allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; vesicle [GO:0031982],BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005615; GO:0006355; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell adhesion; programmed cell death; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_07179,2.538795502536415,FUN_032632-T1,Peve_00033689,Pocillopora_meandrina_HIv1___RNAseq.g24117.t1,three_way,60.99433333333333,FUN_032632-T1,Q5ZIJ9,,,,,45.3,1029.0,1.5e-112,409.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_07183,2.4007076188234397,FUN_032641-T1,Peve_00015953,Pocillopora_meandrina_HIv1___RNAseq.g24113.t1,three_way,69.64766666666667,FUN_032641-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),31.4,2239.0,9.5e-255,882.9,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_07186,1.568644770678084,FUN_032677-T1,Peve_00015961,Pocillopora_meandrina_HIv1___RNAseq.g24111.t1,three_way,50.2185,FUN_032677-T1,Q9D361,,,,,41.7,151.0,6.1e-15,83.6,sp|Q9D361|SNR48_MOUSE U11/U12 small nuclear ribonucleoprotein 48 kDa protein OS=Mus musculus OX=10090 GN=Snrnp48 PE=2 SV=2,,,,,,
OG_07188,1.059842303799449,FUN_032679-T1,Peve_00015963,Pocillopora_meandrina_HIv1___RNAseq.g24109.t1,three_way,79.57666666666667,FUN_032679-T1,A4L9J0,MIP_RABIT,,Lens fiber major intrinsic protein (Aquaporin-0),Oryctolagus cuniculus (Rabbit),39.3,229.0,3.4e-33,143.7,sp|A4L9J0|MIP_RABIT Lens fiber major intrinsic protein OS=Oryctolagus cuniculus OX=9986 GN=MIP PE=2 SV=1,GO:0002088; GO:0005212; GO:0005516; GO:0005886; GO:0006833; GO:0007601; GO:0015250; GO:0016324; GO:0034109; GO:0036438; GO:0070161; GO:0098631; GO:1990349,gap junction-mediated intercellular transport [GO:1990349]; homotypic cell-cell adhesion [GO:0034109]; lens development in camera-type eye [GO:0002088]; maintenance of lens transparency [GO:0036438]; visual perception [GO:0007601]; water transport [GO:0006833],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],calmodulin binding [GO:0005516]; cell adhesion mediator activity [GO:0098631]; structural constituent of eye lens [GO:0005212]; water channel activity [GO:0015250],GO:0005198; GO:0005215; GO:0005886; GO:0007155; GO:0048856; GO:0050877; GO:0098631,structural molecule activity; transporter activity; plasma membrane; cell adhesion; anatomical structure development; nervous system process; cell adhesion mediator activity
OG_07189,1.3337130448693877,FUN_032681-T1,Peve_00015965,Pocillopora_meandrina_HIv1___TS.g12051.t1,three_way,86.97266666666667,FUN_032681-T1,Q9VQX4,,,,,62.7,542.0,8.799999999999999e-200,698.0,sp|Q9VQX4|PNCB_DROME Nicotinate phosphoribosyltransferase OS=Drosophila melanogaster OX=7227 GN=Naprt PE=2 SV=2,,,,,,
OG_07190,1.869098296259177,FUN_032683-T1,Peve_00015966,Pocillopora_meandrina_HIv1___RNAseq.g24105.t1,three_way,78.53933333333333,FUN_032683-T1,P38060,HMGCL_MOUSE,,"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)",Mus musculus (Mouse),71.4,105.0,2.3e-38,159.5,"sp|P38060|HMGCL_MOUSE Hydroxymethylglutaryl-CoA lyase, mitochondrial OS=Mus musculus OX=10090 GN=Hmgcl PE=1 SV=2",GO:0000287; GO:0004419; GO:0005198; GO:0005739; GO:0005743; GO:0005759; GO:0005777; GO:0007005; GO:0030145; GO:0032991; GO:0046872; GO:0046951,ketone body biosynthetic process [GO:0046951]; mitochondrion organization [GO:0007005],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198],GO:0003824; GO:0005198; GO:0005739; GO:0005777; GO:0006091; GO:0006629; GO:0007005; GO:0016829; GO:0043226,catalytic activity; structural molecule activity; mitochondrion; peroxisome; generation of precursor metabolites and energy; lipid metabolic process; mitochondrion organization; lyase activity; organelle
OG_07193,1.48835179847253,FUN_032691-T1,Peve_00032993,Pocillopora_meandrina_HIv1___TS.g12044.t1,three_way,49.66816666666666,,,,,,,,,,,,,,,,,
OG_07195,1.4848731748523076,FUN_032699-T1,Peve_00006288,Pocillopora_meandrina_HIv1___RNAseq.g29941.t1,three_way,87.00933333333333,FUN_032699-T1,Q8CJG0,AGO2_MOUSE,,Protein argonaute-2 (Argonaute2) (mAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Piwi/argonaute family protein meIF2C2) (Protein slicer),Mus musculus (Mouse),68.1,846.0,0.0,1192.9,sp|Q8CJG0|AGO2_MOUSE Protein argonaute-2 OS=Mus musculus OX=10090 GN=Ago2 PE=1 SV=3,GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0009791; GO:0010467; GO:0010586; GO:0010628; GO:0016442; GO:0030154; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0033962; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035925; GO:0043489; GO:0045727; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0090128; GO:0090624; GO:0090625; GO:0098794; GO:0098808; GO:0098978; GO:1900153; GO:1901165; GO:1990904,"cell differentiation [GO:0030154]; gene expression [GO:0010467]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of translational initiation [GO:0045947]; P-body assembly [GO:0033962]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of synapse maturation [GO:0090128]; regulatory ncRNA-mediated gene silencing [GO:0031047]; RISC complex assembly [GO:0070922]; RNA stabilization [GO:0043489]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578],"core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016787; GO:0030154; GO:0031047; GO:0043226; GO:0065003; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; protein-containing complex assembly; catalytic activity, acting on RNA"
OG_07198,1.3241650460475662,FUN_032706-T1,Peve_00029923,Pocillopora_meandrina_HIv1___RNAseq.g29870.t1,three_way,82.68833333333333,FUN_032706-T1,Q63ZI0,,,,,51.8,257.0,2.8e-65,250.4,sp|Q63ZI0|KCNK9_XENLA Potassium channel subfamily K member 9 OS=Xenopus laevis OX=8355 GN=kcnk9 PE=2 SV=1,,,,,,
OG_07199,2.0478479430122984,FUN_032708-T1,Peve_00029922,Pocillopora_meandrina_HIv1___RNAseq.g29872.t1,three_way,49.76916666666667,,,,,,,,,,,,,,,,,
OG_07201,1.279100184586955,FUN_032734-T1,Peve_00029920,Pocillopora_meandrina_HIv1___RNAseq.g29874.t1,three_way,43.718,,,,,,,,,,,,,,,,,
OG_07202,1.865973587959161,FUN_032737-T1,Peve_00029919,Pocillopora_meandrina_HIv1___RNAseq.g29875.t1,three_way,74.34933333333333,FUN_032737-T1,A7SPE8,,,,,41.0,117.0,3.5e-17,89.4,sp|A7SPE8|BL1S5_NEMVE Biogenesis of lysosome-related organelles complex 1 subunit 5 OS=Nematostella vectensis OX=45351 GN=bloc1s5 PE=3 SV=1,,,,,,
OG_07203,3.961988849772738,FUN_032738-T1,Peve_00029918,Pocillopora_meandrina_HIv1___RNAseq.g29876.t1,three_way,86.90433333333334,FUN_032738-T1,P49739,,,,,65.5,823.0,6e-285,981.5,sp|P49739|MCM3M_XENLA Maternal DNA replication licensing factor mcm3 OS=Xenopus laevis OX=8355 GN=mmcm3 PE=1 SV=2,,,,,,
OG_07205,2.724726142939534,FUN_032745-T1,Peve_00029929,Pocillopora_meandrina_HIv1___RNAseq.g29880.t1,three_way,55.068333333333335,FUN_032745-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),29.8,540.0,7.7e-54,213.8,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_07207,1.293368395207378,FUN_032750-T1,Peve_00029924,Pocillopora_meandrina_HIv1___RNAseq.g29869.t1,three_way,91.93033333333334,FUN_032750-T1,Q91YR7,PRP6_MOUSE,,Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein),Mus musculus (Mouse),75.3,938.0,1.4e-200,701.4,sp|Q91YR7|PRP6_MOUSE Pre-mRNA-processing factor 6 OS=Mus musculus OX=10090 GN=Prpf6 PE=1 SV=1,GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005682; GO:0005813; GO:0005829; GO:0006403; GO:0016607; GO:0030674; GO:0036064; GO:0042802; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0005634; GO:0005815; GO:0005829; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0065003; GO:0140110,RNA binding; nucleus; microtubule organizing center; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_07208,1.1207713905111791,FUN_032751-T1,Peve_00029925,Pocillopora_meandrina_HIv1___RNAseq.g29868.t1,three_way,43.476333333333336,,,,,,,,,,,,,,,,,
OG_07209,1.6804609417629102,FUN_032752-T2,Peve_00023813,Pocillopora_meandrina_HIv1___TS.g25116.t1,three_way,46.43383333333333,FUN_032752-T2,F1R983,,,,,50.5,97.0,2.5e-19,99.0,sp|F1R983|CTIP_DANRE DNA endonuclease RBBP8 OS=Danio rerio OX=7955 GN=rbbp8 PE=2 SV=1,,,,,,
OG_07211,2.244270404209933,FUN_032755-T1,Peve_00023820,Pocillopora_meandrina_HIv1___RNAseq.g29864.t1,three_way,82.49766666666667,FUN_032755-T1,Q62825,,,,,43.2,750.0,3.3e-160,567.0,sp|Q62825|EXOC3_RAT Exocyst complex component 3 OS=Rattus norvegicus OX=10116 GN=Exoc3 PE=1 SV=1,,,,,,
OG_07212,1.229502863702595,FUN_032760-T1,Peve_00023814,Pocillopora_meandrina_HIv1___RNAseq.g29862.t1,three_way,41.60766666666667,,,,,,,,,,,,,,,,,
OG_07215,2.779968049576959,FUN_032774-T1,Peve_00010354,Pocillopora_meandrina_HIv1___RNAseq.g29728.t1,three_way,61.269333333333336,,,,,,,,,,,,,,,,,
OG_07216,1.4694659002994164,FUN_032781-T1,Peve_00010377,Pocillopora_meandrina_HIv1___RNAseq.g29726.t1,three_way,78.02833333333334,FUN_032781-T1,Q6Y1H2,HACD2_HUMAN,,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B),Homo sapiens (Human),56.5,207.0,3.5e-67,256.1,sp|Q6Y1H2|HACD2_HUMAN Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 OS=Homo sapiens OX=9606 GN=HACD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0018812; GO:0019899; GO:0030148; GO:0030497; GO:0035338; GO:0042761; GO:0102158,fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity [GO:0102158],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016829; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; lyase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07218,3.653682119437165,FUN_032790-T1,Peve_00010373,Pocillopora_meandrina_HIv1___RNAseq.g29721.t1,three_way,55.391333333333336,FUN_032790-T1,Q68LP1,MIB2_RAT,,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Rattus norvegicus (Rat),38.8,456.0,1.5999999999999999e-83,312.8,sp|Q68LP1|MIB2_RAT E3 ubiquitin-protein ligase MIB2 OS=Rattus norvegicus OX=10116 GN=Mib2 PE=1 SV=2,GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005886; GO:0007219; GO:0008270; GO:0016567; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation protein catabolic process at postsynapse [GO:0140252],cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005886; GO:0008092; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; plasma membrane; cytoskeletal protein binding; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07221,1.5956595218143133,FUN_032814-T1,Peve_00014511,Pocillopora_meandrina_HIv1___RNAseq.g29708.t1,three_way,72.67099999999999,FUN_032814-T1,A7SCH8,KYNU_NEMVE,,Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase),Nematostella vectensis (Starlet sea anemone),58.9,472.0,1.2e-166,587.8,sp|A7SCH8|KYNU_NEMVE Kynureninase OS=Nematostella vectensis OX=45351 GN=kynu PE=3 SV=1,GO:0005737; GO:0019441; GO:0019805; GO:0030170; GO:0030429; GO:0034354; GO:0043420; GO:0097053,'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; L-tryptophan catabolic process to kynurenine [GO:0019441]; quinolinate biosynthetic process [GO:0019805],cytoplasm [GO:0005737],kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0006520; GO:0016787; GO:0055086,catalytic activity; amino acid metabolic process; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_07223,1.4856764912979636,FUN_032817-T1,Peve_00014521,Pocillopora_meandrina_HIv1___RNAseq.g29683.t2,three_way,71.64333333333333,FUN_032817-T1,Q8K0Q5,,,,,40.2,540.0,1.3e-92,342.4,sp|Q8K0Q5|RHG18_MOUSE Rho GTPase-activating protein 18 OS=Mus musculus OX=10090 GN=Arhgap18 PE=1 SV=1,,,,,,
OG_07228,1.1857050010847303,FUN_032874-T1,Peve_00014576,Pocillopora_meandrina_HIv1___RNAseq.g29697.t1,three_way,84.13433333333333,FUN_032874-T1,Q9H3K2,GHITM_HUMAN,,Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5),Homo sapiens (Human),50.6,265.0,1.6000000000000001e-74,281.2,sp|Q9H3K2|GHITM_HUMAN Growth hormone-inducible transmembrane protein OS=Homo sapiens OX=9606 GN=GHITM PE=1 SV=2,GO:0005262; GO:0005739; GO:0005743; GO:0005789; GO:0006816; GO:0006851; GO:0006915; GO:0007007; GO:0015369; GO:0031966; GO:0070062; GO:0090201; GO:0099093; GO:0140141; GO:1905448,apoptotic process [GO:0006915]; calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial potassium ion transmembrane transport [GO:0140141]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448],endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],calcium channel activity [GO:0005262]; calcium:proton antiporter activity [GO:0015369],GO:0005215; GO:0005739; GO:0007005; GO:0012501; GO:0043226; GO:0055085; GO:0061024,transporter activity; mitochondrion; mitochondrion organization; programmed cell death; organelle; transmembrane transport; membrane organization
OG_07229,1.6508519886740085,FUN_032885-T1,Peve_00001722,Pocillopora_meandrina_HIv1___RNAseq.g29858.t1,three_way,52.5095,,,,,,,,,,,,,,,,,
OG_07231,1.557924396007262,FUN_032904-T2,Peve_00014527,Pocillopora_meandrina_HIv1___RNAseq.g24993.t1,three_way,55.487,,,,,,,,,,,,,,,,,
OG_07232,1.3499468836821171,FUN_032905-T1,Peve_00014528,Pocillopora_meandrina_HIv1___RNAseq.g24990.t2,three_way,70.00566666666667,,,,,,,,,,,,,,,,,
OG_07234,1.3552831025456298,FUN_032907-T1,Peve_00014530,Pocillopora_meandrina_HIv1___RNAseq.g24992.t1,three_way,79.497,FUN_032907-T1,Q5PQ53,PEF1_XENLA,,Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1),Xenopus laevis (African clawed frog),49.1,165.0,3.699999999999999e-43,176.4,sp|Q5PQ53|PEF1_XENLA Peflin OS=Xenopus laevis OX=8355 GN=pef1 PE=1 SV=1,GO:0005509; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0031463; GO:0048208; GO:0048306; GO:1902527; GO:1990756,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527],COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; endoplasmic reticulum [GO:0005783],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0065003,endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_07235,2.42179741734709,FUN_032908-T1,Peve_00014533,Pocillopora_meandrina_HIv1___RNAseq.g24988.t1,three_way,75.6895,FUN_032908-T1,Q9JKP8,,,,,42.9,105.0,2.1e-16,86.7,sp|Q9JKP8|CHRC1_MOUSE Chromatin accessibility complex protein 1 OS=Mus musculus OX=10090 GN=Chrac1 PE=1 SV=1,,,,,,
OG_07236,2.5054169519895653,FUN_032909-T1,Peve_00014534,Pocillopora_meandrina_HIv1___TS.g12926.t1,three_way,60.93333333333333,,,,,,,,,,,,,,,,,
OG_07238,2.8224676383590706,FUN_032958-T1,Peve_00014537,Pocillopora_meandrina_HIv1___RNAseq.g24985.t1,three_way,92.142,FUN_032958-T1,Q16204,CCDC6_HUMAN,,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),Homo sapiens (Human),66.4,369.0,7.5e-39,162.9,sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2,GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802,,cytoskeleton [GO:0005856]; cytosol [GO:0005829],identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005829; GO:0005856; GO:0043226,structural molecule activity; cytosol; cytoskeleton; organelle
OG_07239,1.285910471121611,FUN_032960-T1,Peve_00015577,Pocillopora_meandrina_HIv1___RNAseq.g24902.t1,three_way,69.48333333333333,FUN_032960-T1,P07099,HYEP_HUMAN,,Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH),Homo sapiens (Human),46.5,428.0,8.2e-106,385.6,sp|P07099|HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens OX=9606 GN=EPHX1 PE=1 SV=1,GO:0004301; GO:0005789; GO:0006805; GO:0008142; GO:0009636; GO:0019369; GO:0033961; GO:0097176; GO:0120253,arachidonate metabolic process [GO:0019369]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142],GO:0003824; GO:0006629; GO:0008289; GO:0016787,catalytic activity; lipid metabolic process; lipid binding; hydrolase activity
OG_07241,2.933242603823258,FUN_032971-T1,Peve_00017817,Pocillopora_meandrina_HIv1___RNAseq.g29687.t1,three_way,75.51633333333334,FUN_032971-T1,Q8IX29,,,,,52.3,214.0,1.3e-58,228.4,sp|Q8IX29|FBX16_HUMAN F-box only protein 16 OS=Homo sapiens OX=9606 GN=FBXO16 PE=1 SV=1,,,,,,
OG_07242,1.3222645335393244,FUN_032972-T1,Peve_00017816,Pocillopora_meandrina_HIv1___TS.g24940.t1,three_way,69.297,FUN_032972-T1,Q680A5,,,,,48.4,335.0,1.9e-86,320.9,sp|Q680A5|KPRS4_ARATH Ribose-phosphate pyrophosphokinase 4 OS=Arabidopsis thaliana OX=3702 GN=PRS4 PE=1 SV=2,,,,,,
OG_07243,2.197887135976638,FUN_032973-T1,Peve_00015586,Pocillopora_meandrina_HIv1___RNAseq.g29689.t1,three_way,85.39766666666667,FUN_032973-T1,Q4QRK0,MAP11_DANRE,,Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1),Danio rerio (Zebrafish) (Brachydanio rerio),68.7,380.0,8.099999999999999e-160,564.7,sp|Q4QRK0|MAP11_DANRE Methionine aminopeptidase 1 OS=Danio rerio OX=7955 GN=metap1 PE=2 SV=2,GO:0004239; GO:0005829; GO:0006882; GO:0008270; GO:0016485; GO:0022626; GO:0070006,intracellular zinc ion homeostasis [GO:0006882]; protein processing [GO:0016485],cytosol [GO:0005829]; cytosolic ribosome [GO:0022626],initiator methionyl aminopeptidase activity [GO:0004239]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005840; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; cytosol; ribosome; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_07247,1.9822715313746064,FUN_032981-T1,Peve_00014553,Pocillopora_meandrina_HIv1___RNAseq.g24984.t1,three_way,51.269666666666666,FUN_032981-T1,Q7TT16,,,,,35.3,232.0,9.900000000000001e-28,125.6,sp|Q7TT16|IPMK_MOUSE Inositol polyphosphate multikinase OS=Mus musculus OX=10090 GN=Ipmk PE=1 SV=1,,,,,,
OG_07248,1.7061407860238698,FUN_032987-T2,Peve_00014549,Pocillopora_meandrina_HIv1___RNAseq.g24997.t1,three_way,40.58166666666667,,,,,,,,,,,,,,,,,
OG_07256,1.1823647566814457,FUN_033023-T1,Peve_00017506,Pocillopora_meandrina_HIv1___RNAseq.g24455.t1,three_way,46.03516666666667,FUN_033023-T1,Q0P4I1,,,,,32.3,235.0,4.2e-23,111.3,sp|Q0P4I1|CEP44_XENTR Centrosomal protein of 44 kDa OS=Xenopus tropicalis OX=8364 GN=cep44 PE=2 SV=1,,,,,,
OG_07258,2.41259265029592,FUN_033035-T1,Peve_00017503,Pocillopora_meandrina_HIv1___RNAseq.g24452.t1,three_way,61.70483333333333,,,,,,,,,,,,,,,,,
OG_07259,2.283944185195665,FUN_033036-T1,Peve_00017502,Pocillopora_meandrina_HIv1___RNAseq.g24450.t1,three_way,76.906,FUN_033036-T1,Q96QG7,,,,,53.2,329.0,2.6e-101,370.2,sp|Q96QG7|MTMR9_HUMAN Myotubularin-related protein 9 OS=Homo sapiens OX=9606 GN=MTMR9 PE=1 SV=1,,,,,,
OG_07261,1.432095175992006,FUN_033038-T1,Peve_00017501,Pocillopora_meandrina_HIv1___RNAseq.g24448.t1,three_way,84.66233333333334,FUN_033038-T1,Q5ZM55,,,,,46.0,624.0,7.899999999999999e-83,309.7,sp|Q5ZM55|FEM1B_CHICK Protein fem-1 homolog B OS=Gallus gallus OX=9031 GN=FEM1B PE=2 SV=1,,,,,,
OG_07262,2.56078414127271,FUN_033039-T1,Peve_00017500,Pocillopora_meandrina_HIv1___RNAseq.g24445.t1,three_way,64.32033333333334,FUN_033039-T1,O94766,,,,,45.2,303.0,1.9e-65,251.1,sp|O94766|B3GA3_HUMAN Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 OS=Homo sapiens OX=9606 GN=B3GAT3 PE=1 SV=2,,,,,,
OG_07266,3.095049275044944,FUN_033114-T1,Peve_00019518,Pocillopora_meandrina_HIv1___RNAseq.g24261.t1,three_way,54.964666666666666,FUN_033114-T1,Q1EG27,MYO3B_MOUSE,,Myosin-IIIb (EC 2.7.11.1),Mus musculus (Mouse),33.6,769.0,3.6e-116,421.4,sp|Q1EG27|MYO3B_MOUSE Myosin-IIIb OS=Mus musculus OX=10090 GN=Myo3b PE=1 SV=2,GO:0000146; GO:0001750; GO:0001917; GO:0003779; GO:0004674; GO:0005524; GO:0005829; GO:0007601; GO:0007605; GO:0016459; GO:0030832; GO:0032426; GO:0032433; GO:0051491; GO:0060088; GO:0090103; GO:0106310,auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytosol [GO:0005829]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003774; GO:0003824; GO:0005829; GO:0008092; GO:0016740; GO:0016853; GO:0050877; GO:0140096; GO:0140657,"cytoskeletal motor activity; catalytic activity; cytosol; cytoskeletal protein binding; transferase activity; isomerase activity; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07268,2.382924885876736,FUN_033119-T1,Peve_00013204,Pocillopora_meandrina_HIv1___TS.g25013.t2,three_way,69.678,FUN_033119-T1,Q9R1R2,TRIM3_MOUSE,,Tripartite motif-containing protein 3 (EC 2.3.2.27) (RING finger protein 22) (RING finger protein HAC1),Mus musculus (Mouse),23.2,482.0,3.9e-23,111.7,sp|Q9R1R2|TRIM3_MOUSE Tripartite motif-containing protein 3 OS=Mus musculus OX=10090 GN=Trim3 PE=1 SV=1,GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0034141; GO:0042802; GO:0061351; GO:0061630; GO:0070534,neural precursor cell proliferation [GO:0061351]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein K63-linked ubiquitination [GO:0070534]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07269,1.3060062810968027,FUN_033125-T1,Peve_00043512,Pocillopora_meandrina_HIv1___RNAseq.g29766.t1,three_way,79.22233333333334,FUN_033125-T1,Q91616,,,,,56.5,62.0,8.7e-08,58.5,sp|Q91616|NDF1_XENLA Neurogenic differentiation factor 1 OS=Xenopus laevis OX=8355 GN=neurod1 PE=1 SV=1,,,,,,
OG_07272,1.5842014713951045,FUN_033210-T1,Peve_00043517,Pocillopora_meandrina_HIv1___RNAseq.g29763.t1,three_way,93.34833333333331,FUN_033210-T1,P63328,PP2BA_MOUSE,,Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform),Mus musculus (Mouse),80.6,407.0,2.1e-201,703.0,sp|P63328|PP2BA_MOUSE Protein phosphatase 3 catalytic subunit alpha OS=Mus musculus OX=10090 GN=Ppp3ca PE=1 SV=1,GO:0000082; GO:0004721; GO:0004723; GO:0005516; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008287; GO:0008544; GO:0009898; GO:0010613; GO:0010628; GO:0010629; GO:0014883; GO:0014898; GO:0019722; GO:0023057; GO:0030018; GO:0030216; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0042104; GO:0042383; GO:0043197; GO:0045669; GO:0045672; GO:0045807; GO:0045944; GO:0046872; GO:0046878; GO:0046983; GO:0048741; GO:0048813; GO:0050774; GO:0050804; GO:0051117; GO:0051592; GO:0060079; GO:0061006; GO:0070886; GO:0090193; GO:0097205; GO:0098685; GO:0098978; GO:0099170; GO:0110062; GO:1903244; GO:1905205; GO:1905665; GO:1905949,calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy in response to stress [GO:0014898]; dendrite morphogenesis [GO:0048813]; epidermis development [GO:0008544]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiotensin-activated signaling pathway [GO:0110062]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of signaling [GO:0023057]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of saliva secretion [GO:0046878]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; regulation of cell proliferation involved in kidney morphogenesis [GO:0061006]; renal filtration [GO:0097205]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883],calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein serine/threonine phosphatase complex [GO:0008287]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018],ATPase binding [GO:0051117]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein dimerization activity [GO:0046983],GO:0003012; GO:0003014; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"muscle system process; renal system process; catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07273,1.3001164526585935,FUN_033212-T1,Peve_00043513,Pocillopora_meandrina_HIv1___RNAseq.g29767.t1,three_way,73.36633333333333,FUN_033212-T1,Q99NA2,ATOH8_MOUSE,,Transcription factor Atoh8 (Helix-loop-helix protein mATH-6) (mATH6) (Okadin) (Protein atonal homolog 8),Mus musculus (Mouse),47.4,116.0,4.5e-17,89.4,sp|Q99NA2|ATOH8_MOUSE Transcription factor Atoh8 OS=Mus musculus OX=10090 GN=Atoh8 PE=1 SV=1,GO:0001704; GO:0001937; GO:0003700; GO:0005634; GO:0005737; GO:0007399; GO:0008134; GO:0010595; GO:0010629; GO:0016607; GO:0030154; GO:0035148; GO:0045603; GO:0045892; GO:0045893; GO:0046983; GO:0051450; GO:0060391; GO:0070888; GO:0140297; GO:1902895,cell differentiation [GO:0030154]; formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; tube formation [GO:0035148],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; transcription factor binding [GO:0008134],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07275,1.032032258235513,FUN_033214-T1,Peve_00009684,Pocillopora_meandrina_HIv1___RNAseq.g29769.t1,three_way,77.82566666666666,FUN_033214-T1,Q60715,P4HA1_MOUSE,,"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)",Mus musculus (Mouse),43.3,515.0,6.6e-123,442.6,sp|Q60715|P4HA1_MOUSE Prolyl 4-hydroxylase subunit alpha-1 OS=Mus musculus OX=10090 GN=P4ha1 PE=1 SV=2,GO:0004656; GO:0005506; GO:0005739; GO:0005788; GO:0016222; GO:0030199; GO:0031418; GO:0042802,collagen fibril organization [GO:0030199],endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222],identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656],GO:0003824; GO:0005739; GO:0016491; GO:0030198; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; oxidoreductase activity; extracellular matrix organization; organelle; catalytic activity, acting on a protein"
OG_07281,3.1532490880468087,FUN_033488-T1,Peve_00033737,Pocillopora_meandrina_HIv1___RNAseq.g12099.t1,three_way,71.806,FUN_033488-T1,Q60848,HELLS_MOUSE,,Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein),Mus musculus (Mouse),50.1,807.0,3.8e-200,699.9,sp|Q60848|HELLS_MOUSE Lymphocyte-specific helicase OS=Mus musculus OX=10090 GN=Hells PE=1 SV=2,GO:0000775; GO:0001655; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006338; GO:0006346; GO:0006915; GO:0016787; GO:0030098; GO:0031507; GO:0031508; GO:0043066; GO:0044027; GO:0046651; GO:0051301; GO:0141119; GO:1990830; GO:2001243,apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; heterochromatin formation [GO:0031507]; kidney development [GO:0001822]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin formation [GO:0031508]; urogenital system development [GO:0001655],"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]",ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787],GO:0002376; GO:0003824; GO:0005634; GO:0006325; GO:0012501; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0048856; GO:0140657,immune system process; catalytic activity; nucleus; chromatin organization; programmed cell death; hydrolase activity; isomerase activity; cell differentiation; organelle; anatomical structure development; ATP-dependent activity
OG_07282,1.947919023627384,FUN_033509-T1,Peve_00009172,Pocillopora_meandrina_HIv1___RNAseq.g24179.t1,three_way,62.28966666666666,FUN_033509-T1,P14942,GSTA4_RAT,,Glutathione S-transferase alpha-4 (EC 2.5.1.18) (GST 8-8) (GST A4-4) (GST K) (Glutathione S-transferase Yk) (GST Yk),Rattus norvegicus (Rat),30.8,211.0,1.5e-17,91.3,sp|P14942|GSTA4_RAT Glutathione S-transferase alpha-4 OS=Rattus norvegicus OX=10116 GN=Gsta4 PE=1 SV=2,GO:0004364; GO:0005739; GO:0005829; GO:0006749; GO:0006805; GO:0009635; GO:0010043; GO:0015643; GO:0035094; GO:0042802; GO:0042803; GO:0071285,cellular response to lithium ion [GO:0071285]; glutathione metabolic process [GO:0006749]; response to herbicide [GO:0009635]; response to nicotine [GO:0035094]; response to zinc ion [GO:0010043]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; mitochondrion [GO:0005739],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643],GO:0003824; GO:0005739; GO:0005829; GO:0006575; GO:0006790; GO:0016740; GO:0043226,catalytic activity; mitochondrion; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle
OG_07284,1.990321676771415,FUN_033608-T1,Peve_00041752,Pocillopora_meandrina_HIv1___RNAseq.g24385.t1,three_way,81.65133333333334,FUN_033608-T1,Q9QUR6,,,,,66.5,708.0,4.9e-299,1028.1,sp|Q9QUR6|PPCE_MOUSE Prolyl endopeptidase OS=Mus musculus OX=10090 GN=Prep PE=1 SV=1,,,,,,
OG_07285,1.0815659890315286,FUN_033611-T1,Peve_00007851,Pocillopora_meandrina_HIv1___TS.g24988.t1b,three_way,76.69316666666667,FUN_033611-T1,Q80TP3,UBR5_MOUSE,,"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog)",Mus musculus (Mouse),42.4,2918.0,0.0,1864.0,sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2,GO:0003723; GO:0005634; GO:0005737; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0043130; GO:0045879; GO:0048471; GO:0050847; GO:0061630; GO:0071596; GO:0071629; GO:0071630; GO:0140861; GO:0141198,cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of gene expression [GO:0010628]; progesterone receptor signaling pathway [GO:0050847]; protein branched polyubiquitination [GO:0141198]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_07291,1.6371715157604612,FUN_033672-T1,Peve_00037093,Pocillopora_meandrina_HIv1___RNAseq.g25923.t1,three_way,75.25266666666667,FUN_033672-T1,O05218,,,,,36.4,549.0,6.5e-89,329.7,sp|O05218|YWRD_BACSU Glutathione hydrolase-like YwrD proenzyme OS=Bacillus subtilis (strain 168) OX=224308 GN=ywrD PE=1 SV=1,,,,,,
OG_07293,2.873820685940686,FUN_033675-T1,Peve_00006808,Pocillopora_meandrina_HIv1___TS.g8603.t2,three_way,61.733,FUN_033675-T1,Q8R1N4,,,,,33.3,360.0,2.1e-53,211.1,sp|Q8R1N4|NUDC3_MOUSE NudC domain-containing protein 3 OS=Mus musculus OX=10090 GN=Nudcd3 PE=1 SV=3,,,,,,
OG_07299,1.0830909435635956,FUN_033684-T1,Peve_00042858,Pocillopora_meandrina_HIv1___RNAseq.g25847.t1,three_way,79.03466666666667,,,,,,,,,,,,,,,,,
OG_07302,1.089241211370136,FUN_033688-T1,Peve_00010874,Pocillopora_meandrina_HIv1___TS.g18604.t2,three_way,85.6255,,,,,,,,,,,,,,,,,
OG_07304,1.5354287741985917,FUN_033690-T1,Peve_00010870,Pocillopora_meandrina_HIv1___RNAseq.g25853.t1,three_way,71.70283333333333,,,,,,,,,,,,,,,,,
OG_07306,1.2219084125527626,FUN_033692-T1,Peve_00010864,Pocillopora_meandrina_HIv1___RNAseq.g25878.t1,three_way,73.286,FUN_033692-T1,P36366,,,,,26.0,520.0,6.599999999999997e-41,170.2,sp|P36366|FMO2_CAVPO Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Cavia porcellus OX=10141 GN=FMO2 PE=2 SV=2,,,,,,
OG_07307,1.10078146712577,FUN_033693-T1,Peve_00042850,Pocillopora_meandrina_HIv1___RNAseq.g25880.t1,three_way,93.79566666666668,FUN_033693-T1,Q5ZL16,WIPI3_CHICK,,WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45B),Gallus gallus (Chicken),78.4,342.0,5.4e-163,575.1,sp|Q5ZL16|WIPI3_CHICK WD repeat domain phosphoinositide-interacting protein 3 OS=Gallus gallus OX=9031 GN=WDR45B PE=2 SV=1,GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005764; GO:0005829; GO:0009267; GO:0030674; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0061723; GO:0080025,autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; pexophagy [GO:0000425]; protein localization to phagophore assembly site [GO:0034497],cytosol [GO:0005829]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-macromolecule adaptor activity [GO:0030674]",GO:0005764; GO:0005773; GO:0005829; GO:0005975; GO:0006091; GO:0006914; GO:0008289; GO:0043226; GO:0060090,lysosome; vacuole; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; autophagy; lipid binding; organelle; molecular adaptor activity
OG_07309,1.4501868760459895,FUN_033695-T1,Peve_00042861,Pocillopora_meandrina_HIv1___RNAseq.g25901.t1,three_way,82.69466666666666,FUN_033695-T1,Q8K4Y7,CANT1_RAT,,Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog),Rattus norvegicus (Rat),53.5,340.0,5.9e-103,375.9,sp|Q8K4Y7|CANT1_RAT Soluble calcium-activated nucleotidase 1 OS=Rattus norvegicus OX=10116 GN=Cant1 PE=1 SV=1,GO:0004382; GO:0005509; GO:0005789; GO:0016020; GO:0030166; GO:0032580; GO:0042803; GO:0043262; GO:0045134,proteoglycan biosynthetic process [GO:0030166],endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020],ADP phosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; GDP phosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; UDP phosphatase activity [GO:0045134],GO:0003824; GO:0009101; GO:0016787; GO:1901135,catalytic activity; glycoprotein biosynthetic process; hydrolase activity; carbohydrate derivative metabolic process
OG_07313,1.4124924011970557,FUN_033704-T1,Peve_00032797,Pocillopora_meandrina_HIv1___RNAseq.g3999.t1,three_way,55.599,FUN_033704-T1,A0A2B4RNI3,,,,,54.9,692.0,1e-200,701.4,sp|A0A2B4RNI3|CGLR2_STYPI Cyclic GMP-AMP synthase-like receptor 2 OS=Stylophora pistillata OX=50429 GN=cGLR2 PE=1 SV=1,,,,,,
OG_07318,3.1138593151437632,FUN_033711-T1,Peve_00014636,Pocillopora_meandrina_HIv1___RNAseq.g28838.t1,three_way,71.58500000000001,FUN_033711-T1,O00418,EF2K_HUMAN,,Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase),Homo sapiens (Human),45.3,695.0,2.2e-155,550.8,sp|O00418|EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens OX=9606 GN=EEF2K PE=1 SV=2,GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637,cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]",GO:0003824; GO:0005829; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07320,1.0077238845024394,FUN_033713-T1,Peve_00017867,Pocillopora_meandrina_HIv1___RNAseq.g28833.t1,three_way,70.459,FUN_033713-T1,A7E3W5,SNG2_BOVIN,,Synaptogyrin-2 (Cellugyrin),Bos taurus (Bovine),40.1,222.0,3.2e-39,163.3,sp|A7E3W5|SNG2_BOVIN Synaptogyrin-2 OS=Bos taurus OX=9913 GN=SYNGR2 PE=2 SV=1,GO:0030672; GO:0031594; GO:0045055; GO:0048499,regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499],neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672],,GO:0016192; GO:0061024,vesicle-mediated transport; membrane organization
OG_07322,1.7353613963171712,FUN_033715-T1,Peve_00017870,Pocillopora_meandrina_HIv1___RNAseq.g22319.t1,three_way,70.41133333333333,FUN_033715-T1,Q9ZNT0,VPS4_ARATH,,Protein SUPPRESSOR OF K(+) TRANSPORT GROWTH DEFECT 1 (AtSKD1) (EC 3.6.4.6) (Protein VACUOLAR PROTEIN SORTING 4),Arabidopsis thaliana (Mouse-ear cress),47.0,330.0,2.0000000000000003e-74,281.2,sp|Q9ZNT0|VPS4_ARATH Protein SUPPRESSOR OF K(+) TRANSPORT GROWTH DEFECT 1 OS=Arabidopsis thaliana OX=3702 GN=SKD1 PE=1 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005771; GO:0005777; GO:0007032; GO:0007033; GO:0009506; GO:0010091; GO:0015031; GO:0016192; GO:0016887; GO:0032585; GO:0055075; GO:0055078,endosome organization [GO:0007032]; potassium ion homeostasis [GO:0055075]; protein transport [GO:0015031]; sodium ion homeostasis [GO:0055078]; trichome branching [GO:0010091]; vacuole organization [GO:0007033]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasmodesma [GO:0009506],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005634; GO:0005768; GO:0005777; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nucleus; endosome; peroxisome; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_07326,2.000787085346818,FUN_033720-T1,Peve_00027572,Pocillopora_meandrina_HIv1___RNAseq.g25888.t1,three_way,75.48283333333333,FUN_033720-T1,Q8VDL4,ADPGK_MOUSE,,ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147),Mus musculus (Mouse),32.2,428.0,2.5e-49,198.0,sp|Q8VDL4|ADPGK_MOUSE ADP-dependent glucokinase OS=Mus musculus OX=10090 GN=Adpgk PE=1 SV=2,GO:0005576; GO:0006006; GO:0006096; GO:0043843; GO:0046872,glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096],extracellular region [GO:0005576],ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0005975; GO:0006091; GO:0016740; GO:0055086; GO:1901135,catalytic activity; extracellular region; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07329,3.1021189679393197,FUN_033730-T1,Peve_00027615,Pocillopora_meandrina_HIv1___RNAseq.g28784.t1,three_way,68.86500000000001,FUN_033730-T1,Q96RR1,PEO1_HUMAN,,"Twinkle mtDNA helicase (EC 5.6.2.3) (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)",Homo sapiens (Human),40.6,611.0,5.2e-118,426.8,sp|Q96RR1|PEO1_HUMAN Twinkle mtDNA helicase OS=Homo sapiens OX=9606 GN=TWNK PE=1 SV=1,GO:0000262; GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006261; GO:0006264; GO:0006390; GO:0008289; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139,DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214],mitochondrial chromosome [GO:0000262]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005694; GO:0005739; GO:0006260; GO:0006351; GO:0008289; GO:0016787; GO:0016853; GO:0043226; GO:0065003; GO:0140097; GO:0140657,"DNA binding; catalytic activity; chromosome; mitochondrion; DNA replication; DNA-templated transcription; lipid binding; hydrolase activity; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07331,2.8105850661866683,FUN_033732-T1,Peve_00027618,Pocillopora_meandrina_HIv1___RNAseq.g28782.t1,three_way,52.22166666666666,FUN_033732-T1,B3EWY8,,,,,96.7,391.0,2.9e-136,486.5,sp|B3EWY8|SAAR2_ACRMI Skeletal aspartic acid-rich protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_07333,1.6425195664130972,FUN_033736-T1,Peve_00027622,Pocillopora_meandrina_HIv1___RNAseq.g28776.t2,three_way,80.22166666666666,FUN_033736-T1,Q8AVR2,,,,,48.8,201.0,3.5e-40,166.4,sp|Q8AVR2|FGOP2_XENLA FGFR1 oncogene partner 2 homolog OS=Xenopus laevis OX=8355 GN=fgfr1op2 PE=2 SV=1,,,,,,
OG_07336,1.7889146717169124,FUN_033740-T1,Peve_00027590,Pocillopora_meandrina_HIv1___TS.g8552.t1c,three_way,74.79316666666666,FUN_033740-T1,Q3ZBH3,,,,,33.3,192.0,1.9e-26,120.9,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_07340,1.50150770300587,FUN_033745-T1,Peve_00004929,Pocillopora_meandrina_HIv1___RNAseq.g28757.t1,three_way,54.01,FUN_033745-T1,Q8QGQ6,CLOCK_CHICK,,Circadian locomoter output cycles protein kaput,Gallus gallus (Chicken),37.6,367.0,2.7000000000000002e-58,228.0,sp|Q8QGQ6|CLOCK_CHICK Circadian locomoter output cycles protein kaput OS=Gallus gallus OX=9031 GN=CLOCK PE=1 SV=2,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005829; GO:0006357; GO:0006473; GO:0006974; GO:0032922; GO:0046983; GO:0051775; GO:0070888; GO:1990513,circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; protein acetylation [GO:0006473]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775],CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07342,1.5276055379508346,FUN_033747-T1,Peve_00004931,Pocillopora_meandrina_HIv1___RNAseq.g28755.t1,three_way,74.33666666666667,FUN_033747-T1,Q9DCK3,,,,,40.9,220.0,1.4e-37,157.9,sp|Q9DCK3|TSN4_MOUSE Tetraspanin-4 OS=Mus musculus OX=10090 GN=Tspan4 PE=1 SV=1,,,,,,
OG_07348,1.1647372525538917,FUN_033755-T1,Peve_00004913,Pocillopora_meandrina_HIv1___RNAseq.g28749.t2,three_way,76.47383333333333,FUN_033755-T1,P15384,,,,,58.7,392.0,9.1e-108,392.1,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_07350,3.0685073500907283,FUN_033757-T1,Peve_00004916,Pocillopora_meandrina_HIv1___RNAseq.g28746.t2,three_way,69.06666666666666,FUN_033757-T1,Q8IYG6,LRC56_HUMAN,,Leucine-rich repeat-containing protein 56,Homo sapiens (Human),35.6,413.0,1.5000000000000001e-30,136.0,sp|Q8IYG6|LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens OX=9606 GN=LRRC56 PE=1 SV=1,GO:0005929; GO:0030030,cell projection organization [GO:0030030],cilium [GO:0005929],,GO:0005929; GO:0043226,cilium; organelle
OG_07353,1.5819708328695272,FUN_033761-T1,Peve_00009250,Pocillopora_meandrina_HIv1___RNAseq.g28736.t1,three_way,73.48766666666667,FUN_033761-T1,Q2HJ55,,,,,49.7,437.0,2e-117,424.1,sp|Q2HJ55|SAM50_BOVIN Sorting and assembly machinery component 50 homolog OS=Bos taurus OX=9913 GN=SAMM50 PE=2 SV=1,,,,,,
OG_07354,2.001377631907304,FUN_033762-T1,Peve_00009249,Pocillopora_meandrina_HIv1___TS.g8524.t1,three_way,86.10033333333332,FUN_033762-T1,Q9VFC8,GYS_DROME,,Glycogen [starch] synthase (EC 2.4.1.11) (Glycogen synthase),Drosophila melanogaster (Fruit fly),60.9,627.0,8e-232,804.7,sp|Q9VFC8|GYS_DROME Glycogen [starch] synthase OS=Drosophila melanogaster OX=7227 GN=Glys PE=1 SV=2,GO:0004373; GO:0005737; GO:0005776; GO:0005829; GO:0005978; GO:0009267; GO:0009744; GO:0031410; GO:0071329,cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; response to sucrose [GO:0009744],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829],"alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity [GO:0004373]",GO:0003824; GO:0005773; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0031410; GO:0043226,catalytic activity; vacuole; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; cytoplasmic vesicle; organelle
OG_07358,2.827879916823268,FUN_033769-T1,Peve_00006493,Pocillopora_meandrina_HIv1___RNAseq.g26662.t1,three_way,67.60866666666666,FUN_033769-T1,Q6B9X6,VWKA_DICDI,,Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase),Dictyostelium discoideum (Social amoeba),35.0,137.0,1.1e-14,82.4,sp|Q6B9X6|VWKA_DICDI Alpha-protein kinase vwkA OS=Dictyostelium discoideum OX=44689 GN=vwkA PE=1 SV=1,GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006971; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177; GO:0106310,contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288],contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005773; GO:0005829; GO:0007010; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"cytokinesis; catalytic activity; vacuole; cytosol; cytoskeleton organization; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07359,1.4312801541280926,FUN_033770-T1,Peve_00006489,Pocillopora_meandrina_HIv1___RNAseq.g26661.t1,three_way,47.22,FUN_033770-T1,P10733,,,,,27.9,204.0,1.2e-17,92.4,sp|P10733|SEVE_DICDI Severin OS=Dictyostelium discoideum OX=44689 GN=sevA PE=1 SV=1,,,,,,
OG_07360,1.563773708101163,FUN_033771-T1,Peve_00006491,Pocillopora_meandrina_HIv1___RNAseq.g26660.t1,three_way,47.66133333333333,FUN_033771-T1,Q7JQD3,GELS1_LUMTE,,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),Lumbricus terrestris (Common earthworm),34.7,340.0,7.799999999999999e-49,196.1,sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1,GO:0003779; GO:0005509; GO:0005737; GO:0015629; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0005856; GO:0008092; GO:0043226; GO:0065003,cytoskeleton; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_07362,3.342403280027797,FUN_033774-T1,Peve_00005278,Pocillopora_meandrina_HIv1___RNAseq.g26656.t1,three_way,62.04566666666667,,,,,,,,,,,,,,,,,
OG_07363,1.6055437966132244,FUN_033775-T1,Peve_00005277,Pocillopora_meandrina_HIv1___RNAseq.g26655.t1,three_way,73.41866666666667,FUN_033775-T1,Q64127,TIF1A_MOUSE,,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24),Mus musculus (Mouse),28.5,1018.0,1.7e-86,322.4,sp|Q64127|TIF1A_MOUSE Transcription intermediary factor 1-alpha OS=Mus musculus OX=10090 GN=Trim24 PE=1 SV=1,GO:0000791; GO:0001673; GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0008270; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043434; GO:0043565; GO:0045892; GO:0045893; GO:0050673; GO:0050680; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796,calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; epithelial cell proliferation [GO:0050673]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; response to peptide hormone [GO:0043434],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726],chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_07364,1.0432914399447195,FUN_033776-T1,Peve_00005287,Pocillopora_meandrina_HIv1___RNAseq.g26654.t1,three_way,88.918,FUN_033776-T1,P47830,,,,,77.0,148.0,7.8e-42,171.4,sp|P47830|RL27A_XENLA Large ribosomal subunit protein uL15 OS=Xenopus laevis OX=8355 GN=rpl27a PE=2 SV=2,,,,,,
OG_07365,1.7809699737774176,FUN_033777-T1,Peve_00005283,Pocillopora_meandrina_HIv1___RNAseq.g26653.t1,three_way,63.86333333333334,FUN_033777-T1,P35790,CHKA_HUMAN,,Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82),Homo sapiens (Human),42.2,372.0,1.8e-79,297.7,sp|P35790|CHKA_HUMAN Choline kinase alpha OS=Homo sapiens OX=9606 GN=CHKA PE=1 SV=3,GO:0004103; GO:0004104; GO:0004305; GO:0004713; GO:0005524; GO:0005737; GO:0005811; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0006657; GO:0006869; GO:0042149; GO:0042803; GO:1905691,CDP-choline pathway [GO:0006657]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811],ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07366,1.4141063913258998,FUN_033778-T1,Peve_00025001,Pocillopora_meandrina_HIv1___RNAseq.g26651.t1,three_way,74.63816666666666,FUN_033778-T1,O00327,BMAL1_HUMAN,,Basic helix-loop-helix ARNT-like protein 1 (Aryl hydrocarbon receptor nuclear translocator-like protein 1) (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5) (bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3),Homo sapiens (Human),43.1,634.0,9.999999999999999e-123,442.2,sp|O00327|BMAL1_HUMAN Basic helix-loop-helix ARNT-like protein 1 OS=Homo sapiens OX=9606 GN=BMAL1 PE=1 SV=2,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0007623; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0034751; GO:0042634; GO:0042753; GO:0043161; GO:0043231; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0070888; GO:0090263; GO:0090403; GO:0097009; GO:0120163; GO:0140297; GO:1901985; GO:1990513; GO:1990837; GO:2000074; GO:2000323; GO:2000772; GO:2001016,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; energy homeostasis [GO:0097009]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283],aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],"aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030163; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; protein catabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_07370,1.8920617645438085,FUN_033787-T1,Peve_00014255,Pocillopora_meandrina_HIv1___RNAseq.g26644.t1,three_way,95.845,FUN_033787-T1,Q9DE27,,,,,85.8,466.0,1.3e-223,776.9,sp|Q9DE27|RUVB2_XENLA RuvB-like 2 OS=Xenopus laevis OX=8355 GN=ruvbl2 PE=2 SV=1,,,,,,
OG_07372,2.8712854737218665,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,43.9,214.0,1.7e-40,169.9,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07372,2.8712854737218665,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,30.4,171.0,0.00058,48.5,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07373,1.2403689058704168,FUN_033793-T2,Peve_00029690,Pocillopora_meandrina_HIv1___RNAseq.g26316.t1,three_way,63.531666666666666,,,,,,,,,,,,,,,,,
OG_07374,1.1810490888197396,FUN_033796-T1,Peve_00029689,Pocillopora_meandrina_HIv1___RNAseq.g26321.t1,three_way,45.691,,,,,,,,,,,,,,,,,
OG_07375,2.363522126962457,FUN_033797-T1,Peve_00029703,Pocillopora_meandrina_HIv1___RNAseq.g26319.t1,three_way,67.2325,FUN_033797-T1,O95071,,,,,39.0,318.0,1.5e-52,211.1,sp|O95071|UBR5_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2,,,,,,
OG_07378,1.3884290326242146,FUN_033800-T1,Peve_00007584,Pocillopora_meandrina_HIv1___RNAseq.g26322.t1,three_way,43.99316666666667,,,,,,,,,,,,,,,,,
OG_07382,1.9317086569741104,FUN_033804-T1,Peve_00009713,Pocillopora_meandrina_HIv1___RNAseq.g26323.t1,three_way,76.55666666666666,FUN_033804-T1,Q90341,,,,,52.7,91.0,6.4e-15,83.2,sp|Q90341|MYC1_CYPCA Transcriptional regulator Myc-1 OS=Cyprinus carpio OX=7962 GN=myca PE=3 SV=1,,,,,,
OG_07383,1.165276139295479,FUN_033809-T1,Peve_00033385,Pocillopora_meandrina_HIv1___TS.g19094.t1,three_way,82.90566666666666,FUN_033809-T1,Q9W6H5,UBC9A_DANRE,,SUMO-conjugating enzyme UBC9-A (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9-A) (SUMO-protein ligase A) (Ubiquitin carrier protein 9-A) (Ubiquitin carrier protein I-A) (Ubiquitin-conjugating enzyme E2 I-A) (Ubiquitin-protein ligase I-A),Danio rerio (Zebrafish) (Brachydanio rerio),54.2,153.0,1.7e-48,193.7,sp|Q9W6H5|UBC9A_DANRE SUMO-conjugating enzyme UBC9-A OS=Danio rerio OX=7955 GN=ube2ia PE=1 SV=1,GO:0001947; GO:0005524; GO:0005634; GO:0007059; GO:0007088; GO:0016925; GO:0019789; GO:0031099; GO:0036306; GO:0051301; GO:0060216; GO:0061484; GO:0061656,cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; hematopoietic stem cell homeostasis [GO:0061484]; protein sumoylation [GO:0016925]; regeneration [GO:0031099]; regulation of mitotic nuclear division [GO:0007088],nucleus [GO:0005634],ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]; SUMO transferase activity [GO:0019789],GO:0003824; GO:0005634; GO:0007059; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; chromosome segregation; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07384,1.2604396617121143,FUN_033810-T1,Peve_00028712,Pocillopora_meandrina_HIv1___RNAseq.g26344.t1,three_way,76.18866666666666,FUN_033810-T1,Q7T2D4,,,,,43.4,371.0,2.5e-77,290.8,sp|Q7T2D4|ERGI2_DANRE Endoplasmic reticulum-Golgi intermediate compartment protein 2 OS=Danio rerio OX=7955 GN=ergic2 PE=2 SV=1,,,,,,
OG_07385,1.308040285277356,FUN_033812-T1,Peve_00028718,Pocillopora_meandrina_HIv1___RNAseq.g26345.t1,three_way,82.21633333333334,FUN_033812-T1,Q9C040,TRIM2_HUMAN,,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2),Homo sapiens (Human),28.2,550.0,1.4000000000000001e-59,232.6,sp|Q9C040|TRIM2_HUMAN Tripartite motif-containing protein 2 OS=Homo sapiens OX=9606 GN=TRIM2 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],cytoplasm [GO:0005737],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_07386,1.029614969868449,FUN_033813-T1,Peve_00028719,Pocillopora_meandrina_HIv1___RNAseq.g26346.t1,three_way,86.456,FUN_033813-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,533.0,2.9e-60,235.0,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07388,1.028734017443753,FUN_033815-T1,Peve_00028731,Pocillopora_meandrina_HIv1___RNAseq.g26348.t1,three_way,86.71966666666667,FUN_033815-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),32.6,552.0,5.8e-72,273.9,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07390,1.0254134251050404,FUN_033819-T1,Peve_00028739,Pocillopora_meandrina_HIv1___RNAseq.g26353.t1,three_way,66.712,FUN_033819-T1,Q9GZZ6,,,,,30.9,433.0,7.5e-59,229.6,sp|Q9GZZ6|ACH10_HUMAN Neuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1,,,,,,
OG_07391,1.5353177229415338,FUN_033820-T1,Peve_00028743,Pocillopora_meandrina_HIv1___RNAseq.g26352.t1,three_way,71.83,FUN_033820-T1,Q80VW5,WHRN_MOUSE,,Whirlin,Mus musculus (Mouse),32.1,324.0,3.8000000000000004e-36,154.5,sp|Q80VW5|WHRN_MOUSE Whirlin OS=Mus musculus OX=10090 GN=Whrn PE=1 SV=3,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005829; GO:0005884; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032421; GO:0032426; GO:0036064; GO:0042802; GO:0043005; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005829; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; cytosol; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_07395,4.098140184050958,FUN_033834-T1,Peve_00028775,Pocillopora_meandrina_HIv1___RNAseq.g26359.t1,three_way,52.308,FUN_033834-T1,Q6L9W6,B4GN3_HUMAN,,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",Homo sapiens (Human),32.0,328.0,2e-52,208.8,"sp|Q6L9W6|B4GN3_HUMAN Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Homo sapiens OX=9606 GN=B4GALNT3 PE=1 SV=2",GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231,,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0005794; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; transferase activity; organelle
OG_07397,1.90615262837372,FUN_033836-T1,Peve_00013463,Pocillopora_meandrina_HIv1___RNAseq.g26363.t1,three_way,68.35566666666666,FUN_033836-T1,Q8H1F7,,,,,35.8,288.0,1.3e-35,151.8,sp|Q8H1F7|IPK_ARATH Isopentenyl phosphate kinase OS=Arabidopsis thaliana OX=3702 GN=IPK PE=1 SV=1,,,,,,
OG_07402,1.9752848644521608,FUN_033843-T1,Peve_00013534,Pocillopora_meandrina_HIv1___RNAseq.g26141.t1,three_way,90.93266666666668,FUN_033843-T1,Q6P6Z0,,,,,68.4,1095.0,0.0,1486.5,sp|Q6P6Z0|DDB1_XENLA DNA damage-binding protein 1 OS=Xenopus laevis OX=8355 GN=ddb1 PE=2 SV=1,,,,,,
OG_07403,2.982798573778956,FUN_033845-T1,Peve_00039879,Pocillopora_meandrina_HIv1___RNAseq.g26135.t1,three_way,74.83,FUN_033845-T1,P50430,,,,,43.8,525.0,6.2e-118,426.0,sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2,,,,,,
OG_07405,2.113663966544855,FUN_033856-T2,Peve_00043300,Pocillopora_meandrina_HIv1___TS.g8205.t2,three_way,77.4,FUN_033856-T2,Q96KP4,CNDP2_HUMAN,,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase),Homo sapiens (Human),65.4,474.0,6.799999999999999e-188,658.3,sp|Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2,GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070062; GO:0070573,proteolysis [GO:0006508],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07408,5.332038423849486,FUN_033861-T1,Peve_00043296,Pocillopora_meandrina_HIv1___RNAseq.g28415.t1,three_way,63.10766666666667,FUN_033861-T1,Q95JR6,,,,,28.8,295.0,3.5e-27,124.8,sp|Q95JR6|CNBD2_MACFA Cyclic nucleotide-binding domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=CNBD2 PE=2 SV=1,,,,,,
OG_07409,2.271205490519802,FUN_033862-T1,Peve_00043295,Pocillopora_meandrina_HIv1___RNAseq.g28416.t1,three_way,77.74766666666666,,,,,,,,,,,,,,,,,
OG_07420,2.540487789357242,FUN_033882-T1,Peve_00043308,Pocillopora_meandrina_HIv1___RNAseq.g28395.t1,three_way,83.125,FUN_033882-T1,P08510,,,,,61.8,395.0,1.9e-120,434.5,sp|P08510|KCNAS_DROME Potassium voltage-gated channel protein Shaker OS=Drosophila melanogaster OX=7227 GN=Sh PE=1 SV=3,,,,,,
OG_07421,2.362982909858514,FUN_033883-T1,Peve_00043307,Pocillopora_meandrina_HIv1___RNAseq.g28394.t1,three_way,75.87733333333333,FUN_033883-T1,P28739,,,,,55.2,377.0,4.1e-107,390.6,sp|P28739|KLPA_EMENI Kinesin-like protein klpA OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=klpA PE=2 SV=3,,,,,,
OG_07422,2.847104690587197,FUN_033884-T1,Peve_00043305,Pocillopora_meandrina_HIv1___RNAseq.g28393.t1,three_way,52.554,,,,,,,,,,,,,,,,,
OG_07425,2.771227918433845,FUN_033890-T1,Peve_00035943,Pocillopora_meandrina_HIv1___RNAseq.g28382.t1,three_way,42.425,,,,,,,,,,,,,,,,,
OG_07429,2.181082947945207,FUN_033915-T1,Peve_00022636,Pocillopora_meandrina_HIv1___RNAseq.g26598.t1,three_way,74.89316666666667,FUN_033915-T1,E7EY42,PTSS2_DANRE,,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),Danio rerio (Zebrafish) (Brachydanio rerio),61.7,366.0,2.1e-146,520.4,sp|E7EY42|PTSS2_DANRE Phosphatidylserine synthase 2 OS=Danio rerio OX=7955 GN=ptdss2 PE=3 SV=1,GO:0005789; GO:0006659; GO:0106245,phosphatidylserine biosynthetic process [GO:0006659],endoplasmic reticulum membrane [GO:0005789],L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245],GO:0003824; GO:0006575; GO:0006629; GO:0016740,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity
OG_07431,1.2256174154401462,FUN_033919-T1,Peve_00022630,Pocillopora_meandrina_HIv1___RNAseq.g26196.t1,three_way,46.1855,,,,,,,,,,,,,,,,,
OG_07436,3.501490594972681,FUN_033926-T1,Peve_00022622,Pocillopora_meandrina_HIv1___TS.g19337.t1,three_way,74.93,,,,,,,,,,,,,,,,,
OG_07438,2.6042876811498283,FUN_033928-T1,Peve_00022640,Pocillopora_meandrina_HIv1___RNAseq.g26589.t1,three_way,76.85166666666666,FUN_033928-T1,A6H8T2,,,,,34.0,712.0,1.4e-110,402.1,sp|A6H8T2|DNAI7_DANRE Dynein axonemal intermediate chain 7 OS=Danio rerio OX=7955 GN=dnai7 PE=2 SV=2,,,,,,
OG_07439,2.128704764055874,FUN_033929-T1,Peve_00022639,Pocillopora_meandrina_HIv1___TS.g19340.t1,three_way,41.10216666666667,,,,,,,,,,,,,,,,,
OG_07440,1.139967117472038,FUN_033932-T1,Peve_00020979,Pocillopora_meandrina_HIv1___RNAseq.g26584.t1,three_way,60.418,,,,,,,,,,,,,,,,,
OG_07441,4.729845503355182,FUN_033933-T1,Peve_00020980,Pocillopora_meandrina_HIv1___RNAseq.g26583.t1,three_way,86.51866666666666,FUN_033933-T1,Q15915,ZIC1_HUMAN,,Zinc finger protein ZIC 1 (Zinc finger protein 201) (Zinc finger protein of the cerebellum 1),Homo sapiens (Human),37.8,249.0,1.7e-36,155.2,sp|Q15915|ZIC1_HUMAN Zinc finger protein ZIC 1 OS=Homo sapiens OX=9606 GN=ZIC1 PE=1 SV=2,GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007389; GO:0007417; GO:0007420; GO:0007628; GO:0008270; GO:0008589; GO:0010467; GO:0021510; GO:0021766; GO:0021772; GO:0030154; GO:0042307; GO:0042472; GO:0045893; GO:0098727; GO:1990837,adult walking behavior [GO:0007628]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; inner ear morphogenesis [GO:0042472]; maintenance of cell number [GO:0098727]; olfactory bulb development [GO:0021772]; pattern specification process [GO:0007389]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07442,2.687469833800816,FUN_033934-T1,Peve_00020984,Pocillopora_meandrina_HIv1___RNAseq.g26581.t1,three_way,92.2815,FUN_033934-T1,Q9IB89,,,,,45.0,169.0,3.2000000000000005e-33,144.4,sp|Q9IB89|ZIC5_XENLA Zinc finger protein ZIC 5 OS=Xenopus laevis OX=8355 GN=zic5 PE=2 SV=1,,,,,,
OG_07443,1.1773739560927416,FUN_033935-T1,Peve_00020986,Pocillopora_meandrina_HIv1___RNAseq.g26580.t1,three_way,84.01316666666666,FUN_033935-T1,Q6DJQ6,,,,,35.6,281.0,6.4e-32,140.2,sp|Q6DJQ6|ZIC3_XENTR Zinc finger protein ZIC 3 OS=Xenopus tropicalis OX=8364 GN=zic3 PE=2 SV=1,,,,,,
OG_07446,1.1302462832254796,FUN_033938-T1,Peve_00020990,Pocillopora_meandrina_HIv1___RNAseq.g26577.t1,three_way,71.27083333333333,FUN_033938-T1,A7E2M3,,,,,35.3,187.0,1.4e-19,98.2,sp|A7E2M3|EMC10_DANRE ER membrane protein complex subunit 10 OS=Danio rerio OX=7955 GN=emc10 PE=2 SV=1,,,,,,
OG_07448,2.167677665629144,FUN_033942-T1,Peve_00020994,Pocillopora_meandrina_HIv1___RNAseq.g26574.t1,three_way,64.84833333333333,FUN_033942-T1,P48733,,,,,43.3,127.0,1.1000000000000002e-28,131.3,sp|P48733|UROM_BOVIN Uromodulin OS=Bos taurus OX=9913 GN=UMOD PE=2 SV=1,,,,,,
OG_07454,1.5820953539280498,FUN_033950-T1,Peve_00036244,Pocillopora_meandrina_HIv1___RNAseq.g28347.t1,three_way,68.354,FUN_033950-T1,Q6DDY9,,,,,50.6,170.0,3.5e-41,169.9,sp|Q6DDY9|RT07_XENLA Small ribosomal subunit protein uS7m OS=Xenopus laevis OX=8355 GN=mrps7 PE=2 SV=1,,,,,,
OG_07455,1.3777475759088824,FUN_033951-T1,Peve_00032117,Pocillopora_meandrina_HIv1___RNAseq.g28360.t1,three_way,65.717,,,,,,,,,,,,,,,,,
OG_07456,1.0856753430776256,FUN_033957-T1,Peve_00022635,Pocillopora_meandrina_HIv1___RNAseq.g26599.t1,three_way,75.81933333333333,FUN_033957-T1,Q8BGS7,CEPT1_MOUSE,,Choline/ethanolaminephosphotransferase 1 (mCEPT1) (EC 2.7.8.1) (EC 2.7.8.2) (1-alkenyl-2-acylglycerol choline phosphotransferase) (EC 2.7.8.22),Mus musculus (Mouse),49.7,364.0,4.2e-100,366.3,sp|Q8BGS7|CEPT1_MOUSE Choline/ethanolaminephosphotransferase 1 OS=Mus musculus OX=10090 GN=Cept1 PE=1 SV=1,GO:0004142; GO:0004307; GO:0005789; GO:0006646; GO:0006656; GO:0016780; GO:0031965; GO:0046872; GO:0047359,phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646],endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965],"1-alkenyl-2-acylglycerol choline phosphotransferase activity [GO:0047359]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_07457,3.301003296907726,FUN_033958-T1,Peve_00022633,Pocillopora_meandrina_HIv1___RNAseq.g26600.t1,three_way,70.71616666666667,FUN_033958-T1,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),32.6,972.0,1.4e-144,516.2,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_07463,1.1468182276927388,FUN_033967-T1,Peve_00015216,Pocillopora_meandrina_HIv1___RNAseq.g28550.t1,three_way,70.581,FUN_033967-T1,Q5XG58,,,,,46.2,379.0,1.2e-89,331.6,sp|Q5XG58|ELP4_XENLA Elongator complex protein 4 OS=Xenopus laevis OX=8355 GN=elp4 PE=2 SV=1,,,,,,
OG_07466,3.0160895864150503,FUN_033970-T2,Peve_00015222,Pocillopora_meandrina_HIv1___RNAseq.g26371.t1,three_way,71.7745,FUN_033970-T2,Q4V7B1,,,,,32.9,639.0,3.6999999999999998e-56,221.5,sp|Q4V7B1|CF20D_RAT Protein CFAP20DC OS=Rattus norvegicus OX=10116 GN=Cfap20dc PE=2 SV=1,,,,,,
OG_07467,2.8049647659945665,FUN_033971-T3,Peve_00015223,Pocillopora_meandrina_HIv1___RNAseq.g26370.t1,three_way,66.31200000000001,FUN_033971-T3,Q5E9H2,,,,,39.4,419.0,1.4e-85,318.5,sp|Q5E9H2|1A1L1_BOVIN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Bos taurus OX=9913 GN=ACCS PE=2 SV=1,,,,,,
OG_07469,3.184662368749367,FUN_033979-T1,Peve_00004846,Pocillopora_meandrina_HIv1___RNAseq.g26111.t1,three_way,80.1855,FUN_033979-T1,O70247,,,,,40.7,570.0,5.3000000000000004e-111,403.3,sp|O70247|SC5A6_RAT Sodium-dependent multivitamin transporter OS=Rattus norvegicus OX=10116 GN=Slc5a6 PE=1 SV=1,,,,,,
OG_07471,1.2213173862238529,FUN_033981-T1,Peve_00004845,Pocillopora_meandrina_HIv1___RNAseq.g26109.t1,three_way,70.14966666666666,FUN_033981-T1,A7S4N4,,,,,30.2,378.0,5.1e-38,160.2,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_07473,1.3024361018053812,FUN_033988-T1,Peve_00031324,Pocillopora_meandrina_HIv1___RNAseq.g26103.t1,three_way,92.09933333333332,FUN_033988-T1,Q9BV81,EMC6_HUMAN,,ER membrane protein complex subunit 6 (Transmembrane protein 93),Homo sapiens (Human),60.7,89.0,1.0000000000000001e-23,110.5,sp|Q9BV81|EMC6_HUMAN ER membrane protein complex subunit 6 OS=Homo sapiens OX=9606 GN=EMC6 PE=1 SV=1,GO:0000045; GO:0005789; GO:0016020; GO:0045050; GO:0071816; GO:0072546; GO:1903349,autophagosome assembly [GO:0000045]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; omegasome membrane [GO:1903349],,,
OG_07476,2.0691823273307253,FUN_033998-T2,Peve_00000499,Pocillopora_meandrina_HIv1___RNAseq.g26093.t2,three_way,69.55316666666667,FUN_033998-T2,Q8CDK2,,,,,49.7,734.0,1.8e-192,674.9,sp|Q8CDK2|CBPC2_MOUSE Cytosolic carboxypeptidase 2 OS=Mus musculus OX=10090 GN=Agbl2 PE=1 SV=1,,,,,,
OG_07483,1.5551504171018902,FUN_034008-T1,Peve_00033154,Pocillopora_meandrina_HIv1___RNAseq.g26086.t1,three_way,63.45133333333334,FUN_034008-T1,P46023,,,,,46.7,347.0,3.7e-84,314.7,sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_07484,1.5711097716241,FUN_034010-T1,Peve_00030670,Pocillopora_meandrina_HIv1___RNAseq.g26085.t1,three_way,72.63733333333333,FUN_034010-T1,Q9Y2V2,CHSP1_HUMAN,,Calcium-regulated heat-stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24),Homo sapiens (Human),55.4,130.0,8.4e-31,134.8,sp|Q9Y2V2|CHSP1_HUMAN Calcium-regulated heat-stable protein 1 OS=Homo sapiens OX=9606 GN=CARHSP1 PE=1 SV=2,GO:0000177; GO:0000932; GO:0003730; GO:0005737; GO:0005829; GO:0019902; GO:0035556; GO:0043186; GO:0043488,intracellular signal transduction [GO:0035556]; regulation of mRNA stability [GO:0043488],cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932],mRNA 3'-UTR binding [GO:0003730]; phosphatase binding [GO:0019902],GO:0003723; GO:0005829; GO:0043226,RNA binding; cytosol; organelle
OG_07485,1.8738640385399488,FUN_034011-T1,Peve_00007017,Pocillopora_meandrina_HIv1___RNAseq.g26084.t1,three_way,51.6635,FUN_034011-T1,Q8TEQ0,,,,,30.1,1078.0,2.6e-94,348.6,sp|Q8TEQ0|SNX29_HUMAN Sorting nexin-29 OS=Homo sapiens OX=9606 GN=SNX29 PE=1 SV=3,,,,,,
OG_07486,1.231703217125497,FUN_034012-T1,Peve_00007016,Pocillopora_meandrina_HIv1___TS.g18832.t1,three_way,67.49216666666666,FUN_034012-T1,B1AQJ2,UBP36_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 36 (EC 2.3.2.-) (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36),Mus musculus (Mouse),50.0,470.0,3.3e-123,444.5,sp|B1AQJ2|UBP36_MOUSE Ubiquitin carboxyl-terminal hydrolase 36 OS=Mus musculus OX=10090 GN=Usp36 PE=1 SV=1,GO:0003723; GO:0004843; GO:0005730; GO:0005737; GO:0006325; GO:0006508; GO:0007000; GO:0016242; GO:0016579; GO:0016607; GO:0016740; GO:0031647; GO:0050821; GO:0140936; GO:1990380; GO:2000232,chromatin organization [GO:0006325]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730],cysteine-type deubiquitinase activity [GO:0004843]; histone H2B deubiquitinase activity [GO:0140936]; K48-linked deubiquitinase activity [GO:1990380]; RNA binding [GO:0003723]; transferase activity [GO:0016740],GO:0003723; GO:0003824; GO:0005730; GO:0006325; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleolus; chromatin organization; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07487,1.1192406426359438,FUN_034013-T1,Peve_00007013,Pocillopora_meandrina_HIv1___TS.g18830.t1,three_way,57.79133333333333,,,,,,,,,,,,,,,,,
OG_07491,2.658970070307413,FUN_034018-T1,Peve_00024700,Pocillopora_meandrina_HIv1___RNAseq.g26076.t1,three_way,64.037,FUN_034018-T1,Q9Z2E3,,,,,35.4,401.0,2.3e-51,206.5,sp|Q9Z2E3|ERN2_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Mus musculus OX=10090 GN=Ern2 PE=2 SV=2,,,,,,
OG_07494,1.4039824570045465,FUN_034022-T1,Peve_00034126,Pocillopora_meandrina_HIv1___RNAseq.g26020.t1,three_way,90.51583333333332,FUN_034022-T1,Q16960,,,,,77.4,518.0,4.2999999999999994e-251,868.6,"sp|Q16960|DYI3_HELCR Dynein intermediate chain 3, ciliary OS=Heliocidaris crassispina OX=1043166 PE=2 SV=1",,,,,,
OG_07495,1.6278271892893628,FUN_034026-T1,Peve_00034136,Pocillopora_meandrina_HIv1___RNAseq.g25924.t1,three_way,61.47733333333333,FUN_034026-T1,Q3ZBH3,,,,,35.5,242.0,6.9999999999999995e-40,165.6,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_07496,1.943971124006933,FUN_034028-T1,Peve_00043490,Pocillopora_meandrina_HIv1___RNAseq.g16571.t1,three_way,51.52466666666667,,,,,,,,,,,,,,,,,
OG_07497,1.288903943254297,FUN_034029-T1,Peve_00031756,Pocillopora_meandrina_HIv1___RNAseq.g26024.t1,three_way,90.55533333333334,FUN_034029-T1,Q99873,ANM1_HUMAN,,Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1) (Interferon receptor 1-bound protein 4),Homo sapiens (Human),66.6,359.0,2e-142,506.9,sp|Q99873|ANM1_HUMAN Protein arginine N-methyltransferase 1 OS=Homo sapiens OX=9606 GN=PRMT1 PE=1 SV=3,GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0006974; GO:0007166; GO:0008168; GO:0008170; GO:0008276; GO:0008284; GO:0008327; GO:0008380; GO:0016274; GO:0018216; GO:0019082; GO:0019899; GO:0030510; GO:0031175; GO:0034709; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0044020; GO:0045648; GO:0045652; GO:0045653; GO:0045727; GO:0046329; GO:0046985; GO:0048273; GO:0048738; GO:0051260; GO:0061431; GO:0106080; GO:1900745; GO:1904047; GO:1904263; GO:1905168,cardiac muscle tissue development [GO:0048738]; cell surface receptor signaling pathway [GO:0007166]; cellular response to methionine [GO:0061431]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; in utero embryonic development [GO:0001701]; negative regulation of JNK cascade [GO:0046329]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of BMP signaling pathway [GO:0030510]; regulation of DNA-templated transcription [GO:0006355]; regulation of megakaryocyte differentiation [GO:0045652]; RNA splicing [GO:0008380]; viral protein processing [GO:0019082],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],enzyme binding [GO:0019899]; GATOR1 complex binding [GO:0106080]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0065003; GO:0140096,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_07504,1.5480270243429082,FUN_034045-T3,Peve_00038328,Pocillopora_meandrina_HIv1___TS.g18788.t1,three_way,74.62866666666666,FUN_034045-T3,M0R2J8,DCDC1_HUMAN,,Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein),Homo sapiens (Human),30.7,1578.0,5.9999999999999995e-174,614.0,sp|M0R2J8|DCDC1_HUMAN Doublecortin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DCDC1 PE=1 SV=1,GO:0005737; GO:0005874; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412,cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412],cytoplasm [GO:0005737]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686],carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017],GO:0008092; GO:0043226,cytoskeletal protein binding; organelle
OG_07506,1.227292344541144,FUN_034048-T1,Peve_00022954,Pocillopora_meandrina_HIv1___RNAseq.g26035.t1,three_way,53.06433333333334,FUN_034048-T1,Q1LV46,,,,,37.9,198.0,3.2e-35,150.2,sp|Q1LV46|ABHEA_DANRE Protein ABHD14A OS=Danio rerio OX=7955 GN=abhd14a PE=2 SV=1,,,,,,
OG_07509,1.5507350433514828,FUN_034051-T1,Peve_00009941,Pocillopora_meandrina_HIv1___RNAseq.g26031.t1,three_way,79.378,FUN_034051-T1,O93257,XRCC6_CHICK,,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP/AP lyase Ku70) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (DNA repair protein XRCC6) (Ku autoantigen protein p70 homolog) (Ku70),Gallus gallus (Chicken),46.8,583.0,2.6e-147,523.9,sp|O93257|XRCC6_CHICK X-ray repair cross-complementing protein 5 OS=Gallus gallus OX=9031 GN=XRCC6 PE=2 SV=1,GO:0000723; GO:0003678; GO:0003684; GO:0003723; GO:0005524; GO:0005654; GO:0005694; GO:0006303; GO:0006310; GO:0016787; GO:0042162; GO:0043564; GO:0045892; GO:0051575; GO:0070419; GO:0071480; GO:1990904,cellular response to gamma radiation [GO:0071480]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of DNA-templated transcription [GO:0045892]; telomere maintenance [GO:0000723],chromosome [GO:0005694]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904],5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006355; GO:0016787; GO:0016829; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleoplasm; chromosome; DNA repair; DNA recombination; regulation of DNA-templated transcription; hydrolase activity; lyase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07511,1.568230834005305,FUN_034054-T1,Peve_00009943,Pocillopora_meandrina_HIv1___RNAseq.g26029.t1,three_way,82.816,FUN_034054-T1,Q9I829,,,,,52.2,385.0,3.7999999999999997e-90,333.6,sp|Q9I829|KCNA1_ONCMY Shaker-related potassium channel tsha2 OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1,,,,,,
OG_07512,1.8157645606386328,FUN_034055-T1,Peve_00015322,Pocillopora_meandrina_HIv1___RNAseq.g26028.t2,three_way,81.44633333333333,FUN_034055-T1,O08873,MADD_RAT,,MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP),Rattus norvegicus (Rat),38.5,1719.0,1.8e-285,984.2,sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1,GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236,anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483],axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0007018; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; microtubule-based movement; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_07515,1.8930642709026877,FUN_034083-T1,Peve_00037081,Pocillopora_meandrina_HIv1___RNAseq.g26053.t1,three_way,67.07933333333332,,,,,,,,,,,,,,,,,
OG_07516,2.43509120785525,FUN_034084-T1,Peve_00037080,Pocillopora_meandrina_HIv1___RNAseq.g26054.t2,three_way,74.45100000000001,FUN_034084-T1,P07607,,,,,71.9,299.0,1.900000000000001e-130,466.8,sp|P07607|TYSY_MOUSE Thymidylate synthase OS=Mus musculus OX=10090 GN=Tyms PE=1 SV=1,,,,,,
OG_07519,4.955164387738065,FUN_034088-T1,Peve_00037071,Pocillopora_meandrina_HIv1___RNAseq.g26059.t1,three_way,77.17566666666667,FUN_034088-T1,Q4V920,PACN1_DANRE,,Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1),Danio rerio (Zebrafish) (Brachydanio rerio),36.1,449.0,4.1e-70,266.9,sp|Q4V920|PACN1_DANRE Protein kinase C and casein kinase substrate in neurons protein 1 OS=Danio rerio OX=7955 GN=pacsin1b PE=1 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0006897; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0060271; GO:0097320; GO:1900006,actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; regulation of endocytosis [GO:0030100],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; neuron projection [GO:0043005]; ruffle membrane [GO:0032587]; synapse [GO:0045202],phospholipid binding [GO:0005543],GO:0005768; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0044782; GO:0061024,endosome; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; cilium organization; membrane organization
OG_07523,1.604417126504638,FUN_034093-T1,Peve_00037067,Pocillopora_meandrina_HIv1___RNAseq.g26065.t1,three_way,65.31416666666668,FUN_034093-T1,Q641G4,,,,,38.5,642.0,2.6e-94,347.8,sp|Q641G4|CNDH2_XENLA Condensin-2 complex subunit H2 OS=Xenopus laevis OX=8355 GN=ncaph2 PE=1 SV=1,,,,,,
OG_07525,1.2126273909645189,FUN_034095-T1,Peve_00006471,Pocillopora_meandrina_HIv1___TS.g18816.t1a,three_way,78.403,FUN_034095-T1,Q0P4Y8,,,,,47.8,670.0,7e-167,589.0,sp|Q0P4Y8|LMF2_XENTR Lipase maturation factor 2 OS=Xenopus tropicalis OX=8364 GN=lmf2 PE=2 SV=1,,,,,,
OG_07528,3.1170591007890955,FUN_034098-T1,Peve_00042343,Pocillopora_meandrina_HIv1___RNAseq.g26070.t1,three_way,59.001,FUN_034098-T1,Q9NQ36,SCUB2_HUMAN,,"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You)",Homo sapiens (Human),41.2,85.0,1.9e-12,75.9,"sp|Q9NQ36|SCUB2_HUMAN Signal peptide, CUB and EGF-like domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCUBE2 PE=1 SV=3",GO:0005509; GO:0005576; GO:0005615; GO:0007165; GO:0008289; GO:0009986,signal transduction [GO:0007165],cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; lipid binding [GO:0008289],GO:0005576; GO:0005615; GO:0008289,extracellular region; extracellular space; lipid binding
OG_07530,1.574537588182175,FUN_034102-T1,Peve_00042340,Pocillopora_meandrina_HIv1___RNAseq.g26012.t1,three_way,92.093,FUN_034102-T1,B5X277,,,,,77.8,117.0,1.8e-50,199.9,sp|B5X277|MTNB_SALSA Methylthioribulose-1-phosphate dehydratase OS=Salmo salar OX=8030 GN=apip PE=2 SV=1,,,,,,
OG_07531,1.154613731091365,FUN_034107-T1,Peve_00035269,Pocillopora_meandrina_HIv1___RNAseq.g25964.t2,three_way,76.35033333333332,FUN_034107-T1,B5X4E0,,,,,33.2,289.0,2.6e-39,164.1,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_07532,1.1370284422483123,FUN_034108-T1,Peve_00035268,Pocillopora_meandrina_HIv1___RNAseq.g25963.t1,three_way,83.90533333333333,FUN_034108-T1,P17972,KCNAW_DROME,,Potassium voltage-gated channel protein Shaw (Shaw2),Drosophila melanogaster (Fruit fly),49.9,433.0,1.8e-110,401.4,sp|P17972|KCNAW_DROME Potassium voltage-gated channel protein Shaw OS=Drosophila melanogaster OX=7227 GN=Shaw PE=2 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0022843; GO:0030431; GO:0032590; GO:0032809; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; sleep [GO:0030431],axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_07533,2.871726555171267,FUN_034109-T1,Peve_00034853,Pocillopora_meandrina_HIv1___RNAseq.g25962.t1,three_way,67.35366666666667,FUN_034109-T1,P55265,DSRAD_HUMAN,,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),Homo sapiens (Human),33.4,739.0,5.6e-90,334.0,sp|P55265|DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens OX=9606 GN=ADAR PE=1 SV=4,GO:0001649; GO:0002244; GO:0002566; GO:0003677; GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016020; GO:0016553; GO:0030218; GO:0031054; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0097284; GO:0098586; GO:1900369; GO:1903944,adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; hepatocyte apoptotic process [GO:0097284]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530],DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006886; GO:0006913; GO:0012501; GO:0016071; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098542; GO:0140098,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; intracellular protein transport; nucleocytoplasmic transport; programmed cell death; mRNA metabolic process; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA"
OG_07534,2.6998768180509285,FUN_034110-T1,Peve_00034861,Pocillopora_meandrina_HIv1___RNAseq.g25961.t1,three_way,65.22083333333333,,,,,,,,,,,,,,,,,
OG_07535,1.0544618592838784,FUN_034111-T1,Peve_00034867,Pocillopora_meandrina_HIv1___TS.g18705.t1a,three_way,76.7515,FUN_034111-T1,Q0P5H9,TTC5_BOVIN,,Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Protein Strap),Bos taurus (Bovine),50.7,302.0,4.8e-81,302.8,sp|Q0P5H9|TTC5_BOVIN Tetratricopeptide repeat protein 5 OS=Bos taurus OX=9913 GN=TTC5 PE=2 SV=1,GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006281; GO:0006974; GO:0009267; GO:0031410,cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; DNA repair [GO:0006281],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634],,GO:0005634; GO:0005739; GO:0005829; GO:0006281; GO:0031410; GO:0043226,nucleus; mitochondrion; cytosol; DNA repair; cytoplasmic vesicle; organelle
OG_07538,2.9731516727622704,FUN_034114-T1,Peve_00034856,Pocillopora_meandrina_HIv1___RNAseq.g25955.t1,three_way,88.02533333333334,FUN_034114-T1,O54747,DPOD1_RAT,,DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-),Rattus norvegicus (Rat),65.3,1059.0,0.0,1419.8,sp|O54747|DPOD1_RAT DNA polymerase delta catalytic subunit OS=Rattus norvegicus OX=10116 GN=Pold1 PE=2 SV=1,GO:0000109; GO:0000166; GO:0000731; GO:0000781; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0006261; GO:0006287; GO:0006297; GO:0008270; GO:0008296; GO:0008408; GO:0019899; GO:0034644; GO:0043625; GO:0045004; GO:0051539; GO:0055089; GO:0070987; GO:0071897,"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]","chromosome, telomeric region [GO:0000781]; delta DNA polymerase complex [GO:0043625]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]","3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_07539,1.9030254784963991,FUN_034120-T1,Peve_00039587,Pocillopora_meandrina_HIv1___RNAseq.g25948.t2,three_way,82.97233333333334,FUN_034120-T1,A0A0G2K047,ACSS3_RAT,,"Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 3) (Acyl-CoA synthetase short-chain family member 3) (Propionate--CoA ligase) (EC 6.2.1.17)",Rattus norvegicus (Rat),54.1,625.0,2.0000000000000002e-212,740.3,"sp|A0A0G2K047|ACSS3_RAT Acyl-CoA synthetase short-chain family member 3, mitochondrial OS=Rattus norvegicus OX=10116 GN=Acss3 PE=1 SV=1",GO:0003987; GO:0005524; GO:0005759; GO:0006629; GO:0031956; GO:0050218,lipid metabolic process [GO:0006629],mitochondrial matrix [GO:0005759],acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; propionate-CoA ligase activity [GO:0050218],GO:0003824; GO:0006629; GO:0016874; GO:0140657,catalytic activity; lipid metabolic process; ligase activity; ATP-dependent activity
OG_07545,1.0993842871121873,FUN_034126-T1,Peve_00006389,Pocillopora_meandrina_HIv1___RNAseq.g25942.t1,three_way,44.913,,,,,,,,,,,,,,,,,
OG_07546,1.5411969409008135,FUN_034128-T1,Peve_00006388,Pocillopora_meandrina_HIv1___RNAseq.g25941.t1,three_way,73.77066666666667,FUN_034128-T1,Q9JJK3,,,,,43.3,381.0,4.2e-79,296.6,sp|Q9JJK3|PEX3_CRILO Peroxisomal biogenesis factor 3 OS=Cricetulus longicaudatus OX=10030 GN=PEX3 PE=2 SV=1,,,,,,
OG_07548,3.0551469819836266,FUN_034130-T1,Peve_00006386,Pocillopora_meandrina_HIv1___RNAseq.g26664.t1,three_way,57.29133333333333,,,,,,,,,,,,,,,,,
OG_07549,1.0582698540733555,FUN_034131-T1,Peve_00006385,Pocillopora_meandrina_HIv1___RNAseq.g26665.t1,three_way,67.411,FUN_034131-T1,Q9ZE48,RL28_RICPR,,Large ribosomal subunit protein bL28 (50S ribosomal protein L28),Rickettsia prowazekii (strain Madrid E),31.0,87.0,7.7e-06,52.0,sp|Q9ZE48|RL28_RICPR Large ribosomal subunit protein bL28 OS=Rickettsia prowazekii (strain Madrid E) OX=272947 GN=rpmB PE=3 SV=1,GO:0003735; GO:0005840; GO:0006412; GO:1990904,translation [GO:0006412],ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840],structural constituent of ribosome [GO:0003735],GO:0005198; GO:0005840; GO:0043226,structural molecule activity; ribosome; organelle
OG_07551,1.3706817911172653,FUN_034135-T1,Peve_00006366,Pocillopora_meandrina_HIv1___TS.g19061.t1b,three_way,58.830333333333336,,,,,,,,,,,,,,,,,
OG_07552,1.974523559571165,FUN_034143-T1,Peve_00018766,Pocillopora_meandrina_HIv1___RNAseq.g26306.t1,three_way,76.9615,FUN_034143-T1,Q03168,,,,,61.2,335.0,1.4e-113,411.0,sp|Q03168|ASPP_AEDAE Lysosomal aspartic protease OS=Aedes aegypti OX=7159 GN=AAEL006169 PE=1 SV=2,,,,,,
OG_07553,3.456301121561094,FUN_034144-T1,Peve_00018769,Pocillopora_meandrina_HIv1___RNAseq.g26305.t1,three_way,57.939,FUN_034144-T1,Q9UPZ3,HPS5_HUMAN,,BLOC-2 complex member HPS5 (Alpha-integrin-binding protein 63) (Hermansky-Pudlak syndrome 5 protein) (Ruby-eye protein 2 homolog) (Ru2),Homo sapiens (Human),32.0,425.0,2.9e-54,216.1,sp|Q9UPZ3|HPS5_HUMAN BLOC-2 complex member HPS5 OS=Homo sapiens OX=9606 GN=HPS5 PE=1 SV=2,GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232,blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155],BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769],,GO:0005768; GO:0005829; GO:0031410; GO:0043226,endosome; cytosol; cytoplasmic vesicle; organelle
OG_07555,1.946179041556598,FUN_034159-T1,Peve_00018778,Pocillopora_meandrina_HIv1___RNAseq.g26287.t1,three_way,78.49566666666666,FUN_034159-T1,Q8CFE4,SCYL2_MOUSE,,SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa),Mus musculus (Mouse),55.5,600.0,1.7e-193,677.9,sp|Q8CFE4|SCYL2_MOUSE SCY1-like protein 2 OS=Mus musculus OX=10090 GN=Scyl2 PE=1 SV=1,GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0031623; GO:0072583; GO:0090090,brain development [GO:0007420]; clathrin-dependent endocytosis [GO:0072583]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; pyramidal neuron development [GO:0021860]; receptor internalization [GO:0031623],clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005794; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07557,1.6353336544787531,FUN_034162-T1,Peve_00039725,Pocillopora_meandrina_HIv1___RNAseq.g26285.t1,three_way,67.07516666666666,FUN_034162-T1,Q9TRY0,,,,,48.3,402.0,1.3e-98,361.7,sp|Q9TRY0|FKBP4_BOVIN Peptidyl-prolyl cis-trans isomerase FKBP4 OS=Bos taurus OX=9913 GN=FKBP4 PE=1 SV=4,,,,,,
OG_07558,1.4571486042308173,FUN_034167-T1,Peve_00039722,Pocillopora_meandrina_HIv1___RNAseq.g26282.t1,three_way,58.50483333333333,FUN_034167-T1,Q9CR48,DRAM2_MOUSE,,DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77),Mus musculus (Mouse),40.2,239.0,5.1000000000000004e-36,152.9,sp|Q9CR48|DRAM2_MOUSE DNA damage-regulated autophagy modulator protein 2 OS=Mus musculus OX=10090 GN=Dram2 PE=2 SV=1,GO:0001917; GO:0005764; GO:0005765; GO:0005794; GO:0006914; GO:0006915; GO:0007601; GO:0008283; GO:0010087; GO:0010506; GO:0016324; GO:0045494; GO:0060041,apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; phloem or xylem histogenesis [GO:0010087]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917],,GO:0005764; GO:0005773; GO:0005794; GO:0006914; GO:0012501; GO:0043226; GO:0048856; GO:0050877,lysosome; vacuole; Golgi apparatus; autophagy; programmed cell death; organelle; anatomical structure development; nervous system process
OG_07559,2.491507781876195,FUN_034173-T1,Peve_00006812,Pocillopora_meandrina_HIv1___RNAseq.g26278.t1,three_way,85.85433333333333,FUN_034173-T1,Q6UPE0,CHDH_RAT,,"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)",Rattus norvegicus (Rat),63.8,450.0,6.7e-177,621.7,"sp|Q6UPE0|CHDH_RAT Choline dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Chdh PE=1 SV=1",GO:0005743; GO:0008812; GO:0019285; GO:0050660,glycine betaine biosynthetic process from choline [GO:0019285],mitochondrial inner membrane [GO:0005743],choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660],GO:0003824; GO:0006575; GO:0016491,catalytic activity; modified amino acid metabolic process; oxidoreductase activity
OG_07563,2.066245732148575,FUN_034209-T1,Peve_00027534,Pocillopora_meandrina_HIv1___RNAseq.g26169.t1,three_way,56.48,,,,,,,,,,,,,,,,,
OG_07565,1.167376622401201,FUN_034214-T1,Peve_00027532,Pocillopora_meandrina_HIv1___RNAseq.g26163.t1,three_way,52.1425,,,,,,,,,,,,,,,,,
OG_07567,2.764236447923024,FUN_034229-T1,Peve_00040765,Pocillopora_meandrina_HIv1___RNAseq.g28437.t1,three_way,83.228,FUN_034229-T1,Q8IWQ3,BRSK2_HUMAN,,Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A),Homo sapiens (Human),50.3,650.0,3.4999999999999997e-169,596.7,sp|Q8IWQ3|BRSK2_HUMAN Serine/threonine-protein kinase BRSK2 OS=Homo sapiens OX=9606 GN=BRSK2 PE=1 SV=3,GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0019901; GO:0021953; GO:0030010; GO:0030036; GO:0030182; GO:0036503; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0106310; GO:0150034; GO:1904152; GO:2000807,"actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell division [GO:0051301]; central nervous system neuron differentiation [GO:0021953]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005783; GO:0005815; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endoplasmic reticulum; microtubule organizing center; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07568,2.0945798980902266,FUN_034230-T1,Peve_00000636,Pocillopora_meandrina_HIv1___RNAseq.g28438.t1,three_way,78.84533333333333,FUN_034230-T1,P32780,TF2H1_HUMAN,,General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit) (BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit),Homo sapiens (Human),42.3,549.0,9e-112,405.6,sp|P32780|TF2H1_HUMAN General transcription factor IIH subunit 1 OS=Homo sapiens OX=9606 GN=GTF2H1 PE=1 SV=1,GO:0000079; GO:0000439; GO:0003682; GO:0005654; GO:0005675; GO:0006281; GO:0006289; GO:0006360; GO:0006366; GO:0006367; GO:0009755; GO:0045893; GO:0046966,DNA repair [GO:0006281]; hormone-mediated signaling pathway [GO:0009755]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675],chromatin binding [GO:0003682]; nuclear thyroid hormone receptor binding [GO:0046966],GO:0005654; GO:0006281; GO:0006351; GO:0006355,nucleoplasm; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription
OG_07569,2.563732326204751,FUN_034231-T1,Peve_00000637,Pocillopora_meandrina_HIv1___RNAseq.g28439.t1,three_way,80.96333333333334,FUN_034231-T1,Q8VI63,,,,,46.2,212.0,1.0999999999999999e-47,191.4,sp|Q8VI63|MOB2_MOUSE MOB kinase activator 2 OS=Mus musculus OX=10090 GN=Mob2 PE=1 SV=1,,,,,,
OG_07570,1.2201172225401569,FUN_034232-T1,Peve_00000638,Pocillopora_meandrina_HIv1___RNAseq.g28440.t1,three_way,77.614,FUN_034232-T1,Q7ZXF5,FACR1_XENLA,,Fatty acyl-CoA reductase 1 (Far1) (EC 1.2.1.84),Xenopus laevis (African clawed frog),46.0,506.0,1e-133,478.4,sp|Q7ZXF5|FACR1_XENLA Fatty acyl-CoA reductase 1 OS=Xenopus laevis OX=8355 GN=far1 PE=2 SV=1,GO:0005777; GO:0005778; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965,ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025],peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],alcohol-forming long-chain fatty acyl-CoA reductase activity [GO:0102965]; alcohol-forming very long-chain fatty acyl-CoA reductase activity [GO:0080019],GO:0003824; GO:0005777; GO:0006629; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; peroxisome; lipid metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07577,2.122569796505534,FUN_034258-T1,Peve_00009313,Pocillopora_meandrina_HIv1___RNAseq.g26618.t1,three_way,57.11,FUN_034258-T1,A0A386CAB9,NLRP1_DANRE,,"NACHT, LRR and PYD domains-containing protein 1 homolog (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1, C-terminus (NLRP1-CT); NACHT, LRR and PYD domains-containing protein 1, N-terminus (NLRP1-NT)]",Danio rerio (Zebrafish) (Brachydanio rerio),23.4,402.0,5e-16,88.6,"sp|A0A386CAB9|NLRP1_DANRE NACHT, LRR and PYD domains-containing protein 1 homolog OS=Danio rerio OX=7955 GN=nlrp1 PE=1 SV=1",GO:0002221; GO:0005524; GO:0005737; GO:0006508; GO:0006954; GO:0008233; GO:0012501; GO:0032731; GO:0042981; GO:0045087; GO:0050729; GO:0061702; GO:0072558,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981],canonical inflammasome complex [GO:0061702]; cytoplasm [GO:0005737]; NLRP1 inflammasome complex [GO:0072558],ATP binding [GO:0005524]; peptidase activity [GO:0008233],GO:0002376; GO:0003824; GO:0006954; GO:0012501; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; inflammatory response; programmed cell death; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07580,2.1106038278042587,FUN_034263-T1,Peve_00039351,Pocillopora_meandrina_HIv1___TS.g19376.t1,three_way,59.382,FUN_034263-T1,Q6INA9,,,,,36.2,318.0,1.2999999999999998e-47,193.4,sp|Q6INA9|SETB1_XENLA Histone-lysine N-methyltransferase SETDB1 OS=Xenopus laevis OX=8355 GN=setdb1 PE=2 SV=1,,,,,,
OG_07581,1.5400559067166728,FUN_034265-T2,Peve_00039352,Pocillopora_meandrina_HIv1___RNAseq.g26635.t1,three_way,82.47233333333334,FUN_034265-T2,O15992,,,,,76.4,700.0,0.0,1118.6,sp|O15992|KARG_ANTJA Arginine kinase OS=Anthopleura japonica OX=67755 PE=1 SV=1,,,,,,
OG_07582,1.4730788487982716,FUN_034275-T1,Peve_00026012,Pocillopora_meandrina_HIv1___RNAseq.g26314.t1,three_way,81.416,FUN_034275-T1,A7RLE5,DNPH1_NEMVE,,Putative 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-),Nematostella vectensis (Starlet sea anemone),66.0,144.0,8.199999999999999e-49,194.5,sp|A7RLE5|DNPH1_NEMVE Putative 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 OS=Nematostella vectensis OX=45351 GN=v1g160099 PE=3 SV=1,GO:0005634; GO:0005737; GO:0009116; GO:0009117; GO:0009159; GO:0030307; GO:0070694,deoxyribonucleoside monophosphate catabolic process [GO:0009159]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]; positive regulation of cell growth [GO:0030307],cytoplasm [GO:0005737]; nucleus [GO:0005634],5-hydroxymethyl-dUMP N-hydrolase activity [GO:0070694],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07583,1.7218112829187309,FUN_034276-T1,Peve_00035852,Pocillopora_meandrina_HIv1___RNAseq.g26313.t1,three_way,81.86433333333333,FUN_034276-T1,Q8BGC4,PTGR3_MOUSE,,Prostaglandin reductase-3 (PTGR-3) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 2),Mus musculus (Mouse),53.3,349.0,8.2e-107,388.7,sp|Q8BGC4|PTGR3_MOUSE Prostaglandin reductase-3 OS=Mus musculus OX=10090 GN=Ptgr3 PE=1 SV=1,GO:0005739; GO:0005777; GO:0006629; GO:0008270; GO:0045599; GO:0047522,lipid metabolic process [GO:0006629]; negative regulation of fat cell differentiation [GO:0045599],mitochondrion [GO:0005739]; peroxisome [GO:0005777],15-oxoprostaglandin 13-oxidase [NAD(P)+] activity [GO:0047522]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; oxidoreductase activity; organelle
OG_07584,1.7024363020771134,FUN_034278-T1,Peve_00012564,Pocillopora_meandrina_HIv1___RNAseq.g28525.t1,three_way,80.85883333333334,FUN_034278-T1,Q0VCK5,AP2A2_BOVIN,,AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit),Bos taurus (Bovine),67.1,952.0,0.0,1247.6,sp|Q0VCK5|AP2A2_BOVIN AP-2 complex subunit alpha-2 OS=Bos taurus OX=9913 GN=AP2A2 PE=1 SV=1,GO:0006886; GO:0008289; GO:0019901; GO:0030122; GO:0035615; GO:0048268; GO:0048488; GO:0072583; GO:0097718; GO:0098793,clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488],AP-2 adaptor complex [GO:0030122]; presynapse [GO:0098793],clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901],GO:0006886; GO:0008289; GO:0016192; GO:0060090; GO:0065003,intracellular protein transport; lipid binding; vesicle-mediated transport; molecular adaptor activity; protein-containing complex assembly
OG_07588,1.008772986937206,FUN_034291-T1,Peve_00013954,Pocillopora_meandrina_HIv1___RNAseq.g28511.t1,three_way,73.35566666666666,,,,,,,,,,,,,,,,,
OG_07590,1.553709757724939,FUN_034294-T1,Peve_00013952,Pocillopora_meandrina_HIv1___RNAseq.g28509.t1,three_way,53.21816666666667,,,,,,,,,,,,,,,,,
OG_07593,2.2637756593579423,FUN_034298-T1,Peve_00013945,Pocillopora_meandrina_HIv1___RNAseq.g28503.t1,three_way,77.514,FUN_034298-T1,P28285,,,,,30.0,217.0,3.3e-14,80.9,sp|P28285|5HT2A_DROME 5-hydroxytryptamine receptor 2A OS=Drosophila melanogaster OX=7227 GN=5-HT1A PE=2 SV=2,,,,,,
OG_07595,3.188922727187017,FUN_034301-T1,Peve_00019147,Pocillopora_meandrina_HIv1___RNAseq.g28498.t1,three_way,69.90066666666667,FUN_034301-T1,Q803M5,,,,,33.4,392.0,1.2e-47,192.6,sp|Q803M5|SAAL1_DANRE Protein saal1 OS=Danio rerio OX=7955 GN=saal1 PE=2 SV=2,,,,,,
OG_07597,1.3990703382375556,FUN_034305-T1,Peve_00011309,Pocillopora_meandrina_HIv1___RNAseq.g28496.t1,three_way,63.1735,FUN_034305-T1,Q96CN9,GCC1_HUMAN,,GRIP and coiled-coil domain-containing protein 1 (Golgi coiled-coil protein 1),Homo sapiens (Human),28.7,791.0,3.6e-50,201.4,sp|Q96CN9|GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GCC1 PE=1 SV=1,GO:0000138; GO:0000139; GO:0005794; GO:0005829; GO:0031267,,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138],small GTPase binding [GO:0031267],GO:0005794; GO:0005829; GO:0043226,Golgi apparatus; cytosol; organelle
OG_07598,2.188624843541958,FUN_034312-T1,Peve_00011305,Pocillopora_meandrina_HIv1___RNAseq.g28493.t1,three_way,91.465,FUN_034312-T1,Q9VSF3,UBC2M_DROME,,Nedd8-conjugating enzyme UbcE2M (EC 2.3.2.34) (Nedd8 carrier protein),Drosophila melanogaster (Fruit fly),74.9,179.0,1.4e-77,290.4,sp|Q9VSF3|UBC2M_DROME Nedd8-conjugating enzyme UbcE2M OS=Drosophila melanogaster OX=7227 GN=UbcE2M PE=1 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0036211; GO:0045116; GO:0045879; GO:0061059; GO:0061654,negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein modification process [GO:0036211]; protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07601,1.2604786247387008,FUN_034316-T1,Peve_00025514,Pocillopora_meandrina_HIv1___RNAseq.g28488.t1,three_way,64.57783333333333,,,,,,,,,,,,,,,,,
OG_07602,2.228328319582526,FUN_034319-T1,Peve_00016715,Pocillopora_meandrina_HIv1___RNAseq.g28486.t1,three_way,86.86533333333334,FUN_034319-T1,Q501I9,,,,,33.9,445.0,1.6000000000000006e-59,231.9,sp|Q501I9|DIRC2_XENTR Solute carrier family 49 member 4 homolog OS=Xenopus tropicalis OX=8364 GN=slc49a4 PE=2 SV=1,,,,,,
OG_07605,1.76148458675844,FUN_034322-T1,Peve_00015003,Pocillopora_meandrina_HIv1___RNAseq.g28482.t1,three_way,81.48233333333333,FUN_034322-T1,Q14008,,,,,45.2,2083.0,0.0,1544.3,sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3,,,,,,
OG_07606,2.8797971501060564,FUN_034323-T1,Peve_00015002,Pocillopora_meandrina_HIv1___RNAseq.g28481.t1,three_way,65.10766666666666,FUN_034323-T1,Q3UR85,MYRF_MOUSE,,"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]",Mus musculus (Mouse),54.0,404.0,1.5000000000000001e-117,425.6,sp|Q3UR85|MYRF_MOUSE Myelin regulatory factor OS=Mus musculus OX=10090 GN=Myrf PE=1 SV=2,GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0043565; GO:0045893; GO:0048709; GO:0048714,central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0061024; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein maturation; membrane organization; catalytic activity, acting on a protein; transcription regulator activity"
OG_07607,3.709811342505699,FUN_034324-T1,Peve_00013956,Pocillopora_meandrina_HIv1___TS.g8265.t1,three_way,50.318333333333335,,,,,,,,,,,,,,,,,
OG_07611,1.951055616679226,FUN_034333-T1,Peve_00019134,Pocillopora_meandrina_HIv1___RNAseq.g28458.t2,three_way,68.18866666666666,FUN_034333-T1,Q7ZWY2,,,,,47.7,281.0,4.799999999999999e-75,282.7,sp|Q7ZWY2|PIHD1_XENLA PIH1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=pih1d1 PE=2 SV=1,,,,,,
OG_07612,1.545409227821863,FUN_034334-T1,Peve_00019131,Pocillopora_meandrina_HIv1___RNAseq.g28457.t2,three_way,78.18466666666667,FUN_034334-T1,Q8BHR8,,,,,51.1,262.0,1.0000000000000001e-71,271.6,sp|Q8BHR8|CSTP1_MOUSE Centriolar satellite-associated tubulin polyglutamylase complex regulator 1 OS=Mus musculus OX=10090 GN=Cstpp1 PE=1 SV=1,,,,,,
OG_07614,1.3039680084145255,FUN_034339-T3,Peve_00004388,Pocillopora_meandrina_HIv1___RNAseq.g26117.t1,three_way,86.5475,FUN_034339-T3,Q9H0A0,,,,,66.6,1002.0,0.0,1347.8,sp|Q9H0A0|NAT10_HUMAN RNA cytidine acetyltransferase OS=Homo sapiens OX=9606 GN=NAT10 PE=1 SV=2,,,,,,
OG_07615,1.3487161221152577,FUN_034340-T1,Peve_00004387,Pocillopora_meandrina_HIv1___RNAseq.g26119.t1,three_way,76.25116666666666,FUN_034340-T1,Q8BH18,,,,,52.8,415.0,3.0000000000000002e-123,443.7,sp|Q8BH18|TM117_MOUSE Transmembrane protein 117 OS=Mus musculus OX=10090 GN=Tmem117 PE=1 SV=1,,,,,,
OG_07619,2.160677107755396,FUN_034359-T1,Peve_00026451,Pocillopora_meandrina_HIv1___RNAseq.g26125.t2,three_way,53.81183333333333,FUN_034359-T1,Q7Z6G8,ANS1B_HUMAN,,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),Homo sapiens (Human),37.4,417.0,4.7e-65,251.9,sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2,GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013,ephrin receptor signaling pathway [GO:0048013],Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ephrin receptor binding [GO:0046875],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0043226,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; organelle
OG_07619,2.160677107755396,FUN_034359-T1,Peve_00026451,Pocillopora_meandrina_HIv1___RNAseq.g26125.t2,three_way,53.81183333333333,FUN_034359-T1,Q7Z6G8,ANS1B_HUMAN,,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),Homo sapiens (Human),56.3,158.0,7.6e-15,85.1,sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2,GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013,ephrin receptor signaling pathway [GO:0048013],Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ephrin receptor binding [GO:0046875],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0043226,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; organelle
OG_07623,2.291797800503594,FUN_034368-T1,Peve_00036157,Pocillopora_meandrina_HIv1___RNAseq.g26131.t2,three_way,72.677,FUN_034368-T1,Q9TW28,,,,,31.6,269.0,1.9e-30,135.6,sp|Q9TW28|MYOM_DICDI Myosin-M heavy chain OS=Dictyostelium discoideum OX=44689 GN=myoM PE=1 SV=1,,,,,,
OG_07624,1.8816298492531127,FUN_034370-T1,Peve_00036156,Pocillopora_meandrina_HIv1___TS.g18881.t2,three_way,70.096,FUN_034370-T1,Q4QQM4,,,,,30.7,176.0,1.7e-10,67.8,sp|Q4QQM4|P5I11_MOUSE Tumor protein p53-inducible protein 11 OS=Mus musculus OX=10090 GN=Trp53i11 PE=1 SV=1,,,,,,
OG_07626,1.0328794605179406,FUN_034372-T1,Peve_00027170,Pocillopora_meandrina_HIv1___TS.g18909.t1,three_way,77.589,FUN_034372-T1,B4G9L6,,,,,66.9,263.0,2.6e-99,363.6,sp|B4G9L6|KRR1_DROPE KRR1 small subunit processome component homolog OS=Drosophila persimilis OX=7234 GN=dbe PE=3 SV=1,,,,,,
OG_07629,1.3768035534312493,FUN_034379-T1,Peve_00027166,Pocillopora_meandrina_HIv1___RNAseq.g26152.t1,three_way,68.00166666666667,FUN_034379-T1,Q86TZ1,,,,,49.0,206.0,4.2e-56,222.6,sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1,,,,,,
OG_07631,4.051015623513701,FUN_034387-T1,Peve_00027164,Pocillopora_meandrina_HIv1___TS.g18900.t1,three_way,70.562,FUN_034387-T1,Q95K73,ELOV4_MACFA,,Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),52.3,279.0,3e-77,290.0,sp|Q95K73|ELOV4_MACFA Very long chain fatty acid elongase 4 OS=Macaca fascicularis OX=9541 GN=ELOVL4 PE=2 SV=1,GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07632,2.83241008205042,FUN_034388-T1,Peve_00027163,Pocillopora_meandrina_HIv1___RNAseq.g26149.t2,three_way,73.248,FUN_034388-T1,Q9EQC4,ELOV4_MOUSE,,Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),Mus musculus (Mouse),44.2,258.0,3.2e-57,223.4,sp|Q9EQC4|ELOV4_MOUSE Very long chain fatty acid elongase 4 OS=Mus musculus OX=10090 GN=Elovl4 PE=1 SV=2,GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07638,1.7119329595937536,FUN_034397-T1,Peve_00002472,Pocillopora_meandrina_HIv1___RNAseq.g28581.t1,three_way,61.739,FUN_034397-T1,Q20191,,,,,45.7,188.0,3.3e-39,163.7,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_07643,1.3218625012673668,FUN_034422-T1,Peve_00038700,Pocillopora_meandrina_HIv1___RNAseq.g28563.t1,three_way,91.19266666666668,FUN_034422-T1,Q6DEU9,CTR9_XENTR,,RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),77.7,896.0,0.0,1350.1,sp|Q6DEU9|CTR9_XENTR RNA polymerase-associated protein CTR9 homolog OS=Xenopus tropicalis OX=8364 GN=ctr9 PE=2 SV=1,GO:0000122; GO:0000791; GO:0001711; GO:0006368; GO:0016593; GO:0016607; GO:0019827; GO:0045638,endodermal cell fate commitment [GO:0001711]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368],Cdc73/Paf1 complex [GO:0016593]; euchromatin [GO:0000791]; nuclear speck [GO:0016607],,GO:0006355; GO:0043226,regulation of DNA-templated transcription; organelle
OG_07648,1.3538912523777584,FUN_034480-T1,Peve_00008656,Pocillopora_meandrina_HIv1___RNAseq.g25905.t1,three_way,72.97983333333333,,,,,,,,,,,,,,,,,
OG_07649,1.8964084981423357,FUN_034481-T1,Peve_00010882,Pocillopora_meandrina_HIv1___RNAseq.g28844.t1,three_way,80.02866666666667,FUN_034481-T1,P80147,GABT_PIG,,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)",Sus scrofa (Pig),53.6,459.0,4.2e-148,526.2,"sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2",GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537,gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877],4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016740; GO:0043226; GO:0050877,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; transferase activity; organelle; nervous system process
OG_07652,3.5949289108557045,FUN_034486-T1,Peve_00043236,Pocillopora_meandrina_HIv1___RNAseq.g28569.t1,three_way,78.29433333333334,FUN_034486-T1,Q13613,,,,,45.0,387.0,6.2e-98,360.5,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_07654,1.958192514473948,FUN_034488-T1,Peve_00043238,Pocillopora_meandrina_HIv1___RNAseq.g28567.t1,three_way,95.15633333333334,FUN_034488-T1,Q8JFQ2,,,,,74.8,131.0,6.7e-58,224.9,sp|Q8JFQ2|RBTN1_DANRE Rhombotin-1 OS=Danio rerio OX=7955 GN=lmo1 PE=2 SV=1,,,,,,
OG_07655,1.1338480894668628,FUN_034489-T1,Peve_00043240,Pocillopora_meandrina_HIv1___RNAseq.g28566.t1,three_way,65.82883333333334,FUN_034489-T1,Q9Y3B9,,,,,36.4,214.0,3.8e-22,106.7,sp|Q9Y3B9|RRP15_HUMAN RRP15-like protein OS=Homo sapiens OX=9606 GN=RRP15 PE=1 SV=2,,,,,,
OG_07656,1.29996799797834,FUN_034598-T1,Peve_00038719,Pocillopora_meandrina_HIv1___TS.g8610.t1,three_way,51.57266666666667,,,,,,,,,,,,,,,,,
OG_07658,1.919405960478083,FUN_034602-T1,Peve_00039727,Pocillopora_meandrina_HIv1___RNAseq.g25885.t1,three_way,43.3945,,,,,,,,,,,,,,,,,
OG_07662,1.0117247988676132,FUN_034715-T1,Peve_00014894,Pocillopora_meandrina_HIv1___RNAseq.g28726.t1,three_way,68.227,FUN_034715-T1,P31399,,,,,34.0,144.0,3.6e-21,102.8,"sp|P31399|ATP5H_RAT ATP synthase peripheral stalk subunit d, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5pd PE=1 SV=3",,,,,,
OG_07663,3.985107705812299,FUN_034717-T1,Peve_00014893,Pocillopora_meandrina_HIv1___RNAseq.g28725.t1,three_way,59.878,FUN_034717-T1,Q91754,GCKR_XENLA,,Glucokinase regulatory protein (GKRP) (Glucokinase regulator),Xenopus laevis (African clawed frog),39.5,582.0,8.800000000000001e-111,402.5,sp|Q91754|GCKR_XENLA Glucokinase regulatory protein OS=Xenopus laevis OX=8355 GN=gckr PE=1 SV=1,GO:0001678; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0009750; GO:0019210; GO:0019899; GO:0030246; GO:0033132; GO:0034504; GO:0070095; GO:0141089; GO:1901135,carbohydrate derivative metabolic process [GO:1901135]; intracellular glucose homeostasis [GO:0001678]; negative regulation of glucokinase activity [GO:0033132]; protein localization to nucleus [GO:0034504]; response to fructose [GO:0009750],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; fructose-6-phosphate binding [GO:0070095]; glucose sensor activity [GO:0141089]; kinase inhibitor activity [GO:0019210],GO:0005654; GO:0005739; GO:0005829; GO:0043226; GO:0098772; GO:0140299; GO:1901135,nucleoplasm; mitochondrion; cytosol; organelle; molecular function regulator activity; molecular sensor activity; carbohydrate derivative metabolic process
OG_07665,1.7383953700026178,FUN_034720-T1,Peve_00033269,Pocillopora_meandrina_HIv1___RNAseq.g28723.t1,three_way,62.28366666666667,FUN_034720-T1,P82094,TMF1_HUMAN,,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),Homo sapiens (Human),40.1,685.0,2.8999999999999997e-43,179.1,sp|P82094|TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens OX=9606 GN=TMF1 PE=1 SV=2,GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845,acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006355; GO:0007018; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; regulation of DNA-templated transcription; microtubule-based movement; programmed cell death; reproductive process; cell differentiation; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_07666,1.845559375407932,FUN_034721-T1,Peve_00033268,Pocillopora_meandrina_HIv1___RNAseq.g28722.t1,three_way,61.17733333333334,,,,,,,,,,,,,,,,,
OG_07670,1.5797305260380372,FUN_034727-T1,Peve_00033249,Pocillopora_meandrina_HIv1___RNAseq.g28714.t1,three_way,89.599,FUN_034727-T1,Q93009,UBP7_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7),Homo sapiens (Human),59.7,1090.0,0.0,1328.5,sp|Q93009|UBP7_HUMAN Ubiquitin carboxyl-terminal hydrolase 7 OS=Homo sapiens OX=9606 GN=USP7 PE=1 SV=2,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006283; GO:0006307; GO:0006508; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0042752; GO:0044027; GO:0045721; GO:0048511; GO:0050821; GO:0051090; GO:0070203; GO:0075342; GO:0101005; GO:1901796; GO:1904262; GO:1904353; GO:1905279; GO:1990380,"DNA alkylation repair [GO:0006307]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of TORC1 signaling [GO:1904262]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of establishment of protein localization to telomere [GO:0070203]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; symbiont-mediated disruption of host cell PML body [GO:0075342]; transcription-coupled nucleotide-excision repair [GO:0006283]",chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07671,2.574118094188304,FUN_034738-T1,Peve_00010863,Pocillopora_meandrina_HIv1___RNAseq.g25891.t1,three_way,58.40533333333333,,,,,,,,,,,,,,,,,
OG_07672,2.4729372293066287,FUN_034779-T1,Peve_00043699,Pocillopora_meandrina_HIv1___RNAseq.g6184.t1,three_way,61.442,FUN_034779-T1,Q6P3X3,,,,,35.9,830.0,6.2999999999999996e-136,486.5,sp|Q6P3X3|TTC27_HUMAN Tetratricopeptide repeat protein 27 OS=Homo sapiens OX=9606 GN=TTC27 PE=1 SV=1,,,,,,
OG_07673,1.2311880291359631,FUN_034780-T1,Peve_00029729,Pocillopora_meandrina_HIv1___RNAseq.g12275.t1,three_way,82.57533333333333,FUN_034780-T1,Q9Y4W6,AFG32_HUMAN,,Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein),Homo sapiens (Human),68.9,637.0,6.099999999999999e-247,855.1,sp|Q9Y4W6|AFG32_HUMAN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Homo sapiens OX=9606 GN=AFG3L2 PE=1 SV=2,GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0030163; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0051604; GO:0055001; GO:0060013; GO:0072753; GO:0110097; GO:0141164,axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0055085; GO:0061024; GO:0140096; GO:0140657,"catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; cell junction organization; organelle; anatomical structure development; protein maturation; transmembrane transport; membrane organization; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07676,2.756759291164184,FUN_034785-T1,Peve_00029735,Pocillopora_meandrina_HIv1___RNAseq.g12280.t2,three_way,53.20216666666666,FUN_034785-T1,O08699,PGDH_RAT,,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)",Rattus norvegicus (Rat),39.5,205.0,1.4e-37,157.9,sp|O08699|PGDH_RAT 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Rattus norvegicus OX=10116 GN=Hpgd PE=1 SV=2,GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654],"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957]",GO:0003824; GO:0005615; GO:0005654; GO:0005829; GO:0006629; GO:0016491; GO:0022414; GO:0048856; GO:0060089,catalytic activity; extracellular space; nucleoplasm; cytosol; lipid metabolic process; oxidoreductase activity; reproductive process; anatomical structure development; molecular transducer activity
OG_07677,1.7826861613130736,FUN_034795-T1,Peve_00007519,Pocillopora_meandrina_HIv1___RNAseq.g12295.t1,three_way,68.32300000000001,FUN_034795-T1,Q5RFU0,,,,,42.2,500.0,3.2999999999999996e-114,413.7,sp|Q5RFU0|SIAE_PONAB Sialate O-acetylesterase OS=Pongo abelii OX=9601 GN=SIAE PE=2 SV=1,,,,,,
OG_07680,1.161506346869425,FUN_034798-T1,Peve_00007516,Pocillopora_meandrina_HIv1___RNAseq.g12298.t1,three_way,81.09333333333333,FUN_034798-T1,Q09470,KCNA1_HUMAN,,Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1),Homo sapiens (Human),52.4,336.0,1.3000000000000001e-71,271.9,sp|Q09470|KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens OX=9606 GN=KCNA1 PE=1 SV=2,GO:0001508; GO:0001964; GO:0005249; GO:0005251; GO:0005783; GO:0005829; GO:0005886; GO:0006937; GO:0007405; GO:0008076; GO:0009986; GO:0010644; GO:0010960; GO:0016020; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0070161; GO:0071286; GO:0071805; GO:0086011; GO:0097718,action potential [GO:0001508]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; membrane repolarization during action potential [GO:0086011]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],anchoring junction [GO:0070161]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; protein-containing complex assembly
OG_07681,1.0505959060030854,FUN_034799-T1,Peve_00007557,Pocillopora_meandrina_HIv1___RNAseq.g12300.t1,three_way,88.019,FUN_034799-T1,O14744,,,,,58.5,626.0,8.5e-215,748.0,sp|O14744|ANM5_HUMAN Protein arginine N-methyltransferase 5 OS=Homo sapiens OX=9606 GN=PRMT5 PE=1 SV=4,,,,,,
OG_07683,1.8758162677307009,FUN_034801-T1,Peve_00007555,Pocillopora_meandrina_HIv1___RNAseq.g12302.t1,three_way,39.9515,,,,,,,,,,,,,,,,,
OG_07685,1.3341795936215624,FUN_034805-T1,Peve_00007538,Pocillopora_meandrina_HIv1___RNAseq.g12305.t1,three_way,80.764,FUN_034805-T1,P21894,,,,,53.6,623.0,2.3000000000000004e-180,633.6,"sp|P21894|SYAC_BOMMO Alanine--tRNA ligase, cytoplasmic OS=Bombyx mori OX=7091 PE=1 SV=1",,,,,,
OG_07686,1.235189744883388,FUN_034807-T1,Peve_00007533,Pocillopora_meandrina_HIv1___RNAseq.g12306.t1,three_way,71.20566666666667,FUN_034807-T1,Q08BG1,,,,,39.2,400.0,4.3e-80,300.1,sp|Q08BG1|TMPPE_DANRE Transmembrane protein with metallophosphoesterase domain OS=Danio rerio OX=7955 GN=tmppe PE=2 SV=1,,,,,,
OG_07687,1.6097492772996096,FUN_034808-T1,Peve_00034936,Pocillopora_meandrina_HIv1___RNAseq.g12307.t1,three_way,87.922,FUN_034808-T1,Q5R4A0,UBA3_PONAB,,NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),68.8,432.0,2.3e-185,649.8,sp|Q5R4A0|UBA3_PONAB NEDD8-activating enzyme E1 catalytic subunit OS=Pongo abelii OX=9601 GN=UBA3 PE=2 SV=2,GO:0005524; GO:0005634; GO:0005737; GO:0007113; GO:0019781; GO:0032991; GO:0042802; GO:0045116; GO:0046982; GO:0051726,endomitotic cell cycle [GO:0007113]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726],cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982],GO:0000278; GO:0003824; GO:0005634; GO:0016874; GO:0043226; GO:0140096; GO:0140657,"mitotic cell cycle; catalytic activity; nucleus; ligase activity; organelle; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07689,2.2775189026594025,FUN_034812-T1,Peve_00003622,Pocillopora_meandrina_HIv1___TS.g3642.t1,three_way,57.64416666666666,FUN_034812-T1,Q9BQ04,RBM4B_HUMAN,,RNA-binding protein 4B (RNA-binding motif protein 30) (RNA-binding motif protein 4B) (RNA-binding protein 30),Homo sapiens (Human),48.0,75.0,5.9e-13,75.9,sp|Q9BQ04|RBM4B_HUMAN RNA-binding protein 4B OS=Homo sapiens OX=9606 GN=RBM4B PE=1 SV=1,GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006397; GO:0006417; GO:0007623; GO:0008270; GO:0008380; GO:0010628; GO:0016607; GO:0032922; GO:0032991; GO:0043153,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA processing [GO:0006397]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0016071; GO:0043226,RNA binding; nucleoplasm; nucleolus; cytosol; mRNA metabolic process; organelle
OG_07693,1.2297355649711503,FUN_034821-T1,Peve_00040559,Pocillopora_meandrina_HIv1___RNAseq.g27215.t1b,three_way,71.47466666666666,FUN_034821-T1,Q96AQ8,MCUR1_HUMAN,,"Mitochondrial calcium uniporter regulator 1 (MCU regulator 1) (Coiled-coil domain-containing protein 90A, mitochondrial)",Homo sapiens (Human),37.8,193.0,1.1e-22,108.6,sp|Q96AQ8|MCUR1_HUMAN Mitochondrial calcium uniporter regulator 1 OS=Homo sapiens OX=9606 GN=MCUR1 PE=1 SV=1,GO:0005739; GO:0005743; GO:0006851; GO:0036444; GO:0051561; GO:0070509,calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],,GO:0005739; GO:0043226; GO:0055085,mitochondrion; organelle; transmembrane transport
OG_07695,1.361063387628484,FUN_034828-T1,Peve_00040552,Pocillopora_meandrina_HIv1___RNAseq.g27178.t1,three_way,86.10566666666666,FUN_034828-T1,P05202,AATM_MOUSE,,"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)",Mus musculus (Mouse),70.4,406.0,6.100000000000001e-180,631.7,"sp|P05202|AATM_MOUSE Aspartate aminotransferase, mitochondrial OS=Mus musculus OX=10090 GN=Got2 PE=1 SV=1",GO:0004069; GO:0005739; GO:0005743; GO:0005759; GO:0005886; GO:0006103; GO:0006107; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0006538; GO:0015908; GO:0016212; GO:0019550; GO:0030170; GO:0043209; GO:0043490; GO:0045471,2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; fatty acid transport [GO:0015908]; glutamate catabolic process [GO:0006538]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; malate-aspartate shuttle [GO:0043490]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0005886; GO:0006520; GO:0016740; GO:0043226; GO:0055086,catalytic activity; mitochondrion; plasma membrane; amino acid metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07696,3.507633777985506,FUN_034829-T1,Peve_00040555,Pocillopora_meandrina_HIv1___RNAseq.g27179.t1,three_way,62.16466666666667,,,,,,,,,,,,,,,,,
OG_07698,2.2629526390269525,FUN_034832-T1,Peve_00006740,Pocillopora_meandrina_HIv1___TS.g14528.t1,three_way,88.521,FUN_034832-T1,O35242,,,,,46.1,921.0,1.3e-227,791.2,sp|O35242|FAN_MOUSE Protein FAN OS=Mus musculus OX=10090 GN=Nsmaf PE=1 SV=2,,,,,,
OG_07700,1.5480805883200388,FUN_034834-T1,Peve_00010452,Pocillopora_meandrina_HIv1___RNAseq.g27184.t1,three_way,72.52166666666666,FUN_034834-T1,Q7TT47,,,,,53.2,637.0,7.000000000000001e-182,639.0,sp|Q7TT47|SPG7_RAT Mitochondrial inner membrane m-AAA protease component paraplegin OS=Rattus norvegicus OX=10116 GN=Spg7 PE=2 SV=2,,,,,,
OG_07703,1.375831355225662,FUN_034837-T1,Peve_00010449,Pocillopora_meandrina_HIv1___RNAseq.g27187.t1,three_way,85.81433333333334,FUN_034837-T1,Q6IWL4,TRAF6_DANRE,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Danio rerio (Zebrafish) (Brachydanio rerio),29.9,157.0,1.4e-08,62.0,sp|Q6IWL4|TRAF6_DANRE TNF receptor-associated factor 6 OS=Danio rerio OX=7955 GN=traf6 PE=1 SV=2,GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0008270; GO:0009615; GO:0009617; GO:0009898; GO:0031663; GO:0035591; GO:0038061; GO:0042981; GO:0043122; GO:0045087; GO:0045893; GO:0061630; GO:0070534; GO:0098978,innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of DNA-templated transcription [GO:0045893]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; response to bacterium [GO:0009617]; response to virus [GO:0009615],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634],signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07704,1.9182392084893591,FUN_034842-T1,Peve_00037379,Pocillopora_meandrina_HIv1___RNAseq.g27193.t1,three_way,74.40350000000001,FUN_034842-T1,Q7TMC8,FCSK_MOUSE,,L-fucose kinase (Fucokinase) (EC 2.7.1.52),Mus musculus (Mouse),43.7,1102.0,5.899999999999997e-243,842.4,sp|Q7TMC8|FCSK_MOUSE L-fucose kinase OS=Mus musculus OX=10090 GN=Fcsk PE=1 SV=1,GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201,carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352],cytosol [GO:0005829],ATP binding [GO:0005524]; fucokinase activity [GO:0050201],GO:0003824; GO:0005829; GO:0005975; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07707,1.7622091354077587,FUN_034849-T1,Peve_00037374,Pocillopora_meandrina_HIv1___RNAseq.g12146.t1,three_way,54.702333333333335,FUN_034849-T1,Q5ZMS4,,,,,46.5,157.0,1.1e-37,159.8,sp|Q5ZMS4|NCOA7_CHICK Nuclear receptor coactivator 7 OS=Gallus gallus OX=9031 GN=NCOA7 PE=2 SV=1,,,,,,
OG_07710,1.169020452951671,FUN_034856-T1,Peve_00008083,Pocillopora_meandrina_HIv1___TS.g3494.t2,three_way,93.22233333333334,FUN_034856-T1,Q6DJE4,CPSF5_XENLA,,Cleavage and polyadenylation specificity factor subunit 5 (Nudix hydrolase 21),Xenopus laevis (African clawed frog),83.1,195.0,4e-94,345.5,sp|Q6DJE4|CPSF5_XENLA Cleavage and polyadenylation specificity factor subunit 5 OS=Xenopus laevis OX=8355 GN=nudt21 PE=2 SV=1,GO:0003729; GO:0005634; GO:0005737; GO:0005849; GO:0006397; GO:0010608; GO:0030154; GO:0031124; GO:0035925; GO:0042382; GO:0042802; GO:0051290; GO:0110104; GO:0180010; GO:2000738; GO:2000975,"cell differentiation [GO:0030154]; co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; post-transcriptional regulation of gene expression [GO:0010608]; protein heterotetramerization [GO:0051290]",cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382],identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729],GO:0003723; GO:0005634; GO:0016071; GO:0030154; GO:0043226; GO:0065003,RNA binding; nucleus; mRNA metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_07711,2.755847252839151,FUN_034859-T1,Peve_00008084,Pocillopora_meandrina_HIv1___RNAseq.g12156.t1,three_way,75.80933333333333,FUN_034859-T1,Q80V03,,,,,50.4,538.0,3.3e-152,540.0,sp|Q80V03|ADCK5_MOUSE Uncharacterized aarF domain-containing protein kinase 5 OS=Mus musculus OX=10090 GN=Adck5 PE=2 SV=2,,,,,,
OG_07717,1.1231345366034493,FUN_034871-T1,Peve_00005768,Pocillopora_meandrina_HIv1___RNAseq.g27160.t1,three_way,85.68666666666667,FUN_034871-T1,Q5RDE7,NFS1_PONAB,,Cysteine desulfurase (EC 2.8.1.7),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),74.5,432.0,4.7e-191,668.7,sp|Q5RDE7|NFS1_PONAB Cysteine desulfurase OS=Pongo abelii OX=9601 GN=NFS1 PE=2 SV=1,GO:0005634; GO:0005739; GO:0005813; GO:0005829; GO:0006777; GO:0030170; GO:0031071; GO:0042803; GO:0044571; GO:0044572; GO:0046872; GO:0051536; GO:0099128,[2Fe-2S] cluster assembly [GO:0044571]; [4Fe-4S] cluster assembly [GO:0044572]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrial [2Fe-2S] assembly complex [GO:0099128]; mitochondrion [GO:0005739]; nucleus [GO:0005634],cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0016740; GO:0043226,catalytic activity; nucleus; mitochondrion; microtubule organizing center; cytosol; transferase activity; organelle
OG_07726,1.515405142494841,FUN_034887-T1,Peve_00009321,Pocillopora_meandrina_HIv1___RNAseq.g27811.t1,three_way,76.001,FUN_034887-T1,Q5U4I3,,,,,37.3,324.0,1.4e-54,214.9,sp|Q5U4I3|CCDB1_XENLA Cyclin-D1-binding protein 1 homolog OS=Xenopus laevis OX=8355 GN=ccndbp1 PE=2 SV=2,,,,,,
OG_07727,1.0940526244465816,FUN_034888-T1,Peve_00023804,Pocillopora_meandrina_HIv1___RNAseq.g27810.t1,three_way,82.89466666666667,FUN_034888-T1,A7RRG3,AKTIP_NEMVE,,Protein AKTIP homolog (Fused toes protein homolog),Nematostella vectensis (Starlet sea anemone),69.6,306.0,1e-120,434.5,sp|A7RRG3|AKTIP_NEMVE Protein AKTIP homolog OS=Nematostella vectensis OX=45351 GN=v1g232160 PE=3 SV=1,,,,,,
OG_07728,2.063312950339499,FUN_034889-T1,Peve_00037341,Pocillopora_meandrina_HIv1___RNAseq.g27809.t1,three_way,78.04,FUN_034889-T1,Q6P1X6,,,,,54.9,175.0,1.5e-52,207.6,sp|Q6P1X6|CH082_HUMAN UPF0598 protein C8orf82 OS=Homo sapiens OX=9606 GN=C8orf82 PE=1 SV=2,,,,,,
OG_07732,3.5068268796703483,FUN_034893-T1,Peve_00037337,Pocillopora_meandrina_HIv1___RNAseq.g27805.t1,three_way,60.900333333333336,FUN_034893-T1,Q8R4E9,CDT1_MOUSE,,DNA replication factor Cdt1 (Double parked homolog) (DUP) (Retroviral insertion site 2 protein),Mus musculus (Mouse),32.5,449.0,1.2e-50,203.0,sp|Q8R4E9|CDT1_MOUSE DNA replication factor Cdt1 OS=Mus musculus OX=10090 GN=Cdt1 PE=1 SV=1,GO:0000076; GO:0000776; GO:0003677; GO:0003682; GO:0005634; GO:0016604; GO:0030174; GO:0033262; GO:0051315; GO:0071163; GO:0072708; GO:2000104; GO:2000105,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; DNA replication checkpoint signaling [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of DNA-templated DNA replication [GO:2000104]; positive regulation of DNA-templated DNA replication [GO:2000105]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708],kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0043226; GO:0065003,DNA binding; nucleus; organelle; protein-containing complex assembly
OG_07735,1.3153950694989045,FUN_034912-T1,Peve_00039143,Pocillopora_meandrina_HIv1___RNAseq.g14669.t1,three_way,80.86066666666667,FUN_034912-T1,A5D6U8,ACP7_DANRE,,Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form),Danio rerio (Zebrafish) (Brachydanio rerio),45.3,426.0,1.1e-94,348.6,sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1,GO:0003993; GO:0005576; GO:0046872,,extracellular region [GO:0005576],acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0016787,catalytic activity; extracellular region; hydrolase activity
OG_07736,2.1700095907872705,FUN_034913-T1,Peve_00039132,Pocillopora_meandrina_HIv1___RNAseq.g12143.t1,three_way,89.33033333333333,FUN_034913-T1,Q21305,SOX2_CAEEL,,Transcription factor sox-2,Caenorhabditis elegans,71.1,90.0,2.6000000000000002e-30,134.0,sp|Q21305|SOX2_CAEEL Transcription factor sox-2 OS=Caenorhabditis elegans OX=6239 GN=sox-2 PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0005634; GO:0007420; GO:0030182; GO:0036498; GO:0045944; GO:0048665,brain development [GO:0007420]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07737,3.4988772289424475,FUN_034914-T1,Peve_00009290,Pocillopora_meandrina_HIv1___RNAseq.g27121.t1,three_way,69.19466666666666,FUN_034914-T1,B5X4H8,,,,,41.4,452.0,1.5e-80,301.6,sp|B5X4H8|RFT2_SALSA Riboflavin transporter 2 OS=Salmo salar OX=8030 GN=rft2 PE=2 SV=1,,,,,,
OG_07740,2.0828181566386648,FUN_034919-T1,Peve_00039137,Pocillopora_meandrina_HIv1___TS.g3478.t2,three_way,88.44266666666667,FUN_034919-T1,Q5R7R6,COG4_PONAB,,Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),53.4,761.0,1.5e-213,744.2,sp|Q5R7R6|COG4_PONAB Conserved oligomeric Golgi complex subunit 4 OS=Pongo abelii OX=9601 GN=COG4 PE=2 SV=1,GO:0000139; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119,"Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119],,GO:0005829; GO:0016192,cytosol; vesicle-mediated transport
OG_07744,1.0871512652079922,FUN_034931-T1,Peve_00018022,Pocillopora_meandrina_HIv1___TS.g15166.t1a,three_way,46.51616666666666,FUN_034931-T1,F1NPG5,,,,,49.1,110.0,2.4e-24,114.8,sp|F1NPG5|CENPT_CHICK Centromere protein T OS=Gallus gallus OX=9031 GN=CENPT PE=1 SV=2,,,,,,
OG_07745,1.329408410386926,FUN_034933-T1,Peve_00018027,Pocillopora_meandrina_HIv1___RNAseq.10949_t,three_way,79.33566666666667,FUN_034933-T1,O75177,CREST_HUMAN,,Calcium-responsive transactivator (SS18-like protein 1) (SYT homolog 1),Homo sapiens (Human),44.8,154.0,2.3e-20,101.3,sp|O75177|CREST_HUMAN Calcium-responsive transactivator OS=Homo sapiens OX=9606 GN=SS18L1 PE=1 SV=2,GO:0000776; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0016358; GO:0045893; GO:0045944; GO:0050775; GO:0071565,chromatin organization [GO:0006325]; dendrite development [GO:0016358]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytosol [GO:0005829]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription coactivator activity [GO:0003713],GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; cytosol; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_07747,1.834415281283352,FUN_034936-T1,Peve_00018032,Pocillopora_meandrina_HIv1___RNAseq.g27830.t1,three_way,67.77,FUN_034936-T1,Q75QN2,INT8_HUMAN,,Integrator complex subunit 8 (Int8) (Protein kaonashi-1),Homo sapiens (Human),29.4,1071.0,1.8e-108,395.6,sp|Q75QN2|INT8_HUMAN Integrator complex subunit 8 OS=Homo sapiens OX=9606 GN=INTS8 PE=1 SV=1,GO:0000785; GO:0005634; GO:0005654; GO:0016180; GO:0032039; GO:0034243; GO:0034472; GO:0071168; GO:0160232; GO:0160240,protein localization to chromatin [GO:0071168]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],chromatin [GO:0000785]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0006355; GO:0016073; GO:0043226,nucleus; nucleoplasm; regulation of DNA-templated transcription; snRNA metabolic process; organelle
OG_07751,1.7351632708232714,FUN_034941-T1,Peve_00028352,Pocillopora_meandrina_HIv1___RNAseq.g12180.t1,three_way,86.32333333333334,FUN_034941-T1,Q3KQF4,,,,,48.4,124.0,2.1e-29,131.3,sp|Q3KQF4|LRC69_XENLA Leucine-rich repeat-containing protein 69 OS=Xenopus laevis OX=8355 GN=lrrc69 PE=2 SV=1,,,,,,
OG_07752,1.751007764829557,FUN_034942-T1,Peve_00028348,Pocillopora_meandrina_HIv1___RNAseq.g12181.t1,three_way,62.79666666666667,FUN_034942-T1,Q91WE2,,,,,50.6,164.0,6.1e-31,136.0,sp|Q91WE2|PIP30_MOUSE PSME3-interacting protein OS=Mus musculus OX=10090 GN=Psme3ip1 PE=1 SV=1,,,,,,
OG_07754,2.072469194773176,FUN_034946-T1,Peve_00036664,Pocillopora_meandrina_HIv1___RNAseq.g27857.t1,three_way,50.61566666666667,FUN_034946-T1,Q4R366,MRPP3_MACFA,,Mitochondrial ribonuclease P catalytic subunit (EC 3.1.26.5) (Mitochondrial ribonuclease P protein 3) (Mitochondrial RNase P protein 3),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),23.9,414.0,2.8e-19,98.2,sp|Q4R366|MRPP3_MACFA Mitochondrial ribonuclease P catalytic subunit OS=Macaca fascicularis OX=9541 GN=PRORP PE=2 SV=2,GO:0001682; GO:0004526; GO:0030678; GO:0046872; GO:0097745,mitochondrial tRNA 5'-end processing [GO:0097745]; tRNA 5'-leader removal [GO:0001682],mitochondrial ribonuclease P complex [GO:0030678],metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526],GO:0003824; GO:0006399; GO:0016787; GO:0140053; GO:0140098,"catalytic activity; tRNA metabolic process; hydrolase activity; mitochondrial gene expression; catalytic activity, acting on RNA"
OG_07756,1.0135542581809531,FUN_034949-T1,Peve_00036668,Pocillopora_meandrina_HIv1___RNAseq.g27855.t1,three_way,73.09133333333334,FUN_034949-T1,Q6E2N3,TRI33_DANRE,,E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33),Danio rerio (Zebrafish) (Brachydanio rerio),25.4,323.0,9.1e-25,116.7,sp|Q6E2N3|TRI33_DANRE E3 ubiquitin-protein ligase TRIM33 OS=Danio rerio OX=7955 GN=trim33 PE=2 SV=1,GO:0000785; GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266,developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation by RNA polymerase II [GO:0034243],chromatin [GO:0000785]; nucleus [GO:0005634],DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0048870,immune system process; DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; anatomical structure development; cell motility
OG_07757,1.0619343979348717,FUN_034950-T1,Peve_00036669,Pocillopora_meandrina_HIv1___TS.g15196.t1,three_way,81.33766666666666,FUN_034950-T1,Q1LU86,CBAR1_DANRE,,CBY1-interacting BAR domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),41.6,219.0,6.2e-40,166.0,sp|Q1LU86|CBAR1_DANRE CBY1-interacting BAR domain-containing protein 1 OS=Danio rerio OX=7955 GN=cibar1 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005929; GO:0007007; GO:0007283; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0097227; GO:0097546,cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of smoothened signaling pathway [GO:0045880]; spermatogenesis [GO:0007283],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; sperm annulus [GO:0097227],,GO:0005634; GO:0005815; GO:0005929; GO:0007005; GO:0022414; GO:0043226; GO:0044782; GO:0061024,nucleus; microtubule organizing center; cilium; mitochondrion organization; reproductive process; organelle; cilium organization; membrane organization
OG_07758,1.3668575671974772,FUN_034951-T1,Peve_00036670,Pocillopora_meandrina_HIv1___RNAseq.g27851.t1,three_way,76.332,FUN_034951-T1,Q9H490,,,,,43.1,429.0,7.6e-88,325.9,sp|Q9H490|PIGU_HUMAN GPI-anchor transamidase component PIGU OS=Homo sapiens OX=9606 GN=PIGU PE=1 SV=3,,,,,,
OG_07759,2.203915503099963,FUN_034953-T1,Peve_00036672,Pocillopora_meandrina_HIv1___TS.g15182.t2,three_way,75.75533333333334,FUN_034953-T1,Q944H0,,,,,50.2,488.0,3.1e-143,510.0,sp|Q944H0|PEAM2_ARATH Phosphoethanolamine N-methyltransferase 2 OS=Arabidopsis thaliana OX=3702 GN=NMT2 PE=1 SV=2,,,,,,
OG_07761,1.4829177394491349,FUN_034955-T1,Peve_00036678,Pocillopora_meandrina_HIv1___RNAseq.g27837.t1,three_way,88.89633333333333,FUN_034955-T1,Q75WB5,,,,,64.3,1304.0,0.0,1668.7,sp|Q75WB5|OPLA_BOVIN 5-oxoprolinase OS=Bos taurus OX=9913 GN=OPLAH PE=1 SV=2,,,,,,
OG_07762,6.238099064316252,FUN_034956-T1,Peve_00036680,Pocillopora_meandrina_HIv1___RNAseq.g27836.t1,three_way,74.127,FUN_034956-T1,P39949,CCNE1_RAT,,G1/S-specific cyclin-E1,Rattus norvegicus (Rat),51.8,311.0,1.5e-85,318.2,sp|P39949|CCNE1_RAT G1/S-specific cyclin-E1 OS=Rattus norvegicus OX=10116 GN=Ccne1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0001547; GO:0001889; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0006270; GO:0007129; GO:0009410; GO:0014074; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0031100; GO:0031670; GO:0032355; GO:0032570; GO:0032880; GO:0033197; GO:0034097; GO:0044877; GO:0045471; GO:0045597; GO:0048545; GO:0051301; GO:0051412; GO:0051597; GO:0051726; GO:0070192; GO:0097134; GO:1900087; GO:1902462,animal organ regeneration [GO:0031100]; antral ovarian follicle growth [GO:0001547]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to progesterone [GO:0032570]; response to purine-containing compound [GO:0014074]; response to steroid hormone [GO:0048545]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016740; GO:0022414; GO:0032200; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; transferase activity; reproductive process; telomere organization; organelle; anatomical structure development; molecular function regulator activity
OG_07764,4.537105306298807,FUN_034958-T1,Peve_00036684,Pocillopora_meandrina_HIv1___RNAseq.g27833.t1,three_way,75.85683333333333,FUN_034958-T1,Q8IXH6,T53I2_HUMAN,,Tumor protein p53-inducible nuclear protein 2 (Diabetes and obesity-regulated gene) (p53-inducible protein U) (PIG-U),Homo sapiens (Human),47.5,80.0,5.2e-12,72.8,sp|Q8IXH6|T53I2_HUMAN Tumor protein p53-inducible nuclear protein 2 OS=Homo sapiens OX=9606 GN=TP53INP2 PE=1 SV=2,GO:0000045; GO:0001649; GO:0001894; GO:0005634; GO:0005776; GO:0005829; GO:0006511; GO:0008104; GO:0016605; GO:0031410; GO:0043130; GO:0045893; GO:1903828,autophagosome assembly [GO:0000045]; negative regulation of protein localization [GO:1903828]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization [GO:0008104]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511],autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605],ubiquitin binding [GO:0043130],GO:0005634; GO:0005773; GO:0005829; GO:0006355; GO:0030154; GO:0031410; GO:0043226,nucleus; vacuole; cytosol; regulation of DNA-templated transcription; cell differentiation; cytoplasmic vesicle; organelle
OG_07766,3.149470649114841,FUN_034961-T1,Peve_00028347,Pocillopora_meandrina_HIv1___RNAseq.g12173.t1,three_way,58.9135,FUN_034961-T1,P0C7T6,ATX1L_MOUSE,,Ataxin-1-like (Brother of ataxin-1),Mus musculus (Mouse),46.0,150.0,1.8e-30,135.6,sp|P0C7T6|ATX1L_MOUSE Ataxin-1-like OS=Mus musculus OX=10090 GN=Atxn1l PE=1 SV=1,GO:0000122; GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006366; GO:0007420; GO:0007612; GO:0007613; GO:0030198; GO:0030425; GO:0031208; GO:0035176; GO:0048286; GO:1902035,brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; social behavior [GO:0035176]; transcription by RNA polymerase II [GO:0006366],dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006351; GO:0006355; GO:0030198; GO:0043226; GO:0048856; GO:0050877,DNA binding; RNA binding; nucleoplasm; nucleolus; DNA-templated transcription; regulation of DNA-templated transcription; extracellular matrix organization; organelle; anatomical structure development; nervous system process
OG_07769,1.9224472768458567,FUN_034972-T1,Peve_00028365,Pocillopora_meandrina_HIv1___RNAseq.g12164.t1,three_way,71.28216666666667,FUN_034972-T1,Q91820,AURAA_XENLA,,Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265),Xenopus laevis (African clawed frog),63.3,341.0,1.5e-121,437.6,sp|Q91820|AURAA_XENLA Aurora kinase A-A OS=Xenopus laevis OX=8355 GN=aurka-a PE=1 SV=1,GO:0000212; GO:0000776; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0007052; GO:0007100; GO:0008017; GO:0018105; GO:0019894; GO:0032133; GO:0032465; GO:0046777; GO:0051233; GO:0051301; GO:0090307; GO:0106310,cell division [GO:0051301]; meiotic spindle organization [GO:0000212]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_07771,2.3767156952541018,FUN_034974-T1,Peve_00028360,Pocillopora_meandrina_HIv1___RNAseq.g12162.t1,three_way,65.07733333333333,FUN_034974-T1,Q8K4T5,DUS19_MOUSE,,Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1),Mus musculus (Mouse),43.9,198.0,3.4e-40,166.4,sp|Q8K4T5|DUS19_MOUSE Dual specificity protein phosphatase 19 OS=Mus musculus OX=10090 GN=Dusp19 PE=2 SV=1,GO:0004722; GO:0004725; GO:0004860; GO:0005078; GO:0005737; GO:0007254; GO:0008138; GO:0008330; GO:0008579; GO:0030295; GO:0031434; GO:0031435; GO:0043409; GO:0043410; GO:0046329; GO:0046330,JNK cascade [GO:0007254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410],cytoplasm [GO:0005737],JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0016787; GO:0060090; GO:0098772; GO:0140096,"catalytic activity; hydrolase activity; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07775,1.527303864127525,FUN_034990-T1,Peve_00024609,Pocillopora_meandrina_HIv1___RNAseq.g12120.t1,three_way,92.32533333333332,FUN_034990-T1,O08654,,,,,63.1,295.0,1.8e-106,387.1,sp|O08654|PHAF1_RAT Phagosome assembly factor 1 OS=Rattus norvegicus OX=10116 GN=Phaf1 PE=2 SV=1,,,,,,
OG_07779,2.519719427486769,FUN_034996-T1,Peve_00024602,Pocillopora_meandrina_HIv1___RNAseq.g12126.t1,three_way,68.37866666666666,FUN_034996-T1,Q923X6,,,,,27.8,299.0,3.7e-18,94.0,sp|Q923X6|TAA7E_RAT Trace amine-associated receptor 7e OS=Rattus norvegicus OX=10116 GN=Taar7e PE=3 SV=1,,,,,,
OG_07780,1.7557981796295077,FUN_034997-T1,Peve_00024600,Pocillopora_meandrina_HIv1___RNAseq.g4153.t1,three_way,61.30266666666667,FUN_034997-T1,Q8K4Z4,,,,,28.7,310.0,2e-22,108.2,sp|Q8K4Z4|ADRB2_CAVPO Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1,,,,,,
OG_07781,1.190580098299295,FUN_034998-T1,Peve_00024599,Pocillopora_meandrina_HIv1___RNAseq.g12127.t1,three_way,52.55766666666667,FUN_034998-T1,P14316,IRF2_HUMAN,,Interferon regulatory factor 2 (IRF-2),Homo sapiens (Human),48.2,110.0,5.3e-27,124.0,sp|P14316|IRF2_HUMAN Interferon regulatory factor 2 OS=Homo sapiens OX=9606 GN=IRF2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006355; GO:0006357; GO:0008283; GO:0045944; GO:0051607; GO:1990837,cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,immune system process; DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07782,1.708242321288041,FUN_035002-T1,Peve_00024598,Pocillopora_meandrina_HIv1___RNAseq.g12128.t1,three_way,74.33966666666667,FUN_035002-T1,Q9NRW4,,,,,54.7,172.0,8e-51,201.8,sp|Q9NRW4|DUS22_HUMAN Dual specificity protein phosphatase 22 OS=Homo sapiens OX=9606 GN=DUSP22 PE=1 SV=1,,,,,,
OG_07783,2.2895385032230573,FUN_035003-T1,Peve_00024597,Pocillopora_meandrina_HIv1___RNAseq.g12129.t1,three_way,63.208333333333336,FUN_035003-T1,P23819,,,,,30.4,874.0,3.8e-97,357.8,sp|P23819|GRIA2_MOUSE Glutamate receptor 2 OS=Mus musculus OX=10090 GN=Gria2 PE=1 SV=3,,,,,,
OG_07787,1.6471920837287084,FUN_035008-T1,Peve_00024587,Pocillopora_meandrina_HIv1___RNAseq.g12134.t1,three_way,76.40066666666667,FUN_035008-T1,Q9VCA2,,,,,32.9,538.0,3.9e-72,273.9,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_07792,1.9219328886434217,FUN_035013-T1,Peve_00024652,Pocillopora_meandrina_HIv1___RNAseq.g27781.t1,three_way,80.01333333333334,FUN_035013-T1,Q9GV16,,,,,54.1,386.0,2.4e-119,430.3,sp|Q9GV16|EGCSE_CYANO Endoglycoceramidase OS=Cyanea nozakii OX=135523 PE=1 SV=1,,,,,,
OG_07796,1.028320977014157,FUN_035028-T1,Peve_00024629,Pocillopora_meandrina_HIv1___RNAseq.g27762.t1,three_way,45.4505,FUN_035028-T1,G3CJR9,VA5_DIPMA,,Salivary antigen-5 (DMAV),Dipetalogaster maximus (Blood-sucking bug),34.7,121.0,1.5e-08,62.8,sp|G3CJR9|VA5_DIPMA Salivary antigen-5 OS=Dipetalogaster maximus OX=72496 PE=1 SV=1,GO:0005615; GO:0006801; GO:0008201; GO:0016209; GO:0035893; GO:0090729; GO:1903135; GO:1904399,superoxide metabolic process [GO:0006801]; suppression of platelet aggregation in another organism [GO:0035893],extracellular space [GO:0005615],antioxidant activity [GO:0016209]; cupric ion binding [GO:1903135]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; toxin activity [GO:0090729],GO:0005615; GO:0016209; GO:0090729,extracellular space; antioxidant activity; toxin activity
OG_07800,2.210783749884739,FUN_035035-T1,Peve_00024623,Pocillopora_meandrina_HIv1___RNAseq.g27757.t1,three_way,67.09666666666666,FUN_035035-T1,Q6NRQ1,,,,,39.6,470.0,1.8e-101,371.3,"sp|Q6NRQ1|B3GL2_XENLA UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 OS=Xenopus laevis OX=8355 GN=b3galnt2 PE=2 SV=1",,,,,,
OG_07802,1.2213308077850566,FUN_035038-T1,Peve_00044749,Pocillopora_meandrina_HIv1___RNAseq.g27752.t1,three_way,86.15366666666667,FUN_035038-T1,Q3ZBY3,CALB2_BOVIN,,Calretinin (CR),Bos taurus (Bovine),45.5,244.0,2.4e-51,204.1,sp|Q3ZBY3|CALB2_BOVIN Calretinin OS=Bos taurus OX=9913 GN=CALB2 PE=2 SV=1,GO:0005509; GO:0005634; GO:0005829; GO:0006874; GO:0030425; GO:0043195; GO:0044293; GO:0045202; GO:0048167; GO:0098688; GO:0099534; GO:0099536,intracellular calcium ion homeostasis [GO:0006874]; regulation of synaptic plasticity [GO:0048167]; synaptic signaling [GO:0099536],cytosol [GO:0005829]; dendriole [GO:0044293]; dendrite [GO:0030425]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; synapse [GO:0045202]; terminal bouton [GO:0043195],calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534],GO:0005634; GO:0005829; GO:0023052; GO:0043226,nucleus; cytosol; signaling; organelle
OG_07803,1.080114285749712,FUN_035039-T1,Peve_00044750,Pocillopora_meandrina_HIv1___TS.g15093.t1,three_way,84.09616666666668,FUN_035039-T1,Q96GQ7,,,,,59.6,287.0,5.999999999999999e-84,312.4,sp|Q96GQ7|DDX27_HUMAN Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens OX=9606 GN=DDX27 PE=1 SV=3,,,,,,
OG_07805,1.2537651239215268,FUN_035042-T1,Peve_00044753,Pocillopora_meandrina_HIv1___RNAseq.g27744.t1,three_way,66.28966666666666,FUN_035042-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),32.0,338.0,3.8e-41,170.6,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_07807,1.5993330097076564,FUN_035052-T1,Peve_00011121,Pocillopora_meandrina_HIv1___RNAseq.g27741.t1,three_way,68.56233333333333,FUN_035052-T1,Q9C2L8,,,,,29.8,168.0,2.7e-14,80.5,sp|Q9C2L8|RAB7_NEUCR Ypt/Rab-type GTPase Rab7 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=gtp-14 PE=3 SV=1,,,,,,
OG_07810,1.129513116109691,FUN_035057-T1,Peve_00001111,Pocillopora_meandrina_HIv1___RNAseq.g27737.t1,three_way,76.10633333333334,FUN_035057-T1,Q96S44,PRPK_HUMAN,,EKC/KEOPS complex subunit TP53RK (EC 3.6.-.-) (Atypical serine/threonine protein kinase TP53RK) (Nori-2) (TP53-regulating kinase) (EC 2.7.11.1) (p53-related protein kinase),Homo sapiens (Human),60.1,218.0,1.5e-66,254.2,sp|Q96S44|PRPK_HUMAN EKC/KEOPS complex subunit TP53RK OS=Homo sapiens OX=9606 GN=TP53RK PE=1 SV=2,GO:0000408; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0008033; GO:0016787; GO:0070525; GO:0106310; GO:1901796,protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525],cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006399; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; tRNA metabolic process; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07815,2.5243558351031443,FUN_035067-T1,Peve_00002216,Pocillopora_meandrina_HIv1___RNAseq.g27723.t1,three_way,72.051,FUN_035067-T1,A6QQV6,ANM7_BOVIN,,Protein arginine N-methyltransferase 7 (EC 2.1.1.321) (Histone-arginine N-methyltransferase PRMT7) ([Myelin basic protein]-arginine N-methyltransferase PRMT7),Bos taurus (Bovine),41.5,725.0,4.5e-159,563.1,sp|A6QQV6|ANM7_BOVIN Protein arginine N-methyltransferase 7 OS=Bos taurus OX=9913 GN=PRMT7 PE=2 SV=1,GO:0000387; GO:0005634; GO:0005829; GO:0006338; GO:0006355; GO:0016274; GO:0018216; GO:0035241; GO:0035243; GO:0042054; GO:0044020; GO:0071514,chromatin remodeling [GO:0006338]; genomic imprinting [GO:0071514]; peptidyl-arginine methylation [GO:0018216]; regulation of DNA-templated transcription [GO:0006355]; spliceosomal snRNP assembly [GO:0000387],cytosol [GO:0005829]; nucleus [GO:0005634],histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_07818,2.5154060234654243,FUN_035070-T1,Peve_00031377,Pocillopora_meandrina_HIv1___RNAseq.g27719.t1,three_way,82.29666666666667,FUN_035070-T1,Q7ZT01,PSF3_XENLA,,DNA replication complex GINS protein PSF3 (GINS complex subunit 3),Xenopus laevis (African clawed frog),43.1,197.0,9.3e-49,194.9,sp|Q7ZT01|PSF3_XENLA DNA replication complex GINS protein PSF3 OS=Xenopus laevis OX=8355 GN=gins3 PE=1 SV=1,GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902975,DNA replication [GO:0006260]; mitotic DNA replication initiation [GO:1902975],CMG complex [GO:0071162]; GINS complex [GO:0000811],chromatin binding [GO:0003682],GO:0006260,DNA replication
OG_07822,1.4482906916293103,FUN_035090-T2,Peve_00037965,Pocillopora_meandrina_HIv1___RNAseq.g27709.t1,three_way,52.48183333333333,FUN_035090-T2,Q0V8T6,CTP5A_RAT,,Contactin-associated protein like 5-1 (Cell recognition molecule Caspr5-1) (Cell recognition molecule Caspr5a) (Contactin-associated protein-like 5a),Rattus norvegicus (Rat),29.9,626.0,1.1e-68,263.1,sp|Q0V8T6|CTP5A_RAT Contactin-associated protein like 5-1 OS=Rattus norvegicus OX=10116 GN=Cntnap5a PE=2 SV=1,GO:0007155; GO:0016020; GO:0030054,cell adhesion [GO:0007155],cell junction [GO:0030054]; membrane [GO:0016020],,GO:0007155,cell adhesion
OG_07825,2.0739628299624355,FUN_035121-T1,Peve_00005906,Pocillopora_meandrina_HIv1___RNAseq.g27643.t1,three_way,58.49466666666667,FUN_035121-T1,Q86HG9,,,,,32.5,246.0,1e-24,116.3,sp|Q86HG9|Y9871_DICDI Probable serine/threonine-protein kinase DDB_G0271682 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0271682 PE=3 SV=2,,,,,,
OG_07829,3.4291288896104293,FUN_035131-T3,Peve_00005900,Pocillopora_meandrina_HIv1___RNAseq.g27639.t1,three_way,66.834,FUN_035131-T3,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),29.1,983.0,1.9e-97,359.8,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_07832,1.2071011701375087,FUN_035154-T1,Peve_00006880,Pocillopora_meandrina_HIv1___RNAseq.g27634.t1,three_way,56.06466666666667,FUN_035154-T1,Q9UKV3,,,,,30.4,280.0,5e-24,114.8,sp|Q9UKV3|ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens OX=9606 GN=ACIN1 PE=1 SV=2,,,,,,
OG_07834,1.0094972084340086,FUN_035159-T1,Peve_00006321,Pocillopora_meandrina_HIv1___RNAseq.g27599.t1,three_way,55.585,,,,,,,,,,,,,,,,,
OG_07835,4.964753529867273,FUN_035161-T1,Peve_00006324,Pocillopora_meandrina_HIv1___RNAseq.11026_t,three_way,61.05166666666667,FUN_035161-T1,Q923Y6,,,,,26.7,330.0,9.8e-13,75.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_07836,2.692668523886769,FUN_035166-T1,Peve_00036194,Pocillopora_meandrina_HIv1___RNAseq.g27915.t1,three_way,52.95516666666667,FUN_035166-T1,Q29477,TRFL_CAPHI,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-),Capra hircus (Goat),35.5,366.0,2.5e-42,174.5,sp|Q29477|TRFL_CAPHI Lactotransferrin OS=Capra hircus OX=9925 GN=LTF PE=1 SV=1,GO:0001503; GO:0001817; GO:0002227; GO:0005615; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0008236; GO:0019731; GO:0019732; GO:0031665; GO:0032680; GO:0033690; GO:0042581; GO:0043066; GO:0045669; GO:0046872; GO:0055037; GO:0060349; GO:1900159; GO:1900229; GO:1902732; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; bone morphogenesis [GO:0060349]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule [GO:0042581],metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236],GO:0002376; GO:0003824; GO:0005615; GO:0005768; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; endosome; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_07843,1.3042302452340775,FUN_035180-T1,Peve_00021485,Pocillopora_meandrina_HIv1___TS.g15289.t2,three_way,73.132,FUN_035180-T1,O88665,BRD7_MOUSE,,Bromodomain-containing protein 7 (75 kDa bromodomain protein),Mus musculus (Mouse),37.2,540.0,9.400000000000001e-80,299.7,sp|O88665|BRD7_MOUSE Bromodomain-containing protein 7 OS=Mus musculus OX=10090 GN=Brd7 PE=1 SV=1,GO:0000776; GO:0000785; GO:0000976; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0016055; GO:0016363; GO:0016586; GO:0030071; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045892; GO:0070316; GO:0140015; GO:2000045; GO:2000134; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586],histone binding [GO:0042393]; histone H3K14ac reader activity [GO:0140015]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_07844,2.249258312245588,FUN_035182-T1,Peve_00021488,Pocillopora_meandrina_HIv1___RNAseq.g27944.t1,three_way,78.65466666666667,FUN_035182-T1,Q8NBX0,,,,,49.1,424.0,1.2e-111,404.8,sp|Q8NBX0|SCPDL_HUMAN Saccharopine dehydrogenase-like oxidoreductase OS=Homo sapiens OX=9606 GN=SCCPDH PE=1 SV=1,,,,,,
OG_07846,1.1167077884345356,FUN_035184-T1,Peve_00036894,Pocillopora_meandrina_HIv1___RNAseq.g27956.t1,three_way,61.53933333333333,,,,,,,,,,,,,,,,,
OG_07847,1.5528041769346304,FUN_035185-T1,Peve_00036893,Pocillopora_meandrina_HIv1___RNAseq.g27955.t1,three_way,75.83783333333334,FUN_035185-T1,P07090,,,,,41.6,262.0,1.6e-43,177.9,sp|P07090|CALB2_CHICK Calretinin OS=Gallus gallus OX=9031 GN=CALB2 PE=2 SV=3,,,,,,
OG_07848,1.653971274457278,FUN_035190-T1,Peve_00044650,Pocillopora_meandrina_HIv1___RNAseq.g27958.t1,three_way,60.0245,,,,,,,,,,,,,,,,,
OG_07849,2.623458096240977,FUN_035191-T1,Peve_00044663,Pocillopora_meandrina_HIv1___RNAseq.g27959.t1,three_way,74.12833333333333,FUN_035191-T1,Q9VZF4,FBXW7_DROME,,F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago),Drosophila melanogaster (Fruit fly),28.8,198.0,1.8e-18,95.5,sp|Q9VZF4|FBXW7_DROME F-box/WD repeat-containing protein 7 OS=Drosophila melanogaster OX=7227 GN=ago PE=1 SV=1,GO:0005634; GO:0007088; GO:0007096; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1903146; GO:1990381,"branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]",nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381],GO:0005634; GO:0006260; GO:0030163; GO:0043226; GO:0048856,nucleus; DNA replication; protein catabolic process; organelle; anatomical structure development
OG_07851,1.0978890630903275,FUN_035194-T1,Peve_00016110,Pocillopora_meandrina_HIv1___RNAseq.g8466.t1,three_way,62.026,,,,,,,,,,,,,,,,,
OG_07853,1.0645808137688968,FUN_035207-T1,Peve_00027696,Pocillopora_meandrina_HIv1___RNAseq.g27964.t1a,three_way,52.52433333333333,,,,,,,,,,,,,,,,,
OG_07855,3.205489009180582,FUN_035210-T1,Peve_00027693,Pocillopora_meandrina_HIv1___RNAseq.g27630.t1,three_way,70.29866666666666,,,,,,,,,,,,,,,,,
OG_07857,1.6704387616121967,FUN_035212-T1,Peve_00027689,Pocillopora_meandrina_HIv1___RNAseq.g27625.t1,three_way,88.569,FUN_035212-T1,Q6P4W8,,,,,63.3,425.0,6.1e-148,525.4,sp|Q6P4W8|PCH2_XENTR Pachytene checkpoint protein 2 homolog OS=Xenopus tropicalis OX=8364 GN=trip13 PE=2 SV=1,,,,,,
OG_07861,4.766182257988184,FUN_035216-T2,Peve_00035892,Pocillopora_meandrina_HIv1___RNAseq.g27615.t1,three_way,70.04816666666666,FUN_035216-T2,Q503Z8,IRX6A_DANRE,,Iroquois homeobox protein 6a,Danio rerio (Zebrafish) (Brachydanio rerio),47.6,233.0,1.9e-40,168.3,sp|Q503Z8|IRX6A_DANRE Iroquois homeobox protein 6a OS=Danio rerio OX=7955 GN=irx6a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030182; GO:0048468,cell development [GO:0048468]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07862,1.5108647554874917,FUN_035217-T1,Peve_00035882,Pocillopora_meandrina_HIv1___TS.g14965.t1,three_way,86.42566666666667,FUN_035217-T1,O43747,,,,,62.9,851.0,9.3e-281,967.6,sp|O43747|AP1G1_HUMAN AP-1 complex subunit gamma-1 OS=Homo sapiens OX=9606 GN=AP1G1 PE=1 SV=5,,,,,,
OG_07864,4.348783616091959,FUN_035221-T1,Peve_00035886,Pocillopora_meandrina_HIv1___RNAseq.g27610.t1,three_way,84.449,FUN_035221-T1,Q6DE14,E2F4_XENLA,,Transcription factor E2F4 (E2F-4),Xenopus laevis (African clawed frog),54.9,368.0,1.1e-96,354.8,sp|Q6DE14|E2F4_XENLA Transcription factor E2F4 OS=Xenopus laevis OX=8355 GN=e2f4 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003700; GO:0006357; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251,centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0006355; GO:0030154; GO:0044782; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; cilium organization; transcription regulator activity
OG_07865,3.0312770950563945,FUN_035222-T1,Peve_00035887,Pocillopora_meandrina_HIv1___RNAseq.g27609.t1,three_way,55.40566666666666,FUN_035222-T1,Q501V0,KPSH1_DANRE,,Serine/threonine-protein kinase H1 homolog (EC 2.7.11.1),Danio rerio (Zebrafish) (Brachydanio rerio),66.9,323.0,4.8e-116,419.9,sp|Q501V0|KPSH1_DANRE Serine/threonine-protein kinase H1 homolog OS=Danio rerio OX=7955 GN=pskh1 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005737; GO:0106310,,cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_07870,1.2806678248624028,FUN_035228-T1,Peve_00026317,Pocillopora_meandrina_HIv1___RNAseq.g27602.t1,three_way,56.61966666666667,FUN_035228-T1,Q2YDQ5,,,,,52.0,50.0,1.1e-07,59.7,sp|Q2YDQ5|FBXL5_DANRE F-box/LRR-repeat protein 5 OS=Danio rerio OX=7955 GN=fbxl5 PE=2 SV=2,,,,,,
OG_07873,2.278915338149712,FUN_035233-T1,Peve_00044494,Pocillopora_meandrina_HIv1___RNAseq.g27904.t1,three_way,73.75433333333334,FUN_035233-T1,Q3T0C2,PGDH_BOVIN,,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)",Bos taurus (Bovine),40.9,257.0,7.100000000000001e-48,192.2,sp|Q3T0C2|PGDH_BOVIN 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Bos taurus OX=9913 GN=HPGD PE=2 SV=1,GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1905828,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957],GO:0003824; GO:0006629; GO:0016491; GO:0022414; GO:0060089,catalytic activity; lipid metabolic process; oxidoreductase activity; reproductive process; molecular transducer activity
OG_07875,1.297479898447642,FUN_035236-T2,Peve_00007099,Pocillopora_meandrina_HIv1___RNAseq.g27901.t1,three_way,49.373666666666665,FUN_035236-T2,Q96DY7,,,,,23.1,835.0,1.5e-25,119.8,sp|Q96DY7|MTBP_HUMAN Mdm2-binding protein OS=Homo sapiens OX=9606 GN=MTBP PE=1 SV=1,,,,,,
OG_07877,3.551094828812566,FUN_035239-T2,Peve_00042235,Pocillopora_meandrina_HIv1___RNAseq.g27898.t1,three_way,66.54466666666667,FUN_035239-T2,P54278,PMS2_HUMAN,,Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2),Homo sapiens (Human),48.0,891.0,7.499999999999999e-217,755.4,sp|P54278|PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens OX=9606 GN=PMS2 PE=1 SV=2,GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006298; GO:0009410; GO:0016446; GO:0016447; GO:0016887; GO:0032138; GO:0032389; GO:0048298; GO:0048304; GO:0140664,mismatch repair [GO:0006298]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; response to xenobiotic stimulus [GO:0009410]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447],cytosol [GO:0005829]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_07881,2.9264172700528617,FUN_035244-T1,Peve_00042234,Pocillopora_meandrina_HIv1___RNAseq.g27892.t1b,three_way,69.50633333333333,FUN_035244-T1,O32210,,,,,44.7,262.0,5.5e-61,236.1,sp|O32210|GR_BACSU Glyoxal reductase OS=Bacillus subtilis (strain 168) OX=224308 GN=yvgN PE=1 SV=1,,,,,,
OG_07888,1.6022763483333524,FUN_035266-T1,Peve_00032638,Pocillopora_meandrina_HIv1___RNAseq.g27875.t1,three_way,78.45100000000001,FUN_035266-T1,Q5R9K8,AR2BP_PONAB,,ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),59.0,134.0,6.6e-42,171.8,sp|Q5R9K8|AR2BP_PONAB ADP-ribosylation factor-like protein 2-binding protein OS=Pongo abelii OX=9601 GN=ARL2BP PE=2 SV=1,GO:0003713; GO:0005654; GO:0005758; GO:0005813; GO:0005819; GO:0005829; GO:0030496; GO:0036064; GO:0042531; GO:0051457,maintenance of protein location in nucleus [GO:0051457]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrial intermembrane space [GO:0005758]; nucleoplasm [GO:0005654]; spindle [GO:0005819],transcription coactivator activity [GO:0003713],GO:0005654; GO:0005815; GO:0005829; GO:0043226; GO:0060090; GO:0140110,nucleoplasm; microtubule organizing center; cytosol; organelle; molecular adaptor activity; transcription regulator activity
OG_07890,1.033849575329614,FUN_035269-T1,Peve_00029229,Pocillopora_meandrina_HIv1___RNAseq.g27867.t1,three_way,75.15266666666666,FUN_035269-T1,Q9NUD7,,,,,23.3,356.0,2.7e-12,74.7,sp|Q9NUD7|CT096_HUMAN Uncharacterized protein C20orf96 OS=Homo sapiens OX=9606 GN=C20orf96 PE=1 SV=2,,,,,,
OG_07893,2.8685948980161813,FUN_035272-T1,Peve_00044991,Pocillopora_meandrina_HIv1___RNAseq.g27864.t1,three_way,73.48066666666666,FUN_035272-T1,Q6NRC9,,,,,41.0,1022.0,1.9e-99,365.5,sp|Q6NRC9|LRCC1_XENLA Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrrcc1 PE=2 SV=1,,,,,,
OG_07895,1.619257779702203,FUN_035274-T1,Peve_00044989,Pocillopora_meandrina_HIv1___RNAseq.g27861.t1,three_way,96.17166666666668,FUN_035274-T1,Q6PGV1,VA0D1_DANRE,,V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (Vacuolar proton pump subunit d 1),Danio rerio (Zebrafish) (Brachydanio rerio),80.6,350.0,8.699999999999999e-172,604.4,sp|Q6PGV1|VA0D1_DANRE V-type proton ATPase subunit d 1 OS=Danio rerio OX=7955 GN=atp6v0d1 PE=1 SV=1,GO:0001947; GO:0003406; GO:0005765; GO:0005769; GO:0006879; GO:0007034; GO:0007035; GO:0008057; GO:0016471; GO:0032438; GO:0033179; GO:0033181; GO:0035675; GO:0036295; GO:0039022; GO:0045176; GO:0046688; GO:0046961; GO:0060041; GO:0060271; GO:0070986,apical protein localization [GO:0045176]; cellular response to increased oxygen levels [GO:0036295]; cilium assembly [GO:0060271]; eye pigment granule organization [GO:0008057]; heart looping [GO:0001947]; intracellular iron ion homeostasis [GO:0006879]; left/right axis specification [GO:0070986]; melanosome organization [GO:0032438]; neuromast hair cell development [GO:0035675]; pronephric duct development [GO:0039022]; response to copper ion [GO:0046688]; retina development in camera-type eye [GO:0060041]; retinal pigment epithelium development [GO:0003406]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034],"early endosome [GO:0005769]; lysosomal membrane [GO:0005765]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0005768; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0140657,transporter activity; endosome; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; ATP-dependent activity
OG_07896,1.7065006133039833,FUN_035275-T1,Peve_00044988,Pocillopora_meandrina_HIv1___RNAseq.g27860.t1,three_way,93.55466666666666,FUN_035275-T1,Q9D600,,,,,59.8,179.0,7.3e-58,224.9,sp|Q9D600|PSF2_MOUSE DNA replication complex GINS protein PSF2 OS=Mus musculus OX=10090 GN=Gins2 PE=1 SV=1,,,,,,
OG_07897,1.2978974395396083,FUN_035276-T1,Peve_00044995,Pocillopora_meandrina_HIv1___RNAseq.g27859.t1,three_way,66.694,,,,,,,,,,,,,,,,,
OG_07898,2.8119349818899178,FUN_035279-T1,Peve_00001128,Pocillopora_meandrina_HIv1___RNAseq.g10444.t1,three_way,76.0005,FUN_035279-T1,Q9Z2W0,,,,,60.3,441.0,8.4e-151,535.0,sp|Q9Z2W0|DNPEP_MOUSE Aspartyl aminopeptidase OS=Mus musculus OX=10090 GN=Dnpep PE=1 SV=2,,,,,,
OG_07900,1.2734220575842348,FUN_035333-T1,Peve_00029728,Pocillopora_meandrina_HIv1___RNAseq.g12269.t1,three_way,60.7565,,,,,,,,,,,,,,,,,
OG_07903,2.967724617967404,FUN_035340-T1,Peve_00029660,Pocillopora_meandrina_HIv1___RNAseq.g12264.t1,three_way,78.014,FUN_035340-T1,Q9VVY3,,,,,41.0,183.0,8.4e-24,112.1,sp|Q9VVY3|GBS76_DROME Glycogen-binding subunit 76A OS=Drosophila melanogaster OX=7227 GN=Gbs-76A PE=1 SV=1,,,,,,
OG_07904,2.2415179909432084,FUN_035341-T1,Peve_00029661,Pocillopora_meandrina_HIv1___TS.g3597.t1,three_way,81.158,FUN_035341-T1,Q3URV1,BROMI_MOUSE,,Protein broad-minded (TBC1 domain family member 32),Mus musculus (Mouse),41.3,269.0,9.2e-49,195.3,sp|Q3URV1|BROMI_MOUSE Protein broad-minded OS=Mus musculus OX=10090 GN=Tbc1d32 PE=1 SV=2,GO:0001822; GO:0002088; GO:0003406; GO:0005737; GO:0005929; GO:0007224; GO:0007368; GO:0007507; GO:0021532; GO:0021915; GO:0035082; GO:0042733; GO:0043010; GO:0060021; GO:0060041; GO:0060271; GO:0060831; GO:0061512; GO:1905515,axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; neural tube development [GO:0021915]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retina development in camera-type eye [GO:0060041]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005929; GO:0007010; GO:0043226; GO:0044782; GO:0048856,cilium; cytoskeleton organization; organelle; cilium organization; anatomical structure development
OG_07906,1.1665641021618771,FUN_035349-T1,Peve_00032934,Pocillopora_meandrina_HIv1___RNAseq.g12261.t1,three_way,88.37633333333333,FUN_035349-T1,P11387,TOP1_HUMAN,,DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I),Homo sapiens (Human),67.5,511.0,6.8e-202,704.9,sp|P11387|TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens OX=9606 GN=TOP1 PE=1 SV=2,GO:0000932; GO:0000978; GO:0001650; GO:0001651; GO:0001673; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003723; GO:0003917; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0007623; GO:0008301; GO:0009266; GO:0009303; GO:0009410; GO:0010332; GO:0012501; GO:0018105; GO:0019904; GO:0031100; GO:0031490; GO:0032922; GO:0032993; GO:0040016; GO:0043204; GO:0044877; GO:0051591; GO:0071373; GO:0097100,animal organ regeneration [GO:0031100]; cellular response to luteinizing hormone stimulus [GO:0071373]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; programmed cell death [GO:0012501]; response to cAMP [GO:0051591]; response to gamma radiation [GO:0010332]; response to temperature stimulus [GO:0009266]; response to xenobiotic stimulus [GO:0009410]; rRNA transcription [GO:0009303],chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993],"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006325; GO:0006351; GO:0007059; GO:0012501; GO:0016740; GO:0016853; GO:0043226; GO:0048856; GO:0140096; GO:0140097,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA replication; chromatin organization; DNA-templated transcription; chromosome segregation; programmed cell death; transferase activity; isomerase activity; organelle; anatomical structure development; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_07913,1.0060157005704708,FUN_035378-T1,Peve_00016215,Pocillopora_meandrina_HIv1___RNAseq.g12217.t1,three_way,76.479,FUN_035378-T1,O60675,MAFK_HUMAN,,Transcription factor MafK (Erythroid transcription factor NF-E2 p18 subunit),Homo sapiens (Human),47.4,57.0,2.3e-06,54.7,sp|O60675|MAFK_HUMAN Transcription factor MafK OS=Homo sapiens OX=9606 GN=MAFK PE=1 SV=1,GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0043565; GO:0090575,negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07918,2.041964814965646,FUN_035403-T1,Peve_00002640,Pocillopora_meandrina_HIv1___TS.g3526.t1,three_way,88.887,,,,,,,,,,,,,,,,,
OG_07919,3.473182683046016,FUN_035404-T1,Peve_00002644,Pocillopora_meandrina_HIv1___TS.g3527.t2,three_way,68.768,FUN_035404-T1,Q9WYX8,,,,,49.4,172.0,3.9e-43,176.4,sp|Q9WYX8|Y508_THEMA Uncharacterized protein TM_0508 OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0508 PE=3 SV=1,,,,,,
OG_07920,3.589471370418069,FUN_035405-T1,Peve_00002645,Pocillopora_meandrina_HIv1___RNAseq.g12189.t1,three_way,73.37433333333333,,,,,,,,,,,,,,,,,
OG_07926,1.7603587418892503,FUN_035414-T1,Peve_00039842,Pocillopora_meandrina_HIv1___RNAseq.g27562.t1,three_way,52.20816666666667,FUN_035414-T1,Q3SYV3,,,,,36.0,372.0,9.200000000000001e-58,226.1,sp|Q3SYV3|OXA1L_BOVIN Mitochondrial inner membrane protein OXA1L OS=Bos taurus OX=9913 GN=OXA1L PE=2 SV=1,,,,,,
OG_07927,1.45193917455208,FUN_035416-T1,Peve_00039836,Pocillopora_meandrina_HIv1___RNAseq.g27563.t1,three_way,75.12766666666667,,,,,,,,,,,,,,,,,
OG_07929,1.598734785305208,FUN_035418-T1,Peve_00039851,Pocillopora_meandrina_HIv1___RNAseq.g27566.t1,three_way,69.55066666666667,FUN_035418-T1,B8AJ09,,,,,28.2,312.0,1.7e-16,88.6,"sp|B8AJ09|BASS4_ORYSI Probable sodium/metabolite cotransporter BASS4, chloroplastic OS=Oryza sativa subsp. indica OX=39946 GN=BASS4 PE=3 SV=1",,,,,,
OG_07937,2.182956209885526,FUN_035443-T1,Peve_00002173,Pocillopora_meandrina_HIv1___RNAseq.g9412.t1,three_way,74.024,,,,,,,,,,,,,,,,,
OG_07940,1.608355242637049,FUN_035449-T1,Peve_00012113,Pocillopora_meandrina_HIv1___RNAseq.g26981.t2,three_way,76.47,FUN_035449-T1,Q8MYF0,,,,,45.2,217.0,8.4e-49,195.3,sp|Q8MYF0|MG101_DICDI Mitochondrial genome maintenance protein mgm101 homolog OS=Dictyostelium discoideum OX=44689 GN=mgm101 PE=3 SV=1,,,,,,
OG_07941,1.3910963371402558,FUN_035450-T2,Peve_00001658,Pocillopora_meandrina_HIv1___RNAseq.g25308.t1,three_way,52.35066666666667,FUN_035450-T2,A2BGU9,,,,,34.3,303.0,9.8e-42,172.2,sp|A2BGU9|SERHL_DANRE Serine hydrolase-like protein OS=Danio rerio OX=7955 GN=serhl PE=2 SV=1,,,,,,
OG_07942,1.4498621005462962,FUN_035456-T1,Peve_00012138,Pocillopora_meandrina_HIv1___RNAseq.g26976.t1,three_way,62.52466666666667,FUN_035456-T1,F4KGU4,,,,,33.2,1498.0,1.7000000000000002e-214,748.4,"sp|F4KGU4|DEAHC_ARATH ATP-dependent RNA helicase DEAH12, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=At5g10370 PE=3 SV=1",,,,,,
OG_07944,3.193641781223144,FUN_035462-T1,Peve_00012136,Pocillopora_meandrina_HIv1___RNAseq.g27041.t1,three_way,72.29833333333333,FUN_035462-T1,Q9SY73,PTALR_ARATH,,NADPH-dependent pterin aldehyde reductase (EC 1.1.1.-),Arabidopsis thaliana (Mouse-ear cress),45.1,224.0,2e-55,217.2,sp|Q9SY73|PTALR_ARATH NADPH-dependent pterin aldehyde reductase OS=Arabidopsis thaliana OX=3702 GN=At1g10310 PE=1 SV=1,GO:0005829; GO:0006760; GO:0016616,folic acid-containing compound metabolic process [GO:0006760],cytosol [GO:0005829],"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0005829; GO:0006575; GO:0016491,catalytic activity; cytosol; modified amino acid metabolic process; oxidoreductase activity
OG_07945,1.0047152201917784,FUN_035465-T2,Peve_00012135,Pocillopora_meandrina_HIv1___TS.g14389.t1b,three_way,52.7335,FUN_035465-T2,Q0P5K4,TOX4_BOVIN,,TOX high mobility group box family member 4,Bos taurus (Bovine),41.4,58.0,1.9e-06,56.6,sp|Q0P5K4|TOX4_BOVIN TOX high mobility group box family member 4 OS=Bos taurus OX=9913 GN=TOX4 PE=2 SV=1,GO:0001111; GO:0005634; GO:0006357; GO:0031490; GO:0032968; GO:0072357,positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II promoter clearance [GO:0001111],nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357],chromatin DNA binding [GO:0031490],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_07945,1.0047152201917784,FUN_035465-T2,Peve_00012135,Pocillopora_meandrina_HIv1___TS.g14389.t1b,three_way,52.7335,FUN_035465-T2,Q0P5K4,TOX4_BOVIN,,TOX high mobility group box family member 4,Bos taurus (Bovine),39.7,63.0,2.8e-05,52.8,sp|Q0P5K4|TOX4_BOVIN TOX high mobility group box family member 4 OS=Bos taurus OX=9913 GN=TOX4 PE=2 SV=1,GO:0001111; GO:0005634; GO:0006357; GO:0031490; GO:0032968; GO:0072357,positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II promoter clearance [GO:0001111],nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357],chromatin DNA binding [GO:0031490],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_07946,1.8428120322896733,FUN_035466-T1,Peve_00012134,Pocillopora_meandrina_HIv1___RNAseq.g11796.t1,three_way,51.17766666666667,FUN_035466-T1,Q9JIL9,NBN_RAT,,Nibrin (Nijmegen breakage syndrome protein 1 homolog),Rattus norvegicus (Rat),26.3,753.0,1.1e-56,223.0,sp|Q9JIL9|NBN_RAT Nibrin OS=Rattus norvegicus OX=10116 GN=Nbn PE=1 SV=2,GO:0000077; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001701; GO:0001832; GO:0003684; GO:0005634; GO:0005657; GO:0005730; GO:0006302; GO:0007095; GO:0007405; GO:0008284; GO:0009410; GO:0016605; GO:0030870; GO:0031848; GO:0031860; GO:0032206; GO:0035861; GO:0042393; GO:0042405; GO:0043247; GO:0043539; GO:0045190; GO:0045665; GO:0046597; GO:0048145; GO:0050885; GO:0051321; GO:0062176; GO:0070533; GO:0090656; GO:0090737; GO:0097193; GO:0097681; GO:0110025; GO:0140031; GO:0140297; GO:0140463; GO:1904354; GO:1990166; GO:2000781,blastocyst growth [GO:0001832]; DNA damage checkpoint signaling [GO:0000077]; DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; host-mediated suppression of symbiont invasion [GO:0046597]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of telomere capping [GO:1904354]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to site of double-strand break [GO:1990166]; R-loop processing [GO:0062176]; regulation of fibroblast proliferation [GO:0048145]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860],"BRCA1-C complex [GO:0070533]; chromosome, telomeric region [GO:0000781]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",chromatin-protein adaptor activity [GO:0140463]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0002376; GO:0003677; GO:0005634; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0022414; GO:0032200; GO:0042393; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0098542; GO:0098772,immune system process; DNA binding; nucleus; nucleolus; DNA repair; DNA recombination; chromatin organization; reproductive process; telomere organization; histone binding; organelle; anatomical structure development; nervous system process; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_07949,1.1926218581190045,FUN_035470-T1,Peve_00012129,Pocillopora_meandrina_HIv1___RNAseq.g27049.t1,three_way,76.12633333333333,FUN_035470-T1,Q1JPD3,,,,,62.9,496.0,8.699999999999999e-181,634.8,"sp|Q1JPD3|D2HDH_BOVIN D-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=D2HGDH PE=2 SV=2",,,,,,
OG_07951,2.8632542501040423,FUN_035476-T1,Peve_00033971,Pocillopora_meandrina_HIv1___TS.g14334.t1b,three_way,75.7615,FUN_035476-T1,Q58EX7,PKHG4_HUMAN,,Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1),Homo sapiens (Human),31.9,906.0,1.4e-119,433.0,sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056,axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0098772,cytosol; plasma membrane; molecular function regulator activity
OG_07954,3.961332954021375,FUN_035494-T1,Peve_00033964,Pocillopora_meandrina_HIv1___RNAseq.g26989.t1,three_way,76.04083333333334,FUN_035494-T1,P52171,,,,,53.8,240.0,1.4e-69,265.4,sp|P52171|IMA1_XENLA Importin subunit alpha-1 OS=Xenopus laevis OX=8355 GN=kpna2 PE=1 SV=2,,,,,,
OG_07955,2.048990806669007,FUN_035498-T1,Peve_00033959,Pocillopora_meandrina_HIv1___RNAseq.g26992.t1,three_way,53.365833333333335,,,,,,,,,,,,,,,,,
OG_07956,6.191741852840109,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_07960,1.349524261902714,FUN_035513-T1,Peve_00039975,Pocillopora_meandrina_HIv1___RNAseq.g26972.t1,three_way,86.628,FUN_035513-T1,Q0P5Y3,TPPP2_MOUSE,,Tubulin polymerization-promoting protein family member 2,Mus musculus (Mouse),45.7,164.0,1.1000000000000002e-28,127.9,sp|Q0P5Y3|TPPP2_MOUSE Tubulin polymerization-promoting protein family member 2 OS=Mus musculus OX=10090 GN=Tppp2 PE=2 SV=1,GO:0005829; GO:0007283; GO:0015631; GO:0030154; GO:0036126; GO:0046785; GO:1901317,cell differentiation [GO:0030154]; microtubule polymerization [GO:0046785]; regulation of flagellated sperm motility [GO:1901317]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; sperm flagellum [GO:0036126],tubulin binding [GO:0015631],GO:0005829; GO:0005929; GO:0007010; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0065003,cytosol; cilium; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; protein-containing complex assembly
OG_07961,2.2836969126293005,FUN_035519-T1,Peve_00007927,Pocillopora_meandrina_HIv1___RNAseq.g26966.t1,three_way,53.88283333333334,FUN_035519-T1,A3KMR8,MAFA_DANRE,,Transcription factor MafAa (Somite Maf1) (SMaf1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,97.0,4.2e-09,63.2,sp|A3KMR8|MAFA_DANRE Transcription factor MafAa OS=Danio rerio OX=7955 GN=mafaa PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0043565,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07963,2.571523807630027,FUN_035524-T1,Peve_00020842,Pocillopora_meandrina_HIv1___RNAseq.g26954.t1,three_way,73.49983333333333,FUN_035524-T1,O54975,XPP1_RAT,,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",Rattus norvegicus (Rat),44.4,626.0,4.6e-150,533.1,sp|O54975|XPP1_RAT Xaa-Pro aminopeptidase 1 OS=Rattus norvegicus OX=10116 GN=Xpnpep1 PE=1 SV=1,GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006,bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0016787; GO:0140096,"catalytic activity; cytosol; hydrolase activity; catalytic activity, acting on a protein"
OG_07964,2.2485166979261697,FUN_035525-T1,Peve_00020841,Pocillopora_meandrina_HIv1___RNAseq.g27993.t1,three_way,77.325,FUN_035525-T1,Q5ZJX5,MEAK7_CHICK,,MTOR-associated protein MEAK7 (MEAK7) (TBC/LysM-associated domain-containing protein 1) (TLD domain-containing protein 1),Gallus gallus (Chicken),36.1,460.0,2.8e-77,290.8,sp|Q5ZJX5|MEAK7_CHICK MTOR-associated protein MEAK7 OS=Gallus gallus OX=9031 GN=MEAK7 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005765; GO:0006979; GO:0016020; GO:0030334; GO:0031667; GO:0031929; GO:0032868; GO:0042127; GO:0043200; GO:0150032,positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; TOR signaling [GO:0031929],cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634],,GO:0005634; GO:0043226,nucleus; organelle
OG_07966,2.737102609828725,FUN_035535-T1,Peve_00021382,Pocillopora_meandrina_HIv1___RNAseq.g27998.t1,three_way,79.72866666666667,,,,,,,,,,,,,,,,,
OG_07968,2.2841904088808542,FUN_035537-T1,Peve_00026592,Pocillopora_meandrina_HIv1___RNAseq.g28000.t1,three_way,95.7,FUN_035537-T1,Q921M3,,,,,79.5,1222.0,0.0,2003.0,sp|Q921M3|SF3B3_MOUSE Splicing factor 3B subunit 3 OS=Mus musculus OX=10090 GN=Sf3b3 PE=1 SV=1,,,,,,
OG_07971,1.5648695644549606,FUN_035544-T1,Peve_00036928,Pocillopora_meandrina_HIv1___RNAseq.g28003.t1,three_way,75.86166666666666,FUN_035544-T1,Q9NX74,,,,,52.0,431.0,2.6e-125,450.3,sp|Q9NX74|DUS2_HUMAN tRNA-dihydrouridine(20) synthase [NAD(P)+]-like OS=Homo sapiens OX=9606 GN=DUS2 PE=1 SV=1,,,,,,
OG_07975,1.613760423709103,FUN_035552-T1,Peve_00036916,Pocillopora_meandrina_HIv1___RNAseq.g28024.t1,three_way,68.95633333333333,FUN_035552-T1,Q7M767,UB2V2_RAT,,Ubiquitin-conjugating enzyme E2 variant 2 (Ubiquitin-conjugating enzyme variant MMS2),Rattus norvegicus (Rat),69.6,138.0,2.3e-51,203.0,sp|Q7M767|UB2V2_RAT Ubiquitin-conjugating enzyme E2 variant 2 OS=Rattus norvegicus OX=10116 GN=Ube2v2 PE=1 SV=3,GO:0000729; GO:0005634; GO:0006301; GO:0010976; GO:0031371; GO:0031372; GO:0032436; GO:0042275; GO:0043524; GO:0045739; GO:0051965; GO:0070534; GO:1902523; GO:2000781,DNA double-strand break processing [GO:0000729]; error-free postreplication DNA repair [GO:0042275]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of synapse assembly [GO:0051965]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534],nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme complex [GO:0031371],,GO:0005634; GO:0006281; GO:0043226,nucleus; DNA repair; organelle
OG_07976,2.633581931990269,FUN_035554-T2,Peve_00036915,Pocillopora_meandrina_HIv1___TS.g15372.t1,three_way,93.07433333333334,FUN_035554-T2,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),67.4,4652.0,0.0,6165.9,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_07977,2.428491832211087,FUN_035598-T2,Peve_00027482,Pocillopora_meandrina_HIv1___TS.g15377.t1,three_way,86.6325,FUN_035598-T2,Q92620,PRP16_HUMAN,,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38),Homo sapiens (Human),76.7,951.0,0.0,1411.7,sp|Q92620|PRP16_HUMAN Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 OS=Homo sapiens OX=9606 GN=DHX38 PE=1 SV=2,GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0016020; GO:0016887; GO:0034458; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_07979,1.3069711616989017,FUN_035601-T1,Peve_00027479,Pocillopora_meandrina_HIv1___RNAseq.g28039.t1,three_way,66.077,,,,,,,,,,,,,,,,,
OG_07982,3.1059678733345075,FUN_035607-T2,Peve_00025644,Pocillopora_meandrina_HIv1___RNAseq.g28044.t1,three_way,64.08733333333333,,,,,,,,,,,,,,,,,
OG_07983,1.7545049936466386,FUN_035608-T1,Peve_00031575,Pocillopora_meandrina_HIv1___RNAseq.g28045.t1,three_way,61.36366666666667,,,,,,,,,,,,,,,,,
OG_07984,1.2583643920550671,FUN_035609-T1,Peve_00025646,Pocillopora_meandrina_HIv1___RNAseq.g28046.t1a,three_way,55.686166666666665,FUN_035609-T1,Q9JI13,SAS10_MOUSE,,Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (Crl-1) (Disrupter of silencing SAS10) (UTP3 homolog),Mus musculus (Mouse),33.1,360.0,9.1e-37,156.4,sp|Q9JI13|SAS10_MOUSE Something about silencing protein 10 OS=Mus musculus OX=10090 GN=Utp3 PE=1 SV=1,GO:0005634; GO:0005730; GO:0006325; GO:0007420; GO:0032040; GO:0042274,brain development [GO:0007420]; chromatin organization [GO:0006325]; ribosomal small subunit biogenesis [GO:0042274],nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],,GO:0005634; GO:0005730; GO:0006325; GO:0043226; GO:0048856,nucleus; nucleolus; chromatin organization; organelle; anatomical structure development
OG_07987,1.4670388820414637,FUN_035615-T1,Peve_00029654,Pocillopora_meandrina_HIv1___RNAseq.g28080.t1,three_way,72.06366666666666,FUN_035615-T1,P35404,,,,,33.6,348.0,1.1e-32,142.5,sp|P35404|5HT1B_DIDVI 5-hydroxytryptamine receptor 1B OS=Didelphis virginiana OX=9267 GN=HTR1B PE=2 SV=1,,,,,,
OG_07988,1.711104345404883,FUN_035618-T1,Peve_00029653,Pocillopora_meandrina_HIv1___TS.g15425.t1,three_way,87.45883333333333,FUN_035618-T1,Q9Y5B9,,,,,59.7,937.0,0.0,1174.5,sp|Q9Y5B9|SP16H_HUMAN FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1,,,,,,
OG_07992,1.2243206441196397,FUN_035627-T1,Peve_00029656,Pocillopora_meandrina_HIv1___RNAseq.g28069.t1,three_way,82.09766666666667,FUN_035627-T1,P97762,,,,,67.2,122.0,1.3000000000000001e-48,194.5,sp|P97762|RP9_MOUSE Retinitis pigmentosa 9 protein homolog OS=Mus musculus OX=10090 GN=rp9 PE=1 SV=1,,,,,,
OG_07993,1.5150460292153032,FUN_035629-T1,Peve_00044824,Pocillopora_meandrina_HIv1___RNAseq.g28067.t1,three_way,75.19483333333334,FUN_035629-T1,Q9Y2L5,TPPC8_HUMAN,,Trafficking protein particle complex subunit 8 (Protein TRS85 homolog),Homo sapiens (Human),37.0,1516.0,1e-253,878.6,sp|Q9Y2L5|TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens OX=9606 GN=TRAPPC8 PE=1 SV=2,GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0032964; GO:0048208; GO:0099022; GO:1990072,collagen biosynthetic process [GO:0032964]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; vesicle tethering [GO:0099022],cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072],,GO:0005829; GO:0016192; GO:0065003,cytosol; vesicle-mediated transport; protein-containing complex assembly
OG_07995,1.1934765768243696,FUN_035636-T1,Peve_00029723,Pocillopora_meandrina_HIv1___RNAseq.g28084.t1,three_way,75.15066666666667,FUN_035636-T1,Q96BZ9,,,,,47.6,380.0,1.6000000000000001e-87,324.7,sp|Q96BZ9|TBC20_HUMAN TBC1 domain family member 20 OS=Homo sapiens OX=9606 GN=TBC1D20 PE=1 SV=1,,,,,,
OG_07996,2.847625683661711,FUN_035637-T1,Peve_00029721,Pocillopora_meandrina_HIv1___RNAseq.g28085.t1,three_way,59.298,,,,,,,,,,,,,,,,,
OG_07997,1.2908509878832213,FUN_035638-T1,Peve_00029736,Pocillopora_meandrina_HIv1___RNAseq.g28087.t1,three_way,77.51633333333334,FUN_035638-T1,Q8GYM3,,,,,28.8,191.0,4.1e-20,100.5,sp|Q8GYM3|AUG4_ARATH AUGMIN subunit 4 OS=Arabidopsis thaliana OX=3702 GN=AUG4 PE=1 SV=1,,,,,,
OG_07999,3.3778533301257525,FUN_035640-T1,Peve_00020462,Pocillopora_meandrina_HIv1___RNAseq.g28090.t1,three_way,58.150333333333336,FUN_035640-T1,Q58L91,FA5V_OXYSU,,Venom prothrombin activator oscutarin-C non-catalytic subunit (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Oscutarin-C non-catalytic subunit heavy chain; Oscutarin-C non-catalytic subunit light chain],Oxyuranus scutellatus (Coastal taipan),40.5,163.0,8.3e-24,113.2,sp|Q58L91|FA5V_OXYSU Venom prothrombin activator oscutarin-C non-catalytic subunit OS=Oxyuranus scutellatus OX=8668 PE=1 SV=1,GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729,venom-mediated blood coagulation [GO:0044469],extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729],GO:0005576; GO:0005886; GO:0060089; GO:0090729; GO:0098772,extracellular region; plasma membrane; molecular transducer activity; toxin activity; molecular function regulator activity
OG_08000,2.107903597408041,FUN_035645-T1,Peve_00022823,Pocillopora_meandrina_HIv1___RNAseq.g12089.t1,three_way,63.82933333333334,FUN_035645-T1,Q94BV5,,,,,38.8,400.0,1.3e-72,276.2,sp|Q94BV5|GSXL4_ARATH Flavin-containing monooxygenase FMO GS-OX-like 4 OS=Arabidopsis thaliana OX=3702 GN=At1g62600 PE=2 SV=1,,,,,,
OG_08001,3.4640693526521784,FUN_035647-T1,Peve_00022820,Pocillopora_meandrina_HIv1___RNAseq.g28097.t1,three_way,46.10966666666667,,,,,,,,,,,,,,,,,
OG_08002,1.3315396657309495,FUN_035648-T1,Peve_00022818,Pocillopora_meandrina_HIv1___RNAseq.g28098.t1,three_way,65.012,FUN_035648-T1,P53668,LIMK1_MOUSE,,LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (KIZ-1),Mus musculus (Mouse),32.9,210.0,5.1e-23,110.2,sp|P53668|LIMK1_MOUSE LIM domain kinase 1 OS=Mus musculus OX=10090 GN=Limk1 PE=1 SV=1,GO:0001673; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0016020; GO:0016607; GO:0030027; GO:0031072; GO:0031625; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051496; GO:0098794; GO:0098978; GO:0106310; GO:1990948,axon extension [GO:0048675]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; stress fiber assembly [GO:0043149],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794],ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08003,3.095885306967296,FUN_035652-T1,Peve_00022825,Pocillopora_meandrina_HIv1___RNAseq.g28106.t1,three_way,72.28066666666666,FUN_035652-T1,Q80ZW0,,,,,30.1,335.0,1.1000000000000001e-27,125.6,sp|Q80ZW0|STK35_MOUSE Serine/threonine-protein kinase 35 OS=Mus musculus OX=10090 GN=Stk35 PE=1 SV=3,,,,,,
OG_08004,1.9800443065074336,FUN_035653-T1,Peve_00028212,Pocillopora_meandrina_HIv1___RNAseq.g28108.t1,three_way,78.766,FUN_035653-T1,Q568Z7,CIB2_RAT,,Calcium and integrin-binding family member 2,Rattus norvegicus (Rat),52.7,188.0,6.2e-54,213.0,sp|Q568Z7|CIB2_RAT Calcium and integrin-binding family member 2 OS=Rattus norvegicus OX=10116 GN=Cib2 PE=1 SV=1,GO:0000287; GO:0001750; GO:0001917; GO:0005178; GO:0005509; GO:0005737; GO:0005829; GO:0005927; GO:0007204; GO:0031594; GO:0032420; GO:0032437; GO:0042383; GO:0042803; GO:0044877; GO:0045494; GO:0055074; GO:0071318; GO:0071944,calcium ion homeostasis [GO:0055074]; cellular response to ATP [GO:0071318]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cytosolic calcium ion concentration [GO:0007204],cell periphery [GO:0071944]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; sarcolemma [GO:0042383]; stereocilium [GO:0032420],calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0005829; GO:0005886,cytosol; plasma membrane
OG_08005,2.7718038875758,FUN_035654-T1,Peve_00028213,Pocillopora_meandrina_HIv1___RNAseq.g28110.t1,three_way,80.874,FUN_035654-T1,Q9H063,MAF1_HUMAN,,Repressor of RNA polymerase III transcription MAF1 homolog,Homo sapiens (Human),50.8,254.0,2.7999999999999997e-63,243.4,sp|Q9H063|MAF1_HUMAN Repressor of RNA polymerase III transcription MAF1 homolog OS=Homo sapiens OX=9606 GN=MAF1 PE=1 SV=2,GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0016479; GO:0016480; GO:0030424; GO:0030425; GO:0048471; GO:0050811; GO:0060077,negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle
OG_08007,1.1909180980931535,FUN_035656-T1,Peve_00038559,Pocillopora_meandrina_HIv1___TS.g15459.t1b,three_way,59.03066666666666,,,,,,,,,,,,,,,,,
OG_08008,4.384144269308649,FUN_035660-T1,Peve_00020774,Pocillopora_meandrina_HIv1___RNAseq.g28116.t1,three_way,60.16833333333333,,,,,,,,,,,,,,,,,
OG_08009,1.5946149466551822,FUN_035662-T1,Peve_00019696,Pocillopora_meandrina_HIv1___RNAseq.g28118.t1,three_way,56.57933333333333,FUN_035662-T1,Q13637,,,,,29.6,199.0,7e-16,85.9,sp|Q13637|RAB32_HUMAN Ras-related protein Rab-32 OS=Homo sapiens OX=9606 GN=RAB32 PE=1 SV=3,,,,,,
OG_08012,1.4407750923559204,FUN_035665-T1,Peve_00002788,Pocillopora_meandrina_HIv1___RNAseq.g28121.t1,three_way,70.55033333333334,FUN_035665-T1,Q9NRH2,,,,,66.7,330.0,4.4e-126,453.8,sp|Q9NRH2|SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=SNRK PE=1 SV=2,,,,,,
OG_08016,1.5990242531466592,FUN_035670-T1,Peve_00002791,Pocillopora_meandrina_HIv1___RNAseq.g28127.t1,three_way,93.71433333333334,FUN_035670-T1,Q9PV94,,,,,77.2,149.0,1.9e-54,214.2,sp|Q9PV94|RSMB_CHICK Small nuclear ribonucleoprotein-associated protein B' OS=Gallus gallus OX=9031 GN=SNRPB PE=2 SV=1,,,,,,
OG_08017,1.7977119350052324,FUN_035671-T1,Peve_00002792,Pocillopora_meandrina_HIv1___RNAseq.g28139.t1,three_way,83.45733333333334,FUN_035671-T1,Q561X0,,,,,57.4,122.0,3.5000000000000004e-32,139.0,sp|Q561X0|NEPR1_DANRE Nuclear envelope phosphatase-regulatory subunit 1 OS=Danio rerio OX=7955 GN=cnep1r1 PE=2 SV=1,,,,,,
OG_08018,2.529291690113836,FUN_035673-T1,Peve_00002793,Pocillopora_meandrina_HIv1___RNAseq.g28140.t1,three_way,79.00033333333333,,,,,,,,,,,,,,,,,
OG_08019,1.3180029414799668,FUN_035674-T1,Peve_00002794,Pocillopora_meandrina_HIv1___RNAseq.g28141.t1,three_way,76.93833333333333,FUN_035674-T1,Q5JS54,PSMG4_HUMAN,,Proteasome assembly chaperone 4 (PAC-4) (hPAC4) (Proteasome chaperone homolog 4) (Pba4),Homo sapiens (Human),51.8,110.0,6.8e-25,114.8,sp|Q5JS54|PSMG4_HUMAN Proteasome assembly chaperone 4 OS=Homo sapiens OX=9606 GN=PSMG4 PE=1 SV=2,GO:0005829; GO:0032991; GO:0043248; GO:0044877,proteasome assembly [GO:0043248],cytosol [GO:0005829]; protein-containing complex [GO:0032991],protein-containing complex binding [GO:0044877],GO:0005829; GO:0065003,cytosol; protein-containing complex assembly
OG_08020,2.7719781226291142,FUN_035675-T1,Peve_00002795,Pocillopora_meandrina_HIv1___RNAseq.g28142.t1,three_way,59.38916666666667,FUN_035675-T1,Q6NZL6,TONSL_MOUSE,,Tonsoku-like protein (Inhibitor of kappa B-related protein) (I-kappa-B-related protein) (IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2),Mus musculus (Mouse),29.1,1503.0,7.8e-97,357.5,sp|Q6NZL6|TONSL_MOUSE Tonsoku-like protein OS=Mus musculus OX=10090 GN=Tonsl PE=1 SV=2,GO:0000724; GO:0005737; GO:0031297; GO:0035861; GO:0042393; GO:0043596; GO:0140566,double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; site of double-strand break [GO:0035861],histone binding [GO:0042393]; histone reader activity [GO:0140566],GO:0006281; GO:0006310; GO:0042393; GO:0060090,DNA repair; DNA recombination; histone binding; molecular adaptor activity
OG_08029,1.7241936589684834,FUN_035684-T1,Peve_00041295,Pocillopora_meandrina_HIv1___RNAseq.g11804.t1a,three_way,62.284333333333336,FUN_035684-T1,Q6GM78,ASGL1_XENLA,,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],Xenopus laevis (African clawed frog),43.1,269.0,2.8e-45,183.7,sp|Q6GM78|ASGL1_XENLA Isoaspartyl peptidase/L-asparaginase OS=Xenopus laevis OX=8355 GN=asrgl1 PE=2 SV=1,GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917],asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798],GO:0003824; GO:0006520; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; hydrolase activity; catalytic activity, acting on a protein"
OG_08031,2.105921340996366,FUN_035689-T1,Peve_00041293,Pocillopora_meandrina_HIv1___RNAseq.g11805.t1,three_way,90.49,FUN_035689-T1,Q13884,SNTB1_HUMAN,,Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43),Homo sapiens (Human),47.2,527.0,2.4e-127,457.2,sp|Q13884|SNTB1_HUMAN Beta-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTB1 PE=1 SV=3,GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202,muscle contraction [GO:0006936],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202],actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198],GO:0003012; GO:0005198; GO:0005856; GO:0005886; GO:0008092; GO:0043226,muscle system process; structural molecule activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_08032,1.3432320595189502,FUN_035692-T1,Peve_00041299,Pocillopora_meandrina_HIv1___RNAseq.g11811.t1,three_way,77.73133333333334,FUN_035692-T1,Q6DGQ4,,,,,59.6,57.0,1.1e-10,68.6,sp|Q6DGQ4|CP087_DANRE UPF0547 protein C16orf87 homolog OS=Danio rerio OX=7955 GN=zgc:92818 PE=2 SV=1,,,,,,
OG_08035,1.4580871770345778,FUN_035701-T1,Peve_00014072,Pocillopora_meandrina_HIv1___RNAseq.g11834.t1,three_way,65.56466666666667,FUN_035701-T1,Q8BGT5,,,,,45.4,460.0,2e-121,437.6,sp|Q8BGT5|ALAT2_MOUSE Alanine aminotransferase 2 OS=Mus musculus OX=10090 GN=Gpt2 PE=1 SV=1,,,,,,
OG_08038,1.2830625684927357,FUN_035715-T1,Peve_00044094,Pocillopora_meandrina_HIv1___RNAseq.g11846.t1,three_way,79.94233333333334,FUN_035715-T1,O95336,,,,,47.9,242.0,2.6e-58,226.9,sp|O95336|6PGL_HUMAN 6-phosphogluconolactonase OS=Homo sapiens OX=9606 GN=PGLS PE=1 SV=2,,,,,,
OG_08040,1.8910130790484432,FUN_035717-T1,Peve_00044097,Pocillopora_meandrina_HIv1___TS.g3184.t1,three_way,69.33633333333333,FUN_035717-T1,Q1LU86,CBAR1_DANRE,,CBY1-interacting BAR domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),33.9,245.0,1.3000000000000001e-32,141.7,sp|Q1LU86|CBAR1_DANRE CBY1-interacting BAR domain-containing protein 1 OS=Danio rerio OX=7955 GN=cibar1 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005929; GO:0007007; GO:0007283; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0097227; GO:0097546,cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of smoothened signaling pathway [GO:0045880]; spermatogenesis [GO:0007283],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; sperm annulus [GO:0097227],,GO:0005634; GO:0005815; GO:0005929; GO:0007005; GO:0022414; GO:0043226; GO:0044782; GO:0061024,nucleus; microtubule organizing center; cilium; mitochondrion organization; reproductive process; organelle; cilium organization; membrane organization
OG_08041,2.0033809358615087,FUN_035718-T1,Peve_00044098,Pocillopora_meandrina_HIv1___RNAseq.g11849.t1,three_way,49.524,,,,,,,,,,,,,,,,,
OG_08044,1.1620424928156297,FUN_035722-T1,Peve_00044101,Pocillopora_meandrina_HIv1___RNAseq.g11852.t1,three_way,79.41966666666667,FUN_035722-T1,Q90WU3,,,,,58.5,306.0,7.4e-98,358.6,sp|Q90WU3|DDX1_CHICK ATP-dependent RNA helicase DDX1 OS=Gallus gallus OX=9031 GN=DDX1 PE=1 SV=1,,,,,,
OG_08047,3.2451701830618687,FUN_035735-T1,Peve_00044084,Pocillopora_meandrina_HIv1___RNAseq.g11862.t1,three_way,61.315000000000005,FUN_035735-T1,P57769,SNX16_RAT,,Sorting nexin-16,Rattus norvegicus (Rat),44.3,149.0,4.9000000000000005e-27,124.0,sp|P57769|SNX16_RAT Sorting nexin-16 OS=Rattus norvegicus OX=10116 GN=Snx16 PE=1 SV=2,GO:0001881; GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022,early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]; receptor recycling [GO:0001881],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0005764; GO:0005768; GO:0005773; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_08048,2.119978195049854,FUN_035736-T1,Peve_00044086,Pocillopora_meandrina_HIv1___RNAseq.g11863.t1,three_way,69.81016666666667,FUN_035736-T1,Q8JFV8,,,,,53.8,342.0,2.6e-102,374.0,sp|Q8JFV8|VAT1_DANRE Synaptic vesicle membrane protein VAT-1 homolog OS=Danio rerio OX=7955 GN=vat1 PE=2 SV=1,,,,,,
OG_08052,1.6813084229273485,FUN_035743-T1,Peve_00026224,Pocillopora_meandrina_HIv1___TS.g3204.t1,three_way,69.02166666666666,,,,,,,,,,,,,,,,,
OG_08053,2.446666330357941,FUN_035748-T1,Peve_00014368,Pocillopora_meandrina_HIv1___TS.g3212.t1,three_way,61.029833333333336,FUN_035748-T1,Q9P2E3,ZNFX1_HUMAN,,NFX1-type zinc finger-containing protein 1,Homo sapiens (Human),38.2,1862.0,1.3e-311,1071.2,sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2,GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0006325; GO:0016853; GO:0031047; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; chromatin organization; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; defense response to other organism; ATP-dependent activity
OG_08054,2.5097111394689304,FUN_035749-T1,Peve_00016720,Pocillopora_meandrina_HIv1___RNAseq.g11875.t1,three_way,66.67133333333334,,,,,,,,,,,,,,,,,
OG_08055,1.4696370485195784,FUN_035750-T1,Peve_00044196,Pocillopora_meandrina_HIv1___RNAseq.g11876.t1,three_way,69.98333333333333,FUN_035750-T1,Q9BQ70,TCF25_HUMAN,,Ribosome quality control complex subunit TCF25 (Nuclear localized protein 1) (Transcription factor 25) (TCF-25),Homo sapiens (Human),47.6,527.0,3.4e-132,473.8,sp|Q9BQ70|TCF25_HUMAN Ribosome quality control complex subunit TCF25 OS=Homo sapiens OX=9606 GN=TCF25 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005829; GO:0061945; GO:0072344; GO:1990112,regulation of protein K48-linked ubiquitination [GO:0061945]; rescue of stalled ribosome [GO:0072344],cytosol [GO:0005829]; nucleus [GO:0005634]; RQC complex [GO:1990112],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005829; GO:0043226,DNA binding; nucleus; cytosol; organelle
OG_08056,1.918181346986568,FUN_035751-T1,Peve_00044197,Pocillopora_meandrina_HIv1___RNAseq.g11877.t1,three_way,71.535,FUN_035751-T1,P54802,ANAG_HUMAN,,Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form],Homo sapiens (Human),50.3,708.0,3.1000000000000005e-214,746.5,sp|P54802|ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGLU PE=1 SV=2,GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016020; GO:0016042; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030202; GO:0030203; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0097696; GO:0099022; GO:1904389; GO:1904390,adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; lipid catabolic process [GO:0016042]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020],alpha-N-acetylglucosaminidase activity [GO:0004561],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0006629; GO:0006914; GO:0007040; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0051604; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; lipid metabolic process; autophagy; lysosome organization; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; protein maturation; carbohydrate derivative metabolic process
OG_08057,3.958108338002493,FUN_035752-T1,Peve_00044203,Pocillopora_meandrina_HIv1___RNAseq.g11880.t1,three_way,86.57133333333333,FUN_035752-T1,Q64701,RBL1_MOUSE,,Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1),Mus musculus (Mouse),50.0,1056.0,2.6e-275,949.9,sp|Q64701|RBL1_MOUSE Retinoblastoma-like protein 1 OS=Mus musculus OX=10090 GN=Rbl1 PE=1 SV=3,GO:0000122; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0010629; GO:0051726; GO:1990841; GO:2000773,chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],promoter-specific chromatin binding [GO:1990841],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_08058,3.882067257591205,FUN_035753-T1,Peve_00044191,Pocillopora_meandrina_HIv1___RNAseq.g11881.t1,three_way,66.50783333333334,,,,,,,,,,,,,,,,,
OG_08059,2.508819442843196,FUN_035754-T1,Peve_00044192,Pocillopora_meandrina_HIv1___RNAseq.g11883.t1,three_way,63.23283333333333,FUN_035754-T1,Q5NDE7,PMGT2_XENLA,,"Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGnT2) (EC 2.4.1.312) (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2)",Xenopus laevis (African clawed frog),45.0,524.0,2.7e-140,500.4,"sp|Q5NDE7|PMGT2_XENLA Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 OS=Xenopus laevis OX=8355 GN=pomgnt2 PE=2 SV=1",GO:0001764; GO:0005783; GO:0005789; GO:0006493; GO:0008375; GO:0035269; GO:0097363,neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],acetylglucosaminyltransferase activity [GO:0008375]; protein O-acetylglucosaminyltransferase activity [GO:0097363],GO:0003824; GO:0005783; GO:0009101; GO:0016740; GO:0043226; GO:0048870; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; transferase activity; organelle; cell motility; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_08061,1.3638425132755536,FUN_035758-T1,Peve_00033436,Pocillopora_meandrina_HIv1___RNAseq.g11888.t1,three_way,71.446,FUN_035758-T1,Q9PVY8,,,,,68.4,155.0,1.1e-52,209.1,sp|Q9PVY8|FXC2B_XENLA Forkhead box protein C2-B OS=Xenopus laevis OX=8355 GN=foxc2-b PE=2 SV=2,,,,,,
OG_08063,1.7651118556159198,FUN_035761-T1,Peve_00033438,Pocillopora_meandrina_HIv1___RNAseq.g11890.t1,three_way,66.28783333333334,FUN_035761-T1,O70220,,,,,66.0,94.0,2.7e-33,144.1,sp|O70220|FOXQ1_MOUSE Forkhead box protein Q1 OS=Mus musculus OX=10090 GN=Foxq1 PE=2 SV=3,,,,,,
OG_08064,1.414493003219169,FUN_035762-T1,Peve_00033439,Pocillopora_meandrina_HIv1___RNAseq.g11891.t1,three_way,71.21000000000001,,,,,,,,,,,,,,,,,
OG_08065,3.579630521640888,FUN_035765-T1,Peve_00033443,Pocillopora_meandrina_HIv1___RNAseq.g11894.t1,three_way,90.73666666666666,FUN_035765-T1,Q6GL41,MCM4_XENTR,,DNA replication licensing factor mcm4 (EC 3.6.4.12) (Minichromosome maintenance protein 4),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),68.7,836.0,0.0,1105.1,sp|Q6GL41|MCM4_XENTR DNA replication licensing factor mcm4 OS=Xenopus tropicalis OX=8364 GN=mcm4 PE=2 SV=1,GO:0000785; GO:0001878; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0006270; GO:0008270; GO:0016887; GO:0030174; GO:0042555; GO:0044786; GO:0071162,cell cycle DNA replication [GO:0044786]; DNA replication initiation [GO:0006270]; regulation of DNA-templated DNA replication initiation [GO:0030174]; response to yeast [GO:0001878],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0006260; GO:0016787; GO:0016853; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA replication; hydrolase activity; isomerase activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_08067,1.98903036141501,FUN_035770-T1,Peve_00027765,Pocillopora_meandrina_HIv1___RNAseq.g11896.t1,three_way,75.35533333333333,FUN_035770-T1,A2VDS1,SCLY_BOVIN,,Selenocysteine lyase (EC 4.4.1.16),Bos taurus (Bovine),57.0,407.0,1.2999999999999999e-129,464.5,sp|A2VDS1|SCLY_BOVIN Selenocysteine lyase OS=Bos taurus OX=9913 GN=SCLY PE=2 SV=1,GO:0005829; GO:0009000; GO:0016740,,cytosol [GO:0005829],selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740],GO:0003824; GO:0005829; GO:0016740; GO:0016829,catalytic activity; cytosol; transferase activity; lyase activity
OG_08069,2.147622581775513,FUN_035773-T1,Peve_00027763,Pocillopora_meandrina_HIv1___RNAseq.g11898.t1,three_way,88.316,,,,,,,,,,,,,,,,,
OG_08070,2.07284638789821,FUN_035775-T1,Peve_00017724,Pocillopora_meandrina_HIv1___RNAseq.g11904.t1,three_way,71.4095,FUN_035775-T1,Q1LUT1,,,,,33.8,1359.0,3e-127,458.4,sp|Q1LUT1|EDC4_DANRE Enhancer of mRNA-decapping protein 4 OS=Danio rerio OX=7955 GN=edc4 PE=3 SV=1,,,,,,
OG_08071,3.03690973827512,FUN_035776-T1,Peve_00017723,Pocillopora_meandrina_HIv1___RNAseq.g11903.t1,three_way,63.2255,FUN_035776-T1,Q7TSG2,CTDP1_MOUSE,,RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),Mus musculus (Mouse),33.5,714.0,1.6e-88,328.9,sp|Q7TSG2|CTDP1_MOUSE RNA polymerase II subunit A C-terminal domain phosphatase OS=Mus musculus OX=10090 GN=Ctdp1 PE=1 SV=1,GO:0000922; GO:0001096; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006470; GO:0008420; GO:0010458; GO:0030496; GO:0030957; GO:0032991; GO:0043923; GO:0051233; GO:0051301; GO:0061052,cell division [GO:0051301]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096],GO:0003824; GO:0005654; GO:0005815; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; microtubule organizing center; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08074,2.0468979600536072,FUN_035779-T1,Peve_00027194,Pocillopora_meandrina_HIv1___RNAseq.g11900.t1,three_way,82.8665,FUN_035779-T1,Q9CWL8,CTBL1_MOUSE,,Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP),Mus musculus (Mouse),62.4,479.0,1.4e-168,594.3,sp|Q9CWL8|CTBL1_MOUSE Beta-catenin-like protein 1 OS=Mus musculus OX=10090 GN=Ctnnbl1 PE=1 SV=1,GO:0000398; GO:0000974; GO:0002250; GO:0005634; GO:0005654; GO:0005681; GO:0005813; GO:0005829; GO:0006915; GO:0016445; GO:0019899; GO:0043065,"adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]",centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681],enzyme binding [GO:0019899],GO:0002376; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0012501; GO:0016071; GO:0043226,immune system process; nucleus; nucleoplasm; microtubule organizing center; cytosol; programmed cell death; mRNA metabolic process; organelle
OG_08076,2.246641788702532,FUN_035800-T1,Peve_00015196,Pocillopora_meandrina_HIv1___RNAseq.g11910.t1a,three_way,62.337,FUN_035800-T1,O13076,,,,,29.1,313.0,8e-19,96.3,sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1,,,,,,
OG_08078,1.184034781807895,FUN_035802-T1,Peve_00017705,Pocillopora_meandrina_HIv1___RNAseq.g11918.t1,three_way,55.39816666666666,,,,,,,,,,,,,,,,,
OG_08079,1.2721941552927478,FUN_035803-T1,Peve_00017711,Pocillopora_meandrina_HIv1___TS.g3258.t1,three_way,42.588,,,,,,,,,,,,,,,,,
OG_08080,2.296370825091792,FUN_035804-T1,Peve_00017708,Pocillopora_meandrina_HIv1___RNAseq.g11921.t1,three_way,69.93833333333333,FUN_035804-T1,Q8NCN5,,,,,39.3,819.0,1e-170,602.1,"sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2",,,,,,
OG_08083,3.1261474743748106,FUN_035810-T1,Peve_00037792,Pocillopora_meandrina_HIv1___RNAseq.g11929.t1,three_way,63.96066666666667,FUN_035810-T1,O15943,CADN_DROME,,Neural-cadherin (Cadherin-N) (dN-cadherin),Drosophila melanogaster (Fruit fly),31.2,2035.0,2.2e-241,838.2,sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2,GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016020; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609,axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803],GO:0005886; GO:0007155; GO:0048856,plasma membrane; cell adhesion; anatomical structure development
OG_08084,2.640181900297727,FUN_035813-T1,Peve_00037805,Pocillopora_meandrina_HIv1___RNAseq.g11928.t1,three_way,74.87766666666667,FUN_035813-T1,Q969N2,PIGT_HUMAN,,GPI-anchor transamidase component PIGT (Phosphatidylinositol-glycan biosynthesis class T protein),Homo sapiens (Human),45.6,553.0,4.1e-142,506.5,sp|Q969N2|PIGT_HUMAN GPI-anchor transamidase component PIGT OS=Homo sapiens OX=9606 GN=PIGT PE=1 SV=1,GO:0005789; GO:0006506; GO:0016020; GO:0016255; GO:0030182; GO:0031410; GO:0034235; GO:0042765; GO:0051402; GO:0180046,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020],GPI anchor binding [GO:0034235],GO:0006629; GO:0008289; GO:0012501; GO:0030154; GO:0031410; GO:0043226; GO:0051604; GO:1901135,lipid metabolic process; lipid binding; programmed cell death; cell differentiation; cytoplasmic vesicle; organelle; protein maturation; carbohydrate derivative metabolic process
OG_08085,1.0574368587587526,FUN_035816-T1,Peve_00037797,Pocillopora_meandrina_HIv1___RNAseq.g11927.t1,three_way,65.37283333333333,,,,,,,,,,,,,,,,,
OG_08090,3.35151783097647,FUN_035822-T1,Peve_00037801,Pocillopora_meandrina_HIv1___RNAseq.g11932.t1,three_way,75.45,FUN_035822-T1,Q6PJI9,WDR59_HUMAN,,GATOR2 complex protein WDR59 (WD repeat-containing protein 59),Homo sapiens (Human),39.0,885.0,8.999999999999999e-151,535.8,sp|Q6PJI9|WDR59_HUMAN GATOR2 complex protein WDR59 OS=Homo sapiens OX=9606 GN=WDR59 PE=1 SV=2,GO:0005765; GO:0005774; GO:0005829; GO:0008270; GO:0031669; GO:0034198; GO:0035591; GO:0035859; GO:0043231; GO:0061700; GO:1904262; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TORC1 signaling [GO:1904263],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]; vacuolar membrane [GO:0005774],signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270],GO:0005829; GO:0043226; GO:0060090,cytosol; organelle; molecular adaptor activity
OG_08091,4.462948998258952,FUN_035824-T1,Peve_00037802,Pocillopora_meandrina_HIv1___RNAseq.g11933.t1,three_way,90.67833333333334,FUN_035824-T1,P08239,,,,,72.6,354.0,3e-148,526.2,sp|P08239|GNAO_BOVIN Guanine nucleotide-binding protein G(o) subunit alpha OS=Bos taurus OX=9913 GN=GNAO1 PE=1 SV=4,,,,,,
OG_08093,2.378712673972948,FUN_035828-T1,Peve_00002588,Pocillopora_meandrina_HIv1___RNAseq.g11936.t1,three_way,67.353,FUN_035828-T1,Q60751,IGF1R_MOUSE,,Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain],Mus musculus (Mouse),48.0,275.0,4.300000000000001e-71,271.6,sp|Q60751|IGF1R_MOUSE Insulin-like growth factor 1 receptor OS=Mus musculus OX=10090 GN=Igf1r PE=1 SV=3,GO:0000165; GO:0004713; GO:0005010; GO:0005198; GO:0005520; GO:0005524; GO:0005886; GO:0007420; GO:0008544; GO:0009887; GO:0016020; GO:0030238; GO:0030315; GO:0030325; GO:0030879; GO:0031017; GO:0032869; GO:0043235; GO:0043409; GO:0043410; GO:0043491; GO:0043548; GO:0043560; GO:0045840; GO:0045893; GO:0046777; GO:0048009; GO:0048639; GO:0051446; GO:0051897; GO:0051898; GO:0060740; GO:0071333; GO:0098794; GO:0098978; GO:0099170; GO:0120162; GO:0140014,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; insulin-like growth factor receptor signaling pathway [GO:0048009]; male sex determination [GO:0030238]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; mitotic nuclear division [GO:0140014]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; prostate gland epithelium morphogenesis [GO:0060740]; protein autophosphorylation [GO:0046777],glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]; T-tubule [GO:0030315],ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198],GO:0003824; GO:0005198; GO:0005886; GO:0006355; GO:0016740; GO:0022414; GO:0048856; GO:0060089; GO:0140014; GO:0140096,"catalytic activity; structural molecule activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; reproductive process; anatomical structure development; molecular transducer activity; mitotic nuclear division; catalytic activity, acting on a protein"
OG_08102,1.0153780754547757,FUN_035847-T1,Peve_00032506,Pocillopora_meandrina_HIv1___RNAseq.g11953.t2,three_way,67.05083333333333,FUN_035847-T1,Q86VV8,RTTN_HUMAN,,Rotatin,Homo sapiens (Human),28.2,2362.0,1.5000000000000002e-211,739.2,sp|Q86VV8|RTTN_HUMAN Rotatin OS=Homo sapiens OX=9606 GN=RTTN PE=1 SV=3,GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0032053; GO:0036064,centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737],,GO:0005815; GO:0043226; GO:0044782,microtubule organizing center; organelle; cilium organization
OG_08104,1.0799356554784088,FUN_035850-T1,Peve_00032508,Pocillopora_meandrina_HIv1___RNAseq.g11951.t1,three_way,80.12583333333333,,,,,,,,,,,,,,,,,
OG_08106,1.3725860160488037,FUN_035853-T1,Peve_00022799,Pocillopora_meandrina_HIv1___RNAseq.g11949.t1,three_way,50.63183333333333,FUN_035853-T1,Q6H601,RH22_ORYSJ,,DEAD-box ATP-dependent RNA helicase 22 (EC 3.6.4.13),Oryza sativa subsp. japonica (Rice),27.3,594.0,3.6e-37,157.9,sp|Q6H601|RH22_ORYSJ DEAD-box ATP-dependent RNA helicase 22 OS=Oryza sativa subsp. japonica OX=39947 GN=Os09g0383400 PE=2 SV=2,GO:0003724; GO:0003729; GO:0005524; GO:0009507; GO:0016887,,chloroplast [GO:0009507],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0009536; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; plastid; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08109,1.572639794935806,FUN_035862-T1,Peve_00045294,Pocillopora_meandrina_HIv1___RNAseq.g11941.t1,three_way,73.98133333333332,,,,,,,,,,,,,,,,,
OG_08110,1.017235632887689,FUN_035863-T1,Peve_00045295,Pocillopora_meandrina_HIv1___RNAseq.g11940.t1,three_way,67.611,,,,,,,,,,,,,,,,,
OG_08112,1.4455030368522133,FUN_035865-T1,Peve_00012613,Pocillopora_meandrina_HIv1___RNAseq.g11977.t1,three_way,77.13466666666666,FUN_035865-T1,Q8TEL6,TP4AP_HUMAN,,Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS),Homo sapiens (Human),37.4,768.0,3.2e-131,470.7,sp|Q8TEL6|TP4AP_HUMAN Short transient receptor potential channel 4-associated protein OS=Homo sapiens OX=9606 GN=TRPC4AP PE=1 SV=2,GO:0005262; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0070588; GO:0080008; GO:0140627; GO:1990756,calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; phosphatase binding [GO:0019902]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005215; GO:0005829; GO:0005886; GO:0030163; GO:0055085; GO:0060090,transporter activity; cytosol; plasma membrane; protein catabolic process; transmembrane transport; molecular adaptor activity
OG_08114,1.3441411511752994,FUN_035868-T1,Peve_00012617,Pocillopora_meandrina_HIv1___RNAseq.g11975.t1,three_way,69.01,,,,,,,,,,,,,,,,,
OG_08115,1.8171212227744773,FUN_035869-T1,Peve_00012618,Pocillopora_meandrina_HIv1___RNAseq.g11973.t1,three_way,53.684333333333335,FUN_035869-T1,Q8R1F9,,,,,30.0,360.0,5.4e-36,152.9,sp|Q8R1F9|RPP40_MOUSE Ribonuclease P protein subunit p40 OS=Mus musculus OX=10090 GN=Rpp40 PE=2 SV=2,,,,,,
OG_08118,2.2813494548044297,FUN_035872-T1,Peve_00014418,Pocillopora_meandrina_HIv1___RNAseq.g11987.t1,three_way,91.452,FUN_035872-T1,Q10568,,,,,69.1,181.0,3.2e-69,262.7,sp|Q10568|CPSF2_BOVIN Cleavage and polyadenylation specificity factor subunit 2 OS=Bos taurus OX=9913 GN=CPSF2 PE=1 SV=1,,,,,,
OG_08124,1.3040352917107827,FUN_035882-T1,Peve_00014426,Pocillopora_meandrina_HIv1___RNAseq.g11996.t1,three_way,76.97966666666666,FUN_035882-T1,Q9QXA6,BAT1_MOUSE,,"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",Mus musculus (Mouse),50.3,485.0,5.700000000000001e-124,446.0,"sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1",GO:0005886; GO:0015175; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009,L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_08130,2.241829052054595,FUN_035890-T2,Peve_00029398,Pocillopora_meandrina_HIv1___RNAseq.g12007.t1,three_way,73.41116666666667,FUN_035890-T2,Q8TEB1,DCA11_HUMAN,,DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23),Homo sapiens (Human),51.1,493.0,1.3e-147,524.6,sp|Q8TEB1|DCA11_HUMAN DDB1- and CUL4-associated factor 11 OS=Homo sapiens OX=9606 GN=DCAF11 PE=1 SV=1,GO:0003016; GO:0005654; GO:0006979; GO:0007613; GO:0010467; GO:0016567; GO:0035640; GO:0043161; GO:0050821; GO:0080008,exploration behavior [GO:0035640]; gene expression [GO:0010467]; memory [GO:0007613]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; respiratory system process [GO:0003016]; response to oxidative stress [GO:0006979],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654],,GO:0003016; GO:0005654; GO:0030163; GO:0050877,respiratory system process; nucleoplasm; protein catabolic process; nervous system process
OG_08131,2.8239123283323555,FUN_035891-T1,Peve_00029395,Pocillopora_meandrina_HIv1___RNAseq.g12008.t1,three_way,81.82483333333333,FUN_035891-T1,Q9WUU6,,,,,68.0,325.0,9.9e-122,438.3,sp|Q9WUU6|HNF4G_MOUSE Hepatocyte nuclear factor 4-gamma OS=Mus musculus OX=10090 GN=Hnf4g PE=2 SV=2,,,,,,
OG_08132,2.261351226209553,FUN_035892-T1,Peve_00029394,Pocillopora_meandrina_HIv1___RNAseq.g12009.t1,three_way,77.4455,FUN_035892-T1,Q8BH79,,,,,42.9,631.0,1.1e-140,501.9,sp|Q8BH79|ANO10_MOUSE Anoctamin-10 OS=Mus musculus OX=10090 GN=Ano10 PE=1 SV=1,,,,,,
OG_08133,1.391824367778892,FUN_035894-T1,Peve_00029391,Pocillopora_meandrina_HIv1___RNAseq.g12010.t1,three_way,84.60600000000001,FUN_035894-T1,Q9NYG2,,,,,45.2,252.0,8.5e-50,198.7,sp|Q9NYG2|ZDHC3_HUMAN Palmitoyltransferase ZDHHC3 OS=Homo sapiens OX=9606 GN=ZDHHC3 PE=1 SV=2,,,,,,
OG_08135,1.7369477302246112,FUN_035897-T1,Peve_00029404,Pocillopora_meandrina_HIv1___RNAseq.g12021.t1,three_way,83.846,FUN_035897-T1,P35285,RB22A_MOUSE,,Ras-related protein Rab-22A (Rab-22) (Rab-14),Mus musculus (Mouse),55.9,195.0,9.999999999999999e-54,211.5,sp|P35285|RB22A_MOUSE Ras-related protein Rab-22A OS=Mus musculus OX=10090 GN=Rab22a PE=1 SV=2,GO:0001726; GO:0003924; GO:0005525; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0006897; GO:0007032; GO:0010008; GO:0015031; GO:0015629; GO:0019003; GO:0030670; GO:0045335; GO:0097494,endocytosis [GO:0006897]; endosome organization [GO:0007032]; protein transport [GO:0015031]; regulation of vesicle size [GO:0097494],actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005794; GO:0005856; GO:0005886; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; endosome; Golgi apparatus; cytoskeleton; plasma membrane; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_08137,1.4842297017949533,FUN_035899-T1,Peve_00006715,Pocillopora_meandrina_HIv1___RNAseq.g12023.t1,three_way,75.59100000000001,FUN_035899-T1,Q148L7,,,,,49.2,120.0,7.6999999999999975e-25,114.8,sp|Q148L7|PDRG1_BOVIN p53 and DNA damage-regulated protein 1 OS=Bos taurus OX=9913 GN=PDRG1 PE=2 SV=1,,,,,,
OG_08138,1.1494991813434103,FUN_035900-T1,Peve_00006713,Pocillopora_meandrina_HIv1___RNAseq.g12025.t1,three_way,79.64066666666668,,,,,,,,,,,,,,,,,
OG_08142,1.9391446142402056,FUN_035907-T1,Peve_00006737,Pocillopora_meandrina_HIv1___RNAseq.g12031.t1,three_way,87.19116666666667,FUN_035907-T1,Q5RE09,DC1L2_PONAB,,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),51.2,477.0,2.9e-122,440.3,sp|Q5RE09|DC1L2_PONAB Cytoplasmic dynein 1 light intermediate chain 2 OS=Pongo abelii OX=9601 GN=DYNC1LI2 PE=2 SV=1,GO:0000226; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045504,microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874],ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504],GO:0005815; GO:0007010; GO:0007018,microtubule organizing center; cytoskeleton organization; microtubule-based movement
OG_08143,2.116418894278365,FUN_035908-T1,Peve_00006733,Pocillopora_meandrina_HIv1___TS.g3371.t1,three_way,92.83516666666668,,,,,,,,,,,,,,,,,
OG_08144,1.8500886400038887,FUN_035913-T1,Peve_00006734,Pocillopora_meandrina_HIv1___RNAseq.g12035.t1,three_way,56.841,,,,,,,,,,,,,,,,,
OG_08146,2.1625841777708983,FUN_035915-T1,Peve_00006727,Pocillopora_meandrina_HIv1___RNAseq.24982_t,three_way,54.92366666666666,,,,,,,,,,,,,,,,,
OG_08148,3.6614401685586726,FUN_035917-T1,Peve_00006725,Pocillopora_meandrina_HIv1___TS.g3382.t1,three_way,58.83166666666667,FUN_035917-T1,Q3ZBF3,,,,,41.2,245.0,2.2e-49,197.6,sp|Q3ZBF3|RM38_BOVIN Large ribosomal subunit protein mL38 OS=Bos taurus OX=9913 GN=MRPL38 PE=1 SV=2,,,,,,
OG_08152,1.6558247857462156,FUN_035926-T1,Peve_00006729,Pocillopora_meandrina_HIv1___RNAseq.g12054.t1,three_way,74.99366666666667,FUN_035926-T1,A3KG59,P20D2_MOUSE,,Xaa-Arg dipeptidase (EC 3.4.13.4),Mus musculus (Mouse),49.6,399.0,6.3e-102,372.5,sp|A3KG59|P20D2_MOUSE Xaa-Arg dipeptidase OS=Mus musculus OX=10090 GN=Pm20d2 PE=1 SV=1,GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246,proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802],GO:0003824; GO:0005654; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; catalytic activity, acting on a protein"
OG_08156,1.6447175508752905,FUN_035934-T1,Peve_00036623,Pocillopora_meandrina_HIv1___RNAseq.g12071.t1,three_way,75.52133333333333,FUN_035934-T1,Q9Z2D5,,,,,23.1,303.0,5.2e-08,60.1,sp|Q9Z2D5|NPY2R_CAVPO Neuropeptide Y receptor type 2 OS=Cavia porcellus OX=10141 GN=NPY2R PE=3 SV=1,,,,,,
OG_08157,1.8889174689985213,FUN_035935-T1,Peve_00036625,Pocillopora_meandrina_HIv1___RNAseq.g12072.t1,three_way,80.009,FUN_035935-T1,P23709,,,,,72.6,212.0,3.8e-87,322.8,"sp|P23709|NDUS3_BOVIN NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS3 PE=1 SV=1",,,,,,
OG_08160,2.3100265098221047,FUN_035941-T1,Peve_00036629,Pocillopora_meandrina_HIv1___RNAseq.g12076.t1,three_way,64.244,FUN_035941-T1,P36861,,,,,37.7,175.0,9.300000000000001e-27,122.1,sp|P36861|YPTV2_VOLCA GTP-binding protein yptV2 OS=Volvox carteri OX=3067 GN=YPTV2 PE=3 SV=1,,,,,,
OG_08161,1.9599419546657704,FUN_035942-T1,Peve_00036630,Pocillopora_meandrina_HIv1___RNAseq.g12075.t1,three_way,70.11566666666667,FUN_035942-T1,P36410,RAB14_DICDI,,Ras-related protein Rab-14 (EC 3.6.5.2) (Rab4-like GTPase),Dictyostelium discoideum (Social amoeba),37.9,169.0,2.2000000000000004e-28,127.1,sp|P36410|RAB14_DICDI Ras-related protein Rab-14 OS=Dictyostelium discoideum OX=44689 GN=rab14 PE=1 SV=2,GO:0003924; GO:0005525; GO:0005764; GO:0005765; GO:0005769; GO:0005802; GO:0005811; GO:0005829; GO:0006886; GO:0006895; GO:0006970; GO:0006971; GO:0012505; GO:0031164; GO:0032456; GO:0033298; GO:0042742; GO:0045335; GO:0048548; GO:0055037; GO:0062160; GO:0090382; GO:0140220; GO:1905364,contractile vacuole organization [GO:0033298]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; Golgi to endosome transport [GO:0006895]; hypotonic response [GO:0006971]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of pinocytosis [GO:0048548]; response to osmotic stress [GO:0006970],contractile vacuolar membrane [GO:0031164]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; pathogen-containing vacuole [GO:0140220]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; spongiome [GO:0062160]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; lysosome; endosome; vacuole; lipid droplet; cytosol; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_08162,1.380747438501274,FUN_035943-T1,Peve_00036631,Pocillopora_meandrina_HIv1___RNAseq.g12354.t1,three_way,85.26533333333333,,,,,,,,,,,,,,,,,
OG_08166,1.070908009870602,FUN_035965-T1,Peve_00006627,Pocillopora_meandrina_HIv1___RNAseq.g12331.t2,three_way,65.468,,,,,,,,,,,,,,,,,
OG_08169,1.975591259045219,FUN_035973-T1,Peve_00006612,Pocillopora_meandrina_HIv1___RNAseq.g12337.t2,three_way,84.21,FUN_035973-T1,Q11136,PEPD_MOUSE,,Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase 4) (Peptidase D) (Proline dipeptidase) (Prolidase),Mus musculus (Mouse),65.2,492.0,1.2999999999999999e-197,690.6,sp|Q11136|PEPD_MOUSE Xaa-Pro dipeptidase OS=Mus musculus OX=10090 GN=Pepd PE=1 SV=3,GO:0006508; GO:0008233; GO:0030145; GO:0030574; GO:0043069; GO:0070006; GO:0102009,collagen catabolic process [GO:0030574]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],,manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_08176,2.3088316860044227,FUN_035998-T1,Peve_00041845,Pocillopora_meandrina_HIv1___RNAseq.g12328.t1b,three_way,73.96566666666666,FUN_035998-T1,Q5EAC2,GSHB_BOVIN,,Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase),Bos taurus (Bovine),44.9,472.0,1.8e-108,394.4,sp|Q5EAC2|GSHB_BOVIN Glutathione synthetase OS=Bos taurus OX=9913 GN=GSS PE=2 SV=1,GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0042803; GO:0043295,,cytosol [GO:0005829],ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0016874,catalytic activity; cytosol; ligase activity
OG_08178,2.4958049438130416,FUN_036002-T1,Peve_00041842,Pocillopora_meandrina_HIv1___RNAseq.g12326.t1,three_way,67.96933333333334,FUN_036002-T1,O16099,,,,,43.3,506.0,4.3e-112,406.8,sp|O16099|MAL2_DROVI Maltase 2 OS=Drosophila virilis OX=7244 GN=Mal-B2 PE=3 SV=2,,,,,,
OG_08182,1.7694925569269715,FUN_036018-T2,Peve_00024357,Pocillopora_meandrina_HIv1___RNAseq.g12321.t1,three_way,60.927,FUN_036018-T2,Q6ZN54,DEFI8_HUMAN,,Differentially expressed in FDCP 8 homolog (DEF-8),Homo sapiens (Human),51.8,380.0,3.6e-108,394.4,sp|Q6ZN54|DEFI8_HUMAN Differentially expressed in FDCP 8 homolog OS=Homo sapiens OX=9606 GN=DEF8 PE=1 SV=2,GO:0008270; GO:0032418; GO:0045780; GO:1900029,lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029],,zinc ion binding [GO:0008270],,
OG_08183,1.6305709078682886,FUN_036020-T1,Peve_00024356,Pocillopora_meandrina_HIv1___TS.g3652.t1,three_way,70.24316666666667,FUN_036020-T1,Q54PH5,,,,,37.7,371.0,4.7999999999999997e-54,213.8,sp|Q54PH5|CWC2_DICDI Pre-mRNA-splicing factor cwc2 OS=Dictyostelium discoideum OX=44689 GN=cwc2 PE=3 SV=1,,,,,,
OG_08185,1.2515891571237845,FUN_036025-T1,Peve_00011111,Pocillopora_meandrina_HIv1___RNAseq.g27235.t1,three_way,81.50766666666667,FUN_036025-T1,F7B645,,,,,49.8,311.0,1e-83,311.6,sp|F7B645|TM231_XENTR Transmembrane protein 231 OS=Xenopus tropicalis OX=8364 GN=tmem231 PE=2 SV=1,,,,,,
OG_08186,2.714665123484685,FUN_036026-T1,Peve_00011110,Pocillopora_meandrina_HIv1___RNAseq.g27236.t1,three_way,53.73583333333333,FUN_036026-T1,Q9BUB4,,,,,36.3,529.0,4.8e-73,276.9,sp|Q9BUB4|ADAT1_HUMAN tRNA-specific adenosine deaminase 1 OS=Homo sapiens OX=9606 GN=ADAT1 PE=1 SV=1,,,,,,
OG_08191,1.5230250065555606,FUN_036031-T1,Peve_00011103,Pocillopora_meandrina_HIv1___RNAseq.g27241.t1,three_way,81.92866666666667,FUN_036031-T1,A5A779,PGTA_PIG,,Geranylgeranyl transferase type-2 subunit alpha (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha),Sus scrofa (Pig),51.5,305.0,3.7e-86,319.7,sp|A5A779|PGTA_PIG Geranylgeranyl transferase type-2 subunit alpha OS=Sus scrofa OX=9823 GN=RABGGTA PE=2 SV=1,GO:0004663; GO:0005737; GO:0005968; GO:0006888; GO:0008270; GO:0018344; GO:0031267,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein geranylgeranylation [GO:0018344],cytoplasm [GO:0005737]; Rab-protein geranylgeranyltransferase complex [GO:0005968],Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0003824; GO:0016192; GO:0016740; GO:0140096,"catalytic activity; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_08192,2.0199706536490094,FUN_036035-T1,Peve_00011097,Pocillopora_meandrina_HIv1___TS.g14605.t2,three_way,50.55033333333333,FUN_036035-T1,Q0V8S9,,,,,27.5,641.0,1.3e-62,243.4,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_08194,1.087017582917095,FUN_036037-T1,Peve_00011093,Pocillopora_meandrina_HIv1___TS.g14608.t1,three_way,65.38533333333334,,,,,,,,,,,,,,,,,
OG_08198,1.964032123181179,FUN_036042-T1,Peve_00011145,Pocillopora_meandrina_HIv1___RNAseq.g27346.t1,three_way,70.13033333333333,FUN_036042-T1,O00750,P3C2B_HUMAN,,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta),Homo sapiens (Human),40.2,1439.0,5.8e-287,989.2,sp|O00750|P3C2B_HUMAN Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta OS=Homo sapiens OX=9606 GN=PIK3C2B PE=1 SV=2,GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0009267; GO:0016303; GO:0016477; GO:0030139; GO:0031965; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0048015; GO:1905037,autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091],GO:0003824; GO:0005654; GO:0005783; GO:0005829; GO:0005886; GO:0006629; GO:0008289; GO:0016740; GO:0031410; GO:0043226; GO:0048870,catalytic activity; nucleoplasm; endoplasmic reticulum; cytosol; plasma membrane; lipid metabolic process; lipid binding; transferase activity; cytoplasmic vesicle; organelle; cell motility
OG_08200,1.893404828811192,FUN_036044-T1,Peve_00011142,Pocillopora_meandrina_HIv1___RNAseq.g27348.t1,three_way,84.868,FUN_036044-T1,F1QXM5,,,,,66.1,449.0,1e-178,627.9,"sp|F1QXM5|LDHD_DANRE Probable D-lactate dehydrogenase, mitochondrial OS=Danio rerio OX=7955 GN=ldhd PE=2 SV=1",,,,,,
OG_08201,2.958419635868271,FUN_036046-T1,Peve_00029868,Pocillopora_meandrina_HIv1___RNAseq.g27386.t1,three_way,42.30983333333333,FUN_036046-T1,Q6UB98,ANR12_HUMAN,,Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein),Homo sapiens (Human),36.3,113.0,2.4e-08,62.8,sp|Q6UB98|ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ANKRD12 PE=1 SV=3,GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_08204,2.2954557009762144,FUN_036055-T1,Peve_00043184,Pocillopora_meandrina_HIv1___RNAseq.g27393.t1,three_way,66.97699999999999,FUN_036055-T1,Q3U2U7,MET17_MOUSE,,"Ribosome assembly protein METTL17, mitochondrial (Methyltransferase-like protein 17)",Mus musculus (Mouse),36.6,374.0,3.1e-62,241.1,"sp|Q3U2U7|MET17_MOUSE Ribosome assembly protein METTL17, mitochondrial OS=Mus musculus OX=10090 GN=Mettl17 PE=1 SV=2",GO:0005654; GO:0005739; GO:0005759; GO:0006412; GO:0008168; GO:0042274; GO:0046872; GO:0051539; GO:0097177; GO:0180026; GO:1904047,mitochondrial small ribosomal subunit assembly [GO:0180026]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; mitochondrial ribosome binding [GO:0097177]; S-adenosyl-L-methionine binding [GO:1904047]",GO:0003824; GO:0005654; GO:0005739; GO:0016740; GO:0043226; GO:0065003,catalytic activity; nucleoplasm; mitochondrion; transferase activity; organelle; protein-containing complex assembly
OG_08205,2.5313051561295765,FUN_036057-T1,Peve_00043176,Pocillopora_meandrina_HIv1___TS.g14741.t1,three_way,64.9455,FUN_036057-T1,E2RYF8,,,,,34.8,594.0,1.8e-56,222.2,sp|E2RYF8|TPX2_PATPE Targeting protein for Xklp2 homolog OS=Patiria pectinifera OX=7594 GN=TPX2 PE=2 SV=1,,,,,,
OG_08206,1.0519106476449966,FUN_036058-T1,Peve_00043177,Pocillopora_meandrina_HIv1___RNAseq.g27395.t1,three_way,62.19433333333333,,,,,,,,,,,,,,,,,
OG_08215,2.110435469972016,FUN_036073-T1,Peve_00018969,Pocillopora_meandrina_HIv1___TS.g14760.t2,three_way,77.22200000000001,FUN_036073-T1,Q17QH8,,,,,55.4,294.0,1.2e-86,321.2,sp|Q17QH8|D39U1_BOVIN Epimerase family protein SDR39U1 OS=Bos taurus OX=9913 GN=SDR39U1 PE=2 SV=1,,,,,,
OG_08216,2.7504456301057463,FUN_036074-T3,Peve_00018966,Pocillopora_meandrina_HIv1___RNAseq.g27412.t1,three_way,78.726,FUN_036074-T3,Q8CG73,FTM_MOUSE,,Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein),Mus musculus (Mouse),37.4,1341.0,1.0999999999999998e-198,695.7,sp|Q8CG73|FTM_MOUSE Protein fantom OS=Mus musculus OX=10090 GN=Rpgrip1l PE=1 SV=2,GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0007420; GO:0008589; GO:0016607; GO:0021532; GO:0021537; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0035108; GO:0035115; GO:0035116; GO:0035869; GO:0036064; GO:0043010; GO:0043584; GO:0045744; GO:0060039; GO:0060271; GO:0060322; GO:0090102; GO:1905515,brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; telencephalon development [GO:0021537],axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886],thromboxane A2 receptor binding [GO:0031870],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007163; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytosol; plasma membrane; cilium; establishment or maintenance of cell polarity; organelle; cilium organization; anatomical structure development
OG_08219,2.1728149408039776,FUN_036081-T1,Peve_00018988,Pocillopora_meandrina_HIv1___RNAseq.g27414.t1,three_way,75.69716666666666,,,,,,,,,,,,,,,,,
OG_08221,1.7181759943699404,FUN_036085-T1,Peve_00041355,Pocillopora_meandrina_HIv1___RNAseq.g27449.t1,three_way,82.33333333333333,FUN_036085-T1,Q6NX12,,,,,53.2,824.0,2.9e-247,856.3,sp|Q6NX12|NUP93_XENTR Nuclear pore complex protein Nup93 OS=Xenopus tropicalis OX=8364 GN=nup93 PE=2 SV=1,,,,,,
OG_08224,2.4202110141319624,FUN_036095-T1,Peve_00032192,Pocillopora_meandrina_HIv1___RNAseq.g27439.t1,three_way,90.405,FUN_036095-T1,Q9EQH3,VPS35_MOUSE,,Vacuolar protein sorting-associated protein 35 (Maternal-embryonic 3) (Vesicle protein sorting 35),Mus musculus (Mouse),69.9,800.0,0.0,1120.5,sp|Q9EQH3|VPS35_MOUSE Vacuolar protein sorting-associated protein 35 OS=Mus musculus OX=10090 GN=Vps35 PE=1 SV=1,GO:0005737; GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006624; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0016020; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032456; GO:0032463; GO:0033365; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0045202; GO:0045732; GO:0048471; GO:0050728; GO:0050804; GO:0050882; GO:0060161; GO:0061357; GO:0090128; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098691; GO:0098793; GO:0098794; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:0150052; GO:1902823; GO:1902950; GO:1903181; GO:1903828; GO:1904377; GO:1905166; GO:2000331,"endocytic recycling [GO:0032456]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; protein localization to organelle [GO:0033365]; regulation of dendritic spine maintenance [GO:1902950]; regulation of postsynapse assembly [GO:0150052]; regulation of synapse maturation [GO:0090128]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; transcytosis [GO:0045056]; vacuolar protein processing [GO:0006624]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; synapse [GO:0045202]; tubular endosome [GO:0097422]",D1 dopamine receptor binding [GO:0031748],GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006886; GO:0007005; GO:0007040; GO:0016192; GO:0031410; GO:0043226; GO:0050877; GO:0051604; GO:0072659,mitochondrion; lysosome; endosome; vacuole; cytosol; intracellular protein transport; mitochondrion organization; lysosome organization; vesicle-mediated transport; cytoplasmic vesicle; organelle; nervous system process; protein maturation; protein localization to plasma membrane
OG_08226,4.54309234924854,FUN_036097-T2,Peve_00032194,Pocillopora_meandrina_HIv1___RNAseq.g27437.t1,three_way,61.02516666666666,FUN_036097-T2,Q801E2,ANLN_XENLA,,Anillin,Xenopus laevis (African clawed frog),34.7,432.0,4.6e-56,221.5,sp|Q801E2|ANLN_XENLA Anillin OS=Xenopus laevis OX=8355 GN=anln PE=1 SV=1,GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005826; GO:0005938; GO:0031106; GO:0032059; GO:1904172,actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; septin ring organization [GO:0031106],actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; nucleus [GO:0005634],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0007010; GO:0008092; GO:0043226,cytokinesis; nucleus; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08230,3.1195886452817407,FUN_036103-T1,Peve_00003702,Pocillopora_meandrina_HIv1___RNAseq.g27433.t1,three_way,73.634,FUN_036103-T1,P82160,,,,,38.8,147.0,1.8000000000000001e-22,107.8,"sp|P82160|MLE3_CHERA Myosin light chain 3, skeletal muscle isoform OS=Chelon ramada OX=30804 PE=1 SV=1",,,,,,
OG_08231,3.595792468681962,FUN_036106-T1,Peve_00003695,Pocillopora_meandrina_HIv1___RNAseq.g27429.t1,three_way,71.5815,FUN_036106-T1,Q68D86,C102B_HUMAN,,Coiled-coil domain-containing protein 102B,Homo sapiens (Human),37.2,390.0,5.6e-42,173.7,sp|Q68D86|C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens OX=9606 GN=CCDC102B PE=1 SV=4,GO:0005737; GO:0005814; GO:0010457; GO:0120283,centriole-centriole cohesion [GO:0010457],centriole [GO:0005814]; cytoplasm [GO:0005737],protein serine/threonine kinase binding [GO:0120283],GO:0043226,organelle
OG_08232,1.848400402835448,FUN_036108-T1,Peve_00003698,Pocillopora_meandrina_HIv1___RNAseq.g27428.t1,three_way,57.653666666666666,FUN_036108-T1,P25867,UBCD1_DROME,,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),Drosophila melanogaster (Fruit fly),49.7,143.0,6.2e-36,153.3,sp|P25867|UBCD1_DROME Ubiquitin-conjugating enzyme E2-17 kDa OS=Drosophila melanogaster OX=7227 GN=eff PE=1 SV=1,GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625],GO:0000278; GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"mitotic cell cycle; immune system process; catalytic activity; nucleus; cytosol; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_08233,1.8390739543162269,FUN_036109-T1,Peve_00003699,Pocillopora_meandrina_HIv1___RNAseq.g27427.t1,three_way,71.93266666666666,FUN_036109-T1,Q330K2,NDUF6_HUMAN,,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 (Putative phytoene synthase)",Homo sapiens (Human),51.8,301.0,2.4e-85,317.0,"sp|Q330K2|NDUF6_HUMAN NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 OS=Homo sapiens OX=9606 GN=NDUFAF6 PE=1 SV=2",GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0009058; GO:0032981,biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634],,GO:0005634; GO:0005739; GO:0043226; GO:0065003,nucleus; mitochondrion; organelle; protein-containing complex assembly
OG_08234,2.028998247103498,FUN_036110-T1,Peve_00032894,Pocillopora_meandrina_HIv1___RNAseq.g27426.t1,three_way,79.54533333333333,FUN_036110-T1,O35435,PYRD_MOUSE,,"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)",Mus musculus (Mouse),59.0,395.0,3.1e-125,449.9,"sp|O35435|PYRD_MOUSE Dihydroorotate dehydrogenase (quinone), mitochondrial OS=Mus musculus OX=10090 GN=Dhodh PE=1 SV=2",GO:0004151; GO:0004152; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006207; GO:0006225; GO:0044205; GO:0106430,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; UDP biosynthetic process [GO:0006225],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],dihydroorotase activity [GO:0004151]; dihydroorotate dehydrogenase (quinone) activity [GO:0106430]; dihydroorotate dehydrogenase activity [GO:0004152],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016491; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; mitochondrion; cytosol; oxidoreductase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08238,1.0451927070485294,FUN_036118-T1,Peve_00000287,Pocillopora_meandrina_HIv1___RNAseq.g27450.t1,three_way,76.68433333333334,,,,,,,,,,,,,,,,,
OG_08240,3.0291341974104693,FUN_036124-T1,Peve_00000288,Pocillopora_meandrina_HIv1___RNAseq.g27452.t1,three_way,65.2255,FUN_036124-T1,Q9UK23,NAGPA_HUMAN,,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase),Homo sapiens (Human),47.2,369.0,3.6e-90,334.0,sp|Q9UK23|NAGPA_HUMAN N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGPA PE=1 SV=2,GO:0003944; GO:0005975; GO:0006486; GO:0006622; GO:0007040; GO:0016020; GO:0032580; GO:0033299; GO:0036211,carbohydrate metabolic process [GO:0005975]; lysosome organization [GO:0007040]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020],N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [GO:0003944],GO:0003824; GO:0005975; GO:0006486; GO:0006886; GO:0007040; GO:0016787,catalytic activity; carbohydrate metabolic process; protein glycosylation; intracellular protein transport; lysosome organization; hydrolase activity
OG_08241,1.0468296962970536,FUN_036143-T1,Peve_00000292,Pocillopora_meandrina_HIv1___TS.g14803.t1,three_way,87.003,FUN_036143-T1,Q13885,TBB2A_HUMAN,,Tubulin beta-2A chain (Tubulin beta class IIa),Homo sapiens (Human),69.0,432.0,1.8e-185,650.2,sp|Q13885|TBB2A_HUMAN Tubulin beta-2A chain OS=Homo sapiens OX=9606 GN=TUBB2A PE=1 SV=1,GO:0000226; GO:0000278; GO:0001764; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0021987; GO:0045171; GO:0046872; GO:0070062; GO:0072686; GO:1903561,cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0003824; GO:0003924; GO:0005198; GO:0005634; GO:0005856; GO:0007010; GO:0016787; GO:0043226; GO:0048856; GO:0048870,mitotic cell cycle; catalytic activity; GTPase activity; structural molecule activity; nucleus; cytoskeleton; cytoskeleton organization; hydrolase activity; organelle; anatomical structure development; cell motility
OG_08252,1.6706463372850722,FUN_036161-T1,Peve_00039217,Pocillopora_meandrina_HIv1___RNAseq.g27496.t1,three_way,49.679833333333335,FUN_036161-T1,Q9D6X6,,,,,31.2,346.0,1.5e-33,145.2,sp|Q9D6X6|PRS23_MOUSE Serine protease 23 OS=Mus musculus OX=10090 GN=Prss23 PE=2 SV=2,,,,,,
OG_08257,1.829825130786581,FUN_036167-T1,Peve_00027204,Pocillopora_meandrina_HIv1___TS.g14851.t1,three_way,60.79866666666666,FUN_036167-T1,Q64093,S6A20_RAT,,Sodium- and chloride-dependent transporter XTRP3 (Sodium/imino-acid transporter 1) (Solute carrier family 6 member 20) (Transporter rB21A),Rattus norvegicus (Rat),35.0,577.0,1.6e-93,345.5,sp|Q64093|S6A20_RAT Sodium- and chloride-dependent transporter XTRP3 OS=Rattus norvegicus OX=10116 GN=Slc6a20 PE=2 SV=1,GO:0005298; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015193; GO:0015199; GO:0015370; GO:0015816; GO:0015824; GO:0015838; GO:0016324; GO:0031526; GO:0035725; GO:0089718; GO:1903804; GO:1904271; GO:1905647,amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; amino-acid betaine transport [GO:0015838]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; L-proline import across plasma membrane [GO:1904271]; proline import across plasma membrane [GO:1905647]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; amino-acid betaine transmembrane transporter activity [GO:0015199]; L-proline transmembrane transporter activity [GO:0015193]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; proline:sodium symporter activity [GO:0005298]; solute:sodium symporter activity [GO:0015370],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_08258,2.268268913070057,FUN_036169-T2,Peve_00027206,Pocillopora_meandrina_HIv1___TS.g14852.t1,three_way,74.27483333333333,FUN_036169-T2,Q9XS59,,,,,42.6,611.0,6.1e-141,503.1,sp|Q9XS59|S6A15_BOVIN Sodium-dependent neutral amino acid transporter B(0)AT2 OS=Bos taurus OX=9913 GN=SLC6A15 PE=2 SV=1,,,,,,
OG_08260,1.7261526477367108,FUN_036172-T1,Peve_00027209,Pocillopora_meandrina_HIv1___RNAseq.g27505.t1,three_way,60.32333333333333,FUN_036172-T1,Q504M2,,,,,34.6,442.0,8.400000000000001e-57,223.0,"sp|Q504M2|PDP2_MOUSE [Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial OS=Mus musculus OX=10090 GN=Pdp2 PE=1 SV=1",,,,,,
OG_08263,1.46966566083537,FUN_036175-T1,Peve_00027214,Pocillopora_meandrina_HIv1___RNAseq.g27508.t1,three_way,81.739,FUN_036175-T1,Q64414,,,,,54.2,177.0,1.5e-45,184.1,sp|Q64414|APT_DIPCP Adenine phosphoribosyltransferase OS=Dipodillus campestris OX=41199 GN=APRT PE=3 SV=1,,,,,,
OG_08265,1.233545592636665,FUN_036177-T1,Peve_00027216,Pocillopora_meandrina_HIv1___RNAseq.g27511.t1,three_way,55.68066666666667,,,,,,,,,,,,,,,,,
OG_08266,2.3875405955061364,FUN_036178-T1,Peve_00027217,Pocillopora_meandrina_HIv1___RNAseq.g27512.t1,three_way,66.12366666666667,FUN_036178-T1,Q3ZBX6,,,,,42.9,282.0,2.9e-56,220.7,sp|Q3ZBX6|RM03_BOVIN Large ribosomal subunit protein uL3m OS=Bos taurus OX=9913 GN=MRPL3 PE=1 SV=1,,,,,,
OG_08267,2.4696231473724684,FUN_036179-T1,Peve_00027218,Pocillopora_meandrina_HIv1___RNAseq.g27513.t1,three_way,49.457,FUN_036179-T1,O94763,,,,,33.3,249.0,4.4e-29,130.6,sp|O94763|RMP_HUMAN Unconventional prefoldin RPB5 interactor 1 OS=Homo sapiens OX=9606 GN=URI1 PE=1 SV=3,,,,,,
OG_08268,2.656193140287856,FUN_036180-T1,Peve_00015591,Pocillopora_meandrina_HIv1___RNAseq.g27514.t1,three_way,71.41016666666667,FUN_036180-T1,Q5R4M2,,,,,37.6,1344.0,2.1e-234,814.3,sp|Q5R4M2|ULK4_PONAB Serine/threonine-protein kinase ULK4 OS=Pongo abelii OX=9601 GN=ULK4 PE=2 SV=1,,,,,,
OG_08274,1.928610642269289,FUN_036189-T1,Peve_00038735,Pocillopora_meandrina_HIv1___RNAseq.g27372.t1,three_way,67.0075,FUN_036189-T1,P42674,,,,,42.8,208.0,8.1e-39,164.1,sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1,,,,,,
OG_08277,2.310016206223894,FUN_036195-T1,Peve_00011109,Pocillopora_meandrina_HIv1___RNAseq.g27367.t1,three_way,72.57383333333334,FUN_036195-T1,Q3UMR0,ANR27_MOUSE,,Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein),Mus musculus (Mouse),42.3,787.0,1.5999999999999999e-96,355.9,sp|Q3UMR0|ANR27_MOUSE Ankyrin repeat domain-containing protein 27 OS=Mus musculus OX=10090 GN=Ankrd27 PE=1 SV=2,GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0045022; GO:0048812; GO:0050775; GO:0097422,early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031],cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149],GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,lysosome; endosome; vacuole; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08278,3.0815726459582544,FUN_036196-T1,Peve_00025812,Pocillopora_meandrina_HIv1___RNAseq.g27366.t1,three_way,85.65133333333334,FUN_036196-T1,Q3UMM4,CDK10_MOUSE,,Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10),Mus musculus (Mouse),65.4,358.0,4.4e-137,489.2,sp|Q3UMM4|CDK10_MOUSE Cyclin-dependent kinase 10 OS=Mus musculus OX=10090 GN=Cdk10 PE=1 SV=1,GO:0000307; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0007346; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:0097472; GO:0106310; GO:1902018; GO:1902749,cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of mitotic cell cycle [GO:0007346],ciliary basal body [GO:0036064]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08281,1.0535432714130235,FUN_036205-T1,Peve_00038741,Pocillopora_meandrina_HIv1___RNAseq.g27357.t1,three_way,76.24883333333334,FUN_036205-T1,O88554,PARP2_MOUSE,,Poly [ADP-ribose] polymerase 2 (PARP-2) (mPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-),Mus musculus (Mouse),55.8,545.0,8.2e-169,595.5,sp|O88554|PARP2_MOUSE Poly [ADP-ribose] polymerase 2 OS=Mus musculus OX=10090 GN=Parp2 PE=1 SV=3,GO:0003682; GO:0003684; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006284; GO:0016779; GO:0030592; GO:0031491; GO:0046697; GO:0061051; GO:0070212; GO:0070213; GO:0072572; GO:0090649; GO:0090734; GO:0097191; GO:0110088; GO:0140294; GO:0140805; GO:0140806; GO:0140807; GO:0140861; GO:0160004; GO:1990404,base-excision repair [GO:0006284]; decidualization [GO:0046697]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; extrinsic apoptotic signaling pathway [GO:0097191]; hippocampal neuron apoptotic process [GO:0110088]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]; response to oxygen-glucose deprivation [GO:0090649],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; poly-ADP-D-ribose binding [GO:0072572]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006325; GO:0012501; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; chromatin organization; programmed cell death; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08283,1.9392636363614884,FUN_036207-T2,Peve_00038732,Pocillopora_meandrina_HIv1___RNAseq.g27355.t1,three_way,77.35466666666666,FUN_036207-T2,Q5RDW1,,,,,48.1,322.0,7.600000000000001e-80,298.9,sp|Q5RDW1|MTG2_PONAB Mitochondrial ribosome-associated GTPase 2 OS=Pongo abelii OX=9601 GN=MTG2 PE=2 SV=1,,,,,,
OG_08284,1.7827280761137545,FUN_036208-T1,Peve_00038733,Pocillopora_meandrina_HIv1___RNAseq.g27354.t1,three_way,51.08383333333333,FUN_036208-T1,Q5F363,,,,,36.3,658.0,8.7e-114,414.1,sp|Q5F363|JARD2_CHICK Protein Jumonji OS=Gallus gallus OX=9031 GN=JARID2 PE=2 SV=1,,,,,,
OG_08285,1.4153710396942007,FUN_036212-T1,Peve_00025926,Pocillopora_meandrina_HIv1___RNAseq.g27384.t1,three_way,79.80799999999999,FUN_036212-T1,Q96RK4,BBS4_HUMAN,,BBSome complex member BBS4 (Bardet-Biedl syndrome 4 protein),Homo sapiens (Human),38.6,451.0,2.1999999999999998e-75,284.6,sp|Q96RK4|BBS4_HUMAN BBSome complex member BBS4 OS=Homo sapiens OX=9606 GN=BBS4 PE=1 SV=2,GO:0000226; GO:0000242; GO:0000281; GO:0001750; GO:0001764; GO:0001782; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010467; GO:0010629; GO:0015031; GO:0016055; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030674; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0033365; GO:0034101; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0046907; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0061629; GO:0071539; GO:0097730; GO:0120316; GO:1902855; GO:1903546; GO:1905515,adult behavior [GO:0030534]; B cell homeostasis [GO:0001782]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; erythrocyte homeostasis [GO:0034101]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; gene expression [GO:0010467]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750],alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0000910; GO:0002376; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060090,cytokinesis; immune system process; nucleus; microtubule organizing center; cytosol; cilium; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular adaptor activity
OG_08286,2.395482159788256,FUN_036221-T1,Peve_00025940,Pocillopora_meandrina_HIv1___RNAseq.g27543.t1,three_way,83.386,FUN_036221-T1,F1MM41,ZNRF1_BOVIN,,E3 ubiquitin-protein ligase ZNRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF1) (Zinc/RING finger protein 1),Bos taurus (Bovine),57.0,93.0,2.6e-26,120.2,sp|F1MM41|ZNRF1_BOVIN E3 ubiquitin-protein ligase ZNRF1 OS=Bos taurus OX=9913 GN=ZNRF1 PE=3 SV=2,GO:0004842; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0008270; GO:0016020; GO:0030672; GO:0034145; GO:0043161; GO:0043231; GO:0061630; GO:0070936; GO:0160177,positive regulation of autophagosome-lysosome fusion [GO:0160177]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; synaptic vesicle membrane [GO:0030672],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; lysosome; endosome; vacuole; cytosol; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_08287,3.1989990467158687,FUN_036222-T1,Peve_00025942,Pocillopora_meandrina_HIv1___RNAseq.g27544.t1,three_way,56.418,FUN_036222-T1,Q8IZU8,,,,,33.9,921.0,1.2e-134,482.3,sp|Q8IZU8|DSEL_HUMAN Dermatan-sulfate epimerase-like protein OS=Homo sapiens OX=9606 GN=DSEL PE=1 SV=2,,,,,,
OG_08294,2.462475416253651,FUN_036232-T1,Peve_00015682,Pocillopora_meandrina_HIv1___RNAseq.g27553.t2,three_way,83.43166666666666,FUN_036232-T1,O75131,CPNE3_HUMAN,,Copine-3 (Copine III),Homo sapiens (Human),56.6,525.0,3.6e-177,622.9,sp|O75131|CPNE3_HUMAN Copine-3 OS=Homo sapiens OX=9606 GN=CPNE3 PE=1 SV=1,GO:0003723; GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0035577; GO:0038128; GO:0046872; GO:0048306; GO:0070062; GO:0071277; GO:0071363,cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335],azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0008289; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; plasma membrane; lipid binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08297,1.34534301461358,FUN_036246-T1,Peve_00042157,Pocillopora_meandrina_HIv1___RNAseq.g27581.t2,three_way,85.31133333333334,FUN_036246-T1,P08059,,,,,72.2,550.0,9.8e-239,827.4,sp|P08059|G6PI_PIG Glucose-6-phosphate isomerase OS=Sus scrofa OX=9823 GN=GPI PE=1 SV=3,,,,,,
OG_08298,1.7359139577591138,FUN_036247-T1,Peve_00042155,Pocillopora_meandrina_HIv1___RNAseq.g27593.t1,three_way,84.28566666666666,FUN_036247-T1,Q8NDZ6,,,,,42.0,505.0,3.1e-103,377.1,sp|Q8NDZ6|T161B_HUMAN Transmembrane protein 161B OS=Homo sapiens OX=9606 GN=TMEM161B PE=1 SV=1,,,,,,
OG_08300,2.5306590420451385,FUN_036249-T1,Peve_00045287,Pocillopora_meandrina_HIv1___RNAseq.g27590.t1,three_way,48.918,,,,,,,,,,,,,,,,,
OG_08301,1.376641298195394,FUN_036251-T1,Peve_00045290,Pocillopora_meandrina_HIv1___RNAseq.g27588.t1,three_way,74.035,FUN_036251-T1,P20042,IF2B_HUMAN,,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta),Homo sapiens (Human),85.7,168.0,3.3000000000000003e-80,300.1,sp|P20042|IF2B_HUMAN Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens OX=9606 GN=EIF2S2 PE=1 SV=2,GO:0001701; GO:0001731; GO:0002176; GO:0002183; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0008270; GO:0008584; GO:0031369; GO:0045202,cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202],"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]",GO:0003723; GO:0005829; GO:0022414; GO:0048856; GO:0065003,RNA binding; cytosol; reproductive process; anatomical structure development; protein-containing complex assembly
OG_08305,1.7959579741212972,FUN_036260-T1,Peve_00012320,Pocillopora_meandrina_HIv1___RNAseq.g27582.t1,three_way,82.303,FUN_036260-T1,Q8WXH2,JPH3_HUMAN,,Junctophilin-3 (JP-3) (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein),Homo sapiens (Human),66.7,57.0,9.9e-20,99.4,sp|Q8WXH2|JPH3_HUMAN Junctophilin-3 OS=Homo sapiens OX=9606 GN=JPH3 PE=1 SV=2,GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0010880; GO:0010882; GO:0014701; GO:0016020; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060402,calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic plasticity [GO:0048167],endoplasmic reticulum membrane [GO:0005789]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886],,GO:0005886; GO:0050877; GO:0055085,plasma membrane; nervous system process; transmembrane transport
OG_08307,1.2370394514051108,FUN_036264-T1,Peve_00009286,Pocillopora_meandrina_HIv1___RNAseq.g27055.t1,three_way,54.22983333333334,FUN_036264-T1,Q75QI0,,,,,45.5,178.0,1.9e-27,124.4,sp|Q75QI0|CFDP1_CHICK Craniofacial development protein 1 OS=Gallus gallus OX=9031 GN=CFDP1 PE=2 SV=1,,,,,,
OG_08308,1.4631224246146757,FUN_036278-T1,Peve_00043324,Pocillopora_meandrina_HIv1___RNAseq.g2118.t1,three_way,57.734,,,,,,,,,,,,,,,,,
OG_08314,3.1546757580903333,FUN_036524-T1,Peve_00031406,Pocillopora_meandrina_HIv1___RNAseq.g12097.t1,three_way,72.94333333333334,FUN_036524-T1,Q8NG66,NEK11_HUMAN,,Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11),Homo sapiens (Human),37.1,631.0,1.6e-98,361.7,sp|Q8NG66|NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens OX=9606 GN=NEK11 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006468; GO:0031573; GO:0035556; GO:0046872; GO:0106310; GO:1901990,intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08318,1.076234603898704,FUN_036742-T1,Peve_00018098,Pocillopora_meandrina_HIv1___RNAseq.g12110.t1,three_way,78.11333333333333,FUN_036742-T1,Q86U44,MTA70_HUMAN,,N(6)-adenosine-methyltransferase catalytic subunit METTL3 (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N(6)-adenosine-methyltransferase 70 kDa subunit) (MT-A70),Homo sapiens (Human),40.3,442.0,2.4000000000000003e-80,300.8,sp|Q86U44|MTA70_HUMAN N(6)-adenosine-methyltransferase catalytic subunit METTL3 OS=Homo sapiens OX=9606 GN=METTL3 PE=1 SV=2,GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990204,"cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006325; GO:0016071; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098542; GO:0140098,"immune system process; RNA binding; catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; chromatin organization; mRNA metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; defense response to other organism; catalytic activity, acting on RNA"
OG_08319,1.6614511391729796,FUN_036746-T1,Peve_00018099,Pocillopora_meandrina_HIv1___TS.g3451.t1,three_way,67.292,FUN_036746-T1,Q29IC2,RIC8_DROPS,,Chaperone Ric-8 (Synembryn),Drosophila pseudoobscura pseudoobscura (Fruit fly),32.0,565.0,2.9e-63,244.6,sp|Q29IC2|RIC8_DROPS Chaperone Ric-8 OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=ric8a PE=3 SV=1,GO:0001965; GO:0005085; GO:0005737; GO:0005938; GO:0007163; GO:0007186; GO:0008104; GO:0008356; GO:0010004; GO:0040001; GO:0042995; GO:0050821; GO:0055057; GO:0098793,asymmetric cell division [GO:0008356]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation involving germ band extension [GO:0010004]; neuroblast division [GO:0055057]; protein localization [GO:0008104]; protein stabilization [GO:0050821],cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; presynapse [GO:0098793],G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0007010; GO:0007163; GO:0098772,cytoskeleton organization; establishment or maintenance of cell polarity; molecular function regulator activity
OG_08321,2.513322097339371,FUN_036748-T1,Peve_00029513,Pocillopora_meandrina_HIv1___RNAseq.g12118.t1,three_way,83.22666666666667,FUN_036748-T1,Q5ZJ85,PRPF3_CHICK,,U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3),Gallus gallus (Chicken),52.0,696.0,1.8000000000000006e-165,584.3,sp|Q5ZJ85|PRPF3_CHICK U4/U6 small nuclear ribonucleoprotein Prp3 OS=Gallus gallus OX=9031 GN=PRPF3 PE=2 SV=1,GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0016607; GO:0046540,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]",nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540],,GO:0005634; GO:0016071; GO:0043226; GO:0065003,nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_08326,2.891439636583654,FUN_036756-T1,Peve_00001059,Pocillopora_meandrina_HIv1___RNAseq.g27066.t1,three_way,84.369,FUN_036756-T1,Q08CH8,,,,,50.0,340.0,3.7e-95,349.7,sp|Q08CH8|ZTRF1_DANRE Zinc finger TRAF-type-containing protein 1 OS=Danio rerio OX=7955 GN=zftraf1 PE=2 SV=2,,,,,,
OG_08328,3.8269532629118426,FUN_036764-T1,Peve_00006972,Pocillopora_meandrina_HIv1___RNAseq.g10638.t1,three_way,53.79416666666667,,,,,,,,,,,,,,,,,
OG_08329,2.600854925360517,FUN_036767-T1,Peve_00006967,Pocillopora_meandrina_HIv1___RNAseq.g10634.t1,three_way,71.927,FUN_036767-T1,F1N2K1,,,,,39.2,452.0,1.2999999999999999e-83,312.0,sp|F1N2K1|PCYOX_BOVIN Prenylcysteine oxidase 1 OS=Bos taurus OX=9913 GN=PCYOX1 PE=1 SV=2,,,,,,
OG_08330,1.5327519563593728,FUN_036809-T1,Peve_00006528,Pocillopora_meandrina_HIv1___RNAseq.g10614.t1,three_way,83.708,FUN_036809-T1,Q7T0V2,,,,,53.3,122.0,2.4e-28,126.3,sp|Q7T0V2|LTR3A_XENLA Ragulator complex protein LAMTOR3-A OS=Xenopus laevis OX=8355 GN=lamtor3-a PE=2 SV=1,,,,,,
OG_08331,2.338664194206913,FUN_036817-T1,Peve_00006527,Pocillopora_meandrina_HIv1___RNAseq.g10617.t1,three_way,69.63,FUN_036817-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),31.5,2060.0,1.3e-224,782.3,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_08333,1.3772450493648474,FUN_036827-T2,Peve_00006950,Pocillopora_meandrina_HIv1___RNAseq.g10630.t1,three_way,69.77466666666666,FUN_036827-T2,Q6TH47,,,,,45.8,367.0,2e-62,241.1,sp|Q6TH47|STBPA_DANRE STAM-binding protein-like A OS=Danio rerio OX=7955 GN=stambpa PE=2 SV=3,,,,,,
OG_08334,1.615278256801317,FUN_036829-T1,Peve_00006952,Pocillopora_meandrina_HIv1___TS.g13147.t1,three_way,73.91533333333334,FUN_036829-T1,Q9NYI0,PSD3_HUMAN,,PH and SEC7 domain-containing protein 3 (Epididymis tissue protein Li 20mP) (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Hepatocellular carcinoma-associated antigen 67) (Pleckstrin homology and SEC7 domain-containing protein 3),Homo sapiens (Human),44.6,417.0,3.3999999999999997e-91,337.8,sp|Q9NYI0|PSD3_HUMAN PH and SEC7 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=PSD3 PE=1 SV=2,GO:0005085; GO:0014069; GO:0032012; GO:0032587,regulation of ARF protein signal transduction [GO:0032012],postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0043226; GO:0098772,organelle; molecular function regulator activity
OG_08336,2.3865032178984364,FUN_036841-T1,Peve_00006959,Pocillopora_meandrina_HIv1___TS.g13168.t1,three_way,71.919,FUN_036841-T1,P80457,XDH_BOVIN,,Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)],Bos taurus (Bovine),33.5,1310.0,3.4e-197,690.6,sp|P80457|XDH_BOVIN Xanthine dehydrogenase/oxidase OS=Bos taurus OX=9913 GN=XDH PE=1 SV=4,GO:0002197; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0009115; GO:0030151; GO:0042803; GO:0043546; GO:0050660; GO:0051537; GO:0071949,xanthine catabolic process [GO:0009115],extracellular space [GO:0005615]; peroxisome [GO:0005777]; xanthine dehydrogenase complex [GO:0002197],"2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]",GO:0003824; GO:0005615; GO:0005777; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; peroxisome; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_08338,1.7964283362527782,FUN_036852-T1,Peve_00036539,Pocillopora_meandrina_HIv1___RNAseq.g10654.t1,three_way,83.33333333333333,FUN_036852-T1,A0A7U2MMF3,ADHB_ASPFN,,Zinc-type alcohol dehydrogenase B (EC 1.1.1.1),Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167),27.4,296.0,3.4e-19,97.4,sp|A0A7U2MMF3|ADHB_ASPFN Zinc-type alcohol dehydrogenase B OS=Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) OX=332952 GN=adhB PE=1 SV=1,GO:0008270; GO:0016491,,,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_08340,4.432148581409065,FUN_036857-T1,Peve_00001064,Pocillopora_meandrina_HIv1___RNAseq.g27062.t1,three_way,73.51566666666666,FUN_036857-T1,Q8BTI7,,,,,29.1,158.0,2.6e-07,58.9,sp|Q8BTI7|ANR52_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Mus musculus OX=10090 GN=Ankrd52 PE=1 SV=1,,,,,,
OG_08341,2.5629509514228825,FUN_036858-T1,Peve_00001065,Pocillopora_meandrina_HIv1___RNAseq.g27061.t1,three_way,76.1845,FUN_036858-T1,P22412,,,,,50.9,369.0,1.1e-104,381.7,sp|P22412|DPEP1_PIG Dipeptidase 1 OS=Sus scrofa OX=9823 GN=DPEP1 PE=1 SV=1,,,,,,
OG_08342,1.736698842908591,FUN_036865-T1,Peve_00044052,Pocillopora_meandrina_HIv1___RNAseq.g28988.t1,three_way,35.233666666666664,,,,,,,,,,,,,,,,,
OG_08350,2.4990324562187705,FUN_036889-T1,Peve_00018383,Pocillopora_meandrina_HIv1___RNAseq.g10792.t1,three_way,77.267,FUN_036889-T1,Q3SYV5,TSN33_BOVIN,,Tetraspanin-33 (Tspan-33),Bos taurus (Bovine),42.6,251.0,1e-55,218.4,sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1,GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659,protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005886; GO:0051604; GO:0072659,plasma membrane; protein maturation; protein localization to plasma membrane
OG_08351,3.142846266983387,FUN_036892-T1,Peve_00018381,Pocillopora_meandrina_HIv1___RNAseq.g10791.t1,three_way,49.0455,FUN_036892-T1,Q6P1Z5,,,,,37.6,282.0,9.5e-45,183.3,sp|Q6P1Z5|PED1A_MOUSE PC-esterase domain-containing protein 1A OS=Mus musculus OX=10090 GN=Pced1a PE=2 SV=2,,,,,,
OG_08353,1.639154474146767,FUN_036897-T1,Peve_00018373,Pocillopora_meandrina_HIv1___RNAseq.g10782.t1,three_way,84.62,FUN_036897-T1,Q9MYP6,,,,,53.5,256.0,1.8e-76,287.3,sp|Q9MYP6|DHB14_BOVIN L-fucose dehydrogenase OS=Bos taurus OX=9913 GN=HSD17B14 PE=2 SV=1,,,,,,
OG_08358,1.4604202598606386,FUN_036907-T1,Peve_00018423,Pocillopora_meandrina_HIv1___RNAseq.g10812.t1,three_way,90.18,FUN_036907-T1,P61962,DCAF7_HUMAN,,DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog),Homo sapiens (Human),88.8,338.0,2.6e-189,662.5,sp|P61962|DCAF7_HUMAN DDB1- and CUL4-associated factor 7 OS=Homo sapiens OX=9606 GN=DCAF7 PE=1 SV=1,GO:0005654; GO:0005737; GO:0005829; GO:0016363; GO:0016567; GO:0016604; GO:0030674; GO:0032991; GO:0080008,protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],protein-macromolecule adaptor activity [GO:0030674],GO:0005654; GO:0005829; GO:0043226; GO:0060090,nucleoplasm; cytosol; organelle; molecular adaptor activity
OG_08363,1.965974550237244,FUN_036912-T1,Peve_00018402,Pocillopora_meandrina_HIv1___RNAseq.g10818.t1,three_way,83.19500000000001,FUN_036912-T1,Q5ZLY5,,,,,72.2,223.0,1.2e-94,347.8,sp|Q5ZLY5|PKHF2_CHICK Pleckstrin homology domain-containing family F member 2 OS=Gallus gallus OX=9031 GN=PLEKHF2 PE=2 SV=1,,,,,,
OG_08364,1.151609153038313,FUN_036913-T1,Peve_00018400,Pocillopora_meandrina_HIv1___RNAseq.g10819.t1,three_way,58.561,,,,,,,,,,,,,,,,,
OG_08365,2.154149787024385,FUN_036917-T1,Peve_00018360,Pocillopora_meandrina_HIv1___TS.g13339.t1,three_way,60.458,FUN_036917-T1,Q6DJL7,,,,,32.4,238.0,1e-06,55.8,sp|Q6DJL7|BORA_XENLA Protein aurora borealis OS=Xenopus laevis OX=8355 GN=bora PE=2 SV=1,,,,,,
OG_08368,1.4620392719737936,FUN_036921-T1,Peve_00018424,Pocillopora_meandrina_HIv1___RNAseq.g10826.t1,three_way,86.99816666666666,FUN_036921-T1,Q6NV04,HACL2_DANRE,,2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein),Danio rerio (Zebrafish) (Brachydanio rerio),70.3,609.0,1.0999999999999999e-259,897.1,sp|Q6NV04|HACL2_DANRE 2-hydroxyacyl-CoA lyase 2 OS=Danio rerio OX=7955 GN=ilvbl PE=2 SV=1,GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016829; GO:0030976; GO:0048701; GO:0050660,embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; L-valine biosynthetic process [GO:0009099],acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789],acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0006520; GO:0006629; GO:0016740; GO:0016829,catalytic activity; amino acid metabolic process; lipid metabolic process; transferase activity; lyase activity
OG_08373,1.7590754411965546,FUN_036934-T1,Peve_00040009,Pocillopora_meandrina_HIv1___RNAseq.g10839.t1,three_way,68.39766666666667,,,,,,,,,,,,,,,,,
OG_08374,1.5515246836278809,FUN_036939-T1,Peve_00040037,Pocillopora_meandrina_HIv1___TS.g13373.t2,three_way,65.984,FUN_036939-T1,A0A2R8QF68,GRIK2_DANRE,,"Glutamate receptor ionotropic, kainate 2 (GluK2)",Danio rerio (Zebrafish) (Brachydanio rerio),26.9,878.0,3.2999999999999996e-90,334.7,"sp|A0A2R8QF68|GRIK2_DANRE Glutamate receptor ionotropic, kainate 2 OS=Danio rerio OX=7955 GN=grik2 PE=3 SV=1",GO:0005886; GO:0015277; GO:0022849; GO:0032983; GO:0035249; GO:0042734; GO:0050804; GO:0098839; GO:1904315,"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]",kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734],glutamate-gated calcium ion channel activity [GO:0022849]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0060089,transporter activity; plasma membrane; signaling; molecular transducer activity
OG_08375,1.4025635498208635,FUN_036940-T1,Peve_00040036,Pocillopora_meandrina_HIv1___RNAseq.g10861.t1,three_way,62.068666666666665,,,,,,,,,,,,,,,,,
OG_08380,2.7261028278596666,FUN_036957-T1,Peve_00040027,Pocillopora_meandrina_HIv1___RNAseq.g10871.t1,three_way,78.528,FUN_036957-T1,Q68F72,S15A4_XENLA,,Solute carrier family 15 member 4,Xenopus laevis (African clawed frog),36.0,483.0,8.700000000000001e-78,292.7,sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_08381,1.010123713043579,FUN_036966-T1,Peve_00040025,Pocillopora_meandrina_HIv1___RNAseq.g10876.t1,three_way,65.13166666666666,FUN_036966-T1,Q68F72,S15A4_XENLA,,Solute carrier family 15 member 4,Xenopus laevis (African clawed frog),36.3,477.0,1.2e-76,288.9,sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_08382,2.79338572390749,FUN_036967-T1,Peve_00040021,Pocillopora_meandrina_HIv1___RNAseq.g10880.t1,three_way,57.36033333333334,FUN_036967-T1,Q8NBR6,MINY2_HUMAN,,Ubiquitin carboxyl-terminal hydrolase MINDY-2 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-2) (Protein FAM63B),Homo sapiens (Human),57.9,328.0,8.6e-100,365.9,sp|Q8NBR6|MINY2_HUMAN Ubiquitin carboxyl-terminal hydrolase MINDY-2 OS=Homo sapiens OX=9606 GN=MINDY2 PE=1 SV=2,GO:0004843; GO:0005654; GO:0006508; GO:0016807; GO:0036435; GO:0070530; GO:0071795; GO:0071796; GO:1990380,proteolysis [GO:0006508],nucleoplasm [GO:0005654],cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type deubiquitinase activity [GO:0004843]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked deubiquitinase activity [GO:1990380]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530],GO:0003824; GO:0005654; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; catalytic activity, acting on a protein"
OG_08384,1.0015414073687634,FUN_036983-T1,Peve_00003610,Pocillopora_meandrina_HIv1___RNAseq.g26799.t1,three_way,71.97066666666667,FUN_036983-T1,P18293,ANPRA_MOUSE,,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),Mus musculus (Mouse),38.7,1036.0,8.099999999999999e-189,662.5,sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2,GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0007168; GO:0008217; GO:0010753; GO:0016020; GO:0016941; GO:0017046; GO:0019934; GO:0042417; GO:0043235; GO:0048662; GO:0097746; GO:1990620,blood vessel diameter maintenance [GO:0097746]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217],ANPR-A receptor complex [GO:1990620]; membrane [GO:0016020]; receptor complex [GO:0043235],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672],GO:0003013; GO:0003824; GO:0009975; GO:0016740; GO:0016829; GO:0060089; GO:0140096,"circulatory system process; catalytic activity; cyclase activity; transferase activity; lyase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_08385,2.7096446327301766,FUN_036984-T1,Peve_00002155,Pocillopora_meandrina_HIv1___RNAseq.g26705.t1,three_way,55.851333333333336,FUN_036984-T1,O95948,ONEC2_HUMAN,,One cut domain family member 2 (Hepatocyte nuclear factor 6-beta) (HNF-6-beta) (One cut homeobox 2) (Transcription factor ONECUT-2) (OC-2),Homo sapiens (Human),56.5,154.0,9.3e-42,172.6,sp|O95948|ONEC2_HUMAN One cut domain family member 2 OS=Homo sapiens OX=9606 GN=ONECUT2 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0001952; GO:0002064; GO:0005634; GO:0005654; GO:0006357; GO:0007179; GO:0009887; GO:0015629; GO:0030512; GO:0031018; GO:0045165; GO:0045944; GO:0048935; GO:0060271; GO:1905319; GO:1905322; GO:1990837,animal organ morphogenesis [GO:0009887]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; mesenchymal stem cell migration [GO:1905319]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; transforming growth factor beta receptor signaling pathway [GO:0007179],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005856; GO:0006355; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; nucleoplasm; cytoskeleton; regulation of DNA-templated transcription; organelle; cilium organization; anatomical structure development; cell motility; transcription regulator activity
OG_08386,1.1746293022869725,FUN_036993-T1,Peve_00002136,Pocillopora_meandrina_HIv1___RNAseq.g26710.t1,three_way,55.684333333333335,FUN_036993-T1,Q6L8S8,,,,,31.9,990.0,7.700000000000001e-126,453.4,"sp|Q6L8S8|B4GN3_MOUSE Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Mus musculus OX=10090 GN=B4galnt3 PE=2 SV=1",,,,,,
OG_08387,1.807787890511989,FUN_036995-T1,Peve_00002140,Pocillopora_meandrina_HIv1___RNAseq.9756_t,three_way,45.89866666666667,FUN_036995-T1,Q9DEQ4,,,,,26.8,317.0,3.5e-20,100.5,sp|Q9DEQ4|SFRP1_CHICK Secreted frizzled-related protein 1 OS=Gallus gallus OX=9031 GN=SFRP1 PE=2 SV=1,,,,,,
OG_08389,1.6866068221154331,FUN_036997-T1,Peve_00002149,Pocillopora_meandrina_HIv1___RNAseq.g26735.t1,three_way,73.018,FUN_036997-T1,A0A1L8GLK3,,,,,39.7,534.0,6.4e-101,369.8,sp|A0A1L8GLK3|RFW3L_XENLA E3 ubiquitin-protein ligase rfwd3.L OS=Xenopus laevis OX=8355 GN=rfwd3.L PE=1 SV=1,,,,,,
OG_08390,1.4507175050506476,FUN_036999-T1,Peve_00002150,Pocillopora_meandrina_HIv1___TS.g14072.t1,three_way,67.99333333333334,FUN_036999-T1,Q17QR6,,,,,30.8,390.0,1.4e-45,185.7,sp|Q17QR6|MOT13_BOVIN Monocarboxylate transporter 13 OS=Bos taurus OX=9913 GN=SLC16A13 PE=2 SV=1,,,,,,
OG_08391,2.8899871095494185,FUN_037001-T1,Peve_00002157,Pocillopora_meandrina_HIv1___RNAseq.g26679.t1,three_way,50.65266666666667,,,,,,,,,,,,,,,,,
OG_08393,1.9982593973726497,FUN_037005-T1,Peve_00032342,Pocillopora_meandrina_HIv1___RNAseq.g26694.t1,three_way,58.15716666666667,FUN_037005-T1,Q9NZM4,BICRA_HUMAN,,BRD4-interacting chromatin-remodeling complex-associated protein (Glioma tumor suppressor candidate region gene 1 protein),Homo sapiens (Human),50.0,118.0,1.2e-22,110.5,sp|Q9NZM4|BICRA_HUMAN BRD4-interacting chromatin-remodeling complex-associated protein OS=Homo sapiens OX=9606 GN=BICRA PE=1 SV=2,GO:0000785; GO:0005634; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0045893; GO:0140288; GO:0140537; GO:1902459,chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],transcription regulator activator activity [GO:0140537],GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0098772,nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_08396,4.0657613394125365,FUN_037010-T1,Peve_00032338,Pocillopora_meandrina_HIv1___RNAseq.g26698.t1,three_way,85.58966666666667,FUN_037010-T1,Q8N2G6,,,,,56.0,234.0,5.3e-63,242.7,sp|Q8N2G6|ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 OS=Homo sapiens OX=9606 GN=ZCCHC24 PE=1 SV=1,,,,,,
OG_08403,1.970084959016473,FUN_037054-T1,Peve_00042415,Pocillopora_meandrina_HIv1___RNAseq.g26787.t1,three_way,89.36016666666667,FUN_037054-T1,Q3UIK4,MET14_MOUSE,,N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 (Methyltransferase-like protein 14),Mus musculus (Mouse),60.6,436.0,4e-148,526.2,sp|Q3UIK4|MET14_MOUSE N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 OS=Mus musculus OX=10090 GN=Mettl14 PE=1 SV=1,GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0016556; GO:0019827; GO:0021861; GO:0031667; GO:0036396; GO:0042063; GO:0045664; GO:0045727; GO:0048255; GO:0061157; GO:1901533,"forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; positive regulation of translation [GO:0045727]; regulation of neuron differentiation [GO:0045664]; response to nutrient levels [GO:0031667]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_08404,1.0145348097915952,FUN_037055-T2,Peve_00018388,Pocillopora_meandrina_HIv1___RNAseq.g26786.t1,three_way,66.5235,,,,,,,,,,,,,,,,,
OG_08407,2.037860888446022,FUN_037058-T1,Peve_00018392,Pocillopora_meandrina_HIv1___RNAseq.g26774.t2,three_way,52.75666666666667,,,,,,,,,,,,,,,,,
OG_08408,2.056077932284752,FUN_037059-T1,Peve_00018393,Pocillopora_meandrina_HIv1___RNAseq.g26776.t1,three_way,70.49933333333334,,,,,,,,,,,,,,,,,
OG_08413,1.0287915125639175,FUN_037064-T1,Peve_00004737,Pocillopora_meandrina_HIv1___RNAseq.g26781.t1,three_way,82.664,FUN_037064-T1,Q9UBQ7,GRHPR_HUMAN,,Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81),Homo sapiens (Human),58.4,327.0,2.8000000000000002e-101,370.2,sp|Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1,GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:0120509; GO:1902494,carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487],catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782],carboxylic acid binding [GO:0031406]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; hydroxypyruvate reductase [NAD(P)H] activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005739; GO:0005829; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; oxidoreductase activity; organelle
OG_08415,1.5645859856332465,FUN_037071-T1,Peve_00004736,Pocillopora_meandrina_HIv1___RNAseq.g26783.t1,three_way,86.73233333333333,FUN_037071-T1,Q99973,TEP1_HUMAN,,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),Homo sapiens (Human),26.9,577.0,1.6999999999999998e-43,179.9,sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2,GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904,telomere maintenance via recombination [GO:0000722],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0006310; GO:0016740; GO:0032200; GO:0140097,"RNA binding; catalytic activity; DNA recombination; transferase activity; telomere organization; catalytic activity, acting on DNA"
OG_08418,1.120015495975014,FUN_037076-T1,Peve_00004731,Pocillopora_meandrina_HIv1___TS.g13654.t2,three_way,65.30366666666667,FUN_037076-T1,Q6DEW6,,,,,38.3,321.0,3.2e-51,203.8,sp|Q6DEW6|REXO4_XENTR RNA exonuclease 4 OS=Xenopus tropicalis OX=8364 GN=rexo4 PE=2 SV=1,,,,,,
OG_08422,2.6404863375774807,FUN_037080-T1,Peve_00004726,Pocillopora_meandrina_HIv1___RNAseq.g11151.t1,three_way,82.979,FUN_037080-T1,Q5I0J5,,,,,53.9,232.0,3.1e-69,263.5,sp|Q5I0J5|MITD1_RAT MIT domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Mitd1 PE=2 SV=1,,,,,,
OG_08426,2.186972932564048,FUN_037087-T1,Peve_00004772,Pocillopora_meandrina_HIv1___RNAseq.g11102.t1,three_way,80.21233333333333,FUN_037087-T1,Q8IVV2,,,,,26.6,2021.0,6.8e-184,647.5,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_08427,3.0690068213815502,FUN_037089-T1,Peve_00004758,Pocillopora_meandrina_HIv1___RNAseq.g11095.t1,three_way,84.80416666666667,FUN_037089-T1,Q9NQ94,,,,,49.9,583.0,6.8e-140,499.2,sp|Q9NQ94|A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens OX=9606 GN=A1CF PE=1 SV=1,,,,,,
OG_08430,1.7619756078173812,FUN_037093-T1,Peve_00004753,Pocillopora_meandrina_HIv1___RNAseq.g11091.t1,three_way,85.9675,FUN_037093-T1,Q53GS9,UBP39_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 39 (EC 3.4.19.12) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein),Homo sapiens (Human),67.1,477.0,6.8e-191,668.3,sp|Q53GS9|UBP39_HUMAN Ubiquitin carboxyl-terminal hydrolase 39 OS=Homo sapiens OX=9606 GN=USP39 PE=1 SV=2,GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008270; GO:0008380; GO:0016579; GO:0016787; GO:0046540; GO:0051301,"cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540],hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; organelle; protein-containing complex assembly
OG_08435,1.680153997792259,FUN_037170-T1,Peve_00003252,Pocillopora_meandrina_HIv1___TS.g13578.t1b,three_way,65.45,FUN_037170-T1,P36514,,,,,30.8,494.0,4.5e-60,233.8,sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1,,,,,,
OG_08436,1.631578146734744,FUN_037171-T1,Peve_00003251,Pocillopora_meandrina_HIv1___TS.g13578.t1c,three_way,49.90583333333333,FUN_037171-T1,O94481,,,,,26.0,435.0,8.6e-12,73.6,sp|O94481|TFC5_SCHPO Transcription factor TFIIIB component B'' OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=bdp1 PE=3 SV=2,,,,,,
OG_08437,3.331524721750546,FUN_037196-T1,Peve_00004715,Pocillopora_meandrina_HIv1___RNAseq.g11075.t2,three_way,81.52866666666667,FUN_037196-T1,Q15111,PLCL1_HUMAN,,Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein) (PRIP),Homo sapiens (Human),49.5,1043.0,1.4e-302,1040.4,sp|Q15111|PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens OX=9606 GN=PLCL1 PE=1 SV=3,GO:0004435; GO:0004629; GO:0005737; GO:0007214; GO:0032228; GO:0035556; GO:0046488; GO:0048015; GO:0051209; GO:0120163,"gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209]",cytoplasm [GO:0005737],"phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]",GO:0003824; GO:0006629; GO:0016787; GO:0023052; GO:0055085,catalytic activity; lipid metabolic process; hydrolase activity; signaling; transmembrane transport
OG_08438,1.7571553432793072,FUN_037197-T1,Peve_00004751,Pocillopora_meandrina_HIv1___RNAseq.g11073.t1,three_way,80.64233333333334,FUN_037197-T1,O88818,,,,,54.1,628.0,4.1e-185,649.4,sp|O88818|PLST_CRIGR Plastin-3 OS=Cricetulus griseus OX=10029 GN=PLS3 PE=2 SV=3,,,,,,
OG_08439,1.0825699569777267,FUN_037198-T1,Peve_00004769,Pocillopora_meandrina_HIv1___RNAseq.g11072.t1,three_way,63.464,,,,,,,,,,,,,,,,,
OG_08440,1.3842347258573269,FUN_037199-T1,Peve_00004724,Pocillopora_meandrina_HIv1___RNAseq.g11071.t1,three_way,64.9865,FUN_037199-T1,F1M3L7,EPS8_RAT,,Epidermal growth factor receptor kinase substrate 8,Rattus norvegicus (Rat),31.0,826.0,2.5e-71,272.3,sp|F1M3L7|EPS8_RAT Epidermal growth factor receptor kinase substrate 8 OS=Rattus norvegicus OX=10116 GN=Eps8 PE=1 SV=2,GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030036; GO:0030426; GO:0030832; GO:0031267; GO:0032420; GO:0032421; GO:0032426; GO:0032587; GO:0035023; GO:0036336; GO:0045202; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830,actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],brush border [GO:0005903]; cell cortex [GO:0005938]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202],actin binding [GO:0003779]; small GTPase binding [GO:0031267],GO:0002376; GO:0005886; GO:0007010; GO:0008092; GO:0043226; GO:0048870,immune system process; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle; cell motility
OG_08444,1.5165145007018497,FUN_037206-T1,Peve_00019446,Pocillopora_meandrina_HIv1___RNAseq.g11067.t1,three_way,66.86016666666666,FUN_037206-T1,P41236,IPP2_HUMAN,,Protein phosphatase inhibitor 2 (IPP-2),Homo sapiens (Human),35.5,141.0,3.4e-10,66.6,sp|P41236|IPP2_HUMAN Protein phosphatase inhibitor 2 OS=Homo sapiens OX=9606 GN=PPP1R2 PE=1 SV=2,GO:0004864; GO:0004865; GO:0005977; GO:0006091; GO:0009966; GO:0035556; GO:0140678,generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; regulation of signal transduction [GO:0009966],,molecular function inhibitor activity [GO:0140678]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],GO:0005975; GO:0006091; GO:0098772,carbohydrate metabolic process; generation of precursor metabolites and energy; molecular function regulator activity
OG_08447,1.1604560756778992,FUN_037211-T1,Peve_00039306,Pocillopora_meandrina_HIv1___RNAseq.g11063.t1,three_way,76.10916666666667,FUN_037211-T1,Q32NQ7,,,,,42.5,466.0,4.7e-104,379.8,sp|Q32NQ7|DAAF3_XENLA Dynein axonemal assembly factor 3 OS=Xenopus laevis OX=8355 GN=dnaaf3 PE=2 SV=1,,,,,,
OG_08449,2.1725427098273404,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),43.2,586.0,1.7999999999999998e-127,459.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08449,2.1725427098273404,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),49.5,105.0,7.2e-15,85.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08457,1.0229208106570864,FUN_037226-T2,Peve_00044301,Pocillopora_meandrina_HIv1___RNAseq.g11037.t1,three_way,73.50366666666666,FUN_037226-T2,Q6TCG8,PAQR3_MOUSE,,Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG),Mus musculus (Mouse),45.4,280.0,3.4e-71,270.0,sp|Q6TCG8|PAQR3_MOUSE Progestin and adipoQ receptor family member 3 OS=Mus musculus OX=10090 GN=Paqr3 PE=1 SV=1,GO:0000139; GO:0005794; GO:0010977; GO:0032436; GO:0034067; GO:0035359; GO:0043495; GO:0045542; GO:1990756; GO:2000640,negative regulation of neuron projection development [GO:0010977]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of SREBP signaling pathway [GO:2000640]; protein localization to Golgi apparatus [GO:0034067],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],protein-membrane adaptor activity [GO:0043495]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005794; GO:0043226; GO:0060090,Golgi apparatus; organelle; molecular adaptor activity
OG_08462,1.7791254695164511,FUN_037231-T1,Peve_00006214,Pocillopora_meandrina_HIv1___RNAseq.g11018.t1,three_way,95.307,FUN_037231-T1,P61092,SIA1A_MOUSE,,E3 ubiquitin-protein ligase SIAH1A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1A) (Seven in absentia homolog 1a) (Siah-1a) (Siah1a) (mSiah-1a),Mus musculus (Mouse),84.6,266.0,2.4e-135,483.0,sp|P61092|SIA1A_MOUSE E3 ubiquitin-protein ligase SIAH1A OS=Mus musculus OX=10090 GN=Siah1a PE=1 SV=1,GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007141; GO:0007283; GO:0008270; GO:0009791; GO:0016567; GO:0019005; GO:0030154; GO:0040014; GO:0042803; GO:0043161; GO:0051402; GO:0060070; GO:0061630; GO:0097718,canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],disordered domain specific binding [GO:0097718]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"catalytic activity; nucleus; cytosol; programmed cell death; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_08463,1.7091694768687808,FUN_037232-T2,Peve_00006212,Pocillopora_meandrina_HIv1___RNAseq.g11014.t1,three_way,94.32066666666668,FUN_037232-T2,P79101,,,,,70.0,683.0,1.9e-287,989.6,sp|P79101|CPSF3_BOVIN Cleavage and polyadenylation specificity factor subunit 3 OS=Bos taurus OX=9913 GN=CPSF3 PE=1 SV=1,,,,,,
OG_08464,1.801547671877848,FUN_037233-T1,Peve_00034021,Pocillopora_meandrina_HIv1___RNAseq.g14907.t1,three_way,41.4985,FUN_037233-T1,Q7JK24,,,,,27.4,292.0,3.9e-25,117.5,"sp|Q7JK24|B3GT1_GORGO Beta-1,3-galactosyltransferase 1 OS=Gorilla gorilla gorilla OX=9595 GN=B3GALT1 PE=3 SV=1",,,,,,
OG_08466,1.551647007137534,FUN_037278-T1,Peve_00001629,Pocillopora_meandrina_HIv1___RNAseq.g26884.t1,three_way,88.282,FUN_037278-T1,Q14117,DPYS_HUMAN,,Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase),Homo sapiens (Human),66.6,515.0,2.2000000000000004e-201,703.4,sp|Q14117|DPYS_HUMAN Dihydropyrimidinase OS=Homo sapiens OX=9606 GN=DPYS PE=1 SV=1,GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0006248; GO:0006249; GO:0008270; GO:0042802; GO:0046050; GO:0046079; GO:0051219; GO:0070062,CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212],cytosol [GO:0005829]; extracellular exosome [GO:0070062],dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08469,2.176384549416156,FUN_037281-T1,Peve_00001634,Pocillopora_meandrina_HIv1___RNAseq.g26881.t1,three_way,79.723,,,,,,,,,,,,,,,,,
OG_08473,1.4828823443112091,FUN_037290-T1,Peve_00032665,Pocillopora_meandrina_HIv1___RNAseq.g10674.t1,three_way,91.80166666666666,FUN_037290-T1,A7SWD3,,,,,71.6,215.0,1.3999999999999999e-83,310.8,sp|A7SWD3|GID8_NEMVE Glucose-induced degradation protein 8 homolog OS=Nematostella vectensis OX=45351 GN=v1g247787 PE=3 SV=1,,,,,,
OG_08475,1.36769608054624,FUN_037298-T1,Peve_00004415,Pocillopora_meandrina_HIv1___RNAseq.g10685.t1,three_way,84.8545,FUN_037298-T1,Q8IVV2,,,,,40.2,2254.0,0.0,1702.6,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_08476,1.2948601138771905,FUN_037299-T1,Peve_00045277,Pocillopora_meandrina_HIv1___RNAseq.g10686.t1,three_way,70.14133333333334,FUN_037299-T1,Q4KLQ5,,,,,39.0,505.0,1.8e-83,311.6,sp|Q4KLQ5|WDR76_XENLA WD repeat-containing protein 76 OS=Xenopus laevis OX=8355 GN=wdr76 PE=2 SV=1,,,,,,
OG_08478,2.578802816448569,FUN_037305-T1,Peve_00045269,Pocillopora_meandrina_HIv1___RNAseq.g10723.t1,three_way,44.54433333333333,,,,,,,,,,,,,,,,,
OG_08482,4.191284698027022,FUN_037313-T1,Peve_00006178,Pocillopora_meandrina_HIv1___RNAseq.g10707.t1,three_way,74.689,FUN_037313-T1,Q32PP9,,,,,66.0,94.0,6.7e-27,122.5,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_08488,2.788586365566459,FUN_037324-T1,Peve_00006231,Pocillopora_meandrina_HIv1___RNAseq.g10699.t1,three_way,65.4175,FUN_037324-T1,Q8CF97,VCIP1_RAT,,Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein),Rattus norvegicus (Rat),47.3,994.0,4.7e-244,846.3,sp|Q8CF97|VCIP1_RAT Deubiquitinating protein VCPIP1 OS=Rattus norvegicus OX=10116 GN=Vcpip1 PE=1 SV=2,GO:0004843; GO:0005634; GO:0005783; GO:0005795; GO:0006508; GO:0006974; GO:0007030; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0045202; GO:0071108; GO:0090168; GO:0106300; GO:1905634,DNA damage response [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; regulation of protein localization to chromatin [GO:1905634],endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; synapse [GO:0045202],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0005783; GO:0006281; GO:0016787; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; DNA repair; hydrolase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_08491,2.3549546437469555,FUN_037330-T1,Peve_00006234,Pocillopora_meandrina_HIv1___RNAseq.g10692.t1,three_way,60.120000000000005,FUN_037330-T1,Q8IVV2,,,,,39.6,273.0,5.8e-47,192.2,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_08494,1.0525368215423254,FUN_037369-T1,Peve_00006168,Pocillopora_meandrina_HIv1___RNAseq.g10992.t1,three_way,75.4555,FUN_037369-T1,Q9VC57,ATLAS_DROME,,Atlastin (EC 3.6.5.-),Drosophila melanogaster (Fruit fly),22.9,398.0,4.7e-06,54.7,sp|Q9VC57|ATLAS_DROME Atlastin OS=Drosophila melanogaster OX=7227 GN=atl PE=1 SV=1,GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0007019; GO:0007029; GO:0007030; GO:0007517; GO:0007528; GO:0008582; GO:0012505; GO:0016020; GO:0016320; GO:0030742; GO:0031114; GO:0032561; GO:0042802; GO:0048691; GO:0051124; GO:0051260; GO:0061025; GO:0061709; GO:0140506; GO:0140523; GO:1990809,endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; microtubule depolymerization [GO:0007019]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]; positive regulation of axon extension involved in regeneration [GO:0048691]; protein homooligomerization [GO:0051260]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; reticulophagy [GO:0061709]; synaptic assembly at neuromuscular junction [GO:0051124],cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; guanyl ribonucleotide binding [GO:0032561]; identical protein binding [GO:0042802],GO:0003824; GO:0003924; GO:0005783; GO:0005794; GO:0006914; GO:0007010; GO:0016787; GO:0034330; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003,catalytic activity; GTPase activity; endoplasmic reticulum; Golgi apparatus; autophagy; cytoskeleton organization; hydrolase activity; cell junction organization; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly
OG_08497,1.4310392920553112,FUN_037377-T1,Peve_00006192,Pocillopora_meandrina_HIv1___RNAseq.g10998.t1,three_way,90.17766666666668,FUN_037377-T1,O96019,ACL6A_HUMAN,,Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K),Homo sapiens (Human),68.9,434.0,1.2e-172,607.4,sp|O96019|ACL6A_HUMAN Actin-like protein 6A OS=Homo sapiens OX=9606 GN=ACTL6A PE=1 SV=1,GO:0000723; GO:0000776; GO:0000785; GO:0000786; GO:0001825; GO:0003407; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005886; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007165; GO:0007399; GO:0008284; GO:0016363; GO:0016514; GO:0016586; GO:0021510; GO:0030071; GO:0031011; GO:0032991; GO:0033044; GO:0035060; GO:0035267; GO:0042981; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:0070316; GO:0071564; GO:0140288; GO:1902459; GO:1904507; GO:1905168; GO:2000045; GO:2000779; GO:2000781; GO:2000819,blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; telomere maintenance [GO:0000723],brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; Ino80 complex [GO:0031011]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514],chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; plasma membrane; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_08499,1.6454973935064974,FUN_037383-T2,Peve_00006197,Pocillopora_meandrina_HIv1___TS.g13502.t1,three_way,59.019,FUN_037383-T2,Q99MU3,,,,,44.6,505.0,7.2e-106,387.1,sp|Q99MU3|DSRAD_MOUSE Double-stranded RNA-specific adenosine deaminase OS=Mus musculus OX=10090 GN=Adar PE=1 SV=2,,,,,,
OG_08501,1.7668290692990016,FUN_037385-T1,Peve_00014721,Pocillopora_meandrina_HIv1___RNAseq.g26899.t1,three_way,86.40616666666666,FUN_037385-T1,Q8K4Z5,,,,,62.7,762.0,3.3e-170,600.1,sp|Q8K4Z5|SF3A1_MOUSE Splicing factor 3A subunit 1 OS=Mus musculus OX=10090 GN=Sf3a1 PE=1 SV=1,,,,,,
OG_08507,3.3510891310571456,FUN_037415-T1,Peve_00028254,Pocillopora_meandrina_HIv1___RNAseq.g10939.t1,three_way,73.82433333333333,FUN_037415-T1,A5PJF6,,,,,47.9,303.0,2.3000000000000002e-73,277.3,sp|A5PJF6|HSDL1_BOVIN Inactive hydroxysteroid dehydrogenase-like protein 1 OS=Bos taurus OX=9913 GN=HSDL1 PE=2 SV=1,,,,,,
OG_08508,3.1527991176702583,FUN_037416-T2,Peve_00028857,Pocillopora_meandrina_HIv1___RNAseq.g10945.t1,three_way,60.57983333333333,FUN_037416-T2,Q569T7,,,,,33.2,400.0,7.700000000000001e-48,193.0,sp|Q569T7|MFS4B_XENLA Sodium-dependent glucose transporter 1 OS=Xenopus laevis OX=8355 GN=mfsd4b PE=2 SV=1,,,,,,
OG_08509,2.826024506259786,FUN_037422-T1,Peve_00000594,Pocillopora_meandrina_HIv1___RNAseq.g10949.t1,three_way,81.52333333333333,FUN_037422-T1,Q6QA33,,,,,49.3,306.0,1.5e-71,271.2,sp|Q6QA33|DH12B_DANRE Very-long-chain 3-oxoacyl-CoA reductase-B OS=Danio rerio OX=7955 GN=hsd17b12b PE=2 SV=2,,,,,,
OG_08510,3.1367578037554336,FUN_037424-T1,Peve_00000597,Pocillopora_meandrina_HIv1___RNAseq.g10952.t1a,three_way,54.638333333333335,,,,,,,,,,,,,,,,,
OG_08514,2.439486839872487,FUN_037440-T1,Peve_00014235,Pocillopora_meandrina_HIv1___RNAseq.22823_t,three_way,64.086,FUN_037440-T1,Q9M9E8,,,,,30.9,269.0,4.400000000000001e-28,127.1,sp|Q9M9E8|JMJ21_ARATH Lysine-specific demethylase JMJ21 OS=Arabidopsis thaliana OX=3702 GN=JMJ21 PE=2 SV=3,,,,,,
OG_08518,1.5881754760717968,FUN_037448-T1,Peve_00027252,Pocillopora_meandrina_HIv1___RNAseq.g10987.t1,three_way,73.10766666666667,FUN_037448-T1,Q8AVL0,,,,,50.8,543.0,6.4e-150,532.3,sp|Q8AVL0|C19L1_XENLA CWF19-like protein 1 OS=Xenopus laevis OX=8355 GN=cwf19l1 PE=2 SV=1,,,,,,
OG_08519,3.5219933126363627,FUN_037451-T1,Peve_00044121,Pocillopora_meandrina_HIv1___RNAseq.g1365.t1,three_way,62.06366666666667,,,,,,,,,,,,,,,,,
OG_08520,5.388922893810008,FUN_037452-T1,Peve_00044119,Pocillopora_meandrina_HIv1___RNAseq.g1368.t1,three_way,59.91483333333333,FUN_037452-T1,Q9IA95,,,,,32.7,266.0,2.4e-45,184.1,sp|Q9IA95|SFRP3_CHICK Secreted frizzled-related protein 3 OS=Gallus gallus OX=9031 GN=FRZB PE=2 SV=1,,,,,,
OG_08521,1.6186058428950565,FUN_037454-T1,Peve_00044133,Pocillopora_meandrina_HIv1___RNAseq.g1366.t1,three_way,42.83116666666667,,,,,,,,,,,,,,,,,
OG_08522,1.5817957842656447,FUN_037455-T2,Peve_00044122,Pocillopora_meandrina_HIv1___RNAseq.g1369.t1,three_way,78.81866666666667,FUN_037455-T2,B2GUP8,MITOS_XENTR,,"Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial sulfonylurea-receptor) (MITOSUR)",Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),59.1,613.0,1.9999999999999999e-193,677.2,sp|B2GUP8|MITOS_XENTR Mitochondrial potassium channel ATP-binding subunit OS=Xenopus tropicalis OX=8364 GN=abcb8 PE=2 SV=1,GO:0005524; GO:0005739; GO:0005743; GO:0016887; GO:0062157; GO:0071805; GO:0140359,potassium ion transmembrane transport [GO:0071805],mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_08525,1.1102237498519223,FUN_037458-T2,Peve_00036027,Pocillopora_meandrina_HIv1___RNAseq.g1372.t1,three_way,51.31883333333333,,,,,,,,,,,,,,,,,
OG_08527,1.9421394018440687,FUN_037464-T1,Peve_00036017,Pocillopora_meandrina_HIv1___RNAseq.g1379.t1,three_way,57.99766666666667,FUN_037464-T1,B1WAR9,GWL_XENTR,,Serine/threonine-protein kinase greatwall (GW) (GWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),34.7,920.0,2.8e-115,417.9,sp|B1WAR9|GWL_XENTR Serine/threonine-protein kinase greatwall OS=Xenopus tropicalis OX=8364 GN=mastl PE=2 SV=1,GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0032154; GO:0051301; GO:0051721; GO:0106310,cell division [GO:0051301]; DNA damage response [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000278; GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"mitotic cell cycle; catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08528,2.823443824071232,FUN_037469-T1,Peve_00036019,Pocillopora_meandrina_HIv1___RNAseq.g1383.t1,three_way,59.05133333333333,FUN_037469-T1,Q7Z407,CSMD3_HUMAN,,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),Homo sapiens (Human),27.5,262.0,1.4e-15,85.5,sp|Q7Z407|CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens OX=9606 GN=CSMD3 PE=1 SV=3,GO:0005886; GO:0050773,regulation of dendrite development [GO:0050773],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_08530,2.9658116016658784,FUN_037477-T1,Peve_00020433,Pocillopora_meandrina_HIv1___RNAseq.g1391.t1,three_way,71.99733333333333,FUN_037477-T1,Q3TDN2,FAF2_MOUSE,,FAS-associated factor 2 (UBX domain-containing protein 8),Mus musculus (Mouse),45.3,267.0,3.1e-59,230.3,sp|Q3TDN2|FAF2_MOUSE FAS-associated factor 2 OS=Mus musculus OX=10090 GN=Faf2 PE=1 SV=2,GO:0005783; GO:0005811; GO:0006986; GO:0030674; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0035617; GO:0036503; GO:0043130; GO:0043161; GO:0055102,"ERAD pathway [GO:0036503]; lipid droplet organization [GO:0034389]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]",endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005783; GO:0005811; GO:0006886; GO:0030163; GO:0043226; GO:0060090; GO:0098772,endoplasmic reticulum; lipid droplet; intracellular protein transport; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_08535,2.924141511500664,FUN_037485-T2,Peve_00020418,Pocillopora_meandrina_HIv1___RNAseq.g1299.t1,three_way,72.62033333333333,FUN_037485-T2,Q8CHC4,SYNJ1_MOUSE,,"Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)",Mus musculus (Mouse),54.1,1036.0,0.0,1097.0,sp|Q8CHC4|SYNJ1_MOUSE Synaptojanin-1 OS=Mus musculus OX=10090 GN=Synj1 PE=1 SV=3,GO:0003723; GO:0004439; GO:0006836; GO:0007612; GO:0012506; GO:0016082; GO:0016191; GO:0030117; GO:0030118; GO:0030132; GO:0034595; GO:0043195; GO:0046488; GO:0046856; GO:0048015; GO:0048471; GO:0048488; GO:0048489; GO:0097060; GO:0098685; GO:0098978; GO:0099149; GO:1903423,learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of synaptic vesicle recycling [GO:1903423]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191],clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; glutamatergic synapse [GO:0098978]; membrane coat [GO:0030117]; perinuclear region of cytoplasm [GO:0048471]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506],"phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; RNA binding [GO:0003723]",GO:0003723; GO:0003824; GO:0006629; GO:0016192; GO:0016787; GO:0050877; GO:0065003,RNA binding; catalytic activity; lipid metabolic process; vesicle-mediated transport; hydrolase activity; nervous system process; protein-containing complex assembly
OG_08536,3.871429218522221,FUN_037486-T1,Peve_00020414,Pocillopora_meandrina_HIv1___RNAseq.g1300.t1,three_way,64.04466666666667,FUN_037486-T1,Q6TLI7,AA2AR_HORSE,,Adenosine receptor A2a,Equus caballus (Horse),24.3,296.0,4.7e-07,57.0,sp|Q6TLI7|AA2AR_HORSE Adenosine receptor A2a OS=Equus caballus OX=9796 GN=ADORA2A PE=2 SV=1,GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005886; GO:0007189; GO:0007626; GO:0008289; GO:0014074; GO:0019899; GO:0032230; GO:0042755; GO:0042802; GO:0046636; GO:0050728; GO:0060080; GO:0097190; GO:0098794; GO:2001235,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic signaling pathway [GO:0097190]; eating behavior [GO:0042755]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; response to amphetamine [GO:0001975]; response to purine-containing compound [GO:0014074]; synaptic transmission, dopaminergic [GO:0001963]",plasma membrane [GO:0005886]; postsynapse [GO:0098794],calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],GO:0005886; GO:0008289; GO:0023052; GO:0060089,plasma membrane; lipid binding; signaling; molecular transducer activity
OG_08542,1.069648184181607,FUN_037495-T1,Peve_00028567,Pocillopora_meandrina_HIv1___TS.g22722.t1,three_way,69.01516666666667,FUN_037495-T1,Q60431,CASP3_MESAU,,Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12],Mesocricetus auratus (Golden hamster),44.7,255.0,1.6e-54,214.9,sp|Q60431|CASP3_MESAU Caspase-3 OS=Mesocricetus auratus OX=10036 GN=CASP3 PE=2 SV=1,GO:0004175; GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0030182; GO:0030216; GO:0030218; GO:0031264; GO:0031647; GO:0043525; GO:1902004,apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of neuron apoptotic process [GO:0043525]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytoplasm [GO:0005737]; death-inducing signaling complex [GO:0031264],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175],GO:0003824; GO:0012501; GO:0016787; GO:0030154; GO:0140096,"catalytic activity; programmed cell death; hydrolase activity; cell differentiation; catalytic activity, acting on a protein"
OG_08548,1.3918416483172935,FUN_037511-T1,Peve_00028555,Pocillopora_meandrina_HIv1___RNAseq.g1319.t1,three_way,77.14016666666667,,,,,,,,,,,,,,,,,
OG_08549,2.071486655500804,FUN_037517-T1,Peve_00025027,Pocillopora_meandrina_HIv1___RNAseq.g1320.t1,three_way,85.71833333333333,FUN_037517-T1,A4IGP0,,,,,63.3,196.0,1.6e-66,253.8,sp|A4IGP0|HIKES_XENTR Protein Hikeshi OS=Xenopus tropicalis OX=8364 GN=hikeshi PE=2 SV=1,,,,,,
OG_08551,1.476692299961698,FUN_037526-T1,Peve_00044841,Pocillopora_meandrina_HIv1___RNAseq.g10605.t1,three_way,68.244,,,,,,,,,,,,,,,,,
OG_08553,1.7706460807218338,FUN_037529-T1,Peve_00018745,Pocillopora_meandrina_HIv1___RNAseq.g10587.t1,three_way,78.19266666666667,FUN_037529-T1,P97479,,,,,53.2,485.0,6.6e-146,518.8,sp|P97479|MYO7A_MOUSE Unconventional myosin-VIIa OS=Mus musculus OX=10090 GN=Myo7a PE=1 SV=2,,,,,,
OG_08556,2.129155969097917,FUN_037544-T1,Peve_00032232,Pocillopora_meandrina_HIv1___RNAseq.g10583.t1,three_way,85.05866666666667,FUN_037544-T1,Q8R4C2,,,,,36.0,406.0,1.4e-57,226.1,sp|Q8R4C2|RUFY2_MOUSE RUN and FYVE domain-containing protein 2 OS=Mus musculus OX=10090 GN=Rufy2 PE=1 SV=2,,,,,,
OG_08560,2.8650199345290317,FUN_037548-T1,Peve_00032226,Pocillopora_meandrina_HIv1___RNAseq.g1628.t1,three_way,68.57633333333334,FUN_037548-T1,Q8VC74,,,,,40.3,278.0,1.2e-48,195.3,"sp|Q8VC74|COX18_MOUSE Cytochrome c oxidase assembly protein COX18, mitochondrial OS=Mus musculus OX=10090 GN=Cox18 PE=1 SV=5",,,,,,
OG_08564,2.467662547722872,FUN_037564-T1,Peve_00017811,Pocillopora_meandrina_HIv1___RNAseq.g1620.t1,three_way,60.96666666666667,FUN_037564-T1,Q8CFX1,G6PE_MOUSE,,GDH/6PGL endoplasmic bifunctional protein [Includes: Hexose-6-phosphate dehydrogenase (Glucose 1-dehydrogenase) (EC 1.1.1.47) (Glucose-6-phosphate dehydrogenase) (EC 1.1.1.363); 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)],Mus musculus (Mouse),42.7,784.0,1.5e-169,598.2,sp|Q8CFX1|G6PE_MOUSE GDH/6PGL endoplasmic bifunctional protein OS=Mus musculus OX=10090 GN=H6pd PE=1 SV=2,GO:0004345; GO:0005783; GO:0005788; GO:0006006; GO:0006098; GO:0009051; GO:0016529; GO:0017057; GO:0030246; GO:0031667; GO:0047934; GO:0047935; GO:0050661; GO:0097305; GO:2000064,"glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; regulation of cortisol biosynthetic process [GO:2000064]; response to alcohol [GO:0097305]; response to nutrient levels [GO:0031667]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; sarcoplasmic reticulum [GO:0016529],6-phosphogluconolactonase activity [GO:0017057]; carbohydrate binding [GO:0030246]; glucose 1-dehydrogenase (NAD+) activity [GO:0047934]; glucose 1-dehydrogenase (NADP+) activity [GO:0047935]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661],GO:0003824; GO:0005783; GO:0005975; GO:0006091; GO:0016491; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08568,2.41166320153992,FUN_037569-T1,Peve_00035301,Pocillopora_meandrina_HIv1___RNAseq.g1586.t1,three_way,72.47983333333333,FUN_037569-T1,Q9D168,,,,,31.7,259.0,2.5000000000000002e-22,107.8,sp|Q9D168|INT12_MOUSE Integrator complex subunit 12 OS=Mus musculus OX=10090 GN=Ints12 PE=1 SV=1,,,,,,
OG_08573,1.7814832741096114,FUN_037584-T1,Peve_00035296,Pocillopora_meandrina_HIv1___TS.g22988.t1,three_way,76.06266666666667,FUN_037584-T1,Q9D0K0,TBCD7_MOUSE,,TBC1 domain family member 7,Mus musculus (Mouse),42.4,295.0,1.1e-58,228.4,sp|Q9D0K0|TBCD7_MOUSE TBC1 domain family member 7 OS=Mus musculus OX=10090 GN=Tbc1d7 PE=1 SV=1,GO:0005096; GO:0005765; GO:0005829; GO:0009267; GO:0031267; GO:0031398; GO:0031410; GO:0032007; GO:0033596; GO:0036064; GO:0070848; GO:0090630; GO:1902018; GO:1904262,activation of GTPase activity [GO:0090630]; cellular response to starvation [GO:0009267]; negative regulation of cilium assembly [GO:1902018]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of protein ubiquitination [GO:0031398]; response to growth factor [GO:0070848],ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; TSC1-TSC2 complex [GO:0033596],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005815; GO:0005829; GO:0031410; GO:0043226; GO:0098772,microtubule organizing center; cytosol; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08575,2.941378627906618,FUN_037586-T1,Peve_00035294,Pocillopora_meandrina_HIv1___RNAseq.g1594.t1,three_way,57.32,FUN_037586-T1,Q2TBA3,MALT1_MOUSE,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase),Mus musculus (Mouse),30.2,394.0,3.9e-35,151.4,sp|Q2TBA3|MALT1_MOUSE Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog OS=Mus musculus OX=10090 GN=Malt1 PE=1 SV=2,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005829; GO:0006508; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051168; GO:0051603; GO:0061133; GO:0071222; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; cellular response to lipopolysaccharide [GO:0071222]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; protease binding [GO:0002020]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08576,2.9173766064173674,FUN_037588-T1,Peve_00035293,Pocillopora_meandrina_HIv1___RNAseq.g1595.t1,three_way,69.3425,FUN_037588-T1,P38935,SMBP2_HUMAN,,DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2),Homo sapiens (Human),52.6,831.0,1.4e-215,751.1,sp|P38935|SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens OX=9606 GN=IGHMBP2 PE=1 SV=3,GO:0000049; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0003727; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008094; GO:0008186; GO:0008270; GO:0016020; GO:0016604; GO:0016887; GO:0030424; GO:0030426; GO:0032574; GO:0036121; GO:0042802; GO:0043022; GO:0043139; GO:0140296; GO:1990904,,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA helicase activity [GO:0036121]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08577,3.2986469253019126,FUN_037589-T1,Peve_00035292,Pocillopora_meandrina_HIv1___RNAseq.g1596.t1,three_way,82.638,FUN_037589-T1,P70032,,,,,57.4,608.0,4.1e-204,712.6,sp|P70032|PLK1_XENLA Serine/threonine-protein kinase PLK1 OS=Xenopus laevis OX=8355 GN=plk1 PE=1 SV=1,,,,,,
OG_08578,1.9189844198655497,FUN_037681-T1,Peve_00042426,Pocillopora_meandrina_HIv1___RNAseq.g1611.t1,three_way,55.60116666666666,,,,,,,,,,,,,,,,,
OG_08579,2.062938124738422,FUN_037682-T1,Peve_00042425,Pocillopora_meandrina_HIv1___RNAseq.g1612.t1,three_way,55.28383333333333,,,,,,,,,,,,,,,,,
OG_08580,1.6595590012942054,FUN_037683-T1,Peve_00042424,Pocillopora_meandrina_HIv1___RNAseq.g1613.t1,three_way,49.037333333333336,,,,,,,,,,,,,,,,,
OG_08585,1.4343457526763177,FUN_037689-T1,Peve_00001249,Pocillopora_meandrina_HIv1___RNAseq.g1580.t1,three_way,63.23266666666667,FUN_037689-T1,Q5XI67,FBX30_RAT,,F-box only protein 30,Rattus norvegicus (Rat),28.3,703.0,2.900000000000001e-71,271.2,sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1,GO:0006325; GO:0007059; GO:0008270; GO:0010467; GO:0016567; GO:0030261; GO:0061630,chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; gene expression [GO:0010467]; protein ubiquitination [GO:0016567],,ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0006325; GO:0007059; GO:0016740; GO:0140096,"catalytic activity; chromatin organization; chromosome segregation; transferase activity; catalytic activity, acting on a protein"
OG_08591,2.703719142990144,FUN_037700-T1,Peve_00044123,Pocillopora_meandrina_HIv1___RNAseq.g1360.t1,three_way,70.3135,FUN_037700-T1,Q6DCC6,,,,,41.9,434.0,6.4e-86,319.7,sp|Q6DCC6|GTPB6_XENLA Putative GTP-binding protein 6 OS=Xenopus laevis OX=8355 GN=gtpbp6 PE=2 SV=1,,,,,,
OG_08592,1.2154109314647363,FUN_037701-T1,Peve_00027706,Pocillopora_meandrina_HIv1___RNAseq.g1400.t1,three_way,82.70333333333333,FUN_037701-T1,Q9U5N1,,,,,62.8,382.0,5.5e-140,498.8,sp|Q9U5N1|VATC_MANSE V-type proton ATPase subunit C OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_08594,3.018320475329624,FUN_037709-T1,Peve_00027437,Pocillopora_meandrina_HIv1___RNAseq.g1402.t1,three_way,58.09033333333333,FUN_037709-T1,E7F1U2,DNMBP_DANRE,,Dynamin-binding protein (Scaffold protein Tuba),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,728.0,7.8e-103,377.5,sp|E7F1U2|DNMBP_DANRE Dynamin-binding protein OS=Danio rerio OX=7955 GN=dnmbp PE=2 SV=1,GO:0001822; GO:0005085; GO:0005737; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793,cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005794; GO:0005856; GO:0043226; GO:0044782; GO:0048856; GO:0098772,Golgi apparatus; cytoskeleton; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_08595,1.2537922858041668,FUN_037710-T1,Peve_00027436,Pocillopora_meandrina_HIv1___RNAseq.g1403.t1,three_way,86.10866666666666,,,,,,,,,,,,,,,,,
OG_08598,2.225641759271934,FUN_037740-T1,Peve_00037367,Pocillopora_meandrina_HIv1___RNAseq.g1331.t2,three_way,82.32733333333333,,,,,,,,,,,,,,,,,
OG_08599,3.570032785386774,FUN_037741-T1,Peve_00037358,Pocillopora_meandrina_HIv1___RNAseq.g1334.t1,three_way,67.00733333333334,,,,,,,,,,,,,,,,,
OG_08600,2.174439947029635,FUN_037743-T1,Peve_00037357,Pocillopora_meandrina_HIv1___RNAseq.g1333.t1,three_way,65.298,FUN_037743-T1,Q9EP82,,,,,31.0,355.0,1.4e-37,158.7,sp|Q9EP82|WDR4_MOUSE tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 OS=Mus musculus OX=10090 GN=Wdr4 PE=1 SV=2,,,,,,
OG_08602,1.806123100169407,FUN_037745-T1,Peve_00037361,Pocillopora_meandrina_HIv1___RNAseq.g1335.t1,three_way,75.479,FUN_037745-T1,Q91X20,ASH2L_MOUSE,,Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein),Mus musculus (Mouse),60.0,345.0,2.9999999999999997e-116,420.2,sp|Q91X20|ASH2L_MOUSE Set1/Ash2 histone methyltransferase complex subunit ASH2 OS=Mus musculus OX=10090 GN=Ash2l PE=1 SV=1,GO:0000791; GO:0003677; GO:0005634; GO:0005654; GO:0006974; GO:0008270; GO:0035097; GO:0045815; GO:0045944; GO:0048188; GO:0071339,DNA damage response [GO:0006974]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription initiation-coupled chromatin remodeling [GO:0045815],euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_08603,1.6289805693122008,FUN_037746-T1,Peve_00037365,Pocillopora_meandrina_HIv1___RNAseq.g1336.t1,three_way,86.29599999999999,FUN_037746-T1,P12003,,,,,38.8,1139.0,2.9999999999999998e-182,640.6,sp|P12003|VINC_CHICK Vinculin OS=Gallus gallus OX=9031 GN=VCL PE=1 SV=4,,,,,,
OG_08606,3.120647649360371,FUN_037752-T1,Peve_00038306,Pocillopora_meandrina_HIv1___RNAseq.g1340.t1,three_way,82.766,FUN_037752-T1,A2BGM5,FOXN4_DANRE,,Forkhead box protein N4,Danio rerio (Zebrafish) (Brachydanio rerio),68.4,117.0,7.3e-42,172.9,sp|A2BGM5|FOXN4_DANRE Forkhead box protein N4 OS=Danio rerio OX=7955 GN=foxn4 PE=1 SV=1,GO:0000981; GO:0000987; GO:0001947; GO:0003170; GO:0003682; GO:0003700; GO:0005634; GO:0006355; GO:0008016; GO:0010842; GO:0035881; GO:0036302; GO:0043565; GO:0045893; GO:0045944; GO:0060579,amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; heart looping [GO:0001947]; heart valve development [GO:0003170]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of heart contraction [GO:0008016]; retina layer formation [GO:0010842]; ventral spinal cord interneuron fate commitment [GO:0060579],nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_08607,1.9907307778819403,FUN_037753-T1,Peve_00038304,Pocillopora_meandrina_HIv1___RNAseq.g1341.t1,three_way,59.559333333333335,FUN_037753-T1,A7SKJ3,DPH2_NEMVE,,2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2),Nematostella vectensis (Starlet sea anemone),44.1,313.0,3.200000000000001e-65,250.4,sp|A7SKJ3|DPH2_NEMVE 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 OS=Nematostella vectensis OX=45351 GN=dph2 PE=3 SV=1,GO:0017183; GO:0046872; GO:0051539; GO:0090560; GO:0120513,protein histidyl modification to diphthamide [GO:0017183],2-(3-amino-3-carboxypropyl)histidine synthase complex [GO:0120513],"2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]",GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_08610,1.2915211791146843,FUN_037757-T1,Peve_00014341,Pocillopora_meandrina_HIv1___RNAseq.g1500.t1,three_way,54.698166666666665,FUN_037757-T1,Q3KQ71,,,,,36.7,294.0,1.2000000000000001e-30,135.2,sp|Q3KQ71|SCNM1_XENLA Sodium channel modifier 1 OS=Xenopus laevis OX=8355 GN=scnm1 PE=2 SV=1,,,,,,
OG_08615,2.521892253727424,FUN_037763-T1,Peve_00014331,Pocillopora_meandrina_HIv1___RNAseq.g1494.t1,three_way,49.86833333333333,FUN_037763-T1,Q5ZJX4,,,,,57.6,92.0,4.4e-26,120.2,sp|Q5ZJX4|RBM38_CHICK RNA-binding protein 38 OS=Gallus gallus OX=9031 GN=RBM38 PE=2 SV=1,,,,,,
OG_08617,2.507103523271328,FUN_037768-T1,Peve_00014328,Pocillopora_meandrina_HIv1___RNAseq.g1480.t1,three_way,79.92966666666668,FUN_037768-T1,O35552,F263_RAT,,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain-type isozyme) (RB2K) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",Rattus norvegicus (Rat),53.4,440.0,1.1000000000000001e-130,468.4,"sp|O35552|F263_RAT 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 OS=Rattus norvegicus OX=10116 GN=Pfkfb3 PE=2 SV=1",GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0006096; GO:0006110; GO:0006915; GO:0010001; GO:0061744,"apoptotic process [GO:0006915]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; motor behavior [GO:0061744]; regulation of glycolytic process [GO:0006110]",cytosol [GO:0005829]; nucleoplasm [GO:0005654],"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]",GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; programmed cell death; transferase activity; hydrolase activity; cell differentiation; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08618,2.333995480861866,FUN_037769-T1,Peve_00014327,Pocillopora_meandrina_HIv1___RNAseq.g1481.t1,three_way,74.75533333333334,FUN_037769-T1,O95147,,,,,47.9,167.0,1.2999999999999998e-43,177.6,sp|O95147|DUS14_HUMAN Dual specificity protein phosphatase 14 OS=Homo sapiens OX=9606 GN=DUSP14 PE=1 SV=1,,,,,,
OG_08619,2.569758889480859,FUN_037772-T1,Peve_00014348,Pocillopora_meandrina_HIv1___RNAseq.g1505.t1,three_way,75.424,FUN_037772-T1,Q32P28,P3H1_HUMAN,,Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1),Homo sapiens (Human),33.7,692.0,1e-99,365.9,sp|Q32P28|P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapiens OX=9606 GN=P3H1 PE=1 SV=2,GO:0005506; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0008285; GO:0010976; GO:0016020; GO:0018126; GO:0019797; GO:0030199; GO:0030278; GO:0030308; GO:0031418; GO:0032963; GO:0032991; GO:0050708; GO:0050821; GO:0060348; GO:0061077; GO:0070062; GO:1901874,bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of post-translational protein modification [GO:1901874]; positive regulation of neuron projection development [GO:0010976]; protein folding [GO:0006457]; protein hydroxylation [GO:0018126]; protein stabilization [GO:0050821]; regulation of ossification [GO:0030278]; regulation of protein secretion [GO:0050708],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797],GO:0003824; GO:0005634; GO:0005783; GO:0006457; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; protein folding; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08620,1.1940314369441722,FUN_037775-T1,Peve_00040704,Pocillopora_meandrina_HIv1___RNAseq.g1512.t1,three_way,79.25166666666667,FUN_037775-T1,P48630,,,,,49.3,377.0,7.5e-100,365.5,"sp|P48630|FD6E1_SOYBN Omega-6 fatty acid desaturase, endoplasmic reticulum isozyme 1 OS=Glycine max OX=3847 GN=FAD2-1 PE=2 SV=1",,,,,,
OG_08621,2.0087261379619883,FUN_037776-T1,Peve_00040706,Pocillopora_meandrina_HIv1___RNAseq.g1509.t1,three_way,81.93966666666667,,,,,,,,,,,,,,,,,
OG_08624,1.6962507949846604,FUN_037784-T1,Peve_00026141,Pocillopora_meandrina_HIv1___RNAseq.g1520.t1,three_way,78.41366666666667,FUN_037784-T1,Q9VCA2,,,,,27.9,524.0,4.1e-58,227.3,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_08625,1.8670765956873776,FUN_037791-T1,Peve_00026138,Pocillopora_meandrina_HIv1___RNAseq.g10947.t1,three_way,61.035,FUN_037791-T1,Q9Z0E8,,,,,29.9,532.0,1.3e-54,215.7,sp|Q9Z0E8|S22A5_MOUSE Organic cation/carnitine transporter 2 OS=Mus musculus OX=10090 GN=Slc22a5 PE=1 SV=1,,,,,,
OG_08626,1.3078764329832775,FUN_037794-T1,Peve_00026137,Pocillopora_meandrina_HIv1___RNAseq.g1554.t1,three_way,80.52866666666667,FUN_037794-T1,P08836,,,,,56.7,275.0,4.8e-89,329.3,sp|P08836|FPPS_CHICK Farnesyl pyrophosphate synthase OS=Gallus gallus OX=9031 GN=FDPS PE=1 SV=2,,,,,,
OG_08627,3.94741080667555,FUN_037795-T1,Peve_00026136,Pocillopora_meandrina_HIv1___RNAseq.g1555.t3,three_way,71.708,FUN_037795-T1,P51960,,,,,33.6,758.0,4.3e-85,317.4,sp|P51960|MYBA_MOUSE Myb-related protein A OS=Mus musculus OX=10090 GN=Mybl1 PE=1 SV=2,,,,,,
OG_08628,2.359759650071866,FUN_037796-T1,Peve_00026135,Pocillopora_meandrina_HIv1___RNAseq.g1556.t1,three_way,91.083,FUN_037796-T1,Q9CWF6,BBS2_MOUSE,,BBSome complex member BBS2 (Bardet-Biedl syndrome 2 protein homolog),Mus musculus (Mouse),66.9,718.0,8.9e-285,980.7,sp|Q9CWF6|BBS2_MOUSE BBSome complex member BBS2 OS=Mus musculus OX=10090 GN=Bbs2 PE=1 SV=1,GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010467; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033210; GO:0033365; GO:0034451; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0044321; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515,adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0003012; GO:0003013; GO:0005815; GO:0005929; GO:0007010; GO:0016192; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0072659,muscle system process; circulatory system process; microtubule organizing center; cilium; cytoskeleton organization; vesicle-mediated transport; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein localization to plasma membrane
OG_08629,1.4849526594246112,FUN_037798-T1,Peve_00026125,Pocillopora_meandrina_HIv1___RNAseq.g1558.t1,three_way,81.751,,,,,,,,,,,,,,,,,
OG_08632,1.0099712437328972,FUN_037801-T1,Peve_00026143,Pocillopora_meandrina_HIv1___RNAseq.g1561.t1,three_way,77.64,FUN_037801-T1,Q8INF0,GCY8E_DROME,,Soluble guanylate cyclase 88E (EC 4.6.1.2),Drosophila melanogaster (Fruit fly),41.3,620.0,2.4e-140,500.7,sp|Q8INF0|GCY8E_DROME Soluble guanylate cyclase 88E OS=Drosophila melanogaster OX=7227 GN=Gyc88E PE=1 SV=4,GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482,cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302],"guanylate cyclase complex, soluble [GO:0008074]",carbon monoxide binding [GO:0070025]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0009975; GO:0016787; GO:0016829; GO:0098772; GO:0140299,catalytic activity; GTPase activity; cyclase activity; hydrolase activity; lyase activity; molecular function regulator activity; molecular sensor activity
OG_08633,5.070725266820507,FUN_037802-T1,Peve_00026129,Pocillopora_meandrina_HIv1___RNAseq.g1562.t1,three_way,59.398,,,,,,,,,,,,,,,,,
OG_08636,1.084594872763842,FUN_037808-T1,Peve_00003982,Pocillopora_meandrina_HIv1___RNAseq.g1570.t1,three_way,66.05983333333333,FUN_037808-T1,P51954,NEK1_MOUSE,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1),Mus musculus (Mouse),41.6,308.0,5.2e-66,253.4,sp|P51954|NEK1_MOUSE Serine/threonine-protein kinase Nek1 OS=Mus musculus OX=10090 GN=Nek1 PE=1 SV=2,GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0007283; GO:0010212; GO:0030030; GO:0035264; GO:0046872; GO:0051301; GO:0071889; GO:0106310; GO:2000001,cell division [GO:0051301]; cell projection organization [GO:0030030]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08643,2.2656201036532284,FUN_037834-T1,Peve_00029596,Pocillopora_meandrina_HIv1___RNAseq.g1455.t1,three_way,63.28266666666666,FUN_037834-T1,P05423,RPC4_HUMAN,,DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog),Homo sapiens (Human),40.7,413.0,3.7e-38,160.6,sp|P05423|RPC4_HUMAN DNA-directed RNA polymerase III subunit RPC4 OS=Homo sapiens OX=9606 GN=POLR3D PE=1 SV=2,GO:0003677; GO:0003682; GO:0005654; GO:0005666; GO:0005829; GO:0032728; GO:0042797; GO:0045087; GO:0045089; GO:0051607,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666],chromatin binding [GO:0003682]; DNA binding [GO:0003677],GO:0002376; GO:0003677; GO:0005654; GO:0005829; GO:0006351; GO:0006399; GO:0098542,immune system process; DNA binding; nucleoplasm; cytosol; DNA-templated transcription; tRNA metabolic process; defense response to other organism
OG_08644,3.084593857821364,FUN_037835-T1,Peve_00000571,Pocillopora_meandrina_HIv1___RNAseq.g1459.t1,three_way,87.0945,FUN_037835-T1,A0JNC1,CDS2_BOVIN,,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),Bos taurus (Bovine),57.1,410.0,3.5e-138,493.0,sp|A0JNC1|CDS2_BOVIN Phosphatidate cytidylyltransferase 2 OS=Bos taurus OX=9913 GN=CDS2 PE=2 SV=1,GO:0004605; GO:0005783; GO:0005789; GO:0016020; GO:0016024; GO:0140042,CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],phosphatidate cytidylyltransferase activity [GO:0004605],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_08645,3.001681932513224,FUN_037836-T1,Peve_00000570,Pocillopora_meandrina_HIv1___RNAseq.g1460.t1,three_way,80.37733333333334,FUN_037836-T1,P12004,PCNA_HUMAN,,Proliferating cell nuclear antigen (PCNA) (Cyclin),Homo sapiens (Human),65.3,259.0,5e-100,365.5,sp|P12004|PCNA_HUMAN Proliferating cell nuclear antigen OS=Homo sapiens OX=9606 GN=PCNA PE=1 SV=1,GO:0000122; GO:0000307; GO:0000701; GO:0000781; GO:0000785; GO:0001673; GO:0003682; GO:0003684; GO:0005634; GO:0005652; GO:0005654; GO:0005657; GO:0005813; GO:0006272; GO:0006287; GO:0006298; GO:0006325; GO:0007507; GO:0016604; GO:0019899; GO:0019985; GO:0030331; GO:0030337; GO:0030855; GO:0030894; GO:0030971; GO:0031297; GO:0032077; GO:0032139; GO:0032355; GO:0032405; GO:0034644; GO:0035035; GO:0042802; GO:0043596; GO:0043626; GO:0044849; GO:0044877; GO:0045739; GO:0045740; GO:0046686; GO:0070062; GO:0070182; GO:0070301; GO:0070557; GO:0071466; GO:0071548; GO:0097421; GO:1900264; GO:1902065; GO:1902990,"base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; translesion synthesis [GO:0019985]","centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]",chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; nuclear estrogen receptor binding [GO:0030331]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0022414; GO:0030154; GO:0032200; GO:0043226; GO:0048856; GO:0098772; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; reproductive process; cell differentiation; telomere organization; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA"
OG_08649,1.843934303334487,FUN_037845-T1,Peve_00032827,Pocillopora_meandrina_HIv1___RNAseq.g1431.t1,three_way,93.189,FUN_037845-T1,Q8C0E2,VP26B_MOUSE,,Vacuolar protein sorting-associated protein 26B (Vesicle protein sorting 26B),Mus musculus (Mouse),79.1,301.0,1.4e-141,503.8,sp|Q8C0E2|VP26B_MOUSE Vacuolar protein sorting-associated protein 26B OS=Mus musculus OX=10090 GN=Vps26b PE=1 SV=1,GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0030904; GO:0042147; GO:0045335; GO:0071346; GO:0098696; GO:0098837; GO:0098842; GO:0098978,"cellular response to type II interferon [GO:0071346]; intracellular protein transport [GO:0006886]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; postsynaptic early endosome [GO:0098842]; postsynaptic recycling endosome [GO:0098837]; retromer complex [GO:0030904],,GO:0005768; GO:0005829; GO:0006886; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_08654,1.366612496328431,FUN_037852-T1,Peve_00024537,Pocillopora_meandrina_HIv1___RNAseq.g1422.t1,three_way,60.72333333333333,,,,,,,,,,,,,,,,,
OG_08655,1.0022952405356234,FUN_037853-T1,Peve_00024528,Pocillopora_meandrina_HIv1___RNAseq.g1420.t1,three_way,82.55333333333334,FUN_037853-T1,P38487,,,,,66.5,409.0,1.9e-160,567.0,sp|P38487|CREA_BACB0 Creatinase OS=Bacillus sp. (strain B-0618) OX=69000 PE=1 SV=3,,,,,,
OG_08656,1.3624971670315975,FUN_037862-T1,Peve_00022156,Pocillopora_meandrina_HIv1___RNAseq.g1427.t2,three_way,73.77433333333333,FUN_037862-T1,P30839,AL3A2_RAT,,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 4) (Fatty aldehyde dehydrogenase) (Microsomal aldehyde dehydrogenase) (msALDH),Rattus norvegicus (Rat),52.2,454.0,5.5e-140,499.2,sp|P30839|AL3A2_RAT Aldehyde dehydrogenase family 3 member A2 OS=Rattus norvegicus OX=10116 GN=Aldh3a2 PE=1 SV=1,GO:0000302; GO:0004028; GO:0004029; GO:0005737; GO:0005783; GO:0005789; GO:0006081; GO:0006631; GO:0007417; GO:0007422; GO:0008544; GO:0016020; GO:0033306; GO:0042803; GO:0043231; GO:0046292; GO:0046458; GO:0046577; GO:0050061; GO:0052814,aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; formaldehyde metabolic process [GO:0046292]; hexadecanal metabolic process [GO:0046458]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; response to reactive oxygen species [GO:0000302],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; long-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0050061]; long-chain-alcohol oxidase activity [GO:0046577]; medium-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0052814]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226; GO:0048856,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle; anatomical structure development
OG_08658,2.227005763759928,FUN_037870-T1,Peve_00024531,Pocillopora_meandrina_HIv1___RNAseq.g1409.t1,three_way,93.36216666666668,FUN_037870-T1,P08642,,,,,80.5,174.0,5.3e-75,282.0,sp|P08642|RASH_CHICK GTPase HRas OS=Gallus gallus OX=9031 GN=HRAS PE=1 SV=1,,,,,,
OG_08664,1.151954752510024,FUN_037898-T1,Peve_00028732,Pocillopora_meandrina_HIv1___RNAseq.g28683.t1,three_way,62.17966666666667,FUN_037898-T1,Q8CBH5,,,,,22.7,569.0,1.1e-22,109.8,sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1,,,,,,
OG_08666,1.4944714698003745,FUN_037900-T1,Peve_00028723,Pocillopora_meandrina_HIv1___RNAseq.g28679.t1,three_way,73.453,FUN_037900-T1,Q8NEP7,,,,,30.5,295.0,1.8e-27,125.2,sp|Q8NEP7|KLDC9_HUMAN Kelch domain-containing protein 9 OS=Homo sapiens OX=9606 GN=KLHDC9 PE=1 SV=2,,,,,,
OG_08668,1.0326903612696317,FUN_037904-T1,Peve_00028715,Pocillopora_meandrina_HIv1___RNAseq.g28654.t1,three_way,50.38033333333333,,,,,,,,,,,,,,,,,
OG_08669,1.5117717223938285,FUN_037905-T1,Peve_00028714,Pocillopora_meandrina_HIv1___RNAseq.g28655.t1,three_way,58.46,,,,,,,,,,,,,,,,,
OG_08670,2.2433063089970697,FUN_037906-T1,Peve_00004640,Pocillopora_meandrina_HIv1___TS.g3117.t1,three_way,86.05966666666667,FUN_037906-T1,Q8BGX0,TRI23_MOUSE,,E3 ubiquitin-protein ligase TRIM23 (EC 2.3.2.27) (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23),Mus musculus (Mouse),62.5,544.0,6.7e-203,708.4,sp|Q8BGX0|TRI23_MOUSE E3 ubiquitin-protein ligase TRIM23 OS=Mus musculus OX=10090 GN=Trim23 PE=2 SV=1,GO:0000139; GO:0003924; GO:0004842; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0008270; GO:0010508; GO:0016567; GO:0019003; GO:0042802; GO:0061630,positive regulation of autophagy [GO:0010508]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0003924; GO:0005634; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; GTPase activity; nucleus; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08671,3.048670585691229,FUN_037907-T1,Peve_00004641,Pocillopora_meandrina_HIv1___RNAseq.g17360.t1,three_way,85.071,FUN_037907-T1,Q0VFT9,,,,,56.3,423.0,5.6e-120,432.6,sp|Q0VFT9|TPC13_XENTR Trafficking protein particle complex subunit 13 OS=Xenopus tropicalis OX=8364 GN=trappc13 PE=2 SV=1,,,,,,
OG_08674,4.222295880971611,FUN_037910-T1,Peve_00004651,Pocillopora_meandrina_HIv1___TS.g5680.t1,three_way,79.7845,FUN_037910-T1,Q8IV35,,,,,30.2,865.0,1.6e-100,369.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_08676,1.4053507549826287,FUN_037915-T1,Peve_00006148,Pocillopora_meandrina_HIv1___RNAseq.g1174.t1,three_way,75.068,FUN_037915-T1,O43149,,,,,34.5,3025.0,0.0,1415.6,sp|O43149|ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZZEF1 PE=1 SV=6,,,,,,
OG_08680,2.6368304222408248,FUN_037920-T1,Peve_00010402,Pocillopora_meandrina_HIv1___RNAseq.g26500.t1,three_way,76.47983333333333,FUN_037920-T1,Q8BIF2,RFOX3_MOUSE,,RNA binding protein fox-1 homolog 3 (Fox-1 homolog C) (Hexaribonucleotide-binding protein 3) (Fox-3) (Neuronal nuclei antigen) (NeuN antigen),Mus musculus (Mouse),58.4,149.0,1.5e-33,144.8,sp|Q8BIF2|RFOX3_MOUSE RNA binding protein fox-1 homolog 3 OS=Mus musculus OX=10090 GN=Rbfox3 PE=1 SV=2,GO:0000381; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0007399; GO:0008380; GO:0043025; GO:0043204,"mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204],DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0048856,DNA binding; RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; anatomical structure development
OG_08686,2.284961039581533,FUN_037927-T1,Peve_00005836,Pocillopora_meandrina_HIv1___RNAseq.g26223.t1,three_way,75.379,FUN_037927-T1,Q96QE5,TEFM_HUMAN,,"Transcription elongation factor, mitochondrial",Homo sapiens (Human),26.8,235.0,5.2e-14,80.5,"sp|Q96QE5|TEFM_HUMAN Transcription elongation factor, mitochondrial OS=Homo sapiens OX=9606 GN=TEFM PE=1 SV=1",GO:0002082; GO:0003711; GO:0003723; GO:0005739; GO:0005759; GO:0006390; GO:0006392; GO:0030337; GO:0042645; GO:1903109; GO:1990904,mitochondrial transcription [GO:0006390]; positive regulation of mitochondrial transcription [GO:1903109]; regulation of oxidative phosphorylation [GO:0002082]; transcription elongation by mitochondrial RNA polymerase [GO:0006392],mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904],DNA polymerase processivity factor activity [GO:0030337]; RNA binding [GO:0003723]; transcription elongation factor activity [GO:0003711],GO:0003723; GO:0005739; GO:0006351; GO:0006355; GO:0043226; GO:0098772; GO:0140110,RNA binding; mitochondrion; DNA-templated transcription; regulation of DNA-templated transcription; organelle; molecular function regulator activity; transcription regulator activity
OG_08687,3.2820651329437034,FUN_037929-T1,Peve_00005835,Pocillopora_meandrina_HIv1___RNAseq.g26222.t1,three_way,56.6,,,,,,,,,,,,,,,,,
OG_08688,3.737128329263202,FUN_037931-T1,Peve_00015637,Pocillopora_meandrina_HIv1___RNAseq.g26217.t1,three_way,82.56883333333333,FUN_037931-T1,A7M7B9,NTH_CHICK,,Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase),Gallus gallus (Chicken),64.4,225.0,3.1999999999999997e-85,316.6,sp|A7M7B9|NTH_CHICK Endonuclease III-like protein 1 OS=Gallus gallus OX=9031 GN=NTHL1 PE=2 SV=1,GO:0000703; GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006289; GO:0046872; GO:0051539; GO:0140078,"base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair [GO:0006289]",mitochondrion [GO:0005739]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]",GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_08690,1.313280141957428,FUN_037933-T1,Peve_00025647,Pocillopora_meandrina_HIv1___RNAseq.g26215.t1,three_way,47.622,FUN_037933-T1,Q4V832,,,,,29.1,413.0,9.999999999999999e-27,123.2,sp|Q4V832|AP4AT_XENLA AP-4 complex accessory subunit tepsin OS=Xenopus laevis OX=8355 GN=tepsin PE=2 SV=2,,,,,,
OG_08691,2.241965678400512,FUN_037935-T1,Peve_00015640,Pocillopora_meandrina_HIv1___RNAseq.g26204.t1,three_way,78.68583333333333,,,,,,,,,,,,,,,,,
OG_08694,2.1518879082984657,FUN_037938-T1,Peve_00027269,Pocillopora_meandrina_HIv1___RNAseq.g26201.t1,three_way,89.87166666666667,FUN_037938-T1,Q76MZ1,,,,,68.1,282.0,7.8e-115,414.8,sp|Q76MZ1|CYH1_CHLAE Cytohesin-1 OS=Chlorocebus aethiops OX=9534 GN=CYTH1 PE=2 SV=1,,,,,,
OG_08700,1.1218045064232858,FUN_037949-T1,Peve_00040737,Pocillopora_meandrina_HIv1___RNAseq.g26517.t1,three_way,58.639,,,,,,,,,,,,,,,,,
OG_08701,2.3932403188610945,FUN_037950-T1,Peve_00040736,Pocillopora_meandrina_HIv1___RNAseq.g26516.t1,three_way,47.437000000000005,,,,,,,,,,,,,,,,,
OG_08702,1.6161649899031965,FUN_037951-T1,Peve_00040735,Pocillopora_meandrina_HIv1___RNAseq.g26515.t1,three_way,57.99533333333333,FUN_037951-T1,Q7TSH4,,,,,28.3,226.0,1.3e-11,73.6,sp|Q7TSH4|CP110_MOUSE Centriolar coiled-coil protein of 110 kDa OS=Mus musculus OX=10090 GN=Ccp110 PE=1 SV=1,,,,,,
OG_08703,2.599552922887534,FUN_037952-T1,Peve_00040734,Pocillopora_meandrina_HIv1___RNAseq.g26514.t2,three_way,73.35300000000001,FUN_037952-T1,Q6PIF6,MYO7B_HUMAN,,Unconventional myosin-VIIb,Homo sapiens (Human),26.7,797.0,3.1000000000000003e-66,255.4,sp|Q6PIF6|MYO7B_HUMAN Unconventional myosin-VIIb OS=Homo sapiens OX=9606 GN=MYO7B PE=1 SV=2,GO:0000146; GO:0005524; GO:0005737; GO:0005902; GO:0005903; GO:0007015; GO:0007605; GO:0015629; GO:0016020; GO:0016459; GO:0030048; GO:0030154; GO:0051015; GO:0090651; GO:1904970,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory perception of sound [GO:0007605],actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146],GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0016853; GO:0030154; GO:0043226; GO:0050877; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; isomerase activity; cell differentiation; organelle; nervous system process; ATP-dependent activity
OG_08704,4.940368194423757,FUN_037953-T1,Peve_00040733,Pocillopora_meandrina_HIv1___RNAseq.g26512.t1,three_way,50.168,FUN_037953-T1,Q91905,,,,,68.3,60.0,4.7e-18,92.8,sp|Q91905|FXI1B_XENLA Forkhead box protein I1-B OS=Xenopus laevis OX=8355 GN=foxi1-b PE=2 SV=1,,,,,,
OG_08705,4.328079128753138,FUN_037955-T1,Peve_00040732,Pocillopora_meandrina_HIv1___TS.g19261.t1,three_way,55.23566666666667,FUN_037955-T1,Q9PVY9,,,,,40.6,217.0,5.7000000000000006e-36,153.3,sp|Q9PVY9|FXC2A_XENLA Forkhead box protein C2-A OS=Xenopus laevis OX=8355 GN=foxc2-a PE=2 SV=1,,,,,,
OG_08707,1.4047211345406674,FUN_037957-T1,Peve_00040730,Pocillopora_meandrina_HIv1___TS.g19259.t1,three_way,88.39133333333334,FUN_037957-T1,Q96HU1,SGSM3_HUMAN,,Small G protein signaling modulator 3 (Merlin-associated protein) (RUN and TBC1 domain-containing protein 3) (Rab-GTPase-activating protein-like protein) (RabGAPLP),Homo sapiens (Human),61.7,798.0,1.2e-288,993.8,sp|Q96HU1|SGSM3_HUMAN Small G protein signaling modulator 3 OS=Homo sapiens OX=9606 GN=SGSM3 PE=1 SV=1,GO:0005096; GO:0005829; GO:0005921; GO:0031267; GO:0032483; GO:0032486; GO:0043547; GO:0045732; GO:0048227; GO:0051726,plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein catabolic process [GO:0045732]; Rap protein signal transduction [GO:0032486]; regulation of cell cycle [GO:0051726]; regulation of Rab protein signal transduction [GO:0032483],cytosol [GO:0005829]; gap junction [GO:0005921],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0016192; GO:0098772,cytosol; vesicle-mediated transport; molecular function regulator activity
OG_08708,2.5335494418311644,FUN_037960-T1,Peve_00009704,Pocillopora_meandrina_HIv1___RNAseq.17936_t,three_way,68.97666666666666,FUN_037960-T1,Q0V9C9,,,,,31.6,339.0,3e-45,184.1,"sp|Q0V9C9|ECSIT_XENTR Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial OS=Xenopus tropicalis OX=8364 GN=ecsit PE=2 SV=1",,,,,,
OG_08709,1.2074352364191738,FUN_037961-T1,Peve_00009703,Pocillopora_meandrina_HIv1___RNAseq.g26230.t1,three_way,75.68066666666667,FUN_037961-T1,A7RKS5,RSSA_NEMVE,,Small ribosomal subunit protein uS2 (40S ribosomal protein SA),Nematostella vectensis (Starlet sea anemone),75.9,257.0,1e-107,391.3,sp|A7RKS5|RSSA_NEMVE Small ribosomal subunit protein uS2 OS=Nematostella vectensis OX=45351 GN=v1g198553 PE=3 SV=1,GO:0000028; GO:0002181; GO:0003735; GO:0022627,cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028],cytosolic small ribosomal subunit [GO:0022627],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0065003,cytoplasmic translation; structural molecule activity; protein-containing complex assembly
OG_08710,1.3056167520913804,FUN_037962-T1,Peve_00016282,Pocillopora_meandrina_HIv1___RNAseq.g29749.t1,three_way,70.62566666666666,FUN_037962-T1,Q8BZK4,,,,,35.1,385.0,7.4e-49,196.1,sp|Q8BZK4|S35F4_MOUSE Solute carrier family 35 member F4 OS=Mus musculus OX=10090 GN=Slc35f4 PE=2 SV=1,,,,,,
OG_08713,1.252540172247456,FUN_037965-T1,Peve_00009707,Pocillopora_meandrina_HIv1___RNAseq.g26234.t1,three_way,48.86333333333334,,,,,,,,,,,,,,,,,
OG_08714,2.3457218609535038,FUN_037966-T1,Peve_00009699,Pocillopora_meandrina_HIv1___RNAseq.g26235.t1,three_way,47.697,,,,,,,,,,,,,,,,,
OG_08715,3.976122327983688,FUN_037967-T1,Peve_00012656,Pocillopora_meandrina_HIv1___RNAseq.g26236.t1,three_way,59.54,FUN_037967-T1,Q09630,,,,,24.1,906.0,2.2e-38,162.5,sp|Q09630|GRM1_CAEEL Probable metabotropic glutamate receptor mgl-1 OS=Caenorhabditis elegans OX=6239 GN=mgl-1 PE=3 SV=1,,,,,,
OG_08718,4.337397608242232,FUN_037970-T1,Peve_00032390,Pocillopora_meandrina_HIv1___RNAseq.g9858.t1a,three_way,78.12766666666666,FUN_037970-T1,D4D448,,,,,26.9,458.0,2.1999999999999996e-24,115.2,sp|D4D448|EASE_TRIVH FAD-linked oxidoreductase easE OS=Trichophyton verrucosum (strain HKI 0517) OX=663202 GN=easE PE=3 SV=1,,,,,,
OG_08722,2.8294224930685536,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),36.1,280.0,6.1e-42,174.9,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08722,2.8294224930685536,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),43.2,148.0,5.4e-22,108.6,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08724,1.7105853073003712,FUN_037977-T1,Peve_00019559,Pocillopora_meandrina_HIv1___RNAseq.g26186.t1,three_way,79.00166666666667,FUN_037977-T1,A0JP70,,,,,42.9,1940.0,0.0,1565.1,sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1,,,,,,
OG_08725,2.622757139094218,FUN_037978-T1,Peve_00019558,Pocillopora_meandrina_HIv1___RNAseq.g26187.t1,three_way,70.464,FUN_037978-T1,Q9UTA8,,,,,32.4,262.0,8.2e-29,129.0,sp|Q9UTA8|YL8A_SCHPO Uncharacterized methyltransferase-like C25B8.10 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC25B8.10 PE=3 SV=1,,,,,,
OG_08727,1.3572536817057457,FUN_037982-T1,Peve_00018338,Pocillopora_meandrina_HIv1___RNAseq.g26193.t1,three_way,71.84733333333332,,,,,,,,,,,,,,,,,
OG_08728,2.8808894328721206,FUN_037983-T1,Peve_00026785,Pocillopora_meandrina_HIv1___RNAseq.g26190.t1,three_way,60.70233333333333,FUN_037983-T1,Q8BTK5,SMYD4_MOUSE,,Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4),Mus musculus (Mouse),28.3,600.0,9.799999999999999e-55,216.5,sp|Q8BTK5|SMYD4_MOUSE Protein-lysine N-methyltransferase SMYD4 OS=Mus musculus OX=10090 GN=Smyd4 PE=2 SV=2,GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0008270; GO:0032259,heart development [GO:0007507]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; transferase activity; organelle; anatomical structure development
OG_08730,1.8646519680536888,FUN_037986-T1,Peve_00025061,Pocillopora_meandrina_HIv1___RNAseq.g26274.t1,three_way,63.13133333333333,FUN_037986-T1,Q8BX80,,,,,37.7,703.0,9.5e-121,436.0,sp|Q8BX80|ENASE_MOUSE Cytosolic endo-beta-N-acetylglucosaminidase OS=Mus musculus OX=10090 GN=Engase PE=1 SV=1,,,,,,
OG_08731,1.89397955505456,FUN_037988-T1,Peve_00025059,Pocillopora_meandrina_HIv1___RNAseq.g26272.t1,three_way,38.300666666666665,,,,,,,,,,,,,,,,,
OG_08733,1.6720556248914946,FUN_037990-T1,Peve_00023488,Pocillopora_meandrina_HIv1___RNAseq.g26269.t1,three_way,90.14733333333334,FUN_037990-T1,A5PKG7,,,,,68.2,198.0,5.2e-73,275.4,sp|A5PKG7|KCTD5_BOVIN BTB/POZ domain-containing protein KCTD5 OS=Bos taurus OX=9913 GN=KCTD5 PE=2 SV=1,,,,,,
OG_08735,1.3715047594674772,FUN_037992-T1,Peve_00023490,Pocillopora_meandrina_HIv1___RNAseq.g26267.t1,three_way,59.86366666666667,,,,,,,,,,,,,,,,,
OG_08738,1.054582320557404,FUN_037997-T1,Peve_00021251,Pocillopora_meandrina_HIv1___RNAseq.g26260.t1,three_way,62.4075,FUN_037997-T1,Q4WU07,,,,,42.5,299.0,1.2e-52,208.8,sp|Q4WU07|CWC2_ASPFU Pre-mRNA-splicing factor cwc2 OS=Aspergillus fumigatus (strain ATCC MYA-4609 / CBS 101355 / FGSC A1100 / Af293) OX=330879 GN=cwc2 PE=3 SV=1,,,,,,
OG_08739,1.855018033369413,FUN_037998-T1,Peve_00021258,Pocillopora_meandrina_HIv1___RNAseq.g26259.t1,three_way,71.65033333333334,FUN_037998-T1,Q5HZT0,DXO_XENLA,,Decapping and exoribonuclease protein (DXO) (EC 3.6.1.-) (5'-3' exoribonuclease DXO) (EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO) (DeNADding enzyme DXO) (EC 3.6.1.-),Xenopus laevis (African clawed frog),39.8,369.0,5.7e-79,296.2,sp|Q5HZT0|DXO_XENLA Decapping and exoribonuclease protein OS=Xenopus laevis OX=8355 GN=dxo PE=2 SV=1,GO:0000166; GO:0000287; GO:0000956; GO:0003729; GO:0005634; GO:0005829; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090304; GO:0110152; GO:0110155,mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid metabolic process [GO:0090304]; RNA destabilization [GO:0050779],cytosol [GO:0005829]; nucleus [GO:0005634],5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA 5'-diphosphatase activity [GO:0034353]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD+-cap (NAD+-forming) hydrolase activity [GO:0110152],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_08740,1.224623815233223,FUN_037999-T1,Peve_00021257,Pocillopora_meandrina_HIv1___TS.g19007.t1,three_way,55.495666666666665,FUN_037999-T1,Q09655,,,,,34.5,284.0,1.2e-28,129.0,sp|Q09655|GPAN1_CAEEL G patch domain and ankyrin repeat-containing protein 1 homolog OS=Caenorhabditis elegans OX=6239 GN=ZK1320.7 PE=4 SV=3,,,,,,
OG_08741,1.6144547704560883,FUN_038000-T1,Peve_00021256,Pocillopora_meandrina_HIv1___RNAseq.g26257.t1,three_way,91.26966666666668,FUN_038000-T1,Q6GR34,,,,,50.0,164.0,1.5e-41,170.6,sp|Q6GR34|CP52A_XENLA Uncharacterized protein C16orf52 homolog A OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_08745,1.4491579158919576,FUN_038006-T1,Peve_00013512,Pocillopora_meandrina_HIv1___RNAseq.g26245.t1,three_way,55.17616666666667,,,,,,,,,,,,,,,,,
OG_08748,1.827457772551792,FUN_038013-T1,Peve_00013505,Pocillopora_meandrina_HIv1___RNAseq.g26527.t1,three_way,72.60583333333334,,,,,,,,,,,,,,,,,
OG_08751,2.01055237773284,FUN_038018-T1,Peve_00022791,Pocillopora_meandrina_HIv1___RNAseq.g26531.t1,three_way,70.62033333333333,FUN_038018-T1,A7UA95,RADIL_DANRE,,Ras-associating and dilute domain-containing protein,Danio rerio (Zebrafish) (Brachydanio rerio),28.0,1225.0,3e-109,398.7,sp|A7UA95|RADIL_DANRE Ras-associating and dilute domain-containing protein OS=Danio rerio OX=7955 GN=radil PE=2 SV=1,GO:0001755; GO:0005874; GO:0007165; GO:0034446; GO:0051020,neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],microtubule [GO:0005874],GTPase binding [GO:0051020],GO:0007155; GO:0048870,cell adhesion; cell motility
OG_08754,2.038457906708119,FUN_038023-T1,Peve_00018114,Pocillopora_meandrina_HIv1___RNAseq.g26535.t1,three_way,57.67633333333333,FUN_038023-T1,Q8BKN6,,,,,55.4,260.0,1.5e-77,291.6,sp|Q8BKN6|HS3SA_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 OS=Mus musculus OX=10090 GN=Hs3st3a1 PE=2 SV=1,,,,,,
OG_08757,1.9285807171017493,FUN_038028-T1,Peve_00002131,Pocillopora_meandrina_HIv1___TS.g19287.t1a,three_way,79.5965,FUN_038028-T1,Q80U30,CL16A_MOUSE,,Protein CLEC16A,Mus musculus (Mouse),42.5,1092.0,9.9e-206,718.8,sp|Q80U30|CL16A_MOUSE Protein CLEC16A OS=Mus musculus OX=10090 GN=Clec16a PE=1 SV=2,GO:0006914; GO:0031648; GO:0032434; GO:0032435; GO:0036020; GO:0043161; GO:1901098; GO:1901525,autophagy [GO:0006914]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],endolysosome membrane [GO:0036020],,GO:0006914; GO:0030163,autophagy; protein catabolic process
OG_08758,1.1040055491639886,FUN_038031-T1,Peve_00021541,Pocillopora_meandrina_HIv1___RNAseq.g26541.t1,three_way,69.925,FUN_038031-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),28.9,256.0,8.2e-25,116.3,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_08759,1.638912543331165,FUN_038032-T1,Peve_00021540,Pocillopora_meandrina_HIv1___RNAseq.g26542.t1,three_way,53.04466666666666,FUN_038032-T1,Q96B70,,,,,45.8,96.0,1.3e-15,86.7,sp|Q96B70|LENG9_HUMAN Leukocyte receptor cluster member 9 OS=Homo sapiens OX=9606 GN=LENG9 PE=1 SV=2,,,,,,
OG_08761,1.2710582493046112,FUN_038034-T1,Peve_00016941,Pocillopora_meandrina_HIv1___RNAseq.g26545.t1,three_way,84.4425,FUN_038034-T1,O55173,PDPK1_RAT,,3-phosphoinositide-dependent protein kinase 1 (EC 2.7.11.1) (Protein kinase B kinase) (PkB kinase),Rattus norvegicus (Rat),63.1,474.0,4.8e-168,592.4,sp|O55173|PDPK1_RAT 3-phosphoinositide-dependent protein kinase 1 OS=Rattus norvegicus OX=10116 GN=Pdpk1 PE=1 SV=2,GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005925; GO:0006972; GO:0007173; GO:0008286; GO:0010594; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0019722; GO:0019901; GO:0030512; GO:0031410; GO:0032869; GO:0034122; GO:0035556; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043491; GO:0043524; GO:0043536; GO:0045766; GO:0048009; GO:0048041; GO:0051281; GO:0051897; GO:0071364; GO:0097191; GO:0106310; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352,calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of endothelial cell migration [GO:0010594]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005886; GO:0016740; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0098772; GO:0140096,"catalytic activity; nucleus; plasma membrane; transferase activity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08763,1.26858113099677,FUN_038037-T1,Peve_00016939,Pocillopora_meandrina_HIv1___RNAseq.g26547.t1,three_way,82.486,FUN_038037-T1,Q3B8H3,,,,,62.8,164.0,6.6e-56,218.4,"sp|Q3B8H3|TM11B_XENLA Transmembrane protein 11-B, mitochondrial OS=Xenopus laevis OX=8355 GN=tmem11-b PE=2 SV=1",,,,,,
OG_08765,2.771453896439416,FUN_038040-T1,Peve_00024877,Pocillopora_meandrina_HIv1___RNAseq.g26549.t1,three_way,88.22833333333332,FUN_038040-T1,Q5DU02,UBP22_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22),Mus musculus (Mouse),61.3,530.0,6.3e-179,628.6,sp|Q5DU02|UBP22_MOUSE Ubiquitin carboxyl-terminal hydrolase 22 OS=Mus musculus OX=10090 GN=Usp22 PE=1 SV=2,GO:0000086; GO:0000124; GO:0003713; GO:0004843; GO:0005737; GO:0006282; GO:0006357; GO:0006511; GO:0008270; GO:0010485; GO:0016579; GO:0019899; GO:0032481; GO:0033276; GO:0043484; GO:0045893; GO:0045931; GO:0140936; GO:0140950,G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of type I interferon production [GO:0032481]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],cysteine-type deubiquitinase activity [GO:0004843]; enzyme binding [GO:0019899]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; histone H4 acetyltransferase activity [GO:0010485]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0006355; GO:0016740; GO:0016787; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; regulation of DNA-templated transcription; transferase activity; hydrolase activity; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_08769,1.172709100518994,FUN_038049-T1,Peve_00020389,Pocillopora_meandrina_HIv1___RNAseq.g848.t1,three_way,72.76566666666666,FUN_038049-T1,P49842,WHR1_HUMAN,,Winged helix repair factor 1 (Inactive serine/threonine-protein kinase 19) (Protein G11) (Protein RP1) (Tandem winged helix protein formerly known as STK19),Homo sapiens (Human),41.1,219.0,2.1e-45,184.1,sp|P49842|WHR1_HUMAN Winged helix repair factor 1 OS=Homo sapiens OX=9606 GN=WHR1 PE=1 SV=3,GO:0003690; GO:0003725; GO:0005524; GO:0005634; GO:0005737; GO:0016301; GO:0016607; GO:0042803; GO:0046579; GO:1903518,positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of single strand break repair [GO:1903518],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; kinase activity [GO:0016301]; protein homodimerization activity [GO:0042803],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0016740; GO:0043226,DNA binding; RNA binding; catalytic activity; nucleus; transferase activity; organelle
OG_08770,3.09988342007072,FUN_038053-T1,Peve_00018147,Pocillopora_meandrina_HIv1___TS.g5311.t1,three_way,63.9905,,,,,,,,,,,,,,,,,
OG_08771,2.748852197321208,FUN_038055-T1,Peve_00018151,Pocillopora_meandrina_HIv1___TS.g5314.t1,three_way,87.48233333333333,FUN_038055-T1,Q3UJZ3,,,,,44.1,170.0,8.999999999999999e-32,138.3,sp|Q3UJZ3|ARMC7_MOUSE Armadillo repeat-containing protein 7 OS=Mus musculus OX=10090 GN=Armc7 PE=1 SV=2,,,,,,
OG_08772,2.4351607410283687,FUN_038056-T1,Peve_00018152,Pocillopora_meandrina_HIv1___TS.g5315.t2,three_way,86.20166666666667,FUN_038056-T1,Q9D2C6,,,,,63.4,202.0,3.3e-75,282.7,sp|Q9D2C6|RPC8_MOUSE DNA-directed RNA polymerase III subunit RPC8 OS=Mus musculus OX=10090 GN=Polr3h PE=1 SV=2,,,,,,
OG_08775,3.1997009106540584,FUN_038060-T1,Peve_00000948,Pocillopora_meandrina_HIv1___RNAseq.g795.t1,three_way,78.47183333333334,FUN_038060-T1,Q70CQ4,UBP31_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31),Homo sapiens (Human),42.1,537.0,7.000000000000003e-110,399.4,sp|Q70CQ4|UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens OX=9606 GN=USP31 PE=1 SV=2,GO:0004843; GO:0005634; GO:0006508; GO:0016579,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08777,1.4938445705375265,FUN_038063-T1,Peve_00032860,Pocillopora_meandrina_HIv1___TS.g5325.t1a,three_way,74.28,FUN_038063-T1,Q80YF0,,,,,28.1,734.0,6.599999999999999e-49,197.2,sp|Q80YF0|MD1L1_CRIGR Mitotic spindle assembly checkpoint protein MAD1 OS=Cricetulus griseus OX=10029 GN=MAD1L1 PE=2 SV=1,,,,,,
OG_08779,2.6504328947959084,FUN_038065-T1,Peve_00010941,Pocillopora_meandrina_HIv1___RNAseq.g789.t1,three_way,67.371,FUN_038065-T1,O66515,,,,,27.3,388.0,2.3e-27,125.9,sp|O66515|AMT_AQUAE Ammonium transporter OS=Aquifex aeolicus (strain VF5) OX=224324 GN=amt PE=1 SV=1,,,,,,
OG_08780,1.6799524853366836,FUN_038066-T1,Peve_00010943,Pocillopora_meandrina_HIv1___RNAseq.g788.t1,three_way,58.48233333333334,FUN_038066-T1,O43184,,,,,37.5,637.0,5.4e-120,433.3,sp|O43184|ADA12_HUMAN Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ADAM12 PE=1 SV=3,,,,,,
OG_08782,2.795943335406694,FUN_038068-T1,Peve_00030105,Pocillopora_meandrina_HIv1___RNAseq.g786.t1,three_way,71.34216666666667,FUN_038068-T1,Q5HZH2,TSR3_MOUSE,,18S rRNA aminocarboxypropyltransferase (EC 2.5.1.157) (20S S rRNA accumulation protein 3 homolog),Mus musculus (Mouse),58.3,175.0,4.9e-51,202.2,sp|Q5HZH2|TSR3_MOUSE 18S rRNA aminocarboxypropyltransferase OS=Mus musculus OX=10090 GN=Tsr3 PE=1 SV=1,GO:0000455; GO:0005737; GO:0106388; GO:1904047,enzyme-directed rRNA pseudouridine synthesis [GO:0000455],cytoplasm [GO:0005737],18S rRNA aminocarboxypropyltransferase activity [GO:0106388]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0016740; GO:0140098,"catalytic activity; transferase activity; catalytic activity, acting on RNA"
OG_08783,1.951799091444142,FUN_038072-T1,Peve_00000952,Pocillopora_meandrina_HIv1___TS.g5330.t1,three_way,63.88366666666666,FUN_038072-T1,A2A870,,,,,41.9,74.0,6.3e-06,55.5,sp|A2A870|FBF1_MOUSE Fas-binding factor 1 OS=Mus musculus OX=10090 GN=Fbf1 PE=1 SV=1,,,,,,
OG_08784,1.9975115545120028,FUN_038073-T1,Peve_00000951,Pocillopora_meandrina_HIv1___RNAseq.g800.t1,three_way,73.37466666666667,,,,,,,,,,,,,,,,,
OG_08788,2.3599049117862427,FUN_038080-T1,Peve_00030065,Pocillopora_meandrina_HIv1___RNAseq.g805.t1,three_way,70.712,FUN_038080-T1,A7SLC8,,,,,63.6,176.0,5.8e-59,228.8,sp|A7SLC8|NAT9_NEMVE N-acetyltransferase 9-like protein OS=Nematostella vectensis OX=45351 GN=nat9 PE=3 SV=1,,,,,,
OG_08789,1.3346584116347142,FUN_038081-T1,Peve_00004950,Pocillopora_meandrina_HIv1___RNAseq.g806.t1,three_way,60.84433333333333,FUN_038081-T1,O75689,ADAP1_HUMAN,,Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25),Homo sapiens (Human),42.3,364.0,2.9000000000000004e-80,300.4,sp|O75689|ADAP1_HUMAN Arf-GAP with dual PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ADAP1 PE=1 SV=2,GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0008270; GO:0043087; GO:0043231; GO:0043533; GO:1902936,cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; zinc ion binding [GO:0008270]",GO:0005634; GO:0005829; GO:0005886; GO:0008289; GO:0043226; GO:0098772,nucleus; cytosol; plasma membrane; lipid binding; organelle; molecular function regulator activity
OG_08791,2.214284541040619,FUN_038087-T1,Peve_00036442,Pocillopora_meandrina_HIv1___TS.g5341.t2,three_way,72.54633333333332,,,,,,,,,,,,,,,,,
OG_08792,2.8097249631611927,FUN_038088-T1,Peve_00007106,Pocillopora_meandrina_HIv1___RNAseq.g815.t1,three_way,76.33416666666666,FUN_038088-T1,P54922,ADPRH_HUMAN,,ADP-ribosylhydrolase ARH1 (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase) (ADP-ribosylarginine hydrolase) (hARH1),Homo sapiens (Human),57.1,350.0,2.3e-116,420.2,sp|P54922|ADPRH_HUMAN ADP-ribosylhydrolase ARH1 OS=Homo sapiens OX=9606 GN=ADPRH PE=1 SV=1,GO:0000287; GO:0003875; GO:0005615; GO:0030955; GO:0036211; GO:0051725,protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211],extracellular space [GO:0005615],ADP-ribosylarginine hydrolase activity [GO:0003875]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_08796,1.1064467550655137,FUN_038092-T1,Peve_00007110,Pocillopora_meandrina_HIv1___RNAseq.g820.t1,three_way,74.33033333333333,FUN_038092-T1,Q9FPH3,,,,,49.0,361.0,4.0999999999999997e-91,336.7,sp|Q9FPH3|THA2_ARATH Probable low-specificity L-threonine aldolase 2 OS=Arabidopsis thaliana OX=3702 GN=THA2 PE=1 SV=1,,,,,,
OG_08799,1.5520421323375395,FUN_038101-T2,Peve_00009167,Pocillopora_meandrina_HIv1___RNAseq.g25708.t1,three_way,60.379666666666665,,,,,,,,,,,,,,,,,
OG_08803,2.298169936367818,FUN_038122-T1,Peve_00003003,Pocillopora_meandrina_HIv1___RNAseq.g28329.t1,three_way,90.11766666666666,FUN_038122-T1,Q9H1Z4,,,,,48.8,363.0,1.7e-85,317.8,sp|Q9H1Z4|WDR13_HUMAN WD repeat-containing protein 13 OS=Homo sapiens OX=9606 GN=WDR13 PE=1 SV=3,,,,,,
OG_08805,1.0490619879392296,FUN_038126-T1,Peve_00003032,Pocillopora_meandrina_HIv1___RNAseq.g771.t1,three_way,81.03983333333333,FUN_038126-T1,Q2TBT5,RNH2A_BOVIN,,Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A),Bos taurus (Bovine),52.0,298.0,4e-85,316.2,sp|Q2TBT5|RNH2A_BOVIN Ribonuclease H2 subunit A OS=Bos taurus OX=9913 GN=RNASEH2A PE=1 SV=1,GO:0003723; GO:0004523; GO:0005654; GO:0005829; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872,"DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299],metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523],GO:0003723; GO:0003824; GO:0005654; GO:0005829; GO:0006281; GO:0016787; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; cytosol; DNA repair; hydrolase activity; catalytic activity, acting on RNA"
OG_08806,3.721974089317036,FUN_038127-T1,Peve_00003031,Pocillopora_meandrina_HIv1___RNAseq.g770.t1,three_way,67.37616666666666,FUN_038127-T1,Q9FKY3,,,,,25.2,373.0,1.3999999999999999e-24,115.9,sp|Q9FKY3|AVT3A_ARATH Amino acid transporter AVT3A OS=Arabidopsis thaliana OX=3702 GN=AVT3A PE=1 SV=1,,,,,,
OG_08807,1.2458593088446086,FUN_038128-T1,Peve_00003025,Pocillopora_meandrina_HIv1___RNAseq.g769.t1,three_way,53.877,FUN_038128-T1,Q5M9H0,ANKS3_RAT,,Ankyrin repeat and SAM domain-containing protein 3,Rattus norvegicus (Rat),35.6,132.0,4.1e-11,71.2,sp|Q5M9H0|ANKS3_RAT Ankyrin repeat and SAM domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Anks3 PE=1 SV=1,GO:0005737; GO:0005929,,cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005929; GO:0043226,cilium; organelle
OG_08810,1.7897536028912446,FUN_038133-T1,Peve_00043371,Pocillopora_meandrina_HIv1___TS.g5294.t1,three_way,78.59133333333334,FUN_038133-T1,Q9JL56,GDE1_MOUSE,,Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16),Mus musculus (Mouse),41.8,306.0,4.9000000000000004e-60,233.0,sp|Q9JL56|GDE1_MOUSE Glycerophosphodiester phosphodiesterase 1 OS=Mus musculus OX=10090 GN=Gde1 PE=1 SV=1,GO:0004622; GO:0005886; GO:0006580; GO:0006644; GO:0007186; GO:0008081; GO:0008889; GO:0016020; GO:0030659; GO:0046872; GO:0047395; GO:0070291,ethanolamine metabolic process [GO:0006580]; G protein-coupled receptor signaling pathway [GO:0007186]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644],cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; plasma membrane [GO:0005886],glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol glycerophosphodiesterase activity [GO:0047395]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081],GO:0003824; GO:0005886; GO:0006629; GO:0016787,catalytic activity; plasma membrane; lipid metabolic process; hydrolase activity
OG_08812,1.8748579681619089,FUN_038138-T1,Peve_00043375,Pocillopora_meandrina_HIv1___RNAseq.g762.t1,three_way,72.461,FUN_038138-T1,Q1T7B9,,,,,31.4,159.0,1.1e-19,98.2,sp|Q1T7B9|CENPM_CHICK Centromere protein M OS=Gallus gallus OX=9031 GN=CENPM PE=1 SV=1,,,,,,
OG_08813,2.9296120634076668,FUN_038139-T1,Peve_00043370,Pocillopora_meandrina_HIv1___RNAseq.g761.t1,three_way,73.74383333333333,FUN_038139-T1,Q12767,,,,,33.1,1424.0,3.2e-177,624.4,sp|Q12767|TMM94_HUMAN Transmembrane protein 94 OS=Homo sapiens OX=9606 GN=TMEM94 PE=1 SV=1,,,,,,
OG_08817,2.416002520814841,FUN_038145-T1,Peve_00026423,Pocillopora_meandrina_HIv1___RNAseq.g753.t1,three_way,57.66566666666667,FUN_038145-T1,Q4V9P9,,,,,22.8,762.0,2.6999999999999997e-31,138.7,sp|Q4V9P9|NOL11_DANRE Nucleolar protein 11-like OS=Danio rerio OX=7955 GN=nol11 PE=2 SV=1,,,,,,
OG_08818,1.933631844306721,FUN_038146-T1,Peve_00026422,Pocillopora_meandrina_HIv1___RNAseq.g752.t1,three_way,48.41766666666667,,,,,,,,,,,,,,,,,
OG_08819,1.5568606616809693,FUN_038147-T2,Peve_00044177,Pocillopora_meandrina_HIv1___RNAseq.g1065.t1,three_way,70.619,,,,,,,,,,,,,,,,,
OG_08820,1.5313692928481069,FUN_038148-T1,Peve_00044178,Pocillopora_meandrina_HIv1___RNAseq.g1064.t1,three_way,76.99816666666666,FUN_038148-T1,O70157,,,,,53.0,1054.0,0.0,1084.3,sp|O70157|TOP3A_MOUSE DNA topoisomerase 3-alpha OS=Mus musculus OX=10090 GN=Top3a PE=2 SV=1,,,,,,
OG_08825,1.5532638589194323,FUN_038162-T1,Peve_00038319,Pocillopora_meandrina_HIv1___RNAseq.g1076.t1,three_way,58.09933333333333,,,,,,,,,,,,,,,,,
OG_08828,3.4942131760022423,FUN_038165-T1,Peve_00025795,Pocillopora_meandrina_HIv1___RNAseq.g1068.t1,three_way,82.789,FUN_038165-T1,P04047,,,,,61.3,173.0,8.000000000000002e-57,221.5,"sp|P04047|KITH_CHICK Thymidine kinase, cytosolic OS=Gallus gallus OX=9031 GN=TK1 PE=1 SV=1",,,,,,
OG_08829,1.0337935523392243,FUN_038166-T1,Peve_00025794,Pocillopora_meandrina_HIv1___RNAseq.g1069.t1,three_way,75.97183333333332,FUN_038166-T1,P85037,FOXK1_HUMAN,,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),Homo sapiens (Human),48.9,499.0,9.7e-110,399.1,sp|P85037|FOXK1_HUMAN Forkhead box protein K1 OS=Homo sapiens OX=9606 GN=FOXK1 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007517; GO:0010507; GO:0010906; GO:0030154; GO:0042594; GO:0045892; GO:0045893; GO:0061621; GO:0071889; GO:1990837,canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; intracellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005975; GO:0006091; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0140110; GO:1901135,DNA binding; nucleus; nucleoplasm; carbohydrate metabolic process; generation of precursor metabolites and energy; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; transcription regulator activity; carbohydrate derivative metabolic process
OG_08830,2.4174082750607906,FUN_038167-T1,Peve_00025790,Pocillopora_meandrina_HIv1___RNAseq.g1070.t1,three_way,91.073,FUN_038167-T1,P23098,,,,,73.8,4465.0,0.0,6623.9,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_08831,3.0588668481912213,FUN_038168-T1,Peve_00025789,Pocillopora_meandrina_HIv1___RNAseq.g1071.t1,three_way,77.63566666666667,,,,,,,,,,,,,,,,,
OG_08832,1.0706018447364645,FUN_038170-T1,Peve_00025787,Pocillopora_meandrina_HIv1___RNAseq.g1073.t1,three_way,75.25566666666666,FUN_038170-T1,Q71RS6,NCKX5_HUMAN,,Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5),Homo sapiens (Human),38.0,440.0,2.3e-83,312.0,sp|Q71RS6|NCKX5_HUMAN Sodium/potassium/calcium exchanger 5 OS=Homo sapiens OX=9606 GN=SLC24A5 PE=1 SV=1,GO:0005262; GO:0005802; GO:0006811; GO:0006874; GO:0008273; GO:0015293; GO:0032588; GO:0034220; GO:0042438; GO:0042470; GO:0048022; GO:0070509; GO:0070588,calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; melanin biosynthetic process [GO:0042438]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of melanin biosynthetic process [GO:0048022],melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]",GO:0005215; GO:0031410; GO:0043226; GO:0055085,transporter activity; cytoplasmic vesicle; organelle; transmembrane transport
OG_08833,1.0309659193614469,FUN_038171-T1,Peve_00025782,Pocillopora_meandrina_HIv1___RNAseq.g1075.t1,three_way,73.20766666666667,FUN_038171-T1,Q3U829,AP5Z1_MOUSE,,AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit) (Zeta5),Mus musculus (Mouse),37.1,528.0,6.7e-83,310.5,sp|Q3U829|AP5Z1_MOUSE AP-5 complex subunit zeta-1 OS=Mus musculus OX=10090 GN=Ap5z1 PE=2 SV=1,GO:0000045; GO:0000724; GO:0005634; GO:0005737; GO:0005764; GO:0005770; GO:0006886; GO:0006914; GO:0007030; GO:0007040; GO:0010467; GO:0016192; GO:0016197; GO:0016607; GO:0034499; GO:0044599; GO:0061564; GO:1905146,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon development [GO:0061564]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; gene expression [GO:0010467]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; late endosome to Golgi transport [GO:0034499]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; vesicle-mediated transport [GO:0016192],AP-5 adaptor complex [GO:0044599]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; lysosome [GO:0005764]; nuclear speck [GO:0016607]; nucleus [GO:0005634],,GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0006281; GO:0006310; GO:0006886; GO:0006914; GO:0007040; GO:0016192; GO:0030163; GO:0031410; GO:0043226,nucleus; lysosome; endosome; vacuole; DNA repair; DNA recombination; intracellular protein transport; autophagy; lysosome organization; vesicle-mediated transport; protein catabolic process; cytoplasmic vesicle; organelle
OG_08834,1.2583706449570176,FUN_038174-T1,Peve_00010077,Pocillopora_meandrina_HIv1___RNAseq.g1157.t1,three_way,76.404,FUN_038174-T1,C3YWU0,FUCO_BRAFL,,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),Branchiostoma floridae (Florida lancelet) (Amphioxus),67.4,448.0,4.8e-191,668.7,sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2,GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139,fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],extracellular region [GO:0005576]; lysosome [GO:0005764],alpha-L-fucosidase activity [GO:0004560],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0005975; GO:0016787; GO:0043226; GO:1901135,catalytic activity; extracellular region; lysosome; vacuole; carbohydrate metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_08835,3.5933598410549537,FUN_038179-T1,Peve_00009439,Pocillopora_meandrina_HIv1___RNAseq.g965.t1,three_way,67.80166666666668,FUN_038179-T1,Q9Y4F3,,,,,28.7,1454.0,1.1e-132,476.9,sp|Q9Y4F3|MARF1_HUMAN Meiosis regulator and mRNA stability factor 1 OS=Homo sapiens OX=9606 GN=MARF1 PE=1 SV=6,,,,,,
OG_08838,1.1835504372606285,FUN_038182-T2,Peve_00009437,Pocillopora_meandrina_HIv1___TS.g5485.t1,three_way,80.94600000000001,FUN_038182-T2,O14981,,,,,52.2,1928.0,0.0,1865.1,sp|O14981|BTAF1_HUMAN TATA-binding protein-associated factor 172 OS=Homo sapiens OX=9606 GN=BTAF1 PE=1 SV=2,,,,,,
OG_08841,1.3095746935793606,FUN_038186-T1,Peve_00006346,Pocillopora_meandrina_HIv1___RNAseq.g946.t1,three_way,45.531666666666666,,,,,,,,,,,,,,,,,
OG_08843,1.323087949362524,FUN_038188-T1,Peve_00003232,Pocillopora_meandrina_HIv1___RNAseq.g28758.t2,three_way,72.086,FUN_038188-T1,Q94AM1,,,,,47.9,666.0,7.099999999999997e-175,615.5,"sp|Q94AM1|OOPDA_ARATH Organellar oligopeptidase A, chloroplastic/mitochondrial OS=Arabidopsis thaliana OX=3702 GN=OOP PE=1 SV=1",,,,,,
OG_08849,1.3212578903829877,FUN_038210-T1,Peve_00038842,Pocillopora_meandrina_HIv1___TS.g5429.t1,three_way,51.66433333333333,FUN_038210-T1,Q7TN88,,,,,27.8,967.0,4.1e-93,344.7,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08851,1.6212453458756215,FUN_038214-T1,Peve_00038839,Pocillopora_meandrina_HIv1___RNAseq.g898.t1,three_way,50.641666666666666,,,,,,,,,,,,,,,,,
OG_08852,3.2083783581230527,FUN_038217-T1,Peve_00038841,Pocillopora_meandrina_HIv1___RNAseq.g901.t2,three_way,66.15016666666666,FUN_038217-T1,Q9UKN7,,,,,32.5,2688.0,0.0,1096.6,sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2,,,,,,
OG_08856,3.522716435387166,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_08857,1.1402493321797649,FUN_038243-T1,Peve_00029667,Pocillopora_meandrina_HIv1___TS.g5440.t1,three_way,80.75166666666667,FUN_038243-T1,P12389,ACHA2_RAT,,Neuronal acetylcholine receptor subunit alpha-2,Rattus norvegicus (Rat),36.7,436.0,2.8999999999999996e-68,260.8,sp|P12389|ACHA2_RAT Neuronal acetylcholine receptor subunit alpha-2 OS=Rattus norvegicus OX=10116 GN=Chrna2 PE=1 SV=2,GO:0005654; GO:0005886; GO:0005892; GO:0007165; GO:0007271; GO:0007274; GO:0015464; GO:0022848; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0043005; GO:0045171; GO:0045202; GO:0045211; GO:0050997; GO:0051899; GO:0071316; GO:0071944; GO:0095500; GO:0098828; GO:0098878; GO:0120111; GO:1901363; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; cellular response to nicotine [GO:0071316]; membrane depolarization [GO:0051899]; modulation of inhibitory postsynaptic potential [GO:0098828]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cell periphery [GO:0071944]; intercellular bridge [GO:0045171]; neuron projection [GO:0043005]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synapse [GO:0045202],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; nucleoplasm; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_08859,3.088820694662428,FUN_038245-T1,Peve_00007985,Pocillopora_meandrina_HIv1___TS.g5460.t2,three_way,84.75483333333334,FUN_038245-T1,P24733,,,,,61.2,841.0,5e-306,1052.7,"sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",,,,,,
OG_08860,1.2599594509430787,FUN_038246-T1,Peve_00007987,Pocillopora_meandrina_HIv1___RNAseq.g924.t1,three_way,77.44533333333334,FUN_038246-T1,Q9UBH6,S53A1_HUMAN,,Solute carrier family 53 member 1 (Phosphate exporter SLC53A1) (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor) (Xenotropic and polytropic retrovirus receptor 1),Homo sapiens (Human),44.3,395.0,5.400000000000001e-89,329.7,sp|Q9UBH6|S53A1_HUMAN Solute carrier family 53 member 1 OS=Homo sapiens OX=9606 GN=XPR1 PE=1 SV=1,GO:0000822; GO:0001618; GO:0005315; GO:0005886; GO:0006817; GO:0009615; GO:0015562; GO:0016036; GO:0030643; GO:0035435,cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615],plasma membrane [GO:0005886],efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate transmembrane transporter activity [GO:0005315]; virus receptor activity [GO:0001618],GO:0001618; GO:0005215; GO:0005886; GO:0055085,virus receptor activity; transporter activity; plasma membrane; transmembrane transport
OG_08861,1.0238808155930073,FUN_038247-T1,Peve_00007988,Pocillopora_meandrina_HIv1___RNAseq.g923.t1,three_way,78.74566666666666,FUN_038247-T1,P15170,ERF3A_HUMAN,,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (EC 3.6.5.-) (G1 to S phase transition protein 1 homolog),Homo sapiens (Human),71.9,427.0,3.8e-190,666.0,sp|P15170|ERF3A_HUMAN Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens OX=9606 GN=GSPT1 PE=1 SV=1,GO:0000082; GO:0000184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006412; GO:0006415; GO:0006449; GO:0006479; GO:0018444; GO:0022626,"G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; translation release factor complex [GO:0018444],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0005840; GO:0016071; GO:0016787; GO:0043226,RNA binding; catalytic activity; GTPase activity; cytosol; ribosome; mRNA metabolic process; hydrolase activity; organelle
OG_08862,1.7357495822036386,FUN_038252-T1,Peve_00007989,Pocillopora_meandrina_HIv1___RNAseq.g922.t1,three_way,87.688,FUN_038252-T1,Q5ZHN3,,,,,65.4,442.0,1.1e-157,557.8,sp|Q5ZHN3|WIPI2_CHICK WD repeat domain phosphoinositide-interacting protein 2 OS=Gallus gallus OX=9031 GN=WIPI2 PE=2 SV=1,,,,,,
OG_08863,1.5749600313802288,FUN_038255-T1,Peve_00007991,Pocillopora_meandrina_HIv1___RNAseq.g920.t1,three_way,62.71116666666666,FUN_038255-T1,Q91ZW6,TMLH_RAT,,"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)",Rattus norvegicus (Rat),39.7,358.0,4.9e-73,276.6,"sp|Q91ZW6|TMLH_RAT Trimethyllysine dioxygenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Tmlhe PE=1 SV=2",GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0045329; GO:0050353,carnitine biosynthetic process [GO:0045329],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]",GO:0003824; GO:0005739; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_08866,1.4882483653276946,FUN_038258-T1,Peve_00007994,Pocillopora_meandrina_HIv1___RNAseq.g917.t1,three_way,77.65366666666667,FUN_038258-T1,P51798,CLCN7_HUMAN,,H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7),Homo sapiens (Human),54.4,803.0,4.5999999999999997e-237,822.4,sp|P51798|CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens OX=9606 GN=CLCN7 PE=1 SV=2,GO:0005254; GO:0005524; GO:0005765; GO:0009268; GO:0015108; GO:0016020; GO:0030321; GO:0034707; GO:0043231; GO:0062158,response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321],chloride channel complex [GO:0034707]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; chloride:proton antiporter activity [GO:0062158],GO:0005215; GO:0043226,transporter activity; organelle
OG_08870,1.1574303664337855,FUN_038266-T1,Peve_00007998,Pocillopora_meandrina_HIv1___RNAseq.g913.t1,three_way,78.818,FUN_038266-T1,Q15546,,,,,42.0,224.0,7.7e-44,178.7,sp|Q15546|PAQRB_HUMAN Monocyte to macrophage differentiation factor OS=Homo sapiens OX=9606 GN=MMD PE=1 SV=2,,,,,,
OG_08871,2.875886558142682,FUN_038268-T1,Peve_00008000,Pocillopora_meandrina_HIv1___TS.g5412.t1,three_way,67.79916666666666,FUN_038268-T1,Q8N5R6,,,,,28.3,782.0,1.1e-70,270.0,sp|Q8N5R6|CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens OX=9606 GN=CCDC33 PE=1 SV=3,,,,,,
OG_08873,2.771983471576557,FUN_038270-T1,Peve_00007980,Pocillopora_meandrina_HIv1___TS.g21499.t1,three_way,66.01583333333333,FUN_038270-T1,Q8NCG7,DGLB_HUMAN,,Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta),Homo sapiens (Human),36.5,698.0,2.7e-105,384.4,sp|Q8NCG7|DGLB_HUMAN Diacylglycerol lipase-beta OS=Homo sapiens OX=9606 GN=DAGLB PE=1 SV=2,GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0006640; GO:0007405; GO:0010898; GO:0016298; GO:0019369; GO:0022008; GO:0046340; GO:0046872; GO:0047372; GO:0050727; GO:1901696,arachidonate metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727],lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lipase activity [GO:0016298]; metal ion binding [GO:0046872]; monoacylglycerol lipase activity [GO:0047372]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005654; GO:0005886; GO:0006629; GO:0016787; GO:0030154,catalytic activity; nucleoplasm; plasma membrane; lipid metabolic process; hydrolase activity; cell differentiation
OG_08876,1.0891097038145867,FUN_038275-T1,Peve_00041698,Pocillopora_meandrina_HIv1___RNAseq.g28318.t1,three_way,51.19616666666667,,,,,,,,,,,,,,,,,
OG_08881,1.0707570418181227,FUN_038282-T1,Peve_00041717,Pocillopora_meandrina_HIv1___RNAseq.g28312.t1,three_way,62.675,,,,,,,,,,,,,,,,,
OG_08884,2.683365890807302,FUN_038286-T1,Peve_00041723,Pocillopora_meandrina_HIv1___RNAseq.g28308.t1,three_way,69.07466666666667,FUN_038286-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),52.2,69.0,7.9e-14,81.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_08886,1.4166451220613785,FUN_038292-T1,Peve_00041726,Pocillopora_meandrina_HIv1___RNAseq.g28306.t1,three_way,85.80533333333334,FUN_038292-T1,P94598,,,,,64.2,438.0,3.3e-168,592.8,sp|P94598|DHE3_BACTN Glutamate dehydrogenase OS=Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50) OX=226186 GN=gdhA PE=3 SV=2,,,,,,
OG_08890,1.403238345114983,FUN_038296-T1,Peve_00041733,Pocillopora_meandrina_HIv1___RNAseq.g28298.t1,three_way,74.72033333333333,FUN_038296-T1,Q15750,,,,,44.6,424.0,8.1e-89,329.3,sp|Q15750|TAB1_HUMAN TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 OS=Homo sapiens OX=9606 GN=TAB1 PE=1 SV=1,,,,,,
OG_08891,1.034280697483254,FUN_038298-T1,Peve_00041737,Pocillopora_meandrina_HIv1___RNAseq.g28296.t1,three_way,96.35433333333332,FUN_038298-T1,Q6P8E9,,,,,85.9,128.0,2.2e-56,219.5,sp|Q6P8E9|NH2L1_XENTR NHP2-like protein 1 OS=Xenopus tropicalis OX=8364 GN=snu13 PE=2 SV=1,,,,,,
OG_08892,2.2967780993727125,FUN_038299-T1,Peve_00041738,Pocillopora_meandrina_HIv1___RNAseq.g28301.t1,three_way,89.779,FUN_038299-T1,Q9UPM9,,,,,72.0,182.0,2.4e-79,296.6,sp|Q9UPM9|B9D1_HUMAN B9 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=B9D1 PE=1 SV=1,,,,,,
OG_08893,1.077138125259547,FUN_038300-T1,Peve_00041739,Pocillopora_meandrina_HIv1___RNAseq.g28302.t1,three_way,86.363,FUN_038300-T1,E9PY46,IF140_MOUSE,,Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2),Mus musculus (Mouse),53.5,1487.0,0.0,1540.0,sp|E9PY46|IF140_MOUSE Intraflagellar transport protein 140 homolog OS=Mus musculus OX=10090 GN=Ift140 PE=1 SV=1,GO:0005654; GO:0005739; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:0120199; GO:1902017; GO:1905515; GO:1990403,cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589],axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cone photoreceptor outer segment [GO:0120199]; intraciliary transport particle A [GO:0030991]; mitochondrion [GO:0005739]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391],,GO:0005654; GO:0005739; GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,nucleoplasm; mitochondrion; microtubule organizing center; cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_08894,2.2488956066579613,FUN_038301-T1,Peve_00000032,Pocillopora_meandrina_HIv1___TS.g8084.t1,three_way,46.3595,FUN_038301-T1,Q1RLU1,BRAT1_DANRE,,Integrator complex assembly factor BRAT1 (BRCA1-associated ATM activator 1) (BRCA1-associated protein required for ATM activation protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),24.8,404.0,4.7e-23,111.7,sp|Q1RLU1|BRAT1_DANRE Integrator complex assembly factor BRAT1 OS=Danio rerio OX=7955 GN=brat1 PE=2 SV=1,GO:0001934; GO:0005634; GO:0005737; GO:0006974; GO:0008283; GO:0008428; GO:0010212; GO:0034504; GO:0160234,cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; integrator complex assembly [GO:0160234]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to nucleus [GO:0034504]; response to ionizing radiation [GO:0010212],cytoplasm [GO:0005737]; nucleus [GO:0005634],ribonuclease inhibitor activity [GO:0008428],GO:0005634; GO:0043226; GO:0065003; GO:0098772,nucleus; organelle; protein-containing complex assembly; molecular function regulator activity
OG_08899,2.226092789752436,FUN_038313-T1,Peve_00012900,Pocillopora_meandrina_HIv1___RNAseq.g1140.t1,three_way,82.80183333333333,FUN_038313-T1,P51892,,,,,59.5,797.0,1.5e-269,930.6,sp|P51892|DNLI1_XENLA DNA ligase 1 OS=Xenopus laevis OX=8355 GN=lig1 PE=2 SV=1,,,,,,
OG_08901,1.379733776717892,FUN_038315-T1,Peve_00035853,Pocillopora_meandrina_HIv1___RNAseq.g1120.t1,three_way,66.31266666666666,FUN_038315-T1,Q8NDV7,,,,,34.4,224.0,3.4e-17,93.2,sp|Q8NDV7|TNR6A_HUMAN Trinucleotide repeat-containing gene 6A protein OS=Homo sapiens OX=9606 GN=TNRC6A PE=1 SV=2,,,,,,
OG_08904,1.3876858865406314,FUN_038333-T1,Peve_00023105,Pocillopora_meandrina_HIv1___RNAseq.g1117.t1,three_way,47.60166666666667,FUN_038333-T1,Q1JPJ9,,,,,41.1,202.0,1.7999999999999998e-35,151.8,sp|Q1JPJ9|EF2KT_BOVIN Protein-lysine N-methyltransferase EEF2KMT OS=Bos taurus OX=9913 GN=EEF2KMT PE=2 SV=2,,,,,,
OG_08907,3.447392045539695,FUN_038338-T1,Peve_00000098,Pocillopora_meandrina_HIv1___RNAseq.g1110.t1,three_way,67.40100000000001,,,,,,,,,,,,,,,,,
OG_08910,3.1306450860131942,FUN_038344-T1,Peve_00030150,Pocillopora_meandrina_HIv1___TS.g5636.t1,three_way,69.94033333333333,,,,,,,,,,,,,,,,,
OG_08915,1.7648508655638813,FUN_038370-T1,Peve_00000083,Pocillopora_meandrina_HIv1___RNAseq.g1095.t1,three_way,58.55733333333333,,,,,,,,,,,,,,,,,
OG_08916,1.951114181999537,FUN_038372-T1,Peve_00000082,Pocillopora_meandrina_HIv1___TS.g5627.t2,three_way,66.95883333333333,FUN_038372-T1,Q8VCY6,,,,,37.0,332.0,1.1e-48,195.3,sp|Q8VCY6|UTP6_MOUSE U3 small nucleolar RNA-associated protein 6 homolog OS=Mus musculus OX=10090 GN=Utp6 PE=2 SV=1,,,,,,
OG_08918,1.935414114576616,FUN_038374-T1,Peve_00000080,Pocillopora_meandrina_HIv1___RNAseq.g1093.t1,three_way,64.227,FUN_038374-T1,Q9YHV3,,,,,38.1,176.0,5.8999999999999994e-31,136.0,sp|Q9YHV3|NOGG3_DANRE Noggin-3 OS=Danio rerio OX=7955 GN=nog3 PE=1 SV=1,,,,,,
OG_08922,1.7785268445140936,FUN_038378-T1,Peve_00000075,Pocillopora_meandrina_HIv1___TS.g5619.t2,three_way,74.34866666666667,FUN_038378-T1,Q08170,SRSF4_HUMAN,,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",Homo sapiens (Human),55.8,190.0,7.6e-51,202.2,sp|Q08170|SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_08925,3.577573218322532,FUN_038382-T1,Peve_00000067,Pocillopora_meandrina_HIv1___RNAseq.g28293.t1,three_way,74.66466666666666,FUN_038382-T1,O09118,NET1_MOUSE,,Netrin-1,Mus musculus (Mouse),49.0,571.0,1.2000000000000005e-167,591.3,sp|O09118|NET1_MOUSE Netrin-1 OS=Mus musculus OX=10090 GN=Ntn1 PE=1 SV=3,GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0007409; GO:0007411; GO:0008283; GO:0014009; GO:0015629; GO:0030334; GO:0030517; GO:0030879; GO:0032488; GO:0033564; GO:0042472; GO:0045202; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0062023; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147,"anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]",actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; synapse [GO:0045202],,GO:0005576; GO:0005654; GO:0005829; GO:0005856; GO:0007155; GO:0012501; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870,extracellular region; nucleoplasm; cytosol; cytoskeleton; cell adhesion; programmed cell death; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility
OG_08927,1.5196261981045849,FUN_038385-T1,Peve_00000064,Pocillopora_meandrina_HIv1___RNAseq.g28289.t1,three_way,68.722,FUN_038385-T1,Q7JQ32,GC76C_DROME,,Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1),Drosophila melanogaster (Fruit fly),39.3,1091.0,6.199999999999997e-206,719.9,sp|Q7JQ32|GC76C_DROME Receptor-type guanylate cyclase Gyc76C OS=Drosophila melanogaster OX=7227 GN=Gyc76C PE=1 SV=1,GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0030198; GO:0030215; GO:0030510; GO:0035556; GO:0038023; GO:0046872; GO:0050830,"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]",plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023],GO:0003824; GO:0005886; GO:0009975; GO:0016829; GO:0030198; GO:0048856; GO:0055086; GO:0060089; GO:1901135,catalytic activity; plasma membrane; cyclase activity; lyase activity; extracellular matrix organization; anatomical structure development; nucleobase-containing small molecule metabolic process; molecular transducer activity; carbohydrate derivative metabolic process
OG_08930,4.665497689920357,FUN_038392-T1,Peve_00000048,Pocillopora_meandrina_HIv1___RNAseq.g28264.t1,three_way,76.04899999999999,FUN_038392-T1,P16065,,,,,36.6,998.0,4.3999999999999996e-160,567.0,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08931,1.8347276026644683,FUN_038393-T1,Peve_00000047,Pocillopora_meandrina_HIv1___RNAseq.g28265.t1,three_way,73.06066666666668,FUN_038393-T1,P22570,ADRO_HUMAN,,"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase) (EC 1.18.1.-)",Homo sapiens (Human),57.3,464.0,8.3e-144,511.9,"sp|P22570|ADRO_HUMAN NADPH:adrenodoxin oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=FDXR PE=1 SV=3",GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006744; GO:0008203,cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ferredoxin-NADP+ reductase activity [GO:0004324],GO:0003824; GO:0005739; GO:0006091; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; oxidoreductase activity; organelle
OG_08932,3.1716310594812014,FUN_038394-T1,Peve_00000046,Pocillopora_meandrina_HIv1___RNAseq.g28266.t1,three_way,82.16016666666667,FUN_038394-T1,Q9HCN4,,,,,64.7,317.0,5.600000000000002e-111,402.5,sp|Q9HCN4|GPN1_HUMAN GPN-loop GTPase 1 OS=Homo sapiens OX=9606 GN=GPN1 PE=1 SV=1,,,,,,
OG_08933,1.2327249966779017,FUN_038395-T1,Peve_00000045,Pocillopora_meandrina_HIv1___RNAseq.g28267.t1,three_way,81.313,FUN_038395-T1,Q96DY2,,,,,34.0,429.0,5e-53,210.3,sp|Q96DY2|DRC10_HUMAN Dynein regulatory complex protein 10 OS=Homo sapiens OX=9606 GN=IQCD PE=1 SV=2,,,,,,
OG_08934,2.32675688341072,FUN_038396-T1,Peve_00000044,Pocillopora_meandrina_HIv1___RNAseq.g28268.t1,three_way,67.62233333333333,FUN_038396-T1,P52189,KCNJ4_MOUSE,,"Inward rectifier potassium channel 4 (Inward rectifier K(+) channel Kir2.3) (IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4)",Mus musculus (Mouse),44.0,357.0,2.8999999999999997e-75,283.9,sp|P52189|KCNJ4_MOUSE Inward rectifier potassium channel 4 OS=Mus musculus OX=10090 GN=Kcnj4 PE=1 SV=1,GO:0005242; GO:0030659; GO:0034702; GO:0045211; GO:0098978,,cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211],inward rectifier potassium channel activity [GO:0005242],GO:0005215,transporter activity
OG_08935,2.544416832009022,FUN_038398-T1,Peve_00000041,Pocillopora_meandrina_HIv1___RNAseq.g28273.t1,three_way,71.20833333333333,FUN_038398-T1,Q4TZY1,KCJ12_BOVIN,,"ATP-sensitive inward rectifier potassium channel 12 (Potassium channel, inwardly rectifying subfamily J member 12)",Bos taurus (Bovine),44.9,381.0,2.6e-85,317.4,sp|Q4TZY1|KCJ12_BOVIN ATP-sensitive inward rectifier potassium channel 12 OS=Bos taurus OX=9913 GN=KCNJ12 PE=2 SV=1,GO:0005242; GO:0005886; GO:0006813; GO:0016020; GO:0034702; GO:0034765; GO:0046872; GO:0051289; GO:1990573,potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of monoatomic ion transmembrane transport [GO:0034765],membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],inward rectifier potassium channel activity [GO:0005242]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_08936,2.496716613316777,FUN_038400-T1,Peve_00000036,Pocillopora_meandrina_HIv1___RNAseq.g28274.t1,three_way,75.47866666666667,FUN_038400-T1,Q6P5D8,SMHD1_MOUSE,,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-),Mus musculus (Mouse),23.5,2075.0,6.200000000000001e-86,321.6,sp|Q6P5D8|SMHD1_MOUSE Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Mus musculus OX=10090 GN=Smchd1 PE=1 SV=2,GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0016604; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060818; GO:2000042; GO:2001034,chromosome organization [GO:0051276]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],"Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006325; GO:0016787; GO:0043226; GO:0048856,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; chromatin organization; hydrolase activity; organelle; anatomical structure development
OG_08938,1.4051023178719937,FUN_038403-T1,Peve_00000025,Pocillopora_meandrina_HIv1___RNAseq.g28277.t1,three_way,85.76366666666667,FUN_038403-T1,A3KPA3,NAA60_DANRE,,N-alpha-acetyltransferase 60 (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF),Danio rerio (Zebrafish) (Brachydanio rerio),59.1,186.0,6.999999999999999e-62,238.4,sp|A3KPA3|NAA60_DANRE N-alpha-acetyltransferase 60 OS=Danio rerio OX=7955 GN=naa60 PE=2 SV=1,GO:0000139; GO:0004402; GO:0004596; GO:0006334; GO:0006474; GO:0007059; GO:0008283; GO:0010485; GO:0017196; GO:0042803; GO:0120518,cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334],Golgi membrane [GO:0000139],histone acetyltransferase activity [GO:0004402]; histone H4 acetyltransferase activity [GO:0010485]; protein homodimerization activity [GO:0042803]; protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596],GO:0003824; GO:0006325; GO:0007059; GO:0016740; GO:0051604; GO:0065003; GO:0140096,"catalytic activity; chromatin organization; chromosome segregation; transferase activity; protein maturation; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_08939,3.274750540008212,FUN_038404-T1,Peve_00000024,Pocillopora_meandrina_HIv1___RNAseq.g28278.t1,three_way,76.78699999999999,FUN_038404-T1,P9WM78,,,,,42.5,365.0,1e-80,302.0,sp|P9WM78|Y0574_MYCTO Probable polyglutamine synthesis accessory protein MT0602 OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=MT0602 PE=2 SV=1,,,,,,
OG_08940,1.8082343285292604,FUN_038405-T1,Peve_00000017,Pocillopora_meandrina_HIv1___RNAseq.g28279.t1,three_way,71.28666666666668,FUN_038405-T1,Q6PHN1,,,,,25.6,1091.0,7.9000000000000025e-59,230.7,sp|Q6PHN1|CCD57_MOUSE Coiled-coil domain-containing protein 57 OS=Mus musculus OX=10090 GN=Ccdc57 PE=1 SV=1,,,,,,
OG_08943,1.9364493659694024,FUN_038416-T1,Peve_00000009,Pocillopora_meandrina_HIv1___RNAseq.g1188.t1,three_way,76.13,FUN_038416-T1,Q8L7C9,,,,,33.3,216.0,4.1e-29,129.8,sp|Q8L7C9|GSTUK_ARATH Glutathione S-transferase U20 OS=Arabidopsis thaliana OX=3702 GN=GSTU20 PE=1 SV=1,,,,,,
OG_08947,3.522847975980965,FUN_038420-T1,Peve_00000003,Pocillopora_meandrina_HIv1___RNAseq.g1183.t1,three_way,75.96466666666667,FUN_038420-T1,P49005,DPOD2_HUMAN,,DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50),Homo sapiens (Human),55.6,457.0,3.6e-136,486.5,sp|P49005|DPOD2_HUMAN DNA polymerase delta subunit 2 OS=Homo sapiens OX=9606 GN=POLD2 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006261; GO:0006271; GO:0016035; GO:0042276; GO:0043625; GO:0071897,DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276],delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA replication; DNA repair; organelle
OG_08948,1.1727721875400958,FUN_038421-T1,Peve_00000002,Pocillopora_meandrina_HIv1___RNAseq.g1182.t1,three_way,53.663,FUN_038421-T1,Q29RP1,UBP1_BOVIN,,"Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) [Cleaved into: Ubiquitin carboxyl-terminal hydrolase 1, N-terminal fragment]",Bos taurus (Bovine),32.2,423.0,4.6e-41,171.0,sp|Q29RP1|UBP1_BOVIN Ubiquitin carboxyl-terminal hydrolase 1 OS=Bos taurus OX=9913 GN=USP1 PE=2 SV=1,GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006281; GO:0006282; GO:0006508; GO:0009411; GO:0016579; GO:0031647; GO:0035520,DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of DNA repair [GO:0006282]; regulation of protein stability [GO:0031647]; response to UV [GO:0009411],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; DNA repair; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08950,2.42222475882569,FUN_038423-T2,Peve_00000121,Pocillopora_meandrina_HIv1___RNAseq.g1180.t1,three_way,68.95383333333334,FUN_038423-T2,B2RS91,RRN3_MOUSE,,RNA polymerase I-specific transcription initiation factor RRN3,Mus musculus (Mouse),41.0,575.0,1.8e-113,411.4,sp|B2RS91|RRN3_MOUSE RNA polymerase I-specific transcription initiation factor RRN3 OS=Mus musculus OX=10090 GN=Rrn3 PE=1 SV=1,GO:0001164; GO:0001181; GO:0001701; GO:0005730; GO:0006352; GO:0006361; GO:0007000; GO:0007028; GO:0010976; GO:0042254; GO:0045893; GO:0048144; GO:0048872; GO:0070063; GO:0072332; GO:1902254; GO:2000142,cytoplasm organization [GO:0007028]; DNA-templated transcription initiation [GO:0006352]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection development [GO:0010976]; regulation of DNA-templated transcription initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation at RNA polymerase I promoter [GO:0006361],nucleolus [GO:0005730],RNA polymerase binding [GO:0070063]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181],GO:0003677; GO:0005730; GO:0006355; GO:0042254; GO:0043226; GO:0048856; GO:0140223,DNA binding; nucleolus; regulation of DNA-templated transcription; ribosome biogenesis; organelle; anatomical structure development; general transcription initiation factor activity
OG_08953,1.5054723840896107,FUN_038427-T1,Peve_00000113,Pocillopora_meandrina_HIv1___RNAseq.g1177.t1,three_way,70.89833333333333,FUN_038427-T1,Q86XK2,FBX11_HUMAN,,F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1),Homo sapiens (Human),41.5,82.0,9.1e-08,59.3,sp|Q86XK2|FBX11_HUMAN F-box only protein 11 OS=Homo sapiens OX=9606 GN=FBXO11 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0036211; GO:0042981; GO:0043161; GO:1990756,negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0050877; GO:0060090; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; transferase activity; protein catabolic process; organelle; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_08955,1.0809086518718705,FUN_038430-T1,Peve_00000108,Pocillopora_meandrina_HIv1___RNAseq.g1061.t1,three_way,76.83583333333334,FUN_038430-T1,Q6P4S8,INT1_MOUSE,,Integrator complex subunit 1 (Int1),Mus musculus (Mouse),39.8,2366.0,0.0,1481.8,sp|Q6P4S8|INT1_MOUSE Integrator complex subunit 1 OS=Mus musculus OX=10090 GN=Ints1 PE=1 SV=2,GO:0001832; GO:0001833; GO:0005634; GO:0007566; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0160232; GO:0160240,blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; RNA polymerase II transcription initiation surveillance [GO:0160240]; U2 snRNA 3'-end processing [GO:0034474],INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634],,GO:0005634; GO:0016073; GO:0022414; GO:0043226,nucleus; snRNA metabolic process; reproductive process; organelle
OG_08956,2.4354816783116497,FUN_038431-T1,Peve_00000107,Pocillopora_meandrina_HIv1___RNAseq.g1060.t1,three_way,80.83533333333334,FUN_038431-T1,Q8IX18,,,,,54.5,730.0,2.7000000000000003e-223,776.5,sp|Q8IX18|DHX40_HUMAN Probable ATP-dependent RNA helicase DHX40 OS=Homo sapiens OX=9606 GN=DHX40 PE=1 SV=2,,,,,,
OG_08958,1.793066804139837,FUN_038436-T1,Peve_00029448,Pocillopora_meandrina_HIv1___TS.g5415.t2,three_way,79.24033333333334,FUN_038436-T1,Q2TBW2,COQ7_BOVIN,,"NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial (EC 1.14.13.253) (3-demethoxyubiquinone 3-hydroxylase (NADH)) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)",Bos taurus (Bovine),67.6,173.0,7.099999999999999e-62,238.4,"sp|Q2TBW2|COQ7_BOVIN NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial OS=Bos taurus OX=9913 GN=COQ7 PE=2 SV=1",GO:0005634; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0031314; GO:0046872; GO:0110142; GO:0160224; GO:2000377,determination of adult lifespan [GO:0008340]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142],3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; 3-demethoxyubiquinone 3-hydroxylase (NADH) activity [GO:0160224]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0016491; GO:0043226,catalytic activity; nucleus; oxidoreductase activity; organelle
OG_08959,1.1476589400243635,FUN_038437-T2,Peve_00029447,Pocillopora_meandrina_HIv1___RNAseq.25797_t,three_way,40.388666666666666,,,,,,,,,,,,,,,,,
OG_08961,1.4665904797735574,FUN_038439-T1,Peve_00029443,Pocillopora_meandrina_HIv1___RNAseq.g886.t1,three_way,77.404,FUN_038439-T1,Q8VIJ8,,,,,47.7,572.0,3.7e-137,490.0,sp|Q8VIJ8|NPRL3_MOUSE GATOR1 complex protein NPRL3 OS=Mus musculus OX=10090 GN=Nprl3 PE=1 SV=1,,,,,,
OG_08962,1.5777721605541766,FUN_038456-T1,Peve_00020975,Pocillopora_meandrina_HIv1___RNAseq.g28256.t1,three_way,69.28483333333334,FUN_038456-T1,Q5RA17,,,,,43.3,261.0,7.999999999999999e-50,198.7,sp|Q5RA17|RRP7A_PONAB Ribosomal RNA-processing protein 7 homolog A OS=Pongo abelii OX=9601 GN=RRP7A PE=2 SV=1,,,,,,
OG_08965,1.7184371621094512,FUN_038465-T1,Peve_00029024,Pocillopora_meandrina_HIv1___RNAseq.g28233.t1,three_way,83.47149999999999,FUN_038465-T1,Q6NUH3,,,,,57.2,306.0,2.3e-93,343.6,sp|Q6NUH3|NOSIP_XENLA Nitric oxide synthase-interacting protein OS=Xenopus laevis OX=8355 GN=nosip PE=2 SV=1,,,,,,
OG_08966,1.0352618677168983,FUN_038466-T1,Peve_00026092,Pocillopora_meandrina_HIv1___RNAseq.g28232.t1,three_way,60.737,FUN_038466-T1,O75762,TRPA1_HUMAN,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor),Homo sapiens (Human),26.4,1123.0,1.2e-52,210.3,sp|O75762|TRPA1_HUMAN Transient receptor potential cation channel subfamily A member 1 OS=Homo sapiens OX=9606 GN=TRPA1 PE=1 SV=3,GO:0005245; GO:0005262; GO:0005886; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transport [GO:0006811]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_08967,1.6870545191771662,FUN_038472-T1,Peve_00039876,Pocillopora_meandrina_HIv1___RNAseq.g28229.t1,three_way,51.10716666666666,,,,,,,,,,,,,,,,,
OG_08968,1.5768399640244792,FUN_038473-T1,Peve_00039889,Pocillopora_meandrina_HIv1___RNAseq.g28228.t1,three_way,77.87266666666666,FUN_038473-T1,Q9QYU4,CRYM_RAT,,Ketimine reductase mu-crystallin (EC 1.5.1.25) (1-piperideine-2-carboxylate/1-pyrroline-2-carboxylate reductase) (P2C/Pyr2C reductase) (EC 1.5.1.1) (CDK108) (NADP-regulated thyroid-hormone-binding protein),Rattus norvegicus (Rat),50.2,299.0,6e-71,269.2,sp|Q9QYU4|CRYM_RAT Ketimine reductase mu-crystallin OS=Rattus norvegicus OX=10116 GN=Crym PE=1 SV=1,GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0006839; GO:0007605; GO:0009725; GO:0033280; GO:0042403; GO:0042562; GO:0042803; GO:0047127; GO:0050661; GO:0070324; GO:0070327,mitochondrial transport [GO:0006839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to hormone [GO:0009725]; response to vitamin D [GO:0033280]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005739; GO:0006355; GO:0006575; GO:0016491; GO:0043226; GO:0050877; GO:0060090; GO:0140110,catalytic activity; nucleus; mitochondrion; regulation of DNA-templated transcription; modified amino acid metabolic process; oxidoreductase activity; organelle; nervous system process; molecular adaptor activity; transcription regulator activity
OG_08969,1.0528973583183268,FUN_038474-T1,Peve_00039890,Pocillopora_meandrina_HIv1___RNAseq.g28227.t1,three_way,84.79233333333333,FUN_038474-T1,Q9R0Q6,,,,,53.0,372.0,2.5e-108,393.7,sp|Q9R0Q6|ARC1A_MOUSE Actin-related protein 2/3 complex subunit 1A OS=Mus musculus OX=10090 GN=Arpc1a PE=1 SV=1,,,,,,
OG_08974,1.58049768356033,FUN_038480-T1,Peve_00013528,Pocillopora_meandrina_HIv1___RNAseq.g28221.t1,three_way,32.98216666666667,,,,,,,,,,,,,,,,,
OG_08976,1.1413945943084187,FUN_038487-T1,Peve_00013520,Pocillopora_meandrina_HIv1___TS.g8002.t1b,three_way,68.375,FUN_038487-T1,Q91YY4,,,,,49.8,231.0,8.4e-61,235.3,sp|Q91YY4|ATPF2_MOUSE ATP synthase mitochondrial F1 complex assembly factor 2 OS=Mus musculus OX=10090 GN=Atpaf2 PE=1 SV=1,,,,,,
OG_08977,3.9792281503958784,FUN_038488-T1,Peve_00013519,Pocillopora_meandrina_HIv1___TS.g8002.t1a,three_way,57.826,FUN_038488-T1,Q8JHF2,,,,,52.1,263.0,1.5e-77,291.6,"sp|Q8JHF2|LFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe OS=Danio rerio OX=7955 GN=lfng PE=2 SV=2",,,,,,
OG_08979,1.45142311471433,FUN_038496-T1,Peve_00013514,Pocillopora_meandrina_HIv1___RNAseq.g28199.t1,three_way,76.533,FUN_038496-T1,Q9Y6N1,COX11_HUMAN,,"Cytochrome c oxidase assembly protein COX11, mitochondrial",Homo sapiens (Human),67.8,180.0,1.7e-66,254.2,"sp|Q9Y6N1|COX11_HUMAN Cytochrome c oxidase assembly protein COX11, mitochondrial OS=Homo sapiens OX=9606 GN=COX11 PE=1 SV=3",GO:0005507; GO:0005739; GO:0005743; GO:0006754; GO:0009055; GO:0030003; GO:0032991,ATP biosynthetic process [GO:0006754]; intracellular monoatomic cation homeostasis [GO:0030003],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991],copper ion binding [GO:0005507]; electron transfer activity [GO:0009055],GO:0005739; GO:0043226; GO:0055086; GO:1901135,mitochondrion; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08981,1.1530726139042409,FUN_038499-T1,Peve_00013488,Pocillopora_meandrina_HIv1___RNAseq.g28195.t1,three_way,71.18633333333334,FUN_038499-T1,Q6DGP7,,,,,47.9,117.0,2e-24,113.2,sp|Q6DGP7|LYRM1_DANRE LYR motif containing protein 1 OS=Danio rerio OX=7955 GN=lyrm1 PE=3 SV=1,,,,,,
OG_08985,2.8398595351679616,FUN_038504-T1,Peve_00041693,Pocillopora_meandrina_HIv1___TS.g7946.t1,three_way,87.35516666666666,FUN_038504-T1,Q9Y5X2,SNX8_HUMAN,,Sorting nexin-8,Homo sapiens (Human),46.6,399.0,4.6e-97,356.7,sp|Q9Y5X2|SNX8_HUMAN Sorting nexin-8 OS=Homo sapiens OX=9606 GN=SNX8 PE=1 SV=1,GO:0005829; GO:0006886; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231,early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0043226,cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; organelle
OG_08986,2.340389852283972,FUN_038505-T1,Peve_00041692,Pocillopora_meandrina_HIv1___RNAseq.g28161.t1,three_way,75.56566666666666,FUN_038505-T1,Q9WV68,DECR2_MOUSE,,"Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] (EC 1.3.1.124) (2,4-dienoyl-CoA reductase 2)",Mus musculus (Mouse),55.0,291.0,7.899999999999999e-83,308.5,"sp|Q9WV68|DECR2_MOUSE Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] OS=Mus musculus OX=10090 GN=Decr2 PE=1 SV=1",GO:0005777; GO:0006636; GO:0008670; GO:0009062; GO:0019166; GO:0044877; GO:0051020,fatty acid catabolic process [GO:0009062]; unsaturated fatty acid biosynthetic process [GO:0006636],peroxisome [GO:0005777],"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]",GO:0003824; GO:0005777; GO:0006629; GO:0016491; GO:0043226,catalytic activity; peroxisome; lipid metabolic process; oxidoreductase activity; organelle
OG_08987,3.192002895626074,FUN_038507-T2,Peve_00041684,Pocillopora_meandrina_HIv1___RNAseq.g28173.t1,three_way,75.75433333333334,FUN_038507-T2,Q4R7R1,,,,,61.6,357.0,4.3e-122,439.5,sp|Q4R7R1|D42E1_MACFA Short-chain dehydrogenase/reductase family 42E member 1 OS=Macaca fascicularis OX=9541 GN=SDR42E1 PE=2 SV=1,,,,,,
OG_08991,1.198287971081706,FUN_038513-T1,Peve_00041678,Pocillopora_meandrina_HIv1___RNAseq.g28180.t1,three_way,68.10366666666667,FUN_038513-T1,Q9HAS0,,,,,32.8,354.0,1.9e-43,178.3,sp|Q9HAS0|NJMU_HUMAN Protein Njmu-R1 OS=Homo sapiens OX=9606 GN=C17orf75 PE=1 SV=2,,,,,,
OG_08993,2.493517912158873,FUN_038523-T1,Peve_00041676,Pocillopora_meandrina_HIv1___RNAseq.g28185.t1,three_way,88.359,FUN_038523-T1,P0C0A3,CHMP6_MOUSE,,Charged multivesicular body protein 6 (Chromatin-modifying protein 6),Mus musculus (Mouse),62.5,168.0,7.5e-51,201.8,sp|P0C0A3|CHMP6_MOUSE Charged multivesicular body protein 6 OS=Mus musculus OX=10090 GN=Chmp6 PE=1 SV=2,GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005828; GO:0005886; GO:0006914; GO:0006997; GO:0007080; GO:0015031; GO:0030496; GO:0031468; GO:0032585; GO:0036258; GO:0039702; GO:0042176; GO:0043162; GO:0044877; GO:0046761; GO:0051469; GO:0061763; GO:0061952; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904930,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886],protein-containing complex binding [GO:0044877],GO:0005886; GO:0006914; GO:0016192; GO:0043226; GO:0061024,plasma membrane; autophagy; vesicle-mediated transport; organelle; membrane organization
OG_08997,4.100421132599685,FUN_038533-T1,Peve_00013531,Pocillopora_meandrina_HIv1___RNAseq.g28191.t1,three_way,83.86566666666667,FUN_038533-T1,O00116,ADAS_HUMAN,,"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)",Homo sapiens (Human),58.7,623.0,3.6e-226,785.8,"sp|O00116|ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase, peroxisomal OS=Homo sapiens OX=9606 GN=AGPS PE=1 SV=1",GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0071949,ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; transferase activity; organelle
OG_08998,2.41547500672039,FUN_038535-T1,Peve_00009817,Pocillopora_meandrina_HIv1___TS.g7943.t1,three_way,65.10233333333333,FUN_038535-T1,Q9JIA7,SPHK2_MOUSE,,Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91),Mus musculus (Mouse),34.2,547.0,3.6e-73,277.3,sp|Q9JIA7|SPHK2_MOUSE Sphingosine kinase 2 OS=Mus musculus OX=10090 GN=Sphk2 PE=1 SV=2,GO:0000786; GO:0001568; GO:0002720; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006669; GO:0006670; GO:0007420; GO:0007565; GO:0008283; GO:0008284; GO:0008481; GO:0016020; GO:0017050; GO:0030308; GO:0032736; GO:0032755; GO:0032760; GO:0033008; GO:0035556; GO:0038036; GO:0042393; GO:0043065; GO:0043122; GO:0043306; GO:0045815; GO:0046512; GO:1903426; GO:1904628; GO:1904959; GO:2000304; GO:2001169,blood vessel development [GO:0001568]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; female pregnancy [GO:0007565]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ATP biosynthetic process [GO:2001169]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; transcription initiation-coupled chromatin remodeling [GO:0045815],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; histone binding [GO:0042393]; sphingosine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006325; GO:0006629; GO:0016740; GO:0022414; GO:0042393; GO:0043226; GO:0048856; GO:0060089,catalytic activity; nucleus; nucleoplasm; mitochondrion; endoplasmic reticulum; cytosol; plasma membrane; chromatin organization; lipid metabolic process; transferase activity; reproductive process; histone binding; organelle; anatomical structure development; molecular transducer activity
OG_09000,2.1727900179391373,FUN_038541-T1,Peve_00009815,Pocillopora_meandrina_HIv1___RNAseq.g28155.t1,three_way,87.0155,FUN_038541-T1,B5X2S3,,,,,48.5,582.0,3.1e-163,576.6,sp|B5X2S3|ARP8_SALSA Actin-related protein 8 OS=Salmo salar OX=8030 GN=actr8 PE=2 SV=1,,,,,,
OG_09002,1.6316780299466689,FUN_038547-T1,Peve_00037482,Pocillopora_meandrina_HIv1___RNAseq.g1037.t1,three_way,73.7495,FUN_038547-T1,Q5U4T9,MBOA7_XENLA,,Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 (EC 2.3.1.-) (Leukocyte receptor cluster member 4) (Lysophospholipid acyltransferase 7) (LPLAT 7) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7),Xenopus laevis (African clawed frog),37.2,473.0,4.3e-86,320.1,sp|Q5U4T9|MBOA7_XENLA Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 OS=Xenopus laevis OX=8355 GN=mboat7 PE=2 SV=1,GO:0005789; GO:0006661; GO:0008374; GO:0016020; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0071617; GO:0090207,lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233],lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_09011,2.4238933042782445,FUN_038571-T2,Peve_00020178,Pocillopora_meandrina_HIv1___RNAseq.g1016.t1,three_way,72.84416666666667,FUN_038571-T2,Q75V66,ANO5_HUMAN,,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),Homo sapiens (Human),42.9,821.0,8.6e-166,585.9,sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; plasma membrane; organelle; transmembrane transport; membrane organization
OG_09012,1.533285668755326,FUN_038572-T1,Peve_00020175,Pocillopora_meandrina_HIv1___TS.g5545.t1,three_way,48.534666666666666,FUN_038572-T1,Q8C2E4,,,,,25.4,627.0,2.2e-35,152.1,"sp|Q8C2E4|PTCD1_MOUSE Pentatricopeptide repeat-containing protein 1, mitochondrial OS=Mus musculus OX=10090 GN=Ptcd1 PE=2 SV=2",,,,,,
OG_09013,1.783655014878161,FUN_038574-T1,Peve_00020171,Pocillopora_meandrina_HIv1___RNAseq.g1013.t1,three_way,55.36533333333333,FUN_038574-T1,Q10660,DXO_CAEEL,,Decapping nuclease dom-3 (EC 3.6.1.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase dom-3) (DeNADding enzyme dom-3) (EC 3.6.1.-),Caenorhabditis elegans,26.4,254.0,2.9e-12,75.1,sp|Q10660|DXO_CAEEL Decapping nuclease dom-3 OS=Caenorhabditis elegans OX=6239 GN=dom-3 PE=2 SV=1,GO:0000166; GO:0000956; GO:0003723; GO:0004518; GO:0005634; GO:0005829; GO:0034353; GO:0046872; GO:0110152; GO:0110155,NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956],cytosol [GO:0005829]; nucleus [GO:0005634],metal ion binding [GO:0046872]; mRNA 5'-diphosphatase activity [GO:0034353]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA NAD+-cap (NAD+-forming) hydrolase activity [GO:0110152],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_09014,2.2790899009783794,FUN_038576-T1,Peve_00012106,Pocillopora_meandrina_HIv1___RNAseq.g1012.t1,three_way,84.76333333333334,FUN_038576-T1,Q17QF0,AGT2_BOVIN,,"Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (EC 2.6.1.18) (D-3-aminoisobutyrate-pyruvate aminotransferase) (D-AIBAT) (D-beta-aminoisobutyrate-pyruvate aminotransferase)",Bos taurus (Bovine),57.4,462.0,1.3e-163,577.8,"sp|Q17QF0|AGT2_BOVIN Alanine--glyoxylate aminotransferase 2, mitochondrial OS=Bos taurus OX=9913 GN=AGXT2 PE=2 SV=1",GO:0005739; GO:0008453; GO:0009436; GO:0016223; GO:0019481; GO:0030170; GO:0047305; GO:2001299,"glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; N(omega),N(omega)-dimethyl-L-arginine catabolic process [GO:2001299]",mitochondrion [GO:0005739],(R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; beta-alanine:pyruvate transaminase activity [GO:0016223]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0006520; GO:0006575; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; transferase activity; organelle
OG_09015,1.632036136876272,FUN_038577-T1,Peve_00012107,Pocillopora_meandrina_HIv1___RNAseq.g1011.t1,three_way,67.471,FUN_038577-T1,Q0QWG9,GRD2I_MOUSE,,"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)",Mus musculus (Mouse),28.8,420.0,9.800000000000001e-34,147.1,sp|Q0QWG9|GRD2I_MOUSE Delphilin OS=Mus musculus OX=10090 GN=Grid2ip PE=1 SV=1,GO:0007216; GO:0030036; GO:0043197; GO:0045202; GO:0045211; GO:0060292; GO:0098688; GO:0098978; GO:0099072; GO:0099092; GO:0099566; GO:0150048,actin cytoskeleton organization [GO:0030036]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],"cerebellar granule cell to Purkinje cell synapse [GO:0150048]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]",,GO:0007010; GO:0043226,cytoskeleton organization; organelle
OG_09016,1.4618929122046105,FUN_038578-T1,Peve_00012102,Pocillopora_meandrina_HIv1___TS.g5540.t1,three_way,63.539,FUN_038578-T1,Q9Z207,DIAP3_MOUSE,,Protein diaphanous homolog 3 (Diaphanous-related formin-3) (DRF3) (p134mDIA2) (mDIA2),Mus musculus (Mouse),27.2,290.0,2e-21,105.1,sp|Q9Z207|DIAP3_MOUSE Protein diaphanous homolog 3 OS=Mus musculus OX=10090 GN=Diaph3 PE=1 SV=1,GO:0000226; GO:0000813; GO:0000922; GO:0001701; GO:0003779; GO:0005634; GO:0005737; GO:0005815; GO:0007010; GO:0007015; GO:0007026; GO:0007059; GO:0007229; GO:0007605; GO:0008017; GO:0008092; GO:0010467; GO:0016197; GO:0030010; GO:0030030; GO:0030036; GO:0030041; GO:0030182; GO:0030218; GO:0030225; GO:0031267; GO:0031941; GO:0032154; GO:0032432; GO:0034367; GO:0042803; GO:0043131; GO:0045010; GO:0046785; GO:0051017; GO:0051764; GO:0060113; GO:0060322; GO:0061909; GO:0071800; GO:0097470; GO:1990427,actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; autophagosome-lysosome fusion [GO:0061909]; cell projection organization [GO:0030030]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; endosomal transport [GO:0016197]; erythrocyte differentiation [GO:0030218]; erythrocyte enucleation [GO:0043131]; establishment of cell polarity [GO:0030010]; gene expression [GO:0010467]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; inner ear receptor cell differentiation [GO:0060113]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron differentiation [GO:0030182]; podosome assembly [GO:0071800]; protein-containing complex remodeling [GO:0034367]; sensory perception of sound [GO:0007605],actin filament bundle [GO:0032432]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; ESCRT I complex [GO:0000813]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ribbon synapse [GO:0097470]; spindle pole [GO:0000922]; stereocilia tip-link density [GO:1990427],actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],GO:0005634; GO:0005815; GO:0007010; GO:0007059; GO:0007163; GO:0008092; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0061024; GO:0065003,nucleus; microtubule organizing center; cytoskeleton organization; chromosome segregation; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; nervous system process; membrane organization; protein-containing complex assembly
OG_09017,2.2641728149013343,FUN_038580-T1,Peve_00012104,Pocillopora_meandrina_HIv1___RNAseq.g1008.t1,three_way,76.07866666666666,FUN_038580-T1,Q8BYA0,,,,,54.4,1010.0,0.0,1093.2,sp|Q8BYA0|TBCD_MOUSE Tubulin-specific chaperone D OS=Mus musculus OX=10090 GN=Tbcd PE=1 SV=1,,,,,,
OG_09020,1.220706427133223,FUN_038608-T1,Peve_00005403,Pocillopora_meandrina_HIv1___RNAseq.g989.t1,three_way,57.90166666666666,,,,,,,,,,,,,,,,,
OG_09022,2.037809161919996,FUN_038611-T1,Peve_00044574,Pocillopora_meandrina_HIv1___RNAseq.g9728.t2,three_way,43.10066666666667,,,,,,,,,,,,,,,,,
OG_09024,2.4392758208390446,FUN_038614-T1,Peve_00002807,Pocillopora_meandrina_HIv1___RNAseq.g972.t1,three_way,69.6525,FUN_038614-T1,Q9Z0Y8,CAC1I_RAT,,Voltage-dependent T-type calcium channel subunit alpha-1I (CaVT.3) (Voltage-gated calcium channel subunit alpha Cav3.3),Rattus norvegicus (Rat),43.5,1698.0,3.2999999999999997e-299,1030.0,sp|Q9Z0Y8|CAC1I_RAT Voltage-dependent T-type calcium channel subunit alpha-1I OS=Rattus norvegicus OX=10116 GN=Cacna1i PE=1 SV=3,GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0006816; GO:0008332; GO:0019228; GO:0030431; GO:0042391; GO:0043005; GO:0045956; GO:0060402; GO:0070509; GO:0086010,calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of membrane potential [GO:0042391]; sleep [GO:0030431],neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518],low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_09025,2.0955480995209057,FUN_038617-T1,Peve_00042051,Pocillopora_meandrina_HIv1___RNAseq.g971.t1,three_way,90.041,FUN_038617-T1,Q6NRT5,,,,,64.5,476.0,3.4e-176,619.4,sp|Q6NRT5|CSN1_XENLA COP9 signalosome complex subunit 1 OS=Xenopus laevis OX=8355 GN=csn1 PE=2 SV=1,,,,,,
OG_09026,1.0644209260529027,FUN_038619-T1,Peve_00042042,Pocillopora_meandrina_HIv1___RNAseq.g1162.t1,three_way,51.708333333333336,,,,,,,,,,,,,,,,,
OG_09028,1.8112785361832533,FUN_038621-T1,Peve_00042047,Pocillopora_meandrina_HIv1___RNAseq.g1161.t1,three_way,51.117666666666665,FUN_038621-T1,Q5NVA9,,,,,38.2,327.0,3.0999999999999995e-43,178.3,sp|Q5NVA9|EME1_PONAB Structure-specific endonuclease subunit EME1 OS=Pongo abelii OX=9601 GN=EME1 PE=3 SV=1,,,,,,
OG_09029,4.223847894725592,FUN_038622-T1,Peve_00042048,Pocillopora_meandrina_HIv1___RNAseq.g1159.t1,three_way,78.449,FUN_038622-T1,P22448,,,,,31.8,349.0,7.2e-41,169.5,sp|P22448|RARB_CHICK Retinoic acid receptor beta OS=Gallus gallus OX=9031 GN=RARB PE=2 SV=2,,,,,,
OG_09032,1.7504183197327452,FUN_038632-T1,Peve_00013498,Pocillopora_meandrina_HIv1___RNAseq.g26496.t1,three_way,88.648,FUN_038632-T1,Q58DC5,GTPB1_BOVIN,,GTP-binding protein 1,Bos taurus (Bovine),72.5,534.0,3.9e-228,792.3,sp|Q58DC5|GTPB1_BOVIN GTP-binding protein 1 OS=Bos taurus OX=9913 GN=GTPBP1 PE=2 SV=2,GO:0000049; GO:0000177; GO:0002181; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014; GO:1904678,cytoplasmic translation [GO:0002181]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414],cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829],alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049],GO:0002181; GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0055086; GO:1901135,cytoplasmic translation; RNA binding; catalytic activity; GTPase activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09033,2.766074558015467,FUN_038633-T1,Peve_00013497,Pocillopora_meandrina_HIv1___RNAseq.g26495.t1,three_way,75.706,FUN_038633-T1,Q5EAE5,JOS1_BOVIN,,Josephin-1 (EC 3.4.19.12) (Josephin domain-containing protein 1),Bos taurus (Bovine),47.4,175.0,6.499999999999999e-43,175.3,sp|Q5EAE5|JOS1_BOVIN Josephin-1 OS=Bos taurus OX=9913 GN=JOSD1 PE=2 SV=1,GO:0004843; GO:0005737; GO:0005886; GO:0006508; GO:0006897; GO:0016579; GO:0044091; GO:0048870; GO:0061024,cell motility [GO:0048870]; endocytosis [GO:0006897]; membrane biogenesis [GO:0044091]; membrane organization [GO:0061024]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005886; GO:0016192; GO:0016787; GO:0048870; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; vesicle-mediated transport; hydrolase activity; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_09036,3.210009694141354,FUN_038637-T1,Peve_00013493,Pocillopora_meandrina_HIv1___RNAseq.g26491.t1,three_way,71.66766666666666,FUN_038637-T1,P70426,,,,,43.2,183.0,1.3999999999999998e-29,131.7,sp|P70426|RIT1_MOUSE GTP-binding protein Rit1 OS=Mus musculus OX=10090 GN=Rit1 PE=1 SV=1,,,,,,
OG_09038,1.5587145182990254,FUN_038682-T1,Peve_00013483,Pocillopora_meandrina_HIv1___TS.g19232.t2,three_way,92.927,FUN_038682-T1,Q803V5,,,,,76.8,220.0,3.699999999999999e-105,382.9,sp|Q803V5|LST8_DANRE Target of rapamycin complex subunit lst8 OS=Danio rerio OX=7955 GN=mlst8 PE=2 SV=1,,,,,,
OG_09040,1.4010536501433983,FUN_038688-T1,Peve_00013481,Pocillopora_meandrina_HIv1___TS.g19229.t1b,three_way,89.20133333333334,FUN_038688-T1,Q99KI0,,,,,76.7,769.0,0.0,1237.2,"sp|Q99KI0|ACON_MOUSE Aconitate hydratase, mitochondrial OS=Mus musculus OX=10090 GN=Aco2 PE=1 SV=1",,,,,,
OG_09042,3.39551800225414,FUN_038695-T1,Peve_00013474,Pocillopora_meandrina_HIv1___RNAseq.g26473.t1,three_way,63.010333333333335,,,,,,,,,,,,,,,,,
OG_09043,1.6786910433743014,FUN_038697-T1,Peve_00013468,Pocillopora_meandrina_HIv1___RNAseq.g26461.t2,three_way,78.3395,FUN_038697-T1,Q9Y383,LC7L2_HUMAN,,Putative RNA-binding protein Luc7-like 2,Homo sapiens (Human),60.3,239.0,6.6e-79,295.8,sp|Q9Y383|LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004,mRNA splice site recognition [GO:0006376],nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004],enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0043226; GO:0065003,RNA binding; organelle; protein-containing complex assembly
OG_09044,1.9027264138550009,FUN_038706-T1,Peve_00013466,Pocillopora_meandrina_HIv1___TS.g19207.t1,three_way,72.16366666666667,FUN_038706-T1,Q8CGQ8,NCKX4_MOUSE,,Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4),Mus musculus (Mouse),39.6,545.0,1.9e-100,367.9,sp|Q8CGQ8|NCKX4_MOUSE Sodium/potassium/calcium exchanger 4 OS=Mus musculus OX=10090 GN=Slc24a4 PE=1 SV=2,GO:0005432; GO:0005516; GO:0005737; GO:0005886; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0071486; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834,amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608],apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982],"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]",GO:0005215; GO:0005886; GO:0043226; GO:0050877; GO:0055085,transporter activity; plasma membrane; organelle; nervous system process; transmembrane transport
OG_09045,2.0030884643666047,FUN_038707-T1,Peve_00013464,Pocillopora_meandrina_HIv1___RNAseq.g23383.t1,three_way,72.31633333333333,FUN_038707-T1,Q8BGA7,,,,,31.7,436.0,7.5e-40,166.4,sp|Q8BGA7|INT15_MOUSE Integrator complex subunit 15 OS=Mus musculus OX=10090 GN=Ints15 PE=2 SV=1,,,,,,
OG_09047,1.5057902919368356,FUN_038718-T1,Peve_00002623,Pocillopora_meandrina_HIv1___RNAseq.g26441.t1,three_way,74.53816666666667,,,,,,,,,,,,,,,,,
OG_09050,2.372163647830012,FUN_038730-T1,Peve_00016753,Pocillopora_meandrina_HIv1___RNAseq.g26437.t1,three_way,53.7555,,,,,,,,,,,,,,,,,
OG_09053,1.6190033063541165,FUN_038734-T1,Peve_00013933,Pocillopora_meandrina_HIv1___RNAseq.g26434.t1,three_way,82.597,FUN_038734-T1,Q8TB22,,,,,50.1,743.0,9.099999999999999e-217,755.0,sp|Q8TB22|SPT20_HUMAN Spermatogenesis-associated protein 20 OS=Homo sapiens OX=9606 GN=SPATA20 PE=1 SV=3,,,,,,
OG_09054,1.3221553407574005,FUN_038735-T2,Peve_00009270,Pocillopora_meandrina_HIv1___RNAseq.g26433.t2,three_way,69.43966666666667,,,,,,,,,,,,,,,,,
OG_09058,1.288035263115071,FUN_038740-T1,Peve_00009049,Pocillopora_meandrina_HIv1___RNAseq.g26428.t1,three_way,80.50066666666666,FUN_038740-T1,O54922,,,,,41.2,677.0,9.7e-140,498.8,sp|O54922|EXOC7_RAT Exocyst complex component 7 OS=Rattus norvegicus OX=10116 GN=Exoc7 PE=1 SV=1,,,,,,
OG_09059,2.2038082153873004,FUN_038742-T1,Peve_00009051,Pocillopora_meandrina_HIv1___RNAseq.g26426.t1,three_way,86.85000000000001,FUN_038742-T1,Q8TB05,,,,,74.4,86.0,2.5e-28,125.9,sp|Q8TB05|UBAD1_HUMAN UBA-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBALD1 PE=1 SV=1,,,,,,
OG_09061,1.0797673666845833,FUN_038756-T1,Peve_00022724,Pocillopora_meandrina_HIv1___RNAseq.g26409.t1,three_way,77.744,FUN_038756-T1,Q8NBN7,RDH13_HUMAN,,Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3),Homo sapiens (Human),46.0,302.0,6.2e-63,242.7,sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2,GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650,eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226; GO:0048856,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle; anatomical structure development
OG_09062,2.6188017350452286,FUN_038769-T1,Peve_00022730,Pocillopora_meandrina_HIv1___RNAseq.g26408.t1,three_way,76.67533333333333,,,,,,,,,,,,,,,,,
OG_09064,1.292888165203165,FUN_038771-T1,Peve_00022728,Pocillopora_meandrina_HIv1___RNAseq.g26406.t1,three_way,64.24583333333334,,,,,,,,,,,,,,,,,
OG_09067,1.978633231825684,FUN_038786-T1,Peve_00007210,Pocillopora_meandrina_HIv1___RNAseq.g26402.t1,three_way,79.763,FUN_038786-T1,Q7ZX59,,,,,28.9,463.0,5.4e-46,186.8,sp|Q7ZX59|CRLF3_XENLA Cytokine receptor-like factor 3 OS=Xenopus laevis OX=8355 GN=crlf3 PE=2 SV=1,,,,,,
OG_09068,1.0819685720893517,FUN_038789-T1,Peve_00007206,Pocillopora_meandrina_HIv1___RNAseq.g26399.t1,three_way,63.13333333333333,FUN_038789-T1,Q9CS74,ECD_MOUSE,,Protein ecdysoneless homolog,Mus musculus (Mouse),41.7,643.0,1.3999999999999998e-127,458.4,sp|Q9CS74|ECD_MOUSE Protein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2,GO:0005654; GO:0005829; GO:0006397; GO:0008380; GO:0035035; GO:0045944; GO:0048144; GO:2000045,fibroblast proliferation [GO:0048144]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380],cytosol [GO:0005829]; nucleoplasm [GO:0005654],histone acetyltransferase binding [GO:0035035],GO:0005654; GO:0005829; GO:0006355; GO:0016071,nucleoplasm; cytosol; regulation of DNA-templated transcription; mRNA metabolic process
OG_09070,2.1037787469667357,FUN_038795-T1,Peve_00007232,Pocillopora_meandrina_HIv1___RNAseq.g26384.t1,three_way,72.97933333333333,FUN_038795-T1,P09848,LPH_HUMAN,,Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)],Homo sapiens (Human),49.1,489.0,1.3e-139,498.0,sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3,GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892,cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733],external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886],beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005886; GO:0005975; GO:0006629; GO:0016787; GO:1901135,catalytic activity; plasma membrane; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_09072,1.2213640007552444,FUN_038800-T1,Peve_00007227,Pocillopora_meandrina_HIv1___RNAseq.g26372.t1,three_way,62.00983333333333,,,,,,,,,,,,,,,,,
OG_09073,2.007277397994459,FUN_038801-T1,Peve_00007226,Pocillopora_meandrina_HIv1___RNAseq.g28547.t1,three_way,79.16683333333334,FUN_038801-T1,E5RQL4,,,,,37.8,185.0,1e-17,92.4,sp|E5RQL4|FONG_HUMAN Formiminotransferase N-terminal subdomain-containing protein OS=Homo sapiens OX=9606 GN=FTCDNL1 PE=2 SV=1,,,,,,
OG_09074,2.981288204905466,FUN_038803-T1,Peve_00007224,Pocillopora_meandrina_HIv1___RNAseq.g28545.t1,three_way,82.41499999999999,FUN_038803-T1,Q8BL48,UNK_MOUSE,,RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5),Mus musculus (Mouse),46.5,778.0,5.4999999999999996e-160,567.0,sp|Q8BL48|UNK_MOUSE RING finger protein unkempt homolog OS=Mus musculus OX=10090 GN=Unk PE=1 SV=1,GO:0001701; GO:0001764; GO:0005737; GO:0008270; GO:0043022; GO:0048667; GO:1990715; GO:2000766,cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764],cytoplasm [GO:0005737],mRNA CDS binding [GO:1990715]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270],GO:0003723; GO:0048856; GO:0048870,RNA binding; anatomical structure development; cell motility
OG_09078,1.67843450932941,FUN_038807-T1,Peve_00007223,Pocillopora_meandrina_HIv1___RNAseq.g28543.t1,three_way,87.99033333333333,FUN_038807-T1,Q9LQC8,,,,,68.6,153.0,1.1e-56,221.1,sp|Q9LQC8|ARF2A_ARATH ADP-ribosylation factor 2-A OS=Arabidopsis thaliana OX=3702 GN=ARF2-A PE=2 SV=2,,,,,,
OG_09079,2.220016312829117,FUN_038808-T1,Peve_00007219,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1a,three_way,79.655,FUN_038808-T1,A4QNE0,,,,,50.2,297.0,3.1e-83,310.1,sp|A4QNE0|GET4_XENTR Golgi to ER traffic protein 4 homolog OS=Xenopus tropicalis OX=8364 GN=get4 PE=2 SV=1,,,,,,
OG_09084,1.3723195477094094,FUN_038831-T1,Peve_00028780,Pocillopora_meandrina_HIv1___RNAseq.g28634.t1,three_way,67.26416666666667,FUN_038831-T1,F8VPZ5,ERCC6_MOUSE,,DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB),Mus musculus (Mouse),51.2,1068.0,1.6000000000000004e-277,957.6,sp|F8VPZ5|ERCC6_MOUSE DNA excision repair protein ERCC-6 OS=Mus musculus OX=10090 GN=Ercc6 PE=1 SV=1,GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006338; GO:0006362; GO:0006974; GO:0006979; GO:0007254; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0016887; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032786; GO:0034243; GO:0035264; GO:0042262; GO:0045494; GO:0045943; GO:0045944; GO:0045945; GO:0060261; GO:0090734; GO:0097680; GO:0110016; GO:0140463; GO:0140658; GO:0140664; GO:1905168; GO:2001033,"base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription elongation by RNA polymerase I [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]",B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein tyrosine kinase activator activity [GO:0030296]",GO:0003677; GO:0003824; GO:0005634; GO:0005730; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0060090; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleolus; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; cell differentiation; organelle; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_09088,2.2548793611788382,FUN_038886-T1,Peve_00028696,Pocillopora_meandrina_HIv1___RNAseq.g28678.t1,three_way,74.4045,FUN_038886-T1,Q9CZT4,,,,,39.5,714.0,3.8e-131,470.3,sp|Q9CZT4|RPC5_MOUSE DNA-directed RNA polymerase III subunit RPC5 OS=Mus musculus OX=10090 GN=Polr3e PE=1 SV=2,,,,,,
OG_09089,1.3652753970758875,FUN_038887-T1,Peve_00028697,Pocillopora_meandrina_HIv1___RNAseq.g28665.t1,three_way,61.27033333333333,FUN_038887-T1,D2HD32,,,,,48.9,131.0,9.9e-26,118.2,sp|D2HD32|ICT1_AILME Large ribosomal subunit protein mL62 OS=Ailuropoda melanoleuca OX=9646 GN=MRPL58 PE=3 SV=1,,,,,,
OG_09095,1.005024209908102,FUN_038893-T1,Peve_00028708,Pocillopora_meandrina_HIv1___RNAseq.g28659.t1,three_way,61.70583333333334,,,,,,,,,,,,,,,,,
OG_09096,3.422587676988291,FUN_038901-T1,Peve_00028737,Pocillopora_meandrina_HIv1___TS.g8477.t1a,three_way,68.12616666666666,FUN_038901-T1,Q6NU40,,,,,42.3,1032.0,7.199999999999999e-189,662.5,sp|Q6NU40|CTF18_XENLA Chromosome transmission fidelity protein 18 homolog OS=Xenopus laevis OX=8355 GN=chtf18 PE=2 SV=1,,,,,,
OG_09098,2.2054696960461326,FUN_038913-T1,Peve_00006149,Pocillopora_meandrina_HIv1___RNAseq.g1175.t1,three_way,65.38966666666666,FUN_038913-T1,Q504A5,,,,,36.9,198.0,3.2e-30,133.7,sp|Q504A5|TPMT_DANRE Probable thiopurine S-methyltransferase OS=Danio rerio OX=7955 GN=tpmt PE=2 SV=1,,,,,,
OG_09099,1.4238865114356198,FUN_038915-T1,Peve_00004520,Pocillopora_meandrina_HIv1___RNAseq.g1077.t1,three_way,83.61666666666666,FUN_038915-T1,Q8BWQ6,VP35L_MOUSE,,VPS35 endosomal protein-sorting factor-like,Mus musculus (Mouse),55.1,976.0,2.5e-308,1059.7,sp|Q8BWQ6|VP35L_MOUSE VPS35 endosomal protein-sorting factor-like OS=Mus musculus OX=10090 GN=Vps35l PE=1 SV=2,GO:0005768; GO:0006893; GO:0015031; GO:0016020; GO:0032456,endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],endosome [GO:0005768]; membrane [GO:0016020],,GO:0005768; GO:0016192; GO:0031410; GO:0043226,endosome; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09100,1.6607635487111676,FUN_038917-T1,Peve_00004515,Pocillopora_meandrina_HIv1___RNAseq.g1080.t1,three_way,61.212,,,,,,,,,,,,,,,,,
OG_09101,2.601331221152131,FUN_038918-T1,Peve_00004516,Pocillopora_meandrina_HIv1___RNAseq.g1083.t1,three_way,89.98166666666667,FUN_038918-T1,Q5ZL26,,,,,61.2,366.0,3.8e-122,439.5,sp|Q5ZL26|KPRB_CHICK Phosphoribosyl pyrophosphate synthase-associated protein 2 OS=Gallus gallus OX=9031 GN=PRPSAP2 PE=2 SV=1,,,,,,
OG_09102,2.8646765627285826,FUN_038919-T1,Peve_00023621,Pocillopora_meandrina_HIv1___RNAseq.g1058.t1,three_way,88.84166666666667,FUN_038919-T1,Q9R1C6,DGKE_MOUSE,,Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon),Mus musculus (Mouse),48.7,487.0,5.8999999999999995e-148,525.8,sp|Q9R1C6|DGKE_MOUSE Diacylglycerol kinase epsilon OS=Mus musculus OX=10090 GN=Dgke PE=1 SV=1,GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006654; GO:0006661; GO:0007200; GO:0008270; GO:0016020; GO:0046339; GO:0046834; GO:0050804; GO:0098978,diacylglycerol metabolic process [GO:0046339]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0006629; GO:0016740,catalytic activity; nucleoplasm; cytosol; lipid metabolic process; transferase activity
OG_09110,2.6627128533309934,FUN_039036-T1,Peve_00028756,Pocillopora_meandrina_HIv1___RNAseq.g28692.t1,three_way,82.128,FUN_039036-T1,Q8N8E3,,,,,40.0,442.0,1.5e-65,251.9,sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2,,,,,,
OG_09119,1.8495839360884376,FUN_039265-T1,Peve_00019987,Pocillopora_meandrina_HIv1___RNAseq.g13572.t1,three_way,65.6775,FUN_039265-T1,Q1JV40,HVCN1_CIOIN,,Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1) (Voltage sensor domain-only protein),Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis),33.6,128.0,7.3e-09,62.4,sp|Q1JV40|HVCN1_CIOIN Voltage-gated hydrogen channel 1 OS=Ciona intestinalis OX=7719 GN=HVCN1 PE=2 SV=1,GO:0005886; GO:0030171; GO:0034702; GO:0071294; GO:0071467; GO:1902600,cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600],monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],voltage-gated proton channel activity [GO:0030171],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_09121,1.7750358742608523,FUN_039269-T1,Peve_00002766,Pocillopora_meandrina_HIv1___RNAseq.14855_t,three_way,50.418,FUN_039269-T1,P15384,,,,,32.5,428.0,1e-50,202.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_09122,1.262474112455321,FUN_039274-T1,Peve_00034826,Pocillopora_meandrina_HIv1___RNAseq.g13579.t1,three_way,72.836,,,,,,,,,,,,,,,,,
OG_09123,1.1542463362408009,FUN_039296-T1,Peve_00034840,Pocillopora_meandrina_HIv1___RNAseq.g13603.t1,three_way,76.90333333333334,,,,,,,,,,,,,,,,,
OG_09126,1.9373234676509616,FUN_039319-T2,Peve_00037934,Pocillopora_meandrina_HIv1___TS.g2591.t1,three_way,56.69116666666667,FUN_039319-T2,Q9JJP2,P73_MOUSE,,Tumor protein p73 (p53-like transcription factor) (p53-related protein),Mus musculus (Mouse),35.0,369.0,2.7e-50,201.4,sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0001836; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005886; GO:0006954; GO:0006974; GO:0007346; GO:0009410; GO:0009791; GO:0010468; GO:0019901; GO:0021766; GO:0030054; GO:0030900; GO:0033326; GO:0036064; GO:0042771; GO:0042802; GO:0043410; GO:0043523; GO:0043524; GO:0045665; GO:0045793; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0048666; GO:0048714; GO:0051262; GO:0060044; GO:0061629; GO:0097371; GO:1901248; GO:1902167; GO:2001235,cerebrospinal fluid secretion [GO:0033326]; digestive tract morphogenesis [GO:0048546]; DNA damage response [GO:0006974]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein tetramerization [GO:0051262]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron apoptotic process [GO:0043523]; release of cytochrome c from mitochondria [GO:0001836]; response to xenobiotic stimulus [GO:0009410],cell junction [GO:0030054]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005886; GO:0006355; GO:0006954; GO:0007005; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; plasma membrane; regulation of DNA-templated transcription; inflammatory response; mitochondrion organization; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_09129,3.30295750585674,FUN_039435-T1,Peve_00012694,Pocillopora_meandrina_HIv1___RNAseq.g15606.t1,three_way,76.65166666666667,FUN_039435-T1,O57321,,,,,48.3,466.0,6.6e-113,409.5,sp|O57321|EAA1_AMBTI Excitatory amino acid transporter 1 OS=Ambystoma tigrinum OX=8305 GN=SLC1A3 PE=1 SV=1,,,,,,
OG_09134,1.3549916741277093,FUN_039701-T1,Peve_00008100,Pocillopora_meandrina_HIv1___RNAseq.g14123.t1,three_way,57.217333333333336,,,,,,,,,,,,,,,,,
OG_09136,2.3916710259900125,FUN_039774-T1,Peve_00030564,Pocillopora_meandrina_HIv1___RNAseq.g7453.t1,three_way,59.15083333333333,FUN_039774-T1,Q810V0,,,,,40.6,702.0,1.4999999999999998e-68,262.3,sp|Q810V0|MPP10_MOUSE U3 small nucleolar ribonucleoprotein protein MPP10 OS=Mus musculus OX=10090 GN=Mphosph10 PE=1 SV=2,,,,,,
OG_09138,2.7682153419211986,FUN_039777-T1,Peve_00017586,Pocillopora_meandrina_HIv1___TS.g1210.t1,three_way,63.503,,,,,,,,,,,,,,,,,
OG_09149,2.395235284200493,FUN_039803-T1,Peve_00017581,Pocillopora_meandrina_HIv1___RNAseq.g7477.t2,three_way,74.33033333333334,FUN_039803-T1,Q6BZW3,,,,,30.8,399.0,7.6e-32,139.8,sp|Q6BZW3|BTN1_YARLI Protein BTN1 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) OX=284591 GN=BTN1 PE=3 SV=1,,,,,,
OG_09151,1.2429547132544454,FUN_039806-T1,Peve_00020315,Pocillopora_meandrina_HIv1___RNAseq.g7484.t1,three_way,36.24133333333334,,,,,,,,,,,,,,,,,
OG_09152,1.1812900651045557,FUN_039807-T1,Peve_00033774,Pocillopora_meandrina_HIv1___RNAseq.g7485.t1,three_way,53.678666666666665,,,,,,,,,,,,,,,,,
OG_09153,1.360535011657043,FUN_039808-T1,Peve_00020313,Pocillopora_meandrina_HIv1___RNAseq.g7486.t1,three_way,89.93166666666667,FUN_039808-T1,P42026,NDUS7_BOVIN,,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)",Bos taurus (Bovine),82.2,169.0,2.1000000000000002e-81,303.1,"sp|P42026|NDUS7_BOVIN NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS7 PE=1 SV=1",GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0015990; GO:0032981; GO:0045271; GO:0046872; GO:0048038; GO:0051539,"aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]",mitochondrial inner membrane [GO:0005743]; respiratory chain complex I [GO:0045271],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]",GO:0005215; GO:0006091; GO:0055085; GO:0065003,transporter activity; generation of precursor metabolites and energy; transmembrane transport; protein-containing complex assembly
OG_09156,2.2021502363159287,FUN_039815-T1,Peve_00039069,Pocillopora_meandrina_HIv1___RNAseq.g7503.t1,three_way,89.79966666666667,FUN_039815-T1,Q92759,TF2H4_HUMAN,,General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit),Homo sapiens (Human),63.9,457.0,3.2e-166,586.3,sp|Q92759|TF2H4_HUMAN General transcription factor IIH subunit 4 OS=Homo sapiens OX=9606 GN=GTF2H4 PE=1 SV=1,GO:0000438; GO:0000439; GO:0001671; GO:0003690; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006289; GO:0006366; GO:0016251; GO:0016607,DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; transcription by RNA polymerase II [GO:0006366],core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675],ATPase activator activity [GO:0001671]; double-stranded DNA binding [GO:0003690]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0043226; GO:0098772; GO:0140223,DNA binding; nucleus; nucleoplasm; DNA repair; DNA-templated transcription; organelle; molecular function regulator activity; general transcription initiation factor activity
OG_09158,1.507324230403908,FUN_039817-T1,Peve_00039024,Pocillopora_meandrina_HIv1___RNAseq.g7505.t1,three_way,89.61566666666667,FUN_039817-T1,Q9Z1Q9,,,,,66.3,991.0,0.0,1398.6,sp|Q9Z1Q9|SYVC_MOUSE Valine--tRNA ligase OS=Mus musculus OX=10090 GN=Vars1 PE=1 SV=1,,,,,,
OG_09160,1.1198082256362,FUN_039819-T1,Peve_00005180,Pocillopora_meandrina_HIv1___RNAseq.g7317.t2,three_way,75.87833333333333,FUN_039819-T1,Q6AXY7,,,,,72.6,215.0,1.7e-90,334.3,sp|Q6AXY7|PR38B_RAT Pre-mRNA-splicing factor 38B OS=Rattus norvegicus OX=10116 GN=Prpf38b PE=1 SV=1,,,,,,
OG_09163,1.3912726785151477,FUN_039824-T1,Peve_00005158,Pocillopora_meandrina_HIv1___RNAseq.g7312.t1,three_way,81.45366666666666,FUN_039824-T1,P42700,,,,,51.9,536.0,4.3e-154,546.2,sp|P42700|RO60_XENLA RNA-binding protein RO60 OS=Xenopus laevis OX=8355 GN=ro60 PE=1 SV=1,,,,,,
OG_09165,1.9987565063444688,FUN_039827-T1,Peve_00005157,Pocillopora_meandrina_HIv1___RNAseq.g7311.t1,three_way,64.71333333333334,FUN_039827-T1,P00520,,,,,67.9,483.0,8.4e-202,705.7,sp|P00520|ABL1_MOUSE Tyrosine-protein kinase ABL1 OS=Mus musculus OX=10090 GN=Abl1 PE=1 SV=3,,,,,,
OG_09166,1.1296646142394424,FUN_039828-T1,Peve_00005156,Pocillopora_meandrina_HIv1___RNAseq.g7310.t1,three_way,59.853,,,,,,,,,,,,,,,,,
OG_09171,1.440557173759425,FUN_039837-T2,Peve_00006311,Pocillopora_meandrina_HIv1___RNAseq.g7300.t1,three_way,76.486,FUN_039837-T2,Q5R7V3,,,,,48.8,80.0,4.4e-16,86.7,sp|Q5R7V3|ACBD5_PONAB Acyl-CoA-binding domain-containing protein 5 OS=Pongo abelii OX=9601 GN=ACBD5 PE=2 SV=1,,,,,,
OG_09172,2.150743930365117,FUN_039848-T1,Peve_00006309,Pocillopora_meandrina_HIv1___TS.g1047.t1,three_way,71.90033333333334,FUN_039848-T1,Q9JHB4,,,,,40.2,306.0,1.3e-50,201.8,sp|Q9JHB4|WDR31_MOUSE WD repeat-containing protein 31 OS=Mus musculus OX=10090 GN=Wdr31 PE=2 SV=1,,,,,,
OG_09173,1.5638432644380158,FUN_039849-T1,Peve_00006320,Pocillopora_meandrina_HIv1___RNAseq.g7298.t1,three_way,70.33566666666667,FUN_039849-T1,A8WQK3,,,,,33.2,506.0,8.5e-67,256.5,sp|A8WQK3|ACH1_CAEBR Acetylcholine receptor subunit alpha-type acr-16 OS=Caenorhabditis briggsae OX=6238 GN=acr-16 PE=3 SV=2,,,,,,
OG_09189,3.2421525436851764,FUN_039871-T1,Peve_00011726,Pocillopora_meandrina_HIv1___RNAseq.g7376.t1,three_way,52.6305,FUN_039871-T1,Q54PX0,Y4251_DICDI,,Probable serine/threonine-protein kinase DDB_G0284251 (EC 2.7.11.1),Dictyostelium discoideum (Social amoeba),27.9,201.0,3e-07,58.2,sp|Q54PX0|Y4251_DICDI Probable serine/threonine-protein kinase DDB_G0284251 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0284251 PE=3 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0046872; GO:0106310,,cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09190,1.684224210474875,FUN_039872-T1,Peve_00011727,Pocillopora_meandrina_HIv1___RNAseq.g7375.t1,three_way,52.92466666666667,FUN_039872-T1,Q9ULM3,YETS2_HUMAN,,YEATS domain-containing protein 2,Homo sapiens (Human),67.7,155.0,9.9e-59,229.9,sp|Q9ULM3|YETS2_HUMAN YEATS domain-containing protein 2 OS=Homo sapiens OX=9606 GN=YEATS2 PE=1 SV=2,GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0017025; GO:0035267; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140030; GO:0140566; GO:0140672,chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357],ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone binding [GO:0042393]; histone reader activity [GO:0140566]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_09191,2.0916392828569106,FUN_039873-T1,Peve_00011728,Pocillopora_meandrina_HIv1___RNAseq.g7374.t1,three_way,85.6805,FUN_039873-T1,A2AJ77,PRD12_MOUSE,,PR domain zinc finger protein 12 (PR domain-containing protein 12),Mus musculus (Mouse),45.0,289.0,1.8e-61,238.0,sp|A2AJ77|PRD12_MOUSE PR domain zinc finger protein 12 OS=Mus musculus OX=10090 GN=Prdm12 PE=2 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0008168; GO:0008270; GO:0019233; GO:0022008; GO:0031175; GO:0032259; GO:0050965; GO:0140713; GO:1990226,detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; sensory perception of pain [GO:0019233],nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone chaperone activity [GO:0140713]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0050877; GO:0140104,DNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; nervous system process; molecular carrier activity
OG_09193,1.340064127196949,FUN_039875-T1,Peve_00004944,Pocillopora_meandrina_HIv1___RNAseq.g7357.t1,three_way,83.253,FUN_039875-T1,Q3T1G7,,,,,39.1,780.0,1.2e-146,521.9,sp|Q3T1G7|COG7_RAT Conserved oligomeric Golgi complex subunit 7 OS=Rattus norvegicus OX=10116 GN=Cog7 PE=2 SV=1,,,,,,
OG_09194,1.3137316508595227,FUN_039876-T1,Peve_00004937,Pocillopora_meandrina_HIv1___RNAseq.g7360.t1,three_way,87.82566666666666,FUN_039876-T1,Q26626,,,,,65.3,792.0,5.3e-252,872.1,sp|Q26626|KIFA3_STRPU Kinesin-associated protein 3 OS=Strongylocentrotus purpuratus OX=7668 GN=KAP115 PE=1 SV=1,,,,,,
OG_09201,1.8712428166524573,FUN_039886-T1,Peve_00021852,Pocillopora_meandrina_HIv1___RNAseq.g7370.t1,three_way,57.459,FUN_039886-T1,Q9H8P0,SR5A3_HUMAN,,Polyprenal reductase (EC 1.3.1.94) (3-oxo-5-alpha-steroid 4-dehydrogenase 3) (EC 1.3.1.22) (Steroid 5-alpha-reductase 2-like) (Steroid 5-alpha-reductase 3) (S5AR 3) (SR type 3),Homo sapiens (Human),33.1,275.0,6e-33,142.9,sp|Q9H8P0|SR5A3_HUMAN Polyprenal reductase OS=Homo sapiens OX=9606 GN=SRD5A3 PE=1 SV=1,GO:0003865; GO:0005783; GO:0005789; GO:0006488; GO:0006489; GO:0006702; GO:0016095; GO:0016628; GO:0019348; GO:0019408; GO:0047751; GO:0102389; GO:0160198,androgen biosynthetic process [GO:0006702]; dolichol biosynthetic process [GO:0019408]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol catabolic process [GO:0016095],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],"3-oxo-5-alpha-steroid 4-dehydrogenase (NADP+) activity [GO:0047751]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; polyprenal reductase activity [GO:0160198]; polyprenol reductase activity [GO:0102389]",GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle; carbohydrate derivative metabolic process
OG_09205,1.5101316404160354,FUN_039893-T1,Peve_00021861,Pocillopora_meandrina_HIv1___RNAseq.g7363.t1,three_way,81.48033333333333,FUN_039893-T1,Q7ZVB2,,,,,62.8,487.0,9.4e-183,641.3,sp|Q7ZVB2|A9A1A_DANRE 4-trimethylaminobutyraldehyde dehydrogenase A OS=Danio rerio OX=7955 GN=aldh9a1a PE=2 SV=1,,,,,,
OG_09210,1.6662962598990136,FUN_039923-T1,Peve_00010141,Pocillopora_meandrina_HIv1___RNAseq.g7340.t1,three_way,61.899,,,,,,,,,,,,,,,,,
OG_09212,2.1296436457656247,FUN_039928-T1,Peve_00002279,Pocillopora_meandrina_HIv1___TS.g307.t1,three_way,71.687,,,,,,,,,,,,,,,,,
OG_09214,2.531629945441796,FUN_039931-T1,Peve_00036243,Pocillopora_meandrina_HIv1___RNAseq.g7332.t1,three_way,58.890166666666666,FUN_039931-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),40.3,578.0,1.5999999999999999e-96,355.9,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_09215,1.798533175326401,FUN_039932-T1,Peve_00036232,Pocillopora_meandrina_HIv1___RNAseq.g7329.t1,three_way,50.97533333333333,,,,,,,,,,,,,,,,,
OG_09224,1.5893761358926382,FUN_039946-T1,Peve_00010690,Pocillopora_meandrina_HIv1___RNAseq.g7320.t1,three_way,85.51166666666667,FUN_039946-T1,Q9DAJ4,WDR83_MOUSE,,WD repeat domain-containing protein 83 (Mitogen-activated protein kinase organizer 1) (MAPK organizer 1),Mus musculus (Mouse),49.0,302.0,8.000000000000001e-49,195.7,sp|Q9DAJ4|WDR83_MOUSE WD repeat domain-containing protein 83 OS=Mus musculus OX=10090 GN=Wdr83 PE=1 SV=1,GO:0000398; GO:0001666; GO:0001843; GO:0005634; GO:0005737; GO:0005764; GO:0009611; GO:0032496; GO:0043122; GO:0060674; GO:0071013; GO:0090594,"inflammatory response to wounding [GO:0090594]; mRNA splicing, via spliceosome [GO:0000398]; neural tube closure [GO:0001843]; placenta blood vessel development [GO:0060674]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; lysosome [GO:0005764]; nucleus [GO:0005634],,GO:0005634; GO:0005764; GO:0005773; GO:0006954; GO:0016071; GO:0043226; GO:0048856,nucleus; lysosome; vacuole; inflammatory response; mRNA metabolic process; organelle; anatomical structure development
OG_09225,2.742668458287676,FUN_039947-T1,Peve_00039029,Pocillopora_meandrina_HIv1___RNAseq.g7508.t1,three_way,78.4495,FUN_039947-T1,Q5T280,SPOUT_HUMAN,,28S rRNA (uridine-N(3))-methyltransferase (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (Methyltransferase C9orf114) (Ribosomal RNA methyltransferase SPOUT1) (SPOUT domain-containing methyltransferase 1),Homo sapiens (Human),60.8,237.0,1.3e-79,297.7,sp|Q5T280|SPOUT_HUMAN 28S rRNA (uridine-N(3))-methyltransferase OS=Homo sapiens OX=9606 GN=SPOUT1 PE=1 SV=3,GO:0000776; GO:0003723; GO:0005737; GO:0010608; GO:0031616; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0070042; GO:0070475; GO:0072686; GO:1904047,cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608]; rRNA base methylation [GO:0070475],cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616],miRNA binding [GO:0035198]; RNA binding [GO:0003723]; rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003723; GO:0003824; GO:0005815; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on RNA"
OG_09228,1.5948768368584731,FUN_039965-T1,Peve_00039032,Pocillopora_meandrina_HIv1___RNAseq.g7516.t1,three_way,86.89633333333333,FUN_039965-T1,P28700,RXRA_MOUSE,,Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha),Mus musculus (Mouse),37.9,340.0,1.9999999999999998e-53,211.1,sp|P28700|RXRA_MOUSE Retinoic acid receptor RXR-alpha OS=Mus musculus OX=10090 GN=Rxra PE=1 SV=1,GO:0000122; GO:0000977; GO:0000978; GO:0001162; GO:0001223; GO:0001701; GO:0001890; GO:0001893; GO:0002157; GO:0003007; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0006355; GO:0006357; GO:0007507; GO:0007566; GO:0008270; GO:0009755; GO:0010467; GO:0010629; GO:0030501; GO:0031490; GO:0042789; GO:0042802; GO:0043010; GO:0043565; GO:0045893; GO:0045944; GO:0045994; GO:0048384; GO:0055007; GO:0055010; GO:0055012; GO:0060038; GO:0060485; GO:0060528; GO:0060687; GO:0060978; GO:0061032; GO:0070564; GO:0090575,angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; camera-type eye development [GO:0043010]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; embryo implantation [GO:0007566]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; hormone-mediated signaling pathway [GO:0009755]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; mesenchyme development [GO:0060485]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of thyroid hormone receptor signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational initiation by iron [GO:0045994]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral serous pericardium development [GO:0061032],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667],chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006351; GO:0006355; GO:0016071; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_09230,1.6415966113966594,FUN_039968-T1,Peve_00039036,Pocillopora_meandrina_HIv1___RNAseq.g7517.t1c,three_way,57.724,,,,,,,,,,,,,,,,,
OG_09232,2.023616773868214,FUN_039973-T1,Peve_00000409,Pocillopora_meandrina_HIv1___RNAseq.g7541.t1,three_way,75.81366666666666,FUN_039973-T1,A0A1L8GVF0,RA50S_XENLA,,DNA repair protein RAD50.S (EC 3.6.-.-),Xenopus laevis (African clawed frog),38.8,1313.0,5.3e-182,640.2,sp|A0A1L8GVF0|RA50S_XENLA DNA repair protein RAD50.S OS=Xenopus laevis OX=8355 GN=rad50.S PE=1 SV=1,GO:0000722; GO:0000729; GO:0000781; GO:0000794; GO:0003691; GO:0005524; GO:0006302; GO:0007004; GO:0016887; GO:0030870; GO:0035861; GO:0043047; GO:0043539; GO:0046872; GO:0051310; GO:0051880; GO:0062176; GO:0070192; GO:0110025,chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; metaphase chromosome alignment [GO:0051310]; R-loop processing [GO:0062176]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004],"chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; Mre11 complex [GO:0030870]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; protein serine/threonine kinase activator activity [GO:0043539]; single-stranded telomeric DNA binding [GO:0043047],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006310; GO:0006325; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0098772,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; DNA recombination; chromatin organization; hydrolase activity; reproductive process; telomere organization; organelle; molecular function regulator activity
OG_09233,4.790767389873954,FUN_039977-T1,Peve_00029897,Pocillopora_meandrina_HIv1___RNAseq.g7542.t1,three_way,56.55166666666666,FUN_039977-T1,Q9ULJ7,,,,,25.1,427.0,1.1e-26,124.8,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_09237,3.560431154456557,FUN_039990-T1,Peve_00004422,Pocillopora_meandrina_HIv1___RNAseq.g7562.t1,three_way,81.36533333333333,FUN_039990-T1,Q96CN4,EVI5L_HUMAN,,EVI5-like protein (Ecotropic viral integration site 5-like protein),Homo sapiens (Human),45.3,516.0,1.2e-114,415.2,sp|Q96CN4|EVI5L_HUMAN EVI5-like protein OS=Homo sapiens OX=9606 GN=EVI5L PE=1 SV=1,GO:0005096; GO:0031267; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],,GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0098772,molecular function regulator activity
OG_09240,2.3511375829782875,FUN_040028-T1,Peve_00004957,Pocillopora_meandrina_HIv1___RNAseq.g8435.t1,three_way,50.78683333333333,FUN_040028-T1,Q8C1B2,PARPT_MOUSE,,Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (TCDD-inducible poly [ADP-ribose] polymerase),Mus musculus (Mouse),32.0,453.0,8.3e-47,190.3,sp|Q8C1B2|PARPT_MOUSE Protein mono-ADP-ribosyltransferase TIPARP OS=Mus musculus OX=10090 GN=Tiparp PE=2 SV=1,GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0008209; GO:0008210; GO:0008270; GO:0008585; GO:0009791; GO:0010629; GO:0016779; GO:0030097; GO:0045732; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0140803; GO:0140806; GO:0140807; GO:1904612,"androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]",nucleus [GO:0005634],cis-regulatory region sequence-specific DNA binding [GO:0000987]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006629; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; lipid metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09241,2.591003140504456,FUN_040029-T1,Peve_00025977,Pocillopora_meandrina_HIv1___RNAseq.g8448.t1,three_way,44.02483333333333,FUN_040029-T1,Q8BZ20,,,,,27.0,711.0,1.1e-55,220.7,sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3,,,,,,
OG_09245,1.679589401746273,FUN_040035-T1,Peve_00025986,Pocillopora_meandrina_HIv1___RNAseq.g8453.t1,three_way,51.272,FUN_040035-T1,Q8BUH7,RNF26_MOUSE,,E3 ubiquitin-protein ligase RNF26 (EC 2.3.2.27) (RING finger protein 26),Mus musculus (Mouse),35.3,85.0,1.1e-08,62.8,sp|Q8BUH7|RNF26_MOUSE E3 ubiquitin-protein ligase RNF26 OS=Mus musculus OX=10090 GN=Rnf26 PE=2 SV=1,GO:0005789; GO:0007032; GO:0008270; GO:0016567; GO:0032479; GO:0050687; GO:0061630; GO:0070979; GO:1905719,endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479],endoplasmic reticulum membrane [GO:0005789],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09247,3.3864063450212845,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09251,2.835419497781464,FUN_040041-T1,Peve_00040425,Pocillopora_meandrina_HIv1___TS.g20197.t1,three_way,47.19116666666667,,,,,,,,,,,,,,,,,
OG_09259,1.34371735478742,FUN_040062-T1,Peve_00033907,Pocillopora_meandrina_HIv1___RNAseq.g7705.t1,three_way,81.21966666666667,FUN_040062-T1,Q2TBW7,SNX2_BOVIN,,Sorting nexin-2,Bos taurus (Bovine),45.7,523.0,5.7e-97,356.3,sp|Q2TBW7|SNX2_BOVIN Sorting nexin-2 OS=Bos taurus OX=9913 GN=SNX2 PE=2 SV=1,GO:0005768; GO:0005829; GO:0006886; GO:0010008; GO:0030027; GO:0030904; GO:0031901; GO:0034498; GO:0035091; GO:0042147; GO:0072673,"early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; retromer complex [GO:0030904],phosphatidylinositol binding [GO:0035091],GO:0005768; GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09262,2.8570710230391803,FUN_040067-T1,Peve_00033898,Pocillopora_meandrina_HIv1___RNAseq.g7701.t2,three_way,60.609,FUN_040067-T1,A8VU90,ANKL1_MOUSE,,Ankyrin repeat and LEM domain-containing protein 1 (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3),Mus musculus (Mouse),45.4,251.0,4.0999999999999996e-53,210.7,sp|A8VU90|ANKL1_MOUSE Ankyrin repeat and LEM domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankle1 PE=2 SV=1,GO:0004519; GO:0005654; GO:0005829; GO:0006611; GO:0045950; GO:1905453; GO:1905456,negative regulation of mitotic recombination [GO:0045950]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453],cytosol [GO:0005829]; nucleoplasm [GO:0005654],endonuclease activity [GO:0004519],GO:0003824; GO:0005654; GO:0005829; GO:0006886; GO:0006913,catalytic activity; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_09264,1.8844611573719592,FUN_040069-T2,Peve_00033916,Pocillopora_meandrina_HIv1___TS.g1452.t1,three_way,49.821666666666665,,,,,,,,,,,,,,,,,
OG_09266,2.0199753199127746,FUN_040071-T1,Peve_00021006,Pocillopora_meandrina_HIv1___RNAseq.g7693.t1,three_way,74.35883333333334,FUN_040071-T1,P17439,GBA1_MOUSE,,Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase),Mus musculus (Mouse),48.2,500.0,5.999999999999999e-140,499.2,sp|P17439|GBA1_MOUSE Lysosomal acid glucosylceramidase OS=Mus musculus OX=10090 GN=Gba1 PE=1 SV=1,GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0042391; GO:0043161; GO:0043202; GO:0043409; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:1901805; GO:1903052; GO:1904457; GO:1905037; GO:1905091; GO:1905146,antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021],endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295],GO:0002376; GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005794; GO:0006091; GO:0006629; GO:0006914; GO:0007005; GO:0007040; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:1901135,immune system process; catalytic activity; extracellular space; lysosome; vacuole; endoplasmic reticulum; Golgi apparatus; generation of precursor metabolites and energy; lipid metabolic process; autophagy; mitochondrion organization; lysosome organization; programmed cell death; transferase activity; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; cell motility; nervous system process; carbohydrate derivative metabolic process
OG_09267,1.3245956924164244,FUN_040072-T1,Peve_00021005,Pocillopora_meandrina_HIv1___RNAseq.g7692.t2,three_way,86.87233333333333,FUN_040072-T1,Q6PB70,,,,,38.3,838.0,5e-155,549.7,sp|Q6PB70|ANO8_MOUSE Anoctamin-8 OS=Mus musculus OX=10090 GN=Ano8 PE=1 SV=3,,,,,,
OG_09268,1.255721518434168,FUN_040074-T2,Peve_00021004,Pocillopora_meandrina_HIv1___RNAseq.g7691.t1,three_way,66.16066666666667,FUN_040074-T2,Q6DHG8,SKA1_DANRE,,SKA complex subunit 1 (Spindle and kinetochore-associated protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),28.6,196.0,1.6e-16,87.8,sp|Q6DHG8|SKA1_DANRE SKA complex subunit 1 OS=Danio rerio OX=7955 GN=ska1 PE=2 SV=1,GO:0000070; GO:0000278; GO:0000940; GO:0005737; GO:0005876; GO:0007059; GO:0007080; GO:0008017; GO:0031110; GO:0051301; GO:0051315; GO:0072686; GO:0072687,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110],cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876],microtubule binding [GO:0008017],GO:0000278; GO:0007059; GO:0008092; GO:0043226,mitotic cell cycle; chromosome segregation; cytoskeletal protein binding; organelle
OG_09270,3.0910639382351603,FUN_040076-T1,Peve_00011678,Pocillopora_meandrina_HIv1___RNAseq.g7621.t1,three_way,86.5475,FUN_040076-T1,A0JMA9,,,,,57.6,564.0,2.1999999999999998e-169,597.0,sp|A0JMA9|KATL2_XENTR Katanin p60 ATPase-containing subunit A-like 2 OS=Xenopus tropicalis OX=8364 GN=katnal2 PE=2 SV=1,,,,,,
OG_09271,1.1401472033380655,FUN_040077-T1,Peve_00011685,Pocillopora_meandrina_HIv1___RNAseq.g7622.t1,three_way,85.2825,FUN_040077-T1,Q5RCK5,,,,,47.2,324.0,4.2e-40,166.8,sp|Q5RCK5|ASB7_PONAB Ankyrin repeat and SOCS box protein 7 OS=Pongo abelii OX=9601 GN=ASB7 PE=2 SV=1,,,,,,
OG_09273,1.231245016192752,FUN_040082-T1,Peve_00041152,Pocillopora_meandrina_HIv1___RNAseq.g7687.t1,three_way,78.7585,FUN_040082-T1,Q8NFF2,NCKX4_HUMAN,,Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4),Homo sapiens (Human),38.9,609.0,2.7e-103,377.5,sp|Q8NFF2|NCKX4_HUMAN Sodium/potassium/calcium exchanger 4 OS=Homo sapiens OX=9606 GN=SLC24A4 PE=1 SV=2,GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834,amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; monoatomic ion transport [GO:0006811]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]",GO:0005215; GO:0005886; GO:0043226; GO:0048856; GO:0050877; GO:0055085,transporter activity; plasma membrane; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_09275,1.2046014972576835,FUN_040085-T1,Peve_00041155,Pocillopora_meandrina_HIv1___RNAseq.g7619.t1,three_way,75.82766666666666,FUN_040085-T1,Q96M60,,,,,31.1,437.0,5.7e-50,200.3,sp|Q96M60|F227B_HUMAN Protein FAM227B OS=Homo sapiens OX=9606 GN=FAM227B PE=1 SV=2,,,,,,
OG_09276,1.4628331888638344,FUN_040086-T1,Peve_00043013,Pocillopora_meandrina_HIv1___RNAseq.g7618.t1,three_way,61.819833333333335,FUN_040086-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),26.7,420.0,1.1e-39,166.4,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_09277,1.947860119940808,FUN_040087-T1,Peve_00043018,Pocillopora_meandrina_HIv1___RNAseq.g7617.t1,three_way,86.96233333333333,FUN_040087-T1,Q2TBV5,,,,,56.7,187.0,3.4e-61,236.1,sp|Q2TBV5|TF2H2_BOVIN General transcription factor IIH subunit 2 OS=Bos taurus OX=9913 GN=GTF2H2 PE=2 SV=1,,,,,,
OG_09287,1.5251867423750034,FUN_040113-T1,Peve_00019474,Pocillopora_meandrina_HIv1___RNAseq.15744_t,three_way,66.83666666666666,FUN_040113-T1,O75063,XYLK_HUMAN,,Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase),Homo sapiens (Human),56.3,350.0,6.4e-116,419.1,sp|O75063|XYLK_HUMAN Glycosaminoglycan xylosylkinase OS=Homo sapiens OX=9606 GN=FAM20B PE=1 SV=1,GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016301; GO:0016773; GO:0030166; GO:0046872,proteoglycan biosynthetic process [GO:0030166],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654],"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]",GO:0003824; GO:0005654; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; nucleoplasm; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_09289,2.285521095990043,FUN_040116-T1,Peve_00043154,Pocillopora_meandrina_HIv1___RNAseq.g8711.t1,three_way,56.97933333333333,FUN_040116-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),35.8,545.0,3.1999999999999997e-85,317.4,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09290,1.531418359593879,FUN_040133-T1,Peve_00038121,Pocillopora_meandrina_HIv1___RNAseq.g6681.t1,three_way,79.771,FUN_040133-T1,Q08257,QOR_HUMAN,,Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin),Homo sapiens (Human),59.5,321.0,4.100000000000001e-104,379.4,sp|Q08257|QOR_HUMAN Quinone oxidoreductase OS=Homo sapiens OX=9606 GN=CRYZ PE=1 SV=1,GO:0003730; GO:0003960; GO:0005739; GO:0005829; GO:0007601; GO:0008270; GO:0042178; GO:0042802; GO:0051289; GO:0070062; GO:0070402,protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005739; GO:0005829; GO:0016491; GO:0043226; GO:0050877; GO:0065003,RNA binding; catalytic activity; mitochondrion; cytosol; oxidoreductase activity; organelle; nervous system process; protein-containing complex assembly
OG_09292,1.462741610168052,FUN_040137-T1,Peve_00038117,Pocillopora_meandrina_HIv1___RNAseq.g6687.t1,three_way,85.08683333333333,FUN_040137-T1,Q9DC33,HM20A_MOUSE,,High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein HMGX1) (Inhibitor of BRAF35) (iBRAF),Mus musculus (Mouse),39.6,386.0,2.9e-64,247.7,sp|Q9DC33|HM20A_MOUSE High mobility group protein 20A OS=Mus musculus OX=10090 GN=Hmg20a PE=1 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0006325; GO:0033234; GO:0042802; GO:0045665,chromatin organization [GO:0006325]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122],nucleus [GO:0005634],DNA binding [GO:0003677]; identical protein binding [GO:0042802],GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0043226,DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle
OG_09294,1.97699853140933,FUN_040140-T1,Peve_00038114,Pocillopora_meandrina_HIv1___RNAseq.g8514.t1,three_way,65.46633333333334,FUN_040140-T1,Q66LN0,PGES2_BOVIN,,Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) [Cleaved into: Prostaglandin E synthase 2 truncated form],Bos taurus (Bovine),47.7,176.0,2.8e-42,173.7,sp|Q66LN0|PGES2_BOVIN Prostaglandin E synthase 2 OS=Bos taurus OX=9913 GN=PTGES2 PE=1 SV=3,GO:0001516; GO:0005739; GO:0005783; GO:0016020; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220,prostaglandin biosynthetic process [GO:0001516],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739],12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220],GO:0003824; GO:0005739; GO:0005783; GO:0006629; GO:0016491; GO:0016829; GO:0016853; GO:0043226,catalytic activity; mitochondrion; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; lyase activity; isomerase activity; organelle
OG_09296,1.4252757647651244,FUN_040149-T1,Peve_00036065,Pocillopora_meandrina_HIv1___RNAseq.g8499.t1,three_way,87.29899999999999,FUN_040149-T1,O67802,,,,,30.3,211.0,3.5e-17,90.1,sp|O67802|DLHH_AQUAE Putative carboxymethylenebutenolidase OS=Aquifex aeolicus (strain VF5) OX=224324 GN=aq_1997 PE=3 SV=1,,,,,,
OG_09297,1.4128100856713148,FUN_040150-T1,Peve_00038146,Pocillopora_meandrina_HIv1___TS.g20237.t1,three_way,63.22716666666667,FUN_040150-T1,Q7Z591,AKNA_HUMAN,,Microtubule organization protein AKNA (AT-hook-containing transcription factor),Homo sapiens (Human),27.6,254.0,1.3e-09,67.4,sp|Q7Z591|AKNA_HUMAN Microtubule organization protein AKNA OS=Homo sapiens OX=9606 GN=AKNA PE=1 SV=2,GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234,delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654],DNA binding [GO:0003677],GO:0003677; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0030154; GO:0043226,DNA binding; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle
OG_09299,1.0199796678471036,FUN_040152-T1,Peve_00038144,Pocillopora_meandrina_HIv1___RNAseq.g8496.t1,three_way,65.6315,FUN_040152-T1,P17702,,,,,49.2,122.0,2.2999999999999997e-24,113.2,sp|P17702|RL28_RAT Large ribosomal subunit protein eL28 OS=Rattus norvegicus OX=10116 GN=Rpl28 PE=1 SV=4,,,,,,
OG_09300,1.925202657874568,FUN_040153-T1,Peve_00038143,Pocillopora_meandrina_HIv1___RNAseq.g8494.t1,three_way,62.255,FUN_040153-T1,B3RNE8,,,,,46.8,248.0,4.1999999999999996e-47,190.7,sp|B3RNE8|ATAT_TRIAD Alpha-tubulin N-acetyltransferase OS=Trichoplax adhaerens OX=10228 GN=TRIADDRAFT_53139 PE=3 SV=1,,,,,,
OG_09305,2.408043156885305,FUN_040173-T1,Peve_00038124,Pocillopora_meandrina_HIv1___RNAseq.g7732.t2,three_way,76.989,FUN_040173-T1,Q9HAD4,,,,,29.1,433.0,1.6e-50,201.8,sp|Q9HAD4|WDR41_HUMAN WD repeat-containing protein 41 OS=Homo sapiens OX=9606 GN=WDR41 PE=1 SV=3,,,,,,
OG_09307,1.068071826493081,FUN_040204-T1,Peve_00038097,Pocillopora_meandrina_HIv1___RNAseq.g7737.t1,three_way,73.24666666666667,FUN_040204-T1,Q9CXZ1,NDUS4_MOUSE,,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)",Mus musculus (Mouse),60.4,144.0,4.699999999999999e-43,175.6,"sp|Q9CXZ1|NDUS4_MOUSE NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial OS=Mus musculus OX=10090 GN=Ndufs4 PE=1 SV=3",GO:0003016; GO:0005739; GO:0005743; GO:0006099; GO:0006954; GO:0007420; GO:0007601; GO:0007605; GO:0007628; GO:0008137; GO:0009060; GO:0014876; GO:0022904; GO:0030534; GO:0032981; GO:0036343; GO:0042417; GO:0042776; GO:0045087; GO:0045271; GO:0048666; GO:0050890; GO:0051402; GO:0051881; GO:0071453; GO:0072593,adult behavior [GO:0030534]; adult walking behavior [GO:0007628]; aerobic respiration [GO:0009060]; brain development [GO:0007420]; cellular response to oxygen levels [GO:0071453]; cognition [GO:0050890]; dopamine metabolic process [GO:0042417]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; psychomotor behavior [GO:0036343]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]; respiratory electron transport chain [GO:0022904]; respiratory system process [GO:0003016]; response to injury involved in regulation of muscle adaptation [GO:0014876]; sensory perception of sound [GO:0007605]; tricarboxylic acid cycle [GO:0006099]; visual perception [GO:0007601],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271],NADH dehydrogenase (ubiquinone) activity [GO:0008137],GO:0002376; GO:0003016; GO:0005215; GO:0005739; GO:0006091; GO:0006954; GO:0012501; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:0065003; GO:0098542; GO:1901135,immune system process; respiratory system process; transporter activity; mitochondrion; generation of precursor metabolites and energy; inflammatory response; programmed cell death; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; defense response to other organism; carbohydrate derivative metabolic process
OG_09311,1.5982260834040685,FUN_040215-T1,Peve_00023450,Pocillopora_meandrina_HIv1___RNAseq.g7755.t1,three_way,55.80383333333333,FUN_040215-T1,Q6DRL5,MBB1A_DANRE,,Myb-binding protein 1A-like protein,Danio rerio (Zebrafish) (Brachydanio rerio),36.2,519.0,9.5e-36,153.3,sp|Q6DRL5|MBB1A_DANRE Myb-binding protein 1A-like protein OS=Danio rerio OX=7955 GN=mybbp1a PE=1 SV=1,GO:0003714; GO:0005730; GO:0043565; GO:0048511,rhythmic process [GO:0048511],nucleolus [GO:0005730],sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005730; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleolus; organelle; molecular adaptor activity; transcription regulator activity
OG_09312,2.113686030186261,FUN_040217-T1,Peve_00023451,Pocillopora_meandrina_HIv1___RNAseq.g7756.t1,three_way,77.917,FUN_040217-T1,H2FLJ1,,,,,69.5,302.0,1.4e-88,328.2,sp|H2FLJ1|STML1_CAEEL Stomatin-like protein stl-1 OS=Caenorhabditis elegans OX=6239 GN=stl-1 PE=2 SV=1,,,,,,
OG_09313,2.089129388772043,FUN_040220-T1,Peve_00023452,Pocillopora_meandrina_HIv1___RNAseq.g7757.t1,three_way,57.968833333333336,FUN_040220-T1,Q64264,5HT1A_MOUSE,,5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (Serotonin receptor 1A),Mus musculus (Mouse),23.7,396.0,4.7e-13,77.4,sp|Q64264|5HT1A_MOUSE 5-hydroxytryptamine receptor 1A OS=Mus musculus OX=10090 GN=Htr1a PE=2 SV=2,GO:0001586; GO:0001662; GO:0004993; GO:0005886; GO:0007198; GO:0007210; GO:0007214; GO:0014062; GO:0019229; GO:0030425; GO:0035640; GO:0042053; GO:0042428; GO:0046883; GO:0050795; GO:0090722; GO:0099589,adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; behavioral fear response [GO:0001662]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of behavior [GO:0050795]; regulation of dopamine metabolic process [GO:0042053]; regulation of hormone secretion [GO:0046883]; regulation of serotonin secretion [GO:0014062]; regulation of vasoconstriction [GO:0019229]; serotonin metabolic process [GO:0042428]; serotonin receptor signaling pathway [GO:0007210],dendrite [GO:0030425]; plasma membrane [GO:0005886],G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; receptor-receptor interaction [GO:0090722]; serotonin receptor activity [GO:0099589],GO:0003013; GO:0005886; GO:0023052; GO:0060089,circulatory system process; plasma membrane; signaling; molecular transducer activity
OG_09314,1.046119143160221,FUN_040221-T1,Peve_00023453,Pocillopora_meandrina_HIv1___RNAseq.g7758.t1,three_way,81.74016666666667,,,,,,,,,,,,,,,,,
OG_09315,1.8503037384369792,FUN_040222-T1,Peve_00023454,Pocillopora_meandrina_HIv1___RNAseq.g7759.t1,three_way,64.82433333333333,FUN_040222-T1,Q7TN31,AGGF1_MOUSE,,Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q),Mus musculus (Mouse),45.0,300.0,1.7e-60,235.3,sp|Q7TN31|AGGF1_MOUSE Angiogenic factor with G patch and FHA domains 1 OS=Mus musculus OX=10090 GN=Aggf1 PE=2 SV=1,GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0042802; GO:0045766; GO:0048471,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471],identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676],GO:0005576; GO:0007155; GO:0030154,extracellular region; cell adhesion; cell differentiation
OG_09322,1.7133746377486063,FUN_040238-T1,Peve_00021820,Pocillopora_meandrina_HIv1___RNAseq.g7784.t1,three_way,85.20433333333332,FUN_040238-T1,Q5ZIG3,,,,,44.6,332.0,5.1e-77,289.7,sp|Q5ZIG3|S2546_CHICK Mitochondrial outer membrane protein SLC25A46 OS=Gallus gallus OX=9031 GN=SLC25A46 PE=2 SV=1,,,,,,
OG_09325,1.6713384348874731,FUN_040242-T2,Peve_00018572,Pocillopora_meandrina_HIv1___RNAseq.g7781.t1,three_way,83.071,FUN_040242-T2,Q5ZK21,,,,,46.6,506.0,5.4e-119,429.5,sp|Q5ZK21|INT14_CHICK Integrator complex subunit 14 OS=Gallus gallus OX=9031 GN=INTS14 PE=2 SV=1,,,,,,
OG_09328,2.1571646823159227,FUN_040260-T1,Peve_00029136,Pocillopora_meandrina_HIv1___RNAseq.g7787.t1,three_way,84.27333333333333,FUN_040260-T1,Q5VZE5,NAA35_HUMAN,,"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein homolog) (Protein MAK10 homolog)",Homo sapiens (Human),51.8,706.0,1.6e-188,661.0,"sp|Q5VZE5|NAA35_HUMAN N-alpha-acetyltransferase 35, NatC auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA35 PE=1 SV=1",GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0031417; GO:0043066; GO:0048659,negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659],cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],,GO:0005654; GO:0005829; GO:0005886,nucleoplasm; cytosol; plasma membrane
OG_09329,1.4758047541713617,FUN_040263-T1,Peve_00029137,Pocillopora_meandrina_HIv1___RNAseq.g7788.t1,three_way,72.762,,,,,,,,,,,,,,,,,
OG_09331,2.064550928456258,FUN_040267-T1,Peve_00014979,Pocillopora_meandrina_HIv1___RNAseq.g7811.t1,three_way,61.712,FUN_040267-T1,Q5M824,SHC1_RAT,,SHC-transforming protein 1 (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1),Rattus norvegicus (Rat),35.5,541.0,3.7e-73,277.3,sp|Q5M824|SHC1_RAT SHC-transforming protein 1 OS=Rattus norvegicus OX=10116 GN=Shc1 PE=1 SV=1,GO:0001525; GO:0001666; GO:0001784; GO:0005068; GO:0005154; GO:0005158; GO:0005159; GO:0005168; GO:0005829; GO:0005886; GO:0005925; GO:0006940; GO:0007173; GO:0007507; GO:0008284; GO:0008286; GO:0010008; GO:0030036; GO:0030182; GO:0030971; GO:0031100; GO:0031175; GO:0032868; GO:0032869; GO:0035094; GO:0035556; GO:0042127; GO:0042742; GO:0043066; GO:0043410; GO:0044877; GO:0045892; GO:0045893; GO:0045907; GO:0046875; GO:0048009; GO:0048408; GO:0048661; GO:0051219; GO:0051384; GO:0051721; GO:0070301; GO:0070374; GO:0070435; GO:0071363; GO:0097237; GO:0098609; GO:1904628; GO:1990839,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to insulin stimulus [GO:0032869]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to toxic substance [GO:0097237]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of smooth muscle contraction [GO:0006940]; response to endothelin [GO:1990839]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nicotine [GO:0035094],cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435],ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0003013; GO:0005829; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0030154; GO:0048856; GO:0060090,circulatory system process; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; cell differentiation; anatomical structure development; molecular adaptor activity
OG_09332,1.1755051195301112,FUN_040271-T1,Peve_00014976,Pocillopora_meandrina_HIv1___RNAseq.g7810.t1,three_way,81.51333333333334,FUN_040271-T1,P36776,LONM_HUMAN,,"Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)",Homo sapiens (Human),65.2,838.0,0.0,1104.0,"sp|P36776|LONM_HUMAN Lon protease homolog, mitochondrial OS=Homo sapiens OX=9606 GN=LONP1 PE=1 SV=2",GO:0000002; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0030163; GO:0032042; GO:0034599; GO:0035694; GO:0042645; GO:0042731; GO:0042802; GO:0043531; GO:0043560; GO:0043565; GO:0046627; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407,cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]; negative regulation of insulin receptor signaling pathway [GO:0046627]; oxidation-dependent protein catabolic process [GO:0070407]; protein catabolic process [GO:0030163]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; PH domain binding [GO:0042731]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727],GO:0003677; GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0007005; GO:0016787; GO:0030163; GO:0043226; GO:0065003; GO:0140096; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleoplasm; mitochondrion; cytosol; mitochondrion organization; hydrolase activity; protein catabolic process; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; ATP-dependent activity"
OG_09339,1.5352675952741055,FUN_040302-T1,Peve_00038640,Pocillopora_meandrina_HIv1___TS.g20795.t2,three_way,55.475,,,,,,,,,,,,,,,,,
OG_09346,1.0675111337091947,FUN_040329-T1,Peve_00014960,Pocillopora_meandrina_HIv1___TS.g20804.t1,three_way,59.10066666666667,FUN_040329-T1,Q96JI7,SPTCS_HUMAN,,Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein),Homo sapiens (Human),27.8,1418.0,1.1e-133,480.3,sp|Q96JI7|SPTCS_HUMAN Spatacsin OS=Homo sapiens OX=9606 GN=SPG11 PE=1 SV=3,GO:0005730; GO:0005737; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006606; GO:0007040; GO:0007268; GO:0007409; GO:0007528; GO:0007613; GO:0008088; GO:0019901; GO:0021957; GO:0030163; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0047496; GO:0048489; GO:0048675; GO:0048741; GO:0051668; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256,autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; localization within membrane [GO:0051668]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; walking behavior [GO:0090659],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202],protein kinase binding [GO:0019901],GO:0005730; GO:0005783; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0007018; GO:0007040; GO:0012501; GO:0023052; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0061024,nucleolus; endoplasmic reticulum; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; microtubule-based movement; lysosome organization; programmed cell death; signaling; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process; membrane organization
OG_09348,1.9479623185720112,FUN_040403-T1,Peve_00014974,Pocillopora_meandrina_HIv1___RNAseq.g9090.t1,three_way,76.05033333333334,FUN_040403-T1,A7SGF0,,,,,62.4,133.0,2.3999999999999998e-39,163.3,sp|A7SGF0|BORC8_NEMVE BLOC-1-related complex subunit 8 homolog OS=Nematostella vectensis OX=45351 GN=v1g233178 PE=3 SV=1,,,,,,
OG_09350,1.9473731553278484,FUN_040421-T1,Peve_00014973,Pocillopora_meandrina_HIv1___RNAseq.g9088.t2,three_way,72.28966666666666,FUN_040421-T1,Q8K2V6,,,,,45.0,398.0,6.799999999999999e-96,352.4,sp|Q8K2V6|IPO11_MOUSE Importin-11 OS=Mus musculus OX=10090 GN=Ipo11 PE=1 SV=1,,,,,,
OG_09353,1.9376053304654428,FUN_040424-T1,Peve_00004009,Pocillopora_meandrina_HIv1___RNAseq.g6508.t1,three_way,80.8135,FUN_040424-T1,Q13367,,,,,64.1,1065.0,1.8e-297,1023.5,sp|Q13367|AP3B2_HUMAN AP-3 complex subunit beta-2 OS=Homo sapiens OX=9606 GN=AP3B2 PE=1 SV=2,,,,,,
OG_09354,3.0326229643861007,FUN_040425-T1,Peve_00004010,Pocillopora_meandrina_HIv1___RNAseq.g6509.t1,three_way,76.108,,,,,,,,,,,,,,,,,
OG_09357,2.121634110829385,FUN_040443-T1,Peve_00004016,Pocillopora_meandrina_HIv1___RNAseq.g6517.t1,three_way,78.62,FUN_040443-T1,Q8BUY9,,,,,58.1,344.0,1.7e-114,414.1,sp|Q8BUY9|PGTB1_MOUSE Geranylgeranyl transferase type-1 subunit beta OS=Mus musculus OX=10090 GN=Pggt1b PE=1 SV=1,,,,,,
OG_09362,1.666354391988124,FUN_040477-T1,Peve_00015410,Pocillopora_meandrina_HIv1___RNAseq.g6522.t1,three_way,73.125,FUN_040477-T1,Q3UHD6,SNX27_MOUSE,,Sorting nexin-27,Mus musculus (Mouse),49.7,503.0,5.2e-142,506.1,sp|Q3UHD6|SNX27_MOUSE Sorting nexin-27 OS=Mus musculus OX=10090 GN=Snx27 PE=1 SV=2,GO:0001772; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0008333; GO:0016197; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0071203; GO:0090128; GO:0098685; GO:0098794; GO:0098837; GO:0098842; GO:0098978; GO:0099072,endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165],cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; postsynapse [GO:0098794]; postsynaptic early endosome [GO:0098842]; postsynaptic recycling endosome [GO:0098837]; retromer complex [GO:0030904]; Schaffer collateral - CA1 synapse [GO:0098685]; WASH complex [GO:0071203],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0005768; GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09364,1.266772380253457,FUN_040479-T1,Peve_00015393,Pocillopora_meandrina_HIv1___RNAseq.g6524.t1,three_way,54.452,,,,,,,,,,,,,,,,,
OG_09371,2.0632596882605645,FUN_040525-T2,Peve_00024707,Pocillopora_meandrina_HIv1___RNAseq.g1445.t1,three_way,77.679,,,,,,,,,,,,,,,,,
OG_09372,2.6892776106429785,FUN_040547-T1,Peve_00015401,Pocillopora_meandrina_HIv1___RNAseq.g6506.t1,three_way,82.78766666666667,FUN_040547-T1,P46940,IQGA1_HUMAN,,Ras GTPase-activating-like protein IQGAP1 (p195),Homo sapiens (Human),54.6,1653.0,0.0,1496.9,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0009898; GO:0010761; GO:0016323; GO:0016324; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031267; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0070836; GO:0071277; GO:0071364; GO:0072015; GO:1903479; GO:1990138; GO:1990904,caveola assembly [GO:0070836]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; mitotic actomyosin contractile ring assembly actin filament organization [GO:1903479]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; positive regulation of MAPK cascade [GO:0043410]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165],actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057],"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]",GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0061024; GO:0098772,nucleus; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; organelle; anatomical structure development; cell motility; molecular adaptor activity; membrane organization; molecular function regulator activity
OG_09373,2.0377037052414906,FUN_040548-T1,Peve_00015402,Pocillopora_meandrina_HIv1___RNAseq.g6505.t1,three_way,73.82566666666666,FUN_040548-T1,Q9H267,,,,,45.4,579.0,5.8e-143,509.2,sp|Q9H267|VP33B_HUMAN Vacuolar protein sorting-associated protein 33B OS=Homo sapiens OX=9606 GN=VPS33B PE=1 SV=2,,,,,,
OG_09377,2.294164121792913,FUN_040610-T1,Peve_00015406,Pocillopora_meandrina_HIv1___TS.g215.t1,three_way,55.4595,,,,,,,,,,,,,,,,,
OG_09378,1.0796864554362753,FUN_040611-T1,Peve_00015408,Pocillopora_meandrina_HIv1___RNAseq.g6473.t1,three_way,53.87766666666667,FUN_040611-T1,B4F785,EGFLA_RAT,,"Pikachurin (EGF-like, fibronectin type-III and laminin G-like domain-containing protein)",Rattus norvegicus (Rat),24.3,370.0,3.7e-15,85.5,sp|B4F785|EGFLA_RAT Pikachurin OS=Rattus norvegicus OX=10116 GN=Egflam PE=2 SV=1,GO:0005509; GO:0005539; GO:0005604; GO:0005614; GO:0009986; GO:0010811; GO:0030198; GO:0031012; GO:0042995; GO:0043083; GO:0048786; GO:0098684,extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811],basement membrane [GO:0005604]; cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; interstitial matrix [GO:0005614]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083],calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539],GO:0005576; GO:0030198; GO:0030312; GO:0031012,extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_09380,1.7045750815203138,FUN_040663-T1,Peve_00015413,Pocillopora_meandrina_HIv1___RNAseq.g6468.t1,three_way,48.03816666666667,,,,,,,,,,,,,,,,,
OG_09384,2.1111981509227475,FUN_040673-T1,Peve_00015420,Pocillopora_meandrina_HIv1___RNAseq.g6458.t1,three_way,49.12566666666667,,,,,,,,,,,,,,,,,
OG_09386,2.2415990563769164,FUN_040676-T1,Peve_00009590,Pocillopora_meandrina_HIv1___RNAseq.g6455.t1,three_way,80.988,FUN_040676-T1,Q9Y3Y4,,,,,62.9,70.0,4.0000000000000004e-23,109.4,sp|Q9Y3Y4|PYGO1_HUMAN Pygopus homolog 1 OS=Homo sapiens OX=9606 GN=PYGO1 PE=1 SV=2,,,,,,
OG_09387,2.3973537856011653,FUN_040680-T1,Peve_00009589,Pocillopora_meandrina_HIv1___RNAseq.g6447.t1,three_way,74.92949999999999,FUN_040680-T1,Q13972,RGRF1_HUMAN,,Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25),Homo sapiens (Human),40.1,1471.0,1.8e-260,901.0,sp|Q13972|RGRF1_HUMAN Ras-specific guanine nucleotide-releasing factor 1 OS=Homo sapiens OX=9606 GN=RASGRF1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0030426; GO:0031175; GO:0034976; GO:0035022; GO:0035254; GO:0043005; GO:0043409; GO:0043410; GO:0044342; GO:0046578; GO:0046579; GO:0048167; GO:0048168,long-term memory [GO:0007616]; negative regulation of MAPK cascade [GO:0043409]; neuron projection development [GO:0031175]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of Ras protein signal transduction [GO:0046578]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0050877; GO:0098772,cytosol; plasma membrane; nervous system process; molecular function regulator activity
OG_09388,1.303588236309554,FUN_040683-T1,Peve_00009586,Pocillopora_meandrina_HIv1___RNAseq.g6449.t1,three_way,70.731,FUN_040683-T1,P47708,RP3A_MOUSE,,Rabphilin-3A (Exophilin-1),Mus musculus (Mouse),25.4,287.0,6.7e-18,93.2,sp|P47708|RP3A_MOUSE Rabphilin-3A OS=Mus musculus OX=10090 GN=Rph3a PE=1 SV=2,GO:0005509; GO:0005544; GO:0005546; GO:0006886; GO:0008270; GO:0008430; GO:0016082; GO:0019898; GO:0030141; GO:0030672; GO:0031267; GO:0032991; GO:0042301; GO:0043005; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0061669; GO:0070679,intracellular protein transport [GO:0006886]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle priming [GO:0016082],dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0006886; GO:0008289; GO:0031410; GO:0043226; GO:0065003,intracellular protein transport; lipid binding; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_09390,1.0310301761336078,FUN_040686-T1,Peve_00007674,Pocillopora_meandrina_HIv1___RNAseq.g6452.t1,three_way,90.56466666666668,FUN_040686-T1,G1U0Q2,,,,,80.8,146.0,1.8e-62,240.0,sp|G1U0Q2|RS15_RABIT Small ribosomal subunit protein uS19 OS=Oryctolagus cuniculus OX=9986 GN=RPS15 PE=1 SV=1,,,,,,
OG_09391,1.2751903553636017,FUN_040687-T1,Peve_00042976,Pocillopora_meandrina_HIv1___RNAseq.g6440.t2,three_way,44.80716666666667,FUN_040687-T1,Q8AVX1,,,,,26.1,299.0,2.6e-09,64.7,sp|Q8AVX1|GKP1B_XENLA G kinase-anchoring protein 1-B OS=Xenopus laevis OX=8355 GN=gkap1-b PE=2 SV=1,,,,,,
OG_09395,1.0630625416511976,FUN_040693-T1,Peve_00042935,Pocillopora_meandrina_HIv1___RNAseq.g6444.t1,three_way,73.92966666666666,FUN_040693-T1,Q9Y6G5,COMDA_HUMAN,,COMM domain-containing protein 10,Homo sapiens (Human),57.4,197.0,6.3e-55,215.3,sp|Q9Y6G5|COMDA_HUMAN COMM domain-containing protein 10 OS=Homo sapiens OX=9606 GN=COMMD10 PE=1 SV=1,GO:0005654; GO:0005737,,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654],,GO:0005654,nucleoplasm
OG_09397,1.3749401438123872,FUN_040695-T1,Peve_00029579,Pocillopora_meandrina_HIv1___RNAseq.g9092.t1,three_way,83.89,FUN_040695-T1,Q5RF04,,,,,63.8,160.0,1.5999999999999996e-53,210.3,sp|Q5RF04|RLP24_PONAB Probable ribosome biogenesis protein RLP24 OS=Pongo abelii OX=9601 GN=RSL24D1 PE=2 SV=1,,,,,,
OG_09404,1.5439366447839744,FUN_040784-T1,Peve_00042932,Pocillopora_meandrina_HIv1___RNAseq.g17859.t1,three_way,80.83433333333333,FUN_040784-T1,Q9LMI7,,,,,34.0,664.0,2.5e-87,324.7,"sp|Q9LMI7|ACO32_ARATH Putative acyl-coenzyme A oxidase 3.2, peroxisomal OS=Arabidopsis thaliana OX=3702 GN=ACX3.2 PE=3 SV=1",,,,,,
OG_09405,1.1182352984594637,FUN_040854-T1,Peve_00007658,Pocillopora_meandrina_HIv1___RNAseq.g6539.t1,three_way,73.32966666666667,FUN_040854-T1,P82911,,,,,45.1,142.0,2.5e-26,120.2,sp|P82911|RT11_BOVIN Small ribosomal subunit protein uS11m OS=Bos taurus OX=9913 GN=MRPS11 PE=1 SV=2,,,,,,
OG_09406,1.530032345072453,FUN_040856-T2,Peve_00032788,Pocillopora_meandrina_HIv1___RNAseq.g6544.t1,three_way,56.886,,,,,,,,,,,,,,,,,
OG_09407,2.524296233791847,FUN_040857-T1,Peve_00002299,Pocillopora_meandrina_HIv1___RNAseq.4208_ta,three_way,65.18433333333333,FUN_040857-T1,Q6NRK9,,,,,43.9,223.0,2.5999999999999997e-47,190.3,sp|Q6NRK9|CCNQ_XENLA Cyclin-Q OS=Xenopus laevis OX=8355 GN=ccnq PE=2 SV=2,,,,,,
OG_09409,2.827473629938519,FUN_040861-T1,Peve_00002298,Pocillopora_meandrina_HIv1___RNAseq.g6554.t1,three_way,84.35516666666666,FUN_040861-T1,Q5RE70,,,,,41.1,995.0,2.5e-211,737.3,sp|Q5RE70|INT3_PONAB Integrator complex subunit 3 OS=Pongo abelii OX=9601 GN=INTS3 PE=2 SV=1,,,,,,
OG_09413,1.1910776970978276,FUN_040950-T1,Peve_00008820,Pocillopora_meandrina_HIv1___RNAseq.g27113.t1,three_way,67.32266666666666,FUN_040950-T1,Q969X6,UTP4_HUMAN,,U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component),Homo sapiens (Human),32.1,701.0,1.7e-102,375.2,sp|Q969X6|UTP4_HUMAN U3 small nucleolar RNA-associated protein 4 homolog OS=Homo sapiens OX=9606 GN=UTP4 PE=1 SV=1,GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0030490; GO:0030686; GO:0032040; GO:0034455; GO:0042274,"maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of DNA-templated transcription [GO:0006355]; ribosomal small subunit biogenesis [GO:0042274]",90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0043226,RNA binding; nucleoplasm; chromosome; nucleolus; regulation of DNA-templated transcription; organelle
OG_09416,3.3600669650584973,FUN_040957-T1,Peve_00031410,Pocillopora_meandrina_HIv1___RNAseq.g27053.t1,three_way,76.98966666666666,FUN_040957-T1,Q9CQ02,,,,,59.0,188.0,2.6000000000000004e-57,223.8,sp|Q9CQ02|COMD4_MOUSE COMM domain-containing protein 4 OS=Mus musculus OX=10090 GN=Commd4 PE=1 SV=1,,,,,,
OG_09417,2.71945292221608,FUN_040958-T1,Peve_00031409,Pocillopora_meandrina_HIv1___RNAseq.g27054.t1,three_way,67.29966666666667,,,,,,,,,,,,,,,,,
OG_09422,1.0111234228122057,FUN_041209-T1,Peve_00023415,Pocillopora_meandrina_HIv1___RNAseq.g16121.t1,three_way,62.034,FUN_041209-T1,Q96QS3,ARX_HUMAN,,Homeobox protein ARX (Aristaless-related homeobox),Homo sapiens (Human),40.6,234.0,3.3e-23,110.5,sp|Q96QS3|ARX_HUMAN Homeobox protein ARX OS=Homo sapiens OX=9606 GN=ARX PE=1 SV=1,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0006357; GO:0007411; GO:0010628; GO:0021759; GO:0021800; GO:0021831; GO:0021846; GO:0021853; GO:0035265; GO:0044241; GO:0045944; GO:0046622; GO:0048663; GO:0050678; GO:0072148; GO:1990837,axon guidance [GO:0007411]; cell proliferation in forebrain [GO:0021846]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex tangential migration [GO:0021800]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; epithelial cell fate commitment [GO:0072148]; globus pallidus development [GO:0021759]; lipid digestion [GO:0044241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_09426,1.204169053532261,FUN_041310-T1,Peve_00023188,Pocillopora_meandrina_HIv1___TS.g11106.t1,three_way,76.71966666666667,FUN_041310-T1,P50532,,,,,62.6,1213.0,5.000000000000001e-227,789.6,sp|P50532|SMC4_XENLA Structural maintenance of chromosomes protein 4 OS=Xenopus laevis OX=8355 GN=smc4 PE=1 SV=1,,,,,,
OG_09429,2.167476950109219,FUN_041313-T1,Peve_00002269,Pocillopora_meandrina_HIv1___RNAseq.g6990.t1,three_way,68.18166666666667,FUN_041313-T1,P90543,,,,,68.5,108.0,4.9999999999999995e-31,135.6,sp|P90543|H3_EUPCR Histone H3 OS=Euplotes crassus OX=5936 PE=3 SV=3,,,,,,
OG_09431,1.147131670910871,FUN_041369-T1,Peve_00037815,Pocillopora_meandrina_HIv1___RNAseq.g16109.t2,three_way,79.78216666666667,,,,,,,,,,,,,,,,,
OG_09432,1.2158192771904908,FUN_041389-T1,Peve_00044211,Pocillopora_meandrina_HIv1___RNAseq.g15715.t1,three_way,84.4495,FUN_041389-T1,Q32PP9,,,,,49.8,245.0,5.5e-50,199.5,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_09435,2.141953426682523,FUN_041407-T1,Peve_00020004,Pocillopora_meandrina_HIv1___RNAseq.g15728.t1,three_way,74.4565,FUN_041407-T1,Q5HZP1,,,,,41.7,307.0,7.099999999999999e-53,209.1,sp|Q5HZP1|RNH2B_XENLA Ribonuclease H2 subunit B OS=Xenopus laevis OX=8355 GN=rnaseh2b PE=2 SV=1,,,,,,
OG_09437,1.2845052227263567,FUN_041409-T1,Peve_00017538,Pocillopora_meandrina_HIv1___RNAseq.g15730.t1,three_way,78.86233333333334,FUN_041409-T1,O94826,,,,,36.7,578.0,1.9e-104,381.3,sp|O94826|TOM70_HUMAN Mitochondrial import receptor subunit TOM70 OS=Homo sapiens OX=9606 GN=TOMM70 PE=1 SV=1,,,,,,
OG_09445,1.3930176089715454,FUN_041437-T1,Peve_00007743,Pocillopora_meandrina_HIv1___RNAseq.g15744.t2,three_way,80.71600000000001,FUN_041437-T1,Q96MT8,,,,,30.8,240.0,5.7e-19,97.1,sp|Q96MT8|CEP63_HUMAN Centrosomal protein of 63 kDa OS=Homo sapiens OX=9606 GN=CEP63 PE=1 SV=1,,,,,,
OG_09446,1.0086037715555738,FUN_041438-T1,Peve_00007741,Pocillopora_meandrina_HIv1___RNAseq.g15745.t2,three_way,77.23666666666666,,,,,,,,,,,,,,,,,
OG_09448,1.5569450943299226,FUN_041440-T1,Peve_00007732,Pocillopora_meandrina_HIv1___RNAseq.g15747.t1,three_way,78.19133333333333,FUN_041440-T1,Q24JY4,,,,,53.2,158.0,1.2e-37,157.5,sp|Q24JY4|ZNHI1_BOVIN Zinc finger HIT domain-containing protein 1 OS=Bos taurus OX=9913 GN=ZNHIT1 PE=2 SV=1,,,,,,
OG_09450,1.326990491228491,FUN_041442-T1,Peve_00007411,Pocillopora_meandrina_HIv1___RNAseq.g15694.t1,three_way,75.69166666666666,FUN_041442-T1,Q08623,HDHD1_HUMAN,,Pseudouridine-5'-phosphatase (EC 3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase),Homo sapiens (Human),53.4,221.0,1.3999999999999999e-61,237.7,sp|Q08623|HDHD1_HUMAN Pseudouridine-5'-phosphatase OS=Homo sapiens OX=9606 GN=PUDP PE=1 SV=3,GO:0005829; GO:0009117; GO:0016791; GO:0046872; GO:1990738,nucleotide metabolic process [GO:0009117],cytosol [GO:0005829],metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pseudouridine 5'-phosphatase activity [GO:1990738],GO:0003824; GO:0005829; GO:0016787; GO:0055086,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_09452,2.0655949990632787,FUN_041460-T1,Peve_00007409,Pocillopora_meandrina_HIv1___RNAseq.g15692.t1,three_way,85.84066666666666,FUN_041460-T1,Q68FP9,,,,,56.8,628.0,1e-207,724.5,sp|Q68FP9|COG6_RAT Conserved oligomeric Golgi complex subunit 6 OS=Rattus norvegicus OX=10116 GN=Cog6 PE=2 SV=1,,,,,,
OG_09456,1.620871316058231,FUN_041464-T1,Peve_00013686,Pocillopora_meandrina_HIv1___RNAseq.g15688.t1,three_way,73.06016666666666,FUN_041464-T1,Q06AU2,RAP2A_PIG,,Ras-related protein Rap-2a (EC 3.6.5.2),Sus scrofa (Pig),43.6,165.0,3.2999999999999997e-29,130.6,sp|Q06AU2|RAP2A_PIG Ras-related protein Rap-2a OS=Sus scrofa OX=9823 GN=RAP2A PE=2 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005829; GO:0005886; GO:0005923; GO:0008104; GO:0019003; GO:0019904; GO:0030036; GO:0030336; GO:0030496; GO:0031954; GO:0032486; GO:0044291; GO:0045121; GO:0046328; GO:0048814; GO:0055038; GO:0070062; GO:0070527,actin cytoskeleton organization [GO:0030036]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; positive regulation of protein autophosphorylation [GO:0031954]; protein localization [GO:0008104]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328],bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904],GO:0003824; GO:0003924; GO:0005829; GO:0005886; GO:0007010; GO:0007155; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; cytosol; plasma membrane; cytoskeleton organization; cell adhesion; hydrolase activity; organelle; molecular function regulator activity
OG_09457,1.0089200634131328,FUN_041465-T1,Peve_00041301,Pocillopora_meandrina_HIv1___RNAseq.g15686.t1,three_way,66.148,FUN_041465-T1,P51175,,,,,45.3,461.0,4e-111,403.3,sp|P51175|PPOX_MOUSE Protoporphyrinogen oxidase OS=Mus musculus OX=10090 GN=Ppox PE=1 SV=1,,,,,,
OG_09458,2.891918776912556,FUN_041466-T1,Peve_00028293,Pocillopora_meandrina_HIv1___RNAseq.g15685.t1,three_way,68.417,FUN_041466-T1,Q6NYE7,,,,,35.5,231.0,5.700000000000001e-30,132.9,sp|Q6NYE7|TM192_DANRE Transmembrane protein 192 OS=Danio rerio OX=7955 GN=tmem192 PE=2 SV=1,,,,,,
OG_09469,1.5920450027774973,FUN_041494-T2,Peve_00017071,Pocillopora_meandrina_HIv1___RNAseq.g15664.t2,three_way,87.778,FUN_041494-T2,Q14409,,,,,63.3,542.0,7e-203,708.4,sp|Q14409|GLPK3_HUMAN Glycerol kinase 3 OS=Homo sapiens OX=9606 GN=GK3 PE=1 SV=2,,,,,,
OG_09470,1.2183103896848844,FUN_041495-T1,Peve_00017070,Pocillopora_meandrina_HIv1___RNAseq.g15663.t1,three_way,63.118,FUN_041495-T1,Q9H1I8,ASCC2_HUMAN,,Activating signal cointegrator 1 complex subunit 2 (ASC-1 complex subunit p100) (Trip4 complex subunit p100),Homo sapiens (Human),41.7,769.0,1.1e-126,455.7,sp|Q9H1I8|ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens OX=9606 GN=ASCC2 PE=1 SV=3,GO:0005634; GO:0005654; GO:0006307; GO:0006355; GO:0016607; GO:0022626; GO:0032790; GO:0043130; GO:0070530; GO:0072344; GO:0180022; GO:1990116; GO:1990391,DNA alkylation repair [GO:0006307]; regulation of DNA-templated transcription [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytosolic ribosome [GO:0022626]; DNA repair complex [GO:1990391]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RQC-trigger complex [GO:0180022],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130],GO:0005634; GO:0005654; GO:0005840; GO:0006281; GO:0006355; GO:0030163; GO:0043226,nucleus; nucleoplasm; ribosome; DNA repair; regulation of DNA-templated transcription; protein catabolic process; organelle
OG_09471,2.660180724602144,FUN_041497-T1,Peve_00017073,Pocillopora_meandrina_HIv1___RNAseq.g15661.t1,three_way,80.51666666666667,FUN_041497-T1,P62046,,,,,32.5,711.0,2.7e-36,155.2,sp|P62046|LRCH1_MOUSE Leucine-rich repeat and calponin homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrch1 PE=1 SV=2,,,,,,
OG_09473,3.3485868711976385,FUN_041499-T1,Peve_00007701,Pocillopora_meandrina_HIv1___RNAseq.g15656.t1,three_way,76.57366666666667,FUN_041499-T1,Q8WY91,THAP4_HUMAN,,Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (Ferric Homo sapiens nitrobindin) (Hs-Nb(III)) (THAP domain-containing protein 4),Homo sapiens (Human),39.2,166.0,1.3000000000000001e-33,144.4,sp|Q8WY91|THAP4_HUMAN Peroxynitrite isomerase THAP4 OS=Homo sapiens OX=9606 GN=THAP4 PE=1 SV=2,GO:0003677; GO:0005654; GO:0005829; GO:0006570; GO:0008270; GO:0020037; GO:0042126; GO:0042802; GO:0062213; GO:0070026,nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570],cytosol [GO:0005829]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006520; GO:0016853,DNA binding; catalytic activity; nucleoplasm; cytosol; amino acid metabolic process; isomerase activity
OG_09479,1.2422037419968617,FUN_041506-T1,Peve_00039613,Pocillopora_meandrina_HIv1___RNAseq.g15968.t1,three_way,75.15433333333333,FUN_041506-T1,B5DDX6,,,,,48.4,341.0,5.2e-84,313.2,sp|B5DDX6|SMG9_XENTR Nonsense-mediated mRNA decay factor SMG9 OS=Xenopus tropicalis OX=8364 GN=smg9 PE=2 SV=1,,,,,,
OG_09485,1.3946528282124164,FUN_041518-T1,Peve_00024144,Pocillopora_meandrina_HIv1___RNAseq.6295_t,three_way,45.930166666666665,,,,,,,,,,,,,,,,,
OG_09486,1.3652649529355971,FUN_041519-T1,Peve_00024151,Pocillopora_meandrina_HIv1___RNAseq.g15592.t1,three_way,58.06766666666667,FUN_041519-T1,P27393,,,,,62.9,224.0,9e-84,314.3,sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1,,,,,,
OG_09488,2.113682939239523,FUN_041522-T1,Peve_00024135,Pocillopora_meandrina_HIv1___TS.g10406.t1,three_way,83.81533333333333,FUN_041522-T1,Q5JVF3,PCID2_HUMAN,,PCI domain-containing protein 2 (CSN12-like protein),Homo sapiens (Human),66.0,394.0,1e-149,531.2,sp|Q5JVF3|PCID2_HUMAN PCI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PCID2 PE=1 SV=2,GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0015031; GO:0016973; GO:0044615; GO:0045579; GO:0045814; GO:0048536; GO:0070390; GO:1905457,"negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; spleen development [GO:0048536]; transcription elongation by RNA polymerase II [GO:0006368]",cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390],double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006913; GO:0043226; GO:0048856,DNA binding; RNA binding; nucleus; chromatin organization; nucleocytoplasmic transport; organelle; anatomical structure development
OG_09490,1.6507694262418038,FUN_041526-T1,Peve_00017090,Pocillopora_meandrina_HIv1___RNAseq.g2461.t1,three_way,40.93683333333333,FUN_041526-T1,P78345,RPP38_HUMAN,,Ribonuclease P protein subunit p38 (RNaseP protein p38),Homo sapiens (Human),29.5,251.0,2.5e-13,77.8,sp|P78345|RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens OX=9606 GN=RPP38 PE=1 SV=2,GO:0000172; GO:0001650; GO:0001682; GO:0004526; GO:0005654; GO:0005655; GO:0005730; GO:0006364; GO:0030681; GO:0033204,rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682],fibrillar center [GO:0001650]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172],ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204],GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; nucleolus; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_09493,2.201828563811178,FUN_041532-T1,Peve_00017081,Pocillopora_meandrina_HIv1___RNAseq.g15376.t1,three_way,72.252,FUN_041532-T1,Q60525,TCAB1_MESAU,,Telomerase Cajal body protein 1 (Guanine nucleotide-binding protein beta 5) (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene homolog),Mesocricetus auratus (Golden hamster),49.7,346.0,6.4e-92,339.7,sp|Q60525|TCAB1_MESAU Telomerase Cajal body protein 1 OS=Mesocricetus auratus OX=10036 GN=Wrap53 PE=2 SV=1,GO:0000781; GO:0003723; GO:0005697; GO:0005829; GO:0006281; GO:0007004; GO:0015030; GO:0030576; GO:0031625; GO:0032203; GO:0032212; GO:0034337; GO:0035861; GO:0042393; GO:0042802; GO:0044877; GO:0045739; GO:0051087; GO:0070034; GO:0090666; GO:0090671; GO:0140597; GO:0140691; GO:1904851; GO:1904867; GO:1905168; GO:2000781; GO:2001034,Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004],"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]",histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; RNA folding chaperone [GO:0140691]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005829; GO:0006281; GO:0032200; GO:0042393; GO:0043226; GO:0140104,RNA binding; cytosol; DNA repair; telomere organization; histone binding; organelle; molecular carrier activity
OG_09494,3.0065297080360787,FUN_041533-T1,Peve_00017080,Pocillopora_meandrina_HIv1___RNAseq.g15375.t1,three_way,44.41416666666667,,,,,,,,,,,,,,,,,
OG_09496,1.6824355015596466,FUN_041538-T1,Peve_00039114,Pocillopora_meandrina_HIv1___RNAseq.g15372.t1,three_way,79.35366666666667,FUN_041538-T1,B2VG45,,,,,39.6,273.0,2.5e-51,204.5,sp|B2VG45|TATD_ERWT9 3'-5' ssDNA/RNA exonuclease TatD OS=Erwinia tasmaniensis (strain DSM 17950 / CFBP 7177 / CIP 109463 / NCPPB 4357 / Et1/99) OX=465817 GN=tatD PE=3 SV=1,,,,,,
OG_09498,1.914171685979672,FUN_041540-T1,Peve_00007703,Pocillopora_meandrina_HIv1___RNAseq.g15651.t1,three_way,66.28366666666666,FUN_041540-T1,P51521,OVO_DROME,,Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)],Drosophila melanogaster (Fruit fly),66.4,128.0,4.1e-08,60.8,sp|P51521|OVO_DROME Transcriptional regulator ovo OS=Drosophila melanogaster OX=7227 GN=ovo PE=1 SV=2,GO:0000122; GO:0000978; GO:0000981; GO:0001223; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007010; GO:0008270; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0032196; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048067; GO:0048477; GO:1990837,adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]; transposition [GO:0032196],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007010; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09499,1.2397251480120468,FUN_041543-T1,Peve_00021435,Pocillopora_meandrina_HIv1___RNAseq.g15962.t2,three_way,59.63633333333333,,,,,,,,,,,,,,,,,
OG_09502,1.6959406918005102,FUN_041546-T1,Peve_00023189,Pocillopora_meandrina_HIv1___RNAseq.g15991.t1,three_way,94.7,FUN_041546-T1,Q5TTG1,,,,,84.8,613.0,1.2e-309,1063.1,sp|Q5TTG1|VATA_ANOGA V-type proton ATPase catalytic subunit A OS=Anopheles gambiae OX=7165 GN=Vha68-2 PE=3 SV=1,,,,,,
OG_09508,2.3836060535721493,FUN_041556-T1,Peve_00033126,Pocillopora_meandrina_HIv1___RNAseq.g16080.t1,three_way,62.22316666666666,FUN_041556-T1,Q6P549,SHIP2_MOUSE,,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)",Mus musculus (Mouse),30.0,330.0,1.1e-19,99.0,"sp|Q6P549|SHIP2_MOUSE Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 OS=Mus musculus OX=10090 GN=Inppl1 PE=1 SV=1",GO:0000132; GO:0000922; GO:0001958; GO:0002376; GO:0003779; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006006; GO:0006629; GO:0006661; GO:0006897; GO:0006915; GO:0007015; GO:0007155; GO:0008285; GO:0009791; GO:0009925; GO:0010467; GO:0010629; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0032880; GO:0034485; GO:0042169; GO:0043491; GO:0046856; GO:0070371; GO:0097178; GO:0110053,actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; lipid metabolic process [GO:0006629]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; regulation of actin filament organization [GO:0110053]; regulation of protein localization [GO:0032880]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178],basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],"actin binding [GO:0003779]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]",GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006629; GO:0007010; GO:0007155; GO:0008092; GO:0012501; GO:0016192; GO:0016787; GO:0043226,immune system process; catalytic activity; nucleus; Golgi apparatus; cytosol; plasma membrane; carbohydrate metabolic process; lipid metabolic process; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; programmed cell death; vesicle-mediated transport; hydrolase activity; organelle
OG_09511,1.5058746232182925,FUN_041565-T1,Peve_00033117,Pocillopora_meandrina_HIv1___RNAseq.g15976.t1,three_way,84.76766666666667,FUN_041565-T1,O70589,,,,,55.9,942.0,1.7e-296,1020.0,sp|O70589|CSKP_MOUSE Peripheral plasma membrane protein CASK OS=Mus musculus OX=10090 GN=Cask PE=1 SV=2,,,,,,
OG_09512,1.3534723774989434,FUN_041566-T1,Peve_00033115,Pocillopora_meandrina_HIv1___TS.g10998.t1,three_way,76.251,FUN_041566-T1,P57080,UBP25_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25) (mUSP25),Mus musculus (Mouse),40.6,1023.0,9.3e-192,672.2,sp|P57080|UBP25_MOUSE Ubiquitin carboxyl-terminal hydrolase 25 OS=Mus musculus OX=10090 GN=Usp25 PE=1 SV=2,GO:0000502; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0006955; GO:0006979; GO:0016071; GO:0016579; GO:0031098; GO:0097400; GO:0101005,immune response [GO:0006955]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA metabolic process [GO:0016071]; protein deubiquitination [GO:0016579]; response to oxidative stress [GO:0006979]; stress-activated protein kinase signaling cascade [GO:0031098]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502],cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005],GO:0002376; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09513,2.7633256076421704,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,27.8,752.0,2.7e-39,166.4,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_09513,2.7633256076421704,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,36.9,187.0,1.8e-19,100.5,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_09517,1.4393061112761976,FUN_041576-T1,Peve_00028458,Pocillopora_meandrina_HIv1___RNAseq.g15933.t1,three_way,67.36333333333333,FUN_041576-T1,Q7ZZ00,,,,,35.4,237.0,6.799999999999997e-35,149.1,sp|Q7ZZ00|ZN511_DANRE Zinc finger protein 511 OS=Danio rerio OX=7955 GN=znf511 PE=2 SV=1,,,,,,
OG_09521,1.018864590491601,FUN_041581-T1,Peve_00028463,Pocillopora_meandrina_HIv1___RNAseq.g15924.t1,three_way,61.268,FUN_041581-T1,Q8SPH6,,,,,41.1,95.0,2.4e-10,66.2,"sp|Q8SPH6|ATP5J_MACFA ATP synthase peripheral stalk subunit F6, mitochondrial OS=Macaca fascicularis OX=9541 GN=ATP5PF PE=3 SV=1",,,,,,
OG_09524,4.05483244741781,FUN_041586-T1,Peve_00028474,Pocillopora_meandrina_HIv1___RNAseq.g15266.t1,three_way,66.81083333333333,FUN_041586-T1,Q4VSN4,DUSTY_CANLF,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Canis lupus familiaris (Dog) (Canis familiaris),27.4,893.0,3.3000000000000003e-80,301.6,sp|Q4VSN4|DUSTY_CANLF Dual serine/threonine and tyrosine protein kinase OS=Canis lupus familiaris OX=9615 GN=DSTYK PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070161; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09527,1.908170541599772,FUN_041595-T1,Peve_00036094,Pocillopora_meandrina_HIv1___RNAseq.g15283.t1,three_way,62.94383333333334,FUN_041595-T1,A2AQH4,,,,,38.7,331.0,1.8e-09,67.0,sp|A2AQH4|BCORL_MOUSE BCL-6 corepressor-like protein 1 OS=Mus musculus OX=10090 GN=Bcorl1 PE=2 SV=1,,,,,,
OG_09528,1.633577649053788,FUN_041599-T1,Peve_00025739,Pocillopora_meandrina_HIv1___RNAseq.g15300.t1,three_way,61.832,,,,,,,,,,,,,,,,,
OG_09541,1.209228568465642,FUN_041635-T1,Peve_00023644,Pocillopora_meandrina_HIv1___RNAseq.g14220.t1,three_way,80.10966666666667,FUN_041635-T1,Q6DJI4,,,,,50.6,83.0,6.9e-13,74.7,sp|Q6DJI4|RM41A_XENLA Large ribosomal subunit protein mL41A OS=Xenopus laevis OX=8355 GN=mrpl41-a PE=2 SV=1,,,,,,
OG_09545,1.6821888861804537,FUN_041642-T1,Peve_00007386,Pocillopora_meandrina_HIv1___RNAseq.g14207.t1,three_way,91.14133333333334,FUN_041642-T1,Q13620,,,,,73.3,580.0,1.9e-245,849.7,sp|Q13620|CUL4B_HUMAN Cullin-4B OS=Homo sapiens OX=9606 GN=CUL4B PE=1 SV=4,,,,,,
OG_09548,1.1718754070887785,FUN_041647-T1,Peve_00000475,Pocillopora_meandrina_HIv1___RNAseq.g14158.t1b,three_way,82.60300000000001,FUN_041647-T1,A7RR04,EFGM_NEMVE,,"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)",Nematostella vectensis (Starlet sea anemone),76.9,606.0,1.9e-275,949.5,"sp|A7RR04|EFGM_NEMVE Elongation factor G, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g236547 PE=3 SV=1",GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125,mitochondrial translational elongation [GO:0070125],mitochondrion [GO:0005739],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005739; GO:0016787; GO:0043226,catalytic activity; GTPase activity; mitochondrion; hydrolase activity; organelle
OG_09549,2.598665680960624,FUN_041648-T1,Peve_00000476,Pocillopora_meandrina_HIv1___TS.g11937.t1,three_way,62.53166666666666,FUN_041648-T1,B1KHT1,,,,,36.7,120.0,1.2e-13,78.6,sp|B1KHT1|TPMT_SHEWM Thiopurine S-methyltransferase OS=Shewanella woodyi (strain ATCC 51908 / MS32) OX=392500 GN=tpm PE=3 SV=1,,,,,,
OG_09550,1.028746158722256,FUN_041650-T1,Peve_00000473,Pocillopora_meandrina_HIv1___RNAseq.g14154.t1,three_way,53.79916666666667,FUN_041650-T1,Q9P2K2,TXD16_HUMAN,,Thioredoxin domain-containing protein 16,Homo sapiens (Human),26.4,250.0,2.4e-15,86.3,sp|Q9P2K2|TXD16_HUMAN Thioredoxin domain-containing protein 16 OS=Homo sapiens OX=9606 GN=TXNDC16 PE=1 SV=4,GO:0005788; GO:0070062,,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062],,GO:0043226,organelle
OG_09552,1.3807410734692924,FUN_041652-T1,Peve_00012481,Pocillopora_meandrina_HIv1___RNAseq.g13865.t1,three_way,59.31333333333333,FUN_041652-T1,O15266,SHOX_HUMAN,,Short stature homeobox protein (Pseudoautosomal homeobox-containing osteogenic protein) (Short stature homeobox-containing protein),Homo sapiens (Human),49.1,106.0,4.9e-20,99.8,sp|O15266|SHOX_HUMAN Short stature homeobox protein OS=Homo sapiens OX=9606 GN=SHOX PE=1 SV=1,GO:0000785; GO:0000981; GO:0001228; GO:0001501; GO:0005634; GO:0005654; GO:0006357; GO:0043231; GO:0043565; GO:0045944; GO:1990837,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501],chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_09555,1.864206196859889,FUN_041658-T1,Peve_00033089,Pocillopora_meandrina_HIv1___RNAseq.g13859.t2,three_way,82.45566666666667,FUN_041658-T1,Q5XGI1,KMCP1_XENTR,,Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),57.3,293.0,1.7999999999999999e-93,344.0,sp|Q5XGI1|KMCP1_XENTR Kidney mitochondrial carrier protein 1 OS=Xenopus tropicalis OX=8364 GN=slc25a30 PE=2 SV=1,GO:0005452; GO:0005743; GO:0015698,inorganic anion transport [GO:0015698],mitochondrial inner membrane [GO:0005743],solute:inorganic anion antiporter activity [GO:0005452],GO:0005215,transporter activity
OG_09556,3.4438611276884994,FUN_041659-T1,Peve_00033090,Pocillopora_meandrina_HIv1___RNAseq.g13858.t1,three_way,62.041,FUN_041659-T1,P39963,,,,,55.5,274.0,1e-79,298.9,sp|P39963|CCNB3_CHICK G2/mitotic-specific cyclin-B3 OS=Gallus gallus OX=9031 GN=CCNB3 PE=2 SV=1,,,,,,
OG_09562,3.6454874604652576,FUN_041672-T1,Peve_00007760,Pocillopora_meandrina_HIv1___RNAseq.g14001.t1,three_way,59.1795,,,,,,,,,,,,,,,,,
OG_09568,2.0633783004593984,FUN_041699-T1,Peve_00004376,Pocillopora_meandrina_HIv1___TS.g11737.t1,three_way,75.67750000000001,FUN_041699-T1,P17635,,,,,34.0,503.0,4.7999999999999996e-70,266.9,sp|P17635|FMO2_RABIT Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Oryctolagus cuniculus OX=9986 GN=FMO2 PE=1 SV=3,,,,,,
OG_09569,2.5682289274564765,FUN_041700-T1,Peve_00004374,Pocillopora_meandrina_HIv1___RNAseq.g13955.t1,three_way,80.44200000000001,FUN_041700-T1,P49585,PCY1A_HUMAN,,Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A),Homo sapiens (Human),42.7,375.0,6.1e-72,272.7,sp|P49585|PCY1A_HUMAN Choline-phosphate cytidylyltransferase A OS=Homo sapiens OX=9606 GN=PCYT1A PE=1 SV=2,GO:0004105; GO:0005516; GO:0005634; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0006656; GO:0006657; GO:0031210; GO:0042100; GO:0042587; GO:0042802; GO:0042803; GO:0045190; GO:0140678,B cell proliferation [GO:0042100]; CDP-choline pathway [GO:0006657]; isotype switching [GO:0045190]; phosphatidylcholine biosynthetic process [GO:0006656],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634],calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003824; GO:0005634; GO:0005635; GO:0005783; GO:0005829; GO:0006310; GO:0006629; GO:0008289; GO:0016740; GO:0043226; GO:0098772,immune system process; catalytic activity; nucleus; nuclear envelope; endoplasmic reticulum; cytosol; DNA recombination; lipid metabolic process; lipid binding; transferase activity; organelle; molecular function regulator activity
OG_09574,2.120299368603604,FUN_041706-T2,Peve_00001479,Pocillopora_meandrina_HIv1___RNAseq.g13974.t1,three_way,47.231,FUN_041706-T2,Q8BQ48,CE295_MOUSE,,Centrosomal protein of 295 kDa,Mus musculus (Mouse),29.4,452.0,1.2e-32,144.1,sp|Q8BQ48|CE295_MOUSE Centrosomal protein of 295 kDa OS=Mus musculus OX=10090 GN=Cep295 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0008017; GO:0010825; GO:0030030; GO:1901985; GO:1903724; GO:1904951; GO:1990498,cell projection organization [GO:0030030]; centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle microtubule [GO:1990498],microtubule binding [GO:0008017],GO:0005815; GO:0008092; GO:0043226,microtubule organizing center; cytoskeletal protein binding; organelle
OG_09575,1.1016271735819485,FUN_041710-T1,Peve_00021477,Pocillopora_meandrina_HIv1___RNAseq.g13976.t1,three_way,87.94433333333333,FUN_041710-T1,Q91ZA3,PCCA_MOUSE,,"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)",Mus musculus (Mouse),62.9,642.0,5.4e-229,795.4,"sp|Q91ZA3|PCCA_MOUSE Propionyl-CoA carboxylase alpha chain, mitochondrial OS=Mus musculus OX=10090 GN=Pcca PE=1 SV=2",GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0019899; GO:0046872; GO:1902494,lipid catabolic process [GO:0016042],catalytic complex [GO:1902494]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],GO:0003824; GO:0005739; GO:0006629; GO:0016874; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; ligase activity; organelle
OG_09577,3.957068831314291,FUN_041712-T1,Peve_00021480,Pocillopora_meandrina_HIv1___RNAseq.g13978.t1,three_way,69.24766666666667,,,,,,,,,,,,,,,,,
OG_09579,2.365005753642848,FUN_041717-T1,Peve_00024455,Pocillopora_meandrina_HIv1___RNAseq.g13945.t1,three_way,63.239333333333335,FUN_041717-T1,O43543,XRCC2_HUMAN,,DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2),Homo sapiens (Human),35.3,252.0,5.1e-35,149.4,sp|O43543|XRCC2_HUMAN DNA repair protein XRCC2 OS=Homo sapiens OX=9606 GN=XRCC2 PE=1 SV=1,GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007098; GO:0010165; GO:0010332; GO:0022008; GO:0033063; GO:0035264; GO:0042148; GO:0043231; GO:0043524; GO:0050769; GO:0051321; GO:0140664; GO:2000269,centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756],centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677],GO:0000278; GO:0003677; GO:0003824; GO:0005654; GO:0005815; GO:0006281; GO:0006310; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"mitotic cell cycle; DNA binding; catalytic activity; nucleoplasm; microtubule organizing center; DNA repair; DNA recombination; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_09581,1.2868254271498798,FUN_041719-T1,Peve_00020367,Pocillopora_meandrina_HIv1___RNAseq.g13943.t1,three_way,79.1255,,,,,,,,,,,,,,,,,
OG_09585,1.750918475963602,FUN_041725-T1,Peve_00014618,Pocillopora_meandrina_HIv1___RNAseq.g15480.t2b,three_way,60.04133333333333,,,,,,,,,,,,,,,,,
OG_09589,1.486512911098646,FUN_041731-T1,Peve_00023310,Pocillopora_meandrina_HIv1___TS.g10511.t2,three_way,73.30466666666666,FUN_041731-T1,Q5ZLS8,,,,,29.0,758.0,8e-95,349.7,sp|Q5ZLS8|INT10_CHICK Integrator complex subunit 10 OS=Gallus gallus OX=9031 GN=INTS10 PE=2 SV=1,,,,,,
OG_09592,2.6215662235849946,FUN_041737-T1,Peve_00002192,Pocillopora_meandrina_HIv1___RNAseq.g15780.t1,three_way,71.5,FUN_041737-T1,Q61070,EI24_MOUSE,,Etoposide-induced protein 2.4 (p53-induced gene 8 protein),Mus musculus (Mouse),40.5,309.0,4.4e-56,219.9,sp|Q61070|EI24_MOUSE Etoposide-induced protein 2.4 OS=Mus musculus OX=10090 GN=Ei24 PE=1 SV=3,GO:0005789; GO:0005794; GO:0005829; GO:0006914; GO:0008630; GO:0009410; GO:0030308; GO:0031965; GO:0042308; GO:0050885; GO:0061676; GO:0071494; GO:2001244,autophagy [GO:0006914]; cellular response to UV-C [GO:0071494]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cell growth [GO:0030308]; negative regulation of protein import into nucleus [GO:0042308]; neuromuscular process controlling balance [GO:0050885]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965],importin-alpha family protein binding [GO:0061676],GO:0005794; GO:0005829; GO:0006914; GO:0043226; GO:0050877,Golgi apparatus; cytosol; autophagy; organelle; nervous system process
OG_09593,2.5204618209154965,FUN_041738-T1,Peve_00002190,Pocillopora_meandrina_HIv1___RNAseq.g15782.t1,three_way,65.286,FUN_041738-T1,Q766D5,,,,,40.6,320.0,1.8e-71,271.9,sp|Q766D5|B4GN4_MOUSE N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=B4galnt4 PE=2 SV=1,,,,,,
OG_09595,3.423404844785781,FUN_041741-T2,Peve_00002194,Pocillopora_meandrina_HIv1___TS.g10807.t1,three_way,87.13516666666666,FUN_041741-T2,Q9WVF7,DPOE1_MOUSE,,DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A),Mus musculus (Mouse),61.3,2303.0,0.0,2863.2,sp|Q9WVF7|DPOE1_MOUSE DNA polymerase epsilon catalytic subunit A OS=Mus musculus OX=10090 GN=Pole PE=1 SV=3,GO:0000082; GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005654; GO:0005886; GO:0006261; GO:0006287; GO:0006297; GO:0008270; GO:0008622; GO:0016787; GO:0048568; GO:0051539,"base-excision repair, gap-filling [GO:0006287]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; nucleotide-excision repair, DNA gap filling [GO:0006297]",epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005654; GO:0005886; GO:0006260; GO:0016740; GO:0016787; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleoplasm; plasma membrane; DNA replication; transferase activity; hydrolase activity; anatomical structure development; catalytic activity, acting on DNA"
OG_09599,1.401526249228618,FUN_041749-T1,Peve_00042718,Pocillopora_meandrina_HIv1___RNAseq.g15090.t1,three_way,53.022333333333336,,,,,,,,,,,,,,,,,
OG_09600,2.3559195030039586,FUN_041750-T1,Peve_00042716,Pocillopora_meandrina_HIv1___RNAseq.g15091.t1,three_way,84.30533333333332,FUN_041750-T1,Q5ZJH9,DKC1_CHICK,,H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (Dyskerin),Gallus gallus (Chicken),71.6,437.0,1.2e-177,624.4,sp|Q5ZJH9|DKC1_CHICK H/ACA ribonucleoprotein complex subunit DKC1 OS=Gallus gallus OX=9031 GN=DKC1 PE=2 SV=1,GO:0000455; GO:0000495; GO:0003723; GO:0005654; GO:0005697; GO:0007004; GO:0009982; GO:0015030; GO:0031118; GO:0031120; GO:0031429; GO:1990481,box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004],box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697],pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005654; GO:0016071; GO:0016073; GO:0016853; GO:0032200; GO:0043226,RNA binding; catalytic activity; nucleoplasm; mRNA metabolic process; snRNA metabolic process; isomerase activity; telomere organization; organelle
OG_09610,1.5606322328106064,FUN_041768-T1,Peve_00041573,Pocillopora_meandrina_HIv1___RNAseq.g15245.t1,three_way,58.71716666666667,FUN_041768-T1,Q641Q2,WAC2A_HUMAN,,WASH complex subunit 2A,Homo sapiens (Human),43.1,202.0,2.6000000000000002e-37,159.8,sp|Q641Q2|WAC2A_HUMAN WASH complex subunit 2A OS=Homo sapiens OX=9606 GN=WASHC2A PE=1 SV=3,GO:0005730; GO:0005769; GO:0005829; GO:0005886; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0036010; GO:0042147; GO:0043231; GO:0071203; GO:1901981; GO:1905394,"endosomal transport [GO:0016197]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203],phosphatidylinositol phosphate binding [GO:1901981]; retromer complex binding [GO:1905394],GO:0005730; GO:0005768; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleolus; endosome; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09611,6.073905537957246,FUN_041769-T1,Peve_00041575,Pocillopora_meandrina_HIv1___RNAseq.g15246.t1,three_way,89.10266666666666,,,,,,,,,,,,,,,,,
OG_09613,1.6015380016814753,FUN_041771-T1,Peve_00021185,Pocillopora_meandrina_HIv1___RNAseq.g15894.t1,three_way,85.66066666666667,FUN_041771-T1,P17870,ARRB1_BOVIN,,Beta-arrestin-1 (Arrestin beta-1) (Arrestin-2),Bos taurus (Bovine),64.8,341.0,1.1000000000000001e-118,427.9,sp|P17870|ARRB1_BOVIN Beta-arrestin-1 OS=Bos taurus OX=9913 GN=ARRB1 PE=1 SV=1,GO:0000822; GO:0001664; GO:0001934; GO:0002029; GO:0002031; GO:0002092; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0007165; GO:0015031; GO:0030132; GO:0030276; GO:0031143; GO:0031410; GO:0031623; GO:0032050; GO:0033130; GO:0035612; GO:0036094; GO:0045746; GO:0060090; GO:0070374; GO:0072583,clathrin-dependent endocytosis [GO:0072583]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],"acetylcholine receptor binding [GO:0033130]; AP-2 adaptor complex binding [GO:0035612]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; G protein-coupled receptor binding [GO:0001664]; inositol hexakisphosphate binding [GO:0000822]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small molecule binding [GO:0036094]",GO:0005634; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0060090,nucleus; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_09614,2.026296462620207,FUN_041772-T1,Peve_00014829,Pocillopora_meandrina_HIv1___RNAseq.g15893.t1,three_way,61.36133333333333,FUN_041772-T1,Q80T32,AGRD1_MOUSE,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Mus musculus (Mouse),23.3,270.0,6.5e-12,73.9,sp|Q80T32|AGRD1_MOUSE Adhesion G-protein coupled receptor D1 OS=Mus musculus OX=10090 GN=Adgrd1 PE=2 SV=2,GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016607; GO:0022008,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neurogenesis [GO:0022008]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005829; GO:0005886; GO:0030154; GO:0043226; GO:0060089,cytosol; plasma membrane; cell differentiation; organelle; molecular transducer activity
OG_09619,1.9415832980796663,FUN_041779-T1,Peve_00042838,Pocillopora_meandrina_HIv1___RNAseq.g15878.t1,three_way,82.13516666666666,FUN_041779-T1,P23098,,,,,25.2,3572.0,0.0,1097.8,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_09622,1.3413102510683508,FUN_041786-T1,Peve_00038537,Pocillopora_meandrina_HIv1___RNAseq.g15774.t1,three_way,61.81633333333333,FUN_041786-T1,Q01887,,,,,38.8,624.0,3.9e-114,413.7,sp|Q01887|RYK_MOUSE Tyrosine-protein kinase RYK OS=Mus musculus OX=10090 GN=Ryk PE=1 SV=2,,,,,,
OG_09623,3.2321872712030824,FUN_041787-T1,Peve_00038538,Pocillopora_meandrina_HIv1___RNAseq.g15773.t1,three_way,47.7465,FUN_041787-T1,Q9UT40,,,,,34.3,105.0,4.5e-10,67.0,"sp|Q9UT40|YIQ3_SCHPO Uncharacterized protein C824.03c, mitochondrial OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC824.03c PE=4 SV=1",,,,,,
OG_09628,2.7064818892575397,FUN_041799-T1,Peve_00025729,Pocillopora_meandrina_HIv1___RNAseq.g15850.t2,three_way,48.657,FUN_041799-T1,Q4VSN1,DUSTY_DANRE,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Danio rerio (Zebrafish) (Brachydanio rerio),33.2,265.0,3.3e-27,125.6,sp|Q4VSN1|DUSTY_DANRE Dual serine/threonine and tyrosine protein kinase OS=Danio rerio OX=7955 GN=dstyk PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0043066; GO:0044344; GO:0045743; GO:0048568; GO:0048570; GO:0060036; GO:0070161; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; embryonic organ development [GO:0048568]; negative regulation of apoptotic process [GO:0043066]; notochord cell vacuolation [GO:0060036]; notochord morphogenesis [GO:0048570]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_09632,1.7007527535874112,FUN_041818-T2,Peve_00025199,Pocillopora_meandrina_HIv1___RNAseq.g15802.t1,three_way,72.51433333333334,FUN_041818-T2,Q1L8W0,ZBT18_DANRE,,Zinc finger and BTB domain-containing protein 18 (Zinc finger protein 238),Danio rerio (Zebrafish) (Brachydanio rerio),38.6,70.0,6.9e-06,54.3,sp|Q1L8W0|ZBT18_DANRE Zinc finger and BTB domain-containing protein 18 OS=Danio rerio OX=7955 GN=zbtb18 PE=2 SV=1,GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_09633,1.8475959836236435,FUN_041820-T1,Peve_00025198,Pocillopora_meandrina_HIv1___RNAseq.g15803.t1,three_way,68.35566666666666,FUN_041820-T1,P47793,WNT4A_DANRE,,Protein Wnt-4a,Danio rerio (Zebrafish) (Brachydanio rerio),43.4,334.0,3.1000000000000003e-76,287.0,sp|P47793|WNT4A_DANRE Protein Wnt-4a OS=Danio rerio OX=7955 GN=wnt4a PE=2 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0007507; GO:0021986; GO:0030182; GO:0042074; GO:0045165; GO:0045893; GO:0048703; GO:0048841; GO:0060070; GO:0070654,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell migration involved in gastrulation [GO:0042074]; embryonic viscerocranium morphogenesis [GO:0048703]; habenula development [GO:0021986]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of axon extension involved in axon guidance [GO:0048841]; sensory epithelium regeneration [GO:0070654],extracellular space [GO:0005615],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0006355; GO:0030154; GO:0048018; GO:0048856; GO:0048870; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell differentiation; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_09635,1.9879488053288643,FUN_041824-T1,Peve_00039128,Pocillopora_meandrina_HIv1___RNAseq.g15806.t1,three_way,95.95933333333332,FUN_041824-T1,P0C6F1,DYH2_MOUSE,,Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2),Mus musculus (Mouse),72.9,2852.0,0.0,4229.9,sp|P0C6F1|DYH2_MOUSE Dynein axonemal heavy chain 2 OS=Mus musculus OX=10090 GN=Dnah2 PE=1 SV=1,GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0008569; GO:0016887; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285,cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_09636,3.675569576251478,FUN_041827-T1,Peve_00039124,Pocillopora_meandrina_HIv1___RNAseq.g15809.t1,three_way,78.95666666666666,FUN_041827-T1,Q9UL03,,,,,53.7,536.0,5.9e-156,552.4,sp|Q9UL03|INT6_HUMAN Integrator complex subunit 6 OS=Homo sapiens OX=9606 GN=INTS6 PE=1 SV=1,,,,,,
OG_09653,2.425169056618099,FUN_041854-T1,Peve_00025833,Pocillopora_meandrina_HIv1___RNAseq.g15067.t2,three_way,60.3945,FUN_041854-T1,Q8N137,CNTRB_HUMAN,,Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8),Homo sapiens (Human),35.5,242.0,1.8e-21,106.7,sp|Q8N137|CNTRB_HUMAN Centrobin OS=Homo sapiens OX=9606 GN=CNTROB PE=1 SV=1,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0036064; GO:0051299; GO:1902017; GO:1902410,centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829],protein domain specific binding [GO:0019904],GO:0005815; GO:0005829; GO:0043226,microtubule organizing center; cytosol; organelle
OG_09657,1.5766457857690994,FUN_041862-T1,Peve_00030448,Pocillopora_meandrina_HIv1___RNAseq.g15123.t1,three_way,78.17916666666666,FUN_041862-T1,A0A8C0TYJ0,DLG1_CANLF,,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97),Canis lupus familiaris (Dog) (Canis familiaris),54.7,959.0,1.8e-266,920.2,sp|A0A8C0TYJ0|DLG1_CANLF Disks large homolog 1 OS=Canis lupus familiaris OX=9615 GN=DLG1 PE=3 SV=1,GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0005604; GO:0005634; GO:0005789; GO:0005794; GO:0005874; GO:0005923; GO:0007268; GO:0008284; GO:0008360; GO:0009898; GO:0010669; GO:0014069; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019900; GO:0019902; GO:0030041; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031579; GO:0031594; GO:0031641; GO:0033268; GO:0035748; GO:0042098; GO:0042130; GO:0042383; GO:0042982; GO:0043219; GO:0043268; GO:0043491; GO:0043622; GO:0044325; GO:0045121; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0098609; GO:0098911; GO:0098915; GO:0098919; GO:0098978; GO:0099645; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903764; GO:2000134,actin filament polymerization [GO:0030041]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; epithelial structure maintenance [GO:0010669]; establishment of centrosome localization [GO:0051660]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell projection membrane [GO:0031253]; cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060],kinase binding [GO:0019900]; L27 domain binding [GO:0097016]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0003012; GO:0005198; GO:0005634; GO:0005794; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0022414; GO:0023052; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003; GO:0072659; GO:0098772,immune system process; muscle system process; structural molecule activity; nucleus; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; reproductive process; signaling; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly; protein localization to plasma membrane; molecular function regulator activity
OG_09658,1.3584401760110012,FUN_041863-T1,Peve_00030452,Pocillopora_meandrina_HIv1___RNAseq.g15122.t1,three_way,75.155,FUN_041863-T1,Q561X3,,,,,44.8,279.0,1.9e-25,117.9,sp|Q561X3|MED4_DANRE Mediator of RNA polymerase II transcription subunit 4 OS=Danio rerio OX=7955 GN=med4 PE=2 SV=1,,,,,,
OG_09660,1.870339816181408,FUN_041870-T1,Peve_00023975,Pocillopora_meandrina_HIv1___TS.g10144.t1,three_way,73.77166666666666,FUN_041870-T1,Q3B752,KTHY_DANRE,,Thymidylate kinase (EC 2.7.4.9) (dTMP kinase),Danio rerio (Zebrafish) (Brachydanio rerio),51.0,206.0,1.7999999999999997e-55,217.6,sp|Q3B752|KTHY_DANRE Thymidylate kinase OS=Danio rerio OX=7955 GN=dtymk PE=2 SV=1,GO:0004550; GO:0004798; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006227; GO:0006233; GO:0006235; GO:0006281; GO:0021954,central nervous system neuron development [GO:0021954]; DNA repair [GO:0006281]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; dTMP kinase activity [GO:0004798]; nucleoside diphosphate kinase activity [GO:0004550],GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016740; GO:0043226; GO:0048856; GO:0055086; GO:1901135,catalytic activity; nucleus; mitochondrion; DNA repair; transferase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09662,2.743668198538271,FUN_041873-T1,Peve_00040565,Pocillopora_meandrina_HIv1___TS.g10137.t1b,three_way,58.01883333333333,FUN_041873-T1,Q5R9Y1,,,,,42.6,282.0,1.7000000000000002e-58,228.0,sp|Q5R9Y1|FSTL1_PONAB Follistatin-related protein 1 OS=Pongo abelii OX=9601 GN=FSTL1 PE=2 SV=2,,,,,,
OG_09663,1.2126045764922857,FUN_041874-T1,Peve_00040563,Pocillopora_meandrina_HIv1___RNAseq.g15106.t3,three_way,72.21516666666666,FUN_041874-T1,P49959,MRE11_HUMAN,,Double-strand break repair protein MRE11 (EC 3.1.-.-) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A),Homo sapiens (Human),55.2,538.0,4.6e-166,586.3,sp|P49959|MRE11_HUMAN Double-strand break repair protein MRE11 OS=Homo sapiens OX=9606 GN=MRE11 PE=1 SV=3,GO:0000014; GO:0000019; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0003690; GO:0004518; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007004; GO:0007062; GO:0007095; GO:0007129; GO:0007131; GO:0008283; GO:0008296; GO:0008408; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0032206; GO:0035825; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0044818; GO:0045296; GO:0062176; GO:0070533; GO:0097552; GO:0098687; GO:0110025; GO:2000781; GO:2001033,cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; R-loop processing [GO:0062176]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860],"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; cadherin binding [GO:0045296]; DNA endonuclease activity [GO:0004520]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; hydrolase activity; reproductive process; telomere organization; organelle; catalytic activity, acting on DNA"
OG_09667,3.033293642642644,FUN_041884-T1,Peve_00012643,Pocillopora_meandrina_HIv1___RNAseq.g15395.t1,three_way,72.869,FUN_041884-T1,F4IF36,FGT1_ARATH,,Protein FORGETTER 1 (Protein EMBRYO DEFECTIVE 1135),Arabidopsis thaliana (Mouse-ear cress),38.7,1090.0,1.2e-201,705.7,sp|F4IF36|FGT1_ARATH Protein FORGETTER 1 OS=Arabidopsis thaliana OX=3702 GN=FGT1 PE=1 SV=1,GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0009408; GO:0010286; GO:0031490; GO:0040029; GO:0042393; GO:1900036; GO:1990841,chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heat acclimation [GO:0010286]; positive regulation of cellular response to heat [GO:1900036]; regulation of DNA-templated transcription [GO:0006355]; response to heat [GO:0009408],nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle
OG_09668,1.40144778986839,FUN_041885-T1,Peve_00033410,Pocillopora_meandrina_HIv1___RNAseq.g15398.t1,three_way,89.648,FUN_041885-T1,Q6PFS7,,,,,65.3,144.0,1.9e-48,193.4,sp|Q6PFS7|ATG3_DANRE Ubiquitin-like-conjugating enzyme ATG3 OS=Danio rerio OX=7955 GN=atg3 PE=2 SV=1,,,,,,
OG_09676,1.2887290891071668,FUN_041900-T1,Peve_00015834,Pocillopora_meandrina_HIv1___RNAseq.g15356.t1,three_way,56.85066666666667,FUN_041900-T1,Q0P5B7,AAAD_BOVIN,,Arylacetamide deacetylase (EC 3.1.1.3),Bos taurus (Bovine),39.9,308.0,1.2999999999999999e-46,188.7,sp|Q0P5B7|AAAD_BOVIN Arylacetamide deacetylase OS=Bos taurus OX=9913 GN=AADAC PE=2 SV=1,GO:0004806; GO:0005789; GO:0006629; GO:0010898; GO:0017171,lipid metabolic process [GO:0006629]; positive regulation of triglyceride catabolic process [GO:0010898],endoplasmic reticulum membrane [GO:0005789],serine hydrolase activity [GO:0017171]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_09679,1.7790975915989249,FUN_041903-T1,Peve_00030474,Pocillopora_meandrina_HIv1___RNAseq.g15367.t1,three_way,66.04633333333334,FUN_041903-T1,Q80W94,MOGT2_MOUSE,,2-acylglycerol O-acyltransferase 2 (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 1-like) (Monoacylglycerol O-acyltransferase 2),Mus musculus (Mouse),40.6,315.0,1.3000000000000002e-60,235.0,sp|Q80W94|MOGT2_MOUSE 2-acylglycerol O-acyltransferase 2 OS=Mus musculus OX=10090 GN=Mogat2 PE=1 SV=1,GO:0003846; GO:0004144; GO:0005783; GO:0005789; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0016407; GO:0019432; GO:0046462; GO:0050892; GO:1990578,diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; monoacylglycerol metabolic process [GO:0046462]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear endoplasmic reticulum membrane [GO:1990578],2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407]; diacylglycerol O-acyltransferase activity [GO:0004144],GO:0003824; GO:0005783; GO:0005975; GO:0006629; GO:0016740; GO:0022600; GO:0043226,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; lipid metabolic process; transferase activity; digestive system process; organelle
OG_09682,1.448505797592541,FUN_041907-T1,Peve_00007890,Pocillopora_meandrina_HIv1___TS.g10677.t1,three_way,73.91533333333334,FUN_041907-T1,Q64560,TPP2_RAT,,Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II),Rattus norvegicus (Rat),51.1,1253.0,0.0,1293.9,sp|Q64560|TPP2_RAT Tripeptidyl-peptidase 2 OS=Rattus norvegicus OX=10116 GN=Tpp2 PE=2 SV=3,GO:0004177; GO:0004252; GO:0005634; GO:0005829; GO:0006508; GO:0008240; GO:0030163; GO:0042277; GO:0042802; GO:0080144,intracellular amino acid homeostasis [GO:0080144]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cytosol [GO:0005829]; nucleus [GO:0005634],aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09683,4.345850792422378,FUN_041908-T1,Peve_00007888,Pocillopora_meandrina_HIv1___RNAseq.g15648.t1,three_way,83.73049999999999,FUN_041908-T1,Q17QZ4,,,,,57.2,383.0,2e-95,351.3,sp|Q17QZ4|TFDP1_BOVIN Transcription factor Dp-1 OS=Bos taurus OX=9913 GN=TFDP1 PE=2 SV=1,,,,,,
OG_09686,1.4468783219724026,FUN_041913-T1,Peve_00007882,Pocillopora_meandrina_HIv1___RNAseq.g15642.t1,three_way,70.99933333333333,FUN_041913-T1,P16388,KCNA1_MOUSE,,Potassium voltage-gated channel subfamily A member 1 (MBK1) (MKI) (Voltage-gated potassium channel subunit Kv1.1),Mus musculus (Mouse),36.4,382.0,8.799999999999999e-62,239.2,sp|P16388|KCNA1_MOUSE Potassium voltage-gated channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Kcna1 PE=1 SV=1,GO:0001964; GO:0005251; GO:0005783; GO:0005829; GO:0005886; GO:0006937; GO:0007405; GO:0007420; GO:0008076; GO:0009986; GO:0010644; GO:0010960; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030424; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0070161; GO:0071286; GO:0071805; GO:0086011; GO:0097718,brain development [GO:0007420]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; membrane repolarization during action potential [GO:0086011]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],anchoring junction [GO:0070161]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; juxtaparanode region of axon [GO:0044224]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; protein-containing complex assembly
OG_09692,2.5720848389595647,FUN_041921-T1,Peve_00007872,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1a,three_way,76.00366666666666,FUN_041921-T1,Q68F70,,,,,40.3,1001.0,6.6e-185,649.4,sp|Q68F70|INT4_XENLA Integrator complex subunit 4 OS=Xenopus laevis OX=8355 GN=ints4 PE=2 SV=1,,,,,,
OG_09695,1.905811287993396,FUN_041924-T1,Peve_00007863,Pocillopora_meandrina_HIv1___TS.g10650.t1,three_way,81.45066666666666,FUN_041924-T1,Q9H8V3,,,,,44.9,864.0,3.6e-184,646.7,sp|Q9H8V3|ECT2_HUMAN Protein ECT2 OS=Homo sapiens OX=9606 GN=ECT2 PE=1 SV=4,,,,,,
OG_09696,2.3346048091665663,FUN_041927-T1,Peve_00025329,Pocillopora_meandrina_HIv1___RNAseq.g15250.t1,three_way,59.38166666666667,FUN_041927-T1,Q3UPY5,,,,,44.6,630.0,8.2e-144,512.3,sp|Q3UPY5|GLBL2_MOUSE Beta-galactosidase-1-like protein 2 OS=Mus musculus OX=10090 GN=Glb1l2 PE=1 SV=1,,,,,,
OG_09697,1.2739728352866146,FUN_041928-T1,Peve_00022682,Pocillopora_meandrina_HIv1___RNAseq.g15696.t1,three_way,66.166,FUN_041928-T1,Q8BG19,TMTC4_MOUSE,,Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4),Mus musculus (Mouse),52.0,481.0,5.7e-131,469.9,sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1,GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584,endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169],GO:0003824; GO:0005783; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0050877; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; nervous system process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_09701,1.7639552908827347,FUN_041932-T1,Peve_00023598,Pocillopora_meandrina_HIv1___RNAseq.g15699.t1,three_way,75.34166666666667,FUN_041932-T1,P53356,,,,,49.0,796.0,1e-215,751.5,sp|P53356|HTK16_HYDVU Tyrosine-protein kinase HTK16 OS=Hydra vulgaris OX=6087 GN=HTK16 PE=2 SV=1,,,,,,
OG_09702,1.615917065546243,FUN_041933-T1,Peve_00023581,Pocillopora_meandrina_HIv1___RNAseq.g15700.t1,three_way,61.377,FUN_041933-T1,P52594,AGFG1_HUMAN,,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),Homo sapiens (Human),57.9,183.0,3.4e-54,214.9,sp|P52594|AGFG1_HUMAN Arf-GAP domain and FG repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=AGFG1 PE=1 SV=2,GO:0001675; GO:0003677; GO:0003723; GO:0005096; GO:0005643; GO:0005737; GO:0005829; GO:0006406; GO:0007289; GO:0008270; GO:0031410; GO:0042995; GO:0043025; GO:0043231; GO:0045109,acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; mRNA export from nucleus [GO:0006406]; spermatid nucleus differentiation [GO:0007289],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nuclear pore [GO:0005643],DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005829; GO:0006913; GO:0007010; GO:0022414; GO:0031410; GO:0043226; GO:0098772,DNA binding; RNA binding; cytosol; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09704,1.972856735817676,FUN_041938-T1,Peve_00023588,Pocillopora_meandrina_HIv1___TS.g10732.t1,three_way,61.260666666666665,FUN_041938-T1,P05619,,,,,35.9,376.0,1.1e-65,252.3,sp|P05619|ILEU_HORSE Leukocyte elastase inhibitor OS=Equus caballus OX=9796 GN=SERPINB1 PE=1 SV=3,,,,,,
OG_09706,1.3543800088527296,FUN_041940-T1,Peve_00023590,Pocillopora_meandrina_HIv1___RNAseq.g15638.t2,three_way,64.672,FUN_041940-T1,Q9UPV0,CE164_HUMAN,,Centrosomal protein of 164 kDa (Cep164),Homo sapiens (Human),68.5,89.0,1.8e-32,143.7,sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3,GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539,cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],,GO:0005615; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0043226; GO:0044782,extracellular space; nucleoplasm; microtubule organizing center; cytosol; DNA repair; organelle; cilium organization
OG_09706,1.3543800088527296,FUN_041940-T1,Peve_00023590,Pocillopora_meandrina_HIv1___RNAseq.g15638.t2,three_way,64.672,FUN_041940-T1,Q9UPV0,CE164_HUMAN,,Centrosomal protein of 164 kDa (Cep164),Homo sapiens (Human),29.7,138.0,2.2e-06,57.0,sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3,GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539,cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],,GO:0005615; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0043226; GO:0044782,extracellular space; nucleoplasm; microtubule organizing center; cytosol; DNA repair; organelle; cilium organization
OG_09711,2.518232077243157,FUN_041951-T1,Peve_00022248,Pocillopora_meandrina_HIv1___RNAseq.g15252.t1,three_way,67.0045,FUN_041951-T1,Q498F0,,,,,52.2,592.0,2.6e-153,544.3,sp|Q498F0|WDR44_XENLA WD repeat-containing protein 44 OS=Xenopus laevis OX=8355 GN=wdr44 PE=2 SV=1,,,,,,
OG_09712,1.020584972370739,FUN_041952-T1,Peve_00022247,Pocillopora_meandrina_HIv1___RNAseq.g15253.t2,three_way,73.839,FUN_041952-T1,Q8N695,SC5A8_HUMAN,,Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8),Homo sapiens (Human),44.6,552.0,1.9e-121,438.0,sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2,GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0140161; GO:0160081; GO:2001142,acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886],iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552],GO:0005215; GO:0005886; GO:0012501; GO:0043226; GO:0055085,transporter activity; plasma membrane; programmed cell death; organelle; transmembrane transport
OG_09713,2.460768555092656,FUN_041958-T2,Peve_00027292,Pocillopora_meandrina_HIv1___RNAseq.g15161.t1,three_way,50.98183333333333,FUN_041958-T2,O93274,,,,,38.8,116.0,7.3e-23,110.2,sp|O93274|FZD8_XENLA Frizzled-8 OS=Xenopus laevis OX=8355 GN=fzd8 PE=1 SV=1,,,,,,
OG_09720,1.2082510936286197,FUN_041966-T1,Peve_00043494,Pocillopora_meandrina_HIv1___RNAseq.g15916.t1,three_way,81.62733333333334,FUN_041966-T1,P19984,,,,,44.6,130.0,2.5e-20,99.8,sp|P19984|PROF2_ACACA Profilin-2 OS=Acanthamoeba castellanii OX=5755 PE=1 SV=3,,,,,,
OG_09722,1.8362314909901472,FUN_041968-T1,Peve_00033990,Pocillopora_meandrina_HIv1___RNAseq.g15918.t1,three_way,58.185833333333335,,,,,,,,,,,,,,,,,
OG_09725,2.551243835125217,FUN_041971-T1,Peve_00028271,Pocillopora_meandrina_HIv1___RNAseq.g15921.t1,three_way,89.0265,FUN_041971-T1,Q99J62,,,,,66.6,359.0,8.6e-127,454.9,sp|Q99J62|RFC4_MOUSE Replication factor C subunit 4 OS=Mus musculus OX=10090 GN=Rfc4 PE=1 SV=1,,,,,,
OG_09730,1.9088337779908984,FUN_041986-T1,Peve_00010444,Pocillopora_meandrina_HIv1___RNAseq.g15235.t1,three_way,60.22733333333333,,,,,,,,,,,,,,,,,
OG_09731,2.4514514599185366,FUN_041989-T1,Peve_00010446,Pocillopora_meandrina_HIv1___RNAseq.g15231.t1,three_way,48.022,,,,,,,,,,,,,,,,,
OG_09732,2.7355318590410604,FUN_041991-T1,Peve_00020704,Pocillopora_meandrina_HIv1___RNAseq.g15229.t1,three_way,48.99766666666667,,,,,,,,,,,,,,,,,
OG_09734,1.270295682879527,FUN_041993-T1,Peve_00014041,Pocillopora_meandrina_HIv1___RNAseq.g15227.t1,three_way,47.711666666666666,,,,,,,,,,,,,,,,,
OG_09736,4.239479021012283,FUN_041995-T1,Peve_00023725,Pocillopora_meandrina_HIv1___RNAseq.g15224.t1,three_way,92.50633333333332,FUN_041995-T1,Q7ZXB1,MCM7B_XENLA,,DNA replication licensing factor mcm7-B (EC 3.6.4.12) (CDC47 homolog B) (CDC47-2p) (Minichromosome maintenance protein 7-B) (xMCM7-B),Xenopus laevis (African clawed frog),74.5,718.0,1.4e-309,1063.1,sp|Q7ZXB1|MCM7B_XENLA DNA replication licensing factor mcm7-B OS=Xenopus laevis OX=8355 GN=mcm7-b PE=1 SV=1,GO:0000727; GO:0000785; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006270; GO:0006271; GO:0008270; GO:0016887; GO:0017116; GO:0030174; GO:0042555; GO:0071162,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_09737,2.7075804907831835,FUN_041999-T3,Peve_00034150,Pocillopora_meandrina_HIv1___RNAseq.g15222.t1,three_way,51.45166666666667,FUN_041999-T3,Q9ERU9,RBP2_MOUSE,,E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2),Mus musculus (Mouse),23.6,3401.0,5.800000000000001e-178,628.2,sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2,GO:0001975; GO:0003723; GO:0003755; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723,centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975],annulate lamellae [GO:0005642]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068],kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005635; GO:0005654; GO:0005829; GO:0006457; GO:0006886; GO:0006913; GO:0016740; GO:0016853; GO:0098772; GO:0140096,"RNA binding; catalytic activity; nuclear envelope; nucleoplasm; cytosol; protein folding; intracellular protein transport; nucleocytoplasmic transport; transferase activity; isomerase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09738,1.3701736783534726,FUN_042000-T1,Peve_00016463,Pocillopora_meandrina_HIv1___RNAseq.g15221.t1,three_way,69.44083333333333,,,,,,,,,,,,,,,,,
OG_09739,1.3823919290579496,FUN_042001-T1,Peve_00016464,Pocillopora_meandrina_HIv1___RNAseq.g15220.t1,three_way,91.06033333333332,FUN_042001-T1,Q9P013,CWC15_HUMAN,,Spliceosome-associated protein CWC15 homolog,Homo sapiens (Human),73.8,229.0,3.2e-52,206.5,sp|Q9P013|CWC15_HUMAN Spliceosome-associated protein CWC15 homolog OS=Homo sapiens OX=9606 GN=CWC15 PE=1 SV=2,GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005739; GO:0016607; GO:0045292; GO:0071007; GO:0071013,"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mitochondrion; mRNA metabolic process; organelle
OG_09741,1.0717673995084416,FUN_042004-T1,Peve_00026002,Pocillopora_meandrina_HIv1___TS.g7940.t2,three_way,74.858,FUN_042004-T1,P15848,ARSB_HUMAN,,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),Homo sapiens (Human),45.7,497.0,4.5e-123,443.0,sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1,GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813,autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0006914; GO:0007040; GO:0016787; GO:0043226; GO:0048870,catalytic activity; extracellular region; lysosome; vacuole; autophagy; lysosome organization; hydrolase activity; organelle; cell motility
OG_09743,3.688766041055923,FUN_042009-T1,Peve_00031038,Pocillopora_meandrina_HIv1___RNAseq.g15212.t1,three_way,48.658166666666666,,,,,,,,,,,,,,,,,
OG_09744,2.5749668223616835,FUN_042010-T1,Peve_00035507,Pocillopora_meandrina_HIv1___RNAseq.g15214.t1,three_way,59.618,,,,,,,,,,,,,,,,,
OG_09746,1.142614342225148,FUN_042013-T1,Peve_00026003,Pocillopora_meandrina_HIv1___RNAseq.g28153.t1,three_way,77.80266666666667,FUN_042013-T1,P50430,,,,,49.3,495.0,9.7e-137,488.4,sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2,,,,,,
OG_09747,1.6079453514184063,FUN_042015-T1,Peve_00044147,Pocillopora_meandrina_HIv1___RNAseq.g15196.t1,three_way,62.627,FUN_042015-T1,Q8IZQ1,WDFY3_HUMAN,,WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy),Homo sapiens (Human),43.3,67.0,2.3e-09,65.5,sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2,GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204,aggrephagy [GO:0035973],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605],1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270],GO:0005635; GO:0005654; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006914; GO:0008289; GO:0043226,nuclear envelope; nucleoplasm; nucleolus; vacuole; cytosol; plasma membrane; autophagy; lipid binding; organelle
OG_09748,1.9805604469903488,FUN_042017-T1,Peve_00044151,Pocillopora_meandrina_HIv1___RNAseq.g15194.t1,three_way,79.5055,FUN_042017-T1,B5FXE5,FSP1_TAEGU,,Ferroptosis suppressor protein 1 (FSP1) (EC 1.6.5.-) (Apoptosis-inducing factor homologous mitochondrion-associated inducer of death) (AMID) (p53-responsive gene 3 protein),Taeniopygia guttata (Zebra finch) (Poephila guttata),39.4,373.0,2.0999999999999998e-70,267.7,sp|B5FXE5|FSP1_TAEGU Ferroptosis suppressor protein 1 OS=Taeniopygia guttata OX=59729 GN=AIFM2 PE=2 SV=1,GO:0004174; GO:0005634; GO:0005811; GO:0005886; GO:0008637; GO:0016655; GO:0031966; GO:0042373; GO:0043065; GO:0050660,apoptotic mitochondrial changes [GO:0008637]; positive regulation of apoptotic process [GO:0043065]; vitamin K metabolic process [GO:0042373],lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]",GO:0003824; GO:0005634; GO:0005811; GO:0005886; GO:0007005; GO:0016491; GO:0043226,catalytic activity; nucleus; lipid droplet; plasma membrane; mitochondrion organization; oxidoreductase activity; organelle
OG_09749,1.519365580274232,FUN_042018-T1,Peve_00044152,Pocillopora_meandrina_HIv1___RNAseq.g15193.t1,three_way,65.04350000000001,FUN_042018-T1,Q7Z589,EMSY_HUMAN,,BRCA2-interacting transcriptional repressor EMSY,Homo sapiens (Human),63.2,106.0,5.8999999999999994e-31,138.3,sp|Q7Z589|EMSY_HUMAN BRCA2-interacting transcriptional repressor EMSY OS=Homo sapiens OX=9606 GN=EMSY PE=1 SV=2,GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0042802,chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654],identical protein binding [GO:0042802],GO:0005654; GO:0006281; GO:0006325; GO:0006355,nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription
OG_09752,1.0197734946516708,FUN_042022-T1,Peve_00044156,Pocillopora_meandrina_HIv1___RNAseq.g15166.t1,three_way,51.5335,,,,,,,,,,,,,,,,,
OG_09757,5.942331213456124,FUN_042029-T1,Peve_00025063,Pocillopora_meandrina_HIv1___RNAseq.g15174.t1,three_way,47.64533333333333,FUN_042029-T1,Q9QYM2,,,,,31.9,354.0,1.1e-38,163.7,sp|Q9QYM2|PARG_RAT Poly(ADP-ribose) glycohydrolase OS=Rattus norvegicus OX=10116 GN=Parg PE=1 SV=1,,,,,,
OG_09764,2.968212591130155,FUN_042043-T1,Peve_00025406,Pocillopora_meandrina_HIv1___RNAseq.g15137.t1,three_way,85.81366666666666,FUN_042043-T1,Q70VZ7,MOGT1_BOVIN,,2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Monoacylglycerol O-acyltransferase 1),Bos taurus (Bovine),56.3,332.0,2.7e-106,386.7,sp|Q70VZ7|MOGT1_BOVIN 2-acylglycerol O-acyltransferase 1 OS=Bos taurus OX=9913 GN=MOGAT1 PE=2 SV=1,GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006651; GO:0019432,diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum membrane [GO:0005789],2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144],GO:0003824; GO:0005975; GO:0006629; GO:0016740,catalytic activity; carbohydrate metabolic process; lipid metabolic process; transferase activity
OG_09770,1.8010228230292933,FUN_042051-T1,Peve_00025418,Pocillopora_meandrina_HIv1___RNAseq.g15145.t1,three_way,44.09616666666667,FUN_042051-T1,Q8BHR2,,,,,29.9,294.0,1.7e-33,146.4,sp|Q8BHR2|ENOX1_MOUSE Ecto-NOX disulfide-thiol exchanger 1 OS=Mus musculus OX=10090 GN=Enox1 PE=2 SV=1,,,,,,
OG_09771,1.4167107398356424,FUN_042052-T1,Peve_00016579,Pocillopora_meandrina_HIv1___RNAseq.g15147.t1,three_way,47.97166666666666,FUN_042052-T1,Q7Z6V5,ADAT2_HUMAN,,tRNA-specific adenosine deaminase 2 (EC 3.5.4.33) (Deaminase domain-containing protein 1) (tRNA-specific adenosine-34 deaminase subunit ADAT2),Homo sapiens (Human),67.8,118.0,1.7e-41,171.0,sp|Q7Z6V5|ADAT2_HUMAN tRNA-specific adenosine deaminase 2 OS=Homo sapiens OX=9606 GN=ADAT2 PE=1 SV=1,GO:0002100; GO:0005654; GO:0008270; GO:0052717,tRNA wobble adenosine to inosine editing [GO:0002100],nucleoplasm [GO:0005654],tRNA-specific adenosine-34 deaminase activity [GO:0052717]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006399; GO:0016787; GO:0140098,"catalytic activity; nucleoplasm; tRNA metabolic process; hydrolase activity; catalytic activity, acting on RNA"
OG_09776,1.3785658185265273,FUN_042099-T1,Peve_00001856,Pocillopora_meandrina_HIv1___RNAseq.g21788.t1,three_way,68.22566666666667,FUN_042099-T1,Q09143,CTR1_MOUSE,,High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor) (Ecotropic retrovirus receptor) (ERR) (EcoR) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter),Mus musculus (Mouse),36.9,601.0,2.6e-97,357.8,sp|Q09143|CTR1_MOUSE High affinity cationic amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a1 PE=1 SV=1,GO:0000064; GO:0001618; GO:0005290; GO:0015189; GO:0015819; GO:0016020; GO:0016323; GO:0016324; GO:0032991; GO:0042102; GO:0061459; GO:1903352; GO:1903810; GO:1903826,L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; positive regulation of T cell proliferation [GO:0042102],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; protein-containing complex [GO:0032991],L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; virus receptor activity [GO:0001618],GO:0001618; GO:0005215; GO:0055085,virus receptor activity; transporter activity; transmembrane transport
OG_09779,1.619019707726833,FUN_042125-T1,Peve_00009509,Pocillopora_meandrina_HIv1___RNAseq.g19349.t1,three_way,54.792,,,,,,,,,,,,,,,,,
OG_09782,1.6227806106501577,FUN_042478-T1,Peve_00001805,Pocillopora_meandrina_HIv1___RNAseq.g25171.t1,three_way,45.98733333333333,,,,,,,,,,,,,,,,,
OG_09783,1.8243974441534667,FUN_042583-T1,Peve_00034294,Pocillopora_meandrina_HIv1___RNAseq.g16882.t1,three_way,83.662,FUN_042583-T1,P09132,SRP19_HUMAN,,Signal recognition particle 19 kDa protein (SRP19),Homo sapiens (Human),47.1,140.0,3.1000000000000002e-27,122.9,sp|P09132|SRP19_HUMAN Signal recognition particle 19 kDa protein OS=Homo sapiens OX=9606 GN=SRP19 PE=1 SV=3,GO:0003723; GO:0005730; GO:0005786; GO:0005829; GO:0006613; GO:0006617; GO:0008312; GO:0016604; GO:0048500,"cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]","cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]",7S RNA binding [GO:0008312]; RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0005829; GO:0043226; GO:0065003,RNA binding; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_09787,1.4618928656792745,FUN_042589-T1,Peve_00012671,Pocillopora_meandrina_HIv1___RNAseq.g16875.t1,three_way,61.26133333333333,FUN_042589-T1,P25122,KCNC1_RAT,,Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (RAW2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4),Rattus norvegicus (Rat),43.0,461.0,4.9e-93,344.0,sp|P25122|KCNC1_RAT Voltage-gated potassium channel KCNC1 OS=Rattus norvegicus OX=10116 GN=Kcnc1 PE=1 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030425; GO:0030673; GO:0032589; GO:0032590; GO:0032809; GO:0034765; GO:0034767; GO:0035864; GO:0042734; GO:0043025; GO:0043679; GO:0044305; GO:0044325; GO:0045211; GO:0046872; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1901379; GO:1901381; GO:1990089,action potential [GO:0001508]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of monoatomic ion transmembrane transport [GO:0034767]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of potassium ion transmembrane transport [GO:1901379]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636],axolemma [GO:0030673]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; neuron projection membrane [GO:0032589]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0008092; GO:0048856; GO:0055085; GO:0065003,transporter activity; cytoskeletal protein binding; anatomical structure development; transmembrane transport; protein-containing complex assembly
OG_09789,4.3780367660249935,FUN_042591-T1,Peve_00012673,Pocillopora_meandrina_HIv1___RNAseq.g16869.t1,three_way,79.75733333333334,FUN_042591-T1,Q87PP5,,,,,36.3,535.0,8.499999999999999e-92,339.7,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_09790,1.2272871534353482,FUN_042592-T1,Peve_00038355,Pocillopora_meandrina_HIv1___RNAseq.g16868.t1,three_way,96.93166666666666,FUN_042592-T1,Q80UW8,,,,,81.8,209.0,9.8e-99,360.9,"sp|Q80UW8|RPAB1_MOUSE DNA-directed RNA polymerases I, II, and III subunit RPABC1 OS=Mus musculus OX=10090 GN=Polr2e PE=1 SV=1",,,,,,
OG_09794,2.4014759889952093,FUN_042597-T1,Peve_00008125,Pocillopora_meandrina_HIv1___RNAseq.g16860.t1,three_way,82.09866666666666,FUN_042597-T1,Q8BGV9,ATG4D_MOUSE,,"Cysteine protease ATG4D (EC 3.4.22.-) (AUT-like 4 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 4) (Autophagin-4) (Autophagy-related protein 4 homolog D) [Cleaved into: Cysteine protease ATG4D, mitochondrial]",Mus musculus (Mouse),44.8,402.0,5.1e-100,366.3,sp|Q8BGV9|ATG4D_MOUSE Cysteine protease ATG4D OS=Mus musculus OX=10090 GN=Atg4d PE=1 SV=1,GO:0000423; GO:0005654; GO:0005759; GO:0006508; GO:0006914; GO:0006915; GO:0008234; GO:0015031; GO:0019786; GO:0034497; GO:0051697,apoptotic process [GO:0006915]; autophagy [GO:0006914]; mitophagy [GO:0000423]; protein delipidation [GO:0051697]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; proteolysis [GO:0006508],mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654],cysteine-type peptidase activity [GO:0008234]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786],GO:0003824; GO:0005654; GO:0006914; GO:0012501; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; autophagy; programmed cell death; hydrolase activity; catalytic activity, acting on a protein"
OG_09795,2.3530375049726318,FUN_042602-T1,Peve_00034908,Pocillopora_meandrina_HIv1___RNAseq.g16851.t1,three_way,67.051,FUN_042602-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),26.5,701.0,3.2999999999999996e-62,241.9,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_09798,1.562921460855302,FUN_042606-T1,Peve_00034915,Pocillopora_meandrina_HIv1___RNAseq.g16848.t1,three_way,70.83866666666667,FUN_042606-T1,O77627,,,,,34.6,318.0,4.900000000000003e-22,107.5,sp|O77627|JUN_BOVIN Transcription factor Jun OS=Bos taurus OX=9913 GN=JUN PE=2 SV=2,,,,,,
OG_09799,1.2941452361584624,FUN_042609-T1,Peve_00034917,Pocillopora_meandrina_HIv1___RNAseq.g16823.t1b,three_way,64.12866666666666,,,,,,,,,,,,,,,,,
OG_09800,1.1548119508010437,FUN_042610-T1,Peve_00034918,Pocillopora_meandrina_HIv1___RNAseq.g16820.t1,three_way,81.64233333333333,FUN_042610-T1,O02811,,,,,47.5,2112.0,0.0,1828.1,sp|O02811|PI4KA_BOVIN Phosphatidylinositol 4-kinase alpha OS=Bos taurus OX=9913 GN=PI4KA PE=2 SV=2,,,,,,
OG_09802,1.1502649825014992,FUN_042613-T1,Peve_00034927,Pocillopora_meandrina_HIv1___RNAseq.g17029.t1,three_way,47.558,,,,,,,,,,,,,,,,,
OG_09803,2.8049139931767413,FUN_042614-T1,Peve_00034928,Pocillopora_meandrina_HIv1___RNAseq.g17030.t1,three_way,75.631,FUN_042614-T1,A0A1D5PXA5,TRPV4_CHICK,,Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Vanilloid receptor-related osmotically activated channel) (VR-OAC),Gallus gallus (Chicken),20.4,313.0,1.5e-08,63.2,sp|A0A1D5PXA5|TRPV4_CHICK Transient receptor potential cation channel subfamily V member 4 OS=Gallus gallus OX=9031 GN=TRPV4 PE=1 SV=1,GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005886; GO:0005912; GO:0005929; GO:0006874; GO:0007015; GO:0007231; GO:0008289; GO:0016324; GO:0017124; GO:0035091; GO:0046872; GO:0098703,actin filament organization [GO:0007015]; calcium ion import across plasma membrane [GO:0098703]; intracellular calcium ion homeostasis [GO:0006874]; osmosensory signaling pathway [GO:0007231],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cilium [GO:0005929]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; monoatomic cation channel activity [GO:0005261]; phosphatidylinositol binding [GO:0035091]; SH3 domain binding [GO:0017124],GO:0005215; GO:0005886; GO:0005929; GO:0008289; GO:0043226; GO:0055085,transporter activity; plasma membrane; cilium; lipid binding; organelle; transmembrane transport
OG_09804,2.019478951926568,FUN_042622-T1,Peve_00029438,Pocillopora_meandrina_HIv1___RNAseq.g11513.t1,three_way,76.01333333333334,FUN_042622-T1,A7YWD2,,,,,36.5,941.0,1.5e-175,618.2,sp|A7YWD2|IPO13_BOVIN Importin-13 OS=Bos taurus OX=9913 GN=IPO13 PE=2 SV=1,,,,,,
OG_09806,4.42252395539722,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_09807,4.91886457079745,FUN_042628-T1,Peve_00016195,Pocillopora_meandrina_HIv1___RNAseq.g11508.t1,three_way,45.25,FUN_042628-T1,O95390,GDF11_HUMAN,,Growth/differentiation factor 11 (GDF-11) (Bone morphogenetic protein 11) (BMP-11),Homo sapiens (Human),29.0,372.0,2.3000000000000002e-33,144.8,sp|O95390|GDF11_HUMAN Growth/differentiation factor 11 OS=Homo sapiens OX=9606 GN=GDF11 PE=1 SV=1,GO:0001501; GO:0001656; GO:0001657; GO:0005125; GO:0005615; GO:0007399; GO:0007498; GO:0008083; GO:0008283; GO:0008285; GO:0021512; GO:0032924; GO:0032991; GO:0035881; GO:0048593; GO:0060021; GO:0060391; GO:0072560; GO:1902870,activin receptor signaling pathway [GO:0032924]; amacrine cell differentiation [GO:0035881]; camera-type eye morphogenesis [GO:0048593]; cell population proliferation [GO:0008283]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of SMAD protein signal transduction [GO:0060391]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; spinal cord anterior/posterior patterning [GO:0021512]; type B pancreatic cell maturation [GO:0072560]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; protein-containing complex [GO:0032991],cytokine activity [GO:0005125]; growth factor activity [GO:0008083],GO:0005615; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_09809,2.170901026237012,FUN_042631-T1,Peve_00030043,Pocillopora_meandrina_HIv1___RNAseq.g11506.t1,three_way,73.376,FUN_042631-T1,Q5VTB9,RN220_HUMAN,,E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220),Homo sapiens (Human),33.0,657.0,3.9999999999999997e-63,244.2,sp|Q5VTB9|RN220_HUMAN E3 ubiquitin-protein ligase RNF220 OS=Homo sapiens OX=9606 GN=RNF220 PE=1 SV=1,GO:0003358; GO:0004842; GO:0005634; GO:0005652; GO:0005654; GO:0005737; GO:0006513; GO:0008013; GO:0008270; GO:0016567; GO:0021904; GO:0032991; GO:0051091; GO:0051865; GO:0061630; GO:0090263; GO:0098794; GO:0098978; GO:0099149; GO:2000677,dorsal/ventral neural tube patterning [GO:0021904]; noradrenergic neuron development [GO:0003358]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of transcription regulatory region DNA binding [GO:2000677],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],beta-catenin binding [GO:0008013]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09810,3.514594215716691,FUN_042632-T1,Peve_00030047,Pocillopora_meandrina_HIv1___RNAseq.19517_t,three_way,44.0685,FUN_042632-T1,Q14315,FLNC_HUMAN,,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),Homo sapiens (Human),26.4,208.0,3.7e-09,65.5,sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015,sarcomere organization [GO:0045214],costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018],actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_09814,2.8033215144155346,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),49.4,1473.0,0.0,1337.0,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09814,2.8033215144155346,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),30.0,247.0,2.5e-08,63.9,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09816,1.9406353975056945,FUN_042644-T1,Peve_00030045,Pocillopora_meandrina_HIv1___RNAseq.g11519.t1,three_way,70.136,FUN_042644-T1,Q68EI0,WDR18_DANRE,,WD repeat-containing protein 18,Danio rerio (Zebrafish) (Brachydanio rerio),44.1,204.0,6.7e-47,188.7,sp|Q68EI0|WDR18_DANRE WD repeat-containing protein 18 OS=Danio rerio OX=7955 GN=wdr18 PE=2 SV=1,GO:0005656; GO:0005730; GO:0006261; GO:0006364; GO:0007368; GO:0070121; GO:0120293; GO:0120330,determination of left/right symmetry [GO:0007368]; DNA-templated DNA replication [GO:0006261]; Kupffer's vesicle development [GO:0070121]; rRNA processing [GO:0006364],dynein axonemal particle [GO:0120293]; nuclear pre-replicative complex [GO:0005656]; nucleolus [GO:0005730]; rixosome complex [GO:0120330],,GO:0005730; GO:0006260; GO:0043226; GO:0048856,nucleolus; DNA replication; organelle; anatomical structure development
OG_09821,2.669517059291343,FUN_042654-T1,Peve_00031585,Pocillopora_meandrina_HIv1___RNAseq.g4912.t1,three_way,68.26350000000001,FUN_042654-T1,Q9JJP2,P73_MOUSE,,Tumor protein p73 (p53-like transcription factor) (p53-related protein),Mus musculus (Mouse),45.5,266.0,9.2e-51,202.6,sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0001836; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005886; GO:0006954; GO:0006974; GO:0007346; GO:0009410; GO:0009791; GO:0010468; GO:0019901; GO:0021766; GO:0030054; GO:0030900; GO:0033326; GO:0036064; GO:0042771; GO:0042802; GO:0043410; GO:0043523; GO:0043524; GO:0045665; GO:0045793; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0048666; GO:0048714; GO:0051262; GO:0060044; GO:0061629; GO:0097371; GO:1901248; GO:1902167; GO:2001235,cerebrospinal fluid secretion [GO:0033326]; digestive tract morphogenesis [GO:0048546]; DNA damage response [GO:0006974]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein tetramerization [GO:0051262]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron apoptotic process [GO:0043523]; release of cytochrome c from mitochondria [GO:0001836]; response to xenobiotic stimulus [GO:0009410],cell junction [GO:0030054]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005886; GO:0006355; GO:0006954; GO:0007005; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; plasma membrane; regulation of DNA-templated transcription; inflammatory response; mitochondrion organization; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_09822,2.606835354164024,FUN_042655-T1,Peve_00031586,Pocillopora_meandrina_HIv1___RNAseq.g4911.t2,three_way,59.10533333333333,FUN_042655-T1,Q8R4F0,MCLN3_MOUSE,,Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3),Mus musculus (Mouse),39.7,546.0,7.899999999999999e-99,362.8,sp|Q8R4F0|MCLN3_MOUSE Mucolipin-3 OS=Mus musculus OX=10090 GN=Mcoln3 PE=1 SV=1,GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171,inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626],autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171],lipid binding [GO:0008289]; monoatomic anion channel activity [GO:0005253]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289; GO:0030154,transporter activity; plasma membrane; lipid binding; cell differentiation
OG_09826,1.6840721255181006,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_09827,1.3727170903933197,FUN_042663-T1,Peve_00031592,Pocillopora_meandrina_HIv1___RNAseq.g4878.t1,three_way,53.35733333333333,,,,,,,,,,,,,,,,,
OG_09831,3.3104943707642738,FUN_042808-T1,Peve_00003077,Pocillopora_meandrina_HIv1___RNAseq.g7425.t1,three_way,92.786,FUN_042808-T1,Q5F448,GPHR_CHICK,,Golgi pH regulator (Protein GPR89),Gallus gallus (Chicken),68.6,455.0,9.7e-176,617.8,sp|Q5F448|GPHR_CHICK Golgi pH regulator OS=Gallus gallus OX=9031 GN=GPR89 PE=2 SV=1,GO:0000139; GO:0008308; GO:0015031; GO:0030217; GO:0030660; GO:0032580; GO:0034702; GO:0043588; GO:0051452,intracellular pH reduction [GO:0051452]; protein transport [GO:0015031]; skin development [GO:0043588]; T cell differentiation [GO:0030217],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; monoatomic ion channel complex [GO:0034702],voltage-gated monoatomic anion channel activity [GO:0008308],GO:0002376; GO:0005215; GO:0030154; GO:0048856,immune system process; transporter activity; cell differentiation; anatomical structure development
OG_09832,1.5366488314401627,FUN_042809-T1,Peve_00003078,Pocillopora_meandrina_HIv1___RNAseq.g7426.t1,three_way,69.40266666666666,FUN_042809-T1,P15206,,,,,51.8,342.0,4.4e-84,313.2,sp|P15206|CCNB_MARGL G2/mitotic-specific cyclin-B OS=Marthasterias glacialis OX=7609 PE=2 SV=1,,,,,,
OG_09834,1.29996913410882,FUN_042811-T1,Peve_00028976,Pocillopora_meandrina_HIv1___RNAseq.g7428.t1,three_way,73.61033333333333,FUN_042811-T1,Q4R8R3,,,,,51.1,444.0,2.9e-53,211.1,sp|Q4R8R3|CC112_MACFA Coiled-coil domain-containing protein 112 OS=Macaca fascicularis OX=9541 GN=CCDC112 PE=2 SV=1,,,,,,
OG_09836,1.5174449344534582,FUN_042815-T1,Peve_00033308,Pocillopora_meandrina_HIv1___RNAseq.g7431.t1,three_way,72.99733333333333,FUN_042815-T1,Q4V9P6,ADAL_DANRE,,N6-Methyl-AMP deaminase (EC 3.5.4.-) (Adenosine deaminase-like protein),Danio rerio (Zebrafish) (Brachydanio rerio),52.1,317.0,6.4e-88,326.6,sp|Q4V9P6|ADAL_DANRE N6-Methyl-AMP deaminase OS=Danio rerio OX=7955 GN=mapda PE=2 SV=1,GO:0004000; GO:0006154; GO:0009117; GO:0043010; GO:0046103; GO:0046872; GO:0062154,adenosine catabolic process [GO:0006154]; camera-type eye development [GO:0043010]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117],,adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; N6-methyl-AMP deaminase activity [GO:0062154],GO:0003824; GO:0016787; GO:0048856; GO:0055086; GO:1901135,catalytic activity; hydrolase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09839,2.6805628871110243,FUN_042820-T1,Peve_00019572,Pocillopora_meandrina_HIv1___RNAseq.g7438.t1,three_way,89.72666666666667,FUN_042820-T1,P40424,PBX1_HUMAN,,Pre-B-cell leukemia transcription factor 1 (Homeobox protein PBX1) (Homeobox protein PRL),Homo sapiens (Human),69.0,407.0,9.8e-132,471.9,sp|P40424|PBX1_HUMAN Pre-B-cell leukemia transcription factor 1 OS=Homo sapiens OX=9606 GN=PBX1 PE=1 SV=1,GO:0000086; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001222; GO:0001228; GO:0001654; GO:0001655; GO:0001658; GO:0001779; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006694; GO:0007420; GO:0007548; GO:0009887; GO:0009952; GO:0009954; GO:0010971; GO:0030278; GO:0030325; GO:0030326; GO:0035162; GO:0043433; GO:0045665; GO:0045944; GO:0048536; GO:0048538; GO:0048568; GO:0048666; GO:0048706; GO:0072089; GO:0090575; GO:0140297; GO:1990837; GO:2000648,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic hemopoiesis [GO:0035162]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; G2/M transition of mitotic cell cycle [GO:0000086]; natural killer cell differentiation [GO:0001779]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of ossification [GO:0030278]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; steroid biosynthetic process [GO:0006694]; thymus development [GO:0048538]; urogenital system development [GO:0001655],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]",GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006629; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; lipid metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09840,3.747236319515884,FUN_042821-T1,Peve_00019575,Pocillopora_meandrina_HIv1___RNAseq.g7439.t2,three_way,61.8725,FUN_042821-T1,A2RV61,,,,,30.5,1466.0,5.5e-152,540.4,sp|A2RV61|GAPD1_XENLA GTPase-activating protein and VPS9 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=gapvd1 PE=2 SV=1,,,,,,
OG_09841,1.8046758397914096,FUN_042822-T2,Peve_00019576,Pocillopora_meandrina_HIv1___TS.g1194.t1,three_way,82.61283333333333,FUN_042822-T2,Q28WQ1,KIF1A_DROPS,,Kinesin-like protein unc-104,Drosophila pseudoobscura pseudoobscura (Fruit fly),47.8,1673.0,0.0,1395.2,sp|Q28WQ1|KIF1A_DROPS Kinesin-like protein unc-104 OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=unc-104 PE=3 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005875; GO:0008017; GO:0047496; GO:0048489,synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0007018; GO:0008092; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule-based movement; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_09843,1.8056158374867988,FUN_042828-T1,Peve_00041828,Pocillopora_meandrina_HIv1___RNAseq.g7273.t1,three_way,72.41866666666667,FUN_042828-T1,Q5IS35,,,,,48.6,315.0,4e-78,293.1,sp|Q5IS35|TPC_MACFA Mitochondrial thiamine pyrophosphate carrier OS=Macaca fascicularis OX=9541 GN=SLC25A19 PE=2 SV=1,,,,,,
OG_09849,2.5197326510611924,FUN_042840-T1,Peve_00007266,Pocillopora_meandrina_HIv1___RNAseq.g7261.t1,three_way,47.549,,,,,,,,,,,,,,,,,
OG_09854,2.5688022731518787,FUN_042847-T1,Peve_00023278,Pocillopora_meandrina_HIv1___RNAseq.g7253.t2,three_way,70.20666666666666,FUN_042847-T1,Q924L9,,,,,46.9,557.0,1.5e-131,471.5,"sp|Q924L9|FOLC_CRIGR Folylpolyglutamate synthase, mitochondrial OS=Cricetulus griseus OX=10029 GN=FPGS PE=2 SV=1",,,,,,
OG_09857,2.9630975058096207,FUN_042851-T2,Peve_00023271,Pocillopora_meandrina_HIv1___RNAseq.g7248.t1,three_way,55.37016666666667,FUN_042851-T2,P62285,,,,,47.2,733.0,1.3e-174,616.7,sp|P62285|ASPM_BOVIN Abnormal spindle-like microcephaly-associated protein homolog (Fragment) OS=Bos taurus OX=9913 GN=ASPM PE=2 SV=1,,,,,,
OG_09857,2.9630975058096207,FUN_042851-T2,Peve_00023271,Pocillopora_meandrina_HIv1___RNAseq.g7248.t1,three_way,55.37016666666667,FUN_042851-T2,P62285,,,,,26.6,466.0,1.1e-35,155.2,sp|P62285|ASPM_BOVIN Abnormal spindle-like microcephaly-associated protein homolog (Fragment) OS=Bos taurus OX=9913 GN=ASPM PE=2 SV=1,,,,,,
OG_09861,1.8148208826516057,FUN_042856-T1,Peve_00023265,Pocillopora_meandrina_HIv1___TS.g991.t1,three_way,72.62433333333333,FUN_042856-T1,Q8TB37,NUBPL_HUMAN,,Iron-sulfur cluster transfer protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1),Homo sapiens (Human),65.9,270.0,1.1000000000000001e-101,371.3,sp|Q8TB37|NUBPL_HUMAN Iron-sulfur cluster transfer protein NUBPL OS=Homo sapiens OX=9606 GN=NUBPL PE=1 SV=3,GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0007005; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0140663,iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion organization [GO:0007005],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; metal ion binding [GO:0046872]",GO:0005739; GO:0005886; GO:0007005; GO:0043226; GO:0065003; GO:0140104; GO:0140657,mitochondrion; plasma membrane; mitochondrion organization; organelle; protein-containing complex assembly; molecular carrier activity; ATP-dependent activity
OG_09862,3.532245948958837,FUN_042871-T1,Peve_00023282,Pocillopora_meandrina_HIv1___RNAseq.g7234.t1,three_way,64.53166666666667,FUN_042871-T1,Q8CAE2,HENMT_MOUSE,,Small RNA 2'-O-methyltransferase (EC 2.1.1.386) (HEN1 methyltransferase homolog 1) (mHEN1),Mus musculus (Mouse),36.6,366.0,2.9e-54,214.5,sp|Q8CAE2|HENMT_MOUSE Small RNA 2'-O-methyltransferase OS=Mus musculus OX=10090 GN=Henmt1 PE=1 SV=1,GO:0001510; GO:0003723; GO:0005829; GO:0008171; GO:0008173; GO:0034587; GO:0043186; GO:0046872; GO:0090486,piRNA processing [GO:0034587]; RNA methylation [GO:0001510],cytosol [GO:0005829]; P granule [GO:0043186],metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase activity [GO:0090486],GO:0003723; GO:0003824; GO:0005829; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; cytosol; transferase activity; organelle; catalytic activity, acting on RNA"
OG_09863,1.1072455216600932,FUN_042872-T1,Peve_00023268,Pocillopora_meandrina_HIv1___RNAseq.g7235.t1,three_way,71.824,,,,,,,,,,,,,,,,,
OG_09865,2.242684490689962,FUN_042874-T1,Peve_00040164,Pocillopora_meandrina_HIv1___RNAseq.g7232.t1,three_way,80.68933333333334,FUN_042874-T1,Q3MHZ7,GPI8_BOVIN,,GPI-anchor transamidase (EC 2.6.1.-) (GPI-anchor transamidase component PIGK) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K),Bos taurus (Bovine),58.2,366.0,9.999999999999999e-123,441.4,sp|Q3MHZ7|GPI8_BOVIN GPI-anchor transamidase OS=Bos taurus OX=9913 GN=PIGK PE=2 SV=1,GO:0003923; GO:0006506; GO:0006508; GO:0016255; GO:0042765,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; proteolysis [GO:0006508],GPI-anchor transamidase complex [GO:0042765],GPI-anchor transamidase activity [GO:0003923],GO:0003824; GO:0006629; GO:0016740; GO:0016787; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; lipid metabolic process; transferase activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_09867,1.0553010172453383,FUN_042876-T1,Peve_00040153,Pocillopora_meandrina_HIv1___TS.g977.t1,three_way,68.58266666666667,,,,,,,,,,,,,,,,,
OG_09868,2.4990788190374382,FUN_042877-T1,Peve_00040154,Pocillopora_meandrina_HIv1___RNAseq.g7229.t1,three_way,78.41433333333333,FUN_042877-T1,A4IFD0,,,,,38.2,76.0,8.1e-08,57.8,sp|A4IFD0|KAD5_BOVIN Adenylate kinase isoenzyme 5 OS=Bos taurus OX=9913 GN=Ak5 PE=2 SV=1,,,,,,
OG_09871,1.099890309253698,FUN_042907-T1,Peve_00019285,Pocillopora_meandrina_HIv1___RNAseq.g7202.t1,three_way,76.76766666666667,FUN_042907-T1,Q76KB1,HS2ST_CHICK,,Heparan sulfate 2-O-sulfotransferase 1 (EC 2.8.2.-) (2-O-sulfotransferase) (2-OST) (2OST) (HS 2-O-sulfotransferase) (cHS2ST) (Heparan sulfate 2-sulfotransferase),Gallus gallus (Chicken),56.1,303.0,2.1e-104,380.6,sp|Q76KB1|HS2ST_CHICK Heparan sulfate 2-O-sulfotransferase 1 OS=Gallus gallus OX=9031 GN=HS2ST1 PE=1 SV=1,GO:0000139; GO:0004394; GO:0010467; GO:0015012; GO:0030202; GO:0042802; GO:0060676,gene expression [GO:0010467]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan metabolic process [GO:0030202]; ureteric bud formation [GO:0060676],Golgi membrane [GO:0000139],heparan sulfate 2-sulfotransferase activity [GO:0004394]; identical protein binding [GO:0042802],GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_09875,2.026655340265979,FUN_042913-T1,Peve_00019291,Pocillopora_meandrina_HIv1___RNAseq.g7195.t1,three_way,51.347,,,,,,,,,,,,,,,,,
OG_09884,2.760038168673953,FUN_042957-T1,Peve_00039056,Pocillopora_meandrina_HIv1___RNAseq.g7123.t1,three_way,46.98266666666667,FUN_042957-T1,Q5TM64,,,,,30.0,120.0,2.3e-13,78.2,sp|Q5TM64|CF136_MACMU Uncharacterized protein C6orf136 homolog OS=Macaca mulatta OX=9544 PE=4 SV=1,,,,,,
OG_09885,1.4675335676570094,FUN_042958-T1,Peve_00039055,Pocillopora_meandrina_HIv1___RNAseq.g7122.t1,three_way,87.16766666666666,FUN_042958-T1,Q9HD20,,,,,56.8,1187.0,0.0,1261.5,sp|Q9HD20|AT131_HUMAN Endoplasmic reticulum transmembrane helix translocase OS=Homo sapiens OX=9606 GN=ATP13A1 PE=1 SV=2,,,,,,
OG_09889,1.7942826492439576,FUN_042965-T1,Peve_00039044,Pocillopora_meandrina_HIv1___RNAseq.g7111.t1,three_way,59.85383333333333,FUN_042965-T1,Q80ZJ6,,,,,34.8,771.0,3.4e-101,370.9,sp|Q80ZJ6|ZER1_MOUSE Protein zer-1 homolog OS=Mus musculus OX=10090 GN=Zer1 PE=1 SV=1,,,,,,
OG_09890,1.405539018514237,FUN_042969-T1,Peve_00039038,Pocillopora_meandrina_HIv1___RNAseq.g7107.t1,three_way,70.73766666666667,FUN_042969-T1,Q9UJX4,,,,,33.8,754.0,2.1e-106,388.3,sp|Q9UJX4|APC5_HUMAN Anaphase-promoting complex subunit 5 OS=Homo sapiens OX=9606 GN=ANAPC5 PE=1 SV=2,,,,,,
OG_09892,1.7982319333793595,FUN_042971-T1,Peve_00039041,Pocillopora_meandrina_HIv1___RNAseq.g7105.t1,three_way,58.312333333333335,FUN_042971-T1,Q9NRR4,,,,,54.2,879.0,1.8999999999999998e-283,977.6,sp|Q9NRR4|RNC_HUMAN Ribonuclease 3 OS=Homo sapiens OX=9606 GN=DROSHA PE=1 SV=2,,,,,,
OG_09895,2.33325985624254,FUN_042989-T1,Peve_00031072,Pocillopora_meandrina_HIv1___RNAseq.g7089.t1,three_way,80.24966666666667,FUN_042989-T1,Q8BS35,,,,,54.4,397.0,1.2e-125,451.4,sp|Q8BS35|ALKMO_MOUSE Alkylglycerol monooxygenase OS=Mus musculus OX=10090 GN=Agmo PE=1 SV=1,,,,,,
OG_09903,2.136737291535774,FUN_042999-T1,Peve_00017784,Pocillopora_meandrina_HIv1___RNAseq.g7023.t1,three_way,56.351,,,,,,,,,,,,,,,,,
OG_09904,1.1502664647192664,FUN_043000-T1,Peve_00017783,Pocillopora_meandrina_HIv1___RNAseq.g7024.t1,three_way,81.55316666666667,FUN_043000-T1,Q5BJQ7,,,,,42.2,320.0,9.4e-64,245.4,sp|Q5BJQ7|TADA1_RAT Transcriptional adapter 1 OS=Rattus norvegicus OX=10116 GN=Tada1 PE=2 SV=2,,,,,,
OG_09905,2.8002488580929863,FUN_043002-T1,Peve_00017780,Pocillopora_meandrina_HIv1___RNAseq.g7026.t1,three_way,77.39216666666667,FUN_043002-T1,P46209,,,,,33.0,179.0,6.8e-14,79.3,sp|P46209|USF_AQUPY Protein usf OS=Aquifex pyrophilus OX=2714 GN=usf PE=4 SV=1,,,,,,
OG_09906,3.8886657400841766,FUN_043003-T1,Peve_00017777,Pocillopora_meandrina_HIv1___RNAseq.g7027.t1,three_way,86.71766666666667,FUN_043003-T1,Q66L49,SCMC1_DANRE,,Mitochondrial adenyl nucleotide antiporter SLC25A24 (Small calcium-binding mitochondrial carrier protein 1) (SCaMC-1) (Solute carrier family 25 member 24),Danio rerio (Zebrafish) (Brachydanio rerio),54.6,467.0,1e-146,521.5,sp|Q66L49|SCMC1_DANRE Mitochondrial adenyl nucleotide antiporter SLC25A24 OS=Danio rerio OX=7955 GN=slc25a24 PE=2 SV=1,GO:0000295; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0015866; GO:0015867; GO:0016020; GO:0051503; GO:0071277; GO:0140987; GO:0140988; GO:1990544,adenine nucleotide transport [GO:0051503]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; mitochondrial ATP transmembrane transport [GO:1990544],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP:phosphate antiporter activity [GO:0140988]; ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_09907,1.9004985086683317,FUN_043004-T1,Peve_00017776,Pocillopora_meandrina_HIv1___RNAseq.g7028.t1,three_way,85.60833333333333,FUN_043004-T1,Q64380,SARDH_RAT,,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)",Rattus norvegicus (Rat),66.3,750.0,0.0,1121.7,"sp|Q64380|SARDH_RAT Sarcosine dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Sardh PE=1 SV=2",GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006545; GO:0008480; GO:0016491; GO:0035999; GO:0042426; GO:0050660; GO:1901053,choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480],GO:0003824; GO:0005739; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_09912,3.5648843228353497,FUN_043010-T1,Peve_00017768,Pocillopora_meandrina_HIv1___RNAseq.g7034.t1,three_way,65.28,FUN_043010-T1,Q8CGF6,WDR47_MOUSE,,WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin),Mus musculus (Mouse),31.1,1178.0,1.9e-103,379.0,sp|Q8CGF6|WDR47_MOUSE WD repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Wdr47 PE=1 SV=2,GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168,adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150],axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],protein-containing complex binding [GO:0044877],GO:0006914; GO:0007010; GO:0048856; GO:0048870,autophagy; cytoskeleton organization; anatomical structure development; cell motility
OG_09916,1.4064991363619377,FUN_043025-T1,Peve_00041863,Pocillopora_meandrina_HIv1___TS.g23978.t1,three_way,79.40066666666667,,,,,,,,,,,,,,,,,
OG_09917,3.482791852463732,FUN_043027-T1,Peve_00026962,Pocillopora_meandrina_HIv1___TS.g790.t1,three_way,57.98016666666667,FUN_043027-T1,Q8AYG3,TTK_DANRE,,Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap),Danio rerio (Zebrafish) (Brachydanio rerio),30.7,960.0,1.6999999999999998e-92,342.4,sp|Q8AYG3|TTK_DANRE Dual specificity protein kinase Ttk OS=Danio rerio OX=7955 GN=ttk PE=1 SV=2,GO:0000776; GO:0001100; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0007059; GO:0007060; GO:0007094; GO:0016321; GO:0031101; GO:0033316; GO:0034501; GO:0042246; GO:0046872; GO:0051301; GO:0060249; GO:0106310,anatomical structure homeostasis [GO:0060249]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; female meiosis chromosome segregation [GO:0016321]; fin regeneration [GO:0031101]; male meiosis chromosome segregation [GO:0007060]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of exit from mitosis [GO:0001100]; protein localization to kinetochore [GO:0034501]; tissue regeneration [GO:0042246],kinetochore [GO:0000776]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; chromosome segregation; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09918,2.634672174060189,FUN_043029-T2,Peve_00026963,Pocillopora_meandrina_HIv1___RNAseq.g7057.t1,three_way,56.766666666666666,FUN_043029-T2,Q9W6G7,,,,,27.6,428.0,3.2e-37,157.5,"sp|Q9W6G7|DPOG2_XENLA DNA polymerase subunit gamma-2, mitochondrial OS=Xenopus laevis OX=8355 GN=polg2 PE=1 SV=1",,,,,,
OG_09919,2.565036631830421,FUN_043030-T1,Peve_00026964,Pocillopora_meandrina_HIv1___RNAseq.g7058.t1,three_way,69.98333333333333,FUN_043030-T1,Q0P5A6,,,,,35.4,491.0,1.2e-81,305.4,sp|Q0P5A6|PSMD5_BOVIN 26S proteasome non-ATPase regulatory subunit 5 OS=Bos taurus OX=9913 GN=PSMD5 PE=2 SV=1,,,,,,
OG_09921,1.0170625498114616,FUN_043033-T1,Peve_00026967,Pocillopora_meandrina_HIv1___TS.g794.t2,three_way,75.653,FUN_043033-T1,Q9P1Z9,,,,,29.7,851.0,7.199999999999999e-95,350.9,sp|Q9P1Z9|CC180_HUMAN Coiled-coil domain-containing protein 180 OS=Homo sapiens OX=9606 GN=CCDC180 PE=1 SV=3,,,,,,
OG_09922,1.5347475231116905,FUN_043034-T1,Peve_00026968,Pocillopora_meandrina_HIv1___RNAseq.g7061.t1,three_way,59.995666666666665,,,,,,,,,,,,,,,,,
OG_09923,4.078069674136111,FUN_043035-T1,Peve_00026975,Pocillopora_meandrina_HIv1___RNAseq.g7043.t1,three_way,57.261,FUN_043035-T1,Q9UBN4,,,,,29.3,744.0,3.7999999999999996e-68,261.2,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_09924,2.0038677199975727,FUN_043037-T1,Peve_00026463,Pocillopora_meandrina_HIv1___TS.g811.t1,three_way,81.205,FUN_043037-T1,Q3ZBX1,,,,,53.2,280.0,6.7e-72,272.3,sp|Q3ZBX1|PIGC_BOVIN Phosphatidylinositol N-acetylglucosaminyltransferase subunit C OS=Bos taurus OX=9913 GN=PIGC PE=2 SV=1,,,,,,
OG_09927,1.9495993336722104,FUN_043082-T1,Peve_00026459,Pocillopora_meandrina_HIv1___TS.g814.t1,three_way,74.149,FUN_043082-T1,P0DX22,,,,,37.1,280.0,7.699999999999999e-49,195.7,"sp|P0DX22|FCNLN_PSEA6 L-fucono-1,5-lactonase OS=Pseudoalteromonas atlantica (strain T6c / ATCC BAA-1087) OX=3042615 GN=Patl_0798 PE=1 SV=1",,,,,,
OG_09928,3.799576514876427,FUN_043084-T1,Peve_00026456,Pocillopora_meandrina_HIv1___RNAseq.g7081.t1,three_way,62.529833333333336,FUN_043084-T1,Q9UBN4,,,,,30.1,742.0,4.2e-83,310.8,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_09930,2.454863362388136,FUN_043086-T1,Peve_00001644,Pocillopora_meandrina_HIv1___TS.g825.t1,three_way,66.956,FUN_043086-T1,Q501I9,,,,,35.5,445.0,2.3000000000000002e-74,281.2,sp|Q501I9|DIRC2_XENTR Solute carrier family 49 member 4 homolog OS=Xenopus tropicalis OX=8364 GN=slc49a4 PE=2 SV=1,,,,,,
OG_09931,2.4513726301751526,FUN_043087-T1,Peve_00001643,Pocillopora_meandrina_HIv1___RNAseq.g7088.t2,three_way,65.04733333333333,FUN_043087-T1,Q8N9H8,,,,,31.9,793.0,2e-93,345.5,sp|Q8N9H8|MUT7_HUMAN Exonuclease mut-7 homolog OS=Homo sapiens OX=9606 GN=EXD3 PE=1 SV=3,,,,,,
OG_09937,2.293722442520677,FUN_043097-T2,Peve_00033762,Pocillopora_meandrina_HIv1___RNAseq.g7007.t1,three_way,79.86333333333333,FUN_043097-T2,Q6DD44,XPR1_XENLA,,Xenotropic and polytropic retrovirus receptor 1 homolog,Xenopus laevis (African clawed frog),51.0,700.0,4.5e-193,676.0,sp|Q6DD44|XPR1_XENLA Xenotropic and polytropic retrovirus receptor 1 homolog OS=Xenopus laevis OX=8355 GN=xpr1 PE=2 SV=1,GO:0000822; GO:0005315; GO:0005794; GO:0005886; GO:0006817; GO:0015562; GO:0016036; GO:0030643; GO:0035435,cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817],Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate transmembrane transporter activity [GO:0005315],GO:0005215; GO:0005794; GO:0005886; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; plasma membrane; organelle; transmembrane transport
OG_09938,1.4529111460660482,FUN_043098-T1,Peve_00033761,Pocillopora_meandrina_HIv1___RNAseq.g7006.t1,three_way,61.962,FUN_043098-T1,Q08BM0,,,,,41.0,266.0,4.4e-45,184.1,sp|Q08BM0|TM10B_DANRE tRNA methyltransferase 10 homolog B OS=Danio rerio OX=7955 GN=trmt10b PE=2 SV=1,,,,,,
OG_09939,2.999672914368644,FUN_043099-T1,Peve_00026300,Pocillopora_meandrina_HIv1___RNAseq.g7004.t1,three_way,80.35766666666666,FUN_043099-T1,Q92540,SMG7_HUMAN,,Nonsense-mediated mRNA decay factor SMG7 (SMG-7 homolog) (hSMG-7),Homo sapiens (Human),43.2,475.0,1.8e-94,348.6,sp|Q92540|SMG7_HUMAN Nonsense-mediated mRNA decay factor SMG7 OS=Homo sapiens OX=9606 GN=SMG7 PE=1 SV=2,GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0035303; GO:0042162; GO:0051721; GO:0070034,"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0006913; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; cytosol; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_09941,1.0531866579763605,FUN_043104-T1,Peve_00026302,Pocillopora_meandrina_HIv1___RNAseq.g7898.t1,three_way,87.68966666666667,FUN_043104-T1,P53611,PGTB2_HUMAN,,Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta),Homo sapiens (Human),72.1,330.0,9.2e-51,202.2,sp|P53611|PGTB2_HUMAN Geranylgeranyl transferase type-2 subunit beta OS=Homo sapiens OX=9606 GN=RABGGTB PE=1 SV=2,GO:0004663; GO:0005829; GO:0005886; GO:0005968; GO:0006888; GO:0007601; GO:0008270; GO:0018344; GO:0031267; GO:0036211,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; visual perception [GO:0007601],cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968],Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016192; GO:0016740; GO:0050877; GO:0140096,"catalytic activity; cytosol; plasma membrane; vesicle-mediated transport; transferase activity; nervous system process; catalytic activity, acting on a protein"
OG_09942,1.4821086822575695,FUN_043106-T1,Peve_00014958,Pocillopora_meandrina_HIv1___RNAseq.g7005.t1,three_way,83.65,FUN_043106-T1,Q17GZ9,,,,,39.5,731.0,1.6e-124,448.4,sp|Q17GZ9|ARP5_AEDAE Actin-related protein 5 OS=Aedes aegypti OX=7159 GN=Arp5 PE=3 SV=1,,,,,,
OG_09946,1.0932107289158286,FUN_043113-T1,Peve_00031007,Pocillopora_meandrina_HIv1___RNAseq.g7892.t1,three_way,82.40066666666667,FUN_043113-T1,Q99961,SH3G1_HUMAN,,Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1),Homo sapiens (Human),41.6,368.0,3.1e-65,250.4,sp|Q99961|SH3G1_HUMAN Endophilin-A2 OS=Homo sapiens OX=9606 GN=SH3GL1 PE=1 SV=1,GO:0002102; GO:0005737; GO:0005829; GO:0006897; GO:0007165; GO:0007417; GO:0008289; GO:0031901; GO:0042802; GO:0042995; GO:0045296; GO:0070161; GO:0098793; GO:0098978,central nervous system development [GO:0007417]; endocytosis [GO:0006897]; signal transduction [GO:0007165],anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793],cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],GO:0005829; GO:0008289; GO:0016192; GO:0043226; GO:0048856,cytosol; lipid binding; vesicle-mediated transport; organelle; anatomical structure development
OG_09948,3.596707052924806,FUN_043115-T2,Peve_00026298,Pocillopora_meandrina_HIv1___RNAseq.g7890.t1,three_way,78.194,FUN_043115-T2,Q9NQH7,XPP3_HUMAN,,Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3),Homo sapiens (Human),46.0,461.0,1.6e-124,448.0,sp|Q9NQH7|XPP3_HUMAN Xaa-Pro aminopeptidase 3 OS=Homo sapiens OX=9606 GN=XPNPEP3 PE=1 SV=1,GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006,glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003014; GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"renal system process; catalytic activity; mitochondrion; cytosol; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_09949,3.5961875269942,FUN_043116-T1,Peve_00026297,Pocillopora_meandrina_HIv1___RNAseq.g7889.t1,three_way,69.772,FUN_043116-T1,O77633,,,,,35.3,744.0,1.4000000000000001e-117,425.2,sp|O77633|ADA10_PIG Disintegrin and metalloproteinase domain-containing protein 10 OS=Sus scrofa OX=9823 GN=ADAM10 PE=2 SV=2,,,,,,
OG_09956,1.2909452324590678,FUN_043126-T1,Peve_00013593,Pocillopora_meandrina_HIv1___TS.g1627.t1,three_way,55.45466666666667,FUN_043126-T1,Q1LZE9,,,,,32.7,275.0,1.4e-27,125.2,sp|Q1LZE9|PRS23_BOVIN Serine protease 23 OS=Bos taurus OX=9913 GN=PRSS23 PE=2 SV=1,,,,,,
OG_09957,1.6642537992053552,FUN_043127-T1,Peve_00013592,Pocillopora_meandrina_HIv1___RNAseq.g7874.t2,three_way,84.74233333333333,FUN_043127-T1,P61763,,,,,60.6,589.0,3.7e-196,686.0,sp|P61763|STXB1_BOVIN Syntaxin-binding protein 1 OS=Bos taurus OX=9913 GN=STXBP1 PE=1 SV=1,,,,,,
OG_09958,1.7065842725334108,FUN_043129-T1,Peve_00021467,Pocillopora_meandrina_HIv1___RNAseq.g6873.t1,three_way,80.0845,FUN_043129-T1,Q9V6Y3,,,,,52.3,107.0,2.8e-25,116.3,sp|Q9V6Y3|RT16_DROME Small ribosomal subunit protein bS16m OS=Drosophila melanogaster OX=7227 GN=mRpS16 PE=2 SV=1,,,,,,
OG_09959,2.0660834789556635,FUN_043130-T1,Peve_00013596,Pocillopora_meandrina_HIv1___TS.g613.t1,three_way,62.32033333333334,FUN_043130-T1,Q9JI70,MKKS_MOUSE,,Molecular chaperone MKKS (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin) (Protein Bbs6 homolog),Mus musculus (Mouse),30.4,586.0,6.2e-74,280.0,sp|Q9JI70|MKKS_MOUSE Molecular chaperone MKKS OS=Mus musculus OX=10090 GN=Mkks PE=2 SV=2,GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007608; GO:0010467; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0033210; GO:0035176; GO:0036064; GO:0038108; GO:0040018; GO:0042311; GO:0044321; GO:0045444; GO:0045494; GO:0045776; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902140; GO:1902636; GO:1905515,artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to inositol [GO:1902140]; response to leptin [GO:0044321]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; motile cilium [GO:0031514]; nucleus [GO:0005634],ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082],GO:0003012; GO:0003013; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0006457; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0065003,muscle system process; circulatory system process; nucleus; microtubule organizing center; cytosol; cilium; protein folding; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein-containing complex assembly
OG_09964,1.6701683915583103,FUN_043145-T1,Peve_00044698,Pocillopora_meandrina_HIv1___RNAseq.g6860.t1,three_way,79.27533333333334,,,,,,,,,,,,,,,,,
OG_09980,3.5297371168064493,FUN_043169-T1,Peve_00025850,Pocillopora_meandrina_HIv1___RNAseq.g6792.t1,three_way,52.61283333333333,,,,,,,,,,,,,,,,,
OG_09981,3.1190867031539846,FUN_043171-T1,Peve_00025849,Pocillopora_meandrina_HIv1___RNAseq.g6793.t1,three_way,67.71433333333333,,,,,,,,,,,,,,,,,
OG_09982,2.500016730866274,FUN_043174-T1,Peve_00025847,Pocillopora_meandrina_HIv1___RNAseq.g6799.t1,three_way,67.927,,,,,,,,,,,,,,,,,
OG_09983,2.5236326670144056,FUN_043175-T1,Peve_00025846,Pocillopora_meandrina_HIv1___RNAseq.g6800.t1,three_way,71.23483333333334,FUN_043175-T1,Q28036,SL9A1_BOVIN,,Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1),Bos taurus (Bovine),47.8,557.0,4.8999999999999995e-141,503.4,sp|Q28036|SL9A1_BOVIN Sodium/hydrogen exchanger 1 OS=Bos taurus OX=9913 GN=SLC9A1 PE=2 SV=2,GO:0005516; GO:0005543; GO:0005654; GO:0005737; GO:0005886; GO:0006883; GO:0006885; GO:0010447; GO:0010613; GO:0010882; GO:0015385; GO:0015386; GO:0016323; GO:0016324; GO:0030346; GO:0035994; GO:0036376; GO:0042802; GO:0045121; GO:0045944; GO:0048306; GO:0048863; GO:0051259; GO:0051453; GO:0055007; GO:0070886; GO:0071468; GO:0071805; GO:0071872; GO:0086092; GO:0090533; GO:0098719; GO:0098735,cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to epinephrine stimulus [GO:0071872]; intracellular sodium ion homeostasis [GO:0006883]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; stem cell differentiation [GO:0048863],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005654; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0055085; GO:0065003,transporter activity; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; transmembrane transport; protein-containing complex assembly
OG_09987,1.56325921636661,FUN_043181-T1,Peve_00043024,Pocillopora_meandrina_HIv1___RNAseq.g18637.t1,three_way,60.36716666666666,FUN_043181-T1,Q8MIQ9,,,,,52.9,493.0,4.6e-133,476.9,sp|Q8MIQ9|P_PIG P protein OS=Sus scrofa OX=9823 GN=Oca2 PE=2 SV=3,,,,,,
OG_09989,1.0834929698914373,FUN_043190-T1,Peve_00039859,Pocillopora_meandrina_HIv1___RNAseq.g6807.t1,three_way,79.56916666666666,FUN_043190-T1,Q1LUI2,,,,,59.7,181.0,2.6999999999999997e-55,216.5,sp|Q1LUI2|HDDC2_DANRE 5'-deoxynucleotidase HDDC2 OS=Danio rerio OX=7955 GN=hddc2 PE=2 SV=1,,,,,,
OG_09990,1.455116035555136,FUN_043192-T1,Peve_00039864,Pocillopora_meandrina_HIv1___RNAseq.g6808.t1,three_way,67.83833333333334,FUN_043192-T1,Q12904,AIMP1_HUMAN,,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)],Homo sapiens (Human),49.2,315.0,8.1e-58,225.7,sp|Q12904|AIMP1_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Homo sapiens OX=9606 GN=AIMP1 PE=1 SV=2,GO:0000049; GO:0001525; GO:0001937; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006412; GO:0006915; GO:0006954; GO:0007267; GO:0009986; GO:0016020; GO:0017101; GO:0042803; GO:0050900; GO:0051020; GO:0051607; GO:0070094,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634],cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049],GO:0002376; GO:0003723; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006954; GO:0012501; GO:0023052; GO:0043226; GO:0048018; GO:0048870; GO:0098772,immune system process; RNA binding; extracellular space; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; inflammatory response; programmed cell death; signaling; organelle; receptor ligand activity; cell motility; molecular function regulator activity
OG_09994,1.7234401108738264,FUN_043207-T1,Peve_00039862,Pocillopora_meandrina_HIv1___RNAseq.g6814.t1,three_way,65.258,FUN_043207-T1,Q6DCP1,,,,,40.3,273.0,5.8e-50,199.1,sp|Q6DCP1|FXRD1_XENLA FAD-dependent oxidoreductase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=foxred1 PE=2 SV=1,,,,,,
OG_09997,1.894146879104844,FUN_043222-T1,Peve_00007691,Pocillopora_meandrina_HIv1___RNAseq.g6774.t1a,three_way,69.872,FUN_043222-T1,Q22885,,,,,27.1,362.0,1.3e-21,105.5,sp|Q22885|BROX_CAEEL BRO1 domain-containing protein BROX homolog OS=Caenorhabditis elegans OX=6239 GN=B0507.2 PE=3 SV=2,,,,,,
OG_10000,1.1963557750844795,FUN_043232-T1,Peve_00019448,Pocillopora_meandrina_HIv1___TS.g503.t2,three_way,77.37666666666667,FUN_043232-T1,P48053,,,,,33.4,984.0,4e-153,543.9,sp|P48053|YPD1_CAEEL Uncharacterized protein C05D11.1 OS=Caenorhabditis elegans OX=6239 GN=C05D11.1 PE=4 SV=2,,,,,,
OG_10001,2.214289392415506,FUN_043234-T1,Peve_00001448,Pocillopora_meandrina_HIv1___RNAseq.g6754.t1,three_way,72.01266666666666,FUN_043234-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),39.5,309.0,3.7e-52,207.2,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_10002,2.5218148643170584,FUN_043236-T1,Peve_00001435,Pocillopora_meandrina_HIv1___RNAseq.g6748.t1,three_way,69.04316666666666,FUN_043236-T1,Q30D77,COOA1_MOUSE,,Collagen alpha-1(XXIV) chain,Mus musculus (Mouse),41.1,107.0,1.5e-17,94.0,sp|Q30D77|COOA1_MOUSE Collagen alpha-1(XXIV) chain OS=Mus musculus OX=10090 GN=Col24a1 PE=2 SV=2,GO:0002244; GO:0005201; GO:0005576; GO:0005581; GO:0062023,hematopoietic progenitor cell differentiation [GO:0002244],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030154,structural molecule activity; extracellular region; cell differentiation
OG_10003,1.5018839049574448,FUN_043237-T1,Peve_00001437,Pocillopora_meandrina_HIv1___TS.g490.t1,three_way,69.25716666666668,FUN_043237-T1,O00411,RPOM_HUMAN,,"DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6)",Homo sapiens (Human),40.9,938.0,1.7e-193,678.3,"sp|O00411|RPOM_HUMAN DNA-directed RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=POLRMT PE=1 SV=2",GO:0000175; GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006264; GO:0006390; GO:0006391; GO:0032991; GO:0034245; GO:0042645; GO:0043565,mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; transcription initiation at mitochondrial promoter [GO:0006391],mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991],3'-5'-RNA exonuclease activity [GO:0000175]; DNA-directed RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0003723; GO:0003824; GO:0005739; GO:0006260; GO:0006351; GO:0016740; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; mitochondrion; DNA replication; DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_10005,2.845578604555318,FUN_043240-T1,Peve_00001439,Pocillopora_meandrina_HIv1___RNAseq.g6713.t1,three_way,70.26633333333334,FUN_043240-T1,P28304,,,,,38.9,319.0,9.5e-54,212.2,sp|P28304|QOR1_ECOLI Quinone oxidoreductase 1 OS=Escherichia coli (strain K12) OX=83333 GN=qorA PE=1 SV=1,,,,,,
OG_10007,1.1859174296844217,FUN_043242-T1,Peve_00001436,Pocillopora_meandrina_HIv1___RNAseq.g6708.t1,three_way,59.496500000000005,FUN_043242-T1,Q6YHK3,CD109_HUMAN,,CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109),Homo sapiens (Human),25.8,1416.0,2.8e-104,382.1,sp|Q6YHK3|CD109_HUMAN CD109 antigen OS=Homo sapiens OX=9606 GN=CD109 PE=1 SV=2,GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647,hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089],cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; side of membrane [GO:0098552],serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0048856; GO:0098772,extracellular region; extracellular space; cytosol; plasma membrane; anatomical structure development; molecular function regulator activity
OG_10010,1.7917437357755224,FUN_043245-T1,Peve_00001456,Pocillopora_meandrina_HIv1___TS.g20570.t1,three_way,67.59233333333333,FUN_043245-T1,Q60695,,,,,39.4,754.0,3.9e-110,400.6,sp|Q60695|RGL1_MOUSE Ral guanine nucleotide dissociation stimulator-like 1 OS=Mus musculus OX=10090 GN=Rgl1 PE=1 SV=2,,,,,,
OG_10017,2.2768608708056264,FUN_043254-T1,Peve_00030637,Pocillopora_meandrina_HIv1___RNAseq.g8858.t1,three_way,79.7325,,,,,,,,,,,,,,,,,
OG_10019,2.390540462908527,FUN_043260-T1,Peve_00032621,Pocillopora_meandrina_HIv1___TS.g20584.t1,three_way,80.86,FUN_043260-T1,Q32LH4,,,,,54.2,275.0,3.6000000000000004e-86,319.7,sp|Q32LH4|NIT1_BOVIN Deaminated glutathione amidase OS=Bos taurus OX=9913 GN=NIT1 PE=2 SV=1,,,,,,
OG_10020,2.4821438020654205,FUN_043261-T1,Peve_00032607,Pocillopora_meandrina_HIv1___RNAseq.g8893.t1,three_way,65.95816666666667,FUN_043261-T1,Q7Z7G8,VP13B_HUMAN,,Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B),Homo sapiens (Human),28.7,4270.0,0.0,1449.5,sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2,GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168,acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0008289; GO:0016192; GO:0022414; GO:0048856; GO:0050877,lipid binding; vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process
OG_10021,1.8253762144272416,FUN_043262-T1,Peve_00032608,Pocillopora_meandrina_HIv1___RNAseq.g8892.t1,three_way,72.44983333333333,FUN_043262-T1,Q9Z0H0,,,,,35.1,559.0,3.6e-82,307.4,sp|Q9Z0H0|CDC7_MOUSE Cell division cycle 7-related protein kinase OS=Mus musculus OX=10090 GN=Cdc7 PE=1 SV=2,,,,,,
OG_10022,1.5644028172990851,FUN_043264-T1,Peve_00032613,Pocillopora_meandrina_HIv1___RNAseq.g8889.t1,three_way,60.43216666666667,FUN_043264-T1,P79795,NRP1_CHICK,,Neuropilin-1 (A5 protein),Gallus gallus (Chicken),28.2,255.0,3.2e-12,75.9,sp|P79795|NRP1_CHICK Neuropilin-1 OS=Gallus gallus OX=9031 GN=NRP1 PE=2 SV=1,GO:0001570; GO:0001755; GO:0002040; GO:0005021; GO:0005886; GO:0005925; GO:0007155; GO:0007411; GO:0008201; GO:0009611; GO:0010595; GO:0017154; GO:0022035; GO:0030424; GO:0030947; GO:0031966; GO:0032584; GO:0038085; GO:0043679; GO:0044295; GO:0046872; GO:0048010; GO:0048729; GO:0051491; GO:0070852; GO:0098743,axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell aggregation [GO:0098743]; neural crest cell migration [GO:0001755]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to wounding [GO:0009611]; rhombomere cell migration [GO:0022035]; sprouting angiogenesis [GO:0002040]; tissue morphogenesis [GO:0048729]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570],axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell body fiber [GO:0070852]; focal adhesion [GO:0005925]; growth cone membrane [GO:0032584]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886],heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0030154; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; cell differentiation; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10026,1.852105721428327,FUN_043279-T1,Peve_00007455,Pocillopora_meandrina_HIv1___RNAseq.g8875.t1,three_way,77.92,FUN_043279-T1,Q08832,GBRB3_DROME,,Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor),Drosophila melanogaster (Fruit fly),34.6,457.0,7.399999999999999e-75,282.7,sp|Q08832|GBRB3_DROME Gamma-aminobutyric acid receptor subunit beta-like OS=Drosophila melanogaster OX=7227 GN=Lcch3 PE=1 SV=2,GO:0004890; GO:0005886; GO:0022851; GO:0034707; GO:0045211; GO:1902476; GO:1902711,chloride transmembrane transport [GO:1902476],chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_10027,2.0344099294044504,FUN_043281-T1,Peve_00007453,Pocillopora_meandrina_HIv1___TS.g20595.t1c,three_way,70.7575,FUN_043281-T1,Q8IYH5,ZZZ3_HUMAN,,ZZ-type zinc finger-containing protein 3,Homo sapiens (Human),45.6,450.0,2.1e-88,328.2,sp|Q8IYH5|ZZZ3_HUMAN ZZ-type zinc finger-containing protein 3 OS=Homo sapiens OX=9606 GN=ZZZ3 PE=1 SV=1,GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140672,chromatin organization [GO:0006325]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357],ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle
OG_10028,2.8889253225239053,FUN_043283-T1,Peve_00007451,Pocillopora_meandrina_HIv1___RNAseq.g8872.t1,three_way,45.01633333333333,,,,,,,,,,,,,,,,,
OG_10034,1.6003307417376842,FUN_043298-T1,Peve_00016456,Pocillopora_meandrina_HIv1___RNAseq.g8863.t1,three_way,87.58033333333333,FUN_043298-T1,Q52I78,,,,,56.2,475.0,2.3e-159,563.5,sp|Q52I78|NAMPT_PIG Nicotinamide phosphoribosyltransferase OS=Sus scrofa OX=9823 GN=NAMPT PE=2 SV=2,,,,,,
OG_10041,3.14951183597758,FUN_043312-T1,Peve_00007499,Pocillopora_meandrina_HIv1___RNAseq.g8928.t1,three_way,77.94933333333333,FUN_043312-T1,P36916,,,,,53.7,488.0,4.9e-143,509.6,sp|P36916|GNL1_MOUSE Guanine nucleotide-binding protein-like 1 OS=Mus musculus OX=10090 GN=Gnl1 PE=1 SV=4,,,,,,
OG_10042,1.2559262939888272,FUN_043313-T1,Peve_00007500,Pocillopora_meandrina_HIv1___RNAseq.g8929.t1,three_way,90.50566666666668,FUN_043313-T1,Q812D3,,,,,80.6,160.0,5.9e-75,281.6,sp|Q812D3|PPIL3_RAT Peptidyl-prolyl cis-trans isomerase-like 3 OS=Rattus norvegicus OX=10116 GN=Ppil3 PE=2 SV=1,,,,,,
OG_10043,1.0339623167775105,FUN_043315-T1,Peve_00007501,Pocillopora_meandrina_HIv1___RNAseq.g8930.t1,three_way,80.94866666666667,FUN_043315-T1,A0JMW2,,,,,51.3,314.0,1.2e-86,321.6,sp|A0JMW2|DAAF5_XENLA Dynein axonemal assembly factor 5 OS=Xenopus laevis OX=8355 GN=dnaaf5 PE=2 SV=1,,,,,,
OG_10047,1.95616924735312,FUN_043320-T1,Peve_00018052,Pocillopora_meandrina_HIv1___TS.g20669.t1,three_way,62.268,FUN_043320-T1,Q5TYP4,,,,,30.4,859.0,4.3e-98,360.9,sp|Q5TYP4|FIRRM_DANRE FIGNL1-interacting regulator of recombination and mitosis OS=Danio rerio OX=7955 GN=firrm PE=2 SV=1,,,,,,
OG_10048,1.961440830192294,FUN_043322-T1,Peve_00007511,Pocillopora_meandrina_HIv1___RNAseq.g8949.t1,three_way,57.72333333333333,FUN_043322-T1,Q03146,DDR1_MOUSE,,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),Mus musculus (Mouse),49.6,373.0,3.5e-93,344.7,sp|Q03146|DDR1_MOUSE Epithelial discoidin domain-containing receptor 1 OS=Mus musculus OX=10090 GN=Ddr1 PE=2 SV=2,GO:0001558; GO:0001952; GO:0005518; GO:0005524; GO:0005886; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0014909; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138,"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]",plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0022414; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; reproductive process; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10055,2.2556661297266523,FUN_043349-T1,Peve_00043040,Pocillopora_meandrina_HIv1___TS.g20680.t2,three_way,60.5675,FUN_043349-T1,P20909,,,,,33.1,236.0,3.2e-34,149.4,sp|P20909|COBA1_RAT Collagen alpha-1(XI) chain OS=Rattus norvegicus OX=10116 GN=Col11a1 PE=1 SV=2,,,,,,
OG_10058,1.3623648821415248,FUN_043354-T1,Peve_00016648,Pocillopora_meandrina_HIv1___RNAseq.g8962.t1,three_way,73.71866666666666,FUN_043354-T1,Q5U1W5,,,,,65.5,165.0,7.3e-58,225.7,sp|Q5U1W5|U1SBP_RAT U11/U12 small nuclear ribonucleoprotein 35 kDa protein OS=Rattus norvegicus OX=10116 GN=Snrnp35 PE=2 SV=1,,,,,,
OG_10063,1.6927812543354794,FUN_043363-T1,Peve_00016658,Pocillopora_meandrina_HIv1___RNAseq.g8970.t1,three_way,82.36583333333333,FUN_043363-T1,Q8C4Y3,NELFB_MOUSE,,Negative elongation factor B (NELF-B) (Cofactor of BRCA1),Mus musculus (Mouse),45.5,587.0,1.2e-135,485.0,sp|Q8C4Y3|NELFB_MOUSE Negative elongation factor B OS=Mus musculus OX=10090 GN=Nelfb PE=1 SV=2,GO:0003723; GO:0005741; GO:0005829; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737,cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; stem cell differentiation [GO:0048863],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021],RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0006355; GO:0030154,RNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation
OG_10066,2.690343830457043,FUN_043370-T1,Peve_00004904,Pocillopora_meandrina_HIv1___RNAseq.g8975.t1,three_way,68.366,,,,,,,,,,,,,,,,,
OG_10067,4.421056866353981,FUN_043371-T1,Peve_00004903,Pocillopora_meandrina_HIv1___RNAseq.g8976.t1,three_way,72.36966666666666,FUN_043371-T1,Q8VHQ9,ACO11_MOUSE,,Acyl-coenzyme A thioesterase 11 (Acyl-CoA thioesterase 11) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 11) (Adipose-associated thioesterase) (Brown fat-inducible thioesterase) (BFIT) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2),Mus musculus (Mouse),44.0,550.0,4.4e-114,413.3,sp|Q8VHQ9|ACO11_MOUSE Acyl-coenzyme A thioesterase 11 OS=Mus musculus OX=10090 GN=Acot11 PE=1 SV=1,GO:0005737; GO:0005759; GO:0005829; GO:0006631; GO:0008289; GO:0009266; GO:0009409; GO:0035556; GO:0047617; GO:0052689; GO:0052816; GO:0120163,fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759],carboxylic ester hydrolase activity [GO:0052689]; fatty acyl-CoA hydrolase activity [GO:0047617]; lipid binding [GO:0008289]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816],GO:0003824; GO:0005829; GO:0006629; GO:0008289; GO:0016787,catalytic activity; cytosol; lipid metabolic process; lipid binding; hydrolase activity
OG_10068,1.3720057663507013,FUN_043373-T1,Peve_00004901,Pocillopora_meandrina_HIv1___RNAseq.g8977.t1,three_way,57.378,FUN_043373-T1,Q76EC5,,,,,29.8,275.0,1.6000000000000002e-33,144.8,sp|Q76EC5|CHST9_MOUSE Carbohydrate sulfotransferase 9 OS=Mus musculus OX=10090 GN=Chst9 PE=2 SV=1,,,,,,
OG_10069,2.8990682857010803,FUN_043374-T1,Peve_00004909,Pocillopora_meandrina_HIv1___RNAseq.g8978.t1,three_way,63.316,,,,,,,,,,,,,,,,,
OG_10070,2.6369503291369623,FUN_043375-T1,Peve_00004908,Pocillopora_meandrina_HIv1___RNAseq.g8979.t1,three_way,59.082,FUN_043375-T1,Q7T320,,,,,39.1,192.0,1.5e-23,112.1,sp|Q7T320|GORAB_DANRE RAB6-interacting golgin OS=Danio rerio OX=7955 GN=gorab PE=2 SV=1,,,,,,
OG_10071,1.4380915339506584,FUN_043376-T1,Peve_00004907,Pocillopora_meandrina_HIv1___RNAseq.g8980.t1,three_way,66.022,,,,,,,,,,,,,,,,,
OG_10072,1.8414106166314144,FUN_043377-T1,Peve_00004902,Pocillopora_meandrina_HIv1___RNAseq.g8983.t1,three_way,73.03099999999999,FUN_043377-T1,Q5ZIL9,,,,,45.7,588.0,2.2e-138,494.2,sp|Q5ZIL9|KBP_CHICK KIF-binding protein OS=Gallus gallus OX=9031 GN=Kifbp PE=2 SV=1,,,,,,
OG_10073,1.916934266992394,FUN_043379-T1,Peve_00027430,Pocillopora_meandrina_HIv1___RNAseq.g8985.t1,three_way,83.51266666666666,FUN_043379-T1,Q5F3K4,WDR48_CHICK,,WD repeat-containing protein 48 (USP1-associated factor 1),Gallus gallus (Chicken),62.4,697.0,1.0999999999999999e-189,664.8,sp|Q5F3K4|WDR48_CHICK WD repeat-containing protein 48 OS=Gallus gallus OX=9031 GN=WDR48 PE=2 SV=1,GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005764; GO:0005770; GO:0006974; GO:0007283; GO:0007338; GO:0035264; GO:0035800; GO:0043130; GO:0043588; GO:0046427; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1905168,DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283],late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634],deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130],GO:0003677; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0006281; GO:0006310; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0098772,DNA binding; nucleus; lysosome; endosome; vacuole; DNA repair; DNA recombination; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_10074,2.298506876718527,FUN_043382-T1,Peve_00038075,Pocillopora_meandrina_HIv1___TS.g20712.t1,three_way,72.01299999999999,,,,,,,,,,,,,,,,,
OG_10078,1.3707293685075488,FUN_043387-T1,Peve_00024251,Pocillopora_meandrina_HIv1___RNAseq.g8999.t1,three_way,69.81466666666667,FUN_043387-T1,P02468,LAMC1_MOUSE,,Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma),Mus musculus (Mouse),41.9,1369.0,3.9000000000000004e-227,790.4,sp|P02468|LAMC1_MOUSE Laminin subunit gamma-1 OS=Mus musculus OX=10090 GN=Lamc1 PE=1 SV=2,GO:0005201; GO:0005576; GO:0005604; GO:0006325; GO:0007155; GO:0010467; GO:0016477; GO:0022617; GO:0031069; GO:0031175; GO:0031581; GO:0031594; GO:0035315; GO:0043083; GO:0043208; GO:0043259; GO:0045785; GO:0048729; GO:0051149; GO:0062023; GO:0065003; GO:0071335; GO:0098637; GO:0110011; GO:2001046,cell adhesion [GO:0007155]; cell migration [GO:0016477]; chromatin organization [GO:0006325]; extracellular matrix disassembly [GO:0022617]; gene expression [GO:0010467]; hair cell differentiation [GO:0035315]; hair follicle cell proliferation [GO:0071335]; hair follicle morphogenesis [GO:0031069]; hemidesmosome assembly [GO:0031581]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; tissue morphogenesis [GO:0048729],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin-10 complex [GO:0043259]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083],extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208],GO:0005198; GO:0005576; GO:0006325; GO:0007155; GO:0008289; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0034330; GO:0048870; GO:0065003,structural molecule activity; extracellular region; chromatin organization; cell adhesion; lipid binding; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; cell junction organization; cell motility; protein-containing complex assembly
OG_10080,1.281139278903353,FUN_043390-T1,Peve_00024249,Pocillopora_meandrina_HIv1___RNAseq.g9001.t1,three_way,67.44416666666666,FUN_043390-T1,A7SBN6,,,,,51.0,480.0,1.3e-114,414.8,sp|A7SBN6|ZGPAT_NEMVE Zinc finger CCCH-type with G patch domain-containing protein OS=Nematostella vectensis OX=45351 GN=v1g244155 PE=3 SV=1,,,,,,
OG_10083,1.8889740081288453,FUN_043400-T1,Peve_00024252,Pocillopora_meandrina_HIv1___RNAseq.g9065.t1,three_way,77.465,FUN_043400-T1,Q5R513,MPPA_PONAB,,Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),47.8,435.0,3.6999999999999997e-116,419.9,sp|Q5R513|MPPA_PONAB Mitochondrial-processing peptidase subunit alpha OS=Pongo abelii OX=9601 GN=PMPCA PE=2 SV=2,GO:0004222; GO:0005743; GO:0005759; GO:0006627; GO:0046872,protein processing involved in protein targeting to mitochondrion [GO:0006627],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_10085,2.571894821783317,FUN_043403-T1,Peve_00007567,Pocillopora_meandrina_HIv1___RNAseq.g9068.t1,three_way,45.621,,,,,,,,,,,,,,,,,
OG_10086,1.196313112468218,FUN_043412-T1,Peve_00045006,Pocillopora_meandrina_HIv1___RNAseq.g7824.t1,three_way,79.78466666666667,FUN_043412-T1,P54319,,,,,54.9,814.0,2.5999999999999996e-171,604.0,sp|P54319|PLAP_RAT Phospholipase A-2-activating protein OS=Rattus norvegicus OX=10116 GN=Plaa PE=1 SV=3,,,,,,
OG_10087,3.987574789269295,FUN_043414-T1,Peve_00045005,Pocillopora_meandrina_HIv1___RNAseq.g7825.t1,three_way,56.5365,FUN_043414-T1,Q69Z28,ATS16_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Mus musculus (Mouse),30.5,1138.0,9.8e-129,463.0,sp|Q69Z28|ATS16_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Mus musculus OX=10090 GN=Adamts16 PE=2 SV=2,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; catalytic activity, acting on a protein"
OG_10088,2.121564030225416,FUN_043417-T1,Peve_00026858,Pocillopora_meandrina_HIv1___RNAseq.g7829.t1,three_way,78.89,FUN_043417-T1,Q28DG7,,,,,43.1,390.0,3.9e-66,253.4,sp|Q28DG7|UBAC1_XENTR Ubiquitin-associated domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=ubac1 PE=2 SV=1,,,,,,
OG_10090,3.347149640185093,FUN_043420-T1,Peve_00005576,Pocillopora_meandrina_HIv1___TS.g1600.t1,three_way,92.59866666666667,FUN_043420-T1,Q13813,,,,,59.0,2468.0,0.0,2752.6,"sp|Q13813|SPTN1_HUMAN Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTAN1 PE=1 SV=3",,,,,,
OG_10091,1.3403057083209344,FUN_043421-T2,Peve_00005574,Pocillopora_meandrina_HIv1___RNAseq.g7847.t2,three_way,87.131,FUN_043421-T2,Q28141,DHX9_BOVIN,,ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II),Bos taurus (Bovine),58.5,1043.0,0.0,1176.8,sp|Q28141|DHX9_BOVIN ATP-dependent RNA helicase A OS=Bos taurus OX=9913 GN=DHX9 PE=1 SV=1,GO:0000380; GO:0000978; GO:0003677; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0006260; GO:0006325; GO:0006353; GO:0006954; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0031490; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0033679; GO:0034458; GO:0035195; GO:0035613; GO:0036464; GO:0043138; GO:0045087; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050684; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070937; GO:0071360; GO:0097165; GO:0140640; GO:1905172; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000765; GO:2000767,"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; DNA-templated transcription termination [GO:0006353]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RISC complex assembly [GO:0070922]",actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578],"3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside triphosphate diphosphatase activity [GO:0047429]; promoter-specific chromatin binding [GO:1990841]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]",GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005815; GO:0005856; GO:0006260; GO:0006325; GO:0006355; GO:0006954; GO:0016071; GO:0016787; GO:0016853; GO:0031047; GO:0043226; GO:0060090; GO:0065003; GO:0098542; GO:0140097; GO:0140098; GO:0140110; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; microtubule organizing center; cytoskeleton; DNA replication; chromatin organization; regulation of DNA-templated transcription; inflammatory response; mRNA metabolic process; hydrolase activity; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on DNA; catalytic activity, acting on RNA; transcription regulator activity; ATP-dependent activity"
OG_10095,1.6624297122570886,FUN_043427-T1,Peve_00041803,Pocillopora_meandrina_HIv1___RNAseq.g7840.t1,three_way,67.638,,,,,,,,,,,,,,,,,
OG_10099,4.8322481154415176,FUN_043435-T1,Peve_00028842,Pocillopora_meandrina_HIv1___RNAseq.g7834.t1,three_way,66.19233333333334,FUN_043435-T1,Q9WU63,,,,,37.7,151.0,4.9e-23,110.5,sp|Q9WU63|HEBP2_MOUSE Heme-binding protein 2 OS=Mus musculus OX=10090 GN=Hebp2 PE=1 SV=1,,,,,,
OG_10100,2.223963143587859,FUN_043438-T1,Peve_00028841,Pocillopora_meandrina_HIv1___RNAseq.g7850.t1,three_way,48.59733333333333,FUN_043438-T1,F6RRD7,,,,,49.2,181.0,8.9e-38,159.8,sp|F6RRD7|RPAP2_BOVIN Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 OS=Bos taurus OX=9913 GN=RPAP2 PE=2 SV=1,,,,,,
OG_10103,1.2656798272067074,FUN_043441-T1,Peve_00028849,Pocillopora_meandrina_HIv1___TS.g739.t1,three_way,68.189,FUN_043441-T1,Q2KIB7,,,,,36.6,101.0,6.6e-06,51.6,sp|Q2KIB7|BORC7_BOVIN BLOC-1-related complex subunit 7 OS=Bos taurus OX=9913 GN=BORCS7 PE=3 SV=2,,,,,,
OG_10105,2.662417752392512,FUN_043447-T1,Peve_00015294,Pocillopora_meandrina_HIv1___RNAseq.g7900.t1,three_way,62.12,FUN_043447-T1,Q9Z148,EHMT2_MOUSE,,Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a),Mus musculus (Mouse),35.3,538.0,2.6e-88,328.6,sp|Q9Z148|EHMT2_MOUSE Histone-lysine N-methyltransferase EHMT2 OS=Mus musculus OX=10090 GN=Ehmt2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006346; GO:0006357; GO:0007130; GO:0007286; GO:0008270; GO:0009267; GO:0009566; GO:0016279; GO:0016607; GO:0018027; GO:0035265; GO:0036166; GO:0044027; GO:0046974; GO:0046976; GO:0048148; GO:0048599; GO:0048665; GO:0070742; GO:0071314; GO:0140759; GO:0140947; GO:1902902; GO:1990841,behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130],chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],C2H2 zinc finger domain binding [GO:0070742]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K56 methyltransferase activity [GO:0140759]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9me2 methyltransferase activity [GO:0140947]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10106,1.066137142092155,FUN_043448-T1,Peve_00015295,Pocillopora_meandrina_HIv1___RNAseq.g7901.t1,three_way,74.55666666666667,FUN_043448-T1,Q3UNX5,ACSM3_MOUSE,,"Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog)",Mus musculus (Mouse),55.6,347.0,4.4e-119,429.5,"sp|Q3UNX5|ACSM3_MOUSE Acyl-coenzyme A synthetase ACSM3, mitochondrial OS=Mus musculus OX=10090 GN=Acsm3 PE=1 SV=2",GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0015645; GO:0018729; GO:0031956; GO:0043759; GO:0046872; GO:0050218,fatty acid biosynthetic process [GO:0006633],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],2-methylbutanoate-CoA ligase activity [GO:0043759]; ATP binding [GO:0005524]; fatty acid ligase activity [GO:0015645]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0016874; GO:0043226; GO:0140657,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; ligase activity; organelle; ATP-dependent activity
OG_10109,2.725942073454275,FUN_043479-T1,Peve_00021731,Pocillopora_meandrina_HIv1___RNAseq.g7915.t1,three_way,47.53266666666666,,,,,,,,,,,,,,,,,
OG_10110,3.948611201803916,FUN_043480-T1,Peve_00021725,Pocillopora_meandrina_HIv1___RNAseq.g7918.t1,three_way,87.28833333333333,FUN_043480-T1,Q8UVR3,,,,,49.4,237.0,7.3e-58,226.1,sp|Q8UVR3|LMX1B_XENLA LIM homeobox transcription factor 1-beta.1 OS=Xenopus laevis OX=8355 GN=lmx1b.1 PE=2 SV=1,,,,,,
OG_10112,1.0417176984171488,FUN_043482-T1,Peve_00021727,Pocillopora_meandrina_HIv1___RNAseq.g7916.t1,three_way,54.00966666666667,,,,,,,,,,,,,,,,,
OG_10113,3.38865224317614,FUN_043483-T1,Peve_00021710,Pocillopora_meandrina_HIv1___RNAseq.g7933.t1,three_way,81.26899999999999,FUN_043483-T1,Q96E35,,,,,48.1,241.0,4.4e-58,226.1,sp|Q96E35|ZMY19_HUMAN Zinc finger MYND domain-containing protein 19 OS=Homo sapiens OX=9606 GN=ZMYND19 PE=1 SV=1,,,,,,
OG_10115,1.9184473087273688,FUN_043488-T1,Peve_00021724,Pocillopora_meandrina_HIv1___RNAseq.g7937.t1,three_way,57.274,,,,,,,,,,,,,,,,,
OG_10119,2.641186104886372,FUN_043495-T1,Peve_00024915,Pocillopora_meandrina_HIv1___TS.g1707.t3,three_way,64.6395,FUN_043495-T1,Q7Z7A1,CNTRL_HUMAN,,Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110),Homo sapiens (Human),33.3,916.0,5.599999999999997e-29,132.9,sp|Q7Z7A1|CNTRL_HUMAN Centriolin OS=Homo sapiens OX=9606 GN=CNTRL PE=1 SV=2,GO:0001822; GO:0003281; GO:0005794; GO:0005813; GO:0005815; GO:0005829; GO:0005886; GO:0016020; GO:0034451; GO:0035904; GO:0036064; GO:0048471; GO:0051301; GO:0060976; GO:0090543; GO:0090619; GO:0097431; GO:0120103,aorta development [GO:0035904]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; ventricular septum development [GO:0003281],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],,GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0048856,Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; organelle; anatomical structure development
OG_10122,1.3399719406712045,FUN_043500-T1,Peve_00024905,Pocillopora_meandrina_HIv1___RNAseq.g7966.t1,three_way,90.83083333333332,FUN_043500-T1,Q9DCD2,,,,,62.9,852.0,2e-304,1046.2,sp|Q9DCD2|SYF1_MOUSE Pre-mRNA-splicing factor SYF1 OS=Mus musculus OX=10090 GN=Xab2 PE=1 SV=1,,,,,,
OG_10124,2.3544976567442912,FUN_043502-T1,Peve_00024903,Pocillopora_meandrina_HIv1___RNAseq.g7968.t1,three_way,87.12333333333333,FUN_043502-T1,Q642A5,,,,,71.7,99.0,8.2e-34,144.8,sp|Q642A5|DPOE3_RAT DNA polymerase epsilon subunit 3 OS=Rattus norvegicus OX=10116 GN=Pole3 PE=1 SV=1,,,,,,
OG_10125,1.1385533308193911,FUN_043503-T1,Peve_00024902,Pocillopora_meandrina_HIv1___RNAseq.g7969.t1,three_way,98.50533333333334,FUN_043503-T1,P67868,,,,,94.1,205.0,2.2e-117,422.9,sp|P67868|CSK2B_BOVIN Casein kinase II subunit beta OS=Bos taurus OX=9913 GN=CSNK2B PE=1 SV=1,,,,,,
OG_10131,1.224364225470956,FUN_043513-T1,Peve_00011968,Pocillopora_meandrina_HIv1___RNAseq.g7999.t1,three_way,51.190666666666665,,,,,,,,,,,,,,,,,
OG_10134,1.8495022671020995,FUN_043519-T1,Peve_00016245,Pocillopora_meandrina_HIv1___RNAseq.g8030.t1,three_way,81.026,FUN_043519-T1,A7RWD2,,,,,79.0,324.0,1.8e-49,198.0,sp|A7RWD2|CIAO1_NEMVE Probable cytosolic iron-sulfur protein assembly protein CIAO1 homolog OS=Nematostella vectensis OX=45351 GN=v1g226592 PE=3 SV=1,,,,,,
OG_10138,1.463607010215063,FUN_043525-T1,Peve_00027815,Pocillopora_meandrina_HIv1___RNAseq.g8035.t1,three_way,75.3475,FUN_043525-T1,P53547,,,,,61.0,59.0,2e-11,70.9,sp|P53547|HM01_CAEEL Homeobox protein ceh-1 (Fragment) OS=Caenorhabditis elegans OX=6239 GN=ceh-1 PE=3 SV=1,,,,,,
OG_10142,1.9691489557413384,FUN_043531-T1,Peve_00011964,Pocillopora_meandrina_HIv1___RNAseq.g8001.t1,three_way,71.50766666666667,FUN_043531-T1,Q5R792,ATG5_PONAB,,Autophagy protein 5 (APG5-like),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),62.4,194.0,1.2000000000000001e-74,280.8,sp|Q5R792|ATG5_PONAB Autophagy protein 5 OS=Pongo abelii OX=9601 GN=ATG5 PE=2 SV=1,GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005776; GO:0005930; GO:0006325; GO:0006914; GO:0006995; GO:0009410; GO:0009620; GO:0010659; GO:0010667; GO:0016567; GO:0019776; GO:0019883; GO:0030424; GO:0031397; GO:0032480; GO:0034045; GO:0034274; GO:0034727; GO:0035973; GO:0039689; GO:0042311; GO:0044233; GO:0045060; GO:0045087; GO:0045824; GO:0048840; GO:0050687; GO:0050765; GO:0051279; GO:0051607; GO:0055015; GO:0060047; GO:0061908; GO:0070254; GO:0070257; GO:0071500; GO:0098685; GO:0098794; GO:0098930; GO:0098978; GO:0099072; GO:0099170; GO:1901096; GO:1902017; GO:1904093; GO:1904973; GO:2000377,aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axonal transport [GO:0098930]; blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; heart contraction [GO:0060047]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein ubiquitination [GO:0016567]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fungus [GO:0009620]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; glutamatergic synapse [GO:0098978]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; phagophore [GO:0061908]; phagophore assembly site membrane [GO:0034045]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685],Atg8-family ligase activity [GO:0019776],GO:0002376; GO:0003013; GO:0003824; GO:0005773; GO:0006325; GO:0006914; GO:0007018; GO:0012501; GO:0016740; GO:0043226; GO:0048856; GO:0098542; GO:0140096,"immune system process; circulatory system process; catalytic activity; vacuole; chromatin organization; autophagy; microtubule-based movement; programmed cell death; transferase activity; organelle; anatomical structure development; defense response to other organism; catalytic activity, acting on a protein"
OG_10145,1.3385103630167712,FUN_043535-T1,Peve_00016667,Pocillopora_meandrina_HIv1___RNAseq.g8056.t1,three_way,80.87466666666667,FUN_043535-T1,O14733,,,,,44.9,256.0,1.8e-48,194.5,sp|O14733|MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP2K7 PE=1 SV=2,,,,,,
OG_10148,3.247856751023762,FUN_043539-T1,Peve_00012551,Pocillopora_meandrina_HIv1___TS.g1775.t1,three_way,61.17516666666667,FUN_043539-T1,Q9DBQ9,,,,,27.4,592.0,6.5e-46,187.6,sp|Q9DBQ9|SWT1_MOUSE Transcriptional protein SWT1 OS=Mus musculus OX=10090 GN=Swt1 PE=2 SV=3,,,,,,
OG_10149,1.4917333560362105,FUN_043541-T1,Peve_00011556,Pocillopora_meandrina_HIv1___TS.g1771.t2,three_way,54.464666666666666,FUN_043541-T1,P07307,ASGR2_HUMAN,,Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2),Homo sapiens (Human),30.1,153.0,7.5e-13,76.6,sp|P07307|ASGR2_HUMAN Asialoglycoprotein receptor 2 OS=Homo sapiens OX=9606 GN=ASGR2 PE=1 SV=2,GO:0004873; GO:0005537; GO:0005886; GO:0006897; GO:0006955; GO:0007166; GO:0009897; GO:0038187; GO:0042806; GO:0044322; GO:0048471,cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; immune response [GO:0006955],endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],asialoglycoprotein receptor activity [GO:0004873]; D-mannose binding [GO:0005537]; fucose binding [GO:0042806]; pattern recognition receptor activity [GO:0038187],GO:0002376; GO:0005886; GO:0016192; GO:0038024; GO:0060089,immune system process; plasma membrane; vesicle-mediated transport; cargo receptor activity; molecular transducer activity
OG_10150,1.0464742653154089,FUN_043543-T1,Peve_00011561,Pocillopora_meandrina_HIv1___RNAseq.g8017.t1,three_way,66.94916666666667,FUN_043543-T1,Q8R2T8,TF3C5_MOUSE,,General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon),Mus musculus (Mouse),41.8,433.0,5.199999999999999e-90,333.2,sp|Q8R2T8|TF3C5_MOUSE General transcription factor 3C polypeptide 5 OS=Mus musculus OX=10090 GN=Gtf3c5 PE=2 SV=2,GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0006384; GO:0035914,skeletal muscle cell differentiation [GO:0035914]; transcription initiation at RNA polymerase III promoter [GO:0006384],nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127],DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995],GO:0003677; GO:0005654; GO:0030154; GO:0140223,DNA binding; nucleoplasm; cell differentiation; general transcription initiation factor activity
OG_10153,1.8465562407281164,FUN_043546-T1,Peve_00011555,Pocillopora_meandrina_HIv1___RNAseq.g8014.t1,three_way,78.13083333333334,,,,,,,,,,,,,,,,,
OG_10155,1.92995009030374,FUN_043550-T1,Peve_00009532,Pocillopora_meandrina_HIv1___RNAseq.g8005.t3,three_way,70.52333333333333,FUN_043550-T1,Q5XJS0,,,,,31.4,544.0,1.1000000000000004e-59,232.6,sp|Q5XJS0|MIGA1_DANRE Mitoguardin 1 OS=Danio rerio OX=7955 GN=miga1 PE=2 SV=1,,,,,,
OG_10156,2.096717815148459,FUN_043551-T2,Peve_00009530,Pocillopora_meandrina_HIv1___RNAseq.g8004.t1,three_way,67.68966666666667,,,,,,,,,,,,,,,,,
OG_10158,3.0328229744127766,FUN_043553-T1,Peve_00009529,Pocillopora_meandrina_HIv1___RNAseq.g8042.t1,three_way,85.187,FUN_043553-T1,Q8NE28,,,,,26.2,443.0,8.100000000000001e-38,160.2,sp|Q8NE28|STKL1_HUMAN Serine/threonine kinase-like domain-containing protein STKLD1 OS=Homo sapiens OX=9606 GN=STKLD1 PE=1 SV=5,,,,,,
OG_10161,2.6543362604284413,FUN_043559-T1,Peve_00022066,Pocillopora_meandrina_HIv1___RNAseq.g8043.t1,three_way,42.258833333333335,,,,,,,,,,,,,,,,,
OG_10167,2.023449452284676,FUN_043567-T1,Peve_00030048,Pocillopora_meandrina_HIv1___RNAseq.g8054.t1,three_way,49.1965,,,,,,,,,,,,,,,,,
OG_10169,1.230563084322701,FUN_043572-T1,Peve_00017257,Pocillopora_meandrina_HIv1___RNAseq.g8027.t1,three_way,71.741,FUN_043572-T1,Q91YU8,,,,,53.6,302.0,3.1e-84,313.9,sp|Q91YU8|SSF1_MOUSE Suppressor of SWI4 1 homolog OS=Mus musculus OX=10090 GN=Ppan PE=1 SV=2,,,,,,
OG_10171,2.7726155947103224,FUN_043574-T1,Peve_00011699,Pocillopora_meandrina_HIv1___RNAseq.g7870.t2,three_way,82.55833333333334,FUN_043574-T1,Q5ZKK5,,,,,31.7,703.0,1.4e-15,86.7,sp|Q5ZKK5|ODFP2_CHICK Outer dense fiber protein 2 OS=Gallus gallus OX=9031 GN=ODF2 PE=2 SV=1,,,,,,
OG_10172,2.919351049770317,FUN_043581-T1,Peve_00045208,Pocillopora_meandrina_HIv1___RNAseq.g6993.t1,three_way,68.211,FUN_043581-T1,Q803A6,,,,,45.8,631.0,4.3999999999999996e-147,523.1,sp|Q803A6|MCMBP_DANRE Mini-chromosome maintenance complex-binding protein OS=Danio rerio OX=7955 GN=mcmbp PE=2 SV=2,,,,,,
OG_10175,3.268289966196955,FUN_043584-T1,Peve_00045195,Pocillopora_meandrina_HIv1___RNAseq.g6988.t1,three_way,66.09083333333334,FUN_043584-T1,P21180,CO2_MOUSE,,Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)],Mus musculus (Mouse),25.1,491.0,5.4e-29,131.0,sp|P21180|CO2_MOUSE Complement C2 OS=Mus musculus OX=10090 GN=C2 PE=1 SV=2,GO:0004252; GO:0005615; GO:0006508; GO:0006958; GO:0007584; GO:0032496; GO:0045087; GO:0046872; GO:0097066; GO:2000427,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; proteolysis [GO:0006508]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to thyroid hormone [GO:0097066]",extracellular space [GO:0005615],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003824; GO:0005615; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_10176,2.554930585174528,FUN_043585-T1,Peve_00045227,Pocillopora_meandrina_HIv1___RNAseq.g6986.t1,three_way,56.91216666666666,FUN_043585-T1,Q9BYX4,IFIH1_HUMAN,,Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116),Homo sapiens (Human),27.6,1184.0,1.0000000000000001e-88,330.1,sp|Q9BYX4|IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IFIH1 PE=1 SV=3,GO:0002753; GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0038187; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051259; GO:0051607; GO:0060337; GO:0060760; GO:0071360; GO:0098586; GO:0140374,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0065003; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; hydrolase activity; isomerase activity; organelle; molecular transducer activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10184,2.999299145940182,FUN_043599-T1,Peve_00007612,Pocillopora_meandrina_HIv1___RNAseq.g6951.t1,three_way,61.132,FUN_043599-T1,Q68CP4,HGNAT_HUMAN,,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),Homo sapiens (Human),42.6,591.0,3.1e-113,410.6,sp|Q68CP4|HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens OX=9606 GN=HGSNAT PE=1 SV=2,GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821,heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019],GO:0003824; GO:0005886; GO:0016740; GO:0030163; GO:0065003; GO:1901135,catalytic activity; plasma membrane; transferase activity; protein catabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_10185,1.2374467896996375,FUN_043600-T1,Peve_00007617,Pocillopora_meandrina_HIv1___RNAseq.g6950.t1,three_way,63.14633333333333,FUN_043600-T1,Q3UDW8,HGNAT_MOUSE,,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),Mus musculus (Mouse),37.9,504.0,4.2e-82,307.0,sp|Q3UDW8|HGNAT_MOUSE Heparan-alpha-glucosaminide N-acetyltransferase OS=Mus musculus OX=10090 GN=Hgsnat PE=1 SV=2,GO:0005765; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0043202; GO:0051259,heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765],acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019],GO:0003824; GO:0016740; GO:0030163; GO:0065003; GO:1901135,catalytic activity; transferase activity; protein catabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_10187,1.3679751650670415,FUN_043604-T1,Peve_00040380,Pocillopora_meandrina_HIv1___RNAseq.4608_t,three_way,88.10233333333333,FUN_043604-T1,P55008,AIF1_HUMAN,,Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1),Homo sapiens (Human),55.9,143.0,3.8000000000000004e-36,152.5,sp|P55008|AIF1_HUMAN Allograft inflammatory factor 1 OS=Homo sapiens OX=9606 GN=AIF1 PE=1 SV=1,GO:0001726; GO:0001774; GO:0001891; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0006911; GO:0006954; GO:0008284; GO:0010468; GO:0016601; GO:0030027; GO:0030041; GO:0030046; GO:0030335; GO:0032587; GO:0032722; GO:0032755; GO:0034599; GO:0042102; GO:0048471; GO:0048661; GO:0048662; GO:0050921; GO:0051015; GO:0051017; GO:0051764; GO:0071346; GO:0071672; GO:0071673; GO:0071677; GO:0090026; GO:0090271; GO:0097178; GO:0097386; GO:1900087; GO:2000406,"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; cellular response to type II interferon [GO:0071346]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; ruffle assembly [GO:0097178]",actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587],actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0002376; GO:0005634; GO:0005829; GO:0006954; GO:0008092; GO:0043226; GO:0061024; GO:0065003,immune system process; nucleus; cytosol; inflammatory response; cytoskeletal protein binding; organelle; membrane organization; protein-containing complex assembly
OG_10189,1.586298048217481,FUN_043608-T1,Peve_00040378,Pocillopora_meandrina_HIv1___RNAseq.g6946.t1,three_way,60.33733333333333,FUN_043608-T1,Q5TZ07,PLPP6_DANRE,,Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 (EC 3.1.3.-) (EC 3.6.1.-) (EC 3.6.1.68) (Phosphatidic acid phosphatase type 2 domain-containing protein 2) (Phospholipid phosphatase 6),Danio rerio (Zebrafish) (Brachydanio rerio),44.4,180.0,2.8e-34,147.1,sp|Q5TZ07|PLPP6_DANRE Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 OS=Danio rerio OX=7955 GN=plpp6 PE=2 SV=1,GO:0005637; GO:0005789; GO:0016020; GO:0018342; GO:0031965; GO:0033383; GO:0042392; GO:0045339; GO:0046839; GO:1902247,farnesyl diphosphate catabolic process [GO:0045339]; geranyl diphosphate metabolic process [GO:0033383]; geranylgeranyl diphosphate catabolic process [GO:1902247]; phospholipid dephosphorylation [GO:0046839]; protein prenylation [GO:0018342],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],sphingosine-1-phosphate phosphatase activity [GO:0042392],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_10190,2.4488362086968687,FUN_043609-T1,Peve_00040374,Pocillopora_meandrina_HIv1___TS.g684.t1,three_way,52.197833333333335,FUN_043609-T1,P0C6B8,,,,,28.0,1915.0,1.8e-253,879.0,"sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1",,,,,,
OG_10192,2.933677650318353,FUN_043612-T1,Peve_00040372,Pocillopora_meandrina_HIv1___RNAseq.4603_t,three_way,52.043,FUN_043612-T1,P48970,,,,,38.5,104.0,1.5e-19,98.6,sp|P48970|UNIV_STRPU Univin OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2,,,,,,
OG_10195,2.862894700526506,FUN_043619-T1,Peve_00008225,Pocillopora_meandrina_HIv1___RNAseq.g6932.t1,three_way,88.456,FUN_043619-T1,Q6DJ06,,,,,63.2,125.0,1e-48,194.5,sp|Q6DJ06|LMO42_XENTR LIM domain transcription factor LMO4.2 OS=Xenopus tropicalis OX=8364 GN=lmo4.2 PE=2 SV=1,,,,,,
OG_10196,2.42310951217751,FUN_043620-T1,Peve_00008227,Pocillopora_meandrina_HIv1___RNAseq.g6930.t1,three_way,51.489333333333335,,,,,,,,,,,,,,,,,
OG_10197,1.1819444603576788,FUN_043621-T1,Peve_00008231,Pocillopora_meandrina_HIv1___RNAseq.g6929.t1,three_way,80.29433333333333,,,,,,,,,,,,,,,,,
OG_10198,5.118739791937387,FUN_043622-T1,Peve_00008234,Pocillopora_meandrina_HIv1___RNAseq.g6927.t1,three_way,76.94266666666667,FUN_043622-T1,Q9VUX3,NOTUM_DROME,,Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (Protein Notum) (Protein wingful) (dNOTUM),Drosophila melanogaster (Fruit fly),28.2,347.0,8.8e-26,119.8,sp|Q9VUX3|NOTUM_DROME Palmitoleoyl-protein carboxylesterase NOTUM OS=Drosophila melanogaster OX=7227 GN=Notum PE=1 SV=3,GO:0005615; GO:0007419; GO:0009986; GO:0016055; GO:0035220; GO:0035222; GO:0045880; GO:0048076; GO:0048190; GO:0048546; GO:0090090; GO:1990697; GO:1990699,digestive tract morphogenesis [GO:0048546]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of smoothened signaling pathway [GO:0045880]; protein depalmitoleylation [GO:1990697]; regulation of compound eye pigmentation [GO:0048076]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; extracellular space [GO:0005615],palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005615; GO:0016787; GO:0030163; GO:0048856,catalytic activity; extracellular space; hydrolase activity; protein catabolic process; anatomical structure development
OG_10199,1.4110682380477095,FUN_043626-T1,Peve_00008236,Pocillopora_meandrina_HIv1___TS.g640.t1a,three_way,85.859,FUN_043626-T1,Q96J01,THOC3_HUMAN,,THO complex subunit 3 (Tho3) (TEX1 homolog) (hTREX45),Homo sapiens (Human),73.2,321.0,1e-147,524.2,sp|Q96J01|THOC3_HUMAN THO complex subunit 3 OS=Homo sapiens OX=9606 GN=THOC3 PE=1 SV=1,GO:0000346; GO:0000445; GO:0003723; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0016607,mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0006913; GO:0016071; GO:0043226,RNA binding; nucleoplasm; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_10200,3.2155650522719803,FUN_043628-T1,Peve_00008239,Pocillopora_meandrina_HIv1___TS.g640.t1b,three_way,64.35733333333333,FUN_043628-T1,Q504Y2,PKDCC_HUMAN,,"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)",Homo sapiens (Human),40.7,243.0,2.7e-47,190.3,sp|Q504Y2|PKDCC_HUMAN Extracellular tyrosine-protein kinase PKDCC OS=Homo sapiens OX=9606 GN=PKDCC PE=1 SV=2,GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021,bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672],GO:0003824; GO:0005576; GO:0005794; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular region; Golgi apparatus; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10201,1.2452563642872936,FUN_043629-T1,Peve_00008240,Pocillopora_meandrina_HIv1___RNAseq.g6901.t1,three_way,72.333,FUN_043629-T1,B2GUY0,MA1B1_RAT,,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Mannosidase alpha class 1B member 1)",Rattus norvegicus (Rat),48.4,674.0,2.1e-163,577.4,"sp|B2GUY0|MA1B1_RAT Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase OS=Rattus norvegicus OX=10116 GN=Man1b1 PE=2 SV=2",GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0006058; GO:0006486; GO:0016020; GO:0031410; GO:0036503; GO:0044322,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; mannoprotein catabolic process [GO:0006058]; protein glycosylation [GO:0006486],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005975; GO:0006486; GO:0016787; GO:0030163; GO:0031410; GO:0043226,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; protein glycosylation; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle
OG_10206,1.8851704020355224,FUN_043641-T1,Peve_00003065,Pocillopora_meandrina_HIv1___RNAseq.g7412.t1,three_way,54.37166666666667,,,,,,,,,,,,,,,,,
OG_10207,1.17588388863278,FUN_043642-T1,Peve_00041942,Pocillopora_meandrina_HIv1___RNAseq.g7410.t1,three_way,83.61566666666667,,,,,,,,,,,,,,,,,
OG_10209,1.0620859169881711,FUN_043644-T1,Peve_00034903,Pocillopora_meandrina_HIv1___RNAseq.g7405.t1,three_way,71.678,,,,,,,,,,,,,,,,,
OG_10214,1.3693741418478105,FUN_043658-T1,Peve_00044842,Pocillopora_meandrina_HIv1___RNAseq.g10606.t1,three_way,50.08533333333333,,,,,,,,,,,,,,,,,
OG_10222,1.3735343575617105,FUN_044275-T2,Peve_00026564,Pocillopora_meandrina_HIv1___TS.g27908.t1,three_way,73.819,FUN_044275-T2,Q9PT84,,,,,52.5,472.0,4.3e-137,490.0,sp|Q9PT84|KCNH6_CHICK Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Gallus gallus OX=9031 GN=KCNH6 PE=2 SV=2,,,,,,
